Citrus Sinensis ID: 003158
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 843 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGD7 | 953 | Probable LRR receptor-lik | yes | no | 0.992 | 0.878 | 0.714 | 0.0 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.981 | 0.862 | 0.530 | 0.0 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.971 | 0.874 | 0.527 | 0.0 | |
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.905 | 0.806 | 0.362 | 1e-112 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.924 | 0.668 | 0.290 | 2e-82 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.889 | 0.735 | 0.289 | 2e-74 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.334 | 0.332 | 0.481 | 1e-70 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.332 | 0.327 | 0.474 | 2e-68 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.345 | 0.353 | 0.447 | 6e-68 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.329 | 0.316 | 0.493 | 9e-68 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 1224 bits (3168), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/845 (71%), Positives = 713/845 (84%), Gaps = 8/845 (0%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPEELG+LP LDRIQID+N ISG LPKS
Sbjct: 115 MWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPEELGFLPNLDRIQIDENRISGPLPKS 174
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANLNKT+HFHMNNNSISGQIPPEL LPS+VH+LLDNNNL+GYLPPELS +P+LLILQL
Sbjct: 175 FANLNKTKHFHMNNNSISGQIPPELGSLPSIVHILLDNNNLSGYLPPELSNMPRLLILQL 234
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+PDLS IPNLGYLDLS NQLNGSIP G
Sbjct: 235 DNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVPDLSSIPNLGYLDLSQNQLNGSIPAG 294
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+LS +ITTI LSNN LTGTIP+NFSGLPRLQ+L +ANN+LSGSIPS IWQ R LN+TE+
Sbjct: 295 KLSDSITTIDLSNNSLTGTIPTNFSGLPRLQKLSLANNALSGSIPSRIWQERELNSTESI 354
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD-NEIDRSTNSTL 299
I+D +NN +NISG ++ PNVTV L+GNP C + N + CG +++D N+ ++N+T+
Sbjct: 355 IVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSDGNLLRLCGPITEEDINQGSTNSNTTI 414
Query: 300 DCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNL 359
CP YE+SP RCFCAAPLLVGYRLKSPG S F Y++ FE+Y+TSGL LNL
Sbjct: 415 ---CSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKSPGFSDFVPYRSEFEQYITSGLSLNL 471
Query: 360 YQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFG 419
YQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++FN SEV RIR MFTGWNI D D+FG
Sbjct: 472 YQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFIFNRSEVRRIRGMFTGWNIRDEDLFG 531
Query: 420 PYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNY 479
PYEL+NFTL YRDVFP + SG+S A+AGI+LG++A AVT++AI++L+I+R M+ Y
Sbjct: 532 PYELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVLGSVAAAVTLTAIIALIIMRKRMRGY 591
Query: 480 HAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVA 539
A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFNSSTQIGQGGYGKVYKG L GTVVA
Sbjct: 592 SAVARRKRSSKASLKIEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVA 651
Query: 540 VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 599
+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G+CDEEGEQMLVYE+M NGTLRD +S
Sbjct: 652 IKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNIS 711
Query: 600 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659
K KEPL FAMRL IALGS++GILYLHTEA+PP+FHRDIKASNILLD +FTAKVADFGLS
Sbjct: 712 VKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLS 771
Query: 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
RLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH+LTDKSDVYSLGVV LEL TGMQPI
Sbjct: 772 RLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPI 831
Query: 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
+HGKNIVRE+NIAY+S + S +D M S P EC+EKF LAL+CC++ETDARPSM+EV+
Sbjct: 832 THGKNIVREINIAYESGSILSTVDKRMSSVPDECLEKFATLALRCCREETDARPSMAEVV 891
Query: 780 RELESIWNMMPESDT-KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIP 838
RELE IW +MPES KT + T + S+SS++KH Y S DVSGS+LVSGV P
Sbjct: 892 RELEIIWELMPESHVAKTADL---SETMTHPSSSSNSSIMKHHYTSMDVSGSDLVSGVAP 948
Query: 839 TITPR 843
++ PR
Sbjct: 949 SVAPR 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 868 bits (2243), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/867 (53%), Positives = 604/867 (69%), Gaps = 40/867 (4%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN ++G IP E+GN+ L LLL+GN+LTGSLP+ELG L L +QID N ISG LP S
Sbjct: 109 MWNDLTGQIPPELGNLTHLIFLLLSGNQLTGSLPQELGSLSNLLILQIDYNEISGKLPTS 168
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
ANL K +HFHMNNNSI+GQIPPE S L +++H L+DNN LTG LPPEL+++P L ILQL
Sbjct: 169 LANLKKLKHFHMNNNSITGQIPPEYSTLTNVLHFLMDNNKLTGNLPPELAQMPSLRILQL 228
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
D +NF+GT IP+SY ++ L+KLSLRNC+L+GP+PDLS+ L YLD+SSN+L G IP
Sbjct: 229 DGSNFDGTEIPSSYGSIPNLVKLSLRNCNLEGPIPDLSKSLVLYYLDISSNKLTGEIPKN 288
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+ S NITTI L NN L+G+IPSNFSGLPRLQRL + NN+LSG IP IW++R L A E
Sbjct: 289 KFSANITTINLYNNLLSGSIPSNFSGLPRLQRLQVQNNNLSGEIP-VIWENRILKAEEKL 347
Query: 241 ILDFQNNNLTNISGS-FNIPPNVTVRLRGNPFCLNTNAEQ---FCG--SHSDDDNEIDRS 294
ILD +NN +N+S N P NVTV+L GNP C N NA + CG + +
Sbjct: 348 ILDLRNNMFSNVSSVLLNPPSNVTVKLYGNPVCANVNAGKLADLCGISTLEVESPATSSE 407
Query: 295 TNSTLDCRAQSCPT--DYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYK--NLFEEY 350
T ST DC+ QSCP +Y+Y SP+ CFCAAPL + RL+SP S F YK + +
Sbjct: 408 TISTGDCKRQSCPVSENYDYVIGSPVACFCAAPLGIDLRLRSPSFSDFRPYKVSYMLDVA 467
Query: 351 MTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGW 410
L +N YQ+ ID+F W+ GPRL M +K+FP Y S NS FN++EV RI F +
Sbjct: 468 SPKNLGINPYQISIDTFAWQSGPRLFMNMKIFPEY--SELNSK-FNSTEVQRIVDFFATF 524
Query: 411 NIPDSDIFGPYELINFTLQGPYRDV---FPPSRNSGISKAALAGIILGAIAGAVTISAIV 467
+ D GPYE+I+ G Y+DV FP + SG+S GII+GAIA + +S++
Sbjct: 525 TLNTDDSLGPYEIISIN-TGAYKDVTIIFP--KKSGMSIGVSVGIIIGAIAFFLVLSSLA 581
Query: 468 SLLIV----------RAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSST 517
+ + M+ H + K + ++ V+ + + E+ AT++F+ +
Sbjct: 582 LVFFIKRSKRKRKTREVDMEQEHPL------PKPPMNMESVKGYNFTELDSATSSFSDLS 635
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
QIG+GGYGKVYKG LP G VVAVKRA++GSLQG+KEF TEI+ LSRLHHRNLVSL+GYCD
Sbjct: 636 QIGRGGYGKVYKGHLPGGLVVAVKRAEQGSLQGQKEFFTEIELLSRLHHRNLVSLLGYCD 695
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
++GEQMLVYE+M NG+L+D LSA+ ++PL A+RL IALGS+RGILYLHTEADPP+ HRD
Sbjct: 696 QKGEQMLVYEYMPNGSLQDALSARFRQPLSLALRLRIALGSARGILYLHTEADPPIIHRD 755
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
IK SNILLD K KVADFG+S+L + D G+ HV+T+VKGTPGY+DPEY+L+H+LT
Sbjct: 756 IKPSNILLDSKMNPKVADFGISKLIAL-DGGGVQRDHVTTIVKGTPGYVDPEYYLSHRLT 814
Query: 698 DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 757
+KSDVYSLG+VFLE+LTGM+PISHG+NIVREVN A + MM SVID +MG Y ECV++F
Sbjct: 815 EKSDVYSLGIVFLEILTGMRPISHGRNIVREVNEACDAGMMMSVIDRSMGQYSEECVKRF 874
Query: 758 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817
++LA++CCQD +ARP M E++RELE+I+ ++P+ + P S +S + +
Sbjct: 875 MELAIRCCQDNPEARPWMLEIVRELENIYGLIPKEE--KPYSSPSVQSSASGMSGFAVAS 932
Query: 818 LKHPYVS-SDVSGSNLVSGVIPTITPR 843
+ Y + S+ + + LVSGVIP+I PR
Sbjct: 933 PRSSYTTFSEFTANQLVSGVIPSIAPR 959
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 825 bits (2130), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/851 (52%), Positives = 563/851 (66%), Gaps = 32/851 (3%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN ++G IP EIG I SL+LLLLNGN+ TGSLP ELG L L+R+Q+D+N I+GS+P S
Sbjct: 111 MWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNLNRLQVDENNITGSVPFS 170
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
F NL +H H+NNN+ISG+IP ELS+LP LVHM+LDNNNLTG LP EL++LP L ILQL
Sbjct: 171 FGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTGTLPLELAQLPSLTILQL 230
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNNNFEG+TIP +Y + S+L+KLSLRNC LQG +PDLSRI NL YLDLS N L G+IP
Sbjct: 231 DNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENLSYLDLSWNHLTGTIPES 290
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+LS N+TTI+LS N LTG+IP +FS L LQ L + NNSLSGS+P+ IWQ ++ +
Sbjct: 291 KLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGSVPTEIWQDKSFENNKLQ 350
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNA-------EQFCGSHSDDDNEIDR 293
+ D NNN ++ +G+ P NVT+ LRGNP C +T+ E CG
Sbjct: 351 VYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQFFEYICGEKKQT------ 403
Query: 294 STNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAY-KNLFEEYMT 352
STNS C SCP +E SP C C APL + YRLKSP +F Y + F EY+T
Sbjct: 404 STNSNTPCSNVSCP--FENVKVSPGICLCTAPLSIDYRLKSPSFFFFTPYIERQFREYIT 461
Query: 353 SGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNI 412
S L+L +QL ID E R +MYLKL P FN SEV RIR F W+
Sbjct: 462 SSLQLETHQLAIDRLVDENRLRPRMYLKLVP------KGRITFNKSEVIRIRDRFMSWSF 515
Query: 413 PDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIV 472
+D FGPYEL++F LQGPY D+ ++ SGI I+ G++ A +S +LL V
Sbjct: 516 NKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAGSVVAATVLSVTATLLYV 573
Query: 473 RAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL 532
R +N H ++++R S +I GV+ F++ E++ ATN F+SST IG+G YGKVYKGIL
Sbjct: 574 RKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDSSTLIGRGSYGKVYKGIL 633
Query: 533 PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 592
+ T VA+KR +E SLQ EKEFL EI LSRLHHRNLVSL+GY + GEQMLVYE+M NG
Sbjct: 634 SNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNG 693
Query: 593 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 652
+RD LSA + + L F+MR +ALGS++GILYLHTEA+PPV HRDIK SNILLD + AK
Sbjct: 694 NVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIKTSNILLDCQLHAK 753
Query: 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 712
VADFGLSRLAP PAHVSTVV+GTPGYLDPEYF+T +LT +SDVYS GVV LEL
Sbjct: 754 VADFGLSRLAPAFGEGDGEPAHVSTVVRGTPGYLDPEYFMTQQLTVRSDVYSFGVVLLEL 813
Query: 713 LTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR 772
LTGM P G +I+REV A + + SV D MG + V+K +LAL CC+D + R
Sbjct: 814 LTGMHPFFEGTHIIREVRTANECGTVLSVADSRMGQCSPDKVKKLAELALWCCEDRPETR 873
Query: 773 PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 832
P MS+V++ELE I + E PE + T+K +S S P S + GSNL
Sbjct: 874 PPMSKVVKELEGICQSVRE-----PEMFS--ETTKLLCSKTSPSSSSVPSPLSLLPGSNL 926
Query: 833 VSGVIPTITPR 843
SG + PR
Sbjct: 927 DSGFFHAVKPR 937
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1044), Expect = e-112, Method: Compositional matrix adjust.
Identities = 302/834 (36%), Positives = 453/834 (54%), Gaps = 71/834 (8%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
M +G IP IGN++ L L LN N+ +G++P +G L KL I N + G LP S
Sbjct: 125 MGCAFNGPIPDSIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVS 184
Query: 61 -------FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSEL 112
L +T HFH NN +SG+IP +L S +L+H+L D N TG +P L +
Sbjct: 185 DGASLPGLDMLLQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLV 244
Query: 113 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 172
L +L+LD N G IP+S +N++ L +L L + G +P+L+ + +L LD+S+N
Sbjct: 245 QNLTVLRLDRNRLSGD-IPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNP 303
Query: 173 LNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 230
L S P + +++T++L + +L G +P++ +LQ + + +N ++ ++
Sbjct: 304 LALSPVPSWIPFLNSLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNY 363
Query: 231 SRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNE 290
S+ L+ +D ++N +T N P V V L N C + A Q G N
Sbjct: 364 SKQLD-----FVDLRDNFITGYKSPANNP--VNVMLADNQVCQDP-ANQLSGYC----NA 411
Query: 291 ID-RSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--F 347
+ ST STL C E + C C PL + L+SP S F N F
Sbjct: 412 VQPNSTFSTLTKCGNHCGKGKEPNQG----CHCVYPLTGVFTLRSPSFSGFSNNSNFLKF 467
Query: 348 EEYMTSGLKLNLYQLDIDSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRI 403
E + + K Y +D + R + P L + L +FP SG FN +E+ I
Sbjct: 468 GESLMTFFKNGKYPVDSVAMRNISENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSI 521
Query: 404 RSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTI 463
S FT + FGPY + Y+ F +S + ++ + + +
Sbjct: 522 NSAFTIQDYKPPPRFGPYIFV----ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLL 576
Query: 464 SAIVSLLIVRAHMKNYHAISRRRHSSKTSI--------KIDGVRSFTYGEMALATNNFNS 515
A+ + +R + A + +K ++ G ++FT+ E++ TNNF+
Sbjct: 577 LALAGIYALRQKKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSD 636
Query: 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
+ +G GGYG+VYKG LP+G V+A+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+
Sbjct: 637 ANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGF 696
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
C ++ EQMLVYE++ NG+LRD LS K+ L + RL IALGS +G+ YLH ADPP+ H
Sbjct: 697 CFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIH 756
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
RD+K++NILLD TAKVADFGLS+L P+ AHV+T VKGT GYLDPEY++T++
Sbjct: 757 RDVKSNNILLDEHLTAKVADFGLSKLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQ 811
Query: 696 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV--------NIAYQSSMMFSVIDGNMG 747
LT+KSDVY GVV LELLTG PI G +V+EV N+ ++ + I N G
Sbjct: 812 LTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQNSG 871
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM---PESDTKTPE 798
+ + EK++ +AL+C + E RP+MSEV++ELESI ++ P +D+ T E
Sbjct: 872 NL--KGFEKYVDVALQCVEPEGVNRPTMSEVVQELESILRLVGLNPNADSATYE 923
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 267/920 (29%), Positives = 418/920 (45%), Gaps = 141/920 (15%)
Query: 3 NKISGSIPKEIGNI-KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKS 60
N++SG IP E+ + K+L +L L+GN +G LP + L + + NY+SG L
Sbjct: 287 NRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNYLSGDFLNTV 346
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ- 119
+ + + ++ N+ISG +P L+ +L + L +N TG +P L +L+
Sbjct: 347 VSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEK 406
Query: 120 -LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSI 177
L NN+ T+P L + L L GP+P ++ +PNL L + +N L G+I
Sbjct: 407 ILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGTI 466
Query: 178 PPGRL--------------------------SLNITTIKLSNNKLTGTIPSNFSGLPRLQ 211
P G N+ I LS+N+LTG IPS L +L
Sbjct: 467 PEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLA 526
Query: 212 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-NISGSFNIPPNV----TVRL 266
L + NNSLSG++P + ++L LD +NNLT ++ G + +V
Sbjct: 527 ILQLGNNSLSGNVPRQLGNCKSL-----IWLDLNSNNLTGDLPGELASQAGLVMPGSVSG 581
Query: 267 RGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPL 326
+ F N G+ + E R+ SCP YS + + F A
Sbjct: 582 KQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGMT-MYTFSANGS 640
Query: 327 LVGYRLKSPGLSYF--PAYKNLFEEYMTSGLKLNLYQLDI-----DSFRWEKGPRLKMYL 379
++ + + +S F P Y N+ Y+ LNL I DSF L
Sbjct: 641 MIYFDISYNAVSGFIPPGYGNM--GYLQV---LNLGHNRITGTIPDSFGG---------L 686
Query: 380 KLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPS 439
K V D S N + +G + S + ++ ++++ GP G FP S
Sbjct: 687 KAIGVLDLSHNNLQGYLPGSLGSL-SFLSDLDVSNNNLTGPIPF------GGQLTTFPVS 739
Query: 440 R---NSGIS----------------------KAALAGIILGAIAGAVTISAIVSLLIVRA 474
R NSG+ K +A ++ IA + ++ + + R
Sbjct: 740 RYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRV 799
Query: 475 HMKNYHAISRRRH------SSKTSIKIDGV---------------RSFTYGEMALATNNF 513
R ++ S S K+ V R T+ + ATN F
Sbjct: 800 RKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGF 859
Query: 514 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
++ T +G GG+G+VYK L DG+VVA+K+ + QG++EF+ E++ + ++ HRNLV L+
Sbjct: 860 SAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLL 919
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP----LGFAMRLSIALGSSRGILYLHTEA 629
GYC E++LVYE+M G+L L KS + L +A R IA+G++RG+ +LH
Sbjct: 920 GYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSC 979
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGYLDP 688
P + HRD+K+SN+LLD F A+V+DFG++RL D H+S + + GTPGY+ P
Sbjct: 980 IPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALD------THLSVSTLAGTPGYVPP 1033
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK-----NIVREVNIAYQSSMMFSVID 743
EY+ + + T K DVYS GV+ LELL+G +PI G+ N+V Y+ ++D
Sbjct: 1034 EYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILD 1093
Query: 744 GNMGSYPSECVEKF--IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFIN 801
+ + S VE F +K+A +C D RP+M ++M M E T E +
Sbjct: 1094 PELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQLMA-------MFKEMKADTEEDES 1146
Query: 802 SEHTSKEETPPSSSSMLKHP 821
+ S +ETP S K P
Sbjct: 1147 LDEFSLKETPLVEESRDKEP 1166
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (718), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 241/832 (28%), Positives = 384/832 (46%), Gaps = 82/832 (9%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N+ISGSIPKE+GN+ +L L+L N+L+G +P ELG LP L R+ + N +SG +P +FA
Sbjct: 144 NRISGSIPKELGNLTTLSGLVLEYNQLSGKIPPELGNLPNLKRLLLSSNNLSGEIPSTFA 203
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
L +++N +G IP + L +++ + L G +P + L L L++ +
Sbjct: 204 KLTTLTDLRISDNQFTGAIPDFIQNWKGLEKLVIQASGLVGPIPSAIGLLGTLTDLRITD 263
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP------------DLS------------ 158
+ + P NM+ + L LRNC+L G +P DLS
Sbjct: 264 LSGPESPFPP-LRNMTSMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIPATY 322
Query: 159 -RIPNLGYLDLSSNQLNGSIPPGRL----SLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 213
+ ++ ++ +SN LNG +P + +++IT S +K + + L
Sbjct: 323 SGLSDVDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNFSKDKTEECQQKSVNTFSSTSPL 382
Query: 214 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 273
+ANNS + S S +T ++ N +T+ ++ T G
Sbjct: 383 -VANNSSNVSCLSKYTCPKTFYGLH---INCGGNEITSNETKYDAD---TWDTPGYYDSK 435
Query: 274 NTNAEQFCGSHSDDDNEID-----------RSTNSTLDCRAQSCPTDYEYSPTSPIRCFC 322
N G+ DDD + + TNS++D R + S T C
Sbjct: 436 NGWVSSNTGNFLDDDRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLG 495
Query: 323 AAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLF 382
V + Y NL Y ++ D + KG K +K F
Sbjct: 496 KGNYTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVG-KAVVKKF 554
Query: 383 PVYDNSSGNSYVFNASEVGRIRSMFTGWN-IPDSDIFGPYELINFTLQGPYRDVFPPSRN 441
PV V N R++ G IP ++GP LI+ P D PP
Sbjct: 555 PVM--------VTNGKLEIRLQWAGKGTQAIPVRGVYGP--LISAVSVDP--DFIPPKE- 601
Query: 442 SGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIK-ID-GVR 499
G I++ V L+++ + + R + + K +D +
Sbjct: 602 ---PGTGTGGGSSVGTVVGSVIASTVFLVLLIGGILWWRGCLRPKSQMEKDFKNLDFQIS 658
Query: 500 SFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 559
SF+ ++ +AT+NF+ + +IG+GG+G V+KGI+ DGTV+AVK+ S QG +EFL EI
Sbjct: 659 SFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIA 718
Query: 560 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALG 617
+S L H +LV L G C E + +LVYE++ N +L L +++ PL + MR I +G
Sbjct: 719 MISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVG 778
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
+RG+ YLH E+ + HRDIKA+N+LLD + K++DFGL++L + H+ST
Sbjct: 779 IARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEEN------THIST 832
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIA 732
V GT GY+ PEY + LTDK+DVYS GVV LE++ G S ++ V++
Sbjct: 833 RVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVL 892
Query: 733 YQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
+ + + V+D +G+ Y + I++ + C RPSMS V+ LE
Sbjct: 893 REQNTLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLE 944
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 141/293 (48%), Positives = 187/293 (63%), Gaps = 11/293 (3%)
Query: 499 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 558
R FT E+ AT NF+ IG GG+GKVY+G L DGT++A+KRA S QG EF TEI
Sbjct: 506 RKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEI 565
Query: 559 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 618
LSRL HR+LVSL+G+CDE E +LVYE+M+NGTLR L + PL + RL +GS
Sbjct: 566 VMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGS 625
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 678
+RG+ YLHT ++ + HRD+K +NILLD F AK++DFGLS+ P D HVST
Sbjct: 626 ARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMD-----HTHVSTA 680
Query: 679 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS----HGKNIVREVNIAYQ 734
VKG+ GYLDPEYF +LT+KSDVYS GVV E + I+ + + E +++Q
Sbjct: 681 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQ 740
Query: 735 SSM-MFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ S+ID N+ G+Y E +EK+ ++A KC DE RP M EV+ LE +
Sbjct: 741 KQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYV 793
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 138/291 (47%), Positives = 184/291 (63%), Gaps = 11/291 (3%)
Query: 499 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 558
R F + E+ ATN F+ S+ +G GG+G+VYKG L DGT VAVKR S QG EF TEI
Sbjct: 496 RCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEI 555
Query: 559 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 618
+ LS+L HR+LVSL+GYCDE E +LVYE+M+NG LR L PL + RL I +G+
Sbjct: 556 EMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGA 615
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 678
+RG+ YLHT A + HRD+K +NILLD AKVADFGLS+ P D HVST
Sbjct: 616 ARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLD-----QTHVSTA 670
Query: 679 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT---GMQPISHGKNI-VREVNIAYQ 734
VKG+ GYLDPEYF +LT+KSDVYS GVV +E+L + P+ + + + E +A+Q
Sbjct: 671 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQ 730
Query: 735 SS-MMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
++ ++D N+ G ++KF + A KC + RPSM +V+ LE
Sbjct: 731 KKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLE 781
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 6e-68, Method: Compositional matrix adjust.
Identities = 136/304 (44%), Positives = 186/304 (61%), Gaps = 13/304 (4%)
Query: 502 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFL 561
++ E+ TNNF+ S IG GG+G V++G L D T VAVKR GS QG EFL+EI L
Sbjct: 478 SFAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITIL 537
Query: 562 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 621
S++ HR+LVSLVGYC+E+ E +LVYE+M G L+ L + PL + RL + +G++RG
Sbjct: 538 SKIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARG 597
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+ YLHT + + HRDIK++NILLD+ + AKVADFGLSR P D HVST VKG
Sbjct: 598 LHYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCID-----ETHVSTGVKG 652
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------YQS 735
+ GYLDPEYF +LTDKSDVYS GVV E+L +P + +VN+A +
Sbjct: 653 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RPAVDPLLVREQVNLAEWAIEWQRK 711
Query: 736 SMMFSVIDGNMGSYPSEC-VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 794
M+ ++D N+ C ++KF + A KCC D RP++ +V+ LE + +
Sbjct: 712 GMLDQIVDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPL 771
Query: 795 KTPE 798
PE
Sbjct: 772 NIPE 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (661), Expect = 9e-68, Method: Compositional matrix adjust.
Identities = 144/292 (49%), Positives = 184/292 (63%), Gaps = 14/292 (4%)
Query: 499 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEI 558
R F+ E+ AT NF +S IG GG+G VY G L DGT VAVKR S QG EF TEI
Sbjct: 512 RYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEI 571
Query: 559 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS 618
Q LS+L HR+LVSL+GYCDE E +LVYEFMSNG RD L K+ PL + RL I +GS
Sbjct: 572 QMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGS 631
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 678
+RG+ YLHT + HRD+K++NILLD AKVADFGLS+ D+ HVST
Sbjct: 632 ARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-----DV-AFGQNHVSTA 685
Query: 679 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------ 732
VKG+ GYLDPEYF +LTDKSDVYS GVV LE L +P + + +VN+A
Sbjct: 686 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCA-RPAINPQLPREQVNLAEWAMQW 744
Query: 733 YQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
+ ++ +ID ++ G+ E ++KF + A KC +D RP+M +V+ LE
Sbjct: 745 KRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLE 796
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 843 | ||||||
| 225434309 | 959 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.873 | 0.766 | 0.0 | |
| 297745743 | 960 | unnamed protein product [Vitis vinifera] | 0.995 | 0.873 | 0.754 | 0.0 | |
| 297848960 | 941 | predicted protein [Arabidopsis lyrata su | 0.994 | 0.890 | 0.722 | 0.0 | |
| 357460549 | 955 | hypothetical protein MTR_3g062590 [Medic | 0.989 | 0.873 | 0.713 | 0.0 | |
| 224124832 | 926 | predicted protein [Populus trichocarpa] | 0.996 | 0.907 | 0.715 | 0.0 | |
| 334182352 | 953 | putative leucine-rich repeat transmembra | 0.992 | 0.878 | 0.714 | 0.0 | |
| 356569432 | 953 | PREDICTED: probable LRR receptor-like se | 0.990 | 0.876 | 0.704 | 0.0 | |
| 224146594 | 865 | predicted protein [Populus trichocarpa] | 0.967 | 0.943 | 0.725 | 0.0 | |
| 356537716 | 954 | PREDICTED: probable LRR receptor-like se | 0.991 | 0.876 | 0.700 | 0.0 | |
| 449439195 | 952 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.879 | 0.695 | 0.0 |
| >gi|225434309|ref|XP_002276020.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1307 bits (3382), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 647/844 (76%), Positives = 725/844 (85%), Gaps = 6/844 (0%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN I+GSIPKEIGNI +LELLLLNGN+LTGSLPEELG LP LDRIQIDQN ISGS+P+S
Sbjct: 121 MWNNITGSIPKEIGNITTLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRS 180
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANLNKT+HFHMNNNSISGQIP ELSRLP LVH LLDNNNL+GYLPPE SE+PKLLI+QL
Sbjct: 181 FANLNKTKHFHMNNNSISGQIPSELSRLPELVHFLLDNNNLSGYLPPEFSEMPKLLIVQL 240
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNN+F G+ IPASYSNMSKLLKLSLRNCSLQG +P+LS+IP LGYLDLSSNQLNG+IPPG
Sbjct: 241 DNNHFNGS-IPASYSNMSKLLKLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPG 299
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
R S NITTI LSNN LTGTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+
Sbjct: 300 RFSENITTIDLSNNNLTGTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETY 359
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLD 300
++DFQNN+L+NISG+ ++P NVTVRL GNP C N + QFCGS S+++N+ NST+D
Sbjct: 360 VVDFQNNDLSNISGTLDLPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVD 419
Query: 301 CRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLY 360
C A CP YE SP S C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL
Sbjct: 420 CTAVRCPLYYEISPASLEICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLD 479
Query: 361 QLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGP 420
QL IDS WEKGPRLKMY KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGP
Sbjct: 480 QLKIDSVEWEKGPRLKMYFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGP 536
Query: 421 YELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYH 480
YELINFTL Y+DV S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH
Sbjct: 537 YELINFTLTDIYKDVIGSSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYH 596
Query: 481 AISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAV 540
ISRRR S++ SIKIDGV+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+
Sbjct: 597 TISRRRKSTRISIKIDGVKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAI 656
Query: 541 KRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS- 599
KRAQEGSLQG+KEF TEI+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LS
Sbjct: 657 KRAQEGSLQGQKEFFTEIELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSA 716
Query: 600 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659
AKSKEPL FAMRLSIALGSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLS
Sbjct: 717 AKSKEPLSFAMRLSIALGSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLS 776
Query: 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
RLAPVPDIEG PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PI
Sbjct: 777 RLAPVPDIEGSTPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPI 836
Query: 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
SHGKNIVREVN++YQS M+FSVID MGSYPSECVEKF+KLALKCCQ++TDARPSM++V+
Sbjct: 837 SHGKNIVREVNVSYQSGMIFSVIDNRMGSYPSECVEKFVKLALKCCQEDTDARPSMAQVV 896
Query: 780 RELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPT 839
RELE+IW MMPESDTKT E + +E K +PPSSS+ K+PYVSSD+SGS LVSGV+PT
Sbjct: 897 RELENIWLMMPESDTKTTESLITE-PGKLISPPSSSTPTKNPYVSSDISGSELVSGVVPT 955
Query: 840 ITPR 843
I PR
Sbjct: 956 IAPR 959
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745743|emb|CBI15799.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1288 bits (3332), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/844 (75%), Positives = 716/844 (84%), Gaps = 5/844 (0%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN I+GSIPKEIGNI +LELLLLNGN+LTGSLPEELG LP LDRIQIDQN ISGS+P+S
Sbjct: 121 MWNNITGSIPKEIGNITTLELLLLNGNKLTGSLPEELGNLPNLDRIQIDQNQISGSIPRS 180
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANLNKT+HFHMNNNSISGQIP ELSRLP LVH LLDNNNL+GYLPPE SE+PKLLI+QL
Sbjct: 181 FANLNKTKHFHMNNNSISGQIPSELSRLPELVHFLLDNNNLSGYLPPEFSEMPKLLIVQL 240
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNN+F GT + S L+ LSLRNCSLQG +P+LS+IP LGYLDLSSNQLNG+IPPG
Sbjct: 241 DNNHFNGTFFLPKLQSRSMLMNLSLRNCSLQGEIPNLSKIPYLGYLDLSSNQLNGTIPPG 300
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
R S NITTI LSNN LTGTIP+NFSGLP LQ+L + NNSLSG++ SSIWQ+RT N ET+
Sbjct: 301 RFSENITTIDLSNNNLTGTIPANFSGLPHLQKLSLENNSLSGTVSSSIWQNRTSNGNETY 360
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLD 300
++DFQNN+L+NISG+ ++P NVTVRL GNP C N + QFCGS S+++N+ NST+D
Sbjct: 361 VVDFQNNDLSNISGTLDLPLNVTVRLYGNPLCTNESLVQFCGSQSEEENDTLNPVNSTVD 420
Query: 301 CRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLY 360
C A CP YE SP S C CAAPLLVGYRLKSPG S F AY+N+FE Y+TSGL LNL
Sbjct: 421 CTAVRCPLYYEISPASLEICLCAAPLLVGYRLKSPGFSNFLAYQNMFEYYLTSGLSLNLD 480
Query: 361 QLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGP 420
QL IDS WEKGPRLKMY KLFP + NS FN+SEV RIR MFTGWNIPDSD+FGP
Sbjct: 481 QLKIDSVEWEKGPRLKMYFKLFP---DDVNNSSEFNSSEVLRIRGMFTGWNIPDSDVFGP 537
Query: 421 YELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYH 480
YELINFTL Y+DV S +SGIS AL GIILG IA AVT+SAIV LLI++ +K YH
Sbjct: 538 YELINFTLTDIYKDVIGSSSSSGISTGALVGIILGTIAVAVTLSAIVFLLILKNRLKKYH 597
Query: 481 AISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAV 540
ISRRR S++ SIKIDGV+ FTYGEMALATNNFN S ++GQGGYGKVYKGIL DGTVVA+
Sbjct: 598 TISRRRKSTRISIKIDGVKDFTYGEMALATNNFNDSAEVGQGGYGKVYKGILADGTVVAI 657
Query: 541 KRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS- 599
KRAQEGSLQG+KEF TEI+ LSR+HHRNLVSL+GYCDEEGEQMLVYEFM NGTLRD LS
Sbjct: 658 KRAQEGSLQGQKEFFTEIELLSRVHHRNLVSLIGYCDEEGEQMLVYEFMPNGTLRDHLSA 717
Query: 600 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659
AKSKEPL FAMRLSIALGSS+GILYLHTEA+PP+FHRD+KASNILLD KF AKVADFGLS
Sbjct: 718 AKSKEPLSFAMRLSIALGSSKGILYLHTEANPPIFHRDVKASNILLDSKFIAKVADFGLS 777
Query: 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
RLAPVPDIEG PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PI
Sbjct: 778 RLAPVPDIEGSTPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPI 837
Query: 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
SHGKNIVREVN++YQS M+FSVID MGSYPSECVEKF+KLALKCCQ++TDARPSM++V+
Sbjct: 838 SHGKNIVREVNVSYQSGMIFSVIDNRMGSYPSECVEKFVKLALKCCQEDTDARPSMAQVV 897
Query: 780 RELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPT 839
RELE+IW MMPESDTKT E + +E K +PPSSS+ K+PYVSSD+SGS LVSGV+PT
Sbjct: 898 RELENIWLMMPESDTKTTESLITE-PGKLISPPSSSTPTKNPYVSSDISGSELVSGVVPT 956
Query: 840 ITPR 843
I PR
Sbjct: 957 IAPR 960
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297848960|ref|XP_002892361.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297338203|gb|EFH68620.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1230 bits (3183), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 611/846 (72%), Positives = 717/846 (84%), Gaps = 8/846 (0%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPEELG+LP LDRIQID+N ISG LPKS
Sbjct: 101 MWNKITGSIPKEIGNIKSLELLLLNGNLLIGNLPEELGFLPNLDRIQIDENRISGPLPKS 160
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANLNKT+HFHMNNNSISGQIPPE+ LPS+VH+LLDNNNL+GYLPPELS +P LLILQL
Sbjct: 161 FANLNKTKHFHMNNNSISGQIPPEIGSLPSIVHILLDNNNLSGYLPPELSNMPHLLILQL 220
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+PDLS IPNLGYLDLS NQLNGSIP G
Sbjct: 221 DNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVPDLSSIPNLGYLDLSQNQLNGSIPTG 280
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+LS NITTI LS+N LTGTIP+NFSGLPRLQ+L +ANN+LSGSIPS IWQ R LN+TE+
Sbjct: 281 KLSDNITTIDLSSNSLTGTIPTNFSGLPRLQKLSLANNALSGSIPSRIWQERELNSTESI 340
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD-NEIDRSTNS-T 298
I+D +NN +NISG ++ PNVTV L+GNP C + N + CG +++D N+ STNS T
Sbjct: 341 IVDLRNNRFSNISGRSDLRPNVTVWLQGNPLCSDGNLLRLCGPITEEDINQGQGSTNSYT 400
Query: 299 LDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLN 358
C CP YE+SP RCFCAAPLLVGYRLKSPG S F Y++ FEEY+TSGL LN
Sbjct: 401 TTC--SDCPPPYEFSPEPLRRCFCAAPLLVGYRLKSPGFSDFVPYRSEFEEYITSGLSLN 458
Query: 359 LYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIF 418
LYQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++FN SEV RIR MFTGWNI D D+F
Sbjct: 459 LYQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFIFNRSEVRRIRGMFTGWNIRDEDLF 518
Query: 419 GPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKN 478
GPYEL+NFTL YRDVFP + SG+SK A+AGI+LG++A AVT++AI++L+I+R M+
Sbjct: 519 GPYELMNFTLLDVYRDVFPSASPSGLSKGAVAGIVLGSVAAAVTLTAIIALIIMRKRMRG 578
Query: 479 YHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVV 538
Y+A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFNSSTQIGQGGYGKVYKG L GTVV
Sbjct: 579 YNAVARRKRSSKASLKIEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVV 638
Query: 539 AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 598
A+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G+CDEEGEQMLVYE+M NGTLRD +
Sbjct: 639 AIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNI 698
Query: 599 SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658
S K KEPL FAMRL IALGS++GILYLHTEA+PP+FHRDIKASNILLD +FTAKVADFGL
Sbjct: 699 SVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGL 758
Query: 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
SRLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH+LTDKSDVYSLGVVFLELLTGMQP
Sbjct: 759 SRLAPVPDMEGISPHHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVFLELLTGMQP 818
Query: 719 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV 778
I+HGKNIVRE+NIAY+S + S +D M S P EC+EKF LAL+CC++ETDARPSM+EV
Sbjct: 819 ITHGKNIVREINIAYESGSILSAVDKRMSSVPDECLEKFATLALRCCREETDARPSMAEV 878
Query: 779 MRELESIWNMMPESDT-KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVI 837
+RELE IW +MPES KT + T + S+SS++KHPY S DVSGS+LVSG+
Sbjct: 879 VRELEIIWELMPESHVAKTADL---SETMTHPSSSSNSSIMKHPYTSMDVSGSDLVSGIA 935
Query: 838 PTITPR 843
P++ PR
Sbjct: 936 PSVAPR 941
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357460549|ref|XP_003600556.1| hypothetical protein MTR_3g062590 [Medicago truncatula] gi|355489604|gb|AES70807.1| hypothetical protein MTR_3g062590 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1230 bits (3183), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/847 (71%), Positives = 708/847 (83%), Gaps = 13/847 (1%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWNKI+GSIPKEIGNIKSL LLLLNGN+LTGSLPEELG+LPKLDRIQIDQN ISG LPKS
Sbjct: 118 MWNKITGSIPKEIGNIKSLFLLLLNGNQLTGSLPEELGFLPKLDRIQIDQNNISGPLPKS 177
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANLNKT+HFHMNNNSISGQIPPEL+RLPSLVH LLDNNNL+GYLPP+LS+LP LLILQL
Sbjct: 178 FANLNKTKHFHMNNNSISGQIPPELARLPSLVHFLLDNNNLSGYLPPQLSQLPNLLILQL 237
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNNNFEG +IP +YS+MSKLLKLSL+NC+LQGP+PDLSRIP+L YLDLSSNQLN S+P
Sbjct: 238 DNNNFEGNSIPDTYSDMSKLLKLSLKNCNLQGPIPDLSRIPHLLYLDLSSNQLNESLP-S 296
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+L+ NITTI LSNN+LTG IPS+FS L +LQRL +ANNSL+GS+PS+IWQ + LN +E F
Sbjct: 297 KLAENITTIDLSNNQLTGNIPSSFSSLSKLQRLSLANNSLNGSVPSTIWQDKKLNGSERF 356
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLD 300
IL+ +NN T +SGS ++P VTV LRGNP C N Q C S ++ ++ TN+
Sbjct: 357 ILELENNQFTTVSGSTDLPSKVTVLLRGNPLCSNNTLSQLCSSEGVNNTDVLVPTNNNGS 416
Query: 301 CRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLY 360
C QSCP YE+S + CFCAAPLLVGYRLKSPG S F +KN FEEY+T+GL +N+
Sbjct: 417 CLVQSCPPPYEFS----LDCFCAAPLLVGYRLKSPGFSDFLPFKNEFEEYLTTGLSINIS 472
Query: 361 QLDIDSFRWEKGPRLKMYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFG 419
QL+ +FRW GPRL+M LK FP+Y D++S S+ FN +EV RIRSMFTGWNIPDSD+FG
Sbjct: 473 QLNF-TFRWVAGPRLRMDLKFFPLYVDHNS--SHTFNETEVQRIRSMFTGWNIPDSDLFG 529
Query: 420 PYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNY 479
PYELINF + G Y++ S SGIS A+ GI+LGAIA AVT+SAIV+LLI+R +K+Y
Sbjct: 530 PYELINFNM-GLYQNATSTSSKSGISTGAIVGIVLGAIACAVTLSAIVTLLILRTKLKDY 588
Query: 480 HAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVA 539
HA+S+RRH SK IK+DGVRSFTY E++ ATNNF+SS Q+GQGGYGKVYKG++ GT VA
Sbjct: 589 HAVSKRRHVSKIKIKMDGVRSFTYEELSSATNNFSSSAQVGQGGYGKVYKGVISGGTAVA 648
Query: 540 VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 599
+KRAQEGSLQGEKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYE+M NGTLRD LS
Sbjct: 649 IKRAQEGSLQGEKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEYMPNGTLRDHLS 708
Query: 600 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659
+KEPL F MRL IALGS++G++YLH EADPP+FHRD+KASNILLD K +AKVADFGLS
Sbjct: 709 VSAKEPLTFIMRLKIALGSAKGLMYLHNEADPPIFHRDVKASNILLDSKLSAKVADFGLS 768
Query: 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
RLAPVPD+EGIVP HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE+LTGM PI
Sbjct: 769 RLAPVPDMEGIVPGHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEILTGMHPI 828
Query: 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
SHGKNIVREVN++YQS ++FS+ID MGSYPSE VEKF+ LALKC DE D RP+M+EV+
Sbjct: 829 SHGKNIVREVNLSYQSGVIFSIIDERMGSYPSEHVEKFLTLALKCVNDEPDNRPTMAEVV 888
Query: 780 RELESIWNMMPESDTKTPEFINS---EHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGV 836
RELE+IWN+MPESDT+ E I S +SK + PSSSS ++ +VS DVSGS+LVSGV
Sbjct: 889 RELENIWNVMPESDTRRAESITSGSVSDSSKAMSTPSSSSAIRTAFVSGDVSGSDLVSGV 948
Query: 837 IPTITPR 843
IP+I PR
Sbjct: 949 IPSIKPR 955
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124832|ref|XP_002319433.1| predicted protein [Populus trichocarpa] gi|222857809|gb|EEE95356.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1227 bits (3175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/844 (71%), Positives = 703/844 (83%), Gaps = 4/844 (0%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN I+GSIP EIGNIKSLELLLLNGN+LTG LPEELG LPKLDRIQIDQN+ISG +PKS
Sbjct: 86 MWNSITGSIPPEIGNIKSLELLLLNGNQLTGPLPEELGNLPKLDRIQIDQNHISGPIPKS 145
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FA LN T+HFHMNNNSISGQIP ELSRLP+LVH LLDNNNL+G LPP+L +LPKLLILQL
Sbjct: 146 FAYLNSTKHFHMNNNSISGQIPAELSRLPNLVHFLLDNNNLSGTLPPDLYKLPKLLILQL 205
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNN F+G+TIP SY NM++LLKLSLRNCSL+G MPDLS IPNLGYLDLS NQL G IPP
Sbjct: 206 DNNQFDGSTIPPSYGNMTQLLKLSLRNCSLRGLMPDLSGIPNLGYLDLSFNQLAGPIPPN 265
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+L NITTI LSNN L GTIP+ FS LPRLQ L IANNSLSGS+PS+IWQ+RT N E
Sbjct: 266 KLFENITTINLSNNTLNGTIPAYFSDLPRLQLLSIANNSLSGSVPSTIWQTRT-NGNEGL 324
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLD 300
L F+NN L+NISGS ++P NVT+ L+GNP C N+N +FCGS + D N+ + ++
Sbjct: 325 DLHFENNRLSNISGSTSLPQNVTLWLQGNPACSNSNIVKFCGSQNGDMNDQSTTESNVTT 384
Query: 301 CRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLY 360
C QSCP YEY T I C CAAPL+ YRLKSPG S F Y+ F++Y+TSGL+L+LY
Sbjct: 385 CSVQSCPPPYEYFQTPTISCVCAAPLIFEYRLKSPGFSKFIPYRVAFQDYLTSGLELHLY 444
Query: 361 QLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGP 420
QLD+ S WEKGPRLKM LKLFPVY N + +S+ FN SEV RI SMFTGWNIPDS +FGP
Sbjct: 445 QLDLSSAIWEKGPRLKMQLKLFPVYVNEN-SSHKFNDSEVRRIISMFTGWNIPDSQLFGP 503
Query: 421 YELINFTLQGPYRDVFPPS-RNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNY 479
YEL+ L GPY +V + + S +S AL GI+LGAIAGAV +SA+VSLLI+R +N+
Sbjct: 504 YELLYINLLGPYINVLSVTPQKSKLSTGALVGIVLGAIAGAVALSAVVSLLILRKRSRNH 563
Query: 480 HAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVA 539
AIS+RR SK S+KI+GV+ F+Y EMALATNNFNSS+Q+GQGGYGKVYKG L DG VA
Sbjct: 564 GAISKRRRVSKASLKIEGVKYFSYAEMALATNNFNSSSQVGQGGYGKVYKGYLADGRTVA 623
Query: 540 VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 599
+KRA+E S QGE+EFLTEI+ LSR+HHRNLVSL+G+CDE GEQMLVYEFMSNGTLRD LS
Sbjct: 624 IKRAEEASFQGEREFLTEIELLSRVHHRNLVSLIGFCDEGGEQMLVYEFMSNGTLRDHLS 683
Query: 600 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659
AK+KEPL FA RL IAL S++GILYLHTEADPP+FHRD+KASNILLD ++ AKVADFGLS
Sbjct: 684 AKAKEPLSFATRLGIALASAKGILYLHTEADPPIFHRDVKASNILLDSRYNAKVADFGLS 743
Query: 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
+LAPVPDIEG VP H+STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI
Sbjct: 744 KLAPVPDIEGDVPGHISTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 803
Query: 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
SHGKNIVREVNIAYQ+ M+FS++DG MGSYPS+CV+KF+ LA+KCC DETD RPSM +V+
Sbjct: 804 SHGKNIVREVNIAYQTGMIFSIVDGRMGSYPSDCVDKFLTLAMKCCNDETDERPSMIDVV 863
Query: 780 RELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPT 839
RELE++W+MMPESDTKT + +N++ T E T PSS S+LK+PYVSS+VS S+LVSGV PT
Sbjct: 864 RELENMWHMMPESDTKTTDTMNTD-TGMEMTSPSSCSLLKNPYVSSEVSSSDLVSGVAPT 922
Query: 840 ITPR 843
ITPR
Sbjct: 923 ITPR 926
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182352|ref|NP_172169.2| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|264664524|sp|C0LGD7.2|Y1684_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g06840; Flags: Precursor gi|332189923|gb|AEE28044.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1224 bits (3168), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/845 (71%), Positives = 713/845 (84%), Gaps = 8/845 (0%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWNKI+GSIPKEIGNIKSLELLLLNGN L G+LPEELG+LP LDRIQID+N ISG LPKS
Sbjct: 115 MWNKITGSIPKEIGNIKSLELLLLNGNLLNGNLPEELGFLPNLDRIQIDENRISGPLPKS 174
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANLNKT+HFHMNNNSISGQIPPEL LPS+VH+LLDNNNL+GYLPPELS +P+LLILQL
Sbjct: 175 FANLNKTKHFHMNNNSISGQIPPELGSLPSIVHILLDNNNLSGYLPPELSNMPRLLILQL 234
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNN+F+GTTIP SY NMSKLLK+SLRNCSLQGP+PDLS IPNLGYLDLS NQLNGSIP G
Sbjct: 235 DNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVPDLSSIPNLGYLDLSQNQLNGSIPAG 294
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+LS +ITTI LSNN LTGTIP+NFSGLPRLQ+L +ANN+LSGSIPS IWQ R LN+TE+
Sbjct: 295 KLSDSITTIDLSNNSLTGTIPTNFSGLPRLQKLSLANNALSGSIPSRIWQERELNSTESI 354
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD-NEIDRSTNSTL 299
I+D +NN +NISG ++ PNVTV L+GNP C + N + CG +++D N+ ++N+T+
Sbjct: 355 IVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSDGNLLRLCGPITEEDINQGSTNSNTTI 414
Query: 300 DCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNL 359
CP YE+SP RCFCAAPLLVGYRLKSPG S F Y++ FE+Y+TSGL LNL
Sbjct: 415 ---CSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKSPGFSDFVPYRSEFEQYITSGLSLNL 471
Query: 360 YQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFG 419
YQL +DSF+W+KGPRL+MYLK FPV+ +++ NS++FN SEV RIR MFTGWNI D D+FG
Sbjct: 472 YQLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFIFNRSEVRRIRGMFTGWNIRDEDLFG 531
Query: 420 PYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNY 479
PYEL+NFTL YRDVFP + SG+S A+AGI+LG++A AVT++AI++L+I+R M+ Y
Sbjct: 532 PYELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVLGSVAAAVTLTAIIALIIMRKRMRGY 591
Query: 480 HAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVA 539
A++RR+ SSK S+KI+GV+SFTY E+ALAT+NFNSSTQIGQGGYGKVYKG L GTVVA
Sbjct: 592 SAVARRKRSSKASLKIEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVA 651
Query: 540 VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 599
+KRAQEGSLQGEKEFLTEI+ LSRLHHRNLVSL+G+CDEEGEQMLVYE+M NGTLRD +S
Sbjct: 652 IKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNIS 711
Query: 600 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659
K KEPL FAMRL IALGS++GILYLHTEA+PP+FHRDIKASNILLD +FTAKVADFGLS
Sbjct: 712 VKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLS 771
Query: 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
RLAPVPD+EGI P HVSTVVKGTPGYLDPEYFLTH+LTDKSDVYSLGVV LEL TGMQPI
Sbjct: 772 RLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPI 831
Query: 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
+HGKNIVRE+NIAY+S + S +D M S P EC+EKF LAL+CC++ETDARPSM+EV+
Sbjct: 832 THGKNIVREINIAYESGSILSTVDKRMSSVPDECLEKFATLALRCCREETDARPSMAEVV 891
Query: 780 RELESIWNMMPESDT-KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIP 838
RELE IW +MPES KT + T + S+SS++KH Y S DVSGS+LVSGV P
Sbjct: 892 RELEIIWELMPESHVAKTADL---SETMTHPSSSSNSSIMKHHYTSMDVSGSDLVSGVAP 948
Query: 839 TITPR 843
++ PR
Sbjct: 949 SVAPR 953
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569432|ref|XP_003552905.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1224 bits (3166), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 598/849 (70%), Positives = 711/849 (83%), Gaps = 14/849 (1%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN ISGSIP E+GNI SLELLLLNGN+LTGSLPEE+GYLP LDRIQIDQN ISG +P S
Sbjct: 113 MWNNISGSIPNEVGNITSLELLLLNGNKLTGSLPEEIGYLPNLDRIQIDQNQISGPIPTS 172
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANLNKT+HFHMNNNS+SGQIPPELSRLP+LVH+LLDNNNL+GYLP EL+++P LLI+QL
Sbjct: 173 FANLNKTKHFHMNNNSLSGQIPPELSRLPNLVHLLLDNNNLSGYLPRELADMPSLLIIQL 232
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNNNFEG +IP +Y+NMSKLLK+SLRNCSLQGP+PDLSRIP+L YLDLS NQLN SIPP
Sbjct: 233 DNNNFEGNSIPDTYANMSKLLKMSLRNCSLQGPIPDLSRIPHLLYLDLSLNQLNESIPPN 292
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+LS +ITTI LS+N+LTG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++T N T+TF
Sbjct: 293 KLSEHITTIDLSSNRLTGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTSNGTKTF 352
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLD 300
+L+ +NNNLT ISGS ++PPNVTV L GNP C N QFCGS + + +TNS+
Sbjct: 353 LLELENNNLTTISGSIDLPPNVTVGLNGNPLCSNVTLTQFCGSEGANVTDGSFTTNSS-S 411
Query: 301 CRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLY 360
C Q+CP YEYS + CFC PL+V YRLKSPG S F Y N FE YM SG+K++
Sbjct: 412 CPPQACPPPYEYS----VNCFCGLPLIVDYRLKSPGFSNFLPYLNDFEVYMASGVKISTN 467
Query: 361 QLDIDSFRWEKGPRLKMYLKLFPVY-DNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFG 419
QL D F W+ GPRL+M LK FP Y DNSS S+ FN SE+ R+ SMFTGW IPDSD+FG
Sbjct: 468 QLQYD-FYWQVGPRLRMNLKFFPAYVDNSS--SHTFNRSELLRLTSMFTGWLIPDSDLFG 524
Query: 420 PYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNY 479
PYEL+ F L GPY+D S SGIS AL GI++GAIA AVT+SAIV++LI+R +++Y
Sbjct: 525 PYELMGFNLLGPYQDEIGRSSKSGISTGALVGIVIGAIAFAVTLSAIVTILILRIRLRDY 584
Query: 480 HAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVA 539
HA+SRRRH+SK SIKIDGVR+F+YGE++ ATNNF++S Q+GQGGYGKVYKG+L DGT+VA
Sbjct: 585 HAVSRRRHASKISIKIDGVRAFSYGELSSATNNFSTSAQVGQGGYGKVYKGVLSDGTIVA 644
Query: 540 VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 599
+KRAQEGSLQGEKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS
Sbjct: 645 IKRAQEGSLQGEKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLS 704
Query: 600 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659
+K+PL FAMRL +ALG+++G+LYLH+EADPP+FHRD+KASNILLD KF+AKVADFGLS
Sbjct: 705 VTAKDPLTFAMRLKMALGAAKGLLYLHSEADPPIFHRDVKASNILLDSKFSAKVADFGLS 764
Query: 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
RLAPVPD+EG+VP HVSTVVKGTPGYLDPEYFLT KLTDKSDVYSLGVVFLELLTGM PI
Sbjct: 765 RLAPVPDMEGVVPGHVSTVVKGTPGYLDPEYFLTRKLTDKSDVYSLGVVFLELLTGMHPI 824
Query: 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
SHGKNIVREVN+AYQS ++FS+IDG MGSYPSE VEKF+ LA+KCC+DE +ARP M+EV+
Sbjct: 825 SHGKNIVREVNVAYQSGVIFSIIDGRMGSYPSEHVEKFLTLAMKCCEDEPEARPRMAEVV 884
Query: 780 RELESIWNMMPESDTKTPEFINSEHTSKE-----ETPPSSSSMLKHPYVSSDVSGSNLVS 834
RELE+IW+ MPESDTK EF++S+ + + +S+S++K P+VS DVSGS+LVS
Sbjct: 885 RELENIWSTMPESDTKRAEFMSSDSGKADSHSTPSSSSASASIMKTPFVSGDVSGSDLVS 944
Query: 835 GVIPTITPR 843
GVIP+I PR
Sbjct: 945 GVIPSIKPR 953
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146594|ref|XP_002326064.1| predicted protein [Populus trichocarpa] gi|222862939|gb|EEF00446.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1202 bits (3110), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/823 (72%), Positives = 686/823 (83%), Gaps = 7/823 (0%)
Query: 22 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81
LLLNGN+LTG LP+ELGYLP L+RIQIDQN ISG +PKSFANLNKT+HFHMNNNSISG I
Sbjct: 49 LLLNGNQLTGPLPDELGYLPNLERIQIDQNNISGPIPKSFANLNKTQHFHMNNNSISGNI 108
Query: 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLL 141
P ELSRLPSL+H LLDNNNL+G LPPELS P LLILQLDNNNF+G+TIPASY NM+KLL
Sbjct: 109 PAELSRLPSLLHFLLDNNNLSGTLPPELSNFPNLLILQLDNNNFDGSTIPASYGNMTKLL 168
Query: 142 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIP 201
KLSLRNCSLQGPMPDLS IPNLGYLDLS NQL G IP +LS NITTI LS N L GTIP
Sbjct: 169 KLSLRNCSLQGPMPDLSGIPNLGYLDLSFNQLAGPIPTNKLSKNITTIDLSYNNLNGTIP 228
Query: 202 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPN 261
+NFS LP LQ+L IANNSLSGS+P + WQ+R N TE LDF+NN L+NISGS ++P N
Sbjct: 229 ANFSELPLLQQLSIANNSLSGSVPFTTWQTRA-NGTEGLDLDFENNTLSNISGSISLPQN 287
Query: 262 VTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPIRCF 321
VT+RL+GNP C N++ QFC S ++D N ST S C QSCP+ YEYSPTSP CF
Sbjct: 288 VTLRLKGNPVCSNSSIFQFCESQNNDMNN-QSSTESNATCFTQSCPSPYEYSPTSPTSCF 346
Query: 322 CAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKL 381
CAAPL+ GYRLKSPG S F Y+ FE Y+TSGLKL+L+QLD+ S WE GPRLKM+LKL
Sbjct: 347 CAAPLIFGYRLKSPGFSKFVPYRIRFENYLTSGLKLSLFQLDLASVVWESGPRLKMHLKL 406
Query: 382 FPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRN 441
FPVY N + FN SE RI SMFTGW IPDS+IFGPYEL+ TL PYRDV S+
Sbjct: 407 FPVYVNGTN---TFNTSEARRIISMFTGWKIPDSEIFGPYELLYITLLDPYRDVIVTSQK 463
Query: 442 SG-ISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRS 500
S IS AL GI+LGAIAGAVT+SA+VSLLI+R +++Y AIS+RR SK S+KI+GV+
Sbjct: 464 SNKISTGALVGIVLGAIAGAVTLSAVVSLLILRRRLRDYTAISKRRRQSKASLKIEGVKD 523
Query: 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF 560
F+Y EMA+ATNNFNSS+Q+GQGGYGKVYKGIL DG VA+KR +EGSLQGEKEFLTEI+
Sbjct: 524 FSYAEMAMATNNFNSSSQVGQGGYGKVYKGILADGRTVAIKRTEEGSLQGEKEFLTEIEL 583
Query: 561 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR 620
LSRLHHRNLVSL+GYCDE+GEQMLVYEFM NGTLRD LS K KEPL FA RL IA+ S++
Sbjct: 584 LSRLHHRNLVSLLGYCDEQGEQMLVYEFMPNGTLRDHLSVKGKEPLSFATRLKIAMTSAK 643
Query: 621 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
GILYLHTEA+PP+FHRDIKASNIL+D ++ AKVADFGLSRLAPVPDIEG VP H+STVVK
Sbjct: 644 GILYLHTEANPPIFHRDIKASNILVDSRYDAKVADFGLSRLAPVPDIEGSVPDHISTVVK 703
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740
GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG QPISHGKNIVREV IAYQS M+FS
Sbjct: 704 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGKQPISHGKNIVREVKIAYQSGMIFS 763
Query: 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFI 800
+ID MGSYPS+C++KF+ LA+KCC +ETDARPSM++V+RELE IW+MM ESDT T + I
Sbjct: 764 IIDERMGSYPSDCIDKFLTLAMKCCNEETDARPSMADVVRELEGIWHMMSESDTATTDTI 823
Query: 801 NSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 843
++++ KE TPPSSSSM+ +P VSS+VSGS+LVSG +PTITPR
Sbjct: 824 STDN-RKEMTPPSSSSMMMNPCVSSEVSGSDLVSGAVPTITPR 865
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537716|ref|XP_003537371.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1194 bits (3088), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/849 (70%), Positives = 705/849 (83%), Gaps = 13/849 (1%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN ISGSIPKE+GNI SLELLLLNGN LTGSLPEE+GYLP LDRIQIDQN ISG +P S
Sbjct: 113 MWNNISGSIPKEVGNITSLELLLLNGNNLTGSLPEEIGYLPNLDRIQIDQNQISGPIPTS 172
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANLNKT+HFHMNNNS+SGQIPPELSRLP LVH+LLDNNNL+GYLP EL+++P LLI+QL
Sbjct: 173 FANLNKTKHFHMNNNSLSGQIPPELSRLPKLVHLLLDNNNLSGYLPRELADMPSLLIIQL 232
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNNNFEG +IP +Y+NMSKLLK+SLRNC+L+GP+PDL RIP+L YLDLS NQLNGSIPP
Sbjct: 233 DNNNFEGNSIPDTYANMSKLLKMSLRNCNLRGPLPDLRRIPHLLYLDLSFNQLNGSIPPN 292
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+LS NITTI LSNN LTG IPS F+ LPRLQ+L +ANNSL G++ SSIWQ++TLN TE F
Sbjct: 293 KLSENITTIDLSNNLLTGNIPSYFADLPRLQKLSLANNSLDGTVSSSIWQNKTLNGTEKF 352
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLD 300
L+ +NNNLT ISGS ++PPNVTV L GNP C N QFCGS + +TN +
Sbjct: 353 FLELENNNLTTISGSIDLPPNVTVGLNGNPLCSNITLIQFCGSEAATVTNGSLTTNFS-S 411
Query: 301 CRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLY 360
C Q CP +EY+ + CFCA PL+V YRLKSPG + F Y N F++YMT GL+++
Sbjct: 412 CPPQGCPPPFEYT----VDCFCALPLIVFYRLKSPGFTNFLPYLNGFKDYMTHGLEISFD 467
Query: 361 QLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFGP 420
QL+ D F W+ GPRLKM LK FP Y N++ N + FN SE+ RI+S FTGW IPD+D FGP
Sbjct: 468 QLEYD-FYWQVGPRLKMDLKFFPPYLNNTSN-HTFNESELLRIKSKFTGWLIPDNDTFGP 525
Query: 421 YELINFTLQGPYRDVFPP-SRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKNY 479
YELI F L G Y+DV P S + I L GI++GAIA AVT+SAIV++LI+R +++Y
Sbjct: 526 YELIGFNLLGSYQDVIPTRSESQNIRTGVLVGIVIGAIACAVTLSAIVTILILRIKLRDY 585
Query: 480 HAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVA 539
HA+S++RH+SK SIKIDGVR+FTYGE++ ATNNF+ S Q+GQGGYGKVYKG+L DGTVVA
Sbjct: 586 HAVSKQRHASKISIKIDGVRAFTYGELSFATNNFSISAQVGQGGYGKVYKGVLSDGTVVA 645
Query: 540 VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 599
+KRAQEGSLQGEKEFLTEI LSRLHHRNLVSL+GYCDEEGEQMLVYEFMSNGTLRD LS
Sbjct: 646 IKRAQEGSLQGEKEFLTEISLLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDHLS 705
Query: 600 AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659
+K+PL FAMRL IALG+++G++YLHTEADPP+FHRD+KASNILLD KF+AKVADFGLS
Sbjct: 706 VTAKDPLTFAMRLKIALGAAKGLMYLHTEADPPIFHRDVKASNILLDSKFSAKVADFGLS 765
Query: 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
RLAPVPD+EG+VP HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM PI
Sbjct: 766 RLAPVPDMEGVVPGHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMHPI 825
Query: 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
SHGKNIVREVN+AYQS ++FS+IDG MGSYPSE VEKF+ LA+KCC+DE +ARPSM+EV+
Sbjct: 826 SHGKNIVREVNVAYQSGVIFSIIDGRMGSYPSEHVEKFLTLAMKCCEDEPEARPSMTEVV 885
Query: 780 RELESIWNMMPESDTKTPEFINSEHTSKE-----ETPPSSSSMLKHPYVSSDVSGSNLVS 834
RELE+IW+ MPESDTK EFI+S+ + + +S+S++K P+VS DVSGS+LVS
Sbjct: 886 RELENIWSTMPESDTKRAEFISSDSGKADSHSTPSSSSASASVMKTPFVSGDVSGSDLVS 945
Query: 835 GVIPTITPR 843
GVIP+I PR
Sbjct: 946 GVIPSIKPR 954
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439195|ref|XP_004137372.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1157 bits (2994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/845 (69%), Positives = 684/845 (80%), Gaps = 8/845 (0%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWNKISG IP+EIGN+ SLELLLLNGN+L+GSLPE+LG L LDRIQIDQN+ISG +PKS
Sbjct: 114 MWNKISGEIPREIGNLTSLELLLLNGNQLSGSLPEDLGNLLHLDRIQIDQNHISGLIPKS 173
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
FANL T+HFHMNNNSISG+IP ELS LP+LVH LLDNNNL+G LPPEL +LP L ILQL
Sbjct: 174 FANLKATKHFHMNNNSISGEIPSELSGLPNLVHFLLDNNNLSGKLPPELFQLPNLEILQL 233
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNNNF G TIP SY M+KLLKLSLRNC+LQG +PDLSRI NLGYLDLSSNQL+G IP G
Sbjct: 234 DNNNFSGATIPDSYGKMTKLLKLSLRNCTLQGSIPDLSRIKNLGYLDLSSNQLSGLIPRG 293
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+LS NITTI LS+N+LTGTIPS+ GLP LQ+L +ANNSL+GS+PS+IWQSR LN+ ++
Sbjct: 294 KLSENITTIILSDNRLTGTIPSSLLGLPHLQKLSVANNSLNGSVPSTIWQSRMLNSLDSL 353
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLD 300
++ QNNN ++I GS ++P NV+VRL+GNP C N + FCGS S+D ID TN+ L
Sbjct: 354 TVELQNNNFSDILGSIHLPLNVSVRLQGNPACANNSLLDFCGSESEDI--IDIPTNNPLG 411
Query: 301 CRAQSCPTDYE-YSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNL 359
C CP YE YS P C C+APLL+GYRLKSPG S F Y+++FEEY+TSGLK++L
Sbjct: 412 CSGPICPPSYECYSAKCPSSCLCSAPLLIGYRLKSPGFSRFSPYQHMFEEYLTSGLKVHL 471
Query: 360 YQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSDIFG 419
QLDI S WEKGPRL+M LK+FP+Y S +S++FN SEV RI FT W I DSDIFG
Sbjct: 472 EQLDIGSAVWEKGPRLRMSLKVFPLYVADSNSSHMFNDSEVLRIVYKFTNWKIQDSDIFG 531
Query: 420 PYELINFTLQGPYRDVF-PPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKN 478
PYEL++ T+ Y+ VF PS +S +SK ALAGIILGAIAG +SAIV + I+R+ ++
Sbjct: 532 PYELLSLTISDVYKKVFFTPSSDSTMSKGALAGIILGAIAGGAMLSAIVFIFIIRSRVRG 591
Query: 479 YHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVV 538
+H ISRRRH SKTSIKI GV+ F Y EMALATNNF+ S +GQGGYGKVYKGIL D V
Sbjct: 592 HH-ISRRRHLSKTSIKIKGVKEFGYREMALATNNFHCSMVVGQGGYGKVYKGILADSMAV 650
Query: 539 AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 598
A+KRAQEGSLQGEKEFLTEIQ LSRLHHRNLV+L+GYCDEEGEQML YEFMSNGTLRD L
Sbjct: 651 AIKRAQEGSLQGEKEFLTEIQLLSRLHHRNLVALIGYCDEEGEQMLAYEFMSNGTLRDHL 710
Query: 599 SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658
S S EPL FA RL ALG+++GILYLHTEADPP+FHRDIK+SNILLD K+ AKVADFGL
Sbjct: 711 SVNSAEPLSFATRLKAALGAAKGILYLHTEADPPIFHRDIKSSNILLDSKYVAKVADFGL 770
Query: 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
SRLAP+P+ EG VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG P
Sbjct: 771 SRLAPLPNAEGDVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGRHP 830
Query: 719 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV 778
ISHGKNIVREVN AYQS +FS+IDG +GSYP+ECVEKF+ LALKCCQD+TDARPSM EV
Sbjct: 831 ISHGKNIVREVNSAYQSGKIFSIIDGRLGSYPAECVEKFVTLALKCCQDDTDARPSMVEV 890
Query: 779 MRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVSGVIP 838
+R LE+IW M+PESD+K E + ++ P SSS+M Y S+VSGS+LVSGV P
Sbjct: 891 VRTLENIWLMLPESDSKISEPLINDVIKVTSPPSSSSNM---NYYISEVSGSDLVSGVTP 947
Query: 839 TITPR 843
TI PR
Sbjct: 948 TIMPR 952
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 843 | ||||||
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.991 | 0.879 | 0.564 | 1.5e-248 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.975 | 0.877 | 0.494 | 2.4e-202 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.883 | 0.767 | 0.374 | 6e-119 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.897 | 0.794 | 0.370 | 1.6e-116 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.897 | 0.800 | 0.359 | 2.9e-110 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.336 | 0.331 | 0.520 | 3.1e-108 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.368 | 0.326 | 0.404 | 4.9e-80 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.352 | 0.255 | 0.386 | 8.3e-80 | |
| TAIR|locus:2148151 | 866 | AT5G16900 [Arabidopsis thalian | 0.367 | 0.357 | 0.446 | 1.2e-75 | |
| TAIR|locus:2128625 | 898 | AT4G20450 [Arabidopsis thalian | 0.381 | 0.358 | 0.424 | 8.5e-75 |
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2394 (847.8 bits), Expect = 1.5e-248, P = 1.5e-248
Identities = 479/849 (56%), Positives = 582/849 (68%)
Query: 1 MWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN ISGSIP EIG I P ELGYL L+R QID+N I+G +PKS
Sbjct: 110 MWNNISGSIPNEIGQISSLVLLLLNGNKLSGTLPSELGYLSNLNRFQIDENNITGPIPKS 169
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXXXX 120
F+NL K +H H NNNS++GQIP ELS L ++ H+LLDNN L+G
Sbjct: 170 FSNLKKVKHLHFNNNSLTGQIPVELSNLTNIFHVLLDNNKLSGNLPPQLSALPNLQILQL 229
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNNNF G+ IPASY N S +LKLSLRNCSL+G +PD S+I +L YLDLS N+L G IP
Sbjct: 230 DNNNFSGSDIPASYGNFSNILKLSLRNCSLKGALPDFSKIRHLKYLDLSWNELTGPIPSS 289
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
S ++TTI LSNN L G+IP +FS LP LQ L + NN LSGS+P S+W++ +
Sbjct: 290 NFSKDVTTINLSNNILNGSIPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKNISFPKKARL 349
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN---TNAEQFCGSHSDDDNEI-DRSTN 296
+LD +NN+L+ + G P NVT+RL GN C N +NA FC S + + + STN
Sbjct: 350 LLDLRNNSLSRVQGDLTPPQNVTLRLDGNLICTNGSISNANLFCESKGKEWISLPNNSTN 409
Query: 297 STLDCRAQSCPTD--YEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSG 354
S LDC +CPT YEYSP SP+RCFCAAPL +GYRLKSP SYFP Y + F EY+T
Sbjct: 410 SALDCPPLACPTPDFYEYSPASPLRCFCAAPLRIGYRLKSPSFSYFPPYIDQFGEYVTDF 469
Query: 355 LKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPD 414
L++ YQL IDS++WEKGPRL+MYLKLFP + + + FN SEV RIR +F W P
Sbjct: 470 LQMEPYQLWIDSYQWEKGPRLRMYLKLFPKVNETYTRT--FNESEVLRIRGIFASWRFPG 527
Query: 415 SDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRA 474
SD+FGPYEL+NFTLQGPY V S G+S V ISA+V+ L++R
Sbjct: 528 SDLFGPYELLNFTLQGPYSYVNFNSERKGVSWRRLAAITAGAVVTAVAISAVVAALLLRR 587
Query: 475 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD 534
+ K+ ISRRR SSK S+ G+R F++ E+A AT++F+SST +G+GGYGKVY+G+L D
Sbjct: 588 YSKHEREISRRRSSSKASLLNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSD 647
Query: 535 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594
TV A+KRA EGSLQGEKEFL EI+ LSRLHHRNLVSL+GYCDEE EQMLVYEFMSNGTL
Sbjct: 648 NTVAAIKRADEGSLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTL 707
Query: 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 654
RD LSAK KE L F MR+ +ALG+++GILYLHTEA+PPVFHRDIKASNILLD F AKVA
Sbjct: 708 RDWLSAKGKESLSFGMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVA 767
Query: 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 714
DFGLSRLAPV + E VP HVSTVV+GTPGYLDPEYFLTHKLTDKSDVYS+GVVFLELLT
Sbjct: 768 DFGLSRLAPVLEDEEDVPKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLT 827
Query: 715 GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 774
GM ISHGKNIVREV A Q MM S+ID M + E VEKF LAL+C D + RP
Sbjct: 828 GMHAISHGKNIVREVKTAEQRDMMVSLIDKRMEPWSMESVEKFAALALRCSHDSPEMRPG 887
Query: 775 MSEVMRELESIWNMMPESDTKTPEFINXXXXXXXXXXXXXXXMLKHPYVSSDVSGSNLVS 834
M+EV++ELES+ P+ +T+ E + + Y SS + GS+L S
Sbjct: 888 MAEVVKELESLLQASPDRETRV-ELASSSSVLSTSSSNVTRDL----YESSSLLGSDLSS 942
Query: 835 GVIPTITPR 843
G +P+I PR
Sbjct: 943 GFVPSIAPR 951
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1958 (694.3 bits), Expect = 2.4e-202, P = 2.4e-202
Identities = 419/848 (49%), Positives = 529/848 (62%)
Query: 1 MWNKISGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLPKS 60
MWN ++G IP EIG I P ELG L L+R+Q+D+N I+GS+P S
Sbjct: 111 MWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNLNRLQVDENNITGSVPFS 170
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXXXX 120
F NL +H H+NNN+ISG+IP ELS+LP LVHM+LDNNNLTG
Sbjct: 171 FGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTGTLPLELAQLPSLTILQL 230
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
DNNNFEG+TIP +Y + S+L+KLSLRNC LQG +PDLSRI NL YLDLS N L G+IP
Sbjct: 231 DNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENLSYLDLSWNHLTGTIPES 290
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+LS N+TTI+LS N LTG+IP +FS L LQ L + NNSLSGS+P+ IWQ ++ +
Sbjct: 291 KLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGSVPTEIWQDKSFENNKLQ 350
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN---AEQFCGSHSDDDNEIDRSTNS 297
+ D NNN ++ +G+ P NVT+ LRGNP C +T+ QF + + STNS
Sbjct: 351 VYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQFFEYICGEKKQT--STNS 407
Query: 298 TLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAY-KNLFEEYMTSGLK 356
C SCP +E SP C C APL + YRLKSP +F Y + F EY+TS L+
Sbjct: 408 NTPCSNVSCP--FENVKVSPGICLCTAPLSIDYRLKSPSFFFFTPYIERQFREYITSSLQ 465
Query: 357 LNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNIPDSD 416
L +QL ID E R +MYLKL P G FN SEV RIR F W+ +D
Sbjct: 466 LETHQLAIDRLVDENRLRPRMYLKLVP-----KGR-ITFNKSEVIRIRDRFMSWSFNKTD 519
Query: 417 IFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIVRAHM 476
FGPYEL++F LQGPY D+ ++ SGI +S +LL VR
Sbjct: 520 FFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAGSVVAATVLSVTATLLYVRKRR 577
Query: 477 KNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGT 536
+N H ++++R S +I GV+ F++ E++ ATN F+SST IG+G YGKVYKGIL + T
Sbjct: 578 ENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKT 637
Query: 537 VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD 596
VA+KR +E SLQ EKEFL EI LSRLHHRNLVSL+GY + GEQMLVYE+M NG +RD
Sbjct: 638 EVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNGNVRD 697
Query: 597 QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 656
LSA + + L F+MR +ALGS++GILYLHTEA+PPV HRDIK SNILLD + AKVADF
Sbjct: 698 WLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADF 757
Query: 657 GLSRLAPV-PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 715
GLSRLAP + +G PAHVSTVV+GTPGYLDPEYF+T +LT +SDVYS GVV LELLTG
Sbjct: 758 GLSRLAPAFGEGDG-EPAHVSTVVRGTPGYLDPEYFMTQQLTVRSDVYSFGVVLLELLTG 816
Query: 716 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSM 775
M P G +I+REV A + + SV D MG + V+K +LAL CC+D + RP M
Sbjct: 817 MHPFFEGTHIIREVRTANECGTVLSVADSRMGQCSPDKVKKLAELALWCCEDRPETRPPM 876
Query: 776 SEVMRELESIWNMMPESDTKTPEFINXXXXXXXXXXXXXXXMLKHPYVSSDVSGSNLVSG 835
S+V++ELE I + E PE + + P S + GSNL SG
Sbjct: 877 SKVVKELEGICQSVRE-----PEMFSETTKLLCSKTSPSSSSVPSPL--SLLPGSNLDSG 929
Query: 836 VIPTITPR 843
+ PR
Sbjct: 930 FFHAVKPR 937
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1171 (417.3 bits), Expect = 6.0e-119, P = 6.0e-119
Identities = 304/812 (37%), Positives = 438/812 (53%)
Query: 6 SGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLPKSFAN-- 63
+G+IP E+G +K P LG L K+ + + N ++G +P S +
Sbjct: 135 TGTIPNELGYLKDLSFLALNSNNFTGKIPASLGNLTKVYWLDLADNQLTGPIPISSGSSP 194
Query: 64 ----LNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXXX 118
L K +HFH N N +SG IPP+L S L+H+L D N TG
Sbjct: 195 GLDLLLKAKHFHFNKNQLSGTIPPKLFSSEMILIHVLFDGNRFTGSIPSTLGLIQTLEVL 254
Query: 119 XXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 178
D N G +P + SN++ +++L+L + L G +PDLS + ++ Y+DLS+N + S
Sbjct: 255 RLDRNTLTGK-VPENLSNLTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPSES 313
Query: 179 PGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236
P S ++TT+ + L G +P+ G P+LQ++ + N+ +G++ S+ T+
Sbjct: 314 PLWFSTLPSLTTLVMEYGSLQGPLPNKLFGFPQLQQVRLKKNAFNGTL--SLGD--TVGP 369
Query: 237 TETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE-QFCGSHSDDDNEIDRST 295
E ++D Q+N++++++ S N T+ L GNP C + +C I ST
Sbjct: 370 -ELQLVDLQDNDISSVTLSSGYT-N-TLILEGNPVCTTALSNTNYCQIQQQQVKRI-YST 425
Query: 296 NSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSP---GLSYFPAYKNLFEEYMT 352
S +C +SCP D + SP S C CA P + P LS Y +L E +
Sbjct: 426 -SLANCGGKSCPLDQKVSPQS---CECAYPYEGTLYFRGPMFRDLSNVNTYHSL-EMSLW 480
Query: 353 SGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMFTGWNI 412
L L + + + + L++ L LFP Y FN +EV RI +
Sbjct: 481 VKLGLTPGSVSLQNPFFNNDDYLQIQLALFPPM-----GKY-FNRTEVQRIGFDLSNQTY 534
Query: 413 PDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIVSLLIV 472
+FGPY + + PY FP N G S + + +V+L I
Sbjct: 535 KPPPLFGPY----YFIASPY--TFPADGN-GHSLSSRMVTGIITGCSALVL-CLVALGIY 586
Query: 473 RAHMKNY--HAISRRR------HSSKTS---IKIDGVRSFTYGEMALATNNFNSSTQIGQ 521
K AI R S K S ++ G R F+Y E+ TNNF+ S+++G
Sbjct: 587 AMWQKRRAEQAIGLSRPFVSWASSGKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGY 646
Query: 522 GGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581
GGYGKVYKG+L DG +VA+KRAQ+GS QG EF TEI+ LSR+HH+NLV LVG+C E+GE
Sbjct: 647 GGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 706
Query: 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 641
Q+LVYE+MSNG+L+D L+ +S L + RL +ALGS+RG+ YLH ADPP+ HRD+K++
Sbjct: 707 QILVYEYMSNGSLKDSLTGRSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKST 766
Query: 642 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 701
NILLD TAKVADFGLS+L V D HVST VKGT GYLDPEY+ T KLT+KSD
Sbjct: 767 NILLDENLTAKVADFGLSKL--VSDC---TKGHVSTQVKGTLGYLDPEYYTTQKLTEKSD 821
Query: 702 VYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM--MFSVIDG------NMGSYPSEC 753
VYS GVV +EL+T QPI GK IVRE+ + S + + D ++G+ P
Sbjct: 822 VYSFGVVMMELITAKQPIEKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLRDVGTLPE-- 879
Query: 754 VEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ ++++LALKC + D RP+MSEV++E+E I
Sbjct: 880 LGRYMELALKCVDETADERPTMSEVVKEIEII 911
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1148 (409.2 bits), Expect = 1.6e-116, P = 1.6e-116
Identities = 306/826 (37%), Positives = 434/826 (52%)
Query: 6 SGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLPKSFAN-- 63
SG IP+ IG +K P +G L KL I N I G LP S
Sbjct: 127 SGQIPESIGTLKELIYLSLNLNKFSGTIPPSIGLLSKLYWFDIADNQIEGELPVSNGTSA 186
Query: 64 -----LNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXX 117
L +T+HFH N +SG IP EL S SL+H+L D N TG
Sbjct: 187 PGLDMLLQTKHFHFGKNKLSGNIPKELFSSNMSLIHVLFDGNQFTGEIPETLSLVKTLTV 246
Query: 118 XXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS- 176
D N G IP+ +N++ L +L L N G +P+L+ + +L LD+S+N L+ S
Sbjct: 247 LRLDRNKLIGD-IPSYLNNLTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNTLDFSP 305
Query: 177 IPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
IP SL +++T+++ +L G IP +F P+LQ + + NS+ S+ S L
Sbjct: 306 IPSWISSLPSLSTLRMEGIQLNGPIPISFFSPPQLQTVILKRNSIVESLDFGTDVSSQLE 365
Query: 236 ATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNT-NAEQFCGSHSDDDNEIDRS 294
F+ D Q N +T+ S N + V L NP CL N +C + I +
Sbjct: 366 ----FV-DLQYNEITDYKPSAN--KVLQVILANNPVCLEAGNGPSYCSA-------IQHN 411
Query: 295 TN-STLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLS-YFPAYK-NLFEEYM 351
T+ STL C E SPT C CA P + +SP S F + ++ ++ +
Sbjct: 412 TSFSTLPTNCSPCEPGMEASPT----CRCAYPFMGTLYFRSPSFSGLFNSTNFSILQKAI 467
Query: 352 TSGLKLNLYQLDIDSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMF 407
K Y +D R + P +L + L +FP+ S FN + + + F
Sbjct: 468 ADFFKKFNYPVDSVGVRNIRENPTDHQLLIDLLVFPLGRES------FNQTGMSLVGFAF 521
Query: 408 TGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIV 467
+ IFGPY + L + DV S++S S +TI+ I
Sbjct: 522 SNQTYKPPPIFGPY-IFKADLYKQFSDVEVSSKSSNKSILIGAVVGVVVLLLLLTIAGIY 580
Query: 468 SLLIVRAHMKNYHAISRRR-----HSSKTSI---KIDGVRSFTYGEMALATNNFNSSTQI 519
+L R + A + +SK+SI ++ G ++FT+ E+ T+NF+ + +
Sbjct: 581 AL---RQKKRAERATGQNNPFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDV 637
Query: 520 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579
G GGYGKVY+GILP+G ++A+KRAQ+GSLQG EF TEI+ LSR+HH+N+V L+G+C +
Sbjct: 638 GGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDR 697
Query: 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 639
EQMLVYE++SNG+L+D LS KS L + RL IALGS +G+ YLH ADPP+ HRDIK
Sbjct: 698 NEQMLVYEYISNGSLKDSLSGKSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIK 757
Query: 640 ASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK 699
++NILLD TAKVADFGLS+L P+ HV+T VKGT GYLDPEY++T++LT+K
Sbjct: 758 SNNILLDENLTAKVADFGLSKLVGDPE-----KTHVTTQVKGTMGYLDPEYYMTNQLTEK 812
Query: 700 SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF----SVIDGNM--GSYPSEC 753
SDVY GVV LELLTG PI GK +VREV S ++D + S +
Sbjct: 813 SDVYGFGVVLLELLTGRSPIERGKYVVREVKTKMNKSRSLYDLQELLDTTIIASSGNLKG 872
Query: 754 VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM---PESDTKT 796
EK++ LAL+C ++E RPSM EV++E+E+I + P SD+ T
Sbjct: 873 FEKYVDLALRCVEEEGVNRPSMGEVVKEIENIMQLAGLNPNSDSAT 918
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1089 (388.4 bits), Expect = 2.9e-110, P = 2.9e-110
Identities = 298/830 (35%), Positives = 435/830 (52%)
Query: 6 SGSIPKEIGNIKXXXXXXXXXXXXXXXXPEELGYLPKLDRIQIDQNYISGSLP----KSF 61
+G IP IGN++ P +G L KL I N + G LP S
Sbjct: 130 NGPIPDSIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASL 189
Query: 62 ANLN---KTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYXXXXXXXXXXXXX 117
L+ +T HFH NN +SG+IP +L S +L+H+L D N TG
Sbjct: 190 PGLDMLLQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTV 249
Query: 118 XXXDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177
D N G IP+S +N++ L +L L + G +P+L+ + +L LD+S+N L S
Sbjct: 250 LRLDRNRLSGD-IPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSP 308
Query: 178 PPGRLS-LN-ITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234
P + LN ++T++L + +L G +P++ FS L +LQ + + +N ++ ++ S+ L
Sbjct: 309 VPSWIPFLNSLSTLRLEDIQLDGPVPTSLFSPL-QLQTVSLKHNLINTTLDLGTNYSKQL 367
Query: 235 NATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEID-R 293
+ F+ D ++N +T N P NV L N C + A Q G N +
Sbjct: 368 D----FV-DLRDNFITGYKSPANNPVNVM--LADNQVCQDP-ANQLSGYC----NAVQPN 415
Query: 294 STNSTLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRLKSPGLSYFPAYKNL--FEEYM 351
ST STL C E P C C PL + L+SP S F N F E +
Sbjct: 416 STFSTLTKCGNHCGKGKE--PNQG--CHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESL 471
Query: 352 TSGLKLNLYQLDIDSFR-WEKGP---RLKMYLKLFPVYDNSSGNSYVFNASEVGRIRSMF 407
+ K Y +D + R + P L + L +FP SG FN +E+ I S F
Sbjct: 472 MTFFKNGKYPVDSVAMRNISENPTDYHLLINLLIFP-----SGRDR-FNQTEMDSINSAF 525
Query: 408 TGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKXXXXXXXXXXXXXXVTISAIV 467
T + FGPY + Y+ F +S + + A+
Sbjct: 526 TIQDYKPPPRFGPYIFV----ADQYK-TFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALA 580
Query: 468 SLLIVRAHMKNYHAISRRRHSSKTSI---KID-----GVRSFTYGEMALATNNFNSSTQI 519
+ +R + A + +K ++D G ++FT+ E++ TNNF+ + +
Sbjct: 581 GIYALRQKKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDV 640
Query: 520 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579
G GGYG+VYKG LP+G V+A+KRAQ+GS+QG EF TEI+ LSR+HH+N+V L+G+C ++
Sbjct: 641 GGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQ 700
Query: 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 639
EQMLVYE++ NG+LRD LS K+ L + RL IALGS +G+ YLH ADPP+ HRD+K
Sbjct: 701 KEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVK 760
Query: 640 ASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK 699
++NILLD TAKVADFGLS+L P+ AHV+T VKGT GYLDPEY++T++LT+K
Sbjct: 761 SNNILLDEHLTAKVADFGLSKLVGDPE-----KAHVTTQVKGTMGYLDPEYYMTNQLTEK 815
Query: 700 SDVYSLGVVFLELLTGMQPISHGKNIVREV--------NIAYQSSMMFSVIDGNMGSYPS 751
SDVY GVV LELLTG PI G +V+EV N+ ++ + I N G+
Sbjct: 816 SDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQNSGNLKG 875
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM---PESDTKTPE 798
EK++ +AL+C + E RP+MSEV++ELESI ++ P +D+ T E
Sbjct: 876 --FEKYVDVALQCVEPEGVNRPTMSEVVQELESILRLVGLNPNADSATYE 923
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 772 (276.8 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
Identities = 154/296 (52%), Positives = 212/296 (71%)
Query: 497 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT 556
G ++FT+ EM NNF+ + +G GGYG+VYKGILP G ++A+KRAQ GSLQG EF T
Sbjct: 518 GTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKT 577
Query: 557 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 616
EI+ LSR+HH+N+V L+G+C + GEQMLVYE++ NG+LRD LS KS L + RL IAL
Sbjct: 578 EIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGIRLDWTRRLRIAL 637
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
GS +G+ YLH ADPP+ HRD+K+SN+LLD TAKVADFGLS+L V D E A+V+
Sbjct: 638 GSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQL--VEDAE---KANVT 692
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736
VKGT GYLDPEY++T++LT+KSDVY GV+ LELLTG PI +GK +V+E+ + S
Sbjct: 693 AQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKMNKS 752
Query: 737 M-MFSV---IDGNMGSYPSECV---EKFIKLALKCCQDETDARPSMSEVMRELESI 785
++ + +D + + + + EK++ +AL+C E RPSM+EV++E+E+I
Sbjct: 753 KNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENI 808
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 4.9e-80, Sum P(2) = 4.9e-80
Identities = 132/326 (40%), Positives = 192/326 (58%)
Query: 466 IVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYG 525
IV L+ K Y + S+++ + SF+ ++ +ATNNF+S+ +IG+GG+G
Sbjct: 578 IVFLVFGTLWKKGYLRSKSQMEKDFKSLELM-IASFSLRQIKIATNNFDSANRIGEGGFG 636
Query: 526 KVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585
VYKG L DGT++AVK+ GS QG +EFL EI +S LHH NLV L G C E G+ +LV
Sbjct: 637 PVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLV 696
Query: 586 YEFMSNGTLRDQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 643
YEF+ N +L L + L + R I +G +RG+ YLH E+ + HRDIKA+N+
Sbjct: 697 YEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNV 756
Query: 644 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVY 703
LLD + K++DFGL++L D E H+ST + GT GY+ PEY + LTDK+DVY
Sbjct: 757 LLDKQLNPKISDFGLAKL----DEED--STHISTRIAGTFGYMAPEYAMRGHLTDKADVY 810
Query: 704 SLGVVFLELLTGMQ-PISHGKN----IVREVNIAYQSSMMFSVIDGNMGS-YPSECVEKF 757
S G+V LE++ G I KN ++ V + + + + ++D +GS Y E
Sbjct: 811 SFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTM 870
Query: 758 IKLALKCCQDETDARPSMSEVMRELE 783
I++A+ C E RPSMSEV++ LE
Sbjct: 871 IQIAIMCTSSEPCERPSMSEVVKMLE 896
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 8.3e-80, Sum P(3) = 8.3e-80
Identities = 121/313 (38%), Positives = 190/313 (60%)
Query: 498 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE 557
+R T+ + ATN F++ + IG GG+G VYK L DG+VVA+K+ + + QG++EF+ E
Sbjct: 843 LRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAE 902
Query: 558 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP---LGFAMRLSI 614
++ + ++ HRNLV L+GYC E++LVYE+M G+L L K+K+ L ++ R I
Sbjct: 903 METIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKI 962
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
A+G++RG+ +LH P + HRD+K+SN+LLD F A+V+DFG++RL D
Sbjct: 963 AIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTH----LS 1018
Query: 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS---HGK--NIVREV 729
VST+ GTPGY+ PEY+ + + T K DVYS GV+ LELL+G +PI G+ N+V
Sbjct: 1019 VSTLA-GTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWA 1077
Query: 730 NIAYQSSMMFSVIDGNMGSYPSECVE--KFIKLALKCCQDETDARPSMSEVMRELESIWN 787
Y+ ++D + + S VE ++K+A +C D RP+M +VM + +
Sbjct: 1078 KQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKELVQ 1137
Query: 788 MMPESDTKTPEFI 800
+ E+D+ EF+
Sbjct: 1138 VDTENDS-LDEFL 1149
|
|
| TAIR|locus:2148151 AT5G16900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 1.2e-75, Sum P(2) = 1.2e-75
Identities = 145/325 (44%), Positives = 200/325 (61%)
Query: 466 IVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGV-RSFTYGEMALATNNFNSSTQIGQGGY 524
I L+++ +K + R H S+ ++ ++ R TY E+ L TNNF IG+GG+
Sbjct: 527 IAVLVLIIVFIKKRPSSIRALHPSRANLSLENKKRRITYSEILLMTNNFERV--IGEGGF 584
Query: 525 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584
G VY G L D VAVK S QG KEF E++ L R+HH NLVSLVGYCDE+ L
Sbjct: 585 GVVYHGYLNDSEQVAVKVLSPSSSQGYKEFKAEVELLLRVHHINLVSLVGYCDEQAHLAL 644
Query: 585 VYEFMSNGTLRDQLSAKSKE-PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 643
+YE+M+NG L+ LS K + L + RLSIA+ ++ G+ YLH+ P + HRD+K+ NI
Sbjct: 645 IYEYMANGDLKSHLSGKHGDCVLKWENRLSIAVETALGLEYLHSGCKPLMVHRDVKSMNI 704
Query: 644 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVY 703
LLD F AK+ADFGLSR V + +HVST V GTPGYLDPEY+ T++LT+KSDVY
Sbjct: 705 LLDEHFQAKLADFGLSRSFSVGE-----ESHVSTGVVGTPGYLDPEYYRTYRLTEKSDVY 759
Query: 704 SLGVVFLELLTGMQPI----SHGKNIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFI 758
S G+V LE++T QP+ + ++I V S + +++D N+ G Y S V K +
Sbjct: 760 SFGIVLLEIITN-QPVLEQANENRHIAERVRTMLTRSDISTIVDPNLIGEYDSGSVRKAL 818
Query: 759 KLALKCCQDETDARPSMSEVMRELE 783
KLA+ C ARP MS V++EL+
Sbjct: 819 KLAMSCVDPSPVARPDMSHVVQELK 843
|
|
| TAIR|locus:2128625 AT4G20450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 8.5e-75, Sum P(2) = 8.5e-75
Identities = 144/339 (42%), Positives = 208/339 (61%)
Query: 464 SAIVSLLIVRAHMKNYHAISRRRHSSKT-SIKIDGVRSFTYGEMALATNNFNSSTQIGQG 522
+A V ++I + N + +++ S + S + RS+TY E+A+ TNNF +G+G
Sbjct: 543 AASVGIIIAVLLLVNILLLRKKKPSKASRSSMVANKRSYTYEEVAVITNNFERP--LGEG 600
Query: 523 GYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582
G+G VY G + D VAVK E S QG K+F E+ L R+HH NLV+LVGYCDE
Sbjct: 601 GFGVVYHGNVNDNEQVAVKVLSESSAQGYKQFKAEVDLLLRVHHINLVTLVGYCDEGQHL 660
Query: 583 MLVYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 641
+L+YE+MSNG L+ LS + S+ PL + RL IA +++G+ YLH PP+ HRDIK+
Sbjct: 661 VLIYEYMSNGNLKQHLSGENSRSPLSWENRLRIAAETAQGLEYLHIGCKPPMIHRDIKSM 720
Query: 642 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 701
NILLD+ F AK+ DFGLSR PV HVST V G+PGYLDPEY+ T+ LT+KSD
Sbjct: 721 NILLDNNFQAKLGDFGLSRSFPVGS-----ETHVSTNVAGSPGYLDPEYYRTNWLTEKSD 775
Query: 702 VYSLGVVFLELLTGMQPI---SHGKNIVRE-VNIAYQSSMMFSVIDGNM-GSYPSECVEK 756
V+S GVV LE++T QP+ + K+ + E V + + +++D +M G Y S + K
Sbjct: 776 VFSFGVVLLEIITS-QPVIDQTREKSHIGEWVGFKLTNGDIKNIVDPSMNGDYDSSSLWK 834
Query: 757 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 795
++LA+ C + RP+MS+V EL+ ++ E+ K
Sbjct: 835 ALELAMSCVSPSSSGRPNMSQVANELQEC--LLTENSRK 871
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGD7 | Y1684_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7147 | 0.9928 | 0.8782 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 843 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-36 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-30 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 1e-54
Identities = 90/275 (32%), Positives = 133/275 (48%), Gaps = 33/275 (12%)
Query: 518 QIGQGGYGKVYKGIL--PDGTV---VAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 571
++G+G +G+VYKG L G VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
L+G C EE +V E+M G L L K++ L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG---YLDP 688
HRD+ A N L+ K++DFGLSR + +G ++ P
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRD---------LYDDDYYRKRGGKLPIRWMAP 172
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
E K T KSDV+S GV+ E+ T G QP N EV + Y + +G
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--EV-LEY-------LKNGYRL 222
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
P C + L L+C ++ + RP+ SE++ L
Sbjct: 223 PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 4e-54
Identities = 91/276 (32%), Positives = 135/276 (48%), Gaps = 34/276 (12%)
Query: 518 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 571
++G+G +G+VYKG L VAVK +E S Q +EFL E + + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
L+G C EE M+V E+M G L D L + L + LS AL +RG+ YL ++
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----EGIVPAHVSTVVKGTPGYLD 687
HRD+ A N L+ K++DFGLSR D G +P ++ ++
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP------IR----WMA 172
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE K T KSDV+S GV+ E+ T G +P + EV + Y + G
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEV-LEY-------LKKGYR 222
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
P C + KL L+C ++ + RP+ SE++ L
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 4e-52
Identities = 91/287 (31%), Positives = 130/287 (45%), Gaps = 47/287 (16%)
Query: 518 QIGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 572
++G+G +G+VYKG L T VAVK +E S + K+FL E + + +L H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYL 625
+G C EE LV E+M G L D L K L LS A+ ++G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVK 680
HRD+ A N L+ K++DFGLSR D G +P ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP------IR 172
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREVNIAYQSS 736
PE T KSDV+S GV+ E+ T G P +S EV + Y
Sbjct: 173 WMA----PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEV-LEY--- 219
Query: 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
+ G P C ++ +L L C Q + + RP+ SE++ LE
Sbjct: 220 ----LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 74/268 (27%), Positives = 116/268 (43%), Gaps = 28/268 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 575
++G+G +GKVY G +VA+K ++ ++ ++E L EI+ L +L H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
++E + LV E+ G L D L + + A + YLH + H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLH---SKGIVH 120
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
RD+K NILLD K+ADFGL+R + ++T V GTP Y+ PE L
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE-------KLTTFV-GTPEYMAPEVLLGKG 172
Query: 696 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI---DGNMGSYPSE 752
D++SLGV+ ELLTG P + +F I +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQL----------LELFKKIGKPKPPFPPPEWD 222
Query: 753 CVEKFIKLALKCCQDETDARPSMSEVMR 780
+ L K + + R + E ++
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 6e-47
Identities = 88/277 (31%), Positives = 130/277 (46%), Gaps = 36/277 (12%)
Query: 518 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 571
++G+G +G+VYKG L T VAVK +EG+ + E+ EFL E + +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
L+G C + +V E+M G L D L E L L +AL ++G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVSTVVKGTPGYL 686
HRD+ A N L+ K++DFGLSR D G +P +K
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP------IKWMA--- 172
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
PE K T KSDV+S GV+ E+ T G QP N ++ + DG
Sbjct: 173 -PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN----------EEVLELLEDGY 221
Query: 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
P C ++ +L L+C + + RP+ SE++ +L
Sbjct: 222 RLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 78/268 (29%), Positives = 111/268 (41%), Gaps = 57/268 (21%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 576
+G+GG+G VY G VA+K ++ E L EI+ L +L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
++E LV E+ G+L+D L L L I L G+ YLH+ + HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 637 DIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 694
D+K NILLD K+ADFGLS+L + GTP Y+ PE L
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-------LKTIVGTPAYMAPEVLLGKG 169
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
++KSD++SLGV+ EL
Sbjct: 170 YYSEKSDIWSLGVILYEL------------------------------------------ 187
Query: 755 EKFIKLALKCCQDETDARPSMSEVMREL 782
+ L K Q + + RPS E++ L
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 86/269 (31%), Positives = 126/269 (46%), Gaps = 26/269 (9%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
++G G +G VYK G +VAVK + + + ++ EI+ L RL H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+++ LV E+ G L D LS PL IAL RG+ YLH+ +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K NILLD K+ADFGL++ + + T GTP Y+ PE L
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 695 KL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG-NMGSYPSE 752
K DV+SLGV+ ELLTG +P G+NI+ Q ++ ++ P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTG-KPPFSGENILD------QLQLIRRILGPPLEFDEPKW 226
Query: 753 C--VEKFIKLALKCCQDETDARPSMSEVM 779
E+ L KC + RP+ E++
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 76/270 (28%), Positives = 121/270 (44%), Gaps = 33/270 (12%)
Query: 518 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 574
+G+G +G VY + D G ++AVK + E + EI+ LS L H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 575 -YCDEEGEQMLVY-EFMSNGTLRDQLSAKSK--EPLGFAMRL---SIALGSSRGILYLHT 627
DEE + ++ E++S G+L L K EP+ +R I G+ YLH+
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLHS 119
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ HRDIK +NIL+D K+ADFG ++ + I + V+GTP ++
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKR-----LGDIETGEGTGSVRGTPYWMA 171
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
PE + +D++SLG +E+ TG P S N + +++ G
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--------AALYKIGSSGEPP 223
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSE 777
P E+ KC + + RP+ E
Sbjct: 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-36
Identities = 95/263 (36%), Positives = 139/263 (52%), Gaps = 12/263 (4%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
+N +SG IP EIG + SL L L N LTG +P LG L L + + QN +SG +P S
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
+L K +++NS+SG+IP + +L +L + L +NN TG +P L+ LP+L +LQL
Sbjct: 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPG 180
+N F G IP + + L L L +L G +P+ L NL L L SN L G IP
Sbjct: 341 SNKFSG-EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399
Query: 181 RLSLN-ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239
+ + ++L +N +G +PS F+ LP + L I+NN+L G I S W +L
Sbjct: 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ---- 455
Query: 240 FILDFQNNN----LTNISGSFNI 258
+L N L + GS +
Sbjct: 456 -MLSLARNKFFGGLPDSFGSKRL 477
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-35
Identities = 93/250 (37%), Positives = 132/250 (52%), Gaps = 10/250 (4%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N +GSIP+ G+I +LE L L+ N L+G +P ++G L + + N + G +P S
Sbjct: 128 NNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
NL + +N + GQIP EL ++ SL + L NNL+G +P E+ L L L L
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGR 181
NN G IP+S N+ L L L L GP+P + + L LDLS N L+G IP
Sbjct: 246 NNLTG-PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304
Query: 182 LSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+ L N+ + L +N TG IP + LPRLQ L + +N SG IP ++ + L
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT----- 359
Query: 241 ILDFQNNNLT 250
+LD NNLT
Sbjct: 360 VLDLSTNNLT 369
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 6e-34
Identities = 96/278 (34%), Positives = 141/278 (50%), Gaps = 20/278 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N +SG IP +IG+ SL++L L GN L G +P L L L+ + + N + G +P+
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG 209
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+ + ++ N++SG+IP E+ L SL H+ L NNLTG +P L L L L L
Sbjct: 210 QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPGR 181
N G IP S ++ KL+ L L + SL G +P+L ++ NL L L SN G IP
Sbjct: 270 NKLSG-PIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 182 LSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
SL + ++L +NK +G IP N L L ++ N+L+G IP + S L F
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNL-----F 383
Query: 241 ILDFQNNNLTNISGSFNIPPNVT-------VRLRGNPF 271
L +N+L IP ++ VRL+ N F
Sbjct: 384 KLILFSNSLEG-----EIPKSLGACRSLRRVRLQDNSF 416
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 7e-34
Identities = 91/274 (33%), Positives = 133/274 (48%), Gaps = 32/274 (11%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N + G IP + N+ SLE L L N+L G +P ELG + L I + N +SG +P
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL------- 115
L H + N+++G IP L L +L ++ L N L+G +PP + L KL
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293
Query: 116 ---------LILQLDN--------NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DL 157
L++QL N NNF G IP + +++ +L L L + G +P +L
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTG-KIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
Query: 158 SRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 216
+ NL LDLS+N L G IP G S N+ + L +N L G IP + L+R+ +
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ 412
Query: 217 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 250
+NS SG +PS + + LD NNNL
Sbjct: 413 DNSFSGELPSEFTKLPLVY-----FLDISNNNLQ 441
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 31/269 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IG+GG+G+VYK G VA+K + S + +++ + EIQ L + H N+V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
++ E +V EF S G+L+D L + + L + + +G+ YLH+ + HR
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHR 122
Query: 637 DIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
DIKA+NILL K+ DFGLS +L+ +V GTP ++ PE
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---------GTPYWMAPEVINGKP 173
Query: 696 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG----SYPS 751
K+D++SLG+ +EL G P S + ++ +G G S
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYS---------ELPPMKALFKIATNGPPGLRNPEKWS 224
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + F+K KC Q + RP+ ++++
Sbjct: 225 DEFKDFLK---KCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-31
Identities = 85/232 (36%), Positives = 130/232 (56%), Gaps = 7/232 (3%)
Query: 1 MW-NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK 59
+W NK SG IPK +G +L +L L+ N LTG +PE L L ++ + N + G +PK
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
Query: 60 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML-LDNNNLTGYLPPELSELPKLLIL 118
S R + +NS SG++P E ++LP LV+ L + NNNL G + ++P L +L
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLP-LVYFLDISNNNLQGRINSRKWDMPSLQML 457
Query: 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSI 177
L N F G +P S+ + +L L L G +P L + L L LS N+L+G I
Sbjct: 458 SLARNKFFG-GLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515
Query: 178 PPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 228
P S + ++ LS+N+L+G IP++FS +P L +L ++ N LSG IP ++
Sbjct: 516 PDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 30/282 (10%)
Query: 507 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH 566
A+ + IG+G +G V G G VAVK ++ S + FL E ++ L H
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
NLV L+G + +V E+M+ G+L D L ++ + + A +L AL G+ YL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ HRD+ A N+L+ AKV+DFGL++ A G +P VK T
Sbjct: 120 EKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------VKWTA--- 167
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG--KNIVREVNIAYQSSMMFSVID 743
PE K + KSDV+S G++ E+ + G P K++V V Y+
Sbjct: 168 -PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--------- 217
Query: 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
M + P C + K+ C + + RP+ ++ +L I
Sbjct: 218 --MEA-PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 23/283 (8%)
Query: 518 QIGQGGYGKVYKG---ILPDGT--VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVS 571
Q+G+G +GKV L D T VAVK G Q +F EI+ L L H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 572 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
G C++ G + L+ E++ +G+LRD L + ++ + L + +G+ YL ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-YLDP 688
HRD+ A NIL++ + K++DFGL+++ P + +P + P
Sbjct: 130 ---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK-----DYYYVKEPGESPIFWYAP 181
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG-KNIVREVNIAYQSSMMFSVI----D 743
E T K + SDV+S GV EL T P +R + IA ++ ++ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786
G P C ++ L C + E RPS ++++ ++ +
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 85/281 (30%), Positives = 124/281 (44%), Gaps = 47/281 (16%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578
+G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEADPPVF 634
E +V E+MS G+L D L K G +RL +A + G+ YL +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTV--VKGTPGYLDPEYF 691
HRD+ A NIL+ K+ADFGL+RL IE A +K T PE
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL-----IEDDEYTAREGAKFPIKWTA----PEAA 176
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-------GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
+ T KSDV+S G++ E++T GM + ++ +V Y+
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVERGYRMPR------- 225
Query: 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P C E+ L L+C + + RP+ + LE
Sbjct: 226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 31/272 (11%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G+V++G+ + T VAVK + G++ K+FL E Q + +L H L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
E +V E M G+L + L + L + +A + G+ YL + HRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEYFLTHK 695
+ A N+L+ KVADFGL+R+ E I A +K T PE L ++
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTA----PEAALYNR 180
Query: 696 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PS 751
+ KSDV+S G++ E++T +G+ + Y V+ Y P
Sbjct: 181 FSIKSDVWSFGILLTEIVT------YGR-------MPYPGMTNAEVLQQVDQGYRMPCPP 227
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
C ++ + L C +++ D RP+ + +LE
Sbjct: 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 87/281 (30%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 519 IGQGGYGKVYKGILPDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
IG+G +G VY G L D AVK L+ ++FL E + H N++SL+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 574 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHT 627
G C EG ++V +M +G LR+ + +++ P +GF ++++ +G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA------KGMEYL-- 114
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
A HRD+ A N +LD FT KVADFGL+R + D E H T K ++
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSV-HNHTGAKLPVKWMA 170
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
E T K T KSDV+S GV+ EL+T G P V +I ++ G
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VDSFDITVY------LLQGRR 220
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787
P C + ++ L C + + RP+ SE++ +E I++
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G V+ G VA+K +EG++ E +F+ E + + +L H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
++ +V E+M+NG L + L + K LG L + + YL + HRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
+ A N L+ KV+DFGL+R V D + VK P PE F + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP----PEVFDYSRFS 179
Query: 698 DKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
KSDV+S GV+ E+ + G P N +V V+ Y+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR------------PKLAP 227
Query: 755 EKFIKLALKCCQDETDARPSMSEVMREL 782
+ + C ++ + RP+ +++ +L
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 86/310 (27%), Positives = 138/310 (44%), Gaps = 60/310 (19%)
Query: 512 NFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL 564
N +G+G +GKV K T VAVK +E + E ++ L+E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 565 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--------------------- 603
+H +++ L G C ++G +L+ E+ G+LR L K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 604 -EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-- 660
L +S A SRG+ YL A+ + HRD+ A N+L+ K++DFGLSR
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 661 ---LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 716
+ V +G +P VK ++ E H T +SDV+S GV+ E++T G
Sbjct: 178 YEEDSYVKRSKGRIP------VK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 717 QPISHGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSM 775
P IA + +F+++ G P C E+ L L C + E D RP+
Sbjct: 228 NPYP---------GIAPER--LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276
Query: 776 SEVMRELESI 785
+++ +ELE +
Sbjct: 277 ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 83/271 (30%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 518 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
++G G YG+VY+G+ VAVK +E +++ E EFL E + + H NLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
D+ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182
Query: 697 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID-GNMGSYPSECV 754
+ KSDV++ GV+ E+ T GM P S ++ +++ G P C
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYP-----------GIDLSQVYELLEKGYRMERPEGCP 231
Query: 755 EKFIKLALKCCQDETDARPSMSEVMRELESI 785
K +L C Q RPS +E+ + E++
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/213 (33%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRN 568
N+ IG+G +G VYKG+ L G VA+K+ ++ E K + EI L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 626
+V +G + ++ E+ NG+LR + E L A+ + L +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQVL---QGLAYLH 116
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGY 685
+ V HRDIKA+NIL K+ADFG++ +L V + V GTP +
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--------SKDDASVVGTPYW 165
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ PE + SD++SLG +ELLTG P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G+V++G+ + VA+K + L +++F E+Q L RL H++L+SL C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
++ E M G+L L + + L A + +A + G+ YL + HRD
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYFLTHKL 696
+ A NIL+ KVADFGL+RL E + + + K T PE
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIK----EDVYLSSDKKIPYKWTA----PEAASHGTF 181
Query: 697 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSE 752
+ KSDV+S G++ E+ T +G+ + Y V D Y P++
Sbjct: 182 STKSDVWSFGILLYEMFT------YGQ-------VPYPGMNNHEVYDQITAGYRMPCPAK 228
Query: 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
C ++ K+ L+C E + RPS + EL++I
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 83/272 (30%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
IG G +GKVY + L G ++AVK R Q+ + KE E++ L L H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 576 CDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ E++ ++ E+ S GTL + L ++ L G+ YLH+ +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHG---IV 121
Query: 635 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693
HRDIK +NI LDH K+ DFG + +L G ++ GTP Y+ PE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA----GTPAYMAPEVITG 177
Query: 694 HKLTDK---SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
K +D++SLG V LE+ TG +P S N + +MF V G+ P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---------EFQIMFHVGAGHKPPIP 228
Query: 751 -----SECVEKFIKLALKCCQDETDARPSMSE 777
S + F+ C + + RP+ SE
Sbjct: 229 DSLQLSPEGKDFLDR---CLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 77/267 (28%), Positives = 122/267 (45%), Gaps = 21/267 (7%)
Query: 517 TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+GQG G VYK P G + A+K+ + K+ L E++ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+EGE +V E+M G+L D L K P ++ + +G+ YLHT+ +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI--LKGLDYLHTKRH--II 122
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRDIK SN+L++ K K+ADFG+S+ +E + + V GT Y+ PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISK-----VLENTLDQCNTFV--GTVTYMSPERIQGE 175
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
+ +D++SLG+ LE G P +M ++ DG S P+E
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPS-------FFELMQAICDGPPPSLPAEEF 228
Query: 755 -EKFIKLALKCCQDETDARPSMSEVMR 780
+F C Q + RPS +E+++
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 84/274 (30%), Positives = 129/274 (47%), Gaps = 34/274 (12%)
Query: 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
+IG G +G V+ G + VA+K +EG++ E++F+ E Q + +L H LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADP 631
C E LV+EFM +G L D L A+ S+E L L + L G+ YL +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN-- 120
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
V HRD+ A N L+ KV+DFG++R V D + ST K + PE F
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQ----YTSSTGTKFPVKWSSPEVF 173
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGS 748
K + KSDV+S GV+ E+ + G P + N +V +N ++
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----------- 222
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
P + +L C ++ + RPS S ++ +L
Sbjct: 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 25/271 (9%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 576
+IG+G +G VYKG+L T VAVK + K FL E + L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
++ +V E + G+L L K K L L ++L ++ G+ YL ++ HR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHK 695
D+ A N L+ K++DFG+SR + EG + VS +K P + PE +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----EEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171
Query: 696 LTDKSDVYSLGVVFLELLT-GMQPISHGKNI-VREVNIAYQSSMMFSVIDGNMGSYPSEC 753
T +SDV+S G++ E + G P N RE + G P C
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-----------RIESGYRMPAPQLC 220
Query: 754 VEKFIKLALKCCQDETDARPSMSEVMRELES 784
E+ +L L+C + + RPS SE+ EL+
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 88/310 (28%), Positives = 135/310 (43%), Gaps = 64/310 (20%)
Query: 511 NNFNSSTQIGQGGYGKVYK----GILP--DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSR 563
NN IGQG +G+V++ G+LP T+VAVK +E S + +F E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------------K 603
H N+V L+G C L++E+M+ G L + L +S
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 604 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663
PL +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR--- 178
Query: 664 VPDIEGIVPAHVSTVVKGTPG------YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 716
+I + + K + ++ PE ++ T +SDV++ GVV E+ + GM
Sbjct: 179 --NI------YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 717 QP---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 773
QP ++H E I Y V DGN+ S P C + L C RP
Sbjct: 231 QPYYGMAH------EEVIYY-------VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
Query: 774 SMSEVMRELE 783
S + + R L+
Sbjct: 278 SFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 518 QIGQGGYGKVYKG----ILPDG--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLV 570
++G+G +GKV+ G + P+ +VAVK +E + K+F E + L+ H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGS 618
G C E ++V+E+M +G L L + L + L IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHV 675
+ G++YL A HRD+ N L+ + K+ DFG+SR D + G H
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG----HT 184
Query: 676 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP-ISHGKNIVREVNIAY 733
++ P PE + K T +SDV+S GVV E+ T G QP V E
Sbjct: 185 MLPIRWMP----PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---- 236
Query: 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
+ G + P C + + L C + + R ++ ++ L+
Sbjct: 237 -------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 87/267 (32%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
EE +V E+MS G+L D L + + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
++A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 698 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPES 231
Query: 757 FIKLALKCCQDETDARPSMSEVMRELE 783
L +C + E + RP+ + LE
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (282), Expect = 7e-27
Identities = 95/336 (28%), Positives = 146/336 (43%), Gaps = 21/336 (6%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHR 567
++ ++G+G +G+VY D +VA+K E + + FL EIQ L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLH 626
N+V L + +EG LV E++ G+L D L K PL + L I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 627 TEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
++ + HRDIK NILLD K+ DFGL++L P P +PA ST V GTPGY
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 686 LDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQP---ISHGKNIVREVNIAYQSSMMF 739
+ PE L + SD++SLG+ ELLTG+ P + + + I +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM-RELESIWNMMPESDTKTPE 798
+ S P + L K + R S S + +L + + ESD
Sbjct: 235 LASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK-LKESDLSDLL 292
Query: 799 FINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 834
+ + PPS +++ + +
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 78/273 (28%), Positives = 124/273 (45%), Gaps = 35/273 (12%)
Query: 518 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEF-LTEIQFLSRLHHRNLVSLVG 574
QIG+G +GKVY DG + +K + E+E L E++ L +L+H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 575 YCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHT 627
Y + E+G+ +V E+ G L ++ + KE F + + L + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL--ALKYLHS 121
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ HRDIK NI L K+ DFG+S++ + V TVV GTP YL
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSSTVD-LAKTVV-GTPYYLS 171
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
PE KSD++SLG V EL T P G+N + ++ G
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGEN---------LLELALKILKGQYP 221
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
PS+ + L Q + + RPS++++++
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 62/298 (20%)
Query: 517 TQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNL 569
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRG 621
V L+G ++V E M+ G L+ L ++ E P + +A + G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIV 671
+ YL A HRD+ A N ++ T K+ DFG++R DI +G++
Sbjct: 132 MAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYRKGGKGLL 183
Query: 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 730
P ++ PE T KSDV+S GVV E+ T QP
Sbjct: 184 PVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP------------ 221
Query: 731 IAYQ----SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
YQ ++ VIDG P C +K ++L C Q RP+ E++ L+
Sbjct: 222 --YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 32/272 (11%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G V G VA+K +EGS+ E EF+ E + + +L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
++ +V E+MSNG L + L K + L + G+ YL ++ HRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLESKQ---FIHRD 125
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLDPEYFL 692
+ A N L+D + KV+DFGLSR V D E + S+V V+ +P PE L
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRY--VLDDE-----YTSSVGSKFPVRWSP----PEVLL 174
Query: 693 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
K + KSDV++ GV+ E+ + G P N S + V G P
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----------SETVEKVSQGLRLYRPH 224
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
EK + C ++ + RP+ +++ +E
Sbjct: 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCD 577
+G+G +G+V+KG L D T VAVK +E Q K +FL+E + L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
+ +V E + G L K K+ L + AL ++ G+ YL ++ HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLTHKL 696
+ A N L+ K++DFG+SR + +GI + S+ +K P + PE +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----QEDDGI---YSSSGLKQIPIKWTAPEALNYGRY 171
Query: 697 TDKSDVYSLGVVFLELLT-GMQPISHGKN-IVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
+ +SDV+S G++ E + G+ P N RE V G S P +C
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----------QVEKGYRMSCPQKCP 220
Query: 755 EKFIKLALKCCQDETDARPSMSEVMRELES 784
+ K+ +C + + RP SE+ +EL +
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 568
+ + +IG+G G+VYK G VA+K+ + Q ++ + EI + H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEP-LGFAMRLSIALGSSRGILY 624
+V E +V E+M G+L D Q + EP + + R + +G+ Y
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLEY 131
Query: 625 LHTEADPPVFHRDIKASNILLDHKFTAKVADFG----LSRLAPVPDIEGIVPAHVSTVVK 680
LH++ V HRDIK+ NILL + K+ADFG L++ ++VV
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----------KRNSVV- 177
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
GTP ++ PE K D++SLG++ +E+ G P
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-----EIQFLSRLHHRNLVSL 572
+G+G YG VYK G +VA+K+ + L E+E + EI L L H N+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR---LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEAD 630
+ E + LV+E+ L+ L K P + L SI RG+ Y H+
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
+ HRD+K NIL++ K+ADFGL+R +P + + VV T Y PE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-----LRTYTHEVV--TLWYRAPEI 169
Query: 691 FLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
L K + D++S+G +F E++TG +P+ G +
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 90/294 (30%), Positives = 128/294 (43%), Gaps = 57/294 (19%)
Query: 519 IGQGGYGKVYKG----ILPDGT---VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 570
+G G +G+VY+G IL G+ VAVK ++G+ EK EFL E +S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 571 SLVGYCDEEGEQMLVYEFMSNGT----LRDQLSAKSKEP-LGFAMRLSIALGSSRGILYL 625
L+G C Q ++ E M G LRD + P L L I L ++G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 626 HTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDI----------EGI 670
HRD+ A N L+ K K+ DFGL+R DI EG+
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEGEGL 174
Query: 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 729
+P ++ PE L K T +SDV+S GV+ E+LT G QP N EV
Sbjct: 175 LPVR----------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EV 222
Query: 730 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
+ + V G P C +K +L C + RP+ + L+
Sbjct: 223 -LQH-------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 46/227 (20%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 571
QIG+G YG+VYK G +VA+K+ ++ EKE + EI+ L +L H N+V
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 572 LVGYCDEE--GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS---------- 619
L + G +V+E+M + D L+ G + S
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH----D-LT-------GLLDSPEVKFTESQIKCYMKQLL 110
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTV 678
G+ YLH+ + HRDIK SNIL+++ K+ADFGL+R + + V
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-----ADYTNRV 162
Query: 679 VKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
+ T Y PE L + + D++S+G + EL G +PI G
Sbjct: 163 I--TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 82/274 (29%), Positives = 119/274 (43%), Gaps = 29/274 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY 575
IG G VY I LP+ VA+KR Q E E+Q +S+ +H N+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPP 632
E LV ++S G+L D + KS P G IA +G+ YLH+
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
HRDIKA NILL + K+ADFG+S A + D G V GTP ++ PE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVS--ASLAD-GGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 693 THK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
K+D++S G+ +EL TG P S + + M+ + + S +
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLML--TLQNDPPSLET 229
Query: 752 ECVEK-----FIKLALKCCQDETDARPSMSEVMR 780
K F K+ C Q + RP+ E+++
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 80/275 (29%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 518 QIGQGGYGKVYKGI--LPDGTV--VAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
++G G +G V KG+ + G VAVK QE G+KEFL E +++L H +V L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C E MLV E G L L + + P+ + +A + G+ YL E+
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYL--ESKHF 116
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG------YL 686
V HRD+ A N+LL ++ AK++DFG+SR A S + T +
Sbjct: 117 V-HRDLAARNVLLVNRHQAKISDFGMSR-ALGAG---------SDYYRATTAGRWPLKWY 165
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
PE K + KSDV+S GV E + G +P K + + ++++
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------AEVIAMLESG 214
Query: 746 --MGSYPSECVEKFIKLALKCCQDETDARPSMSEV 778
+ P EC ++ + L C + + RP+ SE+
Sbjct: 215 ERLPR-PEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 83/282 (29%), Positives = 120/282 (42%), Gaps = 55/282 (19%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 572
+G G +G VY+G+ L DG AVK A +G E K+ EI LS+L H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
+G EE + E + G+L L EP+ I LG + YLH D
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH---D 120
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGY 685
HRDIK +NIL+D K+ADFG+++ V KG+P +
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-------------QVVEFSFAKSFKGSPYW 167
Query: 686 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
+ PE +D++SLG LE+ TG P S + +F + G
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ----------LEGVAAVFKI--G 215
Query: 745 NMGSYP------SECVEKFIKLALKCCQDETDARPSMSEVMR 780
P S+ + FI LKC Q + RP+ +E++
Sbjct: 216 RSKELPPIPDHLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 519 IGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
IG G +G+V +G L P VA+K + GS ++ +FLTE + + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G + M++ E+M NG+L D+ ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLDP 688
HRD+ A NIL++ KV+DFGLSR + G +P + P
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----------WTAP 177
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
E K T SDV+S G+V E+++ G +P N ++V + +V DG
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDV--------IKAVEDGYRL 227
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
P +C +L L C Q + + RP+ S+++ L+
Sbjct: 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 76/261 (29%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+G+G YG VYK I G VVA+K E LQ E + EI L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
+ + +V E+ G++ D + +K L +I + +G+ YLH HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
DIKA NILL+ + AK+ADFG+S A +TV+ GTP ++ PE
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176
Query: 697 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756
+K+D++SLG+ +E+ G P S + I + S P + +
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD--------PEKWSPE 228
Query: 757 FIKLALKCCQDETDARPSMSE 777
F KC + + RPS +
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 85/267 (31%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
EE +V EFM G+L D L + L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
++A+NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 698 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756
KSDV+S G++ EL+T G P N REV + V G P C E
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVN--REV--------LEQVERGYRMPCPQGCPES 231
Query: 757 FIKLALKCCQDETDARPSMSEVMRELE 783
+L C + + D RP+ + LE
Sbjct: 232 LHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 79/266 (29%), Positives = 123/266 (46%), Gaps = 22/266 (8%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G V+ G VA+K EG++ E++F+ E + + +L H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
++ +V EFM NG L + L + + L M LS+ G+ YL + HRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
+ A N L+ KV+DFG++R V D E + VK +P PE F K +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSP----PEVFNFSKYS 179
Query: 698 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756
KSDV+S GV+ E+ T G P N Y+ M S G P
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMIS--RGFRLYRPKLASMT 229
Query: 757 FIKLALKCCQDETDARPSMSEVMREL 782
++ C ++ + RP+ +E++R +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-24
Identities = 77/240 (32%), Positives = 128/240 (53%), Gaps = 13/240 (5%)
Query: 15 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNKTRHFHMN 73
N + + L+G ++G + + LP + I + N +SG +P F + R+ +++
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 74 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 133
NN+ +G IP +P+L + L NN L+G +P ++ L +L L N G IP S
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG-KIPNS 183
Query: 134 YSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIK 190
+N++ L L+L + L G +P +L ++ +L ++ L N L+G IP G L+ ++ +
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT-SLNHLD 242
Query: 191 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 250
L N LTG IPS+ L LQ LF+ N LSG IP SI+ + L + LD +N+L+
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS-----LDLSDNSLS 297
|
Length = 968 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 83/267 (31%), Positives = 124/267 (46%), Gaps = 22/267 (8%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G+V+ G T VAVK + G++ E FL E Q + +L H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
EE +V E+MS G+L D L L + +A + G+ Y+ HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
++++NIL+ K+ADFGL+RL + D E +K T PE L + T
Sbjct: 128 LRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 698 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756
KSDV+S G++ EL+T G P N REV + V G P +C
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNN--REV--------LEQVERGYRMPCPQDCPIS 231
Query: 757 FIKLALKCCQDETDARPSMSEVMRELE 783
+L L+C + + + RP+ + LE
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 39/294 (13%)
Query: 518 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G+G +GKV+ + P D +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSA--------------KSKEPLGFAMRLSIALG 617
G C + ++V+E+M +G L L A ++K LG + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
+ G++YL A HRD+ N L+ K+ DFG+SR D V H
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-VGGHTML 187
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 736
++ P PE + K T +SDV+S GV+ E+ T G QP N +
Sbjct: 188 PIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----------TE 233
Query: 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790
++ + G + P C ++ + L C Q E R ++ E+ + L ++ P
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 46/292 (15%)
Query: 518 QIGQGGYGKVYKGIL--PDG----TVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 570
++G+G +GKVYKG L P+ T VA+K +E + ++EF E + +S L H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----------------SAKSKEPLGFAMRLS 613
L+G C +E +++E++++G L + L S + F L
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LH 128
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673
IA+ + G+ YL + HRD+ A N L+ T K++DFGLSR D +
Sbjct: 129 IAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 732
+ V ++ PE L K T +SD++S GVV E+ + G+QP N +EV
Sbjct: 186 SLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEV--- 235
Query: 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
+ + + P +C + L ++C + RP ++ L S
Sbjct: 236 -----IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 79/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 519 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
IG G +G+V++GIL VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G + M++ E+M NG L L E + + + + G + G+ YL +D
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDMNY 128
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693
HRD+ A NIL++ KV+DFGLSR+ D EG + ++ K + PE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEG---TYTTSGGKIPIRWTAPEAIAY 184
Query: 694 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752
K T SDV+S G+V E+++ G +P N EV M ++ DG P +
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEV--------MKAINDGFRLPAPMD 234
Query: 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
C +L L+C Q + RP +++ L+ +
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 82/285 (28%), Positives = 122/285 (42%), Gaps = 29/285 (10%)
Query: 519 IGQGGYGKVYKGIL------PDGT--VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNL 569
+G+G +GKV L DGT +VAVK + Q + EI L L+H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 570 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
V G C E+G + L+ E++ G+LRD L K L A L A G+ YLH+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ HRD+ A N+LLD+ K+ DFGL++ P EG V +
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWYA 178
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVID--- 743
E +K + SDV+S GV ELLT S K + + +I+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 744 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787
G P C ++ L C + E RP+ ++ L+ + +
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 82/291 (28%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 518 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G+G +GKV+ + P D +VAVK ++ S K+F E + L+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA-----------MRLSIALGSSR 620
G C E ++V+E+M +G L L A + + A L IA +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 621 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
G++YL A HRD+ N L+ K+ DFG+SR D V H ++
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIR 187
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 739
P PE + K T +SDV+SLGVV E+ T G QP N + ++
Sbjct: 188 WMP----PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----------NEVIE 233
Query: 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790
+ G + P C ++ L L C Q E R ++ E+ L+++ P
Sbjct: 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 82/268 (30%), Positives = 124/268 (46%), Gaps = 30/268 (11%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
IG+G +G V +G G VAVK + + + Q FL E +++LHH+NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
G +V E MS G L + L + + + L +L + G+ YL ++ + HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
D+ A NIL+ AKV+DFGL+R+ + +P VK T PE K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTA----PEALKHKKF 174
Query: 697 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 755
+ KSDV+S GV+ E+ + G P + K ++EV + G P C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP--YPKMSLKEVKECVEK--------GYRMEPPEGCPA 224
Query: 756 KFIKLALKCCQDETDARPSMSEVMRELE 783
L C + E RPS ++ +LE
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 38/287 (13%)
Query: 518 QIGQGGYGKVY----KGILP--DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G+G +GKV+ +LP D +VAVK +E S ++F E + L+ L H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-------------PLGFAMRLSIALGS 618
G C E ++V+E+M +G L L + + L L+IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 678
+ G++YL A HRD+ N L+ K+ DFG+SR DI V
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGGR 183
Query: 679 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 737
++ PE L K T +SD++S GVV E+ T G QP N +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----------TEA 233
Query: 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
+ + G P C + + C Q E R + ++ L++
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/225 (30%), Positives = 96/225 (42%), Gaps = 37/225 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFLT-EIQFLSRLHHRNLVSLVGY 575
IG+G +G V K DG ++ K G++ + EK+ L E+ L L H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 576 CDEE--GEQMLVY---EFMSNGTLRDQLSAKSKEP---------LGFAMRLSIALGSSRG 621
D +Y E+ G L QL K K+ +L +AL
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALY---- 119
Query: 622 ILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
H +DP V HRD+K +NI LD K+ DFGL+++ A T V
Sbjct: 120 --ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG----HDSSFAK--TYV 171
Query: 680 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
GTP Y+ PE +KSD++SLG + EL P +N
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 84/296 (28%), Positives = 132/296 (44%), Gaps = 49/296 (16%)
Query: 518 QIGQGGYGKVYK---GILPDGT--VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
Q+G+G +G V L D T VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 573 VGYCDEEG--EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
G C G LV E++ G+LRD L K +E L L A +G+ YL ++
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----Y 685
HRD+ NIL++ + K+ DFGL+++ P D E V+ PG +
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKE-------YYKVR-EPGESPIFW 177
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTG-----------MQPISHGKNIVREVNIAYQ 734
PE K + SDV+S GVV EL T M+ + + K
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ-------- 229
Query: 735 SSMMFSVIDGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786
+++ +I+ + P C + + +C ++ RPS SE+ ++E+I
Sbjct: 230 -MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 79/283 (27%), Positives = 124/283 (43%), Gaps = 38/283 (13%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-----KEFLTEIQFLSRL 564
N+ +GQG +G+VY D G +AVK+ E EIQ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 565 HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 620
H +V G C + E + ++ E+M G+++DQL A A+ ++ +R
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQIL 114
Query: 621 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPV-PDIEGIVPAHVST 677
G+ YLH+ + HRDIK +NIL D K+ DFG S RL + G+
Sbjct: 115 EGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS----- 166
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737
V GTP ++ PE K+DV+S+G +E+LT P + + + IA Q +
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT- 224
Query: 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + S+ S F++ + RPS E++R
Sbjct: 225 -----NPQLPSHVSPDARNFLRRTFV---ENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 518 QIGQGGYGKVYKG-ILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
++G G G V K P G ++AVK + E + +K+ L E+ L + + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGSSRGILYLHTEADP 631
G+ + E+M G+L L LG IA+ +G+ YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE--KH 120
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDP 688
+ HRD+K SNIL++ + K+ DFG+S V+++ K GT Y+ P
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------------VNSLAKTFVGTSSYMAP 168
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
E + + KSD++SLG+ +EL TG P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 67/256 (26%), Positives = 110/256 (42%), Gaps = 36/256 (14%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-V 573
IG+G +GKV D + A+K + + + L E + L L+H LV+L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIA-LGSSRGILYLHTEA 629
+ DEE ++V + + G LR LS K K F+ ++ I + + YLH++
Sbjct: 68 SFQDEENMYLVV-DLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVL--ALEYLHSKG 120
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRDIK NILLD + + DF ++ P ++T GTPGY+ PE
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNIATKVT--------PDTLTTSTSGTPGYMAPE 169
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE--VNIAYQSSMMFSVIDGNMG 747
+ D +SLGV E L G +P +R+ + +++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW---- 225
Query: 748 SYPSECVEKFIKLALK 763
+E ++ I L+
Sbjct: 226 --STEAID-AINKLLE 238
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 54/291 (18%)
Query: 519 IGQGGYGKVYKGI---LPDGTV---VAVK-RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
+G G +G+VY+G+ V VAVK + S Q E +FL E +S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLS---AKSKEPLGFAMR--LSIALGSSRGILYLH 626
L+G E + ++ E M+ G L+ L + + P M+ L A ++G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 627 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG----------IVPA 673
HRDI A N LL K AK+ADFG++R DI ++P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLP- 184
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 732
+K P PE FL T K+DV+S GV+ E+ + G P N +EV
Sbjct: 185 -----IKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEV--- 230
Query: 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
M F G + P C ++ C Q + RP+ + ++ ++
Sbjct: 231 ----MEFVTGGGRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-23
Identities = 74/238 (31%), Positives = 113/238 (47%), Gaps = 32/238 (13%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYL---------------------- 40
N + G IPK +G +SL + L N +G LP E L
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449
Query: 41 --PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 98
P L + + +N G LP SF + + + ++ N SG +P +L L L+ + L
Sbjct: 450 DMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE 508
Query: 99 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DL 157
N L+G +P ELS KL+ L L +N G IPAS+S M L +L L L G +P +L
Sbjct: 509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQ-IPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
Query: 158 SRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 213
+ +L +++S N L+GS+P L++N + + N L G + SGLP +R+
Sbjct: 568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVA-GNIDLCGGDTT--SGLPPCKRV 622
|
Length = 968 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 29/269 (10%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G+V+ G T VA+K ++GS+ E FL E + +L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVT 71
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
+E ++ E+M NG+L D L L + +A + G+ ++ + HRD
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
++A+NIL+ K+ADFGL+RL + D E +K T PE T
Sbjct: 128 LRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTA----PEAINYGTFT 181
Query: 698 DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSEC 753
KSDV+S G++ E++T +G+ I Y VI Y P C
Sbjct: 182 IKSDVWSFGILLTEIVT------YGR-------IPYPGMTNPEVIQNLERGYRMPRPDNC 228
Query: 754 VEKFIKLALKCCQDETDARPSMSEVMREL 782
E+ +L C +++ + RP+ E +R +
Sbjct: 229 PEELYELMRLCWKEKPEERPTF-EYLRSV 256
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-CD 577
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
E+G +V E+M+ G+L D L ++ + LG L +L + YL EA+ V HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANNFV-HRD 127
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
+ A N+L+ AKV+DFGL++ A G +P VK T PE K +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFS 177
Query: 698 DKSDVYSLGVVFLELLT-GMQPISH--GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
KSDV+S G++ E+ + G P K++V V Y+ M + P C
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------MDA-PDGCP 225
Query: 755 EKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ +C + RPS ++ +LE I
Sbjct: 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 519 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 572
+G G +G VYKG+ +P+G VA+K +E + + KE L E ++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 573 VGYCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
+G C Q L+ + M G L D + K+ +G L+ + ++G+ YL +
Sbjct: 75 LGIC--LSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYL 686
+ HRD+ A N+L+ K+ DFGL++L V + E G VP +K ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP------IK----WM 178
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
E L T KSDV+S GV EL+T G +P G E+ + + G
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP-AVEI-----PDL---LEKGE 228
Query: 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
P C + +KC + ++RP+ E++ E
Sbjct: 229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 70/274 (25%), Positives = 110/274 (40%), Gaps = 29/274 (10%)
Query: 518 QIGQGGYGKVYKG--ILPDGTV--VAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSL 572
++G G +G V +G G V VAVK + L +FL E + L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
G M+V E G+L D+L + + A+ + G+ YL ++
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYF 691
HRD+ A NILL K+ DFGL R P + +V P + PE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNE-----DHYVMEEHLKVPFAWCAPESL 172
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISH--GKNIVREVNIAYQSSMMFSVIDGNMGS 748
T + SDV+ GV E+ T G +P + G I+++++ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----------E 221
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
P C + + L+C RP+ + + L
Sbjct: 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 519 IGQGGYGK--VYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+G +G+ +Y+ D ++V K L + ++ L EI LS L H N+++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ ++ ++ E+ + GTL D++ + + M L + Y+H +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRDIK NI L K+ DFG+S+ I G + TVV GTP Y+ PE
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK------ILGSEYSMAETVV-GTPYYMSPELCQGV 176
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
K KSD+++LG V ELLT + R + +++ ++ GN S
Sbjct: 177 KYNFKSDIWALGCVLYELLT----------LKRTFDATNPLNLVVKIVQGNYTPVVSVYS 226
Query: 755 EKFIKLALKCCQDETDARPSMSEVM 779
+ I L Q + + RP+ EV+
Sbjct: 227 SELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 23/272 (8%)
Query: 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRN 568
+F +IG+G +G V+K + D V A+K+ + + + +E + E + L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
++ ++G+ +V E+ NG L L + PL + G+ +LH++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRDIK+ N+ LD K+ D G+++L +T+V GTP YL P
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIV-GTPYYLSP 170
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748
E +KSDV++LGVV E TG P + Q +++ +I G
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPF----------DANNQGALILKIIRGVFPP 220
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
++ +L +C + RP +++R
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 574
+IG+G YG VYK G +VA+K+ + K L EI+ L L+H N++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+G+ LV+EFM +L + L ++ S +G+ + H+ +
Sbjct: 66 VFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K N+L++ + K+ADFGL+R P V + VV T Y PE L
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSP-----VRPYTHYVV--TRWYRAPELLLGD 173
Query: 695 KLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVN 730
K D++S+G +F ELL+ +P+ GK+ + ++
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 9e-21
Identities = 86/281 (30%), Positives = 125/281 (44%), Gaps = 35/281 (12%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 565
N+ +GQG +G+VY D G +A K+ Q S + KE EIQ L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 566 HRNLVSLVGYCDEEGEQMLV--YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 623
H +V G + E+ L E+M G+++DQL A A+ S+ +R IL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQIL 116
Query: 624 ----YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT--- 170
Query: 680 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739
GTP ++ PE K+DV+SLG +E+LT P + + + IA Q +
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--- 226
Query: 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + S+ SE F L C E RPS E++R
Sbjct: 227 ---NPQLPSHISEHARDF----LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 86/275 (31%), Positives = 124/275 (45%), Gaps = 32/275 (11%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 568
F +IG G +G VY + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
HRDIKA NILL T K+ADFG + L PA+ S V GTP ++ P
Sbjct: 135 E---RIHRDIKAGNILLTEPGTVKLADFGSASLVS--------PAN-SFV--GTPYWMAP 180
Query: 689 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
E L + K DV+SLG+ +EL P+ + + +IA S S D
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW- 239
Query: 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
S+ F+ C Q RPS E+++
Sbjct: 240 -----SDYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 509 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLS 562
++ ++G+G +G+VYK + G VVA+K+ + EK+ L EI+ L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILK 62
Query: 563 RLHHRNLVSL----VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMR 611
+L H N+V L V D+ + +V +M +G L + S K E
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYM 121
Query: 612 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL----APVPDI 667
L + GI YLH + + HRDIKA+NIL+D++ K+ADFGL+R P P
Sbjct: 122 LQLL----EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 723
G T + T Y PE L + T D++ +G VF E+ T +PI GK
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 21/258 (8%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G+V+ G + T VAVK + G++ + FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
+E ++ E+M+ G+L D L + + + + + G+ Y+ + HRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRD 128
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT 697
++A+N+L+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 129 LRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFT 182
Query: 698 DKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756
KSDV+S G++ E++T G P N S +M ++ G C ++
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSN----------SDVMSALQRGYRMPRMENCPDE 232
Query: 757 FIKLALKCCQDETDARPS 774
+ C +++ + RP+
Sbjct: 233 LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 571
+IG+G YG VYK G +VA+K+ + L+ E E + EI L L+H N+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
L+ E + LV+EF+ + L+ + + L + S +GI Y H+
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
V HRD+K N+L+D + K+ADFGL+R VP V + VV T Y PE
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGVP-----VRTYTHEVV--TLWYRAPEIL 171
Query: 692 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 722
L + + + D++S+G +F E++ +P+ G
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNR-RPLFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQ---EGSLQGEKEFLT---EIQFLSRLHHRNLVSL 572
+G+G YG VY G+ G ++AVK+ + L EKE+ E+ L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C ++ + EF+ G++ L+ P + + + G+ YLH +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH---NNC 122
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
V HRDIK +N++L K+ DFG +R + G +++ + GTP ++ PE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG-THSNMLKSMHGTPYWMAPEVIN 181
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYP 750
KSD++S+G E+ TG P++ + + MF + M P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AAMFYIGAHRGLMPRLP 231
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMR 780
I C + RPS +++R
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 571
+IG+G YG VYKG G +VA+K+ + L+ E+E + EI L L H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
L +E L++EF+S + S + + + S +GIL+ H+
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
V HRD+K N+L+D+K K+ADFGL+R +P V + VV T Y PE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-----VRVYTHEVV--TLWYRAPEVL 173
Query: 692 L-THKLTDKSDVYSLGVVFLELLTGMQPISHG 722
L + + + D++S+G +F E+ T +P+ HG
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 576
IG+G +G+VYK I VVA+K + E E + EIQFLS+ + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 577 DEEGEQM-LVYEFMSNGTLRDQL-SAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPV 633
+G ++ ++ E+ G+ D L K E + F +R + G+ YLH E
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHEEG---K 119
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----GTPGYLD 687
HRDIKA+NILL + K+ADFG V ++ T+ K GTP ++
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFG-------------VSGQLTSTMSKRNTFVGTPFWMA 166
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 721
PE +K+D++SLG+ +EL G P+S
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 53/270 (19%)
Query: 536 TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594
+VAVK + + + +FL E++ LSRL N+ L+G C + ++ E+M NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 595 ---------RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 645
A + + L F+ L +A + G+ YL HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 646 DHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 702
+T K+ADFG+SR D ++G P + ++ E L K T KSDV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKSDV 215
Query: 703 YSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG------------S 748
++ GV E+LT QP H + VI+ N G
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTD--------------QQVIE-NAGHFFRDDGRQIYLP 260
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEV 778
P C + +L L+C + + + RP+ E+
Sbjct: 261 RPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 37/279 (13%)
Query: 519 IGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSL 572
+G G +G VYKGI +PDG VA+K +E S + KE L E ++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C Q LV + M G L D + ++K+ +G L+ + ++G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 687
+ HRD+ A N+L+ K+ DFGL+RL + + E G VP ++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----------WMA 179
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
E L + T +SDV+S GV EL+T G +P RE+ + G
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEK--------GER 229
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P C + +KC +++ RP E++ E +
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 519 IGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
IG G +G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G + M+V E+M NG+L D K + + G + G+ YL +D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGY 127
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
HRD+ A NIL++ KV+DFGLSR L P+ A+ + K + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIA 182
Query: 693 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
K T SDV+S G+V E+++ G +P N ++ ++ +G P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----------QDVIKAIEEGYRLPAPM 232
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+C +L L C Q + + RP +++ L+ +
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVSL 572
+G+G Y VYK G +VA+K+ + G + K+ L EI+ L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+ + LV+EFM L + KS L A S L + RG+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSI-VLTPADIKSYMLMTLRGLEYLH---SNW 122
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
+ HRD+K +N+L+ K+ADFGL+R P+ + VV T Y PE
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-----MTHQVV--TRWYRAPELLF 175
Query: 693 THKL-TDKSDVYSLGVVFLELL 713
+ D++S+G +F ELL
Sbjct: 176 GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 41/287 (14%)
Query: 519 IGQGGYGKVYKGIL--PDGTV--VAVKRAQ-EGSLQGE-KEFLTEIQFLSRLHHRNLVSL 572
+G+G +G V +G L DG+ VAVK + + E +EFL+E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 573 VGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 622
+G C E M++ FM +G L L E L L + + G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVSTV-V 679
YL HRD+ A N +L T VADFGLS+ D +G ++ + V
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG----RIAKMPV 179
Query: 680 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 738
K ++ E T KSDV++ GV E+ T G P +N +
Sbjct: 180 K----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----------HEIY 225
Query: 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ GN P +C+++ L C + + RP+ +++ LE+I
Sbjct: 226 DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 87/313 (27%), Positives = 135/313 (43%), Gaps = 54/313 (17%)
Query: 507 ALATNNFNSSTQIGQGGYGKVYKG-ILPDGTVV--AVKRAQE-GSLQGEKEFLTEIQFLS 562
L N+ IG+G +G+V K I DG + A+KR +E S ++F E++ L
Sbjct: 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62
Query: 563 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLG 607
+L HH N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 608 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667
L A +RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--- 176
Query: 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISH 721
VK T G L + L T SDV+S GV+ E+++ G P
Sbjct: 177 ----------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC- 225
Query: 722 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781
G + + + G P C ++ L +C +++ RPS +++
Sbjct: 226 GMTC---------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI--- 273
Query: 782 LESIWNMMPESDT 794
L S+ M+ E T
Sbjct: 274 LVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 519 IGQGGYGKVYKGIL-PDG---TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 573
IG G +G+V +G L G VA+K + G + + ++FL+E + + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G + M++ EFM NG L D ++ + + G + G+ YL ++
Sbjct: 72 GVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFL 692
HRD+ A NIL++ KV+DFGLSR + + P + S++ P + PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 693 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY-- 749
K T SDV+S G+V E+++ G +P Y VI+ Y
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP--------------YWDMSNQDVINAIEQDYRL 230
Query: 750 --PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P +C +L L C Q + +ARP +++ L+ +
Sbjct: 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-19
Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 37/266 (13%)
Query: 535 GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV--GYCDEEGEQMLVYEFM 589
G VA+K + + + E + F E +RL+H N+V+L+ G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 590 SNGTLRDQLSAKSKEPLGFAMRL------SIALGSSRGILYLHTEADPPVFHRDIKASNI 643
TLR+ L+A P G RL ++A ++GI+ HRD+K NI
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIV-----------HRDLKPQNI 110
Query: 644 LL---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVS--TVVKGTPGYLDPEYFLTHKLTD 698
++ + AKV DFG+ L +P + A ++ T V GTP Y PE +T
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTL--LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 699 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 758
SD+Y+ G++FLE LTG Q + G + V E+ S + S + + +P + + +
Sbjct: 169 NSDLYAWGLIFLECLTG-QRVVQGAS-VAEILYQQLSPVDVS-LPPWIAGHP---LGQVL 222
Query: 759 KLAL-KCCQDETDARPSMSEVMRELE 783
+ AL K + + P+++E R LE
Sbjct: 223 RKALNKDPRQRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 44/297 (14%)
Query: 508 LATNNFNSSTQIGQGGYGKVY----KGILPDG--TVVAVKRAQEGSLQGEK-EFLTEIQF 560
+A S ++GQG +G VY KG++ D T VA+K E + E+ EFL E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 561 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRL 612
+ + ++V L+G + +++ E M+ G L+ L + + P +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 613 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----- 667
+A + G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 123 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 726
+G++P ++ PE T SDV+S GVV E+ T QP N
Sbjct: 180 KGLLPVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-- 227
Query: 727 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
++ V++G + P C + +L C Q RPS E++ ++
Sbjct: 228 --------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 74/272 (27%), Positives = 130/272 (47%), Gaps = 26/272 (9%)
Query: 518 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 574
+IG+G +G+V+ G L D T VAVK +E +L + +FL E + L + H N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
C ++ +V E + G L + L + + ++ G+ YL ++
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GYLDPEYFLT 693
HRD+ A N L+ K K++DFG+SR + +G+ + + +K P + PE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYAS--TGGMKQIPVKWTAPEALNY 170
Query: 694 HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752
+ + +SDV+S G++ E + G P + N++ Q + + G P
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYA---------NLSNQQTREA-IEQGVRLPCPEL 220
Query: 753 CVEKFIKLALKCCQDETDARPSMSEVMRELES 784
C + +L +C + + RPS S V +EL+S
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-- 574
IG+G YGKVYK G +VA+K + E+E E L + +H N+ + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 575 ----YCDEEGEQMLVYEFMSNGT-------LRDQLSAKSKEPLGFAMRLSIALGSSRGIL 623
+ + LV E G+ LR + +E + + +R ++ RG+
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL-----RGLA 127
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVK-- 680
YLH + V HRDIK NILL K+ DFG+S A + ST+ +
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS-------------AQLDSTLGRRN 171
Query: 681 ---GTPGYLDPE-----YFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
GTP ++ PE +SDV+SLG+ +EL G P+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 35/281 (12%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKE---FLTEIQFLSRLH 565
N+ +GQG +G+VY D G +AVK+ Q S + KE EIQ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 566 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--- 620
H +V G + E+ L E M G+++DQL + A+ ++ +R
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQIL 116
Query: 621 -GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
G+ YLH+ + HRDIK +NIL D K+ DFG S+ + G V+
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT--- 170
Query: 680 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739
GTP ++ PE K+D++S+G +E+LT P + + + IA Q +
Sbjct: 171 -GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--- 226
Query: 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + + S+ F+K E RPS E++R
Sbjct: 227 ---NPVLPPHVSDHCRDFLKRIFV----EAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 571
+IG+G YG V+K +VA+KR + L + E L EI L L H+N+V
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 572 LVGYCDEEGEQMLVYEFMS----------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 621
L + + LV+E+ NG + D KS F +L +G
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKS-----FMFQLL------KG 111
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+ + H+ V HRD+K N+L++ K+ADFGL+R +P V + + VV
Sbjct: 112 LAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP-----VRCYSAEVV-- 161
Query: 682 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI 725
T Y P+ KL S D++S G +F EL +P+ G ++
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 40/289 (13%)
Query: 518 QIGQGGYGKVYKG--ILP---DGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G+ +GK+YKG LP +VA+K ++ + Q EF E ++ LHH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIAL 616
L+G +E +++E+++ G L + L +S K L L IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
+ G+ YL + H+D+ A NIL+ + K++D GLSR D + P +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 735
+ ++ PE + K + SD++S GVV E+ + G+QP N
Sbjct: 189 PI-----RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----------Q 233
Query: 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
++ V + +C + L +C Q+ RP ++ L S
Sbjct: 234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 78/296 (26%), Positives = 136/296 (45%), Gaps = 53/296 (17%)
Query: 519 IGQGGYGKVYKGIL-----PDGTV-VAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 570
+G+G +G+V K P+ T VAVK ++ + + + + ++E++ + + H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIAL 616
+L+G C +EG +V E+ ++G LRD L A+ +E L +S A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
+RG+ +L A HRD+ A N+L+ K+ADFGL+R DI H+
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIH-----HID 186
Query: 677 TVVKGTPGYLD-----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 730
K T G L PE T +SDV+S GV+ E+ T G P
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP---------G 237
Query: 731 IAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
I + +F ++ +G P C ++ L C + RP+ +++ +L+ +
Sbjct: 238 IPVEE--LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 75/267 (28%), Positives = 117/267 (43%), Gaps = 49/267 (18%)
Query: 513 FNSSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGEKEFLT--------EIQFL 561
+ IG+G YG+VYK DG A+K+ +G+KE T EI L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-----FKGDKEQYTGISQSACREIALL 56
Query: 562 SRLHHRNLVSLVGYC--DEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIAL 616
L H N+VSLV + L++++ + ++ AK + +M S+
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV-SIPPSMVKSLLW 115
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL---APVPDIEG 669
G+ YLH+ V HRD+K +NIL+ + K+ D GL+RL P
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP---- 168
Query: 670 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 728
A + VV T Y PE L T D++++G +F ELLT ++PI G+ +
Sbjct: 169 --LADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIK 224
Query: 729 VNIAYQSSMM---FSVIDGNMGSYPSE 752
+ +Q + F V +G P+E
Sbjct: 225 KSNPFQRDQLERIFEV----LG-TPTE 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 6e-19
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 519 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 574
+G+G +GKV G + A+K ++ + KE LTE LSR++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEAD 630
E + LV E+ G L LS + + +A + +AL YLH+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE------YLHSLG- 113
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
+ +RD+K NILLD K+ DFGL++ + +T GTP YL PE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTNTFC-GTPEYLAPEV 164
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQP 718
L D +SLGV+ E+LTG P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 565
NF +IG+G YG VYK G VVA+K+ + L E E + EI L L+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELN 57
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
H N+V L+ E + LV+EF+ + L+ + A + + S +G+ +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H+ V HRD+K N+L++ + K+ADFGL+R VP V + VV T Y
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-----VRTYTHEVV--TLWY 166
Query: 686 LDPEYFLTHKL-TDKSDVYSLGVVFLELLT 714
PE L K + D++SLG +F E++T
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 83/314 (26%), Positives = 145/314 (46%), Gaps = 61/314 (19%)
Query: 519 IGQGGYGKVYK----GI---LPDGTV-VAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 568
+G+G +G+V + GI PD TV VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 614
+++L+G C +EG ++ E+ + G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------ 668
A +RG+ YL + HRD+ A N+L+ K+ADFGL+R V DI+
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTS 194
Query: 669 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 726
G +P VK ++ PE T +SDV+S G++ E+ T G P
Sbjct: 195 NGRLP------VK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP------ 238
Query: 727 REVNIAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
I + +F ++ +G+ PS C + L +C RP+ +++ L+ +
Sbjct: 239 ---GIPVEE--LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
Query: 786 WNMMPES--DTKTP 797
+ E D P
Sbjct: 294 LAAVSEEYLDLSMP 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 73/284 (25%), Positives = 130/284 (45%), Gaps = 46/284 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRA--------QEGSLQGE--KEFLTEIQFLSRLHHR 567
IG+G YG+VY + + G ++AVK+ + S Q + K +EI+ L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGILYL 625
N+V +G+ E + E++ G++ L + +E + G+ YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ----LVRFFTEQVLEGLAYL 124
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H++ + HRD+KA N+L+D K++DFG+S+ + + I + ++G+ +
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKS-----DDIYDNDQNMSMQGSVFW 176
Query: 686 LDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743
+ PE ++ + K D++SLG V LE+ G +P S + I + MF +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------AAMFKL-- 224
Query: 744 GNMGS---YPSECVEKFIKLALK----CCQDETDARPSMSEVMR 780
GN S P + +AL C D RP+ E+++
Sbjct: 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 518 QIGQGGYGKVYKGILPD------GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLV 570
++GQG +G VY+G D T VAVK E SL+ EFL E + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSA---KSKEPLG-----FAMRLSIALGSSRGI 622
L+G + ++V E M++G L+ L + +++ G + +A + G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPAHVST 677
YL+ + HRD+ A N ++ H FT K+ DFG++R D +G++P
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 736
++ PE T SD++S GVV E+ + QP N +
Sbjct: 187 -------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------EQV 230
Query: 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
+ F V+DG P C E+ L C Q RP+ E++ L+
Sbjct: 231 LKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 33/225 (14%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---F----LTEIQFLSRLHHRNLV 570
I +G YG VY+ G +VA+K+ L+ EKE F L EI L +L H N+V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKK-----LKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 571 SL----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
++ VG + +V E++ + L+ + K+P + + L G+ +LH
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
D + HRD+K SN+LL+++ K+ DFGL+R P + + VV T Y
Sbjct: 124 ---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-----LKPYTQLVV--TLWYR 173
Query: 687 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 730
PE L + + D++S+G +F ELLT +P+ GK+ + ++N
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 33/273 (12%)
Query: 518 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
++G G +GKVYK + G A K Q S + ++F+ EI LS H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 577 DEEGEQMLVYEFMSNGTLR---DQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPP 632
E + ++ EF G L +L EP + + R + + +LH+
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSHK--- 123
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
V HRD+KA NILL K+ADFG+S T + GTP ++ PE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL------QKRDTFI-GTPYWMAPEVVA 176
Query: 693 THKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
D K+D++SLG+ +E L M+P H N +R V + S +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE-LAQMEPPHHELNPMR-VLLKILKS------EPPTL 228
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
PS+ F C + D RP+ +E+++
Sbjct: 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 71/296 (23%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 519 IGQGGYGKVYK----GILPD----GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 568
+G+G +G+V GI D VAVK ++ + + + + ++E++ + + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 614
+++L+G C ++G ++ E+ S G LR+ L A+ E + F +S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDYYK 194
Query: 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 733
+T + ++ PE T +SDV+S GV+ E+ T G P
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-----------GI 243
Query: 734 QSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788
+F ++ +G+ P+ C + + C RP+ +++ +L+ I +
Sbjct: 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGY 575
+G G G V K +P GTV+A K G+ K+ L E+Q + +VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
E + EFM G+L D++ K P+ + IA+ G+ YL+ + H
Sbjct: 72 FLNENNICMCMEFMDCGSL-DRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
RDIK SNIL++ + K+ DFG+S G + ++ GT Y+ PE K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQGGK 178
Query: 696 LTDKSDVYSLGVVFLELLTGMQPIS 720
T KSDV+SLG+ +EL G P +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
+G+G YG V K G +VA+K + E +K L E++ L +L H N+V+L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYLHTEADPP 632
+G LV+E++ TL + L A P G A+R I + I Y H+
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEAS---PGGLPPDAVRSYI-WQLLQAIAYCHSHN--- 120
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
+ HRDIK NIL+ K+ DFG +R PA T T Y PE +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRAR------PASPLTDYVATRWYRAPELLV 174
Query: 693 THKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
K DV+++G + ELL G +P+ G +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 59/234 (25%), Positives = 90/234 (38%), Gaps = 28/234 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRL-H 565
++F IG+G + V A+K + L EK E + L+RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
H ++ L +E V E+ NG L + L A + YL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYL 118
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP------------- 672
H++ + HRD+K NILLD K+ DFG +++
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 673 -AHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKN 724
++ V GT Y+ PE L K K SD+++LG + ++LTG P G N
Sbjct: 176 RRRFASFV-GTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 519 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGY 575
IG+G +G V+K G VA+K+ L+G + L EI+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
+LV E+M L + L + PL A S +G+ Y+H + H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANG---IMH 122
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-TH 694
RD+K +N+L+ K+ADFGL+RL E + V T Y PE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFS----EEEPRLYSHQV--ATRWYRAPELLYGAR 176
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
K D++++G +F ELL G P+ G+N
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG-SPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 39/232 (16%)
Query: 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE-----FLT 556
+G+ + + F+ QIG+G YG+VYK D G +VA+K+ + L EKE +
Sbjct: 1 WGKRCV--DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIR 55
Query: 557 EIQFLSRLHHRNLVSL----------VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSK 603
EI+ L +L+HRN+V+L + + ++G LV+E+M + G L L S+
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 604 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663
+ + M+ + G+ Y H HRDIK SNILL++K K+ADFGL+RL
Sbjct: 116 DHIKSFMKQLL-----EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLT 714
+ + + V+ T Y PE L + DV+S G + EL T
Sbjct: 168 SEESR----PYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 27/274 (9%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
+G G +G VYKGI +P+G V + A + + EF+ E ++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C Q LV + M +G L D + + K+ +G + L+ + ++G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
+ HRD+ A N+L+ K+ DFGL+RL +EG + + K ++ E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARL-----LEGDEKEYNADGGKMPIKWMALECIH 184
Query: 693 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
K T +SDV+S GV EL+T G +P + RE+ + G P
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP--YDGIPTREIPDLLEK--------GERLPQPP 234
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
C + +KC + D+RP E+ E +
Sbjct: 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKE-------FLTEIQFLSRLHHRN 568
IG G +G VY G+ G ++AVK+ + S + EI L L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
+V +G + + E++ G L + A +E L I +G+ YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQIL----KGLNYL 122
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H + HRDIK +NIL+D+K K++DFG+S+ + + ++G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
+ PE T K+D++SLG + +E+LTG P Q +F + +
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD----------CTQLQAIFKIGENA 228
Query: 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
PS + I K + + + RP+ +E+++
Sbjct: 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 61/306 (19%)
Query: 507 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQ 559
A +N T +G+G +G+V+ T+V VK Q+ + + EF E+
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 560 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKE------PLGFAMRL 612
+L H+N+V L+G C E ++ E+ G L+ L A KSK+ PL ++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 613 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR------------ 660
++ + G+ +L HRD+ A N L+ + KV+ LS+
Sbjct: 121 ALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 661 -LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 718
L P+ +L PE + KSDV+S GV+ E+ T G P
Sbjct: 178 ALIPLR-------------------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
Query: 719 ISHGKNIVREVNIAYQS-SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 777
EV Q+ + V P C + KL +C RPS SE
Sbjct: 219 --FYGLSDEEVLNRLQAGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSE 268
Query: 778 VMRELE 783
++ L
Sbjct: 269 LVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-18
Identities = 83/280 (29%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLV 573
+IG G +G VY VVAVK+ + G EK + + E++FL +L H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G +E LV E+ G+ D L K+PL +I G+ +G+ YLH+ +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693
HRDIKA NILL K+ADFG + + PA+ S V GTP ++ PE L
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSS--------PAN-SFV--GTPYWMAPEVILA 191
Query: 694 H---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
+ K DV+SLG+ +EL P+ + + +IA S
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ---------S 242
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790
+E + F C Q RP+ +E++R + + P
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH-DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 519 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLV 573
IG+G +G VY+G+ + VAVK + + +E FL E + + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G E +V E G LR L +K L A + + S + YL ++
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG-----YLDP 688
HRDI A N+L+ K+ DFGLSR + K + G ++ P
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRY-----------LEDESYYKASKGKLPIKWMAP 177
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
E + T SDV+ GV E+L G++P KN + ++ + +G
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----------NDVIGRIENGERL 227
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788
P C L KC + RP +E+ +L I
Sbjct: 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 80/328 (24%), Positives = 150/328 (45%), Gaps = 53/328 (16%)
Query: 519 IGQGGYGKVYK----GILPD----GTVVAVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRN 568
+G+G +G+V GI D VAVK ++ + + + ++E++ + + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 614
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D+ I
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDYYK 191
Query: 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734
+T + ++ PE T +SDV+S GV+ E+ T + + V E
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYPGIPVEE------ 244
Query: 735 SSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 793
+F ++ +G+ P+ C + + +C RP+ +++ +L+ + +
Sbjct: 245 ---LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV----- 296
Query: 794 TKTPEFINSEHTSKEETP-----PSSSS 816
T T E+++ ++ +P PSS S
Sbjct: 297 TSTDEYLDLSVPFEQYSPGCPDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 30/271 (11%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G+V+ T VAVK + GS+ E FL E + L H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
+E ++ EFM+ G+L D L + SK+PL + S + + G+ ++ H
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRN---YIH 125
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
RD++A+NIL+ K+ADFGL+R+ + D E +K T PE
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGS 179
Query: 696 LTDKSDVYSLGVVFLELLT-GMQPISHGKN--IVREVNIAYQSSMMFSVIDGNMGSYPSE 752
T KSDV+S G++ +E++T G P N ++R + Y+ +
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN------------ 227
Query: 753 CVEKFIKLALKCCQDETDARPSMSEVMRELE 783
C E+ + ++C ++ + RP+ + L+
Sbjct: 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 53/243 (21%)
Query: 512 NFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 565
F +IG+G YG VY+ G +VA+K+ + + E++ L EI L L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLREITLLLNLR 64
Query: 566 HRNLVSL---------------VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAM 610
H N+V L + YC EQ L +L D + P +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYC----EQDL-------ASLLDNMPT----PFSESQ 109
Query: 611 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670
+ L RG+ YLH + HRD+K SN+LL K K+ADFGL+R G+
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY------GL 160
Query: 671 VPAHVS-TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVRE 728
++ VV T Y PE L + D++++G + ELL +P+ GK+ + +
Sbjct: 161 PAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQ 217
Query: 729 VNI 731
+++
Sbjct: 218 LDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 33/276 (11%)
Query: 512 NFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSL-QGEKE-FLTEIQFLSRLHHRN 568
+F ++G+G YG VYK L D A+K GS+ Q E+E + EI+ L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 569 LVSLVGYCDE--EGEQM-LVYEFMSNGTLRDQLS--AKSKEPLGFAMRLSIALGSSRGIL 623
++S Y + +G ++ +V E+ G L +S K ++ + I + RG+
Sbjct: 61 IIS---YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
LH + + HRD+K++NILL K+ D G+S++ +++ GTP
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---------KNMAKTQIGTP 165
Query: 684 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743
Y+ PE + + KSD++SLG + E+ T P +++ + + V
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSM---------QDLRYKVQR 215
Query: 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
G P + Q + RP+ +++
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 55/301 (18%)
Query: 519 IGQGGYGKVYK----GILPDG----TVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRN 568
+G+G +G+V G+ + T VAVK + + + + + ++E++ + + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSI 614
+++L+G C ++G ++ E+ S G LR+ L A+ +E L F +S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R DI H
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIH-----H 192
Query: 675 VSTVVKGTPG-----YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 728
+ K T G ++ PE T +SDV+S GV+ E+ T G P
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------- 244
Query: 729 VNIAYQSSMMFSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787
+F ++ +G+ PS C + + C RP+ +++ +L+ I
Sbjct: 245 ---GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
Query: 788 M 788
+
Sbjct: 302 L 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 27/222 (12%)
Query: 511 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 563
NN + +G G +GKV + G+ V VAVK + + E+E L +E++ +S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 564 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622
L +H N+V+L+G C G +++ E+ G L + L K + L LS + ++G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKG 681
+L A HRD+ A N+LL H K+ DFGL+R DI + S VVKG
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DI-----MNDSNYVVKG 201
Query: 682 TP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 718
++ PE T +SDV+S G++ E+ + G P
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 70/268 (26%), Positives = 118/268 (44%), Gaps = 28/268 (10%)
Query: 518 QIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G G +G V KG+ D + +K E S++ E + E + + +L + +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVR 59
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
++G C+ E MLV E S G L LS K K+ + + + + S G+ YL +
Sbjct: 60 MIGVCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
HRD+ A N+LL ++ AK++DFGLS+ D + K + PE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----YKARSAGKWPLKWYAPECI 170
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
K + +SDV+S G+ E + G +P K +M + G P
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----------PEVMSFIEQGKRLDCP 220
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEV 778
+EC + L C + + RP+ ++V
Sbjct: 221 AECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 37/271 (13%)
Query: 519 IGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 575
+G+G +G V+ + V+ + E + E+ E Q L L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYLHTEA 629
E+ M+V E+ GTL + + + L F +++ +AL ++HT+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH------HVHTKL 121
Query: 630 DPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRD+K NILLD HK K+ DFG+S++ + TVV GTP Y+ P
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVV-GTPCYISP 170
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748
E KSD+++LG V EL + + R A +++ ++ G
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFAP 220
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEVM 779
+L L + RP +S++M
Sbjct: 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 79/295 (26%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 568
+ +G+G YG VY V +A+K E + + EI S L HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-----SKEP-LGFAMRLSIALGSSRGI 622
+V +G E G + E + G+L L +K E + F + + G+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGL 121
Query: 623 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK 680
YLH D + HRDIK N+L++ + K++DFG S RLA GI P +
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA------GINP--CTETFT 170
Query: 681 GTPGYLDPEYFLTHKLTDK--------SDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 732
GT Y+ PE + DK +D++SLG +E+ TG P + +
Sbjct: 171 GTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---------IELG 215
Query: 733 YQSSMMFSVIDGNMGSYP------SECVEKFIKLALKCCQDETDARPSMSEVMRE 781
+ MF V G +P S + FI L+C + + D R S +++++
Sbjct: 216 EPQAAMFKV--GMFKIHPEIPESLSAEAKNFI---LRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGY- 575
IG+G YG VY+G +P G VVA+K + + + E+ LS+L ++ Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 576 -CDEEGEQM-LVYEFMSNGTLRDQLSA-KSKEP-LGFAMR-LSIALGSSRGILYLHTEAD 630
+G ++ ++ E+ G++R + A E + +R + +AL Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK------YIHKV-- 120
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
V HRDIKA+NIL+ + K+ DFG++ L + ST V GTP ++ PE
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALL------NQNSSKRSTFV-GTPYWMAPEV 172
Query: 691 FLTHKLTD-KSDVYSLGVVFLELLTGMQPIS 720
K D K+D++SLG+ E+ TG P S
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 519 IGQGGYGKVYKGILP--DGTV--VAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
+G+G +G V + L DG+ VAVK +A S +EFL E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 573 VGYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMR--LSIALGSSRGI 622
+G + M++ FM +G L L S +EP ++ + + + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
YL ++ HRD+ A N +L+ T VADFGLS+ D K
Sbjct: 127 EYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-----YRQGCASKLP 178
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741
+L E + T SDV++ GV E++T G P + +N S + +
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----------SEIYNYL 228
Query: 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786
I GN P +C+E +L +C E RPS + +LE IW
Sbjct: 229 IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 519 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 573
IG+G +G+V + ++ DG + A+K +E S ++F E++ L +L HH N+++L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLS---------AKSKE-----PLGFAMRLSIALGSS 619
G C+ G + E+ G L D L A +KE L L A +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
G+ YL ++ HRD+ A N+L+ +K+ADFGLSR V V
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-------------YV 173
Query: 680 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 733
K T G L + L T KSDV+S GV+ E+++ G P G
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKLP 232
Query: 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
Q M P C ++ +L +C +D RP +++ +L
Sbjct: 233 QGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 74/266 (27%), Positives = 118/266 (44%), Gaps = 39/266 (14%)
Query: 537 VVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 595
+VAVK +E + + + +FL EI+ +SRL N++ L+ C ++ E+M NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 596 DQLSA-KSKEPLGFAMRLSIALGS--------SRGILYLHTEADPPVFHRDIKASNILLD 646
LS + +E A ++I+ + + G+ YL + HRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164
Query: 647 HKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSD 701
+T K+ADFG+SR D I+G ++P ++ E L K T SD
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMSWESILLGKFTTASD 214
Query: 702 VYSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY---PSECVEK 756
V++ GV E+LT QP S + + + + F D Y P+ C +
Sbjct: 215 VWAFGVTLWEILTLCKEQPYSQ----LSDEQVIENTGEFFR--DQGRQVYLPKPALCPDS 268
Query: 757 FIKLALKCCQDETDARPSMSEVMREL 782
KL L C + RPS E+ L
Sbjct: 269 LYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLH 565
NF +IG+G + VYK I L DG VVA+K+ Q + K + L EI L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKEPL------GFAMRLSIALG 617
H N++ + E E +V E G L + K K + + ++L AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
++H++ + HRDIK +N+ + K+ D GL R AH S
Sbjct: 121 ------HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AH-SL 166
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 712
V GTP Y+ PE + KSD++SLG + E+
Sbjct: 167 V--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 575
+G+G YG V K + G +VA+K+ E K + EI+ L +L H NLV+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
+ LV+EF+ + T+ D L K L + RGI + H+ + H
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 636 RDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
RDIK NIL+ K+ DFG +R LA P V T T Y PE +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLA--------APGEVYTDYVATRWYRAPELLVGD 175
Query: 695 -KLTDKSDVYSLGVVFLELLTG 715
K D++++G + E+LTG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 8e-17
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF--------LTEIQFLSRL-HHR 567
Q+G G +G VY G +VA+K+ + K+F L E++ L +L H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
N+V L E E V+E+M G L + + +P ++ SI +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP--AHVSTVVKGTPGY 685
FHRD+K N+L+ K+ADFGL+R +I P +VS T Y
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVS-----TRWY 164
Query: 686 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
PE L D+++LG + EL T ++P+ G +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSS 203
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 9e-17
Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 513 FNSSTQIGQGGYGKVY-KGILPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 568
F +IG G +G VY + VVA+K+ + G EK + + E++FL R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+ G E LV E+ G+ D L K+PL +I G+ +G+ YLH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRDIKA NILL K+ADFG + +A PA+ GTP ++ P
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASIAS--------PANSFV---GTPYWMAP 190
Query: 689 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
E L + K DV+SLG+ +EL P+ + + +IA S
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----- 245
Query: 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
+E + F C Q RP+ E+++ +
Sbjct: 246 ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRA--QEGSLQGEKE---FLTEIQFLSRLH 565
N+ +G+G +G+VY D G +AVK+ S + KE EIQ L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 566 HRNLVSLVGYC--DEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622
H +V G C D E +++ ++ E+M G+++DQL A R + + +G+
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGV 119
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
YLH+ + HRDIK +NIL D K+ DFG S+ + G V+ GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GT 172
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736
P ++ PE K+DV+S+ +E+LT P + + + IA Q +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 519 IGQGGYGKV----YKGILPDG----TVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNL 569
+G+G +GKV Y P+G VAVK + S L EI+ L L+H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 570 VSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
V G C E+G L+ EF+ +G+L++ L ++K + +L A+ +G+ YL +
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
HRD+ A N+L++ + K+ DFGL++ V + + V +
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYA 180
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT----GMQPIS---------HGK-NIVREVNIAY 733
PE + K SDV+S GV ELLT P++ HG+ + R V +
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-- 238
Query: 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ +G P C E+ +L KC + + R + ++ E+I
Sbjct: 239 -------LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 519 IGQGGYGKVY---KGILPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSL 572
I +G YG+V+ K G + A+K ++ + + + LTE LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 573 VGYCDEEGEQML--VYEFMSNGTLR---------DQLSAK--SKEPLGFAMRLSIALGSS 619
Y +G++ L V E++ G L D+ A+ E I L
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE---------IVLA-- 105
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI--EGIVPAHVST 677
+ YLH+ + HRD+K NIL+D K+ DFGLS++ V
Sbjct: 106 --LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
+V GTP Y+ PE L + D +SLG + E L G+ P
Sbjct: 161 IV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 3e-16
Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSLV- 573
IG G YG V + G VA+K+ L K L EI+ L L H N++ L+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66
Query: 574 ----GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT 627
++ + +V E M D L KS +PL RG+ YLH+
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST-VVKGTPGYL 686
A+ V HRD+K SNIL++ K+ DFGL+R D + ++ VV T Y
Sbjct: 122 -AN--VIHRDLKPSNILVNSNCDLKICDFGLARGV---DPDEDEKGFLTEYVV--TRWYR 173
Query: 687 DPEYFLT-HKLTDKSDVYSLGVVFLELLTG 715
PE L+ + T D++S+G +F ELLT
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
+G G G VYK L ++AVK + +++ +K+ ++E++ L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
E + EFM G+L D + LG IA+ +G+ YL + + H
Sbjct: 68 FFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---ILH 118
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
RD+K SN+L++ + K+ DFG+S +V + T V GT Y+ PE +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST--------QLVNSIAKTYV-GTNAYMAPERISGEQ 169
Query: 696 LTDKSDVYSLGVVFLELLTGMQPISH-GKNIVREVNIAYQSSMM-----FSVIDGNMGSY 749
SDV+SLG+ F+EL G P KN Q S+M ++D +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPPVL 220
Query: 750 P-SECVEKFIKLALKCCQDETDARPSMSEVM 779
P + EKF+ +C + + RP+ +M
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 566
+F TQ+GQGGYG+V+ D G +VA+KR ++ L E LTE L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 567 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGI 622
LV L+ Y ++ E + L E++ G R L+ S++ F M +
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
LH HRD+K N L+D K+ DFGLS+ + A+ S V G+
Sbjct: 117 --LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYAN-SVV--GS 161
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
P Y+ PE D +SLG + E L G P S
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 513 FNSSTQIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRN 568
F +IG+G +G+V+KGI D VVA+K + E E + EI LS+
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+ G + + ++ E++ G+ D L A + A L L +G+ YLH+E
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE 120
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
HRDIKA+N+LL + K+ADFG++ I+ +T V GTP ++ P
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR------NTFV-GTPFWMAP 170
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748
E K+D++SLG+ +EL G P S + ++F + N +
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSD----------MHPMRVLFLIPKNNPPT 220
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
E + F + C + RP+ E+++
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 83/334 (24%), Positives = 144/334 (43%), Gaps = 90/334 (26%)
Query: 518 QIGQGGYGKVYK------GILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G G +GKVYK G L V+ K +E ++++ EI+ L+ +H +V
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYMVEIEILATCNHPYIVK 73
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRD---QLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
L+G +G+ ++ EF G + +L EP +++ I + YLH+
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHSM 129
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTP 683
+ HRD+KA N+LL K+ADFG+S +V T+ + GTP
Sbjct: 130 K---IIHRDLKAGNVLLTLDGDIKLADFGVS------------AKNVKTLQRRDSFIGTP 174
Query: 684 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738
++ PE + + D K+D++SLG+ +E + ++P H N +R
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIE-MAQIEPPHHELNPMR----------- 222
Query: 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 798
+ LK + E P++S+ S W+M + +
Sbjct: 223 ---------------------VLLKIAKSEP---PTLSQ-----PSKWSM------EFRD 247
Query: 799 FINSEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 832
F+ + ET PS++ +L+HP+VSS S L
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR----AQEGSLQGEKEFLTEIQFLSRLHH 566
NF ++G+G Y VYKG G +VA+K A+EG+ + EI + L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT---PSTAIREISLMKELKH 57
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
N+V L E + MLV+E+M + + + L S +GI + H
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ V HRD+K N+L++ + K+ADFGL+R +P V + VV T Y
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-----VNTFSNEVV--TLWYR 167
Query: 687 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
P+ L + S D++S+G + E++TG +P+ G N
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 59/282 (20%)
Query: 537 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 595
+VAVK + + + +FL E++ LSRL N++ L+G C +E ++ E+M NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 596 DQLSAKSKE-----------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 638
LS+ + + ++ L +AL + G+ YL + HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164
Query: 639 KASNILLDHKFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLT 693
N L+ T K+ADFG+SR D I+G ++P ++ E L
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----------WMAWECILM 214
Query: 694 HKLTDKSDVYSLGVVFLEL-----------LTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
K T SDV++ GV E+ LT Q I + R+ Q ++
Sbjct: 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRD-----QGRQVYL-- 267
Query: 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
P C + +L L+C + RPS S++ L
Sbjct: 268 -----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+G G V K L + G + A+K LQ K+ L E++ +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66
Query: 575 YCDEEGEQML--VYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGILY 624
+E + E+ G+L D + K K+ LG IA +G+ Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSY 120
Query: 625 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 684
LH+ + HRDIK SNILL K K+ DFG+S V + T GT
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFT-GTSF 168
Query: 685 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
Y+ PE + SDV+SLG+ LE+ P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGYC 576
++G G +GKVYK + V+A + + + E E ++ EI L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E ++ EF + G + D + + + PL + + + YLH + + HR
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK-----GTPGYLDPEYF 691
D+KA NIL K+ADFG+S + T+ + GTP ++ PE
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS------------AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 692 LTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
+ D K+DV+SLG+ +E + ++P H N +R + + + +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIE-MAQIEPPHHELNPMRVL-------LKIAKSEPPT 227
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ PS +F KC + DAR + +++++
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 32/271 (11%)
Query: 519 IGQGGYGKV----YKGILPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
+G+G YG+V ++ DG +K+ + S + K E Q LS+L H N+V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 573 V-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
+ E+G +V F G L +L + + L + + + + YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
+ HRD+K N+ L KV D G++R L D+ ST++ GTP Y+ PE
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-------ASTLI-GTPYYMSPEL 173
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
F KSDV++LG E+ T + H N +++N S+++ +I+G + P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT----LKHAFN-AKDMN-----SLVYRIIEGKLPPMP 223
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRE 781
+ + +L + RPS+ ++R+
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 519 IGQGGYGKVYKGI-LPDGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 572
+G G +G V+KGI +P+G VA+K Q+ S Q +E + + L H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C Q LV + G+L D + + ++ L L+ + ++G+ YL
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
+ HR++ A NILL ++ADFG++ L PD + + T +K ++ E L
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSEHKTPIK----WMALESIL 184
Query: 693 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID----GNMG 747
+ T +SDV+S GV E+++ G +P Y V D G
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEP--------------YAGMRPHEVPDLLEKGERL 230
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
+ P C + +KC + + RP+ E+ E
Sbjct: 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 39/288 (13%)
Query: 508 LATNNFNSSTQIGQGGYGKVYKGI-LPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFL 561
L F +G G +G VYKG+ +P+G VA+K +E S + KE L E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 562 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 621
+ + + ++ L+G C Q L+ + M G L D + + K+ +G L+ + ++G
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKG 121
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVS 676
+ YL + + HRD+ A N+L+ K+ DFGL++L + E G VP
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-- 176
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 735
++ E L T +SDV+S GV EL+T G +P +
Sbjct: 177 --------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----------GIPA 217
Query: 736 SMMFSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
S + S+++ G P C + +KC + D+RP E++ E
Sbjct: 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 51/289 (17%)
Query: 519 IGQGGYGKVYKGILP-DGTVV--AVKRAQE-GSLQGEKEFLTEIQFLSRL-HHRNLVSLV 573
IG+G +G+V K + DG + A+KR +E S ++F E++ L +L HH N+++L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSS 619
G C+ G L E+ +G L D L + L L A +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
RG+ YL + HRD+ A NIL+ + AK+ADFGLSR V V
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------------YV 166
Query: 680 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 733
K T G L + L T SDV+S GV+ E+++ G P G
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTC-------- 217
Query: 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
+ + + G P C ++ L +C +++ RPS ++++ L
Sbjct: 218 -AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 54/284 (19%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLV 573
++G+G YG V K +P GT++AVKR A S Q +K L ++ R + V+
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEP--------LGFAMRLSIALGSSRGILYL 625
G EG+ + E M T D+ K + LG IA+ + + YL
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYL 119
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVKGTPG 684
H++ V HRD+K SN+L++ K+ DFG+S G +V + T+ G
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS---------GYLVDSVAKTIDAGCKP 168
Query: 685 YLDPEYF---LTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740
Y+ PE L K D KSDV+SLG+ +EL TG P K +++
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK---------Q 219
Query: 741 VIDGN-----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
V++ + E + F+ KC + RP+ E++
Sbjct: 220 VVEEPSPQLPAEKFSPEFQD-FVN---KCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 74/277 (26%), Positives = 116/277 (41%), Gaps = 28/277 (10%)
Query: 511 NNFNSSTQIGQGGYGKVYKG-ILPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHH-R 567
N+ + +IG G G+VYK G V+AVK+ + G+ + K L ++ + + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
+V GY + + + E MS T D+L + + P+ + + + + + YL
Sbjct: 75 YIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ V HRD+K SNILLD K+ DFG+S RL V + T G Y+
Sbjct: 133 KHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL---------VDSKAKTRSAGCAAYM 181
Query: 687 DPEYFLTHKLTDK----SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
PE K +DV+SLG+ +EL TG P + K + Q +
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--PSL 239
Query: 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
N G P F C + RP E++
Sbjct: 240 PPNEGFSP-----DFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 30/240 (12%)
Query: 555 LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 614
+EI + +L H N+V L+G C E L++E++ L + L S E R I
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWE-----RRRKI 785
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
A+G ++ + +LH P V ++ I++D K + RL+ P
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSL--------PGL 831
Query: 675 VSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN--IVRE 728
+ T K + Y+ PE T +T+KSD+Y G++ +ELLTG P G + IV
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
Query: 729 VNIAYQSSMMFSVID----GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
Y + ID G++ +E VE + LAL C + ARP ++V++ LES
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 40/267 (14%)
Query: 537 VVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 595
+VAVK + + + +FL EI+ +SRL + N++ L+G C + ++ E+M NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 596 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDH 647
LS + E F +I S +LY+ + A HRD+ N L+ +
Sbjct: 106 QFLSQREIES-TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 648 KFTAKVADFGLSRLAPVPD---IEG--IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 702
+T K+ADFG+SR D I+G ++P ++ E L K T SDV
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----------WMAWESILLGKFTTASDV 214
Query: 703 YSLGVVFLEL--LTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-----SYPSECVE 755
++ GV E+ L QP S ++ + + + F N G S C
Sbjct: 215 WAFGVTLWEMFTLCKEQPYS----LLSDEQVIENTGEFFR----NQGRQIYLSQTPLCPS 266
Query: 756 KFIKLALKCCQDETDARPSMSEVMREL 782
KL ++C + RP+ +++ L
Sbjct: 267 PVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 65/279 (23%), Positives = 125/279 (44%), Gaps = 26/279 (9%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA---QEGSLQGEK---EFLTEIQFLSRL 564
+ Q+G G + Y+ + GT++AVK+ + S + E+ EI+ ++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 565 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 624
+H +++ ++G E+ L E+M+ G++ LS A+ ++ RG+ Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSY 118
Query: 625 LHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGT 682
LH + + HRD+K +N+L+D ++ADFG + RLA G + GT
Sbjct: 119 LH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA--AKGTG--AGEFQGQLLGT 171
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
++ PE + DV+S+G V +E+ T P + + +++F +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-------AEKHSNHLALIFKIA 224
Query: 743 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
S P + L+C + + + RP E+++
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 512 NFNSSTQIGQGGYGKVY--KGILPDGTVVAVKRAQEGSLQGEKEF-LTEIQFLSRLHHRN 568
+ +IG+G +GK+Y K V + EKE E+ L+++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+V+ E G +V E+ G L +++ + LS + S G+ ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-- 118
Query: 629 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
D + HRDIK+ NI L + AK+ DFG++R + D ++ GTP YL
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LND-----SMELAYTCVGTPYYLS 170
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE +K+D++SLG V EL T P
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEK--EFLTEIQFLSRLHHRN 568
F+ +IG G +G VY + + VVA+K+ + G EK + + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+ G E LV E+ G+ D L K+PL ++ G+ +G+ YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRD+KA NILL K+ DFG + + + PA+ GTP ++ P
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASI--------MAPANXFV---GTPYWMAP 180
Query: 689 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPI 719
E L + K DV+SLG+ +EL P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 83/320 (25%), Positives = 132/320 (41%), Gaps = 41/320 (12%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 566
TN + +G G +G V G VA+K+ + + K E++ L L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 567 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
N++SL E + V E + L L+++ E L L RG+ Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL---RGLKYV 124
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H+ V HRD+K SNIL++ K+ DFGL+R+ P + G V T Y
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYV---------STRYY 171
Query: 686 LDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
PE LT K + D++S G +F E+L G +P+ GK+ V + FS+I
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQ----------FSIITD 220
Query: 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 804
+G+ P + + C + T R S RE +D + +
Sbjct: 221 LLGTPPDDVINTI-------CSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272
Query: 805 TSKEETPPSSSSMLKHPYVS 824
+ S++ L HPY++
Sbjct: 273 VFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 518 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNL 569
+IG+G YG VYK D +A+K+ + L+ E E + EI L + H N+
Sbjct: 9 KIGEGTYGVVYKA--RDRVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLH 626
V L E LV+E++ + L+ + + +K P L L RGI Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH 119
Query: 627 TEADPPVFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
+ V HRD+K N+L+D + A K+ADFGL+R +P V VV T Y
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-----VRTFTHEVV--TLWY 169
Query: 686 LDPEYFL-THKLTDKSDVYSLGVVFLELLT 714
PE L + + D++S+G +F E++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 83/274 (30%), Positives = 121/274 (44%), Gaps = 38/274 (13%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
+IG G G VYK I P G + A+K E +++ ++ EI+ L ++H N+V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPNVVKCH 138
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-LSIALGSSRGILYLHTEADPP 632
D GE ++ EFM G+L A + A + LS GI YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLHRRH--- 188
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
+ HRDIK SN+L++ K+ADFG+SR LA D P + S GT Y+ PE
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----PCNSSV---GTIAYMSPERI 240
Query: 692 ---LTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
L H D D++SLGV LE G P G+ +S+M ++
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWASLMCAICMSQP 293
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
P+ +F C Q E R S ++++
Sbjct: 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHR 567
NF +IG+G + +VY+ L DG VA+K+ Q L K + + EI L +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 623
N++ E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
++H+ V HRDIK +N+ + K+ D GL R AH + GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHS---LVGTP 170
Query: 684 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
Y+ PE + KSD++SLG + E+ P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEF------------LTEIQFLSR 563
+G+G YGKV K G +VA+K+ + E S K+ L E++ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALG 617
+ H N++ LV E LV + M+ L+ + K +RL+ I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--------IRLTESQVKCILLQ 127
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH--- 674
G+ LH HRD+ +NI ++ K K+ADFGL+R P +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 675 ------VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 727
S VV T Y PE + K D++S+G +F ELLTG +P+ G+N +
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEID 241
Query: 728 E 728
+
Sbjct: 242 Q 242
|
Length = 335 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+GG+G+V + G + A K+ + L +GE+ L E + L ++ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ + + LV M+ G L+ + + A + A G+ +LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
+RD+K N+LLD +++D GL+ +++G GTPGY+ PE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRA---GTPGYMAPEVLQGE 169
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPI-SHGKNIVRE 728
D ++LG E++ G P + + +E
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 45/222 (20%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEG----SLQGEKEFLTEIQFLSRLHHRNLV 570
+IG G YG VYK + G +VA+K + + G +Q E I L H N+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE------ISMLKECRHPNIV 63
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHT 627
+ G + +V E+ G+L+D ++ PL L IA + +G+ YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVK-----G 681
HRDIK +NILL K+ADFG+S A ++ T+ K G
Sbjct: 120 TG---KIHRDIKGANILLTEDGDVKLADFGVS-------------AQLTATIAKRKSFIG 163
Query: 682 TPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPIS 720
TP ++ PE + K D+++LG+ +EL P+
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 513 FNSSTQIGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 570
F +IG+G +G+VYKGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
G + + ++ E++ G+ D L E A L L +G+ YLH+E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSERK 122
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
HRDIKA+N+LL + K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
K+D++SLG+ +EL G P S
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLV 570
F +IG+G +G+V+KGI VVA+K + E E + EI LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
G ++ + ++ E++ G+ D L + A L L +G+ YLH+E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 122
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
HRDIKA+N+LL K+ADFG++ I+ GTP ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAPEV 172
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN----M 746
K+D++SLG+ +EL G P S + ++F + N
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSE----------LHPMKVLFLIPKNNPPTLE 222
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
G+Y S+ +++F++ C E RP+ E+++
Sbjct: 223 GNY-SKPLKEFVE---ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 519 IGQGGYGKVYKGIL-PDGTVVAVKR---------AQEGSLQGEKEFLTEI--QFLSRLHH 566
+G GG+G+V + A+K Q+ + EKE L E F+ +L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF---AMRLSIALGSSR 620
+ D++ ML+ E+ G L L + + F + L+ +R
Sbjct: 61 T-------FKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 621 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
GI+Y RD+K N+LLD K+ DFG ++ ++ T
Sbjct: 113 GIIY-----------RDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTW--TFC- 153
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
GTP Y+ PE L D +SLG++ ELLTG P
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHRNLVSL--- 572
IG+G YG V P G VA+K+ E ++ L EI+ L R H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDI 71
Query: 573 --VGYCDEEGEQMLVYEFMSNG---TLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLH 626
+ + +V E M ++ Q LS + + + RG+ Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL--------RGLKYIH 123
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGY 685
+ A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 124 S-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-----TRWY 175
Query: 686 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 723
PE L K K+ D++S+G + E+L+ +P+ GK
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 576
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 577 DEEG-----EQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
++ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 131
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 132 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 182
Query: 691 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 719
+ D KSD++SLG+ +E+ G P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 521 QGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVG 574
+G +G+++ GIL D V VK ++ + + + L E L L H+N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 575 YCDEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGILYLHT 627
C E+GE ++Y +M+ G L+ L LS +A+ + G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAP-----VPDIEGIVPAHVSTVVKG 681
V H+DI A N ++D + K+ D LSR L P + D E + VK
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE-------NRPVK- 184
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP 718
++ E + + + SDV+S GV+ EL+T G P
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 519 IGQGGYGKVYKGIL-PDGTV--VAVKRAQEG-SLQGEKE-FLTEIQFLSRLHHRNLVSLV 573
+G+G +G V +G L D ++ VAVK + + E E FL+E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 574 GYCDEEGEQ------MLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSIALGS--SRGIL 623
G C + E +++ FM +G L L S P ++ + + + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
YL +++ HRD+ A N +L+ VADFGLS+ D + K
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-----YRQGRIAKMPV 178
Query: 684 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742
++ E T KSDV+S GV E+ T G P +N S + +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----------SEIYDYLR 228
Query: 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
GN P +C++ L C RPS + ELE
Sbjct: 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-14
Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 47/285 (16%)
Query: 516 STQIGQGGYGKV-YKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH- 565
S +G G G V + DG AVK A + Q E L F S +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 566 HRNLVSLVGYCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIAL 616
H + D + LV ++ + G LR ++ +++K F A L I +
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL--APVPDIEGIVPAH 674
+L +H + HRDIK++NILL K+ DFG S++ A V D
Sbjct: 153 -----LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD-------D 200
Query: 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734
V GTP Y+ PE + + K+D++SLGV+ ELLT +P G+N+ EV
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-GENM-EEV----- 253
Query: 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
M + G P + ++ + RPS S+++
Sbjct: 254 ---MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 517 TQIGQGGYGKVYKGILPD-GTVVAVKR--AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
++IG+G YG V+K + G +VA+K+ E +K L EI+ L +L H NLV+L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 629
+ + LV+E+ + T+ ++L K P G + + I++ +A
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELE---KNPRG------VPEHLIKKIIWQTLQAVNFC 116
Query: 630 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
HRD+K NIL+ + K+ DFG +R+ P + T T Y P
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-------YTDYVATRWYRAP 169
Query: 689 EYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGK 723
E + + DV+++G VF ELLTG QP+ GK
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 36/271 (13%)
Query: 519 IGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 573
+G G +G++ +G L VA+ + G S + + FL E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G M+V E+MSNG L D K + L + + G + G+ YL ++
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYF 691
H+ + A +L++ K++ F RL E I T + G L PE
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RL-QEDKSEAIY-----TTMSGKSPVLWAAPEAI 180
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
H + SDV+S G+V E+++ G +P +S ++ +V DG
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------------QDVIKAVEDGFRL 227
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEV 778
P C +L L C Q E RP S++
Sbjct: 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 29/278 (10%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHR 567
NF +IG+G + +VY+ L D VA+K+ Q + + ++ + EI L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----PLGFAMRLSIALGSSRGIL 623
N++ + E+ E +V E G L + K+ P + + L S+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VE 120
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
++H+ V HRDIK +N+ + K+ D GL R AH S V GTP
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAH-SLV--GTP 170
Query: 684 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743
Y+ PE + KSD++SLG + E+ P K +N+ S+ +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLF---SLCQKIEQ 222
Query: 744 GNMGSYPSE-CVEKFIKLALKCCQDETDARPSMSEVMR 780
+ P+E EK +L C + D RP + V +
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY- 575
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 576 -----CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
+ + LV EF G++ D + L I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK- 141
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
V HRDIK N+LL K+ DFG+S ++ V + + GTP ++ PE
Sbjct: 142 --VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFI--GTPYWMAPEV 192
Query: 691 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPI 719
+ D +SD++SLG+ +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 557 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 616
E L+++ H N+V+ + +G +V E+ G L ++ + + L +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
G+ ++H + V HRDIK+ NI L K+ DFG +RL P A+
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP------GAYAC 158
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIVREV 729
T V GTP Y+ PE + +KSD++SLG + EL T P KN++ +V
Sbjct: 159 TYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 574
+G+G +GKV L G + AVK ++ + + + +TE + LS + ++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 575 YCDEEGEQML-VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALGSSRGILYLHTEA 629
C + +++ V EF++ G L Q S + E +A ++ AL ++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL------MFLH--- 113
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
D + +RD+K N+LLDH+ K+ADFG+ + EGI ++ GTP Y+ PE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTPDYIAPE 166
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
D +++GV+ E+L G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 505 EMALATNNFNSSTQIGQGGYGKVYKGIL-------PDGTVV--AVKRAQEGSLQGEKEFL 555
E+ L+T F ++G+ +GKVYKG L V +K EG L+ +EF
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFK 56
Query: 556 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS------------- 602
E SRL H N+V L+G +E +++ + S+ L + L +S
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 603 -KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661
K L A + I + G+ +L + V H+D+ N+L+ K K++D GL R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 720
D ++ + + ++ PE + K + SD++S GVV E+ + G+QP
Sbjct: 174 VYAADYYKLMGNSLLPI-----RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 721 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
N ++V ++ + P +C L L+C + RP ++
Sbjct: 229 GYSN--QDVIEMIRNRQVLPC--------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278
Query: 781 ELES 784
L +
Sbjct: 279 RLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 19/230 (8%)
Query: 518 QIGQGGYGKVYKGILPDGTVVA---VKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
+IG G +GKV G G A VK + + E+ FL E+Q L+H N++ +
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFA---MRLSIALGSSRGILYLHTEAD 630
G C E +LV EF G L++ L + A + +A + G+L+LH +AD
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP-- 688
H D+ N L + K+ D+GL+ D H + P ++
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN------IVREVNI 731
+ L T KS+++SLGV EL T QP + +VRE +I
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 519 IGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSL 572
+GQG +GKV+ K PD G + A+K ++ +L+ T E L+ ++H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM-RLSIALGS--SRGILYLH 626
EG+ L+ +F+ G L +LS + ++E + F + L++AL S GI+Y
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY-- 121
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
RD+K NILLD + K+ DFGLS+ E I + GT Y+
Sbjct: 122 ---------RDLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYSFCGTVEYM 165
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
PE T +D +S GV+ E+LTG P GK+
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 71/224 (31%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 518 QIGQGGYGKVYKGILPDG---TVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
+IG G +GKV G + G V VK + S+Q + +FL E Q L H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFA-MRLSIALGSSRGILYLH 626
G C E +LV EF G L+ L + K +P M IAL G+L+LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL----GLLHLH 117
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP-GY 685
H D+ N LL T K+ D+GLS D +V+ P +
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY------YVTPDQLWVPLRW 168
Query: 686 LDPEY-------FLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 721
+ PE L T +S+V+SLGV EL G QP H
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 568
++ +IG+G G V I D G VAVK+ Q + E+ + H N
Sbjct: 20 YLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSSRGI 622
+V + E +V EF+ G L D ++ R++ + L + +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKAL 128
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
+LH + V HRDIK+ +ILL K++DFG + VP S V GT
Sbjct: 129 SFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GT 178
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
P ++ PE + D++SLG++ +E++ G P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 64/208 (30%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 518 QIGQGGYGKVYKGILPD-GTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---HRNLVS 571
+IG G YG VYK P G VA+K R Q + E+ L RL H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 572 LVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
L+ C D E + LV+E + LR L L + RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGY 685
+ HRD+K NIL+ K+ADFGL+R I ++ T V T Y
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTPVVVTLWY 173
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELL 713
PE L D++S+G +F E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 516 STQIGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRL---HH 566
+IG+G YG VYK L G VA+K+ ++EG L EI L +L H
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEH 60
Query: 567 RNLVSLVGYC-----DEEGEQMLVYEFMSN--GTLRDQLSAK--SKEPLGFAMRLSIALG 617
N+V L+ C D E + LV+E + T + E + MR +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL--- 117
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
RG+ +LH+ + HRD+K NIL+ K+ADFGL+R I A S
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTSV 166
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 712
VV T Y PE L D++S+G +F EL
Sbjct: 167 VV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 45/238 (18%)
Query: 511 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSR 563
+ + +IGQG +G+V+K +VA+K+ ++ EKE F L EI+ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKT-KQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 564 LHHRNLVSLVGYCDEEGEQ--------MLVYEF--------MSNGTLRDQLSAKSKEPLG 607
L H N+V+L+ C + LV+EF +SN ++ LS K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--- 124
Query: 608 FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667
M L+ G+ Y+H + HRD+KA+NIL+ K+ADFGL+R A
Sbjct: 125 MKMLLN-------GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR-AFSLSK 173
Query: 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKN 724
+ + VV T Y PE L + D++ G + E+ T PI G
Sbjct: 174 NSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 518 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IG+G G V G VAVK+ Q + E+ + HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E +V EF+ G L D ++ A ++ L R + YLH + V HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLHNQG---VIHR 142
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
DIK+ +ILL K++DFG + VP S V GTP ++ PE
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGF-----CAQVSKEVPKRKSLV--GTPYWMAPEVISRLPY 195
Query: 697 TDKSDVYSLGVVFLELLTGMQP 718
+ D++SLG++ +E++ G P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 71/277 (25%)
Query: 512 NFNSSTQIGQGGYGKVY----KG--------------ILPDGTVVAV---KRAQEGSLQG 550
+FN +G+G +GKV KG I+ D V KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL--ALPG 58
Query: 551 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL--RDQLSAKSKE 604
+ FLT++ Q + RL+ V E+++ G L Q K KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYHIQQVGKFKE 100
Query: 605 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---- 149
Query: 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK- 723
E I + GTP Y+ PE D ++ GV+ E+L G QP G+
Sbjct: 150 ---ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG-QPPFDGED 205
Query: 724 -----NIVREVNIAYQSSM---MFSVIDGNMGSYPSE 752
+ E N++Y S+ S+ G + +P++
Sbjct: 206 EDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAK 242
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 518 QIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVS 571
+IG+G +GK IL DG +K + ++ E E+ LS + H N+V
Sbjct: 7 KIGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK------SKEPLGFAMRLSIALGSSRGILYL 625
+E G +V ++ G L +++A+ + L + +++ +AL ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HV 117
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H D + HRDIK+ NI L T K+ DFG++R+ + V ++ GTP Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV-----LNSTV--ELARTCIGTPYY 167
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG--KNIV 726
L PE +KSD+++LG V E+ T G KN+V
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-13
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 508 LATNNFNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 565
L ++F +++G G G V K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
+V G +GE + E M G+L L + P ++SIA+ RG+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYL 119
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
+ PE + +SD++S+G+ +EL G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-13
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 28/283 (9%)
Query: 556 TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 615
+E+ L+ H +V + + +L+ E+ S G L Q+ + KE L F +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEVG 172
Query: 616 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675
L + +L L + HRD+K++NI L K+ DFG S+ V V
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-----QYSDSVSLDV 227
Query: 676 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735
++ GTP YL PE + + + K+D++SLGV+ ELLT +P Q
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----------QR 277
Query: 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIWNMMPE-- 791
+M V+ G +P L RP+ +++ L+ + N+ +
Sbjct: 278 EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIV 337
Query: 792 --SDTKTP----EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828
S+T +P E + S E PP SS +++ V+SDV+
Sbjct: 338 RHSETISPHDREEILRQLQESGERAPPPSS--IRYGVVTSDVT 378
|
Length = 478 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 32/222 (14%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRN--- 568
+IG+G YGKVYK G +VA+K+ + L+ ++E L EI L L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTR---LEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 569 -LVSLVGYCDEEGEQM--LVYEFMSNGTLR--DQLSAKSKEPLGFAMRLSIALGSSRGIL 623
L+ + ++ G+ LV+E++ + + D PL S +G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 624 YLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
+ H V HRD+K N+L+D K K+AD GL R +P V ++ +V T
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP-----VKSYTHEIV--T 174
Query: 683 PGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHG 722
Y PE L TH T D++S+G +F E+ QP+ G
Sbjct: 175 LWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSR-KQPLFPG 214
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFL-TEIQFLSRLHHRNLVSLVGY 575
+IGQG G VY I + G VA+K+ Q +KE + EI + H N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 576 CDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRGILYL 625
E +V E+++ G+L D Q++A +E L + + +L
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------------QALEFL 131
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPG 684
H+ V HRDIK+ NILL + K+ DFG +++ P + ST+V GTP
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPY 180
Query: 685 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
++ PE K D++SLG++ +E++ G P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 508 LATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH 565
L ++F +++G G G V+K P G ++A K E + + E+Q L +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
+V G +GE + E M G+L L + P ++SIA+ +G+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYL 119
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
+ + HRD+K SNIL++ + K+ DFG+S G + ++ GT Y
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSY 168
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
+ PE + +SD++S+G+ +E+ G PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 518 QIGQGGYGKV-YKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IG+G G V + G +VAVK+ Q + E+ + H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E +V EF+ G L D ++ A ++ L + + LH + V HR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---AVCLAVLKALSVLHAQG---VIHR 140
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
DIK+ +ILL H K++DFG + VP S V GTP ++ PE
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGF-----CAQVSKEVPRRKSLV--GTPYWMAPELISRLPY 193
Query: 697 TDKSDVYSLGVVFLELLTGMQP 718
+ D++SLG++ +E++ G P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 573
IG+G +GKV DG AVK Q+ ++ +KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 574 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTE 628
Y + +++ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG------YLHSL 115
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ +RD+K NILLD + + DFGL + EGI + ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTSTFCGTPEYLAP 165
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
E D + LG V E+L G+ P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 513 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 568
F +G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+VSL + + LV M+ G L+ + + + A G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGY 685
+ +RD+K NILLD +++D GL+ VP+ I+G V GT GY
Sbjct: 122 R---IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV---------GTVGY 167
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-GKNIVRE 728
+ PE + T D ++LG + E++ G P K I RE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 74/280 (26%), Positives = 111/280 (39%), Gaps = 34/280 (12%)
Query: 517 TQIGQGGYGKVYKGIL---PDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G G +G V KG+ VAVK + + E L E + +L + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHT 627
++G C+ E MLV E G L L K ++S+ G+ YL
Sbjct: 61 MIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLE- 112
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ HRD+ A N+LL + AK++DFGLS+ + H VK +
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYA 166
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE +K + KSDV+S GV+ E + G +P K EV +S G
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIES--------GER 216
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786
P C + L C D RP + V L + +
Sbjct: 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 64/246 (26%), Positives = 100/246 (40%), Gaps = 56/246 (22%)
Query: 519 IGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKEFLTEIQFLSRLH 565
+G+G +GKV KG + AVK ++ EK L L+
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLA----LAG-K 54
Query: 566 HRNLVSLVGYCDEEGEQML--VYEFMSNGTL--RDQLSAKSKEPLG--FAMRLSIALG-- 617
H L L + + + L V E+++ G L Q S + EP +A + + L
Sbjct: 55 HPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
RGI+Y RD+K N+LLD + K+ADFG+ + EGI+ ++
Sbjct: 113 HERGIIY-----------RDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTS 154
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNI 731
GTP Y+ PE D ++LGV+ E+L G P G + + E +
Sbjct: 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEV 213
Query: 732 AYQSSM 737
Y +
Sbjct: 214 RYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 84/338 (24%), Positives = 128/338 (37%), Gaps = 96/338 (28%)
Query: 519 IGQGGYGKVYK----GI--LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 570
+G+G +GKV + GI VAVK +EG+ E K +TE++ L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 571 SLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRL- 612
+L+G C + G M++ E+ G L + L +K K+ G RL
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 613 ------------------------------------------SIALGSSRGILYLHTEAD 630
S + +RG+ +L A
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTP----GY 685
HRD+ A NILL K+ DFGL+R + PD V KG +
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------VRKGDARLPLKW 241
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
+ PE T +SDV+S GV+ E+ + G P G I E + +G
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQIDEEFCRRLK--------EG 292
Query: 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
P + + L C + + RP+ SE++ L
Sbjct: 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 70/289 (24%), Positives = 113/289 (39%), Gaps = 63/289 (21%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHH-RNLVSLVGY 575
IG+G +G V K + GT++AVKR + + E K L ++ + R +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 576 CDEEGEQMLVYEFMS--------------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 621
EG+ + E M + +++ K IA+ + +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------------IAVATVKA 119
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPAHVSTVVK 680
+ YL E + HRD+K SNILLD K+ DFG+S G +V + T
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---------GQLVDSIAKTRDA 168
Query: 681 GTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737
G Y+ PE +SDV+SLG+ E+ TG P ++ ++
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT------- 221
Query: 738 MFSVIDGN---MGSYP----SECVEKFIKLALKCCQDETDARPSMSEVM 779
V+ G+ + + S FI L C + RP E++
Sbjct: 222 --QVVKGDPPILSNSEEREFSPSFVNFINL---CLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 573
IG+G +GKV DG+ AVK Q+ ++ +KE + E L L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 574 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTE 628
Y + E++ V ++++ G L L + EP +A ++ A+G YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG------YLHSL 115
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ +RD+K NILLD + + DFGL + EG+ P ++ GTP YL P
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGVEPEETTSTFCGTPEYLAP 165
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
E D + LG V E+L G+ P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 37/98 (37%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 621 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
G+ LH + HRDIK N+L+D K+ DFGLSR G+
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-------GLENKKFV---- 154
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
GTP YL PE L SD +SLG V E L G P
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 59/265 (22%), Positives = 114/265 (43%), Gaps = 31/265 (11%)
Query: 527 VYKGILPDGTVV--AVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY----CDEEG 580
+YKGI + V+ K+ +G EI+ L R+ N++ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 640
L+ E+ + G LR+ L K K+ L F +L +A+ +G+ L+ + P ++++ +
Sbjct: 96 RLSLILEYCTRGYLREVLD-KEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 641 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTD 698
+ L+ + K+ GL ++ P + +V+ +V Y + + T
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFK-----NVNFMV-----YFSYKMLNDIFSEYTI 201
Query: 699 KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 758
K D+YSLGVV E+ TG P N+ + + N P +C +
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFE---------NLTTKEIYDLIINKNNSLKLPLDCPLEIK 252
Query: 759 KLALKCCQDETDARPSMSEVMRELE 783
+ C ++ RP++ E++ L
Sbjct: 253 CIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 54/224 (24%)
Query: 518 QIGQGGYGKVYKGILPD---GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRL-HHRNLV 570
++G+G YG V+K I D VVA+K+ A + ++ F EI FL L H N+V
Sbjct: 14 KLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 571 SLVGYCDEEGEQ--MLVYEFMSN--------GTLRD--------QLSAKSKEPLGFAMRL 612
L+ E ++ LV+E+M L D QL
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL------------- 117
Query: 613 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 672
+ + Y+H+ V HRD+K SNILL+ K+ADFGL+R + ++E
Sbjct: 118 -------KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS--LSELEENPE 165
Query: 673 AHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTG 715
V T T Y PE L + + T D++S+G + E+L G
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 33/229 (14%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS---- 571
IG+G YG V I G VA+K+ + + L EI+ L L H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 572 -LVGYCDEEGEQMLVYEFMSNG-----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
L E + +V+E M + D L+ + + + + R + Y+
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------RALKYI 119
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
HT VFHRD+K NIL + K+ DFGL+R+A A T T Y
Sbjct: 120 HTAN---VFHRDLKPKNILANADCKLKICDFGLARVA----FNDTPTAIFWTDYVATRWY 172
Query: 686 LDPEY---FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 731
PE F + K T D++S+G +F E+LTG +P+ GKN+V ++++
Sbjct: 173 RAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDL 219
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 7e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IGQG G V+ I + G VA+K+ ++ + EI + L + N+V+ +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E +V E+++ G+L D ++ + A ++ + + +LH V HR
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA---AVCRECLQALEFLHANQ---VIHR 139
Query: 637 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
DIK+ N+LL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 696 LTDKSDVYSLGVVFLELLTGMQP 718
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 519 IGQGGYGKVYKGILPDGT--VVAVKRAQEGSLQGEKEF---LTEIQFLS-RLHHRNLVSL 572
+G+G +GKV L GT V A+K ++ + + + +TE + L+ H L +L
Sbjct: 3 LGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLG--FAMRLSIALGSSRGILYLHTE 628
+ V E+++ G L Q+ S K EP +A +++AL ++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLHRH 115
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
V +RD+K NILLD + K+ADFG+ + EGI+ +T GTP Y+ P
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYIAP 165
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
E + D ++LGV+ E++ G P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 8e-12
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 511 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSR 563
++F +G G +G+V +K G A+K A+ L+ + L E + L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS--IALGSSRG 621
+ H LV+L G ++ LV E++ G L L + P A + + L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA---- 113
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+ YLH+ + +RD+K N+LLD K+ DFG ++ V T+ G
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK---------RVKGRTYTLC-G 160
Query: 682 TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
TP YL PE L K K+ D ++LG++ E+L G P
Sbjct: 161 TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 81/322 (25%), Positives = 124/322 (38%), Gaps = 57/322 (17%)
Query: 518 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH---HR 567
+IG+G YGKV+K + G VA+KR + +Q +E + E+ L L H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 568 NLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622
N+V L C D E + LV+E + L L + + + RG+
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
+LH+ V HRD+K NIL+ K+ADFGL+R+ T V T
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------QMALTSVVVT 172
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
Y PE L D++S+G +F E+ +P+ G + V Q + VI
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVD------QLGKILDVI 225
Query: 743 DGNMGSYPSECVEKFIKLALKCCQD--ETDARPSMSEVMRELESIWNMMPESDTKTPEFI 800
P E +D A P + + + I + + D + +
Sbjct: 226 -----GLPGE-------------EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 267
Query: 801 NSEHTSKEETPPSSSSMLKHPY 822
T S+ S L HPY
Sbjct: 268 LKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 63/246 (25%), Positives = 94/246 (38%), Gaps = 51/246 (20%)
Query: 511 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRA---------QEGSLQGEKEFLTE 557
++F IG+G +G+V+ L G V A+K Q ++ E++ L +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 558 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 617
+V L +E LV E+M G L + L K P A R IA
Sbjct: 58 A------DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIA-- 108
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS--------------RLAP 663
+L L + HRDIK NIL+D K+ADFGL
Sbjct: 109 --ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 664 VPDIEGIVPA---------HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 714
+ + ++ ++ V GTP Y+ PE + D +SLGV+ E+L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 715 GMQPIS 720
G P
Sbjct: 226 GFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQ-FLSRLHHRNLVSLV 573
IG+G +GKV DG AVK Q+ + KE + E L + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 574 GYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
Y + E++ V +F++ G L L + P A + + S+ G YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHSIN--- 116
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
+ +RD+K NILLD + + DFGL + EGI + +T GTP YL PE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQP 718
+ D + LG V E+L G+ P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 573
IG+G Y KV L + + + L + E + +Q F +H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
E V E+++ G L + + K P A S + S + YLH +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYLHERG---I 117
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693
+RD+K N+LLD + K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 694 HKLTDKSDVYSLGVVFLELLTGMQP 718
D ++LGV+ E++ G P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 519 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 574
+G+GG+G+V + G + A K+ + L+ K + + E + L+++H R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEADPP 632
+ + LV M+ G LR + +E GF + + G+ +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
+ +RD+K N+LLD+ +++D GL+ +E + GTPG++ PE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-------VELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQP 718
+ D ++LGV E++ P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 17/220 (7%)
Query: 513 FNSSTQIGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRN 568
F +G+GG+G+V + G + A KR ++ ++ GE L E Q L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+V+L + + LV M+ G L+ + L A G+ LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLD 687
+RD+K NILLD +++D GL+ P + I G V GT GY+
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMA 169
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 727
PE + T D + LG + E++ G P K V+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IGQG G VY I + G VA+K+ ++ + EI + + N+V+ +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALDFLHSNQ---VIHR 139
Query: 637 DIKASNILLDHKFTAKVADFGL-SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
DIK+ NILL + K+ DFG +++ P + ST+V GTP ++ PE
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 696 LTDKSDVYSLGVVFLELLTGMQP 718
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 41/288 (14%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSR 563
T+ + IG+G YGKVYK DG++ AVK + ++ E L Q L
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNIL---QSLP- 76
Query: 564 LHHRNLVSLVG--YCDEE---GEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIAL 616
+H N+V G Y ++ G+ LV E + G++ + + + L AM I
Sbjct: 77 -NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
G+ G+ +LH + HRD+K +NILL + K+ DFG+S + +
Sbjct: 136 GALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR------N 186
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPISHGKNIVREVNI 731
T V GTP ++ PE + D S DV+SLG+ +EL G P+ + I
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
Query: 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
+P + F +C + +ARPS++ ++
Sbjct: 246 PRNPPPTL--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVG 574
IG+GG G+VY P VA+K+ +E + K FL E + + L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 575 YCDEEGEQMLVY---EFMSNGTLR---------DQLSAKSKEPLGFAMRLSIALGSSRGI 622
C + G+ VY ++ TL+ + LS + E LSI I
Sbjct: 70 ICSD-GD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL------------APVPDI--- 667
Y+H++ V HRD+K NILL + D+G + +I
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 714
+P + GTP Y+ PE L ++ +D+Y+LGV+ ++LT
Sbjct: 184 SMTIPGKIV----GTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 57/285 (20%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEG-SLQGEKEFLT-------------EIQFLSR 563
++G+G +G VY +V K+A L+ KE E Q LS+
Sbjct: 7 RLGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK 58
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALG 617
L H +V E ++ E+ L +L E + + LG
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
+ Y+H + HRD+KA NI L + K+ DFG+SRL + ++T
Sbjct: 119 ----VHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-------MGSCDLAT 163
Query: 678 VVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736
GTP Y+ PE L H+ D KSD++SLG + E+ + G+N + S
Sbjct: 164 TFTGTPYYMSPEA-LKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFL---------S 212
Query: 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA-RPSMSEVMR 780
++ +++G S P E + + ++ ++ + RPS +E++R
Sbjct: 213 VVLRIVEGPTPSLP-ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 39/277 (14%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRN---LVSL 572
++G+G YG VYK + P G +A+K E L+ E +F I L LH +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMK---EIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEAD 630
G EG + E+M G+L D+L A G + I +G+ +L E +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
+ HRD+K +N+L++ K+ DFG+S G + A ++ G Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS---------GNLVASLAKTNIGCQSYMAPER 172
Query: 691 FLTHKLTD------KSDVYSLGVVFLELLTGMQPISHGKNIVREV--NIAYQSSMMFSVI 742
+ +SDV+SLG+ LE+ G P E NI Q S +++
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP------PETYANIFAQLS---AIV 223
Query: 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM 779
DG+ + PS + KC + RP+ ++++
Sbjct: 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 68/222 (30%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 518 QIGQGGYGKVYKGILP-DGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
++G+G Y VYKGI +G +VA+K + +EG + E L L H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV---PFTAIREASLLKGLKHANIVLL 68
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG---FAMRLSIALGSSRGILYLHTEA 629
+ V+E+M D + P G + +RL RG+ Y+H +
Sbjct: 69 HDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQH 123
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRD+K N+L+ + K+ADFGL+R +P + S VV T Y P+
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-----QTYSSEVV--TLWYRPPD 173
Query: 690 YFLTHKLTDKS---DVYSLGVVFLELLTGMQPISHGKNIVRE 728
L TD S D++ G +F+E+L G QP G + V E
Sbjct: 174 VLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 44/225 (19%)
Query: 513 FNSSTQIGQGGYGKV----YKGILPDGTVVAVKRAQEG---------SLQGEKE-FLTEI 558
F +G+G +GKV YK G + A+K ++G SL EK F T
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFET-- 55
Query: 559 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLS 613
+ H LV+L E V E+ + G L D S EP
Sbjct: 56 --ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAAC 109
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673
+ LG + YLH + + +RD+K N+LLD + K+ADFGL + EG+
Sbjct: 110 VVLG----LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-------EGMGFG 155
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
++ GTP +L PE T D + LGV+ E+L G P
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 71/277 (25%)
Query: 512 NFNSSTQIGQGGYGKVY----KG--------ILPDGTVV---------AVKRAQEGSLQG 550
+FN +G+G +GKV KG IL V+ KR +L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVL--ALSG 58
Query: 551 EKEFLTEI----QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS--AKSKE 604
+ FLT++ Q + RL+ V E+++ G L Q+ + KE
Sbjct: 59 KPPFLTQLHSCFQTMDRLY------------------FVMEYVNGGDLMYQIQQVGRFKE 100
Query: 605 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664
P IA+G + +LH++ + +RD+K N++LD + K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---- 149
Query: 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
E + + GTP Y+ PE D ++ GV+ E+L G P G++
Sbjct: 150 ---ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-GED 205
Query: 725 ------IVREVNIAYQSSM---MFSVIDGNMGSYPSE 752
+ E N+AY SM ++ G M +P +
Sbjct: 206 EDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 558 IQFLSRLHHRNLVSLVGYCD---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI 614
I+ L LH N +VG+ +GE + E M G+L L + P ++SI
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI 106
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
A+ RG+ YL + + HRD+K SNIL++ + K+ DFG+S G +
Sbjct: 107 AV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDS 153
Query: 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719
++ GT Y+ PE T +SD++SLG+ +E+ G PI
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 519 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+GG+G+V + G + A K+ ++ ++ GE L E + L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 575 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR--GILYLHTEADP 631
Y E + + LV M+ G L+ + GF + +I + G+ L E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDLQRER-- 122
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD-IEGIVPAHVSTVVKGTPGYLDPEY 690
+ +RD+K NILLD + +++D GL+ P + + G V GT GY+ PE
Sbjct: 123 -IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---------GTVGYMAPEV 172
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 727
K T D + LG + E++ G P K V+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 519 IGQGGYGKV----YKGILPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVS 571
+GQG YG V + VA+K+ K L E++ L H+N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 572 LVG----YCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 625
L + E L E M L +S +PL A S G+ Y+
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEA-----DLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPG 684
H+ A+ V HRD+K N+L++ K+ DFGL+R + P G ++ V T
Sbjct: 122 HS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP---GENAGFMTEYV-ATRW 174
Query: 685 YLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVN 730
Y PE L+ + K+ DV+S+G + ELL G +P+ GK+ V ++N
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL- 572
+IG+G + +V K G A+K SL+ + L EIQ L RL H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLI 64
Query: 573 -VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
V + + G LV+E M + L + L K PL S + + ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
+FHRDIK NIL+ K+ADFG R GI T T Y PE
Sbjct: 121 -IFHRDIKPENILIK-DDILKLADFGSCR--------GIYSKPPYTEYISTRWYRAPECL 170
Query: 692 LTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 730
LT K D++++G VF E+L+ + P+ G N + ++
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIA 209
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 36/205 (17%)
Query: 560 FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTL--RDQLSAKSKEPLGFAMRLSIAL 616
FL++LH C + +++ V E+++ G L Q K KEP I++
Sbjct: 62 FLTQLHS---------CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV 112
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
G + +LH + +RD+K N++LD + K+ADFG+ + E +V +
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTT 158
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVN 730
GTP Y+ PE D ++ GV+ E+L G QP G++ + E N
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG-QPPFDGEDEDELFQSIMEHN 217
Query: 731 IAYQSSM---MFSVIDGNMGSYPSE 752
++Y S+ S+ G M +PS+
Sbjct: 218 VSYPKSLSKEAVSICKGLMTKHPSK 242
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 518 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 574
++G+G Y VYKG L D +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
E LV+E++ + L+ L ++L + RG+ Y H V
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRRK---VL 126
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-T 693
HRD+K N+L++ + K+ADFGL+R +P + + VV T Y P+ L +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYSNEVV--TLWYRPPDILLGS 179
Query: 694 HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734
+ + D++ +G +F E+ TG +P+ G + +++ ++
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E +V E+++ G+L D ++ + A ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ---VIHR 140
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-TVVKGTPGYLDPEYFLTHK 695
DIK+ NILL + K+ DFG I P + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC--------AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 696 LTDKSDVYSLGVVFLELLTGMQP 718
K D++SLG++ +E++ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 519 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 574
IG+G +GKV + D + A+K ++ + E L E L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ LV F++ G L L + + L A + L + L V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL-----LCALENLHKFNVI 115
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
+RD+K NILLD++ + DFGL +L + + GTP YL PE L H
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL-------NMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 695 KLTDKSDVYSLGVVFLELLTGMQP 718
T D ++LGV+ E+LTG+ P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK----EFLTEIQFLSRLHHRNLVSLV 573
+G+G Y VYKG G +VA+K E L+ E+ + E L L H N+V+L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK---EIRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGILYLHTE 628
+ LV+E++ D G +M L L RG+ Y H
Sbjct: 70 DIIHTKKTLTLVFEYLD----TDLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCH-- 120
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
V HRD+K N+L+ + K+ADFGL+R VP + + VV T Y P
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-----SKTYSNEVV--TLWYRPP 172
Query: 689 EYFLTHKLTDKS---DVYSLGVVFLELLTGM 716
+ L T+ S D++ +G +F E+ TG
Sbjct: 173 DVLLGS--TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 573
IG+G Y KV L + + + L + E + +Q F + +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALG--SSRGILYLHT 627
E V EF+S G L + + K P ++ +S+AL RGI+Y
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY--- 119
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
RD+K N+LLD + K+ D+G+ + EGI P ++ GTP Y+
Sbjct: 120 --------RDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCGTPNYIA 164
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE D ++LGV+ E++ G P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 25/258 (9%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT---EIQFLSRLHHR 567
+F +IG G YG VYK + G + A+K + L+ ++F EI + H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
N+V+ G + + EF G+L+D PL + ++ + +G+ YLH+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS 124
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ HRDIK +NILL K+ADFG+S I + S + GTP ++
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFI--GTPYWMA 174
Query: 688 PEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
PE + D++++G+ +E L +QP + +R + + +S+ +
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIE-LAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233
Query: 745 NMGSYPSECVEKFIKLAL 762
M S F+K+AL
Sbjct: 234 KMKW--SNSFHHFVKMAL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 44/250 (17%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
IG G YG V I G VA+K+ K L E++ L H N++++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 576 CDEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGILYL 625
G +V + M + S +PL F +L RG+ Y+
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHH---IIHSDQPLTEEHIRYFLYQLL------RGLKYI 123
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--GIVPAHVSTVVKGTP 683
H+ A+ V HRD+K SN+L++ ++ DFG++R E + +V+T
Sbjct: 124 HS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR----- 175
Query: 684 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
Y PE L+ + T D++S+G +F E+L G + + GKN V +Q ++ SV
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV------HQLKLILSV- 227
Query: 743 DGNMGSYPSE 752
+GS E
Sbjct: 228 ---LGSPSEE 234
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEF---LTEIQFLS-RLHHRNLVSLV 573
+G+G +GKV+ L A+K ++ + + + + E + LS H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 574 GYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
YC + ++ L V E+++ G L + + K L A + + G+ +LH++
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC--GLQFLHSKG-- 116
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
+ +RD+K NILLD K+ADFG+ + E ++ + GTP Y+ PE
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK-------ENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 692 LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
L K D +S GV+ E+L G P HG +
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPF-HGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQ-----FLSRLHHRNLVSLV 573
IG+G Y KV L + + + L + E + +Q F + LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGILYLHTEA 629
LV E+++ G L + + K P +A + IAL +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------FLHERG 116
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ +RD+K N+LLD K+ D+G+ + EG+ P ++ GTP Y+ PE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPGDTTSTFCGTPNYIAPE 166
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ D ++LGV+ E++ G P
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 519 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+GG+G+V + G + A K+ ++ ++ GE L E Q L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 575 YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSI--ALGSSRGILYLHTEADP 631
Y E + + LV M+ G L+ + + GF ++ A + G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLHRER-- 122
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD---IEGIVPAHVSTVVKGTPGYLDP 688
+ +RD+K NILLD +++D GL+ +P+ I G V GT GY+ P
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV---------GTVGYMAP 170
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 727
E + T D + LG + E++ G P K V+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---------QGEKEFLT---EIQFLSRLH 565
+G+G +GKV L G AVK ++ + EK L E FL+ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 566 HRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 623
YC + ++ L V EF++ G L + K + L A + + G+
Sbjct: 62 ---------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQ 110
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
+LH++ + +RD+K N++LD K+ADFG+ + E + + ++ GTP
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCGTP 160
Query: 684 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
Y+ PE K T D +S GV+ E+L G P HG +
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 518 QIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVG 574
++G+G Y V+KG L + +VA+K + +G + E+ L L H N+V+L
Sbjct: 13 KLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS----IALGSSRGILYLHTEAD 630
+ LV+E++ D+ + + G M + RG+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
V HRD+K N+L++ + K+ADFGL+R VP + + VV T Y P+
Sbjct: 125 --VLHRDLKPQNLLINERGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYRPPDV 175
Query: 691 FL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734
L + + + + D++ +G +F E+ +G +P+ G + E+++ ++
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 519 IGQGGYGKVYK-GILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+GG+G+V + G + A K+ + L+ GEK L E + L +++ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ + LV M+ G L+ + + L + + + GIL+LH+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IV 117
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
+RD+K N+LLD + +++D GL+ + D + I T GT GY+ PE
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI------TQRAGTNGYMAPEILKEE 169
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 726
+ D +++G E++ G P K V
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 30/211 (14%)
Query: 519 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 571
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGF-AMRLSIALGSSRGILYLHT 627
L V E+ + G L LS + S++ F + ALG YLH+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHS 113
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 114 CD---VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYLA 163
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE + D + LGVV E++ G P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 518 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-- 572
++G+G YG VYK DG A+K+ + + EI L L H N++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 573 VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGILYLH 626
V + + L++++ + + S +K+P+ M S+ GI YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 627 TEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVSTVVK 680
V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----- 177
Query: 681 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 721
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 13/184 (7%)
Query: 535 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594
G VAVK Q + E+ + H+N+V + E ++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 654
D +S A L + + YLH++ V HRDIK+ +ILL K++
Sbjct: 106 TDIVSQTRLNEEQIATVCESVL---QALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159
Query: 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 714
DFG I VP S V GTP ++ PE + D++SLG++ +E++
Sbjct: 160 DFGF-----CAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212
Query: 715 GMQP 718
G P
Sbjct: 213 GEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 36/225 (16%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLT-----EIQFLSRLHHRNLVS 571
++G+G YG VYK DG K +E +L Q E ++ EI L L H N+++
Sbjct: 8 KVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62
Query: 572 L--VGYCDEEGEQMLVYEFMSNGTLR----DQLSAKSKEPLGF--AMRLSIALGSSRGIL 623
L V + + L++++ + + S +K+P+ +M S+ GI
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 624 YLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSRL--APVPDIEGIVPAHVST 677
YLH V HRD+K +NIL+ + K+AD G +RL +P+ + + P V
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 678 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISH 721
T Y PE L + K+ D++++G +F ELLT +PI H
Sbjct: 178 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 566
+++ ++G G YG VYK L G + AVK + L+ +F EI + H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKH 65
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
N+V+ G + + E+ G+L+D PL + + +G+ YLH
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH 123
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
++ HRDIK +NILL K+ADFG++ I + S + GTP ++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVA-----AKITATIAKRKSFI--GTPYWM 173
Query: 687 DPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 718
PE K D++++G+ +E L +QP
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (150), Expect = 1e-09
Identities = 73/254 (28%), Positives = 104/254 (40%), Gaps = 58/254 (22%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG------SLQGEKE-----FLTEIQ 559
N + +IG G +G+V+ +V KR QE S +G KE + E+
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 560 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 617
+ L H+N+V + + Q L + EF G L + K + G +I +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAI-VD 122
Query: 618 SSRGIL----YLHTEADPP----VFHRDIKASNILLDH------KFTA-----------K 652
+R +L Y H D P V HRD+K NI L K TA K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFL 710
+ DFGLS+ + + AH GTP Y PE L T DKSD+++LG +
Sbjct: 183 IGDFGLSKNIGIESM-----AHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 711 ELLTGMQPISHGKN 724
EL +G P N
Sbjct: 235 ELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPDGTV--VAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 566
+FN +G G +G+V + VA+KR ++ + +K+ +E + L+ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
V+L G +E LV EF+ G L + P +++ +L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIFE 145
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ +RD+K N+LLD K+ DFG ++ +V T+ GTP Y+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---------VVDTRTYTLC-GTPEYI 195
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE L +D ++LG+ E+L G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRN 568
+++ ++G+G Y VYKG +G +VA+K + +G + E L L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF---AMRLSIALGSSRGILYL 625
+V L + LV+E++ D K P G ++L + RG+ Y+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYI 119
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H + HRD+K N+L+ K+ADFGL+R VP+H + T Y
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS-------VPSHTYSNEVVTLWY 169
Query: 686 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 725
P+ L + + + D++ +G +F+E++ G+ K+I
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 518 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLVGY 575
++G+G Y V+KG +VA+K + +G + E+ L L H N+V+L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 576 CDEEGEQMLVYEFMSN---------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
E LV+E++ + G L + K F +L RG+ Y H
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-----FMFQL------LRGLSYCH 120
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ HRD+K N+L++ K K+ADFGL+R VP + + VV T Y
Sbjct: 121 KRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-----TKTYSNEVV--TLWYR 170
Query: 687 DPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734
P+ L + + + D++ +G + E+ TG +P+ G + E+++ ++
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 37/229 (16%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
IG+G YG V + VA+K+ A + + K L EI+ L L H N++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA-KRTLREIKLLRHLDHENVIAIKD 71
Query: 575 YCDEEGEQM-----LVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSSRGIL 623
+ +VYE M T Q+ +S + L F +L RG+
Sbjct: 72 IMPPPHREAFNDVYIVYELMD--TDLHQI-IRSSQTLSDDHCQYFLYQLL------RGLK 122
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
Y+H+ A+ V HRD+K SN+LL+ K+ DFGL+R + + +V T
Sbjct: 123 YIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVV-----TR 172
Query: 684 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 731
Y PE L + T DV+S+G +F ELL G +P+ GK+ V ++ +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKL 220
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 519 IGQGGYGKVYKGILPDGT----VVAVKRAQEGSL-QGEKEFL---TEIQFLSRLHHRNLV 570
+G+GGYGKV++ G + A+K ++ ++ + +K+ E L + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR---------LSIALGSSRG 621
L+ G+ L+ E++S G L L E G M +S+AL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALE---- 114
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+LH + + +RD+K NILLD + K+ DFGL + E I V+ G
Sbjct: 115 --HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVTHTFCG 162
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
T Y+ PE + D +SLG + ++LTG P +
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 513 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 569
+ + + +G G YG+V G VA+K+ S K E++ L + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 570 VSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 619
+ L V E LV M N ++ Q LS + L + +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL-------- 128
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
RG+ Y+H+ A + HRD+K SNI ++ K+ DFGL+R ++ G V
Sbjct: 129 RGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDD-EMTGYV-------- 176
Query: 680 KGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTG 715
T Y PE L H D++S+G + ELLTG
Sbjct: 177 -ATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 25/236 (10%)
Query: 6 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 65
S + + N+ L L LN N L ++ E L L L + +D N I+ P +
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNITDIPPLIGLLKS 140
Query: 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 125
+ +++N I +P L LP+L ++ L N+L+ LP LS L L L L N
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKI 198
Query: 126 E---------------------GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG 164
+ +S SN+ L L L N L+ + + NL
Sbjct: 199 SDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLE 258
Query: 165 YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 220
LDLS+NQ++ SI N+ + LS N L+ +P L L+ L +L
Sbjct: 259 TLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313
|
Length = 394 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 621 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
G+ +LH + + +RD+K N+LLD K+ADFG+ + E + ++
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK-------ENMNGEGKASTFC 157
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
GTP Y+ PE K + D +S GV+ E+L G P HG++
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-HGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 77/339 (22%), Positives = 127/339 (37%), Gaps = 80/339 (23%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+G G G V+ + D VAVK+ Q K L EI+ + RL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSS-------- 619
VYE + S +E + + + G
Sbjct: 67 -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 620 -----RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPA 673
RG+ Y+H+ V HRD+K +N+ ++ K+ DFGL+R IV
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR---------IVDP 167
Query: 674 HVSTVVKG-------TPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 725
H S KG T Y P L+ + T D+++ G +F E+LTG +P+ G +
Sbjct: 168 HYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHE 224
Query: 726 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ ++ + +S + D N E + + R E R L
Sbjct: 225 LEQMQLILESVPVVREEDRN------ELL----------NVIPSFVRNDGGEPRRPLR-- 266
Query: 786 WNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824
+++P + + +F+ T ++ L HPY+S
Sbjct: 267 -DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLV 573
IG+G +GKV + AVK Q+ ++ + EK ++E L + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLG--FAMRLSIALGSSRGILYLHTEA 629
+ V ++++ G L L + EP +A ++ ALG YLH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG------YLHSLN 116
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ +RD+K NILLD + + DFGL + E I ++ GTP YL PE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTSTFCGTPEYLAPE 166
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
D + LG V E+L G+ P
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 25/58 (43%), Positives = 37/58 (63%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
N I G+IP +G+I SLE+L L+ N GS+PE LG L L + ++ N +SG +P +
Sbjct: 452 NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 519 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 571
+G+G +GKV IL G A+K ++ + + E LTE + L H L S
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS--RGILYLHTEA 629
L + V E+++ G L LS + F+ + G+ + YLH+
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSGK 115
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ +RD+K N++LD K+ DFGL + EGI A GTP YL PE
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCK-------EGITDAATMKTFCGTPEYLAPE 165
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ D + LGVV E++ G P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 73/300 (24%), Positives = 112/300 (37%), Gaps = 57/300 (19%)
Query: 520 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCD 577
+ K P T+VAVK+ S E K EI +L H N++ V
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL---GSSRGILYLHTEADPPVF 634
+ E +V M+ G+ D L K+ P G L+IA + Y+H++
Sbjct: 70 VDSELYVVSPLMAYGSCEDLL--KTHFPEGLP-ELAIAFILKDVLNALDYIHSKG---FI 123
Query: 635 HRDIKASNILLDHKFTAKVADFGLS--------RLAPVPDIEGIVPAHVSTVVKGTPGYL 686
HR +KAS+ILL ++ S R V D P + +L
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF----PKSSVKNLP----WL 175
Query: 687 DPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISH---GKNIVREVN---------- 730
PE L L +KSD+YS+G+ EL G P + ++ +V
Sbjct: 176 SPE-VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 731 --IAYQSSMMFSVIDGNMGSYPSECV---------EKFIKLALKCCQDETDARPSMSEVM 779
Y+ SM S N + V E F + C Q + ++RPS S+++
Sbjct: 235 TYPLYEDSMSQSR-SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 519 IGQGGYGKV----YKGILPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHRNLVS 571
+G G +G+V +KG G A+K + +E ++ + E L L H +V+
Sbjct: 26 LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 572 LV-GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL---YLHT 627
++ + DE + EF+ G L L + P A L +L YLH+
Sbjct: 83 MMCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL-----VLAFEYLHS 136
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ + +RD+K N+LLD+K KV DFG ++ VP T+ GTP YL
Sbjct: 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK---------VPDRTFTLC-GTPEYLA 183
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE + D +++GV+ E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 54/282 (19%)
Query: 512 NFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGS-LQGEK---EFLTEIQFLSR 563
NF +G G YGKV+ G G + A+K ++ + +Q K TE Q L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 564 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK----EPLGFAMRLSIALGS 618
+ LV+L + + L+ ++++ G L L + E + + +AL
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 619 --SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR--LAPVPD-------- 666
GI+Y RDIK NILLD + + DFGLS+ LA +
Sbjct: 121 LHQLGIIY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP--ISHGKN 724
IE + P + G+ G+ D +SLGV+ ELLTG P + +N
Sbjct: 170 IEYMAPEVIRG---GSGGH-----------DKAVDWWSLGVLTFELLTGASPFTVDGEQN 215
Query: 725 IVREVN--IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKC 764
E++ I + + + +EK K L
Sbjct: 216 SQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 38/116 (32%), Positives = 53/116 (45%), Gaps = 29/116 (25%)
Query: 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 155
LDN L G++P ++S+L L + L N+ G IP S +
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN-IPPSLGS------------------- 464
Query: 156 DLSRIPNLGYLDLSSNQLNGSIPP--GRL-SLNITTIKLSNNKLTGTIPSNFSGLP 208
I +L LDLS N NGSIP G+L SL I + L+ N L+G +P+ G
Sbjct: 465 ----ITSLEVLDLSYNSFNGSIPESLGQLTSLRI--LNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 31/245 (12%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL 564
+F+ + +G+G +G+V ++ + G + A+K ++ L ++ F E LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 565 HHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAM-RLSIALGSSRGI 622
+ + L Y ++ + + LV E+ G L L+ + ++ M + +A +
Sbjct: 59 NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLA----ELV 112
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKG 681
L +H+ HRDIK N+L+D K+ADFG + RL +V S + G
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL----TANKMV---NSKLPVG 165
Query: 682 TPGYLDPEYFLTHKLTDKS------DVYSLGVVFLELLTGMQPISHGKNIVREVNI-AYQ 734
TP Y+ PE T K D +SLGV+ E++ G P G + NI +Q
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225
Query: 735 SSMMF 739
+ F
Sbjct: 226 RFLKF 230
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVG-Y 575
IG+G YGKV+K + +G+ AVK + ++E E L L H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 576 CDEE---GEQM-LVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYL 625
++ G+Q+ LV E + G++ D + + +EP+ A L AL G+ +L
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-IAYILHEAL---MGLQHL 140
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H HRD+K +NILL + K+ DFG+S A + GTP +
Sbjct: 141 HVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTR-----LRRNTSVGTPFW 190
Query: 686 LDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQPIS 720
+ PE + D + DV+SLG+ +EL G P++
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 519 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVS 571
+G+G +GKV IL G A+K ++ + + E LTE + L H L +
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 572 LVGYCDEEGEQMLVYEFMSNGTL-----RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
L V E+ + G L R+++ ++ + + + AL YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALD------YLH 112
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+E + V +RD+K N++LD K+ DFGL + EGI GTP YL
Sbjct: 113 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYL 163
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE + D + LGVV E++ G P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 518 QIGQGGYGKVYKGILP-DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV- 573
IG G +G V+ P DG VA+K+ +L K E++ L H N++S +
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 574 ----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
+ D E +V E M + + +S + + L L RG+ YLH+
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSAG 123
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRDIK N+L++ K+ DFGL+R+ PD + V T Y PE
Sbjct: 124 ---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE-PDESKHMTQEVVTQY-----YRAPE 174
Query: 690 YFL-THKLTDKSDVYSLGVVFLELLTG 715
+ + T D++S+G +F ELL
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 68/257 (26%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 560
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 561 LSRLHHRNLVSLVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSI- 614
+ +V L Y + E L+ E++ G + L K ++E F + +I
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS---RLAPVPDIEGIV 671
A+ S + Y+H RDIK N+LLD K K++DFGL + + + I+
Sbjct: 113 AIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 672 PAHV------------------------------STVVKGTPGYLDPEYFLTHKLTDKSD 701
+ STV GTP Y+ PE FL + D
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECD 221
Query: 702 VYSLGVVFLELLTGMQP 718
+SLGV+ E+L G P
Sbjct: 222 WWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-08
Identities = 27/83 (32%), Positives = 48/83 (57%)
Query: 7 GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 66
G IP +I ++ L+ + L+GN + G++P LG + L+ + + N +GS+P+S L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 67 TRHFHMNNNSISGQIPPELSRLP 89
R ++N NS+SG++P L
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 572
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 573 VGYCDEEGEQM-LVYEFMSNGTLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHT 627
+ Y +++ + + M+ G L LS KE +A + + G+ ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHN 115
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
V +RD+K +NILLD +++D GL+ D P H S GT GY+
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMA 163
Query: 688 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGK 723
PE D S D +SLG + +LL G P K
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQE----GSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
+IG G +GKV + T VA +E S + + EFL + L H N++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLS-IALGSSRGILYLHTEADP 631
G C E +LV+E+ G L+ LS + + L +A + G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGL--SRLAP---VPDIEGIVPAHVSTVVKGTPGYL 686
H D+ N L T KV D+G+ SR + + VP +L
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----------WL 168
Query: 687 DPEY-------FLTHKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREV 729
PE +T + T S+V++LGV EL QP SH + REV
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REV 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 34/95 (35%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
YLH+ V +RDIK N++LD K+ DFGL + EGI GTP
Sbjct: 110 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTP 159
Query: 684 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
YL PE + D + LGVV E++ G P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLV 573
Q+G G YG V + G VA+K+ Q E K E++ L + H N++ L+
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 574 GY------CDEEGEQMLVYEFMSN--GTL--RDQLSAKSKEPLGFAMRLSIALGSSRGIL 623
D + LV FM G L ++LS + L + M +G+
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML--------KGLK 132
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
Y+H + HRD+K N+ ++ K+ DFGL+R ++ G V T
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVV---------TR 179
Query: 684 GYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
Y PE L T D++S+G + E+LTG +P+ G +
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 28/92 (30%), Positives = 46/92 (50%)
Query: 22 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81
L L+ L G +P ++ L L I + N I G++P S ++ ++ NS +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELP 113
P L +L SL + L+ N+L+G +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 1/91 (1%)
Query: 43 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 102
+D + +D + G +P + L + +++ NSI G IPP L + SL + L N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 103 GYLPPELSELPKLLILQLDNNNFEGTTIPAS 133
G +P L +L L IL L+ N+ G +PA+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSG-RVPAA 509
|
Length = 623 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 59/250 (23%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQFL 561
+F S IG+G +G+V D G V A+K + Q G ++ E++ L E L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 562 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGS 618
+V + ++ L+ EF+ G + L K ++E F +
Sbjct: 62 W------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYI-------- 107
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-------RLAPVPDIEGIV 671
+ +L + + HRDIK N+LLD K K++DFGL R ++ +
Sbjct: 108 AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 672 PAH-----------------------VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 708
P+ STV GTP Y+ PE F+ D +SLGV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 709 FLELLTGMQP 718
E+L G P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 522 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580
G G+V+ P V +K Q+G+ L E L ++H +++ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRM-------- 122
Query: 581 EQMLVYEFMS-------NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
+ LV ++ + L L+ +S+ PL L I G+ YLH + +
Sbjct: 123 KDTLVSGAITCMVLPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---I 178
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPV--PDIEGIVPAHVSTVVKGTPGYLDPEYF 691
HRD+K NI ++ + D G ++ PV P G + GT PE
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG---------LAGTVETNAPEVL 228
Query: 692 LTHKLTDKSDVYSLGVVFLELL 713
K K+D++S G+V E+L
Sbjct: 229 ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 12/89 (13%)
Query: 635 HRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693
HRD+K N+LLD K+ADFG ++ D G+V T V GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM----DANGMV--RCDTAV-GTPDYISPEVLKS 217
Query: 694 HKLTD----KSDVYSLGVVFLELLTGMQP 718
+ D +S+GV E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 64/250 (25%), Positives = 109/250 (43%), Gaps = 25/250 (10%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQ--EGSLQGEKEFLTEIQFLSRLHHR 567
N F +G+G YG V K + +VA+K+ + E + + ++ L E++ L L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
N+V L G+ LV+E++ ++ L + P G + + I +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVE----KNMLELLEEMPNG-VPPEKVRSYIYQLIKAIHW 115
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ HRDIK N+L+ H K+ DFG +R EG + V T Y
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS----EGSNANYTEYV--ATRWYRS 169
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
PE L D++S+G + EL G QP+ G++ + + +F+ I +G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQ---------LFT-IQKVLG 218
Query: 748 SYPSECVEKF 757
P+E ++ F
Sbjct: 219 PLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 59/281 (20%), Positives = 114/281 (40%), Gaps = 44/281 (15%)
Query: 518 QIGQGGYGKVYKGILPDG--TVVAVKRA-----QEGSLQGEKE-----FLTEIQFL-SRL 564
+G G +G VYK + ++A+K G + E++ ++E+ + +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 565 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSK-----EPLGFAMRLSIALGS 618
H N+V E +V + + L + ++ K K E + + + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 678
+ YLH E + HRD+ +NI+L + DFGL++ P T
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ--------PESKLTS 172
Query: 679 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738
V GT Y PE +K+DV++ G + ++ T +QP + N++ S+
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNML---------SLA 222
Query: 739 FSVIDGNMGSYPSECVEKFIKLALK-CCQDETDARPSMSEV 778
+++ P + + + C + +ARP + +V
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 45/224 (20%)
Query: 512 NFNSSTQIGQGGYGKVYKG------------ILPDGTVVAVKRAQEGSLQGEKEFLTEIQ 559
+ +G G +G+V+ ++ V+ +K QE + EK L E+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK--QEQHVHNEKRVLKEVS 59
Query: 560 FLSRLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 617
H ++ L + E ++ L + E++ G L L + F+ +
Sbjct: 60 ------HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYA 107
Query: 618 SS--RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675
S + YLH++ + +RD+K NILLD + K+ DFG ++ + D
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRD--------R 154
Query: 676 STVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
+ + GTP YL PE + K +K+ D ++LG++ E+L G P
Sbjct: 155 TWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 58/187 (31%), Positives = 83/187 (44%), Gaps = 27/187 (14%)
Query: 540 VKRAQEGSLQGEKEFLT--EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 597
+KRA+ + E+ L + Q+++ LH+ +E LV ++ G L
Sbjct: 40 LKRAETACFREERNVLVNGDCQWITTLHYA--------FQDENYLYLVMDYYVGGDLLTL 91
Query: 598 LSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 656
LS + + P A R IA +L +H+ HRDIK N+LLD ++ADF
Sbjct: 92 LSKFEDRLPEDMA-RFYIA----EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF 146
Query: 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLE 711
G S L D G V S+V GTP Y+ PE K + D +SLGV E
Sbjct: 147 G-SCLKMNQD--GTVQ---SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 712 LLTGMQP 718
+L G P
Sbjct: 201 MLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 645
Y+ ++ +++ LS E L LS +RG+ +L A HRD+ A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 646 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV-KGTP----GYLDPEYFLTHKLTDKS 700
K+ DFGL+R DI H S V KG+ ++ PE + T S
Sbjct: 271 AQGKIVKICDFGLAR-----DI-----MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS 320
Query: 701 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKL 760
DV+S G++ E+ + + + IV S+ + G + P ++ +
Sbjct: 321 DVWSYGILLWEIFS-LGGTPYPGMIV-------DSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 761 ALKCCQDETDARPSMSEVMRELESI 785
+KC E + RPS + +ES+
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVG 574
IG+G +G+VY+ D + A+K + + +KE + E L R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 575 Y---CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
+ + LV ++MS G L L + + A + IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIA----ELVLALEHLHKY 115
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
+ +RD+K NILLD + DFGLS+ ++ + GT YL PE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK----ANLTD---NKTTNTFCGTTEYLAPEVL 168
Query: 692 LTHK-LTDKSDVYSLGVVFLELLTGMQP 718
L K T D +SLGV+ E+ G P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRN--LVSL 572
IG+GG+G+VY D G + A+K + + QGE L E LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 573 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
+ Y +++ + + M+ G L LS G + ++ IL L +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
V +RD+K +NILLD +++D GL+ D P H S GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMAPEVL 167
Query: 692 LTHKLTDKS-DVYSLGVVFLELLTGMQP 718
D S D +SLG + +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 35/89 (39%), Positives = 44/89 (49%), Gaps = 11/89 (12%)
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-- 692
HRDIK N+LLD ++ADFG S L + D G V S V GTP Y+ PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG-SCLRLLAD--GTV---QSNVAVGTPDYISPEILQAM 178
Query: 693 ---THKLTDKSDVYSLGVVFLELLTGMQP 718
+ + D +SLGV E+L G P
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 54 SGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP 113
S ++ NL +N N + I L L +L + LDNNN+T +PP + L
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLK 139
Query: 114 -KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 172
L L L +N E ++P+ N+ L L L L LS + NL LDLS N+
Sbjct: 140 SNLKELDLSDNKIE--SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNK 197
Query: 173 LNGSIPPGR-LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 231
++ +PP L + + LSNN + + S+ S L L L ++NN L +P SI
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNL 254
Query: 232 RTLNATETFILDFQNNNLTNISGSFNI 258
L LD NN +++IS ++
Sbjct: 255 SNLE-----TLDLSNNQISSISSLGSL 276
|
Length = 394 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 568
+ S Q+G G YG V I G VA+K+ Q E K E+ L + H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 569 LVSLVGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622
++ L+ DE + LV +M + S++ + + + + G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML-----CGL 130
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
Y+H+ + HRD+K N+ ++ K+ DFGL+R A ++ G V T
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVV---------T 177
Query: 683 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 715
Y PE L +++ D++S+G + E+LTG
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 603 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 661
K PL + + +RG+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 662 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 716
PD V KG+ ++ PE T +SDV+S GV+ E+ + G
Sbjct: 225 YKDPDY----------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274
Query: 717 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 776
P G I E + DG P + ++ L C Q + RP+ S
Sbjct: 275 SPYP-GVQINEEFCQRLK--------DGTRMRAPENATPEIYRIMLACWQGDPKERPTFS 325
Query: 777 EVMREL 782
++ L
Sbjct: 326 ALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 16/216 (7%)
Query: 56 SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 115
S +L+ +++ S E + L N N EL EL L
Sbjct: 64 SSLSRLLSLDLLSPSGISSLDGS-----ENLLNLLPLPSLDLNLNRLRSNISELLELTNL 118
Query: 116 LILQLDNNNFEGTTIPASYSNMSKLLK-LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174
L LDNNN T IP + LK L L + ++ L +PNL LDLS N L+
Sbjct: 119 TSLDLDNNNI--TDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS 176
Query: 175 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234
N+ + LS NK++ +P L L+ L ++NNS+ + SS+
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL-----S 229
Query: 235 NATETFILDFQNNNLTNISGSFNIPPNV-TVRLRGN 269
N L+ NN L ++ S N+ T+ L N
Sbjct: 230 NLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 67/266 (25%), Positives = 96/266 (36%), Gaps = 89/266 (33%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQ- 559
++F S IG+G +G+V D G + A+K + Q ++ E++ L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 560 ------FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAM 610
F S RNL L+ EF+ G + L K S+E F +
Sbjct: 61 AWVVKMFYSFQDKRNL-------------YLIMEFLPGGDMMTLLMKKDTLSEEATQFYI 107
Query: 611 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670
+ +L + HRDIK N+LLD K K++DFGL G+
Sbjct: 108 --------AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC--------TGL 151
Query: 671 VPAH--------------------------------------VSTVVKGTPGYLDPEYFL 692
AH STV GTP Y+ PE F+
Sbjct: 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV--GTPDYIAPEVFM 209
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQP 718
D +SLGV+ E+L G P
Sbjct: 210 QTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 621 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 179
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 715
T Y PE L + D++S+G + E++ G
Sbjct: 180 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 11/103 (10%)
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK--- 680
YLH + HRD+K N+L+ K+ DFGLS++ + + H+ +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 681 -----GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
GTP Y+ PE L D +++G++ E L G P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 28/186 (15%)
Query: 603 KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-L 661
K+ L + + ++G+ +L A HRD+ A NILL K+ DFGL+R +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 662 APVPDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 716
PD V KG ++ PE T +SDV+S GV+ E+ + G
Sbjct: 230 YKDPDY----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 279
Query: 717 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 776
P G I E + +G P + + L C E RP+ S
Sbjct: 280 SPYP-GVKIDEE--------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 330
Query: 777 EVMREL 782
E++ L
Sbjct: 331 ELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 519 IGQGGYGKV---YKGILPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
IG G G V + +L G VAVK R + ++ + E+ L ++H+N++SL
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 573 VGY------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
+ +E + LV E M + E + + + + GI +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ + HRD+K SNI++ T K+ DFGL+R A + + P V T Y
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVV------TRYYR 189
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTG 715
PE L + D++S+G + EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 519 IGQGGYGKVYKGILPDGTVV----------AVKRAQEGSLQGEKEFLT--EIQFLSRLHH 566
IG+G +G+V L + V +KRA+ + E++ L + Q+++ LH+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNG---TLRDQLSAKSKEPLG--FAMRLSIALGSSRG 621
+E LV ++ G TL + + E + + + IA+ S
Sbjct: 69 A--------FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+ Y+H RDIK NIL+D ++ADFG S L + D G V S+V G
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMED--GTVQ---SSVAVG 165
Query: 682 TPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQP 718
TP Y+ PE K + D +SLGV E+L G P
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 55/202 (27%), Positives = 80/202 (39%), Gaps = 54/202 (26%)
Query: 605 PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664
PL L + ++G+ +L A HRD+ A N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---- 260
Query: 665 PDIEGIVPAHVSTVVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
DI + VVKG ++ PE T +SDV+S G++ E+ S
Sbjct: 261 -DIMN----DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------S 309
Query: 721 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE-KFIKLALKCCQ-DETD-ARPSMSE 777
GK+ YP V KF K+ + Q D A P +
Sbjct: 310 LGKS-----------------------PYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS 346
Query: 778 VMRELESIWNMMPESDTKTPEF 799
+M+ WN+ P T+ P F
Sbjct: 347 IMK---MCWNLEP---TERPTF 362
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 512 NFNSSTQIGQGGYGKVY---------------KGILPDGTVVAVKRAQEGSLQGEKEFLT 556
NF +G G YGKV+ +L T+V + E + + E++ L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 557 EIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 613
I+ FL LH+ + + L+ ++++ G L LS + + F +
Sbjct: 60 HIRQSPFLVTLHYA--------FQTDTKLHLILDYINGGELFTHLSQRER----FKEQ-E 106
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673
+ + S +L L + +RDIK NILLD + DFGLS+ ++E
Sbjct: 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER---- 162
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLT-DKS-DVYSLGVVFLELLTGMQPIS 720
+ GT Y+ P+ DK+ D +S+GV+ ELLTG P +
Sbjct: 163 --AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNL 569
+ + + +G G YG V G VAVK+ S+ K E++ L + H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 570 VSLVGY------CDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 619
+ L+ +E + LV M N ++ Q L+ + L + +
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL-------- 130
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
RG+ Y+H+ AD + HRD+K SN+ ++ K+ DFGL+R H +
Sbjct: 131 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEM 174
Query: 680 KG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 715
G T Y PE L +++ D++S+G + ELLTG
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 512 NFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSL-QGEK---EFLTEIQFLSR 563
NF +G G YGKV+ K D G + A+K Q+ +L Q K TE L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 564 LHHRN-LVSLVGYCDEEGEQMLVYEFMSNGTL------RDQLSAKSKEPLGFAMRLSIAL 616
+ LV+L E + L+ +++S G + RD S + L++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
GI+Y RDIK NILLD + + DFGLS+ + E +
Sbjct: 121 LHKLGIVY-----------RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER------T 163
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPIS 720
GT Y+ PE K+ D +SLG++ ELLTG P +
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 26/143 (18%)
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
+Q + E + D+L+ +++ L F+ +++ +G+ +L A H
Sbjct: 191 SGSYIDQDVTSEILEE----DELALDTEDLLSFSYQVA------KGMSFL---ASKNCIH 237
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP----GYLDPEYF 691
RD+ A NILL H K+ DFGL+R DI + VVKG ++ PE
Sbjct: 238 RDLAARNILLTHGRITKICDFGLAR-----DIRN----DSNYVVKGNARLPVKWMAPESI 288
Query: 692 LTHKLTDKSDVYSLGVVFLELLT 714
T +SDV+S G++ E+ +
Sbjct: 289 FNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 32/124 (25%), Positives = 46/124 (37%), Gaps = 40/124 (32%)
Query: 635 HRDIKASNILLDHKFTAKVADFGLS-------------RL-------APVPDIEGIVPAH 674
HRDIK NIL+D K++DFGLS +L + + +
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 675 VSTVVK--------------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 714
++ + GTP Y+ PE FL + D +SLG + E L
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 715 GMQP 718
G P
Sbjct: 244 GWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 38/119 (31%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 166 LDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224
L L + L G IP L ++ +I LS N + G IP + + L+ L ++ NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 225 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR-LRGNPFCLNTNAEQFCG 282
P S+ Q +L IL+ N+L S +P + R L F NA CG
Sbjct: 483 PESLGQLTSLR-----ILNLNGNSL-----SGRVPAALGGRLLHRASFNFTDNA-GLCG 530
|
Length = 623 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 8/126 (6%)
Query: 511 NNFNSSTQIGQGGYGKVYK----GILPDGTV--VAVKRAQEGSLQGEKEFL-TEIQFLSR 563
+N +G G +GKV + G+ + V VAVK + + E+E L +E++ LS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 564 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622
L H+N+V+L+G C G +++ E+ G L + L K++ L F M L +S
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 623 LYLHTE 628
+ E
Sbjct: 158 KNITLE 163
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 5/65 (7%)
Query: 185 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 244
N+ ++ LSNN+LT F GLP L+ L ++ N+L+ P + +L LD
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSL-----RSLDL 55
Query: 245 QNNNL 249
NNL
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-05
Identities = 28/63 (44%), Positives = 37/63 (58%), Gaps = 7/63 (11%)
Query: 162 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 217
NL LDLS+N+L IP G L N+ + LS N LT +I FSGLP L+ L ++
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLP-NLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSG 57
Query: 218 NSL 220
N+L
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 24/153 (15%)
Query: 575 YCDEEGEQML--VYEFMSNGTLRDQLS---AKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
+C + ++ L V E+M G L + +S K + + +AL + +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG 162
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRD+K N+LLD K+ADFG D G+V T V GTP Y+ PE
Sbjct: 163 ---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMV--RCDTAV-GTPDYISPE 213
Query: 690 YFLTHK----LTDKSDVYSLGVVFLELLTGMQP 718
+ + D +S+GV E+L G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 517 TQIGQGGYGKVYKGILPDGTV---VAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVS 571
T +G G YG V D + VAVK+ SL + E++ L + H N++
Sbjct: 21 TPVGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 572 LVGY------CDEEGEQMLVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622
L+ + E LV M N ++ Q S E + F + + RG+
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLL-----RGL 131
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
Y+H+ + HRD+K SN+ ++ ++ DFGL+R A ++ G V T
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYV---------AT 178
Query: 683 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTG 715
Y PE L +++ D++S+G + ELL G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 71/284 (25%), Positives = 111/284 (39%), Gaps = 48/284 (16%)
Query: 519 IGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLHHRN 568
+GQG + +YKG+L + V QE S+ F +S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
LV L G C + M V E++ G L D + K + +L +A + + YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGT 682
D + H ++ NIL VA +GL VP I+ I V+
Sbjct: 119 -DKKLVHGNVCGKNIL--------VARYGL-NEGYVPFIKLSDPGIPITVLSREERVERI 168
Query: 683 PGYLDPEYF--LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS-MM 738
P ++ PE LT +D +S G LE+ + G +P+S SS
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS-----------TLSSSEKE 216
Query: 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
D + P +C E L +C + RPS ++R+L
Sbjct: 217 RFYQDQHRLPMP-DCAELA-NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 18/40 (45%), Positives = 26/40 (65%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP 41
+N +GSIP+ +G + SL +L LNGN L+G +P LG
Sbjct: 475 YNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 33/120 (27%), Positives = 46/120 (38%), Gaps = 36/120 (30%)
Query: 635 HRDIKASNILLDHKFTAKVADFGL---------SR------------LAPVPDIEGIVPA 673
HRDIK NIL+D K+ DFGL S+ + P + I
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 674 HVSTVVK---------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ + + GTP Y+ PE L T D +S+GV+ E+L G P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 40/191 (20%), Positives = 65/191 (34%), Gaps = 34/191 (17%)
Query: 80 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 139
+ L PSL + L N E +P+ L L +
Sbjct: 42 ALASALRPQPSLKELCLSLN--------ETGRIPRGLQSLLQG-----------LTKGCG 82
Query: 140 LLKLSLRNCSLQ----GPMPDLSRIPNLGYLDLSSNQLNGSIPP------GRLSLNITTI 189
L +L L + +L G + L R +L L L++N L L + +
Sbjct: 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142
Query: 190 KLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 245
L N+L G + L+ L +ANN + + ++ + N +LD
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN-CNLEVLDLN 201
Query: 246 NNNLTNISGSF 256
NN LT+ S
Sbjct: 202 NNGLTDEGASA 212
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 519 IGQGGYGKVYKGI---LPDG-----TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
+GQG + K++KGI + D T V +K + + F +S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
G C E ++V E++ G+L D K+K + + +L +A + + +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLE---D 118
Query: 631 PPVFHRDIKASNILL 645
+ H ++ A N+LL
Sbjct: 119 KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 519 IGQGGYGKV---YKGILPDGTVVA-VKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
IG G G V Y +L + + R + ++ + E+ + ++H+N++SL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 83
Query: 575 Y------CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+E + LV E M + E + + + + GI +LH+
Sbjct: 84 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA 138
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--------SFMMTPYVVTRYYRAP 187
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELL 713
E L + D++S+G + E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 519 IGQGGYGKVYK----GILPDGT--VVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNLV 570
+G+G +G+V + GI T VAVK +EG+ E + ++E++ L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 571 SLVGYCDEE-GEQMLVYEFMSNGTLRDQLSAKSKE 604
+L+G C + G M++ EF G L + L +K E
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGE 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 46/312 (14%)
Query: 533 PDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590
P GT+V V+ + E K E+ H N+++ ++ FM+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650
G+ L E + A+ +I G+ RG+ YLH HR+IKAS+IL
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL------ 133
Query: 651 AKVADFGLSRLAPVPDIEGIVP-AHVSTVVKGTPGY-------LDPEYFLT--HKLTDKS 700
++ GL L+ + + +V + VV P + L PE + KS
Sbjct: 134 --ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 701 DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG------NMGSYP-SEC 753
D+YS+G+ EL TG P ++ M+ + G ++ ++P E
Sbjct: 192 DIYSVGITACELATGRVPFQD----------MLRTQMLLQKLKGPPYSPLDITTFPCEES 241
Query: 754 VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP-- 811
K + + E+ M++ M E + P S T +P F N ++ P
Sbjct: 242 RMKNSQSGVDSGIGESVVAAGMTQTMTS-ERLRT--PSSKTFSPAFQNLVELCLQQDPEK 298
Query: 812 -PSSSSMLKHPY 822
PS+SS+L H +
Sbjct: 299 RPSASSLLSHAF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 621 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
GI +LH+ + HRD+K SNI++ T K+ DFGL+R A G VV
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV- 187
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 715
T Y PE L + D++S+G + E++ G
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 25/154 (16%)
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG----FAMRLSIALGSSRGIL 623
N+V L Y E LV + G L +S P +A + +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFG-LSRLAPVPDIEGIVPAHVSTVVKGT 682
LH E + RD+ +NILLD + ++ F S + D E +
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-----------E 145
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM 716
Y PE + T+ D +SLG + ELLTG
Sbjct: 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 15/60 (25%), Positives = 27/60 (45%)
Query: 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 101
L + + N ++ +F L + ++ N+++ P S LPSL + L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 519 IGQGGYGKVYKGILPDGT-VVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-- 575
IG G +G VY+ I D + VA+K+ LQ + E+ + L+H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 576 --CDEEGEQML----VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGS---SRGILYLH 626
C ++ E+ + V EF+ T+ + ++ + L + L S R + Y+H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAYIH 187
Query: 627 TEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
++ + HRD+K N+L+D + T K+ DFG ++ ++ S + Y
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLAGQRSVSYICSRFY 236
Query: 686 LDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 729
PE L T D++SLG + E++ G PI G++ V ++
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 48/248 (19%)
Query: 513 FNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLH 565
F +G+G G+V+ KG G + A+K + + + LTE + L+ L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLG------FAMRLSIALGSS 619
H L +L E LV ++ G L L + + L +A + +AL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE-- 117
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD--IEGIVPAHVS- 676
YLH + +RD+K NILL ++DF LS+ + V + +
Sbjct: 118 ----YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 677 ---------TVVK----------GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 717
T + GT Y+ PE D ++LG++ E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 718 PISHGKNI 725
P G N
Sbjct: 231 PFK-GSNR 237
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K N+LLD K+ADFG + EG+V + GTP Y+ PE +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCDTAV---GTPDYISPEVLKSQ 218
Query: 695 K----LTDKSDVYSLGVVFLELLTGMQP 718
+ D +S+GV E+L G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 33/211 (15%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N +S +PK + N+ +L L L+GN+++ LP
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-------------------------DLPPEIE 206
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
L+ ++NNSI ++ LS L +L + L NN L LP + L L L L N
Sbjct: 207 LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSN 264
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
N + +S +++ L +L L SL +P ++ + L L L+ ++
Sbjct: 265 NQ---ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLN 321
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 213
S+ + LSN + + P S L L L
Sbjct: 322 SILLNNNILSNGET--SSPEALSILESLNNL 350
|
Length = 394 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 49/178 (27%), Positives = 69/178 (38%), Gaps = 18/178 (10%)
Query: 538 VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 597
V +K Q G TE L ++H +++ L G L+ L
Sbjct: 120 VVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCY 172
Query: 598 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657
L+AK + L+I R I YLH + HRDIKA NI ++H + DFG
Sbjct: 173 LAAKRNIAI--CDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG 227
Query: 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 715
+ PV DI A+ GT PE D++S G+V E+ T
Sbjct: 228 -AACFPV-DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
S + +I LS ++G I S LP +Q + ++NN LSG IP I+ + ++ L
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT----SSSLRYL 123
Query: 243 DFQNNNLTNISGSFNIPPNVTVRLRGNPF 271
+ NNN T +IP T+ L N
Sbjct: 124 NLSNNNFTGSIPRGSIPNLETLDLSNNML 152
|
Length = 968 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 47/186 (25%), Positives = 71/186 (38%), Gaps = 32/186 (17%)
Query: 18 SLELLLLNGNELTGS----LPEELGYL-PKLDRIQIDQNYISG----SLPKSFANLNKTR 68
SL+ L LN N L L + L L P L+++ + +N + G +L K+ +
Sbjct: 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLK 168
Query: 69 HFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLT----GYLPPELSELPKLLILQL 120
++ NN I + L +L + L+NN LT L L+ L L +L L
Sbjct: 169 ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNL 228
Query: 121 DNNNFEGTTI----PASYSNMSKLLKLSLRNC--------SLQGPMPDLSRIPNLGYLDL 168
+NN A S LL LSL L + + +L LDL
Sbjct: 229 GDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK---ESLLELDL 285
Query: 169 SSNQLN 174
N+
Sbjct: 286 RGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 8e-04
Identities = 16/61 (26%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 18 SLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 76
+L+ L L+ N LT +P+ LP L + + N ++ P++F+ L R ++ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 77 I 77
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 21/59 (35%), Positives = 26/59 (44%), Gaps = 4/59 (6%)
Query: 117 ILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL 173
L L NN T IP + L L L +L P+ S +P+L LDLS N L
Sbjct: 4 SLDLSNNRL--TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 557 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRLSIA 615
E + L RL H +++L+ G LV ++ S+ L L A+ + PLG A ++A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARLR-PLGLAQVTAVA 266
Query: 616 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL------SRLAPVP-DIE 668
I Y+H E + HRDIK N+L++ + DFG S P I
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLE 711
G V + V+ G P T D++S G+V E
Sbjct: 324 GTVDTNAPEVLAGDP------------YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.002
Identities = 26/85 (30%), Positives = 35/85 (41%), Gaps = 12/85 (14%)
Query: 635 HRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693
H DIK N+L D K + D+GL + + GT Y PE
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK-----------IIGTPSCYDGTLDYFSPEKIKG 180
Query: 694 HKLTDKSDVYSLGVVFLELLTGMQP 718
H D +++GV+ ELLTG P
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 54/201 (26%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 533 PDGTVVAVKRAQEGSLQGEK-EFL-TEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590
P G V V+R + E FL E+ +H N+V + E +V FM+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650
G+ +D + + + I G + + Y+H HR +KAS+IL+
Sbjct: 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILI--SVD 137
Query: 651 AKVADFGL----------SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT--- 697
KV GL RL V D P + V+ +L PE L L
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDF----PKYSVKVLP----WLSPE-VLQQNLQGYD 188
Query: 698 DKSDVYSLGVVFLELLTGMQP 718
KSD+YS+G+ EL G P
Sbjct: 189 AKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 843 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.77 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.77 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.74 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.73 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.23 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.23 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.23 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.22 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.06 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.84 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.74 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.58 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.49 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.47 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.46 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.46 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-68 Score=663.03 Aligned_cols=647 Identities=26% Similarity=0.423 Sum_probs=464.3
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|++++.+|..+.++++|+.|+|++|.+.+..|..++.+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+
T Consensus 293 ~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~ 372 (968)
T PLN00113 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372 (968)
T ss_pred CCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeC
Confidence 68899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRI 160 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l 160 (843)
|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++ .+|..|.++++|+.|+|++|.+++.++. +..+
T Consensus 373 p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 451 (968)
T PLN00113 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG-ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451 (968)
T ss_pred ChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee-ECChhHhcCCCCCEEECcCCcccCccChhhccC
Confidence 9999999999999999999999999999999999999999999987 6788999999999999999999987774 7789
Q ss_pred CCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcce
Q 003158 161 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240 (843)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~ 240 (843)
++|+.|+|++|++.+.+|......+|+.|+|++|++++.+|..|.++++|+.|+|++|++.+.+|..+..+.+ |+
T Consensus 452 ~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-----L~ 526 (968)
T PLN00113 452 PSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK-----LV 526 (968)
T ss_pred CCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccC-----CC
Confidence 9999999999999988888776678999999999999999999999999999999999999999988876554 55
Q ss_pred eEEcCCCCCCCCCCC-C-cCCCCcEEEeccCcccccCCcccccCCCCCCCcccccCCCCCCCcCCCccCCCCccCCCCCC
Q 003158 241 ILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPTDYEYSPTSPI 318 (843)
Q Consensus 241 ~L~l~~N~l~~~~~~-~-~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~p~~~~ 318 (843)
.|+|++|++++..+. + .++.|..|++++|.+.-.-. ..+.. +. .-..++.+.+.. .+ ..|..
T Consensus 527 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~-l~-~L~~l~ls~N~l-~~---~~p~~--------- 590 (968)
T PLN00113 527 SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP-KNLGN-VE-SLVQVNISHNHL-HG---SLPST--------- 590 (968)
T ss_pred EEECCCCcccccCChhHhCcccCCEEECCCCcccccCC-hhHhc-Cc-ccCEEeccCCcc-ee---eCCCc---------
Confidence 899999999876543 3 78889999999998752111 00000 00 000011111100 00 00000
Q ss_pred cceeccceeeeEEecCCCCCCChhHHHHHHHHHhhcccccceeeeeeEEEeecCCcceeeeeecccccCCCCCceeeecc
Q 003158 319 RCFCAAPLLVGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKLFPVYDNSSGNSYVFNAS 398 (843)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (843)
..+.. +...
T Consensus 591 -------------------~~~~~----------------------------------------------------~~~~ 599 (968)
T PLN00113 591 -------------------GAFLA----------------------------------------------------INAS 599 (968)
T ss_pred -------------------chhcc----------------------------------------------------cChh
Confidence 00000 0000
Q ss_pred ccchhcccccccccCCCCCccceeeeeccccCCCCCCCCCCCCCCCCccceeehhHHHHHHHHHHHHHHHHHHHhhcccc
Q 003158 399 EVGRIRSMFTGWNIPDSDIFGPYELINFTLQGPYRDVFPPSRNSGISKAALAGIILGAIAGAVTISAIVSLLIVRAHMKN 478 (843)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~g~~~~~~~~~~~~~~~~~~~~~~~ 478 (843)
+...+...+|+ ++....++......... ...+|++++++++++++++.++++++++++
T Consensus 600 -----------~~~~n~~lc~~----------~~~~~~~~c~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (968)
T PLN00113 600 -----------AVAGNIDLCGG----------DTTSGLPPCKRVRKTPS-WWFYITCTLGAFLVLALVAFGFVFIRGRNN 657 (968)
T ss_pred -----------hhcCCccccCC----------ccccCCCCCccccccce-eeeehhHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 00000011110 00000000000001111 111222222222222222212222222111
Q ss_pred cccccccccCCCccccc-----CCcccccHHHHHHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHH
Q 003158 479 YHAISRRRHSSKTSIKI-----DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK 552 (843)
Q Consensus 479 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~ 552 (843)
....+.. ........ .....+++++. ...|...+.||+|+||.||+|.. .+++.||||++......
T Consensus 658 -~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--- 729 (968)
T PLN00113 658 -LELKRVE-NEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--- 729 (968)
T ss_pred -ccccccc-cccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---
Confidence 1111111 01110110 00112333333 35678889999999999999996 57899999998743322
Q ss_pred HHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCC
Q 003158 553 EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632 (843)
Q Consensus 553 ~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 632 (843)
..+|++++++++||||++++|+|.+++..++||||+++|+|.++++. ++|..+..++.|+++||+|||+.+.++
T Consensus 730 -~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~ 803 (968)
T PLN00113 730 -PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPA 803 (968)
T ss_pred -cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCC
Confidence 23468899999999999999999999999999999999999999953 789999999999999999999776666
Q ss_pred EEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHH
Q 003158 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 712 (843)
Q Consensus 633 iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~el 712 (843)
|+||||||+||+++.++.+++. ||.+..... .....+++.|+|||++.+..++.++|||||||++|||
T Consensus 804 iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 871 (968)
T PLN00113 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871 (968)
T ss_pred eecCCCCHHhEEECCCCceEEE-ecccccccc-----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHH
Confidence 9999999999999999988876 665543211 1123578999999999999999999999999999999
Q ss_pred HhCCCCCCCC----cchHHHHHHHhhcccchhhccCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 713 LTGMQPISHG----KNIVREVNIAYQSSMMFSVIDGNMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 713 ltg~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
+||+.||... ....++.+..+........+++... ..+.+...++.+++.+||+.+|++||+|.++++.|+++
T Consensus 872 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 9999998542 2233444333222222233333321 23456677889999999999999999999999999988
Q ss_pred hhhC
Q 003158 786 WNMM 789 (843)
Q Consensus 786 ~~~~ 789 (843)
....
T Consensus 952 ~~~~ 955 (968)
T PLN00113 952 SRSS 955 (968)
T ss_pred hccc
Confidence 6543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=436.25 Aligned_cols=284 Identities=52% Similarity=0.884 Sum_probs=247.3
Q ss_pred CcccccHHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeee
Q 003158 497 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576 (843)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 576 (843)
..+.|+|.++..+|++|...+.||+|+||.||+|..++|+.||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988764433156699999999999999999999999
Q ss_pred ecCC-cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 577 DEEG-EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 577 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
.+.+ +.+||||||++|+|.++|+.....+++|..|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 599999999999999999875543899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-----cchHHHHH
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG-----KNIVREVN 730 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~-----~~~~~~~~ 730 (843)
||+|+..+... ....+...||.+|+|||++..+..+.++||||||+++.|++||+.+.+.. ....+|..
T Consensus 221 FGLa~~~~~~~------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 221 FGLAKLGPEGD------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred ccCcccCCccc------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99997654200 11111117999999999999999999999999999999999999888743 23567776
Q ss_pred HHhhcccchhhccCCCC--CCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 731 IAYQSSMMFSVIDGNMG--SYPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~--~~~~-~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
..+....+.+++|+.+. .++. +....+..++..|++.+|..||+|.+|+++|+.+.
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 67777788899999874 4554 67888999999999999999999999999996654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=401.72 Aligned_cols=264 Identities=25% Similarity=0.411 Sum_probs=210.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh-------hHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ-------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 580 (843)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++++.... ....+.+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788889999999999999994 57999999999753211 2234679999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC---CcEEEeecc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFG 657 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfG 657 (843)
..|+|||||+||+|.+.+-.++ .+.+...+.++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999986654 4777888899999999999999999 9999999999999766 789999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCC---CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhh
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL---TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~ 734 (843)
+|+.... .......+||+.|.|||++.+... ..++|+||+||+||-+++|..||........
T Consensus 325 lAK~~g~--------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------- 389 (475)
T KOG0615|consen 325 LAKVSGE--------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------- 389 (475)
T ss_pred hhhcccc--------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------
Confidence 9998652 345667899999999999987543 3478999999999999999999975432110
Q ss_pred cccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC
Q 003158 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 814 (843)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa 814 (843)
....+..+.....|. .+ .+.+.++.|||++||+.||++|+|+
T Consensus 390 --l~eQI~~G~y~f~p~-~w-----------------------------------~~Iseea~dlI~~mL~VdP~~R~s~ 431 (475)
T KOG0615|consen 390 --LKEQILKGRYAFGPL-QW-----------------------------------DRISEEALDLINWMLVVDPENRPSA 431 (475)
T ss_pred --HHHHHhcCcccccCh-hh-----------------------------------hhhhHHHHHHHHHhhEeCcccCcCH
Confidence 001111222111111 11 1123345589999999999999999
Q ss_pred ccCCCCCcccCCCCCC
Q 003158 815 SSMLKHPYVSSDVSGS 830 (843)
Q Consensus 815 ~e~L~Hp~f~~~~~~~ 830 (843)
+|||+||||.....++
T Consensus 432 ~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 432 DEALNHPWFKDAPCLS 447 (475)
T ss_pred HHHhcChhhhcccccc
Confidence 9999999998766554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=389.48 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=202.4
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeecCC-cEEEEEecC
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFM 589 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~e~~ 589 (843)
.+..+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|+++++..+||+||++||.|.+++ ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344678999999999999975 7899999999643 3344689999999999999999999999999988 599999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
++|+|++++... ..+++...-+|+.+|++||.|||+ ++ ||||||||+|||+++.|+|||+|||.+..+...
T Consensus 161 DgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999765 458899999999999999999996 66 999999999999999999999999999876532
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc-hHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-IVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
......||..|||||.+.+..|+.++||||||++++|+.+|+.||..... ...+. +.+..++++..+
T Consensus 233 ------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~------~Ll~~Iv~~ppP 300 (364)
T KOG0581|consen 233 ------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF------ELLCAIVDEPPP 300 (364)
T ss_pred ------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH------HHHHHHhcCCCC
Confidence 33567899999999999999999999999999999999999999976411 11111 122345555566
Q ss_pred CCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003158 748 SYPSE-CVEKFIKLALKCCQDETDARPSMSEVM 779 (843)
Q Consensus 748 ~~~~~-~~~~l~~l~~~c~~~~p~~RPs~~~vl 779 (843)
..|.+ +++++..++..|++++|.+||++.+++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl 333 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLL 333 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 66665 777777777777766665555444443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=373.16 Aligned_cols=283 Identities=26% Similarity=0.447 Sum_probs=225.3
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhh--HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.+|...+++|+|.||.||+|+. .+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999995 579999999998654332 4568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
||+. +|+..++.+ ...+...+++.++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+..++
T Consensus 82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 9964 999999765 457899999999999999999999999 9999999999999999999999999999887554
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
...+..+-|.+|+|||.+.| ..|+..+||||.||++.||+-| .||..+++..+++...+. .+
T Consensus 156 ------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~----------~L 218 (318)
T KOG0659|consen 156 ------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFR----------AL 218 (318)
T ss_pred ------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHH----------Hc
Confidence 22333467899999999987 5699999999999999999987 677777776776665443 23
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH-HhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE-SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~-~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+.+.++.++++..+ |++.++.+.=. .....++....++.||+.+|+++||.+|+||+|+|+||||++
T Consensus 219 GTP~~~~WP~~~~l------------pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSL------------PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred CCCCcccCcccccc------------ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 33333333333222 12221110000 001145666677789999999999999999999999999997
Q ss_pred CCC
Q 003158 826 DVS 828 (843)
Q Consensus 826 ~~~ 828 (843)
...
T Consensus 287 ~P~ 289 (318)
T KOG0659|consen 287 LPL 289 (318)
T ss_pred CCC
Confidence 443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=403.51 Aligned_cols=261 Identities=38% Similarity=0.582 Sum_probs=222.4
Q ss_pred CCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhh--HHHHHHHHHHHHhccCCcccceeeeeecCC-cEEEEEecC
Q 003158 513 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLVYEFM 589 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~e~~ 589 (843)
+...+.||+|+||+||+|.++....||||++....... .++|.+|+.+|++++|||||+|+|+|.+.. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33445699999999999999765569999998644333 568999999999999999999999998887 799999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 668 (843)
++|+|.++++......+++..++.++.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 99999999988656679999999999999999999999874 99999999999999998 99999999998754321
Q ss_pred CcccceeeeeecccCCccCchhcc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .+... ..+..+.+
T Consensus 199 -----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~--------~v~~~~~R 264 (362)
T KOG0192|consen 199 -----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVAS--------AVVVGGLR 264 (362)
T ss_pred -----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHH--------HHHhcCCC
Confidence 2233467999999999999 56999999999999999999999999987664 22111 12234556
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
+..|..++..+..++..||+.+|..||++.+++..|+.+......
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 677888999999999999999999999999999999998775544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=408.11 Aligned_cols=253 Identities=25% Similarity=0.445 Sum_probs=214.7
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.+|...+.||+|||+.||.++. ..|..||+|++.+... ...+.+.+||++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999997 7899999999986433 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|+|++++|.+++++ ..++++.+++.+..||+.||.|||+++ |||||||..|++++++.++||+|||+|..+..++
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999973 457999999999999999999999999 9999999999999999999999999999887542
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
......+|||.|+|||++....++..+||||+||++|.|+.|++||....- .
T Consensus 173 -------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-k-------------------- 224 (592)
T KOG0575|consen 173 -------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-K-------------------- 224 (592)
T ss_pred -------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-H--------------------
Confidence 345678899999999999999999999999999999999999999975321 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+.++ |+..+--.+|+ ..+..+.|||++||+.||.+|||++++|.|+||++
T Consensus 225 ---------ety~----~Ik~~~Y~~P~----------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 225 ---------ETYN----KIKLNEYSMPS----------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ---------HHHH----HHHhcCccccc----------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 1111 11111111221 23455668999999999999999999999999933
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=405.37 Aligned_cols=265 Identities=30% Similarity=0.494 Sum_probs=225.9
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.+.+.+..+.+...+.||+|.||+||.|.++....||+|.++... ...++|.+|+++|++++|++||+++|+|..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 344444455555678999999999999999888899999998753 3456889999999999999999999999998899
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
+||||||+.|+|.++|+......+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||+|+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc
Confidence 99999999999999999867778999999999999999999999999 999999999999999999999999999954
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
....+. ......-...|.|||.+....++.+||||||||+||||+| |+.||....+. +.+..+
T Consensus 354 ~d~~Y~------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------ev~~~l 417 (468)
T KOG0197|consen 354 GDDEYT------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------EVLELL 417 (468)
T ss_pred CCCcee------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------HHHHHH
Confidence 433221 1222334568999999999999999999999999999999 99998765431 122234
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
-.+.+.+.|+.|++.++++|..||+.+|++|||++.+...++++..
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 4566667899999999999999999999999999999998888754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=385.20 Aligned_cols=272 Identities=23% Similarity=0.373 Sum_probs=227.3
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
..++|++.+.||+|+||+||.++.+ +++.+|+|++++.... ..+...+|..+|.+++||+||+++-.|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3567999999999999999999965 6899999999865433 24567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|+||+.||.|..+|++++ .+++..++-++..|+.||.|||+++ ||||||||+|||+|.+|.++|+|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999997655 4889999999999999999999999 99999999999999999999999999985432
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. ...+...+||+.|||||++.+..|+.++|+||+|+++|||++|.+||...+. .+..+
T Consensus 178 ~-------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-~~~~~-------------- 235 (357)
T KOG0598|consen 178 D-------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-KKMYD-------------- 235 (357)
T ss_pred C-------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-HHHHH--------------
Confidence 2 2234457899999999999999999999999999999999999999975432 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC-CCCCCCccccCCCCCCCCCCC----CCccCCC
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPP----SSSSMLK 819 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~-~~~~~~dll~~~L~~dp~~R~----sa~e~L~ 819 (843)
-+..+ +++ ..+. .+..+.|+++++|+.||++|. .++++-+
T Consensus 236 ---------------~I~~~------k~~--------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 236 ---------------KILKG------KLP--------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ---------------HHhcC------cCC--------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 11100 001 1122 345566888899999999995 6788999
Q ss_pred CCcccCCCCCCccccccCCCCCC
Q 003158 820 HPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 820 Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
||||.+..+...+.....|+|+|
T Consensus 281 HpfF~~inW~~l~~k~l~PpF~P 303 (357)
T KOG0598|consen 281 HPFFKGINWEKLLAKKLSPPFKP 303 (357)
T ss_pred CcccccCCHHHHHhcCCCCCeec
Confidence 99999999998888889999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=394.89 Aligned_cols=287 Identities=22% Similarity=0.348 Sum_probs=232.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhhH-HHHHHHHHHHHhcc-CCcccceeeeeecCC-cEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLH-HRNLVSLVGYCDEEG-EQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~l 584 (843)
..++|...++||.|.||.||+|+ ...|..||||+++......+ -.=.+|++.|+++. ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45789999999999999999999 45799999999986443332 23378999999998 999999999998877 9999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|||||+ .+|+++++++ ...+++..++.|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+....
T Consensus 88 VfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 999995 5999999887 678999999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
....+..+.|.+|+|||++.. .-|+.+.||||+||+++|+.+-++.|. +.+..++..++.+
T Consensus 163 --------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP-G~sE~Dqi~KIc~--------- 224 (538)
T KOG0661|consen 163 --------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP-GASEIDQIYKICE--------- 224 (538)
T ss_pred --------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC-CCcHHHHHHHHHH---------
Confidence 334577789999999999975 678999999999999999999876665 4445555544321
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
.++.+..+.+.+-.+++..+=-.-|..-|+- +...++....++.++|.+|+.|||.+||||+|+|+||||
T Consensus 225 -VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~---------l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 225 -VLGTPDKDSWPEGYNLASAMNFRFPQVKPSP---------LKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF 294 (538)
T ss_pred -HhCCCccccchhHHHHHHHhccCCCcCCCCC---------hHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence 1233334444444566666555555555532 122345667778899999999999999999999999999
Q ss_pred cCCCC
Q 003158 824 SSDVS 828 (843)
Q Consensus 824 ~~~~~ 828 (843)
+....
T Consensus 295 q~~~~ 299 (538)
T KOG0661|consen 295 QVGRA 299 (538)
T ss_pred ccccc
Confidence 76554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=377.20 Aligned_cols=271 Identities=24% Similarity=0.395 Sum_probs=213.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
..+|...+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+++|+.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888889999999999999965 6899999999876 4445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC------CcEEEeeccccc
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK------FTAKVADFGLSR 660 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DfGla~ 660 (843)
|||.||+|.+|++.++ .+++..++.++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999998765 4899999999999999999999999 9999999999999865 468999999999
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
.+.. .......+|++-|||||+++.++|+.|+|+||+|+++|+|++|+.||...... +... .+.
T Consensus 164 ~L~~--------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-eL~~-~~~------ 227 (429)
T KOG0595|consen 164 FLQP--------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-ELLL-YIK------ 227 (429)
T ss_pred hCCc--------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-HHHH-HHh------
Confidence 8863 33345678999999999999999999999999999999999999999754421 1111 111
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
.-....+.++........++...-++.++.+|-.+.+ .|...++..+|.+|..+.++-.+
T Consensus 228 k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~--------------------~~~~~~l~~~p~~~~~~~~~~~~ 287 (429)
T KOG0595|consen 228 KGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFED--------------------FFDHPFLAANPQDRADAFELESR 287 (429)
T ss_pred ccccccCchhhhccCchhhhhhHHHhcCccccCchHH--------------------hhhhhhcccCcccccCccccccc
Confidence 0111122334444555556666666667666655543 24455566666666665544433
Q ss_pred C
Q 003158 821 P 821 (843)
Q Consensus 821 p 821 (843)
.
T Consensus 288 ~ 288 (429)
T KOG0595|consen 288 T 288 (429)
T ss_pred c
Confidence 3
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=370.38 Aligned_cols=280 Identities=24% Similarity=0.368 Sum_probs=218.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+.|+...++|+|+||+|||++.+ +|+.||||++..... .-.+-..+|+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999965 599999999986433 224667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
||+. ++-+-+.+. ...++...+.+++.|+++|+.|+|+++ +|||||||+|||++.+|.+||||||.|+.+..+
T Consensus 82 ~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred ecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 9976 554555443 345888999999999999999999999 999999999999999999999999999987632
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
....+..+.|.+|+|||.+.+ .+|+.++||||.||++.||++|.+.|.+.. ..+++..+. ..+
T Consensus 155 -----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-DiDQLy~I~----------ktL 218 (396)
T KOG0593|consen 155 -----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-DIDQLYLIR----------KTL 218 (396)
T ss_pred -----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-hHHHHHHHH----------HHH
Confidence 344567788999999999998 789999999999999999999976665444 444443221 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCC---C-CCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDA---R-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~---R-Ps~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
+...+ +..++ +..+|-- | |.. +.++.+...+|.....+.||++.+|..||++|++.+|+|.|||
T Consensus 219 G~L~p----rhq~i----F~~N~~F~Gv~lP~~----~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y 286 (396)
T KOG0593|consen 219 GNLIP----RHQSI----FSSNPFFHGVRLPEP----EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY 286 (396)
T ss_pred cccCH----HHHHH----hccCCceeeeecCCC----CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence 11111 11111 1112210 0 111 1223344566777777889999999999999999999999999
Q ss_pred ccC
Q 003158 823 VSS 825 (843)
Q Consensus 823 f~~ 825 (843)
|.+
T Consensus 287 Fd~ 289 (396)
T KOG0593|consen 287 FDG 289 (396)
T ss_pred HHH
Confidence 943
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=387.54 Aligned_cols=287 Identities=25% Similarity=0.374 Sum_probs=222.0
Q ss_pred HcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecC--CcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 584 (843)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++..+. .....-..+||.+|+++.||||+++.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4567778899999999999999 4689999999987654 33346678999999999999999999998765 78999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|+|||++ +|.-++... .-.+++.+++.++.|++.||+|+|+++ |+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999976 888887543 346999999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. ....+..+.|.+|+|||.+.+ ..|+.++|+||.||||.||++|++.|.. ....+++..++..
T Consensus 271 ~~------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G-~tEveQl~kIfkl-------- 335 (560)
T KOG0600|consen 271 SG------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG-RTEVEQLHKIFKL-------- 335 (560)
T ss_pred CC------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC-ccHHHHHHHHHHH--------
Confidence 43 233566778999999999998 5699999999999999999999777654 4455555544321
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
.+.+.+++|. ..++- .+....| ..+.... +.. .+...+..+.+|+..||.+||.+|.||+++|+|+||
T Consensus 336 --cGSP~e~~W~-~~kLP-~~~~~kp--~~~y~r~---l~E---~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 336 --CGSPTEDYWP-VSKLP-HATIFKP--QQPYKRR---LRE---TFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred --hCCCChhccc-cccCC-cccccCC--CCcccch---HHH---HhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 2334444444 22221 0111111 1111111 111 233445667799999999999999999999999999
Q ss_pred cCCCC
Q 003158 824 SSDVS 828 (843)
Q Consensus 824 ~~~~~ 828 (843)
..+..
T Consensus 404 ~t~p~ 408 (560)
T KOG0600|consen 404 TTEPL 408 (560)
T ss_pred ccCCC
Confidence 65544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=359.90 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=214.8
Q ss_pred cCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceee-eeecCCc-EEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG-YCDEEGE-QMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~lV 585 (843)
.+|++.++||+|.||+|||+. ..+|..||.|.++-+.. ...++...|+.+|++++|||||++++ .+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457788999999999999998 56899999999885433 33567899999999999999999999 4555554 8999
Q ss_pred EecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCC-CCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 586 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEA-DPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
||||..|+|..+++. +.+..+++..+|++..|++.||.++|+.- ...|+||||||.||+++.+|.|||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999975 44567999999999999999999999832 123999999999999999999999999999988
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... .......+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+. +....- ..+.
T Consensus 179 ~s~-------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~---------~KI~ 241 (375)
T KOG0591|consen 179 SSK-------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLC---------KKIE 241 (375)
T ss_pred cch-------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHH---------HHHH
Confidence 643 23345678999999999999999999999999999999999999999866 332221 1344
Q ss_pred cCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 743 DGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 743 ~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.+..++.| +.++.++.+++..|+..||+.||+.-.+++.++.
T Consensus 242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 45566666 7789999999999999999999997666555554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=365.78 Aligned_cols=286 Identities=24% Similarity=0.335 Sum_probs=218.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh--HHHHHHHHHHHHhccCCcccceeeeeec--CCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV 585 (843)
+.|+.+++|++|+||.||+|+++ +++.||+|+++...... .-...+||.+|.+++|||||.+..+... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46778899999999999999964 78999999998543211 2346899999999999999999988743 4579999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||||+. +|..+++.-. +++...+++.+..|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.+..+
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999976 9999997654 67999999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
....+..+.|.+|+|||.+.+ ..|+++.|+||+||++.||+++++.|.+ ....+++..+++.
T Consensus 231 -------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G-~sE~dQl~~If~l--------- 293 (419)
T KOG0663|consen 231 -------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG-KSEIDQLDKIFKL--------- 293 (419)
T ss_pred -------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC-CchHHHHHHHHHH---------
Confidence 234566778999999999998 5699999999999999999999766654 4455566555432
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC--CCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE--SDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~--~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
++.+.+..++.+.++-. ++ -..+|... ...|+. .++. .+....||++.+|++||++|+||+|+|+|+|
T Consensus 294 -lGtPte~iwpg~~~lp~--~k--~~~f~~~p--yn~lr~---kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 294 -LGTPSEAIWPGYSELPA--VK--KMTFSEHP--YNNLRK---KFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred -hCCCccccCCCccccch--hh--ccccCCCC--chhhhh---hccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 12222222222222110 00 00111110 112222 2333 3367789999999999999999999999999
Q ss_pred ccCCCC
Q 003158 823 VSSDVS 828 (843)
Q Consensus 823 f~~~~~ 828 (843)
|.....
T Consensus 364 F~e~P~ 369 (419)
T KOG0663|consen 364 FRETPL 369 (419)
T ss_pred cccCCC
Confidence 988443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=355.71 Aligned_cols=267 Identities=22% Similarity=0.355 Sum_probs=221.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhH---HHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|+..+.||.|+||+|..++.+ +|..+|+|+++....-.. +...+|..+|+.+.||+++++++.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788899999999999999964 689999999987654443 45678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||++||.|..++++.+ .+++..++.+|.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 9999999999997644 5899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
..+...+|||.|+|||++.+..++.++|.|||||++|||+.|.+||...... +..+ .++.+ .
T Consensus 196 -------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~iY~---------KI~~~-~ 257 (355)
T KOG0616|consen 196 -------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-QIYE---------KILEG-K 257 (355)
T ss_pred -------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-HHHH---------HHHhC-c
Confidence 2356789999999999999999999999999999999999999999865431 1111 11111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCC-----CCCccCCCCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP-----PSSSSMLKHP 821 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R-----~sa~e~L~Hp 821 (843)
..+|. .-+.++.||++++|+.|-.+| .-.+++.+||
T Consensus 258 v~fP~---------------------------------------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~ 298 (355)
T KOG0616|consen 258 VKFPS---------------------------------------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHP 298 (355)
T ss_pred ccCCc---------------------------------------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCc
Confidence 11222 233444566667777777777 3578899999
Q ss_pred cccCCCCCCccccccCCCCCC
Q 003158 822 YVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 822 ~f~~~~~~~~~~~~~~~~~~~ 842 (843)
||.+-.+..-..+.+.||+.|
T Consensus 299 wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 299 WFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred ccccccHHHHhhccccCCCCC
Confidence 999999987777887777766
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=369.68 Aligned_cols=286 Identities=23% Similarity=0.366 Sum_probs=226.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEecc--CChhhHHHHHHHHHHHHhccCCcccceeeeeec-----CC
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EG 580 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~ 580 (843)
....|...+.||+|+||.|++|.. .+|+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666678999999999999995 4799999999873 344556889999999999999999999999854 35
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..|+|+|+| .-+|...++.+ +.+....+..+..|+++||+|+|+.+ |+||||||+|++++.+..+||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 789999999 56999999654 34899999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
..... ......+....|.+|+|||++.. .+|+.+.||||.||++.||++|+..|.+.+ ...++...
T Consensus 174 ~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-~v~Ql~lI------- 240 (359)
T KOG0660|consen 174 YLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-YVHQLQLI------- 240 (359)
T ss_pred ecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-hHHHHHHH-------
Confidence 87543 11334567788999999999975 689999999999999999999988776544 44444322
Q ss_pred hhccCCCCCCCHHHHHHHH-HHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 740 SVIDGNMGSYPSECVEKFI-KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~-~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
-...+.++++....+. +-+..-++..|...+. .+.+.+|..++.+.||+.+||++||.+|+||+|||
T Consensus 241 ---~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~---------~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 241 ---LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQ---------PFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred ---HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCC---------CHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 2234444555544443 1222233333332221 12345688899999999999999999999999999
Q ss_pred CCCcccC
Q 003158 819 KHPYVSS 825 (843)
Q Consensus 819 ~Hp~f~~ 825 (843)
+|||++.
T Consensus 309 ~hPYl~~ 315 (359)
T KOG0660|consen 309 AHPYLAP 315 (359)
T ss_pred cChhhhh
Confidence 9999965
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=404.37 Aligned_cols=264 Identities=30% Similarity=0.507 Sum_probs=225.4
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
...+....+.||+|+||+||+|+.. +...||||.++..... ..++|++|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3445556788999999999999853 3568999999986655 67899999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC
Q 003158 582 QMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 649 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 649 (843)
+++|+|||..|||.++|.... +.+++..+.+.||.|||.|++||-++. +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999997532 224889999999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHH
Q 003158 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 728 (843)
Q Consensus 650 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~ 728 (843)
.|||+|||+++..-..|++... ....-..+|||||.++.+++|.+||||||||+|||+++ |+.||..-.+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~-----~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--- 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVR-----GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--- 712 (774)
T ss_pred EEEecccccchhhhhhhhhccc-----CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence 9999999999977665544321 12223578999999999999999999999999999999 99999876542
Q ss_pred HHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 729 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
+.+..+-.+...+.|+.|+.+++++|..||+.+|.+||+++||-..|+++....+
T Consensus 713 -------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 -------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 1222344555667899999999999999999999999999999999999866443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=377.22 Aligned_cols=270 Identities=21% Similarity=0.309 Sum_probs=218.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhh---HHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|...+.||.|+|++|++|+. ..++.||||++.+..... .+.+..|-.+|.+| .||.|++|+-.|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 35677788999999999999995 469999999998654333 35677899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|+||+++|+|.++|++.+ .+++...+.++.+|+.||+|||++| ||||||||+|||+|++|++||+|||.|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999998764 5899999999999999999999999 99999999999999999999999999998864
Q ss_pred CCCCC-----c-ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 665 PDIEG-----I-VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 665 ~~~~~-----~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
..... . .........+||..|.+||++.....++.+|+|+|||++|.|+.|.+||....+..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------------ 294 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------------ 294 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------------
Confidence 43220 0 01111245789999999999999999999999999999999999999997654311
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
-+.+++..-.. ..+...+.+.||++++|..||.+|+|++|+.
T Consensus 295 -----------------iFqkI~~l~y~---------------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 295 -----------------IFQKIQALDYE---------------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred -----------------HHHHHHHhccc---------------------CCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 11111111110 1111223345788889999999999999999
Q ss_pred CCCcccCCCCCCcccc
Q 003158 819 KHPYVSSDVSGSNLVS 834 (843)
Q Consensus 819 ~Hp~f~~~~~~~~~~~ 834 (843)
+||||.+..+...|..
T Consensus 337 ~HpFF~~Vdw~nlw~~ 352 (604)
T KOG0592|consen 337 AHPFFEGVDWENLWQQ 352 (604)
T ss_pred hCcccccCChhhhhhc
Confidence 9999999888664443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=359.13 Aligned_cols=209 Identities=29% Similarity=0.385 Sum_probs=183.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhh-HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
..+.|+..+.||.|..++||+|+ .+.+..||||++..+.... .+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34678999999999999999999 5678999999998654433 478999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
.||.+|++.+++...-...+++..+..|.+++++||.|||++| .||||||+.|||++++|.|||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999998877777999999999999999999999999 9999999999999999999999999886654322
Q ss_pred CCCcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
...........||+.|||||+++. ..|+.|+||||||++..||.+|+.||..-.
T Consensus 181 ---~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 181 ---DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred ---ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 111112256789999999999654 579999999999999999999999997544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=376.70 Aligned_cols=258 Identities=24% Similarity=0.423 Sum_probs=214.1
Q ss_pred cCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
..|....+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467777899999999999999 4578999999998766666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
+||+|.|.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--- 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--- 423 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc---
Confidence 999999998543 3899999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
.......||+.|||||++....|+++.||||||++++||+.|.+||.....+.. +.. +....
T Consensus 424 ----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-lyL---------Ia~ng---- 485 (550)
T KOG0578|consen 424 ----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL---------IATNG---- 485 (550)
T ss_pred ----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH-HHH---------HhhcC----
Confidence 134667899999999999999999999999999999999999999986443211 111 11111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+|.. +..+..++.+.|||.+||+.|+++|++|.|+|+||||..-..
T Consensus 486 ----------------------~P~l-----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 486 ----------------------TPKL-----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred ----------------------CCCc-----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 1110 011222444558999999999999999999999999965444
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.99 Aligned_cols=280 Identities=21% Similarity=0.291 Sum_probs=220.3
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
..++|+.+..||+|+||.||.|+.+ +|..+|+|++++..... .+.+..|-.+|....+|.||+++-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999955 69999999998765443 3567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||++||++..+|... ..+++..++.++.+++.|++-+|+.| +|||||||+|+|||..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999664 46899999999999999999999999 99999999999999999999999999854322
Q ss_pred CCCC------------------Cccc-----ce-----------------eeeeecccCCccCchhcccCCCCchhhhHH
Q 003158 665 PDIE------------------GIVP-----AH-----------------VSTVVKGTPGYLDPEYFLTHKLTDKSDVYS 704 (843)
Q Consensus 665 ~~~~------------------~~~~-----~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 704 (843)
.... ...+ .. .....+|||-|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 1000 0000 00 012346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 705 LGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 705 ~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
+|||+|||+.|.+||........+.+ +.. -..||..-.+.+.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rk--------------------------I~n-wr~~l~fP~~~~~----------- 415 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRK--------------------------IVN-WRETLKFPEEVDL----------- 415 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHH--------------------------HHH-HhhhccCCCcCcc-----------
Confidence 99999999999999986553222111 110 0123332222222
Q ss_pred hhhhCCCCCCCCCccccCCCCCCCCCCCC---CccCCCCCcccCCCCCCccccccCCCCCC
Q 003158 785 IWNMMPESDTKTPEFINSEHTSKEETPPS---SSSMLKHPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 785 ~~~~~~~~~~~~~dll~~~L~~dp~~R~s---a~e~L~Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
++++.|||.+++. ||++|+- ++|+..||||++..+. -+++..|+|.|
T Consensus 416 --------s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~--~l~~~~apfvP 465 (550)
T KOG0605|consen 416 --------SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD--HLREMPAPFVP 465 (550)
T ss_pred --------cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc--hhhcCCCCCCC
Confidence 2445688888888 9999975 8999999999998884 34444466665
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=385.36 Aligned_cols=271 Identities=28% Similarity=0.475 Sum_probs=230.4
Q ss_pred ccccHHHHHHHHcCC---------CCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCChhh-HHHHHHHHHHHHhc
Q 003158 499 RSFTYGEMALATNNF---------NSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRL 564 (843)
Q Consensus 499 ~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l 564 (843)
..++|+|...+...| .+.++||.|.||.||+|+++ ....||||.++....+. ..+|+.|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 456777666655444 45789999999999999975 24679999999765444 57899999999999
Q ss_pred cCCcccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEE
Q 003158 565 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 644 (843)
Q Consensus 565 ~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NIL 644 (843)
.||||++|.|+.......+||+|||++|+|+.+|+.+.. .+.+.+...+.++||.|++||-+++ +|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhhee
Confidence 999999999999999999999999999999999987765 4999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCc
Q 003158 645 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 723 (843)
Q Consensus 645 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~ 723 (843)
++.+..+||+|||+++.++.+. . .........-..+|.|||.+...+++.+|||||||++|||.++ |..||.+..
T Consensus 764 VNsnLvCKVsDFGLSRvledd~-~---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDP-E---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred eccceEEEeccccceeecccCC-C---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 9999999999999999875432 1 1111122223468999999999999999999999999999998 999998765
Q ss_pred chHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+. +.+..+.++-+.+.|.+|+..+.++|..||+++-.+||.+.+++..|.++..
T Consensus 840 NQ----------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 840 NQ----------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred hH----------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 41 2233555666778899999999999999999999999999999999998764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=383.53 Aligned_cols=291 Identities=23% Similarity=0.342 Sum_probs=221.3
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CC-----cccceeeeeecCCcEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCDEEGEQML 584 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~~l 584 (843)
+|++.+.||+|+||.|-+|.+. +++.||||+++.. ..-..+...|+++|..++ |. |+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999954 6999999999863 333456678999999997 43 89999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC--CcEEEeeccccccC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLA 662 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~ 662 (843)
|+|.+ .-+|+++++.+....++...++.|+.||+.||.+||+.+ |||+||||+|||+.+- ..+||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 569999999988888999999999999999999999999 9999999999999754 37999999999976
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.. .......+..|+|||++.+.+|+.+.||||||||++||++| .|+..+++..+++..+.+.
T Consensus 342 ~q----------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~------- 403 (586)
T KOG0667|consen 342 SQ----------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEV------- 403 (586)
T ss_pred CC----------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHH-------
Confidence 42 22356788999999999999999999999999999999999 5666677777777654322
Q ss_pred cCCCCCCCHHHHHHHHH---HH-------HHhcccCCCCCCCHHHHHHHHHHhhh-------------hCC-CCCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIK---LA-------LKCCQDETDARPSMSEVMRELESIWN-------------MMP-ESDTKTPE 798 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~---l~-------~~c~~~~p~~RPs~~~vl~~L~~~~~-------------~~~-~~~~~~~d 798 (843)
.+.+|....+...+ .. ..|...+-.+-+...++...+..... ..+ ..+..+.|
T Consensus 404 ---lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d 480 (586)
T KOG0667|consen 404 ---LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID 480 (586)
T ss_pred ---hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence 22223322221111 11 11222221111111122222211111 111 23344578
Q ss_pred cccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 799 FINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 799 ll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
||.+||.|||++|+|+.|||+||||++...
T Consensus 481 flk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 481 FLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 999999999999999999999999985444
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.85 Aligned_cols=294 Identities=24% Similarity=0.369 Sum_probs=224.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCc-ccceeeeeecCC-----
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEG----- 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~----- 580 (843)
...|+..++||+|+||+||+|+. .+|+.||+|++.....+ ......+|+.+++.++|+| |+++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566678899999999999995 57999999998764332 3456789999999999999 999999997766
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCC--CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 581 -EQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 581 -~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
..++||||++ -+|.+++..... ..++...++.++.||++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999995 599999987553 35666889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~ 736 (843)
+|+....+ ....+...+|..|+|||++.+. .|+...||||+||+++||++++..|.+..+ .++...++..
T Consensus 166 lAra~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~- 236 (323)
T KOG0594|consen 166 LARAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRL- 236 (323)
T ss_pred hHHHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHH-
Confidence 99965533 3345667899999999999986 789999999999999999998777765544 4444443321
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
++.+.++.++.+..+.. ++....+++....+. ...+..++...|++.+||+++|++|+||+.
T Consensus 237 ---------lGtP~e~~Wp~v~~~~~--~k~~f~~~~~~~~l~-------~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 237 ---------LGTPNEKDWPGVSSLPD--YKAPFPKWPGPKDLS-------SILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred ---------cCCCCccCCCCcccccc--ccccCcCCCCccchH-------HhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 12222222222222211 111111222222222 234555578889999999999999999999
Q ss_pred CCCCCcccCCCCCCcccc
Q 003158 817 MLKHPYVSSDVSGSNLVS 834 (843)
Q Consensus 817 ~L~Hp~f~~~~~~~~~~~ 834 (843)
+|.||||+......-.+.
T Consensus 299 al~h~yf~~~~~~~~~~~ 316 (323)
T KOG0594|consen 299 ALTHPYFSELPEKSSQLL 316 (323)
T ss_pred HhcChhhcccccchhhhh
Confidence 999999998766544433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.02 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=211.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+... ...+.+.+|+++++.++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999965 689999999876432 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+.| +|..++...+ .++++.+..++.++..||.|||+.+ |+|||+||.|||++..|.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--- 152 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc---
Confidence 9976 9999997654 4899999999999999999999999 99999999999999999999999999997653
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.....+.+.|||-|||||+..+..|+..+|.||+||++||+++|++||...
T Consensus 153 ----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------------------------- 203 (808)
T KOG0597|consen 153 ----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------------------------- 203 (808)
T ss_pred ----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------------------------
Confidence 245667889999999999999999999999999999999999999999632
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
.+.+++..-+. +|-.-|+ ..+..+..|++.+|..||..|+|=.+++.|||+.+..
T Consensus 204 --------si~~Lv~~I~~-d~v~~p~----------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 204 --------SITQLVKSILK-DPVKPPS----------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred --------HHHHHHHHHhc-CCCCCcc----------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 12222222222 2222221 1123334577778888888888888888888887655
Q ss_pred CC
Q 003158 828 SG 829 (843)
Q Consensus 828 ~~ 829 (843)
.+
T Consensus 259 ~~ 260 (808)
T KOG0597|consen 259 NI 260 (808)
T ss_pred hh
Confidence 54
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=369.07 Aligned_cols=267 Identities=25% Similarity=0.472 Sum_probs=221.0
Q ss_pred cHHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecC
Q 003158 502 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579 (843)
Q Consensus 502 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 579 (843)
+.++|++..+.+.+.+.||+|.||+||+|.|.. .||||+++.... +..+.|+.|+..+++-+|.||+-|.|||...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 346777777888889999999999999999863 699999986543 3457899999999999999999999999988
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
.. .||+.+|+|.+|+.+++... ..++..+.+.||+|||+|+.|||.++ |||||||..||++.++++|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 77 99999999999999998754 56899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~ 736 (843)
..-..-. .........|...|||||+++. .+|++.+|||||||++|||+||..||. ..+. +.
T Consensus 536 tvk~~w~-----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~---------dq 600 (678)
T KOG0193|consen 536 TVKTRWS-----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR---------DQ 600 (678)
T ss_pred eeeeeec-----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh---------hh
Confidence 6533211 1222334458889999999975 568999999999999999999999998 3321 22
Q ss_pred cchhhccCC----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 737 MMFSVIDGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 737 ~~~~~~~~~----~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
.++.+-.+. +......|+.++.+++..||..++++||.+.+++..|+.+....|
T Consensus 601 IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 601 IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 233332231 123356788899999999999999999999999998888765443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=365.19 Aligned_cols=274 Identities=23% Similarity=0.330 Sum_probs=211.8
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.|+..+.||+|+||+||+|.. .+++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999996 5799999999875332 223467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 999999999887655556899999999999999999999999 999999999999999999999999999765321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||........... ....+.....
T Consensus 156 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-------~~~~~~~~~~ 222 (285)
T cd05631 156 ------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-------VDRRVKEDQE 222 (285)
T ss_pred ------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-------HHHHhhcccc
Confidence 112334689999999999999999999999999999999999999975432111000 0000000011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC-----CccCCCCCc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKHPY 822 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s-----a~e~L~Hp~ 822 (843)
.++...+..+. +|+++||..||++|++ ++|+++|||
T Consensus 223 ~~~~~~s~~~~---------------------------------------~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 223 EYSEKFSEDAK---------------------------------------SICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred cCCccCCHHHH---------------------------------------HHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 12222223333 4555566666666654 899999999
Q ss_pred ccCCCCCCccccccCCCCCC
Q 003158 823 VSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 823 f~~~~~~~~~~~~~~~~~~~ 842 (843)
|.+..+...-..-..|++.|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 264 FKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred hcCCCHHHHHhCcCCcCCCC
Confidence 99877765555555677766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=341.85 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=211.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.+++|++.+.||+|.|+.||++.. ++|+.+|+|++.... ..+.+++.+|+++-+.++||||+++.+.+.+.+..++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999984 579999999886432 23457889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEEeeccccccC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLA 662 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~ 662 (843)
+|+|+|++|..-+-.+ ..+++..+-.+++||++||.|+|.++ |||||+||+|+++-+ ..-+|++|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997766444 34778888899999999999999999 999999999999954 346999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.. ........|||+|||||++...+|+..+|||+-||+||-|+.|+.||.+.+. .+..
T Consensus 164 ~~--------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rly------------- 221 (355)
T KOG0033|consen 164 ND--------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLY------------- 221 (355)
T ss_pred CC--------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHH-------------
Confidence 52 2233456799999999999999999999999999999999999999986432 1111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
.+++..-.+.++. .++..++++.+++++||+.||++|+||.|||+|||
T Consensus 222 ---------------e~I~~g~yd~~~~-----------------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 222 ---------------EQIKAGAYDYPSP-----------------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred ---------------HHHhccccCCCCc-----------------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 1111111111111 23455667779999999999999999999999999
Q ss_pred ccCC
Q 003158 823 VSSD 826 (843)
Q Consensus 823 f~~~ 826 (843)
++..
T Consensus 270 i~~r 273 (355)
T KOG0033|consen 270 ICNR 273 (355)
T ss_pred hcch
Confidence 9763
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.29 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=208.8
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccC----Ch-hhHHHHHHHHHHHHhcc-CCcccceeeeeecCC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG----SL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEG 580 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 580 (843)
...++|...+.||+|+||+|+.|.. .+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999985 47899999977653 12 23456778999999998 999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC-CcEEEeecccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 659 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla 659 (843)
..++||||+.||+|.+++.. ..++.+..+..++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999977 345888999999999999999999999 9999999999999999 99999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCC-CC-chhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+... ....
T Consensus 169 ~~~~~-------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~-------- 232 (370)
T KOG0583|consen 169 AISPG-------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLY-------- 232 (370)
T ss_pred cccCC-------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHH--------
Confidence 87631 123456678999999999999977 76 689999999999999999999986331 1100
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCC--CCCCCccccCCCCCCCCCCCCCc
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES--DTKTPEFINSEHTSKEETPPSSS 815 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~--~~~~~dll~~~L~~dp~~R~sa~ 815 (843)
.-+...-- .+|.. ++.+.+|+.+||..||.+|+|+.
T Consensus 233 ---------------------~ki~~~~~---------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~ 270 (370)
T KOG0583|consen 233 ---------------------RKIRKGEF---------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLL 270 (370)
T ss_pred ---------------------HHHhcCCc---------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHH
Confidence 00110000 11111 44455788889999999999999
Q ss_pred cCCCCCcccC
Q 003158 816 SMLKHPYVSS 825 (843)
Q Consensus 816 e~L~Hp~f~~ 825 (843)
|+++||||+.
T Consensus 271 ~i~~h~w~~~ 280 (370)
T KOG0583|consen 271 EILEHPWFQK 280 (370)
T ss_pred HHhhChhhcc
Confidence 9999999987
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.81 Aligned_cols=281 Identities=23% Similarity=0.323 Sum_probs=229.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC-CcEEEEEEeccCChhh---HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
-+.|+..+.||+|.-|+||++...+ +..+|+|++.+..... ..+++.|-+||+.++||.+..||+.|+.++..|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3456667899999999999999764 6999999998765543 35678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||||+||+|..+.+++....+++..++.++..++-||+|||-.| ||.|||||+||||-++|++-|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999999999899999999999999999999999999 999999999999999999999999997543210
Q ss_pred -CC-----------------------------C-C------------------cccceeeeeecccCCccCchhcccCCC
Q 003158 666 -DI-----------------------------E-G------------------IVPAHVSTVVKGTPGYLDPEYFLTHKL 696 (843)
Q Consensus 666 -~~-----------------------------~-~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~ 696 (843)
.. . . ......+...+||-.|+|||++.+..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 0 0 000122345679999999999999999
Q ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 003158 697 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 776 (843)
Q Consensus 697 ~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~ 776 (843)
+.++|+|+|||++|||+.|+.||.+..+... +.+++...+ .+|.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------l~NIv~~~l-~Fp~------------------------- 356 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------LRNIVGQPL-KFPE------------------------- 356 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------HHHHhcCCC-cCCC-------------------------
Confidence 9999999999999999999999987664322 122221111 1110
Q ss_pred HHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC----CccCCCCCcccCCCCCCccccccCCCCCCC
Q 003158 777 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS----SSSMLKHPYVSSDVSGSNLVSGVIPTITPR 843 (843)
Q Consensus 777 ~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s----a~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~ 843 (843)
.++....+.|||+++|.-||++|+- |+|+-+||||.+-.+. +++..+||.-|+
T Consensus 357 ------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa--Lir~~~PP~iP~ 413 (459)
T KOG0610|consen 357 ------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA--LIRCARPPEIPK 413 (459)
T ss_pred ------------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh--heeccCCCcCCC
Confidence 1122344568999999999999999 9999999999999997 888888887664
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.31 Aligned_cols=203 Identities=31% Similarity=0.498 Sum_probs=172.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCC--cEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~e 587 (843)
.++...+.||+|+||+||++... +|...|||..........+.+.+|+++|++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34666789999999999999965 59999999987653333567899999999999999999999854444 6899999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeeccccccCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~ 666 (843)
|+++|+|.+++.+.+. .+++..++.++.||++||+|||+++ ||||||||+|||++. ++.+||+|||+++......
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988766 7999999999999999999999999 999999999999999 7999999999998765300
Q ss_pred CCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
..........||+.|||||++..+ ....++||||+||++.||+||+.||..
T Consensus 173 ----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 ----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 012223456799999999999963 334599999999999999999999975
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=374.47 Aligned_cols=282 Identities=20% Similarity=0.249 Sum_probs=215.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
..+|++.+.||+|+||.||+|... +++.||+|.... +.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999964 689999997542 3567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+ .++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 165 ~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 165 Y-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred C-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 9 478998886543 4788899999999999999999998 9999999999999999999999999997532211
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch------HHHHHHHhhcccchhhc
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI------VREVNIAYQSSMMFSVI 742 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 742 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..... ...
T Consensus 237 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~------~~~ 306 (391)
T PHA03212 237 ----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII------RRS 306 (391)
T ss_pred ----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH------HHh
Confidence 11223456999999999999999999999999999999999999888643321 11111111 111
Q ss_pred cCCCCCCCH---HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 743 DGNMGSYPS---ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 743 ~~~~~~~~~---~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
......++. ........-...+....|..||....+... ...+.+++.+||++||++||||+|+|+
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL-----------PIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhh-----------hhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 111111121 112222222334456667778876554321 223457999999999999999999999
Q ss_pred CCcccCC
Q 003158 820 HPYVSSD 826 (843)
Q Consensus 820 Hp~f~~~ 826 (843)
||||...
T Consensus 376 hp~f~~~ 382 (391)
T PHA03212 376 FAAFQDI 382 (391)
T ss_pred ChhhccC
Confidence 9999773
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=350.97 Aligned_cols=275 Identities=22% Similarity=0.329 Sum_probs=204.7
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecC--C---cEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--G---EQMLV 585 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~---~~~lV 585 (843)
.|...+++|.|+||.||+|... +++.||||+.-.+.. .-.+|+++|+.+.|||||++.-+|... + ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999964 579999998764332 124699999999999999999888432 2 45689
Q ss_pred EecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC-CcEEEeeccccccC
Q 003158 586 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLA 662 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~ 662 (843)
||||+ .+|.+.++. ..+..++...++-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 499999875 23456788888899999999999999998 9999999999999976 89999999999987
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
...+ .......|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+ ++..+++..+..
T Consensus 177 ~~~e--------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik------- 240 (364)
T KOG0658|consen 177 VKGE--------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIK------- 240 (364)
T ss_pred ccCC--------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHH-------
Confidence 6433 2345678899999999998 5799999999999999999999777765 444444443221
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDE--TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~--p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
.++.+..+... |+..+ -.+-|.+...- ..+ -.....++++.||+.++|+++|.+|.+|.|+|.
T Consensus 241 ---~lG~Pt~e~I~--------~mn~~y~~~~~p~ik~~~--~~~--~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 241 ---VLGTPTREDIK--------SMNPNYTEFKFPQIKAHP--WHK--VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ---HhCCCCHHHHh--------hcCcccccccCccccccc--cee--ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 12222222211 11111 11111111110 000 022345677789999999999999999999999
Q ss_pred CCcccC
Q 003158 820 HPYVSS 825 (843)
Q Consensus 820 Hp~f~~ 825 (843)
||||..
T Consensus 306 h~fFde 311 (364)
T KOG0658|consen 306 HPFFDE 311 (364)
T ss_pred chhhHH
Confidence 999954
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=360.46 Aligned_cols=281 Identities=23% Similarity=0.346 Sum_probs=209.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|++.+.||+|+||+||+|... +++.||+|.+..... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999965 689999999875332 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
++ |+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 97 59999886543 35788899999999999999999999 9999999999999999999999999997643221
Q ss_pred CcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... .+....... ..+
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~----------~~~ 221 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-KEELHLIFR----------LLG 221 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH----------HhC
Confidence 11223457899999999876 5689999999999999999999999975432 222211110 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
..+.+.+..+.......-...|..|+.. ..+..+..+....||+++||++||++|+||+|+|+||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQP---------LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCc---------hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1122222211110000000011112111 111223445667799999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=368.20 Aligned_cols=275 Identities=23% Similarity=0.365 Sum_probs=222.4
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHhc-cCCcccceeeeeecCC
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 580 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 580 (843)
.....++|....+||+|.||+|+++..+ +++.+|||++++...-. .+..+.|.+++... +||.++.++.+|...+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3455678999999999999999999965 68899999999765432 35667888888877 5999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
++|+||||+.||++..+. ....+++..+..++..|+.||.|||+++ |||||||.+|||+|.+|.+||+|||+++
T Consensus 443 ~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred eEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 999999999999944333 3456999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
.... ....+...+||+.|||||++.+..|+.++|+|||||+||||+.|..||...+. .+.. .
T Consensus 517 e~m~-------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~F----------d 578 (694)
T KOG0694|consen 517 EGMG-------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEVF----------D 578 (694)
T ss_pred ccCC-------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHH----------H
Confidence 5432 23456778999999999999999999999999999999999999999975542 1111 1
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC-----Cc
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SS 815 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s-----a~ 815 (843)
.+-.....+|..++.+...++.+ +|+.+|++|.- |+
T Consensus 579 sI~~d~~~yP~~ls~ea~~il~~---------------------------------------ll~k~p~kRLG~~e~d~~ 619 (694)
T KOG0694|consen 579 SIVNDEVRYPRFLSKEAIAIMRR---------------------------------------LLRKNPEKRLGSGERDAE 619 (694)
T ss_pred HHhcCCCCCCCcccHHHHHHHHH---------------------------------------HhccCcccccCCCCCCch
Confidence 11112233455555555555444 45555555543 57
Q ss_pred cCCCCCcccCCCCCCccccccCCCCCCC
Q 003158 816 SMLKHPYVSSDVSGSNLVSGVIPTITPR 843 (843)
Q Consensus 816 e~L~Hp~f~~~~~~~~~~~~~~~~~~~~ 843 (843)
++..||||++..+.....+.+.|||.|+
T Consensus 620 ~i~~hpFFr~i~w~~L~~r~i~PPf~P~ 647 (694)
T KOG0694|consen 620 DIKKHPFFRSIDWDDLLNRRIKPPFVPT 647 (694)
T ss_pred hhhhCCccccCCHHHHhhccCCCCCCcc
Confidence 8999999999999988889999999885
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=361.78 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=203.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999965 689999999864322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999997643 5788899999999999999999999 999999999999999999999999999765321
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +..+ .
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~---------i~~~-~ 214 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GIYEK---------ILAG-K 214 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH---------HHhC-C
Confidence 12346899999999999999999999999999999999999999754321 10000 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----CCccCCCCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKHP 821 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~-----sa~e~L~Hp 821 (843)
..++.. .+..+.+++++||..||++|+ +++|+++||
T Consensus 215 ~~~~~~---------------------------------------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 LEFPRH---------------------------------------LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred cCCCcc---------------------------------------CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 001111 122334677778888888888 499999999
Q ss_pred cccCCCCC
Q 003158 822 YVSSDVSG 829 (843)
Q Consensus 822 ~f~~~~~~ 829 (843)
||....+.
T Consensus 256 ~~~~~~~~ 263 (291)
T cd05612 256 WFKSVDWD 263 (291)
T ss_pred cccCCCHH
Confidence 99765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=366.34 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=211.9
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
-|+..+.||+|+.|.|..|+. .+|+.+|||++.+... .....+.+|+-+|+.+.|||++++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 466678999999999999995 5799999999986522 123568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|.|.+++..++ ++++.++.+++.||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|.....
T Consensus 93 yv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--- 164 (786)
T ss_pred ecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence 999999999997755 5889999999999999999999999 99999999999999999999999999987543
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......+|++.|.|||++++.+|. .++||||.|||||.|+||+.||+++. ....+.+ ++.
T Consensus 165 -----gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-ir~LLlK-V~~----------- 226 (786)
T KOG0588|consen 165 -----GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-IRVLLLK-VQR----------- 226 (786)
T ss_pred -----CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-HHHHHHH-HHc-----------
Confidence 3445667899999999999999885 58999999999999999999998432 2111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
..+.+......++-|||++||.+||++|+|.+|+++|||++.-
T Consensus 227 -------------------------------------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 227 -------------------------------------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred -------------------------------------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 1111222234455589999999999999999999999999775
Q ss_pred CCC
Q 003158 827 VSG 829 (843)
Q Consensus 827 ~~~ 829 (843)
..-
T Consensus 270 ~~~ 272 (786)
T KOG0588|consen 270 TSL 272 (786)
T ss_pred CCC
Confidence 553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=363.34 Aligned_cols=264 Identities=27% Similarity=0.462 Sum_probs=210.2
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 578 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 578 (843)
.+..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.+ +||||++++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999974 2357899999875432 3346789999999999 89999999998875
Q ss_pred C-CcEEEEEecCCCCCHHHHHhhcC-------------------------------------------------------
Q 003158 579 E-GEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------- 602 (843)
Q Consensus 579 ~-~~~~lV~e~~~~gsL~~~l~~~~------------------------------------------------------- 602 (843)
. +..++||||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 46899999999999999986532
Q ss_pred -----CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeee
Q 003158 603 -----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677 (843)
Q Consensus 603 -----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 677 (843)
..++++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-----~~~~~ 234 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKG 234 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc-----hhccc
Confidence 134778888999999999999999998 99999999999999999999999999986532110 01112
Q ss_pred eecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHH
Q 003158 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756 (843)
Q Consensus 678 ~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (843)
...+++.|+|||++.+..++.++|||||||++|||++ |..||........... .+..+.....+..+++.
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 305 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---------RLKDGTRMRAPENATPE 305 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---------HHhcCCCCCCCCCCCHH
Confidence 2345678999999999999999999999999999997 9999975432211111 11222233345566778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 757 FIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 757 l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=366.71 Aligned_cols=199 Identities=26% Similarity=0.397 Sum_probs=174.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC--CcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4568889999999999999998543 4689999986432 2234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999997643 4888899999999999999999999 99999999999999999999999999976532
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 1 123468999999999999889999999999999999999999997544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.90 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=214.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|.||.||.|+. +++-.||+|++.+.... .+.++.+|+++-+.++||||++++++|.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46789999999999999999995 57889999998765433 257899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
+||..+|++...|++.....+++.....++.|+|.||.|+|..+ ||||||||+|+|++..+..||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998777778999999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......+||.-|.+||...+..++..+|+|++|++.||++.|.+||.....
T Consensus 176 -------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------------------- 227 (281)
T KOG0580|consen 176 -------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------------------- 227 (281)
T ss_pred -------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------------
Confidence 2344667899999999999999999999999999999999999999964321
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
.+.++-+.++=-..| +..+..+.|+|.++|..+|.+|.+-.|++.|||+..
T Consensus 228 ---------~etYkrI~k~~~~~p--------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 228 ---------SETYKRIRKVDLKFP--------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ---------HHHHHHHHHccccCC--------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 111111111111111 122344568888899999999999999999999865
Q ss_pred C
Q 003158 826 D 826 (843)
Q Consensus 826 ~ 826 (843)
.
T Consensus 279 ~ 279 (281)
T KOG0580|consen 279 N 279 (281)
T ss_pred c
Confidence 4
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.86 Aligned_cols=262 Identities=30% Similarity=0.428 Sum_probs=218.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhh-HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
..+...+.++||+|-||.|..+....+..||||+++...... .++|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345566789999999999999999888999999999765554 5899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
||++|+|..++.++...........+|+.||+.|++||.+.+ +|||||.++|||+|.++++||+|||+++-+-..++
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999998875555566677789999999999999998 99999999999999999999999999997655543
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh--CCCCCCCCcchHHHHHHHhhcccchhhcc-C
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISHGKNIVREVNIAYQSSMMFSVID-G 744 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~ 744 (843)
.. ......-..+|||+|.+.-++++.+||||+||+++||+++ ...||....+..- ++. ...+.+ +
T Consensus 693 y~-----vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-ven------~~~~~~~~ 760 (807)
T KOG1094|consen 693 YR-----VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-VEN------AGEFFRDQ 760 (807)
T ss_pred ee-----eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-HHh------hhhhcCCC
Confidence 32 2233345679999999999999999999999999999987 7789875443211 110 011111 1
Q ss_pred C---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 745 N---MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 745 ~---~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
. ....|.-|+..+++++..||..+..+||+++++...|++.
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 2345788999999999999999999999999999888753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.42 Aligned_cols=241 Identities=29% Similarity=0.515 Sum_probs=207.3
Q ss_pred CCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCC
Q 003158 514 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 514 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 593 (843)
..++-||.|+.|.||+|+++ ++.||||+++. .-..+|+-|++++|+||+.|.|+|...-.+|||||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34577999999999999985 57899998763 12357889999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccc
Q 003158 594 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673 (843)
Q Consensus 594 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 673 (843)
|.+.|+.. .++.......|..+||.|+.|||.+. |||||||.-||||..+..|||+|||.++.... .
T Consensus 199 L~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~--------~ 265 (904)
T KOG4721|consen 199 LYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD--------K 265 (904)
T ss_pred HHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh--------h
Confidence 99999664 45778888899999999999999999 99999999999999999999999999986542 1
Q ss_pred eeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC-CCCCHH
Q 003158 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-GSYPSE 752 (843)
Q Consensus 674 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 752 (843)
.......||..|||||+++..++++|+|||||||+||||+||..||.+.+. ..+++-+-...+ .+.|..
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----------sAIIwGVGsNsL~LpvPst 335 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----------SAIIWGVGSNSLHLPVPST 335 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----------heeEEeccCCcccccCccc
Confidence 223457899999999999999999999999999999999999999976442 233333333333 356899
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 753 ~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
|++.+.-++++||+..|..||+|.+++..|.-.
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 999999999999999999999999999988754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=388.46 Aligned_cols=261 Identities=32% Similarity=0.529 Sum_probs=219.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC--CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP--DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.+.+..+.||+|+||.||.|... +|. .||||.+.... .+...+|.+|..+|+.++|||||+++|+|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 44455788999999999999964 343 49999998754 445689999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC-----CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 584 LVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
|++|||++|+|..+|++.+ ...+...+.+.++.|||+|+.||++++ +|||||.++|||++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998742 345888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
|+.....+++... ....-...|||||.+..+.++.|+|||||||++||++| |..||....+.. .
T Consensus 849 ArDiy~~~yyr~~-----~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~----------v 913 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKH-----GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE----------V 913 (1025)
T ss_pred hHhhhhchheecc-----CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----------H
Confidence 9955443332211 11123468999999999999999999999999999999 999998765421 1
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
+..+..+.+.+.|..|++.++++|..||+.+|++||++..+++.+..+.+..
T Consensus 914 ~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 914 LLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 2234445577889999999999999999999999999999999988886643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=365.78 Aligned_cols=198 Identities=25% Similarity=0.424 Sum_probs=174.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 689999999875322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999997643 4788888999999999999999999 999999999999999999999999999865321
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 172 ---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred ---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 123468999999999999999999999999999999999999997543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.82 Aligned_cols=266 Identities=28% Similarity=0.399 Sum_probs=207.7
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh--------------hHHHHHHHHHHHHhccCCcccce
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--------------GEKEFLTEIQFLSRLHHRNLVSL 572 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~nIv~l 572 (843)
...++|++...||+|.||.|-+|+. .+++.||||++.+.... ..+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999995 47999999998753221 12478999999999999999999
Q ss_pred eeeeec--CCcEEEEEecCCCCCHHHHHhhcCCCC-cchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC
Q 003158 573 VGYCDE--EGEQMLVYEFMSNGTLRDQLSAKSKEP-LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 649 (843)
Q Consensus 573 ~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 649 (843)
+++..+ .+.+|||+|||..|.+... ....+ +.+.+++++.+++..||+|||.++ ||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 999866 4689999999998877553 23334 899999999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCcch
Q 003158 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGKNI 725 (843)
Q Consensus 650 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwS~G~~l~elltg~~pf~~~~~~ 725 (843)
+|||+|||.+.........+ .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~--~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEG--SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred cEEeeccceeeecccCCccc--cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 99999999998764332111 122233468999999999998733 356789999999999999999999754321
Q ss_pred HHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCC
Q 003158 726 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHT 805 (843)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~ 805 (843)
. . +.+++ .+|-.=|... +..+.+.|+|.+||.
T Consensus 326 ~-l----------------------------~~KIv-----n~pL~fP~~p--------------e~~e~~kDli~~lL~ 357 (576)
T KOG0585|consen 326 E-L----------------------------FDKIV-----NDPLEFPENP--------------EINEDLKDLIKRLLE 357 (576)
T ss_pred H-H----------------------------HHHHh-----cCcccCCCcc--------------cccHHHHHHHHHHhh
Confidence 1 0 11111 1222223222 233445578999999
Q ss_pred CCCCCCCCCccCCCCCcccCCCCC
Q 003158 806 SKEETPPSSSSMLKHPYVSSDVSG 829 (843)
Q Consensus 806 ~dp~~R~sa~e~L~Hp~f~~~~~~ 829 (843)
-||+.|++..++..|||.+.+..+
T Consensus 358 KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 358 KDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred cChhheeehhhheecceeccCCCC
Confidence 999999999999999999887553
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=364.27 Aligned_cols=195 Identities=26% Similarity=0.342 Sum_probs=169.2
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999964 789999999875322 22356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCccc
Q 003158 593 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 672 (843)
Q Consensus 593 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 672 (843)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-------
Confidence 999998654 35889999999999999999999999 999999999999999999999999998753211
Q ss_pred ceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 673 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 111234569999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.11 Aligned_cols=278 Identities=24% Similarity=0.365 Sum_probs=207.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC--CCcEEEEEEeccCChh--hHHHHHHHHHHHHhc---cCCcccceeeeee-----c
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCD-----E 578 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~ 578 (843)
++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37889999999999999999863 4788999988743222 234566777777665 6999999999885 3
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
....++||||++ ++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 69999997765566899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+... ...
T Consensus 157 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~------- 220 (290)
T cd07862 157 ARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGK------- 220 (290)
T ss_pred eEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHH-------
Confidence 9765322 112345689999999999988999999999999999999999999976543221 111
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
+++......+.+++... .+...++...+.. ...+ ..+..+....+++.+||+.||++|||+.|+|
T Consensus 221 --i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 221 --ILDVIGLPGEEDWPRDV-ALPRQAFHSKSAQ--PIEK----------FVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred --HHHHhCCCChhhchhhh-cccchhccCCCCC--CHHH----------HccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 11111111122222211 1222222222211 1111 2234455567899999999999999999999
Q ss_pred CCCcc
Q 003158 819 KHPYV 823 (843)
Q Consensus 819 ~Hp~f 823 (843)
+||||
T Consensus 286 ~hp~f 290 (290)
T cd07862 286 SHPYF 290 (290)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.42 Aligned_cols=284 Identities=21% Similarity=0.278 Sum_probs=209.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47889999999999999999975 688999999875322 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 9998777655432 345888999999999999999999998 9999999999999999999999999998654221
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
........|++.|+|||++.+..++.++|||||||++|||++|+.||............ ....+
T Consensus 155 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~-----------~~~~~ 218 (287)
T cd07848 155 -----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI-----------QKVLG 218 (287)
T ss_pred -----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------HHhhC
Confidence 11122346899999999999989999999999999999999999999765432211110 01111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
..+.+....+.. .-.......|........-.. .....+..+.||+++||+.||++|+|++|+|+||||
T Consensus 219 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 219 PLPAEQMKLFYS----NPRFHGLRFPAVNHPQSLERR---YLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CCCHHHHHhhhc----cchhcccccCcccCcccHHHh---hhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 223222221111 000000011111000000001 112234557799999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=332.22 Aligned_cols=290 Identities=26% Similarity=0.356 Sum_probs=218.3
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC---C--CcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeec-CC
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP---D--GTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 580 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~ 580 (843)
....|+....||+|.||.||+|... + .+.+|+|.++..... -.....+|+.+++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3467889999999999999999643 2 237999999854222 23567899999999999999999999866 78
Q ss_pred cEEEEEecCCCCCHHHHHhhcC---CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC----CcEEE
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKV 653 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl 653 (843)
..++++||.+. +|...|+-++ ...++...++.|..||+.|+.|||++- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 99999999976 9999886432 246888999999999999999999999 9999999999999877 89999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcch-------
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI------- 725 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~------- 725 (843)
+|||+|+.+..+-. +-.....++.|..|+|||.+.+ ..||.+.||||.||++.||+|-.+.|...+..
T Consensus 178 aDlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 178 ADLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred ecccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 99999998764421 2223455678999999999998 56899999999999999999987777643211
Q ss_pred -HHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH----------HHHhhhhCCCCCC
Q 003158 726 -VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE----------LESIWNMMPESDT 794 (843)
Q Consensus 726 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~----------L~~~~~~~~~~~~ 794 (843)
.+++.+++ ++ ++.+.++.++.+. +-|.....+.. |-.+.......++
T Consensus 254 q~dQl~rIf------~v----LG~Pt~~~Wp~lk------------k~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~ 311 (438)
T KOG0666|consen 254 QHDQLDRIF------EV----LGTPTDKDWPDLK------------KMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP 311 (438)
T ss_pred hHHHHHHHH------HH----cCCCccccchhhh------------hCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc
Confidence 12222211 11 1222222222221 11222222222 2233444455667
Q ss_pred CCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 795 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 795 ~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
++.|++.+||++||.+|+||+|||+|+||+.|.-
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence 7899999999999999999999999999998844
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.78 Aligned_cols=289 Identities=22% Similarity=0.324 Sum_probs=210.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 6899999998753322 23467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|++ ++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 6888888653 345788889999999999999999999 9999999999999999999999999987543211
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+........... .
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------~---- 221 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV------L---- 221 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH------h----
Confidence 11233457899999999876 458889999999999999999999998655443333221110 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
+......+....... ....+.....+...+.+... . ......+.||+++||+.||++|+|++|+|+||||+..
T Consensus 222 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 222 GTPNEDTWPGVHSLP--HFKPERFTLYSPKNLRQAWN----K-LSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred CCCChhhccchhhcc--ccccccccccCCccHHHHhh----c-cCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000000000000000 00000000001111111111 1 1123455689999999999999999999999999874
Q ss_pred C
Q 003158 827 V 827 (843)
Q Consensus 827 ~ 827 (843)
.
T Consensus 295 ~ 295 (303)
T cd07869 295 P 295 (303)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.43 Aligned_cols=192 Identities=29% Similarity=0.405 Sum_probs=167.8
Q ss_pred ccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 58899999987432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
.+++... ..+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-------~ 148 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-------D 148 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------C
Confidence 9999764 35888999999999999999999999 9999999999999999999999999997542211 1
Q ss_pred eeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 123456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=361.31 Aligned_cols=270 Identities=31% Similarity=0.489 Sum_probs=223.4
Q ss_pred ccHHHHHHHHcCCCCCCcccccCCeeEEEEEeC--CC--cE-EEEEEeccC---ChhhHHHHHHHHHHHHhccCCcccce
Q 003158 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP--DG--TV-VAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSL 572 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l 572 (843)
+..+.|++..++-...++||+|+||.||+|.+. ++ .. ||||..+.. .....++|.+|+++|+.++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 344556666667777799999999999999964 23 23 899998852 34556889999999999999999999
Q ss_pred eeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEE
Q 003158 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 652 (843)
Q Consensus 573 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 652 (843)
+|++..+..+++|||+|.||+|.++|++... .++..++..++.++|+||+|||+++ +|||||.++|||++.++.+|
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999987654 6899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHH
Q 003158 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 731 (843)
Q Consensus 653 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~ 731 (843)
|+|||+++....-. .......-...|+|||.+....+++++|||||||++||+++ |..||....... +.
T Consensus 303 ISDFGLs~~~~~~~-------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~- 372 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYV-------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VK- 372 (474)
T ss_pred eCccccccCCccee-------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HH-
Confidence 99999987643100 00111234578999999999999999999999999999999 888998665421 11
Q ss_pred Hhhcccchhh-ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 732 AYQSSMMFSV-IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 732 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
..+ ..+.+...|...+..+..++.+||..+|+.||+|.++.+.++.+......
T Consensus 373 -------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 373 -------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 122 33444566778889999999999999999999999999999998876543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=359.73 Aligned_cols=296 Identities=22% Similarity=0.371 Sum_probs=223.4
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
..++|++.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+++++.++|+||++++++|.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999975 688999998875422 33467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999996543 478888999999999999999974 5 999999999999999999999999998754321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ......... ...+.
T Consensus 158 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~-----~~~~~ 221 (333)
T cd06650 158 ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGC-----PVEGD 221 (333)
T ss_pred ---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcC-----cccCC
Confidence 11234688999999999998899999999999999999999999975432 111111110 00000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC------CCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE------SDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~------~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
... .............|....|..||++.. .+....+.+..+. .+....+|+.+||+.||++|||++|++.
T Consensus 222 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 222 PAE--SETSPRPRPPGRPLSSYGPDSRPPMAI-FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccc--cccCcccCCccchhhhhcccccccccH-HHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000 000011112223455567888887643 2222222221111 1233468999999999999999999999
Q ss_pred CCcccCCCC
Q 003158 820 HPYVSSDVS 828 (843)
Q Consensus 820 Hp~f~~~~~ 828 (843)
||||+....
T Consensus 299 h~~~~~~~~ 307 (333)
T cd06650 299 HAFIKRSEA 307 (333)
T ss_pred CHHHhcCcc
Confidence 999987644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.32 Aligned_cols=274 Identities=23% Similarity=0.336 Sum_probs=211.5
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+|++.+.||+|+||+||++... +++.||+|++...... ....+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 6899999998753322 23457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999999987655556899999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
......|+..|+|||++.+..++.++||||+||++|||++|+.||........... +...+.....
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~-------~~~~~~~~~~ 222 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE-------VERRVKEDQE 222 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH-------HHHHhhhccc
Confidence 11234688999999999998999999999999999999999999975432111000 0000111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----CCccCCCCCc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKHPY 822 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~-----sa~e~L~Hp~ 822 (843)
.++...+..+.+ ++.+|+..||++|+ +++++++|||
T Consensus 223 ~~~~~~~~~~~~---------------------------------------li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 223 EYSEKFSEAARS---------------------------------------ICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred ccCcccCHHHHH---------------------------------------HHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 222233333444 45555555555555 8889999999
Q ss_pred ccCCCCCCccccccCCCCCC
Q 003158 823 VSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 823 f~~~~~~~~~~~~~~~~~~~ 842 (843)
|..-.+.....+...|++.|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 264 FRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred ccCCCHHHHhhCCCCCCCCC
Confidence 98866655555556677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=358.52 Aligned_cols=298 Identities=23% Similarity=0.374 Sum_probs=214.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||.||++... ++..||+|.+..... ...+++.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 688999999875432 334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999996643 4788899999999999999999853 2999999999999999999999999998755321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .++...
T Consensus 158 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~----~~~~~~ 224 (331)
T cd06649 158 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPV----VDGEEG 224 (331)
T ss_pred -------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccc----cccccC
Confidence 122346899999999999999999999999999999999999999654321 1111111000 000000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC-C-----CCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM-P-----ESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~-~-----~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
. +.............+....+..+|.+. +...+..+.... + ...+.+.+|+++||+.||++|||++|+++||
T Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 E-PHSISPRPRPPGRPVSGHGMDSRPAMA-IFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred C-ccccCcccccccccccccccccccchh-HHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 000000000000001111222333332 111122111111 1 1123356899999999999999999999999
Q ss_pred cccCCCC
Q 003158 822 YVSSDVS 828 (843)
Q Consensus 822 ~f~~~~~ 828 (843)
||.....
T Consensus 303 ~~~~~~~ 309 (331)
T cd06649 303 FIKRSEV 309 (331)
T ss_pred HHhhccc
Confidence 9976544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=328.00 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=207.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh----hh----HHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL----QG----EKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 579 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 579 (843)
-+.|...+.+|+|..++|.++..+ +|..+|+|++..... +. .+.-.+|+.+|+++ .||+|+++.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356788899999999999999854 688999998864221 11 23457899999998 699999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
...++|+|.|+.|.|.|++... -.+++...++|+.|+.+|++|||.+. ||||||||+|||+|++.++||+|||.|
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999653 45899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~ 733 (843)
+.++. .......+|||+|+|||.+.. ..|+...|+||.||++|.|+.|.+||.+.....
T Consensus 171 ~~l~~--------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml------- 235 (411)
T KOG0599|consen 171 CQLEP--------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML------- 235 (411)
T ss_pred eccCC--------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-------
Confidence 98764 344567889999999999964 357888999999999999999999997543211
Q ss_pred hcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC
Q 003158 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 813 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s 813 (843)
.+..+..+.. ++.. | .+.+.+...+|++.++|+.||++|+|
T Consensus 236 ---MLR~ImeGky-qF~s---------------------p--------------eWadis~~~KdLIsrlLqVdp~~Rit 276 (411)
T KOG0599|consen 236 ---MLRMIMEGKY-QFRS---------------------P--------------EWADISATVKDLISRLLQVDPTKRIT 276 (411)
T ss_pred ---HHHHHHhccc-ccCC---------------------c--------------chhhccccHHHHHHHHHeeCchhccc
Confidence 0001111110 1100 1 11223455678999999999999999
Q ss_pred CccCCCCCcccC
Q 003158 814 SSSMLKHPYVSS 825 (843)
Q Consensus 814 a~e~L~Hp~f~~ 825 (843)
++|+|.||||..
T Consensus 277 ake~LaHpff~q 288 (411)
T KOG0599|consen 277 AKEALAHPFFIQ 288 (411)
T ss_pred HHHHhcChHHHH
Confidence 999999999954
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=347.13 Aligned_cols=195 Identities=25% Similarity=0.400 Sum_probs=168.0
Q ss_pred ccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
||+|+||+||++... +++.||+|.+...... ..+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999964 6899999998753322 234677899999999999999999999999999999999999999
Q ss_pred HHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCccc
Q 003158 595 RDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 672 (843)
Q Consensus 595 ~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 672 (843)
.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------ 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ------ 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC------
Confidence 9887542 3346889999999999999999999999 9999999999999999999999999997654321
Q ss_pred ceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 673 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.78 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=214.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhh-HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
...|+..+.||+|.||.||+|.. ..++.||+|++....... ..++++|+.++..++++||.++||.+..+..+|++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34677789999999999999996 468999999998654443 4688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
||.||++.+.++.. ..+.+..+..|.++++.||.|||+++ .+|||||+.|||+..+|.+|++|||.+..+....
T Consensus 92 y~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred HhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999999653 33577788889999999999999999 9999999999999999999999999997765432
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
......+||+.|||||++.+..|+.++||||||++.+||.+|.+|+..... ...++.+.....+
T Consensus 166 ------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 166 ------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------MRVLFLIPKSAPP 229 (467)
T ss_pred ------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------ceEEEeccCCCCC
Confidence 223567899999999999999999999999999999999999999976542 2334444444455
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
.....+...+.+++..|++++|+.||++.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 5666888999999999999999999999999854
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=356.17 Aligned_cols=234 Identities=23% Similarity=0.290 Sum_probs=186.0
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
+.||+|+||.||++... +|+.||+|++..... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999964 689999999875322 22356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCccc
Q 003158 593 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 672 (843)
Q Consensus 593 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 672 (843)
+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~------ 149 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC------
Confidence 9999886543 5889999999999999999999999 9999999999999999999999999987532211
Q ss_pred ceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHH
Q 003158 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752 (843)
Q Consensus 673 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... . .....+|..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~---------~-~~~~~~p~~ 217 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELI---------L-MEEIRFPRT 217 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHH---------h-cCCCCCCCC
Confidence 11233568999999999999999999999999999999999999997544211 11110 0 011123344
Q ss_pred HHHHHHHHHHHhcccCCCCCC
Q 003158 753 CVEKFIKLALKCCQDETDARP 773 (843)
Q Consensus 753 ~~~~l~~l~~~c~~~~p~~RP 773 (843)
+++++.+++.+|++.+|.+|+
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhC
Confidence 455666666666666666665
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=356.76 Aligned_cols=234 Identities=24% Similarity=0.294 Sum_probs=185.9
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999964 68999999987532 223457788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCccc
Q 003158 593 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 672 (843)
Q Consensus 593 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 672 (843)
+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-------
Confidence 999988654 35889999999999999999999999 999999999999999999999999998753211
Q ss_pred ceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHH
Q 003158 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752 (843)
Q Consensus 673 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +......+|..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~----------~~~~~~~~p~~ 217 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFEL----------ILMEDIKFPRT 217 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-HHHHH----------hccCCccCCCC
Confidence 11123356899999999999999999999999999999999999999754321 11111 11111123344
Q ss_pred HHHHHHHHHHHhcccCCCCCC
Q 003158 753 CVEKFIKLALKCCQDETDARP 773 (843)
Q Consensus 753 ~~~~l~~l~~~c~~~~p~~RP 773 (843)
.+.++.+++.+|+..+|.+|+
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcC
Confidence 455566666666666666664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=373.17 Aligned_cols=296 Identities=22% Similarity=0.308 Sum_probs=208.7
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccC------Ccccceeeeee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH------RNLVSLVGYCD 577 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~ 577 (843)
++...+++|++.+.||+|+||+||+|... .++.||||+++... ....++..|+++++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999964 68899999986422 223455667777777754 45888999886
Q ss_pred cC-CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCC------
Q 003158 578 EE-GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKF------ 649 (843)
Q Consensus 578 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~------ 649 (843)
.+ ++.++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+ .+ ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 54 5789999998 78999988654 358899999999999999999997 47 99999999999998765
Q ss_pred ----------cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCC
Q 003158 650 ----------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719 (843)
Q Consensus 650 ----------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf 719 (843)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999876432 1123457899999999999999999999999999999999999999
Q ss_pred CCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHH-HHHHHHhcccCCCCCCCH--HHHHHHHHHhhhhCCCCCCCC
Q 003158 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSM--SEVMRELESIWNMMPESDTKT 796 (843)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~--~~vl~~L~~~~~~~~~~~~~~ 796 (843)
....... .+.. +....+.+|.++.... .+....++......+|.. ..+..............++.+
T Consensus 346 ~~~~~~~-~~~~----------i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (467)
T PTZ00284 346 DTHDNLE-HLHL----------MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414 (467)
T ss_pred CCCChHH-HHHH----------HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHH
Confidence 7654321 1111 1112233343332211 000111111111112211 111111100000001123456
Q ss_pred CccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 797 PEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 797 ~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
.|||.+||++||++|+||+|+|+||||...-.
T Consensus 415 ~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 415 CDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 79999999999999999999999999987544
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=359.96 Aligned_cols=285 Identities=23% Similarity=0.362 Sum_probs=215.6
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCC-----cEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 583 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 583 (843)
+|++.+.||+|+||+||+|.. .+++.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999996 47899999998643 2234567889999999999999999999997766 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 6888887543 35889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... ........++..|+|||++.+. .++.++||||+||++|||++|+.||...... +......
T Consensus 155 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~--------- 218 (372)
T cd07853 155 PDE------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLIT--------- 218 (372)
T ss_pred cCc------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHH---------
Confidence 221 1112334578899999999874 5789999999999999999999999765432 2222111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
...+..+.+......+-....+...+...|....+. ......+..+.+|+.+||.+||++|+|++|+|+|||
T Consensus 219 -~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 219 -DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY-------TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred -HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc-------ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 111222222222222222333334455555433221 122334556778999999999999999999999999
Q ss_pred ccCC
Q 003158 823 VSSD 826 (843)
Q Consensus 823 f~~~ 826 (843)
|.+.
T Consensus 291 ~~~~ 294 (372)
T cd07853 291 LDEG 294 (372)
T ss_pred hCCC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.08 Aligned_cols=195 Identities=27% Similarity=0.420 Sum_probs=167.1
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|+.. +++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 68999999987532 12235667888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------ 149 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------ 149 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------
Confidence 99999986543 4888999999999999999999999 999999999999999999999999998753211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.15 Aligned_cols=261 Identities=20% Similarity=0.333 Sum_probs=209.3
Q ss_pred CcccccHHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhh---HHHHHHHHHHHHhccCCccccee
Q 003158 497 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLV 573 (843)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~ 573 (843)
+.+.+..+++ +......||+|++|.||+|.+ +|+.||||++....... .+.+.+|+++|++++||||++++
T Consensus 11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 3444555555 222236799999999999998 68899999987543322 36778999999999999999999
Q ss_pred eeeec----CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCC
Q 003158 574 GYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHK 648 (843)
Q Consensus 574 ~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~ 648 (843)
|++.+ ....++||||+++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+||+++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 99866 34789999999999999999764 3588899999999999999999985 6 8899999999999999
Q ss_pred CcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchH
Q 003158 649 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 726 (843)
Q Consensus 649 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~ 726 (843)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 160 ~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~ 228 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-K 228 (283)
T ss_pred CcEEEcccchHhhhcccc----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-H
Confidence 999999999998653221 22357889999999976 6889999999999999999999999976542 1
Q ss_pred HHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 727 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+...... ........|..+++.+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 229 ~~~~~i~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 229 EIYDLII--------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHH--------hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111110 0111223455678899999999999999999999999999998753
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.91 Aligned_cols=192 Identities=26% Similarity=0.389 Sum_probs=166.3
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999987532 22345677899888776 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----- 150 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----- 150 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-----
Confidence 9999988654 35889999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~ 720 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 11234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=355.74 Aligned_cols=283 Identities=25% Similarity=0.376 Sum_probs=208.8
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC-----CcEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQM 583 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 583 (843)
+|++.+.||+|+||.||+|... +++.||||++... ......++.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788899999999999999964 6899999998743 223345788999999999999999999988543 2479
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+. ++|.+++.... .+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 79999886543 4889999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCCCcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 155 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-~~~~~~~--------- 220 (338)
T cd07859 155 NDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLI--------- 220 (338)
T ss_pred cccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHH---------
Confidence 21110 111234568999999999876 6789999999999999999999999975442 2211111
Q ss_pred ccCCCCCCCHHHHHHHH-----HHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 742 IDGNMGSYPSECVEKFI-----KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~-----~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
....+..+.+....+. +....+.. ..|.. ....++..++...+++.+||..||++|||++|
T Consensus 221 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e 286 (338)
T cd07859 221 -TDLLGTPSPETISRVRNEKARRYLSSMRK----KQPVP---------FSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286 (338)
T ss_pred -HHHhCCCCHHHHHHhhhhhHHHHHHhhcc----cCCCc---------hHHhcCCCChHHHHHHHHHcCcCcccCCCHHH
Confidence 0111122222222211 11111111 11110 01123344556678999999999999999999
Q ss_pred CCCCCcccCCCC
Q 003158 817 MLKHPYVSSDVS 828 (843)
Q Consensus 817 ~L~Hp~f~~~~~ 828 (843)
+|+||||.+...
T Consensus 287 ~l~hp~f~~~~~ 298 (338)
T cd07859 287 ALADPYFKGLAK 298 (338)
T ss_pred HhcCchhhhcCc
Confidence 999999977544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.70 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=217.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHhcc-CCcccceeeeeecCCcEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 583 (843)
....|+..+.||+|.||.||+++.+ +|+.+|+|++.+..... ...+.+|+++|+++. ||||+.+++.|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457888899999999999999976 49999999998655433 358899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC----CcEEEeecccc
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLS 659 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla 659 (843)
+|||++.||.|.+.+... .+++.++..++.|++.|+.|||+.+ |+||||||+|+|+... +.+|++|||+|
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999776 2899999999999999999999999 9999999999999643 47999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||..........
T Consensus 187 ~~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------- 248 (382)
T KOG0032|consen 187 KFIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------- 248 (382)
T ss_pred eEccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------
Confidence 87653 234567889999999999999999999999999999999999999998655322111
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
.+..+.. . -.+ ..++..+..+.||++.||..||.+|+||.++|+
T Consensus 249 ~i~~~~~-~---------------------f~~--------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 249 AILRGDF-D---------------------FTS--------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHcCCC-C---------------------CCC--------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111110 0 011 122333455678999999999999999999999
Q ss_pred CCcccCCCCC
Q 003158 820 HPYVSSDVSG 829 (843)
Q Consensus 820 Hp~f~~~~~~ 829 (843)
|||+++....
T Consensus 293 HpWi~~~~~~ 302 (382)
T KOG0032|consen 293 HPWIKSIGEA 302 (382)
T ss_pred CccccCCccc
Confidence 9999986443
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=355.60 Aligned_cols=199 Identities=27% Similarity=0.346 Sum_probs=169.8
Q ss_pred CCCCCCcccccCCeeEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcE
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 582 (843)
+|++.+.||+|+||+||+++. .+++.||+|++.... ....+.+.+|+++++.+ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999885 358899999987432 12235678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999654 34888999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 156 LSEE------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccC------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 3221 1112345689999999999875 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.09 Aligned_cols=195 Identities=27% Similarity=0.414 Sum_probs=167.7
Q ss_pred CcccccCCeeEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 517 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 3578999999875321 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|+|.+++.... .+.+..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999996543 4778888899999999999999999 9999999999999999999999999987532211
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 11233568999999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.30 Aligned_cols=198 Identities=30% Similarity=0.441 Sum_probs=175.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999975 589999999875322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999996543 5788899999999999999999999 99999999999999999999999999976432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.36 Aligned_cols=195 Identities=26% Similarity=0.337 Sum_probs=167.9
Q ss_pred CcccccCCeeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCC
Q 003158 517 TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999996 478999999987532 222356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 593 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 593 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
+|.+++.... .+++..++.++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 150 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----- 150 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-----
Confidence 9999886543 58899999999999999999997 67 9999999999999999999999999987532211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 11233569999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=350.71 Aligned_cols=281 Identities=25% Similarity=0.342 Sum_probs=196.9
Q ss_pred CCcccccCCeeEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec--CCcEEEEEecCC
Q 003158 516 STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVYEFMS 590 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e~~~ 590 (843)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46889999987532 23457889999999999999999999854 456899999995
Q ss_pred CCCHHHHHhhc-------CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE----cCCCcEEEeecccc
Q 003158 591 NGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLS 659 (843)
Q Consensus 591 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 659 (843)
++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 6898887532 1235888999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchH--------HHHH
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV--------REVN 730 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~--------~~~~ 730 (843)
+....... +........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ++..
T Consensus 160 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 160 RLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred eccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 86543211 1112234568999999999987 458899999999999999999999996433210 1111
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHH------HHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCC
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKL------ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 804 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l------~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L 804 (843)
..+ . ..+..+...++.+... +.. +..+...... +...++. .....+..+.||+.+||
T Consensus 236 ~~~------~----~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~---~~~~~~~~~~dli~~mL 298 (317)
T cd07868 236 RIF------N----VMGFPADKDWEDIKKMPEHSTLMKD-FRRNTYTNCS---LIKYMEK---HKVKPDSKAFHLLQKLL 298 (317)
T ss_pred HHH------H----hcCCCChHHhHHHhhccchhhhhhh-hhccccCccc---ccchHHh---cCCCCChHHHHHHHHHh
Confidence 100 0 0111111112211110 000 0000000000 1111111 11223445678999999
Q ss_pred CCCCCCCCCCccCCCCCcc
Q 003158 805 TSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 805 ~~dp~~R~sa~e~L~Hp~f 823 (843)
++||++|+||+|+|+||||
T Consensus 299 ~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 299 TMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.53 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=219.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCc-EEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE-QMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lV~ 586 (843)
++|...+.+|+|+||.++..+.+ +++.+|+|.+..... .......+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999854 688999998875432 234478899999999999999999999999888 99999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
+|++||++.+.+.++...-+++..+..++.|++.|+.|||++. |+|||||+.||+++.++.|||+|||+|+.+...+
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998887778999999999999999999999888 9999999999999999999999999999876543
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.||.||.+.+.+|+.|+||||+||++|||++-+++|...+ ....+ ..+.....
T Consensus 161 -------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-m~~Li---------~ki~~~~~ 223 (426)
T KOG0589|consen 161 -------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-MSELI---------LKINRGLY 223 (426)
T ss_pred -------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-hHHHH---------HHHhhccC
Confidence 23456789999999999999999999999999999999999999997544 22222 23334445
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
.+.|..+..++..++..|++++|..||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 56788899999999999999999999999999876
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=360.36 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=202.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
..++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999965 68999999986422 1223457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998653 3677888889999999999999999 99999999999999999999999999976532
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccC----CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 195 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~--------- 258 (370)
T cd05596 195 NG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSK--------- 258 (370)
T ss_pred CC------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHH---------
Confidence 21 1112345699999999998753 37889999999999999999999997543211 1100
Q ss_pred hccCC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCC--CCCCccC
Q 003158 741 VIDGN-MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET--PPSSSSM 817 (843)
Q Consensus 741 ~~~~~-~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~--R~sa~e~ 817 (843)
+.... ...+|. ....+..+.+|+.+||+.+|++ |+|++|+
T Consensus 259 i~~~~~~~~~~~-------------------------------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 259 IMDHKNSLTFPD-------------------------------------DIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred HHcCCCcCCCCC-------------------------------------cCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 00000 000000 0011233446777788877877 8899999
Q ss_pred CCCCcccCCCCC
Q 003158 818 LKHPYVSSDVSG 829 (843)
Q Consensus 818 L~Hp~f~~~~~~ 829 (843)
++||||++..+.
T Consensus 302 l~h~~~~~~~~~ 313 (370)
T cd05596 302 KSHPFFKNDQWT 313 (370)
T ss_pred hcCcccCCCChh
Confidence 999998876554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=347.65 Aligned_cols=288 Identities=22% Similarity=0.342 Sum_probs=212.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|.+.+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 688999999875332 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
++ ++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 96 58988886543 35788889999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...... +...... .. .+
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~------~~----~~ 222 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIF------RL----LG 222 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH------HH----hC
Confidence 11123457889999999875 56889999999999999999999999754421 2111111 00 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
..+.+.++.+.......-...|..+|.. ..+..+..+....|++.+||.+||++|+|++|+|+||||+.-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQP---------LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCCc---------hhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 1112222211111000001112222111 1112233455667999999999999999999999999998755
Q ss_pred CCC
Q 003158 828 SGS 830 (843)
Q Consensus 828 ~~~ 830 (843)
...
T Consensus 294 ~~~ 296 (309)
T cd07872 294 TRI 296 (309)
T ss_pred ccc
Confidence 443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=354.90 Aligned_cols=204 Identities=23% Similarity=0.318 Sum_probs=174.5
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999965 68899999986422 222456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|....
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999643 4788889999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||....
T Consensus 194 ~~~------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 194 ETG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred cCC------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 221 11123456999999999997643 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.84 Aligned_cols=239 Identities=24% Similarity=0.391 Sum_probs=189.4
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHH---HhccCCcccceeeeeecCCcEEEE
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFL---SRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
|++.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999964 689999999975321 2234566676654 566899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|..+++. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 35899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +.... +.. .
T Consensus 155 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~---------i~~-~ 216 (324)
T cd05589 155 -------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDS---------IVN-D 216 (324)
T ss_pred -------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHH---------HHh-C
Confidence 11123456899999999999999999999999999999999999999754321 11111 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSM 775 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~ 775 (843)
...+|..++..+.+++.+|++.+|.+||++
T Consensus 217 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 217 EVRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 122344556667778888888888888743
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=352.00 Aligned_cols=193 Identities=26% Similarity=0.388 Sum_probs=167.4
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999965 689999999975322 2235678899999988 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------ 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------ 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC------
Confidence 9999988654 35899999999999999999999999 999999999999999999999999998743211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 1122345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.00 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=208.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999853 367899999886432 334678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997643 46889999999999999999999998 99999999999999999999999998765321
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. ........++..|+|||.+.+..++.++|||||||++||+++ |..||...... +... .+.+
T Consensus 160 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~---------~~~~ 223 (266)
T cd05064 160 EA------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIK---------AVED 223 (266)
T ss_pred cc------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHH---------HHHC
Confidence 11 011112335678999999999999999999999999999875 99999754321 1111 1122
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
+...+.+..++..+.+++.+||+.+|.+||++.++.+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 222344666788899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=360.65 Aligned_cols=286 Identities=22% Similarity=0.252 Sum_probs=206.3
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
...+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3557999999999999999999975 588999996432 245689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
++ .++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 241 ~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99 479999886532 36899999999999999999999999 99999999999999999999999999986542211
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc------hHHHHHHHhhcccchhh
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN------IVREVNIAYQSSMMFSV 741 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~------~~~~~~~~~~~~~~~~~ 741 (843)
........||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...++.........
T Consensus 316 -----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~--- 387 (461)
T PHA03211 316 -----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV--- 387 (461)
T ss_pred -----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc---
Confidence 1112245699999999999999999999999999999999998877653221 01111111110000
Q ss_pred ccCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 742 IDGNMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 742 ~~~~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
........ .......+.... ......+..|+... .+...+....+|+.+||++||++||||+|+|+|
T Consensus 388 ~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~-----------~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 388 HVDEFPQHAGSRLVSQYRHRA-ARNRRPAYTRPAWT-----------RYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccCCCCcchHHHHHHHhhh-hcccCCccCCcchh-----------hhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00001111 111111111100 00111111111111 111234456789999999999999999999999
Q ss_pred CcccC
Q 003158 821 PYVSS 825 (843)
Q Consensus 821 p~f~~ 825 (843)
|||.+
T Consensus 456 p~f~~ 460 (461)
T PHA03211 456 PLFQS 460 (461)
T ss_pred cccCC
Confidence 99975
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=350.08 Aligned_cols=200 Identities=23% Similarity=0.367 Sum_probs=170.9
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccC-CcccceeeeeecCCcEEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~ 586 (843)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 57899999987532 2234567889999999976 56888999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 9999999999986543 4788899999999999999999998 999999999999999999999999998743211
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 ------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred ------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.90 Aligned_cols=268 Identities=25% Similarity=0.367 Sum_probs=214.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecC-----CcE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 582 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 582 (843)
..++|.+.+.+|+|||+.||.++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999999 678999999999987778888999999999999999999999998543 358
Q ss_pred EEEEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 583 MLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
||+++|+..|+|.+.+... ++..+++.++++|+.+|++||++||+.. |+++||||||.|||+.+++.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999998763 3446999999999999999999999986 689999999999999999999999999997
Q ss_pred cCCCCCCCCc--ccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhc
Q 003158 661 LAPVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 661 ~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~ 735 (843)
.....-.+.. ..-+.-.....|..|+|||.+.- ...++++|||||||++|+|+.|..||+..-.. ..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------Gg 249 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------GG 249 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------CC
Confidence 6543211110 00111234568999999999964 56789999999999999999999999632110 00
Q ss_pred ccchhhccCCCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 736 SMMFSVIDGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 736 ~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
.....+..+... +....+++.+.+++..|++.||.+||+..+++..+.++
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111122222211 11223788999999999999999999999999887764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=340.97 Aligned_cols=261 Identities=27% Similarity=0.426 Sum_probs=203.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 571 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 571 (843)
.++|.+.+.||+|+||.||+|.+++ +..||+|.+.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999998532 3479999987643 233567999999999999999999
Q ss_pred eeeeeecCCcEEEEEecCCCCCHHHHHhhcC-----------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEE
Q 003158 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634 (843)
Q Consensus 572 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 634 (843)
+++++.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986532 124677889999999999999999999 99
Q ss_pred eccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh
Q 003158 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 714 (843)
Q Consensus 635 H~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt 714 (843)
||||||+|||+++++.+||+|||+++.....+. ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999976543221 111223345788999999998899999999999999999997
Q ss_pred --CCCCCCCCcchH--HHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 715 --GMQPISHGKNIV--REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 715 --g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
+..||....... ......... .........+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRD-----QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhh-----ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 556776433211 111110000 0001111224456778999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.57 Aligned_cols=264 Identities=30% Similarity=0.494 Sum_probs=225.9
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeCC-CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
+++|+....+....++||-|.||.||.|.|+. .-.||||.++.+..+ ..+|..|+.+|+.++|||+|+++|+|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 46777777888889999999999999999864 678999999875444 4689999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
+|||+|||..|+|.+||++-.+..++....+.+|.||+.|++||..++ +|||||.++|+|+.++..|||+|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999877777888889999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
+..+.++.. ....-.+-|.|||.+....++.|+|||+|||+|||+.| |..||...+ ..+ + +.
T Consensus 415 MtgDTYTAH------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-lSq-V---------Y~ 477 (1157)
T KOG4278|consen 415 MTGDTYTAH------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQ-V---------YG 477 (1157)
T ss_pred hcCCceecc------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-HHH-H---------HH
Confidence 865443221 11223567999999999999999999999999999999 888886543 111 1 11
Q ss_pred hc-cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 741 VI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 741 ~~-~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
++ .+.+-..|+.|++.++++|..||+.+|.+||+++++-+.++.++.
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 22 223345688999999999999999999999999999999998754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=358.03 Aligned_cols=208 Identities=26% Similarity=0.377 Sum_probs=175.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999965 68999999997532 222356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997643 5889999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCccc-------------------------------ceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhC
Q 003158 667 IEGIVP-------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 715 (843)
Q Consensus 667 ~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg 715 (843)
...... ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000000 0001124699999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 003158 716 MQPISHGK 723 (843)
Q Consensus 716 ~~pf~~~~ 723 (843)
..||....
T Consensus 236 ~~Pf~~~~ 243 (364)
T cd05599 236 YPPFCSDN 243 (364)
T ss_pred CCCCCCCC
Confidence 99997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=357.38 Aligned_cols=207 Identities=22% Similarity=0.319 Sum_probs=173.7
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.|+..+.||+|+||+||+|+. .+++.||+|++..... ...+.+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999996 4689999999975322 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999996543 4788888999999999999999999 99999999999999999999999999864321100
Q ss_pred CCc----------------------------------------ccceeeeeecccCCccCchhcccCCCCchhhhHHHHH
Q 003158 668 EGI----------------------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 707 (843)
Q Consensus 668 ~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~ 707 (843)
... ..........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000112346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCc
Q 003158 708 VFLELLTGMQPISHGK 723 (843)
Q Consensus 708 ~l~elltg~~pf~~~~ 723 (843)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (381)
T cd05626 237 ILFEMLVGQPPFLAPT 252 (381)
T ss_pred HHHHHHhCCCCCcCCC
Confidence 9999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.05 Aligned_cols=194 Identities=28% Similarity=0.422 Sum_probs=164.9
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|... +|+.||+|++..... ...+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999965 689999999875322 12344555555 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------ 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC------
Confidence 9999998654 35788899999999999999999999 999999999999999999999999998753221
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=337.38 Aligned_cols=250 Identities=37% Similarity=0.595 Sum_probs=200.5
Q ss_pred CCCcccccCCeeEEEEEeC-----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 515 SSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 515 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+++.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 25789999997543 33467899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|+|.+++.......+++..+..|+.||++||.|||+++ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 99999999998875677999999999999999999999998 99999999999999999999999999987632111
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
............|+|||.+.+..++.++||||||+++|||++ |+.||..... .+... .+.++...
T Consensus 159 ----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~---------~~~~~~~~ 224 (259)
T PF07714_consen 159 ----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIE---------KLKQGQRL 224 (259)
T ss_dssp ----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHH---------HHHTTEET
T ss_pred ----ccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc---------cccccccc
Confidence 112233446778999999999999999999999999999999 7788865532 22111 12223333
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
..+..++..+.+++..||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 45666788899999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=356.98 Aligned_cols=208 Identities=26% Similarity=0.342 Sum_probs=177.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999965 689999999875322 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 45889999999999999999999998 9999999999999999999999999997654322
Q ss_pred CC----------------------CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IE----------------------GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.. ............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 00 0000011234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.62 Aligned_cols=284 Identities=25% Similarity=0.404 Sum_probs=222.0
Q ss_pred CCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|...++||+|.||+||+|+ ++.++.||+|+...+. ........+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999 5568999999876432 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
| ..+|..+...-. ..++.+.++.++.|+++||.++|+++ +.|||+||.|.|++.+|+.|++|||+|+-+..+
T Consensus 83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 9 568988886543 45888899999999999999999999 999999999999999999999999999976543
Q ss_pred CcccceeeeeecccCCccCchhcccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.........|..|++|.++.+.+ |+...|+||-||++.|+.....|..++.+..+++.+++.. ++
T Consensus 155 ----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~----------lg 220 (292)
T KOG0662|consen 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL----------LG 220 (292)
T ss_pred ----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH----------hC
Confidence 34456667899999999999854 8889999999999999999667777777777777665432 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
...++.++.+.++ .|..--|.+.... .+.+..|.......|+++++|.-+|..|++|+++|+||||+...
T Consensus 221 ~p~ed~wps~t~l------pdyk~yp~ypatt----swsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 221 TPTEDQWPSMTKL------PDYKPYPIYPATT----SWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCccccCCccccC------CCCcccCCccccc----hHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 1222222222221 1111122221111 12223355556677999999999999999999999999998643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.76 Aligned_cols=208 Identities=26% Similarity=0.364 Sum_probs=175.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 689999999875322 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999764 35889999999999999999999999 9999999999999999999999999997643211
Q ss_pred CCC-------c---------------------ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCC
Q 003158 667 IEG-------I---------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718 (843)
Q Consensus 667 ~~~-------~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~p 718 (843)
... . ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 000 0 000011235799999999999999999999999999999999999999
Q ss_pred CCCCc
Q 003158 719 ISHGK 723 (843)
Q Consensus 719 f~~~~ 723 (843)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.20 Aligned_cols=193 Identities=26% Similarity=0.423 Sum_probs=168.4
Q ss_pred ccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
||+|+||.||++... +|+.||+|.+..... ...+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999964 689999999864322 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--------~ 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--------K 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--------c
Confidence 99987766667889999999999999999999999 999999999999999999999999998765421 1
Q ss_pred eeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 123346899999999999988999999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.81 Aligned_cols=279 Identities=23% Similarity=0.343 Sum_probs=203.9
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHh-ccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSR-LHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|... +++.||+|+++.... ...+.+..|..+++. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999965 588999999875321 223456678888876 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 150 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-----
Confidence 9999999654 34788889999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCH
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +......+|.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~----------i~~~~~~~~~ 217 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQS----------IRMDNPCYPR 217 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHH----------HHhCCCCCCc
Confidence 122345689999999999999999999999999999999999999975432 111111 0011122333
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 752 ECVEKFIKLALKCCQDETDARPSMS-EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 752 ~~~~~l~~l~~~c~~~~p~~RPs~~-~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
....++.+++.+|++.+|.+||++. ++.+. . + +...+ ...+. ....+|.-++...+...+.||....
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h-~-~---~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQH-P-F---FREID---WSALE-EREIEPPFKPKVKSANDCSNFDKEF 285 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHcC-c-c---cCCCC---HHHHH-hCCCCCCcCCCCCCccchhhcChhh
Confidence 4555667777777777777777775 33211 0 0 00000 00011 1234455666667777777765533
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=351.33 Aligned_cols=290 Identities=23% Similarity=0.315 Sum_probs=212.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCC-----
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 580 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 580 (843)
..++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999964 6899999998643 2233567889999999999999999999986443
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 581 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 581 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
..++||||++ ++|.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 4799999996 467776632 3778888999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.... .....
T Consensus 171 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~------ 235 (359)
T cd07876 171 RTACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVI------ 235 (359)
T ss_pred cccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH------
Confidence 754321 112334688999999999999999999999999999999999999986543222 11110
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHH--HhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELE--SIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~vl~~L~--~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
...+..+.+....+...+.......|.... ++.++..... .........+....+|+.+||++||++|+|++|
T Consensus 236 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 236 ----EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred ----HhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 112223344444444433333333333221 2222111000 000001112345678999999999999999999
Q ss_pred CCCCCcccC
Q 003158 817 MLKHPYVSS 825 (843)
Q Consensus 817 ~L~Hp~f~~ 825 (843)
+|+||||..
T Consensus 312 ~l~hp~~~~ 320 (359)
T cd07876 312 ALRHPYITV 320 (359)
T ss_pred HhcCchhhh
Confidence 999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.26 Aligned_cols=262 Identities=29% Similarity=0.474 Sum_probs=224.9
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeCC---C--cEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeec
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILPD---G--TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 578 (843)
+..+..+.....++||.|-||.||+|.+.+ | -.||||..+.+. ....+.|..|..+|+.++||||++++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 334445555667899999999999999643 2 358999998743 4456789999999999999999999999985
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
...|+|||.++-|.|..|++.+ +..++......++.||+.||+|||+.. +|||||.++|||+.+..-||++|||+
T Consensus 463 -~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 5789999999999999999764 456888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
++.++...++.. +...-..-|||||.+.-.+++.+||||.|||++||++. |..||....+ .+.
T Consensus 538 SR~~ed~~yYka------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------sDV 601 (974)
T KOG4257|consen 538 SRYLEDDAYYKA------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------SDV 601 (974)
T ss_pred hhhccccchhhc------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------cce
Confidence 999876554321 22334567999999999999999999999999999998 9999987553 334
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+..+..+.+.+.|+.|++.++.++.+||..+|.+||.+.++...|.++..
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 55667788889999999999999999999999999999999999988765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.89 Aligned_cols=201 Identities=28% Similarity=0.464 Sum_probs=181.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHH---HHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
..+|++.+.||+|.||+|-+|.. ..|+.||||.+.++...+++ .+.+|+++|+.++||||+.++.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788889999999999999995 67999999999876655544 568999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||..+|.|+||+.+.+ .+++.+.+.+++||..|+.|+|+++ ++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 99999999999997754 4899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......+|++-|.+||++.+.+|. +.+|-||+|++||.|+.|..||++.+
T Consensus 206 -------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 206 -------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred -------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 3455678899999999999998874 67999999999999999999997643
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.69 Aligned_cols=256 Identities=25% Similarity=0.441 Sum_probs=210.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 346788999999999999999998888899999987533 2356889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|+|.++++......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 99999999997765567888999999999999999999998 99999999999999999999999999986543210
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +.... .. .....
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~-~~--------~~~~~ 223 (261)
T cd05072 159 -----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSA-LQ--------RGYRM 223 (261)
T ss_pred -----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHHH-HH--------cCCCC
Confidence 11122345678999999998889999999999999999998 99998654321 11111 11 11111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
+.+..++.++.+++.+|+..+|++||+++++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2233456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=358.44 Aligned_cols=207 Identities=22% Similarity=0.307 Sum_probs=173.4
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+|+..+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 689999999875322 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999664 34788888999999999999999999 99999999999999999999999999854321000
Q ss_pred CC----------------------------------------cccceeeeeecccCCccCchhcccCCCCchhhhHHHHH
Q 003158 668 EG----------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 707 (843)
Q Consensus 668 ~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~ 707 (843)
.. ...........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00 00000112346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCc
Q 003158 708 VFLELLTGMQPISHGK 723 (843)
Q Consensus 708 ~l~elltg~~pf~~~~ 723 (843)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=336.03 Aligned_cols=256 Identities=31% Similarity=0.524 Sum_probs=210.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeCC------CcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
++|++.+.||+|+||.||+|.... ...||+|.+..... ....++.+|+++++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998642 25799999875432 33467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCC--------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 649 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 649 (843)
++|||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975422 45788889999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHH
Q 003158 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 728 (843)
Q Consensus 650 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~ 728 (843)
.+||+|||+++.....+. ........+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+
T Consensus 162 ~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QE- 234 (283)
T ss_pred cEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HH-
Confidence 999999999976532221 111223346788999999998899999999999999999998 9999975432 11
Q ss_pred HHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 729 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.. ..+..+.....+..++.++.+++.+||+.+|.+||++.++++.|+.
T Consensus 235 ~~--------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VI--------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH--------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 1122233334567788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=350.65 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=206.9
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 578 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 578 (843)
....++|++.+.||+|+||+||+|.+ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456788899999999999999973 236689999987533 23356788999999999 89999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 602 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 602 (843)
.+..++||||+++|+|.++++...
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999986532
Q ss_pred -----------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 603 -----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 603 -----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124678889999999999999999998 999999999999999999999999999765422
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.. ........++..|+|||++.+..++.++|||||||++|||++ |..||............ . ..+
T Consensus 268 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~-~--------~~~ 333 (375)
T cd05104 268 SN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-I--------KEG 333 (375)
T ss_pred cc-----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH-H--------HhC
Confidence 10 011122335678999999999999999999999999999998 88888654322111111 1 111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.....+...+.++.+++..||+.+|++||++.++++.|++
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112233445788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.99 Aligned_cols=255 Identities=28% Similarity=0.423 Sum_probs=195.0
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556788999999999999964 689999999865432 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+.. ...+..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 222 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--- 222 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence 999986532 2456777889999999999999999 9999999999999999999999999998654211
Q ss_pred cccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ++
T Consensus 223 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~---------------- 281 (353)
T PLN00034 223 ----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DW---------------- 281 (353)
T ss_pred ----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cH----------------
Confidence 11233468999999998853 23456899999999999999999999632210 00
Q ss_pred CCCCCCHHHHHHHHHHHHH-hcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 745 NMGSYPSECVEKFIKLALK-CCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~-c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
..++.. +....+. .+ ......+.+|+.+||..||++|+|++|+++||||
T Consensus 282 -------------~~~~~~~~~~~~~~-~~----------------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 282 -------------ASLMCAICMSQPPE-AP----------------ATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred -------------HHHHHHHhccCCCC-CC----------------CccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 000000 0111111 00 1112234467888889999999999999999999
Q ss_pred cCCCCC
Q 003158 824 SSDVSG 829 (843)
Q Consensus 824 ~~~~~~ 829 (843)
......
T Consensus 332 ~~~~~~ 337 (353)
T PLN00034 332 LRAQPG 337 (353)
T ss_pred ccCCcc
Confidence 876544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=350.70 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=208.7
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeee
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 577 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 577 (843)
+....++|++.+.||+|+||.||+|+.. ++..||+|++.... ......+.+|+++++.+ +|+||++++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3445668999999999999999999842 24589999997543 23345788999999999 8999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC-------------------------------------------------------
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKS------------------------------------------------------- 602 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~------------------------------------------------------- 602 (843)
..+..++||||+++|+|.++++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999986421
Q ss_pred -------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 603 -------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 603 -------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
..++++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-- 267 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-- 267 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--
Confidence 124778889999999999999999998 99999999999999999999999999976532210
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
........++..|+|||++.+..++.++|||||||++|||++ |+.||............ . ..+....
T Consensus 268 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-~--------~~~~~~~ 335 (374)
T cd05106 268 ---YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-V--------KRGYQMS 335 (374)
T ss_pred ---eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-H--------HcccCcc
Confidence 111122335678999999999999999999999999999997 99999754321111111 0 0111112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
.+...+.++.+++.+||+.+|.+||++.++++.|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23334678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=349.17 Aligned_cols=195 Identities=26% Similarity=0.412 Sum_probs=167.3
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||.||+|... +++.||+|++..... ...+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 588999999875322 2234577888888866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++.... .+++..+..++.|+++||.|||+++ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 150 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----- 150 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-----
Confidence 99999986543 4788899999999999999999999 9999999999999999999999999987533211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 11234568999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=344.79 Aligned_cols=237 Identities=22% Similarity=0.341 Sum_probs=191.2
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|... +++.||+|+++.... ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 588999999875321 2234456677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 99999986543 5888899999999999999999998 9999999999999999999999999997543211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCH
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... +....+.+|.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~----------i~~~~~~~~~ 217 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDS----------ILNDRPHFPR 217 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHH----------HHcCCCCCCC
Confidence 122345689999999999999999999999999999999999999975442 111111 1112233455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 003158 752 ECVEKFIKLALKCCQDETDARPSMS 776 (843)
Q Consensus 752 ~~~~~l~~l~~~c~~~~p~~RPs~~ 776 (843)
.++.++.+++..||+.+|.+||++.
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCh
Confidence 5667788899999999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.71 Aligned_cols=194 Identities=26% Similarity=0.409 Sum_probs=165.9
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||.||+|... +|+.||+|+++.... ...+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 689999999875321 2234567788887754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------ 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC------
Confidence 9999998664 34788889999999999999999999 999999999999999999999999998743211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 11223456899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=361.92 Aligned_cols=281 Identities=22% Similarity=0.328 Sum_probs=201.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecC--------C
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--------G 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~ 580 (843)
..+|++.+.||+|+||+||+|... +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999964 68999999886432 2345799999999999999999886321 2
Q ss_pred cEEEEEecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeecc
Q 003158 581 EQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFG 657 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfG 657 (843)
..++||||++ ++|.+++.. .....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999996 578777753 23456889999999999999999999999 99999999999999665 79999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~ 736 (843)
+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 217 la~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~-- 285 (440)
T PTZ00036 217 SAKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQ-- 285 (440)
T ss_pred cchhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH--
Confidence 998654221 1223468999999999876 4689999999999999999999999976543221 111110
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC-CCCCCCCccccCCCCCCCCCCCCCc
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP-ESDTKTPEFINSEHTSKEETPPSSS 815 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~-~~~~~~~dll~~~L~~dp~~R~sa~ 815 (843)
. .+..+.+....+..-.. -+ .-|...+ .+ + ...++ .....+.+||.+||++||++|+||.
T Consensus 286 ----~----~~~p~~~~~~~~~~~~~-~~-~~~~~~~--~~----l---~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~ 346 (440)
T PTZ00036 286 ----V----LGTPTEDQLKEMNPNYA-DI-KFPDVKP--KD----L---KKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346 (440)
T ss_pred ----H----hCCCCHHHHHHhchhhh-cc-cCCccCc--hh----H---HHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 0 11111111110000000 00 0011110 11 1 11122 2345567999999999999999999
Q ss_pred cCCCCCcccCCCC
Q 003158 816 SMLKHPYVSSDVS 828 (843)
Q Consensus 816 e~L~Hp~f~~~~~ 828 (843)
|+|+||||..-..
T Consensus 347 e~l~hp~f~~~~~ 359 (440)
T PTZ00036 347 EALADPFFDDLRD 359 (440)
T ss_pred HHhCChhHHhhhc
Confidence 9999999976433
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=330.31 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=205.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4678889999999999999998888899999887433 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce---
Confidence 999999997543 35889999999999999999999999 99999999999999999999999999876532211
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +.... +..+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~~~---------i~~~~~~~~ 222 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEM---------ISRGFRLYR 222 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH---------HHCCCCCCC
Confidence 11122235668999999998889999999999999999999 88998755432 11111 111122223
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
|...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 444567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.16 Aligned_cols=193 Identities=24% Similarity=0.376 Sum_probs=167.2
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 688999999985432 2235678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 149 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------ 149 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC------
Confidence 99999886543 5889999999999999999999999 999999999999999999999999998753211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 150 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred -CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 1122345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=333.45 Aligned_cols=256 Identities=29% Similarity=0.502 Sum_probs=215.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
...+|+..+.||.|+||+||+|...+++.+|+|.+.........++.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678889999999999999999888999999999876655567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 99999999998766667899999999999999999999998 9999999999999999999999999997653221
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .+..+...
T Consensus 159 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~---------~~~~~~~~ 223 (261)
T cd05148 159 -----YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYD---------QITAGYRM 223 (261)
T ss_pred -----ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHH---------HHHhCCcC
Confidence 11122335678999999998899999999999999999998 88999654321 1111 11122223
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
+.+..+++.+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 3455677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.55 Aligned_cols=208 Identities=25% Similarity=0.338 Sum_probs=173.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 78999999986432 122456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999654 35788889999999999999999999 9999999999999999999999999996432110
Q ss_pred CC----------Cccc------------------------------ceeeeeecccCCccCchhcccCCCCchhhhHHHH
Q 003158 667 IE----------GIVP------------------------------AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLG 706 (843)
Q Consensus 667 ~~----------~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G 706 (843)
.. .... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 0000 0000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCc
Q 003158 707 VVFLELLTGMQPISHGK 723 (843)
Q Consensus 707 ~~l~elltg~~pf~~~~ 723 (843)
|++|||++|+.||....
T Consensus 236 vil~elltG~~Pf~~~~ 252 (377)
T cd05629 236 AIMFECLIGWPPFCSEN 252 (377)
T ss_pred hhhhhhhcCCCCCCCCC
Confidence 99999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=346.06 Aligned_cols=241 Identities=20% Similarity=0.332 Sum_probs=192.7
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
+|++.+.||+|+||+||+|... +++.||+|++..... ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 578999999875322 2234567788888777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999986543 4788999999999999999999999 9999999999999999999999999987533211
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +.. ..
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~---------i~~-~~ 217 (323)
T cd05616 156 -------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQS---------IME-HN 217 (323)
T ss_pred -------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHH---------HHh-CC
Confidence 1123456899999999999999999999999999999999999999764421 11111 111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSM 775 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~ 775 (843)
..+|...+.++.+++.+|++.+|.+|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 23344556677778888888888888764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=346.46 Aligned_cols=289 Identities=19% Similarity=0.289 Sum_probs=203.2
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
....+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999975 5789999975432 2356899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+ .++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 137 PHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred Ecc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 999 56898888653 346899999999999999999999999 999999999999999999999999999753211
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchH-HHHHHHhhcccchhhcc--
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REVNIAYQSSMMFSVID-- 743 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~-- 743 (843)
.......||+.|+|||++.+..++.++|||||||++|||+++..++....... ...... ....+..++.
T Consensus 211 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~-~~~~l~~~~~~~ 282 (357)
T PHA03209 211 -------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS-CHSHLLKIISTL 282 (357)
T ss_pred -------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHH-HHHHHHHHHHHh
Confidence 11233568999999999999999999999999999999999666654322111 000000 0000001100
Q ss_pred -CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 744 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 744 -~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
.....++.+....+ ....+......|..... ...++. ........+||.+||++||++||||+|+|+|||
T Consensus 283 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 283 KVHPEEFPRDPGSRL---VRGFIEYASLERQPYTR-YPCFQR-----VNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred ccChhhcCCCCccHH---HHHHHhhcccCCCcccc-cHHHhc-----cCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 00001110000000 11111111111111100 000110 122344567999999999999999999999999
Q ss_pred ccC
Q 003158 823 VSS 825 (843)
Q Consensus 823 f~~ 825 (843)
|+.
T Consensus 354 f~~ 356 (357)
T PHA03209 354 FAQ 356 (357)
T ss_pred hcc
Confidence 975
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=349.41 Aligned_cols=290 Identities=21% Similarity=0.298 Sum_probs=212.7
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 579 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 579 (843)
..++|++.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999964 68899999987532 23346788999999999999999999987543
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
...++||||++ ++|.+++.. .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999996 578777743 3778888999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 174 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~------- 237 (364)
T cd07875 174 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKV------- 237 (364)
T ss_pred cccCCC--------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHH-------
Confidence 765321 112334689999999999999999999999999999999999999976553322 2111
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHH-Hh-hhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELE-SI-WNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~vl~~L~-~~-~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
+. ..+....+....+...+.......|... ..+.++..... .. ..........+.|||.+||+.||.+|+|++|
T Consensus 238 --~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 238 --IE-QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred --HH-hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 11 1222233444444433333333222221 11221111000 00 0001112334568999999999999999999
Q ss_pred CCCCCcccC
Q 003158 817 MLKHPYVSS 825 (843)
Q Consensus 817 ~L~Hp~f~~ 825 (843)
+|+||||..
T Consensus 315 ~L~hp~~~~ 323 (364)
T cd07875 315 ALQHPYINV 323 (364)
T ss_pred HhcCccccc
Confidence 999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=331.45 Aligned_cols=255 Identities=31% Similarity=0.481 Sum_probs=210.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.+|+..+.||+|+||.||+|.+. +++.||+|.+... ....+++.+|+++++.++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999965 5889999998753 333567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-- 159 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 159 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee--
Confidence 9999999997766667899999999999999999999998 99999999999999999999999999986543211
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.... +.......
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~---------~~~~~~~~ 225 (263)
T cd05052 160 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYEL---------LEKGYRME 225 (263)
T ss_pred ----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH---------HHCCCCCC
Confidence 01111234568999999999999999999999999999998 8888865432 221111 11111223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
.+..++..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 4556678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.36 Aligned_cols=195 Identities=29% Similarity=0.413 Sum_probs=165.5
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHH-HHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|... +|+.||+|++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999964 68999999987532 122345556655 56779999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------ 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------ 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC------
Confidence 9999988654 35889999999999999999999999 999999999999999999999999998753211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.10 Aligned_cols=268 Identities=27% Similarity=0.388 Sum_probs=204.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc--cCCcccceeeeeecCC----cEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEEG----EQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~~----~~~l 584 (843)
...+..+.||+|.||.||||.+. ++.||||++.. +..+.|..|-++++.. +|+||++|+++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34455678999999999999985 49999999964 4456788888887764 8999999999875544 8999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCC------CCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA------DPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
|+||.+.|+|.+||..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||.+|+++.|+|||+
T Consensus 286 Vt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999654 5899999999999999999999753 67899999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCC-CC-----chhhhHHHHHHHHHHHhCCCCCCCCc--c----hH
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LT-----DKSDVYSLGVVFLELLTGMQPISHGK--N----IV 726 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwS~G~~l~elltg~~pf~~~~--~----~~ 726 (843)
|..+...... ......+||.+|||||++.+.. +. .+.||||+|.+||||+++..-+..+. + ..
T Consensus 363 Al~~~p~~~~-----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 363 ALRLEPGKPQ-----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eEEecCCCCC-----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9988754322 2233478999999999998742 22 36899999999999999876553211 1 00
Q ss_pred HHHHHHhhcccchh--hccCCCCCCCHHH-----HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 727 REVNIAYQSSMMFS--VIDGNMGSYPSEC-----VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 727 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~-----~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
..+-..-..+.+.+ +.+..++.+|+.+ ..-+.+.+..||+.|++.|-|+.=+.+++..+....+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 01100000011111 2233445555544 3567889999999999999999998888887755444
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=357.62 Aligned_cols=208 Identities=23% Similarity=0.317 Sum_probs=173.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++.++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999964 689999999864322 22456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999996643 4788888899999999999999999 9999999999999999999999999985332100
Q ss_pred CCC------------------------------------cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHH
Q 003158 667 IEG------------------------------------IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 710 (843)
Q Consensus 667 ~~~------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ 710 (843)
... ...........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 00000112346999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCc
Q 003158 711 ELLTGMQPISHGK 723 (843)
Q Consensus 711 elltg~~pf~~~~ 723 (843)
||++|+.||....
T Consensus 236 ell~G~~Pf~~~~ 248 (376)
T cd05598 236 EMLVGQPPFLADT 248 (376)
T ss_pred ehhhCCCCCCCCC
Confidence 9999999997544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.62 Aligned_cols=241 Identities=21% Similarity=0.337 Sum_probs=189.0
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~ 586 (843)
+|+..+.||+|+||+||+|... +++.||+|++..... ...+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999964 689999999875321 22356778888888885 578889999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999986543 4889999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +.. ..
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~---------i~~-~~ 217 (323)
T cd05615 156 -------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQS---------IME-HN 217 (323)
T ss_pred -------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHH---------HHh-CC
Confidence 112334689999999999999999999999999999999999999975432 111111 111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSM 775 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~ 775 (843)
..+|...+.++.+++.+|++++|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12334445556666677777777777653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.39 Aligned_cols=203 Identities=26% Similarity=0.349 Sum_probs=175.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|... +++.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999964 689999999875322 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999764 235889999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCCcccceeeeeecccCCccCchhcc------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 157 ------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 11223346899999999987 4567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=349.58 Aligned_cols=209 Identities=22% Similarity=0.302 Sum_probs=177.3
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeec
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 578 (843)
..+.....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556789999999999999999999965 68899999986422 1223457889999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998653 3778888899999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
++...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 189 a~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 189 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eeEcCcCC------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 98654221 11123456999999999997543 7889999999999999999999997544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.74 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=217.6
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCC-cEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeee-ee---c---C
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY-CD---E---E 579 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~-~~---~---~ 579 (843)
...++++.+.|.+|||+.||.|....+ ..||+|++........+.+.+||++|+.|+ |+|||.+++. .. . .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345667789999999999999997765 999999998777777888999999999997 9999999993 21 1 2
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
-+.+|.||||+||.|-|++..+....|.+.++++|+.|+++|+++||.. +|||||||||-+|||++.++..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 3678999999999999999876666699999999999999999999997 488999999999999999999999999999
Q ss_pred ccCCCCCC--CCcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhh
Q 003158 660 RLAPVPDI--EGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734 (843)
Q Consensus 660 ~~~~~~~~--~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~ 734 (843)
........ .+...-...-....|+.|+|||.+. +..+++|+|||||||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 75332110 0000000111234789999999984 67899999999999999999999999986532
Q ss_pred cccchhhccCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 735 SSMMFSVIDGNMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 735 ~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
..++.+...-+ .+.++..+..+|..|++.+|++||++-+|+..+..+.+.
T Consensus 264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 24455544322 368999999999999999999999999999999888664
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=354.16 Aligned_cols=288 Identities=20% Similarity=0.233 Sum_probs=209.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
..+|.+.+.||+|+||.||+|... .++.||+|.+... +...+|+++++.++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3678999988643 24567999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|++. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 789998843 346889999999999999999999999 9999999999999999999999999997654322
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch--HHHHHHHhhcccchhhccC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 744 (843)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..... .+..
T Consensus 240 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~------~~~~ 308 (392)
T PHA03207 240 D-----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR------CMQV 308 (392)
T ss_pred c-----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH------Hhcc
Confidence 1 11123456999999999999999999999999999999999999999754321 111111110 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
....++......+.+-.. +.....||...- -..+.. ...+..+.+||.+||++||++|+||.|+|.||||.
T Consensus 309 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~ 379 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFK---QYAIVLRPPYTI-PPVIRK-----YGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT 379 (392)
T ss_pred CccccCCccchhHHHHHH---hhcccccCCccc-cchhhc-----cCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence 011111111111111111 112223332210 000000 01123455789999999999999999999999997
Q ss_pred CCCC
Q 003158 825 SDVS 828 (843)
Q Consensus 825 ~~~~ 828 (843)
....
T Consensus 380 ~~~~ 383 (392)
T PHA03207 380 KEPI 383 (392)
T ss_pred ccch
Confidence 7544
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.67 Aligned_cols=195 Identities=25% Similarity=0.402 Sum_probs=167.3
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|... +++.||+|++..... .....+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 588999999875321 2234567888988887 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 150 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----- 150 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-----
Confidence 99999986543 5889999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 11233468999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=348.74 Aligned_cols=238 Identities=24% Similarity=0.311 Sum_probs=190.2
Q ss_pred CcccccCCeeEEEEEe----CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 517 TQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3589999999875332 223467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----
Confidence 99999999654 35889999999999999999999999 9999999999999999999999999987643221
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..... +. ......|
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~---------i~-~~~~~~p 218 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMTM---------IL-KAKLGMP 218 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HHHHH---------HH-cCCCCCC
Confidence 1223456899999999999988999999999999999999999999754321 11111 11 1111234
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSE 777 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~ 777 (843)
...+..+.+++..||+.+|.+||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 444556667777777777777777665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.24 Aligned_cols=277 Identities=25% Similarity=0.380 Sum_probs=201.4
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhc---cCCcccceeeeeec-----CC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDE-----EG 580 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 580 (843)
+|++.+.||+|+||+||+|... +++.||+|.+...... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5788899999999999999965 6899999988753221 234556777777665 69999999998854 34
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||++ ++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999996 59999987765556899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
...... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .......
T Consensus 157 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~------ 221 (288)
T cd07863 157 IYSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFD------ 221 (288)
T ss_pred cccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHH------
Confidence 654221 1123457899999999999999999999999999999999999986543321 1111110
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
.... .....++.. ..+..... .+..... +....+..+....|++.+||+.||++|+|++|++.|
T Consensus 222 ~~~~---~~~~~~~~~-~~~~~~~~--~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 222 LIGL---PPEDDWPRD-VTLPRGAF--SPRGPRP----------VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HhCC---CChhhCccc-cccccccc--CCCCCCc----------hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000000000 00000000 0000001 111223334455689999999999999999999999
Q ss_pred Ccc
Q 003158 821 PYV 823 (843)
Q Consensus 821 p~f 823 (843)
|||
T Consensus 286 p~f 288 (288)
T cd07863 286 PFF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=330.19 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=211.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456788899999999999999998778899999987543 3356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997755556899999999999999999999998 99999999999999999999999999987642211
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
........+..|+|||++.+..++.++||||||+++|||++ |+.||...... ..... +......
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~---------~~~~~~~ 223 (261)
T cd05068 159 -----EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQQ---------VDQGYRM 223 (261)
T ss_pred -----cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH---------HHcCCCC
Confidence 01111223457999999999999999999999999999999 99898654321 11111 1111112
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
..+..++..+.+++.+|++.+|.+||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 2344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.82 Aligned_cols=200 Identities=28% Similarity=0.411 Sum_probs=174.1
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
|+..+.||+|+||+||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999964 6899999998754322 234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999987655557999999999999999999999999 9999999999999999999999999987543211
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.82 Aligned_cols=256 Identities=28% Similarity=0.506 Sum_probs=209.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC------CcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|.+.+.||+|+||.||+|...+ ++.||||.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998632 478999998765444 457899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc
Q 003158 583 MLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 650 (843)
++||||+++++|.+++...+ ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997542 235788899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 729 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~ 729 (843)
+||+|||+++.....+. ........+++.|+|||++.+..++.++|||||||++|||++ |..||...... +..
T Consensus 161 ~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVI 234 (280)
T ss_pred EEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Confidence 99999999975432211 011123345678999999999999999999999999999999 99998754432 111
Q ss_pred HHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 730 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
. .+..+.....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 235 ~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 E---------CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 11122333345567788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.56 Aligned_cols=261 Identities=30% Similarity=0.491 Sum_probs=212.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.++|.+.+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888999999999999999842 35679999988665555678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC-----------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEE
Q 003158 584 LVYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 652 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 652 (843)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997532 234899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHH
Q 003158 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 731 (843)
Q Consensus 653 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~ 731 (843)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 161 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-~~~~~- 233 (288)
T cd05093 161 IGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIE- 233 (288)
T ss_pred eccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH-
Confidence 999999976532210 011122335678999999999999999999999999999999 8888865432 11111
Q ss_pred HhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.+..+.....+..++..+.+++.+||+.+|.+||++.++.+.|+++...
T Consensus 234 --------~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 --------CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --------HHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111222223344567799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.13 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=207.7
Q ss_pred CCCCCCcccccCCeeEEEEEeC-C-CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-D-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999853 4 6788999876555555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 590 SNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 590 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
++|+|.+++... ...++++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 3446888999999999999999999998 99999999999999999999999999986542210
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+..+...
T Consensus 225 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~~~~---------~~~~~~~~~ 289 (478)
T PTZ00267 225 -----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-REIM---------QQVLYGKYD 289 (478)
T ss_pred -----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHH---------HHHHhCCCC
Confidence 1122345699999999999999999999999999999999999999975432 1111 122223333
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
..+..++..+.+++..||..+|++||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 445566778999999999999999999998864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.70 Aligned_cols=260 Identities=29% Similarity=0.512 Sum_probs=213.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.+|...+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999842 356799999887666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc
Q 003158 585 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 650 (843)
||||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 234788999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 729 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~ 729 (843)
++|+|||++........ ........++..|+|||.+.+..++.++|||||||++|||+| |+.||....... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VI 235 (291)
T ss_pred EEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999976543211 111223446788999999999999999999999999999999 999986544321 11
Q ss_pred HHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 730 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
. .+..+.....+..++..+.+++.+||+.+|.+||++.+++++|+++.+.
T Consensus 236 ~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 E---------CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H---------HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 1122222233445667899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=334.75 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=203.6
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999965 689999999865322 223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999999997655567899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~------------------- 210 (285)
T cd05630 157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------------- 210 (285)
T ss_pred -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-------------------
Confidence 112346899999999999999999999999999999999999999753321100
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC-----CccCCCCCc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKHPY 822 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s-----a~e~L~Hp~ 822 (843)
+ ....+.. ..+.. ......+...+|+++||+.||++|+| ++|+++|||
T Consensus 211 ----~---~~~~~~~----~~~~~----------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 211 ----E---EVERLVK----EVQEE----------------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ----H---HHHhhhh----hhhhh----------------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 0 0000000 00000 00111223457888899999999998 899999999
Q ss_pred ccCC
Q 003158 823 VSSD 826 (843)
Q Consensus 823 f~~~ 826 (843)
|..-
T Consensus 264 ~~~~ 267 (285)
T cd05630 264 FKQI 267 (285)
T ss_pred hhcc
Confidence 9764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.61 Aligned_cols=256 Identities=31% Similarity=0.470 Sum_probs=208.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.++|++.++||+|+||.||+|...+...||+|++.... ...+++.+|+++++.++|+||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45789999999999999999998777789999987533 234678999999999999999999998754 5689999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-- 157 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence 9999999997655556789999999999999999999998 99999999999999999999999999976543221
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||+..+..++.++|||||||++|||++ |+.||....... .... +.......
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~---------~~~~~~~~ 223 (262)
T cd05071 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQ---------VERGYRMP 223 (262)
T ss_pred ----ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHH---------HhcCCCCC
Confidence 11122346678999999998899999999999999999999 888886543211 1111 11111223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
.+.+++..+.+++.+|++.+|++||++.++.+.|+.++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 34567788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.62 Aligned_cols=263 Identities=25% Similarity=0.380 Sum_probs=209.6
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcc-CCcccceeeeeec
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE 578 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 578 (843)
....++|.+.+.||+|+||.||+|... .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 344678889999999999999999852 134799999975433 33467899999999996 9999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 602 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 602 (843)
.+..++|||||++|+|.++++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999999886421
Q ss_pred --------------------------------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEE
Q 003158 603 --------------------------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 644 (843)
Q Consensus 603 --------------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NIL 644 (843)
...+++..+..++.|+++||+|||+.+ |+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 124677888999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCc
Q 003158 645 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 723 (843)
Q Consensus 645 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~ 723 (843)
+++++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred EeCCCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999999999999986532211 011122346788999999999999999999999999999997 889986532
Q ss_pred chHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
....... .+..+.....+..++..+.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 345 ~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 345 VDSTFYN---------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hhHHHHH---------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 2111111 11112222345567788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=346.55 Aligned_cols=291 Identities=21% Similarity=0.283 Sum_probs=210.2
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecC-----
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 579 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 579 (843)
...++|++.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 68999999987532 23346778999999999999999999988543
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 580 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 580 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
...++||||++ +++.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+||++++++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 35799999996 577777643 3778888999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 166 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~----- 231 (355)
T cd07874 166 ARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVI----- 231 (355)
T ss_pred cccCCCc--------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-----
Confidence 9764321 112334689999999999999999999999999999999999999976543222 11111
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHH-HHHHHh-hhhCCCCCCCCCccccCCCCCCCCCCCCCc
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVM-RELESI-WNMMPESDTKTPEFINSEHTSKEETPPSSS 815 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~vl-~~L~~~-~~~~~~~~~~~~dll~~~L~~dp~~R~sa~ 815 (843)
. ..+....++...+...+..+....|... ..+.... ..+... ..........+.+|+.+||+.||++|||++
T Consensus 232 ----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ 306 (355)
T cd07874 232 ----E-QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_pred ----H-HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence 0 0112223333333333333332222210 0111000 000000 000011223456899999999999999999
Q ss_pred cCCCCCcccC
Q 003158 816 SMLKHPYVSS 825 (843)
Q Consensus 816 e~L~Hp~f~~ 825 (843)
|+|+||||..
T Consensus 307 ell~hp~~~~ 316 (355)
T cd07874 307 EALQHPYINV 316 (355)
T ss_pred HHhcCcchhc
Confidence 9999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=344.91 Aligned_cols=255 Identities=30% Similarity=0.458 Sum_probs=214.1
Q ss_pred CCCCCcccccCCeeEEEEEe-CCC----cEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 513 FNSSTQIGQGGYGKVYKGIL-PDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
....++||+|+||+||+|.| +.| -+||+|++... ..+..+++.+|+-+|.+++|||+++++|+|..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34467899999999999995 444 46899988754 3445678999999999999999999999998765 88999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
+||+.|+|.++++.+ +..+.....+.|..|||+||.|||.+. +|||||.++||||.+-..+||.|||+|+.+...+
T Consensus 777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999874 456888999999999999999999998 9999999999999999999999999999887544
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.+ .......-.+.|||-|.+....|+.++|||||||++||++| |..|++.... +. .-..+..+.
T Consensus 853 ~e-----y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--~e--------I~dlle~ge 917 (1177)
T KOG1025|consen 853 KE-----YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--EE--------IPDLLEKGE 917 (1177)
T ss_pred cc-----ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--HH--------hhHHHhccc
Confidence 21 12223344578999999999999999999999999999999 9999976432 11 111234455
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+.+.|+.|+.+++.++.+||..|+..||+++++...+.++..
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 677899999999999999999999999999999988887644
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=345.74 Aligned_cols=281 Identities=23% Similarity=0.367 Sum_probs=206.7
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecC-----
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE----- 579 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 579 (843)
...++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999996 4688999999875322 2345678899999999999999999987533
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 580 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 580 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
...++++|++ +++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 4579999998 7899988753 34889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+.....
T Consensus 165 ~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~--- 230 (343)
T cd07878 165 ARQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME--- 230 (343)
T ss_pred ceecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH---
Confidence 9865321 123468899999999987 56889999999999999999999999754422 21111100
Q ss_pred chhhccCCCCCCCHHHHHHHH-HHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 738 MFSVIDGNMGSYPSECVEKFI-KLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~-~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
. .+..+.+....+. .........-|. .|.. + ....+...++.+.+|+.+||..||++|+|++|
T Consensus 231 ---~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~-------~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 231 ---V----VGTPSPEVLKKISSEHARKYIQSLPH-MPQQ-D-------LKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred ---H----hCCCCHHHHHhcchhhHHHHhhcccc-ccch-h-------HHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 0 0111111111110 001111111111 1100 0 11112233445678999999999999999999
Q ss_pred CCCCCcccC
Q 003158 817 MLKHPYVSS 825 (843)
Q Consensus 817 ~L~Hp~f~~ 825 (843)
+|+||||..
T Consensus 295 ll~hp~~~~ 303 (343)
T cd07878 295 ALAHPYFSQ 303 (343)
T ss_pred HhcCcchhc
Confidence 999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=327.42 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=208.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.++|++.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457888999999999999999988888999999875433 3467899999999999999999999885 45689999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence 9999999997755556899999999999999999999998 99999999999999999999999999976543211
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+.... +......+
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~---------~~~~~~~~ 223 (260)
T cd05070 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQ---------VERGYRMP 223 (260)
T ss_pred ----ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHH---------HHcCCCCC
Confidence 11112235678999999998899999999999999999999 8888865432 111111 11122223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.+...+..+.+++.+|+..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 455667889999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.35 Aligned_cols=284 Identities=19% Similarity=0.312 Sum_probs=219.5
Q ss_pred ccHHHHHHHHcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeec
Q 003158 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE 578 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 578 (843)
-+++++...++ +.||+|+++.|.-++ +.+|..+|||++.+......+++.+|++++.+.+ |+||+.++++|++
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 34677777774 679999999999998 6789999999999876667889999999999985 9999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---cEEEee
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVAD 655 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~D 655 (843)
+...|||||-|.||+|...|+++. .+++.++.+++.+|+.||.+||.+| |.|||+||+|||..+-. -+||+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 999999999999999999997654 4899999999999999999999999 99999999999997654 489999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchH-HHH
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REV 729 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~-~~~ 729 (843)
|.++.-......-.+.........+|+..|||||+..- ..|+.+.|.||+||++|-|+.|..||.+.-... .|.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 99987654332222222333456779999999998742 458889999999999999999999997532100 000
Q ss_pred HH---HhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCC
Q 003158 730 NI---AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 806 (843)
Q Consensus 730 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~ 806 (843)
+. ......+++.+......+|++.|..+ +..++|++..+|..
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahI-----------------------------------S~eakdlisnLlvr 347 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHI-----------------------------------SSEAKDLISNLLVR 347 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCChhhhHHh-----------------------------------hHHHHHHHHHHHhc
Confidence 00 00011122333333334444444333 22345788889999
Q ss_pred CCCCCCCCccCCCCCcccCCCCC
Q 003158 807 KEETPPSSSSMLKHPYVSSDVSG 829 (843)
Q Consensus 807 dp~~R~sa~e~L~Hp~f~~~~~~ 829 (843)
|+..|.+|.+.++|||+..-...
T Consensus 348 da~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 348 DAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred cHHhhhhhhhccCCccccccchh
Confidence 99999999999999999775554
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.37 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=207.4
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 580 (843)
..+++|+..+.||+|+||.||+|.+. .+..||+|.+.... .....++.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 25679999986432 234567889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCC--------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEE
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSK--------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 652 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 652 (843)
..++||||+++|+|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999965321 23577888999999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHH
Q 003158 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 731 (843)
Q Consensus 653 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~ 731 (843)
|+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 160 l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~- 232 (277)
T cd05062 160 IGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLR- 232 (277)
T ss_pred ECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH-
Confidence 9999998765432210 11112245678999999999899999999999999999999 6888865432 11111
Q ss_pred HhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
.+........+..++..+.+++.+||+.+|++||++.++++.++
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 --------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11222233445566778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=350.71 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=175.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|+..+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 68999999987432 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999654 35888999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCc----------------------------ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCC
Q 003158 667 IEGI----------------------------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718 (843)
Q Consensus 667 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~p 718 (843)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011234699999999999999999999999999999999999999
Q ss_pred CCCCc
Q 003158 719 ISHGK 723 (843)
Q Consensus 719 f~~~~ 723 (843)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.27 Aligned_cols=252 Identities=30% Similarity=0.472 Sum_probs=206.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
++|+..+.||+|+||+||+|.+.++..||+|.+.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998777789999887533 335678999999999999999999999998889999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++......
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~---- 154 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---- 154 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc----
Confidence 9999999976433 6899999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ... .+..+.....
T Consensus 155 --~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~---------~~~~~~~~~~ 222 (256)
T cd05113 155 --YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-TVE---------KVSQGLRLYR 222 (256)
T ss_pred --eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHH---------HHhcCCCCCC
Confidence 111112335678999999998889999999999999999999 999986544211 111 1122222223
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
+...+..+.+++.+||+.+|.+||++.+++..++
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 4445678899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.10 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=206.7
Q ss_pred cCCCCCCcccccCCeeEEEEEe-----CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++|++.+.||+|+||+||+|.. .++..||+|.+.... ....+++.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999984 246789999987533 3334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC---------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC
Q 003158 585 VYEFMSNGTLRDQLSAKS---------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 649 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 649 (843)
||||+++++|.+++.... ...+++.....++.|++.||+|||+++ |+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985432 234788889999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHH
Q 003158 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 728 (843)
Q Consensus 650 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~ 728 (843)
.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEV 235 (283)
T ss_pred cEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999976543221 111223345678999999998889999999999999999999 9889865432 111
Q ss_pred HHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 729 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
... +........+..++..+.+++.+||+.+|.+||++.++.+.+..+
T Consensus 236 ~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 236 IEM---------VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH---------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 111 111112234556678899999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=342.18 Aligned_cols=196 Identities=29% Similarity=0.388 Sum_probs=160.1
Q ss_pred CcccccCCeeEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeee--cCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lV~e~~~~ 591 (843)
.+||+|+||+||+|... ++..||+|.+.... ....+.+|+++++.++||||+++++++. .+...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999964 35789999987532 2346788999999999999999999984 3567899999995
Q ss_pred CCHHHHHhhc-------CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE----cCCCcEEEeeccccc
Q 003158 592 GTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 660 (843)
Q Consensus 592 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla~ 660 (843)
++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||++ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5888877532 1235788889999999999999999999 9999999999999 566799999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
........ ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 65432210 112234568899999999976 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.13 Aligned_cols=263 Identities=27% Similarity=0.455 Sum_probs=208.1
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeec-
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 578 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~- 578 (843)
...++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++++ +|+||++++++|..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34568999999999999999999742 257899999875432 2345678899999999 89999999998864
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------------------------------------------------
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKS-------------------------------------------------------- 602 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 602 (843)
+...++||||+++|+|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 457889999999999999986432
Q ss_pred ---CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeee
Q 003158 603 ---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679 (843)
Q Consensus 603 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~ 679 (843)
..++++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++....... .......
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-----~~~~~~~ 235 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGDA 235 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----hhhccCC
Confidence 126789999999999999999999998 99999999999999999999999999986543211 0111233
Q ss_pred cccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHH
Q 003158 680 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI 758 (843)
Q Consensus 680 ~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 758 (843)
.++..|+|||++.+..++.++|||||||++|||++ |..||........ ..... ..+.....+..+.+++.
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRL--------KEGTRMRAPEYATPEIY 306 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHH--------hccCCCCCCccCCHHHH
Confidence 45678999999999999999999999999999998 9999965332111 11111 11112223455667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 759 KLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 759 ~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+++.+||+.+|++||++.++++.|+++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.42 Aligned_cols=277 Identities=23% Similarity=0.320 Sum_probs=219.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
..+.|..-++||+|+||.||-+..+ +|+.+|.|.+.+... .++.....|-.+|++++.+.||.+--.|...+.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467888899999999999999865 699999998876443 345667889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|+..|.||+|.-+|...+...+++..++.++.+|+.||++||+++ ||.||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998887778999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.+ .....+||.+|||||++....|+...|+||+||++|||+.|+.||.....-..+.. +...+..
T Consensus 340 g~--------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE-------vdrr~~~ 404 (591)
T KOG0986|consen 340 GK--------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE-------VDRRTLE 404 (591)
T ss_pred CC--------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH-------HHHHHhc
Confidence 32 23444799999999999999999999999999999999999999965432211100 0011111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCC-----CCCccCCC
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP-----PSSSSMLK 819 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R-----~sa~e~L~ 819 (843)
....+++.++++. .++++.+|+-||++| =.|+++-+
T Consensus 405 ~~~ey~~kFS~ea---------------------------------------kslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 405 DPEEYSDKFSEEA---------------------------------------KSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred chhhcccccCHHH---------------------------------------HHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 1112233333333 345555566666665 36789999
Q ss_pred CCcccCCCCCCccccccCCCCCC
Q 003158 820 HPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 820 Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
||||..-.+...-.+-..|||-|
T Consensus 446 HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 446 HPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred CcccccCCHhHHhccCCCCCCCC
Confidence 99999977754444446677655
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.26 Aligned_cols=257 Identities=29% Similarity=0.471 Sum_probs=209.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC----CcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+|+||+||+|.+.. ...||||.+..... ...+++.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999999742 45899999875433 335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||++++++.++|+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999997643 36889999999999999999999998 99999999999999999999999999987642
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.+. ........++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... .+..
T Consensus 159 ~~~-----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~--------~~~~ 223 (266)
T cd05033 159 SEA-----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIK--------AVED 223 (266)
T ss_pred ccc-----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHH--------HHHc
Confidence 211 111122335678999999999999999999999999999998 999986543221 111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
....+.+..+++.+.+++.+||+.+|++||++.++++.|+++
T Consensus 224 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222233455678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=341.85 Aligned_cols=202 Identities=28% Similarity=0.344 Sum_probs=172.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999964 68999999987421 223456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999653 335888899999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCcccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 ------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 111223468999999999973 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=341.91 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=185.4
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 678999999875321 22234445544 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++.... .+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----- 150 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----- 150 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-----
Confidence 99999996543 4778888889999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCH
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (843)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +..... ... ....+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i---------~~~-~~~~~~ 217 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNI---------LNK-PLQLKP 217 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHH---------HhC-CcCCCC
Confidence 1223456999999999999999999999999999999999999999754421 111111 111 111223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003158 752 ECVEKFIKLALKCCQDETDARPSMSEVM 779 (843)
Q Consensus 752 ~~~~~l~~l~~~c~~~~p~~RPs~~~vl 779 (843)
..+..+.+++.+|++.+|.+||+..+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 3455666777777777777777766433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.65 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=202.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc--cCCcccceeeeeecC----CcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE----GEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~----~~~~ 583 (843)
..+....+.||+|.||.||+|.| .|+.||||++.. .+++.+.+|.++++.+ +|+||+.|++.-..+ .++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 35667789999999999999999 588999999964 3456778888888874 999999999986443 3789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-----CCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-----EADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
||++|.+.|||+|||.+ ..++....++++..+|.||++||. +|+|.|.|||||+.||||.+++...|+|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999965 468899999999999999999995 5889999999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCC----C--CchhhhHHHHHHHHHHHhC----------CCCCCCC
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----L--TDKSDVYSLGVVFLELLTG----------MQPISHG 722 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwS~G~~l~elltg----------~~pf~~~ 722 (843)
|........ .. .......+||.+|||||++...- + -..+||||||.++||+.-+ +.||.+.
T Consensus 363 Av~h~~~t~--~i-di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 363 AVRHDSDTD--TI-DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred eEEecccCC--cc-cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 987654321 11 12234567999999999996532 1 2368999999999999764 3466532
Q ss_pred ---cchHHHHHHHhhcccchhhccCCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 723 ---KNIVREVNIAYQSSMMFSVIDGNMGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 723 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+...++.+..+- ++..++.+ ..++...+.++|..||..+|..|-++-.+.+.+.++.+
T Consensus 440 Vp~DPs~eeMrkVVC-------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVC-------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhccee-------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222222222111 12222222 45677889999999999999999999988888887754
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.13 Aligned_cols=206 Identities=22% Similarity=0.247 Sum_probs=168.4
Q ss_pred CCCccccc--CCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 515 SSTQIGQG--GYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 515 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+.++||+| +||+||++.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999986 479999999987543 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997655556889999999999999999999999 9999999999999999999999998754432111000
Q ss_pred cccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
...........++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 000011122346778999999976 468899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.25 Aligned_cols=283 Identities=23% Similarity=0.376 Sum_probs=207.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999965 688999999874332 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 96 69999886543 35788999999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .++..... .. .+
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~------~~----~~ 222 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIF------RI----LG 222 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH------HH----cC
Confidence 11123356889999999876 4578899999999999999999999975442 22221111 00 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
......+..+......+....|..++.. + ....+..++...+++.+||+.||++|+|++|+|+||||..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPKYRADC------L---HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred CCChhhchhhhccccccccccCcccccc------H---HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1111111111110000000111111100 0 0112333455678999999999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=325.29 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=209.7
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
..++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4567889999999999999999988899999999875433 3467899999999999999999999874 4578999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 99999999997766667899999999999999999999998 99999999999999999999999999976542211
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||...... +.... +......
T Consensus 158 -----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~---------~~~~~~~ 222 (260)
T cd05067 158 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQN---------LERGYRM 222 (260)
T ss_pred -----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHH---------HHcCCCC
Confidence 11122345678999999998889999999999999999999 99999754421 11111 1111112
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
..+...+.++.+++.+||..+|++||+++++...|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2344556789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.62 Aligned_cols=237 Identities=25% Similarity=0.353 Sum_probs=187.2
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 689999999875322 22344555654 67889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 150 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE----- 150 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-----
Confidence 9999988653 34778888899999999999999998 9999999999999999999999999987532211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCH
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (843)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+. ...... +. ......|.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~---------i~-~~~~~~~~ 217 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-SQMYDN---------IL-HKPLQLPG 217 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-HHHHHH---------Hh-cCCCCCCC
Confidence 112345689999999999999999999999999999999999999976532 111111 11 11123344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 003158 752 ECVEKFIKLALKCCQDETDARPSMS 776 (843)
Q Consensus 752 ~~~~~l~~l~~~c~~~~p~~RPs~~ 776 (843)
.....+.+++..|++.+|.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 4556677888888888888887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=329.27 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=207.8
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 580 (843)
...++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 24589999886443 233456888999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcC--------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEE
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAK 652 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 652 (843)
..++||||+++|+|.+++.... .....+..+..++.|++.||.|||+++ |+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532 123456778899999999999999998 99999999999999999999
Q ss_pred EeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHH
Q 003158 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 731 (843)
Q Consensus 653 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~ 731 (843)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 160 L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~~~~- 232 (288)
T cd05061 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLK- 232 (288)
T ss_pred ECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH-
Confidence 999999976543221 011122235678999999999899999999999999999999 7888865332 12111
Q ss_pred HhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
.+.++.....+..++..+.+++.+|++.+|++||++.++++.+++.
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 --------FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1222333344555678899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.00 Aligned_cols=284 Identities=21% Similarity=0.320 Sum_probs=208.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|++.+.||+|+||.||++... ++..+|+|.+..... ....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999964 688999999875422 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
+++++|.++++.. ..+++..+..++.|+++||.|||+ .+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999764 457888999999999999999997 46 999999999999999999999999998754321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC--
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN-- 745 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 745 (843)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .. ....+... ........
T Consensus 154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~-~~~~~~~~~~ 223 (308)
T cd06615 154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KE-LEAMFGRP-VSEGEAKESH 223 (308)
T ss_pred -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hh-HHHhhcCc-cccccccCCc
Confidence 11234688999999999888899999999999999999999999965432 11 11111100 00000000
Q ss_pred ----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 746 ----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 746 ----~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
....+........++...+....+...|.. ..+....+|+.+|+..||++|||++|+++||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG---------------AFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCc---------------ccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000001111111111111111111100 0122355899999999999999999999999
Q ss_pred cccCC
Q 003158 822 YVSSD 826 (843)
Q Consensus 822 ~f~~~ 826 (843)
||...
T Consensus 289 ~~~~~ 293 (308)
T cd06615 289 FIKRA 293 (308)
T ss_pred hhhhc
Confidence 99763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=333.88 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=206.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
..+|++.+.||+|+||+||+|.+. +++ .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 457899999999999999999863 343 48999987543 33456889999999999999999999999764 578
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+|+||+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999997643 34788889999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... + ......
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~-~~~~~~-------- 225 (316)
T cd05108 161 ADEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-ISSILE-------- 225 (316)
T ss_pred CCCc-----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-H-HHHHHh--------
Confidence 3221 111122234678999999999999999999999999999998 99998754321 1 111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+.....+..+..++.+++..||..+|.+||++.+++..+..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111223344566788999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.89 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=207.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.+|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34667789999999999999853 2578999999754333 2456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC
Q 003158 584 LVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 649 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 649 (843)
+++||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 234788889999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHH
Q 003158 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 728 (843)
Q Consensus 650 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~ 728 (843)
.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDV 235 (283)
T ss_pred ceEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999886542221 111223345778999999998889999999999999999998 8888865432 121
Q ss_pred HHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 729 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.. .+..+.....+.+++..+.+++..||+.+|.+||++.++++.|+.
T Consensus 236 ~~---------~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IE---------MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH---------HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 222333344566788889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.96 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=204.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
.+|++.+.||+|+||.||+|.++++..+|+|++..... ...++.+|+++++.++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999987778899999875332 34578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+++|.+++..... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~---- 154 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---- 154 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc----
Confidence 9999999976433 6889999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .... +........
T Consensus 155 --~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~---------~~~~~~~~~ 222 (256)
T cd05059 155 --YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVES---------VSAGYRLYR 222 (256)
T ss_pred --ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HHHH---------HHcCCcCCC
Confidence 001111223457999999999999999999999999999999 888886543321 1111 111112233
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
+..++.++.+++.+||..+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=342.55 Aligned_cols=234 Identities=23% Similarity=0.277 Sum_probs=177.8
Q ss_pred ccccCCeeEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHhc---cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
||+|+||+||+|+.. +++.||||++....... ...+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 68999999986432222 23445666776665 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 150 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN----- 150 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-----
Confidence 9999998654 35889999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.... +..+......
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-~~~~~---------i~~~~~~~~~ 218 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-QMYRN---------IAFGKVRFPK 218 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-HHHHH---------HHcCCCCCCC
Confidence 112345689999999999764 4789999999999999999999999754321 11111 1111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC
Q 003158 751 SECVEKFIKLALKCCQDETDARPS 774 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs 774 (843)
....+.+.+++.+|+..+|.+||+
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~ 242 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLG 242 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCC
Confidence 123445556666666666666663
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=328.09 Aligned_cols=292 Identities=20% Similarity=0.274 Sum_probs=220.3
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-C-C----cccceeeeeecCC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-H-R----NLVSLVGYCDEEG 580 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----nIv~l~~~~~~~~ 580 (843)
..+++|.+...+|+|.||.|-.+.++ .+..||||+++.- ....+...-|+++++++. + | -++.+.+||...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34889999999999999999999865 4789999999842 223445677999999993 2 2 4788899999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-------------
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH------------- 647 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~------------- 647 (843)
+.|+|+|.+ |-|+.+++..++..+++...++.|+.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999 679999999988889999999999999999999999999 999999999999932
Q ss_pred -------CCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 003158 648 -------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720 (843)
Q Consensus 648 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~ 720 (843)
+..++|+|||.|.+.... ...++.|..|+|||++.+-.++.++||||+||+|+|++||...|.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~----------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH----------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC----------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 335899999999875422 255678999999999999999999999999999999999999997
Q ss_pred CCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHH---HHHHHhcc--cCCCCCCCHHHHHHH---HHHhhhhCCCC
Q 003158 721 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFI---KLALKCCQ--DETDARPSMSEVMRE---LESIWNMMPES 792 (843)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~l~~~c~~--~~p~~RPs~~~vl~~---L~~~~~~~~~~ 792 (843)
..++.+.. .++...++++|.....+.. -.-..+++ .....| .+..+.+. |..+......+
T Consensus 311 tHen~EHL-----------aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~-~~k~v~~~ckpl~~~~~~~d~e 378 (415)
T KOG0671|consen 311 THENLEHL-----------AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKG-KSKYVFEPCKPLKKYMLQDDLE 378 (415)
T ss_pred cCCcHHHH-----------HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccc-cchhhhcCCccHHHHhccCcHH
Confidence 66543321 1111223344544433220 01111222 112222 12222222 22222222333
Q ss_pred CCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 793 DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 793 ~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
..++.|||++||.+||.+|+|+.|||.||||..-
T Consensus 379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 379 HVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 4556799999999999999999999999999763
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=323.64 Aligned_cols=257 Identities=30% Similarity=0.495 Sum_probs=212.1
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+..++|++.+.||+|+||.||+|..++++.||||.+.... ...+++.+|++++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3467899999999999999999998888899999987533 345678999999999999999999999998899999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++.......+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999998765567899999999999999999999998 99999999999999999999999999876542110
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......++..|+|||.+.+..++.++||||+||++||+++ |+.||...... ..... +.....
T Consensus 159 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~---------~~~~~~ 222 (261)
T cd05034 159 ------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQ---------VERGYR 222 (261)
T ss_pred ------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH---------HHcCCC
Confidence 01112234568999999999899999999999999999999 99999654321 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
...+...+.++.+++.+|+..+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 22344456789999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=322.60 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=207.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.++|.+.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|+++++.++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688889999999999999998777789999876533 23467889999999999999999999885 45689999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc--
Confidence 9999999997755556889999999999999999999998 99999999999999999999999999976543211
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||...+..++.++|||||||++|||++ |+.||........ .. .........
T Consensus 158 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~---------~~~~~~~~~ 223 (260)
T cd05069 158 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LE---------QVERGYRMP 223 (260)
T ss_pred ----cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH---------HHHcCCCCC
Confidence 11112345678999999998899999999999999999999 8889875443211 11 111111223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.+...+..+.+++.+||..+|.+||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 345667889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.22 Aligned_cols=280 Identities=24% Similarity=0.398 Sum_probs=207.9
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|+..+.||+|+||.||+|... +|+.||+|++...... ....+.+|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999965 6899999998753222 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
++ ++|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 96 58888876532 45899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......++..|+|||.+.+. .++.++|||||||++|||+||..|+....+.......... . .+
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~------~----~~ 218 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR------L----LG 218 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH------H----hC
Confidence 111234578899999998774 4789999999999999999999998765554333322111 0 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
..+......+.++... ...+...... .+....+.....+.+++++||..||++|||++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 219 TPTEESWPGVSKLPDY------KPYPMYPATT----SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCChHHhHHhhhcccc------cccCCCCCcc----hhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1112222221111110 0011111000 0111223345566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=351.22 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=208.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCC-----
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 580 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 580 (843)
..++|.+.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 356899999999999999999985 479999999987543 233457889999999999999999988774332
Q ss_pred ---cEEEEEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 581 ---EQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 581 ---~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
..++||||+++|+|.+++..+ ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999999653 2346889999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhc
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~ 735 (843)
||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 187 FGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-~~~~~----- 255 (496)
T PTZ00283 187 FGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-EEVMH----- 255 (496)
T ss_pred cccCeecccccc-----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHH-----
Confidence 999986543211 1122345699999999999999999999999999999999999999975432 22111
Q ss_pred ccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
....+.....+..+++++.+++..||+.+|.+||++.++++.
T Consensus 256 ----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 ----KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 122233334556677889999999999999999999998764
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.12 Aligned_cols=281 Identities=24% Similarity=0.444 Sum_probs=220.4
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeee
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 577 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 577 (843)
...++|.+.+.||+|+||.||+|... ....||+|.+.... .....++.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34567888999999999999999742 24579999987533 23356788999999999 6999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcE
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 643 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NI 643 (843)
+.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9999999999999999999996532 235788899999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 003158 644 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 722 (843)
Q Consensus 644 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~ 722 (843)
++++++.+||+|||.++.....+.. .......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred EEcCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999865422111 11112234567999999999899999999999999999999 88888643
Q ss_pred cchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccC
Q 003158 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINS 802 (843)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~ 802 (843)
.. .+.... +..+.....+..++.++.+++.+||..+|++||++.++++.|+++.....+ ...++...
T Consensus 241 ~~-~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~---~~~~~~~~ 307 (314)
T cd05099 241 PV-EELFKL---------LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE---EYLDLSMP 307 (314)
T ss_pred CH-HHHHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC---CceeeEEe
Confidence 32 111111 111222234556677888999999999999999999999999998765433 33456667
Q ss_pred CCCCCCC
Q 003158 803 EHTSKEE 809 (843)
Q Consensus 803 ~L~~dp~ 809 (843)
+.+++|+
T Consensus 308 ~~~~~~~ 314 (314)
T cd05099 308 FEQYSPS 314 (314)
T ss_pred hhhcCCC
Confidence 7777763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.02 Aligned_cols=282 Identities=24% Similarity=0.383 Sum_probs=210.2
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 689999999876442 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+ +++|.+++.... .++++..++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999986543 56899999999999999999999998 99999999999999999999999999986643221
Q ss_pred CcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......++..|+|||.+.+. .++.++||||+||++|||++|..||....+. ........ ...
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~----------~~~ 218 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFR----------TLG 218 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHH----------HcC
Confidence 112234688999999998764 4688999999999999999997777544332 21111110 001
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
......+..+.++....-...+..++.. +.+..++.+....+++.+||..||++|||++++|+||||.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIP---------LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcch---------HHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1111111111111100000011111111 1122344456667899999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.67 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=207.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.+|...++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999742 366899999887666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCC-------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcE
Q 003158 585 VYEFMSNGTLRDQLSAKSK-------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 651 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 651 (843)
||||+++|+|.+++..... ..+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999976432 34788999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHH
Q 003158 652 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 730 (843)
Q Consensus 652 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~ 730 (843)
||+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 162 kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AIE 235 (280)
T ss_pred EECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-HHH
Confidence 9999999875432210 011122335678999999999999999999999999999998 899986543221 111
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
....+.....+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 ---------CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11222222334556778999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.89 Aligned_cols=244 Identities=30% Similarity=0.480 Sum_probs=207.1
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.|..++.||.|+||.||-|+. .+.++||||++.....+ .-+++..|++.|++++|||++.+.|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 455578899999999999995 57899999998754433 34678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|| -|+-.|++.-. +.++.+.++..|+.+.++||+|||+.+ .||||||+.|||+++.|.|||+|||.|.....
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99 57999988654 457999999999999999999999999 99999999999999999999999999987542
Q ss_pred CCcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
....+|||.|||||++.. +.|+-++||||+|++..||..+++|++..+..... +.+...
T Consensus 179 --------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL----------YHIAQN 240 (948)
T KOG0577|consen 179 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------YHIAQN 240 (948)
T ss_pred --------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH----------HHHHhc
Confidence 245689999999999963 78999999999999999999999998865543322 223333
Q ss_pred CCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 745 NMGSY-PSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 745 ~~~~~-~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
..+.. ..++++.+..++..|+++-|.+||+..++++.
T Consensus 241 esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 33332 56788999999999999999999999988754
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=329.66 Aligned_cols=264 Identities=27% Similarity=0.489 Sum_probs=212.4
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 576 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 576 (843)
++....++|+..+.||+|+||.||+|... ....+|+|.+.... .....++.+|+++++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34455678999999999999999999864 23689999987532 23345788999999999 799999999999
Q ss_pred ecCCcEEEEEecCCCCCHHHHHhhc--------------CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCc
Q 003158 577 DEEGEQMLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 642 (843)
Q Consensus 577 ~~~~~~~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~N 642 (843)
..++..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 9999999999999999999999652 2346889999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCC
Q 003158 643 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 721 (843)
Q Consensus 643 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~ 721 (843)
|++++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred EEEcCCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 99999999999999999876432211 11122235678999999998899999999999999999998 9899865
Q ss_pred CcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 722 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
... .+... .+..+.....+..++..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 238 ~~~-~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 238 IPV-EELFK---------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCH-HHHHH---------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 432 11111 11112222345566778999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.46 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=202.3
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|+..+.||+|++|.||+|... +++.|++|.+... .....+++.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999965 6899999998643 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 99999999998765567899999999999999999999998 9999999999999999999999999988654321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||...... .... ....+....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~~~ 220 (256)
T cd08529 156 -----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-ALIL---------KIIRGVFPP 220 (256)
T ss_pred -----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHH---------HHHcCCCCC
Confidence 1122345788999999999999999999999999999999999999755421 1111 112222333
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
.+..++..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 44455667777777777777777777776654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=327.96 Aligned_cols=279 Identities=27% Similarity=0.401 Sum_probs=204.9
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999965 689999999864322 2246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
++ ++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 68999886543 256899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||............ .. ..
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~------~~---- 218 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FR------IL---- 218 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HH------Hh----
Confidence 11223356889999999875 45788999999999999999999999765432221111 00 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCC-CCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 747 GSYPSECVEKFIKLALKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~-~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
+......+.....+... -...+. ..+. ........+....+++++||..||++|||++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 219 GTPTEDVWPGVTSLPDY-KNTFPKWKKGS----------LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCCChhhhhcchhhHHH-HhhccccCcch----------hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00111111111110000 000000 0000 001122234455689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=328.40 Aligned_cols=282 Identities=23% Similarity=0.358 Sum_probs=206.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|+..+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999965 6899999998753322 234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
++ ++|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 97 59999886543 36888999999999999999999998 9999999999999999999999999987543211
Q ss_pred CcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.......+.+...+. . ..
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~------~----~~ 222 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR------V----LG 222 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH------h----cC
Confidence 11122346788999999876 45889999999999999999999999765433333222111 0 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCC--CCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD--TKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~--~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
....+...........+-...+...+ ..+ ....+... ....+++.+||..||++|||++|+++||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 223 TPTEETWPGVSSNPEFKPYSFPFYPP--RPL-------INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CCChhhhhhhhhccccccccccccCC--hhH-------HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11111121111110000000011111 111 11111222 455689999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=319.51 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=209.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999964 7899999987642 2233457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 587 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 587 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||+++|+|.+++... ....+++..++.++.|+++||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988642 2345788899999999999999999998 99999999999999999999999999886542
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||............. +...
T Consensus 159 ~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--------~~~~ 223 (267)
T cd08228 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK--------IEQC 223 (267)
T ss_pred hh-------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH--------HhcC
Confidence 21 11123458889999999998889999999999999999999999996543221111111 1111
Q ss_pred CCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 745 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 745 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
..+. .+...+..+.+++.+||..+|++||++.++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1222 2345678899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.30 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=212.5
Q ss_pred CCCCcccccCCeeEEEEEeC--CCc--EEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 514 NSSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 514 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
...++||+|.||.|++|.|. +|+ .||||.+..+... ...+|.+|+.+|.+++|+|+++|||+..+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999985 344 5899999876555 46799999999999999999999999987 788999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
++.|+|.+.|++.....+.......++.|||.||.||.+++ +|||||.++|+|+-....|||+|||+.+-+...+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999998866677889999999999999999999999 999999999999999999999999999987654321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
. .......-...|+|||.+....++.++|||+|||++||||| |..||.+... .+ .+..+-++.+.
T Consensus 269 Y----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-~q---------IL~~iD~~erL 334 (1039)
T KOG0199|consen 269 Y----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-IQ---------ILKNIDAGERL 334 (1039)
T ss_pred e----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-HH---------HHHhccccccC
Confidence 1 11122334578999999999999999999999999999999 8889875442 11 12233345566
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
.-|..|++++++++..||..+|.+||+|..+.+.+-
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 778999999999999999999999999999974433
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.15 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=200.3
Q ss_pred cccccCCeeEEEEEeC---CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCC
Q 003158 518 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
.||+|+||+||+|.++ ++..||+|+++.... ...+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578999999875432 23567899999999999999999999886 45678999999999
Q ss_pred CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCccc
Q 003158 593 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVP 672 (843)
Q Consensus 593 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 672 (843)
+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---- 151 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---- 151 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe----
Confidence 999999654 35889999999999999999999998 999999999999999999999999999865432210
Q ss_pred ceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCH
Q 003158 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751 (843)
Q Consensus 673 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (843)
........++..|+|||.+....++.++|||||||++|||++ |+.||..... ...... +..+...+.|.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~---------i~~~~~~~~~~ 221 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQM---------IESGERMECPQ 221 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH---------HHCCCCCCCCC
Confidence 011122234578999999988889999999999999999998 9999975432 111111 11222334556
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 752 ~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
.++.++.+++.+||+.+|++||++.+|.+.|+++
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 6778899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.69 Aligned_cols=203 Identities=28% Similarity=0.329 Sum_probs=172.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+++.+ +++.||+|++..... .....+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 578999999864221 12345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997532 35888899999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 157 ------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 11123356999999999986 3467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.39 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=206.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CC--cEEEEEEeccC-ChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DG--TVVAVKRAQEG-SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 585 (843)
++|++.+.||+|+||.||+|... ++ ..+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888999999999999999865 33 35788888742 233456789999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcE
Q 003158 586 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 651 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 651 (843)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 124788899999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHH
Q 003158 652 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 730 (843)
Q Consensus 652 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~ 730 (843)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 159 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYE 229 (297)
T ss_pred EECCcCCCccccce--------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH
Confidence 99999998643211 00111223457999999998899999999999999999998 9999975432 11111
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
....+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.+..
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 ---------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11112222334556778999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.15 Aligned_cols=279 Identities=27% Similarity=0.397 Sum_probs=208.3
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|+..+.||+|++|.||+|+.. +++.||||.+..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999965 689999998875332 2235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+. ++|.+++.......+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 95 68999987766667899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CcccceeeeeecccCCccCchhcccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......++..|+|||.+.+.. ++.++|||||||++|||+||+.||........ ....... .+
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~----------~~ 218 (284)
T cd07860 155 -----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRT----------LG 218 (284)
T ss_pred -----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHH----------hC
Confidence 1112334678999999987644 68899999999999999999999976543221 1111100 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
..+....+.+..+...+. ..|.. +....++ .+..+....+++.+|++.||++|||++|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKP-SFPKWARQDFSKV----------VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCChhhhhhhhHHHHHHh-hcccccccCHHHH----------cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111222222222211111 11111 1111111 12233445689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.95 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=203.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++|++.+.||+|+||+||+|.+. +++ .|++|.+..... ....++..|+.+++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999963 444 478888754322 234577888889999999999999999864 56789
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 35889999999999999999999998 99999999999999999999999999986532
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.+. ........++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ...... .
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~--------~ 226 (279)
T cd05111 162 DDK-----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLE--------K 226 (279)
T ss_pred CCc-----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--------C
Confidence 211 111233457788999999999999999999999999999998 999986543211 111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+.....+..+...+.+++.+||..+|.+||++.++++.+..+.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11222334456678889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.90 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=205.9
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
..++|.+.+.||+|+||.||+|.+. .+..||+|.+.... ...+..+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567889999999999999999964 35789999887443 3335678999999999999999999999998899
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-----CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---cEEE
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKV 653 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl 653 (843)
.++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 25889999999999999999999998 99999999999998765 6999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHH
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 732 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~ 732 (843)
+|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~- 233 (277)
T cd05036 161 ADFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEF- 233 (277)
T ss_pred ccCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH-
Confidence 999999865322110 00112223567999999999999999999999999999997 99998754321 11111
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
+........+..++..+.+++.+|++.+|++||++.++++.|+
T Consensus 234 --------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 --------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111222345566788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=336.23 Aligned_cols=265 Identities=22% Similarity=0.388 Sum_probs=210.8
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChhh-HHHHHHHHHHHHhcc-CCcccceeeee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLH-HRNLVSLVGYC 576 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~ 576 (843)
++....++|.+.+.||+|+||.||+|+++ .++.||+|+++...... .+.+.+|++++.++. ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 45566678888999999999999999853 34689999998543322 357889999999997 99999999999
Q ss_pred ecCCcEEEEEecCCCCCHHHHHhhcCC-----------------------------------------------------
Q 003158 577 DEEGEQMLVYEFMSNGTLRDQLSAKSK----------------------------------------------------- 603 (843)
Q Consensus 577 ~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------- 603 (843)
...+..++||||+++|+|.+++++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999965321
Q ss_pred -------------------------------------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCC
Q 003158 604 -------------------------------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 640 (843)
Q Consensus 604 -------------------------------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp 640 (843)
..+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 23567778899999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 003158 641 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPI 719 (843)
Q Consensus 641 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf 719 (843)
+|||+++++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999976432110 001122346788999999998889999999999999999998 88898
Q ss_pred CCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
............ +..+.....|..++.++.+++.+||..+|.+||++.++++.|+++.
T Consensus 343 ~~~~~~~~~~~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 343 PELPMNEQFYNA---------IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCchHHHHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 654322111111 1111122345556788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.77 Aligned_cols=250 Identities=29% Similarity=0.470 Sum_probs=209.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999874 78999999986544 5678999999999999999999999999899999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999998766557899999999999999999999999 9999999999999999999999999998653211
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.....+..|+|||.+.+..++.++||||||+++||+++ |..||..... .+ ..... .......
T Consensus 157 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~-~~~~~--------~~~~~~~ 219 (256)
T cd05039 157 -------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD-VVPHV--------EKGYRME 219 (256)
T ss_pred -------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HH-HHHHH--------hcCCCCC
Confidence 12234568999999998889999999999999999998 9999865432 11 11111 1111223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.+..+++.+.+++.+|+..+|++||++.+++.+|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 345567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.80 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=200.5
Q ss_pred cccccCCeeEEEEEeC---CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCC
Q 003158 518 QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 593 (843)
.||+|+||.||+|.+. .+..||+|++..... ...+++.+|+.++++++|+||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 356799999876433 23467899999999999999999999885 457899999999999
Q ss_pred HHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccc
Q 003158 594 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673 (843)
Q Consensus 594 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 673 (843)
|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......... .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc----e
Confidence 99998653 346889999999999999999999998 999999999999999999999999999765432210 0
Q ss_pred eeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHH
Q 003158 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752 (843)
Q Consensus 674 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (843)
.......++..|+|||.+.+..++.++|||||||++||+++ |..||...... +... .+..+.....+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~---------~~~~~~~~~~~~~ 222 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMS---------FIEQGKRLDCPAE 222 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHH---------HHHCCCCCCCCCC
Confidence 11122234578999999998889999999999999999997 99999754421 1111 1122223345566
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 753 ~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
+++++.+++.+||..+|++||++.++.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.31 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=210.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCC-----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeec-CCc
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGE 581 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 581 (843)
..++|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788899999999999999999765 6889999987543 3335678899999999999999999998765 567
Q ss_pred EEEEEecCCCCCHHHHHhhcCC------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSK------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
.++++||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999965322 45889999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhh
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQ 734 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~ 734 (843)
||+++.+...+. ........++..|+|||++.+..++.++|||||||++||+++ |+.||..... .+....
T Consensus 161 ~g~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~--- 231 (280)
T cd05043 161 NALSRDLFPMDY-----HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAY--- 231 (280)
T ss_pred CCCcccccCCce-----EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHH---
Confidence 999986533221 011122345678999999998889999999999999999999 9999975432 221111
Q ss_pred cccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+..+.....+..+++.+.+++.+||..+|++||++.++++.|+++.+
T Consensus 232 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 ------LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ------HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111222334566788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=325.30 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=209.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCC------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
..++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45688899999999999999998642 4689999987543 2335678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcC--------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEE
Q 003158 582 QMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 653 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 653 (843)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999996532 124678889999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHH
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 732 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~ 732 (843)
+|||+++.....+.. .......++..|+|||.+.+..++.++|||||||++||+++ |..||..... .+...
T Consensus 161 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~-- 232 (277)
T cd05032 161 GDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLK-- 232 (277)
T ss_pred CCcccchhhccCccc-----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HHHHH--
Confidence 999998765432210 11123346788999999998889999999999999999998 8889865432 11111
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
.+..+.....|..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 233 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 -------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11223333455667889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.49 Aligned_cols=263 Identities=25% Similarity=0.493 Sum_probs=211.6
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeee
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 577 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 577 (843)
...++|++.+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44678889999999999999999741 24579999987532 33456789999999999 8999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcE
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 643 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NI 643 (843)
..+..++||||+++|+|.+++.... ...+++..+..++.||++||.|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997642 234778889999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 003158 644 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 722 (843)
Q Consensus 644 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~ 722 (843)
++++++.+||+|||+++....... ........+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-----cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999986643221 111122345678999999999889999999999999999998 77887543
Q ss_pred cchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
. ..+.... +..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 244 ~-~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 P-VEELFKL---------LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred C-HHHHHHH---------HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2 2222211 111122233556778899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.97 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=211.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+-|.++++||+|+||.||+|.++ .|++||||.+.. ..+.+++..|+.+|++.+.+++|++||.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34667889999999999999965 699999998874 345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
.-|++.+.++.+ ..++.+.++..+.++.++||+|||... -||||||+.|||++.+|.+|++|||.|-.+...
T Consensus 111 GAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---- 182 (502)
T KOG0574|consen 111 GAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---- 182 (502)
T ss_pred CCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh----
Confidence 999999999765 457999999999999999999999988 799999999999999999999999999755321
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
......+.||+.|||||++..-.|+.++||||+|++..||..|++||.+-... ..++-+-....+.+
T Consensus 183 ---MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------RAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 183 ---MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------RAIFMIPTKPPPTF 249 (502)
T ss_pred ---HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------ceeEeccCCCCCCC
Confidence 12335678999999999999999999999999999999999999999865431 11222222223333
Q ss_pred --CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 750 --PSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 750 --~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
|+.++.++.+++..|+-+.|++|-++.++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 88899999999999999999999998877653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=320.27 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=204.8
Q ss_pred CCCCCcccccCCeeEEEEEeC-C---CcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCc-----
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 581 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 581 (843)
|++.+.||+|+||.||+|... + +..||+|+++... ......+.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2 3789999987533 2334678999999999999999999998865543
Q ss_pred -EEEEEecCCCCCHHHHHhhc----CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeec
Q 003158 582 -QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 656 (843)
Q Consensus 582 -~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 656 (843)
.++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543 2246888999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhc
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 735 (843)
|+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||....+ .+...
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~----- 226 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYD----- 226 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHH-----
Confidence 999865432211 01112234678999999988899999999999999999999 8888865432 11111
Q ss_pred ccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
.+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 ----YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2222333345566778899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=316.51 Aligned_cols=258 Identities=25% Similarity=0.407 Sum_probs=212.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 7999999988632 2223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 587 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 587 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||+++|+|.+++... ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998652 3345889999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||............ ....+
T Consensus 159 ~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 223 (267)
T cd08224 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------KIEKC 223 (267)
T ss_pred CC-------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh--------hhhcC
Confidence 21 1112345788999999999888999999999999999999999999654321111111 11122
Q ss_pred CCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 745 NMGSYPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 745 ~~~~~~~-~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
.....+. .++..+.+++.+||..+|++||++.++++.++.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2333333 66778999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.44 Aligned_cols=261 Identities=26% Similarity=0.484 Sum_probs=209.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 579 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 579 (843)
.++|.+.+.||+|+||.||+|... +...+|+|.+.... .....++.+|+++++.+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999752 23579999987542 23346788899999999 799999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC--------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 645 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl 645 (843)
+..++||||+++|+|.+++..+.. ..+++..++.++.|++.||+|||+++ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976421 34788999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcc
Q 003158 646 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 724 (843)
Q Consensus 646 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~ 724 (843)
++++.+||+|||.++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~- 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247 (307)
T ss_pred cCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-
Confidence 99999999999998765422110 11112234568999999999889999999999999999998 888886433
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 725 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
..+.... +........+..++.++.+++.+||..+|++||++.++++.|+.+...
T Consensus 248 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFKL---------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHH---------HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 2211111 111122234556678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=323.33 Aligned_cols=258 Identities=30% Similarity=0.484 Sum_probs=207.0
Q ss_pred CCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
+|++.+.||+|+||.||+|... ....+|+|.+..... ....++.+|+++++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235799998875433 334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC----------------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCc
Q 003158 585 VYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 642 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~N 642 (843)
||||+.+|+|.+++.... ..++++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 135788899999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCC
Q 003158 643 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 721 (843)
Q Consensus 643 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~ 721 (843)
|++++++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999765322110 01122345678999999998899999999999999999999 9988864
Q ss_pred CcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 722 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.. ..+.... . ........+..++.++.+++..||+.+|++||++.++++.|+++..
T Consensus 233 ~~-~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 233 IA-PERLFNL-L--------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CC-HHHHHHH-H--------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 43 2221111 1 1111223355667789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.80 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=200.1
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999964 78999999876433 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~ 151 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-----AS 151 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-----cc
Confidence 99996543 35789999999999999999999999 99999999999999999999999999875432110 00
Q ss_pred eeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHH
Q 003158 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 753 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (843)
......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... .+........+..+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~--------~~~~~~~~~~~~~~ 221 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TRE--------AIEQGVRLPCPELC 221 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHH--------HHHcCCCCCCcccC
Confidence 0011123457999999999889999999999999999998 888886443211 111 11111222345566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 754 VEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 754 ~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
+..+.+++.+|++.+|++||++.++.+.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=324.36 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=209.7
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 578 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 578 (843)
....++|...+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+++++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344567999999999999999999741 34589999987543 23346789999999999 79999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
.+..++||||+++|+|.++++......+++.++..++.|++.||+|||+++ |+|+||||+||+++.++.++++|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999997655445899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||........... ...
T Consensus 188 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-~~~--- 258 (302)
T cd05055 188 ARDIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-LIK--- 258 (302)
T ss_pred cccccCCCc-----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-HHH---
Confidence 976542210 011122345678999999999999999999999999999998 9999875432211111 111
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
.+.....+...++++.+++.+|++.+|++||++.++++.|++.
T Consensus 259 -----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 -----EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111122334467899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.06 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=208.9
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+..++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+++++.++|+||+++++++.+ ...++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3456888999999999999999998778889999887532 334678899999999999999999999887 78899999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999997765566888999999999999999999998 99999999999999999999999999976542211
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......++..|+|||++....++.++|+|||||++||+++ |+.||...... +.... +..+..
T Consensus 158 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~---------~~~~~~ 221 (260)
T cd05073 158 ------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRA---------LERGYR 221 (260)
T ss_pred ------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHH---------HhCCCC
Confidence 11122345678999999998889999999999999999999 89898754321 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
...+...+.++.+++.+||+.+|++||++.++...|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22334566788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=336.81 Aligned_cols=203 Identities=27% Similarity=0.318 Sum_probs=173.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999965 68899999986422 122345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997632 35788899999999999999999999 9999999999999999999999999997654321
Q ss_pred CCCcccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 ------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 111233569999999999876 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.04 Aligned_cols=288 Identities=26% Similarity=0.410 Sum_probs=226.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457788899999999999999863 443 578998875432 2345788999999999999999999998654 567
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999986543 35788899999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... +.......
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~-------- 225 (303)
T cd05110 161 GDEK-----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE-------- 225 (303)
T ss_pred Cccc-----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH--------
Confidence 2211 111122345678999999999999999999999999999998 8899865321 11111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
.+.....+..++..+.+++..||..+|++||++.++++.++.+.+.. .+.+...+++|+.+...-.|||
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 294 (303)
T cd05110 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP-----------QRYLVIQGDDRMKLPSPNDSKF 294 (303)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch-----------hhheeeccCCcCCCCCCchhhH
Confidence 11112223445678899999999999999999999999998864321 2346778999999999999999
Q ss_pred ccCCCC
Q 003158 823 VSSDVS 828 (843)
Q Consensus 823 f~~~~~ 828 (843)
|..-..
T Consensus 295 ~~~~~~ 300 (303)
T cd05110 295 FQNLLD 300 (303)
T ss_pred Hhcccc
Confidence 987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.20 Aligned_cols=249 Identities=30% Similarity=0.484 Sum_probs=204.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeee-ecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV~e~ 588 (843)
..+|++.+.||+|+||.||+|... |+.||+|...... ..+.+.+|+.++++++|+|++++++++ ...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357888999999999999999864 7789999986432 346789999999999999999999976 455678999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999998766556889999999999999999999998 9999999999999999999999999987543211
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+.... +..+...
T Consensus 157 --------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~~~~---------~~~~~~~ 218 (256)
T cd05082 157 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPR---------VEKGYKM 218 (256)
T ss_pred --------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH---------HhcCCCC
Confidence 12234567999999998889999999999999999998 999986432 1111111 1111122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
..++.++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 3345667889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.33 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=201.9
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|+..+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3677889999999999999995 47899999998654 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997653 3677888899999999999999999 999999999999999999999999999754321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-------------------~ 203 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-------------------L 203 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-------------------c
Confidence 122346889999999999999999999999999999999999999642210000 0
Q ss_pred CCHHHHHHHHHHHHHhcc-cCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 749 YPSECVEKFIKLALKCCQ-DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~-~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
.+ ... ..|+. .++...|. ...+....+++.+|+..||++||+++|+++||||..-.
T Consensus 204 ~~----~~~----~~~~~~~~~~~~~~---------------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 204 MP----LQL----LQCIVDEDPPVLPV---------------GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred ch----HHH----HHHHhccCCCCCCC---------------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 00 000 01111 11111100 01122344788889999999999999999999998765
Q ss_pred CC
Q 003158 828 SG 829 (843)
Q Consensus 828 ~~ 829 (843)
.+
T Consensus 261 ~~ 262 (279)
T cd06619 261 DG 262 (279)
T ss_pred Cc
Confidence 54
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=314.79 Aligned_cols=247 Identities=29% Similarity=0.488 Sum_probs=201.2
Q ss_pred CcccccCCeeEEEEEeCCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHH
Q 003158 517 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 595 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 595 (843)
+.||+|+||.||+|...+++.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999875433 23457889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCccccee
Q 003158 596 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675 (843)
Q Consensus 596 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 675 (843)
+++.... ..+++..++.++.|++.||.|+|+.+ ++||||||+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------~~ 150 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------SS 150 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc------cc
Confidence 9986543 35789999999999999999999998 99999999999999999999999999875432110 01
Q ss_pred eeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHH
Q 003158 676 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754 (843)
Q Consensus 676 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (843)
.....++..|+|||++.+..++.++||||||+++||+++ |..||...... .... .+..+.....+..++
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~~~~---------~~~~~~~~~~~~~~~ 220 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QARE---------QVEKGYRMSCPQKCP 220 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH---------HHHcCCCCCCCCCCC
Confidence 112234568999999998899999999999999999999 99999654321 1111 111112223345567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 755 EKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 755 ~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
..+.+++.+|+..+|++||++.++.+.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 88999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.13 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=211.8
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhh--HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.-|...+.||+|.|..|-.|++ -.|..||||++.+..... ...+.+|+++|+.++|||||++|++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999984 489999999998754433 4578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE-cCCCcEEEeeccccccCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DfGla~~~~~~~ 666 (843)
.-++|+|.|||-++. ..+.+....+++.||+.|+.|+|+.. +|||||||+||.+ .+-|-|||.|||++..+.
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 999999999997654 35889999999999999999999999 9999999999876 567899999999997665
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCc-hhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
+....+..+|+..|-|||++.+..|+. ++||||+||+||.|++|+.||....+-+. +
T Consensus 171 -----PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------L------- 228 (864)
T KOG4717|consen 171 -----PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------L------- 228 (864)
T ss_pred -----CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------h-------
Confidence 345567788999999999999998875 68999999999999999999976543111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
-.|+.|--.-| .....+..|||.+||+-||++|.|.+|+..|+|++.
T Consensus 229 -------------TmImDCKYtvP--------------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 229 -------------TMIMDCKYTVP--------------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred -------------hhhhcccccCc--------------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 12233322111 011223347888899999999999999999999987
Q ss_pred CCCC
Q 003158 826 DVSG 829 (843)
Q Consensus 826 ~~~~ 829 (843)
.+.|
T Consensus 276 ~D~~ 279 (864)
T KOG4717|consen 276 GDRG 279 (864)
T ss_pred CCCC
Confidence 6654
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.85 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=208.2
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 6899999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+++.......+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--- 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc---
Confidence 9999999987655566889999999999999999999999 9999999999999999999999999987654221
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .... .+..+.....
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~~~~ 220 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-NLIL---------KVCQGSYKPL 220 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-HHHH---------HHhcCCCCCC
Confidence 1123346888999999999988999999999999999999999999754321 1111 1222333344
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
+..++..+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 55667788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=318.23 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=207.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+++..|+++++.++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999964 33 379999987543 3335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 45889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.... .........+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.... +..
T Consensus 160 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~---------i~~ 225 (268)
T cd05063 160 DPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKA---------IND 225 (268)
T ss_pred cccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHH---------Hhc
Confidence 2110 111111223457999999998889999999999999999998 9999965432 111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
....+.+.+++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 122233445677889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.91 Aligned_cols=265 Identities=28% Similarity=0.421 Sum_probs=205.2
Q ss_pred CC-CCCCcccccCCeeEEEEEe-----CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecC--CcE
Q 003158 512 NF-NSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 582 (843)
Q Consensus 512 ~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 582 (843)
+| +..+.||+|+||+||++.. .+++.||+|.+..... ...+.+.+|+++++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7889999999999988653 3578999999875432 3456788999999999999999999988653 468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++... .+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999999653 4899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHH-Hh---hcccc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI-AY---QSSMM 738 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~-~~---~~~~~ 738 (843)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+............ .. .....
T Consensus 158 ~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 158 PEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred CCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 432110 01112223566799999999888999999999999999999999998654321111000 00 00001
Q ss_pred hhhcc-CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 739 FSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 739 ~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
....+ ....+.+..++..+.+++.+||+.+|.+||+++++++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111 1122335566789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.43 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=200.5
Q ss_pred CCCCCcccccCCeeEEEEEeCC-Cc--EEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC------Cc
Q 003158 513 FNSSTQIGQGGYGKVYKGILPD-GT--VVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GE 581 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 581 (843)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999754 33 6899988753 233456788999999999999999999987432 25
Q ss_pred EEEEEecCCCCCHHHHHhhc----CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 582 QMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 2345789999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 736 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~ 736 (843)
+++....... ........+++.|+|||...+..++.++|||||||++|||++ |+.||..... .+...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~------ 225 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYD------ 225 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH------
Confidence 9986543221 011122345678999999999999999999999999999999 7888865432 11111
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
.+..+.....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 ---YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112222233445677899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=311.79 Aligned_cols=271 Identities=22% Similarity=0.314 Sum_probs=220.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHH---HHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|+.+++||+|.||+|-.++- ..++.+|+|++++....... .-..|-++|+..+||.+..+.-.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46778889999999999999995 47999999999876544433 346788999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||..||.|.-++.+. ..+++...+.+...|..||.|||+++ ||.||||.+|.|+|.+|.+||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence 9999999999988664 35888888899999999999999998 9999999999999999999999999997432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.........+|||.|+|||++....|+.++|+|.+||++|||++|+.||...++
T Consensus 320 -----~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------------------- 373 (516)
T KOG0690|consen 320 -----KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------------------- 373 (516)
T ss_pred -----cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---------------------
Confidence 224456678999999999999999999999999999999999999999975432
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----CCccCCCC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKH 820 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~-----sa~e~L~H 820 (843)
+.+.++|..|=-+-| ...++++..++..+|..||++|. .|.|+.+|
T Consensus 374 ---------~kLFeLIl~ed~kFP--------------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 374 ---------EKLFELILMEDLKFP--------------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---------hHHHHHHHhhhccCC--------------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 223333333211111 12234445667777777888885 46889999
Q ss_pred CcccCCCCCCccccccCCCCCC
Q 003158 821 PYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 821 p~f~~~~~~~~~~~~~~~~~~~ 842 (843)
+||.+..+.-...-...|||+|
T Consensus 425 ~FF~~v~W~~~~~Kki~PPfKP 446 (516)
T KOG0690|consen 425 RFFASVDWEATYRKKIEPPFKP 446 (516)
T ss_pred hhhccCCHHHHHHhccCCCCCC
Confidence 9999988876666678888888
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=321.19 Aligned_cols=267 Identities=28% Similarity=0.435 Sum_probs=206.0
Q ss_pred cCCCCCCcccccCCeeEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec--CCcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 583 (843)
.+|++.+.||+|+||+||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788889999999999999974 2578999999987666666789999999999999999999998743 35689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999996542 35889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchH-HHHHHHhh-c---ccc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REVNIAYQ-S---SMM 738 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~-~~~~~~~~-~---~~~ 738 (843)
..... ........++..|+|||++.+..++.++|||||||++|||++|..++....... +....... . ..+
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 32110 001111223456999999998899999999999999999999877764332110 00000000 0 000
Q ss_pred hhhc-cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 739 FSVI-DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 739 ~~~~-~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
...+ .....+.+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111 1112233455677899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=327.19 Aligned_cols=210 Identities=26% Similarity=0.354 Sum_probs=177.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|+..+.||+|+||+||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999975 5899999998754332 3467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+.+++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999997665567899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CCCcc----------------------cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIV----------------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
..... .........|+..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10000 0001123467889999999999889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.36 Aligned_cols=257 Identities=32% Similarity=0.503 Sum_probs=207.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|++.+.||+|+||.||+|... ++..||+|.+..... ...+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 567899999999999999999853 467899999875432 3356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC--------------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCc
Q 003158 583 MLVYEFMSNGTLRDQLSAKS--------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 642 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~N 642 (843)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996432 124678889999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCC
Q 003158 643 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISH 721 (843)
Q Consensus 643 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~ 721 (843)
|++++++.++|+|||+++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999998754322110 11112234567999999999999999999999999999998 8888865
Q ss_pred CcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 722 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
... .+... .+..+.....+..++.++.+++.+||+.+|.+||++.++++.|++
T Consensus 236 ~~~-~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 236 MAH-EEVIY---------YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCH-HHHHH---------HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 432 11111 112222223345567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=308.69 Aligned_cols=295 Identities=23% Similarity=0.333 Sum_probs=212.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC-Chh-hHHHHHHHHHHHHhccCCcccceeeeeec--------C
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------E 579 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~ 579 (843)
+.|+...+||+|.||.||+|+.. .|+.||+|+.--. ... -.....+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666788999999999999965 5788999865421 111 23467899999999999999999998843 2
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
..+++||++|+. +|.-++... ...++..++.+++.++..||.|+|+.. |+|||+||+|+|++.+|.+||+|||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 358999999976 888888543 345888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
+.+...+... ....+..+.|..|++||.+.+ ..|+++.|||+-||++.||+||.+-+....+ .+++..
T Consensus 172 r~fs~~~n~~---kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-qqql~~------- 240 (376)
T KOG0669|consen 172 RAFSTSKNVV---KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-QQQLHL------- 240 (376)
T ss_pred cceecccccC---CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-HHHHHH-------
Confidence 8765443221 222456677999999999997 5799999999999999999999776665443 222222
Q ss_pred hhhccCCCCCCCHHHHHHHHHHH-HHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLA-LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
+....+....+.++.+.++- ..-++..|--.-+...+-..++ .+ ..++.+.|++.+||++||.+|+.|+++
T Consensus 241 ---Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k----p~-~kd~~a~dLle~ll~~DP~kR~~ad~a 312 (376)
T KOG0669|consen 241 ---ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK----PY-VKDDEALDLLEKLLKLDPTKRIDADQA 312 (376)
T ss_pred ---HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcc----cc-cCChhHHHHHHHHhccCcccCcchHhh
Confidence 11112222222222221110 0011112211112222222222 11 236678899999999999999999999
Q ss_pred CCCCcccCCCCC
Q 003158 818 LKHPYVSSDVSG 829 (843)
Q Consensus 818 L~Hp~f~~~~~~ 829 (843)
|+|.||..|..-
T Consensus 313 lnh~~F~kdp~p 324 (376)
T KOG0669|consen 313 LNHDFFWKDPMP 324 (376)
T ss_pred hchhhhhcCCcc
Confidence 999999887653
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.83 Aligned_cols=282 Identities=23% Similarity=0.379 Sum_probs=204.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh-HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+++++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999864 68999999987543222 3467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+. +++.+++.... ..+.+..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 995 68877765432 34678888899999999999999998 9999999999999999999999999987543221
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......+.....+. . .
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~------~----~ 221 (291)
T cd07870 158 ------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT------V----L 221 (291)
T ss_pred ------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH------H----c
Confidence 11122346889999999876 45788999999999999999999999765443332222110 0 0
Q ss_pred CCCCHHHHHHHHHHHH---HhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 747 GSYPSECVEKFIKLAL---KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~---~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
+.........+..+-. ..+... .++... ....... ......+++.+|+..||++|+|++|++.||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~-~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 222 GVPTEDTWPGVSKLPNYKPEWFLPC--KPQQLR-------VVWKRLS-RPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred CCCChhhhhhhhhcccccchhcccc--CCcchh-------hhccccC-CChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0011111111110000 000000 011111 1111111 13455689999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=329.91 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=205.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeecC-
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE- 579 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~- 579 (843)
..++|++.+.||+|+||+||+|.+ .+++.||||+++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456899999999999999999973 3478999999975432 2345788999999999 689999999988654
Q ss_pred CcEEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKS--------------------------------------------------------- 602 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 602 (843)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56799999999999999986432
Q ss_pred --------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 603 --------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 603 --------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
...+++..+..++.||++||+|||+++ |+||||||+||++++++.+||+|||++........ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~ 236 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YV 236 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc-----hh
Confidence 123677888899999999999999998 99999999999999999999999999976432110 01
Q ss_pred eeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHH
Q 003158 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 753 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (843)
......++..|+|||.+.+..++.++|||||||++|||++ |..||......... ... +..+.....|...
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~--------~~~~~~~~~~~~~ 307 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CRR--------LKEGTRMRAPDYT 307 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-HHH--------HhccCCCCCCCCC
Confidence 1112335678999999999899999999999999999997 88998654321111 111 1111222233334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 754 VEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 754 ~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+++.+++..||+.+|.+||++.++++.|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=351.13 Aligned_cols=270 Identities=25% Similarity=0.357 Sum_probs=208.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.++||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 68999999987532 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcC---------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 587 EFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
||++||+|.+++.... ....++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 123556778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCCCc-----------ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchH
Q 003158 658 LSRLAPVPDIEGI-----------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 726 (843)
Q Consensus 658 la~~~~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~ 726 (843)
+++.......... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986622110000 00011123469999999999999999999999999999999999999997533211
Q ss_pred HHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhhCCC
Q 003158 727 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPE 791 (843)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~vl~~L~~~~~~~~~ 791 (843)
.... . ....+.......+.+..+.+++.+|+..+|++|| +++++.+.|+.+....++
T Consensus 239 i~~~-----~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 ISYR-----D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred hhhh-----h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 0000 0 0111111111234567788999999999999995 667788888887654443
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.76 Aligned_cols=198 Identities=26% Similarity=0.438 Sum_probs=174.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 689999999875322 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999765 45888999999999999999999998 999999999999999999999999998765422
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 123458899999999988888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=315.88 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=209.7
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|.. .+++.||||.+.... ....+++.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999995 578999999876422 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 587 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 587 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||+++++|.+++.. .....+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999864 22346889999999999999999999999 99999999999999999999999999876542
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.. .......++..|+|||.+.+..++.++||||||+++|||++|..||............ .+...
T Consensus 159 ~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 223 (267)
T cd08229 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------KIEQC 223 (267)
T ss_pred CC-------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--------hhhcC
Confidence 21 1112345888999999999888999999999999999999999999654321111111 11111
Q ss_pred CCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 745 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 745 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
..+. .+..+++.+.+++.+||..+|++||++.++++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1222 2345778899999999999999999999999988865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=318.61 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=193.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999996 47899999998765444456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.++++.. .++++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 9999999998654 35788999999999999999999998 9999999999999999999999999997653211
Q ss_pred CcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||........... . ........
T Consensus 161 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~----~--~~~~~~~~ 229 (267)
T cd06646 161 -----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL----M--SKSNFQPP 229 (267)
T ss_pred -----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee----e--ecCCCCCC
Confidence 1112345788999999985 34578899999999999999999999864432111000 0 00000000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
.......++..+.+++.+||..+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 00111223455666666666666666666666553
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.88 Aligned_cols=260 Identities=23% Similarity=0.393 Sum_probs=206.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeCC-CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+-|.++..||.|+||+||+|..++ +-..|.|++...+.+...+|.-||+||....||+||++++.|..++.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345567789999999999999654 5566788888777777789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
.||-.+.++-.-+ .++.+.++..++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+.....
T Consensus 112 ~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~----- 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS----- 182 (1187)
T ss_pred CCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-----
Confidence 9999999886643 46899999999999999999999999 99999999999999999999999999864321
Q ss_pred cccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.........|||+|||||+.+. .+|++++||||||++|.||..+.+|...-....- + ..+...
T Consensus 183 --t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-l---------lKiaKS 250 (1187)
T KOG0579|consen 183 --TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-L---------LKIAKS 250 (1187)
T ss_pred --HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-H---------HHHhhc
Confidence 1233456789999999999864 5799999999999999999999888754332111 0 011111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
+| |+.. ....++..+.||+.++|.-||..||+|+|+|+||||+
T Consensus 251 -----------------------eP---PTLl-----------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 251 -----------------------EP---PTLL-----------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred -----------------------CC---Cccc-----------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 11 1111 1123344455677777777888888999999999998
Q ss_pred CCCC
Q 003158 825 SDVS 828 (843)
Q Consensus 825 ~~~~ 828 (843)
+...
T Consensus 294 ~~~S 297 (1187)
T KOG0579|consen 294 NAPS 297 (1187)
T ss_pred cCCc
Confidence 6544
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.39 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=204.0
Q ss_pred ccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
||+|+||+||+|... +|+.||+|.+..... ...+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 689999999865322 2244667899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
.+++.......+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+...... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--------~ 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--------K 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--------C
Confidence 99997766557899999999999999999999999 999999999999999999999999998765321 1
Q ss_pred eeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHH
Q 003158 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (843)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||............ ...........+..
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~~-- 220 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------KRRTLEMAVEYPDK-- 220 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-------HhccccccccCCcc--
Confidence 112345778999999999888999999999999999999999999654321100000 00000000001111
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----CCccCCCCCcccCCCCC
Q 003158 755 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKHPYVSSDVSG 829 (843)
Q Consensus 755 ~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~-----sa~e~L~Hp~f~~~~~~ 829 (843)
.++...+++.+||+.||++|+ ++.++++||||....+.
T Consensus 221 -------------------------------------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 221 -------------------------------------FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred -------------------------------------CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 123334677777777888888 77779999999876664
Q ss_pred CccccccCCCCCC
Q 003158 830 SNLVSGVIPTITP 842 (843)
Q Consensus 830 ~~~~~~~~~~~~~ 842 (843)
.-.....+|++.|
T Consensus 264 ~~~~~~~~~~~~~ 276 (277)
T cd05577 264 RLEAGMLEPPFIP 276 (277)
T ss_pred hhhcCCCCCCCCC
Confidence 3333334566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.01 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=204.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCc--EEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++... ....+++.+|++++.++ +|+||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999964 454 46888776432 33456788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc
Q 003158 585 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 650 (843)
||||+++|+|.++++... ...+++..++.++.|+++||+|||+++ |+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 125788899999999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 729 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~ 729 (843)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||...... +..
T Consensus 163 ~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELY 233 (303)
T ss_pred EEeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHH
Confidence 999999998642210 00111224567999999988889999999999999999998 99998654321 111
Q ss_pred HHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 730 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.. ...+.....+..++..+.+++.+||+.+|++||++.++++.++++..
T Consensus 234 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EK---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HH---------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 11111122334456678999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=323.95 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=208.0
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999985 578999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999998543 4789999999999999999999999 9999999999999999999999999987643221
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||........... .... .......
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-~~~~-------~~~~~~~ 237 (296)
T cd06655 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATN-------GTPELQN 237 (296)
T ss_pred ----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc-------CCcccCC
Confidence 111234578899999999988899999999999999999999999976543211110 0000 0000001
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCCC
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 829 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~~ 829 (843)
+..++. ...+++.+|+..||++|+|+++++.||||..-...
T Consensus 238 ~~~~~~---------------------------------------~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~ 278 (296)
T cd06655 238 PEKLSP---------------------------------------IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278 (296)
T ss_pred cccCCH---------------------------------------HHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccc
Confidence 111111 22346667777788888888888888888876665
Q ss_pred Ccccccc
Q 003158 830 SNLVSGV 836 (843)
Q Consensus 830 ~~~~~~~ 836 (843)
+.+..+.
T Consensus 279 ~~~~~~~ 285 (296)
T cd06655 279 SSLTPLI 285 (296)
T ss_pred ccCCccc
Confidence 5555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.44 Aligned_cols=266 Identities=25% Similarity=0.480 Sum_probs=211.6
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeee
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGY 575 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 575 (843)
+.+...+|++.+.||+|+||.||+|... .+..||+|.+.... ....+++.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4455567999999999999999999742 12368999887533 23356789999999999 79999999999
Q ss_pred eecCCcEEEEEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCC
Q 003158 576 CDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 641 (843)
Q Consensus 576 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~ 641 (843)
|.+.+..++||||+++|+|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999997532 234788889999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 003158 642 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPIS 720 (843)
Q Consensus 642 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~ 720 (843)
||++++++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999976542211 011122334567999999999999999999999999999998 888886
Q ss_pred CCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 721 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
... ..+.... +..+.....+..++.++.+++.+||+.+|.+||++.+++..|+.+....
T Consensus 239 ~~~-~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 239 GIP-VEELFKL---------LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCC-HHHHHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 543 2221111 1112222334556778999999999999999999999999999887533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=316.73 Aligned_cols=258 Identities=28% Similarity=0.462 Sum_probs=206.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-C---CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
..+|++.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999863 2 3479999987543 2335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999997643 35788999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.... ........++..|+|||.+.+..++.++|||||||++||+++ |..||...... +.... +.+
T Consensus 159 ~~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~---------~~~ 224 (267)
T cd05066 159 DPEA----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKA---------IEE 224 (267)
T ss_pred ccce----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHH---------HhC
Confidence 2110 011112223568999999999899999999999999999887 99999754321 11111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
+...+.+..++..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111223445667889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.87 Aligned_cols=289 Identities=21% Similarity=0.313 Sum_probs=213.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------ 579 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 579 (843)
..++|+..+.||+|+||.||+|... +++.||+|.+... .....+++.+|+++++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 7899999998643 223345678899999999999999999988543
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 5888887542 788889999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
+...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ....
T Consensus 166 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~------- 229 (353)
T cd07850 166 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKI------- 229 (353)
T ss_pred eeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHH-------
Confidence 8654221 12234578899999999999999999999999999999999999976543222 2111
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhh---CCCCCCCCCccccCCCCCCCCCCCCCc
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNM---MPESDTKTPEFINSEHTSKEETPPSSS 815 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~vl~~L~~~~~~---~~~~~~~~~dll~~~L~~dp~~R~sa~ 815 (843)
....+..+.++...+...........+..++ .+.++.......... .......+.+++.+||++||++|||++
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 230 ---IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred ---HHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 1112333445544444333333333332221 222221110000000 001123356899999999999999999
Q ss_pred cCCCCCccc
Q 003158 816 SMLKHPYVS 824 (843)
Q Consensus 816 e~L~Hp~f~ 824 (843)
|+|.||||.
T Consensus 307 eiL~~~~~~ 315 (353)
T cd07850 307 DALQHPYIN 315 (353)
T ss_pred HHhcChhHh
Confidence 999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.88 Aligned_cols=284 Identities=24% Similarity=0.328 Sum_probs=205.1
Q ss_pred CCCCCCcccccCCeeEEEEEeC---CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecC--CcEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP---DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQM 583 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 583 (843)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999964 47999999988632 22345678899999999999999999999887 7899
Q ss_pred EEEecCCCCCHHHHHhhcC---CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC----CCcEEEeec
Q 003158 584 LVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH----KFTAKVADF 656 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~Df 656 (843)
+||||++ +++.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777765322 236889999999999999999999999 999999999999999 999999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhc
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~ 735 (843)
|++......... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .
T Consensus 157 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~-~---- 227 (316)
T cd07842 157 GLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS-N---- 227 (316)
T ss_pred ccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc-c----
Confidence 999865432210 111223457889999999876 457899999999999999999999997543211000 0
Q ss_pred ccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH----------------HHHHHhhhhCCCCCCCCCcc
Q 003158 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM----------------RELESIWNMMPESDTKTPEF 799 (843)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl----------------~~L~~~~~~~~~~~~~~~dl 799 (843)
......+.+++..+-...+..++.+.+.. ..+..........+....++
T Consensus 228 ---------------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (316)
T cd07842 228 ---------------PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292 (316)
T ss_pred ---------------hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence 00001111111111111111111111000 01111111112445566789
Q ss_pred ccCCCCCCCCCCCCCccCCCCCcc
Q 003158 800 INSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 800 l~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
+.+||++||++|||++|+++||||
T Consensus 293 i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 293 LRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhcCCcccCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.59 Aligned_cols=287 Identities=25% Similarity=0.345 Sum_probs=207.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh--HHHHHHHHHHHHhccCCcccceeeeeecC--CcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 584 (843)
.++|++.+.||+|+||.||+|... +|+.||+|.+....... ...+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457899999999999999999964 68999999987433222 33567899999999999999999998654 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58988886533 46899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... +.......
T Consensus 161 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~--------- 223 (309)
T cd07845 161 PA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQ--------- 223 (309)
T ss_pred cc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH---------
Confidence 21 11122345788999999876 55789999999999999999999999755432 22111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
..+......++.+..+........+.... ..+...++...+...||+.+||.+||++|+|++|+++||||
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 224 -LLGTPNESIWPGFSDLPLVGKFTLPKQPY---------NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred -hcCCCChhhchhhhcccccccccccCCCC---------CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 01111111111111111100000010000 01111223335566789999999999999999999999999
Q ss_pred cCCCC
Q 003158 824 SSDVS 828 (843)
Q Consensus 824 ~~~~~ 828 (843)
.....
T Consensus 294 ~~~~~ 298 (309)
T cd07845 294 KEKPL 298 (309)
T ss_pred ccCCC
Confidence 75443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=323.59 Aligned_cols=198 Identities=36% Similarity=0.588 Sum_probs=172.3
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHH--HHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEK--EFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
|+..+.||+|+||+||++... +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999975 5779999999876544432 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++... ..+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---- 151 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST----
T ss_pred cccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc----
Confidence 999999999733 35899999999999999999999999 999999999999999999999999999754111
Q ss_pred cccceeeeeecccCCccCchhcc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
........++..|+|||++. +..++.++||||+|+++|+|++|..||...
T Consensus 152 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 ---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp ---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22334456889999999998 788999999999999999999999999765
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.72 Aligned_cols=283 Identities=27% Similarity=0.401 Sum_probs=208.9
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh-----hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-----GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+|+..+.||+|+||.||+|... +++.||+|.+...... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 6899999998754332 245677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+ +|+|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997644 36899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. .......+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+. +....... .
T Consensus 156 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~------~--- 218 (298)
T cd07841 156 N-------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE------A--- 218 (298)
T ss_pred C-------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH------H---
Confidence 1 11122346788999999865 46788999999999999999997776544332 21111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
..............+...+.. ...+... ....+........+++.+|+..||++|+|++|+++||||+
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 219 -LGTPTEENWPGVTSLPDYVEF---KPFPPTP--------LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred -cCCCchhhhhhcccccccccc---cccCCcc--------hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 001111111111111111111 0111110 0111223344566899999999999999999999999998
Q ss_pred CCCC
Q 003158 825 SDVS 828 (843)
Q Consensus 825 ~~~~ 828 (843)
+...
T Consensus 287 ~~~~ 290 (298)
T cd07841 287 NDPA 290 (298)
T ss_pred CCCC
Confidence 8554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=351.38 Aligned_cols=293 Identities=19% Similarity=0.241 Sum_probs=200.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCC--CcEEEEEEe--------------c---cCChhhHHHHHHHHHHHHhccCCcc
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRA--------------Q---EGSLQGEKEFLTEIQFLSRLHHRNL 569 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~nI 569 (843)
..++|++.+.||+|+||+||+|..+. +..+++|.+ . .........+.+|++++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987532 222222211 0 0111224567899999999999999
Q ss_pred cceeeeeecCCcEEEEEecCCCCCHHHHHhhcC---CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc
Q 003158 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD 646 (843)
Q Consensus 570 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~ 646 (843)
+++++++.+.+..++|+|++ .++|.+++.... ........++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 99999999999999999999 468887775432 112335567789999999999999999 99999999999999
Q ss_pred CCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCC-CCCCc-c
Q 003158 647 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGK-N 724 (843)
Q Consensus 647 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~p-f~~~~-~ 724 (843)
.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||++|..+ +.... .
T Consensus 302 ~~~~vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKER------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCEEEEeCCCceecCccc------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 99999999999998664321 1112235689999999999999999999999999999999998754 43222 2
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhhhCCCCCCCCCccccCC
Q 003158 725 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPESDTKTPEFINSE 803 (843)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~vl~~L~~~~~~~~~~~~~~~dll~~~ 803 (843)
...+........ ..... .+|+. ...+.+.+.. ......+ ....+++.+ .....+.+++.+|
T Consensus 376 ~~~~~~~~~~~~---~~~~~---~~p~~-~~~~~~~i~~---~~~~~~~~~~~~~~~~~--------~~~~~~~~li~km 437 (501)
T PHA03210 376 PGKQLLKIIDSL---SVCDE---EFPDP-PCKLFDYIDS---AEIDHAGHSVPPLIRNL--------GLPADFEYPLVKM 437 (501)
T ss_pred HHHHHHHHHHhc---ccChh---hcCCc-HHHHHHHhhh---hhcccCccchhhHHHhc--------CCChHHHHHHHHH
Confidence 222222211100 00111 11111 1112222111 1111111 222222211 1233456789999
Q ss_pred CCCCCCCCCCCccCCCCCcccCCCCC
Q 003158 804 HTSKEETPPSSSSMLKHPYVSSDVSG 829 (843)
Q Consensus 804 L~~dp~~R~sa~e~L~Hp~f~~~~~~ 829 (843)
|++||++||||+|+|.||||+.....
T Consensus 438 L~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 438 LTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred hccCcccCcCHHHHhhChhhhcCCch
Confidence 99999999999999999999876543
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.76 Aligned_cols=279 Identities=24% Similarity=0.366 Sum_probs=207.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999975 689999998864322 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|..++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888877543 35889999999999999999999998 99999999999999999999999999986643221
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||................. ..+.
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~--- 222 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG---DLIP--- 222 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC---CCCh---
Confidence 1123457789999999876 5578899999999999999999999976543221111000000 0000
Q ss_pred CCCCHHHHHHHHH---HHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 747 GSYPSECVEKFIK---LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 747 ~~~~~~~~~~l~~---l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
. ...... .........+..++.... .++..+....+|+.+|+..||++|||+.|++.||||
T Consensus 223 -----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 223 -----R-HQQIFSTNQFFKGLSIPEPETREPLES----------KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred -----H-HhhhcccccccccccCCCcccccCHHH----------HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 000000 000000111222222211 122334556789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.72 Aligned_cols=250 Identities=26% Similarity=0.458 Sum_probs=195.5
Q ss_pred CCcccccCCeeEEEEEeC-CCcEEEEEEec---c-CChhhHHHHHHHHHHHHhccCCcccceeeeeecCC--cEEEEEec
Q 003158 516 STQIGQGGYGKVYKGILP-DGTVVAVKRAQ---E-GSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLVYEF 588 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~---~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~e~ 588 (843)
..+||+|+|-+||||.+. +|..||---++ . ......++|..|+.+|+.|+|+||+++++++.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999975 57777632222 1 13334578999999999999999999999997655 47899999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~ 667 (843)
|..|+|+.|.++.+. ++...++.|++||++||.|||++ +|||||||||-+||+|+. -|.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 999999999987654 77788999999999999999997 589999999999999985 589999999999876532
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
....+.|||.|||||... ..|++.+||||||++++||+|+..||..-.+..+..++ ++.|..+
T Consensus 200 -------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK---------V~SGiKP 262 (632)
T KOG0584|consen 200 -------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK---------VTSGIKP 262 (632)
T ss_pred -------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH---------HHcCCCH
Confidence 234478999999999987 78999999999999999999999999866554443332 2222211
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
. .+. ...++++.+||.+||.. .++|+||.|+|.||||..+
T Consensus 263 ---~----sl~-------------------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 263 ---A----ALS-------------------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ---H----Hhh-------------------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 0 000 11233444566666666 7788899999999999886
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=316.50 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=208.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|.+.+.||+|+||.||+|...+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3567888999999999999998643 3579999887654 3445688999999999999999999999875 56789
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999996543 35899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
... .......++..|+|||.+....++.++|||||||++||+++ |+.||......... . .+..
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~---------~~~~ 223 (270)
T cd05056 160 ESY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-G---------RIEN 223 (270)
T ss_pred ccc------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-H---------HHHc
Confidence 211 11122234568999999988889999999999999999996 99999765432111 1 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+.....+..++..+.+++.+|+..+|.+||++.+++..|+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 22223455667889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.72 Aligned_cols=258 Identities=27% Similarity=0.439 Sum_probs=205.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.++|+..+.||+|+||+||+|.+. +++ .||+|++.... ....+++.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457888999999999999999853 444 48999987543 3345678899999999999999999999975 4578
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
++|||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997543 35889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... ........++..|+|||...+..++.++|||||||++|||++ |..||....... .... +.
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~--------~~ 225 (279)
T cd05109 161 IDET-----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDL--------LE 225 (279)
T ss_pred cccc-----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH--------HH
Confidence 3211 011112235678999999999999999999999999999998 888886543211 1111 11
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+.....+..++..+.+++.+||..+|++||++.++++.++.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111223344567788999999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.13 Aligned_cols=204 Identities=29% Similarity=0.441 Sum_probs=173.7
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh-----hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL-----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++|.+.+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999996 4689999998864321 123568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999986543 4788889999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.... ........++..|+|||.+.+..++.++||||+||++|||++|+.||....
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 157 ICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred cccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 1100 011123457789999999999889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.56 Aligned_cols=281 Identities=25% Similarity=0.355 Sum_probs=207.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecC--CcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV 585 (843)
++|+..+.||+|+||.||+|..+ +++.||+|.++..... ....+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999975 6899999998754322 234577899999999999999999998776 899999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 59999986643 36899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. .......+++.|+|||.+.+. .++.++|+||+||++|||++|+.||....... ...... .
T Consensus 160 ~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~----------~ 221 (293)
T cd07843 160 L-------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIF----------K 221 (293)
T ss_pred c-------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH----------H
Confidence 1 111234577899999998764 46889999999999999999999997554321 111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCC--CCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES--DTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~--~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
..+...+..++.+.++...- .....++....+ ...++.. .+...+++++||+.||++|||++|+|.|||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAK--KKTFTKYPYNQL-------RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred HhCCCchHHHHHhhccchhc--ccccccccchhh-------hccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 11111122222221111000 000111111111 1222322 555678999999999999999999999999
Q ss_pred c
Q 003158 823 V 823 (843)
Q Consensus 823 f 823 (843)
|
T Consensus 293 f 293 (293)
T cd07843 293 F 293 (293)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=321.02 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=202.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC---------------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCccccee
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD---------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLV 573 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~ 573 (843)
.++|++.+.||+|+||.||+|...+ ...||+|.+.... ......+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578999999999999999987532 2358999987543 23346789999999999999999999
Q ss_pred eeeecCCcEEEEEecCCCCCHHHHHhhcC----------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcE
Q 003158 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 643 (843)
Q Consensus 574 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NI 643 (843)
+++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986532 123678889999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh--CCCCCCC
Q 003158 644 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPISH 721 (843)
Q Consensus 644 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt--g~~pf~~ 721 (843)
++++++.+||+|||++........ ........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999976532211 111122345678999999999899999999999999999998 6667764
Q ss_pred CcchH--HHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 722 GKNIV--REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 722 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
..... ......+.. .........+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRN-----QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhh-----ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 33211 111110000 0001111223345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.81 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=201.9
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 444567999999999999964 6899999998765555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||++++++.++|+|||++.......
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 9999988542 4788999999999999999999998 9999999999999999999999999987543211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCH
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (843)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~---------------------- 227 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-M---------------------- 227 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H----------------------
Confidence 111234588999999999988899999999999999999999999965432110 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCCCC
Q 003158 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSGS 830 (843)
Q Consensus 752 ~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~~~ 830 (843)
..+............ .......+++.+|+..||++|||++|+++||||......+
T Consensus 228 -------~~~~~~~~~~~~~~~-----------------~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 228 -------RRIRDNLPPRVKDSH-----------------KVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred -------HHHHhcCCCcccccc-----------------ccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 001111110000000 0111223567778888999999999999999998765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=328.70 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=205.7
Q ss_pred cccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHHH
Q 003158 518 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD 596 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 596 (843)
+||+|.||+||.|++. +...+|||-+.....+..+-+..|+.+-++++|.|||+++|.|.++++.-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6899999999999965 567899999886665556678899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCc--chhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-CCCcEEEeeccccccCCCCCCCCcccc
Q 003158 597 QLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPA 673 (843)
Q Consensus 597 ~l~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~ 673 (843)
+++.+ -.|+ .+.+.-.+.+||++||.|||+.. |||||||-+|||++ -.|.+||+|||.++.+..- .
T Consensus 662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-------n 730 (1226)
T KOG4279|consen 662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-------N 730 (1226)
T ss_pred HHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-------C
Confidence 99763 2345 77888889999999999999999 99999999999996 5789999999999876532 1
Q ss_pred eeeeeecccCCccCchhcccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCH
Q 003158 674 HVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751 (843)
Q Consensus 674 ~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (843)
..+....||..|||||++..+ .|+.++|||||||++.||.||++||..-.+...... .--+-...++.|+
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--------kVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--------KVGMYKVHPPIPE 802 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--------hhcceecCCCCcH
Confidence 234556799999999999864 588999999999999999999999975444322111 1112234567899
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 752 ECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 752 ~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
+.+.+...++.+|+.++|..||++.++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999999999874
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.11 Aligned_cols=263 Identities=28% Similarity=0.430 Sum_probs=206.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD-----------------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 571 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 571 (843)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999998542 2468999987543 334568899999999999999999
Q ss_pred eeeeeecCCcEEEEEecCCCCCHHHHHhhcC---------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCc
Q 003158 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS---------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 642 (843)
Q Consensus 572 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~N 642 (843)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997643 125889999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh--CCCCCC
Q 003158 643 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 720 (843)
Q Consensus 643 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt--g~~pf~ 720 (843)
|++++++.++|+|||+++.....+. ........++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999876543221 111223446778999999998889999999999999999998 677876
Q ss_pred CCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 721 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
....... ...... .....-.......+..++.++.+++.+|++.+|.+||++.++++.|+
T Consensus 236 ~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQV-IENAGH--FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHHH-HHHHHh--ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 5432111 111100 00000000111223445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.13 Aligned_cols=200 Identities=25% Similarity=0.426 Sum_probs=175.6
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788889999999999999995 468999999988655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 999999998543 4788899999999999999999999 9999999999999999999999999987643221
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......+++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 171 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred ----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11123458889999999998889999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=316.24 Aligned_cols=259 Identities=28% Similarity=0.470 Sum_probs=205.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
..|++.+.||+|+||.||+|... ++ ..||||.+.... ....+++..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34778899999999999999964 33 369999987542 33456899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999997543 35889999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
..... .........+..|+|||.+.+..++.++|||||||++||+++ |..||...... +.... +...
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~---------i~~~ 227 (269)
T cd05065 160 TSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINA---------IEQD 227 (269)
T ss_pred ccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHH---------HHcC
Confidence 21100 000011112457999999999999999999999999999987 99999754421 11111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
...+.+.+++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11233456677889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.35 Aligned_cols=203 Identities=31% Similarity=0.465 Sum_probs=172.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecC------C
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE------G 580 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~ 580 (843)
+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5677888999999999999999964 68899999987533 3446788999999998 799999999998643 4
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+++++|.+++.......+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 5899999999999999998755567899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 160 QLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred eccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 653211 1123456889999999986 345788999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.76 Aligned_cols=254 Identities=31% Similarity=0.501 Sum_probs=197.2
Q ss_pred CcccccCCeeEEEEEeC----CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeee-cCCcEEEEEecCC
Q 003158 517 TQIGQGGYGKVYKGILP----DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLVYEFMS 590 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV~e~~~ 590 (843)
+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2467999988643 2334567889999999999999999999775 4567899999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|.+++.... ....+..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~- 155 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS- 155 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee-
Confidence 999999997543 23567778889999999999999998 9999999999999999999999999997543211100
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhC-CCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
........++..|+|||.+.+..++.++|||||||++|||++| ..||.... ....... +..+.....
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~---------~~~~~~~~~ 223 (262)
T cd05058 156 --VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-SFDITVY---------LLQGRRLLQ 223 (262)
T ss_pred --ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH---------HhcCCCCCC
Confidence 0111233456789999999988999999999999999999995 44554332 2222111 122222233
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+..++..+.+++..||+.+|++||++.+++..++++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 44556789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.53 Aligned_cols=249 Identities=29% Similarity=0.482 Sum_probs=200.5
Q ss_pred CcccccCCeeEEEEEeC--C--CcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP--D--GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
++||+|+||.||+|.+. + +..||+|.+..... ...+++.+|+++++.+.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 36899999886544 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc---
Confidence 99999997654 5889999999999999999999998 999999999999999999999999999865432110
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.... . ........+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~-~--------~~~~~~~~~ 220 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAM-L--------ESGERLPRP 220 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHH-H--------HcCCcCCCC
Confidence 011112224568999999998899999999999999999998 99999754431 11111 1 111122345
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
..++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 56678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.82 Aligned_cols=249 Identities=30% Similarity=0.489 Sum_probs=198.2
Q ss_pred CcccccCCeeEEEEEeC-CCc--EEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||.||+|... ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 343 57888887432 33456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 592 GTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 592 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 124788999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 736 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~ 736 (843)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||..... .+....
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~----- 223 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEK----- 223 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHH-----
Confidence 98632210 00111224567999999988889999999999999999997 9999965432 111111
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
+..+.....+..++.++.+++.+||..+|.+||++.+++..|+++.
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 ----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111122234445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.11 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=203.6
Q ss_pred CcccccCCeeEEEEEeCC--C--cEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILPD--G--TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+++.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3699999987665 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999997754356899999999999999999999998 999999999999999999999999999876432210
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +....... .......+
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~--------~~~~~~~~ 223 (257)
T cd05040 154 -YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKKIDK--------EGERLERP 223 (257)
T ss_pred -eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh--------cCCcCCCC
Confidence 111123456788999999999899999999999999999999 99999654322 11111110 11112234
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 456678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.84 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=201.3
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|+..+.||+|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999985 468999999876532 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.......+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999997765566899999999999999999999998 99999999999999999999999999976543221
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
......+++.|+|||.+.+..++.++|||||||++|||++|..||..... .+... .+..+....
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~---------~~~~~~~~~ 220 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVV---------KIVQGNYTP 220 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHH---------HHHcCCCCC
Confidence 12334588999999999988899999999999999999999999965432 11111 112222223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
.+..++.++.+++.+||..+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 33445566777777777777777777776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.66 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=173.1
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec-CCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e 587 (843)
+|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999964 57899999986532 2334578899999999999999999998764 446799999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++......++++.+++.++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999998755567899999999999999999999999 9999999999999999999999999997654221
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......+++.|+|||+..+..++.++|||||||+++||++|+.||...
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1123345788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=326.91 Aligned_cols=280 Identities=26% Similarity=0.374 Sum_probs=206.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|+..+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 589999998764322 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.++.... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998877543 34889999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... ....
T Consensus 155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~------~~~~--- 218 (286)
T cd07846 155 ------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHII------KCLG--- 218 (286)
T ss_pred ------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHH------HHhC---
Confidence 11223457889999999875 4578899999999999999999988865443221 11110 0000
Q ss_pred CCCCHHHHHHH--HHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 747 GSYPSECVEKF--IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 747 ~~~~~~~~~~l--~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
.........+ ..+..... .|... .. .......+.......+++.+|+..+|++||+++++++||||
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~--~~~~~----~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 219 -NLIPRHQEIFQKNPLFAGMR--LPEVK----EI----EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred -CCchhhHHHhccchHhhccc--ccccc----Cc----chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000 00001111 11110 00 01111233445566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.93 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=203.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-----------------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-----------------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVS 571 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 571 (843)
.++|++.+.||+|+||.||++... ++..||+|++.... ....+++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999998532 24579999987543 334568899999999999999999
Q ss_pred eeeeeecCCcEEEEEecCCCCCHHHHHhhcCC---------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCc
Q 003158 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK---------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 642 (843)
Q Consensus 572 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~N 642 (843)
+++++...+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999976432 23667789999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh--CCCCCC
Q 003158 643 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT--GMQPIS 720 (843)
Q Consensus 643 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt--g~~pf~ 720 (843)
|++++++.++|+|||+++....... ........++..|+|||...+..++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999976532211 011122234678999999988899999999999999999998 777886
Q ss_pred CCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 721 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
..... +....... ...........+.+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 236 ~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 236 QLSDE-QVIENTGE--FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccChH-HHHHHHHH--HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 44321 11111000 00000001111223456688999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.38 Aligned_cols=202 Identities=27% Similarity=0.422 Sum_probs=175.6
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|++.+.||+|+||.||++... +++.||+|.+... .....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999954 6899999998643 223346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999997655556889999999999999999999998 9999999999999999999999999997654321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......|++.|+|||+..+..++.++|||||||+++||++|+.||....
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 11123457889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.50 Aligned_cols=205 Identities=27% Similarity=0.394 Sum_probs=173.7
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+.+++++.....||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445666777789999999999999954 6889999998876666677899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCc--chhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeeccccccC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPL--GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLA 662 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~ 662 (843)
+||+++++|.+++.... .++ ++..+..++.||++||+|||+.+ |+||||||+||+++. ++.++|+|||.+...
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 84 MEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999997642 234 77888899999999999999998 999999999999986 679999999998755
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCC--CCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.... .......|+..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 160 AGIN-------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred ccCC-------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 3211 1112235788999999987643 788999999999999999999998643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.92 Aligned_cols=248 Identities=35% Similarity=0.546 Sum_probs=206.7
Q ss_pred CcccccCCeeEEEEEeCC----CcEEEEEEeccCChhh-HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 8899999998654433 57889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 592 GTLRDQLSAKS-------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 592 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
++|.+++.... ...+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 356899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
... ........++..|+|||.+....++.++||||+||++|||++ |..||..... .+... .+..
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~---------~~~~ 222 (262)
T cd00192 158 DDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLE---------YLRK 222 (262)
T ss_pred ccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHH---------HHHc
Confidence 321 111233457889999999998889999999999999999999 6999976532 11111 1222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
+.....+..++.++.+++.+||+.+|.+||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 333345666788999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.71 Aligned_cols=239 Identities=21% Similarity=0.371 Sum_probs=189.6
Q ss_pred CcccccCCeeEEEEEeCC-------------CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 517 TQIGQGGYGKVYKGILPD-------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
+.||+|+||.||+|+... ...||+|.+........+.+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655455567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc-------EEEeec
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-------AKVADF 656 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~Df 656 (843)
+||||+++|+|..++..+. ..+++..++.++.||++||+|||+++ |+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999886543 45889999999999999999999998 999999999999987664 899999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhcc-cCCCCchhhhHHHHHHHHHHH-hCCCCCCCCcchHHHHHHHhh
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELL-TGMQPISHGKNIVREVNIAYQ 734 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~G~~l~ell-tg~~pf~~~~~~~~~~~~~~~ 734 (843)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||..... ..... ...
T Consensus 157 g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~-~~~ 223 (262)
T cd05077 157 GIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKER-FYE 223 (262)
T ss_pred CCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-hHHHH-HHh
Confidence 998754311 2235778999999987 467899999999999999998 58878754321 11111 000
Q ss_pred cccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
... .......+++.+++.+||+.+|.+||++.++++.+
T Consensus 224 ---------~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 ---------GQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---------cCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 11122346788999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=321.11 Aligned_cols=281 Identities=24% Similarity=0.358 Sum_probs=204.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcc-CCcccceeeeeecCCc-----
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGE----- 581 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~----- 581 (843)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 6899999987653222 2357888999999995 6999999999876655
Q ss_pred EEEEEecCCCCCHHHHHhhcC---CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeecc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFG 657 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfG 657 (843)
.++||||+++ +|.+++.... ...+++..++.++.||++||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8988886532 246899999999999999999999998 999999999999998 8899999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~ 736 (843)
+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||........... .+.
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~-- 226 (295)
T cd07837 157 LGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFK-- 226 (295)
T ss_pred cceecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHH--
Confidence 987653221 11122346788999999875 4578999999999999999999999976544322211 110
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
.+ ...+....+....+.... ..|..+|.. .....+..+..+.+||.+||..||++|+|++|
T Consensus 227 ----~~----~~~~~~~~~~~~~~~~~~--~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 227 ----LL----GTPTEQVWPGVSKLRDWH--EFPQWKPQD---------LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred ----Hh----CCCChhhCcchhhccchh--hcCcccchh---------HHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 00 001111111111110000 011111111 11122344556678999999999999999999
Q ss_pred CCCCCccc
Q 003158 817 MLKHPYVS 824 (843)
Q Consensus 817 ~L~Hp~f~ 824 (843)
++.||||.
T Consensus 288 il~~~~~~ 295 (295)
T cd07837 288 ALTHPYFD 295 (295)
T ss_pred HhcCCCcC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.70 Aligned_cols=206 Identities=28% Similarity=0.504 Sum_probs=174.5
Q ss_pred CCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCC------hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS------LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+|...+.||+|+||+||+|...+++.+|+|.+.... ....+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886432 11235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.+.. ++++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999996543 5788999999999999999999998 999999999999999999999999998765321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
..... .........|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 156 GLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 11110 0111233468899999999999889999999999999999999999997543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.08 Aligned_cols=267 Identities=25% Similarity=0.414 Sum_probs=205.7
Q ss_pred cCCCCCCcccccCCeeEEEEEe-----CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecC--CcE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 582 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 582 (843)
..|++.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 357899999987543 33346789999999999999999999998765 568
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999996543 35889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHH----HHhh-ccc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN----IAYQ-SSM 737 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~----~~~~-~~~ 737 (843)
...... ........++..|+|||++.+..++.++|||||||++|||++++.|............ .... ...
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 432210 1111234567789999999988899999999999999999998776533211000000 0000 000
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
......+...+.+..++..+.+++.+|++.+|++||++.++++.++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001111222233455678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.84 Aligned_cols=251 Identities=31% Similarity=0.515 Sum_probs=203.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+.... ....++.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778899999887533 234578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+++|.+++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+.......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc----
Confidence 999999986543 35788999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
........++.+|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... +..+.....
T Consensus 155 --~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~---------~~~~~~~~~ 222 (256)
T cd05112 155 --YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVET---------INAGFRLYK 222 (256)
T ss_pred --ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHH---------HhCCCCCCC
Confidence 011122235578999999998899999999999999999998 9999875432 111111 111111112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 333467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.12 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=172.0
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
-|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3667788999999999999975 578899999876555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+++|.+++... ..++++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 86 GGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99999988653 346899999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 1122345889999999984 345778999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.05 Aligned_cols=206 Identities=27% Similarity=0.479 Sum_probs=173.1
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---------hHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
+|.+...||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 6889999988643221 12567899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 35788889999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......... .........|+..|+|||.+.+..++.++||||+||++|||++|+.||....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 642211100 0111123458889999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.41 Aligned_cols=248 Identities=30% Similarity=0.488 Sum_probs=201.6
Q ss_pred CcccccCCeeEEEEEeCCCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHH
Q 003158 517 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 595 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 595 (843)
++||+|+||.||+|...+++.||+|.+...... ..+.+.+|+++++.++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998764433 4567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCccccee
Q 003158 596 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675 (843)
Q Consensus 596 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 675 (843)
+++.... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||.+........ ...
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-----~~~ 151 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-----TVS 151 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-----eec
Confidence 9996543 35788899999999999999999998 99999999999999999999999999976432110 000
Q ss_pred eeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHH
Q 003158 676 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754 (843)
Q Consensus 676 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (843)
......+..|+|||.+.+..++.++|||||||++|||+| |..||...... ..... +........+...+
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~~---------~~~~~~~~~~~~~~ 221 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRER---------IESGYRMPAPQLCP 221 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHHH---------HhcCCCCCCCccCC
Confidence 111223567999999998899999999999999999999 88888654321 11111 11111223455667
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 755 EKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 755 ~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
..+.+++.+||..+|.+||++.++++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 88999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=301.38 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=206.3
Q ss_pred HcCCCCC-CcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeec----CCcE
Q 003158 510 TNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQ 582 (843)
Q Consensus 510 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~ 582 (843)
+++|.+. ++||-|-.|+|-.+..+ +|+.+|+|++.+. ....+|++.--.. .|||||.++++|.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556553 57999999999999854 7999999998742 3456788754333 69999999999843 4577
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEEeecccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLS 659 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla 659 (843)
.+|||.|+||.|...+++++...+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999999999999999999999999999999999999 999999999999964 557999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
+.-.. .........|+.|.|||++...+|+...|+||+||++|-|+.|.+||....... ....+.
T Consensus 212 K~t~~--------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------ispgMk 276 (400)
T KOG0604|consen 212 KETQE--------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISPGMK 276 (400)
T ss_pred cccCC--------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------CChhHH
Confidence 86542 122345668999999999999999999999999999999999999997543210 011111
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
..+...-..||.+.|..+.+ .++|+|+.+|+.+|++|+|.+|.++
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe-----------------------------------~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSE-----------------------------------AAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCccCCChhHhHHHH-----------------------------------HHHHHHHHHhcCCchhheeHHHhhc
Confidence 22222223445544443322 2347899999999999999999999
Q ss_pred CCcccCCCC
Q 003158 820 HPYVSSDVS 828 (843)
Q Consensus 820 Hp~f~~~~~ 828 (843)
|||+.+...
T Consensus 322 hpwi~~~~~ 330 (400)
T KOG0604|consen 322 HPWINQYEA 330 (400)
T ss_pred Cchhccccc
Confidence 999987654
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.36 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=195.1
Q ss_pred HHHHHHcCCCCCCcc--cccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCC
Q 003158 505 EMALATNNFNSSTQI--GQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 580 (843)
Q Consensus 505 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 580 (843)
+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+........ |+.....+ +|+||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 444455677777776 9999999999995 4688999999875322211 22222222 7999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeecccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLS 659 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla 659 (843)
..++||||+++++|.+++.... ++++..++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997653 6899999999999999999999999 99999999999999998 9999999998
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
...... ....++..|+|||++.+..++.++|||||||++|||++|+.||.......-.
T Consensus 158 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----------- 215 (267)
T PHA03390 158 KIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD----------- 215 (267)
T ss_pred eecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-----------
Confidence 765321 1235788999999999989999999999999999999999999743211000
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC-ccCC
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-SSML 818 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa-~e~L 818 (843)
...+. ......+ ...+..++.+.+||.+||+.||.+|+++ +|+|
T Consensus 216 --------------~~~~~----~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 216 --------------LESLL----KRQQKKL-----------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred --------------HHHHH----HhhcccC-----------------CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 00000 0000000 0011233445678999999999999975 9999
Q ss_pred CCCcccC
Q 003158 819 KHPYVSS 825 (843)
Q Consensus 819 ~Hp~f~~ 825 (843)
+||||.+
T Consensus 261 ~h~~~~~ 267 (267)
T PHA03390 261 KHPFLKI 267 (267)
T ss_pred cCCcccC
Confidence 9999964
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.68 Aligned_cols=253 Identities=27% Similarity=0.357 Sum_probs=192.2
Q ss_pred CcccccCCeeEEEEEeCC---CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCC
Q 003158 517 TQIGQGGYGKVYKGILPD---GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
+.||+|+||.||+|.+.+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 4679999887543 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcC---CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 593 TLRDQLSAKS---KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 593 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
+|.+++.... ....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 9999997532 224567778889999999999999999 99999999999999999999999999875432211
Q ss_pred cccceeeeeecccCCccCchhcccC-------CCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTH-------KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
........++..|+|||++.+. .++.++|||||||++|||++ |+.||........ ......... ...
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~-~~~ 230 (269)
T cd05087 156 ---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVREQQ-LKL 230 (269)
T ss_pred ---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhccc-CCC
Confidence 0111234567889999998642 35789999999999999997 9999975443221 111111100 011
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
. .+......++.+.+++..|| .+|++||+++++++.|+
T Consensus 231 ~---~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 P---KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C---CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 11112234566888999999 57999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.34 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=207.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
..+|++.+.||+|+||+||+|... +|+ .||+|.+..... ....++.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356788899999999999999964 333 689998875543 345678899999999999999999999987 7899
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++...
T Consensus 85 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999997643 34889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... ........++..|+|||.+....++.++|||||||++||+++ |+.||..... .+... .+.
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~---------~~~ 225 (279)
T cd05057 161 VDEK-----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPD---------LLE 225 (279)
T ss_pred Cccc-----ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHHHH---------HHh
Confidence 3211 011112224568999999988889999999999999999999 9999975432 11111 111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+.....+..+...+.+++.+||..+|..||++.++++.++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 226 KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122223344566788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.84 Aligned_cols=247 Identities=30% Similarity=0.480 Sum_probs=202.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
++|++.+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 67889999986532 345788999999999999999999998754 4799999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999998766556889999999999999999999998 999999999999999999999999998754211
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||...... .... .. ..+.....
T Consensus 154 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~-~~--------~~~~~~~~ 218 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKE-CV--------EKGYRMEP 218 (254)
T ss_pred -----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHH-HH--------hCCCCCCC
Confidence 111234567999999998899999999999999999998 99998654321 1111 11 11112233
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
+..++..+.+++.+||+.+|++||++++++..+++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 45567888999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.93 Aligned_cols=200 Identities=25% Similarity=0.417 Sum_probs=170.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999975 78999999887532 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
+++++|.+++.... ...+++..+..++.|+++||.|||+ .+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999986532 2368999999999999999999997 46 999999999999999999999999998755321
Q ss_pred CCCcccceeeeeecccCCccCchhcccCC------CCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 --------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred --------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 112335788999999986543 478999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.23 Aligned_cols=207 Identities=24% Similarity=0.387 Sum_probs=172.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|+..+.||+|+||.||++... .++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999965 578999999875432 22457789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 35888899999999999999999998 9999999999999999999999999987422111
Q ss_pred CCCc--------ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 667 IEGI--------VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 667 ~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.... ..........++..|+|||.+.+..++.++|+|||||++|||++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0000 0001112245788999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.30 Aligned_cols=249 Identities=32% Similarity=0.508 Sum_probs=200.3
Q ss_pred CcccccCCeeEEEEEeCC-------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 517 TQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+.||+|+||.||+|...+ ++.||+|.+.... .....++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-----CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-----cEEEeeccc
Q 003158 589 MSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-----TAKVADFGL 658 (843)
Q Consensus 589 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DfGl 658 (843)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234788999999999999999999998 99999999999999887 899999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
+......... .......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~------- 224 (269)
T cd05044 158 ARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQ------- 224 (269)
T ss_pred cccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHH-------
Confidence 9765432211 11122345678999999999999999999999999999998 999986544321 111
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
.+..+.....+...+..+.+++.+||..+|.+||++.++.+.|+
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 --HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11112222345566788999999999999999999999998876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.49 Aligned_cols=199 Identities=31% Similarity=0.429 Sum_probs=175.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999965 68999999987543 33346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++... ++++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999654 6889999999999999999999998 9999999999999999999999999998765321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 1123345788999999999988999999999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.42 Aligned_cols=276 Identities=26% Similarity=0.337 Sum_probs=207.5
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCC----
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG---- 580 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 580 (843)
...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 689999999875332 23456788999999999999999999986654
Q ss_pred ------cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEe
Q 003158 581 ------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 654 (843)
Q Consensus 581 ------~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 654 (843)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 777777543 346899999999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh
Q 003158 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 655 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~ 733 (843)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 159 dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~------ 225 (302)
T cd07864 159 DFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-A------ 225 (302)
T ss_pred cccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-H------
Confidence 9999986543221 11122345778999998865 45788999999999999999999998654321 1
Q ss_pred hcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH---------HHHhhhhCCCCCCCCCccccCCC
Q 003158 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE---------LESIWNMMPESDTKTPEFINSEH 804 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~---------L~~~~~~~~~~~~~~~dll~~~L 804 (843)
.+..+...|....|..+|.+.+.... ...+...+........+++.+|+
T Consensus 226 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 283 (302)
T cd07864 226 ----------------------QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHML 283 (302)
T ss_pred ----------------------HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHc
Confidence 11222223333333333322221100 00111122223455678999999
Q ss_pred CCCCCCCCCCccCCCCCcc
Q 003158 805 TSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 805 ~~dp~~R~sa~e~L~Hp~f 823 (843)
..||++|||+++++.||||
T Consensus 284 ~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 284 TLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cCChhhCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=313.59 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=174.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.+.|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367888999999999999999975 5899999999876666667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|..++.+.. ..+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999998876533 35889999999999999999999998 999999999999999999999999998653221
Q ss_pred CcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
........++..|+|||++. ...++.++|||||||++|||++|..||...
T Consensus 164 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 164 ----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 11123345788999999985 345678999999999999999999998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.81 Aligned_cols=238 Identities=24% Similarity=0.370 Sum_probs=188.4
Q ss_pred cccccCCeeEEEEEeCC-------------------------CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccce
Q 003158 518 QIGQGGYGKVYKGILPD-------------------------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 572 (843)
.||+|+||.||+|.... ...||+|++.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999876544445678899999999999999999
Q ss_pred eeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---
Q 003158 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF--- 649 (843)
Q Consensus 573 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~--- 649 (843)
++++.+....++||||+++|+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998653 335788889999999999999999998 99999999999998654
Q ss_pred ----cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHH-hCCCCCCCCc
Q 003158 650 ----TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELL-TGMQPISHGK 723 (843)
Q Consensus 650 ----~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~ell-tg~~pf~~~~ 723 (843)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999988643211 12346788999999876 56899999999999999995 6999986543
Q ss_pred chHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
.... ...+. . ....+......+.+++.+||+.+|++||++.++++.|
T Consensus 227 ~~~~--~~~~~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PSEK--ERFYE---------K-KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hHHH--HHHHH---------h-ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2111 11100 0 0112222345788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.35 Aligned_cols=206 Identities=30% Similarity=0.410 Sum_probs=176.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 68899999987533 23457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCC-CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
+++++|.++++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433 56889999999999999999999999 99999999999999999999999999876653321
Q ss_pred CCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.. ........|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 158 ~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 158 RT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 10 0122344688999999999876 7899999999999999999999999654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.33 Aligned_cols=278 Identities=26% Similarity=0.397 Sum_probs=205.7
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
|++.+.||.|++|.||+|... +|+.||+|++..... ...+.+.+|+++++.++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999964 799999999875432 22357888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
+ ++|.+++.......+++..++.++.|+++||+|||+++ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---
Confidence 4 79999997765556899999999999999999999998 9999999999999999999999999997653221
Q ss_pred cccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||........... .... ...
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~----------~~~ 218 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR-IFRT----------LGT 218 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHH----------hCC
Confidence 111223467899999988764 578899999999999999999999976544322111 1100 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCC-CCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 749 YPSECVEKFIKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~-RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
...........+... ...-+.. .+... ...+.......+++.+|+..||++|||++|++.||||
T Consensus 219 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 219 PDEDVWPGVTSLPDY-KPTFPKWARQDLS----------KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CChHHhhhhhhchhh-hhhcccccccchh----------hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 111111111111000 0001111 11111 1122333455689999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.05 Aligned_cols=200 Identities=26% Similarity=0.425 Sum_probs=176.1
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788999999999999999995 579999999997655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 999999998543 4788899999999999999999998 9999999999999999999999999987543221
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred ----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11123457889999999999889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.04 Aligned_cols=200 Identities=31% Similarity=0.475 Sum_probs=176.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC-CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|+..+.||+|+||.||+|...+ ++.||+|.+..... .+++.+|+++++.++|+||+++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999999764 89999999875322 67899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++... ...+++..++.++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 80 CGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 9999999998653 346899999999999999999999998 9999999999999999999999999998654321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 154 -----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1122344788999999999999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=346.50 Aligned_cols=280 Identities=24% Similarity=0.305 Sum_probs=219.6
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeec
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 578 (843)
..++....++|+++++||+|+||.|..++.+ .+++||.|++++... ....-|..|-.+|..-..+=|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3466667789999999999999999999965 689999999986322 223467888889999899999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
+.++|+|||||+||+|-.++.+.. ++++..++.++..|.-||.-+|+.| +|||||||+|||+|..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999997655 6889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~ 733 (843)
+-.+.... .-.+...+|||-|++||++.. +.|+..+|+||+||++|||+.|..||.... +......+.
T Consensus 222 Clkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-lveTY~KIm 294 (1317)
T KOG0612|consen 222 CLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-LVETYGKIM 294 (1317)
T ss_pred HHhcCCCC------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-HHHHHHHHh
Confidence 87665322 234456789999999999963 568999999999999999999999997433 221111111
Q ss_pred hcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC
Q 003158 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 813 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s 813 (843)
... ....+|+ . .+.+..+.|||.++++ +|+.|..
T Consensus 295 ~hk--------~~l~FP~--------------------------~-----------~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 295 NHK--------ESLSFPD--------------------------E-----------TDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred chh--------hhcCCCc--------------------------c-----------cccCHHHHHHHHHHhc-Chhhhcc
Confidence 000 0011110 0 1123334456666544 5778888
Q ss_pred ---CccCCCCCcccCCCCCCccccccCCCCCC
Q 003158 814 ---SSSMLKHPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 814 ---a~e~L~Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
.+++-.||||.++.| +-+++-.||+.|
T Consensus 329 rngiedik~HpFF~g~~W--~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 329 RNGIEDIKNHPFFEGIDW--DNIRESVPPVVP 358 (1317)
T ss_pred cccHHHHHhCccccCCCh--hhhhhcCCCCCC
Confidence 999999999999999 556665566655
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=313.16 Aligned_cols=202 Identities=29% Similarity=0.392 Sum_probs=175.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999964 6899999999866656667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 99999999986543 35899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......+++.|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 1123346889999999985 345678999999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.09 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=174.3
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999964 68899999987543 23356788999999999999999999999989999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC-CcEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~~~ 667 (843)
+++++|.+++.......+++..++.++.|+++||+|||+++ ++||||||+||+++++ +.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998766667899999999999999999999998 9999999999999855 468999999998654321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 1123457889999999998889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.40 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=173.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346777889999999999999964 6899999998765444455688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999999986543 5889999999999999999999999 9999999999999999999999999987553211
Q ss_pred CcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......|+..|+|||++. ...++.++|||||||++|||++|..||...
T Consensus 161 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 161 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 1123346889999999985 456888999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=308.72 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=190.8
Q ss_pred cccccCCeeEEEEEeCC---CcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCC
Q 003158 518 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 593 (843)
.||+|+||+||+|...+ ...+|+|.+..... .....+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 45788998764332 334578899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCC---CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 594 LRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 594 L~~~l~~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
|.+++..... ...++.....++.||+.||+|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999976432 23467778899999999999999998 99999999999999999999999999865432210
Q ss_pred ccceeeeeecccCCccCchhccc-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
........++..|+|||++.. ..++.++|||||||++|||++ |..||....+.. ......... ..
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~----~~ 228 (269)
T cd05042 156 --YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ----DI 228 (269)
T ss_pred --eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc----Cc
Confidence 001122345678999999753 356789999999999999999 778886544322 111111110 00
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
....+..+..++..+.+++..|| .+|++||++++|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11112234456677888999999 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.93 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=198.5
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999864 58899999987443 333567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++.. ..+++..++.++.|+++|+.|||+++ ++|+||+|+||++++++.++++|||++.......
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999999854 35788999999999999999999998 9999999999999999999999999987654221
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
.......++..|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+........
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~---------~~~~~~~~~~~ 221 (277)
T cd06642 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VL---------FLIPKNSPPTL 221 (277)
T ss_pred ----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HH---------hhhhcCCCCCC
Confidence 11122457889999999999899999999999999999999999986433211 00 01111122233
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
+..++..+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 44556677788888888888888888888763
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=347.37 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=203.3
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec--
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-- 578 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 578 (843)
.+.....++|.+.+.||+|+||+||+|... ++..||+|.+.... ......+..|+.+++.++||||++++++|.+
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 344455678999999999999999999965 57899999887432 2335678999999999999999999998854
Q ss_pred CCcEEEEEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCC----CCEEeccCCCCcEEEcC-----
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEAD----PPVFHRDIKASNILLDH----- 647 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~iiH~Dlkp~NILl~~----- 647 (843)
....+|||||+++|+|.++|... ....+++..++.|+.||+.||.|||+.+. .+||||||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 35689999999999999999753 23468999999999999999999998542 34999999999999964
Q ss_pred ------------CCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHH
Q 003158 648 ------------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELL 713 (843)
Q Consensus 648 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~ell 713 (843)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 3359999999997653221 1234468999999999864 45889999999999999999
Q ss_pred hCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 714 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 714 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
+|+.||............. ...........+.++.+++..||..+|.+||++.+++.
T Consensus 238 TGk~PF~~~~~~~qli~~l----------k~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 238 SGKTPFHKANNFSQLISEL----------KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HCCCCCCcCCcHHHHHHHH----------hcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999997655433322211 11111111234577889999999999999999999984
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.60 Aligned_cols=239 Identities=23% Similarity=0.408 Sum_probs=191.8
Q ss_pred CcccccCCeeEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 517 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998632 234888888755445556788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc--------EEEeeccccc
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKVADFGLSR 660 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DfGla~ 660 (843)
+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976433 5788999999999999999999999 999999999999987765 6999999886
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCC-CCCCCCcchHHHHHHHhhcccc
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGM-QPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~-~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+..... ......
T Consensus 157 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~------- 217 (258)
T cd05078 157 TVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQF------- 217 (258)
T ss_pred ccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHH-------
Confidence 5431 122457889999999987 45789999999999999999985 45543222 111110
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
. ......|...+.++.+++.+||+.+|++||+++++++.|
T Consensus 218 ---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 218 ---Y-EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---H-HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 111233444557889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.41 Aligned_cols=190 Identities=27% Similarity=0.392 Sum_probs=158.2
Q ss_pred cccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHH---hccCCcccceeeeeecCCcEEEEEecCC
Q 003158 518 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLS---RLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
.||+|+||.||++... +++.||+|.+...... ....+.+|..+++ ..+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 6899999988653221 2233445544443 3479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|.+++..+. .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999986543 5899999999999999999999999 9999999999999999999999999987543211
Q ss_pred ccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
.....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 122358999999999874 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=306.97 Aligned_cols=202 Identities=28% Similarity=0.421 Sum_probs=176.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|+++++.++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999964 57899999998655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence 999999998664 245889999999999999999999998 9999999999999999999999999987653211
Q ss_pred cccceeeeeecccCCccCchhcccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112334578899999999876 88999999999999999999999997644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.84 Aligned_cols=280 Identities=25% Similarity=0.369 Sum_probs=205.2
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecC--CcEEEEEe
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVYE 587 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e 587 (843)
|++.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|+++++.++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999975 58999999998653 23345788999999999999999999999887 89999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 58998886542 46899999999999999999999998 99999999999999999999999999986643321
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......... . .
T Consensus 156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~------~----~ 218 (287)
T cd07840 156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFE------L----C 218 (287)
T ss_pred ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH------H----h
Confidence 11223356788999998765 4578999999999999999999999976543 221111110 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC-CCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~-~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
...+......+.++ +.......++.....+ ... +.. ......+++++|+..+|++||++++++.||||
T Consensus 219 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 219 GSPTDENWPGVSKL---PWFENLKPKKPYKRRL---REF---FKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred CCCchhhccccccc---hhhhhccccccchhHH---HHH---hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00111111111111 1111111111111111 111 111 24456789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=321.48 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=211.4
Q ss_pred CCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCC
Q 003158 516 STQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
.+.||+|.||+||-|+. ++|+.||||++.+... ..+.++.+|+.+|+.++||.||.+...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999996 4799999999986433 34578899999999999999999999999999999999999 56
Q ss_pred CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC---CcEEEeeccccccCCCCCCCC
Q 003158 593 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 593 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~~~~ 669 (843)
+..+++-......+++...+.++.||+.||.|||.++ |+|+||||+|||+.+. -++||+|||.|++...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE----- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE----- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch-----
Confidence 7777776666677999999999999999999999999 9999999999999654 3799999999998764
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
......+.||+.|+|||+++...|...-|+||+||++|--++|..||..+.+..++.+.+. .+ +
T Consensus 720 ---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa---FM----------y 783 (888)
T KOG4236|consen 720 ---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA---FM----------Y 783 (888)
T ss_pred ---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc---cc----------c
Confidence 3345678899999999999999999999999999999999999999987776655543210 00 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
|. +| |.+.+..+.|||+.+|+..=++|.|.+..|.|||+++-.
T Consensus 784 Pp----------------~P-------------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 784 PP----------------NP-------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred CC----------------Cc-------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 11 11 223345566899999999999999999999999997644
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.77 Aligned_cols=199 Identities=31% Similarity=0.454 Sum_probs=173.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+++.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356788899999999999999964 68999999886543 3345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|+++++|.+++... .++++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999998664 358899999999999999999997 46 999999999999999999999999998654211
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
......|+..|+|||++.+..++.++|||||||++||+++|+.||...
T Consensus 158 --------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 158 --------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred --------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 112346889999999998889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=310.56 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=204.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
++|++...||+|+||+||+|+.+ +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999963 2467999988754433 3567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCC-------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeec
Q 003158 584 LVYEFMSNGTLRDQLSAKSK-------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 656 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 656 (843)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976441 25899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhc
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 735 (843)
|++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+...
T Consensus 162 ~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~--- 231 (275)
T cd05046 162 SLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRL--- 231 (275)
T ss_pred ccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHH---
Confidence 99875432211 11122345677999999998888999999999999999999 78888643321 111111
Q ss_pred ccchhhccCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 736 SMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 736 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
..+.. ...+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 232 ------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 ------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 10111 1223456678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=306.83 Aligned_cols=250 Identities=34% Similarity=0.548 Sum_probs=204.2
Q ss_pred CCCCCcccccCCeeEEEEEeCC-----CcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 513 FNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
|++.+.||+|+||.||+|...+ +..||+|++...... ..+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999753 388999999765443 5678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654433899999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.. ......++..|+|||.+.+..++.++||||+||+++||++ |+.||..... ..... .+....
T Consensus 158 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~---------~~~~~~ 221 (258)
T smart00219 158 YY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLE---------YLKKGY 221 (258)
T ss_pred cc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH---------HHhcCC
Confidence 11 0112236789999999988889999999999999999999 7788764322 11111 111122
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
....+..++.++.+++.+|+..+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 233344567889999999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.46 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=197.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++++.|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999965 68899999987543 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|+|.+++.. .++++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 999999999864 34788889999999999999999998 9999999999999999999999999997654321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||++.+..++.++|||||||++|||++|..||........ . ..+.......
T Consensus 156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~---------~~~~~~~~~~ 220 (277)
T cd06640 156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-L---------FLIPKNNPPT 220 (277)
T ss_pred -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-h---------hhhhcCCCCC
Confidence 112234578899999999988899999999999999999999999975432110 0 0111111223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
.+..++..+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 44556666777777777777766666666654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.61 Aligned_cols=280 Identities=24% Similarity=0.400 Sum_probs=207.5
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+|+..+.||+|++|.||+|+.. +|+.||||.+...... ..+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 6899999998754332 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 590 SNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 590 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 7 58998886543 346899999999999999999999998 9999999999999999999999999997543211
Q ss_pred CcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +........ ..
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~----------~~ 218 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRI----------MG 218 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH----------hC
Confidence 11123346889999999876 45788999999999999999999999765432 211111100 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
.......+.+... .. +..+...+ ..... ....+..+....+++.+|++.||++|++++|+++||||
T Consensus 219 ~~~~~~~~~~~~~-~~-~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 219 TPTESTWPGISQL-PE-YKPTFPRY-PPQDL-------QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChhhHHHHhcC-ch-hcccccCC-ChHHH-------HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0111111111110 00 11111011 11111 11123345667789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.89 Aligned_cols=199 Identities=29% Similarity=0.407 Sum_probs=175.2
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 68999999987532 2345688999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++... .++++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999664 46889999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 1233457889999999998889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.60 Aligned_cols=288 Identities=23% Similarity=0.323 Sum_probs=202.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 580 (843)
-++|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999965 689999998864322 22345678999999999999999999986543
Q ss_pred --cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 581 --EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 581 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999995 58888886543 35889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
+.......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .....
T Consensus 166 ~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~~~----- 236 (310)
T cd07865 166 ARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTLI----- 236 (310)
T ss_pred cccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-----
Confidence 98664332111 1112234578899999998764 47889999999999999999999987544321 11110
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
..+ .+..+.+..+....+ .++............+...+.. ...+....|++.+||..||++|||++|+
T Consensus 237 -~~~----~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~-----~~~~~~~~dli~~~l~~~P~~R~t~~e~ 304 (310)
T cd07865 237 -SQL----CGSITPEVWPGVDKL--ELFKKMELPQGQKRKVKERLKP-----YVKDPHALDLIDKLLVLDPAKRIDADTA 304 (310)
T ss_pred -HHH----hCCCChhhcccccch--hhhhhccCCCccchhhHHhccc-----ccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 000 111111111111000 0000000000000001111100 1123455689999999999999999999
Q ss_pred CCCCcc
Q 003158 818 LKHPYV 823 (843)
Q Consensus 818 L~Hp~f 823 (843)
|+||||
T Consensus 305 l~h~~f 310 (310)
T cd07865 305 LNHDFF 310 (310)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=323.11 Aligned_cols=289 Identities=24% Similarity=0.387 Sum_probs=208.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecC-----CcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 582 (843)
+++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 468999999986422 22345678899999999999999999987543 357
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++|+||++ ++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 588888744 35889999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
...... ........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ....... ..
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~------~~ 225 (336)
T cd07849 157 DPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLIL------GV 225 (336)
T ss_pred cccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH------HH
Confidence 432110 111233468899999998765 56889999999999999999999999654321 1111100 00
Q ss_pred ccCCCCCCCHHHHHHHHHHHH-HhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLAL-KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~-~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
.+..+.+....+..... ..+...|. .+... +....+..+....+++.+||..||++|||+.|+++|
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 ----LGTPSQEDLNCIISLRARNYIKSLPF-KPKVP--------WNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred ----cCCCCHHHHHHhhchhhhhHHhhcCc-CCccc--------HHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111111111111 11111111 11110 001123345667799999999999999999999999
Q ss_pred CcccCCCCC
Q 003158 821 PYVSSDVSG 829 (843)
Q Consensus 821 p~f~~~~~~ 829 (843)
|||..-...
T Consensus 293 p~~~~~~~~ 301 (336)
T cd07849 293 PYLEQYHDP 301 (336)
T ss_pred ccccccCCC
Confidence 999765543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.14 Aligned_cols=284 Identities=22% Similarity=0.340 Sum_probs=206.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|++|+||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999965 689999998865322 223578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeeccccccCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~ 666 (843)
|++ ++|.+++.......+++..++.++.||+.||+|||+++ ++||||||+||++++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 68888886655555678888899999999999999998 999999999999985 5679999999997543211
Q ss_pred CCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||........ ....+. ..
T Consensus 158 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~------~~--- 220 (294)
T PLN00009 158 -------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFR------IL--- 220 (294)
T ss_pred -------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH------Hh---
Confidence 11123356789999999876 4578899999999999999999999976543221 111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+......+.....+-.. ....|..++.. .....+..+..+.+++.+|++.+|++||+++++++||||..
T Consensus 221 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 221 -GTPNEETWPGVTSLPDY-KSAFPKWPPKD---------LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred -CCCChhhccccccchhh-hhhcccCCCCC---------HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00001111000000000 00011111110 01112344555678999999999999999999999999976
Q ss_pred C
Q 003158 826 D 826 (843)
Q Consensus 826 ~ 826 (843)
-
T Consensus 290 ~ 290 (294)
T PLN00009 290 L 290 (294)
T ss_pred H
Confidence 3
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=313.20 Aligned_cols=267 Identities=26% Similarity=0.430 Sum_probs=207.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-----CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeec--CCcE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 582 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 582 (843)
..|+..+.||+|+||.||+|.+. +++.||||.+...... ..+++.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777889999999999999853 3689999999865443 46789999999999999999999999877 5578
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 25889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHH-H---hhcccc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI-A---YQSSMM 738 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~-~---~~~~~~ 738 (843)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+............ . .....+
T Consensus 160 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 522110 01111223556799999999889999999999999999999999998643221100000 0 000000
Q ss_pred hhhcc-CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 739 FSVID-GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 739 ~~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
...+. ......+..++.++.+++.+||+.+|++||++.+++++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 112233456678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=311.91 Aligned_cols=256 Identities=21% Similarity=0.381 Sum_probs=201.8
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
.|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344567999999999999995 4789999999876555556678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---- 169 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---- 169 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC----
Confidence 9999999866 34788999999999999999999999 9999999999999999999999999887543211
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .....
T Consensus 170 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~------------------- 226 (285)
T cd06648 170 ---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKR------------------- 226 (285)
T ss_pred ---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHH-------------------
Confidence 1112345889999999999888999999999999999999999998653321 11100
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
+.... .|...+ ....+....+++++|++.+|++|||++|+++||||..-.
T Consensus 227 ----------~~~~~------~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 227 ----------IRDNL------PPKLKN-----------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ----------HHhcC------CCCCcc-----------cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 00000 000000 000122344678888889999999999999999997633
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.87 Aligned_cols=203 Identities=31% Similarity=0.450 Sum_probs=170.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhccCCcccceeeeeec--CCcE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 582 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 582 (843)
.+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 68999999876422 1223568889999999999999999998865 3567
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
+++|||+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999996543 4788889999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 157 QTICMS----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccc----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 321110 11112345788999999999988999999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.56 Aligned_cols=279 Identities=26% Similarity=0.384 Sum_probs=206.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999975 58899999887532 2234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9988777665543 234889999999999999999999998 99999999999999999999999999987653321
Q ss_pred CCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||........ ..... .. .
T Consensus 156 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~------~~----~ 218 (288)
T cd07833 156 ------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQ------KC----L 218 (288)
T ss_pred ------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH------HH----h
Confidence 112334578899999999887 889999999999999999999999875433211 11100 00 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHhhhhCCC-CCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETD----ARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~----~RPs~~~vl~~L~~~~~~~~~-~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
+..+......+ ..++. +.|...+. ..+...++. ......+|+++|+..+|++|||+++++.||
T Consensus 219 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 286 (288)
T cd07833 219 GPLPPSHQELF--------SSNPRFAGVAFPEPSQP----ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286 (288)
T ss_pred CCCCHHHhhhc--------ccCccccccccCCCCCc----HHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence 01111000000 00110 01111110 011111222 256677899999999999999999999999
Q ss_pred cc
Q 003158 822 YV 823 (843)
Q Consensus 822 ~f 823 (843)
||
T Consensus 287 ~f 288 (288)
T cd07833 287 YF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.36 Aligned_cols=192 Identities=24% Similarity=0.384 Sum_probs=168.2
Q ss_pred ccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 589999999875332 2346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
.+++.... .+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--------
Confidence 99996643 4788999999999999999999998 9999999999999999999999999998654321
Q ss_pred eeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......++..|+|||.+.+..++.++|+||+|+++|||++|..||....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1123457889999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=313.62 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=175.4
Q ss_pred ccHHHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeee-
Q 003158 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD- 577 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~- 577 (843)
+.++.+....++|++.+.||+|+||.||+|... +++.+|+|++.... ....++.+|+.+++.+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334556667889999999999999999999964 68899999876422 2345688899999999 6999999999873
Q ss_pred ----cCCcEEEEEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcE
Q 003158 578 ----EEGEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 651 (843)
Q Consensus 578 ----~~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 651 (843)
.++..++||||+++++|.+++... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999988642 2346888899999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 652 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 652 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
||+|||+++...... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 164 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEccCCceeecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999987653221 11223458899999999853 457889999999999999999999997543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.94 Aligned_cols=204 Identities=24% Similarity=0.298 Sum_probs=165.3
Q ss_pred Cccccc--CCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
..||+| +||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999964 79999999987532 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998765556889999999999999999999998 999999999999999999999999865433211100000
Q ss_pred cceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 0000111235667999999976 347889999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.09 Aligned_cols=210 Identities=29% Similarity=0.454 Sum_probs=176.1
Q ss_pred cHHHHHHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeec-
Q 003158 502 TYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE- 578 (843)
Q Consensus 502 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~- 578 (843)
++.++....+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4455556778999999999999999999996 468999999986533 3345688899999998 69999999999843
Q ss_pred -----CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEE
Q 003158 579 -----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 653 (843)
Q Consensus 579 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 653 (843)
....++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999997765566888889999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 163 ~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 163 VDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred eeCcchhhhhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999987543211 1112345889999999986 346788999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.73 Aligned_cols=200 Identities=28% Similarity=0.384 Sum_probs=171.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecC--CcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~ 586 (843)
++|+..+.||.|++|.||+|... +++.||+|.+..... ....++.+|+++++.++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999974 689999999875332 3456789999999999999999999998543 4689999
Q ss_pred ecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 587 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 587 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||+++++|.+++.. .....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998754 23345788899999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.. .....++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 158 ~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11 12335778999999999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.86 Aligned_cols=283 Identities=23% Similarity=0.360 Sum_probs=206.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecC----------
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE---------- 579 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---------- 579 (843)
.+|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67899999999999999999964 6899999998766555567789999999999999999999876543
Q ss_pred ----CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEe
Q 003158 580 ----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVA 654 (843)
Q Consensus 580 ----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~ 654 (843)
...++||||++ ++|.+++.. ..+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+|++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 599888853 24788999999999999999999999 999999999999974 5678999
Q ss_pred eccccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh
Q 003158 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 655 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~ 733 (843)
|||+++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........
T Consensus 158 dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~--- 230 (342)
T cd07854 158 DFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL--- 230 (342)
T ss_pred CcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence 99999765322110 111122357889999998764 5678899999999999999999999976554322111
Q ss_pred hcccchhhccCCCCCCCHHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC
Q 003158 734 QSSMMFSVIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~ 812 (843)
.++. .+....+....+ ..+...+.......+.+..+ ..+..+....+|+.+||+.||++|+
T Consensus 231 -------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 231 -------ILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD----------LLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred -------HHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHH----------HccCCCHHHHHHHHHHhCCCchhcc
Confidence 1111 111111111111 12222222112112222221 1233445566899999999999999
Q ss_pred CCccCCCCCcccC
Q 003158 813 SSSSMLKHPYVSS 825 (843)
Q Consensus 813 sa~e~L~Hp~f~~ 825 (843)
|++|++.||||+.
T Consensus 293 t~~ell~h~~~~~ 305 (342)
T cd07854 293 TAEEALMHPYMSC 305 (342)
T ss_pred CHHHHhCCCcccc
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.73 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=199.9
Q ss_pred CCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 003158 513 FNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 580 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 580 (843)
|.+.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 36889999987542 233567889999999999999999999885432
Q ss_pred cEEEEEecCCCCCHHHHHhhc----CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeec
Q 003158 581 EQMLVYEFMSNGTLRDQLSAK----SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 656 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 656 (843)
..++++||+++|+|.+++... ....+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887532 1224788889999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhc
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 735 (843)
|.++....... ........+++.|++||.+....++.++|||||||++|||++ |+.||..... ......
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~---- 227 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNY---- 227 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHH----
Confidence 99986542211 011122335678999999998889999999999999999999 8888865432 111111
Q ss_pred ccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
+........+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 -----LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111223345667899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.39 Aligned_cols=290 Identities=22% Similarity=0.360 Sum_probs=212.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeec----CCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 582 (843)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999964 699999999875422 334677889999999999999999998753 3468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+. |+|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999998654 34889999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
...... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~-------- 225 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLIL-------- 225 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHH--------
Confidence 432211 1111233468889999999866 56889999999999999999999999654432 1111110
Q ss_pred ccCCCCCCCHHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 742 IDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
...+..+.+..... .+.+..+++..+...+... ....+.....+.+++.+||+.||++|||+++++.|
T Consensus 226 --~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 226 --SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW---------SKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred --HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCH---------HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01111122221111 1222233333333222211 01123345556789999999999999999999999
Q ss_pred CcccCCCC
Q 003158 821 PYVSSDVS 828 (843)
Q Consensus 821 p~f~~~~~ 828 (843)
|||..-..
T Consensus 295 ~~~~~~~~ 302 (334)
T cd07855 295 PFLAQYHD 302 (334)
T ss_pred hhhhhccC
Confidence 99965443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.22 Aligned_cols=199 Identities=30% Similarity=0.480 Sum_probs=172.9
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+|+..+.||+|+||.||+|... +++.||+|.+.... .+..+.+.+|+++++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999975 78999999886433 22346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.... ++++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999996543 4788999999999999999999999 999999999999999999999999998765422
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
. ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||....
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 1 123345888999999998766 8999999999999999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.65 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=188.9
Q ss_pred cccccCCeeEEEEEeCCC---cEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCC
Q 003158 518 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 593 (843)
.||+|+||+||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985433 356677766433 3345789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcC--CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 594 LRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 594 L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|.++++... ....++..++.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999997642 234566778889999999999999998 99999999999999999999999999864321110
Q ss_pred cceeeeeecccCCccCchhccc-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
........++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+........ ......+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKD-QQVKLFK 231 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhh-cccccCC
Confidence 011123457889999999853 245778999999999999997 5667764432 2222211111 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
+..+..+.+.+.+++..|| .+|++||+++++++.|
T Consensus 232 ---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 ---PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ---CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 2223335677888999999 5799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.80 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=174.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999975 68999999987643 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
+++++|.+++.... .++++..+..++.|+++||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 99999999997643 568889999999999999999999 88 9999999999999999999999999987543211
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11156888999999999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=312.15 Aligned_cols=199 Identities=27% Similarity=0.365 Sum_probs=168.8
Q ss_pred CCCCCCcccccCCeeEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcE
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 582 (843)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 3689999999875322 2245678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++... .++++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999764 35788889999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccC--CCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
..... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..
T Consensus 156 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 156 HEDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 33211 111234588899999998753 467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.31 Aligned_cols=203 Identities=29% Similarity=0.433 Sum_probs=170.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhccCCcccceeeeeecC--CcE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 582 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 582 (843)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999964 58999999875321 12245788899999999999999999998653 467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++.... .+++...+.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986543 4778888999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
...... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 321110 11122345888999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.52 Aligned_cols=237 Identities=24% Similarity=0.409 Sum_probs=190.0
Q ss_pred CcccccCCeeEEEEEeCC-C----------cEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 517 TQIGQGGYGKVYKGILPD-G----------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999754 3 25788887654333 6788999999999999999999999988 788999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-------cEEEeeccc
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-------TAKVADFGL 658 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~DfGl 658 (843)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976442 5888899999999999999999998 99999999999999888 799999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccC--CCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~ 735 (843)
+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||...... .... .+.
T Consensus 155 a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~-~~~- 220 (259)
T cd05037 155 PITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKER-FYQ- 220 (259)
T ss_pred cccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHH-HHh-
Confidence 976432 1223466789999999876 78999999999999999999 57777654321 1111 111
Q ss_pred ccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
.......+ ....+.+++.+||..+|.+||++.++++.|
T Consensus 221 -------~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -------DQHRLPMP--DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------cCCCCCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111111 127888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.56 Aligned_cols=202 Identities=25% Similarity=0.425 Sum_probs=172.0
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec--CCcEEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLVY 586 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~ 586 (843)
+|++.+.||.|+||.||+|.. .+++.||+|.+.... ....+++.+|+++++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 468899999987532 3335678899999999999999999998753 45679999
Q ss_pred ecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHh-----cCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 587 EFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLH-----TEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 587 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
||+++++|.+++... ...++++..++.++.|+++||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999653 2456899999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
....... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~-------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDS-------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCc-------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 8764322 11223468899999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.40 Aligned_cols=288 Identities=26% Similarity=0.360 Sum_probs=203.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecC-------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------- 579 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 579 (843)
.++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 6899999988643322 234678899999999999999999987443
Q ss_pred -CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 580 -GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 580 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
...++||||+. +++...+... ...+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999996 5777777543 335899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcc----cceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh
Q 003158 659 SRLAPVPDIEGIV----PAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 659 a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~ 733 (843)
++........... .....+...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 9765432211110 1112234567889999998875 45789999999999999999999998754432 2111111
Q ss_pred hcccchhhccCCCCCCCHHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC
Q 003158 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c-~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~ 812 (843)
... ...++...+....+.... +...+...+...+ .+........+|+.+||..||++||
T Consensus 241 ------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 241 ------KLC----GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE----------RFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred ------HHh----CCCChhhchhhhhcccccccccCCCCCccHHH----------HcccCChhHHHHHHHHcccCcccCc
Confidence 000 000000000000000000 0001111111111 1223335567899999999999999
Q ss_pred CCccCCCCCcc
Q 003158 813 SSSSMLKHPYV 823 (843)
Q Consensus 813 sa~e~L~Hp~f 823 (843)
|+.|++.||||
T Consensus 301 t~~ell~~~~f 311 (311)
T cd07866 301 TASDALEHPYF 311 (311)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.18 Aligned_cols=282 Identities=21% Similarity=0.339 Sum_probs=208.1
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecC-
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE- 579 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 579 (843)
+++...+++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45556778999999999999999999985 578999999987532 22345688899999999999999999988543
Q ss_pred -----CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEe
Q 003158 580 -----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 654 (843)
Q Consensus 580 -----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 654 (843)
...+++++++ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3478888887 78999888543 4889999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh
Q 003158 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 655 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~ 733 (843)
|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 163 dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~ 231 (345)
T cd07877 163 DFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLIL 231 (345)
T ss_pred cccccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 9999875421 1123457889999999876 568889999999999999999999996543321 111110
Q ss_pred hcccchhhccCCCCCCCHHHHH----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCC
Q 003158 734 QSSMMFSVIDGNMGSYPSECVE----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 809 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~----~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~ 809 (843)
.. ....+..... ...+....++...|..+. . +.....++...+++.+||..||+
T Consensus 232 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----------~~~~~~~~~~~~li~~~L~~dp~ 289 (345)
T cd07877 232 RL----------VGTPGAELLKKISSESARNYIQSLTQMPKMNF--A----------NVFIGANPLAVDLLEKMLVLDSD 289 (345)
T ss_pred HH----------hCCCCHHHHhhcccHhHHHHHHHhcccCCcch--h----------hhcCCCCHHHHHHHHHHcCCChh
Confidence 00 0001111111 111111122222222111 0 01112345567899999999999
Q ss_pred CCCCCccCCCCCcccC
Q 003158 810 TPPSSSSMLKHPYVSS 825 (843)
Q Consensus 810 ~R~sa~e~L~Hp~f~~ 825 (843)
+|+|+.|+++||||..
T Consensus 290 ~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 290 KRITAAQALAHAYFAQ 305 (345)
T ss_pred hcCCHHHHhcChhhhh
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.68 Aligned_cols=279 Identities=21% Similarity=0.358 Sum_probs=221.3
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHH---HHHHHHHHHhc-cCCcccceeeeeecCCcE
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 582 (843)
+...+|..+.+||+|+||+|-+|..+ +.+.+|||+++++......+ -+.|-++|... +-|.+++++.+|..-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457888999999999999999865 46889999998764433222 24566677665 578999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
|+||||+.||+|-..+++-++ +.+..+..+|..||-||-+||+++ ||.||||.+|||+|.+|.+||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999999976543 778888899999999999999999 999999999999999999999999999743
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
......+....||+.|+|||++...+|+.++|+|||||+||||+.|+.||+..+. .+ + +..+
T Consensus 501 -------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-~e-l---------F~aI 562 (683)
T KOG0696|consen 501 -------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DE-L---------FQAI 562 (683)
T ss_pred -------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-HH-H---------HHHH
Confidence 2234556678999999999999999999999999999999999999999986542 11 1 1112
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
....-.+|...+.+...+....+.+.|.+|-... |+ ...++-.|||
T Consensus 563 ~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg-------------------------------~~---ge~di~~H~F 608 (683)
T KOG0696|consen 563 MEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCG-------------------------------PE---GERDIREHPF 608 (683)
T ss_pred HHccCcCcccccHHHHHHHHHHhhcCCccccCCC-------------------------------Cc---cccchhhCcc
Confidence 2222345666666666666666666666553211 11 2257788999
Q ss_pred ccCCCCCCccccccCCCCCCC
Q 003158 823 VSSDVSGSNLVSGVIPTITPR 843 (843)
Q Consensus 823 f~~~~~~~~~~~~~~~~~~~~ 843 (843)
|+..++...-.++.-|+++|+
T Consensus 609 FR~iDWek~E~~eiqPPfkPk 629 (683)
T KOG0696|consen 609 FRRIDWEKLERREIQPPFKPK 629 (683)
T ss_pred hhhccHHHHhhccCCCCCCCc
Confidence 999999988888999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.26 Aligned_cols=251 Identities=20% Similarity=0.361 Sum_probs=201.8
Q ss_pred CCCCCCcccccCCeeEEEEEeCC--CcEEEEEEeccCC----------hhhHHHHHHHHHHHHh-ccCCcccceeeeeec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGS----------LQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE 578 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 578 (843)
.|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999754 7889999875321 1223457788888865 799999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998854 234468889999999999999999996 56 99999999999999999999999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhc
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~ 735 (843)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~---- 224 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATK---- 224 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHH----
Confidence 99997654221 223456888999999999988999999999999999999999999654322 11111
Q ss_pred ccchhhccCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 736 SMMFSVIDGNMGSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 736 ~~~~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
+..+...+.+ ..++..+.+++.+||+.+|++||++.++..+++
T Consensus 225 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 -----IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111222 245678899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=322.02 Aligned_cols=281 Identities=23% Similarity=0.365 Sum_probs=203.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 580 (843)
.++|...+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999964 68999999987532 12235678999999999999999999998654 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++|+||+. .+|.++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4699999995 47777652 34788999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~----- 229 (342)
T cd07879 166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILK----- 229 (342)
T ss_pred CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-----
Confidence 54321 122356788999999876 46889999999999999999999999754422 21211110
Q ss_pred hhccCCCCCCCHHHHHHHHHHHH-HhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 740 SVIDGNMGSYPSECVEKFIKLAL-KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~-~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
. .+.......+.+..... ......| ..|. ..+...++..+....+|+.+||+.||++|++++|++
T Consensus 230 ----~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 230 ----V-TGVPGPEFVQKLEDKAAKSYIKSLP-KYPR--------KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred ----h-cCCCCHHHHHHhcccchHHHHhhcC-Cccc--------chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0 01111222111111000 0000000 0000 011112234455567899999999999999999999
Q ss_pred CCCcccCCCC
Q 003158 819 KHPYVSSDVS 828 (843)
Q Consensus 819 ~Hp~f~~~~~ 828 (843)
.||||..-..
T Consensus 296 ~h~~f~~~~~ 305 (342)
T cd07879 296 EHPYFDSFRD 305 (342)
T ss_pred cCcchhhccc
Confidence 9999976543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.37 Aligned_cols=210 Identities=30% Similarity=0.446 Sum_probs=174.0
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecC-
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE- 579 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~- 579 (843)
.+++..++++|++.+.||+|+||.||+|.. .+++.+|+|++.... ....++.+|+.+++++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 344445678999999999999999999996 468999999987532 2345678899999998 799999999998643
Q ss_pred ----CcEEEEEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEE
Q 003158 580 ----GEQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 653 (843)
Q Consensus 580 ----~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 653 (843)
+..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 3589999999999999988642 3346889999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
+|||++....... .......|+..|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 170 ~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 170 VDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred eecccchhccccc-------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 9999987654221 111234578899999998643 36789999999999999999999997543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.26 Aligned_cols=203 Identities=32% Similarity=0.468 Sum_probs=174.5
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|+..+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999964 7899999998765443 467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999754 34788889999999999999999999 999999999999999999999999999876433211
Q ss_pred CcccceeeeeecccCCccCchhcccCC---CCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
. ........++..|+|||++.+.. ++.++||||||+++||+++|+.||...
T Consensus 156 ~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 156 M---GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred c---cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 0 11012345788999999998766 889999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.79 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=197.8
Q ss_pred ccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
||+|+||.||++... +|+.||+|.+..... ...+.+.+|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 499999999875443 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC-cccc
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG-IVPA 673 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~ 673 (843)
.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 5889999999999999999999998 9999999999999999999999999987643321100 0001
Q ss_pred eeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHH
Q 003158 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSEC 753 (843)
Q Consensus 674 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (843)
.......++..|+|||......++.++||||||+++||+++|+.||...... ....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~----------------------- 211 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIFQ----------------------- 211 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHH-----------------------
Confidence 1223455788999999999888999999999999999999999999654321 0000
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC---ccCCCCCcccCC
Q 003158 754 VEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS---SSMLKHPYVSSD 826 (843)
Q Consensus 754 ~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa---~e~L~Hp~f~~~ 826 (843)
.+.. ....+|... .......+++.+|+..+|++|||+ .|+|+||||+..
T Consensus 212 -----~~~~-----~~~~~~~~~--------------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 212 -----NILN-----GKIEWPEDV--------------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred -----HHhc-----CCcCCCccc--------------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0000 000011000 012233467778888889999999 899999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.56 Aligned_cols=195 Identities=26% Similarity=0.394 Sum_probs=170.2
Q ss_pred CCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 516 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999964 6899999998765445566788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-------~ 172 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------P 172 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-------c
Confidence 998754 34788999999999999999999998 9999999999999999999999999987543211 1
Q ss_pred eeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233568899999999999899999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=310.86 Aligned_cols=276 Identities=24% Similarity=0.354 Sum_probs=198.9
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcc-CCcccceeeeeecC--CcEEEEEe
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLVYE 587 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lV~e 587 (843)
|++.+.||+|+||.||+|... +++.||+|+++.... .......+|+.+++++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999964 689999999875322 22334567899999885 99999999999877 89999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|++ |+|.+.+.... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++ +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 58888886543 46899999999999999999999998 999999999999999 999999999998654221
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+.. +.+.... . ..
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~------~----~~ 215 (282)
T cd07831 154 -------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIH------D----VL 215 (282)
T ss_pred -------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHH------H----Hc
Confidence 1122357889999998754 55788999999999999999999999654432 1111110 0 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
+..+......+..- ...-...|..-+. .+....+.......+++.+||..||++|||++|+++||||
T Consensus 216 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 216 GTPDAEVLKKFRKS-RHMNYNFPSKKGT---------GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CCCCHHHHHhhccc-ccccccCcccccc---------cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11122121110000 0000000100000 0111122335566789999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.92 Aligned_cols=292 Identities=21% Similarity=0.290 Sum_probs=208.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-----C---Ccccceeeeeec--
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----H---RNLVSLVGYCDE-- 578 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~-- 578 (843)
..+|.+.++||.|.|++||+|.+ .+.+.||+|+.+.. ....+....||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 47899999999999999999995 57899999999853 233456788999999984 2 379999999965
Q ss_pred --CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC--------
Q 003158 579 --EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------- 648 (843)
Q Consensus 579 --~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-------- 648 (843)
+.+.|+|+|++ |.+|..+|....-..++...+++|++||+.||.|||+++ +|||.||||+|||+...
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 45899999999 789999998877777999999999999999999999987 49999999999999110
Q ss_pred --------------------------------------------------------------------------------
Q 003158 649 -------------------------------------------------------------------------------- 648 (843)
Q Consensus 649 -------------------------------------------------------------------------------- 648 (843)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 003158 649 ------------------------------------------------------------------------------FT 650 (843)
Q Consensus 649 ------------------------------------------------------------------------------~~ 650 (843)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc--h-HH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--I-VR 727 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~--~-~~ 727 (843)
+||+|||-|+... ...+.-..|..|+|||++.+..|++.+||||++|+++||.||...|++... . .+
T Consensus 393 vKIaDlGNACW~~----------khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD 462 (590)
T KOG1290|consen 393 VKIADLGNACWVH----------KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD 462 (590)
T ss_pred EEEeeccchhhhh----------hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence 3334444433321 112334578899999999999999999999999999999999999975321 1 11
Q ss_pred HHHHHhhcccchhhccCCCCCCCHH------HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCcccc
Q 003158 728 EVNIAYQSSMMFSVIDGNMGSYPSE------CVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFIN 801 (843)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~ 801 (843)
....+... ++ ++..|.. .+.++..--... .. -.|-.+--+.+.|.+.++...+.+.++.|||.
T Consensus 463 EDHiA~i~----EL----LG~iPr~ia~~Gk~SRdFFnr~G~L-rh--I~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~ 531 (590)
T KOG1290|consen 463 EDHIALIM----EL----LGKIPRKIALGGKYSRDFFNRRGEL-RH--IRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLS 531 (590)
T ss_pred HHHHHHHH----HH----HhhccHHHHhcCcchHhhhccccce-ec--ccccCCCcHHHHHHHHhCCCHHHHHHHHHHHH
Confidence 11111111 11 1111211 111111110000 00 01222222334455555555566778889999
Q ss_pred CCCCCCCCCCCCCccCCCCCcccCC
Q 003158 802 SEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 802 ~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
.||+++|++|+||.++|+|||+...
T Consensus 532 PmLef~PeKR~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 532 PMLEFDPEKRPTAAQCLKHPWLNPV 556 (590)
T ss_pred HHHhcCccccccHHHHhcCccccCC
Confidence 9999999999999999999999863
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.45 Aligned_cols=201 Identities=27% Similarity=0.464 Sum_probs=173.7
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 58899999986532 22345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 667 (843)
+++++|.+++.......+++..++.++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997765556899999999999999999999998 99999999999999886 56999999987654221
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 157 ------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 157 ------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred ------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1122345889999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.03 Aligned_cols=203 Identities=25% Similarity=0.357 Sum_probs=171.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~ 586 (843)
...|++.+.||+||.++||++...+.+.+|+|++... ..+....|..|+..|.+++ |.+|+++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4578889999999999999999888888998876542 3334578999999999995 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||- ..+|..+|+.+......| .++.+..||+.|+.++|.+| |||.||||.|.|+-+ |.+||+|||+|.....+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 987 469999998876665555 78889999999999999999 999999999998875 689999999998765432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCC-----------CCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----------LTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
..-.....+||+.||+||.+.... .+.++||||+||+||+|+.|+.||..-.
T Consensus 514 -----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 514 -----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred -----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 123345568999999999996432 4568999999999999999999997544
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.68 Aligned_cols=203 Identities=25% Similarity=0.434 Sum_probs=172.4
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh------hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
+|+..+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999995 5789999999874321 124678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAP 663 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~ 663 (843)
||||+++++|.+++.... ++++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997543 5788999999999999999999998 99999999999998776 69999999987664
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
...... ........++..|+|||.+.+..++.++||||+||++|+|++|..||...
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 156 AKGTGA---GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccC---CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 321100 11122345788999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.80 Aligned_cols=203 Identities=32% Similarity=0.452 Sum_probs=172.4
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCC------
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG------ 580 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------ 580 (843)
.+++|++.+.||+|+||.||+|... +++.+|+|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999975 678999999875433 346789999999999 6999999999996544
Q ss_pred cEEEEEecCCCCCHHHHHhhcC--CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
..++||||+++++|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987533 456899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 160 SAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ceecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 87653211 11233458889999999864 34678899999999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=319.95 Aligned_cols=293 Identities=25% Similarity=0.360 Sum_probs=213.7
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCC-----cEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-----EQM 583 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 583 (843)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999965 58999999987643 334568899999999999999999999997765 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||++ ++|.+++.... ++++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58999886543 6899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
..... ........++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... .......
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~i~--------- 220 (330)
T cd07834 155 PDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNLIV--------- 220 (330)
T ss_pred ccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHH---------
Confidence 33210 0112334578899999999887 7899999999999999999999999765432 1111110
Q ss_pred cCCCCCCCHHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 743 DGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
...+..+.+..... ...+...+...+..++ . .+....+.....+.+++.+||..+|++|||++++++||
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 221 -EVLGTPSEEDLKFITSEKARNYLKSLPKKPK-K--------PLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred -HhcCCCChhHhhhccccchhhHHhhcccCCc-c--------hhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 00111111111100 0000000000000000 0 01112233455567899999999999999999999999
Q ss_pred cccCCCCCCcccc
Q 003158 822 YVSSDVSGSNLVS 834 (843)
Q Consensus 822 ~f~~~~~~~~~~~ 834 (843)
||.+-...++-.+
T Consensus 291 ~~~~~~~~~~~~~ 303 (330)
T cd07834 291 YLAQLHDPEDEPV 303 (330)
T ss_pred cHHhhcccccCCC
Confidence 9977555443333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=301.06 Aligned_cols=201 Identities=30% Similarity=0.429 Sum_probs=177.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999976 599999999876543 3457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
+++++|.+++... .++++..++.++.|+++|++|||+ .+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999764 458899999999999999999999 88 99999999999999999999999999986543221
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 156 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 156 -------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred -------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1123457889999999999999999999999999999999999997553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=303.15 Aligned_cols=202 Identities=27% Similarity=0.455 Sum_probs=170.2
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh----------hHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ----------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 580 (843)
+|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 6899999987532111 1246788999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 35888899999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
...... .........|+..|+|||.+.... ++.++||||||+++||+++|..||....
T Consensus 157 ~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 157 KSDDIY-----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred cccccc-----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 643211 011123345888999999988654 7889999999999999999999996443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.99 Aligned_cols=200 Identities=29% Similarity=0.424 Sum_probs=166.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHH-HHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|+||.||+|... +|+.||+|++..... ....++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999965 699999999875432 334566667665 666789999999999999999999999
Q ss_pred cCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 588 FMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 588 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|++ |+|.+++... ....+++..++.++.||+.||+|||++ + ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 7898888652 234689999999999999999999987 7 99999999999999999999999999876532
Q ss_pred CCCCCcccceeeeeecccCCccCchhccc----CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
. .......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...
T Consensus 157 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 157 S--------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred c--------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 1 11123457889999999865 45688999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=346.11 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=207.7
Q ss_pred HcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
+-+++....||.|.||.||.|. .++|...|+|-++... ....+.+.+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4577778999999999999999 5679999999776432 223467789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|||++|+|.++++..+ ..++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|......-
T Consensus 1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999996543 3667777789999999999999999 9999999999999999999999999998876431
Q ss_pred CCCcccceeeeeecccCCccCchhcccC---CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
. ..+ .......||+.|||||++.+. ...-+.||||+||++.||+||+.||..-++.. ..|+.+-.
T Consensus 1389 ~--~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---------aIMy~V~~ 1456 (1509)
T KOG4645|consen 1389 Q--TMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---------AIMYHVAA 1456 (1509)
T ss_pred h--cCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---------HHHhHHhc
Confidence 1 111 222356799999999999863 45668999999999999999999997655422 34566667
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
+..+++|+..+.+-.+++..|+..||++|-++.|+++
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 7778888887777778888888888877766555543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.03 Aligned_cols=199 Identities=28% Similarity=0.351 Sum_probs=168.3
Q ss_pred CCCCCCcccccCCeeEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcE
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 582 (843)
+|++.+.||+|+||.||++.. .+++.||||.+..... ...+.+.+|+++++++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477788999999999999984 2578999999874322 2235688999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998653 35788899999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCC--CCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
.... ........|+..|+|||.+.+.. .+.++||||||+++|||++|..||..
T Consensus 156 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 156 LAEE------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccc------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 4321 11112345788999999987755 78899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.24 Aligned_cols=278 Identities=26% Similarity=0.405 Sum_probs=209.0
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
|++.+.||+|++|.||+|... +++.+|+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999964 7899999998754332 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
+ ++|.+++.... ..+++..++.++.|+++||.|||+.+ |+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 6 48988886643 46899999999999999999999999 9999999999999999999999999997664321
Q ss_pred cccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... +....... ..+.
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~----------~~~~ 217 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFR----------TLGT 217 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH----------HcCC
Confidence 111234577889999999876 7899999999999999999999999765432 22221110 0111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 749 YPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
...+....+.+....+....|... ....++. +..+....+|+.+|+..||.+||+++|++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF----------PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CchHhcccchhhhhhhhhhhccccccCHHHhh----------hhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 111222222222222211112211 1221111 2234556689999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.15 Aligned_cols=291 Identities=25% Similarity=0.338 Sum_probs=206.6
Q ss_pred cCCCC-CCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh--------------HHHHHHHHHHHHhccCCcccceee
Q 003158 511 NNFNS-STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--------------EKEFLTEIQFLSRLHHRNLVSLVG 574 (843)
Q Consensus 511 ~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~~ 574 (843)
++|.. .+.||+|+||+||+|... +++.||||.+....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999965 68999999886432221 125778999999999999999999
Q ss_pred eeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEe
Q 003158 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 654 (843)
Q Consensus 575 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 654 (843)
++...+..++||||++ |+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6999998653 34788999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCCCc-------ccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchH
Q 003158 655 DFGLSRLAPVPDIEGI-------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 726 (843)
Q Consensus 655 DfGla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~ 726 (843)
|||++........... ..........++..|+|||.+.+. .++.++|||||||++|||++|+.||....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999976542111000 001111233467889999999764 46889999999999999999999997654322
Q ss_pred HHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCC
Q 003158 727 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 806 (843)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~ 806 (843)
. ...... .. +..+...+.....+... ....+...+... ...+.....+.+++.+||..
T Consensus 242 ~-~~~i~~------~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 242 Q-LGRIFE------LL----GTPNEDNWPQAKKLPLY-TEFTPRKPKDLK----------TIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred H-HHHHHH------Hh----CCCchhhCcchhhcccc-cccCcCCcccHH----------HhCcCCChHHHHHHHHHcCC
Confidence 1 111100 00 00000000000000000 000011111111 11233345567899999999
Q ss_pred CCCCCCCCccCCCCCcccCCCCC
Q 003158 807 KEETPPSSSSMLKHPYVSSDVSG 829 (843)
Q Consensus 807 dp~~R~sa~e~L~Hp~f~~~~~~ 829 (843)
||++|+|++|+|.||||++...-
T Consensus 300 ~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 300 NPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred CchhccCHHHHhcCcccCCCCCC
Confidence 99999999999999999877553
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.51 Aligned_cols=191 Identities=27% Similarity=0.383 Sum_probs=159.0
Q ss_pred cccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHH---HHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 518 QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQ---FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
.||+|+||.||+|... +++.||+|.+...... ....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 6899999988753322 1223344443 4445579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|.+++... ..+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99999988653 35899999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.....|+..|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1233588999999999754 6889999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.24 Aligned_cols=200 Identities=26% Similarity=0.435 Sum_probs=174.9
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
++|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6888999999999999999985 468899999987554455567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 999999998653 3678889999999999999999999 9999999999999999999999999887554221
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......+++.|+|||.+....++.++|||||||++||+++|+.||....
T Consensus 170 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223458889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.74 Aligned_cols=283 Identities=24% Similarity=0.374 Sum_probs=207.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC-----Cc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 581 (843)
.++|.+.+.||+|+||+||+|.. .+++.||||.+... .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788999999999999999995 46899999998753 223345678899999999999999999988543 35
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7999988654 35889999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ....... .
T Consensus 158 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~------~ 223 (337)
T cd07858 158 TSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLIT------E 223 (337)
T ss_pred cCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHH------H
Confidence 54321 11223457889999999875 46889999999999999999999999654321 1111100 0
Q ss_pred hccCCCCCCCHHHHH-----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCc
Q 003158 741 VIDGNMGSYPSECVE-----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 815 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~-----~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~ 815 (843)
.. +..+.+... ...+.+. ......++... ...+.......+++++||+.||++|||++
T Consensus 224 ~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 224 LL----GSPSEEDLGFIRNEKARRYIR---SLPYTPRQSFA----------RLFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred Hh----CCCChHHhhhcCchhhhHHHH---hcCcccccCHH----------HHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 10 111111000 0000000 00011112221 11234455567899999999999999999
Q ss_pred cCCCCCcccCCCCC
Q 003158 816 SMLKHPYVSSDVSG 829 (843)
Q Consensus 816 e~L~Hp~f~~~~~~ 829 (843)
|+++||||......
T Consensus 287 ell~h~~~~~~~~~ 300 (337)
T cd07858 287 EALAHPYLASLHDP 300 (337)
T ss_pred HHHcCcchhhhcCc
Confidence 99999999764443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.58 Aligned_cols=276 Identities=26% Similarity=0.365 Sum_probs=200.3
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhc---cCCcccceeeeeecCCc-----
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCDEEGE----- 581 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~----- 581 (843)
|++.+.||+|+||.||+|+.+ +++.||+|++...... ....+.+|+.+++++ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 5899999998743222 234566788777666 59999999999987766
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.+++|||+. ++|.+++.......+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 58999987655456899999999999999999999998 99999999999999999999999999977
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||..... .+...........
T Consensus 157 ~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~--- 224 (287)
T cd07838 157 YSFEM--------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGL--- 224 (287)
T ss_pred ccCCc--------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCC---
Confidence 54321 11223478899999999999999999999999999999999888865432 2222211110000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
......+. .......++...+. +.+.++. +.......+++.+|+..||++||+++|++.||
T Consensus 225 ------~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 225 ------PSEEEWPR-NVSLPRSSFPSYTP--RSFKSFV----------PEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred ------CChHhcCC-Ccccchhhcccccc--cchhhhh----------hhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 00000000 00000001110000 1111111 12234455899999999999999999999999
Q ss_pred cc
Q 003158 822 YV 823 (843)
Q Consensus 822 ~f 823 (843)
||
T Consensus 286 ~~ 287 (287)
T cd07838 286 YF 287 (287)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=315.86 Aligned_cols=290 Identities=26% Similarity=0.397 Sum_probs=209.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhc-cCCcccceeeeeecC--CcE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE--GEQ 582 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~ 582 (843)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999965 6889999988542 223345677899999999 999999999998643 368
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||++ ++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 5999988653 5788899999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
....... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~------ 228 (337)
T cd07852 158 SELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEV------ 228 (337)
T ss_pred ccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH------
Confidence 4322110 0112233468899999998865 557889999999999999999999996544321 11111000
Q ss_pred ccCCCCCCCHHHHHHHH-HHHHHhcccCC-CCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 742 IDGNMGSYPSECVEKFI-KLALKCCQDET-DARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~-~l~~~c~~~~p-~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
.+..+.+....+. .....++...+ ..++.+.+ ..+.......+++.+|++.||++|||+.++++
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 229 ----IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE----------LLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred ----hCCCCHHHHHHHHhhhHHHhhhhcccccccchhh----------hccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0111222222111 11111222111 11122211 12233455668999999999999999999999
Q ss_pred CCcccCCCC
Q 003158 820 HPYVSSDVS 828 (843)
Q Consensus 820 Hp~f~~~~~ 828 (843)
||||..-..
T Consensus 295 ~~~~~~~~~ 303 (337)
T cd07852 295 HPYVAQFHN 303 (337)
T ss_pred Chhhhhhcc
Confidence 999976533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=283.80 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=201.2
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+.+.+..||.|..|.||++..+ .|...|||.+... ..+..+++...+.++..-+ +|.||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3444677999999999999965 5899999998754 4455688888888776654 99999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
| .-.++.++.+ -..++++..+-++...+.+||.||-+++ .|||||+||+|||+|+.|++|++|||++-.+..
T Consensus 173 M-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---- 244 (391)
T KOG0983|consen 173 M-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---- 244 (391)
T ss_pred H-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec----
Confidence 9 4466666644 4457999999999999999999998866 399999999999999999999999999976543
Q ss_pred CcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
+...+...|.+.|||||.+.- ..|+-++||||||++++||.||+.||...+...+.+.. +.+..
T Consensus 245 ----SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk---------vln~e 311 (391)
T KOG0983|consen 245 ----SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK---------VLNEE 311 (391)
T ss_pred ----ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH---------HHhcC
Confidence 233455679999999999964 46888999999999999999999999875544443333 22222
Q ss_pred CCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 746 MGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 746 ~~~--~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
.+. ....+++.+.+++..|+.+|+.+||.+.+++++
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222 233478899999999999999999999988754
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.85 Aligned_cols=198 Identities=29% Similarity=0.470 Sum_probs=171.0
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcc---CCcccceeeeeecCCcEEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|+++++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 478999999987543 233467889999999997 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++++|.++++.. ++++..++.++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998543 5889999999999999999999999 9999999999999999999999999998664322
Q ss_pred CCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223458889999999875 45688999999999999999999999654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=303.16 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=196.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+-|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34677889999999999999864 68999999886433 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 84 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 999999999854 35789999999999999999999998 9999999999999999999999999987654321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||.+.+..++.++|||||||++|||++|..||..... ..... .+.......
T Consensus 156 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~---------~~~~~~~~~ 220 (277)
T cd06641 156 -----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MKVLF---------LIPKNNPPT 220 (277)
T ss_pred -----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HHHHH---------HHhcCCCCC
Confidence 111234578899999999988889999999999999999999999964332 11111 011111222
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
.+..++..+.+++.+||+.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 34445566777777777777777777777665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.83 Aligned_cols=208 Identities=25% Similarity=0.371 Sum_probs=176.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV 585 (843)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999965 79999999987532 233467889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997643 5899999999999999999999999 999999999999999999999999999866432
Q ss_pred CCCCcc-------------cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 666 DIEGIV-------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 666 ~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
...... .........++..|+|||...+..++.++||||||++++++++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 211000 0012233457889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=310.90 Aligned_cols=277 Identities=28% Similarity=0.432 Sum_probs=206.4
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+..|+++++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999965 59999999988643 223467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
+ ++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||.++......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 152 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--- 152 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc---
Confidence 7 59999997643 35889999999999999999999998 9999999999999999999999999997654321
Q ss_pred cccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ........ ....
T Consensus 153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~----------~~~~ 217 (282)
T cd07829 153 ----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQ----------ILGT 217 (282)
T ss_pred ----cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHH----------HhCC
Confidence 111233456789999999876 7899999999999999999999888654432 11111100 0111
Q ss_pred CCHHHHHHHHHHHHHhcccC-CCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 749 YPSECVEKFIKLALKCCQDE-TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~-p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
..+..+..+..+. -+... |..... .....++..+..+.+++++|+..||++||++++++.||||
T Consensus 218 ~~~~~~~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 218 PTEESWPGVTKLP--DYKPTFPKFPPK---------DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CcHHHHHhhcccc--cccccccccCcc---------chHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1112222221111 00000 000000 0011223335567789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.51 Aligned_cols=193 Identities=26% Similarity=0.438 Sum_probs=168.6
Q ss_pred CcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHH
Q 003158 517 TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 595 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 595 (843)
..||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 478999999987555555667899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCccccee
Q 003158 596 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675 (843)
Q Consensus 596 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 675 (843)
+++... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... ..
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------~~ 172 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------PR 172 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-------cc
Confidence 987542 4788899999999999999999998 9999999999999999999999999887543211 11
Q ss_pred eeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 676 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 676 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.....|+..|+|||.+.+..++.++|+||+|+++|||++|..||...
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12345788999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.86 Aligned_cols=291 Identities=20% Similarity=0.200 Sum_probs=198.3
Q ss_pred CcccccCCeeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 517 TQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344444444444444 6899999998754 233456899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
.+++.......+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+...............
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99998765566889999999999999999999999 999999999999999999999999998755322211111111
Q ss_pred eeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHH
Q 003158 675 VSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (843)
......++..|+|||++.. ..++.++|||||||++|||++|+.||............. .......++... .+..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~ 239 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV--RGTVPCLLDKST--YPLY 239 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCccccccCc--hhhh
Confidence 2234457788999999976 458889999999999999999999998654332222111 000000000000 0000
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 753 ~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
.. .... .+ .....+......-..... ..+....+|+.+||++||++|||++|+|+||||....
T Consensus 240 ~~-~~~~---~~--~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 240 ED-SMSQ---SR--SSNEHPNNRDSVDHPYTR------TFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cC-CcCc---cc--ccccccchhhhhhcchhh------HHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00 0000 00 000000000000000000 0112345789999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.65 Aligned_cols=281 Identities=22% Similarity=0.353 Sum_probs=207.4
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCC-----
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----- 580 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 580 (843)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++|+||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999985 478999999986432 223456889999999999999999999986543
Q ss_pred -cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 581 -EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 581 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7899988853 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
...... .....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||........ ......
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~---- 230 (343)
T cd07880 166 RQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMK---- 230 (343)
T ss_pred cccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH----
Confidence 764321 123356889999999876 4588899999999999999999999976543221 111100
Q ss_pred hhhccCCCCCCCHHHHHHHHHH-HHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKL-ALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l-~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
.....+.++...+... ...-...-|..++. + +....+.....+.+++.+||..||++|+|+.++
T Consensus 231 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 231 ------VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKK--D-------FRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred ------hcCCCCHHHHHhhcchhHHHHHHhccccCcc--h-------HHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 0011122222222100 00000011111111 0 111223445556789999999999999999999
Q ss_pred CCCCcccCC
Q 003158 818 LKHPYVSSD 826 (843)
Q Consensus 818 L~Hp~f~~~ 826 (843)
+.||||+..
T Consensus 296 l~~~~~~~~ 304 (343)
T cd07880 296 LAHPYFEEF 304 (343)
T ss_pred hcCccHhhh
Confidence 999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.26 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=177.4
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++.|+..+.||+|++|.||+|..+ +++.||+|++..... ..+.+.+|+++++.++|+||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566888899999999999999976 689999999986444 55678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999997754 46899999999999999999999988 9999999999999999999999999987543221
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 171 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 171 ------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 11123457889999999998889999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=291.59 Aligned_cols=285 Identities=24% Similarity=0.344 Sum_probs=215.3
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC-----CcEEE
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQML 584 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l 584 (843)
.+..+.||.|+||.||...++ +|+.||.|++..- +...-+++.+|+++|..++|.|++..++..... .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344678999999999999964 7999999988642 334457899999999999999999998876543 36789
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|+|.|. .+|...+- +.++++.+.++-+..||++||+|||+.+ |.||||||.|.|++++..+||+|||+|+..+.
T Consensus 135 ~TELmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 999995 58887773 4567888899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.+ ....+....|..|+|||.+++ ..|+.+.||||+||++.|++.++..|.... ..++++. +.
T Consensus 209 d~------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-PiqQL~l----------It 271 (449)
T KOG0664|consen 209 RD------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-PIEQLQM----------II 271 (449)
T ss_pred hh------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-hHHHHHH----------HH
Confidence 43 334455677899999999998 568999999999999999998877776543 3333322 22
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
..++....+......+-++.-+-..+.+-|+..-+... . .......+..+++.+||.+||.+|++.++++.|+|.
T Consensus 272 dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtl-s----S~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 272 DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKI-A----SPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeee-c----CCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 23344444444444444444334445555555433211 0 001223345678999999999999999999999997
Q ss_pred cC
Q 003158 824 SS 825 (843)
Q Consensus 824 ~~ 825 (843)
..
T Consensus 347 ~e 348 (449)
T KOG0664|consen 347 EE 348 (449)
T ss_pred cc
Confidence 43
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.12 Aligned_cols=244 Identities=30% Similarity=0.466 Sum_probs=190.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
..|+..+.||+|+||+||+|... +++.||+|.+.... ....+++.+|+++++.++||||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999964 68999999886432 223457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9996 68877775432 35889999999999999999999998 999999999999999999999999998754321
Q ss_pred CCCcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
....++..|+|||++. ...++.++||||||+++|||++|+.||........... +..
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----------~~~ 228 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----------IAQ 228 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----------Hhc
Confidence 2235778999999985 35688899999999999999999999975543221111 111
Q ss_pred CCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 744 GNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 744 ~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
..... .+..++..+.+++.+||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11111 12345556666666666666666666666654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.04 Aligned_cols=279 Identities=26% Similarity=0.381 Sum_probs=205.0
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEecC
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
|++.+.||+|+||+||+|... +++.||+|++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 588999999875332 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
+|+|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 889999997765556899999999999999999999998 9999999999999999999999999997654221
Q ss_pred cccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
......++..|+|||.+.. ..++.++|+||||++++||++|+.||....... ...... .. .+.
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~------~~----~~~ 217 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKIC------SV----LGT 217 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHH------Hh----cCC
Confidence 1123457889999998854 557899999999999999999999986544321 111100 01 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
...+.+.+...+.. .+...-..++.. . + ....+.......+++++|++.||++|||++|++.||||
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~-~----~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 218 PTKQDWPEGYKLAS-KLGFRFPQFAPT-S----L---HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred CChhhhhhHhhhhc-cccccccccccc-c----H---HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11111111111111 111100000000 0 0 11223334556789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=299.78 Aligned_cols=190 Identities=27% Similarity=0.370 Sum_probs=160.8
Q ss_pred CcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHH-HhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFL-SRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||.||+|... +++.||+|++....... ...+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999964 68999999987543222 23345555544 445899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
++|.+++.... ++++..+..++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 99999996543 5788889999999999999999998 99999999999999999999999999875432
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 12335788999999999888899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=331.57 Aligned_cols=264 Identities=28% Similarity=0.477 Sum_probs=218.9
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC----C----CcEEEEEEeccCChh-hHHHHHHHHHHHHhc-cCCcccceee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP----D----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSLVG 574 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~ 574 (843)
.++...++..+.+.||+|.||.||+|... . ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 46666677777789999999999999843 1 457999999865433 457899999999998 6999999999
Q ss_pred eeecCCcEEEEEecCCCCCHHHHHhhcC------------C--CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCC
Q 003158 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKS------------K--EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 640 (843)
Q Consensus 575 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp 640 (843)
+|...+..++|+||+..|+|.++++..+ . ..+...+.+.++.|||.|++||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998755 0 23888999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecc--cCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCC
Q 003158 641 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 717 (843)
Q Consensus 641 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~ 717 (843)
+|||+.++..+||+|||+|+.....+.. ......| ...|||||.+....++.+|||||||++||||+| |..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y------~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYY------RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCce------EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999965543321 1111122 345999999999999999999999999999999 889
Q ss_pred CCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 718 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 718 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
||.......+. +..+.++.+...|..|.++++++|..||+.+|++||++.++.+.++...
T Consensus 521 PYp~~~~~~~l---------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 521 PYPGIPPTEEL---------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCCCCcHHHH---------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 99753211111 1134556677789999999999999999999999999999999999854
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.96 Aligned_cols=280 Identities=22% Similarity=0.366 Sum_probs=207.7
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCc----
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE---- 581 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 581 (843)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999975 6889999998643 22234567889999999999999999998866554
Q ss_pred --EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 582 --QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 582 --~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6799999864 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+.....
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~---- 230 (343)
T cd07851 166 RHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMN---- 230 (343)
T ss_pred cccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH----
Confidence 765321 123357888999999875 46788999999999999999999999755432 22221110
Q ss_pred hhhccCCCCCCCHHHHHHHHHHH--HHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLA--LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~--~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
. .+..++.....+..-. ..+-......++.+.++ .+..+..+.+++.+||..||++|||++|
T Consensus 231 --~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 231 --L----VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV----------FSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred --h----cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHH----------hccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 0 1112222222111000 00000011112222221 1223556678999999999999999999
Q ss_pred CCCCCcccCC
Q 003158 817 MLKHPYVSSD 826 (843)
Q Consensus 817 ~L~Hp~f~~~ 826 (843)
+++||||..-
T Consensus 295 ll~h~~~~~~ 304 (343)
T cd07851 295 ALAHPYLAEY 304 (343)
T ss_pred HhcCCCcccc
Confidence 9999999653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.79 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=176.6
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|++.+.||+|+||.||++... +++.||+|++..... ...+++.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5778899999999999999965 689999999876433 4456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC--CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
+++++|.+++.... ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 467899999999999999999999998 9999999999999999999999999997654321
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||...
T Consensus 158 -------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1223346888999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.85 Aligned_cols=199 Identities=29% Similarity=0.412 Sum_probs=165.3
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999964 68999999987533 234567889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHH---hhcCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 589 MSNGTLRDQL---SAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 589 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
+. +++.++. .......+++..+..++.|+++||+|||+. + |+||||||+||++++++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 4665543 233345689999999999999999999975 6 99999999999999999999999999975432
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccC---CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 161 SI--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CC--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 11 11233578899999999876 6889999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=290.40 Aligned_cols=268 Identities=23% Similarity=0.331 Sum_probs=224.4
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeCC------CcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeee
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGY 575 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~ 575 (843)
..++.+...+++....+-+|.||.||.|.|.+ .+.|-||.++.... .....+..|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34677778889999999999999999998653 34577787765432 334678889999999999999999999
Q ss_pred eec-CCcEEEEEecCCCCCHHHHHhh------cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC
Q 003158 576 CDE-EGEQMLVYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 648 (843)
Q Consensus 576 ~~~-~~~~~lV~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 648 (843)
+.+ ....+++|.++.-|+|..++.. ...+.+...+...++.|++.|++|||+++ |||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 854 4677999999999999999972 34456788888999999999999999999 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHH
Q 003158 649 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 727 (843)
Q Consensus 649 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~ 727 (843)
.++||+|=.+++.+...++... .........||+||.+....|+.++||||||++||||+| |+.||..-+..+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred eeEEeccchhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 9999999999998876664332 223345678999999999999999999999999999999 999997655321
Q ss_pred HHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 728 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
....+.++.+...|-+|++++..+|..||...|++||++++++.-|.++..+
T Consensus 507 ---------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 ---------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ---------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 1224567777788999999999999999999999999999999999887654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.76 Aligned_cols=273 Identities=25% Similarity=0.395 Sum_probs=210.5
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccC-Chhh------HHHHHHHHHHHHhccCCcccceeeee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEG-SLQG------EKEFLTEIQFLSRLHHRNLVSLVGYC 576 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~ 576 (843)
+-....++|-.++.||+|||+.||+|. +...+.||||+-... .... .+...+|.++-+.+.||.||++|+||
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 334456788889999999999999999 457899999985421 2221 24578899999999999999999999
Q ss_pred e-cCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc---CCCcEE
Q 003158 577 D-EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAK 652 (843)
Q Consensus 577 ~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~k 652 (843)
. +.+.+|-|+|||+|.+|+-||+.+. .+++.+++.|+.||+.||.||.+. ++||||-||||.|||+. ..|.+|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 5 5568899999999999999997653 488999999999999999999987 58899999999999995 457899
Q ss_pred EeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC----CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHH
Q 003158 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 728 (843)
Q Consensus 653 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~ 728 (843)
|.|||+++.++...++.......+.-..||.+|++||.+.-+ +.+.++||||+||++|.++.|+.||.......+.
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 999999999886655444444555667899999999998643 5788999999999999999999999865432222
Q ss_pred HHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCC
Q 003158 729 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE 808 (843)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp 808 (843)
+.. .. ++....-.|| .-|..+..+.+||++||.+.-
T Consensus 694 Lqe----NT---IlkAtEVqFP-------------------------------------~KPvVsseAkaFIRRCLaYRK 729 (775)
T KOG1151|consen 694 LQE----NT---ILKATEVQFP-------------------------------------PKPVVSSEAKAFIRRCLAYRK 729 (775)
T ss_pred Hhh----hc---hhcceeccCC-------------------------------------CCCccCHHHHHHHHHHHHhhh
Confidence 111 11 1111101111 112234445578888888888
Q ss_pred CCCCCCccCCCCCccc
Q 003158 809 ETPPSSSSMLKHPYVS 824 (843)
Q Consensus 809 ~~R~sa~e~L~Hp~f~ 824 (843)
++|+...|+-.||||.
T Consensus 730 eDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 730 EDRIDVQQLACDPYLL 745 (775)
T ss_pred hhhhhHHHHccCcccc
Confidence 8888888888888883
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=291.55 Aligned_cols=200 Identities=34% Similarity=0.511 Sum_probs=177.0
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
.|+..+.||+|++|.||++... +++.+++|++........+.+.+|+++++.++|+||+++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3777899999999999999975 689999999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+++|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999986643 46899999999999999999999988 99999999999999999999999999876543210
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 234468889999999998889999999999999999999999997543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=276.30 Aligned_cols=278 Identities=16% Similarity=0.332 Sum_probs=211.1
Q ss_pred HcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeecC--CcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lV 585 (843)
.++|++.+++|+|.++.||.|. ..+.+.++||+++. -..+.+.+|+++|+.+. ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5689999999999999999999 56789999999974 23467899999999997 99999999998664 467899
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPV 664 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~ 664 (843)
+||+.+-+...+.. .+...++..+..++++||.|+|++| |+|||+||.||++|... .++|+|+|+|.+...
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999988877663 3677788899999999999999999 99999999999999654 699999999998764
Q ss_pred CCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. .......+..|--||.+.. ..|+.+-|+|||||++..|+..+.||+.+.+-.+++..+...-..
T Consensus 186 ~~--------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt----- 252 (338)
T KOG0668|consen 186 GK--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT----- 252 (338)
T ss_pred Cc--------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh-----
Confidence 32 2233445677889999986 568899999999999999999999999888766666543211100
Q ss_pred CCCCCCCHHHHHHHHH-HHHHhcccCCCCCCCHHHHHHHHHH--hhhhCCC-----CCCCCCccccCCCCCCCCCCCCCc
Q 003158 744 GNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELES--IWNMMPE-----SDTKTPEFINSEHTSKEETPPSSS 815 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~-l~~~c~~~~p~~RPs~~~vl~~L~~--~~~~~~~-----~~~~~~dll~~~L~~dp~~R~sa~ 815 (843)
+++.. +...-+. --|.+.+++..-.+ +...... ..+++.||+.++|.+|-.+|+||+
T Consensus 253 -----------~el~~Yl~KY~i~----Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak 317 (338)
T KOG0668|consen 253 -----------DELYAYLNKYQID----LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK 317 (338)
T ss_pred -----------HHHHHHHHHHccC----CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence 01111 1111111 12233333322111 1111111 246678999999999999999999
Q ss_pred cCCCCCcccCC
Q 003158 816 SMLKHPYVSSD 826 (843)
Q Consensus 816 e~L~Hp~f~~~ 826 (843)
||+.||||..-
T Consensus 318 Eam~HpyF~~~ 328 (338)
T KOG0668|consen 318 EAMAHPYFAPV 328 (338)
T ss_pred HHhcCchHHHH
Confidence 99999999653
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.65 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=197.5
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|++.+.||+|+||.||++... +++.+|+|.+.... .....++.+|+++++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 68899999987533 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998662 2346889999999999999999999999 999999999999999999999999999766432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... .... .+..+..
T Consensus 157 --------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~~---------~~~~~~~ 218 (256)
T cd08530 157 --------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLRY---------KVQRGKY 218 (256)
T ss_pred --------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH---------HHhcCCC
Confidence 112235788999999999999999999999999999999999999754421 1111 1112223
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
+..+..+..++.+++.+|+..+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3344455666677777777766666666666553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=292.83 Aligned_cols=202 Identities=29% Similarity=0.449 Sum_probs=176.6
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecC--CcEEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLVY 586 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~ 586 (843)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 689999999876443 3457889999999999999999999999888 8899999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 6899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.. .......++..|+|||.+.+...+.++||||||+++++|++|..||....
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 10 01234568889999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.42 Aligned_cols=264 Identities=14% Similarity=0.165 Sum_probs=188.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC----CcEEEEEEeccCChh--hH---------HHHHHHHHHHHhccCCcccceee
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQ--GE---------KEFLTEIQFLSRLHHRNLVSLVG 574 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~---------~~~~~E~~~l~~l~h~nIv~l~~ 574 (843)
.++|.+.+.||+|+||+||+|...+ +..+|+|+....... .+ .....+...+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999653 456777754322211 11 11223344556678999999999
Q ss_pred eeecCC----cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc
Q 003158 575 YCDEEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650 (843)
Q Consensus 575 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 650 (843)
++.... ..++++|++. .++.+.+.... ..++..+..++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 765443 3478888873 47777765432 3567788899999999999999998 999999999999999999
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 730 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~ 730 (843)
++|+|||+|+....................||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986643211111011112334699999999999999999999999999999999999999976532221111
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L 782 (843)
.. .......+..+.. ....++..+.+++..||+.+|++||++.++.+.+
T Consensus 245 ~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AA-KCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred Hh-HHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10 0000111111111 1223467789999999999999999999998764
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=293.53 Aligned_cols=203 Identities=29% Similarity=0.430 Sum_probs=170.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC-----ChhhHHHHHHHHHHHHhccCCcccceeeeeecC--CcE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQ 582 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 582 (843)
.+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999964 6899999987532 122345788999999999999999999998654 457
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999986543 4788889999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 157 QTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 321110 11112345889999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=301.86 Aligned_cols=245 Identities=29% Similarity=0.469 Sum_probs=194.4
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
|+..+.||+|+||.||+|... ++..||+|.+..... ...+++.+|+++++.++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999964 689999999864322 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+. |+|.+++... ..++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 96 5888877543 345889999999999999999999999 999999999999999999999999998754321
Q ss_pred CcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
....|+..|+|||++. ...++.++|||||||++|||++|+.||.......... .+....
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~----------~~~~~~ 240 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----------HIAQNE 240 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH----------HHHhcc
Confidence 2235788999999984 4568889999999999999999999987543221111 111111
Q ss_pred C-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 746 M-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 746 ~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
. ...+..++..+.+++.+||+.+|.+||++.++++..-
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1 1223345567788888888888888888888776544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=309.83 Aligned_cols=286 Identities=25% Similarity=0.377 Sum_probs=207.3
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec-CC
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EG 580 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~ 580 (843)
++...+++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456789999999999999999999854 79999999876422 2234678899999999999999999999865 56
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+ +++|.+++.. .++++.....++.|+++||.|||+.+ |+||||||+||++++++.++|+|||.+.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999999 6799988853 34778888899999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 157 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-~~~-------- 217 (328)
T cd07856 157 IQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-FSI-------- 217 (328)
T ss_pred ccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH--------
Confidence 54321 122356788999999876 5689999999999999999999999965432111 100
Q ss_pred hhccCCCCCCCHHHHHHHHH-HHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 740 SVIDGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~-l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
+....+..+++....+.. -...++..-+...+.. .....+..+....+++.+|++.+|++|+|++|++
T Consensus 218 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 218 --ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVP---------FSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred --HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCc---------HHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000111122222211100 0000111111111100 0011233345566899999999999999999999
Q ss_pred CCCcccCCC
Q 003158 819 KHPYVSSDV 827 (843)
Q Consensus 819 ~Hp~f~~~~ 827 (843)
.||||....
T Consensus 287 ~~~~~~~~~ 295 (328)
T cd07856 287 AHPYLAPYH 295 (328)
T ss_pred cCCcccccc
Confidence 999996443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=293.18 Aligned_cols=200 Identities=32% Similarity=0.521 Sum_probs=175.5
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 688999999886544 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999999664 46899999999999999999999998 99999999999999999999999999987653221
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......++..|+|||...+..++.++||||+|+++|+|++|+.||....
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1233457889999999988888999999999999999999999997543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.24 Aligned_cols=281 Identities=24% Similarity=0.334 Sum_probs=201.3
Q ss_pred CCCCCCcccccCCeeEEEEEeC-C--CcEEEEEEeccCC--hhhHHHHHHHHHHHHhc-cCCcccceeeeeec----CCc
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-D--GTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGE 581 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~ 581 (843)
+|++.+.||+|+||.||++... . +..||+|++.... ....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999964 4 7899999886432 22346788899999999 59999999987532 245
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999985 6999988543 45889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
....... .........|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...... ........
T Consensus 155 ~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~------ 224 (332)
T cd07857 155 FSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ------ 224 (332)
T ss_pred ccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH------
Confidence 5432211 1111233568999999998876 56899999999999999999999998754422 11111100
Q ss_pred hccCCCCCCCHHHHHHHHH----HHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 741 VIDGNMGSYPSECVEKFIK----LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~----l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
..+..+.+....+.. ....-....+ ++.+. ...+..+....+|+.+|++.||++|+|++|
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 288 (332)
T cd07857 225 ----VLGTPDEETLSRIGSPKAQNYIRSLPNIP--KKPFE----------SIFPNANPLALDLLEKLLAFDPTKRISVEE 288 (332)
T ss_pred ----HhCCCCHHHHHhhhhhhHHHHHHhccccC--CcchH----------hhCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 011112211111100 0000000000 11111 112333455668999999999999999999
Q ss_pred CCCCCccc
Q 003158 817 MLKHPYVS 824 (843)
Q Consensus 817 ~L~Hp~f~ 824 (843)
++.||||.
T Consensus 289 ll~~~~~~ 296 (332)
T cd07857 289 ALEHPYLA 296 (332)
T ss_pred HhcChhhh
Confidence 99999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=286.05 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=199.1
Q ss_pred CCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHH-HHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 515 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 515 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
....||.|+||+|+|-.++ .|+..|||++..... ...+++..|.+. ++.-++||||+++|.+..++..|+.||.|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 3567999999999999864 799999999986554 456788999985 455579999999999999999999999994
Q ss_pred CCHHHHHh---hcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 592 GTLRDQLS---AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 592 gsL~~~l~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
-||+.+.. ......+++...-.|+.....||.||-+.-+ |||||+||+|||++..|.+||+|||++-.+..
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---- 220 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---- 220 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH----
Confidence 57765543 3344568888888899999999999987653 99999999999999999999999999865432
Q ss_pred CcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
+...+.-.|...|||||.+.. ..|+-+|||||+|++|||+.||..||....+..+++.. ++.+..
T Consensus 221 ----SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~---------Vv~gdp 287 (361)
T KOG1006|consen 221 ----SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ---------VVIGDP 287 (361)
T ss_pred ----HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH---------HHcCCC
Confidence 233355678899999999974 45889999999999999999999999877665555543 233333
Q ss_pred C--CCCHH---HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 747 G--SYPSE---CVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 747 ~--~~~~~---~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
+ .++.+ +...+...+..|+.++-..||.+.++...
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2 23444 67789999999999999999999988653
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.77 Aligned_cols=200 Identities=29% Similarity=0.454 Sum_probs=166.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCC-CcEEEEEEeccCCh-hhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~ 586 (843)
-++|++.+.||+|+||.||+|..++ ++.||||.++.... ....++..|+.++.+.. |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4568889999999999999999764 89999999875432 23456777887776665 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||+. +++.+++.... .++++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++......
T Consensus 94 e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9984 58887775533 368899999999999999999997 46 999999999999999999999999998765321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCC----CCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 169 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 169 K--------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred C--------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 112234778999999997654 788999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.96 Aligned_cols=271 Identities=20% Similarity=0.308 Sum_probs=186.9
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-----------------CCCcEEEEEEeccCChhhHHH--------------HHHH
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-----------------PDGTVVAVKRAQEGSLQGEKE--------------FLTE 557 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 557 (843)
..++|++.++||+|+||+||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235789999987543322222 3346
Q ss_pred HHHHHhccCCcc-----cceeeeeec--------CCcEEEEEecCCCCCHHHHHhhcCC---------------------
Q 003158 558 IQFLSRLHHRNL-----VSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKSK--------------------- 603 (843)
Q Consensus 558 ~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------- 603 (843)
+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 677888743 3578999999999999999864211
Q ss_pred -CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeeccc
Q 003158 604 -EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682 (843)
Q Consensus 604 -~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt 682 (843)
..+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++....... ........++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~------~~~~~~g~~t 373 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI------NFNPLYGMLD 373 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC------ccCccccCCC
Confidence 12456778899999999999999998 9999999999999999999999999997543211 0111123357
Q ss_pred CCccCchhcccCCC----------------------CchhhhHHHHHHHHHHHhCCC-CCCCCcchHHHHHHHhhcccch
Q 003158 683 PGYLDPEYFLTHKL----------------------TDKSDVYSLGVVFLELLTGMQ-PISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 683 ~~y~aPE~~~~~~~----------------------~~~sDvwS~G~~l~elltg~~-pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
+.|+|||.+..... ..+.||||+||+++||++|.. ||............
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-------- 445 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-------- 445 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh--------
Confidence 89999999864321 124799999999999999875 66432211110000
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCC---CCCCCCcc
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKE---ETPPSSSS 816 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp---~~R~sa~e 816 (843)
. ...... |......+..+. .+...+....||+.+||+.+| .+|+||+|
T Consensus 446 ---------~-~~~~~~--------~r~~~~~~~~~~-----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 446 ---------Y-DNDLNR--------WRMYKGQKYDFS-----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred ---------c-cchHHH--------HHhhcccCCCcc-----------cccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 0 000000 111111111111 122335556789999999766 68999999
Q ss_pred CCCCCcccC
Q 003158 817 MLKHPYVSS 825 (843)
Q Consensus 817 ~L~Hp~f~~ 825 (843)
+|+||||..
T Consensus 497 aL~Hp~f~~ 505 (507)
T PLN03224 497 ALSHRFFLP 505 (507)
T ss_pred HhCCCCcCC
Confidence 999999964
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.85 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=207.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh--HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
...|.+...||+|.|++|..|+.. ++..||+|.+++..... .+.+.+|+++|..+.|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457888999999999999999964 69999999998754332 345899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+.+|.+.+++...+. ..+..+..++.|+.+|++|||+++ |||||||++|||++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 99999999999987665 455788889999999999999999 99999999999999999999999999988763
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......+|++.|.|||++.+.+| ++.+|+||+|+++|.|+.|..||+...-.. ++ ..++.+.
T Consensus 208 ------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--Lr--------~rvl~gk 271 (596)
T KOG0586|consen 208 ------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--LR--------PRVLRGK 271 (596)
T ss_pred ------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--cc--------chheeee
Confidence 234456789999999999999776 568999999999999999999997543100 00 0001000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
.. .| --...+..++|+++|..+|.+|++.++++.|.|...
T Consensus 272 ~r-Ip---------------------------------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 272 YR-IP---------------------------------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred ec-cc---------------------------------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 00 00 011233346888888899999999999999999865
Q ss_pred CCCC
Q 003158 826 DVSG 829 (843)
Q Consensus 826 ~~~~ 829 (843)
.-..
T Consensus 312 ~~~~ 315 (596)
T KOG0586|consen 312 LLEA 315 (596)
T ss_pred hhhh
Confidence 5444
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=330.99 Aligned_cols=146 Identities=25% Similarity=0.381 Sum_probs=130.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|.+.++||+|+||+||+|... +++.||||++..... .....+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999975 689999999875332 22367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
||+.+++|.+++.... .+++..++.++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999996543 4788889999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.94 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=197.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++.|.....+|.|+|+.|-.+.. .+++..+||++... ..+..+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45677778899999999999985 46899999999864 22344577666555 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE-cCCCcEEEeeccccccCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-DHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DfGla~~~~~~~ 666 (843)
.+.++-+.+.+..... + ...+..|+.+|+.|+.|||++| ||||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--F-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--h-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988887755432 2 2667789999999999999999 9999999999999 69999999999999876432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
....+-|..|.|||+....+|++++|+||||++||+|++|+.||....+..
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-------------------- 520 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-------------------- 520 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--------------------
Confidence 223346788999999999999999999999999999999999997543210
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
-+..|+ .+|.++ ...+..++||+++||++||++|+++.|++.||||.+
T Consensus 521 -------------ei~~~i-----~~~~~s-------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 521 -------------EIHTRI-----QMPKFS-------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred -------------HHHHhh-----cCCccc-------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 111111 123222 223556679999999999999999999999999933
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.98 Aligned_cols=193 Identities=31% Similarity=0.428 Sum_probs=168.2
Q ss_pred ccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 519 IGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
||+|+||.||++... +++.||+|.+...... ....+..|+++++.++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5899999998754332 345788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccce
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 674 (843)
.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~ 148 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------S 148 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-------C
Confidence 99996643 5889999999999999999999988 9999999999999999999999999997654321 1
Q ss_pred eeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 675 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......++..|+|||...+..++.++|+||||+++||+++|..||....
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1234457889999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=292.40 Aligned_cols=200 Identities=26% Similarity=0.363 Sum_probs=166.0
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+|.+.+.||+|+||.||++... .+..+++|.++... .....++..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999864 34556666654321 12234577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 586 YEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
|||+++++|.+++.. .....+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999865 23456899999999999999999999998 999999999999975 569999999987653
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
... .......|+..|+|||...+..++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 157 GSC-------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CCc-------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 221 1122345788999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=287.67 Aligned_cols=282 Identities=23% Similarity=0.319 Sum_probs=215.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 580 (843)
..+|.....+|.|.- .|..|.+. .++.||+|..... .....++..+|..++..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788999988 56556543 5899999987643 234457889999999999999999999998543 4
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..|+|||+| .++|...+.- .++-.....|..|++.|++|||+.+ |+||||||+||++..++.+||.|||+|+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 679999999 5799998863 3667788899999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
.... ....+....|..|+|||++.+..+.+.+||||+||++.||++|+..|.+.....+ +...
T Consensus 167 ~e~~--------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ-~~ki-------- 229 (369)
T KOG0665|consen 167 TEDT--------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ-WNKI-------- 229 (369)
T ss_pred ccCc--------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH-HHHH--------
Confidence 6542 2345667788999999999998899999999999999999999999875444333 3322
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh-hC-------CCCCCCCCccccCCCCCCCCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN-MM-------PESDTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~-~~-------~~~~~~~~dll~~~L~~dp~~R~ 812 (843)
...++...+.+..++...+..... .||.... ...-+.+.+ .+ +.....+.|++.+||..||++|+
T Consensus 230 --~~~lgtpd~~F~~qL~~~~r~yv~----~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri 302 (369)
T KOG0665|consen 230 --IEQLGTPDPSFMKQLQPTVRNYVE----NRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI 302 (369)
T ss_pred --HHHhcCCCHHHHHHhhHHHHHHhh----cChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc
Confidence 223455667777777766665544 3332222 111111111 01 11223356799999999999999
Q ss_pred CCccCCCCCccc
Q 003158 813 SSSSMLKHPYVS 824 (843)
Q Consensus 813 sa~e~L~Hp~f~ 824 (843)
+++++|+|||+.
T Consensus 303 sv~daL~HPY~~ 314 (369)
T KOG0665|consen 303 SVDDALRHPYIK 314 (369)
T ss_pred cHHHHhcCCeee
Confidence 999999999997
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=290.35 Aligned_cols=179 Identities=23% Similarity=0.214 Sum_probs=152.9
Q ss_pred cCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHHHHHhh
Q 003158 522 GGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 600 (843)
Q Consensus 522 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 600 (843)
|.+|+||++... +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 68999999987532 233455555566799999999999999999999999999999999865
Q ss_pred cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeec
Q 003158 601 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680 (843)
Q Consensus 601 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 680 (843)
.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------~~~~~ 143 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------CDGEA 143 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----------cccCC
Confidence 43 4889999999999999999999998 999999999999999999999999987654321 11233
Q ss_pred ccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 003158 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720 (843)
Q Consensus 681 gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~ 720 (843)
++..|+|||.+.+..++.++||||+||++|||++|+.|+.
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 5678999999988889999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=324.94 Aligned_cols=277 Identities=23% Similarity=0.316 Sum_probs=178.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-C----CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeee------ee
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-D----GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY------CD 577 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~ 577 (843)
..++|+..+.||+|+||.||+|.+. + +..||+|++...... +....| .++...+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999965 4 689999987642211 111111 1122223333332222 24
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCC------------------CcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCC
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKSKE------------------PLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIK 639 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlk 639 (843)
.+...++||||+++++|.+++...... ......+..++.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999999998653211 0123345679999999999999998 9999999
Q ss_pred CCcEEEcC-CCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC----------------------CC
Q 003158 640 ASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH----------------------KL 696 (843)
Q Consensus 640 p~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 696 (843)
|+|||+++ ++.+||+|||+|+...... ........+++.|+|||.+... .+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999986 5799999999998653221 1122345688999999976432 23
Q ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 003158 697 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 776 (843)
Q Consensus 697 ~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~ 776 (843)
+.++|||||||++|||+++..++.. .. ......+... ..+. ..+.... .+..++...
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~--~~-~~~~~~l~~~-----------~~~~---~~~~~~~------~~~~~~~~~ 413 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDS--NL-IQFNRQLKRN-----------DYDL---VAWRKLV------EPRASPDLR 413 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCch--HH-HHHHHHHHhc-----------CCcH---HHHHHhh------ccccchhhh
Confidence 4467999999999999987655431 11 1111110000 0000 0111100 111112111
Q ss_pred HHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 777 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 777 ~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+. .+.+........||+.+||+.||++|+|++|+|+||||++...
T Consensus 414 ~~-------~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 414 RG-------FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hh-------hhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 11 1111122233458999999999999999999999999987554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=296.07 Aligned_cols=196 Identities=32% Similarity=0.514 Sum_probs=166.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
+.|+..+.||+|+||.||+|+.. +++.||+|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999964 6889999988642 2233457888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+. |++.+++... ..++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 6888877543 345889999999999999999999998 999999999999999999999999998754321
Q ss_pred CCCcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2235788999999985 356788999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=294.16 Aligned_cols=195 Identities=33% Similarity=0.522 Sum_probs=165.9
Q ss_pred CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
|...+.||+|+||+||+|+.. +++.||+|.+..... ...+.+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999964 689999999864322 2335688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+. |++.+++... ..++++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 6888887553 346889999999999999999999999 99999999999999999999999999864321
Q ss_pred CcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12345788999999984 3568889999999999999999999987544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=320.60 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=188.3
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeec-------
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------- 578 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------- 578 (843)
.-.++|+..+.||+||||.|||++-+ ||+.||||++.... ...-..+.+|+.++++++|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888999999999999999965 89999999987543 2234678899999999999999998632100
Q ss_pred --------------------------------------------------------------------------------
Q 003158 579 -------------------------------------------------------------------------------- 578 (843)
Q Consensus 579 -------------------------------------------------------------------------------- 578 (843)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHh
Q 003158 579 ------------------------E--------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626 (843)
Q Consensus 579 ------------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH 626 (843)
+ ..+||=||||+.-+++++++++.... .....++++++|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 0 12478899999888888886643321 46778899999999999999
Q ss_pred cCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC----CC-----CC--CCcccceeeeeecccCCccCchhcccC-
Q 003158 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP----VP-----DI--EGIVPAHVSTVVKGTPGYLDPEYFLTH- 694 (843)
Q Consensus 627 ~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~----~~-----~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~- 694 (843)
++| ||||||||.||++|+++.|||+|||+|.... .. .. .........+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998722 00 00 011122245677899999999999864
Q ss_pred --CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC---CHHHHHHHHHHHHHhcccCC
Q 003158 695 --KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY---PSECVEKFIKLALKCCQDET 769 (843)
Q Consensus 695 --~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~p 769 (843)
.|+.|+|+||+|++++||+ +||........ .+..+.++..+.. .....+.-.+++..+++.||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~---------iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEML---YPFGTSMERAS---------ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cccccchhhhHHHHHHHHHHh---ccCCchHHHHH---------HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 4999999999999999999 57764432211 1122333333322 33333444566677777777
Q ss_pred CCCCCHHHHHH
Q 003158 770 DARPSMSEVMR 780 (843)
Q Consensus 770 ~~RPs~~~vl~ 780 (843)
.+||++.+++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 77777776653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=304.56 Aligned_cols=201 Identities=30% Similarity=0.462 Sum_probs=172.3
Q ss_pred CCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeec------CCcEEE
Q 003158 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQML 584 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~l 584 (843)
+...+.||+|+||.||+|+ ...|+.||||.+.... ....+...+|+++|++++|+|||++++.-.+ .....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3446789999999999999 5579999999998643 3445678899999999999999999998644 346789
Q ss_pred EEecCCCCCHHHHHhhc-CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc--CCC--cEEEeecccc
Q 003158 585 VYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKF--TAKVADFGLS 659 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DfGla 659 (843)
|||||.+|||+..+.+. ....+++.+.+.+..+++.||.|||+++ ||||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999763 3456999999999999999999999999 99999999999984 333 5899999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~ 724 (843)
+.++.. ...+..+||..|.+||.... ..|+..+|.|||||++||+.||..||.+...
T Consensus 172 rel~d~--------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDDN--------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCCC--------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 977632 34577889999999999995 8889999999999999999999999976443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.27 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=213.5
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeee---
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCD--- 577 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~--- 577 (843)
++.+...++-|++.+.||+|.+|.||+++ .++++.+|+|+..... ..+++++.|.++++.. +|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34444557788999999999999999999 5689999999988643 3345778899999887 6999999999983
Q ss_pred --cCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 578 --EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 578 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
.++++|||||||.+||..|+++.-....+.|..+..|+..++.|+.+||... ++|||||-.|||++.++.||+.|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 3578999999999999999998766778999999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhcccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHH
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 730 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~ 730 (843)
||.+..+... ........||+.|||||++... .|+.++|+||+|++..||--|.+|+.+.....
T Consensus 167 FGvSaQldsT-------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---- 235 (953)
T KOG0587|consen 167 FGVSAQLDST-------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---- 235 (953)
T ss_pred eeeeeeeecc-------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh----
Confidence 9999876532 2334567899999999999753 46778999999999999999999998654321
Q ss_pred HHhhcccchhhccCCCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 731 IAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
.++.+.....+. .|..+..++.+.+..|+.++.++||++.++++
T Consensus 236 ------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 122222222222 37889999999999999999999999988764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.32 Aligned_cols=203 Identities=22% Similarity=0.345 Sum_probs=179.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCC-cEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDG-TVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
-.+++.+..||-|+||.|-....+.. ..+|+|++++... ..++.+..|-++|...+.|.||++|-.|.++...|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34566677899999999999887543 3589998876433 3345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||-|-||.|+..+++++ .++....+.++..+.+|++|||+++ ||.|||||+|+++|.+|-+||.|||.|+....
T Consensus 499 mEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred HHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 99999999999997754 4888999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 725 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~ 725 (843)
...+...+||+.|.|||++....++.++|.||+|+++|||++|.+||...+..
T Consensus 573 -------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 573 -------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred -------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 34567789999999999999999999999999999999999999999876643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=277.89 Aligned_cols=203 Identities=24% Similarity=0.387 Sum_probs=177.8
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCC
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 580 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 580 (843)
+.+..++|..+++||+|+|.+|-.+++. +.+.+|+|++++.-. +.....+.|-.+.... +||.+|.++.+|..+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3445678999999999999999999964 688999999886432 2334567787777776 6999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
.+++|.||++||+|--+++++. .++++.++.+...|.-||.|||++| ||.||||.+|||+|..|.+|+.|+|+++
T Consensus 325 rlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred eEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 9999999999999988886654 4889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~ 720 (843)
.- ..+...+...+||+.|+|||.+++..|...+|+|++||+++||+.|+.||+
T Consensus 400 e~-------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 400 EG-------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred cC-------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 43 223455677899999999999999999999999999999999999999996
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-34 Score=297.28 Aligned_cols=302 Identities=21% Similarity=0.278 Sum_probs=220.8
Q ss_pred CCcccccHHHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcc------CCc
Q 003158 496 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH------HRN 568 (843)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~n 568 (843)
+...+|.+.-.++...+|.+....|+|-|++|.+|... .|..||||++...... .+.=+.|+++|++|. --|
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhH
Confidence 34456777788888999999999999999999999965 4789999999864333 345578999999995 348
Q ss_pred ccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCC-CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC
Q 003158 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH 647 (843)
Q Consensus 569 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~ 647 (843)
+++++..|....++|||||-+ .-+|.++|+..+. ..+....+..++.|+.-||..|-..+ |+|.||||+||||++
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc
Confidence 999999999999999999998 5699999987543 45888999999999999999999988 999999999999986
Q ss_pred C-CcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchH
Q 003158 648 K-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 726 (843)
Q Consensus 648 ~-~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~ 726 (843)
. ..+||||||.|......+ .+....+..|+|||++.+.+|+...|+||+||+||||.||+..|.+..+-.
T Consensus 572 ~k~iLKLCDfGSA~~~~ene---------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENE---------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred CcceeeeccCcccccccccc---------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 5 478999999998765433 233445678999999999999999999999999999999999997655421
Q ss_pred HHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhc---------ccC-----------CCCCCCHHHHHHHHHHhh
Q 003158 727 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCC---------QDE-----------TDARPSMSEVMRELESIW 786 (843)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~---------~~~-----------p~~RPs~~~vl~~L~~~~ 786 (843)
.+... -...+.+|..+...- ++..+-+ ..| +.-.|| .++...|....
T Consensus 643 -MLrl~----------me~KGk~p~KmlRKg-qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt-kdl~s~l~~~q 709 (752)
T KOG0670|consen 643 -MLRLF----------MELKGKFPNKMLRKG-QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT-KDLGSELIAVQ 709 (752)
T ss_pred -HHHHH----------HHhcCCCcHHHhhhc-chhhhhcccccceEEEeccccccceeEEEecccCcc-hhHHHHHhccC
Confidence 11100 001112222111100 0000000 000 011121 22333333221
Q ss_pred hhCCCC----CCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 787 NMMPES----DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 787 ~~~~~~----~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
. +|++ -.++.|||.+||..||++|+|..|||.||||+.
T Consensus 710 ~-~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 710 R-LPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred C-CCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 1 2222 133568999999999999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=285.66 Aligned_cols=297 Identities=22% Similarity=0.336 Sum_probs=217.2
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 578 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 578 (843)
+.+....+.|...++||+|.|++||+|.+. .++.||+|.+...+ ...++..|+++|..+ .+.||+++.+++..
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 345556778999999999999999999853 46899999987533 345789999999998 59999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeecc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFG 657 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfG 657 (843)
.+..++|+||++...-.++... ++...+..+.+.+..||+++|+.| ||||||||+|+|.+. .+.-.|.|||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 9999999999999999998854 567888899999999999999999 999999999999984 4678999999
Q ss_pred ccccCCCCC----CCC---------------------------------cccceeeeeecccCCccCchhccc-CCCCch
Q 003158 658 LSRLAPVPD----IEG---------------------------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDK 699 (843)
Q Consensus 658 la~~~~~~~----~~~---------------------------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 699 (843)
+|...+... ... ...........||++|+|||++.. ...+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997211000 000 000111234569999999999976 567889
Q ss_pred hhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHH--hcccCCCCCCCHHH
Q 003158 700 SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALK--CCQDETDARPSMSE 777 (843)
Q Consensus 700 sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~~p~~RPs~~~ 777 (843)
+||||.|+++.-+++++.||....+..+........ +-.....+...+-.+ -|++ ..+|+..+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~ti-------------fG~~~mrk~A~l~g~~~l~~k--sn~~~~~e 323 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATI-------------FGSAEMRKCAALPGRILLWQK--SNIPTIPE 323 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHH-------------hChHHHHHHhhcCCceeeecc--ccccccHH
Confidence 999999999999999999998765543322221100 001111111111111 2332 34666666
Q ss_pred HHHHHHHhh-hhCCC--------------CCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 778 VMRELESIW-NMMPE--------------SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 778 vl~~L~~~~-~~~~~--------------~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+....+.+. +.... ....+.||++++|..||.+|+||++||.||||..
T Consensus 324 ~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 324 LRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred HHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 665555541 11111 1124568999999999999999999999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-33 Score=307.58 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=195.8
Q ss_pred CCCCCCcccccCCe-eEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecC
Q 003158 512 NFNSSTQIGQGGYG-KVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 512 ~~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
-|...+.+|.|+.| .||+|.. +|+.||||++-.. ..+-+.+|+..|+.- .|||||++++.-.+.++.||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 34445778999998 4799998 6789999988542 334568899999887 6999999999999999999999999
Q ss_pred CCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---C--CcEEEeeccccccC
Q 003158 590 SNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---K--FTAKVADFGLSRLA 662 (843)
Q Consensus 590 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~~kl~DfGla~~~ 662 (843)
..+|.+++... ..........+.+..|+++||++||+.+ ||||||||.|||++. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 56999999763 1111222455778999999999999988 999999999999976 3 47999999999988
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
..... .-.......||-+|+|||++....-+.++||||+||++|+.++ |.+||.+. ..++.+.
T Consensus 662 ~~~~s----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NI---------- 725 (903)
T KOG1027|consen 662 AGGKS----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANI---------- 725 (903)
T ss_pred CCCcc----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhh----------
Confidence 65431 1222456789999999999999888889999999999999999 59999643 2232221
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
+.+... ..+++.+ .+..+.|||.+|+..||..||+|.++|.||
T Consensus 726 l~~~~~--------------L~~L~~~-----------------------~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 726 LTGNYT--------------LVHLEPL-----------------------PDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred hcCccc--------------eeeeccC-----------------------chHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 111100 0011111 111455899999999999999999999999
Q ss_pred cccCCCC
Q 003158 822 YVSSDVS 828 (843)
Q Consensus 822 ~f~~~~~ 828 (843)
+|.....
T Consensus 769 lFW~~ek 775 (903)
T KOG1027|consen 769 LFWDSEK 775 (903)
T ss_pred ccCChHH
Confidence 9976543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=288.60 Aligned_cols=210 Identities=22% Similarity=0.304 Sum_probs=174.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhh---HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
..-|..++.||-|+||+|.++.. ++...+|.|.+.+...-. ...++.|-.||.....+=||+|+-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34566778899999999999984 457789999987654332 34567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||++||++-.+|-+.+ .+.+..++.++..+..|+++.|.+| +|||||||+|||||.+|.+||.|||++.-+...
T Consensus 708 MdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999999986644 4888889999999999999999999 999999999999999999999999998533211
Q ss_pred C---CCC------------------cc--------------cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHH
Q 003158 666 D---IEG------------------IV--------------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFL 710 (843)
Q Consensus 666 ~---~~~------------------~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ 710 (843)
. ++. .. ........+||+.|+|||++....++..+|+||.||+||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 000 00 000112356999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCcc
Q 003158 711 ELLTGMQPISHGKN 724 (843)
Q Consensus 711 elltg~~pf~~~~~ 724 (843)
||+.|+.||.....
T Consensus 863 em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTP 876 (1034)
T ss_pred HHhhCCCCccCCCC
Confidence 99999999986654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=251.19 Aligned_cols=216 Identities=25% Similarity=0.377 Sum_probs=176.4
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHH-HhccCCcccceeeeeecCCc
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFL-SRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~ 581 (843)
.++...+.......||+|++|.|-+-++ .+|+..|+|++...- .+..++..+|+.+. +...+|.+|.|+|....++.
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3455556666678899999999988884 589999999987532 33456788898864 45579999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 582 QMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
.|+.||.|+ -||+.+-.+ .....+++...-+||..+.+||.|||++-+ +||||+||+|||++.+|++|+||||.+
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccc
Confidence 999999995 488776544 345568899999999999999999999764 999999999999999999999999998
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc----CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHH
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 731 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~ 731 (843)
-.+.. +-..+...|...|||||.+.. ..|+-++||||+|+++.||.+++.||.......+++..
T Consensus 197 G~L~d--------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 197 GYLVD--------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred eeehh--------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 76542 112233568889999999964 36889999999999999999999999877766665553
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=263.44 Aligned_cols=187 Identities=35% Similarity=0.548 Sum_probs=165.5
Q ss_pred CCeeEEEEEeC-CCcEEEEEEeccCChhh-HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHHHHHhh
Q 003158 523 GYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA 600 (843)
Q Consensus 523 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 600 (843)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999998655444 67899999999999999999999999999999999999999999999976
Q ss_pred cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeec
Q 003158 601 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680 (843)
Q Consensus 601 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 680 (843)
... +++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--------cccccc
Confidence 443 788999999999999999999998 9999999999999999999999999998764321 223445
Q ss_pred ccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 681 gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
++..|++||...+..++.++||||||++++++++|..||...
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 788999999999888999999999999999999999999763
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-31 Score=278.51 Aligned_cols=281 Identities=22% Similarity=0.233 Sum_probs=191.5
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
|+|+.+--.+|..-.++++|+|++|.|+..--+.|.+|.+|..|.|++|+|+...+..|.+|++|+.|+|..|+|.-+..
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 45553333445455566666666666666666666666666666666666665556666666666666666666664435
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIP 161 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~ 161 (843)
..|.++++|+.|.|..|+|...-...|..+.++++|+|+.|+++. .-..++.++++|+.|+|+.|.|..+..+ +..++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~-vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq 317 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA-VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ 317 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh-hhcccccccchhhhhccchhhhheeecchhhhcc
Confidence 556666666666666666665555666677777777777777764 2345667777777777777777776664 66777
Q ss_pred CCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcc
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L 239 (843)
+|+.|+|++|+|+ .+++..+. ..|+.|+|++|.|+.+....|.++.+|++|||++|.|+..+-++-..... ++.|
T Consensus 318 kL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~g--l~~L 394 (873)
T KOG4194|consen 318 KLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNG--LPSL 394 (873)
T ss_pred cceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhcc--chhh
Confidence 7777777777777 55544332 26777777777777776777777777777778777777666654333333 4567
Q ss_pred eeEEcCCCCCCCCCCCC--cCCCCcEEEeccCc-----------------------ccccCCcccccCCCCCC
Q 003158 240 FILDFQNNNLTNISGSF--NIPPNVTVRLRGNP-----------------------FCLNTNAEQFCGSHSDD 287 (843)
Q Consensus 240 ~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np-----------------------~~c~~~~~~~~~~~~~~ 287 (843)
+.|+|.+|+|..++... +++.|..|+|.+|+ |-|||++.|+-.|+-..
T Consensus 395 rkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl~~~ 467 (873)
T KOG4194|consen 395 RKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQWLYRR 467 (873)
T ss_pred hheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHHHHHHHhc
Confidence 77888888888887654 67888888887776 46999999999998643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=302.74 Aligned_cols=265 Identities=29% Similarity=0.494 Sum_probs=243.6
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|++++.+|..+.++++|++|+|++|.+.+.+|..+.++++|++|++++|.+.+..|..+..+++|+.|+|++|.+++.+
T Consensus 269 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 348 (968)
T PLN00113 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348 (968)
T ss_pred CCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcC
Confidence 68899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRI 160 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l 160 (843)
|..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|.+.+ .+|..+..+++|+.|+|++|++++..+ .+..+
T Consensus 349 p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~-~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l 427 (968)
T PLN00113 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG-EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427 (968)
T ss_pred ChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecc-cCCHHHhCCCCCCEEECcCCEeeeECChhHhcC
Confidence 9999999999999999999999999999999999999999999987 789999999999999999999998666 59999
Q ss_pred CCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcc
Q 003158 161 PNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239 (843)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L 239 (843)
++|+.|++++|.+++.+|..... .+|+.|+|++|.+.+.+|..+ ..++|+.|+|++|++++.+|..+..+.+ |
T Consensus 428 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~-----L 501 (968)
T PLN00113 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSE-----L 501 (968)
T ss_pred CCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhc-----c
Confidence 99999999999999888875443 489999999999999988866 4689999999999999999998876554 5
Q ss_pred eeEEcCCCCCCCCCC-CC-cCCCCcEEEeccCcccc
Q 003158 240 FILDFQNNNLTNISG-SF-NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 240 ~~L~l~~N~l~~~~~-~~-~~~~l~~l~l~~Np~~c 273 (843)
+.|+|++|++++..+ .+ .++.++.|+|++|.+..
T Consensus 502 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 537 (968)
T PLN00113 502 MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537 (968)
T ss_pred CEEECcCCcceeeCChHHcCccCCCEEECCCCcccc
Confidence 589999999986544 44 78999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=271.96 Aligned_cols=300 Identities=20% Similarity=0.281 Sum_probs=223.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|+...++|.|.+|.||||+. +.++..|+|+++.......+-+++|+-+++..+||||+.++|.+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35788899999999999999995 57999999999876666666778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
|.+|+|.+.-+. ..++++.++..+++..++||+|||+++ =+|||||-.||++++.|.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--- 165 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh---
Confidence 999999998754 456899999999999999999999999 799999999999999999999999998654321
Q ss_pred CcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
-.......||+.|||||+.. .+.|...+|||+.|+...|+-.-+.|.++...... .+.. .....++.
T Consensus 166 ----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~----l~Lm--TkS~~qpp 235 (829)
T KOG0576|consen 166 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA----LFLM--TKSGFQPP 235 (829)
T ss_pred ----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH----HHHh--hccCCCCC
Confidence 22335578999999999985 46789999999999999999887777664332111 0000 01122222
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC-ccCCCCCccc
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-SSMLKHPYVS 824 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa-~e~L~Hp~f~ 824 (843)
...-+..+.+.+.++++.|+.++|++||++..+++. .+ -..+.....+.++|.++=..+|.-|--- .|.=.++|+.
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h--~f-vs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH--PF-VSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheec--ee-eccchhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 223356677888899999999999999998876641 11 1112223333455555555554333222 2222355655
Q ss_pred CCCCCC
Q 003158 825 SDVSGS 830 (843)
Q Consensus 825 ~~~~~~ 830 (843)
....+.
T Consensus 313 ~~i~s~ 318 (829)
T KOG0576|consen 313 MRICST 318 (829)
T ss_pred hhhhcC
Confidence 554443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=261.43 Aligned_cols=196 Identities=25% Similarity=0.365 Sum_probs=169.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh--------HHHHHHHHHHHHhcc---CCcccceeeeeec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--------EKEFLTEIQFLSRLH---HRNLVSLVGYCDE 578 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 578 (843)
..|.....+|+|+||.|+.|.++ +...|+||.+.+...-. ...+-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999975 56789999887643211 123567999999997 9999999999999
Q ss_pred CCcEEEEEecC-CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 579 EGEQMLVYEFM-SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 579 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
++.+||+||-. ++.+|.+++..+. .+++.+...|+.||+.|+++||+.+ |||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 99999999975 5679999997654 4889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCC-chhhhHHHHHHHHHHHhCCCCCC
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPIS 720 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~G~~l~elltg~~pf~ 720 (843)
.|..... ......+||..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 716 saa~~ks---------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKS---------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcC---------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987653 234567899999999999998874 56899999999999999888885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-26 Score=233.07 Aligned_cols=210 Identities=37% Similarity=0.605 Sum_probs=182.1
Q ss_pred ccccCCeeEEEEEeCC-CcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHHH
Q 003158 519 IGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD 596 (843)
Q Consensus 519 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 596 (843)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999865433 34678999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeeccccccCCCCCCCCccccee
Q 003158 597 QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIEGIVPAHV 675 (843)
Q Consensus 597 ~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~ 675 (843)
++.... ..+++..++.++.++++++.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------h
Confidence 997642 35788999999999999999999998 999999999999999 89999999999986543210 1
Q ss_pred eeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHH
Q 003158 676 STVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754 (843)
Q Consensus 676 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (843)
.....+...|++||..... ..+.++|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2334577889999999887 888999999999999998
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 755 EKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 755 ~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 456788999999999999999988753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=234.89 Aligned_cols=199 Identities=36% Similarity=0.527 Sum_probs=172.8
Q ss_pred CCCCCcccccCCeeEEEEEeCC-CcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 513 FNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 899999999875554 56788999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+++|.+++...... +++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~---- 152 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL---- 152 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc----
Confidence 99999999764322 788899999999999999999998 9999999999999999999999999998765321
Q ss_pred ccceeeeeecccCCccCchhc-ccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 --AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0012334577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=225.65 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=186.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeee-eecCCcEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY-CDEEGEQMLV 585 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~lV 585 (843)
..+.|.+.+.+|+|.||.+-++.++ ..+.+|+|.+... ....++|.+|..---.+ .|.||+.-|+. |+..+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467899999999999999999975 5788999988753 33457899998754444 58999988775 6777889999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc--CCCcEEEeeccccccCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGLSRLAP 663 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~ 663 (843)
+||++.|+|.+-+.. ..+.+...+.++.|++.|+.|+|++. +||||||.+|||+- +..++||+|||..+..+
T Consensus 101 qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999998854 34778889999999999999999999 99999999999983 34489999999987543
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCcchH-HHH-HHHhhcc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REV-NIAYQSS 736 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~-~~~-~~~~~~~ 736 (843)
.. .....-+..|.|||..... ...+.+|||+||++++.++||+.||....... .++ ...++..
T Consensus 175 ~t----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 175 TT----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred ce----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 21 1223345679999988642 35678999999999999999999997432111 111 1111111
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.. ...+..-.-+.+...++..+-+..++++|-...++.++...
T Consensus 245 k~-----~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 245 KN-----PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred cC-----ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 11 11111112345677788888888999988655555544433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=252.00 Aligned_cols=262 Identities=22% Similarity=0.264 Sum_probs=208.2
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
||+++.+-+..|.++++|+.++|..|.++ .+|...+...+|+.|+|.+|.|+.....+++.++.|+.||||.|.|+.+.
T Consensus 87 nNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~ 165 (873)
T KOG4194|consen 87 NNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIP 165 (873)
T ss_pred ccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhccc
Confidence 78888888888889999999999999998 78876666777999999999998777888888888999999999888666
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRI 160 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l 160 (843)
-..|..-.++++|+|++|+|+..-...|.++.+|.+|.|++|+++. ..+..|.++++|+.|+|..|.|....- .|.++
T Consensus 166 ~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt-Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL 244 (873)
T KOG4194|consen 166 KPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT-LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGL 244 (873)
T ss_pred CCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc-cCHHHhhhcchhhhhhccccceeeehhhhhcCc
Confidence 6677777888888888888887777888888888888888888873 334577888888888888888875533 58888
Q ss_pred CCCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCc
Q 003158 161 PNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 238 (843)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~ 238 (843)
++|+.|.|..|.+. .+.++.+. .++++|+|+.|++...-..++-+|++|+.|+||+|.|+...++++.-.. +
T Consensus 245 ~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq-----k 318 (873)
T KOG4194|consen 245 PSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ-----K 318 (873)
T ss_pred hhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc-----c
Confidence 88888888888887 56655443 2788888888888877777888888888888888888877777665443 4
Q ss_pred ceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcc
Q 003158 239 TFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPF 271 (843)
Q Consensus 239 L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~ 271 (843)
|+.|||++|+|+.+++.. .+..|..|+|+.|.+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi 353 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSI 353 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccch
Confidence 557888888888887654 567777777777765
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-27 Score=253.42 Aligned_cols=259 Identities=28% Similarity=0.402 Sum_probs=166.1
Q ss_pred CCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCC
Q 003158 9 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 88 (843)
Q Consensus 9 ~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 88 (843)
||.+|..|..|+.||||+|+++ +.|..+..-+++-.|+||+|+|..+....|.+|+.|-.||||+|++. .+|.....+
T Consensus 95 iP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL 172 (1255)
T KOG0444|consen 95 IPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRL 172 (1255)
T ss_pred CCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHH
Confidence 4444444444555555555544 44444444444445555555544222233444444444455555544 344444444
Q ss_pred CCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEc
Q 003158 89 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDL 168 (843)
Q Consensus 89 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L 168 (843)
.+|++|+|++|.+...--..+..+++|++|.+++.+-+-..+|.++..+.+|..+|||.|.+..+|..+..+++|+.|+|
T Consensus 173 ~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNL 252 (1255)
T KOG0444|consen 173 SMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNL 252 (1255)
T ss_pred hhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheecc
Confidence 45555555555444222233344445555555554433345788888899999999999999988888999999999999
Q ss_pred ccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCC-CCchhhccccCC------------
Q 003158 169 SSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS-IPSSIWQSRTLN------------ 235 (843)
Q Consensus 169 s~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~l~------------ 235 (843)
|+|+|+..--......+|++|+||+|+|+ ..|.++..|++|+.|++.+|+|+-. +|+.++++.+|+
T Consensus 253 S~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElV 331 (1255)
T KOG0444|consen 253 SGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELV 331 (1255)
T ss_pred CcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccC
Confidence 99999832222222348999999999999 8899999999999999999998744 788887776552
Q ss_pred ------CCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCc
Q 003158 236 ------ATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNP 270 (843)
Q Consensus 236 ------~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np 270 (843)
...|+.|.|+.|+|-++|..+ -++.+..|+++.||
T Consensus 332 PEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 332 PEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred chhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCc
Confidence 244556777777777776665 46777777777776
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=270.04 Aligned_cols=201 Identities=19% Similarity=0.183 Sum_probs=133.8
Q ss_pred hccC-Ccccceeeee-------ecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEE
Q 003158 563 RLHH-RNLVSLVGYC-------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634 (843)
Q Consensus 563 ~l~h-~nIv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 634 (843)
.++| +||++++++| .+.+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 6888898887 2334677889988 67999999653 345899999999999999999999999 99
Q ss_pred eccCCCCcEEEcCCCcEE-------------------EeeccccccCCCCC---CC------CcccceeeeeecccCCcc
Q 003158 635 HRDIKASNILLDHKFTAK-------------------VADFGLSRLAPVPD---IE------GIVPAHVSTVVKGTPGYL 686 (843)
Q Consensus 635 H~Dlkp~NILl~~~~~~k-------------------l~DfGla~~~~~~~---~~------~~~~~~~~~~~~gt~~y~ 686 (843)
||||||+|||++..+.+| ++|||+++...... .. ............||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996655554 55555554321000 00 000000112245888999
Q ss_pred CchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcc
Q 003158 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQ 766 (843)
Q Consensus 687 aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~ 766 (843)
|||++.+..++.++|||||||+||||++|..|+............ .. .+............++..||+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~--------~~----~~~~~~~~~~~~~~~~~~~L~ 250 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH--------RV----LPPQILLNWPKEASFCLWLLH 250 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH--------hh----cChhhhhcCHHHHHHHHHhCC
Confidence 999999999999999999999999999988876432211111100 00 011111112334456666777
Q ss_pred cCCCCCCCHHHHHH
Q 003158 767 DETDARPSMSEVMR 780 (843)
Q Consensus 767 ~~p~~RPs~~~vl~ 780 (843)
++|.+||++.++++
T Consensus 251 ~~P~~Rps~~eil~ 264 (793)
T PLN00181 251 PEPSCRPSMSELLQ 264 (793)
T ss_pred CChhhCcChHHHhh
Confidence 77777777777654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=215.18 Aligned_cols=247 Identities=18% Similarity=0.343 Sum_probs=197.2
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCC
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 593 (843)
..+|.+...|..|+|+|+. ..+++|++.-... ...++|..|.-.|+-+.||||++++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 4468899999999999964 4556677653222 224689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccc
Q 003158 594 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673 (843)
Q Consensus 594 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 673 (843)
|+..+++...-..+..++.+++.+||+|++|||+.. |-|-.--|.+..|++|++.+++|+= +-+++ +
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf-----------s 340 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----------S 340 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----------e
Confidence 999999988777888999999999999999999975 3344446889999999999888751 11111 1
Q ss_pred eeeeeecccCCccCchhcccCCCC---chhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 674 HVSTVVKGTPGYLDPEYFLTHKLT---DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 674 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
.......-.+.||+||.+...+-+ .++|+|||++++||+.|+..||.+-...+- .+.-.+++.+...|
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------gmkialeglrv~ip 411 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------GMKIALEGLRVHIP 411 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------hhhhhhccccccCC
Confidence 111223456899999999875533 478999999999999999999987654322 22234455666778
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
+..+..+.+++.-|..+||.+||.+..++-.|+++
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 88999999999999999999999999999888875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-27 Score=242.26 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=172.7
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEc-cCCccccCCCcccCCCCCCceeec
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM-NNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L-s~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
....++|..|+|+.+.+.+|+.+++|+.|||++|+|+.+.|++|.++++|.+|-+ ++|+|+.+....|.++..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 4555666666666666666666666666666666666666666666666555533 336666554555666666666666
Q ss_pred cCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCc-cccCCCCCcEEEcCCCCC-------------------------
Q 003158 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSL------------------------- 150 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~l~~L~~L~L~~N~l------------------------- 150 (843)
.-|++.-+..+.|..+++|..|.|-+|.+. .++. .|..+.+++.+.+..|.+
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q--~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc 225 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ--SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC 225 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhh--hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence 666666555566666666666666666664 2333 556666666666655552
Q ss_pred -----------CCCCCC-CC-CCCCCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeC
Q 003158 151 -----------QGPMPD-LS-RIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 215 (843)
Q Consensus 151 -----------~~~~~~-~~-~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 215 (843)
..+... |. .+.++..--.+.+...+..|...+. .+|++|+|++|+|+.+-+.+|.++..+++|+|
T Consensus 226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 211111 11 1111111111222222233433332 38999999999999999999999999999999
Q ss_pred cCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccCCcccccCCCCCCC
Q 003158 216 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD 288 (843)
Q Consensus 216 ~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~~ 288 (843)
..|+|....-..|.++ ..|+.|+|.+|+|+.+.+.. .+..+.+|++-.|||+|+|.+.|+-+|+.+..
T Consensus 306 ~~N~l~~v~~~~f~~l-----s~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~ 375 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGL-----SGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS 375 (498)
T ss_pred CcchHHHHHHHhhhcc-----ccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC
Confidence 9999985555555444 45668999999999997654 67889999999999999999999999997654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-27 Score=239.15 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=233.0
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+++ .+-+++.++..|.+|++++|++. ..|.+++.+..++.|+.++|++. .+|..+..+.+|..|+++.|.+. .+
T Consensus 54 ~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el 129 (565)
T KOG0472|consen 54 HNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-EL 129 (565)
T ss_pred cCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ec
Confidence 46666 45567889999999999999999 89999999999999999999999 89999999999999999999999 77
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
++.++.+-.|+.++..+|+++ ..|..+..+.+|..|++.+|++. ..|...-+++.|++||+.+|-++.+|++++.+.
T Consensus 130 ~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~--~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~ 206 (565)
T KOG0472|consen 130 PDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK--ALPENHIAMKRLKHLDCNSNLLETLPPELGGLE 206 (565)
T ss_pred CchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh--hCCHHHHHHHHHHhcccchhhhhcCChhhcchh
Confidence 888999999999999999999 78889999999999999999996 567767679999999999999999999999999
Q ss_pred CCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcc-cCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcce
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~ 240 (843)
+|+.|+|.+|+|. .+|.......|+.|+++.|+|+ .+|.+ ...+++|..|||.+|++. ++|+.+..+++|+
T Consensus 207 ~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~----- 278 (565)
T KOG0472|consen 207 SLELLYLRRNKIR-FLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLE----- 278 (565)
T ss_pred hhHHHHhhhcccc-cCCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhh-----
Confidence 9999999999999 8887666668999999999999 55554 559999999999999999 8999999888776
Q ss_pred eEEcCCCCCCCCCCCCcCCCCcEEEeccCccc
Q 003158 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 272 (843)
Q Consensus 241 ~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~ 272 (843)
.||+|+|.|+++|.+.+--.+..|.+.|||+.
T Consensus 279 rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 279 RLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred hhcccCCccccCCcccccceeeehhhcCCchH
Confidence 79999999999999884338999999999984
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=205.77 Aligned_cols=168 Identities=21% Similarity=0.291 Sum_probs=125.6
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.++++.. ..++++..++.++.|+++||+|||+++ ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 7899999754 346999999999999999999999876 999999999999999 9998765321
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCH
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (843)
...||+.|||||++.+..++.++|||||||++|||+||+.||.................. . ........+.
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~ 133 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--A-DDPRDRSNLE 133 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc--c-CCccccccHH
Confidence 125889999999999999999999999999999999999999754332222221110000 0 0000011223
Q ss_pred HHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 752 ECVE--KFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 752 ~~~~--~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
.... .+.+++.+||..+|.+||++.++++.+....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 3333 5888888888888888888888888776553
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-26 Score=231.85 Aligned_cols=260 Identities=28% Similarity=0.479 Sum_probs=183.1
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|+ ++|+++.++.+|..|++.+|+++...|+.+. ++.|++||...|.++ .+|..++.+.+|..|+|..|+|. .+
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~l 221 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FL 221 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cC
Confidence 56777 7777888888888888888888854444444 788888888888777 67777888888888888888887 55
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCc-ccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPP-ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRI 160 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l 160 (843)
| .|.++..|.+|+++.|+|+ .+|. ...++++|.+|||.+|++. +.|..++-+.+|+.||+++|.|+++++.++++
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk--e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl 297 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK--EVPDEICLLRSLERLDLSNNDISSLPYSLGNL 297 (565)
T ss_pred C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc--cCchHHHHhhhhhhhcccCCccccCCcccccc
Confidence 5 6777777777777777777 3443 3447777777777777775 56777777777777777777777777777776
Q ss_pred CCCCEEEcccCcCCC-----------------------------------------------------------------
Q 003158 161 PNLGYLDLSSNQLNG----------------------------------------------------------------- 175 (843)
Q Consensus 161 ~~L~~L~Ls~N~l~~----------------------------------------------------------------- 175 (843)
.|+.|-+-+|.+..
T Consensus 298 -hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~ 376 (565)
T KOG0472|consen 298 -HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTL 376 (565)
T ss_pred -eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccccc
Confidence 67777666665530
Q ss_pred -------------------------CCCC------------------------CCCC-cCcCEEEccCCcCCCCCCcccC
Q 003158 176 -------------------------SIPP------------------------GRLS-LNITTIKLSNNKLTGTIPSNFS 205 (843)
Q Consensus 176 -------------------------~~p~------------------------~~~~-~~L~~L~Ls~N~l~~~~p~~~~ 205 (843)
.+|. .... .+|..|+|++|-+. .+|..++
T Consensus 377 VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~ 455 (565)
T KOG0472|consen 377 VPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMG 455 (565)
T ss_pred CCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhh
Confidence 1111 1111 15666777776666 6677777
Q ss_pred CCCCCcEEeCcCccCCCCCCchhhccccC-------------------CCCcceeEEcCCCCCCCCCCCC-cCCCCcEEE
Q 003158 206 GLPRLQRLFIANNSLSGSIPSSIWQSRTL-------------------NATETFILDFQNNNLTNISGSF-NIPPNVTVR 265 (843)
Q Consensus 206 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~l-------------------~~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~ 265 (843)
.+..|+.|+++.|+|. .+|..+..+..+ .+.+|.+|||++|.|+.+|+.. ++.++++|.
T Consensus 456 ~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLe 534 (565)
T KOG0472|consen 456 SLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLE 534 (565)
T ss_pred hhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEE
Confidence 7777777777777765 455433222111 2356779999999999999887 789999999
Q ss_pred eccCccc
Q 003158 266 LRGNPFC 272 (843)
Q Consensus 266 l~~Np~~ 272 (843)
+.||||.
T Consensus 535 L~gNpfr 541 (565)
T KOG0472|consen 535 LDGNPFR 541 (565)
T ss_pred ecCCccC
Confidence 9999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=224.58 Aligned_cols=174 Identities=18% Similarity=0.201 Sum_probs=132.9
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC--CCcEEEEEEeccC-----ChhhHHHHHHHHHHHHhccCCcccc-eeeee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEG-----SLQGEKEFLTEIQFLSRLHHRNLVS-LVGYC 576 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~ 576 (843)
......++|...+.||+|+||+||+|... +++.||||++... .....+.+.+|+++|+.++|+|+++ ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34455678999999999999999999864 5788899987532 1223457899999999999999985 4432
Q ss_pred ecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccC-CCCcEEEcCCCcEEEee
Q 003158 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVAD 655 (843)
Q Consensus 577 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~D 655 (843)
+..++||||++|++|.. +... . ...++.++++||.|||+++ |+|||| ||+|||++.++.+||+|
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARPH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCcc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 46799999999999973 2111 1 1457889999999999999 999999 99999999999999999
Q ss_pred ccccccCCCCCCCCccc-ceeeeeecccCCccCchhcccC
Q 003158 656 FGLSRLAPVPDIEGIVP-AHVSTVVKGTPGYLDPEYFLTH 694 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 694 (843)
||+|+........+... ....+...+++.|+|||.+...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99998765432111111 1112456788899999999653
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-26 Score=241.85 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=187.2
Q ss_pred Ccccc-ccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCcccc-
Q 003158 2 WNKIS-GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG- 79 (843)
Q Consensus 2 ~N~i~-~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~- 79 (843)
-|.++ +.+|.+...+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..++.|+.|+.+.+.+|+++.
T Consensus 16 gNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKns 93 (1255)
T KOG0444|consen 16 GNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNS 93 (1255)
T ss_pred CCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccC
Confidence 47777 589999999999999999999999 89999999999999999999998 566778999999999999999873
Q ss_pred CCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCc-cccCCCCCcEEEcCCCCCCCCCCCCC
Q 003158 80 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLS 158 (843)
Q Consensus 80 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~ 158 (843)
-+|..+.++..|+.|||++|+++ ..|..+..-.++-.|+||+|+|. .+|. .|.+++.|-.||||+|++..+||.+.
T Consensus 94 GiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie--tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~R 170 (1255)
T KOG0444|consen 94 GIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE--TIPNSLFINLTDLLFLDLSNNRLEMLPPQIR 170 (1255)
T ss_pred CCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc--cCCchHHHhhHhHhhhccccchhhhcCHHHH
Confidence 36778889999999999999999 78888888899999999999997 4665 56789999999999999999999999
Q ss_pred CCCCCCEEEcccCcCCCCC-CCCCCCcCcCEEEccCCcCC-CCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCC
Q 003158 159 RIPNLGYLDLSSNQLNGSI-PPGRLSLNITTIKLSNNKLT-GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~l~~~~-p~~~~~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~ 236 (843)
.+..|++|+|++|.+...- -......+|+.|++++.+=+ .-+|.++.++.+|..+|||.|.|. .+|+.+.++++|
T Consensus 171 RL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~L-- 247 (1255)
T KOG0444|consen 171 RLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNL-- 247 (1255)
T ss_pred HHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhh--
Confidence 9999999999999875210 00011124444555444322 134445555555555555555554 455554443332
Q ss_pred CcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCcc
Q 003158 237 TETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPF 271 (843)
Q Consensus 237 ~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~ 271 (843)
+.|+||+|+|+.+.... ...++.+|+++.|.+
T Consensus 248 ---rrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 248 ---RRLNLSGNKITELNMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred ---heeccCcCceeeeeccHHHHhhhhhhccccchh
Confidence 23444444444444333 233444444444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-22 Score=215.51 Aligned_cols=265 Identities=21% Similarity=0.267 Sum_probs=200.2
Q ss_pred CCCCCCcccccCCeeEEEEEeCC--CcEEEEEEeccCChhhHHHHHHHHHHHHhccC----Ccccceeeee-ecCCcEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILPD--GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH----RNLVSLVGYC-DEEGEQML 584 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~l 584 (843)
+|.+.+.||+|+||.||.+.... ...+|+|.-..........+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999654 35788888765433332367788888888863 6889999998 57788999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC-----CcEEEeecccc
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLS 659 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DfGla 659 (843)
||+.+ |.+|.++........++..+...|+.|++.+|+++|+.| ++||||||.|+++... ..+.|.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999 889999886666677999999999999999999999999 9999999999999865 46999999999
Q ss_pred ccCC--CCCCCCccccee-eeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHH--HHHHHhh
Q 003158 660 RLAP--VPDIEGIVPAHV-STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR--EVNIAYQ 734 (843)
Q Consensus 660 ~~~~--~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~--~~~~~~~ 734 (843)
+... ........+... .....||..|.++....+.+.+.+.|+||++.++.|++.|..||........ .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8433 222111111111 2446699999999999999999999999999999999999999965442211 1111100
Q ss_pred cccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
. ..... .....+..+.++...+-..+...+|....+...++.....
T Consensus 255 ~----~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 255 K----LLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred h----hcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0 00000 1222345566666666668899999999999988877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=241.99 Aligned_cols=260 Identities=21% Similarity=0.268 Sum_probs=189.1
Q ss_pred CCCcccccCCeeEEEEEeC-CCcEEEEEEec----c-CCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 515 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQ----E-GSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 515 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
..+.+|.|++|.|+..... ....++.|.+. . ... .....+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988877643 34444444332 1 111 112236678888888999999988888877666666699
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
||++ +|..++... ..+...++..+..|+..|++|+|+.| |.|||+|++|++++.+|.+||+|||.+.....+..
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9998 999998664 24777788889999999999999999 99999999999999999999999999987654331
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
. .........|+..|+|||++.+.+|.+. .||||.|+++..|.+|+.||.......++.. ...
T Consensus 476 ~---~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------~~~---- 539 (601)
T KOG0590|consen 476 K---NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------TNN---- 539 (601)
T ss_pred h---hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------hhc----
Confidence 1 1244567789999999999999999875 8999999999999999999965432111100 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDAR---PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~R---Ps~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
...+| -....++..| |. .....|.+||++||++|+|++++++++||
T Consensus 540 ---------------------~~~~~~~~~~~~~~~~~l-------p~---~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 540 ---------------------YSDQRNIFEGPNRLLSLL-------PR---ETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred ---------------------cccccccccChHHHHHhc-------hh---hHHHHHHHHccCChhheecHHHHhhChHh
Confidence 00000 0111111111 11 22357889999999999999999999999
Q ss_pred cCCC
Q 003158 824 SSDV 827 (843)
Q Consensus 824 ~~~~ 827 (843)
++..
T Consensus 589 ~~i~ 592 (601)
T KOG0590|consen 589 RSIE 592 (601)
T ss_pred hhcc
Confidence 8754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=191.30 Aligned_cols=275 Identities=19% Similarity=0.277 Sum_probs=207.9
Q ss_pred CCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecC
Q 003158 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.|.+.++||+|.||..+.|+ +-+++.||||.-...+ ...++..|.+.++.+ ..+.|...+-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68889999999999999999 5689999999755332 234677889888888 4789999888888888899999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-----CCcEEEeeccccccCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLAPV 664 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~~~~ 664 (843)
|.+|+|++. .....++..++.-+|.|++.-++|+|++. .|.|||||+|.||.. ...+.|+|||+|+.+..
T Consensus 107 -GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 889999874 34556999999999999999999999999 999999999999964 34699999999998876
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc--hHHHHHHHhhcccchhhc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 742 (843)
++-....+-.......||.+||+--...+.+-+.+.|+=|+|-++...+-|..||..-.. ..+..+++-..... ..+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~-T~i 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS-TPI 260 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc-CCH
Confidence 664444455555677899999999999999999999999999999999999999975322 11111111110000 000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 798 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~d 798 (843)
. ..-+.+++++..-+...-..+-++-|..+-+...+.++.+..-+.++...|
T Consensus 261 ~----~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yD 312 (449)
T KOG1165|consen 261 E----VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYD 312 (449)
T ss_pred H----HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccc
Confidence 0 011234455555555555667788899988887777777665554444434
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=188.45 Aligned_cols=271 Identities=20% Similarity=0.287 Sum_probs=204.3
Q ss_pred HHcCCCCCCcccccCCeeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccC-CcccceeeeeecCCcEEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~ 586 (843)
..++|.++++||.|+||.+|.|. ..+|..||||.-..... ..++..|.++++.+++ ..|..+.-|..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35689999999999999999999 67899999998664332 2467789999999975 57777777888888999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc---CCCcEEEeeccccccCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAP 663 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~~ 663 (843)
|.+ |.+|.+++.- ....++..+++-++-|++.-++|+|.++ +|||||||+|.|.. ....+.++|||+|+.+-
T Consensus 91 dLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999 8899998854 2335888899999999999999999999 99999999999985 34579999999998765
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHH-HHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV-NIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 742 (843)
........+-.......||.+|.+--...+.+.+.+.|+=|+|.+|...--|..||.+-....+.. ...+.+..+...+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 443333334444566789999999888888888889999999999999999999998643322111 1111111111001
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
. ..-..++.++.-.+..|-...-++-|...-+.+....++..+-
T Consensus 246 e----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 246 E----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred H----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 0 1122345667777888988888899998877777666655443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-20 Score=199.94 Aligned_cols=257 Identities=31% Similarity=0.489 Sum_probs=196.9
Q ss_pred CCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCC-cccceeeeeecCCcEEEEEec
Q 003158 513 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHR-NLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lV~e~ 588 (843)
|.....||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +|+++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999976 78999988754332 367899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhcCC-CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~ 666 (843)
+.++++.+++..... ..+.......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977755332 25888899999999999999999999 99999999999999988 79999999998554322
Q ss_pred CCCcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcc---hHHHHHHHhhcccchh
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREVNIAYQSSMMFS 740 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~ 740 (843)
..... ........|+..|+|||.+.+ .......|+||+|++++++++|..||..... ........... .
T Consensus 157 ~~~~~-~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~--- 231 (384)
T COG0515 157 STSSI-PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-P--- 231 (384)
T ss_pred ccccc-cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc-C---
Confidence 11000 012356679999999999988 5788899999999999999999999765543 11111111110 0
Q ss_pred hccC-CCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 741 VIDG-NMGSYP----SECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 741 ~~~~-~~~~~~----~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
.+ ...... ......+.+++..|+..+|..|.+..+....
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 --TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 001111 1223567888899999999999988876654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=221.01 Aligned_cols=238 Identities=26% Similarity=0.458 Sum_probs=191.3
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+
T Consensus 187 ~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~L 256 (754)
T PRK15370 187 ILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-EL 256 (754)
T ss_pred CCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cC
Confidence 35666 5776664 58999999999999 5676554 58999999999999 5676553 47999999999998 66
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|+|++|+++.++..+. +
T Consensus 257 P~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~--LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~ 325 (754)
T PRK15370 257 PERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT--LPAHLP--SGITHLNVQSNSLTALPETLP--P 325 (754)
T ss_pred ChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc--Ccccch--hhHHHHHhcCCccccCCcccc--c
Confidence 76664 58999999999999 5676664 589999999999974 565543 479999999999998766443 6
Q ss_pred CCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCccee
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~ 241 (843)
+|+.|++++|.++ .+|.... .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+.. .|+.
T Consensus 326 sL~~L~Ls~N~Lt-~LP~~l~-~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~-------sL~~ 392 (754)
T PRK15370 326 GLKTLEAGENALT-SLPASLP-PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPA-------ALQI 392 (754)
T ss_pred cceeccccCCccc-cCChhhc-CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHH-------HHHH
Confidence 8999999999998 5776543 58999999999998 5676553 68999999999999 57776532 4778
Q ss_pred EEcCCCCCCCCCCCC-----cCCCCcEEEeccCcccc
Q 003158 242 LDFQNNNLTNISGSF-----NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 242 L~l~~N~l~~~~~~~-----~~~~l~~l~l~~Np~~c 273 (843)
|++++|+|+.+|... ..+.+..|++.+||+..
T Consensus 393 LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 393 MQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred HhhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 999999999998754 35788999999999873
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=215.91 Aligned_cols=232 Identities=27% Similarity=0.380 Sum_probs=149.7
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
.|+|+ .+|..|. .+|+.|+|.+|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+
T Consensus 210 ~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~L 277 (788)
T PRK15387 210 ESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HL 277 (788)
T ss_pred CCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hh
Confidence 46777 6787775 47888999999888 4564 3578888999998888 44532 356677777777666 33
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCcccc-----------------CCCCCcEEE
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS-----------------NMSKLLKLS 144 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----------------~l~~L~~L~ 144 (843)
|..+ .+|+.|+|++|+|+ .+|.. +++|+.|+|++|++++ +|.... ...+|+.|+
T Consensus 278 p~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~--Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~Ld 348 (788)
T PRK15387 278 PALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS--LPALPSELCKLWAYNNQLTSLPTLPSGLQELS 348 (788)
T ss_pred hhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc--CCCCcccccccccccCccccccccccccceEe
Confidence 3322 34555555555555 23321 2455555555555543 222110 113566777
Q ss_pred cCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCC
Q 003158 145 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224 (843)
Q Consensus 145 L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 224 (843)
|++|+|+++++. ..+|+.|++++|+|+ .+|... .+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+
T Consensus 349 LS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l~--~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sI 417 (788)
T PRK15387 349 VSDNQLASLPTL---PSELYKLWAYNNRLT-SLPALP--SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SL 417 (788)
T ss_pred cCCCccCCCCCC---Ccccceehhhccccc-cCcccc--cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CC
Confidence 777777665542 235666677777776 455432 367888888888874 4433 356888888888887 35
Q ss_pred CchhhccccCCCCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCcccc
Q 003158 225 PSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 225 p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~c 273 (843)
|... .+|+.|+|++|+|+.+|..+ .++.+..|+|++|||..
T Consensus 418 P~l~--------~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 418 PMLP--------SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred Ccch--------hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCc
Confidence 6432 24567899999999988766 78899999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=185.32 Aligned_cols=140 Identities=19% Similarity=0.152 Sum_probs=109.7
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChh--h------------------------HHHHHHHHHHHHhccCCcc
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--G------------------------EKEFLTEIQFLSRLHHRNL 569 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~nI 569 (843)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998754211 0 1123459999999988877
Q ss_pred cceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHH-hcCCCCCEEeccCCCCcEEEcCC
Q 003158 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDIKASNILLDHK 648 (843)
Q Consensus 570 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiH~Dlkp~NILl~~~ 648 (843)
.....+.. ...++||||++++++...... ..+++......++.|++.+|.|+ |+.+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 54433322 234899999998877655322 23578889999999999999999 6888 99999999999998 4
Q ss_pred CcEEEeeccccccCC
Q 003158 649 FTAKVADFGLSRLAP 663 (843)
Q Consensus 649 ~~~kl~DfGla~~~~ 663 (843)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=188.95 Aligned_cols=172 Identities=15% Similarity=0.107 Sum_probs=134.7
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHH---------HHHHHHHHHhccCCcccceeeeeec
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE---------FLTEIQFLSRLHHRNLVSLVGYCDE 578 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~ 578 (843)
...++|...+.+|.|+||.||.+.. ++..+|+|.+.......++. +.+|++.+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3478999999999999999999766 57789999997543333222 6899999999999999999988653
Q ss_pred C--------CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc
Q 003158 579 E--------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650 (843)
Q Consensus 579 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 650 (843)
. +..+|||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+|+++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3 35899999999999988741 222 24568999999999999 99999999999999988
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELL 713 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ell 713 (843)
++|+|||.......... ...+.....+..++|+|+||+++.-..
T Consensus 173 i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998875432110 011344555677899999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=214.48 Aligned_cols=251 Identities=20% Similarity=0.242 Sum_probs=183.0
Q ss_pred CCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCC-hhhHHHH---HHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS-LQGEKEF---LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+|...+.||.+.|=+|.+|++++|. |+||++-+.. ......| ..|++ ...++|||.+++.-+...+...|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666789999999999999998887 8899886543 2223333 44555 556689999999988888888899999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+.+ +|+|.+..+. -+...+.++|+.|++.||.-+|+.+ |+|||||.+|||+++-.-+.|+||..-+..-.++.
T Consensus 102 yvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9954 9999986543 3788889999999999999999999 99999999999999999999999987654433322
Q ss_pred CCcccceeeeeecccCCccCchhcccC----------C-CCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhh-
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTH----------K-LTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQ- 734 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~- 734 (843)
+...-............|+|||.+... . .+++.||||+||++.||++ |++||.-. +.......
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccC
Confidence 211112233344455689999998542 1 5678999999999999999 77777521 11111000
Q ss_pred cccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
......++. ..+ ...+..++..|++.+|.+|-++++.++.
T Consensus 252 ~~~~e~~Le----~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLE----KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHH----hCc---CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000000000 001 1257889999999999999999999876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-21 Score=212.10 Aligned_cols=222 Identities=27% Similarity=0.295 Sum_probs=171.8
Q ss_pred cccccCCeeEEEEE----eCCCcEEEEEEeccCChhh--HHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEecCC
Q 003158 518 QIGQGGYGKVYKGI----LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
.+|+|.||.|+.+. .+.|..+|.|+.++..... ......|-.++...+ ||.++++.-.+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998765 2347889999887643322 124456788888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|...+.... .+.+.....+...++-|++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-..+
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999988875433 3666777778888899999999999 9999999999999999999999999998654322
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
..+||..|||||++. .+..++|.||||++++||+||..||.. +.. ..+-......|
T Consensus 152 -------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~----------~~Il~~~~~~p 207 (612)
T KOG0603|consen 152 -------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTM----------KRILKAELEMP 207 (612)
T ss_pred -------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHH----------HHHhhhccCCc
Confidence 117899999999998 567889999999999999999999975 111 11111122345
Q ss_pred HHHHHHHHHHHHHhcccCCCCC
Q 003158 751 SECVEKFIKLALKCCQDETDAR 772 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~R 772 (843)
.+.+.....++......+|..|
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHH
Confidence 5666666666666655555555
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=175.90 Aligned_cols=191 Identities=14% Similarity=0.074 Sum_probs=141.3
Q ss_pred CCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhh----HHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEec
Q 003158 514 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----EKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 514 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++++ |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 67888888777543311 235789999999995 5889999886 457999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccC-CCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI-KASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
++|.+|...+.. ....+..|++++|.++|+.| |+|||| ||+|||+++++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998765421 11346789999999999999 999999 79999999999999999999985442210
Q ss_pred C-Cccc----ce-eeeeecccCCccCchhcccC-CCC-chhhhHHHHHHHHHHHhCCCCCCC
Q 003158 668 E-GIVP----AH-VSTVVKGTPGYLDPEYFLTH-KLT-DKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 668 ~-~~~~----~~-~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
- .... .+ .......++.|++|+...-. ..+ .+.+.++-|+.+|.++|+..++..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0000 00 01123467888888876532 333 567899999999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-19 Score=177.62 Aligned_cols=139 Identities=20% Similarity=0.155 Sum_probs=111.1
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChh---------------------h-----HHHHHHHHHHHHhccCCcc
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ---------------------G-----EKEFLTEIQFLSRLHHRNL 569 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~nI 569 (843)
...||+|+||.||+|...+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 0 1224678999999999988
Q ss_pred cceeeeeecCCcEEEEEecCCCCCHHHH-HhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcC
Q 003158 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 647 (843)
Q Consensus 570 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~ 647 (843)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655444333 34899999988865443 322 346778889999999999999999 88 99999999999999
Q ss_pred CCcEEEeeccccccCC
Q 003158 648 KFTAKVADFGLSRLAP 663 (843)
Q Consensus 648 ~~~~kl~DfGla~~~~ 663 (843)
++.++|+|||+|....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.4e-22 Score=179.97 Aligned_cols=167 Identities=28% Similarity=0.507 Sum_probs=146.5
Q ss_pred cCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCc
Q 003158 37 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 116 (843)
Q Consensus 37 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 116 (843)
+-++++.+.|.||+|+++ .+|..++++.+|+.|++.+|+|+ .+|..++.++.|+.|+++-|++. .+|..|+.+|.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 446778888999999998 67778899999999999999998 78888999999999999999998 8899999999999
Q ss_pred EEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcC
Q 003158 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 196 (843)
Q Consensus 117 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l 196 (843)
.|||+.|+++.-.+|..|..++.|+.|+|++|.+.-+|++++.+++|+.|.+.+|.+-
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll---------------------- 163 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL---------------------- 163 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh----------------------
Confidence 9999999998777899999999999999999999999999999999999999999886
Q ss_pred CCCCCcccCCCCCCcEEeCcCccCCCCCCchhhcc
Q 003158 197 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 231 (843)
Q Consensus 197 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 231 (843)
..|..++.+++|++|++.+|+++ .+|..++.+
T Consensus 164 --~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 164 --SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred --hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 56778888888999999999888 677666543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-19 Score=196.45 Aligned_cols=217 Identities=26% Similarity=0.409 Sum_probs=163.0
Q ss_pred HHhccCCcccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCC
Q 003158 561 LSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 640 (843)
Q Consensus 561 l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp 640 (843)
|+.+.|.|+.+|+|.+.++...+.|.+||..|+|.|.+.. ....+++.....++++|+.||+|+|... -..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 3568999999999999999999999999999999999976 3456899999999999999999999865 239999999
Q ss_pred CcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCC-------CCchhhhHHHHHHHHHHH
Q 003158 641 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-------LTDKSDVYSLGVVFLELL 713 (843)
Q Consensus 641 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwS~G~~l~ell 713 (843)
+|+++|....+|++|||+......... ........-..-|.|||.+.... .+.+.||||||++++|++
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ccceeeeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999887642100 01111222445799999998631 466799999999999999
Q ss_pred hCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC-H-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 714 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP-S-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 714 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+.+.||.......+..+....... .-....++... . +..+.+..++..||..+|.+||++.++...++.+..
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hccCccccccccCChHHHHHHHHh--cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999999864332221111111000 00011112111 1 455578999999999999999999999888877654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=177.08 Aligned_cols=229 Identities=22% Similarity=0.257 Sum_probs=147.2
Q ss_pred CCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcc----------CCcccceeeeee---
Q 003158 515 SSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLH----------HRNLVSLVGYCD--- 577 (843)
Q Consensus 515 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------h~nIv~l~~~~~--- 577 (843)
..+.||.|+++.||.+.+. +++.+|||++..... ...+++.+|.-....+. |-.++-.++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4578999999999999976 589999998764332 22356666665554432 222222222221
Q ss_pred ------cC---C-----cEEEEEecCCCCCHHHHHhh---cC--CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccC
Q 003158 578 ------EE---G-----EQMLVYEFMSNGTLRDQLSA---KS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 638 (843)
Q Consensus 578 ------~~---~-----~~~lV~e~~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dl 638 (843)
.. . ..+++|+-+ -++|.+++.. .. ...+....++.+..|+.+.+++||+.| ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 11 1 337788888 5699887642 22 224556677788899999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC--------CCCchhhhHHHHHHHH
Q 003158 639 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--------KLTDKSDVYSLGVVFL 710 (843)
Q Consensus 639 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwS~G~~l~ 710 (843)
||+|++++.+|.++|+||+...... ........+..|.+||..... .++.+.|.|++|+++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g----------~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG----------TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT----------EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC----------ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 9999999999999999999876532 111213456789999987542 4788999999999999
Q ss_pred HHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 003158 711 ELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR 772 (843)
Q Consensus 711 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R 772 (843)
.|++|..||........ .+....... +.++.+..++...++.+|.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~--------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEAD--------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGST--------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCcccc--------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999975432110 000122233 677888888888888888776
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.2e-18 Score=171.00 Aligned_cols=137 Identities=17% Similarity=0.206 Sum_probs=106.4
Q ss_pred CCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-----cCCcccceeeeeecCC---cE-E
Q 003158 513 FNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-----HHRNLVSLVGYCDEEG---EQ-M 583 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~~-~ 583 (843)
+...+.||+|+||.||. .-.++.. +||++........+.+.+|+++++.+ .||||++++|++.++. .. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 2224444 79988765445567899999999999 5799999999998763 33 3
Q ss_pred EEEec--CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHH-HHHhcCCCCCEEeccCCCCcEEEcC----CCcEEEeec
Q 003158 584 LVYEF--MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI-LYLHTEADPPVFHRDIKASNILLDH----KFTAKVADF 656 (843)
Q Consensus 584 lV~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~Df 656 (843)
+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999653 24444 35677888777 9999999 999999999999974 348999995
Q ss_pred ccc
Q 003158 657 GLS 659 (843)
Q Consensus 657 Gla 659 (843)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=203.87 Aligned_cols=224 Identities=25% Similarity=0.387 Sum_probs=182.9
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.+...|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 46789999999999 6776654 58999999999999 5666553 58999999999999 5676554 48999999
Q ss_pred cCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCC
Q 003158 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 176 (843)
++|+++ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+.++..+. ++|+.|++++|+++ .
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~--~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~ 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS--CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-A 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC--ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-c
Confidence 999999 6677665 58999999999997 4677664 589999999999998876543 57999999999999 5
Q ss_pred CCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC
Q 003158 177 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 256 (843)
Q Consensus 177 ~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~ 256 (843)
+|.... .+|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+.+|...
T Consensus 319 LP~~l~-~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp-------~~L~~LdLs~N~Lt~LP~~l 386 (754)
T PRK15370 319 LPETLP-PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP-------PTITTLDVSRNALTNLPENL 386 (754)
T ss_pred CCcccc-ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc-------CCcCEEECCCCcCCCCCHhH
Confidence 665433 589999999999995 666654 79999999999998 5776552 36789999999999998754
Q ss_pred cCCCCcEEEeccCccc
Q 003158 257 NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 257 ~~~~l~~l~l~~Np~~ 272 (843)
. ..+..|++++|.+.
T Consensus 387 ~-~sL~~LdLs~N~L~ 401 (754)
T PRK15370 387 P-AALQIMQASRNNLV 401 (754)
T ss_pred H-HHHHHHhhccCCcc
Confidence 2 35778889998765
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=199.14 Aligned_cols=213 Identities=27% Similarity=0.345 Sum_probs=146.6
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccc-----------------cC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA-----------------NL 64 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----------------~l 64 (843)
+|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+. .+
T Consensus 231 ~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp~~L~~L~Ls~N~Lt~LP~~p 301 (788)
T PRK15387 231 DNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQLTSLPVLP 301 (788)
T ss_pred CCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhchhhcCEEECcCCccccccccc
Confidence 58888 5664 3578999999999999 45543 346666666666665 3332211 12
Q ss_pred CCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEE
Q 003158 65 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 144 (843)
Q Consensus 65 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 144 (843)
++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|. + ..+|+.|+|++|+|+. +|.. ..+|+.|+
T Consensus 302 ~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~-l--p~~Lq~LdLS~N~Ls~--LP~l---p~~L~~L~ 368 (788)
T PRK15387 302 PGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPT-L--PSGLQELSVSDNQLAS--LPTL---PSELYKLW 368 (788)
T ss_pred cccceeECCCCcccc-CCCCc---ccccccccccCcccc-ccc-c--ccccceEecCCCccCC--CCCC---Ccccceeh
Confidence 344555555555542 22211 234445555555542 232 1 1479999999999974 5653 35788999
Q ss_pred cCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCC
Q 003158 145 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224 (843)
Q Consensus 145 L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 224 (843)
+++|+|+.++.. ..+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+
T Consensus 369 Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt-~LP~l--~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~L 437 (788)
T PRK15387 369 AYNNRLTSLPAL---PSGLKELIVSGNRLT-SLPVL--PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RL 437 (788)
T ss_pred hhccccccCccc---ccccceEEecCCccc-CCCCc--ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-cc
Confidence 999999987653 357999999999999 56653 2489999999999995 6654 346889999999998 78
Q ss_pred CchhhccccCCCCcceeEEcCCCCCCCC
Q 003158 225 PSSIWQSRTLNATETFILDFQNNNLTNI 252 (843)
Q Consensus 225 p~~~~~l~~l~~~~L~~L~l~~N~l~~~ 252 (843)
|..+..+.+ |..|+|++|+|++.
T Consensus 438 P~sl~~L~~-----L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 438 PESLIHLSS-----ETTVNLEGNPLSER 460 (788)
T ss_pred ChHHhhccC-----CCeEECCCCCCCch
Confidence 998876654 55899999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-20 Score=211.38 Aligned_cols=241 Identities=31% Similarity=0.422 Sum_probs=177.0
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.+|++++++.|+++ .+|+.++.+.+|+.|+..+|+|+ .+|..+....+|+.|.+..|.++ -+|..+..++.|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 45677777777777 45577777777777777777775 66666667777777777777776 55556666777777777
Q ss_pred cCCCCCCCCCcccCCCCC-CcEEEcCCCCCCCCCCCc-cccCCCCCcEEEcCCCCCCCC-CCCCCCCCCCCEEEcccCcC
Q 003158 97 DNNNLTGYLPPELSELPK-LLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGP-MPDLSRIPNLGYLDLSSNQL 173 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~-~~~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~Ls~N~l 173 (843)
..|+|....+..+.-+.. |..|+.+.|++.. .|. .=..++.|+.|++.+|.|+.- .|.+.+.++|+.|+|++|+|
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~--lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL 395 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLST--LPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL 395 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccc--cccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence 777777333333333333 6666666676652 231 113356788999999999863 44588889999999999999
Q ss_pred CCCCCCCCCCc--CcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCC
Q 003158 174 NGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 251 (843)
Q Consensus 174 ~~~~p~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~ 251 (843)
. .+|...... .|+.|+||+|.|+ .+|..+..++.|++|...+|+|. ..| .+.++ +.|+++|++.|+|+.
T Consensus 396 ~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l-----~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 396 N-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQL-----PQLKVLDLSCNNLSE 466 (1081)
T ss_pred c-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhc-----CcceEEecccchhhh
Confidence 8 788765543 7999999999999 77899999999999999999998 666 45443 456799999999998
Q ss_pred CCCCC--cCCCCcEEEeccCcc
Q 003158 252 ISGSF--NIPPNVTVRLRGNPF 271 (843)
Q Consensus 252 ~~~~~--~~~~l~~l~l~~Np~ 271 (843)
+.... .-|+|++|+++||+|
T Consensus 467 ~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 467 VTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhhCCCcccceeeccCCcc
Confidence 86655 347899999999996
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-18 Score=197.37 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=184.6
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc---CCcccceeeeeecCCc
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGE 581 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~ 581 (843)
+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+=+....- +|.-=.+++.+|+ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 556667889999999999999999999888999999987654322 2222233444444 2345555555566778
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-------CCCcEEEe
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-------HKFTAKVA 654 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~-------~~~~~kl~ 654 (843)
-+||+||.+.|+|.+++. ....++|..++.++.|+++.+++||..+ |||+||||+|.|+. +..-++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 899999999999999996 4456899999999999999999999999 99999999999994 23469999
Q ss_pred eccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhh
Q 003158 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734 (843)
Q Consensus 655 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~ 734 (843)
|||.+-.+..-. .........+|-.+-.+|...+..|++.+|-|.++.+++-|+.|+..= ..
T Consensus 844 DfG~siDm~lfp-----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------~~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFP-----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------VK 905 (974)
T ss_pred ecccceeeeEcC-----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------hc
Confidence 999986553221 123456677899999999999999999999999999999999986421 01
Q ss_pred cccchhhccCCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 735 SSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 735 ~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+..+.+... ... ...+.|.++..++ ++.+-..-|...++...++.++.
T Consensus 906 ~g~~~~~~~~-~~Ry~~~~~W~~~F~~l---LN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 NGSSWMVKTN-FPRYWKRDMWNKFFDLL---LNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CCcceecccc-chhhhhHHHHHHHHHHH---hCcCcccchhHHHHHHHHHHHHH
Confidence 1111111111 111 1334455554444 44666666777888777777654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-17 Score=207.56 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=150.7
Q ss_pred cccCCccccCCC-CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcc
Q 003158 6 SGSIPKEIGNIK-SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPE 84 (843)
Q Consensus 6 ~~~~p~~i~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 84 (843)
...+|+.|..++ +|+.|++.++.++ .+|..| ...+|++|+|++|++. .++..+..+++|+.|+|++|.....+| .
T Consensus 577 ~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ 652 (1153)
T PLN03210 577 RWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-D 652 (1153)
T ss_pred eeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-c
Confidence 334566665553 4666666666665 555555 3566666777666666 455556666667777776654333444 3
Q ss_pred cCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCC
Q 003158 85 LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG 164 (843)
Q Consensus 85 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~ 164 (843)
+..+++|+.|+|++|.....+|..+.++++|+.|+|++|.... .+|..+ ++++|+.|+|++|......+.+ ..+|+
T Consensus 653 ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~-~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~--~~nL~ 728 (1153)
T PLN03210 653 LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE-ILPTGI-NLKSLYRLNLSGCSRLKSFPDI--STNIS 728 (1153)
T ss_pred cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcC-ccCCcC-CCCCCCEEeCCCCCCccccccc--cCCcC
Confidence 5666667777776665555666666666667777666653322 345443 5566666666665432222221 23555
Q ss_pred EEEcccCcCCCCCCCCC-------------------------------CCcCcCEEEccCCcCCCCCCcccCCCCCCcEE
Q 003158 165 YLDLSSNQLNGSIPPGR-------------------------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 213 (843)
Q Consensus 165 ~L~Ls~N~l~~~~p~~~-------------------------------~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 213 (843)
.|+|++|.+. .+|... ...+|+.|+|++|...+.+|..++++++|+.|
T Consensus 729 ~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L 807 (1153)
T PLN03210 729 WLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHL 807 (1153)
T ss_pred eeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEE
Confidence 6666666554 333221 11367788888887777788888888888888
Q ss_pred eCcCccCCCCCCchhhccccC-----------C-----CCcceeEEcCCCCCCCCCCCC-cCCCCcEEEecc
Q 003158 214 FIANNSLSGSIPSSIWQSRTL-----------N-----ATETFILDFQNNNLTNISGSF-NIPPNVTVRLRG 268 (843)
Q Consensus 214 ~L~~N~l~~~~p~~~~~l~~l-----------~-----~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~ 268 (843)
+|++|...+.+|..+ .+.+| . ..+|+.|+|++|.|+.+|... .++.|..|++.+
T Consensus 808 ~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 808 EIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred ECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCCCCCccChHHHhcCCCCCEEECCC
Confidence 888875444666543 11111 0 135667777777777776655 577777777766
|
syringae 6; Provisional |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-19 Score=203.54 Aligned_cols=172 Identities=28% Similarity=0.428 Sum_probs=122.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|+.++.|-.|++|.||..+++ ..+.+|.|+-+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence 457888999999999999999876 4678888543321 11110 22222233322
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC---
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP--- 665 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~--- 665 (843)
|+=.+.++.-+. ++... +.+++|||+.+ |+|||+||+|.+++.-|.+|+.|||+++..-..
T Consensus 136 ---gDc~tllk~~g~--lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP--LPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC--Ccchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 444455533333 33222 67899999999 999999999999999999999999998653211
Q ss_pred -----CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 666 -----DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 666 -----~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.............++||+.|+|||++....|+..+|+|++|+++||.+.|+.||+...
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 0000000111234589999999999999999999999999999999999999998754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.6e-17 Score=203.07 Aligned_cols=248 Identities=18% Similarity=0.237 Sum_probs=154.8
Q ss_pred cCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCC
Q 003158 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 87 (843)
Q Consensus 8 ~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 87 (843)
.+|..| ...+|+.|+|.+|++. .++..+..+++|+.|+|++|.....+|. +..+++|+.|+|++|.....+|..+.+
T Consensus 603 ~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~ 679 (1153)
T PLN03210 603 CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQY 679 (1153)
T ss_pred CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhc
Confidence 555555 4566667777776666 5566666666666666666543334443 566666666666666544456666666
Q ss_pred CCCCceeeccCCCCCCCCCcccCCCCCCcEEEcC---------------------CCCCCCCCCCccc------------
Q 003158 88 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD---------------------NNNFEGTTIPASY------------ 134 (843)
Q Consensus 88 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls---------------------~N~l~~~~~~~~~------------ 134 (843)
+++|+.|+|++|.....+|..+ ++++|+.|+|+ +|.+. .+|..+
T Consensus 680 L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~--~lP~~~~l~~L~~L~l~~ 756 (1153)
T PLN03210 680 LNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE--EFPSNLRLENLDELILCE 756 (1153)
T ss_pred cCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc--cccccccccccccccccc
Confidence 6666666666654333444433 34445554444 44443 223211
Q ss_pred ------------------cCCCCCcEEEcCCCCCCC-CCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCc
Q 003158 135 ------------------SNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 195 (843)
Q Consensus 135 ------------------~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~ 195 (843)
...++|+.|+|++|.... +|..+..+++|+.|+|++|...+.+|......+|+.|+|++|.
T Consensus 757 ~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~ 836 (1153)
T PLN03210 757 MKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCS 836 (1153)
T ss_pred cchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCC
Confidence 012356666666664333 3335777777888888776544467766555577888888775
Q ss_pred CCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCC-CCCCCCCCCC-cCCCCcEEEeccCc
Q 003158 196 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN-NNLTNISGSF-NIPPNVTVRLRGNP 270 (843)
Q Consensus 196 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~-N~l~~~~~~~-~~~~l~~l~l~~Np 270 (843)
....+|.. .++|+.|+|++|.|+ .+|.++..+. +|+.|+|++ |+|+.++... .++.+..+++.+++
T Consensus 837 ~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~-----~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 837 RLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFS-----NLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cccccccc---ccccCEeECCCCCCc-cChHHHhcCC-----CCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 44444432 357888889998887 6787776554 556899988 8999998766 78888888887643
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.3e-20 Score=205.40 Aligned_cols=162 Identities=27% Similarity=0.329 Sum_probs=100.6
Q ss_pred cccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCC---
Q 003158 107 PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--- 183 (843)
Q Consensus 107 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--- 183 (843)
+++..+.+|+.|++.+|++. .+|..+..+++|+.|++..|.+..+++...++++|+.|+|..|+|. ..|+..+.
T Consensus 258 ~wi~~~~nle~l~~n~N~l~--~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~ 334 (1081)
T KOG0618|consen 258 EWIGACANLEALNANHNRLV--ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLN 334 (1081)
T ss_pred HHHHhcccceEecccchhHH--hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhcccc-ccchHHHhhhh
Confidence 44444444444444444442 3344444444444444455555556666777889999999999887 33331110
Q ss_pred ------------------------cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcc
Q 003158 184 ------------------------LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239 (843)
Q Consensus 184 ------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L 239 (843)
..|+.|+|.+|.|+...-..|.+++.|+.|+|++|+|. .+|++.. . ++..|
T Consensus 335 ~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~--~--kle~L 409 (1081)
T KOG0618|consen 335 ASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKL--R--KLEEL 409 (1081)
T ss_pred HHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHH--h--chHHh
Confidence 13667777777777766667777888888888888887 5555432 2 23356
Q ss_pred eeEEcCCCCCCCCCCCC-cCCCCcEEEeccCcccccCC
Q 003158 240 FILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTN 276 (843)
Q Consensus 240 ~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~c~~~ 276 (843)
+.|+||+|+|+.+|... .++.+.+|...+|.+.|-.+
T Consensus 410 eeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fPe 447 (1081)
T KOG0618|consen 410 EELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFPE 447 (1081)
T ss_pred HHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeechh
Confidence 67888888888887655 66777777777777666543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.7e-20 Score=188.39 Aligned_cols=246 Identities=23% Similarity=0.322 Sum_probs=197.4
Q ss_pred EEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccC-C
Q 003158 21 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN-N 99 (843)
Q Consensus 21 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~-N 99 (843)
..+-++-.|+ .+|..+- +.-+.++|..|+|+.+.+.+|+.+++|++||||+|+|+.+-|.+|.++.+|..|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 4455666677 5665443 4578899999999988889999999999999999999999999999999998886666 9
Q ss_pred CCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCC---
Q 003158 100 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNG--- 175 (843)
Q Consensus 100 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~--- 175 (843)
+|+.+....|.+|..|+.|.+.-|++.. .....|..+++|..|.+.+|.++.+.. .|..+..++.+.+..|.+..
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~C-ir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINC-IRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcc-hhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 9998777899999999999999999986 457789999999999999999998888 59999999999999998321
Q ss_pred --------------------------------CCCCCCCCcCcCEE--EccC-CcCCCCCC-cccCCCCCCcEEeCcCcc
Q 003158 176 --------------------------------SIPPGRLSLNITTI--KLSN-NKLTGTIP-SNFSGLPRLQRLFIANNS 219 (843)
Q Consensus 176 --------------------------------~~p~~~~~~~L~~L--~Ls~-N~l~~~~p-~~~~~l~~L~~L~L~~N~ 219 (843)
.++...+...++.+ .++. +...+..| ..|.+|++|+.|+|++|+
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 01111111122222 1222 22322333 578999999999999999
Q ss_pred CCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccC
Q 003158 220 LSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNT 275 (843)
Q Consensus 220 l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~ 275 (843)
|++.-+.+|.++..+ +.|.|..|+|..+.... ++..|.+|+|+||.+.|--
T Consensus 286 i~~i~~~aFe~~a~l-----~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~ 338 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAEL-----QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVA 338 (498)
T ss_pred cchhhhhhhcchhhh-----hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEe
Confidence 999999999876655 48999999999998765 7999999999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.7e-17 Score=164.40 Aligned_cols=134 Identities=20% Similarity=0.330 Sum_probs=114.2
Q ss_pred CcccccCCeeEEEEEeCCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 517 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
+.||+|++|.||+|.+ +|..|++|+....... ...++.+|++++..++|++|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986543211 124578899999999999998888888777888999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
++|++|.+++.... . .+..++.+++.+|.++|+.+ ++|||++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985432 1 77889999999999999999 99999999999999 78999999998864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-19 Score=166.37 Aligned_cols=161 Identities=29% Similarity=0.480 Sum_probs=150.3
Q ss_pred ccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCc
Q 003158 13 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 92 (843)
Q Consensus 13 i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 92 (843)
+.++++.+.|.|++|+++ .+|+.+..|.+|+.|++++|+|. .+|.+++.+++|+.|+++-|++. +.|..|+.+|.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 446788999999999999 88889999999999999999999 88999999999999999999998 8999999999999
Q ss_pred eeeccCCCCC-CCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccC
Q 003158 93 HMLLDNNNLT-GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 171 (843)
Q Consensus 93 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N 171 (843)
.|||.+|++. ..+|..|..++.|+-|+|++|.+. .+|..++++++|+.|.+..|.+-.+|..++.+..|+.|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe--~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE--ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc--cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccc
Confidence 9999999998 568889999999999999999997 5899999999999999999999999999999999999999999
Q ss_pred cCCCCCCC
Q 003158 172 QLNGSIPP 179 (843)
Q Consensus 172 ~l~~~~p~ 179 (843)
+++ .+|+
T Consensus 184 rl~-vlpp 190 (264)
T KOG0617|consen 184 RLT-VLPP 190 (264)
T ss_pred eee-ecCh
Confidence 998 4544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.6e-17 Score=165.92 Aligned_cols=202 Identities=21% Similarity=0.259 Sum_probs=143.5
Q ss_pred cCCcccceeeeeec---------------------------CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHH
Q 003158 565 HHRNLVSLVGYCDE---------------------------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 617 (843)
Q Consensus 565 ~h~nIv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 617 (843)
+|||||++.++|.+ ...+|+||.-++ .+|..++-.+. .+.....-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999887633 235699999884 59999996543 344555668889
Q ss_pred HHHHHHHHhcCCCCCEEeccCCCCcEEEc--CCC--cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc
Q 003158 618 SSRGILYLHTEADPPVFHRDIKASNILLD--HKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693 (843)
Q Consensus 618 ia~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 693 (843)
+++|+.|||+++ |.|||+|++|||+. +|+ .+.|+|||++---+.....-.. .......-|...-||||+...
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy-~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPY-ESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeecccccccccc-ccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999983 444 5789999987432211000000 011122346778999999875
Q ss_pred CC------CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhccc
Q 003158 694 HK------LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQD 767 (843)
Q Consensus 694 ~~------~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~ 767 (843)
.+ --.++|.|+.|.+.||+++...||.......-..+ .++ +..++..|+.++..+.+++...++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-~Yq--------e~qLPalp~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-TYQ--------ESQLPALPSRVPPVARQLVFDLLKR 496 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-hhh--------hhhCCCCcccCChHHHHHHHHHhcC
Confidence 32 12489999999999999999999986332111111 112 2235567888999999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 003158 768 ETDARPSMSEVMRELE 783 (843)
Q Consensus 768 ~p~~RPs~~~vl~~L~ 783 (843)
+|.+|++..-....++
T Consensus 497 ~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 497 DPSKRVSPNIAANVLN 512 (598)
T ss_pred CccccCCccHHHhHHH
Confidence 9999998765554444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=160.87 Aligned_cols=140 Identities=19% Similarity=0.166 Sum_probs=110.7
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChh----------------------hHHHHHHHHHHHHhccC
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----------------------GEKEFLTEIQFLSRLHH 566 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h 566 (843)
....|.+.+.||+|+||.||+|...+|+.||||++...... ....+..|+.++..+.|
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 33347788999999999999999888999999987642200 11236778999999988
Q ss_pred Cc--ccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEE
Q 003158 567 RN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 644 (843)
Q Consensus 567 ~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NIL 644 (843)
++ +.+.++ ....++||||+++++|.++... .....++.++++++.++|+.+ |+||||||+||+
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil 157 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL 157 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence 74 444443 2456899999999999776421 234568899999999999998 999999999999
Q ss_pred EcCCCcEEEeeccccccCC
Q 003158 645 LDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 645 l~~~~~~kl~DfGla~~~~ 663 (843)
+++++.++|+|||++....
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=165.03 Aligned_cols=143 Identities=20% Similarity=0.159 Sum_probs=110.2
Q ss_pred CCCCCCcccccCCeeEEEEE--eCCCcEEEEEEeccCChh------------------------hHHHHHHHHHHHHhcc
Q 003158 512 NFNSSTQIGQGGYGKVYKGI--LPDGTVVAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 565 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 565 (843)
-|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36677899999999999998 568999999998743210 0123578999999997
Q ss_pred CCc--ccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcE
Q 003158 566 HRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 643 (843)
Q Consensus 566 h~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NI 643 (843)
+.. +.+++++ ...++||||+++++|....... ..........++.|++.++.+||+.+. |+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhE
Confidence 633 3344432 2358999999998887664222 235556677899999999999998763 99999999999
Q ss_pred EEcCCCcEEEeeccccccCC
Q 003158 644 LLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 644 Ll~~~~~~kl~DfGla~~~~ 663 (843)
+++ ++.++|+|||.|....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=160.44 Aligned_cols=131 Identities=22% Similarity=0.337 Sum_probs=108.2
Q ss_pred cccccCCeeEEEEEeCCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.||+|+||+||+|.+ ++..|++|........ ...++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 5788999986532211 1256788999999999988766666666677789999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
+|++|.+++..... .++.+++++|.++|+.+ ++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998754211 68999999999999999 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-16 Score=182.57 Aligned_cols=140 Identities=21% Similarity=0.282 Sum_probs=113.0
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccC-Ch------hhHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG-SL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 580 (843)
.....|...+.||+|+||+||+|.+.+...++.+..... .. ...+++.+|+++++.++|++++....++.+..
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 334556678999999999999998755443332222211 11 12356889999999999999998888887777
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+||++ +++.++|+|||+++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 8899999999999999884 34678999999999999999 9999999999999 67899999999997
Q ss_pred c
Q 003158 661 L 661 (843)
Q Consensus 661 ~ 661 (843)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.1e-19 Score=192.19 Aligned_cols=267 Identities=20% Similarity=0.255 Sum_probs=181.2
Q ss_pred cccc-ccCCccccCCCCCCEEEccCCcCCc----cCccccCCCCCCcEEEcccCcCCc------cCccccccCCCCCEEE
Q 003158 3 NKIS-GSIPKEIGNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYISG------SLPKSFANLNKTRHFH 71 (843)
Q Consensus 3 N~i~-~~~p~~i~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~~L~~L~ 71 (843)
|+++ +..+..|..+.+|+.|++++|.++. .++..+...++|++|+++++.+.+ .++..+..+++|+.|+
T Consensus 8 ~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~ 87 (319)
T cd00116 8 ELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELD 87 (319)
T ss_pred CcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEE
Confidence 3444 3444555667789999999998853 256667778889999999888772 2345567788999999
Q ss_pred ccCCccccCCCcccCCCCC---CceeeccCCCCCC----CCCcccCCC-CCCcEEEcCCCCCCCC---CCCccccCCCCC
Q 003158 72 MNNNSISGQIPPELSRLPS---LVHMLLDNNNLTG----YLPPELSEL-PKLLILQLDNNNFEGT---TIPASYSNMSKL 140 (843)
Q Consensus 72 Ls~N~l~~~~~~~l~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~---~~~~~~~~l~~L 140 (843)
+++|.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|+|++|.+++. .+...+..+++|
T Consensus 88 l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L 167 (319)
T cd00116 88 LSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDL 167 (319)
T ss_pred ccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCc
Confidence 9999887655555554444 9999999998873 223345566 8889999999988741 123456677889
Q ss_pred cEEEcCCCCCCCC-----CCCCCCCCCCCEEEcccCcCCCCCCC----C-CCCcCcCEEEccCCcCCCCCCcccC-----
Q 003158 141 LKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQLNGSIPP----G-RLSLNITTIKLSNNKLTGTIPSNFS----- 205 (843)
Q Consensus 141 ~~L~L~~N~l~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~p~----~-~~~~~L~~L~Ls~N~l~~~~p~~~~----- 205 (843)
++|+|++|.+++. ...+..+++|+.|+|++|.+++.... . ....+|+.|++++|.+++.....+.
T Consensus 168 ~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~ 247 (319)
T cd00116 168 KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLS 247 (319)
T ss_pred CEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhc
Confidence 9999999988742 12245567899999999988643221 1 1123788999999888753333322
Q ss_pred CCCCCcEEeCcCccCCCCCCchhh-ccccCCCCcceeEEcCCCCCCCCCCCC------cC-CCCcEEEeccCcc
Q 003158 206 GLPRLQRLFIANNSLSGSIPSSIW-QSRTLNATETFILDFQNNNLTNISGSF------NI-PPNVTVRLRGNPF 271 (843)
Q Consensus 206 ~l~~L~~L~L~~N~l~~~~p~~~~-~l~~l~~~~L~~L~l~~N~l~~~~~~~------~~-~~l~~l~l~~Np~ 271 (843)
..+.|++|++++|.++......+. .+.. .++|+.+++++|.++..+... .. +.+..+++.+|||
T Consensus 248 ~~~~L~~L~l~~n~i~~~~~~~l~~~~~~--~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 248 PNISLLTLSLSCNDITDDGAKDLAEVLAE--KESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cCCCceEEEccCCCCCcHHHHHHHHHHhc--CCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 247889999999988733222221 1222 256778999999888664311 23 6788888888876
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-17 Score=175.55 Aligned_cols=128 Identities=27% Similarity=0.401 Sum_probs=108.2
Q ss_pred CcEEEEEecCCCCCHHHHHhh-cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
...++.|++|.-.+|.+||.+ ......++.....++.|++.|++| ++ .+|+|+||.||++..+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 357899999999999999974 334557788899999999999999 67 89999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT 714 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt 714 (843)
........ ....+....+...||..||+||.+.+..|+.++||||+|++++|++.
T Consensus 403 ~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87665432 11112233456779999999999999999999999999999999996
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-18 Score=185.90 Aligned_cols=241 Identities=22% Similarity=0.251 Sum_probs=185.3
Q ss_pred CCccccCCCCCCEEEccCCcCC------ccCccccCCCCCCcEEEcccCcCCccCccccccCCC---CCEEEccCCcccc
Q 003158 9 IPKEIGNIKSLELLLLNGNELT------GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK---TRHFHMNNNSISG 79 (843)
Q Consensus 9 ~p~~i~~l~~L~~L~L~~n~l~------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~ 79 (843)
++..+...++|+.|+++++.+. ..++..+..+++|++|+|++|.+.+..+..+..+.+ |+.|++++|+++.
T Consensus 43 i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~ 122 (319)
T cd00116 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD 122 (319)
T ss_pred HHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccch
Confidence 5566777888999999999887 234567888999999999999998777777776666 9999999999973
Q ss_pred ----CCCcccCCC-CCCceeeccCCCCCCC----CCcccCCCCCCcEEEcCCCCCCCCC---CCccccCCCCCcEEEcCC
Q 003158 80 ----QIPPELSRL-PSLVHMLLDNNNLTGY----LPPELSELPKLLILQLDNNNFEGTT---IPASYSNMSKLLKLSLRN 147 (843)
Q Consensus 80 ----~~~~~l~~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~~l~~L~~L~L~~ 147 (843)
.+...+..+ ++|+.|+|++|.+++. +...+..+++|++|+|++|.+++.. ++..+..+++|+.|+|++
T Consensus 123 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~ 202 (319)
T cd00116 123 RGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202 (319)
T ss_pred HHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccC
Confidence 233455667 8999999999999842 3445677889999999999997422 233456667999999999
Q ss_pred CCCCCCCC-----CCCCCCCCCEEEcccCcCCCCCCC----CCC--CcCcCEEEccCCcCCC----CCCcccCCCCCCcE
Q 003158 148 CSLQGPMP-----DLSRIPNLGYLDLSSNQLNGSIPP----GRL--SLNITTIKLSNNKLTG----TIPSNFSGLPRLQR 212 (843)
Q Consensus 148 N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~p~----~~~--~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~ 212 (843)
|.+++... .+..+++|+.|++++|.+++.... ... ..+|+.|++++|.++. .+...+..+++|+.
T Consensus 203 n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~ 282 (319)
T cd00116 203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE 282 (319)
T ss_pred CccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence 99975432 367789999999999999852111 111 2489999999999972 33456677899999
Q ss_pred EeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCC
Q 003158 213 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 249 (843)
Q Consensus 213 L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l 249 (843)
|++++|.++......+.......-++|+.||+.+|.+
T Consensus 283 l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 283 LDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 9999999997655555554444446788999998864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=7e-15 Score=146.87 Aligned_cols=136 Identities=23% Similarity=0.207 Sum_probs=98.0
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChhh--HHH----------------------HHHHHHHHHhccCCc--c
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG--EKE----------------------FLTEIQFLSRLHHRN--L 569 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--I 569 (843)
.+.||+|+||+||+|...+++.||||++....... ... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999887532211 111 134566666664433 3
Q ss_pred cceeeeeecCCcEEEEEecCCCCCHHHH-HhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcC
Q 003158 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDH 647 (843)
Q Consensus 570 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~ 647 (843)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 246899999998543221 11110 11 5577899999999999999 87 99999999999999
Q ss_pred CCcEEEeeccccccCC
Q 003158 648 KFTAKVADFGLSRLAP 663 (843)
Q Consensus 648 ~~~~kl~DfGla~~~~ 663 (843)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-14 Score=139.71 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=114.3
Q ss_pred CCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccC--CcccceeeeeecCCcEEEEEecCCCC
Q 003158 515 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 515 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999754 7899999875433 5678899999999977 58999999988888999999999887
Q ss_pred CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 593 TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 593 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77554 3455667889999999999986545599999999999999999999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5e-16 Score=179.38 Aligned_cols=262 Identities=21% Similarity=0.251 Sum_probs=195.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC--CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV 585 (843)
..|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45677788999999999887753 35567777766433 222345556777777776 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHh-cCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAP 663 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~ 663 (843)
++|.+++++.+-+........+......+..|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999883222223555666779999999999999 888 99999999999999999 99999999998765
Q ss_pred C-CCCCCcccceeeeeecc-cCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 664 V-PDIEGIVPAHVSTVVKG-TPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 664 ~-~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
. .. .........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........
T Consensus 177 ~~~g-----~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~------------- 238 (601)
T KOG0590|consen 177 NKNG-----AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG------------- 238 (601)
T ss_pred ccCC-----cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-------------
Confidence 4 22 1233344567 9999999999884 456679999999999999999999864332100
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
.....+..| .|.. ...+........+++.++++.+|..|.+.+++-.|
T Consensus 239 ---------------~~~~~~~~~------~~~~-----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 239 ---------------RYSSWKSNK------GRFT-----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---------------cceeecccc------cccc-----------cCccccCChhhhhcccccccCCchhcccccccccc
Confidence 000000000 0000 01122334556688999999999999999999999
Q ss_pred CcccC
Q 003158 821 PYVSS 825 (843)
Q Consensus 821 p~f~~ 825 (843)
||++.
T Consensus 287 ~~~~~ 291 (601)
T KOG0590|consen 287 NWLSS 291 (601)
T ss_pred ccccc
Confidence 99988
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.6e-14 Score=146.56 Aligned_cols=135 Identities=23% Similarity=0.286 Sum_probs=105.2
Q ss_pred CCccc-ccCCeeEEEEEeCCCcEEEEEEeccCCh-------------hhHHHHHHHHHHHHhccCCcc--cceeeeeecC
Q 003158 516 STQIG-QGGYGKVYKGILPDGTVVAVKRAQEGSL-------------QGEKEFLTEIQFLSRLHHRNL--VSLVGYCDEE 579 (843)
Q Consensus 516 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 579 (843)
...|| .|+.|+||.+... +..+|||++..... .....+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999874 67889998753211 123567889999999998875 6677765332
Q ss_pred -Cc---EEEEEecCCC-CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEe
Q 003158 580 -GE---QMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVA 654 (843)
Q Consensus 580 -~~---~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 654 (843)
.. .++|||++++ .+|.+++... +++.. .+.++++++.+||+.| |+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 22 2599999997 6999988542 23332 3568999999999999 9999999999999999999999
Q ss_pred ecccccc
Q 003158 655 DFGLSRL 661 (843)
Q Consensus 655 DfGla~~ 661 (843)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998874
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.9e-15 Score=162.58 Aligned_cols=200 Identities=28% Similarity=0.440 Sum_probs=174.2
Q ss_pred EEEccCCcCCccCc-ccc-CCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccC
Q 003158 21 LLLLNGNELTGSLP-EEL-GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 98 (843)
Q Consensus 21 ~L~L~~n~l~~~~p-~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 98 (843)
+|.|++-++. ..| .++ -.|..-...||+.|++. .+|..+..+..|+.+.|..|.|. .+|..+.++..|+.|+|+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 4666666666 333 222 24566678999999999 88999999999999999999999 8899999999999999999
Q ss_pred CCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCC
Q 003158 99 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 178 (843)
Q Consensus 99 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 178 (843)
|+++ .+|..++.|+ |+.|.+++|++. .+|..++.+..|..||.+.|.+..+++.++.+.+|+.|.+..|.+. .+|
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~--~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT--SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc--cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence 9999 7888888774 999999999996 6899999999999999999999999999999999999999999998 777
Q ss_pred CCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhc
Q 003158 179 PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 230 (843)
Q Consensus 179 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 230 (843)
.......|..||+|+|+++ .+|-.|..|+.|++|-|.+|.|+ .-|..++.
T Consensus 206 ~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~ 255 (722)
T KOG0532|consen 206 EELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE 255 (722)
T ss_pred HHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence 7777789999999999999 89999999999999999999998 55665543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.3e-13 Score=136.46 Aligned_cols=154 Identities=25% Similarity=0.390 Sum_probs=115.3
Q ss_pred HHHhccCCcccceeeeeecCC-----cEEEEEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCC
Q 003158 560 FLSRLHHRNLVSLVGYCDEEG-----EQMLVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPP 632 (843)
Q Consensus 560 ~l~~l~h~nIv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 632 (843)
-+-.+.|.|||+++.|+.+.+ ...++.|||..|++..+|++. ....+....-.+|+.||..||.|||+. .|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344557999999999986543 568999999999999999763 334567777788999999999999985 699
Q ss_pred EEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHH
Q 003158 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 712 (843)
Q Consensus 633 iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~el 712 (843)
|+|+++..+-|++..+|-+|++----...- ..... ..........+-++|.|||+-.....+.++|||+||+...||
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h--~s~~~-~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTH--PSVNS-TREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccc--hhhhh-hhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 999999999999999998888632111100 00000 000111223467899999998877888899999999999999
Q ss_pred HhCCC
Q 003158 713 LTGMQ 717 (843)
Q Consensus 713 ltg~~ 717 (843)
.-+..
T Consensus 276 ailEi 280 (458)
T KOG1266|consen 276 AILEI 280 (458)
T ss_pred HHhee
Confidence 87643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.2e-13 Score=148.31 Aligned_cols=141 Identities=23% Similarity=0.247 Sum_probs=100.9
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChhh----------------------------------------HHHHH
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG----------------------------------------EKEFL 555 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 555 (843)
.+.||.|++|.||+|++++|+.||||+........ +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986532111 01244
Q ss_pred HHHHHHHhcc----CCcccceeeee-ecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHH-HHHHHhcCC
Q 003158 556 TEIQFLSRLH----HRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR-GILYLHTEA 629 (843)
Q Consensus 556 ~E~~~l~~l~----h~nIv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~~ 629 (843)
+|++.+.+++ |.+-+.+-.++ ...+..+|||||++|++|.++...... .. .+..++..+++ .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 5565555552 22223322222 334567999999999999987653211 11 24456666666 478899988
Q ss_pred CCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 630 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
++|+|++|.||+++++++++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.4e-12 Score=146.56 Aligned_cols=170 Identities=29% Similarity=0.463 Sum_probs=74.5
Q ss_pred EEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCC-CCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCC
Q 003158 46 IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP-SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 124 (843)
Q Consensus 46 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 124 (843)
|+++.|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 98 l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 98 LDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 444444443 11222333344455555555544 3333333332 4555555555544 333344444555555555555
Q ss_pred CCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCccc
Q 003158 125 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNF 204 (843)
Q Consensus 125 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~ 204 (843)
+. .+|...+.+++|+.|++++|+++.+++.......|+.|.+++|.+...+.......++..|.+++|++. ..+..+
T Consensus 175 l~--~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~ 251 (394)
T COG4886 175 LS--DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESI 251 (394)
T ss_pred hh--hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchh
Confidence 43 233433344455555555555554444333334455555555532212221222224444444555444 224444
Q ss_pred CCCCCCcEEeCcCccCC
Q 003158 205 SGLPRLQRLFIANNSLS 221 (843)
Q Consensus 205 ~~l~~L~~L~L~~N~l~ 221 (843)
..+++|++|++++|.++
T Consensus 252 ~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 252 GNLSNLETLDLSNNQIS 268 (394)
T ss_pred ccccccceecccccccc
Confidence 55555555555555555
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.3e-12 Score=138.63 Aligned_cols=166 Identities=19% Similarity=0.196 Sum_probs=129.0
Q ss_pred eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHH
Q 003158 532 LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 611 (843)
Q Consensus 532 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~ 611 (843)
..++.+|.|...+...........+-++.|+.++||||+++++.+..++..|||+|-+. .|..++.+.+ ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence 44788899988876544344567788999999999999999999999999999999984 7888886643 5566
Q ss_pred HHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhc
Q 003158 612 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691 (843)
Q Consensus 612 ~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 691 (843)
...+.||++||.+||..++ ++|++|.-+-|+|+..|..||++|.++........ ......---.|..|+.+
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------ccccchhhhcccChhhc
Confidence 6788999999999997764 99999999999999999999999998865432110 00111122346677765
Q ss_pred ccCCCCchhhhHHHHHHHHHHHhC
Q 003158 692 LTHKLTDKSDVYSLGVVFLELLTG 715 (843)
Q Consensus 692 ~~~~~~~~sDvwS~G~~l~elltg 715 (843)
.... -..|.|.|||+++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 4333 346999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.1e-12 Score=141.66 Aligned_cols=142 Identities=20% Similarity=0.204 Sum_probs=93.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeCC-CcEEEEEEeccCChhh----------------------------------HH---
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQG----------------------------------EK--- 552 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~--- 552 (843)
..|+. +.||+|++|.||+|++++ |+.||||+........ .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999887 9999999987542110 11
Q ss_pred ---HHHHHHHHHHhcc----CCcccceeeeee-cCCcEEEEEecCCCCCHHHHH--hhcCC--CCcchhHHHHHHHHHHH
Q 003158 553 ---EFLTEIQFLSRLH----HRNLVSLVGYCD-EEGEQMLVYEFMSNGTLRDQL--SAKSK--EPLGFAMRLSIALGSSR 620 (843)
Q Consensus 553 ---~~~~E~~~l~~l~----h~nIv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~ia~ 620 (843)
++.+|+..+.+++ +...+.+-.++. .....+|||||++|+.+.++- ...+. ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1333444333332 333333333332 245678999999999998753 22211 123333333344443
Q ss_pred HHHHHhcCCCCCEEeccCCCCcEEEcCCC----cEEEeeccccccCC
Q 003158 621 GILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGLSRLAP 663 (843)
Q Consensus 621 aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~~ 663 (843)
...| ++|+|+||.||+++.++ ++++.|||++..+.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4567 99999999999999988 99999999987664
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-13 Score=148.97 Aligned_cols=193 Identities=25% Similarity=0.423 Sum_probs=132.9
Q ss_pred CCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceee
Q 003158 16 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 95 (843)
Q Consensus 16 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 95 (843)
+.--...||+.|++. ++|..++.+..|+.|.|..|.+. .+|..+.++..|+.|||+.|+++ .+|..++.| -|+.|.
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEE
Confidence 344556677777777 77777777777777777777777 67777777777777777777777 666666665 467777
Q ss_pred ccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCC
Q 003158 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 96 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 175 (843)
+++|+++ .+|..++.++.|..|+.+.|.+. .+|..++++.+|+.|.+..|++..+++.+. .-.|..||+|.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~--slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ--SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh--hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-
Confidence 7777777 66777777777777777777774 567777777777777777777777777666 335777777777777
Q ss_pred CCCCCCCCc-CcCEEEccCCcCCCCCCcccCC---CCCCcEEeCcCc
Q 003158 176 SIPPGRLSL-NITTIKLSNNKLTGTIPSNFSG---LPRLQRLFIANN 218 (843)
Q Consensus 176 ~~p~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~---l~~L~~L~L~~N 218 (843)
.||..+... .|++|-|.+|.|. ..|..++- ..=.++|+..-+
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 677655544 6777777777776 44444432 222345555444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-12 Score=145.80 Aligned_cols=200 Identities=33% Similarity=0.452 Sum_probs=165.5
Q ss_pred EEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCC-CCCEEEccCCccccCCCcccCCCCCCceeeccCC
Q 003158 21 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN-KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 99 (843)
Q Consensus 21 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 99 (843)
.|++..|.+. .....+..++.++.|++.+|.++ .++.....++ +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5888888886 45555667789999999999999 6777777775 9999999999998 66677899999999999999
Q ss_pred CCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCC
Q 003158 100 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 179 (843)
Q Consensus 100 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 179 (843)
+++ .++.....++.|+.|++++|++. .+|.....+..|+.|.+++|.+...+..+..+.++..|.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~--~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS--DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc--cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccc
Confidence 999 56666668899999999999997 5677776777799999999977667777888999999999999997 3333
Q ss_pred CCC-CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhh
Q 003158 180 GRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 229 (843)
Q Consensus 180 ~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 229 (843)
... ..+++.|++++|+++.... +..+.+|+.|++++|.+....|....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 333 3479999999999995444 99999999999999999977666543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.8e-13 Score=133.29 Aligned_cols=221 Identities=19% Similarity=0.198 Sum_probs=139.9
Q ss_pred CCCCcEEEcccC--------cCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCC
Q 003158 40 LPKLDRIQIDQN--------YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSE 111 (843)
Q Consensus 40 l~~L~~L~L~~N--------~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 111 (843)
..+|..|.+++. -+...+|-.+.-+++|+.+.+|.+.-..+ ......-|.|+++...+..++ ..|. +-.
T Consensus 181 ~~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~-~~~~-l~p 257 (490)
T KOG1259|consen 181 CTQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQ-DVPS-LLP 257 (490)
T ss_pred hhheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhhe-eceeecCchhheeeeeccccc-cccc-ccc
Confidence 345666665442 22233444455556677777666654422 222223366777776666555 2221 111
Q ss_pred CCCCcEEEcCCCCC-CCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEE
Q 003158 112 LPKLLILQLDNNNF-EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIK 190 (843)
Q Consensus 112 l~~L~~L~Ls~N~l-~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ 190 (843)
...+..+.-+.-.. .| ..-.....+..|+.|||++|.|+.+.....-+++++.|++|+|.|. .+.......+|+.||
T Consensus 258 e~~~~D~~~~E~~t~~G-~~~~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~nLa~L~~L~~LD 335 (490)
T KOG1259|consen 258 ETILADPSGSEPSTSNG-SALVSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQNLAELPQLQLLD 335 (490)
T ss_pred hhhhcCccCCCCCccCC-ceEEecchHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eehhhhhcccceEee
Confidence 12222221111111 11 2223345566788888888888888777778888888888888887 555555555888888
Q ss_pred ccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC---cCCCCcEEEec
Q 003158 191 LSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLR 267 (843)
Q Consensus 191 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~---~~~~l~~l~l~ 267 (843)
||+|.++ .+..+-..+-+.++|.|+.|.|+ .+.++.+| -+|..||+++|+|+.++... ++|-+..+.|.
T Consensus 336 LS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-----~LSGL~KL--YSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~ 407 (490)
T KOG1259|consen 336 LSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-----TLSGLRKL--YSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLT 407 (490)
T ss_pred cccchhH-hhhhhHhhhcCEeeeehhhhhHh-----hhhhhHhh--hhheeccccccchhhHHHhcccccccHHHHHhhc
Confidence 8888887 44556667888899999999887 34444433 25678999999999987643 78999999999
Q ss_pred cCcccc
Q 003158 268 GNPFCL 273 (843)
Q Consensus 268 ~Np~~c 273 (843)
+||+.-
T Consensus 408 ~NPl~~ 413 (490)
T KOG1259|consen 408 GNPLAG 413 (490)
T ss_pred CCCccc
Confidence 999863
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=2e-11 Score=119.68 Aligned_cols=131 Identities=16% Similarity=0.115 Sum_probs=97.4
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCccc-ceeeeeecCCcEEEEEecCCCCCH
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV-SLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
.+.++.|.++.||++... ++.|++|+...... ....+..|+++++.+.+.+++ +++.+.. +..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999999874 77899999765332 223567899999988765554 4444432 345899999999887
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCC--CCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.+.- . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 1 11235678999999999987 23359999999999999 67899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-11 Score=136.73 Aligned_cols=247 Identities=22% Similarity=0.236 Sum_probs=180.1
Q ss_pred cCCCCCCcccc--cCCeeEEEEEe---CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcE
Q 003158 511 NNFNSSTQIGQ--GGYGKVYKGIL---PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 511 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 582 (843)
..|.+...+|. |.+|.||.+.. .++..+|+|.-+.... ...++=.+|+...+.+ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999986 3688999997443222 2223345677766666 499999988899999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHH----HHHHHhcCCCCCEEeccCCCCcEEEcCC-CcEEEeecc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFG 657 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfG 657 (843)
++-+|++ +.+|.++.+.... .++....+.+..+..+ ||.++|+.. ++|-|+||.||+..++ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999999 5788888765432 3667778888888888 999999998 9999999999999999 889999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
+...+........ ........|...|++||...+ -++..+|+|++|.+..+..++..++..+.+..
T Consensus 269 ~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------- 334 (524)
T KOG0601|consen 269 LVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS----------- 334 (524)
T ss_pred eeEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------
Confidence 9987765442221 111222357788999999754 46789999999999999999877765442100
Q ss_pred chhhccCCCCCCCHHH----HHHHHHHHHHhcccCCCCCCCHHHHH
Q 003158 738 MFSVIDGNMGSYPSEC----VEKFIKLALKCCQDETDARPSMSEVM 779 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~----~~~l~~l~~~c~~~~p~~RPs~~~vl 779 (843)
+.. +++. ..+.++ ..++...+..+++.++..|++.+.+.
T Consensus 335 W~~-~r~~--~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 335 WSQ-LRQG--YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccc-cccc--cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 000 0000 012222 23455578888999998888877664
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.6e-13 Score=138.09 Aligned_cols=89 Identities=18% Similarity=0.188 Sum_probs=54.1
Q ss_pred CcCEEEccCCcCCCCC-CcccCCCCCCcEEeCcCccCCCC-CCchhhccccCCCCcceeEEcCCCCCCCCCCCC---cCC
Q 003158 185 NITTIKLSNNKLTGTI-PSNFSGLPRLQRLFIANNSLSGS-IPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIP 259 (843)
Q Consensus 185 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~---~~~ 259 (843)
.|+.|||++|++-... -...+.++.|+.|+++.+.+... .|+.=........++|++|+++.|++..++..- .++
T Consensus 247 ~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~ 326 (505)
T KOG3207|consen 247 TLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLE 326 (505)
T ss_pred HHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccc
Confidence 4555555555544221 13455677777777777777643 333322222335677888888888887776533 566
Q ss_pred CCcEEEeccCcccc
Q 003158 260 PNVTVRLRGNPFCL 273 (843)
Q Consensus 260 ~l~~l~l~~Np~~c 273 (843)
++..|.+.+|++.-
T Consensus 327 nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 327 NLKHLRITLNYLNK 340 (505)
T ss_pred hhhhhhcccccccc
Confidence 77777777777653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.5e-12 Score=145.00 Aligned_cols=272 Identities=18% Similarity=0.232 Sum_probs=183.6
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
..+.+.+.+-+-+|.++.++.+.-. .|...+.|....... ..-+....+-.++-..+||.+++..-.+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456667778889999999887632 344444443332111 111222333333333456777766655666778899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|++|..+++|...++..+ ..+..........+.++++|||... +.|||++|.|.+...++..+++|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999997654 3555555666777889999999987 89999999999999999999999984432210
Q ss_pred C----CC-----------------CCcc---cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 003158 665 P----DI-----------------EGIV---PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720 (843)
Q Consensus 665 ~----~~-----------------~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~ 720 (843)
- +. .... .........||+.|.+||...+......+|+|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 0000 0122345679999999999999999999999999999999999999997
Q ss_pred CCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccc
Q 003158 721 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFI 800 (843)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll 800 (843)
..... + .+.++.....+ +-....+....+.+++
T Consensus 1037 a~tpq-~---------~f~ni~~~~~~-------------------------------------~p~g~~~~s~~aq~~~ 1069 (1205)
T KOG0606|consen 1037 AETPQ-Q---------IFENILNRDIP-------------------------------------WPEGPEEGSYEAQDLI 1069 (1205)
T ss_pred Ccchh-h---------hhhccccCCCC-------------------------------------CCCCccccChhhhhhh
Confidence 54320 0 01111111100 0011122344556788
Q ss_pred cCCCCCCCCCCCCCc---cCCCCCcccCCCCCCcc
Q 003158 801 NSEHTSKEETPPSSS---SMLKHPYVSSDVSGSNL 832 (843)
Q Consensus 801 ~~~L~~dp~~R~sa~---e~L~Hp~f~~~~~~~~~ 832 (843)
..+++.+|.+|..|. +.-.||+|+...++...
T Consensus 1070 ~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1070 NRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred hhhhccCchhccCcccccccccCCccCCCCccccc
Confidence 888999999998888 88899999998886443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.3e-12 Score=123.34 Aligned_cols=127 Identities=28% Similarity=0.363 Sum_probs=43.8
Q ss_pred CCCCCCcEEEcccCcCCccCccccc-cCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCccc-CCCCCC
Q 003158 38 GYLPKLDRIQIDQNYISGSLPKSFA-NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKL 115 (843)
Q Consensus 38 ~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L 115 (843)
.+..++++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+.+ +.+..+++|++|++++|+|+.+ .+.+ ..+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred ccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcC
Confidence 34445666777777766 232 344 456677777777777643 2466677777777777777743 3333 346777
Q ss_pred cEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC----CCCCCCCCEEEcc
Q 003158 116 LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD----LSRIPNLGYLDLS 169 (843)
Q Consensus 116 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~l~~L~~L~Ls 169 (843)
+.|+|++|+|.....-..+..+++|+.|+|.+|.+...... +..+|+|+.||-.
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 77777777776533334566677777777777777655432 5667777777643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.1e-13 Score=137.35 Aligned_cols=241 Identities=19% Similarity=0.273 Sum_probs=144.2
Q ss_pred cccCCCCCCEEEccCCcCCcc----CccccCCCCCCcEEEcccCcCC---ccCccc-------cccCCCCCEEEccCCcc
Q 003158 12 EIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYIS---GSLPKS-------FANLNKTRHFHMNNNSI 77 (843)
Q Consensus 12 ~i~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~---~~~~~~-------~~~l~~L~~L~Ls~N~l 77 (843)
.+..+.+++.|+|++|.+... +...+.+.++|+..++++-.-. ..+|.. +..+++|+.|+||+|.+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 345567888888888888733 4455667778888887764322 233433 34456888888888888
Q ss_pred ccCCCcc----cCCCCCCceeeccCCCCCCCCCcc-------------cCCCCCCcEEEcCCCCCCCC---CCCccccCC
Q 003158 78 SGQIPPE----LSRLPSLVHMLLDNNNLTGYLPPE-------------LSELPKLLILQLDNNNFEGT---TIPASYSNM 137 (843)
Q Consensus 78 ~~~~~~~----l~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N~l~~~---~~~~~~~~l 137 (843)
....+.. +.++..|++|+|.||.+...-... .+.-+.|+++...+|++... .+...|...
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~ 184 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSH 184 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhc
Confidence 7554443 346778888888888876322222 23345666666666666431 112234555
Q ss_pred CCCcEEEcCCCCCCCCCC-----CCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcE
Q 003158 138 SKLLKLSLRNCSLQGPMP-----DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 212 (843)
Q Consensus 138 ~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 212 (843)
+.|+.+.++.|.|..-.. .+..+++|+.|||.+|-++..... .+...+..+++|+.
T Consensus 185 ~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~-------------------~LakaL~s~~~L~E 245 (382)
T KOG1909|consen 185 PTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV-------------------ALAKALSSWPHLRE 245 (382)
T ss_pred cccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH-------------------HHHHHhcccchhee
Confidence 566666666665542111 255556666666666655411110 23345666777777
Q ss_pred EeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCC-----C-cCCCCcEEEeccCcc
Q 003158 213 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-----F-NIPPNVTVRLRGNPF 271 (843)
Q Consensus 213 L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~-----~-~~~~l~~l~l~~Np~ 271 (843)
|+++++.+....-.++..--+=..|+|++|.+.+|.++.=... . ..|.+..|+|+||.+
T Consensus 246 l~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 246 LNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 7777777776655555433222366777888888877753321 1 467788888888887
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-12 Score=134.86 Aligned_cols=205 Identities=21% Similarity=0.267 Sum_probs=131.3
Q ss_pred CCCCCCEEEccCCcCCccCc--cccCCCCCCcEEEcccCcCCccC--ccccccCCCCCEEEccCCccccCCCccc-CCCC
Q 003158 15 NIKSLELLLLNGNELTGSLP--EELGYLPKLDRIQIDQNYISGSL--PKSFANLNKTRHFHMNNNSISGQIPPEL-SRLP 89 (843)
Q Consensus 15 ~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~l-~~l~ 89 (843)
++.+|+...|.++.+. ..+ .....|++++.|||++|-+.... -.....|++|+.|+|+.|++.....+.. ..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 5677888888888777 333 35667888888888888777332 2445667888888888888763333222 2567
Q ss_pred CCceeeccCCCCCC-CCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC--CCCCCCCCCEE
Q 003158 90 SLVHMLLDNNNLTG-YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP--DLSRIPNLGYL 166 (843)
Q Consensus 90 ~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L 166 (843)
+|+.|.|+.|.|+- .+-..+..+|+|+.|+|..|.... ........+..|+.|||++|++-..+. ..+.++.|..|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~-~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIIL-IKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccc-eecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 78888888888872 122234556788888888885321 223345556778888888888776663 47778888888
Q ss_pred EcccCcCCC-CCCCC------CCCcCcCEEEccCCcCCC-CCCcccCCCCCCcEEeCcCccCC
Q 003158 167 DLSSNQLNG-SIPPG------RLSLNITTIKLSNNKLTG-TIPSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 167 ~Ls~N~l~~-~~p~~------~~~~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~ 221 (843)
+++.|.+.. .+|+. ....+|++|+++.|+|.. ..-..+..+++|+.|....|.|+
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 888888763 12222 112367777777777742 11233445566666666666665
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.2e-12 Score=143.81 Aligned_cols=195 Identities=23% Similarity=0.297 Sum_probs=100.3
Q ss_pred CCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceee
Q 003158 16 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 95 (843)
Q Consensus 16 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 95 (843)
+..++.+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|+.|+|++|.|+.+. .+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 344555555555555 23334555566666666666665 23333555666666666666665442 244555566666
Q ss_pred ccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCcc-ccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCC
Q 003158 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 96 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 174 (843)
+++|.|+.. ..+..++.|+.+++++|++.. +... ...+.+|+.+++.+|.+..+.. +..+..+..+++..|.++
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~--ie~~~~~~~~~l~~l~l~~n~i~~i~~-~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVD--IENDELSELISLEELDLGGNSIREIEG-LDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhh--hhhhhhhhccchHHHhccCCchhcccc-hHHHHHHHHhhcccccce
Confidence 666666532 344445666666666666643 1221 3555566666666665553221 233333444455555555
Q ss_pred CCCCCCCCCcC--cCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCC
Q 003158 175 GSIPPGRLSLN--ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 175 ~~~p~~~~~~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 221 (843)
.+........ |+.+++++|.+. ..+..+..+.++..|++.+|++.
T Consensus 222 -~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 222 -KLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred -eccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 2222211112 556666666665 22244555556666666666655
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.9e-12 Score=126.22 Aligned_cols=224 Identities=21% Similarity=0.182 Sum_probs=116.6
Q ss_pred CCCCEEEccCC--------cCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCC
Q 003158 17 KSLELLLLNGN--------ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 88 (843)
Q Consensus 17 ~~L~~L~L~~n--------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 88 (843)
.+|.+|..+.- -+...+|-.+.-+++|+.+.++.+.-. .+.+....-+.|+++...+..+... | .+-..
T Consensus 182 ~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~-~-~l~pe 258 (490)
T KOG1259|consen 182 TQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDV-P-SLLPE 258 (490)
T ss_pred hheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccccc-c-cccch
Confidence 56666666542 222344555555677777777777644 2222223335677777766555411 1 12222
Q ss_pred CCCceeeccCCC-CCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEE
Q 003158 89 PSLVHMLLDNNN-LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 167 (843)
Q Consensus 89 ~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ 167 (843)
..+.....+.-. .+|..-..+.....|++||||+|.|+ .+..+..-++.++.|++++|.|..+.. +..+++|+.||
T Consensus 259 ~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~--~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LD 335 (490)
T KOG1259|consen 259 TILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT--QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLD 335 (490)
T ss_pred hhhcCccCCCCCccCCceEEecchHhhhhhccccccchh--hhhhhhhhccceeEEeccccceeeehh-hhhcccceEee
Confidence 222222221111 11233333444456666666666664 355566666666666666666664433 66666666666
Q ss_pred cccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCC
Q 003158 168 LSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 246 (843)
Q Consensus 168 Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~ 246 (843)
||+|.++ .+..+... .|+++|.|++|.|... ..+..+-+|..||+++|+|+.. +....+- ++|-|+.|.|.+
T Consensus 336 LS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~l--deV~~IG--~LPCLE~l~L~~ 408 (490)
T KOG1259|consen 336 LSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEEL--DEVNHIG--NLPCLETLRLTG 408 (490)
T ss_pred cccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhH--HHhcccc--cccHHHHHhhcC
Confidence 6666666 33333222 2666666766666521 2344555666677777776521 1111111 133455666777
Q ss_pred CCCCCCC
Q 003158 247 NNLTNIS 253 (843)
Q Consensus 247 N~l~~~~ 253 (843)
|.|..++
T Consensus 409 NPl~~~v 415 (490)
T KOG1259|consen 409 NPLAGSV 415 (490)
T ss_pred CCccccc
Confidence 7666654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.5e-10 Score=109.69 Aligned_cols=137 Identities=17% Similarity=0.085 Sum_probs=98.7
Q ss_pred CCcccccCCeeEEEEEeCC-------CcEEEEEEeccCCh----------------------hhHHH----HHHHHHHHH
Q 003158 516 STQIGQGGYGKVYKGILPD-------GTVVAVKRAQEGSL----------------------QGEKE----FLTEIQFLS 562 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~----~~~E~~~l~ 562 (843)
...||.|--+.||.|...+ +..+|||+.+.... ...+. ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 57999997652100 00122 348999999
Q ss_pred hccC--CcccceeeeeecCCcEEEEEecCCCCCHHH-HHhhcCCCCcchhHHHHHHHHHHHHHHHH-hcCCCCCEEeccC
Q 003158 563 RLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTLRD-QLSAKSKEPLGFAMRLSIALGSSRGILYL-HTEADPPVFHRDI 638 (843)
Q Consensus 563 ~l~h--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiH~Dl 638 (843)
++.. -++.+++++ ...+|||||+.+..+.. .++. ..++......+..+++.+|..+ |+.+ +||+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9853 455666654 56789999997644422 2221 1234455667788999999999 7888 999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccCC
Q 003158 639 KASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 639 kp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
++.||+++ ++.+.|+|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-11 Score=132.22 Aligned_cols=246 Identities=20% Similarity=0.239 Sum_probs=175.4
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEeC--CCcEEEEEEeccCChhhHHH--HHHHHHHHHhc-cCCcccceeeeeecCC
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRL-HHRNLVSLVGYCDEEG 580 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 580 (843)
......+|..+..||.|.|+.|++...+ ++..+++|.+.........+ -..|+-+...+ .|.+++.....+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3344568888999999999999998743 68899999877644333222 24566666665 5888998888887778
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC-CcEEEeecccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLS 659 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla 659 (843)
..++=-|||+++++...+ .....+++..++.+..|++.++.++|++. ++|+|+||+||++..+ +..+++|||++
T Consensus 340 ~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 888999999999987766 22345778888999999999999999998 9999999999999886 78999999998
Q ss_pred ccCCCCCCCCcccceeeeeecccCCcc--CchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYL--DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
..+... .....+.-++. +++......+..+.|++|||..+.|.+++..--.... .
T Consensus 415 t~~~~~----------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------~ 471 (524)
T KOG0601|consen 415 TRLAFS----------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------Q 471 (524)
T ss_pred ccccee----------cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------------c
Confidence 643211 11122333444 5555566788899999999999999999854322211 1
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
+..+..+..+..+... ..+..+...+...++..||.+.++..
T Consensus 472 ~~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 472 SLTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ceeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcc
Confidence 1223333333333333 66666667777777777777766543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.7e-10 Score=104.17 Aligned_cols=144 Identities=22% Similarity=0.234 Sum_probs=109.1
Q ss_pred CCCcccccCCeeEEEEEeCCCcEEEEEEe-ccCCh-------hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 515 SSTQIGQGGYGKVYKGILPDGTVVAVKRA-QEGSL-------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 515 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
....+-||+-+.|+++.+ .|+.+.||.- .+... -..++..+|++.+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467889999999999998 5677777743 22111 12356788999999987556655555677777788999
Q ss_pred ecCCC-CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---cEEEeeccccccC
Q 003158 587 EFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLA 662 (843)
Q Consensus 587 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~ 662 (843)
||++| .++.+++......+.........+..|-+.+.-||..+ |||+||..+||++.+++ .+.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99976 48888887654444444444678889999999999999 99999999999997665 4689999998653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.9e-12 Score=143.17 Aligned_cols=237 Identities=24% Similarity=0.275 Sum_probs=169.3
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
.++.++...+.+...--. ...+..++.+++..|.|. .+-..+..+++|+.|++.+|.|..+ ...+..+++|+.|+|+
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheecc
Confidence 344555555544421111 145677888889999988 4455688889999999999999844 4447889999999999
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS 176 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~ 176 (843)
+|+|+.+ ..+..++.|+.|++++|.|+. ...+..+.+|+.+++++|.+..+... ...+.+|+.+++..|.+. .
T Consensus 127 ~N~I~~i--~~l~~l~~L~~L~l~~N~i~~---~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~-~ 200 (414)
T KOG0531|consen 127 FNKITKL--EGLSTLTLLKELNLSGNLISD---ISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR-E 200 (414)
T ss_pred ccccccc--cchhhccchhhheeccCcchh---ccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh-c
Confidence 9999965 457777889999999999964 34566688999999999999877664 578889999999999987 4
Q ss_pred CCCCCCCcCcCEEEccCCcCCCCCCcccCCCC--CCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCC
Q 003158 177 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP--RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254 (843)
Q Consensus 177 ~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~ 254 (843)
+........+..+++..|.++...+ +..+. .|+.+++++|++.- ++..+.. ...+..|++.+|++..+..
T Consensus 201 i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~-----~~~l~~l~~~~n~~~~~~~ 272 (414)
T KOG0531|consen 201 IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISR-SPEGLEN-----LKNLPVLDLSSNRISNLEG 272 (414)
T ss_pred ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccc-ccccccc-----cccccccchhhcccccccc
Confidence 4444334466667889998884332 22233 38899999999983 3222322 2345578999999988876
Q ss_pred CCcCCCCcEEEeccCcc
Q 003158 255 SFNIPPNVTVRLRGNPF 271 (843)
Q Consensus 255 ~~~~~~l~~l~l~~Np~ 271 (843)
....+.+..+....|+.
T Consensus 273 ~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 273 LERLPKLSELWLNDNKL 289 (414)
T ss_pred ccccchHHHhccCcchh
Confidence 65666666666666654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.5e-10 Score=114.12 Aligned_cols=142 Identities=23% Similarity=0.349 Sum_probs=110.2
Q ss_pred CcccccCCeeEEEEEeCCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCC--cccceeeeeecC---CcEEEEEecCC
Q 003158 517 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHR--NLVSLVGYCDEE---GEQMLVYEFMS 590 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~---~~~~lV~e~~~ 590 (843)
+.|+.|.++.||++...+|+.+++|....... ....++..|+++++.+++. .+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999765332 1345788999999999763 457777777654 36789999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA----------------------------------------- 629 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------------- 629 (843)
|.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888776531 23566677778888888888888521
Q ss_pred ------------CCCEEeccCCCCcEEEcC--CCcEEEeecccccc
Q 003158 630 ------------DPPVFHRDIKASNILLDH--KFTAKVADFGLSRL 661 (843)
Q Consensus 630 ------------~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~ 661 (843)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=6e-11 Score=114.67 Aligned_cols=127 Identities=29% Similarity=0.413 Sum_probs=53.8
Q ss_pred ccCCCCCCEEEccCCcCCccCccccC-CCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCccc-CCCCC
Q 003158 13 IGNIKSLELLLLNGNELTGSLPEELG-YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPS 90 (843)
Q Consensus 13 i~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l-~~l~~ 90 (843)
+.+..+++.|+|++|+|+. + +.++ .+.+|+.|+|++|.|+.. . .+..+++|++|++++|+|+.+ ...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCcc-ccchHHhCCc
Confidence 3455679999999999994 3 3465 689999999999999943 3 588899999999999999954 4444 46899
Q ss_pred CceeeccCCCCCCCC-CcccCCCCCCcEEEcCCCCCCCCCCCc----cccCCCCCcEEEcC
Q 003158 91 LVHMLLDNNNLTGYL-PPELSELPKLLILQLDNNNFEGTTIPA----SYSNMSKLLKLSLR 146 (843)
Q Consensus 91 L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~~l~~L~~L~L~ 146 (843)
|++|+|++|+|.... -..+..+++|+.|+|.+|.+.. .+. .+..+|+|+.||-.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~--~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE--KKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG--STTHHHHHHHH-TT-SEETTE
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc--hhhHHHHHHHHcChhheeCCE
Confidence 999999999998532 2567789999999999999964 232 46779999998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.3e-09 Score=101.75 Aligned_cols=132 Identities=22% Similarity=0.305 Sum_probs=101.4
Q ss_pred CcccccCCeeEEEEEeCCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 517 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
..+++|+-+.+|.+.+. |..+++|.-...... ...+-.+|++++.+++--.|...+-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 444777754322211 124567899999998766666666677778888999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++|-.|.+.+... ...++..+-.-+.-||..+ |||+||.++||++..+. +.++|||++.+-
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888654 1345666667778899999 99999999999998765 999999999753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.8e-10 Score=133.90 Aligned_cols=109 Identities=27% Similarity=0.494 Sum_probs=96.4
Q ss_pred CCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcC
Q 003158 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 121 (843)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.|++.+|..++.+++|+.|+|++|++++.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999998999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccCC-CCCcEEEcCCCCCC
Q 003158 122 NNNFEGTTIPASYSNM-SKLLKLSLRNCSLQ 151 (843)
Q Consensus 122 ~N~l~~~~~~~~~~~l-~~L~~L~L~~N~l~ 151 (843)
+|++++ .+|..+..+ .++..+++.+|...
T Consensus 499 ~N~l~g-~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 499 GNSLSG-RVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCcccc-cCChHHhhccccCceEEecCCccc
Confidence 999987 678887664 46788999988644
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.5e-10 Score=132.18 Aligned_cols=112 Identities=29% Similarity=0.528 Sum_probs=100.7
Q ss_pred CCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEc
Q 003158 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 145 (843)
Q Consensus 66 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 145 (843)
.++.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++ .+|..++++++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg-~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG-SIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCC-CCchHHhcCCCCCEEEC
Confidence 47889999999999999999999999999999999999999999999999999999999997 78999999999999999
Q ss_pred CCCCCCCCCCC-CCC-CCCCCEEEcccCcCCCCCC
Q 003158 146 RNCSLQGPMPD-LSR-IPNLGYLDLSSNQLNGSIP 178 (843)
Q Consensus 146 ~~N~l~~~~~~-~~~-l~~L~~L~Ls~N~l~~~~p 178 (843)
++|++++..|. +.. +.++..+++.+|......|
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999987774 554 3577899999998654333
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.9e-08 Score=106.36 Aligned_cols=167 Identities=19% Similarity=0.252 Sum_probs=128.4
Q ss_pred CeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeee----cCCcEEEEEecCCC-CCHHHH
Q 003158 524 YGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----EEGEQMLVYEFMSN-GTLRDQ 597 (843)
Q Consensus 524 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lV~e~~~~-gsL~~~ 597 (843)
..+.||+.. .||..|++|+++............-+++++++.|+|+|+|.+++. .+..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899985 489999999996544443333455688999999999999999885 34578999999875 577776
Q ss_pred Hhhc-------------CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 598 LSAK-------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 598 l~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
-... .....++...|.++.|+..||.++|+.| ..-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5321 1224678899999999999999999999 88899999999999999999998888765543
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQ 717 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~ 717 (843)
++ . |-+.+ -.+-|.-.||.++..|.||..
T Consensus 446 d~-------------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP-------------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC-------------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 21 0 11111 135688999999999999954
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.2e-12 Score=137.59 Aligned_cols=185 Identities=24% Similarity=0.325 Sum_probs=114.5
Q ss_pred ccccccCCCCCEEEccCCccccCCCcccCCC-CCCceeeccCCCCC----------CCCCcccCCCCCCcEEEcCCCCCC
Q 003158 58 PKSFANLNKTRHFHMNNNSISGQIPPELSRL-PSLVHMLLDNNNLT----------GYLPPELSELPKLLILQLDNNNFE 126 (843)
Q Consensus 58 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~----------~~~~~~~~~l~~L~~L~Ls~N~l~ 126 (843)
|-.+..+++|++|.|.++.|... ..+..+ ..|+.|... |.+. |.+-+.+. ...|.+.+.+.|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence 44566677777777777777631 112111 244444332 2222 11111111 236777788888885
Q ss_pred CCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccC
Q 003158 127 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFS 205 (843)
Q Consensus 127 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~ 205 (843)
....++.-++.|+.|+|++|+++... .+..|++|+.|||++|.++ .+|..... ..|+.|.|.+|.++.. ..+.
T Consensus 178 --~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 --LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred --hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHhh--hhHH
Confidence 45667788888888888888888665 6778888888888888888 66654322 3677778877777632 2344
Q ss_pred CCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccccCCcc
Q 003158 206 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE 278 (843)
Q Consensus 206 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c~~~~~ 278 (843)
+|.+|+.|||++|-|.+-. .+.+...+..|..|+|.|||+||....+
T Consensus 252 ~LksL~~LDlsyNll~~hs--------------------------eL~pLwsLs~L~~L~LeGNPl~c~p~hR 298 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHS--------------------------ELEPLWSLSSLIVLWLEGNPLCCAPWHR 298 (1096)
T ss_pred hhhhhhccchhHhhhhcch--------------------------hhhHHHHHHHHHHHhhcCCccccCHHHH
Confidence 5566666666666665210 1111224566778899999999987543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-08 Score=98.76 Aligned_cols=126 Identities=25% Similarity=0.311 Sum_probs=84.2
Q ss_pred eEEEEEeCCCcEEEEEEeccCCh-------------h-------------hHHHHHHHHHHHHhccCC--cccceeeeee
Q 003158 526 KVYKGILPDGTVVAVKRAQEGSL-------------Q-------------GEKEFLTEIQFLSRLHHR--NLVSLVGYCD 577 (843)
Q Consensus 526 ~Vy~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--nIv~l~~~~~ 577 (843)
.||.|...+|..+|||+...... . ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999998653110 0 123567899999999765 456666553
Q ss_pred cCCcEEEEEecCC--CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHH-HhcCCCCCEEeccCCCCcEEEcCCCcEEEe
Q 003158 578 EEGEQMLVYEFMS--NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY-LHTEADPPVFHRDIKASNILLDHKFTAKVA 654 (843)
Q Consensus 578 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 654 (843)
..+|||||++ |..+..+.... +.......++.+++..+.. +|..| |+|+|+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4579999998 65555543221 2234456677788875555 57888 9999999999999988 99999
Q ss_pred eccccccCC
Q 003158 655 DFGLSRLAP 663 (843)
Q Consensus 655 DfGla~~~~ 663 (843)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.1e-08 Score=102.63 Aligned_cols=135 Identities=15% Similarity=0.159 Sum_probs=98.7
Q ss_pred CCeeEEEEEeCCCcEEEEEEeccCChhh-H----------HHHHHHHHHHHhccCCcc--cceeeeeec-----CCcEEE
Q 003158 523 GYGKVYKGILPDGTVVAVKRAQEGSLQG-E----------KEFLTEIQFLSRLHHRNL--VSLVGYCDE-----EGEQML 584 (843)
Q Consensus 523 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~nI--v~l~~~~~~-----~~~~~l 584 (843)
....|.+..+ +|+.|.||......... . ..+.+|.+.+.++...+| .+.+++... ....+|
T Consensus 34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3344667665 67789999775433211 1 247889998888854444 344555532 235789
Q ss_pred EEecCCCC-CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-------CCcEEEeec
Q 003158 585 VYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------KFTAKVADF 656 (843)
Q Consensus 585 V~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kl~Df 656 (843)
|||++++. +|.+++......+.+...+..++.+++..+.-||..| |+|+|++++|||++. ++.+.++||
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 99999875 8999986432334556677789999999999999999 999999999999975 468999999
Q ss_pred ccccc
Q 003158 657 GLSRL 661 (843)
Q Consensus 657 Gla~~ 661 (843)
+.++.
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98753
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.8e-11 Score=122.39 Aligned_cols=210 Identities=20% Similarity=0.266 Sum_probs=143.8
Q ss_pred ccccCCCCCCEEEccCCc---CCccCcc-------ccCCCCCCcEEEcccCcCCccCccc----cccCCCCCEEEccCCc
Q 003158 11 KEIGNIKSLELLLLNGNE---LTGSLPE-------ELGYLPKLDRIQIDQNYISGSLPKS----FANLNKTRHFHMNNNS 76 (843)
Q Consensus 11 ~~i~~l~~L~~L~L~~n~---l~~~~p~-------~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~Ls~N~ 76 (843)
..+.+.++|+..++++-- +...+|+ ++...++|++||||+|-|....+.. +.++..|++|.|.+|.
T Consensus 52 ~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~G 131 (382)
T KOG1909|consen 52 KVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCG 131 (382)
T ss_pred HHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCC
Confidence 456677889999988753 3334443 4556789999999999998544433 4567899999999999
Q ss_pred cccCCC-------------cccCCCCCCceeeccCCCCCCCC----CcccCCCCCCcEEEcCCCCCCCC---CCCccccC
Q 003158 77 ISGQIP-------------PELSRLPSLVHMLLDNNNLTGYL----PPELSELPKLLILQLDNNNFEGT---TIPASYSN 136 (843)
Q Consensus 77 l~~~~~-------------~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~~ 136 (843)
+...-- .....-+.|+++..++|++..-. ...|...+.|+.+.++.|.|..- .+...|..
T Consensus 132 lg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~ 211 (382)
T KOG1909|consen 132 LGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEH 211 (382)
T ss_pred CChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHh
Confidence 873221 12345579999999999998432 33566779999999999998521 12345788
Q ss_pred CCCCcEEEcCCCCCCCCC-----CCCCCCCCCCEEEcccCcCCCCCCCCCC------CcCcCEEEccCCcCCC----CCC
Q 003158 137 MSKLLKLSLRNCSLQGPM-----PDLSRIPNLGYLDLSSNQLNGSIPPGRL------SLNITTIKLSNNKLTG----TIP 201 (843)
Q Consensus 137 l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------~~~L~~L~Ls~N~l~~----~~p 201 (843)
+++|+.|||.+|-++... ..+..+++|+.|++++|.++......+. .++|+.|.|.+|.|+. .+.
T Consensus 212 ~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la 291 (382)
T KOG1909|consen 212 CPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALA 291 (382)
T ss_pred CCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHH
Confidence 999999999999997532 2377888999999999999743322111 1256666666666653 122
Q ss_pred cccCCCCCCcEEeCcCccC
Q 003158 202 SNFSGLPRLQRLFIANNSL 220 (843)
Q Consensus 202 ~~~~~l~~L~~L~L~~N~l 220 (843)
......+.|..|+|++|++
T Consensus 292 ~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 292 ACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHhcchhhHHhcCCcccc
Confidence 2333455555555555555
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.3e-08 Score=122.41 Aligned_cols=229 Identities=23% Similarity=0.268 Sum_probs=117.7
Q ss_pred CCCEEEccCCc--CCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceee
Q 003158 18 SLELLLLNGNE--LTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 95 (843)
Q Consensus 18 ~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 95 (843)
.|++|-+.+|. +..+..+.|..++.|..|||++|.=-+.+|..+++|-+|+.|+|++..++ .+|..+.++..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 56666666664 44344444566666666666666555566666666666666666666666 6666666666666666
Q ss_pred ccCCCCCCCCCcccCCCCCCcEEEcCCCCCCC-CCCCccccCCCCCcEEEcCC--------------------------C
Q 003158 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFEG-TTIPASYSNMSKLLKLSLRN--------------------------C 148 (843)
Q Consensus 96 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~l~~L~~L~L~~--------------------------N 148 (843)
+..+.-...++.....+++|++|.+..-.... ...-..+.++.+|+.|.... +
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~ 704 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIEGC 704 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhccc
Confidence 66665544445555556666666665433211 01112233344444333322 2
Q ss_pred CCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCC-------cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCC
Q 003158 149 SLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-------LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 149 ~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 221 (843)
........+..+.+|+.|.+.++.+.......... .++..+...++..- ..+...--.++|+.|++..+...
T Consensus 705 ~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~ 783 (889)
T KOG4658|consen 705 SKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLL 783 (889)
T ss_pred ccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEeccccc
Confidence 22223334666777777777777775221111000 01111111111111 22223334578888888877766
Q ss_pred CCCCchhhccccCCCCcceeEEcCCCCCCCCC
Q 003158 222 GSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253 (843)
Q Consensus 222 ~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~ 253 (843)
..+......+..+. .+-+..+.+..+.
T Consensus 784 e~~i~~~k~~~~l~-----~~i~~f~~~~~l~ 810 (889)
T KOG4658|consen 784 EDIIPKLKALLELK-----ELILPFNKLEGLR 810 (889)
T ss_pred ccCCCHHHHhhhcc-----cEEecccccccce
Confidence 55555444443332 2444555555543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.4e-09 Score=81.95 Aligned_cols=60 Identities=32% Similarity=0.573 Sum_probs=32.4
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCcc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 77 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 77 (843)
+|++|+|++|+|+.+.+..|.++++|++|+|++|.++...+..|.++++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555555555555555555544445555555555555555543
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.2e-09 Score=81.72 Aligned_cols=59 Identities=31% Similarity=0.533 Sum_probs=29.9
Q ss_pred CCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCC
Q 003158 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 100 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 100 (843)
+|++|+|++|+|+...+..|.++++|++|++++|.|+.+.+..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444445555555555555555554444445555555555555554
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-06 Score=92.97 Aligned_cols=260 Identities=15% Similarity=0.153 Sum_probs=162.7
Q ss_pred CCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeee------ecC-CcEEEEE
Q 003158 515 SSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC------DEE-GEQMLVY 586 (843)
Q Consensus 515 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~------~~~-~~~~lV~ 586 (843)
..+.||+|+-+.+|--- .-+..+.|++.........+ .+..|... .||-+-.=+.+= .+. ....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35779999999998532 22234567776543333322 22333333 465433312221 122 2367888
Q ss_pred ecCCCC-CHHHHHh----hcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 587 EFMSNG-TLRDQLS----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 587 e~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
+.+.+. .+.+++. ++.-...+|+..++.++.+|.+.+-||..| .+-+|+.++|+|+.+++.|.+.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 887654 2233332 123345789999999999999999999999 89999999999999999999988543322
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhC-CCCCCCCcch---HHHHHHH
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTG-MQPISHGKNI---VREVNIA 732 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg-~~pf~~~~~~---~~~~~~~ 732 (843)
.. .........|...|.+||.-. +..-+...|-|.+|+++++++.| ++||..-... ..-.+..
T Consensus 167 ~~--------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 167 NA--------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cc--------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 11 123345567889999999875 34556789999999999999995 9999742110 0000000
Q ss_pred hhcccchhhccCCC------CCCCH-HHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhhhhCC
Q 003158 733 YQSSMMFSVIDGNM------GSYPS-ECVEKFIKLALKCCQDE--TDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 733 ~~~~~~~~~~~~~~------~~~~~-~~~~~l~~l~~~c~~~~--p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
+....+....+... ...|- -.++.+..+..+|+... +.-||+++..+..|..+...+.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 11111111111111 12222 23467888888998764 5689999999988887766543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.9e-07 Score=94.24 Aligned_cols=138 Identities=22% Similarity=0.194 Sum_probs=98.6
Q ss_pred CCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh----------------------hhHHHHHHHHHHHHhccCC--
Q 003158 512 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------------------QGEKEFLTEIQFLSRLHHR-- 567 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~-- 567 (843)
-..+.+.||-|--+.||.|..++|..+|||.=..... -.....++|.++|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3455789999999999999999999999995221100 0123467899999998755
Q ss_pred cccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC
Q 003158 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH 647 (843)
Q Consensus 568 nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~ 647 (843)
.+.+.+++ +..++||||++|-.|...- ++......++..|++-+.-+-..| |||+|+.+-||++++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 66666554 4668999999886665432 112223334445555555454677 999999999999999
Q ss_pred CCcEEEeeccccccCC
Q 003158 648 KFTAKVADFGLSRLAP 663 (843)
Q Consensus 648 ~~~~kl~DfGla~~~~ 663 (843)
+|.+.++||--+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998776443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.5e-09 Score=115.17 Aligned_cols=184 Identities=19% Similarity=0.304 Sum_probs=120.6
Q ss_pred HHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC--CcccceeeeeecccCCccCchhccc
Q 003158 616 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--GIVPAHVSTVVKGTPGYLDPEYFLT 693 (843)
Q Consensus 616 ~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~ 693 (843)
.+++.|+.|+|... .+||++|.|++|.++..+.+||+.|+.+.....+... ............-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999854 5999999999999999999999999988654431100 0000111122334568999999999
Q ss_pred CCCCchhhhHHHHHHHHHHHhCCCC-CCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 003158 694 HKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR 772 (843)
Q Consensus 694 ~~~~~~sDvwS~G~~l~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R 772 (843)
...+.++|+||+||++|.+..|..+ +.........-... ...+-....++.+.+.++.+-+.+.+..++..|
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------cccccccccccccCcHHHHHHHHHHhcCCcccC
Confidence 8899999999999999999954444 43322211111000 011111112345666778888888899999999
Q ss_pred CCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC
Q 003158 773 PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 813 (843)
Q Consensus 773 Ps~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s 813 (843)
|++..+... ..+.+....+..|+..+.+.||.+--.
T Consensus 257 p~~~~l~~~-----~ff~D~~~~aLrfLD~l~~kdn~qKs~ 292 (700)
T KOG2137|consen 257 PTLDLLLSI-----PFFSDPGLKALRFLDDLPQKDNSQKSS 292 (700)
T ss_pred cchhhhhcc-----cccCCchhhhhhhcccccccCcHHHHH
Confidence 977655422 233344455667888888888876543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.6e-09 Score=104.74 Aligned_cols=213 Identities=20% Similarity=0.269 Sum_probs=114.7
Q ss_pred ccccCCCCCCcEEEcccCcCCccCc-ccc-ccCCCCCEEEccCCcccc--CCCcccCCCCCCceeeccCCCCCCCCCccc
Q 003158 34 PEELGYLPKLDRIQIDQNYISGSLP-KSF-ANLNKTRHFHMNNNSISG--QIPPELSRLPSLVHMLLDNNNLTGYLPPEL 109 (843)
Q Consensus 34 p~~~~~l~~L~~L~L~~N~l~~~~~-~~~-~~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 109 (843)
+-.+..+..+..|.+.++.|..+.. ..| ...+.++.|||.+|.|+. .+...+.++|.|+.|+|+.|.+...+-..-
T Consensus 38 ~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp 117 (418)
T KOG2982|consen 38 YLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP 117 (418)
T ss_pred eeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc
Confidence 3334444455566666666653221 112 233667777777777762 233345677777777777777774333222
Q ss_pred CCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC---CCCC-CCCCEEEcccCcCCCCCCCCCCCcC
Q 003158 110 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD---LSRI-PNLGYLDLSSNQLNGSIPPGRLSLN 185 (843)
Q Consensus 110 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~ 185 (843)
..+.+|++|.|.+..+..+.....+..++.++.|.|+.|.+..+..+ .... +.+.+|++..|.
T Consensus 118 ~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~------------- 184 (418)
T KOG2982|consen 118 LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCL------------- 184 (418)
T ss_pred ccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcH-------------
Confidence 34567777777777776545555666777777777777754322110 1111 122222222221
Q ss_pred cCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCC-chhhccccCCCCcceeEEcCCCCCCCCCCC---CcCCCC
Q 003158 186 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP-SSIWQSRTLNATETFILDFQNNNLTNISGS---FNIPPN 261 (843)
Q Consensus 186 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~---~~~~~l 261 (843)
..+.++-|++. .-++++..+.+..|.|....- ..... .+.+..|+|+.|+|.++... .+++.+
T Consensus 185 -~~~w~~~~~l~-------r~Fpnv~sv~v~e~PlK~~s~ek~se~-----~p~~~~LnL~~~~idswasvD~Ln~f~~l 251 (418)
T KOG2982|consen 185 -EQLWLNKNKLS-------RIFPNVNSVFVCEGPLKTESSEKGSEP-----FPSLSCLNLGANNIDSWASVDALNGFPQL 251 (418)
T ss_pred -HHHHHHHHhHH-------hhcccchheeeecCcccchhhcccCCC-----CCcchhhhhcccccccHHHHHHHcCCchh
Confidence 11222222222 124556666666666543221 12222 23333677788888777542 378999
Q ss_pred cEEEeccCccc
Q 003158 262 VTVRLRGNPFC 272 (843)
Q Consensus 262 ~~l~l~~Np~~ 272 (843)
..|++.+||+.
T Consensus 252 ~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 252 VDLRVSENPLS 262 (418)
T ss_pred heeeccCCccc
Confidence 99999999963
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.3e-08 Score=102.25 Aligned_cols=213 Identities=20% Similarity=0.302 Sum_probs=131.3
Q ss_pred CCccccCCCCCCEEEccCCcCCccCc-cccC-CCCCCcEEEcccCcCCc--cCccccccCCCCCEEEccCCccccCCCcc
Q 003158 9 IPKEIGNIKSLELLLLNGNELTGSLP-EELG-YLPKLDRIQIDQNYISG--SLPKSFANLNKTRHFHMNNNSISGQIPPE 84 (843)
Q Consensus 9 ~p~~i~~l~~L~~L~L~~n~l~~~~p-~~~~-~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 84 (843)
-+-.+..+.-++.|.+.++.|..+.- ..|+ ..+.++.|||.+|.|+. .+...+.+++.|+.|+|+.|.+...+...
T Consensus 37 s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~l 116 (418)
T KOG2982|consen 37 SYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSL 116 (418)
T ss_pred ceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccC
Confidence 33334444556677888888773322 2232 46789999999999984 34556788999999999999999665543
Q ss_pred cCCCCCCceeeccCCCCC-CCCCcccCCCCCCcEEEcCCCCCCCCCCCc-cccCC-CCCcEEEcCCCCCCCCCC--C-CC
Q 003158 85 LSRLPSLVHMLLDNNNLT-GYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNM-SKLLKLSLRNCSLQGPMP--D-LS 158 (843)
Q Consensus 85 l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~l-~~L~~L~L~~N~l~~~~~--~-~~ 158 (843)
-..+.+|++|-|.+..+. ...-..+..+|.++.|++|.|++....+.+ ..... +.++.|.+..|....-.. . -.
T Consensus 117 p~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r 196 (418)
T KOG2982|consen 117 PLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR 196 (418)
T ss_pred cccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHh
Confidence 356789999999998886 234456788999999999999554222211 11111 234444443333221000 0 12
Q ss_pred CCCCCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCC-CCcccCCCCCCcEEeCcCccCC
Q 003158 159 RIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~ 221 (843)
-++++..+-+..|.|+..-...... +.+.-|+|+.|+|..- .-+++.++++|..|.+++|.|.
T Consensus 197 ~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 197 IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 3456777777777766322222111 1455667777776542 2345667777777777777776
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.7e-06 Score=85.56 Aligned_cols=137 Identities=19% Similarity=0.185 Sum_probs=103.8
Q ss_pred cccCCeeEEEEEeCCCcEEEEEEeccC---C---hhhHHHHHHHHHHHHhccCCc--ccceeeeee-c----CCcEEEEE
Q 003158 520 GQGGYGKVYKGILPDGTVVAVKRAQEG---S---LQGEKEFLTEIQFLSRLHHRN--LVSLVGYCD-E----EGEQMLVY 586 (843)
Q Consensus 520 g~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~-~----~~~~~lV~ 586 (843)
|+||-+.|++-... |..+-+|+-... + .-+...|.+|+..++.+..-+ +.+.+ ++. . .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888889987764 446888875421 1 235678999999999986332 44444 332 1 12458999
Q ss_pred ecCCC-CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc--EEEeecccccc
Q 003158 587 EFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 661 (843)
Q Consensus 587 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~ 661 (843)
|-+++ .+|.+++......+.+...+..+..++++.+.-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 58999987655556778888899999999999999999 999999999999986666 99999987654
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.2e-09 Score=101.96 Aligned_cols=248 Identities=18% Similarity=0.196 Sum_probs=119.5
Q ss_pred CCCCCEEEccCCcCCccCc----cccCCCCCCcEEEcccCcCC---ccCc-------cccccCCCCCEEEccCCccccCC
Q 003158 16 IKSLELLLLNGNELTGSLP----EELGYLPKLDRIQIDQNYIS---GSLP-------KSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 16 l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~L~~N~l~---~~~~-------~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+..++.++||+|.|..... ..+.+-++|+..++++-... ..++ ..+..+++|+.++||+|.+....
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 4556666666666663322 33334455555555543322 1111 22344555666666666655444
Q ss_pred Cccc----CCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-
Q 003158 82 PPEL----SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD- 156 (843)
Q Consensus 82 ~~~l----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~- 156 (843)
|+.+ ++-+.|..|.|+||.+....-.-++. .|. .|..| .-..+-+.|+..+...|++...+..
T Consensus 109 ~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigk--al~--~la~n--------KKaa~kp~Le~vicgrNRlengs~~~ 176 (388)
T COG5238 109 PEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK--ALF--HLAYN--------KKAADKPKLEVVICGRNRLENGSKEL 176 (388)
T ss_pred chHHHHHHhcCCCceeEEeecCCCCccchhHHHH--HHH--HHHHH--------hhhccCCCceEEEeccchhccCcHHH
Confidence 4332 34455555555555554221111110 000 00000 0012234455555555555443321
Q ss_pred ----CCCCCCCCEEEcccCcCCCCCCC-----C-CCCcCcCEEEccCCcCCCC----CCcccCCCCCCcEEeCcCccCCC
Q 003158 157 ----LSRIPNLGYLDLSSNQLNGSIPP-----G-RLSLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSG 222 (843)
Q Consensus 157 ----~~~l~~L~~L~Ls~N~l~~~~p~-----~-~~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 222 (843)
+..-.+|+.+.+.+|.|....-. . ....+|+.|||.+|-++.. ...++..++.|++|.+.+|.++.
T Consensus 177 ~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~ 256 (388)
T COG5238 177 SAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSN 256 (388)
T ss_pred HHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhcc
Confidence 22224555555555555411000 0 1112566666666655532 23455667777888888887776
Q ss_pred CCCchh-hccccCCCCcceeEEcCCCCCCCCCC------C---CcCCCCcEEEeccCcccccC
Q 003158 223 SIPSSI-WQSRTLNATETFILDFQNNNLTNISG------S---FNIPPNVTVRLRGNPFCLNT 275 (843)
Q Consensus 223 ~~p~~~-~~l~~l~~~~L~~L~l~~N~l~~~~~------~---~~~~~l~~l~l~~Np~~c~~ 275 (843)
....++ ........|+|..|-+.+|....=.. . -.+|.|..|.+.||.+.=+.
T Consensus 257 ~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E~~ 319 (388)
T COG5238 257 EGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKELA 319 (388)
T ss_pred ccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchhHH
Confidence 544433 33344556777778888776553211 0 15677777888888876433
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.9e-09 Score=94.17 Aligned_cols=110 Identities=19% Similarity=0.309 Sum_probs=68.4
Q ss_pred CCcEEEcccCcCCccCccccccC---CCCCEEEccCCccccCCCcccC-CCCCCceeeccCCCCCCCCCcccCCCCCCcE
Q 003158 42 KLDRIQIDQNYISGSLPKSFANL---NKTRHFHMNNNSISGQIPPELS-RLPSLVHMLLDNNNLTGYLPPELSELPKLLI 117 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 117 (843)
.+..++|++|.+. .+++...++ ..|+.++|++|.+. ..|..|. ..+.++.|+|++|+|. .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3555666666665 444444333 45555677777776 4444443 3446777777777777 45666777777777
Q ss_pred EEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC
Q 003158 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD 156 (843)
Q Consensus 118 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 156 (843)
|+++.|.+. ..|..+..+.+|..|+..+|.+..++.+
T Consensus 105 lNl~~N~l~--~~p~vi~~L~~l~~Lds~~na~~eid~d 141 (177)
T KOG4579|consen 105 LNLRFNPLN--AEPRVIAPLIKLDMLDSPENARAEIDVD 141 (177)
T ss_pred cccccCccc--cchHHHHHHHhHHHhcCCCCccccCcHH
Confidence 777777775 4566666666677777776666655554
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-08 Score=100.28 Aligned_cols=219 Identities=19% Similarity=0.163 Sum_probs=128.6
Q ss_pred cCCCCCCcEEEcccCcCCccCc----cccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCC
Q 003158 37 LGYLPKLDRIQIDQNYISGSLP----KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSEL 112 (843)
Q Consensus 37 ~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 112 (843)
+..+..++.++||+|.|...-. +.+++-.+|+..++++--.. ...+.+. .+|+ .+..++..|
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftg-r~kde~~--~~L~-----------~Ll~aLlkc 91 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTG-RDKDELY--SNLV-----------MLLKALLKC 91 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhc-ccHHHHH--HHHH-----------HHHHHHhcC
Confidence 3346778888888888874433 33455567777777653322 1111100 0011 111234455
Q ss_pred CCCcEEEcCCCCCCCCCCCc----cccCCCCCcEEEcCCCCCCCCCC--------------CCCCCCCCCEEEcccCcCC
Q 003158 113 PKLLILQLDNNNFEGTTIPA----SYSNMSKLLKLSLRNCSLQGPMP--------------DLSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~--------------~~~~l~~L~~L~Ls~N~l~ 174 (843)
|+|+..+||+|.|.. ..|. .++.-+.|.+|.|++|.+..+.. ....-|.|+.+....|++.
T Consensus 92 p~l~~v~LSDNAfg~-~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRle 170 (388)
T COG5238 92 PRLQKVDLSDNAFGS-EFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLE 170 (388)
T ss_pred CcceeeeccccccCc-ccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhc
Confidence 566666666665543 3332 23445566666666666543221 1345588999999999997
Q ss_pred CCCCCCC----C-C-cCcCEEEccCCcCCCC-----CCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEE
Q 003158 175 GSIPPGR----L-S-LNITTIKLSNNKLTGT-----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243 (843)
Q Consensus 175 ~~~p~~~----~-~-~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~ 243 (843)
..+... + . -+|+.+.+.+|.|.-. +-..+..+.+|+.|||.+|-++-.....++..- -..+.|+.|.
T Consensus 171 -ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al-~~W~~lrEL~ 248 (388)
T COG5238 171 -NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADAL-CEWNLLRELR 248 (388)
T ss_pred -cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHh-cccchhhhcc
Confidence 444321 1 1 2799999999988632 112344578999999999999855444433221 1345578999
Q ss_pred cCCCCCCCCCCC--------CcCCCCcEEEeccCccc
Q 003158 244 FQNNNLTNISGS--------FNIPPNVTVRLRGNPFC 272 (843)
Q Consensus 244 l~~N~l~~~~~~--------~~~~~l~~l~l~~Np~~ 272 (843)
+.++-++.-... ...|++..|....|-..
T Consensus 249 lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 249 LNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred ccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 999988865431 15677777766666543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-09 Score=121.37 Aligned_cols=102 Identities=31% Similarity=0.378 Sum_probs=55.5
Q ss_pred CCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCc-cccCCCCCcEEE
Q 003158 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLS 144 (843)
Q Consensus 66 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~l~~L~~L~ 144 (843)
.|...+.+.|.+. ....++.-++.|+.|+|++|+++.. ..+..+++|+.|||+.|.+. .+|. ...++. |+.|.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~--~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR--HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc--cccccchhhhh-heeee
Confidence 4555566666665 4455555556666666666666533 25555666666666666664 2332 122222 66666
Q ss_pred cCCCCCCCCCCCCCCCCCCCEEEcccCcCC
Q 003158 145 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 145 L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 174 (843)
|++|.++.+ .++.++.+|+.||+++|-|.
T Consensus 239 lrnN~l~tL-~gie~LksL~~LDlsyNll~ 267 (1096)
T KOG1859|consen 239 LRNNALTTL-RGIENLKSLYGLDLSYNLLS 267 (1096)
T ss_pred ecccHHHhh-hhHHhhhhhhccchhHhhhh
Confidence 666655532 22455556666666666555
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 843 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-52 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-26 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-155
Identities = 122/314 (38%), Positives = 174/314 (55%), Gaps = 17/314 (5%)
Query: 483 SRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKR 542
SS + + ++ ATNNF+ IG G +GKVYKG+L DG VA+KR
Sbjct: 12 INDALSSSYLVPFES-YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 543 AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SA 600
S QG +EF TEI+ LS H +LVSL+G+CDE E +L+Y++M NG L+ L S
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 601 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660
+ + RL I +G++RG+ YLHT + HRD+K+ NILLD F K+ DFG+S+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
D H+STVVKGT GY+DPEYF+ +LT+KSDVYS GVV E+L I
Sbjct: 188 KGTELD-----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 721 HGK-----NIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPS 774
N+ ++ + + ++D N+ E + KF A+KC ++ RPS
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 775 MSEVMRELESIWNM 788
M +V+ +LE +
Sbjct: 303 MGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-127
Identities = 123/298 (41%), Positives = 184/298 (61%), Gaps = 17/298 (5%)
Query: 498 VRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-EKEFLT 556
++ F+ E+ +A++NF++ +G+GG+GKVYKG L DGT+VAVKR +E QG E +F T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 557 EIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--SAKSKEPLGFAMRLSI 614
E++ +S HRNL+ L G+C E++LVY +M+NG++ L +S+ PL + R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
ALGS+RG+ YLH DP + HRD+KA+NILLD +F A V DFGL++L D H
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD------TH 190
Query: 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI-------SHGKNIVR 727
V+T V+GT G++ PEY T K ++K+DV+ GV+ LEL+TG + ++
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 728 EVNIAYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
V + + +++D ++ Y E VE+ I++AL C Q RP MSEV+R LE
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-125
Identities = 100/304 (32%), Positives = 164/304 (53%), Gaps = 25/304 (8%)
Query: 497 GVRSFTYGEMALATNNFNSSTQ------IGQGGYGKVYKGILPDGTVVAVKR----AQEG 546
SF++ E+ TNNF+ +G+GG+G VYKG + + T VAVK+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 547 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL-SAKSKEP 605
+ + +++F EI+ +++ H NLV L+G+ + + LVY +M NG+L D+L P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 606 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665
L + MR IA G++ GI +LH + HRDIK++NILLD FTAK++DFGL+R +
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 725
+++ + GT Y+ PE L ++T KSD+YS GVV LE++TG+ + +
Sbjct: 187 AQT-----VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 726 VREVNIAY----QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781
++I + + ID M S VE +A +C ++ + RP + +V +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 782 LESI 785
L+ +
Sbjct: 301 LQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 5e-77
Identities = 64/316 (20%), Positives = 109/316 (34%), Gaps = 44/316 (13%)
Query: 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF 560
+ + +G +G V+K VAVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 561 LSRLHHRNLVSLVGYCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 616
L + H N++ +G + + L+ F G+L D L + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAE 128
Query: 617 GSSRGILYLHTEAD-------PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669
+RG+ YLH + P + HRDIK+ N+LL + TA +ADFGL+ G
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 670 IVPAHVSTVVKGTPGYLDPEYF-----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
+ GT Y+ PE + D+Y++G+V EL +
Sbjct: 189 -----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG--- 240
Query: 725 IVREVNIAYQS---------SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDET 769
V E + ++ M V+ + + +C +
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 770 DARPSMSEVMRELESI 785
+AR S V + +
Sbjct: 301 EARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 237 bits (605), Expect = 3e-71
Identities = 78/334 (23%), Positives = 129/334 (38%), Gaps = 45/334 (13%)
Query: 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--I 558
E +L +N IG+G YG VYKG L D VAVK S + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 559 QFLSRLHHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 613
+ + H N+ + D E +LV E+ NG+L LS +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 614 IALGSSRGILYLHTEAD------PPVFHRDIKASNILLDHKFTAKVADFGLSR-LAPVPD 666
+A +RG+ YLHTE P + HRD+ + N+L+ + T ++DFGLS L
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 667 IEGIVPAHVSTVVKGTPGYLDPEYF-------LTHKLTDKSDVYSLGVVFLELLTGMQPI 719
+ + + GT Y+ PE + D+Y+LG+++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 720 SHGKNIVREVNIAYQS---------SMMFSVIDGNM-------GSYPSECVEKFIKLALK 763
G++ V E +A+Q+ M V S V +
Sbjct: 236 FPGES-VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 764 CCQDETDARPSMSEVMRELESIWNMMPESDTKTP 797
C + +AR + + + + + + +P
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-70
Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 25/303 (8%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+G+G +G V K VA+K+ + S K F+ E++ LSR++H N+V L G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 578 EEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
LV E+ G+L + L A+ A +S L S+G+ YLH+ + HR
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 637 DIKASNILLDHKFT-AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
D+K N+LL T K+ DFG + T KG+ ++ PE F
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI----------QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 696 LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 755
++K DV+S G++ E++T +P + M++V +G +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--------MWAVHNGTRPPLIKNLPK 231
Query: 756 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 815
L +C + RPSM E+++ + + P +D E+
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 291
Query: 816 SML 818
Sbjct: 292 VDF 294
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 5e-69
Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 23/272 (8%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
+IG G +G V++ G+ VAVK Q+ + EFL E+ + RL H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 576 CDEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ +V E++S G+L L + ++E L RLS+A ++G+ YLH +PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HR++K+ N+L+D K+T KV DFGLSRL + S GTP ++ PE
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-------SKSAAGTPEWMAPEVLRDE 214
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG-SYPSEC 753
+KSDVYS GV+ EL T QP + ++ +V P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPA----------QVVAAVGFKCKRLEIPRNL 264
Query: 754 VEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ + C +E RPS + +M L +
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 4e-67
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-------KEFLTEIQFLSRLHHRNL 569
QIG+GG+G V+KG + D +VVA+K G +GE +EF E+ +S L+H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
V L G +V EF+ G L +L P+ ++++L + L + GI Y+ +
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 630 DPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 684
+PP+ HRD+++ NI L AKVADFGLS+ + H + + G
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----------VHSVSGLLGNFQ 191
Query: 685 YLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
++ PE + T+K+D YS ++ +LTG P + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--------KIKFINMIR 243
Query: 743 DGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ + + P +C + + C + RP S +++EL +
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-65
Identities = 83/281 (29%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ----GEKEFLTEIQFLSRLHHRNLVSLV 573
IG GG+GKVY+ G VAVK A+ + + E + + L H N+++L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G C +E LV EF G L L S + + + ++ A+ +RG+ YLH EA P+
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 634 FHRDIKASNILLDHKF--------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
HRD+K+SNIL+ K K+ DFGL+R G +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---------EWHRTTKMSAAGAYAW 180
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
+ PE + SDV+S GV+ ELLTG P + ++ + V
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----------AVAYGVAMNK 230
Query: 746 M-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ PS C E F KL C + +RPS + ++ +L +I
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-64
Identities = 93/266 (34%), Positives = 132/266 (49%), Gaps = 19/266 (7%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKS 60
N G++P G+ LE L L+ N +G LP + L + L + + N SG LP+S
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
Query: 61 FANLNKT-RHFHMNNNSISGQIPPELSR--LPSLVHMLLDNNNLTGYLPPELSELPKLLI 117
NL+ + +++N+ SG I P L + +L + L NN TG +PP LS +L+
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS 176
L L N G TIP+S ++SKL L L L+G +P L + L L L N L G
Sbjct: 423 LHLSFNYLSG-TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481
Query: 177 IPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234
IP + N+ I LSNN+LTG IP L L L ++NNS SG+IP+ + R+L
Sbjct: 482 IPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540
Query: 235 NATETFILDFQNNNLTNISGSFNIPP 260
LD N +G+ IP
Sbjct: 541 I-----WLDLNTNLF---NGT--IPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-61
Identities = 80/278 (28%), Positives = 117/278 (42%), Gaps = 18/278 (6%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N S IP +G+ +L+ L ++GN+L+G + +L + I N G +P
Sbjct: 210 NNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-- 266
Query: 63 NLNKTRHFHMNNNSISGQIPPELS-RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
L ++ + N +G+IP LS +L + L N+ G +PP L L L
Sbjct: 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 122 NNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD-LSRI-PNLGYLDLSSNQLNGSIP 178
+NNF G +P M L L L G +P+ L+ + +L LDLSSN +G I
Sbjct: 327 SNNFSG-ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
Query: 179 P--GRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
P + + + L NN TG IP S L L ++ N LSG+IPSS+ L
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445
Query: 236 ATETFILDFQNNNLT-NISGSFNIPPN-VTVRLRGNPF 271
L N L I T+ L N
Sbjct: 446 -----DLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-60
Identities = 81/283 (28%), Positives = 129/283 (45%), Gaps = 37/283 (13%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N +SG+IP +G++ L L L N L G +P+EL Y+ L+ + +D N ++G +P +
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
N ++NN ++G+IP + RL +L + L NN+ +G +P EL + L+ L L+
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 123 NNFEGTTIPASYSNMSKLLK----------------------LSLRNCSLQGPMP-DLSR 159
N F G TIPA+ S + + QG L+R
Sbjct: 548 NLFNG-TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 160 IPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 217
+ +++S G P ++ + +S N L+G IP +P L L + +
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665
Query: 218 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPP 260
N +SGSIP + R LN ILD +N L G IP
Sbjct: 666 NDISGSIPDEVGDLRGLN-----ILDLSSNKL---DGR--IPQ 698
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-58
Identities = 70/253 (27%), Positives = 110/253 (43%), Gaps = 14/253 (5%)
Query: 3 NKISGSIPKEIGNI--KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
N SG I + +L+ L L N TG +P L +L + + NY+SG++P S
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
+L+K R + N + G+IP EL + +L ++LD N+LTG +P LS L + L
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP 179
NN G IP + L L L N S G +P L +L +LDL++N NG+IP
Sbjct: 498 SNNRLTG-EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
Query: 180 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN--SLSGSIPSSIWQSRTLNAT 237
++ + K++ N + G + A N G + + T N
Sbjct: 557 ---AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN-- 611
Query: 238 ETFILDFQNNNLT 250
+ +
Sbjct: 612 ---PCNITSRVYG 621
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 7e-57
Identities = 65/257 (25%), Positives = 106/257 (41%), Gaps = 17/257 (6%)
Query: 2 WNKISGSIPKEI---GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP 58
N ISG+ L+ L ++GN+++G + + L+ + + N S +P
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217
Query: 59 KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 118
+ + +H ++ N +SG +S L + + +N G +PP L L L
Sbjct: 218 -FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYL 274
Query: 119 QLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS 176
L N F G IP L L L G +P L L LSSN +G
Sbjct: 275 SLAENKFTG-EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333
Query: 177 IPPGRLSL--NITTIKLSNNKLTGTIPSNFSGL-PRLQRLFIANNSLSGSIPSSIWQSRT 233
+P L + + LS N+ +G +P + + L L L +++N+ SG I ++ Q+
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
Query: 234 LNATETFILDFQNNNLT 250
E L QNN T
Sbjct: 394 NTLQE---LYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-54
Identities = 58/252 (23%), Positives = 104/252 (41%), Gaps = 14/252 (5%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N ++G IP + N +L + L+ N LTG +P+ +G L L +++ N SG++P
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+ +N N +G IP + + + N + G +
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAG 591
Query: 123 NNFEGT-TIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP- 179
N E + +S ++ + G ++ +LD+S N L+G IP
Sbjct: 592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651
Query: 180 -GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 238
G + + + L +N ++G+IP L L L +++N L G IP ++ L
Sbjct: 652 IGSMP-YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT--- 707
Query: 239 TFILDFQNNNLT 250
+D NNNL+
Sbjct: 708 --EIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-52
Identities = 52/256 (20%), Positives = 101/256 (39%), Gaps = 19/256 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP--KS 60
N ++ + ++ LE L L+ + + GS+ L + + +N +SG + S
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 61 FANLNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPEL---SELPKLL 116
+ + + ++++N++ +L SL + L N+++G +L
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176
L + N G + S L L + + + +P L L +LD+S N+L+G
Sbjct: 182 HLAISGNKISGD-VD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGD 238
Query: 177 IPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234
+ + + +S+N+ G IP L LQ L +A N +G IP +
Sbjct: 239 FSRAISTCT-ELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSG---- 291
Query: 235 NATETFILDFQNNNLT 250
LD N+
Sbjct: 292 ACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 9e-48
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 23/261 (8%)
Query: 14 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 73
+ S++L N ++ L L L+ + + ++I+GS+ F ++
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 74 NNSISGQIPP--ELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTI 130
NS+SG + L L + + +N L +L L +L L N+ G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG-AN 167
Query: 131 PASY---SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNI 186
+ +L L++ + G + +SR NL +LD+SSN + IP G S +
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIPFLGDCS-AL 225
Query: 187 TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 246
+ +S NKL+G S L+ L I++N G IP +S L
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQ-------YLSLAE 278
Query: 247 NNLTNISGSFNIPPNVTVRLR 267
N T G IP ++
Sbjct: 279 NKFT---GE--IPDFLSGACD 294
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-29
Identities = 51/197 (25%), Positives = 76/197 (38%), Gaps = 26/197 (13%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLL--NGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP 58
N I+G I N + N E G E+L L + I G
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
Query: 59 KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 118
+F N M+ N +SG IP E+ +P L + L +N+++G +P E+ +L L IL
Sbjct: 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685
Query: 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 178
L +N +G IP + S ++ L +DLS+N L+G IP
Sbjct: 686 DLSSNKLDG-RIPQAMSALT-----------------------MLTEIDLSNNNLSGPIP 721
Query: 179 PGRLSLNITTIKLSNNK 195
K NN
Sbjct: 722 EMGQFETFPPAKFLNNP 738
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-64
Identities = 65/306 (21%), Positives = 119/306 (38%), Gaps = 20/306 (6%)
Query: 518 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+G+G +G+ K G V+ +K + ++ FL E++ + L H N++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
++ + E++ GTLR + ++ R+S A + G+ YLH+ + HR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 637 DIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGYLDPE 689
D+ + N L+ VADFGL+RL V G P ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749
+K DV+S G+V E++ + + +V
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY--------LPRTMDFGLNVRGFLDRYC 244
Query: 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 809
P C F + ++CC + + RPS ++ LE++ + P+ + E
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWET 304
Query: 810 TPPSSS 815
S
Sbjct: 305 YRRGES 310
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-63
Identities = 54/278 (19%), Positives = 111/278 (39%), Gaps = 34/278 (12%)
Query: 517 TQIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
T++ + G+++KG G + VK + ++ S + ++F E L H N++ ++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 575 YCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
C L+ +M G+L + L + + + + AL +RG+ +LHT +P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
+ + + ++++D TA+++ + S P ++ PE L
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS------------FQSPGRMYAPAWVAPE-AL 180
Query: 693 THK----LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG- 747
K +D++S V+ EL+T P + N+ + V +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----------EIGMKVALEGLRP 230
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ P KL C ++ RP ++ LE +
Sbjct: 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 3e-61
Identities = 73/255 (28%), Positives = 116/255 (45%), Gaps = 16/255 (6%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGS--LPEELGYLPKLDRIQI-DQNYISGSLPK 59
G + + L L+G L +P L LP L+ + I N + G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 60 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
+ A L + + ++ + ++SG IP LS++ +LV + N L+G LPP +S LP L+ +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 120 LDNNNFEGTTIPASYSNMSKLLK-LSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSI 177
D N G IP SY + SKL +++ L G +P + + NL ++DLS N L G
Sbjct: 156 FDGNRISG-AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 178 PP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
G N I L+ N L + L L + NN + G++P + Q + L+
Sbjct: 214 SVLFGSDK-NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 236 ATETFILDFQNNNLT 250
L+ NNL
Sbjct: 272 -----SLNVSFNNLC 281
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 6e-61
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 10/231 (4%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
N + G IP I + L L + ++G++P+ L + L + N +SG+LP S
Sbjct: 86 INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML-LDNNNLTGYLPPELSELPKLLILQL 120
++L + N ISG IP L + + N LTG +PP + L L + L
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDL 204
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP- 179
N EG + + K+ L SL + + NL LDL +N++ G++P
Sbjct: 205 SRNMLEG-DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG 263
Query: 180 -GRLSLNITTIKLSNNKLTGTIPS--NFSGLPRLQRLFIANNSLSGSIPSS 227
+L + ++ +S N L G IP N + N L GS +
Sbjct: 264 LTQLK-FLHSLNVSFNNLCGEIPQGGNLQRFDVSA--YANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 58 PKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG--YLPPELSELPKL 115
P + ++ T N + G + ++ + ++ L NL +P L+ LP L
Sbjct: 21 PTTLSSWLPTTDC--CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78
Query: 116 LILQL-DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL 173
L + NN G IP + + +++L L + + ++ G +PD LS+I L LD S N L
Sbjct: 79 NFLYIGGINNLVG-PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137
Query: 174 NGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR-LFIANNSLSGSIPSSIWQ 230
+G++PP L N+ I N+++G IP ++ +L + I+ N L+G IP +
Sbjct: 138 SGTLPPSISSLP-NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
Query: 231 SRTLNATETFILDFQNNNLT-NISGSF 256
LN +D N L + S F
Sbjct: 197 ---LNLAF---VDLSRNMLEGDASVLF 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 1e-05
Identities = 22/84 (26%), Positives = 31/84 (36%), Gaps = 11/84 (13%)
Query: 179 PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS--IPSSIWQSRTLNA 236
P LS + T N G + + R+ L ++ +L IPSS+ LN
Sbjct: 21 PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN- 79
Query: 237 TETFILDFQNNNLTNISGSFNIPP 260
L N N+ G IPP
Sbjct: 80 ----FLYIGGIN--NLVGP--IPP 95
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-61
Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 575
+IG G +G VYKG G V AVK + + + F E+ L + H N++ +GY
Sbjct: 31 RIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
+ +V ++ +L L S+ + IA ++RG+ YLH + H
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---YFL 692
RD+K++NI L T K+ DFGL+ +H + G+ ++ PE
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM----GS 748
++ + +SDVY+ G+V EL+TG P S+ N ++ V G++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---------DQIIEMVGRGSLSPDLSK 249
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
S C ++ +L +C + + D RPS ++ E+E +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-59
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 31/280 (11%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVGY 575
IG+G +G+VY G G V A++ + K F E+ + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
C ++ TL + +K L IA +G+ YLH + H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
+D+K+ N+ D+ + DFGL ++ V + G +L PE
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLS 210
Query: 696 L---------TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
+ SDV++LG ++ EL P ++++ + G
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----------EAIIWQMGTGMK 260
Query: 747 GSYP-SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ ++ + L C E + RP+ +++M LE +
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-57
Identities = 66/300 (22%), Positives = 108/300 (36%), Gaps = 46/300 (15%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 575
+G+G YG+V++G G VAVK S + EK + TE+ L H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 576 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 630
+ L+ + G+L D L L L I L + G+ +LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 631 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
P + HRD+K+ NIL+ +AD GL+ + + V + GT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG---NNPRVGTKRYM 184
Query: 687 DPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ------ 734
PE + D+++ G+V E+ M IV + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG----IVEDYKPPFYDVVPND 240
Query: 735 ---SSMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
M V + + KL +C AR + + + L I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 74/304 (24%), Positives = 113/304 (37%), Gaps = 46/304 (15%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFL--TEIQFLSRLHHRNLVSLVGY 575
QIG+G YG+V+ G G VAVK E + TEI + H N++ +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 576 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 630
+ L+ ++ NG+L D L L L +A S G+ +LHTE
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 631 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
P + HRD+K+ NIL+ T +AD GL+ E +P GT Y+
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP---PNTRVGTKRYM 213
Query: 687 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS----- 735
PE H + +D+YS G++ E+ IV E + Y
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG----IVEEYQLPYHDLVPSD 269
Query: 736 ----SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
M V + EC+ + KL +C +R + V + L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 786 WNMM 789
Sbjct: 330 SESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 3e-53
Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 46/300 (15%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTE--IQFLSRLHHRNLVSLVGY 575
IG+G +G+V++G G VAVK S + E+ + E I L H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 576 C----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD- 630
+ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 631 ----PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
P + HRD+K+ NIL+ T +AD GL+ D GT Y+
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYM 218
Query: 687 DPE-----YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS----- 735
PE + H + ++D+Y++G+VF E+ + + Y
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI----HEDYQLPYYDLVPSD 274
Query: 736 ----SMMFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
M V + + E + K+ +C AR + + + L +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-47
Identities = 53/283 (18%), Positives = 98/283 (34%), Gaps = 35/283 (12%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYI--------S 54
+ + + N+K L + + LP L LP++ I + N
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 55 GSLPKSFANLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP 113
K + ++ N++ + + L ++ L + N L G P
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEI 353
Query: 114 KLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSS 170
KL L L N T IPA+ ++ LS + L+ + D + + +D S
Sbjct: 354 KLASLNLAYNQI--TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSY 411
Query: 171 NQLNG-------SIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 222
N++ + P N+++I LSNN+++ FS L + + N L+
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
Query: 223 -------SIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 258
+ + L +D + N LT +S F
Sbjct: 472 IPKNSLKDENENFKNTYLLT-----SIDLRFNKLTKLSDDFRA 509
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-44
Identities = 45/288 (15%), Positives = 94/288 (32%), Gaps = 34/288 (11%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N I+ + K + + L + + E + + +
Sbjct: 193 NNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWD 246
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY--------LPPELSELPK 114
NL + N ++P L LP + + + N + K
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 115 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174
+ I+ + NN + + S M KL L L+G +P L L+L+ NQ+
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 175 GSIPPGRLSL--NITTIKLSNNKLTGTIPSNFS--GLPRLQRLFIANNSLSG-------S 223
IP + + ++NKL IP+ F + + + + N +
Sbjct: 367 E-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 224 IPSSIWQSRTLNATETFILDFQNNNLT-NISGSFNIPPNVTV-RLRGN 269
+ + ++ ++ ++ NN ++ F+ ++ L GN
Sbjct: 425 LDPTPFKGINVS-----SINLSNNQISKFPKELFSTGSPLSSINLMGN 467
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-36
Identities = 41/244 (16%), Positives = 79/244 (32%), Gaps = 31/244 (12%)
Query: 3 NKISGSIPK--EIGNIKSLELLLLNGNELTG-------SLPEELGYLPKLDRIQIDQNYI 53
NK+ IP + ++ + + + NE+ L + I + N I
Sbjct: 387 NKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445
Query: 54 SGSLPKSFANLNKTRHFHMNNNSISG-------QIPPELSRLPSLVHMLLDNNNLTGYLP 106
S + F+ + ++ N ++ L + L N LT L
Sbjct: 446 SKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LS 504
Query: 107 PEL--SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNC------SLQGPMPD-L 157
+ + LP L+ + L N+F + P N S L +RN P+ +
Sbjct: 505 DDFRATTLPYLVGIDLSYNSF--SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGI 562
Query: 158 SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 217
+ P+L L + SN + + NI+ + + +N S +
Sbjct: 563 TLCPSLTQLQIGSNDIR-KVNEKITP-NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFY 620
Query: 218 NSLS 221
+
Sbjct: 621 DKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-36
Identities = 36/269 (13%), Positives = 78/269 (28%), Gaps = 31/269 (11%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG----S 56
MW G + + + L L G +G +P+ +G L +L+ + + +
Sbjct: 68 MWGAQPGV---SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 57 LPKSFANLNKTRHFHMNNNSISGQIPPELSRL--PSLVHMLLDNNNLTGYLPPELSELPK 114
PK + R L+ ++++ + K
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 115 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174
+ +NN T + + ++KL + + N + Q
Sbjct: 185 DTQIGQLSNNI--TFVSKAVMRLTKLRQFYMGNSPFVAENI----CEAWENENSEYAQQY 238
Query: 175 GSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL--------SGSI 224
+ L ++T +++ N +P+ LP +Q + +A N
Sbjct: 239 KTEDLKWDNLK-DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 225 PSSIWQSRTLNATETFILDFQNNNLTNIS 253
+ + I+ NNL
Sbjct: 298 LADAPVGEKIQ-----IIYIGYNNLKTFP 321
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 41/278 (14%), Positives = 77/278 (27%), Gaps = 38/278 (13%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPE--ELGYLPKLDRIQIDQNYISG----- 55
N+I+ G + +E L N+L +P + + + I N I
Sbjct: 363 NQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421
Query: 56 --SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG-------YLP 106
L + +++NN IS S L + L N LT
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
Query: 107 PELSELPKLLILQLDNNNFEGTTIPAS--YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG 164
L + L N T + + + L+ + L S L
Sbjct: 482 ENFKNTYLLTSIDLRFNKL--TKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLK 539
Query: 165 YLDL------SSNQLNGSIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 216
+ N+ P ++T +++ +N + + P + L I
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCP-SLTQLQIGSNDIR-KVNEKI--TPNISVLDIK 595
Query: 217 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254
+N S + + + +I G
Sbjct: 596 DNPNISIDLSYVCPYIEAG-----MYMLFYDKTQDIRG 628
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 27/190 (14%), Positives = 61/190 (32%), Gaps = 17/190 (8%)
Query: 75 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG---TTIP 131
+ Q L+ + + L+ +G +P + +L +L +L L ++ + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 132 ASYSNMSKLLKLSLRNCSLQGPMPD---LSRIPNLGYLDLSSNQLNGSIPPG-RLSLNIT 187
S + Q D +L ++S+ SI R++L T
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 188 TIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 247
I +N +T + L +L++ ++ N+ W++
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE---------YAQ 236
Query: 248 NLTNISGSFN 257
++
Sbjct: 237 QYKTEDLKWD 246
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 14/126 (11%), Positives = 35/126 (27%), Gaps = 15/126 (11%)
Query: 157 LSRIPNLGYLDLSSNQLNGSIPP--GRLSLNITTIKLSNNKLTG----TIPSNFSGLPRL 210
L+ + L L +G +P G+L+ + + L ++ P S
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLT-ELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 211 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 270
++ + D + + + +I + + L+
Sbjct: 136 EQKQKMRMHYQKTFVDYD--------PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187
Query: 271 FCLNTN 276
+N
Sbjct: 188 IGQLSN 193
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-46
Identities = 81/314 (25%), Positives = 138/314 (43%), Gaps = 30/314 (9%)
Query: 478 NYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGT 536
++ +++ + K+ + + R+ + L + QIG+G +G+V+ G L D T
Sbjct: 83 DHLLSTQQPLTKKSGVVL--HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNT 140
Query: 537 VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLR 595
+VAVK +E + +FL E + L + H N+V L+G C ++ +V E + G
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 596 DQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655
L L L + ++ G+ YL ++ HRD+ A N L+ K K++D
Sbjct: 201 TFLR-TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISD 256
Query: 656 FGLSRLAPVPDIEGIVPAHVSTV---VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLEL 712
FG+SR +G+ A VK T PE + + +SDV+S G++ E
Sbjct: 257 FGMSREEA----DGVYAASGGLRQVPVKWTA----PEALNYGRYSSESDVWSFGILLWET 308
Query: 713 LT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDA 771
+ G P + N ++ V G P C + +L +C E
Sbjct: 309 FSLGASPYPNLSN--QQT--------REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQ 358
Query: 772 RPSMSEVMRELESI 785
RPS S + +EL+SI
Sbjct: 359 RPSFSTIYQELQSI 372
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-43
Identities = 58/285 (20%), Positives = 104/285 (36%), Gaps = 16/285 (5%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
+N IS P+ + L++L L NEL+ + + L + + N I F
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS--ELPKLLILQ 119
+++N +S +L +L +LL NN + EL L L+
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD----LSRIPNLGYLDLSSNQLNG 175
L +N + P + + +L L L N L + + ++ L LS++QL+
Sbjct: 178 LSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 176 SIPP---GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 232
+ G N+T + LS N L +F+ LP+L+ F+ N++ S+
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 233 TLN----ATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 271
+ +L I SF + + N
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-43
Identities = 63/293 (21%), Positives = 107/293 (36%), Gaps = 15/293 (5%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N++ L L + N ++ PE LP L + + N +S K+FA
Sbjct: 35 NQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA 94
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
H+ +NSI + +L+ + L +N L+ +L L L L N
Sbjct: 95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154
Query: 123 NNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPG 180
N + S L KL L + ++ P I L L L++ QL S+
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
Query: 181 RLS----LNITTIKLSNNKLTGTIPSNFSGL--PRLQRLFIANNSLSGSIPSSIWQSRTL 234
+I + LSN++L+ T + F GL L L ++ N+L+ S L
Sbjct: 215 LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274
Query: 235 NATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPFCLNTNAEQFCGSHS 285
+ NN+ ++ S S + NV L+ + + +
Sbjct: 275 E-----YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-42
Identities = 55/290 (18%), Positives = 105/290 (36%), Gaps = 25/290 (8%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGY---LPKLDRIQIDQNYISGSLPK 59
N+I P I L L LN +L SL E+L + + + + +S +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 60 SFANLNKT--RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 117
+F L T ++ N+++ + LP L + L+ NN+ L L +
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 118 LQLDNNNFEGTT--------IPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDL 168
L L + + + S+ + L L++ + + G + + + NL YL L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 169 SSNQLNGSIPPGRL-----SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 223
S++ + + + L+ NK++ FS L L+ L + N +
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 224 IPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 271
+ W+ F + N + SF + P++ LR
Sbjct: 421 LTGQEWR----GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-40
Identities = 57/288 (19%), Positives = 100/288 (34%), Gaps = 24/288 (8%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELG----YLPKLDRIQIDQNYISGSLP 58
N I G + +L+ L L+ + + L + + +N IS
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
Query: 59 KSFANLNKTRHFHMNNNSISGQIPP-ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 117
+F+ L + N I ++ E L ++ + L N + +P L
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458
Query: 118 LQLDNNNFEG-TTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQL-- 173
L L + + P+ + + L L L N ++ D L + L LDL N L
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
Query: 174 -----NGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 226
N P L ++ + L +N F L L+ + + N+L+ S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 227 SIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTV-RLRGNPF 271
+L L+ Q N +T++ N+T +R NPF
Sbjct: 579 VFNNQVSLK-----SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-39
Identities = 50/263 (19%), Positives = 103/263 (39%), Gaps = 14/263 (5%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
K++ +P ++ ++ +L L N+L +L + + N IS P+
Sbjct: 12 SHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
L + ++ +N +S + +L + L +N++ + L+ L L
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRI---PNLGYLDLSSNQLNGSI 177
+N T + + L +L L N +Q + I +L L+LSSNQ+
Sbjct: 129 SHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187
Query: 178 PPGRLSL-NITTIKLSNNKLTGTIPSNFS---GLPRLQRLFIANNSLSGSIPSSIWQSRT 233
P ++ + + L+N +L ++ ++ L ++N+ LS + ++ +
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 234 LNATETFILDFQNNNLTNISGSF 256
N T LD NNL +
Sbjct: 248 TNLTM---LDLSYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 58/290 (20%), Positives = 98/290 (33%), Gaps = 27/290 (9%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS--LPK 59
+ +K LE L + N++ G L L + + ++ S +
Sbjct: 314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE 373
Query: 60 SFANLNKT--RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP-ELSELPKLL 116
+F +L + ++ N IS S L L + L N + L E L +
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG---PMPDLSRIPNLGYLDLSSNQL 173
+ L N + S++ + L +L LR +L+ + NL LDLS+N +
Sbjct: 434 EIYLSYNKYLQ-LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492
Query: 174 NGSIPPGRLS--LNITTIKLSNNKLT--------GTIPSNFSGLPRLQRLFIANNSLSGS 223
I L + + L +N L G GL L L + +N
Sbjct: 493 AN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 224 IPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 271
L I+D NNL + + FN ++ L+ N
Sbjct: 552 PVEVFKDLFELK-----IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-18
Identities = 35/221 (15%), Positives = 65/221 (29%), Gaps = 38/221 (17%)
Query: 3 NKISG--SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS------ 54
+ S P +++L +L L+ N + + L L KL+ + + N ++
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA 523
Query: 55 --GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSEL 112
G L+ ++ +N L L + L NNL +
Sbjct: 524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQ 583
Query: 113 PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 172
L L L N T++ NL LD+ N
Sbjct: 584 VSLKSLNLQKNLI--TSVEKK---------------VFGPAF------RNLTELDMRFNP 620
Query: 173 LNGSIPPGR-----LSLNITTIKLSNNKLTGTIPSNFSGLP 208
+ + ++ T I ++ P ++ G P
Sbjct: 621 FDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP 661
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-14
Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 9/110 (8%)
Query: 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
+ D S +L +P L NIT + L++N+L +NF+ +L L + N++S
Sbjct: 5 SHEVADCSHLKLT-QVPDD-LPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 222 GSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 269
P + L +L+ Q+N L+ +S +F N+T L N
Sbjct: 63 KLEPELCQKLPMLK-----VLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-43
Identities = 53/284 (18%), Positives = 100/284 (35%), Gaps = 39/284 (13%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG------- 55
K + N+K L + L LP+ L LP+L + I N
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 56 --SLPKSFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPELSE 111
L K + F+M N++ P L ++ L + +N +
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH--LEAFGT 593
Query: 112 LPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDL 168
KL L+LD N IP + + ++ L + L+ + + + +G +D
Sbjct: 594 NVKLTDLKLDYNQI--EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDF 651
Query: 169 SSNQLNGSIPPGRLS-------LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
S N++ GS +N +T+ LS N++ F+ + + ++NN ++
Sbjct: 652 SYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
Query: 222 -------GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 258
+ + L +D + N LT++S F
Sbjct: 711 SIPENSLKPKDGNYKNTYLLT-----TIDLRFNKLTSLSDDFRA 749
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 1e-35
Identities = 45/268 (16%), Positives = 88/268 (32%), Gaps = 30/268 (11%)
Query: 12 EIGNIKSLELLLLNGNELTG------SLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 65
E+ IK + L ++ + + + L KL I + +
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472
Query: 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 125
+ + S L L + L N LP L +LP+L L + N
Sbjct: 473 -----NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527
Query: 126 EG--------TTIPASYSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNG 175
T + K+ + +L+ L ++ LG LD N++
Sbjct: 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR- 586
Query: 176 SIPP-GRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRT 233
+ G +T +KL N++ IP + + +++ L ++N L IP+
Sbjct: 587 HLEAFGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV 643
Query: 234 LNATETFILDFQNNNLTNISGSFNIPPN 261
+DF N + + + + +
Sbjct: 644 YVMGS---VDFSYNKIGSEGRNISCSMD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-32
Identities = 49/294 (16%), Positives = 97/294 (32%), Gaps = 40/294 (13%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGY-LPKLDRIQIDQNYISGSLPK-- 59
NK+ + G L L L+ N++ +PE+ +++ + N + +P
Sbjct: 583 NKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIF 638
Query: 60 SFANLNKTRHFHMNNNSISGQIPPELS------RLPSLVHMLLDNNNLTGYLPPELSELP 113
+ ++ + N I +S + + + L N + + +
Sbjct: 639 NAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 114 KLLILQLDNNNFE------GTTIPASYSNMSKLLKLSLRNCSLQGPMPDL--SRIPNLGY 165
+ + L NN +Y N L + LR L D + +P L
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSN 757
Query: 166 LDLSSNQLNGSIPPGRLSLN-------ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218
+D+S N + S P L+ + N++ P+ + P L +L I +N
Sbjct: 758 MDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816
Query: 219 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP--PNVTVRLRGNP 270
+ + + L ILD +N +I + P L +
Sbjct: 817 DIR-KVDEKLTPQ--LY-----ILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-31
Identities = 41/274 (14%), Positives = 77/274 (28%), Gaps = 29/274 (10%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
+ ++ N + L L G G +P+ +G L +L + + + S
Sbjct: 308 LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367
Query: 62 ANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
+ I L L L + + PE+ + K + L
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISL 425
Query: 121 DNNNFEG-----TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG 175
+ T I + ++KL + N + + + +
Sbjct: 426 KDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV----DWEDANSDYAKQYE 481
Query: 176 SIPP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG---------SI 224
+ L ++T ++L N +P LP LQ L IA N +
Sbjct: 482 NEELSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 225 PSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 258
+ I NNL S ++
Sbjct: 541 ADDEDTGPKIQ-----IFYMGYNNLEEFPASASL 569
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-24
Identities = 34/228 (14%), Positives = 74/228 (32%), Gaps = 26/228 (11%)
Query: 3 NKISGSIPKEIG------NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS-- 54
NKI S + I + + L+ NE+ E + I + N ++
Sbjct: 654 NKIG-SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
Query: 55 -----GSLPKSFANLNKTRHFHMNNNSISGQIPPEL--SRLPSLVHMLLDNNNLTGYLPP 107
++ N + N ++ + + + LP L +M + N + P
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPT 770
Query: 108 ELSELPKLLILQLDNN-----NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN 162
+ +L + + N P + L++L + + ++ L+ P
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLT--PQ 828
Query: 163 LGYLDLSSNQL-NGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 209
L LD++ N + + + L +K + G+ R
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-22
Identities = 27/236 (11%), Positives = 62/236 (26%), Gaps = 34/236 (14%)
Query: 49 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 108
+ + N + + G++P + +L L + ++ T
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 109 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDL 168
E + + + +L L ++ P++ I + L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISL 425
Query: 169 SSNQLNG------SIPP--GRLSLNITTIKLSNNKLTGTIP------------------- 201
Q+ I RL+ + I +N+ T
Sbjct: 426 KDTQIGNLTNRITFISKAIQRLT-KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE 484
Query: 202 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 257
++S L L + + N +P ++ L L+ N + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ-----SLNIACNRGISAAQLKA 535
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 20/216 (9%), Positives = 48/216 (22%), Gaps = 42/216 (19%)
Query: 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK-----------LSLR 146
+ + E + +DN + +P ++ +K L +
Sbjct: 225 SQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK 284
Query: 147 NCSLQGPMPD------------------------LSRIPNLGYLDLSSNQLNGSIPP--G 180
N + L + L L+ G +P G
Sbjct: 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+L+ + + + T + + +
Sbjct: 345 QLT-ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD----YDQRLN 399
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 276
+ D + + I + + L+ TN
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 15/77 (19%), Positives = 27/77 (35%), Gaps = 3/77 (3%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
N+I P I SL L + N++ + E+L P+L + I N S
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSV 847
Query: 62 ANLNKTRHFHMNNNSIS 78
+ + + +
Sbjct: 848 CPYIEAGMYVLLYDKTQ 864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 26/311 (8%)
Query: 518 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
Q+G+G +G V G +VAVK+ Q +++F EIQ L LH +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 573 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
G G Q LV E++ +G LRD L + + L + L + +G+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR- 147
Query: 631 PPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
HRD+ A NIL++ + K+ADFGL++L P+ +V + + PE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA----PE 200
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748
+ + +SDV+S GVV EL T + S +R + + +++
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 749 Y----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 804
P C + +L C RPS S + +L+ +W+ +T F + H
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG--SRGCETHAF--TAH 316
Query: 805 TSKEETPPSSS 815
+ S S
Sbjct: 317 PEGKHHSLSFS 327
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 79/307 (25%), Positives = 132/307 (42%), Gaps = 65/307 (21%)
Query: 518 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G+G +GKV+ + +VAVK ++ +L K+F E + L+ L H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALG 617
G C + ++V+E+M +G L L A K LG + L IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE--------- 668
+ G++YL A HRD+ N L+ K+ DFG+SR D+
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGG 193
Query: 669 -GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGK 723
++P ++ P PE + K T +SDV+S GV+ E+ T G QP +S+
Sbjct: 194 HTMLP------IRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-- 241
Query: 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
EV + + G + P C ++ + L C Q E R ++ E+ + L
Sbjct: 242 ---TEV--------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 784 SIWNMMP 790
++ P
Sbjct: 291 ALGKATP 297
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 36/274 (13%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC- 576
IG+G +G V G G VAVK + + + FL E +++L H NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
+E+G +V E+M+ G+L D L ++ + LG L +L + YL HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
D+ A N+L+ AKV+DFGL++ A G +P VK T PE K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKF 191
Query: 697 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PS 751
+ KSDV+S G++ E+ + G P ++V + V G Y P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL--KDV--------VPRVEKG----YKMDAPD 237
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
C ++ C + RPS ++ +LE I
Sbjct: 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 79/320 (24%), Positives = 128/320 (40%), Gaps = 58/320 (18%)
Query: 518 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 570
++GQG +G VY+G+ T VA+K E + E+ EFL E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE--------PLGFAMRLSIALGSSRGI 622
L+G + +++ E M+ G L+ L + P + + +A + G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI----------EGIVP 672
YL HRD+ A N ++ FT K+ DFG++R DI +G++P
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLP 203
Query: 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 731
V+ PE T SDV+S GVV E+ T QP N +V
Sbjct: 204 ------VRWMS----PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQV-- 249
Query: 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791
+ V++G + P C + +L C Q RPS E++ ++ E
Sbjct: 250 ------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE----EME 299
Query: 792 SDTKTPEFINSEHTSKEETP 811
+ F SE E
Sbjct: 300 PGFREVSFYYSEENKLPEPE 319
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-42
Identities = 83/321 (25%), Positives = 128/321 (39%), Gaps = 37/321 (11%)
Query: 472 VRAHMKNYHAISRR-RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKG 530
V + + + R + F AL IG+G +G V G
Sbjct: 153 VEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG 212
Query: 531 ILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFM 589
G VAVK + + + FL E +++L H NLV L+G +E+G +V E+M
Sbjct: 213 DY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 649
+ G+L D L ++ + LG L +L + YL HRD+ A N+L+
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 326
Query: 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVF 709
AKV+DFGL++ A G +P VK T PE K + KSDV+S G++
Sbjct: 327 VAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFSTKSDVWSFGILL 376
Query: 710 LELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSECVEKFIKLALKC 764
E+ + G P Y + V+ Y P C + C
Sbjct: 377 WEIYSFGRVP--------------YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC 422
Query: 765 CQDETDARPSMSEVMRELESI 785
+ RP+ ++ +LE I
Sbjct: 423 WHLDAATRPTFLQLREQLEHI 443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 25/283 (8%)
Query: 518 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 571
+G+G +GKV G VAVK + S + EI+ L L+H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 572 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
G C E+G L+ EF+ +G+L++ L K+K + +L A+ +G+ YL +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLD 687
HRD+ A N+L++ + K+ DFGL++ + + V
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKA--IETDKEYYTVKDDRDSPVFWYA---- 197
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID--- 743
PE + K SDV+S GV ELLT S ++ + + + +++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 744 -GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
G P C ++ +L KC + + R S ++ E++
Sbjct: 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-42
Identities = 46/277 (16%), Positives = 95/277 (34%), Gaps = 21/277 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
I + L L + +L L +L G S
Sbjct: 292 VTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEV 344
Query: 63 NLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
+L ++ N +S G SL ++ L N + + L +L L
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 403
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP 179
++N + + + + ++ L+ L + + + + + +L L ++ N + P
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 180 GRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 237
+ N+T + LS +L P+ F+ L LQ L +++N+ +L
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ-- 521
Query: 238 ETFILDFQNNNLTNISGS--FNIPPN-VTVRLRGNPF 271
+LD+ N++ + P + + L N F
Sbjct: 522 ---VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-39
Identities = 39/250 (15%), Positives = 91/250 (36%), Gaps = 8/250 (3%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELT--GSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
G ++ SLE L L+ N L+ G + L + + N + + +
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 61 FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
F L + H ++++ L +L+++ + + + + L L +L+
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIP 178
+ N+F+ +P ++ + L L L C L+ P + + +L L++S N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 179 PGRLSL-NITTIKLSNNKLTGTIPSNFSGLPR-LQRLFIANNSLSGSIPSSIWQSRTLNA 236
L ++ + S N + + P L L + N + + + +
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE-HQSFLQWIKD 570
Query: 237 TETFILDFQN 246
+++ +
Sbjct: 571 QRQLLVEVER 580
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-39
Identities = 48/261 (18%), Positives = 88/261 (33%), Gaps = 10/261 (3%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
IP + S + L L+ N L P+L + + + I ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 127
+ N I S L SL ++ NL + L L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGY----LDLSSNQLNGSIPPGRL 182
+P +SN++ L L L + +Q DL + + LDLS N +N P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 183 SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
+ + + L NN + + GL L+ + + L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN-- 256
Query: 242 LDFQNNNLTNISGSFNIPPNV 262
L + L + + ++
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDL 277
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-35
Identities = 42/283 (14%), Positives = 86/283 (30%), Gaps = 16/283 (5%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
+N + + L++L L+ E+ L L + + N I +F
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY-LPPELSELPKLLILQL 120
+ L+ + +++ + L +L + + +N + + LP S L L L L
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 121 DNNNFEGTTIPASYSNMSKL----LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176
+N + + ++ L L L + P + L L L +N + +
Sbjct: 157 SSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLN 215
Query: 177 IPPGRL----SLNITTIKL----SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 228
+ + L + + L + L S GL L L + I
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 229 WQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 271
L + + + + + L F
Sbjct: 276 DLFNCLTNVSS--FSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-24
Identities = 27/211 (12%), Positives = 64/211 (30%), Gaps = 28/211 (13%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKS 60
+ + + ++++L L ++ + L L+ +++ N + P
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
F L ++ + P + L SL + + +NN L L +L
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 525
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
N+ + + +L +L+L+ N +
Sbjct: 526 SLNHIMT-SKKQELQHFPS----------------------SLAFLNLTQNDFACTCEHQ 562
Query: 181 RLSLNI---TTIKLSNNKLTGTIPSNFSGLP 208
I + + ++ PS+ G+P
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 79/302 (26%), Positives = 127/302 (42%), Gaps = 54/302 (17%)
Query: 518 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
++G+G +GKV+ + +VAVK +E S ++F E + L+ L H+++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQL-------------SAKSKEPLGFAMRLSIALGS 618
G C E ++V+E+M +G L L + PLG L++A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EGIVPA 673
+ G++YL A HRD+ N L+ K+ DFG+SR D ++P
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 223
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVREV 729
++ P PE L K T +SDV+S GVV E+ T G QP +S+ E
Sbjct: 224 -----IRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEA 269
Query: 730 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789
+ + G P C + + C Q E R S+ +V L+++
Sbjct: 270 --------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
Query: 790 PE 791
P
Sbjct: 322 PV 323
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-42
Identities = 87/282 (30%), Positives = 126/282 (44%), Gaps = 22/282 (7%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 638
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 251 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 639 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 698
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 307 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 360
Query: 699 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 757
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPESL 410
Query: 758 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 799
L +C + E + RP+ + LE +
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 8e-42
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 38/289 (13%)
Query: 519 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
IG+G +G VY G D A+K + + FL E + L+H N+++L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 574 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
G EG ++ +M +G L + + +S L +RG+ YL A+
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL---AEQK 144
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRL-------APVPDIEGIVPAHVSTVVKGTPGY 685
HRD+ A N +LD FT KVADFGL+R + +P VK T
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP------VKWTA-- 196
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
E T++ T KSDV+S GV+ ELLT G P H ++ + G
Sbjct: 197 --LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDL--------THFLAQG 244
Query: 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 793
P C + ++ +C + + RP+ ++ E+E I + +
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 86/294 (29%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 519 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
IG+G +G VY G L D AVK + GE +FLTE + H N++SL+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 574 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
G C EG ++V +M +G LR+ + + L ++G+ YL A
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------------GIVPAHVSTVVK 680
HRD+ A N +LD KFT KVADFGL+R D+ +P VK
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKLP------VK 197
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 739
E T K T KSDV+S GV+ EL+T G P ++
Sbjct: 198 WMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI--------TV 243
Query: 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 793
++ G P C + ++ LKC + + RPS SE++ + +I++
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+IG G +G V+ G + VA+K +EG++ E++F+ E + + +L H LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
E+ LV EFM +G L D L + L + L G+ YL + V HRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 691
+ A N L+ KV+DFG++R V D + P VK PE F
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFP------VKWAS----PEVF 177
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
+ + KSDV+S GV+ E+ + G P + N EV + + G P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEV--------VEDISTGFRLYKP 227
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
++ C ++ + RP+ S ++R+L I
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-41
Identities = 84/284 (29%), Positives = 128/284 (45%), Gaps = 22/284 (7%)
Query: 518 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
++G G YG+VY+G+ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E ++ EFM+ G L D L +++ + + L +A S + YL + HR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHR 342
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
++ A N L+ KVADFGLSRL + A +K T PE +K
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 396
Query: 697 TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVE 755
+ KSDV++ GV+ E+ T GM P +V + P C E
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV--------YELLEKDYRMERPEGCPE 446
Query: 756 KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 799
K +L C Q RPS +E+ + E+++ SD E
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 80/314 (25%), Positives = 125/314 (39%), Gaps = 56/314 (17%)
Query: 518 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 571
+G+G +G V + L VAVK + + +EFL E + H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 572 LVGYCDEEGEQ------MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRG 621
LVG + M++ FM +G L L ++ L + + + G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIV 671
+ YL + HRD+ A N +L T VADFGLSR I +
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKL 201
Query: 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 730
P VK E + T SDV++ GV E++T G P + +N E+
Sbjct: 202 P------VKWLA----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEI- 248
Query: 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW-NMM 789
+I GN P EC+E+ L +C + RPS + + ELE+I ++
Sbjct: 249 -------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 790 PESDTKTPEFINSE 803
S ++ P +IN E
Sbjct: 302 VLSTSQDPLYINIE 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 25/285 (8%)
Query: 518 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 573 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 134
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 688
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPGESPIFWYA----P 186
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS-VIDGNM 746
E K + SDV+S GVV EL T + S +R + Q M+ +I+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 747 GSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787
+ P C ++ + +C + + RPS ++ ++ I +
Sbjct: 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 518 QIGQGGYGKVYKGILPDGTV-VAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
++G G YG+VY+G+ ++ VAVK +E +++ +EFL E + + H NLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E ++ EFM+ G L D L +++ + + L +A S + YL HR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAP----VPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
D+ A N L+ KVADFGLSRL P +K T PE
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTA----PESLA 185
Query: 693 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
+K + KSDV++ GV+ E+ T GM P +V + P
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV--------YELLEKDYRMERPE 235
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 799
C EK +L C Q RPS +E+ + E+++ SD E
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 35/288 (12%)
Query: 518 QIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHRNLVS 571
+G+G +GKV G +VAVK + + + EI L L+H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 572 LVGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
G C++ G LV E++ G+LRD L + +G A L A G+ YLH +
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 630 DPPVF-HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL-- 686
+ HRD+ A N+LLD+ K+ DFGL++ VP G
Sbjct: 155 ----YIHRDLAARNVLLDNDRLVKIGDFGLAKA---------VPEGHEYYRVREDGDSPV 201
Query: 687 ---DPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742
PE +K SDV+S GV ELLT S + + IA + +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 743 DGNMGSY----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786
+ P +C + L C + E RP+ ++ L+++
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 518 QIGQGGYGKVYKGILPDG----TVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
+G+G +G V +G L VAVK + S + +EFL+E + H N++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 572 LVGYCDEEGEQ-----MLVYEFMSNGTLRDQL----SAKSKEPLGFAMRLSIALGSSRGI 622
L+G C E Q M++ FM G L L + + L + + G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE----------GIVP 672
YL ++ HRD+ A N +L T VADFGLS+ I +P
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMP 212
Query: 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 731
VK E T KSDV++ GV E+ T GM P +N E+
Sbjct: 213 ------VKWIA----IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEM-- 258
Query: 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791
++ G+ P +C+++ ++ C + + RP+ S + +LE + +P+
Sbjct: 259 ------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 34/275 (12%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G+V+ G T VAVK ++GS+ FL E + +L H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
+E ++ E+M NG+L D L S L L +A + G+ ++ + HRD
Sbjct: 79 QEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 691
++A+NIL+ + K+ADFGL+RL + D E P +K T PE
Sbjct: 135 LRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFP------IKWTA----PEAI 182
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
T KSDV+S G++ E++T G P N EV + ++ G P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV--------IQNLERGYRMVRP 232
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
C E+ +L C ++ + RP+ + LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 25/287 (8%)
Query: 518 QIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
Q+G+G +G V G VVAVK+ Q + + ++F EI+ L L H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 573 VGYCDEEGEQ--MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
G C G + L+ E++ G+LRD L K KE + L +G+ YL T+
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR- 165
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDP 688
HRD+ NIL++++ K+ DFGL+++ +P + + P
Sbjct: 166 --YIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEYYKVKEPGESPIFWYA----P 217
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSM-----MFSVI 742
E K + SDV+S GVV EL T + S +R + Q M + +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789
+ P C ++ + +C + + RPS ++ ++ I + M
Sbjct: 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 34/275 (12%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G V G VAVK +EGS+ E EF E Q + +L H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
+E +V E++SNG L + L + K L + L + G+ +L HRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 691
+ A N L+D KV+DFG++R V D + P VK + PE F
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP------VKWSA----PEVF 177
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
K + KSDV++ G++ E+ + G P N EV + V G+ P
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEV--------VLKVSQGHRLYRP 227
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ ++ C + + RP+ +++ +E +
Sbjct: 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 30/272 (11%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578
+G G +G+V+ T VAVK + GS+ + FL E + L H LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 638
E ++ EFM+ G+L D L + + + + G+ ++ HRD+
Sbjct: 255 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDL 310
Query: 639 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 698
+A+NIL+ K+ADFGL+R+ + D E +K T PE T
Sbjct: 311 RAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFTI 364
Query: 699 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY----PSEC 753
KSDV+S G++ +E++T G P N EV + ++ G Y P C
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSN--PEV--------IRALERG----YRMPRPENC 410
Query: 754 VEKFIKLALKCCQDETDARPSMSEVMRELESI 785
E+ + ++C ++ + RP+ + L+
Sbjct: 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-40
Identities = 87/282 (30%), Positives = 126/282 (44%), Gaps = 22/282 (7%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578
+GQG +G+V+ G T VA+K + G++ E FL E Q + +L H LV L E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 638
E +V E+MS G+L D L ++ + L + +A + G+ Y+ HRD+
Sbjct: 334 EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 639 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD 698
+A+NIL+ KVADFGL+RL + D E +K T PE L + T
Sbjct: 390 RAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 443
Query: 699 KSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKF 757
KSDV+S G++ EL T G P N REV + V G P EC E
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVN--REV--------LDQVERGYRMPCPPECPESL 493
Query: 758 IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 799
L +C + E + RP+ + LE +
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
++G G +G V G VA+K +EGS+ E EF+ E + + L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
++ ++ E+M+NG L + L + + L + + YL HRD
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLDPEYF 691
+ A N L++ + KV+DFGLSR V D E P V+ +P PE
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP------VRWSP----PEVL 193
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
+ K + KSD+++ GV+ E+ + G P N E + G P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SET--------AEHIAQGLRLYRP 243
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788
EK + C ++ D RP+ ++ + + +
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 44/313 (14%)
Query: 518 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 570
+G G +G+VY+G + P VAVK E + ++ +FL E +S+ +H+N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 625
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 626 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI-----EGIVPAHVST 677
+ HRDI A N LL AK+ DFG++R ++P
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP----- 208
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSS 736
VK P PE F+ T K+D +S GV+ E+ + G P N +EV
Sbjct: 209 -VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV------- 254
Query: 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKT 796
+ V G P C ++ +C Q + + RP+ + ++ +E +T
Sbjct: 255 -LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 797 PEFINSEHTSKEE 809
P +E+
Sbjct: 314 PIEYGPLVEEEEK 326
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 66/305 (21%), Positives = 124/305 (40%), Gaps = 66/305 (21%)
Query: 518 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 570
++G+ +GKVYKG L VA+K ++ +EF E +RL H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIAL 616
L+G ++ +++ + S+G L + L +S K L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------- 668
+ G+ YL + V H+D+ N+L+ K K++D GL R ++
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLL 187
Query: 669 --GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHG 722
++P ++ PE + K + SD++S GVV E+ + G+QP S+
Sbjct: 188 GNSLLP------IRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 236
Query: 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
++V + + + + P +C L ++C + RP ++ L
Sbjct: 237 ----QDV--------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 783 ESIWN 787
+ N
Sbjct: 285 RAWGN 289
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-40
Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 26/283 (9%)
Query: 519 IGQGGYGKVYKGILPDG----TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLV 573
IG+G +G VY G L D AVK + +FLTE + H N++SL+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 574 GYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
G C EG ++V +M +G LR+ + + L ++G+ +L A
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYF 691
HRD+ A N +LD KFT KVADFGL+R + + + + + VK E
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LESL 268
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
T K T KSDV+S GV+ EL+T G P ++ ++ G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI--------TVYLLQGRRLLQP 318
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 793
C + ++ LKC + + RPS SE++ + +I++
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-39
Identities = 74/331 (22%), Positives = 136/331 (41%), Gaps = 62/331 (18%)
Query: 518 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 567
+G+G +G+V T VAVK + + + + + ++E++ + + H+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 613
N+++L+G C ++G ++ E+ S G LR+ L S +E L +S
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 668
A +RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 724
G +P VK PE T +SDV+S GV+ E+ T G P +
Sbjct: 253 GRLP------VKWMA----PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299
Query: 725 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
E+ + +G+ PS C + + C RP+ +++ +L+
Sbjct: 300 --EEL--------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD- 348
Query: 785 IWNMMPESDTKTPEFINSEHTSKEETPPSSS 815
++ + + + + H + P + +
Sbjct: 349 --RIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-39
Identities = 80/318 (25%), Positives = 127/318 (39%), Gaps = 54/318 (16%)
Query: 518 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 570
+G G +G+VY+G + VAVK E S Q E +FL E +S+ +H+N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQL-----SAKSKEPLGFAMRLSIALGSSRGILYL 625
+G + + ++ E M+ G L+ L L L +A + G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 626 HTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDI----------EGIVP 672
+ HRDI A N LL AK+ DFG++R DI ++P
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLP 249
Query: 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNI 731
VK P PE F+ T K+D +S GV+ E+ + G P N +EV
Sbjct: 250 ------VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV-- 295
Query: 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791
+ V G P C ++ +C Q + + RP+ + ++ +E
Sbjct: 296 ------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
Query: 792 SDTKTPEFINSEHTSKEE 809
+T P +E+
Sbjct: 350 INTALPIEYGPLVEEEEK 367
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 67/294 (22%), Positives = 112/294 (38%), Gaps = 33/294 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
++G+GG+ V L DG A+KR Q +E E +H N++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 577 DEEGEQM----LVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEAD 630
E L+ F GTL +++ + L + LG RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLA--PVPDIEGIVPAHVSTVVKGTPGYLDP 688
HRD+K +NILL + + D G A V + + T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 689 EYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
E F + +++DV+SLG V ++ G P ++ +Q ++ N
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY----------DMVFQKGDSVALAVQN 262
Query: 746 MGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 794
S P S + + + + RP + ++ +LE++ P T
Sbjct: 263 QLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 519 IGQGGYGKVYKGIL-PDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 572
+G G +G VYKG+ P+G VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 687
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
E L T +SDV+S GV EL+T G +P E+ + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI--------SSILEKGER 237
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P C + KC + D+RP E++ E +
Sbjct: 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 519 IGQGGYGKVYKGIL----PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
+G+G +G+VY+G+ + VAVK ++ K +F++E + L H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G +EE ++ E G L L ++K L + +L + + YL E+ V
Sbjct: 80 GIIEEE-PTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL--ESINCV 135
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE---------GIVPAHVSTVVKGTPG 684
HRDI NIL+ K+ DFGLSR IE +P +K
Sbjct: 136 -HRDIAVRNILVASPECVKLGDFGLSR-----YIEDEDYYKASVTRLP------IKWMS- 182
Query: 685 YLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743
PE + T SDV+ V E+L+ G QP +N ++V + +
Sbjct: 183 ---PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDV--------IGVLEK 229
Query: 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788
G+ P C L +C + RP +E++ L ++ M
Sbjct: 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-39
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 59/301 (19%)
Query: 518 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 567
+G+G +G+V + VAVK ++ + + + + ++E++ + + H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 613
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 668
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 724
G +P VK PE T +SDV+S GV+ E+ T G P I
Sbjct: 265 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311
Query: 725 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
E+ + +G+ P+ C + + C RP+ +++ +L+
Sbjct: 312 --EEL--------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 785 I 785
I
Sbjct: 362 I 362
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 32/306 (10%)
Query: 518 QIGQGGYGKVYKGILPDGTV-----VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVS 571
IG G +G+VYKG+L + VA+K + G + ++ +FL E + + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
L G + M++ E+M NG L L + + + G + G+ YL A+
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEY 690
HRD+ A NIL++ KV+DFGLSR+ D E + ++ T PE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEATYTTSGGKIPIRWTA----PEA 221
Query: 691 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749
K T SDV+S G+V E++T G +P N EV M ++ DG
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV--------MKAINDGFRLPT 271
Query: 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 809
P +C +L ++C Q E RP ++++ L+ + P+S +F
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-APDSLKTLADFDPRVSIR--- 327
Query: 810 TPPSSS 815
PS+S
Sbjct: 328 -LPSTS 332
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-39
Identities = 55/279 (19%), Positives = 102/279 (36%), Gaps = 17/279 (6%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSF 61
+S +P + + +L+ L+L+ N+ P L + I N L
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 62 ANLNKTRHFHMNNNSI--SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
NL R ++++ I S +L L L + L N E P+L +L
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIP 178
L + + + N+ L L+L + L +P L +L+L N
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
Query: 179 PGRLSL----NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234
SL + + LS L+ F+ L + + +++N L+ S ++ + +
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526
Query: 235 NATETFILDFQNNNLTNIS-GSFNIPPN-VTVRLRGNPF 271
L+ +N+++ I I T+ LR NP
Sbjct: 527 ------YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-37
Identities = 51/292 (17%), Positives = 90/292 (30%), Gaps = 14/292 (4%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
+I + L+ L+L N L L L + Q IS
Sbjct: 66 RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
N ++ +N IS P+ L + NN + ++S L + L L+
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP---DLSRIPNLGYLDLSSNQLNG--- 175
N + I + + L+ + S I +L
Sbjct: 186 LNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 176 SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
++ G +++ +I L + + F LQ L + LS +PS + TL
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK 304
Query: 236 ATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPFCLNTNAEQFCGSHS 285
L N N+ S + P++T ++GN L +
Sbjct: 305 -----KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-36
Identities = 55/274 (20%), Positives = 94/274 (34%), Gaps = 11/274 (4%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
IS ++ + + + S+E + L + L + + ++S LP
Sbjct: 241 EDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLV 298
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLD 121
L+ + ++ N S PSL H+ + N L L L L L L
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358
Query: 122 NNNFEGTTI-PASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPP 179
+++ E + N+S L L+L + P L LDL+ +L
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
Query: 180 GRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 237
+ + LS++ L + F GLP LQ L + N +TL
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478
Query: 238 ETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 269
E L +L++I +F + L N
Sbjct: 479 EI--LVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-35
Identities = 49/281 (17%), Positives = 92/281 (32%), Gaps = 21/281 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+ L+ L L L+ LP L L L ++ + N S +
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 63 NLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQ 119
N H + N+ ++ L L +L + L ++++ +L L L L
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 120 LDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGS 176
L N ++ +L L L L+ + L L+LS + L+
Sbjct: 383 LSYNEP--LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD-I 439
Query: 177 IPPGRLSL--NITTIKLSNNKLTGTI---PSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 231
+ + L N ++ L RL+ L ++ LS +
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 232 RTLNATETFILDFQNNNLTNIS-GSFNIPPNVTVRLRGNPF 271
+ +N +D +N LT+ S + + + + L N
Sbjct: 500 KMMN-----HVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-33
Identities = 48/263 (18%), Positives = 90/263 (34%), Gaps = 17/263 (6%)
Query: 3 NKISGSIPKEIGN--IKSLELLLLNGNELTGSLPEELGYLPKLDRIQID--QNYISGSLP 58
+ I K + N I+SL L + P L ++ I+ ++Y
Sbjct: 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
Query: 59 KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 118
+F + + + +S ++P L L +L ++L N S P L L
Sbjct: 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD---LSRIPNLGYLDLSSNQLNG 175
+ N N+ L +L L + ++ L + +L L+LS N+
Sbjct: 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL- 389
Query: 176 SIPPGRLS--LNITTIKLSNNKLTGTIP-SNFSGLPRLQRLFIANNSLSGSIPSSIWQSR 232
S+ + + L+ +L S F L L+ L ++++ L S
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 233 TLNATETFILDFQNNNLTNISGS 255
L L+ Q N+ +
Sbjct: 450 ALQ-----HLNLQGNHFPKGNIQ 467
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-33
Identities = 48/253 (18%), Positives = 94/253 (37%), Gaps = 10/253 (3%)
Query: 2 WNKISGSIPKE-IGNIKSLELLLLNGNELTGS--LPEELGYLPKLDRIQIDQNYISGSLP 58
N + + N+++L L L+ +++ S +L L L + + N
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393
Query: 59 KSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 117
++F + + + + L L + L ++ L LP L
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453
Query: 118 LQLDNNNFEGTTI--PASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLN 174
L L N+F I S + +L L L C L + + + ++DLS N+L
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 175 GSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 233
S LS L + L++N ++ +PS L + + + + N L + S+I+
Sbjct: 514 -SSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT-CSNIYFLEW 571
Query: 234 LNATETFILDFQN 246
+ D ++
Sbjct: 572 YKENMQKLEDTED 584
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-33
Identities = 39/261 (14%), Positives = 82/261 (31%), Gaps = 13/261 (4%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N + + +L L L ++ + +LD + + N + + +
Sbjct: 43 NVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALS 102
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+H IS L +L + L +N+++ P+ KL +L N
Sbjct: 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN 162
Query: 123 NNFEGTTIPASYSNMSKL--LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
N + S++ + L L+L + G P L+ Q I G
Sbjct: 163 NAIHYLS-KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKG 221
Query: 181 RLSLNITTIK---LSNNKLTGTIPSNFSGLPR--LQRLFIANNSLSGSIPSSIWQSRTLN 235
+ I ++ + P+ F GL ++ + + + ++ L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ 281
Query: 236 ATETFILDFQNNNLTNISGSF 256
LD +L+ +
Sbjct: 282 -----ELDLTATHLSELPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-32
Identities = 45/270 (16%), Positives = 85/270 (31%), Gaps = 15/270 (5%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
IP + N S E L + N L L L + + + I +F + ++
Sbjct: 26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 127
+ N + LS +L H+ ++ L L L L +N+
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLG--YLDLSSNQLNGSIPPGRL-S 183
KL L +N ++ D+S + L+L+ N + I PG S
Sbjct: 144 -IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
Query: 184 LNITTIKLSNNKLTGTIPSN--FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
++ + I S + L + P+ ++
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVES--- 258
Query: 242 LDFQNNNLTNIS-GSFNIPPNV-TVRLRGN 269
++ Q + NIS +F+ + + L
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTAT 288
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 72/320 (22%), Positives = 132/320 (41%), Gaps = 64/320 (20%)
Query: 518 QIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHR 567
+G+G +G+V VAVK ++ + + + + ++E++ + + H+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLS 613
N+++L+G C ++G ++ E+ S G LR+ L + +E + F +S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 668
+RG+ YL A HRD+ A N+L+ K+ADFGL+R D
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKN 724
G +P VK PE T +SDV+S GV+ E+ T G P I
Sbjct: 219 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265
Query: 725 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784
E+ + +G+ P+ C + + C RP+ +++ +L+
Sbjct: 266 --EEL--------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 785 IWNMMPESDTKTPEFINSEH 804
I + T E+++
Sbjct: 316 IL-----TLTTNEEYLDLSQ 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 41/274 (14%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 574
+IG+G + VYKG+ VA Q+ L + F E + L L H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 575 YC-DEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTE 628
+ + E M++GTL+ L K +++ S +G+ +LHT
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 629 ADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
PP+ HRD+K NI + + K+ D GL+ + A + V GTP ++
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---------LKRASFAKAVIGTPEFMA 198
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
PE + K + DVY+ G+ LE+ T P S +N + + V G
Sbjct: 199 PEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKP 248
Query: 748 SYP----SECVEKFIKLALKCCQDETDARPSMSE 777
+ V++ I+ C + D R S+ +
Sbjct: 249 ASFDKVAIPEVKEIIE---GCIRQNKDERYSIKD 279
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 74/297 (24%), Positives = 118/297 (39%), Gaps = 51/297 (17%)
Query: 518 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 569
+G+G +G+V + VAVK +EG+ E ++E++ L + HH N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 570 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSI 614
V+L+G C G M++ EF G L L K+ L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----EG 669
+ ++G+ +L A HRD+ A NILL K K+ DFGL+R +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 728
+P +K PE T +SDV+S GV+ E+ + G P G I E
Sbjct: 211 RLP------LKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEE 259
Query: 729 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ +G P + + L C E RP+ SE++ L ++
Sbjct: 260 F--------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 74/311 (23%)
Query: 518 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLV 570
+G+G +GKV K T VAVK +E + E + L+E L +++H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------------SAKSKEPLGF 608
L G C ++G +L+ E+ G+LR L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 609 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 667
+S A S+G+ YL A+ + HRD+ A NIL+ K++DFGLSR D+
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVY 201
Query: 668 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 717
+G +P VK E H T +SDV+S GV+ E++T G
Sbjct: 202 EEDSYVKRSQGRIP------VKWMA----IESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 718 P---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 774
P I + + G+ P C E+ +L L+C + E D RP
Sbjct: 252 PYPGIPP-----ERL--------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 775 MSEVMRELESI 785
+++ ++LE +
Sbjct: 299 FADISKDLEKM 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 24/280 (8%)
Query: 517 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 572
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C E MLV E G L L +E + + + S G+ YL +
Sbjct: 76 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
HRD+ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186
Query: 693 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
K + +SDV+S GV E L+ G +P K EV M + G P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV--------MAFIEQGKRMECPP 236
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791
EC + L C + + RP V + + + + +
Sbjct: 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 61/298 (20%)
Query: 518 QIGQGGYGKVYKGILPDG---TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNLVSL 572
IG+G +G+V K + A+KR +E + + + +F E++ L +L HH N+++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMRLSIALGS 618
+G C+ G L E+ +G L D L + + L L A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-------GIV 671
+RG+ YL + HRD+ A NIL+ + AK+ADFGLSR E G +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 203
Query: 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQP---ISHGKNIVR 727
P V+ E T SDV+S GV+ E+++ G P ++
Sbjct: 204 P------VRWMA----IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 248
Query: 728 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
E+ + G P C ++ L +C +++ RPS ++++ L +
Sbjct: 249 EL--------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-38
Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 518 QIGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 572
IG G G+V G L VA+K + G + ++ +FL+E + + H N++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
G M+V E+M NG+L L + + G G+ YL +D
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-VKGTPGYLDPEYF 691
HRD+ A N+L+D KV+DFGLSR+ D + + ++ T PE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTA----PEAI 226
Query: 692 LTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
+ SDV+S GVV E+L G +P + N R+V + SV +G P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDV--------ISSVEEGYRLPAP 276
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
C +L L C + RP S+++ L+++
Sbjct: 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 68/304 (22%)
Query: 518 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 569
+G G +GKV + VAVK + + EK ++E++ +S L H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------SAKSKEPLGFAMRLSIALG 617
V+L+G C G +++ E+ G L + L A + L +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI---------- 667
++G+ +L A HRD+ A N+LL + AK+ DFGL+R DI
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKG 224
Query: 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIV 726
+P VK PE T +SDV+S G++ E+ + G+ P
Sbjct: 225 NARLP------VKWMA----PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-------- 266
Query: 727 REVNIAYQSSM-----MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781
Y + V DG + P+ + + C E RP+ ++
Sbjct: 267 ------YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
Query: 782 LESI 785
L+
Sbjct: 321 LQEQ 324
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 74/276 (26%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 518 QIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSL 572
++G G +G V KG VAVK + + + E L E + +L + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C+ E MLV E G L L + + + + S G+ YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EESNF 138
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV--VKGTPGYLDPEY 690
V HRD+ A N+LL + AK++DFGLS+ + E A VK PE
Sbjct: 139 V-HRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKWYA----PEC 191
Query: 691 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749
+K + KSDV+S GV+ E + G +P K EV + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEV--------TAMLEKGERMGC 241
Query: 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P+ C + L C + + RP + V L +
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 519 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL--ESKRFV 138
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 687
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 139 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 185
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE + T SDV+ GV E+L G++P KN +V + + +G
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--------IGRIENGER 235
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P C L KC + RP +E+ +L +I
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-38
Identities = 83/311 (26%), Positives = 131/311 (42%), Gaps = 74/311 (23%)
Query: 518 QIGQGGYGKVYKGILPDG------TVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLV 570
IG+G +G+V++ P T+VAVK +E S + +F E ++ + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE----------------------PLGF 608
L+G C L++E+M+ G L + L + S PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 609 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 667
A +L IA + G+ YL ++ HRD+ N L+ K+ADFGLSR +I
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIY 225
Query: 668 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 717
+P ++ P PE ++ T +SDV++ GVV E+ + G+Q
Sbjct: 226 SADYYKADGNDAIP------IRWMP----PESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 718 P---ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPS 774
P ++H EV I Y V DGN+ + P C + L C RPS
Sbjct: 276 PYYGMAH-----EEV-IYY-------VRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322
Query: 775 MSEVMRELESI 785
+ R L+ +
Sbjct: 323 FCSIHRILQRM 333
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 66/310 (21%), Positives = 116/310 (37%), Gaps = 54/310 (17%)
Query: 518 QIGQGGYGKVYKGIL--------PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 569
+GQG + K++KG+ T V +K + + F +S+L H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
V G C E +LV EF+ G+L L K+K + +L +A + + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 630 DPPVFHRDIKASNILLDHKFT--------AKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+ + H ++ A NILL + K++D G+S +P +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQER------IPW 183
Query: 682 TPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMF 739
P PE K +D +S G E+ + G +P+S + + +
Sbjct: 184 VP----PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRK--------LQ 229
Query: 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 799
D + P + L C E D RPS ++R+L S++ TP+
Sbjct: 230 FYEDRHQLPAPKAA--ELANLINNCMDYEPDHRPSFRAIIRDLNSLF---------TPDL 278
Query: 800 INSEHTSKEE 809
+
Sbjct: 279 VPRGSHHHHH 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-38
Identities = 65/336 (19%), Positives = 123/336 (36%), Gaps = 30/336 (8%)
Query: 487 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE 545
H +S G + + M + +IG+G +GK DG +K
Sbjct: 4 HHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI 59
Query: 546 GSL-QGEKEF-LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 603
+ E+E E+ L+ + H N+V +E G +V ++ G L +++A+
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 604 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663
L + + ++H D + HRDIK+ NI L T ++ DFG++R+
Sbjct: 120 VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723
+ GTP YL PE +KSD+++LG V EL T
Sbjct: 177 STV------ELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAG 228
Query: 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE-- 781
++ +++ +I G+ L + + RPS++ ++ +
Sbjct: 229 SM---------KNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279
Query: 782 -LESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816
+ I + + + + P+
Sbjct: 280 IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 48/304 (15%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 569
+F IG GG+G+V+K DG +KR + ++ E++ L++L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 570 VSLVGYCDEEGEQM----------------LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS 613
V G D + EF GTL + + E L + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673
+ ++G+ Y+H + +RD+K SNI L K+ DFGL +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--------LKND 175
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733
T KGT Y+ PE + + D+Y+LG++ ELL ++
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL---- 231
Query: 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 793
G +K L K + + RP+ SE++R L +W PE +
Sbjct: 232 -----------RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT-VWKKSPEKN 279
Query: 794 TKTP 797
+
Sbjct: 280 ERHT 283
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 72/311 (23%), Positives = 124/311 (39%), Gaps = 42/311 (13%)
Query: 519 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSL 572
+G G +G V+KG+ V +K ++ S Q + + + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C LV +++ G+L D + + + LG + L+ + ++G+ YL +
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL---EEHG 135
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 687
+ HR++ A N+LL +VADFG++ L P D + P +K
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------IKWMA---- 185
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
E K T +SDV+S GV EL+T G +P + + EV + G
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEV--------PDLLEKGER 235
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 806
+ P C + +KC + + RP+ E+ E + P I E
Sbjct: 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLV-----IKRESGP 290
Query: 807 KEETPPSSSSM 817
P +
Sbjct: 291 GIAPGPEPHGL 301
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 45/310 (14%)
Query: 519 IGQGGYGKVYKGILPDG-----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 572
+G G +G VYKG+ VA+K +E + E L E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C L+ + M G L D + + K+ +G L+ + ++G+ YL D
Sbjct: 83 LGICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE-----GIVPAHVSTVVKGTPGYLD 687
+ HRD+ A N+L+ K+ DFGL++L + E G VP +K
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA---- 187
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
E L T +SDV+S GV EL+T G +P E+ + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI--------SSILEKGER 237
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 806
P C + +KC + D+RP E++ E + + P+
Sbjct: 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--------ARDPQRYLVIQGD 289
Query: 807 KEETPPSSSS 816
+ PS +
Sbjct: 290 ERMHLPSPTD 299
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 68/298 (22%), Positives = 114/298 (38%), Gaps = 52/298 (17%)
Query: 518 QIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 569
+G G +GKV + VAVK + + E+ ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL----------------SAKSKEPLGFAMRLS 613
V+L+G C G +++ E+ G L + L + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI-----E 668
+ ++G+ +L A HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 727
+P VK PE T +SDV+S G+ EL + G P G +
Sbjct: 207 ARLP------VKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-GMPVDS 255
Query: 728 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ + +G P + + C + RP+ ++++ +E
Sbjct: 256 KF--------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 76/311 (24%), Positives = 132/311 (42%), Gaps = 34/311 (10%)
Query: 518 QIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 572
+G G +G+V G L VA+K + G + ++ +FL E + + H N++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
G + M+V E+M NG+L L K + + G + G+ YL +D
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGTPGYLD 687
HRD+ A NIL++ KV+DFGL R +E A +T ++ T
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKIPIRWTS---- 218
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE K T SDV+S G+V E+++ G +P N ++V + +V +G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDV--------IKAVDEGYR 268
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 806
P +C +L L C Q + + RP +++ L+ + T +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLL 328
Query: 807 KEETPPSSSSM 817
+++ ++
Sbjct: 329 LDQSNVDITTF 339
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 26/284 (9%)
Query: 518 QIGQGGYGKVYKGIL--PDGTV--VAVKRAQEGSLQGEK---EFLTEIQFLSRLHHRNLV 570
++G G +G V +G P G VAVK + L + +F+ E+ + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
L G +V E G+L D+L K + A+ + G+ YL E+
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL--ESK 140
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
+ HRD+ A N+LL + K+ DFGL R P D ++ H PE
Sbjct: 141 RFI-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PES 195
Query: 691 FLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749
T + SD + GV E+ T G +P ++ + +G
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQI-------LHKIDKEGERLPR 246
Query: 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 793
P +C + + ++C + + RP+ + L ++
Sbjct: 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAE 290
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 70/308 (22%), Positives = 114/308 (37%), Gaps = 67/308 (21%)
Query: 518 QIGQGGYGKVYKGILPDG------TVVAVKRAQEGSLQGEK-EFLTEIQFLSRL-HHRNL 569
+G G +GKV VAVK +E + E+ ++E++ +++L H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQL---------------------SAKSKEPLGF 608
V+L+G C G L++E+ G L + L + L F
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 609 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI- 667
L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R DI
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIM 223
Query: 668 ---------EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 717
+P VK PE T KSDV+S G++ E+ + G+
Sbjct: 224 SDSNYVVRGNARLP------VKWMA----PESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 718 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 777
P G + + +G P E+ + C ++ RPS
Sbjct: 274 P-YPGIPVDANF--------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324
Query: 778 VMRELESI 785
+ L
Sbjct: 325 LTSFLGCQ 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 30/289 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHHRNLVSLV 573
+IG+G + +VY+ L DG VA+K+ Q L K + EI L +L+H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF--AMRLSIALGSSRGILYLHTEADP 631
E+ E +V E G L + K+ + + ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
V HRDIK +N+ + K+ D GL R ++V GTP Y+ PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------TAAHSLV-GTPYYMSPERI 208
Query: 692 LTHKLTDKSDVYSLGVVFLELLTGMQP-ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
+ KSD++SLG + E+ P N+ S+ + + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---------SLCKKIEQCDYPPLP 259
Query: 751 SECV-EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 798
S+ E+ +L C + + RP ++ V + M + +
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYV---YDVAKRMHACTASSLEH 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 49/269 (18%), Positives = 98/269 (36%), Gaps = 25/269 (9%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
+I + N ++ + + L +L + + + N +S A K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 127
++++N + +L L +L + L+NN + EL P + L NNN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-- 111
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRL---S 183
+ + S + L N + D + YLDL N+++ ++ L S
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS 168
Query: 184 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243
+ + L N + + +L+ L +++N L+ + + + +
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WIS 220
Query: 244 FQNNNLTNISGSFNIPPNVTV-RLRGNPF 271
+NN L I + N+ LRGN F
Sbjct: 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 48/254 (18%), Positives = 97/254 (38%), Gaps = 23/254 (9%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+ + ++ + +++ L L+GN L+ +L KL+ + + N +
Sbjct: 20 SSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLE 77
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+L+ R +NNN + EL PS+ + NNN++ + + L N
Sbjct: 78 SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 123 NNFEGTTIP-ASYSNMSKLLKLSLRNCSLQG-PMPDL-SRIPNLGYLDLSSNQLNGSIPP 179
N T + S++ L L+ + +L + L +L+L N + +
Sbjct: 130 NKI--TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
Query: 180 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239
+ + T+ LS+NKL + F + + + NN L I ++ S+ L
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE---- 240
Query: 240 FILDFQNNNLTNIS 253
D + N +
Sbjct: 241 -HFDLRGNGFHCGT 253
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 34/212 (16%), Positives = 68/212 (32%), Gaps = 11/212 (5%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG-SLPKSF 61
N IS + G + + + L N++T + G ++ + + N I + +
Sbjct: 109 NNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
A+ + H ++ N I + ++ L + L +N L ++ PE + + L
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
NN I + L LR N ++ +
Sbjct: 223 NNKL--VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRL 213
+ T+ +P+ F RL L
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPF--ADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 36/214 (16%), Positives = 70/214 (32%), Gaps = 15/214 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N + E+ S+E L N ++ + I + N I+
Sbjct: 90 NYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEG 141
Query: 63 NLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
++ ++ + N I + +L H+ L N + + ++ KL L L
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLS 199
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN-GSIPPG 180
+N + + + + + +SLRN L L NL + DL N + G++
Sbjct: 200 SNKL--AFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 181 RLSLN-ITTIKLSNNKLTGTIPSNFSGLPRLQRL 213
+ T+ K +P L
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 27/168 (16%), Positives = 50/168 (29%), Gaps = 6/168 (3%)
Query: 3 NKISG-SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
N+I + + + +LE L L N + + ++ KL + + N ++ + F
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEF 210
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
+ + NN + I L +L H L N + +
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVA 268
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 169
+ T L C P P R+ LG+
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-36
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 24/281 (8%)
Query: 517 TQIGQGGYGKVYKGIL--PDGTV-VAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSL 572
++G G +G V +G+ + VA+K ++G+ + + E + E Q + +L + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C E MLV E G L L +E + + + S G+ YL E
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL--EEKNF 457
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
V HR++ A N+LL ++ AK++DFGLS+ D + +K PE
Sbjct: 458 V-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 512
Query: 693 THKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
K + +SDV+S GV E L+ G +P K EV M + G P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEV--------MAFIEQGKRMECPP 562
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 792
EC + L C + + RP V + + + + +
Sbjct: 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 26/284 (9%)
Query: 506 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL-QGEKEFL-TEIQFLS 562
M ++ IG G YG+ K DG ++ K GS+ + EK+ L +E+ L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 563 RLHHRNLVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGS 618
L H N+V + L V E+ G L ++ +KE L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 619 SRGILYLHTEADPP--VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
+ + H +D V HRD+K +N+ LD K K+ DFGL+R+ +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------SFAK 174
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736
T V GTP Y+ PE +KSD++SLG + EL M P +
Sbjct: 175 TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQ---------KE 223
Query: 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + +G P ++ ++ + + RPS+ E++
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 519 IGQGGYGKVYKGILPDG----TVVAVKRAQEGSLQGEK-EFLTEIQFLSRLHHRNLVSLV 573
IG+G +G V++GI VA+K + + + +FL E + + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
G E ++ E + G LR L K L A + A S + YL E+ V
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYL--ESKRFV 513
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE------GIVPAHVSTVVKGTPGYLD 687
HRDI A N+L+ K+ DFGLSR + D G +P +K
Sbjct: 514 -HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP------IKWMA---- 560
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE + T SDV+ GV E+L G++P KN +V + + +G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--------IGRIENGER 610
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P C L KC + RP +E+ +L +I
Sbjct: 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 40/295 (13%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN 568
++F +GQG +G+V K D A+K+ + + L+E+ L+ L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 569 LVSLVG-YCDEEGEQM------------LVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSI 614
+V + + + E+ NGTL D + S + RL
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDI 667
+ + Y+H++ + HRD+K NI +D K+ DFGL++ + +
Sbjct: 124 QILE--ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 725
+ T GT Y+ E L K D+YSLG++F E++ P S G
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234
Query: 726 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
V + S+ F + + +K I+ + + RP ++
Sbjct: 235 VNILKKLRSVSIEF---PPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 57/282 (20%), Positives = 104/282 (36%), Gaps = 43/282 (15%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 573
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
Y + +V E N L L K + + +H +
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 148
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 689
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 690 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 253
Query: 743 DGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
D N P + ++ +K C + + R S+ E++
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 292
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-35
Identities = 49/295 (16%), Positives = 98/295 (33%), Gaps = 34/295 (11%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS-------- 54
+ + ++ + L G + E++ K + I + +
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLP 328
Query: 55 -----------GSLPKSFANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNL 101
GS+ L + ++ N++S G SL H+ L N
Sbjct: 329 FLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 102 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRI 160
+ L +L L ++ + T +++ ++ KLL L + + + +
Sbjct: 389 II-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447
Query: 161 PNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218
+L L ++ N + + N+T + LS +L F L RLQ L +++N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 219 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPN-VTVRLRGNPF 271
+L S Q +L+ LD N + + P + L N
Sbjct: 508 NLLFLDSSHYNQLYSLS-----TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 45/250 (18%), Positives = 94/250 (37%), Gaps = 11/250 (4%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPE--ELGYLPKLDRIQIDQNYISGSLPKS 60
NK S I + + SL L L+ N L+ S L + + N + +
Sbjct: 338 NKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSAN 394
Query: 61 FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
F L + +H ++++ L L+++ + N L L L+
Sbjct: 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454
Query: 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIP 178
+ N+F+ T+ ++N + L L L C L+ + L L++S N L +
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL-FLD 513
Query: 179 PGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236
+ +++T+ S N++ + L + NNS++ I + +
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKE 572
Query: 237 TETFILDFQN 246
+ F+++ +
Sbjct: 573 QKQFLVNVEQ 582
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-33
Identities = 49/274 (17%), Positives = 93/274 (33%), Gaps = 15/274 (5%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
+P +I + S + + L+ N L +L + + + I K++ L+
Sbjct: 25 KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 127
+ + N I P S L SL +++ L + +L L L + +N
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLG----YLDLSSNQLNGSIPPGRL 182
+PA +SN++ L+ + L +Q + DL + LD+S N ++ I
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAF 201
Query: 183 S-LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRT---LNAT 237
+ + + L N + I L L + I++ L
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 238 ETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 269
N + F+ NV+ L G
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 46/271 (16%), Positives = 81/271 (29%), Gaps = 25/271 (9%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
+I K + L L+L GN + P L L+ + + ++
Sbjct: 65 RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
Query: 62 ANLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL----L 116
L + ++ +N I ++P S L +LVH+ L N + +L L + L
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLN 174
L + N I KL +L+LR + L + L L +
Sbjct: 185 SLDMSLNPI--DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 175 G---------SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 225
SI G + I +L+ F L + + +A S+ +
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE 301
Query: 226 SSIWQSRTLNATETFILDFQNNNLTNISGSF 256
+ L L
Sbjct: 302 DVPKHFKWQ------SLSIIRCQLKQFPTLD 326
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-25
Identities = 49/308 (15%), Positives = 104/308 (33%), Gaps = 46/308 (14%)
Query: 2 WNKISG-SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLD----RIQIDQNYISGS 56
N I +P N+ +L + L+ N + +L +L + + + N I
Sbjct: 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFI 196
Query: 57 LPKSFANLNKTRHFHMNNNSISGQIPPE-------LSRLPSLVHMLLDNNNLTGYLPPEL 109
++F + + N S I L ++ D NL + P +
Sbjct: 197 QDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 110 SELPKLLILQLDNNNFEGTTI-PASYSNMSKLLKLSLRNCSLQGPMP----------DLS 158
L + I + + + ++ + +SL S++ +
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSII 315
Query: 159 R----------IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFS--G 206
R +P L L L+ N+ + S L +++ + LS N L+ + ++S G
Sbjct: 316 RCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP-SLSYLDLSRNALSFSGCCSYSDLG 374
Query: 207 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS--GSFNIPPNVTV 264
L+ L ++ N + ++ L LDFQ++ L ++ +F +
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLEELQ-----HLDFQHSTLKRVTEFSAFLSLEKLLY 428
Query: 265 -RLRGNPF 271
+
Sbjct: 429 LDISYTNT 436
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-14
Identities = 18/125 (14%), Positives = 39/125 (31%), Gaps = 1/125 (0%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKS 60
+ + SL L + GN + L + + + +
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
F L++ + +M++N++ ++L SL + N + L L
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552
Query: 121 DNNNF 125
NN+
Sbjct: 553 TNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 19/119 (15%), Positives = 36/119 (30%), Gaps = 30/119 (25%)
Query: 175 GSIPPGRLSLNITTIKLSNNKLTGTIPSN----------------------FSGLPRLQR 212
GS+ P + T + + KL+ +P + FS LQ
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 213 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 269
L ++ + + L+ L N + + S GSF+ ++
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLS-----NLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 48/269 (17%), Positives = 98/269 (36%), Gaps = 25/269 (9%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
+I + N ++ + + L +L + + + N +S A K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 127
++++N + +L L +L + L+NN + EL P + L NNN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-- 111
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-- 184
+ + S + L N + D + YLDL N+++ ++ L+
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS 168
Query: 185 -NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243
+ + L N + + +L+ L +++N L+ + + + +
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-----WIS 220
Query: 244 FQNNNLTNISGSFNIPPNVTV-RLRGNPF 271
+NN L I + N+ LRGN F
Sbjct: 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-32
Identities = 48/254 (18%), Positives = 97/254 (38%), Gaps = 23/254 (9%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+ + ++ + +++ L L+GN L+ +L KL+ + + N +
Sbjct: 20 SSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLE 77
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+L+ R +NNN + EL PS+ + NNN++ + + L N
Sbjct: 78 SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 123 NNFEGTTIPA-SYSNMSKLLKLSLRNCSLQG-PMPDL-SRIPNLGYLDLSSNQLNGSIPP 179
N T + S++ L L+ + +L + L +L+L N + +
Sbjct: 130 NKI--TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
Query: 180 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239
+ + T+ LS+NKL + F + + + NN L I ++ S+ L
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE---- 240
Query: 240 FILDFQNNNLTNIS 253
D + N +
Sbjct: 241 -HFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 39/270 (14%), Positives = 76/270 (28%), Gaps = 14/270 (5%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N + E+ S+E L N ++ + I + N I+
Sbjct: 90 NYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEG 141
Query: 63 NLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
++ ++ + N I + +L H+ L N + + ++ KL L L
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLS 199
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
+N + + + + + +SLRN L L NL + DL N +
Sbjct: 200 SNKL--AFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
S N ++ + N + L E +
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL 317
Query: 242 LDFQNNNLTNI-SGSFNIPPNVTVRLRGNP 270
L Q + + N +
Sbjct: 318 LSGQGSETERLECERENQARQREIDALKEQ 347
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 42/284 (14%), Positives = 84/284 (29%), Gaps = 35/284 (12%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTG-SLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
NKI+ + G ++ L L NE+ + E L+ + + N+I +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ- 187
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
K + +++N ++ + PE + + L NN L + L L L
Sbjct: 188 VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLR-----------------------NCSLQGPMPDLS 158
N F T+ +S ++ ++ + C P P
Sbjct: 246 GNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
Query: 159 RIPNLGYLDLSSNQLNGS----IPPGRLSLN-ITTIKLSNNKLTGTIPSNFSGLPRLQRL 213
R+ L + + GS + R + I + I L
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITL 365
Query: 214 FIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 257
+L + + L+ T + L + + +
Sbjct: 366 EQKKKALDEQVSNGRRAHAELDGTLQQAV--GQIELQHATEEQS 407
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 26/264 (9%), Positives = 73/264 (27%), Gaps = 37/264 (14%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNEL-TGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
NK+ I K + ++LE L GN G+L + ++ + + + ++
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVKKLTGQNE 280
Query: 62 ANLNKTRHFHMNNNSIS----------------------------GQIPPELSRLPSLVH 93
H ++ E
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 94 MLLDNNNLTGYLPPELSE-LPKLLILQLDNNNFEG--TTIPASYSNMSKLLKLSLRNCSL 150
+ + +++ + L+ + + +++ + L+ ++ L
Sbjct: 341 IDALKEQYRT-VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIEL 399
Query: 151 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 210
Q + S + L + ++ + + I + +K T N
Sbjct: 400 QHATEEQSPLQLLRAIVKRYEEMYVEQQSVQ-NNAIRDWDMYQHKETQLAEENARLKKLN 458
Query: 211 QRLFIANNSLSGSIPSSIWQSRTL 234
+A S + ++ + + + L
Sbjct: 459 GEADLALASANATLQELVVREQNL 482
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 70/275 (25%), Positives = 111/275 (40%), Gaps = 39/275 (14%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+G+G YG VY G L + +A+K E + + EI L H+N+V +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SF 88
Query: 578 EEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPVF 634
E + ++ E + G+L L +K PL + G+ YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 635 HRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693
HRDIK N+L++ K++DFG S+ + GI P + GT Y+ PE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 694 HKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP- 750
+D++SLG +E+ TG P MF V G +P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------AMFKV--GMFKVHPE 246
Query: 751 -----SECVEKFIKLALKCCQDETDARPSMSEVMR 780
S + FI KC + + D R ++++
Sbjct: 247 IPESMSAEAKAFIL---KCFEPDPDKRACANDLLV 278
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 37/279 (13%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRL--HHRNLVSLV 573
QIG GG KV++ + + A+K + + EI +L++L H ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
Y + +V E N L L K + + +H +
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 129
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 689
H D+K +N L+ K+ DFG++ ++ + V GT Y+ PE
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 690 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 234
Query: 743 DGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
D N +P + + C + + R S+ E++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-34
Identities = 50/269 (18%), Positives = 104/269 (38%), Gaps = 21/269 (7%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
NKI+ + N+ +L L LN + ++ L L K+ + + N+ S
Sbjct: 97 TNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPL 151
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
+N+ + + + + ++ L L + L+ N + L+ L L
Sbjct: 152 SNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAY 207
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
N T I +NM++L L + N + + L+ + L +L++ +NQ++
Sbjct: 208 VNQI--TDIT-PVANMTRLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQISDINAVKD 263
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
L+ + + + +N+++ S + L +L LF+ NN L I L
Sbjct: 264 LT-KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT-----T 315
Query: 242 LDFQNNNLTNISGSFNIPPNVTVRLRGNP 270
L N++T+I ++ +
Sbjct: 316 LFLSQNHITDIRPLASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-34
Identities = 51/252 (20%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
++ + ++S+ L++ G ++ + + YL L+ + ++ N I+ P +
Sbjct: 32 ASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LS 85
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
NL K + ++ N I+ L L +L + L+ +N++ L+ L K+ L L
Sbjct: 86 NLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGA 141
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
N+ + + SNM+ L L++ ++ + ++ + +L L L+ NQ+ P L
Sbjct: 142 NHN--LSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSLNYNQIEDISPLASL 198
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
+ ++ N++T P + + RL L I NN ++ P + N ++ L
Sbjct: 199 T-SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLA-------NLSQLTWL 248
Query: 243 DFQNNNLTNISG 254
+ N +++I+
Sbjct: 249 EIGTNQISDINA 260
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-33
Identities = 54/248 (21%), Positives = 101/248 (40%), Gaps = 21/248 (8%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+ IS P + N+ + L L N S L + L+ + + ++ + P A
Sbjct: 120 DNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IA 174
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
NL +N N I P L+ L SL + N +T ++ + +L L++ N
Sbjct: 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGN 230
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
N T + +N+S+L L + + + + L L++ SNQ++ L
Sbjct: 231 NKI--TDLSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISDISVLNNL 286
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
S + ++ L+NN+L GL L LF++ N ++ P + + ++
Sbjct: 287 S-QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA-------SLSKMDSA 338
Query: 243 DFQNNNLT 250
DF N +
Sbjct: 339 DFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 23/253 (9%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
K++ SI I + +LE L LNGN++T L L KL + I N I+ +
Sbjct: 53 GEKVA-SIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISAL 106
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
NL R ++N ++IS L+ L + + L N+ LS + L L +
Sbjct: 107 QNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVT 163
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
+ + +N++ L LSL ++ + L+ + +L Y NQ+ P
Sbjct: 164 ESKV--KDVTP-IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITPVAN 219
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
++ + ++K+ NNK+T P + L +L L I N +S +++ L +
Sbjct: 220 MT-RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLK-----M 269
Query: 242 LDFQNNNLTNISG 254
L+ +N +++IS
Sbjct: 270 LNVGSNQISDISV 282
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 37/193 (19%), Positives = 68/193 (35%), Gaps = 17/193 (8%)
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
A+L + + S++ L S+ +++ + + L L L L+
Sbjct: 19 ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLN 74
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
N T I SN+ KL L + + L + NL L L+ + ++ P
Sbjct: 75 GNQI--TDISP-LSNLVKLTNLYIGTNKITDI-SALQNLTNLRELYLNEDNISDISPLAN 130
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
L+ + ++ L N + S S + L L + + + P I L
Sbjct: 131 LT-KMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLY-----S 181
Query: 242 LDFQNNNLTNISG 254
L N + +IS
Sbjct: 182 LSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-15
Identities = 28/175 (16%), Positives = 64/175 (36%), Gaps = 25/175 (14%)
Query: 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP 155
+ P ++L + + L + T + + + KL + + +
Sbjct: 7 TLPAPINQIFP--DADLAEGIRAVLQKASV---TDVVTQEELESITKLVVAGEKVAS-IQ 60
Query: 156 DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 215
+ + NL YL+L+ NQ+ P L +T + + NK+ T S L L+ L++
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISPLSNLV-KLTNLYIGTNKI--TDISALQNLTNLRELYL 117
Query: 216 ANNSLSGSIPSSIWQS-RTL----NATETFI-----------LDFQNNNLTNISG 254
+++S P + +L N + + L + + +++
Sbjct: 118 NEDNISDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP 172
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 61/292 (20%), Positives = 106/292 (36%), Gaps = 39/292 (13%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRN 568
+F +G+GG+G V++ D A+KR + + + +E + E++ L++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 569 LVSLVGYCDEEGEQM------------LVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIA 615
+V E+ + + L+D ++ + E ++ L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 616 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR-------LAPVPDIE 668
L + + +LH + HRD+K SNI KV DFGL V
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVRE 728
H V GT Y+ PE + + K D++SLG++ ELL P S VR
Sbjct: 182 PAYARHTGQV--GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236
Query: 729 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ V + ++ + RP ++
Sbjct: 237 LTD---------VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 58/307 (18%)
Query: 504 GEMALATN---NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR--AQEGSLQGEKEFLTE 557
G M + + F+ +IG G +G V+K + DG + A+KR E+ L E
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 558 IQFLSRL-HHRNLVSLVGYCDEEGEQMLVY-EFMSNGTLRDQLSAKSKEPLGF--AMRLS 613
+ + L H ++V E + ML+ E+ + G+L D +S + F A
Sbjct: 61 VYAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------------KFTAKVA 654
+ L RG+ Y+H+ + + H DIK SNI + K K+
Sbjct: 120 LLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELL 713
D G P V +G +L E + K+D+++L + +
Sbjct: 177 DLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225
Query: 714 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARP 773
+G + G + P ++F +L + + RP
Sbjct: 226 GAEPLPRNG-------------DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP 272
Query: 774 SMSEVMR 780
S +++
Sbjct: 273 SAMALVK 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 58/270 (21%), Positives = 103/270 (38%), Gaps = 36/270 (13%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRL-HHRNLVSL 572
++G G YG+V+K DG + AVKR+ +G K+ L E+ ++ H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 573 VGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
EEG + L E +L+ L A + + +LH++
Sbjct: 123 EQ-AWEEGGILYLQTEL-CGPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
+ H D+K +NI L + K+ DFGL + A V +G P Y+ PE
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVE--------LGTAGAGEVQEGDPRYMAPE-L 227
Query: 692 LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-GSYP 750
L +DV+SLG+ LE+ M+ + + G + +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL-------------PHGGEGWQQLRQGYLPPEFT 274
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + + + + + R + ++
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-33
Identities = 66/297 (22%), Positives = 118/297 (39%), Gaps = 34/297 (11%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N+I E + LE L LN N ++ P L L + + N + F
Sbjct: 42 NRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT 101
Query: 63 NLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQL 120
L+ ++ N I + + L +L + + +N+L Y+ S L L L L
Sbjct: 102 GLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTL 159
Query: 121 DNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIP 178
+ N T+IP + S++ L+ L LR+ ++ R+ L L++S ++
Sbjct: 160 EKCNL--TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217
Query: 179 PGRLS-LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS----R 232
P L LN+T++ +++ LT +P L L+ L ++ N +S +I S+ +
Sbjct: 218 PNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQ 275
Query: 233 TLN---------ATETF-------ILDFQNNNLTNIS-GSFNIPPN-VTVRLRGNPF 271
+ F +L+ N LT + F+ N T+ L NP
Sbjct: 276 EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 40/227 (17%), Positives = 92/227 (40%), Gaps = 15/227 (6%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKS 60
NKI + + ++ +L+ L + N+L + L L+++ +++ ++ ++
Sbjct: 114 NKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171
Query: 61 FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
++L+ + + +I+ I RL L + + + + P L L
Sbjct: 172 LSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLS 230
Query: 120 LDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSI 177
+ + N T +P + ++ L L+L + L + L + L QL +
Sbjct: 231 ITHCNL--TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VV 287
Query: 178 PPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLS 221
P + + +S N+LT T+ + F + L+ L + +N L+
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 20/107 (18%), Positives = 40/107 (37%), Gaps = 11/107 (10%)
Query: 166 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 225
+ + ++P G + + L N++ F+ P L+ L + N +S ++
Sbjct: 16 VLCHRKRFV-AVPEG-IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVE 72
Query: 226 SSIWQS-RTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 269
+ + L L ++N L I G F N+T + N
Sbjct: 73 PGAFNNLFNLR-----TLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 51/259 (19%), Positives = 91/259 (35%), Gaps = 26/259 (10%)
Query: 8 SIPKEIGNIKSLEL--LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 65
+ + + L L L P++ L L + ID + LP +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL---------SELPKLL 116
+ N + +P ++ L L + + LP L L L
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176
L+L+ ++PAS +N+ L L +RN L P + +P L LDL +
Sbjct: 187 SLRLEWTGI--RSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244
Query: 177 IPP--GRLSLNITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 233
PP G + + + L + + L T+P + L +L++L + +PS I Q
Sbjct: 245 YPPIFGGRA-PLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 234 LNATETFILDFQNNNLTNI 252
I+ + +
Sbjct: 303 NC-----IILVPPHLQAQL 316
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 43/257 (16%), Positives = 89/257 (34%), Gaps = 22/257 (8%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYL--PKLDRIQIDQNYISGSLPKSFANLN 65
N + ++ G L + + L P +++ + P L+
Sbjct: 47 HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104
Query: 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN- 124
+H ++ + ++P + + L + L N L LP ++ L +L L +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPE 162
Query: 125 -------FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177
T + + L L L ++ ++ + NL L + ++ L+ ++
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-AL 221
Query: 178 PP--GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
P L + + L P F G L+RL + + S ++P I + L
Sbjct: 222 GPAIHHLP-KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL- 279
Query: 236 ATETFILDFQNNNLTNI 252
E L NL+ +
Sbjct: 280 --EKLDLR-GCVNLSRL 293
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 43/184 (23%), Positives = 73/184 (39%), Gaps = 16/184 (8%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELG---------YLPKLDRIQIDQNY 52
N + ++P I ++ L L + LPE L L L ++++
Sbjct: 136 RNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
Query: 53 ISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSEL 112
I SLP S ANL + + N+ +S + P + LP L + L PP
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 113 PKLLILQL-DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSS 170
L L L D +N T+P +++L KL LR C +P ++++P + +
Sbjct: 253 APLKRLILKDCSNL--LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310
Query: 171 NQLN 174
+
Sbjct: 311 HLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 39/261 (14%), Positives = 75/261 (28%), Gaps = 48/261 (18%)
Query: 7 GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 66
GS + E L G+ + L + ++ AN N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 67 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 126
+ ++ L P + L+L +
Sbjct: 58 PQIETRTGRALK-ATADLLEDA----------------------TQPGRVALELRSVPL- 93
Query: 127 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP--GRLSL 184
P +S L +++ L + + L L L+ N L ++P L+
Sbjct: 94 -PQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLN- 150
Query: 185 NITTIKLS-NNKLT--------GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
+ + + +LT GL LQ L + + S+P+SI + L
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209
Query: 236 ATETFILDFQNNNLTNISGSF 256
L +N+ L+ + +
Sbjct: 210 -----SLKIRNSPLSALGPAI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 22/115 (19%), Positives = 46/115 (40%), Gaps = 6/115 (5%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQI-DQNYISGSLPKSF 61
+ +S ++ I ++ LE L L G + P G L R+ + D + + +LP
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDI 273
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN---NLTGYLPPELSELP 113
L + + ++P +++LP+ +L+ + L + P P
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 64/340 (18%), Positives = 119/340 (35%), Gaps = 47/340 (13%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNL--VSLV 573
QIG GG KV++ + + A+K + + EI +L++L + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
Y + +V E N L L K + + +H +
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE--AVHTIHQHG---I 176
Query: 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE---- 689
H D+K +N L+ K+ DFG++ ++ + V G Y+ PE
Sbjct: 177 VHSDLKPANFLIVDG-MLKLIDFGIANQ-----MQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 690 -------YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
K++ KSDV+SLG + + G P N + + + ++I
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 281
Query: 743 DGN----MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIWNMMPESDTKT 796
D N P + ++ +K C + + R S+ E++ ++ + + + T
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 338
Query: 797 PEFINS--EHTSKEETPPSSSSMLKHPYVSSDVSGSNLVS 834
E + +P S K Y S+ S
Sbjct: 339 TEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSS 378
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-33
Identities = 65/321 (20%), Positives = 120/321 (37%), Gaps = 41/321 (12%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 575
+ +GG+ VY+ + G A+KR + + + E+ F+ +L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 576 C-------DEEGEQMLVYEFMSNGTLRDQL-SAKSKEPLGFAMRLSIALGSSRGILYLHT 627
D + L+ + G L + L +S+ PL L I + R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV-----VKGT 682
PP+ HRD+K N+LL ++ T K+ DFG + + V T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 683 PGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739
P Y PE + + +K D+++LG + L P ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--------------FEDGAKL 259
Query: 740 SVIDGN--MGSYP--SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 795
+++G + + I+ Q + R S++EV+ +L+ I + K
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEI-AAARNVNPK 315
Query: 796 TPEFINSEHTSKEETPPSSSS 816
+P E + S
Sbjct: 316 SPITELLEQNGGYGSATLSRG 336
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 66/313 (21%), Positives = 123/313 (39%), Gaps = 33/313 (10%)
Query: 519 IGQGGYGKVYKGIL-PDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+G G G V+K P G V+A K E + + E+Q L + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
+GE + E M G+L L K + + +++ +G+ YL + + HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHR 156
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
D+K SNIL++ + K+ DFG+S ++ + ++ V GT Y+ PE
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 697 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756
+ +SD++S+G+ +E+ G PI + + + + +E +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIP-----------PPDAKELELMFGCQVEGDAAETPPR 256
Query: 757 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTP------EFINSEHTSKEET 810
+ D+RP M+ + L+ I N P +F+N
Sbjct: 257 PRTPGRPLNKFGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 811 PPSSSSMLKHPYV 823
++ H ++
Sbjct: 316 RADLKQLMVHAFI 328
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 53/265 (20%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
+PK++ LL L N++T + L L + + N IS P +FA L K
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFE 126
+++ N + ++P ++ +L + + N +T + + L ++++++L N +
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 127 GTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-- 183
+ I ++ M KL + + + ++ L P+L L L N++ + L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKIT-KVDAASLKGL 215
Query: 184 LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
N+ + LS N ++ + + + P L+ L + NN L +P + + + ++
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-----VV 268
Query: 243 DFQNNNLTNISGSFNIPPNVTVRLR 267
NNN++ I + PP +
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 52/251 (20%), Positives = 93/251 (37%), Gaps = 42/251 (16%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
NKIS I + LE L L+ N+L LPE++ L +++ +N I+ F
Sbjct: 86 NKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVF 141
Query: 62 ANLNKTRHFHMNNNSI-SGQIPPE-LSRLPSLVHMLLDNNNLTG---YLPPELSEL---- 112
LN+ + N + S I + L ++ + + N+T LPP L+EL
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG 201
Query: 113 --------------PKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDL 157
L L L N+ + + S +N L +L L N L L
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSI--SAVDNGSLANTPHLRELHLNNNKLVKVPGGL 259
Query: 158 SRIPNLGYLDLSSNQLNGSIPPGRLSL--------NITTIKLSNNKLTGT-IPSN-FSGL 207
+ + + L +N ++ +I + + + L +N + I + F +
Sbjct: 260 ADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 208 PRLQRLFIANN 218
+ + N
Sbjct: 319 YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 26/111 (23%), Positives = 39/111 (35%), Gaps = 14/111 (12%)
Query: 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 220
+L + S L +P L + + L NNK+T I F L L L + NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKD-LPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKI 88
Query: 221 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 269
S I + L L N L + +P + R+ N
Sbjct: 89 S-KISPGAFAPLVKLE-----RLYLSKNQLKELPE--KMPKTLQELRVHEN 131
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 55/272 (20%), Positives = 97/272 (35%), Gaps = 26/272 (9%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKS 60
+ + +P + + + +ELL LN ++ + Y + ++ + N I P
Sbjct: 55 STMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 112
Query: 61 FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLIL 118
F N+ + N +S +P + P L + + NNNL + + L L
Sbjct: 113 FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 170
Query: 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 178
QL +N T + S + L ++ L L+ + LD S N +N +
Sbjct: 171 QLSSNRL--THVDL--SLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSIN-VVR 221
Query: 179 PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 238
+T +KL +N LT P L + ++ N L I +
Sbjct: 222 GPVNV-ELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFV----KMQR 273
Query: 239 TFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 269
L NN L ++ P + V L N
Sbjct: 274 LERLYISNNRLVALNLYGQPIPTLKVLDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 51/266 (19%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
I + + ++ E L + + + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 68 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 125
++N+ I +I + ++ + + N + YLPP +P L +L L+ N+
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 126 EGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 183
+++P + N KL LS+ N +L+ +L L LSSN+L + +
Sbjct: 130 --SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 186
Query: 184 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243
++ +S N L+ + ++ L ++NS++ + + T IL
Sbjct: 187 -SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELT-------ILK 232
Query: 244 FQNNNLTNISGSFNIPPNVTVRLRGN 269
Q+NNLT+ + N P V V L N
Sbjct: 233 LQHNNLTDTAWLLNYPGLVEVDLSYN 258
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 50/272 (18%), Positives = 108/272 (39%), Gaps = 40/272 (14%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS 60
N I +P + N+ L +L+L N+L+ SLP + PKL + + N + +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 61 FANLNKTRHFHMNNNSISGQIPP-----------------ELSRLPSLVHMLLDNNNLTG 103
F ++ +++N ++ + L+ ++ + +N++
Sbjct: 161 FQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN- 218
Query: 104 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPN 162
+ + +L IL+L +NN T N L+++ L L+ ++
Sbjct: 219 VVRGPV--NVELTILKLQHNNL--TDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQR 273
Query: 163 LGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
L L +S+N+L ++ + + + LS+N L + N RL+ L++ +NS+
Sbjct: 274 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
Query: 222 GSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253
++ S + L +N+ S
Sbjct: 332 -TLKLSTHHTLK-------NLTLSHNDWDCNS 355
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 518 QIGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRN 568
++G GG VY IL VA+K + ++E L E+ S+L H+N
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIP---PREKEETLKRFEREVHNSSQLSHQN 72
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+VS++ +E+ LV E++ TL + + +S PL ++ GI + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRDIK NIL+D T K+ DFG+++ + + V+ GT Y P
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNHVL-GTVQYFSP 181
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748
E + +D+YS+G+V E+L G P + G+ V+IA + I ++ +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFN-GET---AVSIAIKH------IQDSVPN 231
Query: 749 YPSECV----EKFIKLALKCCQDETDARP-SMSEVMRELESI 785
++ + + L+ + + R ++ E+ +L S+
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
++PKEI LL L N+++ ++ L L + + N IS K+F+ L K
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFE 126
+ +++ N + +IPP L SLV + + +N + +P S L + +++ N E
Sbjct: 105 QKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 127 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--L 184
+ + KL L + L G DL L L L N++ +I L
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYS 217
Query: 185 NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243
+ + L +N++ I + S LP L+ L + NN LS +P+ + + L ++
Sbjct: 218 KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ-----VVY 270
Query: 244 FQNNNLTNIS-GSF-------NIPPNVTVRLRGNP 270
NN+T + F + L NP
Sbjct: 271 LHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 51/251 (20%), Positives = 83/251 (33%), Gaps = 43/251 (17%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
NKIS I ++ ++ L+ L ++ N L +P L L ++I N I F
Sbjct: 88 NKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVF 143
Query: 62 ANLNKTRHFHMNNNSI-SGQIPPE----------------LSRLP-----SLVHMLLDNN 99
+ L M N + + P L+ +P +L + LD+N
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHN 203
Query: 100 NLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDL 157
+ + E L KL L L +N I S S + L +L L N L L
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQI--RMIENGSLSFLPTLRELHLDNNKLSRVPAGL 260
Query: 158 SRIPNLGYLDLSSNQLNGSIPPG--------RLSLNITTIKLSNNKLT-GTIPSN-FSGL 207
+ L + L +N + + I L NN + + F +
Sbjct: 261 PDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319
Query: 208 PRLQRLFIANN 218
+ N
Sbjct: 320 TDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 37/183 (20%), Positives = 70/183 (38%), Gaps = 19/183 (10%)
Query: 2 WNKI-SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
N + + + L L ++ +LT +P++L L+ + +D N I +
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELED 212
Query: 61 FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
+K + +N I I LS LP+L + LDNN L+ +P L +L L ++
Sbjct: 213 LLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270
Query: 120 LDNNNFEGTTIPAS-------YSNMSKLLKLSLRNCSLQGPM--PDL-SRIPNLGYLDLS 169
L NN T + + + +SL N + P + + +
Sbjct: 271 LHTNNI--TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 170 SNQ 172
+ +
Sbjct: 329 NYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 14/111 (12%)
Query: 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 220
+L + S L ++P +S + T + L NN ++ + + F GL L L + NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKE-ISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 221 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 269
S I + R L L N+L I N+P ++ R+ N
Sbjct: 91 S-KIHEKAFSPLRKLQ-----KLYISKNHLVEIPP--NLPSSLVELRIHDN 133
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 76/315 (24%), Positives = 131/315 (41%), Gaps = 41/315 (13%)
Query: 519 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 569
+G GG +V+ VAVK RA L + F E Q + L+H +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRAD---LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 570 VSL--VGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
V++ G + + +V E++ TLRD + ++ P+ + + + + + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFS 132
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H + + HRD+K +NI++ KV DFG++R + + V GT Y
Sbjct: 133 H-QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIGTAQY 185
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ--SSMMFSVID 743
L PE + +SDVYSLG V E+LTG P + G + V++AYQ
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDS---PVSVAYQHVREDPIPPSA 241
Query: 744 GNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWNMMPESDTKTPEFINS 802
+ G ++ + LK + R + +E+ +L + N P K ++
Sbjct: 242 RHEGLSAD--LDAVV---LKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT--DA 294
Query: 803 EHTSKEETPPSSSSM 817
E TS + + S
Sbjct: 295 ERTSLLSSAAGNLSG 309
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 55/265 (20%), Positives = 96/265 (36%), Gaps = 30/265 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+G+G +G+V++ G AVK+ + + E E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 578 EEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
E + E + G+L + E L AL G+ YLHT + H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-ALYYLGQAL---EGLEYLHTRR---ILH 173
Query: 636 RDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
D+KA N+LL A + DFG + + + + GT ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVVMGK 231
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN--MGSYPSE 752
K D++S + L +L G P + ++ + + + P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQ----------YFRGPLCLKIASEPPPIREIPPS 281
Query: 753 CVEKFIKLALKCCQDETDARPSMSE 777
C + + + E R S E
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAME 306
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 57/248 (22%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
+P I + LL L+ N++ +L L+ +Q+ +N+I +F L
Sbjct: 57 EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 68 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 125
+ +N ++ IP L L + L NN + +P + +P L L L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK- 171
Query: 126 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS- 183
+ I ++ +S L L+L C+L+ +P+L+ + L LDLS N L+ +I PG
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS-AIRPGSFQG 229
Query: 184 -LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
+++ + + +++ I N F L L + +A+N+L+ +P ++ L+ E
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTP--LHHLER-- 283
Query: 242 LDFQNNNL 249
+ +N
Sbjct: 284 IHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
+P+ I + L L N + + +L L+ +Q+ +N I +F L
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 68 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 125
+ +N ++ IP L L + L NN + +P + +P L+ L L
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK- 182
Query: 126 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS- 183
+ I ++ + L L+L C+++ MP+L+ + L L++S N I PG
Sbjct: 183 KLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFP-EIRPGSFHG 240
Query: 184 -LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
++ + + N++++ I N F GL L L +A+N+LS S+P ++ L
Sbjct: 241 LSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTP--LRYLVE-- 294
Query: 242 LDFQNNNL 249
L +N
Sbjct: 295 LHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 11/114 (9%)
Query: 161 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 220
+ + L+ +P G + N + L N + F L L+ L + NS+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQG-IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 221 SGSIPSSI-WQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 271
I +LN L+ +N LT I SG+F + LR NP
Sbjct: 112 R-QIEVGAFNGLASLN-----TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 519 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLT----EIQFLSRLHHRNL 569
+G+GG G VY+ + +VA+K L + F T E + RL ++
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMSET---LSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
V + + + +G+ + ++ L L + + PL ++I + H A
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH-AA 153
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
HRD+K NIL+ A + DFG++ + + V GT Y+ PE
Sbjct: 154 G--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNTV-GTLYYMAPE 205
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
F T ++D+Y+L V E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 60/253 (23%), Positives = 101/253 (39%), Gaps = 25/253 (9%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
I + + +L + + N+LT L L KL I ++ N I+
Sbjct: 55 RLGIK--SIDGVEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIAD--ITPL 108
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
ANL + NN I+ L L +L + L +N ++ LS L L L
Sbjct: 109 ANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG 164
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
N T +N++ L +L + + + L+++ NL L ++NQ++ P G
Sbjct: 165 NQV----TDLKPLANLTTLERLDISSNKVSDI-SVLAKLTNLESLIATNNQISDITPLGI 219
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
L+ N+ + L+ N+L + L L L +ANN +S P + L
Sbjct: 220 LT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLT-----E 269
Query: 242 LDFQNNNLTNISG 254
L N ++NIS
Sbjct: 270 LKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-30
Identities = 72/269 (26%), Positives = 112/269 (41%), Gaps = 25/269 (9%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N IS + + SL+ L N++T P L L L+R+ I N +S A
Sbjct: 144 NTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLA 196
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
L NN IS P L L +L + L+ N L L+ L L L L N
Sbjct: 197 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 252
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
N + + S ++KL +L L + + L+ + L L+L+ NQL P L
Sbjct: 253 NQI--SNLAP-LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNL 308
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
N+T + L N ++ P S L +LQRLF NN +S SS+ +N L
Sbjct: 309 K-NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNIN-----WL 358
Query: 243 DFQNNNLTNISGSFNIPPNVTVRLRGNPF 271
+N +++++ N+ + L +
Sbjct: 359 SAGHNQISDLTPLANLTRITQLGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 43/219 (19%), Positives = 85/219 (38%), Gaps = 15/219 (6%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N++ + ++ +L L L N+++ L L KL +++ N IS P A
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISP--LA 284
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
L + +N N + +S L +L ++ L NN++ +S L KL L N
Sbjct: 285 GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYN 340
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
N + +S +N++ + LS + + + L+ + + L L+ + +
Sbjct: 341 NKV---SDVSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
+++I + P+ S I N S
Sbjct: 397 NVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-20
Identities = 41/195 (21%), Positives = 77/195 (39%), Gaps = 19/195 (9%)
Query: 60 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
+ L + + +++ + + L + + D + + L L +
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74
Query: 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 179
NN T I N++KL+ + + N + L+ + NL L L +NQ+ P
Sbjct: 75 FSNNQL--TDITP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITDIDPL 130
Query: 180 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239
L+ N+ ++LS+N ++ S SGL LQ+L N + TL
Sbjct: 131 KNLT-NLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLE---- 180
Query: 240 FILDFQNNNLTNISG 254
LD +N +++IS
Sbjct: 181 -RLDISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 18/128 (14%), Positives = 44/128 (34%), Gaps = 7/128 (5%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
NK+S + N+ ++ L N+++ L L ++ ++ ++ + + A
Sbjct: 341 NKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
N++ ++ P +S S + N + Y + + +
Sbjct: 397 NVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGT 453
Query: 123 NNFEGTTI 130
F GT
Sbjct: 454 TTFSGTVT 461
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 71/314 (22%), Positives = 118/314 (37%), Gaps = 53/314 (16%)
Query: 488 SSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ-E 545
S +KI + + + +IG+G YG V K + P G ++AVKR +
Sbjct: 4 ESSGKLKISPEQHWD-----FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 546 GSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE 604
+ +K+ L ++ + R +V G EG+ + E MS + S
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 605 PLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS-RL 661
+ I L + + + +L + HRDIK SNILLD K+ DFG+S +L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 662 APVPDIEGIVPAHVSTVVK----GTPGYLDPEYFLTHKLTD----KSDVYSLGVVFLELL 713
V ++ K G Y+ PE +SDV+SLG+ EL
Sbjct: 177 -------------VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 714 TGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK-------FIKLALKCCQ 766
TG P ++ + V+ G+ + + F+ C
Sbjct: 224 TGRFPYPKWNSVFD---------QLTQVVKGDPPQLSNSEEREFSPSFINFVN---LCLT 271
Query: 767 DETDARPSMSEVMR 780
+ RP E+++
Sbjct: 272 KDESKRPKYKELLK 285
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 45/265 (16%), Positives = 101/265 (38%), Gaps = 23/265 (8%)
Query: 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 77
S + N LT S+P + R++++ N + F L + +++N +
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 78 SGQ--IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-- 133
S + SL ++ L N + + L +L L ++N +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL--KQMSEFSV 121
Query: 134 YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIK 190
+ ++ L+ L + + + + + +L L ++ N + P + N+T +
Sbjct: 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 191 LSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 249
LS +L + F+ L LQ L +++N+ S+ + ++ +LD+ N++
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK----CLNSLQVLDYSLNHI 235
Query: 250 TNISGS--FNIPPN-VTVRLRGNPF 271
+ P + + L N F
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 47/252 (18%), Positives = 93/252 (36%), Gaps = 22/252 (8%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS--GSLPKSFANLN 65
S+P I S L L N+L L +L ++ + N +S G +S
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNN 123
++ ++ N + + L L H+ ++NL + L L+ L + +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 124 NFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPG 180
+ ++ +S L L + S Q + + NL +LDLS QL + P
Sbjct: 137 HT--RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193
Query: 181 RLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 237
+ ++ + +S+N ++ + + L LQ L + N + + Q +
Sbjct: 194 AFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLA 251
Query: 238 ETFILDFQNNNL 249
L+ N+
Sbjct: 252 F---LNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 40/230 (17%), Positives = 87/230 (37%), Gaps = 15/230 (6%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELT--GSLPEELGYLPKLDRIQIDQNYISGSLPK 59
NK+ + L L L+ N L+ G + L + + N + ++
Sbjct: 37 SNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS 95
Query: 60 SFANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLL 116
+F L + H ++++ Q+ L +L+++ + + + + L L
Sbjct: 96 NFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLE 153
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG 175
+L++ N+F+ +P ++ + L L L C L+ P + + +L L++S N
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF- 212
Query: 176 SIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPR-LQRLFIANNSLS 221
S+ ++ + S N + T P L L + N +
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-30
Identities = 56/272 (20%), Positives = 99/272 (36%), Gaps = 26/272 (9%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKS 60
+ + +P + + + +ELL LN ++ + Y + ++ + N I P
Sbjct: 61 STMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 118
Query: 61 FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLIL 118
F N+ + N +S +P + P L + + NNNL + + L L
Sbjct: 119 FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 176
Query: 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 178
QL +N T + S + L ++ L L+ + LD S N +N +
Sbjct: 177 QLSSNRL--THVDL--SLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSIN-VVR 227
Query: 179 PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 238
+T +KL +N LT P L + ++ N L I + + E
Sbjct: 228 GPVNV-ELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK--MQRLE 281
Query: 239 TFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 269
L NN L ++ P + V L N
Sbjct: 282 R--LYISNNRLVALNLYGQPIPTLKVLDLSHN 311
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 57/273 (20%), Positives = 109/273 (39%), Gaps = 28/273 (10%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS 60
N I +P + N+ L +L+L N+L+ SLP + PKL + + N + +
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
F ++ +++N ++ + S +PSL H + N L+ L+ + L
Sbjct: 167 FQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 218
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
+N+ + +L L L++ +L L P L +DLS N+L I
Sbjct: 219 SHNSI--NVVRGP--VNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYH 272
Query: 181 RLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATE 238
+ + +SNN+L + +P L+ L +++N L + + Q L
Sbjct: 273 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE--- 327
Query: 239 TFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 271
L +N++ + S + L N +
Sbjct: 328 --NLYLDHNSIVTLKLS-THHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 47/256 (18%), Positives = 97/256 (37%), Gaps = 23/256 (8%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
I + + ++ E L + + + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 68 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 125
++N+ I +I + ++ + + N + YLPP +P L +L L+ N+
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 126 EGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 183
+++P + N KL LS+ N +L+ +L L LSSN+L + +
Sbjct: 136 --SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 192
Query: 184 LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243
++ +S N L+ + ++ L ++NS++ + + T IL
Sbjct: 193 -SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELT-------ILK 238
Query: 244 FQNNNLTNISGSFNIP 259
Q+NNLT+ + N P
Sbjct: 239 LQHNNLTDTAWLLNYP 254
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-23
Identities = 54/253 (21%), Positives = 97/253 (38%), Gaps = 27/253 (10%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
N + I + SL+ L L+ N LT + L +P L + N +S +
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TL 207
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
A ++NSI+ + + L + L +NNLT L P L+ + L
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLS 262
Query: 122 NNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
N I + M +L +L + N L IP L LDLS N L +
Sbjct: 263 YNEL--EKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERN 319
Query: 181 RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS----IPSSIWQSRTLN 235
+ + + L +N + T+ S L+ L +++N + + ++ + +
Sbjct: 320 QPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDD 376
Query: 236 ATETFILDFQNNN 248
A + +D+Q +
Sbjct: 377 ADQHCKIDYQLEH 389
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-30
Identities = 64/310 (20%), Positives = 108/310 (34%), Gaps = 48/310 (15%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYL--------------PKLDRIQI 48
N+++ S+P + L + L +LP L L P L + +
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSV 148
Query: 49 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 108
N ++ SLP + L NN ++ +P S L + + +N L LP
Sbjct: 149 SDNQLA-SLPALPSEL---CKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTL 199
Query: 109 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDL 168
SEL KL NN T++PA S L +L + L +P L L L +
Sbjct: 200 PSELYKL---WAYNNRL--TSLPAL---PSGLKELIVSGNRLTS-LPVL--PSELKELMV 248
Query: 169 SSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 228
S N+L S+P L ++ + N+LT +P + L + + N LS
Sbjct: 249 SGNRLT-SLPMLPSGL--LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQA 303
Query: 229 WQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD 288
+ T + + + P T L A + + +D
Sbjct: 304 LREITS-------APGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRW 356
Query: 289 NEIDRSTNST 298
+ + N+
Sbjct: 357 HMFGQEDNAD 366
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 57/300 (19%), Positives = 99/300 (33%), Gaps = 88/300 (29%)
Query: 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS 76
+L + + LT +LP+ L + +N+
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLP--------------------------AHITTLVIPDNN 72
Query: 77 ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG--------- 127
++ +P L +L + N LT LP L +L I +
Sbjct: 73 LT-SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLW 127
Query: 128 ------TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
T++P L +LS+ + L +P L L L +NQL S+P
Sbjct: 128 IFGNQLTSLPVLPPG---LQELSVSDNQLAS-LPAL--PSELCKLWAYNNQLT-SLPMLP 180
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRL-----------------QRLFIANNSLSGSI 224
L + +S+N+L ++P+ S L +L + L ++ N L+ S+
Sbjct: 181 SGL--QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SL 236
Query: 225 PSSIWQSRTLNATETFI------------LDFQNNNLTNISGSFNIPPNVTV-RLRGNPF 271
P + + L + + L N LT + S + T L GNP
Sbjct: 237 PVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPL 296
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-30
Identities = 43/210 (20%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 519 IGQGGYGKVYKG---ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL- 572
I GG G +Y + +G V +K G + + + E QFL+ + H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 573 -VGYCDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+ + Y E++ +L+ + L A ++ L + YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ + D+K NI+L + K+ D G + GTPG+ P
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----------NSFGYLY-GTPGFQAP 246
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
E + T +D+Y++G L +
Sbjct: 247 EI-VRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 48/281 (17%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQF-LSRLHHRNLVSLVGY 575
+G+G YG V K +P G ++AVKR + Q +K L ++ + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPV 633
EG+ + E M + +L + + IA+ + + +LH++ V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 634 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDP 688
HRD+K SN+L++ K+ DFG+S L V V K G Y+ P
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL-------------VDDVAKDIDAGCKPYMAP 178
Query: 689 EYFLTHKLTD----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
E KSD++SLG+ +EL P + + V++
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------QLKQVVEE 229
Query: 745 NM-----GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ +E V+ F +C + + RP+ E+M+
Sbjct: 230 PSPQLPADKFSAEFVD-FTS---QCLKKNSKERPTYPELMQ 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ ++ +V E +L + + A + G YLH V
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 137
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 189
Query: 695 KLTD-KSDVYSLGVVFLELLTGMQP 718
K + DV+S+G + LL G P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 37/232 (15%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVK-----------------RAQEGSLQGEKEFLTEIQFL 561
+ QG + K+ D A+K + +F E+Q +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 562 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS-- 619
+ + + ++ G E ++YE+M N ++ + + I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 620 ----RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675
Y+H E + + HRD+K SNIL+D K++DFG S +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--------DKKI 207
Query: 676 STVVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNI 725
GT ++ PE+F + K D++SLG+ + + P S ++
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 576
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 577 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 630
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 631 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 687 DPEYFLTHKLTD--------KSDVYSLGVVFLELLTGMQP 718
P+ + L D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+GG+ K ++ V A K ++ ++ EI L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ ++ +V E +L + + A + G YLH V
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL--GCQYLHRNR---VI 163
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K N+ L+ K+ DFGL+ V+ GTP Y+ PE L+
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-------ERKKVLCGTPNYIAPE-VLSK 215
Query: 695 KLTD-KSDVYSLGVVFLELLTGMQP 718
K + DV+S+G + LL G P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-29
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 29/239 (12%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLV--- 573
+G GG+G V + I G VA+K+ ++ +E EIQ + +L+H N+VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 574 ---GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLH 626
+L E+ G LR L+ G L + S + YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISS--ALRYLH 138
Query: 627 TEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
+ HRD+K NI+L + K+ D G ++ + + T GT
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--------LDQGELCTEFVGTL 187
Query: 684 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
YL PE K T D +S G + E +TG +P V+ + S V+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 41/277 (14%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGY 575
+G G G+V+K G V+AVK+ + G+ + K L ++ + + H +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
+ + E M GT ++L + + P+ + + + + + YL + V H
Sbjct: 93 FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIH 148
Query: 636 RDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVK----GTPGYLDPEY 690
RD+K SNILLD + K+ DFG+S RL V K G Y+ PE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL-------------VDDKAKDRSAGCAAYMAPER 195
Query: 691 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
T ++DV+SLG+ +EL TG P + K ++ V+
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---------VLTKVLQEE 246
Query: 746 MGSYPSECV--EKFIKLALKCCQDETDARPSMSEVMR 780
P F C + RP ++++
Sbjct: 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-29
Identities = 68/254 (26%), Positives = 99/254 (38%), Gaps = 40/254 (15%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N + +P + LE + N+L LPE L LP L I D N + LP
Sbjct: 163 NSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPL 215
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+L NN + PEL LP L + DNN L LP P L L + +
Sbjct: 216 SL---ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRD 266
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
N T +P +++ L L PNL YL+ SSN++ S+ L
Sbjct: 267 NYL--TDLPELPQSLTFLDVSENIFSGLS------ELPPNLYYLNASSNEIR-SLCD--L 315
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
++ + +SNNKL +P+ PRL+RL + N L+ +P + L
Sbjct: 316 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQ--------L 362
Query: 243 DFQNNNLTNISGSF 256
+ N L
Sbjct: 363 HVEYNPLREFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 66/288 (22%), Positives = 106/288 (36%), Gaps = 54/288 (18%)
Query: 2 WNKISGSIPKEIGN-------------IKSLELLLLNGNELTGSLPEELGYLPKLDRIQI 48
W++ + P G + L LN L+ SLPE +L L
Sbjct: 43 WSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---A 98
Query: 49 DQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 108
N ++ LP+ +L + N ++S P L ++ + NN L PE
Sbjct: 99 SCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP-------PLLEYLGVSNNQLEKL--PE 148
Query: 109 LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDL 168
L L I+ +DNN+ +P L ++ N L+ P+L +P L +
Sbjct: 149 LQNSSFLKIIDVDNNSL--KKLP---DLPPSLEFIAAGNNQLEEL-PELQNLPFLTAIYA 202
Query: 169 SSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 228
+N L +P LSL +I NN L LP L ++ NN L ++P
Sbjct: 203 DNNSLK-KLPDLPLSL--ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLP 256
Query: 229 WQSRTLNATETFI------------LDFQNNNLTNISGSFNIPPNVTV 264
LN + ++ LD N + +S +PPN+
Sbjct: 257 PSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS---ELPPNLYY 301
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 55/273 (20%), Positives = 93/273 (34%), Gaps = 49/273 (17%)
Query: 10 PKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL----- 64
P+ + N L+ L + + LT +P E + + + P
Sbjct: 5 PRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 65 --------NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 116
+ +NN +S +P L SLV N+LT LP L LL
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLL 117
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176
+ + + +P L L + N L+ +P+L L +D+ +N L
Sbjct: 118 VDNNNLKAL--SDLP------PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLK-K 167
Query: 177 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236
+P L ++ I NN+L +P LP L ++ NNSL +P ++ A
Sbjct: 168 LPD--LPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVA 222
Query: 237 TETFI--------------LDFQNNNLTNISGS 255
+ + NN L +
Sbjct: 223 GNNILEELPELQNLPFLTTIYADNNLLKTLPDL 255
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-21
Identities = 36/219 (16%), Positives = 78/219 (35%), Gaps = 32/219 (14%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N ++ +P+ ++ L++ + L+ LP L YL N I SL
Sbjct: 267 NYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLYYL------NASSNEIR-SLCDLPP 317
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+L +++NN + ++P RL L+ N+L +P L L ++
Sbjct: 318 SL---EELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQ---NLKQLHVEY 366
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
N P + L + + + P NL L + +N L P +
Sbjct: 367 NPL--REFPDI---PESVEDLRMNSHLAEVP----ELPQNLKQLHVETNPLR-EFPD--I 414
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
++ +++++ ++ +L+ ++
Sbjct: 415 PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 34/172 (19%), Positives = 57/172 (33%), Gaps = 28/172 (16%)
Query: 81 IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 140
I P L L ++NLT +P E + + +E P ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWER-NAPPGNGEQREM 60
Query: 141 LKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI 200
LR+C + L+L++ L+ S+P L ++ ++ S N LT +
Sbjct: 61 AVSRLRDCLDR----------QAHELELNNLGLS-SLPE--LPPHLESLVASCNSLT-EL 106
Query: 201 PSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 252
P L L +LS P + L NN L +
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPLLEY------------LGVSNNQLEKL 146
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQ-EGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
IG G V P VA+KR E E L EIQ +S+ HH N+VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLS---IAL---GSSRGILYLHTEAD 630
+ E LV + +S G++ D + + + L IA G+ YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
HRD+KA NILL + ++ADFG+S LA DI T V GTP ++ PE
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK--TFV-GTPCWMAPE 196
Query: 690 YFLTHKLTD-KSDVYSLGVVFLELLTGMQPISH 721
+ D K+D++S G+ +EL TG P
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+G +G VY ++A+K +AQ E + E++ S L H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 632
Y + L+ E+ GT+ +L SK E +A + Y H++
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYCHSKR--- 129
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
V HRDIK N+LL K+ADFG S A P+ T + GT YL PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRTDLCGTLDYLPPEMIE 180
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQP 718
+K D++SLGV+ E L G P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 576
+GQG V++G G + A+K S + E + L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 577 DEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEAD 630
+E + L+ EF G+L L S G + + + G+ +L
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVG--GMNHLRENG- 132
Query: 631 PPVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ HR+IK NI+ D + K+ DFG +R + + GT YL
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEYL 182
Query: 687 DPEYF--------LTHKLTDKSDVYSLGVVFLELLTGMQP 718
P+ + K D++S+GV F TG P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 64/284 (22%), Positives = 112/284 (39%), Gaps = 40/284 (14%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRL-HH 566
+F +G G G + + D VAVKR E + E+Q L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 567 RNLVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 624
N++ +C E+ Q + E + TL++ + K LG ++ ++ G+ +
Sbjct: 78 PNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 625 LHTEADPPVFHRDIKASNILLDHK-----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
LH+ + HRD+K NIL+ A ++DFGL + G + V
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA----VGRHSFSRRSGV 186
Query: 680 KGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736
GT G++ PE T D++S G VF +++ GK++ R+ NI +
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANILLGAC 245
Query: 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + + + I+ K + RPS V++
Sbjct: 246 SLDCLHPEK---HEDVIARELIE---KMIAMDPQKRPSAKHVLK 283
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-28
Identities = 52/280 (18%), Positives = 97/280 (34%), Gaps = 25/280 (8%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
+ I E + L N +E + R+ I Q Y+ L
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 61 FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE---LSELPKLL 116
++ L K + + N+ + +P L SL + L N + P L
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 117 ILQLDNNNFEGTTIPASY---SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQL 173
L L N+ ++ + + L L + + + +L+LSS +
Sbjct: 365 TLVLSQNHL--RSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422
Query: 174 NGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 233
+ + + +SNN L + LPRLQ L+I+ N L ++P +
Sbjct: 423 R-VVKTCIPQ-TLEVLDVSNNNLD-SFSLF---LPRLQELYISRNKLK-TLPDA-SLFPV 474
Query: 234 LNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 271
L ++ N L ++ G F+ ++ + L NP+
Sbjct: 475 LL-----VMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 41/246 (16%), Positives = 86/246 (34%), Gaps = 14/246 (5%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-- 60
+ + ++ ++ + + +++ +L L+ + + +N + K+
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 61 -FANLNKTRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 117
+ ++ N + + L L +L + + N +P K+
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177
L L + + L L + N +L L P L L +S N+L ++
Sbjct: 415 LNLSSTGI--RVVKTCI--PQTLEVLDVSNNNLDSFSLFL---PRLQELYISRNKLK-TL 466
Query: 178 PPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 237
P L + +K+S N+L F L LQ++++ N S P + SR LN
Sbjct: 467 PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 526
Query: 238 ETFILD 243
Sbjct: 527 SQKEQG 532
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 45/318 (14%), Positives = 97/318 (30%), Gaps = 50/318 (15%)
Query: 2 WNKISG-SIPKEIGNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPK 59
N + N+ +L+ L + E + L L+ ++I + +
Sbjct: 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166
Query: 60 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
S ++ H ++ + + + L S+ ++ L + NL + L ++
Sbjct: 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226
Query: 120 LDNN------NFEGTTIPASYSNMSKLLKLSLRNCSLQG----------PMPDLSRI--P 161
+ + + +L ++ +C+L G + +L ++
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286
Query: 162 NLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANN 218
+ L + L SL + I + N+K+ +P + L L+ L ++ N
Sbjct: 287 TIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN 344
Query: 219 SLSG-----SIPSSIWQS-RTLN-----------ATETF-------ILDFQNNNLTNISG 254
+ S W S +TL E LD N +
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPD 404
Query: 255 SFNIPPNVTV-RLRGNPF 271
S P + L
Sbjct: 405 SCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-21
Identities = 42/261 (16%), Positives = 93/261 (35%), Gaps = 16/261 (6%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
SIP + +++ L L+ N++T +L L + + + I+ +F +L
Sbjct: 19 SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 68 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTG-YLPPELSELPKLLILQLDNNNF 125
H +++N +S + L SL ++ L N + L L L++ N
Sbjct: 77 EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 126 EGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 184
++ ++ L +L ++ SL+ L I ++ +L L ++ + +
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADI 194
Query: 185 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW------QSRTLNA 236
++ ++L + L S + S + + L
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS-VLTDESFNELLKLLRYILEL 253
Query: 237 TETFILDFQNNNLTNISGSFN 257
+E D N L + + S +
Sbjct: 254 SEVEFDDCTLNGLGDFNPSES 274
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 52/321 (16%), Positives = 107/321 (33%), Gaps = 61/321 (19%)
Query: 2 WNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG-SLPK 59
++I+ +I + ++ SLE L L+ N L+ G L L + + N +
Sbjct: 59 SSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 60 SFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 118
F NL + + N +I + L SL + + +L Y L + + L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-------------------------- 152
L + + +S + L LR+ +L
Sbjct: 178 TLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 153 -----------------PMPDLSRIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNN 194
+ G D + ++ + G++ ++ I + +
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 195 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS-RTLNATETFILDFQNNNLTNI- 252
L + + +S L +++R+ + N+ + +P S Q ++L LD N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLE-----FLDLSENLMVEEY 350
Query: 253 ---SGSFNIPPNV-TVRLRGN 269
S P++ T+ L N
Sbjct: 351 LKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 37/289 (12%), Positives = 95/289 (32%), Gaps = 22/289 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
NKI+ ++ +L++L+L + + + L L+ + + N++S F
Sbjct: 36 NKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 63 NLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQL 120
L+ ++ ++ N + L +L + + N + + L L L++
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155
Query: 121 DNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLN---- 174
+ + ++ + L+L + + ++ YL+L L
Sbjct: 156 KALSL--RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213
Query: 175 GSIPPGRLSLNITTIKLSNNKLT----GTIPSNFSGLPRLQRLFIANNSLSG------SI 224
+P +S + + + LT + + L + + +L+G S
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273
Query: 225 PSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 271
+ + + L L S +++ V + +
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 161 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 220
G D S SIP G L+ + ++ LS NK+T + LQ L + ++ +
Sbjct: 5 DASGVCDGRSRSFT-SIPSG-LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 221 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 271
+ + + +L LD +N+L+++S F ++ L GNP+
Sbjct: 63 NTIEGDAFYSLGSLE-----HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 60/320 (18%), Positives = 111/320 (34%), Gaps = 30/320 (9%)
Query: 519 IGQG--GYGKVYKGI-LPDGTVVAVKRA--QEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
IG+G V P G V V+R + S + E+ +H N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
+ E +V FM+ G+ +D + + + I G + + Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---Y 149
Query: 634 FHRDIKASNILLDHKFTAKVADFGLS-RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
HR +KAS+IL+ ++ + + + +V V +L PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLSPEVLQ 208
Query: 693 THKL--TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS-MMFSVIDGNM--- 746
+ KSD+YS+G+ EL G P ++ M+ ++G +
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKD-----------MPATQMLLEKLNGTVPCL 257
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 806
+ E+ + + + + R P T +P F +
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 807 KEETP---PSSSSMLKHPYV 823
+ P PS+S++L H +
Sbjct: 318 LQRNPDARPSASTLLNHSFF 337
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 42/220 (19%), Positives = 81/220 (36%), Gaps = 14/220 (6%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
++P I + + + L+GN ++ L + + N ++ +F L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 68 RHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNF 125
+++N+ + P L L + LD L L P L L L L +N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 126 EGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS 183
+P ++ ++ L L L + + +L L L N++ + P
Sbjct: 142 --QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
Query: 184 --LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 220
+ T+ L N L+ +P+ + L LQ L + +N
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+G + VY+ + G VA+K + + E++ +L H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK---EPLGFAMRLSIALGSSRGILYLHTEADP 631
Y ++ LV E NG + L + K E I G+LYLH+
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG-- 132
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
+ HRD+ SN+LL K+ADFGL+ +P + GTP Y+ PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-------EKHYTLCGTPNYISPE-I 183
Query: 692 LTHKLTD-KSDVYSLGVVFLELLTGMQP 718
T +SDV+SLG +F LL G P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-28
Identities = 50/262 (19%), Positives = 90/262 (34%), Gaps = 12/262 (4%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
IP + S + L L+ N L P+L + + + I ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 127
+ N I S L SL ++ NL + L L L + +N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGY----LDLSSNQLNGSIPPGRL 182
+P +SN++ L L L + +Q DL + + LDLS N +N I PG
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 183 S-LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+ + + L NN + + GL L+ + + L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN- 256
Query: 241 ILDFQNNNLTNISGSFNIPPNV 262
L + L + + ++
Sbjct: 257 -LTIEEFRLAYLDYYLDDIIDL 277
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 45/281 (16%), Positives = 91/281 (32%), Gaps = 26/281 (9%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPK 59
+ I + ++ L + L+ + K
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 60 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLI 117
S L +N LPSL + L N L+ G L
Sbjct: 326 SLKRLT------FTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNG 175
L L N T+ +++ + +L L ++ +L+ + NL YLD+S
Sbjct: 378 LDLSFNGV--ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR- 434
Query: 176 SIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSR 232
G + ++ +K++ N + F+ L L L ++ L + + +
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN-- 491
Query: 233 TLNATETFILDFQNNNLTNI-SGSFNIPPN-VTVRLRGNPF 271
+ + +L+ +N L ++ G F+ + + L NP+
Sbjct: 492 --SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 45/248 (18%), Positives = 96/248 (38%), Gaps = 36/248 (14%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELT--GSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
NK + + ++ SLE L L+ N L+ G + L + + N + ++ +
Sbjct: 335 NKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN 391
Query: 61 FANLNKTRHFHMNNNSISGQIPPE--LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLI 117
F L + H ++++ Q+ L +L+++ + + + + L L +
Sbjct: 392 FLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEV 449
Query: 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177
L++ N+F+ +P ++ + L +LDLS QL +
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLT-----------------------FLDLSQCQLE-QL 485
Query: 178 PPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
P + ++ + +++N+L F L LQ++++ N S P + SR LN
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 545
Query: 236 ATETFILD 243
Sbjct: 546 KNSQKEQG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-24
Identities = 49/283 (17%), Positives = 105/283 (37%), Gaps = 24/283 (8%)
Query: 2 WNKI-SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLD----RIQIDQNYISGS 56
N I S +P+ N+ +LE L L+ N++ +L L ++ + + N ++
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 57 LPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSL------VHMLLDNNNLTGYLPPEL 109
P +F + + NN S + + L L + + NL + L
Sbjct: 193 QPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 110 SELPKLLILQLDNN--NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 167
L L I + ++ I ++ ++ + SL + +++ + D S +L+
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLE 310
Query: 168 LSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 227
L + + P +L ++ + ++NK LP L+ L ++ N LS
Sbjct: 311 LVNCKFG-QFPTLKLK-SLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLS-FKGCC 365
Query: 228 IWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 269
+ + LD N + +S +F + + +
Sbjct: 366 SQSDFGTTSLKY--LDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 53/316 (16%), Positives = 99/316 (31%), Gaps = 34/316 (10%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
+I ++ L L+L GN + L L ++ + ++
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 62 ANLNKTRHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL----L 116
+L + ++ +N I S ++P S L +L H+ L +N + +L L ++ L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLN 174
L L N I +L KL+LRN + + + L L +
Sbjct: 181 SLDLSLNPM--NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 175 G-----SIPPGRL----SLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSGSI 224
L +L I +L+ I F+ L + + + ++
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 225 PSSIWQS--------------RTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 270
S TL L F +N N ++P + L N
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 271 F-CLNTNAEQFCGSHS 285
++ G+ S
Sbjct: 359 LSFKGCCSQSDFGTTS 374
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 71/255 (27%), Positives = 106/255 (41%), Gaps = 36/255 (14%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
S+ KE I L LN L+ SLP+ L P++ ++I QN + SLP+ A+L
Sbjct: 51 SLLKEC-LINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL--- 102
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 127
+ +N +S +P SL H+ +DNN LT LP + L + DNN
Sbjct: 103 EYLDACDNRLS-TLPELP---ASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQL-- 152
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG-----RL 182
T +P + L LS+RN L +P+L +L LD+S+N L S+P
Sbjct: 153 TMLPEL---PTSLEVLSVRNNQLTF-LPEL--PESLEALDVSTNLLE-SLPAVPVRNHHS 205
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
+ N++T IP N L + + +N LS I S+ Q T
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ-----TAQPDY 259
Query: 243 DFQNNNLTNISGSFN 257
+ G N
Sbjct: 260 HGPRIYFSMSDGQQN 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-21
Identities = 59/246 (23%), Positives = 90/246 (36%), Gaps = 30/246 (12%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+S S+P + + +L + N L SLPE L LD N +S +LP+ A
Sbjct: 69 LNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLPELPA 120
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+L +H ++NN ++ +P + L + DNN LT LP + L +L + N
Sbjct: 121 SL---KHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPT---SLEVLSVRN 169
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL----GYLDLSSNQLNGSIP 178
N T +P L L + L+ R + + N++ IP
Sbjct: 170 NQL--TFLPEL---PESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIP 223
Query: 179 PGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 237
LSL TI L +N L+ I + S S S R L
Sbjct: 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADA 283
Query: 238 ETFILD 243
T
Sbjct: 284 VTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 40/228 (17%), Positives = 83/228 (36%), Gaps = 18/228 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N+++ +P+ + LE+L + N+LT LPE L LD + N + SLP
Sbjct: 150 NQLT-MLPELPTS---LEVLSVRNNQLT-FLPELPESLEALD---VSTNLLE-SLPAVPV 200
Query: 63 NLNKTR----HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 118
+ + F N I+ IP + L ++L++N L+ + LS+
Sbjct: 201 RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259
Query: 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 178
F + + + + L ++ + D+S+I + + +N + +
Sbjct: 260 HGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLD 317
Query: 179 PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL-QRLFIANNSLSGSIP 225
+++ ++ S L Q+ F + S
Sbjct: 318 RLSDTVSARNTSGFREQVA-AWLEKLSASAELRQQSFAVAADATESCE 364
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 576
IG+G +G+V+KGI VVA+K + E E + EI LS+ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
++ + ++ E++ G+ D L PL +I +G+ YLH+E HR
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHR 143
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
DIKA+N+LL K+ADFG++ + D + +T V GTP ++ PE
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQ----IKRNTFV-GTPFWMAPEVIKQSAY 196
Query: 697 TDKSDVYSLGVVFLELLTGMQPISH 721
K+D++SLG+ +EL G P S
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSE 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+G +G VY + ++A+K ++Q E + EI+ S L H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
Y + L+ EF G L +L + + L + Y H V
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD--ALHYCHERK---VI 136
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK---GTPGYLDPEYF 691
HRDIK N+L+ +K K+ADFG S AP S + GT YL PE
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAP------------SLRRRTMCGTLDYLPPEMI 184
Query: 692 LTHKLTDKSDVYSLGVVFLELLTGMQP 718
+K D++ GV+ E L GM P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 56/280 (20%), Positives = 109/280 (38%), Gaps = 27/280 (9%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
SIP + ++++ L L+ N +T +L L + + N I+ SF++L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 68 RHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNN 124
H ++ N +S + L SL + L N L S L KL IL++ N +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 125 FEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 183
++ ++ L +L + LQ L I N+ +L L Q + +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 184 L--NITTIKLSNNKLTGT----IPS----NFSGLPRLQRLFIANNSLSGSIPSSIWQSRT 233
+ ++ ++L + L + + + + + I + SL + + Q
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 234 LNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 271
L L+F N L ++ G F+ ++ + L NP+
Sbjct: 279 LL-----ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 24/236 (10%)
Query: 2 WNKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPK 59
N I+ +I ++ ++ SLE L L+ N L+ +L L L + + N +L +
Sbjct: 85 SNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGE 141
Query: 60 S--FANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 116
+ F++L K + + N +I + + L L + +D ++L Y P L + +
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 117 ILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQ---------GPMPDLSRIPNLGYL 166
L L + S + L LR+ L G L + +
Sbjct: 202 HLILHMKQH--ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 167 DLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 220
++ L + + + ++ S N+L ++P F L LQ++++ N
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 161 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 220
G SS LN SIP G L+ + ++ LSNN++T S+ LQ L + +N +
Sbjct: 31 DRNGICKGSSGSLN-SIPSG-LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88
Query: 221 SGSIPSSIWQS-RTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 271
+ +I + S +L LD N L+N+ S F ++T L GNP+
Sbjct: 89 N-TIEEDSFSSLGSLE-----HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 17/110 (15%), Positives = 32/110 (29%), Gaps = 13/110 (11%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTG----SLPE----ELGYLPKLDRIQIDQNYI 53
+ + + S+E L L +L L L ++I +
Sbjct: 208 KQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 54 SGSLPKSFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLT 102
+ K ++ + N + +P RL SL + L N
Sbjct: 267 F-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+G G +GKVYK G + A K + S + ++++ EI+ L+ H +V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
+G+ ++ EF G + + + L + + +LH++ + HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKR---IIHRD 142
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTPGYLDPEY 690
+KA N+L+ + ++ADFG+S A + + GTP ++ PE
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS-------------AKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 691 FLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 721
+ + D K+D++SLG+ +E+ P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
+ +IGQG G VY + + G VA+++ ++ + EI + + N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
+ E +V E+++ G+L D ++ + A ++ + + +LH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSNQ-- 136
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDP 688
V HRDIK+ NILL + K+ DFG + S T+V GTP ++ P
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFC---------AQITPEQSKRSTMV-GTPYWMAP 185
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
E K D++SLG++ +E++ G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 29/300 (9%), Positives = 59/300 (19%), Gaps = 55/300 (18%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+ G V+ + A+K E S + +RL +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 575 YC--------------------------DEEGEQMLVYEFMSNGTLRDQLSA-----KSK 603
+L+ S L S +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 604 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663
G + R L ++ + H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL--TDKSDVYSLGVVFLELLTGMQPISH 721
Y E+ T + + LG+ + P
Sbjct: 243 -------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 722 GKNIVRE-VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
++ + + + V+ I + + R E M
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVS----- 571
+G G YG+VYKG + G + A+K + + E+E EI L + HHRN+ +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 572 LVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
+ +Q+ LV EF G++ D + L I RG+ +LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS-------TVVKGTP 683
V HRDIK N+LL K+ DFG+S A + T + GTP
Sbjct: 150 --VIHRDIKGQNVLLTENAEVKLVDFGVS-------------AQLDRTVGRRNTFI-GTP 193
Query: 684 GYLDPEYFLTHKLTD-----KSDVYSLGVVFLELLTGMQPISH 721
++ PE + D KSD++SLG+ +E+ G P+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+G G + +V+ G + A+K ++ + EI L ++ H N+V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ LV + +S G L D++ + E + + + YLH +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----SAVKYLHENG---IV 128
Query: 635 HRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
HRD+K N+L + DFGLS++ +ST GTPGY+ PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM--------EQNGIMSTAC-GTPGYVAPEVL 179
Query: 692 LTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ D +S+GV+ LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 34/217 (15%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
+S +IG+G G V G VAVK Q + E+ + H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRD----------QLSAKSKEPLGFAMRLSIALGSSRG 621
+ E ++ EF+ G L D Q++ + L +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL-------------QA 153
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+ YLH + V HRDIK+ +ILL K++DFG A + ++V G
Sbjct: 154 LAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDV----PKRKSLV-G 203
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
TP ++ PE + D++SLG++ +E++ G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 567
F+ ++G+G YG VYK I G +VA+K+ ++ + +E + EI + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
++V G + + +V E+ G++ D + ++K L +I + +G+ YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHF 143
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
HRDIKA NILL+ + AK+ADFG++ + D A +TV+ GTP ++
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTM----AKRNTVI-GTPFWMA 193
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 721
PE +D++SLG+ +E+ G P +
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 486 RHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQ 544
H +S G + + M + + +G+G YG V K G +VA+K+
Sbjct: 4 HHHHHSSGVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 545 EGSLQGEKEF-----LTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLS 599
E + + + EI+ L +L H NLV+L+ C ++ LV+EF+ + T+ D L
Sbjct: 60 ESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE 115
Query: 600 AKSKEPLGFAMRL--SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657
P G ++ GI + H+ + HRDIK NIL+ K+ DFG
Sbjct: 116 LF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFG 169
Query: 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGM 716
+R P + V T Y PE + K+ DV+++G + E+ G
Sbjct: 170 FARTLAAP-----GEVYDDEVA--TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG- 221
Query: 717 QPISHGKN 724
+P+ G +
Sbjct: 222 EPLFPGDS 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 564
+ +IG+G YG V+K +VA+KR + L + E L EI L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL 58
Query: 565 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGI 622
H+N+V L + + LV+EF D + L + S +G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
+ H+ V HRD+K N+L++ K+A+FGL+R +P V + + VV T
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----VRCYSAEVV--T 164
Query: 683 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
Y P+ KL S D++S G +F EL +P+ G +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-26
Identities = 60/302 (19%), Positives = 100/302 (33%), Gaps = 31/302 (10%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
+ + +K L++L L N++ E L L + + N + +F
Sbjct: 275 HGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF 334
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT--GYLPP---------ELS 110
L K + + N I+ L L + L +N LT ++P +L
Sbjct: 335 YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV 394
Query: 111 ELPKLLI----LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD--LSRIPNLG 164
LPK+ + + L N E I + L L L D S P+L
Sbjct: 395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454
Query: 165 YLDLSSNQLNG----SIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218
L L N L + ++ + L++N L P FS L L+ L + +N
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514
Query: 219 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAE 278
L+ + + + L ILD N L + + + N F
Sbjct: 515 RLT-VLSHNDLPAN-LE-----ILDISRNQLLAPNPDV-FVSLSVLDITHNKFICECELS 566
Query: 279 QF 280
F
Sbjct: 567 TF 568
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-26
Identities = 45/290 (15%), Positives = 100/290 (34%), Gaps = 35/290 (12%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNK 66
+P+ + + E LLL+ N + +L +L +++ Y ++ ++F NL
Sbjct: 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 67 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNN 123
R + ++ I + P+ L L + L L+ + + L L L L N
Sbjct: 75 LRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 124 NFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLS--RIPNLGYLDLSSNQLNGSIPPG 180
+ S+ ++ L + + + +L + L + L++N L +
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193
Query: 181 RLS-------LNITTIKLSNNKLTGTIPSNFS------------GLPRLQRLFIANNSLS 221
+ + + +S N T I NFS + +++
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 222 GSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 269
+ + ++ LD + + ++ S F ++ V L N
Sbjct: 254 -DPDQNTFAGLARSSVRH--LDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 58/302 (19%), Positives = 102/302 (33%), Gaps = 42/302 (13%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPK--LDRIQIDQNYISGSLPK 59
N IS S + + + + L + + + + ++ +
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284
Query: 60 SFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 118
F L + ++ N I+ +I E L +L + L N L LPK+ +
Sbjct: 285 VFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343
Query: 119 QLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177
L N+ I ++ + KL L LR+ +L + IP++ + LS N+L ++
Sbjct: 344 DLQKNHI--AIIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLV-TL 396
Query: 178 PPGRLSLNITTIKLSNNKLTG-TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS----R 232
P L+ N I LS N+L I +P LQ L + N S
Sbjct: 397 PKINLTAN--LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454
Query: 233 TLN--------------ATETF-------ILDFQNNNLTNIS-GSFNIPPNVTV-RLRGN 269
L + F +L +N L ++ G F+ + L N
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514
Query: 270 PF 271
Sbjct: 515 RL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-25
Identities = 46/258 (17%), Positives = 93/258 (36%), Gaps = 28/258 (10%)
Query: 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 77
+ LT +P+ L +R+ + NYI SF L + + + +
Sbjct: 5 DGRIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 78 SGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY- 134
I E LP+L + L ++ + +L P+ L L L+L + Y
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 135 SNMSKLLKLSLRNCSLQ--GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS----LNITT 188
N+ L +L L ++ P ++ +L +D SSNQ+ + L ++
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSF 178
Query: 189 IKLSNNKLTGTIPSNFSGLP------RLQRLFIANNSLSGSIPSSIWQSRTLNATETFI- 241
L+ N L + ++ L+ L ++ N + I + + + + + I
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238
Query: 242 ------LDFQNNNLTNIS 253
F +N+ +
Sbjct: 239 AHHIMGAGFGFHNIKDPD 256
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 9e-21
Identities = 57/299 (19%), Positives = 101/299 (33%), Gaps = 37/299 (12%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSL--PEELGYLPKLDRIQIDQNYISG-SLP 58
+KI + + + L L L L+ ++ L L R+ + +N I L
Sbjct: 83 SKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 59 KSFANLNKTRHFHMNNNSISGQIPPELSRL--PSLVHMLLDNNNLTGYLPPELSELPKLL 116
SF LN + ++N I EL L +L L N+L + + +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 117 ------ILQLDNNNFEGTTIPASYSNMSKLLKLSLRN----CSLQGPMPDLSRIP----- 161
IL + N + + +SK SL ++
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 162 -----NLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLF 214
++ +LDLS + S+ ++ + L+ NK+ F GL LQ L
Sbjct: 262 GLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLN 320
Query: 215 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNVTV-RLRGNPF 271
++ N L S+ + + +D Q N++ I +F + LR N
Sbjct: 321 LSYNLLGELYSSNFYGLPKVA-----YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 60/253 (23%), Positives = 95/253 (37%), Gaps = 23/253 (9%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N I+ + ++ L+ L L N LT + ++P + I + N + +LPK
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINL 401
Query: 63 NLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQ 119
N H++ N + I L R+P L ++L+ N + + SE P L L
Sbjct: 402 TAN---LIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLF 457
Query: 120 LDNNNFEGTTI----PASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLN 174
L N + + +S L L L + L P S + L L L+SN+L
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517
Query: 175 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234
+ L N+ + +S N+L P F L L I +N S L
Sbjct: 518 -VLSHNDLPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELS-TFINWL 572
Query: 235 NATETFILDFQNN 247
N T I +
Sbjct: 573 NHTNVTIAGPPAD 585
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 77/352 (21%), Positives = 130/352 (36%), Gaps = 55/352 (15%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNL 569
N S +G G G V G VAVKR + L EI+ L+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 570 VSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMR-----LSIALGSSRGI 622
+ YC E ++ + E N L+D + +K+ ++ +S+ + G+
Sbjct: 72 IRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 623 LYLHTEADPPVFHRDIKASNILLDHK-------------FTAKVADFGLSRLAPVPDIEG 669
+LH+ + HRD+K NIL+ ++DFGL + + +
Sbjct: 129 AHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--LDSGQS 183
Query: 670 IVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHG 722
+++ GT G+ PE +LT D++S+G VF +L+ +
Sbjct: 184 SFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR-E 781
K RE NI + + I + + RP+ +V+R
Sbjct: 243 KYS-RESNI-IRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKVLRHP 297
Query: 782 LESIWNMMPESDTKTPEFIN--SEHTSKEETPPSSSSMLKHPYVSSDVSGSN 831
L W +K EF+ S+ E P S+ ++K S V S
Sbjct: 298 L--FWP-----KSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLHHRNLVSL 572
++G G Y VYKG+ G VA+K + L E+ + EI + L H N+V L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 573 VGYCDEEGEQMLVYEFMSN---GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
E + LV+EFM N + + + L + +G+ + H
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRD+K N+L++ + K+ DFGL+R +P V S VV T Y P+
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-----VNTFSSEVV--TLWYRAPD 178
Query: 690 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
+ + S D++S G + E++TG +P+ G N
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTN 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-26
Identities = 63/250 (25%), Positives = 103/250 (41%), Gaps = 21/250 (8%)
Query: 475 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 533
H ++H+ R + ++ F + + + ++G G YG+V
Sbjct: 2 HHHHHHSSGRENLYFQGDLQA-TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 534 DGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591
A+K ++ S+ L E+ L L H N++ L + +++ LV E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--- 648
G L D++ + K A + + S G+ YLH + HRD+K N+LL+ K
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLS--GVTYLHKHN---IVHRDLKPENLLLESKEKD 175
Query: 649 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 708
K+ DFGLS + GT Y+ PE L K +K DV+S+GV+
Sbjct: 176 ALIKIVDFGLSAV--------FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 709 FLELLTGMQP 718
LL G P
Sbjct: 227 LFILLAGYPP 236
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 565
+ ++G+G YG VYK G +VA+KR + L E E + EI L LH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELH 77
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 623
H N+VSL+ E LV+EFM D ++ ++K L + RG+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
+ H + HRD+K N+L++ K+ADFGL+R +P V ++ VV T
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-----VRSYTHEVV--TL 183
Query: 684 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
Y P+ + K S D++S+G +F E++TG +P+ G
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVT 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+G G +G V++ + G V K + EI +++LHH L++L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----GILYLHTEADPPV 633
++ E +L+ EF+S G L D+++A+ + M + + R G+ ++H + +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 634 FHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
H DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIV 222
Query: 692 LTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ +D++++GV+ LL+G+ P
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 57/249 (22%), Positives = 89/249 (35%), Gaps = 54/249 (21%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVS 571
IGQG YG V I + A+K + ++ + + + TE++ + +LHH N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR----------- 620
L ++E LV E G L D+L+ + G +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 621 ---------------------------GILYLHTEADPPVFHRDIKASNILLDHKFTA-- 651
+ YLH + + HRDIK N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 652 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE--YFLTHKLTDKSDVYSLGVVF 709
K+ DFGLS+ + ++T GTP ++ PE K D +S GV+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYG--MTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 710 LELLTGMQP 718
LL G P
Sbjct: 267 HLLLMGAVP 275
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
+G+G +G+V G AVK + Q ++ L E+Q L +L H N++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPV 633
+ +++G LV E + G L D++ ++ + A R+ + S GI Y+H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS--GITYMHKNK---I 147
Query: 634 FHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
HRD+K N+LL+ K ++ DFGLS + GT Y+ PE
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTH--------FEASKKMKDKIGTAYYIAPE- 198
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQP 718
L +K DV+S GV+ LL+G P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLH 565
++ +IG+G YG VYK G A+K+ + L+ E E + EI L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 623
H N+V L + +LV+E + D +L + L S L GI
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
Y H V HRD+K N+L++ + K+ADFGL+R +P V + +V T
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-----VRKYTHEIV--TL 164
Query: 684 GYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
Y P+ + K + D++S+G +F E++ G P+ G +
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVS 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
IG G +G VY + + VVA+K+ + + S + ++ + E++FL +L H N + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
E LV E+ G+ D L K PL ++ G+ +G+ YLH+ +
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHN---MI 176
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS---TVVKGTPGYLDPEYF 691
HRD+KA NILL K+ DFG + + ++ + V GTP ++ PE
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSA-------------SIMAPANSFV-GTPYWMAPEVI 222
Query: 692 LTHKLTD---KSDVYSLGVVFLELLTGMQPISH 721
L K DV+SLG+ +EL P+ +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-F----LTEIQFLSRL 564
+ + +IGQG +G+V+K G VA+K+ ++ EKE F L EI+ L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 565 HHRNLVSLVGYCDEEGEQM--------LVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSI 614
H N+V+L+ C + LV++F + D L + + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIKRV 129
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
G+ Y+H + HRD+KA+N+L+ K+ADFGL+R + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNRY 185
Query: 675 VSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733
+ VV T Y PE L D++ G + E+ T PI G E +
Sbjct: 186 TNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNT---EQH--- 236
Query: 734 QSSMMFSVIDGNMGSYPSE 752
Q +++ + GS +
Sbjct: 237 QLALISQL----CGS-ITP 250
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEF-----LTEIQFLSRL 564
+ +IG+G YG V+K G +VA+K+ E + L EI+ L +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59
Query: 565 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGI 622
H NLV+L+ + LV+E+ + T+ +L G L SI + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY---QRGVPEHLVKSITWQTLQAV 115
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
+ H HRD+K NIL+ K+ DFG +RL P + V T
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-----SDYYDDEVA--T 165
Query: 683 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
Y PE + DV+++G VF ELL+G P+ GK+
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKS 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 576
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 697 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 728
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT----EIQFLSRLHHRNLVSLV 573
+G+G YGKV + + AVK ++ L+ EIQ L RL H+N++ LV
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 574 GYCDEEGEQM--LVYEFMSNGT--LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
E +Q +V E+ G + D + K + P+ A L G+ YLH++
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLID--GLEYLHSQG 129
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ H+DIK N+LL T K++ G++ + S G+P + PE
Sbjct: 130 ---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQ---GSPAFQPPE 181
Query: 690 YFLTHKLTD--KSDVYSLGVVFLELLTGMQPISHGKNIVR 727
K D++S GV + TG+ P G NI +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYK 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 44/305 (14%), Positives = 93/305 (30%), Gaps = 46/305 (15%)
Query: 505 EMALATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEI 558
E L + +G+G + +VY+ + +K + + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 559 QFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKE-----PLGFAMRLS 613
+ L + + +LV E S GTL + ++ P G + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA-----------KVADFGLSRLA 662
+ + I +H + H DIK N +L + F + D G S
Sbjct: 179 MRM--LYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-- 231
Query: 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722
D++ + T T G+ E + D + + +L G
Sbjct: 232 ---DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM---- 284
Query: 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMREL 782
V+ + +F + +F + L + PS+ + ++L
Sbjct: 285 --KVKNEGGECKPEGLFR------RLPHLDMWNEFFHVMLN--IPDCHHLPSLDLLRQKL 334
Query: 783 ESIWN 787
+ ++
Sbjct: 335 KKVFQ 339
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 41/211 (19%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLV 573
+G+G +G V++ + K + + + EI L+ HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLH 67
Query: 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTEA 629
+ E ++++EF+S + ++++ F + + + +LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 630 DPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ H DI+ NI+ + ++ K+ +FG +R + P ++ P Y
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--------LKPGDNFRLLFTAPEYYA 171
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE ++ +D++SLG + LL+G+ P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
+ + +G G +G+V+K G +A K + ++ ++E EI +++L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGIL 623
L + + + +LV E++ G L D++ +S + + F M+ GI
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-MKQICE-------GIR 201
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
++H + H D+K NIL ++ K+ DFGL+R P V G
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--------YKPREKLKVNFG 250
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
TP +L PE ++ +D++S+GV+ LL+G+ P
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK-------------RAQEGSLQGEKEFLTEIQFLSR 563
++G G YG+V + A+K + + +E EI L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 623
L H N++ L +++ LV EF G L +Q+ + K A + + S GI
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS--GIC 160
Query: 624 YLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
YLH + HRDIK NILL++K K+ DFGLS +
Sbjct: 161 YLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF--------FSKDYKLRDRL 209
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
GT Y+ PE L K +K DV+S GV+ LL G P
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRLHHRNLVS 571
+G+G + VYK +VA+K+ + G K+ L EI+ L L H N++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
L+ + LV++FM D + + L + + L + +G+ YLH
Sbjct: 77 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRD+K +N+LLD K+ADFGL++ P A+ VV T Y PE
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVV--TRWYRAPE 182
Query: 690 YFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
++ D++++G + ELL P G +
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDS 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSLVGY 575
++G G +G V+ G +K + Q E EI+ L L H N++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 631
++ +V E G L +++ + L + + + Y H++
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN--ALAYFHSQH-- 144
Query: 632 PVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
V H+D+K NIL K+ DFGL+ L ST GT Y+ P
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--------FKSDEHSTNAAGTALYMAP 195
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
E +T K D++S GVV LLTG P
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 18/205 (8%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
IG+G +G+V + A K+ + ++ F EI+ + L H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
++ + LV E + G L +++ K A R+ + S + Y H V HR
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS--AVAYCHKLN---VAHR 130
Query: 637 DIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693
D+K N L K+ DFGL+ P + GTP Y+ P+ L
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAAR--------FKPGKMMRTKVGTPYYVSPQ-VLE 181
Query: 694 HKLTDKSDVYSLGVVFLELLTGMQP 718
+ D +S GV+ LL G P
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+G G +G V++ G A K ++ EIQ +S L H LV+L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMR--LSIALGSSRGILYLHTEAD 630
++ E +++YEFMS G L ++++ + E + + MR G+ ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQVCK-------GLCHMHENN- 275
Query: 631 PPVFHRDIKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
H D+K NI+ K + K+ DFGL+ + P V GT + P
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAAP 325
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
E + +D++S+GV+ LL+G+ P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 58/220 (26%), Positives = 84/220 (38%), Gaps = 34/220 (15%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK---------RAQEGSLQGEKEFLTEIQFLSRL-HH 566
+G+G V + I P AVK + E + + L E+ L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILY 624
N++ L + LV++ M G L D L+ K E + ++ I
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL----EVICA 139
Query: 625 LHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 684
LH + HRD+K NILLD K+ DFG S + P V GTP
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVCGTPS 188
Query: 685 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
YL PE + D++S GV+ LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 574
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
++ +V E + G L D++ + + A R+ + S GI Y+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMHKHN---IV 143
Query: 635 HRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE-V 194
Query: 692 LTHKLTDKSDVYSLGVVFLELLTGMQP 718
L +K DV+S GV+ LL+G P
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT-EIQFLSRLHHRNLVSLVGYC 576
+G+G YG+V + VAVK E + EI L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E Q L E+ S G L D++ P A R L + G++YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG---ITHR 129
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
DIK N+LLD + K++DFGL+ + ++ + GT Y+ PE L +
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR----YNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 697 TD--KSDVYSLGVVFLELLTGMQPISHGKNIVRE 728
DV+S G+V +L G P + +E
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE--FLTEIQFLSRLHHRNLVSLVG 574
+G+G +G+V K AVK + S + + L E++ L +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 632
++ +V E + G L D++ + + E + + GI Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITYMHKHN--- 141
Query: 633 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRD+K NILL+ K K+ DFGLS GT Y+ PE
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------FQQNTKMKDRIGTAYYIAPE 193
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
L +K DV+S GV+ LL+G P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 32/240 (13%), Positives = 63/240 (26%), Gaps = 49/240 (20%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL---------- 564
+GQ + G V + K+ E+ L L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 565 ------------HHRNLVSLVGYCDEEGEQMLVYEF-------MSNGTLRDQLSAKSK-- 603
++ +E + ++ F + T + L + S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 604 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663
+ L RL + L R + LH + H ++ +I+LD + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-----LTDKSDVYSLGVVFLELLTGMQP 718
+G P + +T D ++LG+ + P
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLV 570
++G G + V K G A K R S +G +E E+ L + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILY 624
+L + + + +L+ E +S G L D L+ K E F ++ L G+ Y
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVHY 123
Query: 625 LHTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
LH++ + H D+K NI+L K K+ DFG++ I + +
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--------IEAGNEFKNIF 172
Query: 681 GTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
GTP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 571
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 625
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 626 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 25/213 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 572
IG+G + V + I G AVK S E E L H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL----YLHTE 628
+ +G +V+EFM L ++ ++ ++ ++ R IL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY--MRQILEALRYCHDN 149
Query: 629 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
+ HRD+K +LL K K+ FG++ + V GTP +
Sbjct: 150 N---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV------AGGRV-GTPHF 199
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ PE DV+ GV+ LL+G P
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 574
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 632
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 125
Query: 633 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 177
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ D+++ GV+ LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 38/282 (13%), Positives = 72/282 (25%), Gaps = 74/282 (26%)
Query: 485 RRHSSKTSIKIDGVRSFTY--GEMALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK 541
G R T G + +GQ + G V
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTV------------LGQEDPYAYLEATDQETGESFEVH 104
Query: 542 ------RAQEGSLQGEKE----------------------FLTEIQFLSRLHHRNLVSLV 573
R +++ KE F+ + + ++ +
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 574 GYCDEEGEQMLVYEFM----SNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHT 627
+ + + + T + L + S + L RL + L R + LH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ H ++ +I+LD + + F V V + G+
Sbjct: 225 YG---LVHTYLRPVDIVLDQRGGVFLTGFEHL-----------VRDGARVVSSVSRGFEP 270
Query: 688 PEYFLTHKL-----------TDKSDVYSLGVVFLELLTGMQP 718
PE T D ++LG+V + P
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 57/250 (22%), Positives = 98/250 (39%), Gaps = 36/250 (14%)
Query: 484 RRRHSSKTSIKIDGVRSFTYGEMALATNNFN-SSTQIGQGGYGKVYKGI-LPDGTVVAVK 541
HSS + + + + N + +S ++G+G + V + I G A K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENF---NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 542 --RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL 598
+ + E L EI L +++L + E +L+ E+ + G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 599 SAKSKEPLG-----FAMR--LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 651
+ E + ++ L G+ YLH + H D+K NILL +
Sbjct: 121 LPELAEMVSENDVIRLIKQILE-------GVYYLHQNN---IVHLDLKPQNILLSSIYPL 170
Query: 652 ---KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 708
K+ DFG+SR I A + GTP YL PE +T +D++++G++
Sbjct: 171 GDIKIVDFGMSRK--------IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 709 FLELLTGMQP 718
LLT P
Sbjct: 223 AYMLLTHTSP 232
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF----LTEIQFLSRLH 565
+ ++G+G Y VYKG +VA+K + L+ E+ + E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLK 58
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRD--QLSAKSKEPLGFAMRLSIALGSSRGIL 623
H N+V+L E LV+E++ +D Q + RG+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
Y H V HRD+K N+L++ + K+ADFGL+R +P + + VV T
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-----TKTYDNEVV--TL 164
Query: 684 GYLDPEYFL-THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
Y P+ L + + + D++ +G +F E+ TG +P+ G
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGST 205
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 44/274 (16%), Positives = 93/274 (33%), Gaps = 29/274 (10%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+ ++ L L + N++T L + L+R+ D N I+ L
Sbjct: 156 HLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LN 209
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+ ++N ++ +I ++ L L + N LT L +S L KL L
Sbjct: 210 QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQ 263
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
+ I + + ++L+ C + D++ L LD + + + +
Sbjct: 264 TDL--LEIDLT--HNTQLIYFQAEGCR-KIKELDVTHNTQLYLLDCQAAGIT-ELDLSQN 317
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
+ + L+N +LT + S +L+ L N + S + + LN
Sbjct: 318 P-KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALN-----NN 366
Query: 243 DFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 276
+ ++T+ + + N
Sbjct: 367 FEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGN 400
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 49/255 (19%), Positives = 95/255 (37%), Gaps = 32/255 (12%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+ I+ + I + L L+ N +T +L L L + D N ++ +L
Sbjct: 52 SSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VT 103
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
L K + + + N ++ ++ +S+ P L ++ N LT ++S +L L
Sbjct: 104 PLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHL 157
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
N + ++L L + D+S+ L L+ +N + + +
Sbjct: 158 NKK---ITKLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNIT-KLDLNQN 211
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242
+T + S+NKLT I + L +L + N L+ + S T L
Sbjct: 212 I-QLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLT-------TL 259
Query: 243 DFQNNNLTNISGSFN 257
+L I + N
Sbjct: 260 HCIQTDLLEIDLTHN 274
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-22
Identities = 41/247 (16%), Positives = 88/247 (35%), Gaps = 21/247 (8%)
Query: 12 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 71
++ K L L + N +T L L +L + N ++ + L + +F
Sbjct: 186 DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 72 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 131
+ N ++ ++ +S L L + +L + L+ +L+ Q +
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK---IKE 290
Query: 132 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 191
++ ++L L + + DLS+ P L YL L++ +L + + + ++
Sbjct: 291 LDVTHNTQLYLLDCQAAGIT--ELDLSQNPKLVYLYLNNTELT-ELDVSHNT-KLKSLSC 346
Query: 192 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 251
N + S +P L F A ++ + A +LD N +
Sbjct: 347 VNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNI 404
Query: 252 ISGSFNI 258
G +
Sbjct: 405 EPGDGGV 411
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 43/258 (16%), Positives = 84/258 (32%), Gaps = 29/258 (11%)
Query: 12 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 71
++ + L L + N+ L + +L + N I+ L + +
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLN 197
Query: 72 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 131
+ N+I+ +L++ L + +N LT +++ L +L N T +
Sbjct: 198 CDTNNITK---LDLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPL--TELD 249
Query: 132 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 191
S +SKL L L DL+ L Y + + + + +
Sbjct: 250 VS--TLSKLTTLHCIQTDLLEI--DLTHNTQLIYFQAEGCRKIKELDVTHNT-QLYLLDC 304
Query: 192 SNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN 251
+T + S P+L L++ N L+ + S L L N ++ +
Sbjct: 305 QAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNTK--LK-----SLSCVNAHIQD 353
Query: 252 ISGSFNIPPNVTVRLRGN 269
S IP
Sbjct: 354 FSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 47/274 (17%), Positives = 92/274 (33%), Gaps = 49/274 (17%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
NK++ ++ + + L L + N+LT L + P L + +N ++ + +
Sbjct: 95 NKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VS 145
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
+ + + N +++ L + N +T ++S+ L L D
Sbjct: 146 HNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDT 200
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
NN T + + +L L + L D++ + L Y D S N L + L
Sbjct: 201 NNI--TKLDLN--QNIQLTFLDCSSNKLT--EIDVTPLTQLTYFDCSVNPLT-ELDVSTL 253
Query: 183 SLNITTIKLSNNKLT-------------------GTIPSNFSGLPRLQRLFIANNSLSGS 223
S +TT+ L + + +L L ++
Sbjct: 254 S-KLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-E 311
Query: 224 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 257
+ + Q+ L L N LT + S N
Sbjct: 312 LD--LSQNPKLV-----YLYLNNTELTELDVSHN 338
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 29/161 (18%), Positives = 56/161 (34%), Gaps = 20/161 (12%)
Query: 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD 156
+ + P + + + + ++ L L N S+ M
Sbjct: 7 QTQSFNDWFP--DDNFASEVAAAFEMQATDTISE----EQLATLTSLDCHNSSITD-MTG 59
Query: 157 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 216
+ ++ L L +SN + ++ + + N+T + +NKLT + + L +L L
Sbjct: 60 IEKLTGLTKLICTSNNIT-TLDLSQNT-NLTYLACDSNKLT-NLD--VTPLTKLTYLNCD 114
Query: 217 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 257
N L+ + S L+ N LT I S N
Sbjct: 115 TNKLT-KLDVS-------QNPLLTYLNCARNTLTEIDVSHN 147
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 37/165 (22%), Positives = 60/165 (36%), Gaps = 18/165 (10%)
Query: 95 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM 154
+ + +L L L N++ T + ++ L KL + ++
Sbjct: 24 VAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTG-IEKLTGLTKLICTSNNITT-- 78
Query: 155 PDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 214
DLS+ NL YL SN+L ++ L+ +T + NKLT + S P L L
Sbjct: 79 LDLSQNTNLTYLACDSNKLT-NLDVTPLT-KLTYLNCDTNKLT---KLDVSQNPLLTYLN 133
Query: 215 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 259
A N+L+ I S + T+ LD N
Sbjct: 134 CARNTLT-EIDVS-------HNTQLTELDCHLNKKITKLDVTPQT 170
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 65/233 (27%), Positives = 94/233 (40%), Gaps = 33/233 (14%)
Query: 509 ATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLT--------EIQ 559
AT+ + +IG G YG VYK G VA+K + + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVA 63
Query: 560 FLSRLH---HRNLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR 611
L RL H N+V L+ D E + LV+E + LR L L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 612 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671
+ RG+ +LH + HRD+K NIL+ T K+ADFGL+R+
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ------ 173
Query: 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
A VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 174 MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNS 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 54/224 (24%), Positives = 86/224 (38%), Gaps = 33/224 (14%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 568
+G G G+V VA++ TEI+ L +L+H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 626
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 202 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 256
Query: 627 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 257 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 305
Query: 684 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
YL PE T D +SLGV+ L+G P S +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 571
+G G + V K G A K R + S +G ++ E+ L + H N+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 625
L + + + +L+ E ++ G L D L+ K +E F ++ L+ G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVYYL 130
Query: 626 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
H+ + H D+K NI+L + K+ DFGL+ I + + G
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFG 179
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 46/241 (19%), Positives = 88/241 (36%), Gaps = 20/241 (8%)
Query: 41 PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNN 99
++ + + N I+ SF+ L + + + I L SL+ + LD N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 100 NLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQ--GPMP 155
L + L L +L L N +G + ++ ++ L L LR+ +++ P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 156 DLSRIPNLGYLDLSSNQLNGSIPPGRL----SLNITTIKLSNNKLT--------GTIPSN 203
+ LDL+ N++ SI L + T ++LS+ L N
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 204 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPNV 262
+ L ++ N S+ + + ++ IL N ++ +F P N
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 263 T 263
T
Sbjct: 268 T 268
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-22
Identities = 48/304 (15%), Positives = 98/304 (32%), Gaps = 42/304 (13%)
Query: 2 WNKI-SGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLP 58
+ + + SLE+L+L N + P + + + + N +
Sbjct: 112 QCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE 171
Query: 59 KSFANLNKTR----------HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE 108
+ N MN + + + S+ + L N +
Sbjct: 172 EDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR 231
Query: 109 LSELP---KLLILQLDNNNFEGTTIPASY-----------SNMSKLLKLSLRNCSLQG-P 153
+ K+ L L N+ G++ + S + L +
Sbjct: 232 FFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALL 291
Query: 154 MPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPR 209
S +L L L+ N++N I L+ ++ + LS N L +I S F L +
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLT-HLLKLNLSQNFLG-SIDSRMFENLDK 348
Query: 210 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLR 267
L+ L ++ N + ++ + L N L ++ G F+ ++ + L
Sbjct: 349 LEVLDLSYNHIR-ALGDQSFL----GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 403
Query: 268 GNPF 271
NP+
Sbjct: 404 TNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 42/302 (13%), Positives = 88/302 (29%), Gaps = 43/302 (14%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKSF 61
N I+ ++ L+ L + + L L +++D N +F
Sbjct: 40 NSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAF 99
Query: 62 ANLNKTRHFHMNNNSI-SGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLI 117
L + ++ + L SL ++L +NN+ + P + + +
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHV 158
Query: 118 LQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQ-----------GPMPDLSRIPNLGY 165
L L N +I N LR S+ + + ++
Sbjct: 159 LDLTFNKV--KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITT 216
Query: 166 LDLSSNQLNGSIPPGRLSL--------------NITTIKLSNNKLTGTIPSNFSGLPR-- 209
LDLS N S+ + F GL
Sbjct: 217 LDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG 276
Query: 210 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLR 267
++ ++ + + ++ S++ + T+ L N + I +F ++ L
Sbjct: 277 VKTCDLSKSKIF-ALLKSVFS----HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLS 331
Query: 268 GN 269
N
Sbjct: 332 QN 333
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 35/201 (17%), Positives = 73/201 (36%), Gaps = 19/201 (9%)
Query: 85 LSRLPSL----VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL 140
L ++P L ++ L N++ S L L L+++ ++ +S L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 141 LKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGS-IPPG---RLSLNITTIKLSNNK 195
+ L L + + NL L L+ L+G+ + L+ ++ + L +N
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNN 140
Query: 196 LTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254
+ P++ F + R L + N + SI + +L + L +++
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLN--FQGKHFTLLRLSSITLQDMN- 196
Query: 255 SFNIPPNVTVRLRGNPFCLNT 275
+ GNPF +
Sbjct: 197 ----EYWLGWEKCGNPFKNTS 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 8/92 (8%)
Query: 167 DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 226
+ L+ +P L ++ + LS N + ++FS L LQ L + + I +
Sbjct: 16 ICINRGLH-QVPE--LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72
Query: 227 SIWQSRTLNATETFILDFQNNNLTNI-SGSFN 257
+ ++ + IL N + +G+FN
Sbjct: 73 NTFR----GLSSLIILKLDYNQFLQLETGAFN 100
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 65/233 (27%), Positives = 92/233 (39%), Gaps = 47/233 (20%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK----------------------RAQEGSLQGEKEFL 555
IG+G YG V D T A+K R G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 556 T----EIQFLSRLHHRNLVSL--VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLGF 608
EI L +L H N+V L V E +V+E ++ G + + + K E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ-- 138
Query: 609 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668
A L GI YLH + + HRDIK SN+L+ K+ADFG+S D
Sbjct: 139 ARFYFQDLIK--GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-- 191
Query: 669 GIVPAHVSTVVKGTPGYLDPEYFL-THKLTD--KSDVYSLGVVFLELLTGMQP 718
A +S V GTP ++ PE T K+ DV+++GV + G P
Sbjct: 192 ----ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK----RAQEGSLQGE--KEFLTEIQFLSRLHHRNLVS 571
+G G + V K G A K R S +G +E E+ L ++ H N+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMR--LSIALGSSRGILYL 625
L + + +L+ E +S G L D L+ K +E F ++ L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 626 HTEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
HT+ + H D+K NI+L K K+ DFGL+ I + G
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------IEDGVEFKNIFG 180
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
TP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 31/254 (12%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 576
+G+G + +V I L AVK ++ E++ L + HRN++ L+ +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+EE LV+E M G++ + + E A + + S + +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELE----ASVVVQDVAS--ALDFLH---NKG 131
Query: 633 VFHRDIKASNILLDHK---FTAKVADFGLSR-LAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRD+K NIL +H K+ DF L + D I + T G+ Y+ P
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAP 190
Query: 689 EYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP-----ISHGKNIVREVNIAYQSSMM 738
E D++SLGV+ LL+G P S E A Q+ +
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 739 FSVIDGNMGSYPSE 752
S+ +G +P +
Sbjct: 251 ESIQEGKY-EFPDK 263
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 69/254 (27%), Positives = 109/254 (42%), Gaps = 34/254 (13%)
Query: 518 QIGQGGYGKVYKGI---LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
++G+G YG VYK D A+K+ + + EI L L H N++SL
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 575 YCDEEGEQ--MLVYEFMSN------GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
++ L++++ + R + K L M S+ GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 627 TEADPPVFHRDIKASNILLDHKFTA----KVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
V HRD+K +NIL+ + K+AD G +RL P + VV T
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL--KPLADLDPVVV--T 198
Query: 683 PGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAY---QSSMM 738
Y PE L + K+ D++++G +F ELLT +PI H + + + Y Q +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLDRI 257
Query: 739 FSVIDGNMGSYPSE 752
F+V MG P++
Sbjct: 258 FNV----MGF-PAD 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 35/220 (15%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLH-HR 567
IG+G V + + G AVK + E + + E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYL 625
++++L+ + LV++ M G L D L+ K E ++ S+ + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL----EAVSFL 216
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV-STVVKGTPG 684
H + HRD+K NILLD +++DFG S + P + GTPG
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--------LEPGEKLRELC-GTPG 264
Query: 685 YLDPE------YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
YL PE + D+++ GV+ LL G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 29/226 (12%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSRL 564
+ + T++G+G YG+VYK I VA+KR + L+ E+E + E+ L L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90
Query: 565 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILY 624
HRN++ L L++E+ N L+ + + + S G+ +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNF 147
Query: 625 LHTEADPPVFHRDIKASNILLDHKFTA-----KVADFGLSRLAPVPDIEGIVPAHVSTVV 679
H HRD+K N+LL + K+ DFGL+R +P + ++
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-----IRQFTHEII 199
Query: 680 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
T Y PE L + S D++S+ ++ E+L P+ G +
Sbjct: 200 --TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDS 242
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 511 NNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVKRAQEGSLQGEKE-----FLTEIQFLSR 563
+ +IG+G YGKV+K + G VA+KR + +Q +E + E+ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 564 LH---HRNLVSL-----VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIA 615
L H N+V L V D E + LV+E + L L + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 616 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+ A
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALT 177
Query: 676 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
S VV T Y PE L D++S+G +F E+ +P+ G +
Sbjct: 178 SVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSS 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 44/266 (16%)
Query: 484 RRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILPD 534
++ +K++ + LA++ + IG G +G V++ L +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 535 GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL------VGYCDEEGEQMLVYEF 588
VA+K+ LQ ++ E+Q + + H N+V L G +E LV E+
Sbjct: 64 SDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASN 642
+ T+ +K + + L R + Y+H+ + HRDIK N
Sbjct: 120 VPE-TVYRASRHYAKLK----QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171
Query: 643 ILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKS 700
+LLD K+ DFG ++ + +VS + + Y PE T
Sbjct: 172 LLLDPPSGVLKLIDFGSAK-ILIAG-----EPNVSYIC--SRYYRAPELIFGATNYTTNI 223
Query: 701 DVYSLGVVFLELLTGMQPISHGKNIV 726
D++S G V EL+ G QP+ G++ +
Sbjct: 224 DIWSTGCVMAELMQG-QPLFPGESGI 248
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 518 QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
IG G +G VY+ L G +VA+K+ LQ ++ E+Q + +L H N+V L +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 577 DEEGEQM------LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS------RGILY 624
GE+ LV +++ + + ++ L + R + Y
Sbjct: 117 YSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 625 LHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
+H+ + HRDIK N+LLD K+ DFG ++ V +VS + +
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-QLVRG-----EPNVSYIC--SR 220
Query: 684 GYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIV 726
Y PE T DV+S G V ELL G QPI G + V
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGV 263
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 13/173 (7%)
Query: 67 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE 126
T H++ N + L L + LD LT LP L L L +N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQL- 89
Query: 127 GTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG---RL 182
++P + L L + L + L L L N+L ++PPG
Sbjct: 90 -QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 183 SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234
+ + L+NN LT +P+ +GL L L + NSL +IP + S L
Sbjct: 148 P-KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 16/206 (7%)
Query: 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 77
S + + LT +LP +L + + +N + + + +++ +
Sbjct: 11 SHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 78 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSN 136
LP L + L +N L LP LP L +L + N T++P
Sbjct: 68 --TKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRL--TSLPLGALRG 122
Query: 137 MSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLS 192
+ +L +L L+ L+ P L + P L L L++N L +P G L N+ T+ L
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLE-NLDTLLLQ 180
Query: 193 NNKLTGTIPSNFSGLPRLQRLFIANN 218
N L TIP F G L F+ N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 51/195 (26%), Positives = 70/195 (35%), Gaps = 33/195 (16%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
N + + L L L+ ELT L + LP L + + N + SLP
Sbjct: 41 NLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGT-LPVLGTLDLSHNQLQ-SLPLLGQ 97
Query: 63 NLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQL 120
L ++ N ++ +P L L + L N L LPP L + PKL L L
Sbjct: 98 TLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
NNN T +PA L+ + NL L L N L +IP G
Sbjct: 156 ANNNL--TELPAGL----------------------LNGLENLDTLLLQENSLY-TIPKG 190
Query: 181 RL-SLNITTIKLSNN 194
S + L N
Sbjct: 191 FFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 10/110 (9%)
Query: 161 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 220
+ ++ L ++PP L + T + LS N L + RL +L + L
Sbjct: 10 ASHLEVNCDKRNL-TALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 221 SGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTV-RLRGN 269
+ + TL T LD +N L ++ P +TV + N
Sbjct: 68 -----TKLQVDGTLPVLGT--LDLSHNQLQSLPLLGQTLPALTVLDVSFN 110
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 50/226 (22%), Positives = 82/226 (36%), Gaps = 18/226 (7%)
Query: 12 EIGNIKSLELLLLNGNELTGSLPEELG--YLPKLDRIQIDQNYISG---SLPKSFANLNK 66
+ I L+ L L E+TG+ P L P L+ + + + L + L
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 67 T-RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELS----ELPKLLILQLD 121
+ + ++ P+L + L +N G + + P L +L L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 122 NNNFE--GTTIPASYSNMSKLLKLSLRNCSLQG--PMPDLSRIPNLGYLDLSSNQLNGSI 177
N E A + +L L L + SL+ P L L+LS L +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 178 PPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 223
P G L ++ + LS N+L PS LP++ L + N S
Sbjct: 269 PKG-LPAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 56/279 (20%), Positives = 94/279 (33%), Gaps = 42/279 (15%)
Query: 28 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 87
EL G L ++D + + + I +I R
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTD------IIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 88 L---PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLS 144
+ L + L+N +TG PP L E + L+ N T A + + + LK
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 145 LRNCSLQG------PMPDLSRIPNLGYLDLSSNQLNG------SIPPGRLSLNITTIKLS 192
L+ S+ + P L LDLS N G ++ P + + + L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP-TLQVLALR 209
Query: 193 NNKLT---GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS----RTLNATETFI---- 241
N + G + + +LQ L +++NSL + + +LN + T +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 242 ---------LDFQNNNLTNISGSFNIPPNVTVRLRGNPF 271
LD N L +P + L+GNPF
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH----HR 567
+G+GG+G V+ G L D VA+K L E+ L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRG 621
++ L+ + + + MLV E L D ++ K E F ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-------A 151
Query: 622 ILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
I + H+ V HRDIK NIL+D + AK+ DFG L +
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--------DEPYTDFD- 199
Query: 681 GTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 727
GT Y PE+ H+ + V+SLG++ +++ G P + I+
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE 247
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL--VG 574
+G+G Y +V++ I + + V VK + +K+ EI+ L L N+++L +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADPP 632
LV+E ++N + + + F M L + + Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------KALDYCHSMG--- 150
Query: 633 VFHRDIKASNILLDHKFTA-KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
+ HRD+K N+++DH+ ++ D+GL+ P V + + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAE--------FYHPGQEYNVRVASRYFKGPELL 202
Query: 692 LTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKN 724
+ +++ D S D++SLG + ++ +P HG +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ +V E++S G L D + + A RL + S + Y H V
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--AVDYCHRHM---VV 133
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 184
Query: 695 KLTD--KSDVYSLGVVFLELLTGMQP 718
+L + D++S GV+ LL G P
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLHHR--NL 569
+G GG+G VY GI + D VA+K + G L E+ L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 570 VSLVGYCDEEGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+ L+ + + +L+ E L D ++ + A + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--AVRHCHNC 168
Query: 629 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
V HRDIK NIL+D ++ K+ DFG L + GT Y
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--------DTVYTDFD-GTRVYSP 216
Query: 688 PEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVR 727
PE+ H+ + V+SLG++ +++ G P H + I+R
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 257
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSLVG 574
++G+G + V + + G A K L ++ E + +L H N+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 632
EE LV++ ++ G L + + A+ E I I Y H+
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNG--- 148
Query: 633 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HR++K N+LL K K+ADFGL+ + + GTPGYL PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--------VNDSEAWHGFAGTPGYLSPE 200
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
+ D+++ GV+ LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
IG+G + KV + G VA+K + Q +K F E++ + L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ E L+ E+ S G + D L A + A + S + Y H + +
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--AVQYCHQKR---IV 136
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+KA N+LLD K+ADFG S + G P Y PE F
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNE-FTVG------GKLDAFC-GAPPYAAPELFQ-G 187
Query: 695 KLTD--KSDVYSLGVVFLELLTGMQP 718
K D + DV+SLGV+ L++G P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 17/221 (7%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNK 66
IP + S + L L+ N L P+L + + + I ++ ++ +L+
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 67 TRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 124
+ N I + S L SL ++ NL L L L L + +N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 125 FEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGY----LDLSSNQLNGSIPP 179
+ +P +SN++ L L L + +Q DL + + LDLS N +N I P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 180 GRL-SLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANN 218
G + + + L N+L ++P F L LQ++++ N
Sbjct: 195 GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 43/224 (19%), Positives = 75/224 (33%), Gaps = 46/224 (20%)
Query: 81 IPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPAS-YSNMS 138
+P L L N L +L P+L +L L TI Y ++S
Sbjct: 26 LPFSTKNL------DLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI--QTIEDGAYQSLS 76
Query: 139 KLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNN 194
L L L +Q + S + +L L L S+ L + + +++N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLK-TLKELNVAHN 134
Query: 195 KLTGTIPSN--FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 252
+ + FS L L+ L +++N + SI + + LD N + I
Sbjct: 135 LIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 253 -SGSF----------------NIPPNV--------TVRLRGNPF 271
G+F ++P + + L NP+
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 176 SIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234
IP L + + LS N L + S F P LQ L ++ + +I +QS L
Sbjct: 21 KIPDN-LPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS--L 75
Query: 235 NATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNP 270
+ T L N + ++ G+F+ ++
Sbjct: 76 SHLST--LILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 7e-22
Identities = 45/242 (18%), Positives = 83/242 (34%), Gaps = 25/242 (10%)
Query: 547 SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSA-KSKEP 605
S +I+ + +N V + + + + L+D ++ S E
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 606 LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR----- 660
+ L I + + + +LH++ + HRD+K SNI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 661 --LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
V H V GT Y+ PE + + K D++SLG++ ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQV--GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
Query: 719 ISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV 778
I+ +V + ++ + + RP +++
Sbjct: 276 QMERVRIITDVR------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
Query: 779 MR 780
+
Sbjct: 324 IE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 568
+F +G+GG+G V++ D A+KR ++ + E++ L++L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 569 LVSLVGYCDEEGEQMLVYEFMSN 591
+V E + E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEI 88
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 36/217 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK-----RAQEGSLQGEKEFLT---EIQFLSRLHHRNL 569
+G G +G V+ + V VK + E + + EI LSR+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGT-LRDQLSAKSK--EPLG---FAMRLSIALGSSRGIL 623
+ ++ + +G LV E +G L + + EPL F +S +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-------AVG 144
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
YL + + HRDIK NI++ FT K+ DFG + T GT
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERG------KLFYTFC-GTI 193
Query: 684 GYLDPEYFLTHKLTD--KSDVYSLGVVFLELLTGMQP 718
Y PE L + +++SLGV L+ P
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--------RAQEGSLQGEKEFLTEIQFLSRLHHRN 568
+G G G+V VA+K TEI+ L +L+H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLH 626
++ + + D E + +V E M G L D++ + E + L + YLH
Sbjct: 77 IIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLH 131
Query: 627 TEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
+ HRD+K N+LL + K+ DFG S++ + + + GTP
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--------LGETSLMRTLCGTP 180
Query: 684 GYLDPE---YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
YL PE T D +SLGV+ L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 22/209 (10%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVG 574
++G+G + V + + + G A L ++ E + L H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEADPP 632
EEG L+++ ++ G L + + A+ E I +L+ H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----EAVLHCHQMG--- 130
Query: 633 VFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
V HR++K N+LL K K+ADFGL+ GTPGYL PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ------QAWFGFA-GTPGYLSPE 183
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
D+++ GV+ LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 36/214 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 575
+G G GKV + G A+K L + E+ + ++V ++ Y
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 576 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 627
+ + + E M G L ++ + + MR I I +LH+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-DIG----TAIQFLHS 146
Query: 628 EADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 684
+ HRD+K N+L K K+ DFG ++ + T TP
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--------TTQNALQTPC-YTPY 194
Query: 685 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
Y+ PE K D++SLGV+ LL G P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 6e-21
Identities = 45/227 (19%), Positives = 77/227 (33%), Gaps = 15/227 (6%)
Query: 15 NIKSLELLLLNGNELTGSLPEELGY-----LPKLDRIQIDQNYISGSLPKSFANLNKTRH 69
++ ++ +L G L L L Q+ + + +
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 70 FHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 129
+ + S++ +H+ NN LT + L +L L L N
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL--KE 362
Query: 130 IPASYS---NMSKLLKLSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIPPGRLSL 184
+ M L +L + S+ S +L L++SSN L L
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT-DTIFRCLPP 421
Query: 185 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 231
I + L +NK+ +IP L LQ L +A+N L S+P I+
Sbjct: 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 9e-16
Identities = 54/316 (17%), Positives = 98/316 (31%), Gaps = 55/316 (17%)
Query: 3 NKISGSIP--KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLD-RIQIDQNYISGSLPK 59
N ++P KE GN+ L+ L L+ L S + +L + + + Y P+
Sbjct: 100 NAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE 158
Query: 60 SFANLNKTRHFHMN---NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 116
+ N T H+ N + + + +L + LS L KL
Sbjct: 159 GLQDFN-TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQ 217
Query: 117 I------LQLDNNNFEGTTIPASYSNM--SKLLKLSLRNCSLQGPMP------------- 155
L L+N + + + + S+ N LQG +
Sbjct: 218 TNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277
Query: 156 ---------DLSRIP----------NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 196
N+ +S ++ + P ++S + SNN L
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS-PFLHLDFSNNLL 336
Query: 197 TGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS--G 254
T T+ N L L+ L + N L + T LD N+++ G
Sbjct: 337 TDTVFENCGHLTELETLILQMNQLK-ELSKIA--EMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 255 SFNIPPNVTV-RLRGN 269
+ ++ + N
Sbjct: 394 DCSWTKSLLSLNMSSN 409
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 36/166 (21%), Positives = 71/166 (42%), Gaps = 10/166 (6%)
Query: 14 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS---FANLNKTRHF 70
I L + N LT ++ E G+L +L+ + + N + L K + +
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379
Query: 71 HMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 129
++ NS+S S SL+ + + +N LT + L P++ +L L +N +
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI--KS 435
Query: 130 IPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLN 174
IP + L +L++ + L+ P R+ +L + L +N +
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 6e-12
Identities = 44/274 (16%), Positives = 84/274 (30%), Gaps = 19/274 (6%)
Query: 24 LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 83
+ N L +P++L K + I QNYIS +L+K R +++N I +
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDI 62
Query: 84 E-LSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 142
L ++ L +N L + L L L N F+ I + NMS+L
Sbjct: 63 SVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
Query: 143 LSLRNCSLQ-GPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS----LNITTIKLSNNKLT 197
L L L+ + ++ + L + P L ++ + +N +
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 198 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF------ILDFQNNNLTN 251
+ + + L+ I + L ++ N+
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 252 ISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 285
I + + F S +
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 46/314 (14%), Positives = 92/314 (29%), Gaps = 55/314 (17%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS- 60
N+I + LE L L+ N+L + L + + N +LP
Sbjct: 54 HNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICK 109
Query: 61 -FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELP--KLL 116
F N+++ + ++ + ++ L +L+ PE L + L
Sbjct: 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLH 169
Query: 117 ILQLDNNNFE-------GTTIPASYSNMSKLL----------------------KLSLRN 147
I+ N F T SN+ +L L+L N
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229
Query: 148 CSLQGP----MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIK------LSNNKLT 197
+ L + Y +S+ +L G + + T++K + ++
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 198 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSF 256
+ + + + ++ LDF NN LT+ +
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSK--ISPFLH--LDFSNNLLTDTVFENC 344
Query: 257 NIPPNVTV-RLRGN 269
+ L+ N
Sbjct: 345 GHLTELETLILQMN 358
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G G +GKV G G VAVK R + SL + EIQ L H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ +V E++S G L D + + + RL + S G+ Y H V
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHRHM---VV 138
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K N+LLD AK+ADFGLS + + T G+P Y PE ++
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDG------EFLRTSC-GSPNYAAPE-VISG 189
Query: 695 KLTD--KSDVYSLGVVFLELLTGMQP 718
+L + D++S GV+ LL G P
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 34/213 (15%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSL 572
+G+G + K + AVK + E + Q EI L H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKL 71
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTE 628
++ LV E ++ G L +++ K E A + L S + ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE----ASYIMRKLVS--AVSHMHDV 125
Query: 629 ADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
V HRD+K N+L + K+ DFG +RL P + + T T Y
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN------QPLKTPC-FTLHY 175
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE + + D++SLGV+ +L+G P
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAV----KRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
++G+G VY+ A+ K + ++ TEI L RL H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEIGVLLRLSHPNIIKL 113
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLGFAMRLSIALGSSRGILYLHTEAD 630
+ E LV E ++ G L D++ K E I + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENG- 168
Query: 631 PPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ HRD+K N+L K+ADFGLS++ + + V GTPGY
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--------VEHQVLMKTVCGTPGYCA 218
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
PE + D++S+G++ LL G +P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGY 575
IG G Y + I AVK + +E I+ L R H N+++L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKDV 84
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTEADP 631
D+ +V E M G L D++ + F A + + + YLH +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASAVLFTITK--TVEYLHAQG-- 136
Query: 632 PVFHRDIKASNILL----DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
V HRD+K SNIL + + ++ DFG ++ + + T T ++
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN------GLLMTPC-YTANFVA 188
Query: 688 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
PE L + D + D++SLGV+ +LTG P
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 40/237 (16%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEF----LTEIQFLSRL 564
+ F GQG +G V G G VA+K+ + + F L +Q L+ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 565 HHRNLVSLVGYCDEEGEQ-------MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 617
HH N+V L Y GE+ +V E++ D L + + L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILI 131
Query: 618 SS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGI 670
R I LH + V HRDIK N+L++ T K+ DFG ++ P
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPS---- 185
Query: 671 VPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIV 726
+V+ + + Y PE ++ T D++S+G +F E++ G +PI G N
Sbjct: 186 -EPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSA 238
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 3e-20
Identities = 67/344 (19%), Positives = 113/344 (32%), Gaps = 95/344 (27%)
Query: 518 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRL-HHRNL 569
+G+G +G+V + VAVK +EG+ E + ++E++ L + HH N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 570 VSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR----------------- 611
V+L+G C G M++ EF G L L +K E + + +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 612 --------------LSIALGSSRGILYLHTEADPPVFHRDIKASNILL------------ 645
S + + + E P ++D L+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 646 ------------------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
K K+ DFGL+R DI V+ L
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIY-----KDPDYVRKGDARLP 258
Query: 688 -----PEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741
PE T +SDV+S GV+ E+ + G P + +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---------GVKIDEEFCRRL 309
Query: 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+G P + + L C E RP+ SE++ L ++
Sbjct: 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 32/233 (13%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 566
+ + IG G G V VA+K+ + K E+ + ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 567 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 617
+N++ L V + E+ +V E M ++ +L + L + M
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML------ 137
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
GI +LH+ A + HRD+K SNI++ T K+ DFGL+R + + T
Sbjct: 138 --CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMT 184
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 730
T Y PE L + D++S+G + E++ G + G + + + N
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWN 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-20
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 566
+ F +G+GG+G+V+ + G + A K+ + L+ K + + E + L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 567 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 619
R +VSL Y E + LV M+ G +R + ++ GF + I G
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
+ +LH + +RD+K N+LLD +++D GL+ E +
Sbjct: 302 --LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV-------ELKAGQTKTKGY 349
Query: 680 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
GTPG++ PE L + D ++LGV E++ P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 59/342 (17%), Positives = 109/342 (31%), Gaps = 57/342 (16%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNK 66
IP ++ ++ L +L L++I+I QN + + F+NL K
Sbjct: 23 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 67 TRHFHM-NNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNN 123
+ N++ I PE LP+L ++L+ N + +LP + ++L + +N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 124 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG--R 181
N+ + + S S L L+ N + I
Sbjct: 139 I-----------NIHTIERNSFVGLS-----------FESVILWLNKNGIQ-EIHNSAFN 175
Query: 182 LSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+ NN L +P++ F G L I+ + S+PS + N +
Sbjct: 176 GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLE----NLKKLR 229
Query: 241 ILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC--------LNTNAEQFCGSHSDDDNEID 292
NL + + + L C + C + S E+D
Sbjct: 230 ARS--TYNLKKLPTLEKLVALMEASLTYPSHCCAFANWRRQISELHPIC-NKSILRQEVD 286
Query: 293 RSTN------STLDCRAQSCPTDYEYSPTSPIRCFCAAPLLV 328
T S + S ++ + T C + V
Sbjct: 287 YMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDLCNEVVDV 328
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 21/209 (10%)
Query: 73 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIP 131
+ ++ +IP +L + + + L + S L +++ N+ I
Sbjct: 17 QESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL-EVIE 71
Query: 132 AS-YSNMSKLLKLSLRNC-SLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNI 186
A +SN+ KL ++ + +L P+ +PNL YL +S+ + +P SL
Sbjct: 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQK 130
Query: 187 TTIKLSNNKLTGTIPSN-FSGLP-RLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 244
+ + +N TI N F GL L++ N + I +S + E + D
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG--TQLDELNLSD- 186
Query: 245 QNNNLTNIS-GSF-NIPPNVTVRLRGNPF 271
NNNL + F V + +
Sbjct: 187 -NNNLEELPNDVFHGASGPVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 39/224 (17%), Positives = 68/224 (30%), Gaps = 35/224 (15%)
Query: 2 WNKISGSIPKEI-GNIKSL-ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK 59
N + I ++ N+ L E+ + N L PE LP L + I I
Sbjct: 63 QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 122
Query: 60 SFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHML-LDNNNLTGYLPPELSELPKLL- 116
+ + + +N I L +L L+ N + + +L
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE 181
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176
+ DNNN +P LD+S +++ S
Sbjct: 182 LNLSDNNNL--EELPND----------------------VFHGASGPVILDISRTRIH-S 216
Query: 177 IPPGRLSLNITTIK-LSNNKLTGTIPSNFSGLPRLQRLFIANNS 219
+P L N+ ++ S L +P+ L L + S
Sbjct: 217 LPSYGLE-NLKKLRARSTYNLK-KLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 22/107 (20%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 166 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSI 224
+++ IP L N ++ KL I FSG L+++ I+ N + I
Sbjct: 14 FLCQESKVT-EIPSD-LPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 225 PSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 269
+ ++ + L ++ + NNL I +F PN+ +
Sbjct: 71 EADVFSN--LPKLHEIRIE-KANNLLYINPEAFQNLPNLQYLLISNT 114
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 60/271 (22%), Positives = 91/271 (33%), Gaps = 45/271 (16%)
Query: 519 IGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHR 567
I G YG V G+ +G VA+KR G K L EI+ L+ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 568 NLVSLV-----GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622
N++ L + LV E M T Q+ + + G+
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 623 LYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST--VVK 680
LH A V HRD+ NILL + DF L+R T V
Sbjct: 148 HVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAR--------EDTADANKTHYVT- 195
Query: 681 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739
Y PE + K K D++S G V E+ + + G Q + +
Sbjct: 196 -HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYN------QLNKIV 247
Query: 740 SVI----DGNMGSYPSECVEKFIKLALKCCQ 766
V+ ++ + S +++ +L
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 20/205 (9%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
IG G +G +VAVK + G+ E EI L H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFKEVIL 86
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
++ E+ S G L +++ + A L S G+ Y H+ + HRD
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--GVSYCHSMQ---ICHRD 141
Query: 638 IKASNILLDHKFTA--KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
+K N LLD K+ DFG S+ V + + V GTP Y+ PE L +
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKS-SVLH------SQPKSTV-GTPAYIAPE-VLLRQ 192
Query: 696 LTD--KSDVYSLGVVFLELLTGMQP 718
D +DV+S GV +L G P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G+G +GKV VA+K R EI +L L H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ ++V E+ + G L D + K + R + I Y H +
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC--AIEYCHRHK---IV 130
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K N+LLD K+ADFGLS + + T G+P Y PE +
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNI-MTDG------NFLKTSC-GSPNYAAPE-VING 181
Query: 695 KLTD--KSDVYSLGVVFLELLTGMQP 718
KL + DV+S G+V +L G P
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 2e-19
Identities = 54/285 (18%), Positives = 95/285 (33%), Gaps = 27/285 (9%)
Query: 15 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 74
L +T L +D+I + + I S+ + L +N
Sbjct: 19 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 75 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 134
N ++ I P L+ L +L + LD N + L +L KL L L++N + I
Sbjct: 75 NKLT-DIKP-LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI--SDING-L 127
Query: 135 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 194
++ +L L L N + + LSR+ L L L NQ++ I P + + LS N
Sbjct: 128 VHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKN 185
Query: 195 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254
+ + +GL L L + + N + N G
Sbjct: 186 HI--SDLRALAGLKNLDVLELFSQEC------------LNKPINHQSNLVVPNTVKNTDG 231
Query: 255 SFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTL 299
S P ++ + + +F S + +
Sbjct: 232 SLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 30/195 (15%), Positives = 71/195 (36%), Gaps = 26/195 (13%)
Query: 91 LVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 150
+ + + + P + + L + + + ++ + ++ N +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAV---TQNELNSIDQIIANNSDI 55
Query: 151 QGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRL 210
+ + + +PN+ L L+ N+L I P N+ + L NK+ + S+ L +L
Sbjct: 56 KS-VQGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKL 111
Query: 211 QRLFIANNSLSGSIP--SSIWQSRTLNATETFI--------------LDFQNNNLTNISG 254
+ L + +N +S I + Q +L I L ++N +++I
Sbjct: 112 KSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP 170
Query: 255 SFNIPPNVTVRLRGN 269
+ + L N
Sbjct: 171 LAGLTKLQNLYLSKN 185
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 575
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 576 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPL-----GFAMRLSIALGSSRGILYLHT 627
+ + + E + G L ++ + + M+ SI I YLH+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-SIG----EAIQYLHS 179
Query: 628 EADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 684
+ HRD+K N+L K K+ DFG ++ + ++T TP
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-------LTTPC-YTPY 228
Query: 685 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
Y+ PE K D++SLGV+ LL G P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 8e-19
Identities = 39/219 (17%), Positives = 70/219 (31%), Gaps = 10/219 (4%)
Query: 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSI 77
++ L + L L + S ++ + ++ +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 78 SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM 137
S + N T + S L +L L L N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL--KNFFKVALMT 399
Query: 138 SKLLKLSLRNCSLQ----GPMPDLSRIP-NLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 192
+ L + SL ++ L+LSSN L GS+ L + + L
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLH 458
Query: 193 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 231
NN++ +IP + + L LQ L +A+N L S+P ++
Sbjct: 459 NNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 50/288 (17%), Positives = 96/288 (33%), Gaps = 26/288 (9%)
Query: 3 NKISGSIPKEIGNIKSLELLL-LNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
K + ++ +LL L + G E L + + + S +
Sbjct: 156 AKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVN 214
Query: 62 ANLNKTRHFHMNNNSISGQ-------IPPELSRLPSLVHMLLDNNNLTGYLPPELSEL-- 112
++N H ++N ++ + EL+R P+L+++ L + T +L +
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274
Query: 113 -PKLLILQLDNNNFEGTTIPASYSNMSKLLK----LSLRNCSLQGPMPDL-SRIPNLGYL 166
+ L + N ++ LK ++N L S +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 167 DLSSNQLNG--SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224
LS + + P S + T + + N T ++ S L RLQ L + N L +
Sbjct: 335 MLSISDTPFIHMVCPPSPS-SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392
Query: 225 PSSIWQSRTLNATETFILDFQNNNLTNI--SGSFNIPPNVTV-RLRGN 269
T N + LD N+L + + ++ V L N
Sbjct: 393 FKVA--LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 41/188 (21%), Positives = 72/188 (38%), Gaps = 37/188 (19%)
Query: 14 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 73
+ S L N T S+ + L +L + + +N + + K
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408
Query: 74 NNSI----SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTT 129
+ S+ S + S++ + L +N LTG + L PK+ +L L NN +
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRI--MS 464
Query: 130 IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNI 186
IP +++ L L L+++SNQL S+P G RL+ ++
Sbjct: 465 IPK---DVTHL--------------------QALQELNVASNQLK-SVPDGVFDRLT-SL 499
Query: 187 TTIKLSNN 194
I L +N
Sbjct: 500 QYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 49/297 (16%), Positives = 98/297 (32%), Gaps = 46/297 (15%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS-FANLNK 66
+PK++ + L L+ N ++ ++ +L +L +++ N I SL F
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 67 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNN 124
+ +++N + I + SL H+ L N+ LP E L KL L L
Sbjct: 102 LEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTFLGLSAAK 157
Query: 125 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 184
F + + L L + ++G + +IPN L L + + +S+
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 185 N-ITTIKLSNNKLTGTIPSNFSGL----------------------------------PR 209
N + ++LSN KL
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 210 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTVR 265
++ L I N +++ I + I +N +++ + ++
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 165 YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224
+D S+ L +P L + LS N ++ + S L L+ L +++N + S+
Sbjct: 35 MVDYSNRNLT-HVPKD-LPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SL 91
Query: 225 PSSIWQSRTLNATETFILDFQNNNLTNIS 253
++ E LD +N L NIS
Sbjct: 92 DFHVFLF--NQDLEY--LDVSHNRLQNIS 116
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 45/267 (16%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHH 566
+ S T +G G YG V I G VA+K+ S K E+ L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 567 RNLVSL--VGYCDEEGEQM----LVYEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALG 617
N++ L V LV FM + + S + + L + M
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML------ 136
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
+G+ Y+H+ A V HRD+K N+ ++ K+ DFGL+R A ++ G V
Sbjct: 137 --KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYV------ 184
Query: 678 VVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736
T Y PE L+ +++ D++S+G + E+LTG + + GK+ + Q +
Sbjct: 185 ---VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLD------QLT 234
Query: 737 MMFSVI----DGNMGSYPSECVEKFIK 759
+ V + + + +I+
Sbjct: 235 QILKVTGVPGTEFVQKLNDKAAKSYIQ 261
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 42/234 (17%), Positives = 90/234 (38%), Gaps = 20/234 (8%)
Query: 37 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96
L +I ++ ++ + A+L+ ++ I + L +L+ + L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD 156
+N +T L L K+ L+L N + A + + + L L + + +
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPL--KNVSA-IAGLQSIKTLDLTSTQITD-VTP 124
Query: 157 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 216
L+ + NL L L NQ+ +I P N+ + + N +++ + + L +L L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKAD 181
Query: 217 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNP 270
+N +S P + + + +NN ++++S N V L
Sbjct: 182 DNKISDISPLA-------SLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 53/262 (20%), Positives = 104/262 (39%), Gaps = 19/262 (7%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
++ +I + + +L L L N++T L L K+ +++ N + +
Sbjct: 50 GTGVT-TIE-GVQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKN--VSAI 103
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
A L + + + I+ P L+ L +L + LD N +T L+ L L L +
Sbjct: 104 AGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIG 159
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
N + + +N+SKL L + + + L+ +PNL + L +NQ++ P
Sbjct: 160 NAQV--SDLTP-LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSPLAN 215
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
S N+ + L+N +T + L + S + P++I S +
Sbjct: 216 TS-NLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATI--SDNGTYASPNL 270
Query: 242 LDFQNNNLTNISGSFNIPPNVT 263
+ + N+S +FN
Sbjct: 271 TWNLTSFINNVSYTFNQSVTFK 292
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-18
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 32/264 (12%)
Query: 475 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LP 533
+ I++ + SK+ + + + IG G G V
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 534 DGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LV 585
VA+K+ + K E+ + ++H+N++SL V + E+ LV
Sbjct: 86 LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 586 YEFMS---NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 642
E M ++ +L + L + M GI +LH+ A + HRD+K SN
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQML--------CGIKHLHS-AG--IIHRDLKPSN 194
Query: 643 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDV 702
I++ T K+ DFGL+R A + + T T Y PE L + D+
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 703 YSLGVVFLELLTGMQPISHGKNIV 726
+S+G + E++ + + G++ +
Sbjct: 247 WSVGCIMGEMVRH-KILFPGRDYI 269
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 27/164 (16%), Positives = 59/164 (35%), Gaps = 7/164 (4%)
Query: 12 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 71
+ SL + L +T L + Y + + I+ + + + L+
Sbjct: 39 TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 72 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 131
+ ++ P LS L SL + + ++ + +++ LPK+ + L N T
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG--AITDI 152
Query: 132 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG 175
+ +L L+++ + + P L L S + G
Sbjct: 153 MPLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 35/162 (21%), Positives = 68/162 (41%), Gaps = 11/162 (6%)
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
+ + + +S + +++ SL ++ L N N+T L + + L ++
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTIN 74
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
N + T S +S L +L + + +P+LS + +L LD+S + + SI
Sbjct: 75 NIHA--TNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 181 RLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
+L + +I LS N I LP L+ L I + +
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 27/168 (16%), Positives = 62/168 (36%), Gaps = 14/168 (8%)
Query: 88 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 147
+ ++ LL ++ +++ L + L N N T + L++ N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLT---GIEYAHNIKDLTINN 75
Query: 148 CSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSG 206
P +S + NL L + + P L ++T + +S++ +I + +
Sbjct: 76 IHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 207 LPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254
LP++ + ++ N I + L L+ Q + + + G
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELK-----SLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 26/122 (21%), Positives = 44/122 (36%), Gaps = 5/122 (4%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+ P I + +LE L + G ++T L L L + I + S+
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
L K ++ N I P L LP L + + + + Y + + PKL L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 123 NN 124
Sbjct: 191 QT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 30/146 (20%), Positives = 59/146 (40%), Gaps = 12/146 (8%)
Query: 110 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 169
S L L ++ T + + M+ L ++L N ++ + + N+ L ++
Sbjct: 20 STFKAYLNGLLGQSS----TANITEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTIN 74
Query: 170 SNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIW 229
+ P LS N+ +++ +T N SGL L L I++++ SI + I
Sbjct: 75 NIHATNYNPISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 230 QSRTLNATETFILDFQNNN-LTNISG 254
+N +D N +T+I
Sbjct: 134 TLPKVN-----SIDLSYNGAITDIMP 154
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 19/184 (10%)
Query: 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY--SNMSKLLKLSLRNCSLQGPMP 155
L +P L +L L +NN + + A + + ++ L L L + L
Sbjct: 27 KQQLPN-VPQSLP--SYTALLDLSHNNL--SRLRAEWTPTRLTNLHSLLLSHNHLNFISS 81
Query: 156 D-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQ 211
+ +PNL YLDLSSN L+ ++ S + + L NN + + N F + +LQ
Sbjct: 82 EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQ 139
Query: 212 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS-GSFNIPPN---VTVRLR 267
+L+++ N +S P + + + +LD +N L + P + L
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGN-KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 268 GNPF 271
NP
Sbjct: 198 NNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 45/280 (16%), Positives = 88/280 (31%), Gaps = 55/280 (19%)
Query: 41 PKLDRIQIDQNYISGSLPK--SFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLD 97
+ + N +S L + L +++N ++ I E +P+L ++ L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 98 NNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD 156
+N+L L S+L L +L L NN+ + +
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHI--VVVDRN----------------------A 131
Query: 157 LSRIPNLGYLDLSSNQLNGSIPPG------RLSLNITTIKLSNNKLTGTIPSNFSGLPRL 210
+ L L LS NQ++ P +L + + LS+NKL ++ LP
Sbjct: 132 FEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLP-KLMLLDLSSNKLKKLPLTDLQKLPAW 189
Query: 211 QR--LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRG 268
+ L++ NN L + + +L + +L
Sbjct: 190 VKNGLYLHNNPLECD-CKLYQLFSHWQYRQLSSVMDFQEDLYCMHSK---------KLHN 239
Query: 269 NPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPT 308
+ + C + + E T+ C +
Sbjct: 240 ----IFSLDFFNCSEYKESAWEAHLGDTLTIRCDTKQQGM 275
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 34/154 (22%), Positives = 63/154 (40%), Gaps = 17/154 (11%)
Query: 3 NKISGSIPKEI--GNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPK 59
N +S + E + +L LLL+ N L + E +P L + + N++ +L +
Sbjct: 49 NNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDE 105
Query: 60 -SFANLNKTRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE----LSELP 113
F++L + NN I + + L + L N ++ P E ++LP
Sbjct: 106 FLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLP 163
Query: 114 KLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLR 146
KL++L L +N +P + +K L
Sbjct: 164 KLMLLDLSSNKL--KKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 11/131 (8%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLPKS 60
N ++ I E + +L L L+ N L +L E L L+ + + N+I +
Sbjct: 74 NHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNA 131
Query: 61 FANLNKTRHFHMNNNSISGQIPPE----LSRLPSLVHMLLDNNNLTGYLPPELSELPKL- 115
F ++ + + +++ N IS + P E ++LP L+ + L +N L +L +LP
Sbjct: 132 FEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 116 -LILQLDNNNF 125
L L NN
Sbjct: 191 KNGLYLHNNPL 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 61/268 (22%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 573
+G+G YG V P G +VA+K+ + L EI+ L H N++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 574 --GYCDEEGEQMLVYEFM--------SNGTLRD--------QLSAKSKEPLGFAMRLSIA 615
+ E ++ E M S L D Q
Sbjct: 79 RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT----------------- 121
Query: 616 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675
L R + LH ++ V HRD+K SN+L++ KV DFGL+R+ + P
Sbjct: 122 L---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 676 STVVKG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNI 731
+ + T Y PE LT ++ DV+S G + EL +PI G++
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRH---- 230
Query: 732 AYQSSMMFSVIDGNMGSYPSECVEKFIK 759
Q ++F +I G+ S+ + I+
Sbjct: 231 --QLLLIFGII----GTPHSDNDLRCIE 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 511 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 563
++F IG+G +GKV + A+K + E E+Q +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 564 LHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGS 618
L H LV+L Y ++ E M +V + + G LR L E F L +AL
Sbjct: 72 LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD- 129
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 678
YL + + HRD+K NILLD + DF ++ + + T
Sbjct: 130 -----YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM--------LPRETQITT 173
Query: 679 VKGTPGYLDPEYFLTHKLT--DKS-DVYSLGVVFLELLTGMQP 718
+ GT Y+ PE F + K + D +SLGV ELL G +P
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 23/207 (11%), Positives = 51/207 (24%), Gaps = 49/207 (23%)
Query: 518 QIGQGGYGKVYKGILPD---GTVVAVK--RAQEGSLQGEKE-FLTEIQFLSRLHHRNLVS 571
G + ++ + D VA+ Q + L+ LSR+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 572 LVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADP 631
++ ++V E++ G+L++ + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 632 PVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF 691
V S + + +A + +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPAT--MPDA----------------------NPQ-- 182
Query: 692 LTHKLTDKSDVYSLGVVFLELLTGMQP 718
D+ +G LL P
Sbjct: 183 --------DDIRGIGASLYALLVNRWP 201
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 45/208 (21%), Positives = 77/208 (37%), Gaps = 17/208 (8%)
Query: 18 SLELLLLNGNELTGSLPEE-LGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHM-NN 74
S + L L L ++P LP + RI + + L SF NL+K H + N
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 75 NSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNNFEGTTIP 131
+++ I P+ L LP L + + N L P + IL++ +N + T+IP
Sbjct: 91 RNLT-YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM-TSIP 147
Query: 132 A-SYSNMSKLLK-LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNI 186
++ + L L N L + L+ N+ I +
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 187 TTIKLSNNKLTGTIPSN-FSGLPRLQRL 213
+ + +S +T +PS L L
Sbjct: 208 SLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 39/198 (19%), Positives = 73/198 (36%), Gaps = 18/198 (9%)
Query: 67 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 124
T+ + + IP S LP++ + + + L L K+ +++ N
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 125 FEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRI---PNLGYLDLSSNQLNGSIPPG 180
T I + L L + N L+ PDL+++ L+++ N SIP
Sbjct: 92 NL-TYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 181 ---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236
L T+KL NN T ++ F+G +L +++ N I +
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 237 TETFILDFQNNNLTNISG 254
+ LD ++T +
Sbjct: 208 SL---LDVSQTSVTALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 39/214 (18%), Positives = 80/214 (37%), Gaps = 15/214 (7%)
Query: 40 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDN 98
P +++ + ++ +F+NL +++ + Q+ L + H+ + N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 99 NNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASY--SNMSKLLKLSLRNCSLQGPMP 155
Y+ P+ L ELP L L + N P + L + + +P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGL--KMFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 156 D--LSRIPN-LGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSN-FSGLPR- 209
+ N L L +N S+ + + + L+ NK I + F G+
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 210 LQRLFIANNSLSGSIPSSIWQS-RTLNATETFIL 242
L ++ S++ ++PS + + L A T+ L
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 35/152 (23%), Positives = 59/152 (38%), Gaps = 15/152 (9%)
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--L 184
IP S L L L+ P S +PN+ + +S + +
Sbjct: 24 QRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 185 NITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243
+T I++ N + I + LP L+ L I N L P ++ + FIL+
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL---TKVYSTDIFFILE 136
Query: 244 FQNNN-LTNIS-GSFNIPPN--VTVRLRGNPF 271
+N +T+I +F N +T++L N F
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 22/153 (14%), Positives = 52/153 (33%), Gaps = 12/153 (7%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEE--LGYLPKLDRIQIDQNYISGSLPK 59
+ I + + L+ L + L P+ + ++I N S+P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 60 -SFANL-NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLL 116
+F L N+T + NN + + L + L+ N + + +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 117 -ILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRN 147
+L + + T +P+ ++ +L+ +
Sbjct: 208 SLLDVSQTSV--TALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 22/93 (23%), Positives = 39/93 (41%), Gaps = 8/93 (8%)
Query: 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSL 220
++ + IP L + T+KL L TIPS+ FS LP + R++++ +
Sbjct: 12 QEEDFRVTCKDIQ-RIP--SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVT 67
Query: 221 SGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253
+ S + + L+ + NLT I
Sbjct: 68 LQQLESHSFYN--LSKVTHIEI-RNTRNLTYID 97
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 8e-18
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHH 566
N F +G+GG+G+V + G + A K+ ++ ++ K L E Q L +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 567 RNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------IALGSS 619
R +VSL Y E + + LV M+ G L+ + + GF + I G
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAEICCG-- 298
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
+ LH E + +RD+K NILLD +++D GL+ + V
Sbjct: 299 --LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV-------HVPEGQTIKGRV 346
Query: 680 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
GT GY+ PE + T D ++LG + E++ G P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 68/257 (26%), Positives = 103/257 (40%), Gaps = 33/257 (12%)
Query: 475 HMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY----KG 530
R S S + S + + N F +G+G +GKV K
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171
Query: 531 ILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVY 586
G A+K ++ + + E LTE + L H L +L Y + +++ V
Sbjct: 172 ---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM 227
Query: 587 EFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 642
E+ + G L LS + E + + AL YLH+E + V +RD+K N
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALD------YLHSEKN--VVYRDLKLEN 279
Query: 643 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 701
++LD K+ DFGL + EGI GTP YL PE L ++ D
Sbjct: 280 LMLDKDGHIKITDFGLCK-------EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 331
Query: 702 VYSLGVVFLELLTGMQP 718
+ LGVV E++ G P
Sbjct: 332 WWGLGVVMYEMMCGRLP 348
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 511 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 563
+F +G+G + V A+K ++ + E + E +SR
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 619
L H V L ++ + + NG L + E + + AL
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE-- 144
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
YLH + + HRD+K NILL+ ++ DFG +++ + A+ + V
Sbjct: 145 ----YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV--LSPESKQARAN--SFV 193
Query: 680 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
GT Y+ PE LT K KS D+++LG + +L+ G+ P
Sbjct: 194 -GTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 573
IG G YG V + + VVA+K+ L K L EI L+RL+H ++V ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 574 ---GYCDEEGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE 628
++ E +V E + D ++ L ++ G+ Y+H+
Sbjct: 121 VIPKDVEKFDELYVVLEIA--DS--D-FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
A + HRD+K +N L++ + KV DFGL+R P+
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 689 EYFLTHKLTD--------------------KS-DVYSLGVVFLELLTGMQP 718
L +LT ++ DV+S+G +F ELL ++
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 42/236 (17%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVK---------RAQEGSLQGEKEFLTEIQF 560
N+F+ IG+GG+G+VY D G + A+K + E E+ L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-- 246
Query: 561 LSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLS------ 613
S +V + Y +++ + + M+ G L LS F+
Sbjct: 247 -STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAE 300
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673
I LG + ++H V +RD+K +NILLD +++D GL+ V
Sbjct: 301 IILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVRE 728
GT GY+ PE D S D +SLG + +LL G P K +
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 67 TRHFHMNNNSISGQIPPE-LSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNN 124
T+ + +N +S +P + RL L + L++N L LP + EL L L + +N
Sbjct: 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 125 FEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG-- 180
+P + + L +L L L+ P + + L YL L N+L S+P G
Sbjct: 97 L--QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 181 -RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI 228
+L+ ++ ++L NN+L +P F L L+ L + NN L +P
Sbjct: 154 DKLT-SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 15/184 (8%)
Query: 43 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNL 101
++ + N +S K+F L K R ++N+N + +P + L +L + + +N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 102 TGYLPPEL-SELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPD--L 157
LP + +L L L+LD N ++P + +++KL LSL LQ +P
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQL--KSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVF 153
Query: 158 SRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 214
++ +L L L +NQL +P G +L+ + T+KL NN+L F L +L+ L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLT-ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211
Query: 215 IANN 218
+ N
Sbjct: 212 LQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS 60
NK+ ++P I +K+LE L + N+L +LP + L L +++D+N + SLP
Sbjct: 71 NKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPR 127
Query: 61 -FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLI 117
F +L K + + N + +P + +L SL + L NN L +P +L +L
Sbjct: 128 VFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKT 185
Query: 118 LQLDNNNFEGTTIPA-SYSNMSKLLKLSLRN 147
L+LDNN +P ++ ++ KL L L+
Sbjct: 186 LKLDNNQL--KRVPEGAFDSLEKLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 31/112 (27%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
N +D SS +L +IP + + + L +NKL+ F L +L+ L++ +N L
Sbjct: 17 NKNSVDCSSKKLT-AIPSN-IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 222 GSIPSSIWQSRTLNATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGNPF 271
++P+ I++ L ET L +N L + G F+ N+ RL N
Sbjct: 75 -TLPAGIFKE--LKNLET--LWVTDNKLQALPIGVFDQLVNLAELRLDRNQL 121
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 6/100 (6%)
Query: 3 NKISGSIPKEI-GNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS 60
N++ S+P + ++ L L L NEL SLP+ + L L +++ N + +P+
Sbjct: 119 NQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEG 175
Query: 61 -FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 99
F L + + ++NN + L L + L N
Sbjct: 176 AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 68/255 (26%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY-- 575
+G G +G V + + G A+K+ LQ + E+ + L H N++ LV Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 576 ------------------------------------CDEEGEQMLVYEFMSNGTLRDQLS 599
+ ++ E++ D L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----DTLH 125
Query: 600 AKSKEPLGFAMRLSIALGSS------RGILYLHTEADPPVFHRDIKASNILLD-HKFTAK 652
K + + + L S R + ++H+ + HRDIK N+L++ T K
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLK 182
Query: 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLE 711
+ DFG ++ +P V+ + + Y PE L + T D++S+G VF E
Sbjct: 183 LCDFGSAKKL-IPS-----EPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 712 LLTGMQPISHGKNIV 726
L+ G +P+ G+ +
Sbjct: 235 LILG-KPLFSGETSI 248
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 59/259 (22%), Positives = 102/259 (39%), Gaps = 46/259 (17%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--V 573
+G G YG V + G VA+K+ S K E++ L + H N++ L V
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 574 GYCDEEGEQM----LVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYL 625
DE + LV FM ++ + L + L + M +G+ Y+
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML--------KGLRYI 144
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
H A + HRD+K N+ ++ K+ DFGL+R VV T Y
Sbjct: 145 HA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVV--TRWY 191
Query: 686 LDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI-- 742
PE L ++ D++S+G + E++TG + + G + + Q + V
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLD------QLKEIMKVTGT 244
Query: 743 --DGNMGSYPSECVEKFIK 759
+ S+ + ++K
Sbjct: 245 PPAEFVQRLQSDEAKNYMK 263
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 9e-17
Identities = 57/250 (22%), Positives = 82/250 (32%), Gaps = 64/250 (25%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSLV-- 573
IG+G YG VY VA+K+ L K L EI L+RL ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 574 ---GYCDEEGEQMLVYEFM---------SNGTLRD--------QLSAKSKEPLGFAMRLS 613
+ E +V E + L + L
Sbjct: 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL--------------- 138
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673
L G ++H + + HRD+K +N LL+ + KV DFGL+R IV
Sbjct: 139 --L---LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 674 HVSTVVKGTPGYLD---------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 717
G PE L + KS D++S G +F ELL +Q
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 718 PISHGKNIVR 727
+
Sbjct: 251 SHINDPTNRF 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 53/302 (17%)
Query: 476 MKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGI-LPD 534
M ++H + + +++ + + + + +G G YG V
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTI-WE------VPERYQNLSPVGSGAYGSVCAAFDTKT 53
Query: 535 GTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLHHRNLVSL--VGYCDEEGEQM----LVY 586
G VAVK+ S+ K E++ L + H N++ L V E+ LV
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 587 EFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASN 642
M N ++ Q L+ + L + + RG+ Y+H+ AD + HRD+K SN
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQFLIYQIL--------RGLKYIHS-AD--IIHRDLKPSN 162
Query: 643 ILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-D 701
+ ++ K+ DFGL+R ++ G V T Y PE L +++ D
Sbjct: 163 LAVNEDCELKILDFGLARHT-ADEMTGYV---------ATRWYRAPEIMLNWMHYNQTVD 212
Query: 702 VYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI----DGNMGSYPSECVEKF 757
++S+G + ELLTG + + G + + Q ++ ++ + SE +
Sbjct: 213 IWSVGCIMAELLTG-RTLFPGTDHID------QLKLILRLVGTPGAELLKKISSESARNY 265
Query: 758 IK 759
I+
Sbjct: 266 IQ 267
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 45/219 (20%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
++ ++ + S++ ++ N +++ S+ + + YLP + ++ ++ N ++ + K
Sbjct: 33 KKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DI-KPL 86
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
ANL ++ N + + L L L + L++N ++ + L LP+L L L
Sbjct: 87 ANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLG 142
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
NN T I S ++KL LSL + + + L+ + L L LS N ++ +
Sbjct: 143 NNKI--TDITVL-SRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHIS-DLRALA 197
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 220
N+ ++L + + ++ S L + + SL
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 39/218 (17%), Positives = 81/218 (37%), Gaps = 18/218 (8%)
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
+T ++ S++ + + L S+ ++ +N+++ + LP + L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
N T I +N+ L L L ++ + L + L L L N ++ I
Sbjct: 77 GNKL--TDIK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DINGLV 131
Query: 182 LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
+ ++ L NNK+T + S L +L L + +N +S I L +
Sbjct: 132 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQN-- 182
Query: 242 LDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQ 279
L N+++++ + + L Q
Sbjct: 183 LYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQ 220
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 157 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA 216
+L + ++ L+ +I I +N+ + ++ LP + +LF+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQNELN-SIDQIIANNSDIK-SV-QGIQYLPNVTKLFLN 76
Query: 217 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254
N L+ I + + L L N + ++S
Sbjct: 77 GNKLT-DI-KPLANLKNLG-----WLFLDENKVKDLSS 107
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL----- 572
+G GG G V+ + VA+K+ Q K L EI+ + RL H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 573 ---------VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSS 619
VG E +V E+M L L + + +
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL-------- 130
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSR-LAPVPDIEGIVPAHVST 677
RG+ Y+H+ A+ V HRD+K +N+ ++ + K+ DFGL+R + P +G + +
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV- 186
Query: 678 VVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 726
T Y P L+ + T D+++ G +F E+LTG + + G + +
Sbjct: 187 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHEL 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 43/198 (21%), Positives = 75/198 (37%), Gaps = 19/198 (9%)
Query: 73 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 132
I+ Q+ P L + V L ++T + EL + DN+N ++
Sbjct: 5 RPTPIN-QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLA- 57
Query: 133 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 192
+ L +L L + + + L + L L ++ N+L ++ ++ + L
Sbjct: 58 GMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLK-NLNGIPS-ACLSRLFLD 114
Query: 193 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 252
NN+L T + L L+ L I NN L SI + L +LD N +TN
Sbjct: 115 NNELRDT--DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLE-----VLDLHGNEITNT 165
Query: 253 SGSFNIPPNVTVRLRGNP 270
G + + L G
Sbjct: 166 GGLTRLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 38/209 (18%), Positives = 68/209 (32%), Gaps = 14/209 (6%)
Query: 13 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 72
+ ++ + + + SL + + L + + N IS L +L K +
Sbjct: 37 QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSV 92
Query: 73 NNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPA 132
N N + + L + LDNN L L L L IL + NN +I
Sbjct: 93 NRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKL--KSIV- 144
Query: 133 SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLS 192
+SKL L L + L+R+ + ++DL+ + + P T +
Sbjct: 145 MLGFLSKLEVLDLHGNEITN-TGGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVK 202
Query: 193 NNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
+ P S +
Sbjct: 203 DPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 66/258 (25%), Positives = 114/258 (44%), Gaps = 40/258 (15%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQE-GSLQGEKEFLTEIQFLSRLHHRNLVSLV--- 573
IG+G YG V + VA+K+ + L EI+ L R H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 574 --GYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
++ + +V + M L+ Q LS + + L RG+ Y+H+
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI-----L---RGLKYIHS 146
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA-PVPDIEGIVPAHVSTVVKGTPGYL 686
A+ V HRD+K SN+LL+ K+ DFGL+R+A P D G + +V+ T Y
Sbjct: 147 -AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-----TRWYR 198
Query: 687 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI--- 742
PE L K KS D++S+G + E+L+ +PI GK+ + Q + + ++
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLD------QLNHILGILGSP 251
Query: 743 -DGNMGSYPSECVEKFIK 759
++ + ++
Sbjct: 252 SQEDLNCIINLKARNYLL 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 85/343 (24%), Positives = 138/343 (40%), Gaps = 61/343 (17%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQE--GSLQGEKEFLTEIQFLSRLH-HRNLVSL-- 572
+G+G YG V+K I G VVAVK+ + + + EI L+ L H N+V+L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 573 VGYCDEEGEQMLVYEFMS---NGTLRDQ-LSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
V D + + LV+++M + +R L K+ + + + + + I YLH+
Sbjct: 77 VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL-----I---KVIKYLHS- 127
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD- 687
+ HRD+K SNILL+ + KVADFGLSR
Sbjct: 128 GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 688 -------------PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733
PE L K D++SLG + E+L G +PI G + +
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSSTMN------ 238
Query: 734 QSSMMFSVI----DGNMGSYPSECVEKFIK-LALKCCQDETDARPSMSEVMRELESIWNM 788
Q + VI + ++ S S + I+ L K +++ R ++ L I
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 789 MPESD------TKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825
++ K +F ++ S + LKHP+VS
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISAND-------ALKHPFVSI 334
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 4e-15
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 48/241 (19%)
Query: 500 SFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQE 545
S G + F +G+GGYGKV+ K + G + A+K
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 546 GSLQGEKEFLTEIQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKS 602
+ E+ L E++ F+ L Y + G ++ L+ E++S G L QL +
Sbjct: 66 AHTKAERNILEEVKHPFIVDLI---------YAFQTGGKLYLILEYLSGGELFMQLEREG 116
Query: 603 K--EPLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658
E + +S+ALG +LH + + +RD+K NI+L+H+ K+ DFGL
Sbjct: 117 IFMEDTACFYLAEISMALG------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167
Query: 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQ 717
+ E I V+ GT Y+ PE L +++ D +SLG + ++LTG
Sbjct: 168 CK-------ESIHDGTVTHTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAP 219
Query: 718 P 718
P
Sbjct: 220 P 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 511 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 557
N+F+ +G+G +GKV K G A+K + + E L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 558 IQ--FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FAM 610
+ FL+ L Y + +++ V E+ + G L LS + E +
Sbjct: 62 TRHPFLTALK---------YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 112
Query: 611 RLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670
+ AL YLH+ V +RDIK N++LD K+ DFGL + EGI
Sbjct: 113 EIVSALE------YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGI 156
Query: 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
GTP YL PE L ++ D + LGVV E++ G P
Sbjct: 157 SDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 511 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 557
+F+ IG+G Y KV K + A+K +Q EK +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 558 IQ---FLSRLHHRNLVSLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FA 609
FL LH C + E V E+++ G L + + K E ++
Sbjct: 66 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116
Query: 610 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 117 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 160
Query: 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 161 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 494 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVKRAQEGSLQ 549
+I G + F +GQG +GKV+ K D + A+K ++ +L+
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 550 --GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--E 604
E L ++H +V L Y + ++ L+ +F+ G L +LS + E
Sbjct: 67 VRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125
Query: 605 PLG--FAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662
+ L++AL +LH+ + +RD+K NILLD + K+ DFGLS+
Sbjct: 126 EDVKFYLAELALALD------HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-- 174
Query: 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
E I + GT Y+ PE + + +S D +S GV+ E+LTG P
Sbjct: 175 -----ESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 511 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 557
+NF +G+G +GKV K G + AVK EK L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 558 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 609
+ FL++L C + +++ V EF++ G L + + E +A
Sbjct: 80 ARNHPFLTQLF---------CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 610 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669
+ AL +LH + + +RD+K N+LLDH+ K+ADFG+ + EG
Sbjct: 131 AEIISALM------FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-------EG 174
Query: 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
I + GTP Y+ PE L L + D +++GV+ E+L G P
Sbjct: 175 ICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-14
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 511 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 557
+FN +G+G +GKV KG + AVK EK L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 558 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLS--AKSKEPLG--FA 609
FL++LH C + +++ V E+++ G L + + KEP +A
Sbjct: 398 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 448
Query: 610 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 449 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 492
Query: 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 493 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 51/230 (22%)
Query: 511 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 557
+FN +G+G +GKV KG + AVK EK L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 558 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 609
FL++LH C + +++ V E+++ G L + + EP +A
Sbjct: 77 PGKPPFLTQLH---------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127
Query: 610 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669
++I L +L ++ + +RD+K N++LD + K+ADFG+ + E
Sbjct: 128 AEIAIGLF------FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 171
Query: 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
I + GTP Y+ PE + ++ KS D ++ GV+ E+L G P
Sbjct: 172 IWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 57/235 (24%), Positives = 86/235 (36%), Gaps = 41/235 (17%)
Query: 505 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 557
E+ L ++F IG+G + +V K G V A+K + + E F E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 558 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 611
L R + L + ++ + LV E+ G L LS + + +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 612 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671
+ +A+ +H HRDIK NILLD ++ADFG +
Sbjct: 171 IVMAID------SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL-------KLRA 214
Query: 672 PAHVST-VVKGTPGYLDPEYFLTHKLTDKSDVY-------SLGVVFLELLTGMQP 718
V + V GTP YL PE + Y +LGV E+ G P
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 511 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 557
+F+ IG+G Y KV K + A++ +Q EK +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 558 IQ---FLSRLHHRNLVSLVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FA 609
FL LH C + E V E+++ G L + + K E ++
Sbjct: 109 ASNHPFLVGLH---------SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 159
Query: 610 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669
+S+AL YLH + +RD+K N+LLD + K+ D+G+ + EG
Sbjct: 160 AEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EG 203
Query: 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
+ P ++ GTP Y+ PE L + S D ++LGV+ E++ G P
Sbjct: 204 LRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 47/213 (22%), Positives = 75/213 (35%), Gaps = 54/213 (25%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVG-Y 575
+G G GKV + A+K LQ + E++ R ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 576 CDEEGEQMLVY---EFMSNGTLRDQLSAKSKEPLGF----AMRLSIALGSSRGILYLHTE 628
+ + + E + G L ++ + + F A + ++G I YLH+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGE--AIQYLHSI 136
Query: 629 ADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
+ HRD+K N+L K K+ DFG A Y
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE-------------TTGE--KY 175
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718
D D++SLGV+ LL G P
Sbjct: 176 -DKS----------CDMWSLGVIMYILLCGYPP 197
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 32/144 (22%), Positives = 59/144 (40%), Gaps = 17/144 (11%)
Query: 81 IPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPA-SYSNMS 138
+P ++ + L+ N + +PP S KL + L NN + + ++ +
Sbjct: 30 LPETITEI------RLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQI--SELAPDAFQGLR 80
Query: 139 KLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNN 194
L L L + P + +L L L++N++N + L N+ + L +N
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLH-NLNLLSLYDN 138
Query: 195 KLTGTIPSNFSGLPRLQRLFIANN 218
KL FS L +Q + +A N
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 36/160 (22%), Positives = 59/160 (36%), Gaps = 38/160 (23%)
Query: 118 LQLDNNNFEGTTIPASY-SNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG 175
++L+ N IP S KL ++ L N + PD + +L L L N++
Sbjct: 37 IRLEQNTI--KVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 176 SIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS 231
+P L ++ + L+ NK+ + + F L L L + +N L +I
Sbjct: 94 ELPKSLFEGLF-SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK----- 145
Query: 232 RTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 271
TF + L I T+ L NPF
Sbjct: 146 ------GTF------SPLRAIQ---------TMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 8/135 (5%)
Query: 44 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLT 102
I+++QN I P +F+ K R ++NN IS ++ P+ L SL ++L N +T
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 103 GYLPPEL-SELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQG-PMPDLSR 159
LP L L L +L L+ N + ++ ++ L LSL + LQ S
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKI--NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 160 IPNLGYLDLSSNQLN 174
+ + + L+ N
Sbjct: 151 LRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 31/127 (24%), Positives = 51/127 (40%), Gaps = 6/127 (4%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS- 60
N I P K L + L+ N+++ L + L L+ + + N I+ LPKS
Sbjct: 42 NTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSL 99
Query: 61 FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
F L + +N N I+ + + L +L + L +N L S L + +
Sbjct: 100 FEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMH 158
Query: 120 LDNNNFE 126
L N F
Sbjct: 159 LAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 24/84 (28%), Positives = 36/84 (42%), Gaps = 11/84 (13%)
Query: 176 SIPPGRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSI-WQSRT 233
IP L IT I+L N + IP FS +L+R+ ++NN +S + R+
Sbjct: 25 EIPTN-LPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 234 LNATETFILDFQNNNLTNI-SGSF 256
LN L N +T + F
Sbjct: 82 LN-----SLVLYGNKITELPKSLF 100
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 58/233 (24%), Positives = 89/233 (38%), Gaps = 39/233 (16%)
Query: 505 EMALATNNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKE---FLTE 557
+M L +F IG+G +G+V K V A+K + + E F E
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREE 124
Query: 558 IQFLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK---EPLG--FAMR 611
L + + +L Y ++ + LV ++ G L LS E + +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 612 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671
+ IA+ +H HRDIK NIL+D ++ADFG + +
Sbjct: 184 MVIAID------SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL-------KLME 227
Query: 672 PAHVSTVVK-GTPGYLDPEYFLTHKLTDKS-----DVYSLGVVFLELLTGMQP 718
V + V GTP Y+ PE + D +SLGV E+L G P
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 51/230 (22%)
Query: 511 NNFNSSTQIGQGGYGKV----YKGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 557
+F +G+G +GKV +K A+K EK L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 558 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 609
FL+ + + E + V E+++ G L + + K +A
Sbjct: 74 AWEHPFLTHMF---------CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 610 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669
+ + L +LH++ + +RD+K NILLD K+ADFG+ + E
Sbjct: 125 AEIILGLQ------FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-------EN 168
Query: 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
++ + GTP Y+ PE L + + S D +S GV+ E+L G P
Sbjct: 169 MLGDAKTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 30/159 (18%), Positives = 65/159 (40%), Gaps = 35/159 (22%)
Query: 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS 176
L+L+NN F + + +L K++ N + + + L+SN+L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 177 IPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSR 232
+ L ++ T+ L +N++T + ++ F GL ++ L + +N ++ ++
Sbjct: 96 VQHKMFKGLE-SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAP------ 146
Query: 233 TLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 271
F + L ++S T+ L NPF
Sbjct: 147 -----GAF------DTLHSLS---------TLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 18/154 (11%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGY--LPKLDRIQIDQNYISGSLPKSFANLN 65
IP+ I + L LN NE T L + LP+L +I N I+ +F +
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81
Query: 66 KTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNN 123
+ +N + + ++ L SL ++L +N +T + + L + +L L +N
Sbjct: 82 GVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 124 NFEGTTIPA-SYSNMSKLLKLSLRN------CSL 150
TT+ ++ + L L+L C L
Sbjct: 140 QI--TTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 51/230 (22%)
Query: 511 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTE 557
++F+ IG+G +GKV K + AVK + +E + E+ L +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 558 IQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--FA 609
FL LH + + +++ V ++++ G L L + EP +A
Sbjct: 95 NVKHPFLVGLH---------FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 610 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669
++ ALG YLH+ + +RD+K NILLD + + DFGL + E
Sbjct: 146 AEIASALG------YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-------EN 189
Query: 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
I ++ GTP YL PE L + D++ D + LG V E+L G+ P
Sbjct: 190 IEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 511 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 563
+ F+ +G G +G+V K G A+K + + K+ L E + L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 619
++ LV L + +V E+++ G + L + EP +A ++ +
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE-- 155
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
YLH+ + +RD+K N+L+D + +V DFG ++ V T+
Sbjct: 156 ----YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLC 199
Query: 680 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
GTP L PE + K +K+ D ++LGV+ E+ G P
Sbjct: 200 -GTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 5e-13
Identities = 37/223 (16%), Positives = 72/223 (32%), Gaps = 13/223 (5%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
++ + L L+ + T L EL +L ++ + + ++
Sbjct: 334 LKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM 392
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
L+ + S + R L + + E + +L L
Sbjct: 393 RALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL---RSKFLLENSVLKMEYADVRVLHLA 449
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-G 180
+ + T + + + L L + L+ P L+ + L L S N L ++
Sbjct: 450 HKDL--TVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDGVA 505
Query: 181 RLSLNITTIKLSNNKLTGTIPS--NFSGLPRLQRLFIANNSLS 221
L + + L NN+L + PRL L + NSL
Sbjct: 506 NLP-RLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 9e-13
Identities = 39/228 (17%), Positives = 73/228 (32%), Gaps = 16/228 (7%)
Query: 48 IDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 107
+ + A + ++ + + EL L + +N +
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390
Query: 108 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 167
+ L LL + F M LR+ L ++ L
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAV---DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH 447
Query: 168 LSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 227
L+ L + L +T + LS+N+L +P + L L+ L ++N+L ++
Sbjct: 448 LAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG- 503
Query: 228 IWQSRTLNATETFILDFQNNNLTNISGSFNIP--PN-VTVRLRGNPFC 272
+ L L NN L + + P V + L+GN C
Sbjct: 504 VANLPRLQ-----ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 76 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-Y 134
S+ IP + +L L + L L KL L LD N T+ A +
Sbjct: 28 SVPSGIPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQL--QTLSAGVF 79
Query: 135 SNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIK 190
++++L L L N L + + L L L NQL S+P G RL+ + ++
Sbjct: 80 DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT-KLKELR 137
Query: 191 LSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIP 225
L+ N+L +IP+ F L LQ L ++ N L S+P
Sbjct: 138 LNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVP 171
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 118 LQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNG 175
L L + T+ + + ++KL L+L LQ + LG L L++NQL
Sbjct: 40 LDLQSTGL--ATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 176 SIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQS 231
S+P G L+ + + L N+L ++PS F L +L+ L + N L SIP+ +
Sbjct: 97 SLPLGVFDHLT-QLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 232 RTLNATETFILDFQNNNLTNIS-GSFNIPPNVT-VRLRGNPF 271
T L N L ++ G+F+ + + L GN F
Sbjct: 154 ----LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 34/156 (21%), Positives = 64/156 (41%), Gaps = 15/156 (9%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS- 60
++ + L L L+ N+L +L + L +L + + N ++ SLP
Sbjct: 45 TGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGV 102
Query: 61 FANLNKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLIL 118
F +L + ++ N + +P + RL L + L+ N L +P +L L L
Sbjct: 103 FDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTL 160
Query: 119 QLDNNNFEGTTIPA-SYSNMSKLLKLSLRN----CS 149
L N ++P ++ + KL ++L CS
Sbjct: 161 SLSTNQL--QSVPHGAFDRLGKLQTITLFGNQFDCS 194
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 23/96 (23%), Positives = 40/96 (41%), Gaps = 8/96 (8%)
Query: 176 SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
S+P G + + + L + L + F GL +L L + N L ++ + ++
Sbjct: 28 SVPSG-IPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDD---- 81
Query: 236 ATETFILDFQNNNLTNI-SGSFNIPPNVTV-RLRGN 269
TE L NN L ++ G F+ + L GN
Sbjct: 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN 117
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 66/284 (23%)
Query: 462 TISAIVSLLIVRAHMKNYHAISRRRHSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQ 521
+ A+V L A KN + + T KI +R + ++ IG+
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLR--------MKAEDYEVVKVIGR 79
Query: 522 GGYGKVY----KGILPDGTVVAVK---------RAQEGSLQGEKEFLTEIQ--FLSRLHH 566
G +G+V K V A+K R+ E++ + ++ +L +
Sbjct: 80 GAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 567 -----RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKS-KEPLG--FAMRLSIALGS 618
R L Y +V E+M G L + +S E + + +AL
Sbjct: 137 AFQDDRYL-----Y--------MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD- 182
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTV 678
+H+ HRD+K N+LLD K+ADFG + EG+V T
Sbjct: 183 -----AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM---NKEGMVRCD--TA 229
Query: 679 VKGTPGYLDPEYFLTHKLT---DKS-DVYSLGVVFLELLTGMQP 718
V GTP Y+ PE + + D +S+GV E+L G P
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 511 NNFNSSTQIGQGGYGKVY----KGILPDGTVVAVKRAQEGSLQGEKEF---LTEIQFLSR 563
+F +G G +G+V+ + +G A+K ++ + K+ E LS
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK--EPLG--FAMRLSIALGSS 619
+ H ++ + G + + ++ +++ G L L + P+ +A + +AL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE-- 120
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
YLH++ + +RD+K NILLD K+ DFG ++ VP T+
Sbjct: 121 ----YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTYTLC 164
Query: 680 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQP 718
GTP Y+ PE ++ K +KS D +S G++ E+L G P
Sbjct: 165 -GTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 63/233 (27%), Positives = 95/233 (40%), Gaps = 50/233 (21%)
Query: 511 NNFNSSTQIGQGGYGKVY---KGILPD-GTVVAVK----------RAQEGSLQGEKEFLT 556
NF +G G YGKV+ K D G + A+K + E++ L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 557 EIQ---FLSRLHHRNLVSLVGYCDEEGEQM-LVYEFMSNGTLRDQLSAKSK--EPLG--F 608
I+ FL LH Y + ++ L+ ++++ G L LS + + E +
Sbjct: 114 HIRQSPFLVTLH---------YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 609 AMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668
+ +AL +LH + +RDIK NILLD + DFGLS+ E
Sbjct: 165 VGEIVLALE------HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-------E 208
Query: 669 GIVPAHVSTV-VKGTPGYLDPEYFLTHKL-TDKS-DVYSLGVVFLELLTGMQP 718
+ GT Y+ P+ DK+ D +SLGV+ ELLTG P
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 49/264 (18%), Positives = 94/264 (35%), Gaps = 49/264 (18%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLH---------- 565
+G G + V+ + + T VA+K R + + EI+ L R++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 566 -HRNLVSLVG---YCDEEGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGS 618
+++ L+ + G + +V+E + L + K E G + I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI--KKYEHRGIPLIYVKQISKQL 140
Query: 619 SRGILYLHTEADPPVFHRDIKASNILLDH------KFTAKVADFGLSRLAPVPDIEGIVP 672
G+ Y+H + H DIK N+L++ K+AD G +
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---------YD 189
Query: 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 732
H + ++ T Y PE L +D++S + EL+TG +
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDD 247
Query: 733 YQSSMMFSVIDGNMGSYPSECVEK 756
+ + ++ G PS +
Sbjct: 248 DHIAQIIELL----GELPSYLLRN 267
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 9e-11
Identities = 38/217 (17%), Positives = 61/217 (28%), Gaps = 56/217 (25%)
Query: 496 DGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVK--------RAQEGS 547
G F++ L T +IG+G +G+V++ I D T VA+K
Sbjct: 8 KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 548 LQGEKEFLTEIQFLSRLH---------HRNLVSLVGYCDEEGE----------------- 581
+ +E L EI L + L +G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 582 -------------QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+V EF G L + A SI + +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665
HRD+ N+LL K+ + + +P
Sbjct: 181 --LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 26/170 (15%), Positives = 46/170 (27%), Gaps = 23/170 (13%)
Query: 155 PDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQ 211
L NL L + + Q + L + + + + L + + F PRL
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83
Query: 212 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT-------------NISGSFNI 258
RL ++ N+L S+ Q +L L N L G
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQ-----ELVLSGNPLHCSCALRWLQRWEEEGLGGVPE 137
Query: 259 PPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQSCPT 308
N + + +D + L C+ +
Sbjct: 138 QKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGL 187
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 8e-08
Identities = 18/105 (17%), Positives = 40/105 (38%), Gaps = 6/105 (5%)
Query: 72 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTI 130
+ ++ L +L + ++N +L L L +L L + + +
Sbjct: 16 TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL--RFV 71
Query: 131 PA-SYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174
++ +L +L+L +L+ + +L L LS N L+
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 17/96 (17%), Positives = 39/96 (40%), Gaps = 2/96 (2%)
Query: 8 SIPKEIGNIKSL-ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 66
+ ++L EL + N L +L L +L + I ++ + P +F +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 67 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 102
+++ N++ + + + SL ++L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 1e-09
Identities = 57/350 (16%), Positives = 104/350 (29%), Gaps = 97/350 (27%)
Query: 520 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579
G G GK T VA+ +Q + +F +I +L+ + C+
Sbjct: 157 GVLGSGK---------TWVALDVCLSYKVQCKMDF--KIFWLN----------LKNCNSP 195
Query: 580 GE-----QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
Q L+Y+ N T R S+ K +R+ R +L
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLL----------K 239
Query: 635 HRDIKASNILLDHKFTAKVAD-FGL-------SRLAPVPD-IEGIVPAHVSTVVKGTPGY 685
+ + ++L + AK + F L +R V D + H+S + +
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS-LDHHSMTL 298
Query: 686 LDPEYFLTHKLTDKSDVYSLGVV--FLELLTGMQPISHGKNIVREVN------IAYQSSM 737
E ++ +L+ P V N IA
Sbjct: 299 TPDE--------------VKSLLLKYLDCRPQDLPRE-----VLTTNPRRLSIIAESIRD 339
Query: 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE--VMRE--------LESIWN 787
+ D N + + I+ +L + + R V L IW
Sbjct: 340 GLATWD-NWKHVNCDKLTTIIESSLNV-LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397
Query: 788 MMPESDTKTPEFINSEHTSK---EETPPSSSSMLKHPYVSSDVSGSNLVS 834
+ +SD + ++ E+ P S+ + Y+ V N +
Sbjct: 398 DVIKSD---VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 3e-09
Identities = 70/413 (16%), Positives = 129/413 (31%), Gaps = 114/413 (27%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNE-----LTGSLPEELGYLPKLDRIQIDQNYISGSL 57
+ I S G ++ LL E + L +L + I+ +Q S
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL--MSPIKTEQRQPSMMT 109
Query: 58 PKSFANLNKTRHFHMNNNSISGQIPP-ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 116
++ N+N + +SR +L + L
Sbjct: 110 RMYIEQRDRL----YNDNQV---FAKYNVSR------------------LQPYLKLRQAL 144
Query: 117 ILQLDNNNF---EG------TTIPASYSNMSKLLK--------LSLRNCSLQGPMPDLSR 159
L+L +G T + K+ L+L+NC P L
Sbjct: 145 -LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC--NSPETVLEM 201
Query: 160 IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIA--- 216
+ L + N + S + L I +I+ L+RL +
Sbjct: 202 LQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQ-----------------AELRRLLKSKPY 243
Query: 217 NNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN 276
N L + ++ ++ NA F + L +T R + L+
Sbjct: 244 ENCLL--VLLNVQNAKAWNA---F--NLSCKIL------------LTTRFKQVTDFLSAA 284
Query: 277 AE-QFCGSHSDDDNEIDRSTN---STLDCRAQSCPTDYEYSPTSPIRCFCAAPLLVGYRL 332
H D + LDCR Q P E T+P R ++ +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR--EVLTTNPRRL-----SIIAESI 337
Query: 333 KSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRWEKGPRLKMYLKL--FP 383
+ GL+ + +K++ + +T+ ++ +L L+ +R KM+ +L FP
Sbjct: 338 R-DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR-------KMFDRLSVFP 382
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 1e-05
Identities = 30/169 (17%), Positives = 59/169 (34%), Gaps = 40/169 (23%)
Query: 17 KSLELLLLNGNELTGSLPEE--------LGYLPKLDRIQID--QNYISGSLPKSFANLNK 66
+ LLL + LP E L + + R + N+ ++N
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW---------KHVNC 352
Query: 67 TRHFHMNNNSISGQIPPELSRL-PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 125
+ + +S++ P E ++ L + + + +P L L ++ D
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLS-VFPPSAH----IPTIL-----LSLIWFDVIKS 402
Query: 126 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174
+ + ++KL K SL + P IP++ YL+L N
Sbjct: 403 DVMVV------VNKLHKYSLVE---KQPKESTISIPSI-YLELKVKLEN 441
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 69/504 (13%), Positives = 139/504 (27%), Gaps = 192/504 (38%)
Query: 13 IGNIKSLELLLLNGNEL--------------TGSLPEELGYL-PKLDRIQIDQNY----- 52
+ N S E +L +L + ++ + + +L R+ + Y
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 53 I-----SGSLPKSFAN----LNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTG 103
+ + +F L TR ++ + + SL H +
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTR-----FKQVTDFLSAATTTHISLDHHSM------T 297
Query: 104 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 163
P E+ L L+ LD + +P + LS+ S++ L+ N
Sbjct: 298 LTPDEVKSL---LLKYLDCRPQD---LPREVLTTNPRR-LSIIAESIR---DGLATWDN- 346
Query: 164 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 223
+ ++ ++L T I+ S N L P+ + RL +
Sbjct: 347 -WKHVNCDKLT------------TIIESSLNVLE---PAEYR--KMFDRLSV-------- 380
Query: 224 IPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQF--- 280
F + +IP + + + + ++
Sbjct: 381 --------------------FPPS--------AHIPTILLSLIWFDV--IKSDVMVVVNK 410
Query: 281 CGSHSDDDNEIDRSTNS----TLDCRAQSCPTDYE--------YSPTSPIRCFCAAPLL- 327
+S + + ST S L+ + + +Y Y+ + F + L+
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVK-LENEYALHRSIVDHYNIP---KTFDSDDLIP 466
Query: 328 ----------VGYRLKSPGLSYFPAYKNLFEEYMTSGLKLNLYQLDIDSFRW-------- 369
+G+ LK+ LF ++ LD FR+
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHP---ERMTLFRM---------VF-LD---FRFLEQKIRHD 510
Query: 370 -----EKGP------RLKMYLKLF----PVYDNSSGN--SYVFNASEVGRIRSMFTGWNI 412
G +LK Y P Y+ ++ E I S
Sbjct: 511 STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN-LICS------- 562
Query: 413 PDSDIFGPYELINFTLQGPYRDVF 436
+D+ + L +F
Sbjct: 563 KYTDL------LRIALMAEDEAIF 580
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
P + L +T + L +D+I + + I S+ L
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNV 65
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFE 126
R+ + N + L L +L +++L N L LP + +L L L L N
Sbjct: 66 RYLALGGNKL--HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQL- 121
Query: 127 GTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNGSIPPG---R 181
++P + ++ L L+L + LQ + ++ NL LDLS NQL S+P G +
Sbjct: 122 -QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDK 179
Query: 182 LSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANN 218
L+ + ++L N+L ++P F L LQ +++ +N
Sbjct: 180 LT-QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 32/147 (21%), Positives = 64/147 (43%), Gaps = 20/147 (13%)
Query: 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177
L + T + ++ + ++ N ++ + + +PN+ YL L N+L+ I
Sbjct: 24 ANLKKKSV--TDAVT-QNELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH-DI 78
Query: 178 PP-GRLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235
L+ N+T + L+ N+L ++P+ F L L+ L + N L S+P ++
Sbjct: 79 SALKELT-NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDK---- 131
Query: 236 ATETFILDFQNNNLTNISGSFNIPPNV 262
T L+ +N L ++P V
Sbjct: 132 LTNLTYLNLAHNQLQ------SLPKGV 152
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-09
Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 21/161 (13%)
Query: 12 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 71
E+G LEL +++ +EL LD + ++ + G +
Sbjct: 2 EMGRRIHLELRNRTPSDV-----KEL----VLDNSRSNEGKLEGLT----DEFEELEFLS 48
Query: 72 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 131
N ++ I L +L L + L +N ++G L + P L L L N + +
Sbjct: 49 TINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI 106
Query: 132 ASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLD 167
+ L L L NC + + D +P L YLD
Sbjct: 107 EPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 32/117 (27%), Positives = 47/117 (40%), Gaps = 8/117 (6%)
Query: 7 GSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK 66
G + + LE L LT S+ L L KL ++++ N +SG L
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 67 TRHFHMNNNSIS--GQIPPELSRLPSLVHMLLDNN---NLTGYLPPELSELPKLLIL 118
H +++ N I I P L +L +L + L N NL Y LP+L L
Sbjct: 90 LTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 25/146 (17%), Positives = 54/146 (36%), Gaps = 22/146 (15%)
Query: 136 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSN 193
M + + L LRN + ++ L L +++ N G + + N
Sbjct: 2 EMGRRIHLELRNRTPS----------DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTIN 51
Query: 194 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253
LT +I +N L +L++L +++N +SG + + L L+ N + ++S
Sbjct: 52 VGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT-----HLNLSGNKIKDLS 104
Query: 254 GSFNIPPN---VTVRLRGNPFCLNTN 276
+ ++ L +
Sbjct: 105 TIEPLKKLENLKSLDLFNCEVTNLND 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 42/167 (25%), Positives = 60/167 (35%), Gaps = 21/167 (12%)
Query: 6 SGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLN 65
SGS ++ LEL + EL LD + + I G L F NL
Sbjct: 3 SGSSGMDMKRRIHLELRNRTPAAVR-----EL----VLDNCKSNDGKIEG-LTAEFVNL- 51
Query: 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 125
+ N + + L +LP L + L N + G L +LP L L L N
Sbjct: 52 --EFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 126 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLD 167
+ + + L L L NC + + D +P L YLD
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 11/111 (9%)
Query: 111 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 170
++ + + L+L N + L L + + NL +L L +
Sbjct: 9 DMKRRIHLELRNRTPAAV----------RELVLDNCKSNDGKIEGLTAEFVNLEFLSLIN 58
Query: 171 NQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
L S+ + ++LS N++ G + LP L L ++ N L
Sbjct: 59 VGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 28/142 (19%), Positives = 53/142 (37%), Gaps = 22/142 (15%)
Query: 136 NMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 193
+M + + L LRN + + L L + + N G + N+ + L N
Sbjct: 9 DMKRRIHLELRNRTPA----------AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLIN 58
Query: 194 NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253
L ++ SN LP+L++L ++ N + G + + L L+ N L +IS
Sbjct: 59 VGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT-----HLNLSGNKLKDIS 111
Query: 254 GSFNIPPN---VTVRLRGNPFC 272
+ ++ L
Sbjct: 112 TLEPLKKLECLKSLDLFNCEVT 133
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 13/115 (11%)
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG-P--MPDLSRIPNLGYLDLSSNQL 173
IL L +N P + ++ L +L L + L P + D + L LDL +NQL
Sbjct: 44 ILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGALPVGVFD--SLTQLTVLDLGTNQL 100
Query: 174 NGSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 225
+P RL ++ + + NKLT +P L L L + N L SIP
Sbjct: 101 T-VLPSAVFDRLV-HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 35/146 (23%), Positives = 56/146 (38%), Gaps = 12/146 (8%)
Query: 76 SISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-Y 134
S+ IP L L +N +T P L L L L +N +P +
Sbjct: 33 SVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQL--GALPVGVF 84
Query: 135 SNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLS 192
++++L L L L P R+ +L L + N+L +P G L ++T + L
Sbjct: 85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD 143
Query: 193 NNKLTGTIPSNFSGLPRLQRLFIANN 218
N+L F L L ++ N
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 10/133 (7%)
Query: 67 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNF 125
+ ++++N I+ P L +L + L +N L LP + L +L +L L N
Sbjct: 42 AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQL 100
Query: 126 EGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---R 181
T +P++ + + L +L + L + R+ +L +L L NQL SIP G R
Sbjct: 101 --TVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLK-SIPHGAFDR 157
Query: 182 LSLNITTIKLSNN 194
LS ++T L N
Sbjct: 158 LS-SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 32/123 (26%), Positives = 53/123 (43%), Gaps = 5/123 (4%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEEL-GYLPKLDRIQIDQNYISGSLPKS- 60
N+I+ P ++ +L+ L L N+L +LP + L +L + + N ++ LP +
Sbjct: 50 NQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAV 107
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
F L + M N ++ +P + RL L H+ LD N L L L L
Sbjct: 108 FDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL 166
Query: 121 DNN 123
N
Sbjct: 167 FGN 169
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 142 KLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTG 198
+L L +LS +L +DLS+N+++ ++ ++ + T+ LS N+L
Sbjct: 35 ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT-QLLTLILSYNRLR- 91
Query: 199 TIPSN-FSGLPRLQRLFIANNSLSGSIP 225
IP F GL L+ L + N +S +P
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 16/121 (13%)
Query: 158 SRIP-NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSN-FSGLPRLQRL 213
IP ++ L L NQ ++ P LS ++T I LSNN+++ T+ + FS + +L L
Sbjct: 27 KGIPRDVTELYLDGNQF--TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTL 83
Query: 214 FIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLTNI-SGSFNIPPNVT-VRLRGNP 270
++ N L IP + L +L N+++ + G+FN ++ + + NP
Sbjct: 84 ILSYNRLR-CIPPRTFDGLKSLR-----LLSLHGNDISVVPEGAFNDLSALSHLAIGANP 137
Query: 271 F 271
Sbjct: 138 L 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK-SFANLNK 66
+PK I + + L L+GN+ T +P+EL L I + N IS +L SF+N+ +
Sbjct: 24 VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 67 TRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNL 101
++ N + IPP L SL + L N++
Sbjct: 80 LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 28/154 (18%), Positives = 59/154 (38%), Gaps = 7/154 (4%)
Query: 108 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 167
+ + ++L + A+ S + L+L +++ + LS + NL L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILS 76
Query: 168 LSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSS 227
L N + ++ + + +S N++ ++ S L L+ L+++NN ++
Sbjct: 77 LGRNLIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN--WGE 132
Query: 228 IWQSRTLNATETFILDFQNNNLTNISGSFNIPPN 261
I + L+ E L N L N N
Sbjct: 133 IDKLAALDKLED--LLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 37/161 (22%), Positives = 58/161 (36%), Gaps = 30/161 (18%)
Query: 71 HMNNNSISGQIPPELSRLPSLVHMLLDNNNLT---GYLPPELSELPKLLILQLDNNNFEG 127
H I + LS L + H+ L NN+ LS + L IL L N
Sbjct: 31 HGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLI-- 82
Query: 128 TTIPASYSNMSKLLKLSLRN---CSLQGPMPDLSRIPNLGYLDLSSNQLN--GSIPPGRL 182
I + L +L + SL G + ++ NL L +S+N++ G I
Sbjct: 83 KKIENLDAVADTLEELWISYNQIASLSG----IEKLVNLRVLYMSNNKITNWGEIDKLAA 138
Query: 183 SLNITTIKLSNNKLTGTIPSNFSG----------LPRLQRL 213
+ + L+ N L N + LP L++L
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 24/123 (19%), Positives = 51/123 (41%), Gaps = 7/123 (5%)
Query: 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
I + + +K+ + L L+ N + + L + L + + +N I +
Sbjct: 34 IPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLD 89
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQL 120
A + ++ N I+ + + +L +L + + NN +T + + L+ L KL L L
Sbjct: 90 AVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLL 147
Query: 121 DNN 123
N
Sbjct: 148 AGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 29/145 (20%), Positives = 56/145 (38%), Gaps = 14/145 (9%)
Query: 139 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP-GRLSLNITTIKLSNNKLT 197
+ ++L ++ LS + +L LS+N + I + N+ + L N +
Sbjct: 26 EKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKISSLSGME-NLRILSLGRNLIK 83
Query: 198 GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFN 257
I + + L+ L+I+ N ++ S+ S I + L +L NN +TN
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLR-----VLYMSNNKITNWGEIDK 135
Query: 258 IPPN---VTVRLRGNPFCLNTNAEQ 279
+ + L GNP +
Sbjct: 136 LAALDKLEDLLLAGNPLYNDYKENN 160
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 49/233 (21%), Positives = 89/233 (38%), Gaps = 46/233 (19%)
Query: 518 QIGQGGYGKVYKGI---------LPDGTVVAVKR-AQEGSLQGEKEFLT------EIQFL 561
+ G +Y+ P ++K A++G L E+ F ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 562 SRLHHRNLV---SLVGYCDEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 617
+L+ L+ + +G+ + + + LV + +L+ L K L L +A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLS-RLAP----VPDIEGI 670
+ +LH H ++ A NI +D + ++V A +G + R P V +EG
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 671 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 718
H G + +D HK + +SD+ SLG L+ L G P
Sbjct: 225 RSPHE-----GDLEFISMD-----LHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------N 568
IG+G +G+V K + VA+K + ++ Q E++ L ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+V L + LV+E +S L D L + + + A +L+L T
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 629 ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ + H D+K NILL + + K+ DFG S + + ++ + Y
Sbjct: 177 -ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---------QLGQRIYQYIQ-SRFYR 225
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724
PE L D++SLG + +E+ TG +P+ G N
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 262
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 46/272 (16%), Positives = 91/272 (33%), Gaps = 33/272 (12%)
Query: 17 KSLELLLLNGNELT-GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANL---NKT-RHFH 71
++ L + EL+ E L L + +++D ++ + K ++ N +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 72 MNNNSISGQIPPELSRL-----PSLVHMLLDNNNLT----GYLPPELSELPKLLILQLDN 122
+ +N + + + + + L N LT G L L LP L L L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 123 NNFEGTTIP----ASYSNMSKLLKLSLRNCSL-----QGPMPDLSRIPNLGYLDLSSNQL 173
N + +L KL L CSL + L P+ L +S+N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 174 NGS----IPPG--RLSLNITTIKLSNNKLT----GTIPSNFSGLPRLQRLFIANNSLSGS 223
N + + G + +KL + +T + + L+ L + +N L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 224 IPSSIWQSRTLNATETFILDFQNNNLTNISGS 255
+ + ++ L +T
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCG 274
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 32/158 (20%), Positives = 53/158 (33%), Gaps = 17/158 (10%)
Query: 115 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP--MPDLSRI----PNLGYLDL 168
+ L + + + + L +C L D+S P L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL-TEARCKDISSALRVNPALAELNL 63
Query: 169 SSNQLNGS----IPPG--RLSLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANN 218
SN+L + G S I + L N LTG + S LP LQ L +++N
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 219 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 256
L + + + L + +L+ S
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 54/309 (17%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSL-QGEKEFLTEIQFLSRLHHR------N 568
IG+G +G+V K VA+K R ++ Q EI+ L L + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYLH 626
++ ++ + +E +S L + + K + GF++ L A + + LH
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELI--KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 627 TEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPG 684
+ H D+K NILL + KV DFG S V T ++ +
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---------YEHQRVYTYIQ-SRF 264
Query: 685 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
Y PE L + D++SLG + ELLTG P+ G++ E + Q + M ++
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGED---EGD---QLACMIELL-- 315
Query: 745 NMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVM---RELESIWNMMPESDTK 795
G + ++ F+ S V+ R PES
Sbjct: 316 --GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREW 373
Query: 796 TPEFINSEH 804
+
Sbjct: 374 GNALKGCDD 382
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IG G +G +Y G + G VA+K E + E + + + + +C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 577 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 631
EG+ ++V E + S L + S K F+++ L +A I Y+H++
Sbjct: 74 GAEGDYNVMVMELLGPSLEDLFNFCSRK------FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 632 PVFHRDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
HRD+K N L+ + DFGL++ +P + + GT Y
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 689 EYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 718
TH ++S D+ SLG V + G P
Sbjct: 185 N---THLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 50/271 (18%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVK--------RAQEGSLQGEKEFLTEIQ---FLSRLHH 566
IGQGG+G +Y + V + G L E +F + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 567 RNLVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMR--L 612
+ +G + Y FM + + + + F+ + L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR------FSRKTVL 155
Query: 613 SIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGI 670
++L + Y+H H DIKASN+LL++K +V D+GL+ +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 671 VPAHVSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGM---QPISHG 722
A GT + +D H + + D+ LG ++ LTG +
Sbjct: 213 YAADPKRCHDGTIEFTSID-----AHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
Query: 723 KNIVREVNIAYQ-SSMMFSVIDGNMGSYPSE 752
VR+ I Y+ + + P E
Sbjct: 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGE 298
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 25/106 (23%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL-SRIPNLGYLDLSSNQLNG 175
L L++N + + + L+KL L+ L G P+ ++ L L N++
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 176 SIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218
I L + T+ L +N+++ +P +F L L L +A+N
Sbjct: 92 EISNKMFLGLH-QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 33/136 (24%), Positives = 58/136 (42%), Gaps = 22/136 (16%)
Query: 147 NCSLQGPMPDLSRIP-----NLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGT 199
+C+ +G L IP + L L+ N+L G ++ ++L N+LT
Sbjct: 14 DCTGRG----LKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-G 68
Query: 200 IPSN-FSGLPRLQRLFIANNSLSGSIPSSIWQSRT-LNATETFILDFQNNNLTNIS-GSF 256
I N F G +Q L + N + I + ++ L L+ +N ++ + GSF
Sbjct: 69 IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLK-----TLNLYDNQISCVMPGSF 122
Query: 257 NIPPNVT-VRLRGNPF 271
++T + L NPF
Sbjct: 123 EHLNSLTSLNLASNPF 138
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 21/140 (15%), Positives = 45/140 (32%), Gaps = 13/140 (9%)
Query: 35 EELGYLPKLDRIQIDQNYIS--GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 92
+ + + + I +L + ++N I ++ L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQF---DAIDFSDNEIR-KLDG-FPLLRRLK 67
Query: 93 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 152
+L++NN + LP L L L NN+ +++ L L + +
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 127
Query: 153 PMPD-----LSRIPNLGYLD 167
+ ++P + LD
Sbjct: 128 -KKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 21/90 (23%), Positives = 38/90 (42%), Gaps = 1/90 (1%)
Query: 132 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 191
A Y+N + +L LR + + + +D S N++ + L + T+ +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLV 71
Query: 192 SNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
+NN++ LP L L + NNSL
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 58/335 (17%), Positives = 109/335 (32%), Gaps = 52/335 (15%)
Query: 519 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 567
+G+G +GKV + + + VA+K R EI L ++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENKF 82
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRL--SIALGSSRGILYL 625
V + + + G + +E + + L K + + +A + +L
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGK-NTFEFL--KENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHV 675
H + + H D+K NIL + + + S I H
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 676 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735
+T+V T Y PE L DV+S+G + E G +
Sbjct: 197 TTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLFQTHE---NRE---HL 248
Query: 736 SMMFSVIDGNMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVMRELESIWNMM 789
MM ++ G PS + + F K L ++ +D R + E + L+S
Sbjct: 249 VMMEKIL----GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR-YVKENCKPLKSYMLQD 303
Query: 790 PESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824
+ + + + + L HP+ +
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 577 DEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILYLHTEADP 631
+EG +LV + + S L D K F+++ A + +H ++
Sbjct: 75 GQEGLHNVLVIDLLGPSLEDLLDLCGRK------FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 632 PVFHRDIKASNILLDHKFTAK-----VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ +RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 687 DPEYFLTHKLTDKS---DVYSLGVVFLELLTGMQP 718
TH ++S D+ +LG VF+ L G P
Sbjct: 186 SIN---THLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 18/209 (8%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IG G +G++Y G + VA+K E + L E + L + V +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 577 DEEGE-QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
EG+ +LV + + G + L L L +A + ++H+++ H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126
Query: 636 RDIKASNILLDHKFTAK---VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
RDIK N L+ A + DFGL++ +P + + GT Y
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS---VN 183
Query: 693 THKLTDKS---DVYSLGVVFLELLTGMQP 718
TH ++S D+ SLG V + L G P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 53/229 (23%), Positives = 80/229 (34%), Gaps = 41/229 (17%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVA-----VKRAQEGSLQGEKEFLTEIQ---FLSRLHHRN 568
+IG GG+G +Y A V+ + G L E +F + + + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 569 LVSLVG-----YCDEEGEQMLVYEFM-------SNGTLRDQLSAKSKEPLGFAMRLSIAL 616
+ +G + Y FM L+ ++L I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID---LQKISGQNGTFKKSTVLQLGIRM 160
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV--ADFGLSRLAPVPDIEGIVPAH 674
+ Y+H H DIKA+N+LL +K +V AD+GLS +
Sbjct: 161 LDV--LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 675 VSTVVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQP 718
GT + LD HK L+ +SDV LG L L G P
Sbjct: 216 PRKGHNGTIEFTSLD-----AHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 4e-06
Identities = 31/175 (17%), Positives = 59/175 (33%), Gaps = 16/175 (9%)
Query: 79 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY-SNM 137
+ P L +P L ++ + N L L I+ + I S N+
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 138 SKL-LKLSLRNCSLQGPMPDLS------RIPNLGYLDLSSNQLNGSIPPGRLSL----NI 186
KL L + + + G M R PNL +L + + + L +
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 187 TTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNAT 237
T+ +S LT + + + L+ + + N LS + + +S +
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKID 336
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 5e-05
Identities = 23/161 (14%), Positives = 53/161 (32%), Gaps = 21/161 (13%)
Query: 31 GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPEL--SRL 88
L L +P L+ ++I K NL + + + + + ++ S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSDL 218
Query: 89 PSLVHMLLD---NNNLTGYLPPELSEL------PKLLILQLDNNNF--EGTTIPASYSNM 137
P+L ++L + L P L L + + + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 138 SKLLKLSLRNCSLQGP-----MPDLSRIPNLGYLDLSSNQL 173
+L + + L + + +I +L ++++ N L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 54/305 (17%), Positives = 96/305 (31%), Gaps = 91/305 (29%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL-----HHRNLV 570
+G G + V+ + VA+K ++ E + + EI+ L + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 571 SLVGYCDE------EGEQM-LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 623
+V D+ G + +V+E + + L + + + L I +G+
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 624 YLHTEADPPVFHRDIKASNILL-------------------------------------- 645
YLHT+ + H DIK NILL
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 646 -----------DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
K K+AD G + E I Y E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----------YRSLEVLIGS 268
Query: 695 KLTDKSDVYSLGVVFLELLTG---MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
+D++S + EL TG +P S + E +IA ++ + +G P
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA----LIIEL----LGKVPR 320
Query: 752 ECVEK 756
+ +
Sbjct: 321 KLIVA 325
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 24/68 (35%), Positives = 37/68 (54%), Gaps = 8/68 (11%)
Query: 162 NLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNNKLTGTIPSN-FSGLPRLQRLFIAN 217
L L LS NQ+ S+P G +L+ +T + L NKL ++P+ F L +L+ L +
Sbjct: 53 QLTKLSLSQNQIQ-SLPDGVFDKLT-KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDT 109
Query: 218 NSLSGSIP 225
N L S+P
Sbjct: 110 NQLK-SVP 116
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 28/107 (26%), Positives = 51/107 (47%), Gaps = 9/107 (8%)
Query: 117 ILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-PMPDLSRIPNLGYLDLSSNQLN 174
L+L++N ++P + +++L KLSL +Q P ++ L L L N+L
Sbjct: 32 RLELESNKL--QSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 175 GSIPPG---RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218
S+P G +L+ + + L N+L F L LQ++++ N
Sbjct: 90 -SLPNGVFDKLT-QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 9/104 (8%)
Query: 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQG-P 153
L++N L +L +L L L N ++P + ++KL L L LQ P
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQI--QSLPDGVFDKLTKLTILYLHENKLQSLP 92
Query: 154 MPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSLNITTIKLSNN 194
++ L L L +NQL S+P G RL+ ++ I L N
Sbjct: 93 NGVFDKLTQLKELALDTNQLK-SVPDGIFDRLT-SLQKIWLHTN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 13/149 (8%)
Query: 128 TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG---RLSL 184
T++P + L L N P + +L L L N+L S+P G +L+
Sbjct: 20 TSVPTGIPAQTTYLDLE-TNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLT- 76
Query: 185 NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 244
++T + LS N+L F L +L+ L + N L S+P ++ T+ L
Sbjct: 77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFD----KLTQLKDLRL 131
Query: 245 QNNNLTNI-SGSFNIPPNVT-VRLRGNPF 271
N L ++ G F+ ++ + L NP+
Sbjct: 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPW 160
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 63/333 (18%), Positives = 111/333 (33%), Gaps = 48/333 (14%)
Query: 519 IGQGGYGKVYKGI--LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRLHHR------ 567
+G+G +GKV + I G VAVK + + +EIQ L L+
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNSTF 77
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
V ++ + + G +V+E + + D + P +A + + +LH
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH- 135
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI----------VPAHVST 677
+ H D+K NIL + + + R I H ST
Sbjct: 136 --SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737
+V T Y PE L + DV+S+G + +E G + + +M
Sbjct: 194 LVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG-FTVFPTHD---SKE---HLAM 245
Query: 738 MFSVIDGNMGSYPSECVEK------FIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791
M ++ G P ++K F L + + R +S + L+
Sbjct: 246 MERIL----GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR-YVSRACKPLKEFMLSQDV 300
Query: 792 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824
+ + I + LKHP+
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 22/161 (13%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 569
NF +IG G +G++ G L VA+K E + E +F +L +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 570 VSLVGYCDEEGE-QMLVYEFM--SNGTLRDQLSAKSKEPLGFAMR--LSIALGSSRGILY 624
+ V Y G+ +V E + S L D F+++ L IA+ + Y
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT------FSLKTVLMIAIQLISRMEY 120
Query: 625 LHTEADPPVFHRDIKASNILLDHKFTAK-----VADFGLSR 660
+H++ + +RD+K N L+ + DF L++
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 42/301 (13%), Positives = 87/301 (28%), Gaps = 65/301 (21%)
Query: 9 IPKEIGNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYIS---------- 54
+ + S++ ++L+GN + L E + L+ + +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 55 GSLPKSFANLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLT-------- 102
L ++ K +++N+ + LS+ L H+ L NN L
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 103 -----GYLPPELSELPKLLILQLDNNNFE---GTTIPASYSNMSKLLKLSLRNCSL--QG 152
+ + P L + N E ++ + L + + + +G
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 153 PMPDLSRI----PNLGYLDLSSNQLNGSIPPGRLSL--------NITTIKLSNNKLTG-- 198
L L LDL N G +L N+ + L++ L+
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTFT---HLGSSALAIALKSWPNLRELGLNDCLLSARG 260
Query: 199 --------TIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 250
+ N LQ L + N + ++ + L+ N +
Sbjct: 261 AAAVVDAFSKLEN----IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
Query: 251 N 251
Sbjct: 317 E 317
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 51/303 (16%), Positives = 97/303 (32%), Gaps = 48/303 (15%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVK--RAQEG-SLQGEKEFLTEIQFLSRL-----HHRNL 569
+G G +G+V + + AVK R + + E L ++ ++ N+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNNI 98
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
V G L++E + +L + ++ + + + + YL
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--- 154
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA---------------- 673
+ H D+K NILLD + K +
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733
+ +++ T Y PE L SD++S G V EL TG + +
Sbjct: 215 YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLLFRTHE---HME--- 266
Query: 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI---WNMMP 790
+MM S+I P + + K ++ + + + E + SI +P
Sbjct: 267 HLAMMESII----QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 791 ESD 793
Sbjct: 323 LYK 325
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 30/140 (21%), Positives = 47/140 (33%), Gaps = 31/140 (22%)
Query: 43 LDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 102
L ++ D + ++ ++ LN+ I +P L+ + L NN L
Sbjct: 134 LKGLRSDPDLVAQNI---DVVLNRRSCMAATLRIIE-------ENIPELLSLNLSNNRLY 183
Query: 103 G--YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK-----LLKLSLRNCSLQGPMP 155
+ + + P L IL L N + S + K L +L L SL
Sbjct: 184 RLDDMSSIVQKAPNLKILNLSGNELK------SERELDKIKGLKLEELWLDGNSLCDTFR 237
Query: 156 D--------LSRIPNLGYLD 167
D R P L LD
Sbjct: 238 DQSTYISAIRERFPKLLRLD 257
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 843 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.98 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.98 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.95 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.93 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.91 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.91 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.83 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.69 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.49 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.66 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.64 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.51 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.46 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.35 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.23 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.83 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.77 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.72 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.63 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.0 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.0 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.6 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.54 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.29 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.95 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 95.69 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 95.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.48 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 94.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.56 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.43 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 94.27 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 94.07 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 93.76 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 93.31 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 93.31 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 92.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 92.61 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 92.5 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 92.37 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 91.98 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 91.9 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 91.81 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 91.51 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 91.26 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 90.84 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 90.69 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 90.68 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 90.53 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 90.15 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 89.45 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.34 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 89.18 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 88.43 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.24 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=458.93 Aligned_cols=262 Identities=30% Similarity=0.488 Sum_probs=222.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999863 478899999987776777899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-----------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEE
Q 003158 585 VYEFMSNGTLRDQLSAKS-----------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 653 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 653 (843)
|||||++|+|.++|+..+ ...++|..++.|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997632 356999999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHH
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 732 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~ 732 (843)
+|||+|+.....+. ........||+.|||||++.+..++.++|||||||++|||+| |+.||...... +.
T Consensus 170 ~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-~~---- 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EV---- 239 (299)
T ss_dssp CCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HH----
T ss_pred CCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH----
Confidence 99999986543211 112233568999999999999999999999999999999999 89999765431 11
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
+..+..+.....|..+++++.+++.+||+.+|++||++.++.+.|+++.+..|
T Consensus 240 -----~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 240 -----IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -----HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -----HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 12233445556778888999999999999999999999999999999876544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=460.08 Aligned_cols=261 Identities=29% Similarity=0.484 Sum_probs=216.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++|...++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666789999999999999864 478999999987776777899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcE
Q 003158 585 VYEFMSNGTLRDQLSAKS-------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 651 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 651 (843)
|||||++|+|.++++... ..+++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997642 246899999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHH
Q 003158 652 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 730 (843)
Q Consensus 652 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~ 730 (843)
||+|||+|+.....+. ........||+.|||||++.+..++.++|||||||++|||+| |+.||...... +..
T Consensus 198 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EAI- 270 (329)
T ss_dssp EECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-HHH-
T ss_pred EEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-HHH-
Confidence 9999999987643321 122344679999999999999999999999999999999999 89999765432 111
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
..+..+.....|..+++++.+++.+||+.+|++||++.++++.|+.+.+..
T Consensus 271 --------~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 271 --------DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp --------HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred --------HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 123334455667788899999999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=456.22 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=217.1
Q ss_pred CCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
+++..++||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3555788999999999999863 468999999975432 335789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc
Q 003158 585 VYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 650 (843)
|||||++|+|.++|..+. ...+++..+..|+.|||+||+|||+++ ||||||||+|||++++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996532 235899999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREV 729 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~ 729 (843)
+||+|||+|+.....+. ........||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+..
T Consensus 184 ~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~~~~ 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVV 257 (308)
T ss_dssp EEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-HHHH
T ss_pred EEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-HHHH
Confidence 99999999986543221 122344579999999999999999999999999999999999 8999976543 1111
Q ss_pred HHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 730 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
..+..+...+.|+++++.+.+++.+||+.+|.+||+|.+|++.|+.+.+
T Consensus 258 ---------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 258 ---------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred ---------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 1233444556788899999999999999999999999999999997643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=457.43 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=212.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999965 79999999997654445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 224 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 224 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC---
Confidence 999999999753 4899999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
.......||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+...
T Consensus 225 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~------------------- 280 (346)
T 4fih_A 225 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMK------------------- 280 (346)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHH-------------------
T ss_pred ----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHH-------------------
Confidence 223456799999999999999999999999999999999999999975432 11111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
.+.... +..-+.. +..++.+.|||.+||+.||++|+||+|+|+||||+....
T Consensus 281 ----------~i~~~~---~~~~~~~--------------~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 281 ----------MIRDNL---PPRLKNL--------------HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp ----------HHHHSS---CCCCSCG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ----------HHHcCC---CCCCCcc--------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 111100 0000000 111233457888999999999999999999999987544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=442.82 Aligned_cols=267 Identities=25% Similarity=0.450 Sum_probs=214.1
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+..+++...++||+|+||+||+|++++ .||||+++.. .....++|.+|++++++++|||||+++|++.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 344677888999999999999998753 5999998743 33445789999999999999999999999865 568999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||||++|+|.++++... .++++..+..|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999997643 46999999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.. ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||....+........ .. ...
T Consensus 186 ~~-----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~-~~----~~~ 255 (307)
T 3omv_A 186 SG-----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV-GR----GYA 255 (307)
T ss_dssp -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HT----TCC
T ss_pred Cc-----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH-hc----CCC
Confidence 21 222345679999999999974 468999999999999999999999998655432222111 11 112
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
.+.....+.++++.+.+++.+||+.+|++||++.++++.|+.+...+|.
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 2233345677888999999999999999999999999999988766553
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=449.13 Aligned_cols=260 Identities=19% Similarity=0.312 Sum_probs=212.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999964 799999999975322 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|||+||+|.+++.+.+ .+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997654 5899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ...... +....
T Consensus 187 ~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~---------i~~~~- 250 (311)
T 4aw0_A 187 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAK---------IIKLE- 250 (311)
T ss_dssp T-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH---------HHHTC-
T ss_pred C-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH---------HHcCC-
Confidence 1 1223456799999999999999999999999999999999999999975432 111110 00000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC------CCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM------LKH 820 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~------L~H 820 (843)
..+|+ ..++++.|||.+||+.||++|+|++|+ ++|
T Consensus 251 ~~~p~---------------------------------------~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~H 291 (311)
T 4aw0_A 251 YDFPE---------------------------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 291 (311)
T ss_dssp CCCCT---------------------------------------TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred CCCCc---------------------------------------ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCC
Confidence 01111 112234478888899999999999985 789
Q ss_pred CcccCCCCCC
Q 003158 821 PYVSSDVSGS 830 (843)
Q Consensus 821 p~f~~~~~~~ 830 (843)
|||++..+..
T Consensus 292 p~F~~idw~~ 301 (311)
T 4aw0_A 292 PFFESVTWEN 301 (311)
T ss_dssp GGGTTCCCTT
T ss_pred CCcCCCCHHH
Confidence 9999877754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-54 Score=454.47 Aligned_cols=270 Identities=22% Similarity=0.301 Sum_probs=210.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++|++.+.||+|+||+||+|+.. .++.||||+++.... ....++.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 478999999875322 223468889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|||||+||+|.+++.+.. .+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997654 5899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.. .......||+.|||||++.+..|+.++||||+||++|||+||+.||...+. .+.... +...
T Consensus 179 ~~-------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~~---------i~~~ 241 (304)
T 3ubd_A 179 HE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTM---------ILKA 241 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH---------HHHC
T ss_pred CC-------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-HHHHHH---------HHcC
Confidence 21 223456799999999999999999999999999999999999999975432 111111 1100
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC-----ccCCC
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-----SSMLK 819 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa-----~e~L~ 819 (843)
...+|..+++ .+.+|+.+||+.||++|+|| +|+++
T Consensus 242 -~~~~p~~~s~---------------------------------------~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 -KLGMPQFLSP---------------------------------------EAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCCCTTSCH---------------------------------------HHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCCCcCCH---------------------------------------HHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112222222 23356677777777777776 68999
Q ss_pred CCcccCCCCCCccccccCCCCCC
Q 003158 820 HPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 820 Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
||||++..+.....+...||+.|
T Consensus 282 Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 282 HSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp SGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CccccCCCHHHHHhCCCCcCcCC
Confidence 99999877766666677888887
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=458.84 Aligned_cols=258 Identities=22% Similarity=0.380 Sum_probs=213.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999965 69999999998655555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
+||+|.+++... .+++..+..++.||++||+|||+++ ||||||||+|||++.+|.+||+|||+|+......
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--- 301 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 301 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC---
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC---
Confidence 999999999653 4889999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +..
T Consensus 302 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~-------------------- 356 (423)
T 4fie_A 302 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAM-------------------- 356 (423)
T ss_dssp ----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHH--------------------
T ss_pred ----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHH--------------------
Confidence 2234567999999999999999999999999999999999999999754321 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+.+......... .....++.+.|||.+||+.||++|+||+|+|+||||+....
T Consensus 357 ---------~~i~~~~~~~~~-----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 357 ---------KMIRDNLPPRLK-----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp ---------HHHHHSCCCCCS-----------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ---------HHHHcCCCCCCc-----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 111111000000 01122334457899999999999999999999999987544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=445.61 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=209.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+.|+..++||+|+||+||+|+.. +|+.||||+++.... ..+|+++++.++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999964 699999999975432 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 668 (843)
+||+|.+++++.+ ++++..++.++.||+.||+|||+++ ||||||||+|||++.+| .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997654 5899999999999999999999999 99999999999999988 6999999999876532211
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC--
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM-- 746 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 746 (843)
. .........||+.|||||++.+..|+.++|||||||++|||+||+.||...... ..+..+.....
T Consensus 208 ~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----------~~~~~i~~~~~~~ 275 (336)
T 4g3f_A 208 K--SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----------PLCLKIASEPPPI 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS----------CCHHHHHHSCCGG
T ss_pred c--ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----------HHHHHHHcCCCCc
Confidence 0 011123457999999999999999999999999999999999999999754321 11111111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
...+..+++.+.+++.+||.+||.+||++.|+++.+.....
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 23456778889999999999999999999999999887653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=448.98 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=208.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 79999999997543 2335679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
||+||+|.+++..+....+++..++.|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999998776667899999999999999999999999 999999999999999999999999999865321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
........||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+.. ..+..+..+
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~---------~~i~~~~~~ 243 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNLV---------LKIISGSFP 243 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHH---------HHHHHTCCC
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHH---------HHHHcCCCC
Confidence 1223456799999999999999999999999999999999999999976542 2222 123334444
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
..+..+++++.+++.+||++||.+||++.++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 556667788889999999999999999998875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=436.22 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=195.4
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999996 4799999999975432 23467999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+ +|+|.+++.++. ++++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 689999997653 5899999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ...
T Consensus 166 -------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~----------------- 220 (275)
T 3hyh_A 166 -------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVL----------------- 220 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHH-----------------
T ss_pred -------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHH-----------------
Confidence 22345679999999999998876 5799999999999999999999975431 111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
.+.+..+--.-| ...++.+.+|+.+||+.||++|+|++|+|+||||+.
T Consensus 221 ------------~~~i~~~~~~~p--------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 221 ------------FKNISNGVYTLP--------------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------HHHHHHTCCCCC--------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------HHHHHcCCCCCC--------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 111111100001 011223447888999999999999999999999987
Q ss_pred CC
Q 003158 826 DV 827 (843)
Q Consensus 826 ~~ 827 (843)
+.
T Consensus 269 ~~ 270 (275)
T 3hyh_A 269 DL 270 (275)
T ss_dssp TC
T ss_pred CC
Confidence 64
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=437.41 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=198.5
Q ss_pred CCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec----CCcEEEEE
Q 003158 514 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 586 (843)
Q Consensus 514 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~ 586 (843)
+..++||+|+||+||+|.+. +++.||+|++.... ....++|.+|++++++++|||||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999965 68999999987532 3335679999999999999999999999864 35689999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeeccccccCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~ 665 (843)
|||++|+|.+++.+.. .+++..++.++.||++||+|||+++ ++||||||||+|||+++ ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999997653 5889999999999999999999875 46999999999999984 78999999999986432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|||||++.+ .|+.++|||||||++|||+||+.||....+........ ..+
T Consensus 185 --------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i---------~~~- 245 (290)
T 3fpq_A 185 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------TSG- 245 (290)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---------TTT-
T ss_pred --------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH---------HcC-
Confidence 12345679999999998865 69999999999999999999999997654322211110 000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
.+|.. ......+.+.+|+.+||+.||++|||++|+|+||||+.
T Consensus 246 -------------------------~~~~~------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 -------------------------VKPAS------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------------------CCCGG------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------------------CCCCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 00100 00011122346778888899999999999999999986
Q ss_pred C
Q 003158 826 D 826 (843)
Q Consensus 826 ~ 826 (843)
+
T Consensus 289 ~ 289 (290)
T 3fpq_A 289 E 289 (290)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=443.27 Aligned_cols=271 Identities=25% Similarity=0.418 Sum_probs=225.5
Q ss_pred ccHHHHHHHHcCCCCCCcccccCCeeEEEEEeCC------CcEEEEEEeccCChh-hHHHHHHHHHHHHhccC-Ccccce
Q 003158 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHH-RNLVSL 572 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~nIv~l 572 (843)
+...+|++..++|++.+.||+|+||+||+|.+.. ++.||||+++..... ..++|.+|+++|+++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3345677778999999999999999999998642 468999999865433 35679999999999965 899999
Q ss_pred eeeeecC-CcEEEEEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEecc
Q 003158 573 VGYCDEE-GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637 (843)
Q Consensus 573 ~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~D 637 (843)
+|+|.+. +..+||||||++|+|.++|+... ...+++..+..++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999664 57899999999999999997532 245899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CC
Q 003158 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 716 (843)
Q Consensus 638 lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~ 716 (843)
|||+|||+++++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 999999999999999999999987643321 123345679999999999999999999999999999999998 99
Q ss_pred CCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 717 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 717 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.||........... .+..+.....|+.+++++.+++..||+.+|.+||++.+++++|+.+.+.
T Consensus 286 ~Pf~~~~~~~~~~~---------~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 286 SPYPGVKIDEEFCR---------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CSSTTCCCSHHHHH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHH---------HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 99976543221111 2223445566778889999999999999999999999999999988654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=440.61 Aligned_cols=302 Identities=19% Similarity=0.268 Sum_probs=213.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 583 (843)
..++|++.+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +||||+++++++.+.++.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4678999999999999999999853 46899999987533 345788999999998 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC-CcEEEeeccccccC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLA 662 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~ 662 (843)
+|||||++|+|.+++. .+++.+++.++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999999983 3888999999999999999999999 9999999999999877 79999999999865
Q ss_pred CCCCCCCc---------------------ccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCC
Q 003158 663 PVPDIEGI---------------------VPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPIS 720 (843)
Q Consensus 663 ~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~ 720 (843)
........ ......+...||+.|||||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 43221000 001122345799999999999875 58999999999999999999999998
Q ss_pred CCcchHHHHHHHhhcccc----------hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 721 HGKNIVREVNIAYQSSMM----------FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
.+.+..+++......... ...... ....|......+.+.+...-...|. ...-..........+.
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~p~----~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILC-SKEVPAQDLRKLCERLRGMDSSTPK----LTSDIQGHATNLEGWN 323 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEE-SSCCCCCCHHHHHHHHC--------------------------CT
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccc-cccCcchhhhHHHHhhccccccccc----cccccccccccccccc
Confidence 877655544432211000 000000 0011111111111111111111111 1111111111112234
Q ss_pred CCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 791 ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 791 ~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
..++++.|||++||++||++|+||+|||+||||++
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 44566789999999999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=442.06 Aligned_cols=287 Identities=22% Similarity=0.355 Sum_probs=215.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec------CCc
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 581 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 581 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999964 79999999997543 2335678899999999999999999998753 467
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.|||||||+ |+|.+++... .++++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 7899999654 46999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
+...... .........||+.|||||++.+. .++.++||||+||++|||++|+.||..... .++........
T Consensus 208 ~~~~~~~---~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-~~~l~~I~~~~---- 279 (398)
T 4b99_A 208 LCTSPAE---HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-VHQLQLIMMVL---- 279 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHH----
T ss_pred cccCccc---cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhc----
Confidence 6432111 12233456899999999999875 569999999999999999999999976543 33222221110
Q ss_pred hccCCCCCCCHHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 741 VIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
+.++....... .......+...|...|.. +...++..++.+.|||.+||++||++|+||+|+|+
T Consensus 280 ------g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 280 ------GTPSPAVIQAVGAERVRAYIQSLPPRQPVP---------WETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ------CCCCGGGTC-----CHHHHHHSSCCCCCCC---------HHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCCChHHhhhhhhhhhhhhhhcCCCcCCCC---------HHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01111110000 001112222333333322 11234555667789999999999999999999999
Q ss_pred CCcccCC
Q 003158 820 HPYVSSD 826 (843)
Q Consensus 820 Hp~f~~~ 826 (843)
||||+.-
T Consensus 345 Hp~f~~~ 351 (398)
T 4b99_A 345 HPFLAKY 351 (398)
T ss_dssp SGGGTTT
T ss_pred CHhhCcC
Confidence 9999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=421.04 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=191.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCC--------
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-------- 580 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 580 (843)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999964 799999999875443 33567999999999999999999999986543
Q ss_pred ----cEEEEEecCCCCCHHHHHhhcCC-CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 581 ----EQMLVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 581 ----~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
..|+|||||++|+|.+++..+.. ...++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36999999999999999976543 23445668899999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCCCcc-----cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHH
Q 003158 656 FGLSRLAPVPDIEGIV-----PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 730 (843)
Q Consensus 656 fGla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~ 730 (843)
||+|+........... .....+...||+.|||||++.+..|+.++|||||||++|||++ ||....+......
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9999876543211110 0112244579999999999999999999999999999999996 7753221111000
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCC
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 810 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~ 810 (843)
.+.. ..+|.. +.+. .+...+|+.+||+.||++
T Consensus 239 ---------~~~~---~~~p~~----------------------~~~~--------------~~~~~~li~~~L~~dP~~ 270 (299)
T 4g31_A 239 ---------DVRN---LKFPPL----------------------FTQK--------------YPCEYVMVQDMLSPSPME 270 (299)
T ss_dssp ---------HHHT---TCCCHH----------------------HHHH--------------CHHHHHHHHHHTCSSGGG
T ss_pred ---------HHhc---CCCCCC----------------------Cccc--------------CHHHHHHHHHHcCCChhH
Confidence 0000 011111 0000 111236788899999999
Q ss_pred CCCCccCCCCCcccCCCC
Q 003158 811 PPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 811 R~sa~e~L~Hp~f~~~~~ 828 (843)
||||+|+|+||||++-.+
T Consensus 271 Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 271 RPEAINIIENAVFEDLDF 288 (299)
T ss_dssp SCCHHHHHTSGGGCCC--
T ss_pred CcCHHHHhcCHhhCCCCC
Confidence 999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=419.22 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=200.0
Q ss_pred CCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCC----cEEEEEe
Q 003158 512 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQMLVYE 587 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~e 587 (843)
+|.+.++||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+++ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 566778999999999999998 68999999997532 22223345666777899999999999997654 5799999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-----CCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-----ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
||++|+|.++++.. ++++..+.+++.|+++||+|||++ .+++||||||||+|||+++++++||+|||+|+..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999764 488999999999999999999987 2345999999999999999999999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccC------CCCchhhhHHHHHHHHHHHhCCCCCCCCcc------------
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHGKN------------ 724 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwS~G~~l~elltg~~pf~~~~~------------ 724 (843)
...... .........||+.|||||++.+. .++.++|||||||++|||+||+.||.....
T Consensus 159 ~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 159 DSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp ETTTTE---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred cCCCCc---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 432210 01122345799999999999764 367799999999999999999877643211
Q ss_pred -hHHHHHHHhhcccchhhccCCCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 725 -IVREVNIAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 725 -~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
........... ....+..+. .+.++++.+.+++.+||+.+|.+|||+.++++.|+++.+
T Consensus 236 ~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111111100 111111111 123577889999999999999999999999999998865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=442.49 Aligned_cols=271 Identities=22% Similarity=0.310 Sum_probs=212.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHH---HHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFL---TEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++.+... .....+. .++++++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999965 699999999974321 1122333 3466777789999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+|||||+||+|.++|...+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999997754 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.. .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||........
T Consensus 344 ~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--------------- 399 (689)
T 3v5w_A 344 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------- 399 (689)
T ss_dssp SC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---------------
T ss_pred CC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---------------
Confidence 32 1234579999999999975 5799999999999999999999999964321000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC-----CccC
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSM 817 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s-----a~e~ 817 (843)
..+.+.+ +...+ .-| ...++.+.|||.+||+.||++|++ |+|+
T Consensus 400 ------------~~i~~~i---~~~~~-~~p----------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei 447 (689)
T 3v5w_A 400 ------------HEIDRMT---LTMAV-ELP----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447 (689)
T ss_dssp ------------HHHHHHH---HHCCC-CCC----------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH
T ss_pred ------------HHHHHhh---cCCCC-CCC----------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH
Confidence 0000000 00000 000 111233446777788888888887 6999
Q ss_pred CCCCcccCCCCCCccccccCCCCCC
Q 003158 818 LKHPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 818 L~Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
++||||++..+.........||+.|
T Consensus 448 ~~HpfF~~idW~~l~~~~~~pP~~P 472 (689)
T 3v5w_A 448 KESPFFRSLDWQMVFLQKYPPPLIP 472 (689)
T ss_dssp TTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred hcCccccCCCHHHHHcCCCCcCccC
Confidence 9999999988876666666677766
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=435.40 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=215.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|+++|+.++||||++++++|.+++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999965 6999999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC--CcEEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~~~~ 666 (843)
|+||+|.+++..+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999653 346999999999999999999999999 9999999999999854 89999999999876532
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|||||++.+..|+.++||||+||++|||++|+.||...... +...
T Consensus 311 -------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~~---------------- 366 (573)
T 3uto_A 311 -------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLR---------------- 366 (573)
T ss_dssp -------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH----------------
T ss_pred -------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHH----------------
Confidence 2344567999999999999999999999999999999999999999754421 1111
Q ss_pred CCCCHHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 747 GSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c-~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
.+..+ +...+ ..++..++.+.|||.+||+.||++|+||+|+|+||||+.
T Consensus 367 -------------~i~~~~~~~~~-----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 367 -------------NVKSCDWNMDD-----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp -------------HHHTTCCCCCS-----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred -------------HHHhCCCCCCc-----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 01111 00000 001122334558999999999999999999999999987
Q ss_pred CCC
Q 003158 826 DVS 828 (843)
Q Consensus 826 ~~~ 828 (843)
...
T Consensus 417 ~~~ 419 (573)
T 3uto_A 417 GNA 419 (573)
T ss_dssp CCC
T ss_pred CCC
Confidence 544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=386.43 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=208.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999996 579999999987532 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999997654 4889999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|+|||++.+..+. .++||||+||++|||++|+.||..... ....
T Consensus 168 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~---------------- 223 (328)
T 3fe3_A 168 -------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-KELR---------------- 223 (328)
T ss_dssp -------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----------------
T ss_pred -------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-HHHH----------------
Confidence 122345699999999999988775 789999999999999999999975432 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+.+...-...|. ..++.+.+|+++||..||++|||++|+++||||..
T Consensus 224 -------------~~i~~~~~~~p~--------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 224 -------------ERVLRGKYRIPF--------------------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp -------------HHHHHCCCCCCT--------------------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred -------------HHHHhCCCCCCC--------------------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 111110000010 01222346788899999999999999999999987
Q ss_pred CCCCC
Q 003158 826 DVSGS 830 (843)
Q Consensus 826 ~~~~~ 830 (843)
.....
T Consensus 271 ~~~~~ 275 (328)
T 3fe3_A 271 GHEED 275 (328)
T ss_dssp TCTTC
T ss_pred CCccc
Confidence 55433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=397.62 Aligned_cols=281 Identities=20% Similarity=0.295 Sum_probs=217.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+|+||+||+|+.. +++.||+|+++..... ..+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999965 6889999999754322 224578899999887 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999997653 4889999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 206 ~-------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~--------------- 263 (396)
T 4dc2_A 206 P-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------------- 263 (396)
T ss_dssp T-------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------------
T ss_pred C-------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc---------------
Confidence 1 122345679999999999999999999999999999999999999996432110000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC------ccCC
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS------SSML 818 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa------~e~L 818 (843)
... ...+.+.+...--.-| ...+..+.+||++||+.||++|+++ +|++
T Consensus 264 ---~~~---~~~~~~~i~~~~~~~p--------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~ 317 (396)
T 4dc2_A 264 ---QNT---EDYLFQVILEKQIRIP--------------------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 317 (396)
T ss_dssp ----CC---HHHHHHHHHHCCCCCC--------------------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHH
T ss_pred ---hhh---HHHHHHHHhccccCCC--------------------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHh
Confidence 000 0011111111000000 1112334467888888888888887 6899
Q ss_pred CCCcccCCCCCCccccccCCCCCCC
Q 003158 819 KHPYVSSDVSGSNLVSGVIPTITPR 843 (843)
Q Consensus 819 ~Hp~f~~~~~~~~~~~~~~~~~~~~ 843 (843)
+||||++..+.......+.|++.|.
T Consensus 318 ~Hpff~~i~w~~l~~~~~~pp~~p~ 342 (396)
T 4dc2_A 318 GHPFFRNVDWDMMEQKQVVPPFKPN 342 (396)
T ss_dssp HSTTTTTCCHHHHHTTCSCCSCCCC
T ss_pred cCccccCCCHHHHHcCCCCCCCcCC
Confidence 9999998777655556667777773
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=406.37 Aligned_cols=283 Identities=23% Similarity=0.268 Sum_probs=221.4
Q ss_pred cHHHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh---HHHHHHHHHHHHhccCCcccceeeeee
Q 003158 502 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG---EKEFLTEIQFLSRLHHRNLVSLVGYCD 577 (843)
Q Consensus 502 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~ 577 (843)
.+.++....++|++.++||+|+||+||+|+.. +++.||+|++....... .+.+.+|+.+++.++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44566667789999999999999999999976 58899999997532211 234788999999999999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
+.+..++|||||++|+|.+++... ...+++..++.++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999763 345899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHH
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 732 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~ 732 (843)
+|+...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...... +...
T Consensus 221 la~~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~-- 291 (437)
T 4aw2_A 221 SCLKLMEDG------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYG-- 291 (437)
T ss_dssp TCEECCTTS------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHH--
T ss_pred hhhhcccCC------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHH--
Confidence 997654321 22234467999999999997 466899999999999999999999999754321 1111
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCC-
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCC-QDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET- 810 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~-~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~- 810 (843)
+++.... -.-|.. .+..++.+.+||++||..+|++
T Consensus 292 --------------------------~i~~~~~~~~~p~~-----------------~~~~s~~~~dLi~~lL~~~~~r~ 328 (437)
T 4aw2_A 292 --------------------------KIMNHKERFQFPTQ-----------------VTDVSENAKDLIRRLICSREHRL 328 (437)
T ss_dssp --------------------------HHHTHHHHCCCCSS-----------------CCCSCHHHHHHHHTTSSCGGGCT
T ss_pred --------------------------hhhhccccccCCcc-----------------cccCCHHHHHHHHHHhccccccc
Confidence 1100000 000110 1112334457888999888888
Q ss_pred -CCCCccCCCCCcccCCCCCCccccccCCCCCC
Q 003158 811 -PPSSSSMLKHPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 811 -R~sa~e~L~Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
|++++|+++||||++..+... ....|++.|
T Consensus 329 ~r~~~~eil~Hpff~~i~w~~l--~~~~~p~~P 359 (437)
T 4aw2_A 329 GQNGIEDFKKHPFFSGIDWDNI--RNCEAPYIP 359 (437)
T ss_dssp TTTTTHHHHTSGGGTTCCTTTG--GGSCCSCCC
T ss_pred CCCCHHHHhCCCccCCCCHHHH--hhCCCCCCC
Confidence 999999999999998777543 344555554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=382.33 Aligned_cols=286 Identities=43% Similarity=0.745 Sum_probs=234.1
Q ss_pred ccCCcccccHHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccce
Q 003158 494 KIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSL 572 (843)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l 572 (843)
.......+++.++....++|++.+.||+|+||+||+|...+++.||||++...... ....+.+|+++++.++||||+++
T Consensus 13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 34456778999999999999999999999999999999888999999998764322 23468999999999999999999
Q ss_pred eeeeecCCcEEEEEecCCCCCHHHHHhhcC--CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc
Q 003158 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT 650 (843)
Q Consensus 573 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 650 (843)
++++.+.+..++||||+++|+|.+++.... ..++++..++.++.|++.||+|||+++.++|+||||||+|||+++++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999997643 345899999999999999999999993223999999999999999999
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCC-------Cc
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH-------GK 723 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~-------~~ 723 (843)
+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.. ..
T Consensus 173 ~kl~Dfg~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246 (326)
T ss_dssp EEECCCSSCEECCSSS------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred EEeccCccccccCccc------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence 9999999998764322 2233445699999999999999999999999999999999999999952 11
Q ss_pred chHHHHHHHhhcccchhhccCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
...++..............+... ...+.+.+..+.+++..||+.+|.+||++.+++++|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp BHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 12223222222223333333333 356788999999999999999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=386.83 Aligned_cols=202 Identities=26% Similarity=0.343 Sum_probs=177.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357889999999999999999965 69999999997532 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999997643 4889999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 159 -------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp -------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 122344579999999999999999999999999999999999999997543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=394.65 Aligned_cols=274 Identities=24% Similarity=0.354 Sum_probs=211.9
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcE
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 582 (843)
...++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999965 68999999997532 22345678899999988 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999997653 4889999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... .
T Consensus 175 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i---------~ 237 (353)
T 3txo_A 175 ICN-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI---------L 237 (353)
T ss_dssp CC----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH---------H
T ss_pred ccC-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-HHHHHHH---------H
Confidence 321 1223456799999999999999999999999999999999999999975432 1111110 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC------cc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS------SS 816 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa------~e 816 (843)
.. ...+|... ...+.+++++||+.||++|+++ +|
T Consensus 238 ~~-~~~~p~~~---------------------------------------~~~~~~li~~lL~~dP~~R~~~~~~~~~~~ 277 (353)
T 3txo_A 238 ND-EVVYPTWL---------------------------------------HEDATGILKSFMTKNPTMRLGSLTQGGEHA 277 (353)
T ss_dssp HC-CCCCCTTS---------------------------------------CHHHHHHHHHHTCSSGGGSTTSGGGTCTHH
T ss_pred cC-CCCCCCCC---------------------------------------CHHHHHHHHHHhhhCHHHccCCcccCCHHH
Confidence 00 00111111 1223356777777788888887 88
Q ss_pred CCCCCcccCCCCCCccccccCCCCCCC
Q 003158 817 MLKHPYVSSDVSGSNLVSGVIPTITPR 843 (843)
Q Consensus 817 ~L~Hp~f~~~~~~~~~~~~~~~~~~~~ 843 (843)
+++||||++..+.....+...|++.|+
T Consensus 278 il~hp~f~~~~w~~l~~~~~~~p~~p~ 304 (353)
T 3txo_A 278 ILRHPFFKEIDWAQLNHRQIEPPFRPR 304 (353)
T ss_dssp HHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HhhCCcccCCCHHHHhcCcCCCCccCC
Confidence 999999988776655555566666664
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=374.77 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=210.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999995 57999999999765555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|+|.+++... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999999764 4888999999999999999999999 9999999999999999999999999998654322
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ... .....
T Consensus 171 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~-------~~~~~ 237 (297)
T 3fxz_A 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNG-------TPELQ 237 (297)
T ss_dssp -----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HHC-------SCCCS
T ss_pred -----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCC-------CCCCC
Confidence 12234569999999999999999999999999999999999999997554321111100 000 00000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
.+..+ ...+.+|+.+||..||++|||++|+|+||||+....
T Consensus 238 ~~~~~---------------------------------------~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 238 NPEKL---------------------------------------SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp CGGGS---------------------------------------CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred Ccccc---------------------------------------CHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 01111 112236777888899999999999999999987544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=382.11 Aligned_cols=277 Identities=25% Similarity=0.347 Sum_probs=209.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|...+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4689999999999999999999988999999998754322 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|++ |+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 997 5888888654 345889999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 174 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---------------- 231 (311)
T 3niz_A 174 ------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---------------- 231 (311)
T ss_dssp ------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH----------------
T ss_pred ------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH----------------
Confidence 22234568999999999986 5689999999999999999999999975443211110
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH---------HhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE---------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~---------~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
+...+-...|...+...++....+ .+....+...+.+.+|+.+||++||++|||++|+
T Consensus 232 -------------i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 232 -------------IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp -------------HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred -------------HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 111111111111111111000000 0011122334445689999999999999999999
Q ss_pred CCCCcccCCC
Q 003158 818 LKHPYVSSDV 827 (843)
Q Consensus 818 L~Hp~f~~~~ 827 (843)
|+||||++..
T Consensus 299 l~hp~f~~~~ 308 (311)
T 3niz_A 299 MNHPYFKDLD 308 (311)
T ss_dssp HTSGGGTTSC
T ss_pred hcCcccccCC
Confidence 9999998743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=379.00 Aligned_cols=276 Identities=43% Similarity=0.726 Sum_probs=230.1
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++...+++|+..+.||+|+||+||+|.+++++.||||++........+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34446789999999999999999999988899999999887666667789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 585 VYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999996543 235899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc-----hHHHHHHHhhccc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQSSM 737 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~-----~~~~~~~~~~~~~ 737 (843)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.........
T Consensus 190 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 190 TELDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp SSSSC-----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred ccccc-----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 42221 1222345689999999999999999999999999999999999999975322 2222222222223
Q ss_pred chhhccCCCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 738 MFSVIDGNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 738 ~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
+...+++... ..+.+++..+.+++.+||+.+|++||++.++++.|+.+.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 3334444333 45788999999999999999999999999999999988654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=396.70 Aligned_cols=281 Identities=19% Similarity=0.256 Sum_probs=222.1
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecC
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 579 (843)
.++....++|++.+.||+|+||+||+|+.. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 445556789999999999999999999975 6899999998742211 123578899999999999999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
+..++||||+++|+|.++++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999999653 4788999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~ 735 (843)
+...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .....
T Consensus 216 ~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~---- 284 (410)
T 3v8s_A 216 MKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSK---- 284 (410)
T ss_dssp EECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH----
T ss_pred EeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHH----
Confidence 8654321 12233567999999999998765 788999999999999999999999754321 11110
Q ss_pred ccchhhccCCCCCCCHHHHHHHHHHHHHhcc-cCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCC--CC
Q 003158 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQ-DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET--PP 812 (843)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~-~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~--R~ 812 (843)
++..-.. ..|. .+..+..+.+||.+||+.+|++ |+
T Consensus 285 ------------------------i~~~~~~~~~p~------------------~~~~s~~~~~li~~lL~~~~~rlgR~ 322 (410)
T 3v8s_A 285 ------------------------IMNHKNSLTFPD------------------DNDISKEAKNLICAFLTDREVRLGRN 322 (410)
T ss_dssp ------------------------HHTHHHHCCCCT------------------TCCCCHHHHHHHHHHSSCGGGCTTSS
T ss_pred ------------------------HHhccccccCCC------------------cccccHHHHHHHHHHccChhhhCCCC
Confidence 0000000 0000 0111233446777888888888 99
Q ss_pred CCccCCCCCcccCCCCCCccccccCCCCCCC
Q 003158 813 SSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 843 (843)
Q Consensus 813 sa~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~ 843 (843)
+++|+++||||++..+.....+...|++.|+
T Consensus 323 ~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~ 353 (410)
T 3v8s_A 323 GVEEIKRHLFFKNDQWAWETLRDTVAPVVPD 353 (410)
T ss_dssp CHHHHHTSGGGCCSSCCSTTGGGSCCSCCCC
T ss_pred CHHHHhcCccccCCCHHHHhhcccCCCCCCc
Confidence 9999999999999888777777777888774
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=383.65 Aligned_cols=268 Identities=21% Similarity=0.362 Sum_probs=212.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999965 699999999975322 2346778999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999997643 5889999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +....
T Consensus 159 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~---------i~~~~ 219 (318)
T 1fot_A 159 ---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEK---------ILNAE 219 (318)
T ss_dssp ---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH---------HHHCC
T ss_pred ---------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHH---------HHhCC
Confidence 123456999999999999999999999999999999999999999764421 11111 11110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----CCccCCCC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLKH 820 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~-----sa~e~L~H 820 (843)
..+|..++.++. +++.+||+.||++|+ +++|+++|
T Consensus 220 -~~~p~~~~~~~~---------------------------------------~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 -LRFPPFFNEDVK---------------------------------------DLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCCTTSCHHHH---------------------------------------HHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHH---------------------------------------HHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 112222223333 455556666666666 89999999
Q ss_pred CcccCCCCCCccccccCCCCCC
Q 003158 821 PYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 821 p~f~~~~~~~~~~~~~~~~~~~ 842 (843)
|||++..+.........|++.|
T Consensus 260 p~f~~~~~~~~~~~~~~~p~~p 281 (318)
T 1fot_A 260 PWFKEVVWEKLLSRNIETPYEP 281 (318)
T ss_dssp GGGSSCCHHHHHTTCSCCSCCC
T ss_pred ccccCCCHHHHHhCCCCCCCCC
Confidence 9998877654444444455544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=385.72 Aligned_cols=279 Identities=21% Similarity=0.311 Sum_probs=214.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 585 (843)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57889999999999999999975 68999999997542 23345688999999988 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997653 4889999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 164 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------------- 220 (345)
T 3a8x_A 164 -------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------------- 220 (345)
T ss_dssp -------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------------
T ss_pred -------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc----------------
Confidence 122345579999999999999999999999999999999999999996422100000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC------ccCCC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS------SSMLK 819 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa------~e~L~ 819 (843)
......+.+.+... .+ .-| +..+..+.+++.+||+.||++|+++ +|+++
T Consensus 221 -----~~~~~~~~~~i~~~---~~-~~p----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 221 -----QNTEDYLFQVILEK---QI-RIP----------------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -------CHHHHHHHHHHC---CC-CCC----------------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -----cccHHHHHHHHHcC---CC-CCC----------------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 00001111111110 00 000 0112233467778888888888887 68999
Q ss_pred CCcccCCCCCCccccccCCCCCC
Q 003158 820 HPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 820 Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
||||++..+.....+...|++.|
T Consensus 276 hp~f~~~~w~~~~~~~~~~p~~p 298 (345)
T 3a8x_A 276 HPFFRNVDWDMMEQKQVVPPFKP 298 (345)
T ss_dssp SGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CCccCCCCHHHHHhCCCCCCcCC
Confidence 99998876644444555666665
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=385.29 Aligned_cols=274 Identities=22% Similarity=0.327 Sum_probs=213.5
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCc
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 581 (843)
....++|.+.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+..|.++++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999975 68999999997532 12345678899999887 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999997643 4889999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 168 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~----------- 228 (345)
T 1xjd_A 168 NMLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFH----------- 228 (345)
T ss_dssp CCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH-----------
T ss_pred cccCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HHHH-----------
Confidence 43221 1234567999999999999999999999999999999999999999754321 1110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCc-cCCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS-SMLKH 820 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~-e~L~H 820 (843)
.+.. ..+.- | ...+..+.+++.+||+.||++|+++. |+++|
T Consensus 229 ------------------~i~~---~~~~~-p----------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 229 ------------------SIRM---DNPFY-P----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ------------------HHHH---CCCCC-C----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ------------------HHHh---CCCCC-C----------------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 0000 00000 0 00122234688888999999999998 99999
Q ss_pred CcccCCCCCCccccccCCCCCC
Q 003158 821 PYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 821 p~f~~~~~~~~~~~~~~~~~~~ 842 (843)
|||++..+.........|++.|
T Consensus 271 p~f~~~~w~~l~~~~~~~p~~p 292 (345)
T 1xjd_A 271 PLFREINWEELERKEIDPPFRP 292 (345)
T ss_dssp GGGTTCCHHHHHTTCSCC----
T ss_pred ccccCCCHHHHhhCCCCCCcCC
Confidence 9998876644444445555554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=381.98 Aligned_cols=202 Identities=26% Similarity=0.407 Sum_probs=168.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+++++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999996 4789999999976432 234567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997643 4788899999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 171 SIHD-------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccC-------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 4321 112234568999999999999999999999999999999999999997544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=381.91 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=210.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|++.+.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999965 6999999998764322 246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC----cEEEeeccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 658 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGl 658 (843)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999653 45899999999999999999999999 99999999999998877 799999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....
T Consensus 166 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~------- 229 (361)
T 2yab_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLAN------- 229 (361)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHH-------
T ss_pred ceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-------
Confidence 98754321 123456999999999999999999999999999999999999999764321 11110
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
+.. ....++... ++..+..+.+||.+||..||++|||++|+|
T Consensus 230 --i~~-~~~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 230 --ITA-VSYDFDEEF-----------------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp --HHT-TCCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred --HHh-cCCCCCchh-----------------------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 011111111 011223345789999999999999999999
Q ss_pred CCCcccCCC
Q 003158 819 KHPYVSSDV 827 (843)
Q Consensus 819 ~Hp~f~~~~ 827 (843)
+||||+...
T Consensus 272 ~hp~~~~~~ 280 (361)
T 2yab_A 272 RHPWITPVD 280 (361)
T ss_dssp TSTTTSCSS
T ss_pred cCcCcCCCc
Confidence 999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=381.48 Aligned_cols=262 Identities=25% Similarity=0.473 Sum_probs=218.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 579 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 579 (843)
.++|++.+.||+|+||+||+|.+. ++..||||+++.... ...+++.+|+++++.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 356899999976533 3356799999999999 899999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC--------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 645 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl 645 (843)
+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 35788999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcc
Q 003158 646 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 724 (843)
Q Consensus 646 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~ 724 (843)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999865432211 11223457789999999999999999999999999999999 9999975432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 725 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
. +. ...+..+.....+..++..+.+++..||+.+|.+||++.++++.|+++....
T Consensus 312 ~-~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 E-EL---------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp G-GH---------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H-HH---------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 11 1122233344556677889999999999999999999999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=384.39 Aligned_cols=272 Identities=19% Similarity=0.289 Sum_probs=212.1
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 583 (843)
..++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+..|.++++.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4568999999999999999999976 488999999975322 2345678899999988 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999997653 4889999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +..
T Consensus 173 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~---------i~~ 235 (353)
T 2i0e_A 173 WD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQS---------IME 235 (353)
T ss_dssp CT-------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH---------HHH
T ss_pred cC-------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-HHHHHH---------HHh
Confidence 21 1123445799999999999999999999999999999999999999975432 111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----CCccCC
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSML 818 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~-----sa~e~L 818 (843)
. ...+|...+.++. +++.+||+.||++|+ +++|++
T Consensus 236 ~-~~~~p~~~s~~~~---------------------------------------~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 236 H-NVAYPKSMSKEAV---------------------------------------AICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp C-CCCCCTTSCHHHH---------------------------------------HHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred C-CCCCCCCCCHHHH---------------------------------------HHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1 1112222333333 455555666666666 457888
Q ss_pred CCCcccCCCCCCccccccCCCCCC
Q 003158 819 KHPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 819 ~Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
+||||++..+.........|++.|
T Consensus 276 ~h~~f~~~~w~~l~~~~~~~p~~p 299 (353)
T 2i0e_A 276 EHAFFRYIDWEKLERKEIQPPYKP 299 (353)
T ss_dssp TSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred cCccccCCCHHHHHhCCCCCCcCC
Confidence 899998766655444556666666
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=375.93 Aligned_cols=276 Identities=24% Similarity=0.397 Sum_probs=210.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999975 689999999875432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++ ++.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9975 666666543 345899999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCcccceeeeeecccCCccCchhcccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||....+..+.......
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~------------ 217 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR------------ 217 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH------------
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH------------
Confidence 1223456899999999998765 899999999999999999999998766554443332211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--------HHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR--------ELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~--------~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
.+-...+...+.+.+... .........+..+..+.+|+.+||+.||++||||+|+|
T Consensus 218 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 218 ----------------LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp ----------------HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ----------------HhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 111111111111110000 00000111122333445899999999999999999999
Q ss_pred CCCcccCC
Q 003158 819 KHPYVSSD 826 (843)
Q Consensus 819 ~Hp~f~~~ 826 (843)
+||||++.
T Consensus 282 ~hp~f~~~ 289 (292)
T 3o0g_A 282 QHPYFSDF 289 (292)
T ss_dssp TSGGGTTC
T ss_pred cCcccccC
Confidence 99999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=383.72 Aligned_cols=267 Identities=20% Similarity=0.296 Sum_probs=211.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999975 699999999875322 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997654 4889999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... +..+ .
T Consensus 195 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~---------i~~~-~ 254 (350)
T 1rdq_E 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEK---------IVSG-K 254 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH---------HHHC-C
T ss_pred ---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHH---------HHcC-C
Confidence 23456999999999999999999999999999999999999999754321 11111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC-----CccCCCCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSSMLKHP 821 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s-----a~e~L~Hp 821 (843)
..+|..++..+. ++|.+||+.||++|++ ++|+++||
T Consensus 255 ~~~p~~~~~~~~---------------------------------------~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 255 VRFPSHFSSDLK---------------------------------------DLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp CCCCTTCCHHHH---------------------------------------HHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCCCCCHHHH---------------------------------------HHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 112222333333 4555556666666665 88888888
Q ss_pred cccCCCCCCccccccCCCCCC
Q 003158 822 YVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 822 ~f~~~~~~~~~~~~~~~~~~~ 842 (843)
||.+..+.........|++.|
T Consensus 296 ~f~~~~w~~~~~~~~~~p~~p 316 (350)
T 1rdq_E 296 WFATTDWIAIYQRKVEAPFIP 316 (350)
T ss_dssp GGTTCCHHHHHTTCSCCSCCC
T ss_pred CcCCCCHHHHhhccCCCCCCC
Confidence 888766654444445555554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=390.19 Aligned_cols=283 Identities=24% Similarity=0.271 Sum_probs=216.6
Q ss_pred cHHHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeee
Q 003158 502 TYGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCD 577 (843)
Q Consensus 502 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 577 (843)
.+++.....++|++.+.||+|+||+||+|+.. +|+.||+|++...... ..+.+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555566789999999999999999999975 7999999999753221 1235788999999999999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
+.+..++||||+++|+|.+++...+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999997643 35889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcc-------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHH
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 730 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~ 730 (843)
+++...... ........||+.|+|||++. +..++.++|||||||++|||++|+.||....... ...
T Consensus 208 la~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~ 280 (412)
T 2vd5_A 208 SCLKLRADG------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYG 280 (412)
T ss_dssp TCEECCTTS------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHH
T ss_pred hheeccCCC------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 998654321 11223457999999999997 3568999999999999999999999997644211 111
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCC
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 810 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~ 810 (843)
...... ..+ ..|.. ....+..+.+||++||+ +|++
T Consensus 281 ~i~~~~--------------------------~~~-----~~p~~-------------~~~~s~~~~dli~~lL~-~p~~ 315 (412)
T 2vd5_A 281 KIVHYK--------------------------EHL-----SLPLV-------------DEGVPEEARDFIQRLLC-PPET 315 (412)
T ss_dssp HHHTHH--------------------------HHC-----CCC-----------------CCCHHHHHHHHTTSS-CGGG
T ss_pred HHHhcc--------------------------cCc-----CCCcc-------------ccCCCHHHHHHHHHHcC-Chhh
Confidence 100000 000 00000 01112334467777787 7777
Q ss_pred C---CCCccCCCCCcccCCCCCCccccccCCCCCC
Q 003158 811 P---PSSSSMLKHPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 811 R---~sa~e~L~Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
| ++++|+++||||++..+... ....|++.|
T Consensus 316 Rlgr~~~~ei~~Hpff~~i~w~~l--~~~~~p~~p 348 (412)
T 2vd5_A 316 RLGRGGAGDFRTHPFFFGLDWDGL--RDSVPPFTP 348 (412)
T ss_dssp CTTTTTHHHHHTSGGGTTCCSTTS--TTSCCSCCC
T ss_pred cCCCCCHHHHhcCCCcCCCCHHHH--hhcCCCCCC
Confidence 7 48899999999988766543 345566666
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=373.15 Aligned_cols=269 Identities=22% Similarity=0.319 Sum_probs=214.5
Q ss_pred ccccHHHHHHHHcC----------CCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCC
Q 003158 499 RSFTYGEMALATNN----------FNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR 567 (843)
Q Consensus 499 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 567 (843)
+.++++++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 44677777777654 666789999999999999976 7999999999876656667899999999999999
Q ss_pred cccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC
Q 003158 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH 647 (843)
Q Consensus 568 nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~ 647 (843)
||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 999999999999999999999999999999864 35899999999999999999999999 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHH
Q 003158 648 KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 727 (843)
Q Consensus 648 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~ 727 (843)
++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~- 248 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV-------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ- 248 (321)
T ss_dssp TCCEEECCCTTCEECCSSS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred CCcEEEeeeeeeeecccCc-------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 9999999999998654321 11234569999999999999999999999999999999999999997543211
Q ss_pred HHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCC
Q 003158 728 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 807 (843)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~d 807 (843)
.... +.... .|... .. ....+...+++.+||..|
T Consensus 249 ~~~~-----------------------------~~~~~--~~~~~-~~--------------~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 249 AMKR-----------------------------LRDSP--PPKLK-NS--------------HKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp HHHH-----------------------------HHHSS--CCCCT-TG--------------GGSCHHHHHHHHHHSCSS
T ss_pred HHHH-----------------------------HhcCC--CCCcC-cc--------------ccCCHHHHHHHHHHccCC
Confidence 1100 00000 00000 00 001112336777888899
Q ss_pred CCCCCCCccCCCCCcccCCC
Q 003158 808 EETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 808 p~~R~sa~e~L~Hp~f~~~~ 827 (843)
|++|||++|+++||||....
T Consensus 283 p~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 283 PQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp TTTSCCHHHHHTSGGGGGCC
T ss_pred hhhCcCHHHHhcChhhccCC
Confidence 99999999999999997644
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=374.18 Aligned_cols=275 Identities=23% Similarity=0.341 Sum_probs=205.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|++.+.||+|+||+||+|...+++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578899999999999999999988999999998754332 236788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++ +|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 974 9999986542 45889999999999999999999999 9999999999999999999999999997654221
Q ss_pred CcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~-------------- 214 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIF-------------- 214 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH--------------
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH--------------
Confidence 12234568999999999976 4589999999999999999999999976543221 11111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH--------HHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMREL--------ESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L--------~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
...-...+...|...+....- ..+....+..+....+|+.+||..||++|||++|+|+
T Consensus 215 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 215 --------------RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp --------------HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------------HHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000011000000000 0001111223334458999999999999999999999
Q ss_pred CCcccCC
Q 003158 820 HPYVSSD 826 (843)
Q Consensus 820 Hp~f~~~ 826 (843)
||||++.
T Consensus 281 hp~f~~~ 287 (288)
T 1ob3_A 281 HAYFKEN 287 (288)
T ss_dssp SGGGGC-
T ss_pred Ccchhhc
Confidence 9999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=386.66 Aligned_cols=301 Identities=19% Similarity=0.255 Sum_probs=226.5
Q ss_pred CcccccHHHHHHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-----CCccc
Q 003158 497 GVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----HRNLV 570 (843)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv 570 (843)
....+++.+.....++|.+.+.||+|+||+||+|.. .+++.||||++.. .....+.+..|+++++.++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345677777778889999999999999999999997 4789999999974 3344567788999999996 99999
Q ss_pred ceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---
Q 003158 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--- 647 (843)
Q Consensus 571 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--- 647 (843)
++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9999999999999999999 999999998876667999999999999999999999999 999999999999975
Q ss_pred ----------------------CCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHH
Q 003158 648 ----------------------KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSL 705 (843)
Q Consensus 648 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~ 705 (843)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 789999999999864321 234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHH-H------hcccCCCCCCCHHHH
Q 003158 706 GVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLAL-K------CCQDETDARPSMSEV 778 (843)
Q Consensus 706 G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~------c~~~~p~~RPs~~~v 778 (843)
||++|||++|+.||........ .... .......|............ . .....|.........
T Consensus 246 G~il~ell~g~~pf~~~~~~~~-~~~~----------~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 314 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHMEH-LAMM----------ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHH-HHHH----------HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHH-HHHH----------HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhh
Confidence 9999999999999976543221 1110 01112233333222111000 0 001112222222221
Q ss_pred HHHHHHhhh-hCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 779 MRELESIWN-MMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 779 l~~L~~~~~-~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
. .+..... .....++.+.+|+.+||+.||++||||+|+|+||||+
T Consensus 315 ~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 315 K-HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp H-HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred h-hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1 1111100 0011234455899999999999999999999999995
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=372.48 Aligned_cols=264 Identities=28% Similarity=0.435 Sum_probs=216.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+|+||+||+|.+. .+..||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999974 35569999998643 3345789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999654 345899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ... .+..
T Consensus 204 ~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~---------~~~~ 269 (325)
T 3kul_A 204 DPDA----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-VIS---------SVEE 269 (325)
T ss_dssp ---C----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHH---------HHHT
T ss_pred Cccc----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-HHH---------HHHc
Confidence 2211 122233456788999999999999999999999999999999 999997654321 111 1222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
+.....+..+++.+.+++..||..+|.+||++.++++.|+.+.+..+.
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 233345667788999999999999999999999999999998775443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=400.84 Aligned_cols=277 Identities=23% Similarity=0.340 Sum_probs=217.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
..++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999975 799999999875322 234668899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999998766666999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 339 ~--------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----------------- 393 (576)
T 2acx_A 339 G--------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----------------- 393 (576)
T ss_dssp T--------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-----------------
T ss_pred C--------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-----------------
Confidence 2 122345799999999999999999999999999999999999999975431000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----CCccCCC
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLK 819 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~-----sa~e~L~ 819 (843)
...+.+.+... +..-| ...++.+.+||.+||+.||++|+ +++|+++
T Consensus 394 ---------~~~i~~~i~~~----~~~~p----------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 394 ---------REEVERLVKEV----PEEYS----------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---------HHHHHHHHHHC----CCCCC----------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---------HHHHHHHhhcc----cccCC----------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00111111110 00000 01122334677777888888888 7899999
Q ss_pred CCcccCCCCCCccccccCCCCCC
Q 003158 820 HPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 820 Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
||||++..+.....+...|++.|
T Consensus 445 HpfF~~i~w~~l~~~~~~pp~~p 467 (576)
T 2acx_A 445 HPLFKKLNFKRLGAGMLEPPFKP 467 (576)
T ss_dssp SGGGTTCCHHHHHTTCSCCSCCC
T ss_pred ChhhccCCHHHHhcCCCCCCCCC
Confidence 99999866643333445566655
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=384.31 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=175.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999965 68999999987432 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999754 35899999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 169 --------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 169 --------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp --------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 22345679999999999974 45899999999999999999999999743
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=387.43 Aligned_cols=307 Identities=19% Similarity=0.214 Sum_probs=212.7
Q ss_pred HcCCCCCCccccc--CCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQG--GYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+| +||+||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999975 79999999997543 3334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998776667999999999999999999999999 99999999999999999999999999865432
Q ss_pred CCCCCcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
................||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. . .......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~-~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-N-GTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-c-CCCCccc
Confidence 11111111111233468899999999987 678999999999999999999999997644322111100 0 0000000
Q ss_pred cCCCCCCCHHH-HHHH-HHHH---HHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 743 DGNMGSYPSEC-VEKF-IKLA---LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 743 ~~~~~~~~~~~-~~~l-~~l~---~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
+... .+.+. .... .... ..........||...+.. ........++.+.+|+.+||+.||++|||++|+
T Consensus 259 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 259 DTST--IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP-----SHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred cccc--cccccccccccccccccccccccccCccccccCCCC-----CCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 0000 00000 0000 0000 000000001111111100 000112234446689999999999999999999
Q ss_pred CCCCcccCCCC
Q 003158 818 LKHPYVSSDVS 828 (843)
Q Consensus 818 L~Hp~f~~~~~ 828 (843)
|+||||+....
T Consensus 332 l~hp~f~~~~~ 342 (389)
T 3gni_B 332 LNHSFFKQIKR 342 (389)
T ss_dssp TTSGGGGGC--
T ss_pred hcCHHHHHHhh
Confidence 99999987544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=374.82 Aligned_cols=259 Identities=19% Similarity=0.341 Sum_probs=209.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||+||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367899999999999999999965 6899999998754 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC--CCcEEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~ 666 (843)
+++|+|.+++... ...+++..++.++.|+++||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999653 345899999999999999999999999 999999999999997 789999999999876432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...... +.... +....
T Consensus 158 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~---------i~~~~- 219 (321)
T 1tki_A 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIEN---------IMNAE- 219 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH---------HHHTC-
T ss_pred -------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHH---------HHcCC-
Confidence 2234567999999999999988999999999999999999999999764421 11110 00000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
..++... ++..+..+.+|+.+||..||++|||++|+|+||||...
T Consensus 220 ~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 220 YTFDEEA-----------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCCHHH-----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCChhh-----------------------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 0011100 01222334578889999999999999999999999765
Q ss_pred C
Q 003158 827 V 827 (843)
Q Consensus 827 ~ 827 (843)
.
T Consensus 265 ~ 265 (321)
T 1tki_A 265 I 265 (321)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.50 Aligned_cols=290 Identities=22% Similarity=0.401 Sum_probs=199.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999964 6899999998754332 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcC----CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 588 FMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
|++ |+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999986532 245889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....... ..
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~------~~ 225 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFD------IM 225 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH------HH
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH------Hh
Confidence 321 11234468999999999986 468999999999999999999999997654322 1111110 00
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARP--SMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP--s~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
.. .+...+..+..+. -+..+...++ ...+. +.. ......+..+.+|+.+||+.||++|||++|+|+|
T Consensus 226 ~~----~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GT----PNESLWPSVTKLP--KYNPNIQQRPPRDLRQV---LQP--HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CS----CCTTTCGGGGGCT--TCCTTCCCCCCCCSHHH---HGG--GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC----CChhHhhhhhhhh--hcccccccccchhHHHh---hcc--cccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 0000000000000 0000001111 11111 111 0111233446689999999999999999999999
Q ss_pred CcccCCCC
Q 003158 821 PYVSSDVS 828 (843)
Q Consensus 821 p~f~~~~~ 828 (843)
|||+.-..
T Consensus 295 p~f~~~~~ 302 (317)
T 2pmi_A 295 PWFAEYYH 302 (317)
T ss_dssp GGGGGGCC
T ss_pred hhhhcccc
Confidence 99976443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=383.61 Aligned_cols=305 Identities=25% Similarity=0.345 Sum_probs=208.1
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcc-CCcccceeeeeecC--CcE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE--GEQ 582 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~ 582 (843)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+++.+. ||||+++++++..+ ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4678999999999999999999964 7999999998643 3344567889999999997 99999999999654 378
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++|||||+ |+|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999996 6999999753 5888999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCC--------------cccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHH
Q 003158 663 PVPDIEG--------------IVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 727 (843)
Q Consensus 663 ~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~ 727 (843)
....... .......+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 4211000 001122345679999999999987 67899999999999999999999999765432 2
Q ss_pred HHHHHhhccc--chhhccCCCCCCCHHHHHHHHHHHHHhcc-cCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCC
Q 003158 728 EVNIAYQSSM--MFSVIDGNMGSYPSECVEKFIKLALKCCQ-DETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 804 (843)
Q Consensus 728 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~c~~-~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L 804 (843)
+......... ....+......+... +.+-...... .....+..+......+... ......++.+.||+.+||
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKT----MIESLKEKVEIRQSNKRDIFTKWKNLLLKI-NPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHH----HHHHHHHHCC-----CCCCHHHHHHHHHHH-CTTCCCCHHHHHHHHHHC
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHH----HHHhCcccccccCCCHHHhCcchhhhcccc-cccccCCHHHHHHHHHhh
Confidence 2222211000 000000000111111 1111111111 1122233333333322222 122234556779999999
Q ss_pred CCCCCCCCCCccCCCCCcccCC
Q 003158 805 TSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 805 ~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
++||++|+||+|+|+||||+.-
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTT
T ss_pred ccCcccCCCHHHHhCCHHHHHh
Confidence 9999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.45 Aligned_cols=265 Identities=32% Similarity=0.495 Sum_probs=211.1
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
+....++|++.+.||+|+||+||+|.. +|+.||||++.... ....+++.+|++++++++||||+++++++.+.+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 334456889999999999999999987 68899999987543 233467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCC-CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 584 LVYEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
+||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999976432 24889999999999999999999875 45999999999999999999999999999754
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ..
T Consensus 190 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-~~~~--------~~ 253 (309)
T 3p86_A 190 ASTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-VAAV--------GF 253 (309)
T ss_dssp -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-HHHH--------HH
T ss_pred cccc-------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH--------Hh
Confidence 3221 122345699999999999999999999999999999999999999976543221 1110 11
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.......+..+++.+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2223345667778899999999999999999999999999988653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=377.58 Aligned_cols=260 Identities=22% Similarity=0.397 Sum_probs=210.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||+||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357999999999999999999965 6899999999876655667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC--CCcEEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~ 666 (843)
+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999653 346899999999999999999999999 999999999999974 578999999999876432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 205 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~---------------- 260 (387)
T 1kob_A 205 -------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQ---------------- 260 (387)
T ss_dssp -------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH----------------
T ss_pred -------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHH----------------
Confidence 12234569999999999999999999999999999999999999997643211 110
Q ss_pred CCCCHHHHHHHHHHHHHh-cccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 747 GSYPSECVEKFIKLALKC-CQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c-~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
. +..+ +...+.. +...++.+.+|+.+||..||++|||++|+|+||||.+
T Consensus 261 ------------~-i~~~~~~~~~~~-----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 261 ------------N-VKRCDWEFDEDA-----------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp ------------H-HHHCCCCCCSST-----------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ------------H-HHhCCCCCCccc-----------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 0 1111 1111100 0111223447888899999999999999999999987
Q ss_pred CCC
Q 003158 826 DVS 828 (843)
Q Consensus 826 ~~~ 828 (843)
+..
T Consensus 311 ~~~ 313 (387)
T 1kob_A 311 DHS 313 (387)
T ss_dssp CCT
T ss_pred Ccc
Confidence 543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=397.11 Aligned_cols=203 Identities=24% Similarity=0.420 Sum_probs=179.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|...+.||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999975 699999999975322 2346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 586 YEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 446899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 321 1123457999999999999999999999999999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=357.05 Aligned_cols=280 Identities=35% Similarity=0.610 Sum_probs=231.8
Q ss_pred CcccccHHHHHHHHcCCCCC------CcccccCCeeEEEEEeCCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhccC
Q 003158 497 GVRSFTYGEMALATNNFNSS------TQIGQGGYGKVYKGILPDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHH 566 (843)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 566 (843)
....|++.++..++++|... +.||+|+||+||+|.. +++.||||++.... ....+.+.+|+++++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 8999999999999987 68899999987432 2335688999999999999
Q ss_pred CcccceeeeeecCCcEEEEEecCCCCCHHHHHhhc-CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE
Q 003158 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK-SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 645 (843)
Q Consensus 567 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl 645 (843)
|||+++++++.+.+..++||||+++|+|.+++... ...++++..++.++.|+++||.|||+++ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999999753 2346899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch
Q 003158 646 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 725 (843)
Q Consensus 646 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~ 725 (843)
++++.+||+|||+++....... ........||+.|+|||.+.+ .++.++|||||||++|||++|+.||......
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSS-----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cCCCcEEEeecccccccccccc-----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999986543211 122234568999999998865 5789999999999999999999999764321
Q ss_pred ---HHHHHHHh-hcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 726 ---VREVNIAY-QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 726 ---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
........ ....+...++......+..+++.+.+++..||+.+|.+||++.++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111 11223344555566678889999999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.03 Aligned_cols=286 Identities=25% Similarity=0.357 Sum_probs=207.1
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhcc---CCcccceeeeeec
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDE 578 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 578 (843)
...++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567999999999999999999996 478999999986322 111346677888777765 9999999999976
Q ss_pred CC-----cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEE
Q 003158 579 EG-----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 653 (843)
Q Consensus 579 ~~-----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 653 (843)
.. ..++||||+. |+|.+++.......+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 54 5799999996 69999998776666999999999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~ 733 (843)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 162 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~ 232 (308)
T 3g33_A 162 ADFGLARIYSYQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIF 232 (308)
T ss_dssp CSCSCTTTSTTCC--------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHH
T ss_pred eeCccccccCCCc--------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 9999998654321 2234578999999999999999999999999999999999999997654322 111111
Q ss_pred hcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC
Q 003158 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 813 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s 813 (843)
.... .......+... .+....+ .+....... ...++....+.+|+.+||+.||++|||
T Consensus 233 ~~~~-----~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~t 290 (308)
T 3g33_A 233 DLIG-----LPPEDDWPRDV-----SLPRGAF--PPRGPRPVQ----------SVVPEMEESGAQLLLEMLTFNPHKRIS 290 (308)
T ss_dssp HHHC-----CCCTTTSCSSC-----SSCGGGS--CCCCCCCHH----------HHSCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhC-----CCChhhccchh-----hcccccc--CCCCCCcHH----------HhCccccHHHHHHHHHHhcCCCccCCC
Confidence 1000 00000000000 0000000 011111111 122344455668999999999999999
Q ss_pred CccCCCCCcccCCCC
Q 003158 814 SSSMLKHPYVSSDVS 828 (843)
Q Consensus 814 a~e~L~Hp~f~~~~~ 828 (843)
++|+|+||||+.+..
T Consensus 291 ~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 291 AFRALQHSYLHKDEG 305 (308)
T ss_dssp HHHHHTSTTC-----
T ss_pred HHHHhcCccccCCCC
Confidence 999999999987643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=396.22 Aligned_cols=271 Identities=21% Similarity=0.294 Sum_probs=205.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 6899999998753 222345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|||+++|+|.+++.... .+++..+..++.||++||+|||+ .+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997653 58899999999999999999998 88 99999999999999999999999999985432
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .
T Consensus 302 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~---------~- 363 (446)
T 4ejn_A 302 D-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELIL---------M- 363 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH---------H-
T ss_pred C-------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHHHHHH---------h-
Confidence 1 12234467999999999999999999999999999999999999999754321 1111000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----CCccCCC
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP-----SSSSMLK 819 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~-----sa~e~L~ 819 (843)
....+|..+ .+.+.+||.+||..||++|+ ||+|+++
T Consensus 364 ~~~~~p~~~---------------------------------------~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 EEIRFPRTL---------------------------------------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCCCTTS---------------------------------------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCccC---------------------------------------CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 000111111 12233677778888888888 9999999
Q ss_pred CCcccCCCCCCccccccCCCCCC
Q 003158 820 HPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 820 Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
||||.+..+.........|++.|
T Consensus 405 hp~f~~~~~~~~~~~~~~pp~~p 427 (446)
T 4ejn_A 405 HRFFAGIVWQHVYEKKLSPPFKP 427 (446)
T ss_dssp SGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CccccCCCHHHHhhCcCCCCccC
Confidence 99999876654444445556655
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=371.24 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=208.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457999999999999999999975 6899999998754322 356799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC----cEEEeeccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 658 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGl 658 (843)
++||||+++|+|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999653 45899999999999999999999999 99999999999999887 899999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 165 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~------ 229 (326)
T 2y0a_A 165 AHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANV------ 229 (326)
T ss_dssp CEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHH------
T ss_pred CeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHH------
Confidence 98764321 1234569999999999999999999999999999999999999997543211 11100
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
... ...++... ++..+..+.+|+.+||..||++|||++|+|
T Consensus 230 ---~~~-~~~~~~~~-----------------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 230 ---SAV-NYEFEDEY-----------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp ---HHT-CCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ---Hhc-CCCcCccc-----------------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 000 00011100 011222334788889999999999999999
Q ss_pred CCCcccCCC
Q 003158 819 KHPYVSSDV 827 (843)
Q Consensus 819 ~Hp~f~~~~ 827 (843)
+||||....
T Consensus 271 ~hp~~~~~~ 279 (326)
T 2y0a_A 271 QHPWIKPKD 279 (326)
T ss_dssp HSTTTSCCS
T ss_pred cCCCccCCc
Confidence 999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=382.66 Aligned_cols=202 Identities=27% Similarity=0.386 Sum_probs=168.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHH-HHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQF-LSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999975 689999999975432 223456677776 577899999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999997643 4788899999999999999999999 99999999999999999999999999986332
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 192 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 192 H-------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp C-------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred C-------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 1 112345679999999999999999999999999999999999999997543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.45 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=216.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.++|++.+.||+|+||+||+|...+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46788899999999999999998889999999998643 33467999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 160 (269)
T 4hcu_A 88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 160 (269)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc---
Confidence 9999999996543 45889999999999999999999999 9999999999999999999999999998654221
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
........+++.|+|||.+.+..++.++||||+||++|||++ |+.||...... .... .+..+....
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-~~~~---------~~~~~~~~~ 227 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVE---------DISTGFRLY 227 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH---------HHHTTCCCC
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-HHHH---------HHhcCccCC
Confidence 111223446778999999999999999999999999999999 99999765432 1111 112222333
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+..+++.+.+++..||+.+|.+||++.++++.|+.+.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 455567789999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.06 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=217.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
..++|++.+.||+|+||+||+|...++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3568899999999999999999998888999999986432 346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-- 158 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh--
Confidence 99999999997643 35889999999999999999999999 9999999999999999999999999998654322
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... .+..+...
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----------~~~~~~~~ 224 (268)
T 3sxs_A 159 ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL----------KVSQGHRL 224 (268)
T ss_dssp ----EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----------HHHTTCCC
T ss_pred ----hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH----------HHHcCCCC
Confidence 122233456778999999999899999999999999999999 999997654322111 11222223
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
..+..+++.+.+++..||+.+|.+||++.++++.|+.+.+.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 33455667899999999999999999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=366.25 Aligned_cols=268 Identities=23% Similarity=0.426 Sum_probs=215.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|.+.+.||+|+||+||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 457888999999999999999975 6899999998776666778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999764 345899999999999999999999999 999999999999999999999999999876433211
Q ss_pred Ccc-------cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 669 GIV-------PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 669 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
... .........||+.|+|||++.+..++.++|||||||++|||++|..|+.......... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----~~~~~~~ 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----GLNVRGF 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----SBCHHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----hhhhhcc
Confidence 000 0011124579999999999999999999999999999999999999986432110000 0000000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
.. ...+..+++.+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 240 ~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 240 LD---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HH---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 0123445667899999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=374.97 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=204.3
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|.+.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788999999999999999996 5789999999874321 12357899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+ +|+|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 789999987653 4889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+...+...
T Consensus 162 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~i~~~ 223 (336)
T 3h4j_B 162 -------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----------NLFKKVNSC 223 (336)
T ss_dssp -------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----------TCBCCCCSS
T ss_pred -------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHHcC
Confidence 12234569999999999988776 68999999999999999999999653210 011111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
....|..+ ++.+.+|+++||+.||++|||++|+++||||+.
T Consensus 224 ~~~~p~~~---------------------------------------s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 224 VYVMPDFL---------------------------------------SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CCCCCTTS---------------------------------------CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CCCCcccC---------------------------------------CHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 11111111 122336788889999999999999999999986
Q ss_pred CCC
Q 003158 826 DVS 828 (843)
Q Consensus 826 ~~~ 828 (843)
+..
T Consensus 265 ~~~ 267 (336)
T 3h4j_B 265 NLP 267 (336)
T ss_dssp TCC
T ss_pred CCc
Confidence 543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=392.47 Aligned_cols=265 Identities=24% Similarity=0.439 Sum_probs=220.9
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.+++.+..++|++.+.||+|+||+||+|.+.++..||||+++... ...+++.+|+++++.++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 344556678899999999999999999999888999999998643 34678999999999999999999999987 5678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++|+|.++++......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999997654445788899999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
.... ........+++.|+|||++....++.++|||||||++|||+| |+.||...... +... .+
T Consensus 335 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-~~~~---------~i 398 (454)
T 1qcf_A 335 EDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIR---------AL 398 (454)
T ss_dssp CCHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH---------HH
T ss_pred CCCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-HHHH---------HH
Confidence 4211 011123346778999999999999999999999999999999 99999765432 1111 11
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
..+.....|..+++.+.+++.+||+.+|++||++.++++.|+++...
T Consensus 399 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 22223345667788999999999999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=383.14 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=206.7
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
..++|++.+.||+|+||+||+|.. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 467899999999999999999996 4789999999876443 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc---CCCcEEEeeccccccC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLA 662 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~ 662 (843)
|||+++|+|.+++.... .+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999997653 4889999999999999999999999 99999999999998 4678999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...
T Consensus 164 ~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~------------ 223 (444)
T 3soa_A 164 EGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQ------------ 223 (444)
T ss_dssp CTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH------------
T ss_pred cCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHH------------
Confidence 4321 12234579999999999999999999999999999999999999997543211 110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
.+........+.. ++..++.+.+|+.+||+.||++|||++|+|+|||
T Consensus 224 ----------------~i~~~~~~~~~~~-----------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 224 ----------------QIKAGAYDFPSPE-----------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp ----------------HHHHTCCCCCTTT-----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred ----------------HHHhCCCCCCccc-----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 0000000000000 0111233447888899999999999999999999
Q ss_pred ccC
Q 003158 823 VSS 825 (843)
Q Consensus 823 f~~ 825 (843)
|+.
T Consensus 271 ~~~ 273 (444)
T 3soa_A 271 ISH 273 (444)
T ss_dssp THH
T ss_pred ccC
Confidence 964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=379.06 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=201.8
Q ss_pred CCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 516 STQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
.+.||+|+||.||+|.. .+|+.||+|++........+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999996 46999999999876666677899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE--cCCCcEEEeeccccccCCCCCCCCccc
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL--DHKFTAKVADFGLSRLAPVPDIEGIVP 672 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~~~~ 672 (843)
.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------ 243 (373)
T 2x4f_A 174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------ 243 (373)
T ss_dssp HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC------
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc------
Confidence 9988653 235889999999999999999999999 9999999999999 567899999999998764322
Q ss_pred ceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHH
Q 003158 673 AHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752 (843)
Q Consensus 673 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (843)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~------------------------ 296 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-T------------------------ 296 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H------------------------
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-H------------------------
Confidence 1233469999999999999999999999999999999999999997544211 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 753 ~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
+.++....+...+.. ++...+.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 297 ----~~~i~~~~~~~~~~~-----------------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 297 ----LNNILACRWDLEDEE-----------------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----HHHHHHTCCCSCSGG-----------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----HHHHHhccCCCChhh-----------------hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 111111111111110 11223334578999999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=391.92 Aligned_cols=284 Identities=21% Similarity=0.321 Sum_probs=206.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 580 (843)
.++|++.+.||+|+||+||+|... +++.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999964 6899999999753 233456789999999999999999999999654 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+++ +|.+.+.. .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 57999999965 57777643 3888999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
..... ...+...||+.|+|||++.+..++.++||||+||++|||++|+.||...... +++.....
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~------ 277 (464)
T 3ttj_A 213 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIE------ 277 (464)
T ss_dssp ----C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH------
T ss_pred ecCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH------
Confidence 65421 2234567999999999999999999999999999999999999999765433 22222111
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhhCCCC-------CCCCCccccCCCCCCCCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPES-------DTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~vl~~L~~~~~~~~~~-------~~~~~dll~~~L~~dp~~R~ 812 (843)
. .+..+.+....+...........|... ..+..... . ..++.. .+.+.|||.+||++||++|+
T Consensus 278 ~----lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 348 (464)
T 3ttj_A 278 Q----LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP---D--SLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348 (464)
T ss_dssp H----HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSC---G--GGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred h----cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCc---c--cccccccccccccCHHHHHHHHHHcCCChhhCC
Confidence 0 111222222222222222222222211 12221100 0 000000 22356899999999999999
Q ss_pred CCccCCCCCcccC
Q 003158 813 SSSSMLKHPYVSS 825 (843)
Q Consensus 813 sa~e~L~Hp~f~~ 825 (843)
||+|+|+||||+.
T Consensus 349 ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 349 SVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHTSTTTGG
T ss_pred CHHHHhcChhhhh
Confidence 9999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=364.29 Aligned_cols=272 Identities=25% Similarity=0.406 Sum_probs=215.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec--CCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 582 (843)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46888999999999999999984 3689999999987666667789999999999999999999999854 4568
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997643 35889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHH------hhcc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------YQSS 736 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~------~~~~ 736 (843)
...... ........++..|+|||.+.+..++.++|||||||++|||++|..|+............. ....
T Consensus 165 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 165 PQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 432210 112233457778999999999999999999999999999999999986432111000000 0000
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
....+........+..+++++.+++..||+.+|.+||++.++++.|+.+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11122233344557778889999999999999999999999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=387.28 Aligned_cols=297 Identities=22% Similarity=0.293 Sum_probs=196.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeec-----CCcE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EGEQ 582 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~ 582 (843)
++|++.+.||+|+||+||+|... +++.||||++... .....+++.+|+++++.++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999965 7899999998653 23345788999999999999999999999843 3578
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+ +|+|.+++... ..+++..++.++.||++||+|||+.+ ||||||||+|||++.++.+||+|||+|+..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 57999999654 45899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcc--------------------cceeeeeecccCCccCchhcc-cCCCCchhhhHHHHHHHHHHHhC------
Q 003158 663 PVPDIEGIV--------------------PAHVSTVVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVFLELLTG------ 715 (843)
Q Consensus 663 ~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~G~~l~elltg------ 715 (843)
......... .....+...||+.|+|||++. +..++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 532211000 011234567899999999874 56799999999999999999994
Q ss_pred -----CCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH--------HHHH
Q 003158 716 -----MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEV--------MREL 782 (843)
Q Consensus 716 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~v--------l~~L 782 (843)
+.+|............ ................+..+...+ . .|+..++ ...+
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~i~~~~-g-----~p~~~~~~~~~~~~~~~~~ 351 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQ---------KAGNDFKFHTRGNRDQLNVIFNIL-G-----TPSEEDIEALEKEDAKRYI 351 (458)
T ss_dssp SGGGCCCSCC-----------------------------CHHHHHHHHHHHHHH-C-----CCCHHHHHTSSCHHHHHHH
T ss_pred ccccccccCCCCccccccccc---------cccccccccccCCHHHHHHHHHHc-C-----CCCHHHHhhcCCHHHHHHH
Confidence 4444322110000000 000000000111111221111111 0 1111111 0000
Q ss_pred H--------HhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 783 E--------SIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 783 ~--------~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+ .+...++..++.+.|||++||++||++|+|++|+|+||||++...
T Consensus 352 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp TTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 0 112234445666779999999999999999999999999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=382.30 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=216.4
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCC-cEEEE
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG-EQMLV 585 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV 585 (843)
.+..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 345578889999999999999999985 7899999998643 4467999999999999999999999986654 79999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999998776666889999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+..+
T Consensus 343 ----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------~~~~i~~~ 402 (450)
T 1k9a_A 343 ----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------VVPRVEKG 402 (450)
T ss_dssp --------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----------HHHHHHTT
T ss_pred ----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------HHHHHHcC
Confidence 122357889999999999999999999999999999999 999997543211 11122233
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.....|..+++.+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 34456777889999999999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=377.03 Aligned_cols=203 Identities=23% Similarity=0.338 Sum_probs=176.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999964 68999999986422 123567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc---EEEeeccc
Q 003158 584 LVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGL 658 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGl 658 (843)
+||||+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888653 3345889999999999999999999999 999999999999987655 99999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 98764321 1123456999999999999999999999999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=379.38 Aligned_cols=265 Identities=28% Similarity=0.454 Sum_probs=218.3
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
++....++|.+.+.||+|+||.||+|.+. +++.||||++..... ...+++.+|+++++.++||||+++++++.+.+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 34445678899999999999999999976 789999999875432 2345788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++|+|.++++... ..+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999997543 35888999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
..... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ... .+
T Consensus 264 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~--------~~ 328 (377)
T 3cbl_A 264 ADGVY-----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TRE--------FV 328 (377)
T ss_dssp TTSEE-----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHH--------HH
T ss_pred CCCce-----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH--------HH
Confidence 32110 001112235678999999999999999999999999999999 999997654321 111 11
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
..+.....|..+++.+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 329 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 22233445667788999999999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=374.32 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=206.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999965 68999999997543 23346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---cEEEeeccccccC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLA 662 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~ 662 (843)
|||+++|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999999654 35889999999999999999999999 99999999999998654 5999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 182 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~------------ 240 (362)
T 2bdw_A 182 NDSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYA------------ 240 (362)
T ss_dssp TTCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH------------
T ss_pred cCCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHH------------
Confidence 4321 123456999999999999999999999999999999999999999754321 1110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
.+.......|. +. +....+.+.+|+.+||..||++|||++|+|+|||
T Consensus 241 -----------------~i~~~~~~~~~--~~--------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 241 -----------------QIKAGAYDYPS--PE--------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp -----------------HHHHTCCCCCT--TG--------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred -----------------HHHhCCCCCCc--cc--------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00000000000 00 0011222346888899999999999999999999
Q ss_pred ccC
Q 003158 823 VSS 825 (843)
Q Consensus 823 f~~ 825 (843)
|+.
T Consensus 288 ~~~ 290 (362)
T 2bdw_A 288 ICN 290 (362)
T ss_dssp HHT
T ss_pred cCC
Confidence 965
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=388.13 Aligned_cols=264 Identities=30% Similarity=0.465 Sum_probs=216.3
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
+.+....++|++.+.||+|+||+||+|.+.++..||||+++... ...+++.+|+++|++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34455667899999999999999999999888889999998643 335689999999999999999999999976 6789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999997654456889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... +... .+.
T Consensus 332 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~---------~i~ 395 (452)
T 1fmk_A 332 DNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLD---------QVE 395 (452)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH---------HHH
T ss_pred CCc------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-HHHH---------HHH
Confidence 321 111223456788999999999999999999999999999999 99999765432 1111 122
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.+.....|..+++.+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 2333445667888999999999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=374.21 Aligned_cols=270 Identities=25% Similarity=0.434 Sum_probs=221.5
Q ss_pred ccHHHHHHHHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccce
Q 003158 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSL 572 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l 572 (843)
+...++....++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45567777889999999999999999999984 2468999999986433 3356799999999999 79999999
Q ss_pred eeeeecCC-cEEEEEecCCCCCHHHHHhhcCC------------------------------------------------
Q 003158 573 VGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK------------------------------------------------ 603 (843)
Q Consensus 573 ~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------ 603 (843)
++++.+.+ ..++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99997755 48999999999999999976432
Q ss_pred ----------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 604 ----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 604 ----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~- 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc-
Confidence 12889999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||........... .+..+..
T Consensus 248 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---------~~~~~~~ 314 (359)
T 3vhe_A 248 ----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR---------RLKEGTR 314 (359)
T ss_dssp ----TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH---------HHHHTCC
T ss_pred ----cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH---------HHHcCCC
Confidence 1223345568899999999999999999999999999999998 9999976543222111 1112223
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
...+..+++++.+++..||+.+|.+||++.+++++|+.+.+
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 34455667889999999999999999999999999998765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=369.03 Aligned_cols=204 Identities=27% Similarity=0.405 Sum_probs=174.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|... +++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999975 7899999998754332 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999998643 35889999999999999999999999 99999999999999999999999999986542211
Q ss_pred CCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 161 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp -----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred -----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 112234579999999999988775 778999999999999999999997544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=374.55 Aligned_cols=261 Identities=27% Similarity=0.459 Sum_probs=204.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+++.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457999999999999999999864 57789999997643 3345689999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.++++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999754 345899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... +... .+..
T Consensus 200 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~~~~---------~i~~ 265 (373)
T 2qol_A 200 DPEA----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-DVIK---------AVDE 265 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-HHHH---------HHHT
T ss_pred CCcc----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH---------HHHc
Confidence 2110 111122345788999999999999999999999999999998 99999765431 1111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
+.....+..++..+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 222334556778899999999999999999999999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=372.10 Aligned_cols=287 Identities=22% Similarity=0.384 Sum_probs=206.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh-HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|.+.+.||+|+||+||+|... +++.||+|++....... ...+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999975 78999999987533222 12456799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
++ |+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 153 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC---
Confidence 96 69999987643 45889999999999999999999999 999999999999999999999999999865422
Q ss_pred CcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC-
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM- 746 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 746 (843)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +...... .......
T Consensus 154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~------~~~~~~~~ 222 (324)
T 3mtl_A 154 ----TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIF------RILGTPTE 222 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH------HHHCCCCT
T ss_pred ----ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH------HHhCCCCh
Confidence 122234568999999999987 56899999999999999999999999765432 2111111 0000000
Q ss_pred CCCCHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 747 GSYPSECV-EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 747 ~~~~~~~~-~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
...+.... ..+.. ...|..+... .....+..++.+.+|+.+||++||++|||++|+|+||||.+
T Consensus 223 ~~~~~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 223 ETWPGILSNEEFKT------YNYPKYRAEA---------LLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp TTSTTGGGCHHHHH------TCCCCCCCCC---------HHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred Hhchhhhcchhhcc------cccccccchh---------hhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 00010000 00000 0011111110 11122334455678999999999999999999999999987
Q ss_pred CCCCCc
Q 003158 826 DVSGSN 831 (843)
Q Consensus 826 ~~~~~~ 831 (843)
......
T Consensus 288 ~~~~~~ 293 (324)
T 3mtl_A 288 LGERIH 293 (324)
T ss_dssp GCSTTS
T ss_pred cccccc
Confidence 655433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=370.39 Aligned_cols=264 Identities=29% Similarity=0.486 Sum_probs=218.4
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 580 (843)
...++|++.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999974 348999999986433 33567999999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcC----------------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccC
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 638 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dl 638 (843)
..++||||+++|+|.+++.... ...+++..++.++.||++||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9999999999999999997642 156899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCC
Q 003158 639 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 717 (843)
Q Consensus 639 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~ 717 (843)
||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999976532211 112234567889999999999999999999999999999999 999
Q ss_pred CCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 718 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 718 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
||...... +.. ..+..+.....+..++..+.+++..||+.+|.+||++.++++.|+++....
T Consensus 276 p~~~~~~~-~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 276 PYYGMAHE-EVI---------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTTSCHH-HHH---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred cCCCCChH-HHH---------HHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 99765431 111 122333344556677889999999999999999999999999999986544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=372.55 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=195.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||+||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467999999999999999999976 58899999998532 345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEEeeccccccCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~ 665 (843)
+++|+|.+++... ..+++..++.++.|+++||.|||+.+ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 130 VTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999654 35889999999999999999999999 999999999999975 889999999999865421
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 205 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------------- 262 (349)
T 2w4o_A 205 --------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-------------- 262 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH--------------
T ss_pred --------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH--------------
Confidence 1223456899999999999999999999999999999999999999755432211111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+..+-...+. | ..+.....+.+|+.+||..||++|||++|+|+||||.+
T Consensus 263 ---------------i~~~~~~~~~--~--------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 263 ---------------ILNCEYYFIS--P--------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp ---------------HHTTCCCCCT--T--------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ---------------HHhCCCccCC--c--------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 1111000000 0 00112223447899999999999999999999999987
Q ss_pred CCC
Q 003158 826 DVS 828 (843)
Q Consensus 826 ~~~ 828 (843)
...
T Consensus 312 ~~~ 314 (349)
T 2w4o_A 312 KAA 314 (349)
T ss_dssp TTC
T ss_pred Ccc
Confidence 654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=367.11 Aligned_cols=283 Identities=20% Similarity=0.305 Sum_probs=204.2
Q ss_pred HcCCCCC-CcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSS-TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++. +.||+|+||+||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 7899999999999995 47999999999876555567899999999985 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc---EEEeeccccccCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAP 663 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~~~~ 663 (843)
||+++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||+++.++. +||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999997653 5889999999999999999999999 999999999999998776 9999999997654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhccc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------~~ 235 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----------CG 235 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC----------SC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc----------cc
Confidence 322111111112234569999999999975 557889999999999999999999997543210 00
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
+ ............+.+.+..... .-|. . ..+.....+.+|+.+||..||++|||++|+|
T Consensus 236 ~-----~~~~~~~~~~~~~~~~i~~~~~----~~~~-~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 236 W-----DRGEACPACQNMLFESIQEGKY----EFPD-K-----------DWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp C---------CCHHHHHHHHHHHHHCCC----CCCH-H-----------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred c-----cccccchhHHHHHHHHHhccCc----ccCc-h-----------hcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 0 0000111112222222221111 0110 0 0012233445799999999999999999999
Q ss_pred CCCcccCCCC
Q 003158 819 KHPYVSSDVS 828 (843)
Q Consensus 819 ~Hp~f~~~~~ 828 (843)
+||||++...
T Consensus 295 ~hp~~~~~~~ 304 (316)
T 2ac3_A 295 QHPWVQGCAP 304 (316)
T ss_dssp HSTTCC----
T ss_pred cChhhcCCCC
Confidence 9999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.70 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=196.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--------------------------hHHHHHHHHHHHH
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--------------------------GEKEFLTEIQFLS 562 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 562 (843)
.++|++.+.||+|+||.||+|... +++.||||++...... ..+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999964 6899999998754321 1246889999999
Q ss_pred hccCCcccceeeeeec--CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCC
Q 003158 563 RLHHRNLVSLVGYCDE--EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 640 (843)
Q Consensus 563 ~l~h~nIv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp 640 (843)
.++||||+++++++.+ .+..++||||+++++|.+++. ..++++..++.++.||++||+|||+++ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999976 568899999999999988653 346899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCC---CCchhhhHHHHHHHHHHHhCCC
Q 003158 641 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQ 717 (843)
Q Consensus 641 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwS~G~~l~elltg~~ 717 (843)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999998654321 1233457999999999998765 3778999999999999999999
Q ss_pred CCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCC
Q 003158 718 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTP 797 (843)
Q Consensus 718 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~ 797 (843)
||....... .. ..+.......|. . +...+...
T Consensus 239 pf~~~~~~~-~~-----------------------------~~~~~~~~~~~~-~-----------------~~~~~~l~ 270 (298)
T 2zv2_A 239 PFMDERIMC-LH-----------------------------SKIKSQALEFPD-Q-----------------PDIAEDLK 270 (298)
T ss_dssp SSCCSSHHH-HH-----------------------------HHHHHCCCCCCS-S-----------------SCCCHHHH
T ss_pred CCCCccHHH-HH-----------------------------HHHhcccCCCCC-c-----------------cccCHHHH
Confidence 997543211 00 000000000010 0 11122234
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
+++.+||..||++|||++|+++||||+
T Consensus 271 ~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 271 DLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 678888999999999999999999996
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=372.16 Aligned_cols=265 Identities=26% Similarity=0.455 Sum_probs=220.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 578 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 578 (843)
..++|.+.+.||+|+||+||+|... ++..||||++..... ...+++.+|+++++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4568889999999999999999852 246899999976433 3357789999999999 99999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCC--------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEE
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 644 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NIL 644 (843)
.+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999976542 45899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCc
Q 003158 645 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 723 (843)
Q Consensus 645 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~ 723 (843)
+++++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999876533211 12233457889999999999999999999999999999999 999997544
Q ss_pred chHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
. .+... .+..+.....+..++.++.+++..||+.+|.+||++.++++.|+++......
T Consensus 299 ~-~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 299 V-EELFK---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp H-HHHHH---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred H-HHHHH---------HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2 11111 1222223344566778899999999999999999999999999999775543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=366.36 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=184.1
Q ss_pred CCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEecCCCCC
Q 003158 516 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~gs 593 (843)
.+.||+|+||+||+|... +++.||||++... ....+.+|+++++.+. ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 6899999999642 3457788999999997 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---cEEEeeccccccCCCCCCCCc
Q 003158 594 LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 594 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~~~~~~~~~ 670 (843)
|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++ .+||+|||+++......
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---- 163 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---- 163 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC----
Confidence 99999764 35899999999999999999999999 99999999999998766 89999999998654321
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..
T Consensus 164 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~-------------~~ 220 (325)
T 3kn6_A 164 ---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-------C-------------TS 220 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------------C-------------CC
T ss_pred ---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-------c-------------cc
Confidence 222345689999999999999999999999999999999999999975332100 0 00
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
..+++...........+ .. ++..++.+.+|+.+||..||++|||++|+++||||.....
T Consensus 221 ------~~~~~~~i~~~~~~~~~--~~-----------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 221 ------AVEIMKKIKKGDFSFEG--EA-----------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ------HHHHHHHHTTTCCCCCS--HH-----------HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ------HHHHHHHHHcCCCCCCc--cc-----------ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 00011111111110000 00 0011233457888999999999999999999999987544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=364.93 Aligned_cols=262 Identities=29% Similarity=0.467 Sum_probs=217.7
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 580 (843)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+++++.++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3467899999999999999999985 245899999997543 334577899999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCC----------------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccC
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSK----------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 638 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dl 638 (843)
..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999976432 34889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCC
Q 003158 639 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 717 (843)
Q Consensus 639 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~ 717 (843)
||+||++++++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred chheEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999986643221 111233457788999999999999999999999999999999 999
Q ss_pred CCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 718 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 718 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
||........ . ..+..+.....+..+++.+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 252 p~~~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 252 PYPGIPPERL-F---------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SSTTCCGGGH-H---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHH-H---------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9975543111 1 1112222334556677889999999999999999999999999998865
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.74 Aligned_cols=263 Identities=25% Similarity=0.428 Sum_probs=216.1
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.+....++|++.+.||+|+||+||+|.+.++..||+|++..... ..+++.+|+++++.++||||+++++++.+.+..++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 33445678999999999999999999998888999999986432 34678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999997632 35889999999999999999999999 99999999999999999999999999986542
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........ .. .+..
T Consensus 173 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-~~---------~~~~ 236 (283)
T 3gen_A 173 DE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AE---------HIAQ 236 (283)
T ss_dssp HH------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HH---------HHHT
T ss_pred cc------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-HH---------HHhc
Confidence 21 111123346778999999999999999999999999999998 9999976543211 11 1122
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
+.....+..+++.+.+++..||+.+|.+||++.++++.|+++.+.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 222334555567899999999999999999999999999988653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=374.23 Aligned_cols=285 Identities=22% Similarity=0.344 Sum_probs=203.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh--HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++.+.||+|+||+||+|... +++.||||++....... .+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 468999999999999999999954 78999999997543322 456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE-----cCCCcEEEeecccccc
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL-----DHKFTAKVADFGLSRL 661 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl-----~~~~~~kl~DfGla~~ 661 (843)
||++ |+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 113 e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9997 59999997654 4889999999999999999999999 9999999999999 4555699999999986
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 187 ~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~--- 255 (329)
T 3gbz_A 187 FGIP-------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLG--- 255 (329)
T ss_dssp HC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC---
T ss_pred cCCc-------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhC---
Confidence 5422 1222345689999999999874 489999999999999999999999976543222 111111000
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
.+.....+. ... ........|..+ ......+. ...+..+.+|+.+||+.||++|||++|+|+
T Consensus 256 --~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 256 --LPDDTTWPG-----VTA-LPDWKQSFPKFRGKTLKRVLG---------ALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp --CCCTTTSTT-----GGG-STTCCTTCCCCCCCCHHHHHG---------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCchhhhhh-----hhh-hhhhhhhhhhhccccHhhhcc---------cccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000000 000 000001111111 12221110 012334568999999999999999999999
Q ss_pred CCcccCCCC
Q 003158 820 HPYVSSDVS 828 (843)
Q Consensus 820 Hp~f~~~~~ 828 (843)
||||++..+
T Consensus 319 hp~f~~~~~ 327 (329)
T 3gbz_A 319 HPYFSHNDF 327 (329)
T ss_dssp SGGGSSSCS
T ss_pred CcccCCCCC
Confidence 999998765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=386.45 Aligned_cols=262 Identities=30% Similarity=0.465 Sum_probs=220.4
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeCC-CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
++....++|++.+.||+|+||.||+|.+.. +..||||+++... ...+++.+|+++|++++||||++++++|.+.+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 344456778899999999999999999764 8899999998643 34568999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999998766667899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... ........+++.|+|||++.+..++.++|||||||++|||++ |..||....... ... .+.
T Consensus 370 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-~~~---------~~~ 433 (495)
T 1opk_A 370 GDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE---------LLE 433 (495)
T ss_dssp TCC------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHH---------HHH
T ss_pred CCc------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHH
Confidence 321 111123346778999999999999999999999999999999 999997544211 111 111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
.+.....+..+++.+.+++..||+.+|.+||++.++++.|+.+.
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 22233456677889999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=374.36 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=195.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999975 789999999976432 335788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc--EEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~~~~~~ 666 (843)
+++|+|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999997644 4889999999999999999999999 999999999999987765 999999999743221
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........
T Consensus 172 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------------ 226 (361)
T 3uc3_A 172 -------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD------------------ 226 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC------------------
T ss_pred -------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH------------------
Confidence 12234569999999999998887666 8999999999999999999975332100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
....+..+. .... ..|. ....++.+.+||.+||..||++|||++|+++||||..
T Consensus 227 -------~~~~~~~~~----~~~~-~~~~--------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 227 -------YRKTIQRIL----SVKY-SIPD--------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp -------HHHHHHHHH----TTCC-CCCT--------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred -------HHHHHHHHh----cCCC-CCCC--------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 000000000 0000 0000 0011222346888889999999999999999999965
Q ss_pred CC
Q 003158 826 DV 827 (843)
Q Consensus 826 ~~ 827 (843)
..
T Consensus 281 ~~ 282 (361)
T 3uc3_A 281 NL 282 (361)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=364.60 Aligned_cols=267 Identities=24% Similarity=0.294 Sum_probs=207.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCC----cEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 584 (843)
..++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.++++++||||+++++++.+.. ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999999999999875 7999999997533 33345677999999999999999999997754 3699
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC----------CCCCEEeccCCCCcEEEcCCCcEEEe
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------ADPPVFHRDIKASNILLDHKFTAKVA 654 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------~~~~iiH~Dlkp~NILl~~~~~~kl~ 654 (843)
||||+++|+|.++++.. .+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999764 489999999999999999999998 7 9999999999999999999999
Q ss_pred eccccccCCCCCCCCcccceeeeeecccCCccCchhcccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCcchH--H
Q 003158 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV--R 727 (843)
Q Consensus 655 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~--~ 727 (843)
|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||+||+.||....+.. .
T Consensus 174 DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 174 DFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CCTTCEEECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred cCCcccccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 9999986643321 1112335689999999999873 45668899999999999999999996532210 0
Q ss_pred HHHHHhhc---ccch-hhccCC-CCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 728 EVNIAYQS---SMMF-SVIDGN-MGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 728 ~~~~~~~~---~~~~-~~~~~~-~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
........ ..+. ...... .+.. ...+++.+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000000 0000 011111 1111 335677899999999999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=366.46 Aligned_cols=280 Identities=21% Similarity=0.302 Sum_probs=216.3
Q ss_pred ccccHHHHHHHHcCCCCC-CcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhc-cCCccccee
Q 003158 499 RSFTYGEMALATNNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLV 573 (843)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~ 573 (843)
+...+.......++|.+. +.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.+ +||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 345566667778888887 88999999999999965 69999999987533 23357889999999999 569999999
Q ss_pred eeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCc
Q 003158 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFT 650 (843)
Q Consensus 574 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~ 650 (843)
+++.+.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999999997665667999999999999999999999999 999999999999998 789
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN 730 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~ 730 (843)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 173 ~kL~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 244 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA--------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244 (327)
T ss_dssp EEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEeeCccccccCCc--------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 999999999875422 112345699999999999999999999999999999999999999976543211110
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCC
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 810 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~ 810 (843)
+........+... +.....+.+++.+||..||++
T Consensus 245 -----------------------------i~~~~~~~~~~~~-----------------~~~~~~~~~li~~~L~~dP~~ 278 (327)
T 3lm5_A 245 -----------------------------ISQVNVDYSEETF-----------------SSVSQLATDFIQSLLVKNPEK 278 (327)
T ss_dssp -----------------------------HHHTCCCCCTTTT-----------------TTSCHHHHHHHHHHSCSSGGG
T ss_pred -----------------------------HHhcccccCchhh-----------------cccCHHHHHHHHHHcCCChhh
Confidence 0000000000000 111222336788889999999
Q ss_pred CCCCccCCCCCcccCCCCCCccccc
Q 003158 811 PPSSSSMLKHPYVSSDVSGSNLVSG 835 (843)
Q Consensus 811 R~sa~e~L~Hp~f~~~~~~~~~~~~ 835 (843)
|||++|+|+||||++..+.....+.
T Consensus 279 Rpt~~~ll~h~~~~~~~~~~~~~~~ 303 (327)
T 3lm5_A 279 RPTAEICLSHSWLQQWDFENLFHPE 303 (327)
T ss_dssp SCCHHHHTTCGGGCCCCTTCC----
T ss_pred CcCHHHHhCCHhhcccccccccCcc
Confidence 9999999999999887765554443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=373.71 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=214.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|++.+.||+|+||+||+|.+. +++.||||++... ......++.+|+.+++.++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999953 4678999999754 334456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCC-----CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---cEEEe
Q 003158 583 MLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVA 654 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 654 (843)
++||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 35889999999999999999999999 99999999999999555 59999
Q ss_pred eccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHh
Q 003158 655 DFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 655 DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~ 733 (843)
|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...... +...
T Consensus 227 DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-~~~~--- 297 (367)
T 3l9p_A 227 DFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLE--- 297 (367)
T ss_dssp CCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH---
T ss_pred CCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH---
Confidence 9999975422110 111233457899999999999999999999999999999998 99999765432 1111
Q ss_pred hcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+..+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 298 ------~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 298 ------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 222233344566677889999999999999999999999999998765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.30 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=209.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999964 68999999986432 23346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.... ++++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997654 5889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .... ....
T Consensus 165 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~-~~~~---- 232 (294)
T 4eqm_A 165 S------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDS-VPNV---- 232 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH-HSSC-CCCH----
T ss_pred c------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hhcc-CCCc----
Confidence 1 11223456999999999999999999999999999999999999999765543222111 1110 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhh
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 787 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~vl~~L~~~~~ 787 (843)
....+..+++.+.+++.+|++.+|.+|| ++.++.+.|+.+..
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0012334567889999999999999998 88899988887643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=402.85 Aligned_cols=274 Identities=19% Similarity=0.284 Sum_probs=218.4
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcE
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 582 (843)
...++|++.+.||+|+||+||+|... +++.||||+++... ....+.+..|.+++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999965 68999999987532 12235678899999987 799999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++|+|.++++... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999997654 4889999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... +.
T Consensus 493 ~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~---------i~ 555 (674)
T 3pfq_A 493 IWDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQS---------IM 555 (674)
T ss_dssp CCTT-------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH---------HH
T ss_pred ccCC-------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-HHHHHH---------HH
Confidence 3221 223456799999999999999999999999999999999999999976432 111111 11
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC-----ccC
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS-----SSM 817 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa-----~e~ 817 (843)
.. ...+|... ++.+.+||++||+.||++|+++ +|+
T Consensus 556 ~~-~~~~p~~~---------------------------------------s~~~~~li~~lL~~dP~~R~~~~~~~~~ei 595 (674)
T 3pfq_A 556 EH-NVAYPKSM---------------------------------------SKEAVAICKGLMTKHPGKRLGCGPEGERDI 595 (674)
T ss_dssp SS-CCCCCTTS---------------------------------------CHHHHHHHHHHSCSSSTTCTTCSTTHHHHH
T ss_pred hC-CCCCCccC---------------------------------------CHHHHHHHHHHccCCHHHCCCCCCCcHHHH
Confidence 11 11122211 2223467777788888888887 899
Q ss_pred CCCCcccCCCCCCccccccCCCCCCC
Q 003158 818 LKHPYVSSDVSGSNLVSGVIPTITPR 843 (843)
Q Consensus 818 L~Hp~f~~~~~~~~~~~~~~~~~~~~ 843 (843)
++||||++..+.........|++.|+
T Consensus 596 ~~h~ff~~i~w~~l~~~~~~pp~~p~ 621 (674)
T 3pfq_A 596 KEHAFFRYIDWEKLERKEIQPPYKPK 621 (674)
T ss_dssp HSSGGGSSCCHHHHTTTCSCCSCCCB
T ss_pred hcCccccCCCHHHHHhCCCCCCCCCc
Confidence 99999998777666666677888774
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=359.01 Aligned_cols=264 Identities=30% Similarity=0.459 Sum_probs=222.5
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
++....++|++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+.+|+++++.++||||+++++++.+++..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 44456778999999999999999999976 58899999997543 34567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999998877777999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ... .+.
T Consensus 163 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-~~~---------~~~ 226 (288)
T 3kfa_A 163 GDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE---------LLE 226 (288)
T ss_dssp SSS------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHH---------HHH
T ss_pred CCc------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---------HHh
Confidence 322 122334557889999999999999999999999999999999 999987543211 111 111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.......+..+++.+.+++..|+..+|.+||++.++++.|+.+...
T Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1222344566778899999999999999999999999999987653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=355.54 Aligned_cols=261 Identities=27% Similarity=0.456 Sum_probs=207.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
++|++.+.||+|+||+||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56888999999999999999974 788999998743 345678999999999999999999999874 5899999999
Q ss_pred CCCHHHHHhhcCC-CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc-EEEeeccccccCCCCCCC
Q 003158 591 NGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-AKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 591 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DfGla~~~~~~~~~ 668 (843)
+|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976443 24678889999999999999999932223999999999999998886 799999999754321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....+....
T Consensus 160 -------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~ 224 (307)
T 2eva_A 160 -------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--------WAVHNGTRPP 224 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH--------HHHHTTCCCC
T ss_pred -------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH--------HHHhcCCCCC
Confidence 1234589999999999999999999999999999999999999975433221111 1112223334
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCC
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 794 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~ 794 (843)
.+..++..+.+++.+||+.+|.+||++.++++.|+.+...++..+.
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 4556677899999999999999999999999999999887765443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=357.38 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=204.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
..++|++.+.||+|+||+||+|.... +..||+|++.... ....+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45689999999999999999999642 5679999987543 334567899999999999999999999985 46789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999999764 346889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ...+.
T Consensus 168 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~----------~~~i~ 231 (281)
T 1mp8_A 168 DST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----------IGRIE 231 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------HHHHH
T ss_pred ccc------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH----------HHHHH
Confidence 322 111233456788999999999999999999999999999997 9999976543211 11222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+.....+..+++.+.+++..||+.+|.+||++.++++.|+.+.+
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 232 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 233344566778889999999999999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=357.53 Aligned_cols=265 Identities=28% Similarity=0.455 Sum_probs=218.3
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++....++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|+++++.++||||+++++++.+ +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3444567899999999999999999998888899999997543 345688999999999999999999999874 56899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++++|.+++.......+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999997544335889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. ........++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +... .+..
T Consensus 162 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~---------~~~~ 225 (279)
T 1qpc_A 162 NE------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ---------NLER 225 (279)
T ss_dssp SC------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH---------HHHT
T ss_pred cc------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHH---------HHhc
Confidence 22 111223456788999999998899999999999999999999 89999765432 1111 1112
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
+.....+..+++.+.+++..|++.+|.+||++.++++.|+.+.....
T Consensus 226 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 22233455667889999999999999999999999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=378.66 Aligned_cols=286 Identities=20% Similarity=0.258 Sum_probs=211.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc------cCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL------HHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~ 582 (843)
..+|++.+.||+|+||+||+|... +++.||||++... ....+++.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999865 5899999999753 33346778899888887 467999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc--EEEeeccccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--AKVADFGLSR 660 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~ 660 (843)
++||||+. ++|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||+|+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 79999998876667999999999999999999999999 999999999999999987 9999999997
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+.....
T Consensus 251 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~l~~i~~------ 313 (429)
T 3kvw_A 251 YEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIE------ 313 (429)
T ss_dssp ETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH------
T ss_pred ecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH------
Confidence 64321 23356899999999999999999999999999999999999999765432 22221110
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCC---------------------------CCCHHHHHHHHHHhhhhCCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDA---------------------------RPSMSEVMRELESIWNMMPESD 793 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~---------------------------RPs~~~vl~~L~~~~~~~~~~~ 793 (843)
. .+..+.+....... ....+...... .|...+....+ ....+
T Consensus 314 ~----~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------~~~~~ 382 (429)
T 3kvw_A 314 L----LGMPSQKLLDASKR-AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNAL------KGCDD 382 (429)
T ss_dssp H----HCCCCHHHHHTBTT-HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHT------TTCCC
T ss_pred H----cCCCCHHHHHhhhh-hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhc------cccch
Confidence 0 11122222211111 01111100000 00001111000 01223
Q ss_pred CCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 794 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 794 ~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+.+.+||.+||++||++||||+|+|+||||+....
T Consensus 383 ~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred HHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence 44568999999999999999999999999987544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=375.60 Aligned_cols=276 Identities=22% Similarity=0.371 Sum_probs=206.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 580 (843)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35788999999999999999996 47999999998643 223356789999999999999999999999765 3
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 8899999976 34889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... +++.....
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~----- 240 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMK----- 240 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-----
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-----
Confidence 65321 234568999999999987 77999999999999999999999999765432 22222111
Q ss_pred hhccCCCCCCCHHHHHHH-----HHHHHHhcccCCCC-CCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC
Q 003158 740 SVIDGNMGSYPSECVEKF-----IKLALKCCQDETDA-RPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 813 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l-----~~l~~~c~~~~p~~-RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s 813 (843)
..+..+.+....+ ...+.. -|.. +.. +...++...+.+.+|+.+||+.||++|+|
T Consensus 241 -----~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~~~ll~~mL~~dP~~R~t 301 (367)
T 1cm8_A 241 -----VTGTPPAEFVQRLQSDEAKNYMKG----LPELEKKD----------FASILTNASPLAVNLLEKMLVLDAEQRVT 301 (367)
T ss_dssp -----HHCCCCHHHHHTCSCHHHHHHHHH----SCCCCCCC----------GGGTCTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred -----hcCCCCHHHHHHhhhHHHHHHHHh----CCCCCCCC----------HHHHCCCCCHHHHHHHHHHccCChhHCCC
Confidence 0112233222211 111111 1111 111 11223344555678999999999999999
Q ss_pred CccCCCCCcccCCC
Q 003158 814 SSSMLKHPYVSSDV 827 (843)
Q Consensus 814 a~e~L~Hp~f~~~~ 827 (843)
++|+|+||||.+..
T Consensus 302 ~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 302 AGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHSGGGTTTC
T ss_pred HHHHhcChHHHhhc
Confidence 99999999997643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=364.78 Aligned_cols=264 Identities=28% Similarity=0.419 Sum_probs=202.1
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEeCC-C---cEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGILPD-G---TVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 579 (843)
.....++|++.+.||+|+||+||+|.... + ..||||++... .....+++.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33456789999999999999999999653 3 38999998754 233457899999999999999999999999776
Q ss_pred CcE------EEEEecCCCCCHHHHHhhcC----CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC
Q 003158 580 GEQ------MLVYEFMSNGTLRDQLSAKS----KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 649 (843)
Q Consensus 580 ~~~------~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 649 (843)
... ++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||++++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 655 99999999999999996532 225889999999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHH
Q 003158 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVRE 728 (843)
Q Consensus 650 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~ 728 (843)
.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 175 ~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~- 248 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI- 248 (323)
T ss_dssp CEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-
T ss_pred CEEEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-
Confidence 999999999986543221 112233456788999999999999999999999999999999 8999976543211
Q ss_pred HHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 729 VNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
...+..+.....+..+++.+.+++.+||+.+|.+||++.++++.|+++.+
T Consensus 249 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 249 ---------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11223333344566677889999999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.99 Aligned_cols=295 Identities=22% Similarity=0.317 Sum_probs=212.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeec--------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 578 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 578 (843)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999997 47999999998654322 24578899999999999999999999876
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
.+..++||||++ |+|.+.+.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 446899999997 58888775532 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
++........ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 171 a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~--- 243 (351)
T 3mi9_A 171 ARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQ--- 243 (351)
T ss_dssp CEECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH---
T ss_pred cccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH---
Confidence 9876532211 1122344568999999999986 5589999999999999999999999976543221 111100
Q ss_pred chhhccCCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 738 MFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 738 ~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
........ .+...... . ..-+......++...+.+.... .++.+.+|+.+||+.||++|+|++|
T Consensus 244 ---~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 244 ---LCGSITPEVWPNVDNYE---L-YEKLELVKGQKRKVKDRLKAYV--------RDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp ---HHCCCCTTTSTTGGGCG---G-GTSSCCCSSCCCCHHHHHHHHH--------CCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ---HhCCCChhhccccccch---h-hcccccccccccCHHHHhhhcc--------CChHHHHHHHHHhcCChhhCCCHHH
Confidence 00000000 00000000 0 0001111122222322221111 1334568999999999999999999
Q ss_pred CCCCCcccCCCCCCc
Q 003158 817 MLKHPYVSSDVSGSN 831 (843)
Q Consensus 817 ~L~Hp~f~~~~~~~~ 831 (843)
+|+||||.++...+.
T Consensus 309 ~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 309 ALNHDFFWSDPMPSD 323 (351)
T ss_dssp HHTSGGGGSSSCCCC
T ss_pred HhCCCCcCCCCCccc
Confidence 999999988766443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=355.64 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=208.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||+||+|... ++..||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 567999999999999999999975 5789999999865555677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE---cCCCcEEEeeccccccCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~~ 665 (843)
+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999987653 4889999999999999999999999 9999999999999 78899999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
. ......||+.|+|||.+.+. ++.++|||||||++|||++|+.||........ ... +..+
T Consensus 163 ~--------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~---------~~~~- 222 (277)
T 3f3z_A 163 K--------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLK---------IREG- 222 (277)
T ss_dssp S--------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH---------HHHC-
T ss_pred c--------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHH---------HHhC-
Confidence 1 22344689999999998654 89999999999999999999999976443111 100 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
....+.... ...++...+++.+||..||++|||+.|+|+||||+.
T Consensus 223 ~~~~~~~~~-----------------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 223 TFTFPEKDW-----------------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CCCCCHHHH-----------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CCCCCchhh-----------------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 001111100 011223346788899999999999999999999976
Q ss_pred CCC
Q 003158 826 DVS 828 (843)
Q Consensus 826 ~~~ 828 (843)
...
T Consensus 268 ~~~ 270 (277)
T 3f3z_A 268 QLS 270 (277)
T ss_dssp HHC
T ss_pred ccc
Confidence 443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=361.92 Aligned_cols=286 Identities=23% Similarity=0.333 Sum_probs=209.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999975 5899999998654332 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999988654 34889999999999999999999999 9999999999999999999999999998754221
Q ss_pred CCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. ...
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~---- 219 (311)
T 4agu_A 157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR-------KTL---- 219 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HHH----
T ss_pred ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------HHh----
Confidence 12234568999999999986 678999999999999999999999997655432211110 000
Q ss_pred CCCCHHHHHHHHH--HHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 747 GSYPSECVEKFIK--LALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 747 ~~~~~~~~~~l~~--l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
..........+.. ........+|....... ...+..+..+.+|+.+||..||++|||++|+|+||||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLE----------LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHH----------HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccccccccccccccccCcCCCccccchhh----------hhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 0111111111000 00000011111111111 12233444456899999999999999999999999998
Q ss_pred CCCCC
Q 003158 825 SDVSG 829 (843)
Q Consensus 825 ~~~~~ 829 (843)
+-..-
T Consensus 290 ~~~~~ 294 (311)
T 4agu_A 290 NIREI 294 (311)
T ss_dssp TCC--
T ss_pred hccCH
Confidence 75543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=380.52 Aligned_cols=294 Identities=24% Similarity=0.333 Sum_probs=207.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC-----Cc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 581 (843)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 6899999999753 233457889999999999999999999999765 57
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||++ |+|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999995 6999999653 45899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCcc---------------cceeeeeecccCCccCchhc-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCC---
Q 003158 662 APVPDIEGIV---------------PAHVSTVVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVFLELLTGMQPISHG--- 722 (843)
Q Consensus 662 ~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS~G~~l~elltg~~pf~~~--- 722 (843)
.......... .....+...||+.|+|||++ ....++.++||||+||++|||++|..||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6533211000 00123566799999999987 4567999999999999999999865555321
Q ss_pred -------cch-----------------HHHHHHHhhcccchhhccCCCCCCCHHHHHHH-HHHHHHhcccCCCCCCCHHH
Q 003158 723 -------KNI-----------------VREVNIAYQSSMMFSVIDGNMGSYPSECVEKF-IKLALKCCQDETDARPSMSE 777 (843)
Q Consensus 723 -------~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~c~~~~p~~RPs~~~ 777 (843)
.+. .+++.. +..+ .+..+.+....+ ..-+...+...|...+..
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~------i~~~----~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 326 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNI------IFNI----IGTPTEDDLKNINKPEVIKYIKLFPHRKPIN-- 326 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHH------HHHH----HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC--
T ss_pred ccccCCCccccccCcccccccccccchHHHHHH------HHHh----cCCCCHHHHHhccCHHHHHHHHhCCCCCCCC--
Confidence 110 000000 0000 111111111100 000001111111111100
Q ss_pred HHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 778 VMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 778 vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+...++..++.+.+||++||++||++|+||+|+|+||||++...
T Consensus 327 -------~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 327 -------LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp -------HHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred -------HHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 11123445566778999999999999999999999999987544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=365.57 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=207.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcE----EEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTV----VAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888999999999999999964 4443 8888875432 222356788999999999999999999986 56789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999999654 346889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... ........|+..|+|||++.+..++.++|||||||++|||++ |+.||.......- .. .+.
T Consensus 167 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~---------~~~ 231 (325)
T 3kex_A 167 PDDK-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-PD---------LLE 231 (325)
T ss_dssp CCTT-----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-HH---------HHH
T ss_pred cccc-----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-HH---------HHH
Confidence 4321 122344568889999999999999999999999999999999 9999976442211 11 111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 222233455566778899999999999999999999999998743
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=364.50 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=206.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+.... ....+++.+|++++++++||||++++++|.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 457888999999999999999964 444 36888876432 33457899999999999999999999999875 478
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+|+||+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997643 45899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......- . ..+.
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~--------~~~~ 233 (327)
T 3poz_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S--------SILE 233 (327)
T ss_dssp TTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H--------HHHH
T ss_pred CCcc-----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--H--------HHHH
Confidence 3321 112233457889999999999999999999999999999999 9999975442111 0 1111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222334566677889999999999999999999999999998754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.73 Aligned_cols=279 Identities=18% Similarity=0.321 Sum_probs=210.7
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeec--CCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|.. .+++.||||++... ..+.+.+|+++++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999986 57899999999743 3467899999999997 9999999999987 66889999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVP 665 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~ 665 (843)
||+++++|.+++.. +++..++.++.|+++||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999843 788899999999999999999999 99999999999999777 8999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......+..........
T Consensus 185 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~------- 249 (330)
T 3nsz_A 185 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG------- 249 (330)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC-------
T ss_pred C--------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC-------
Confidence 2 1234468899999999987 67899999999999999999999999776554443332211100
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH--HhhhhCC-----CCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE--SIWNMMP-----ESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~--~~~~~~~-----~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
...+.+.+.. ......|...+...... .+....+ ..++.+.+||.+||.+||++||||+|+
T Consensus 250 ---------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~ 317 (330)
T 3nsz_A 250 ---------TEDLYDYIDK---YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317 (330)
T ss_dssp ---------HHHHHHHHHH---TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred ---------CchhhhHHHH---hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 0111111111 11112222222110000 0000000 123345679999999999999999999
Q ss_pred CCCCcccCCC
Q 003158 818 LKHPYVSSDV 827 (843)
Q Consensus 818 L~Hp~f~~~~ 827 (843)
|+||||++..
T Consensus 318 l~hp~f~~~~ 327 (330)
T 3nsz_A 318 MEHPYFYTVV 327 (330)
T ss_dssp HTSGGGTTCC
T ss_pred hcCccHhhhc
Confidence 9999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.36 Aligned_cols=253 Identities=32% Similarity=0.511 Sum_probs=201.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999974 88999999875332 2246789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC--------CCcEEEeecc
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--------KFTAKVADFG 657 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kl~DfG 657 (843)
|||+++++|.+++.. ..+++..++.++.|+++||+|||+++..+|+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999853 35889999999999999999999998666899999999999986 7789999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
+++..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 162 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------ 226 (271)
T 3dtc_A 162 LAREWHRT---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV------ 226 (271)
T ss_dssp C----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------
T ss_pred cccccccc---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh------
Confidence 99865422 122346899999999999999999999999999999999999999765432221111
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.........+..+++.+.+++.+||+.+|.+||++.++++.|+.
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 227 ---AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11112234456677889999999999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.31 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=209.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+++.+|+++++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567999999999999999999975 6899999998754322 356799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC----cEEEeeccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 658 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGl 658 (843)
++||||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999653 45899999999999999999999999 99999999999999888 799999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....
T Consensus 166 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~------- 229 (321)
T 2a2a_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLAN------- 229 (321)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHH-------
T ss_pred ceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHH-------
Confidence 98654321 123446899999999999999999999999999999999999999754321 11110
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
+.. ....++... .+..+..+.+++.+||..||++|||++|++
T Consensus 230 --i~~-~~~~~~~~~-----------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 271 (321)
T 2a2a_A 230 --ITS-VSYDFDEEF-----------------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEAL 271 (321)
T ss_dssp --HHT-TCCCCCHHH-----------------------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHH
T ss_pred --HHh-cccccChhh-----------------------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 000 000111110 011222344789999999999999999999
Q ss_pred CCCcccCCC
Q 003158 819 KHPYVSSDV 827 (843)
Q Consensus 819 ~Hp~f~~~~ 827 (843)
+||||+...
T Consensus 272 ~hp~~~~~~ 280 (321)
T 2a2a_A 272 RHPWITPVD 280 (321)
T ss_dssp HSTTTSCSS
T ss_pred cCccccCCC
Confidence 999997643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=356.49 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=218.8
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 579 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 579 (843)
...++|++.+.||+|+||+||+|.+ .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999984 2468999999986443 3457789999999999 999999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC----------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcE
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSK----------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNI 643 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NI 643 (843)
+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999976542 25899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 003158 644 LLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHG 722 (843)
Q Consensus 644 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~ 722 (843)
+++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EEcCCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999987653321 112233457889999999999999999999999999999999 99999765
Q ss_pred cchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
.......... . .......+..++..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 252 ~~~~~~~~~~-~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 252 PVDSKFYKMI-K--------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CSSHHHHHHH-H--------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cchhHHHHHh-c--------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 4322211111 1 11122234556788999999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=360.94 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=197.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 584 (843)
..++|++.++||+|+||+||+|... +++.||||++.... .....+...|+..+..+ +||||++++++|.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999976 79999999986532 23334556666666555 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 99999 779999987653 46899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... . .+..+
T Consensus 210 ~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~------------~~~~~ 267 (311)
T 3p1a_A 210 A--------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-Q------------QLRQG 267 (311)
T ss_dssp -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-H------------HHTTT
T ss_pred C--------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-H------------HHhcc
Confidence 2 12234568999999999876 7899999999999999999997776542211 0 00000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
..+.+.. +..+..+.+++.+||..||++|||++|+|+||||+
T Consensus 268 ---~~~~~~~-----------------------------------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 268 ---YLPPEFT-----------------------------------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp ---CCCHHHH-----------------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred ---CCCcccc-----------------------------------cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence 0111100 11122334688889999999999999999999997
Q ss_pred C
Q 003158 825 S 825 (843)
Q Consensus 825 ~ 825 (843)
.
T Consensus 310 ~ 310 (311)
T 3p1a_A 310 Q 310 (311)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.49 Aligned_cols=254 Identities=20% Similarity=0.345 Sum_probs=212.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecC--CcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV 585 (843)
.++|++.+.||+|+||+||+|.+. ++.||||++.... ....+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999984 8899999997543 33456799999999999999999999999876 788999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++.......+++..++.++.|+++||+|||+++ ++|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 99999999999998766667999999999999999999999875 4599999999999999999999999998764321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCc---hhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTD---KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.||........... ...
T Consensus 166 -----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---------~~~ 225 (271)
T 3kmu_A 166 -----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK---------VAL 225 (271)
T ss_dssp -----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH---------HHH
T ss_pred -----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH---------HHh
Confidence 2235789999999998765544 79999999999999999999976543222111 111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
.+.....+..++..+.+++..||+.+|.+||++.++++.|+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 22233456667788999999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.30 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=215.6
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeee
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 577 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 577 (843)
+....++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 444567899999999999999999995 2466899999975432 2346789999999999 8999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcCC---------------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEec
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~ 636 (843)
..+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 99999999999999999999976432 24789999999999999999999999 9999
Q ss_pred cCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-C
Q 003158 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-G 715 (843)
Q Consensus 637 Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g 715 (843)
||||+||+++.++.+||+|||++........ ........||+.|+|||.+.+..++.++|||||||++|||+| |
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999986543221 122334567889999999999999999999999999999998 9
Q ss_pred CCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 716 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 716 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
..||............ +..+.....+..+++.+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 272 ~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKL---------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCSSTTCCCSHHHHHH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCcccCCcHHHHHHH---------HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 9999765432221111 1111223345566788999999999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=359.52 Aligned_cols=276 Identities=27% Similarity=0.437 Sum_probs=213.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeCC-----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPD-----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++|...+.||+|+||+||+|.... +..||||++.... .....++.+|+++++.++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999998642 2469999997643 3345678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999764 346889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... +... .+..
T Consensus 200 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~---------~~~~ 265 (333)
T 1mqb_A 200 DPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMK---------AIND 265 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH---------HHHT
T ss_pred cccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHH---------HHHC
Confidence 2110 111223346788999999999999999999999999999999 99999765431 1111 1222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~ 812 (843)
+.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.... +.+..+..++|..|+
T Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~--------~~~~~~~~~~p~~~~ 326 (333)
T 1mqb_A 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP--------DSLKTLADFDPRVSI 326 (333)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG--------GGGGSBCCC------
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc--------hhhhhhcCCCccchh
Confidence 2233445667788999999999999999999999999999987532 445566777776654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=382.44 Aligned_cols=200 Identities=29% Similarity=0.435 Sum_probs=176.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999975 799999999975322 22467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999653 45899999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 171 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 171 --------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp --------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 2234569999999999998765 689999999999999999999997543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=358.90 Aligned_cols=272 Identities=17% Similarity=0.233 Sum_probs=215.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+++++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788999999999999999996 5799999999875432 24688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc-----EEEeeccccccC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 662 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla~~~ 662 (843)
|+ +++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999764 346899999999999999999999999 999999999999998887 999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc--hHHHHHHHhhcccchh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 740 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~ 740 (843)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-AT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-HS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-cC
Confidence 54332221122223456799999999999999999999999999999999999999976432 2221111100000 00
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDT 794 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~ 794 (843)
.. ......++ ++.+++..||+.+|.+||++.++.+.|+++.+.......
T Consensus 240 ~~----~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 240 PI----EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp CH----HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred CH----HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 00 00011134 899999999999999999999999999998876654333
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.61 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=200.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999964 68999999987543 2345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE---cCCCcEEEeeccccccC
Q 003158 588 FMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLA 662 (843)
Q Consensus 588 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 662 (843)
|+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998653 2356899999999999999999999999 9999999999999 45678999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... .......||+.|+|||.+. ..++.++|||||||++|||++|+.||............
T Consensus 178 ~~~--------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~----------- 237 (285)
T 3is5_A 178 KSD--------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA----------- 237 (285)
T ss_dssp -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----------
T ss_pred CCc--------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh-----------
Confidence 432 1223456899999999985 56899999999999999999999999754321110000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
...........++ ..+.+.+++.+||+.||++|||++|+|+|||
T Consensus 238 ------------------~~~~~~~~~~~~~------------------~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 238 ------------------TYKEPNYAVECRP------------------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp ------------------HHCCCCCCC--CC------------------CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ------------------ccCCcccccccCc------------------CCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 0000000000111 1122336788889999999999999999999
Q ss_pred ccC
Q 003158 823 VSS 825 (843)
Q Consensus 823 f~~ 825 (843)
|+.
T Consensus 282 f~~ 284 (285)
T 3is5_A 282 FKQ 284 (285)
T ss_dssp GGC
T ss_pred hhc
Confidence 975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=355.17 Aligned_cols=271 Identities=18% Similarity=0.253 Sum_probs=216.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ..+.+.+|+++++.+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 579999999987533 234678899999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc-----EEEeeccccccC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADFGLSRLA 662 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla~~~ 662 (843)
|+ +++|.+++.... .++++..++.++.||++||+|||+++ |+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997643 35899999999999999999999999 999999999999987776 999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc--hHHHHHHHhhcccchh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 740 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~ 740 (843)
.........+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~--- 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-K--- 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-H---
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh-c---
Confidence 54432222122233456799999999999999999999999999999999999999976432 11111111000 0
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 792 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~ 792 (843)
...........+++.+.+++..||+.+|.+||++.++++.|+++.+.....
T Consensus 238 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 238 -QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp -HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 000000112245678999999999999999999999999999998765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=351.52 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=206.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999965 68999999987532 333467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc---EEEeeccccccCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFGLSRLAP 663 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~~~~ 663 (843)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999887653 4889999999999999999999999 999999999999987665 9999999997654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 160 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~------------ 218 (284)
T 3kk8_A 160 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQ------------ 218 (284)
T ss_dssp SSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------
T ss_pred cCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-HHH------------
Confidence 321 12335689999999999999999999999999999999999999975442111 100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
+....+. .|... .....+...+++.+||..||++|||++|+|+||||
T Consensus 219 ----------------~~~~~~~-~~~~~----------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 219 ----------------IKAGAYD-YPSPE----------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp ----------------HHHTCCC-CCTTT----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred ----------------HHhcccc-CCchh----------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 0000000 00000 00111223367888899999999999999999999
Q ss_pred cCCCC
Q 003158 824 SSDVS 828 (843)
Q Consensus 824 ~~~~~ 828 (843)
+....
T Consensus 266 ~~~~~ 270 (284)
T 3kk8_A 266 CNRER 270 (284)
T ss_dssp HSCCC
T ss_pred cCChh
Confidence 77544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=352.75 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=215.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467888999999999999999988889999999986433 3468899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 158 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 158 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc---
Confidence 9999999997643 45889999999999999999999999 9999999999999999999999999998653211
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
........++..|+|||++.+..++.++||||||+++|||++ |+.||...... .... .+..+....
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~---------~i~~~~~~~ 225 (267)
T 3t9t_A 159 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVE---------DISTGFRLY 225 (267)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH---------HHHTTCCCC
T ss_pred ---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-HHHH---------HHhcCCcCC
Confidence 111123346778999999999999999999999999999999 89999765432 1111 111222233
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+..++..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 455567789999999999999999999999999998864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=391.63 Aligned_cols=265 Identities=30% Similarity=0.461 Sum_probs=220.3
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.+.+.+..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344555677899999999999999999999888889999998644 335689999999999999999999999976 678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999997654456889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +... .+
T Consensus 414 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-~~~~---------~i 477 (535)
T 2h8h_A 414 EDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLD---------QV 477 (535)
T ss_dssp CCHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-HHHH---------HH
T ss_pred CCCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH---------HH
Confidence 4211 011123346788999999999999999999999999999999 99999765431 1111 12
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
..+.....+..+++.+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 478 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 22223345667788999999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=369.63 Aligned_cols=285 Identities=22% Similarity=0.351 Sum_probs=204.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh-----HHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
..++|++.+.||+|+||.||+|... +|+.||||++....... .+.+.+|+++++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999965 68999999987532221 24678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++ +|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999975 899988654 346889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...... +.....+....
T Consensus 163 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~---- 230 (346)
T 1ua2_A 163 GSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLG---- 230 (346)
T ss_dssp TSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC----
T ss_pred cCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcC----
Confidence 4321 122345689999999999764 5889999999999999999999888765432 22211111000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
.......+..+ .+.. ......+|... .....+.....+.+|+.+||..||++|||++|+|+||
T Consensus 231 -~~~~~~~~~~~-----~~~~---~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 231 -TPTEEQWPDMC-----SLPD---YVTFKSFPGIP--------LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp -CCCTTTSSSTT-----SSTT---CCCCCCCCCCC--------HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred -CCChhhhhhhc-----cCcc---cccccccCCCC--------hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000000000 0000 00000111100 0011233344556799999999999999999999999
Q ss_pred cccCCC
Q 003158 822 YVSSDV 827 (843)
Q Consensus 822 ~f~~~~ 827 (843)
||+...
T Consensus 294 ~f~~~~ 299 (346)
T 1ua2_A 294 YFSNRP 299 (346)
T ss_dssp GGTSSS
T ss_pred hhhcCC
Confidence 998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=374.71 Aligned_cols=277 Identities=21% Similarity=0.359 Sum_probs=196.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------G 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 580 (843)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999995 46899999998753 233456788999999999999999999998653 5
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899999864 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+++.....
T Consensus 181 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~----- 244 (367)
T 2fst_X 181 HTAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILR----- 244 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHH-----
T ss_pred cccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-----
Confidence 6432 1234578999999999987 6789999999999999999999999976543 222222111
Q ss_pred hhccCCCCCCCHHHHH-----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC
Q 003158 740 SVIDGNMGSYPSECVE-----KFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 814 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~-----~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa 814 (843)
.+ +..+.+... .....+. .+...| +..+.+ .++..++.+.|||.+||++||++|+|+
T Consensus 245 -~~----g~p~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~----------~~~~~~~~~~dLl~~mL~~dP~~R~t~ 306 (367)
T 2fst_X 245 -LV----GTPGAELLKKISSESARNYIQ-SLTQMP--KMNFAN----------VFIGANPLAVDLLEKMLVLDSDKRITA 306 (367)
T ss_dssp -HH----CSCCHHHHTTCCCHHHHHHHH-TSCCCC--CCCHHH----------HTTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred -Hh----CCCCHHHHHHhhhHHHHHHHh-ccCCCC--CCCHHH----------HCCCCCHHHHHHHHHhCCCCcccCcCH
Confidence 00 111111111 1111111 111111 122221 233445566789999999999999999
Q ss_pred ccCCCCCcccCCC
Q 003158 815 SSMLKHPYVSSDV 827 (843)
Q Consensus 815 ~e~L~Hp~f~~~~ 827 (843)
+|+|+||||+...
T Consensus 307 ~e~L~hp~~~~~~ 319 (367)
T 2fst_X 307 AQALAHAYFAQYH 319 (367)
T ss_dssp HHHHTSGGGTTTC
T ss_pred HHHhcChhhhhcc
Confidence 9999999998643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.27 Aligned_cols=279 Identities=18% Similarity=0.202 Sum_probs=212.1
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCC------CcEEEEEEeccCChhhH-----------HHHHHHHHHHHhccCCcccc
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGE-----------KEFLTEIQFLSRLHHRNLVS 571 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~ 571 (843)
..++|++.+.||+|+||+||+|.+.+ ++.||||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999999754 47899999876542211 12345666777888999999
Q ss_pred eeeeeecC----CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-
Q 003158 572 LVGYCDEE----GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD- 646 (843)
Q Consensus 572 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~- 646 (843)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99998664 4589999999 99999999764 346899999999999999999999999 99999999999999
Q ss_pred -CCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch
Q 003158 647 -HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 725 (843)
Q Consensus 647 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~ 725 (843)
.++.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876432211111111223456999999999999999999999999999999999999999753222
Q ss_pred HHHH---HHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCC
Q 003158 726 VREV---NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 795 (843)
Q Consensus 726 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~ 795 (843)
.... ...+. ..+..+++..+. +..++.++.+++..||+.+|.+||++.++++.|+.+.+........
T Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~ 337 (364)
T 3op5_A 268 PKYVRDSKIRYR-ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG 337 (364)
T ss_dssp HHHHHHHHHHHH-HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHHHhh-hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence 2111 11111 111122221111 1234578899999999999999999999999999998866544443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=372.43 Aligned_cols=296 Identities=20% Similarity=0.323 Sum_probs=213.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467899999999999999999975 68999999998653 3335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|+++|+|.+++.... .+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999997654 488899999999999999999996 8 99999999999999999999999999865421
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... ...+..
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~-----~~~~~~ 250 (360)
T 3eqc_A 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGC-----QVEGDA 250 (360)
T ss_dssp -------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH--HC------------
T ss_pred -------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--hcc-----cccccC
Confidence 122345689999999999999999999999999999999999999976543221111 000 000000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh-hCCC--CCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN-MMPE--SDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~-~~~~--~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
...+..... ..... .-+..+........++.+.+..... ..+. .+..+.+|+.+||+.||++|||++|+|+||||
T Consensus 251 ~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 251 AETPPRPRT-PGRPL-NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp -------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCCCccc-CCCcc-cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 000000000 00000 0011111122233333333322111 0110 12234589999999999999999999999999
Q ss_pred cCCCC
Q 003158 824 SSDVS 828 (843)
Q Consensus 824 ~~~~~ 828 (843)
+....
T Consensus 329 ~~~~~ 333 (360)
T 3eqc_A 329 KRSDA 333 (360)
T ss_dssp HHHHH
T ss_pred hcchH
Confidence 76444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=360.01 Aligned_cols=264 Identities=25% Similarity=0.478 Sum_probs=217.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 578 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 578 (843)
..++|++.+.||+|+||+||+|... +++.||||++..... ...+++.+|+++++.+ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 467899999976433 3456789999999999 89999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCC--------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEE
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 644 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NIL 644 (843)
.+..++||||+++|+|.+++..... ..+++..++.++.||++||+|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999976432 24889999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCc
Q 003158 645 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 723 (843)
Q Consensus 645 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~ 723 (843)
++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999986643221 112233457788999999999999999999999999999999 999997543
Q ss_pred chHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
. .+... .+..+.....+..++..+.+++..||+.+|.+||++.++++.|+++....+
T Consensus 265 ~-~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 265 V-EELFK---------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp H-HHHHH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H-HHHHH---------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 2 11111 111222334456677889999999999999999999999999999877543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.69 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=207.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999975 58899999986532 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999987643 5889999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .. +...
T Consensus 169 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~---------~~~~- 230 (294)
T 2rku_A 169 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-LR---------IKKN- 230 (294)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH---------HHTT-
T ss_pred c-------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH---------Hhhc-
Confidence 1 1123456899999999999999999999999999999999999999754321110 00 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
....+.. .+....+++.+||..||++|||++|+++||||.+
T Consensus 231 ~~~~~~~---------------------------------------~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 231 EYSIPKH---------------------------------------INPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp CCCCCTT---------------------------------------SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred cCCCccc---------------------------------------cCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 0001111 1112235777888999999999999999999987
Q ss_pred CCC
Q 003158 826 DVS 828 (843)
Q Consensus 826 ~~~ 828 (843)
...
T Consensus 272 ~~~ 274 (294)
T 2rku_A 272 GYI 274 (294)
T ss_dssp SCC
T ss_pred CCc
Confidence 654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=374.84 Aligned_cols=295 Identities=24% Similarity=0.326 Sum_probs=194.5
Q ss_pred cCCCC-CCcccccCCeeEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeee--cCCcEEE
Q 003158 511 NNFNS-STQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQML 584 (843)
Q Consensus 511 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~l 584 (843)
+.|++ .++||+|+||+||+|... +++.||||++..... ...+.+|+++++.++||||+++++++. .....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45665 457999999999999965 578999999975432 346889999999999999999999994 4678999
Q ss_pred EEecCCCCCHHHHHhhc-------CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE----cCCCcEEE
Q 003158 585 VYEFMSNGTLRDQLSAK-------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKV 653 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl 653 (843)
||||++ |+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 5888887532 1234889999999999999999999999 9999999999999 77889999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchH------
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIV------ 726 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~------ 726 (843)
+|||+|+....... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 174 ~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 174 ADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 99999987643211 11223446789999999999874 58999999999999999999999997543211
Q ss_pred --HHHHHHhhcccchhhccCCCCC-CCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccC
Q 003158 727 --REVNIAYQSSMMFSVIDGNMGS-YPS-ECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINS 802 (843)
Q Consensus 727 --~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~ 802 (843)
+++...+ ..+...... .+. ........+.. .+...........+ .++ ......+..+.+||.+
T Consensus 250 ~~~~l~~i~------~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~Ll~~ 316 (405)
T 3rgf_A 250 HHDQLDRIF------NVMGFPADKDWEDIKKMPEHSTLMK-DFRRNTYTNCSLIK---YME---KHKVKPDSKAFHLLQK 316 (405)
T ss_dssp CHHHHHHHH------HHHCCCCTTTCGGGGGSTTHHHHHH-HCCGGGGTTCCHHH---HHH---TTTCCTTSHHHHHHHH
T ss_pred hHHHHHHHH------HhhCCCChhhcchhhcCcchhhhhh-hccccCCCcchhhh---hHh---hcCCCCCHHHHHHHHH
Confidence 1111110 000000000 000 00000000111 01111111111111 111 1122335566789999
Q ss_pred CCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 803 EHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 803 ~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
||++||++|+||+|+|+||||.+...
T Consensus 317 ~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 317 LLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred HccCCcccCCCHHHHhcChhhccCCC
Confidence 99999999999999999999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=364.25 Aligned_cols=286 Identities=24% Similarity=0.364 Sum_probs=209.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999975 589999999865432 23466889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999998887543 35889999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 179 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 241 (331)
T 4aaa_A 179 -------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL---------- 241 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH----------
T ss_pred -------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh----------
Confidence 122345689999999999875 78999999999999999999999997665432221111000
Q ss_pred CCCCCHHHHHHHHHHHH--HhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 746 MGSYPSECVEKFIKLAL--KCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~--~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
+..+......+..-.. .........+.... ...+..+....+|+.+||..||++|||++|+|+||||
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 242 -GNLIPRHQELFNKNPVFAGVRLPEIKEREPLE----------RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp -CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHH----------HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -CCCChhhhhHhhhccccccccCccccccchhh----------hcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0111111111100000 00000001111111 1223334456689999999999999999999999999
Q ss_pred cCCCC
Q 003158 824 SSDVS 828 (843)
Q Consensus 824 ~~~~~ 828 (843)
+.+..
T Consensus 311 ~~~~~ 315 (331)
T 4aaa_A 311 QMDGF 315 (331)
T ss_dssp HGGGH
T ss_pred ccCCh
Confidence 87643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=367.33 Aligned_cols=257 Identities=21% Similarity=0.350 Sum_probs=200.6
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
..++|++.+.||+|+||+||+|... +++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4568999999999999999999975 689999999976432 235688888888 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC----CcEEEeeccccccC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRLA 662 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~~ 662 (843)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999664 35899999999999999999999999 9999999999998543 35999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc-hHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN-IVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~ 741 (843)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 171 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------------- 229 (342)
T 2qr7_A 171 RAEN-------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE-------------- 229 (342)
T ss_dssp BCTT-------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH--------------
T ss_pred cCCC-------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH--------------
Confidence 4321 122345689999999999988889999999999999999999999975321 010
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
++.+.+...-...+.. .++..+..+.+|+++||..||++|+|++|+++||
T Consensus 230 --------------~~~~~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 230 --------------EILARIGSGKFSLSGG----------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp --------------HHHHHHHHCCCCCCST----------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred --------------HHHHHHccCCcccCcc----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 0111111100000000 0011223344788889999999999999999999
Q ss_pred cccC
Q 003158 822 YVSS 825 (843)
Q Consensus 822 ~f~~ 825 (843)
||..
T Consensus 280 ~~~~ 283 (342)
T 2qr7_A 280 WIVH 283 (342)
T ss_dssp HHHT
T ss_pred eecC
Confidence 9954
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=361.20 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=206.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999975 58899999987532 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987643 5889999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... . ...
T Consensus 195 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~---------~~~- 256 (335)
T 2owb_A 195 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-I---------KKN- 256 (335)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-H---------HHT-
T ss_pred c-------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-H---------hcC-
Confidence 1 112345689999999999999999999999999999999999999975432111000 0 000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
....+..+ +....+++.+||..||++|||++|+++||||++
T Consensus 257 ~~~~~~~~---------------------------------------~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 257 EYSIPKHI---------------------------------------NPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CCCCCTTS---------------------------------------CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCCCCccC---------------------------------------CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 00011111 112235777788889999999999999999987
Q ss_pred CCC
Q 003158 826 DVS 828 (843)
Q Consensus 826 ~~~ 828 (843)
...
T Consensus 298 ~~~ 300 (335)
T 2owb_A 298 GYI 300 (335)
T ss_dssp SCC
T ss_pred CCc
Confidence 654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=368.69 Aligned_cols=291 Identities=22% Similarity=0.280 Sum_probs=211.1
Q ss_pred cHHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh-----------hhHHHHHHHHHHHHhccCCccc
Q 003158 502 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL-----------QGEKEFLTEIQFLSRLHHRNLV 570 (843)
Q Consensus 502 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv 570 (843)
...++....++|.+.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 34577778899999999999999999999988899999999864221 1136789999999999999999
Q ss_pred ceeeeeec-----CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE
Q 003158 571 SLVGYCDE-----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 645 (843)
Q Consensus 571 ~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl 645 (843)
++++++.. ....++||||++ |+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99999843 346899999997 6898888653 346899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcc
Q 003158 646 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724 (843)
Q Consensus 646 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~ 724 (843)
+.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCCEEEEecCcccccccc--------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999754321 22234568899999999987 6789999999999999999999999976543
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCCHHHH-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCcc
Q 003158 725 IVREVNIAYQSSMMFSVIDGNMGSYPSECV-----EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 799 (843)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dl 799 (843)
. ........ .. +..+.+.. ....+.........|..+ +....+..++.+.+|
T Consensus 240 ~-~~~~~i~~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l 296 (362)
T 3pg1_A 240 Y-NQLNKIVE------VV----GTPKIEDVVMFSSPSARDYLRNSLSNVPARA------------WTAVVPTADPVALDL 296 (362)
T ss_dssp H-HHHHHHHH------HH----CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC------------HHHHSTTSCHHHHHH
T ss_pred H-HHHHHHHH------Hc----CCCChHHhhhccchhhhHHHHhhcccCChhh------------HHhhCCCCCHHHHHH
Confidence 2 21111110 00 00111110 011111111111111111 111223344556689
Q ss_pred ccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 800 INSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 800 l~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+.+||..||++|||++|+|+||||++...
T Consensus 297 i~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 297 IAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 99999999999999999999999987544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=355.74 Aligned_cols=271 Identities=25% Similarity=0.427 Sum_probs=220.8
Q ss_pred ccHHHHHHHHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCChh-hHHHHHHHHHHHHhc-cCCcccce
Q 003158 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRL-HHRNLVSL 572 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l 572 (843)
+...++....++|++.+.||+|+||+||+|.+ .+++.||||++...... ..+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34456666778999999999999999999984 24689999999864433 346789999999999 79999999
Q ss_pred eeeeecCC-cEEEEEecCCCCCHHHHHhhcCC--------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEecc
Q 003158 573 VGYCDEEG-EQMLVYEFMSNGTLRDQLSAKSK--------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637 (843)
Q Consensus 573 ~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~D 637 (843)
++++...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987654 58999999999999999976542 23889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CC
Q 003158 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GM 716 (843)
Q Consensus 638 lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~ 716 (843)
|||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceEEECCCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999986543221 122334567889999999999999999999999999999998 99
Q ss_pred CCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 717 QPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 717 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.||............ +..+.....+..+++.+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 249 ~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 249 SPYPGVKIDEEFCRR---------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CSSTTCCCSHHHHHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccchhHHHHHH---------hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 999765432221111 111222334555677899999999999999999999999999988653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.59 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=211.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCC--cEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV 585 (843)
.++|.+.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357889999999999999999975 589999999975432 33567889999999999999999999987654 78999
Q ss_pred EecCCCCCHHHHHhhcCC-CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE----cCCCcEEEeeccccc
Q 003158 586 YEFMSNGTLRDQLSAKSK-EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 660 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla~ 660 (843)
|||+++|+|.+++..... ..+++..++.++.||++||+|||+.+ |+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976432 34899999999999999999999999 9999999999999 888899999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcc--------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc---hHHHH
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--------THKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREV 729 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~---~~~~~ 729 (843)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... .....
T Consensus 165 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 165 ELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred ecCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 764322 123456899999999986 57789999999999999999999999964322 12222
Q ss_pred HHHhhccc---chhh---------cc---CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 730 NIAYQSSM---MFSV---------ID---GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 730 ~~~~~~~~---~~~~---------~~---~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
........ +..+ .. +.....+......+.+++.+|++.||++||++.++++...+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 21111100 0000 00 111234678888999999999999999999999999887764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.83 Aligned_cols=196 Identities=24% Similarity=0.363 Sum_probs=162.7
Q ss_pred cCCCCC-CcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHh-ccCCcccceeeeeec----CCcEE
Q 003158 511 NNFNSS-TQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSR-LHHRNLVSLVGYCDE----EGEQM 583 (843)
Q Consensus 511 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~ 583 (843)
++|.+. +.||+|+||+||+|... +++.||||++... ..+.+|++++.+ .+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999965 6899999998642 356788888744 589999999999865 56789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEEeeccccc
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 660 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~ 660 (843)
+||||+++|+|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998766667999999999999999999999999 999999999999998 7899999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 213 ETTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccCCC--------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 65421 1224456899999999999999999999999999999999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=371.51 Aligned_cols=202 Identities=27% Similarity=0.345 Sum_probs=172.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEG 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 580 (843)
.++|++.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35799999999999999999997 368999999987432 12234677899999999 6999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+++|+|.+++.... .+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997653 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 208 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 208 EFVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp ECCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ecccCC------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 653211 112234569999999999986 34788999999999999999999999643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.18 Aligned_cols=281 Identities=21% Similarity=0.326 Sum_probs=202.5
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec-------
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------- 578 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------- 578 (843)
....++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999996 5799999999875422 23469999999999999999999843
Q ss_pred -------------------------------CCcEEEEEecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHH
Q 003158 579 -------------------------------EGEQMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYL 625 (843)
Q Consensus 579 -------------------------------~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yL 625 (843)
....++||||++ |+|.+.+.. .....+++..++.++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 234889999997 688888764 3445689999999999999999999
Q ss_pred hcCCCCCEEeccCCCCcEEEc-CCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhH
Q 003158 626 HTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVY 703 (843)
Q Consensus 626 H~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvw 703 (843)
|+++ |+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++|||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999 99999999999998 68899999999998654321 22345689999999999875 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 704 SLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 704 S~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
|+||++|||++|+.||........ ...... . .+..+.+..... .-......-|.... .
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~-~~~i~~------~----~g~p~~~~~~~~------~~~~~~~~~~~~~~-----~ 284 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQ-LVRIIQ------I----MGTPTKEQMIRM------NPHYTEVRFPTLKA-----K 284 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH------H----HCCCCHHHHHHH------CTTC--CCCCCCCC-----C
T ss_pred hHHHHHHHHHhCCCCCCCCChHHH-HHHHHH------H----hCCCCHHHHHHh------CcccccccCCccCc-----c
Confidence 999999999999999976543222 111110 0 011111111100 00000000000000 0
Q ss_pred HhhhhCCC-CCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 784 SIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 784 ~~~~~~~~-~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
.+...++. ..+.+.+|+.+||++||++|+|++|+|+||||+.
T Consensus 285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred cHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 01111122 2344568999999999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=360.93 Aligned_cols=266 Identities=24% Similarity=0.384 Sum_probs=216.7
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeCC------CcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYC 576 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 576 (843)
++....++|++.+.||+|+||+||+|.... ...||+|++..... ...+.+.+|+++++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455567889999999999999999999642 24899999976433 3456789999999999 899999999999
Q ss_pred ecCCcEEEEEecCCCCCHHHHHhhcC------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEE
Q 003158 577 DEEGEQMLVYEFMSNGTLRDQLSAKS------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 644 (843)
Q Consensus 577 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NIL 644 (843)
.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999997532 345789999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCc
Q 003158 645 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 723 (843)
Q Consensus 645 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~ 723 (843)
++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECCCCeEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999986543221 112234457889999999999999999999999999999999 999997644
Q ss_pred chHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
........ . ..+.....+..+++.+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 272 ~~~~~~~~-~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 272 VNSKFYKL-V--------KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SSHHHHHH-H--------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHH-H--------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 32221111 0 1111222344556788999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=356.50 Aligned_cols=270 Identities=26% Similarity=0.440 Sum_probs=209.4
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeee
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 577 (843)
+++....++|.+.+.||+|+||.||+|... .++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344455678999999999999999999853 34589999987542 333567899999999999999999999997
Q ss_pred cCC-----cEEEEEecCCCCCHHHHHhh----cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC
Q 003158 578 EEG-----EQMLVYEFMSNGTLRDQLSA----KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 648 (843)
Q Consensus 578 ~~~-----~~~lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 648 (843)
+.+ ..++||||+++|+|.+++.. .....+++..++.++.|+++||.|||+++ |+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 654 35999999999999999854 23456899999999999999999999998 9999999999999999
Q ss_pred CcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHH
Q 003158 649 FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVR 727 (843)
Q Consensus 649 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~ 727 (843)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp SCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 9999999999986543221 112234457889999999999999999999999999999999 8888875543211
Q ss_pred HHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 728 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
...+..+.....+..+++.+.+++..||..+|.+||++.++++.|+++.+..|+
T Consensus 259 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 259 ----------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp ----------HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred ----------HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 112223333445666778899999999999999999999999999999887653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=374.41 Aligned_cols=198 Identities=22% Similarity=0.277 Sum_probs=172.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc--------CCcccceeeeee---
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH--------HRNLVSLVGYCD--- 577 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~--- 577 (843)
.++|++.+.||+|+||+||+|+. .+++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999996 46899999999753 334567889999999986 788999999987
Q ss_pred -cCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCC------
Q 003158 578 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKF------ 649 (843)
Q Consensus 578 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~------ 649 (843)
.....++||||+ +++|.+++.......+++..++.++.||++||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 556889999999 67787777666556799999999999999999999998 8 99999999999999775
Q ss_pred -------------------------------------------cEEEeeccccccCCCCCCCCcccceeeeeecccCCcc
Q 003158 650 -------------------------------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686 (843)
Q Consensus 650 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ 686 (843)
.+||+|||+++..... .....||+.|+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~~y~ 260 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCGGGC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCCccc
Confidence 7999999999865421 23346899999
Q ss_pred CchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 687 aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
|||++.+..++.++|||||||++|||++|+.||...
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=365.47 Aligned_cols=285 Identities=21% Similarity=0.321 Sum_probs=204.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 580 (843)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999964 68999999987532 334567889999999999999999999997654
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||++ |+|.+++.. .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 6899999996 588888853 3788999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 176 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i-------- 238 (371)
T 2xrw_A 176 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKV-------- 238 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH--------
T ss_pred ccccc--------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH--------
Confidence 65321 122345789999999999999999999999999999999999999976554322 2211
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhhCCCC-------CCCCCccccCCCCCCCCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPES-------DTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~vl~~L~~~~~~~~~~-------~~~~~dll~~~L~~dp~~R~ 812 (843)
+ ...+....+....+...+.......|... .++.++.. .. .++.. ...+.+|+.+||+.||++||
T Consensus 239 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 311 (371)
T 2xrw_A 239 -I-EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP---DV--LFPADSEHNKLKASQARDLLSKMLVIDASKRI 311 (371)
T ss_dssp -H-C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSC---GG--GSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC
T ss_pred -H-HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcc---cc--cCcccccccccccHHHHHHHHHHCcCChhhCC
Confidence 1 11222233333322222222222222211 12221110 00 00100 12345899999999999999
Q ss_pred CCccCCCCCcccCC
Q 003158 813 SSSSMLKHPYVSSD 826 (843)
Q Consensus 813 sa~e~L~Hp~f~~~ 826 (843)
|++|+|+||||+..
T Consensus 312 t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 312 SVDEALQHPYINVW 325 (371)
T ss_dssp CHHHHHHSHHHHTT
T ss_pred CHHHHhCCcchhhh
Confidence 99999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=349.35 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=183.9
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5788899999999999999996 4799999999874322 12467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++++|.+++... ..++++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999754 346899999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ........
T Consensus 167 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~~~~- 228 (278)
T 3cok_A 167 -------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------LNKVVLAD- 228 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSSC-
T ss_pred -------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------HHHHhhcc-
Confidence 112335689999999999998999999999999999999999999975432100 00000000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
...|.. ......+++.+||..||++|||++|+++||||...
T Consensus 229 ~~~~~~---------------------------------------~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 229 YEMPSF---------------------------------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp CCCCTT---------------------------------------SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred cCCccc---------------------------------------cCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 000110 11122367788888999999999999999999765
Q ss_pred CC
Q 003158 827 VS 828 (843)
Q Consensus 827 ~~ 828 (843)
..
T Consensus 270 ~~ 271 (278)
T 3cok_A 270 SS 271 (278)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.53 Aligned_cols=269 Identities=26% Similarity=0.448 Sum_probs=220.2
Q ss_pred ccHHHHHHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCccccee
Q 003158 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLV 573 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~ 573 (843)
+..+++....++|++.+.||+|+||.||+|... +++.||||++..... ....++.+|+++++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344556667889999999999999999999854 378899999975433 3456789999999999999999999
Q ss_pred eeeecCCcEEEEEecCCCCCHHHHHhhcC--------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE
Q 003158 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKS--------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 645 (843)
Q Consensus 574 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl 645 (843)
+++.+.+..++||||+++|+|.+++.... ..++++..++.++.|+++||.|||+++ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999997532 245688999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcc
Q 003158 646 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKN 724 (843)
Q Consensus 646 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~ 724 (843)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred cCCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 9999999999999976532210 111223456889999999999999999999999999999999 8888875432
Q ss_pred hHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 725 IVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
..... .+..+.....+..++..+.+++.+||+.+|.+||++.++++.|++...
T Consensus 247 -~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 -EQVLR---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HHHHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHH---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111 122233344556677889999999999999999999999999987643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=384.71 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=210.9
Q ss_pred CCCCCC-cccccCCeeEEEEEeC---CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 512 NFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 512 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++.+.+ .||+|+||.||+|.+. ++..||||+++.... ...+++.+|+++|+.++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999864 467899999986432 346789999999999999999999999976 5699999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999654 346899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.. ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+..+.
T Consensus 491 ~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~---------~~i~~~~ 556 (613)
T 2ozo_A 491 SY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VM---------AFIEQGK 556 (613)
T ss_dssp ---------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HH---------HHHHTTC
T ss_pred ce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HH---------HHHHcCC
Confidence 10 111123346789999999999999999999999999999998 999997654321 11 1222333
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
....|..+++++.+++..||+.+|.+||++.++++.|+.+......
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 4456777889999999999999999999999999999998765433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=352.68 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=202.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHh--ccCCcccceeeeeec----CCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDE----EGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~~~ 583 (843)
.++|++.+.||+|+||+||+|.. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999988 6899999998642 34556667777766 799999999998644 34689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHh--------cCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
+||||+++|+|.++++. ..+++..++.++.|+++||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999954 35899999999999999999999 777 99999999999999999999999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhcccC------CCCchhhhHHHHHHHHHHHhC----------CCCC
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVFLELLTG----------MQPI 719 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwS~G~~l~elltg----------~~pf 719 (843)
||+|+........ .........||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 157 fg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999765432210 01112234699999999999876 455789999999999999999 8888
Q ss_pred CCCcc---hHHHHHHHhhcccchhhccCCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 720 SHGKN---IVREVNIAYQSSMMFSVIDGNMGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 720 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
..... ......... ......... +..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVV-------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHH-------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHH-------hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 64321 112121111 111112222 346788999999999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=352.55 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=198.4
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 584 (843)
..++|++.+.||+|+||+||+|... +++.||+|++.... .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3568999999999999999999975 79999999987542 33456788999999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC--------------
Q 003158 585 VYEFMSNGTLRDQLSAKS--KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------------- 648 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-------------- 648 (843)
||||+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997642 245899999999999999999999999 9999999999999844
Q ss_pred -----CcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 649 -----FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 649 -----~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 479999999998754321 23489999999999875 5678999999999999999998776433
Q ss_pred cchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccC
Q 003158 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINS 802 (843)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~ 802 (843)
... . .+..+.....+..++ ....+++.+
T Consensus 235 ~~~-~------------~~~~~~~~~~~~~~~---------------------------------------~~~~~li~~ 262 (289)
T 1x8b_A 235 DQW-H------------EIRQGRLPRIPQVLS---------------------------------------QEFTELLKV 262 (289)
T ss_dssp HHH-H------------HHHTTCCCCCSSCCC---------------------------------------HHHHHHHHH
T ss_pred hHH-H------------HHHcCCCCCCCcccC---------------------------------------HHHHHHHHH
Confidence 211 0 011111111111111 222356777
Q ss_pred CCCCCCCCCCCCccCCCCCcccCC
Q 003158 803 EHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 803 ~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
||..||++|||++|+++||||.+.
T Consensus 263 ~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 263 MIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTCSSGGGSCCHHHHHTCTTC---
T ss_pred HhCCCcccCCCHHHHhhChHhhhh
Confidence 788888899999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=374.61 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=195.6
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHhccCCcccceeeeeec
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 578 (843)
...++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45689999999999999999999965 689999999875321 112357899999999999999999999864
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---cEEEee
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAKVAD 655 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~D 655 (843)
+..++||||+++|+|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 4589999999999999988654 45899999999999999999999999 99999999999997544 599999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHH
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 732 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~ 732 (843)
||+|+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 286 FG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--- 354 (419)
T 3i6u_A 286 FGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--- 354 (419)
T ss_dssp SSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH---
T ss_pred cccceecCCC--------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH---
Confidence 9999875422 22344579999999999864 667889999999999999999999997543211000
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~ 812 (843)
..+......++.+. ++.....+.+|+.+||..||++||
T Consensus 355 -------~~i~~~~~~~~~~~-----------------------------------~~~~~~~~~~li~~~L~~dP~~Rp 392 (419)
T 3i6u_A 355 -------DQITSGKYNFIPEV-----------------------------------WAEVSEKALDLVKKLLVVDPKARF 392 (419)
T ss_dssp -------HHHHTTCCCCCHHH-----------------------------------HTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred -------HHHhcCCCCCCchh-----------------------------------hcccCHHHHHHHHHHccCChhHCc
Confidence 00000001111100 011223344788889999999999
Q ss_pred CCccCCCCCcccCC
Q 003158 813 SSSSMLKHPYVSSD 826 (843)
Q Consensus 813 sa~e~L~Hp~f~~~ 826 (843)
|++|+|+||||+..
T Consensus 393 s~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 393 TTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHSGGGCCH
T ss_pred CHHHHhCCcccCCh
Confidence 99999999999764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=354.80 Aligned_cols=269 Identities=27% Similarity=0.412 Sum_probs=214.5
Q ss_pred CCCCCcccccCCeeEEEEEeC-----CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecC--CcEEE
Q 003158 513 FNSSTQIGQGGYGKVYKGILP-----DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GEQML 584 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 584 (843)
|++.+.||+|+||+||++.+. +++.||||++..... ...+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 388899999999999998752 588999999986432 3456789999999999999999999999764 57899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999654 3889999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHH----Hhhcccchh
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI----AYQSSMMFS 740 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~----~~~~~~~~~ 740 (843)
... .........++..|+|||++.+..++.++|||||||++|||++|+.||............ ......+..
T Consensus 187 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 187 GHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp TCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 221 012233455788899999999999999999999999999999999998653221100000 000000111
Q ss_pred -hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 741 -VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 741 -~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
+........+..++..+.+++..||+.+|.+||++.++++.|+.+.+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 222333455677788999999999999999999999999999998876544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.63 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=210.1
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
..++|.+.+.||+|+||+||+|.+.+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35688899999999999999998542 3469999988653 3446789999999999999999999999875 4568
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 45889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ .. .+.
T Consensus 165 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-~~---------~~~ 228 (281)
T 3cc6_A 165 DED------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-IG---------VLE 228 (281)
T ss_dssp --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-HH---------HHH
T ss_pred ccc------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-HH---------HHh
Confidence 322 111233457789999999999999999999999999999998 9999975433211 10 111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.+.....+..+++.+.+++.+||..+|.+||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1222334556678899999999999999999999999999987653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=355.62 Aligned_cols=201 Identities=24% Similarity=0.428 Sum_probs=174.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
..++|.+.+.||+|+||+||+|... +|+.||+|++........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567999999999999999999975 799999999986555455678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE---cCCCcEEEeeccccccCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~ 664 (843)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++ ++++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999987643 4889999999999999999999999 9999999999999 7889999999999975432
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 162 G---------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp B---------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred C---------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 1233468999999999999999999999999999999999999997543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=363.14 Aligned_cols=263 Identities=31% Similarity=0.510 Sum_probs=202.5
Q ss_pred CCCCCCcccccCCeeEEEEEeC--CC--cEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeee-cCCcEEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD-EEGEQMLV 585 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV 585 (843)
.|+..+.||+|+||+||+|.+. ++ ..||||.+.... ....+++.+|+.++++++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4666789999999999999863 22 468999987533 334578999999999999999999999875 45688999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999654 345788999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
... .........+++.|+|||.+.+..++.++|||||||++|||++ |..||....... . ...+..+
T Consensus 246 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~---------~~~~~~~ 312 (373)
T 3c1x_A 246 EFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-I---------TVYLLQG 312 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-H---------HHHHHTT
T ss_pred ccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-H---------HHHHHcC
Confidence 211 1112234457889999999999999999999999999999999 666775433211 1 1112223
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
.....|..++..+.+++.+||+.+|.+||++.++++.|+.+...+..
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 33344666778899999999999999999999999999999876653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=358.44 Aligned_cols=273 Identities=27% Similarity=0.389 Sum_probs=217.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeee--cCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~ 582 (843)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46788999999999999999984 368899999998776666778999999999999999999999886 45678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999997643 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHH-HH----hhccc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVN-IA----YQSSM 737 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~-~~----~~~~~ 737 (843)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .....
T Consensus 178 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ccCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 432210 1122334578889999999999999999999999999999999999864322110000 00 00001
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
...+..+.....+..+++.+.+++..||+.+|.+||++.++++.|+.+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11222333445567788899999999999999999999999999999866443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.70 Aligned_cols=254 Identities=31% Similarity=0.518 Sum_probs=207.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhh-------HHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQG-------EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
.++|++.+.||+|+||+||+|.. .+++.||+|++....... .+++.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788899999999999999996 478999999986533221 167899999999999999999999997654
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc-----EEEeec
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT-----AKVADF 656 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~Df 656 (843)
++||||+++|+|.+++... ..++++..++.++.|+++||+|||+++ ++|+||||||+||+++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999999988654 346899999999999999999999875 45999999999999988776 999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhcc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhh
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~ 734 (843)
|+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..............
T Consensus 174 g~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~- 242 (287)
T 4f0f_A 174 GLSQQSVH----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI- 242 (287)
T ss_dssp TTCBCCSS----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH-
T ss_pred Cccccccc----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH-
Confidence 99975321 234456999999999994 45678899999999999999999999976543221111111
Q ss_pred cccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
.........+..+++.+.+++..||+.+|.+||++.++++.|++
T Consensus 243 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 ------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11122334566778899999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.35 Aligned_cols=263 Identities=31% Similarity=0.487 Sum_probs=209.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeCC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeee-ecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~l 584 (843)
.+|++.+.||+|+||+||+|...+ +..||+|.+.... ....+.+.+|++++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467888999999999999998642 2368999987543 33457889999999999999999999986 45668899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999653 345788999999999999999999999 99999999999999999999999999986643
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhC-CCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG-MQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.... .........+|+.|+|||.+.+..++.++|||||||++|||++| ..||..... .+... .+..
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~---------~~~~ 247 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV---------YLLQ 247 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHH---------HHHT
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHH---------HHhc
Confidence 2211 11223445678899999999999999999999999999999995 445543322 11111 1222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
+.....+..++..+.+++..||+.+|.+||++.++++.|+++.+.+.
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 23333455667789999999999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.25 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=214.5
Q ss_pred HcCCCCCC-cccccCCeeEEEEEeC---CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 510 TNNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
.++|.+.+ .||+|+||.||+|.+. +++.||||++.... ....+++.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566666 8999999999999853 57889999998643 33457899999999999999999999999 4567999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999653 345899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+..
T Consensus 163 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~---------~i~~ 228 (287)
T 1u59_A 163 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMA---------FIEQ 228 (287)
T ss_dssp CSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHH---------HHHT
T ss_pred Ccce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HHH---------HHhc
Confidence 2210 111223346889999999998899999999999999999999 999997654321 111 1222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
+.....+..+++.+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 2334456677889999999999999999999999999999986643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=363.02 Aligned_cols=270 Identities=15% Similarity=0.172 Sum_probs=209.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeCC---------CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccc----------
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVS---------- 571 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------- 571 (843)
++|++.+.||+|+||+||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 678999999999999999999753 789999998753 36788999999999999998
Q ss_pred -----eeeeeec-CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE
Q 003158 572 -----LVGYCDE-EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL 645 (843)
Q Consensus 572 -----l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl 645 (843)
+++++.. ++..++||||+ +++|.+++.......+++..++.++.||++||+|||+++ |+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 5666655 67889999999 999999998764467999999999999999999999999 9999999999999
Q ss_pred cCCC--cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 646 DHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 646 ~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
+.++ .+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 99999999998764322111101112234479999999999999999999999999999999999999997643
Q ss_pred chHHHHHHHhhc--ccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 724 NIVREVNIAYQS--SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 724 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
............ .......... .....+++.+.+++..||+.+|.+||++.++++.|+.+.+....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPC--GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTT--SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHhccCChhhhhhhc--cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 212211111100 0000000000 00123457899999999999999999999999999999876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=348.83 Aligned_cols=254 Identities=30% Similarity=0.451 Sum_probs=205.9
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec-CCcEEEEEe
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYE 587 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e 587 (843)
..++|++.+.||+|+||+||+|.. +|+.||||++.... ..+.+.+|+++++.++||||+++++++.+ .+..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 356889999999999999999987 48899999997543 45678999999999999999999999754 457899999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|+|.+++.......+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997654445788899999999999999999999 999999999999999999999999998754321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... .. ..+..+..
T Consensus 171 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~---------~~~~~~~~ 232 (278)
T 1byg_A 171 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VV---------PRVEKGYK 232 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HH---------HHHTTTCC
T ss_pred --------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HH---------HHHhcCCC
Confidence 123357889999999999999999999999999999998 999997543211 11 11222223
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
...+..+++.+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 345666778899999999999999999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.27 Aligned_cols=285 Identities=24% Similarity=0.350 Sum_probs=211.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecC-----CcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 582 (843)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999965 68899999997533 33347789999999999999999999998654 468
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 6999999653 4889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ . ..
T Consensus 179 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~------~~ 247 (364)
T 3qyz_A 179 DPDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI-L------GI 247 (364)
T ss_dssp CGGGCB----CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH-H------HH
T ss_pred CCCCCc----cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH-H------HH
Confidence 422110 111234579999999998765 55899999999999999999999999765432211111 0 00
Q ss_pred ccCCCCCCCHHHHHHHHHHH-HHhcccCCC-CCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLA-LKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~-~~c~~~~p~-~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
.+..+.+....+.... .......|. .+.... ...+..+..+.+|+.+||..||++|||++|+|+
T Consensus 248 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 ----LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN----------RLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp ----HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH----------HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHH----------HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111222111110000 000011111 111111 122334455678999999999999999999999
Q ss_pred CCcccCC
Q 003158 820 HPYVSSD 826 (843)
Q Consensus 820 Hp~f~~~ 826 (843)
||||+..
T Consensus 314 hp~~~~~ 320 (364)
T 3qyz_A 314 HPYLEQY 320 (364)
T ss_dssp SGGGTTT
T ss_pred Ccchhhc
Confidence 9999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=351.78 Aligned_cols=269 Identities=25% Similarity=0.402 Sum_probs=211.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-----CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecC--Cc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE--GE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 581 (843)
..+|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688899999999999999984 368999999997543 23357889999999999999999999999776 67
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999996543 35889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh-----hcc
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY-----QSS 736 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~-----~~~ 736 (843)
...... .........||..|+|||.+.+..++.++|||||||++|||++|+.|+.............. ...
T Consensus 176 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 176 IETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CCTTCC----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccCCCc----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 653321 01222345678889999999999999999999999999999999998643211100000000 000
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
....+..+.....+..+++.+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 01122223334456677889999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=361.37 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=207.7
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHhc-cCCccccee
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRL-HHRNLVSLV 573 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l~ 573 (843)
.......++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344555678999999999999999999975 799999999875431 1135678999999999 799999999
Q ss_pred eeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEE
Q 003158 574 GYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKV 653 (843)
Q Consensus 574 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 653 (843)
+++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999764 35889999999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhccc------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHH
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR 727 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~ 727 (843)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 242 ~DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 312 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL- 312 (365)
T ss_dssp CCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred EecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-
Confidence 9999998664321 1234569999999999864 357889999999999999999999997543211
Q ss_pred HHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCC
Q 003158 728 EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSK 807 (843)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~d 807 (843)
.... +..+.. ++.... +......+.+++.+||..|
T Consensus 313 ~~~~---------i~~~~~-------------------------~~~~~~-----------~~~~~~~~~~li~~~L~~d 347 (365)
T 2y7j_A 313 MLRM---------IMEGQY-------------------------QFSSPE-----------WDDRSSTVKDLISRLLQVD 347 (365)
T ss_dssp HHHH---------HHHTCC-------------------------CCCHHH-----------HSSSCHHHHHHHHHHSCSS
T ss_pred HHHH---------HHhCCC-------------------------CCCCcc-----------cccCCHHHHHHHHHHcCCC
Confidence 1100 000000 000000 0111223346888899999
Q ss_pred CCCCCCCccCCCCCccc
Q 003158 808 EETPPSSSSMLKHPYVS 824 (843)
Q Consensus 808 p~~R~sa~e~L~Hp~f~ 824 (843)
|++|||++|+|+||||+
T Consensus 348 P~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 348 PEARLTAEQALQHPFFE 364 (365)
T ss_dssp TTTSCCHHHHHHSGGGC
T ss_pred hhHCcCHHHHhcCcccC
Confidence 99999999999999996
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=359.40 Aligned_cols=288 Identities=21% Similarity=0.318 Sum_probs=210.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEe--CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCc------ccceeeeeecCCc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL--PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN------LVSLVGYCDEEGE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 581 (843)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 36899999999753 344567889999999987665 9999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC--------------
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-------------- 647 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------------- 647 (843)
.++||||+ +++|.+++......++++..++.++.|+++||+|||+++ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 899999998876667899999999999999999999999 999999999999987
Q ss_pred -----CCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 648 -----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 648 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999864321 23346899999999999999999999999999999999999999765
Q ss_pred cchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh----hhCC---CCCCC
Q 003158 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW----NMMP---ESDTK 795 (843)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~----~~~~---~~~~~ 795 (843)
..... .... ... .+..|......... ...+..+...-+............. .... ...+.
T Consensus 238 ~~~~~-~~~~------~~~----~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 238 DSKEH-LAMM------ERI----LGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304 (339)
T ss_dssp CHHHH-HHHH------HHH----HCSCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred ChHHH-HHHH------HHH----hCCCCHHHHhhccc--hhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence 43221 1110 000 11122222111000 0000000000000000111111100 0000 00122
Q ss_pred CCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 796 TPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 796 ~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+.+|+.+||..||++|||++|+++||||..
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred HHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 347999999999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=350.39 Aligned_cols=261 Identities=27% Similarity=0.391 Sum_probs=211.7
Q ss_pred HHHcCCCCCC-cccccCCeeEEEEEe---CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 508 LATNNFNSST-QIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 508 ~~~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
...++|.+.+ .||+|+||+||+|.+ .+++.||||++..... ...+++.+|+++++.++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788877 999999999999964 2478999999975432 2256799999999999999999999999 5678
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 899999999999999997643 4889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ... .
T Consensus 167 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~--------~ 232 (291)
T 1xbb_A 167 LRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTA--------M 232 (291)
T ss_dssp CCTTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH--------H
T ss_pred eccCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH--------H
Confidence 6433210 111223446788999999999889999999999999999999 999997654321 111 1
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
+..+.....+..+++.+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 233 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 122233445667788999999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.73 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=199.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCc----
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE---- 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 581 (843)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 5789999999976432 234578899999999999999999999876543
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+++|+|.+++.... ++++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999997653 5889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||............ ........
T Consensus 166 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~- 239 (311)
T 3ork_A 166 IADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDPIPP- 239 (311)
T ss_dssp --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHCCCCCH-
T ss_pred ccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCCCc-
Confidence 5432110 11223456899999999999999999999999999999999999999765432221111 11100000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHhh
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVM-RELESIW 786 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl-~~L~~~~ 786 (843)
......++.++.+++.+||+.+|.+||+..+++ +.+....
T Consensus 240 -----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 -----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 001223567889999999999999999766554 4554443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.21 Aligned_cols=262 Identities=27% Similarity=0.485 Sum_probs=201.9
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+..++|++.+.||+|+||+||+|...+ .||||+++... ....+.+.+|+++++.++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 345789999999999999999998643 59999987543 33456789999999999999999999966 45678999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999999654 345889999999999999999999999 999999999999999999999999999765422
Q ss_pred CCCCcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
. .........||+.|+|||.+. +..++.++|||||||++|||++|+.||............. ... ..
T Consensus 174 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~----~~ 243 (289)
T 3og7_A 174 S-----GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-GRG----SL 243 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH-HHT----SC
T ss_pred c-----ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh-ccc----cc
Confidence 1 112223456899999999997 5678889999999999999999999998655433322221 111 11
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
..........+++.+.+++..||+.+|.+||++.++++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 12222334567788999999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=350.74 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=208.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CC-------cEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DG-------TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
.++|.+.+.||+|+||+||+|... ++ ..||+|++........+.+.+|+++++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457888999999999999999864 33 5799999987666667889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc--------EEE
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT--------AKV 653 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl 653 (843)
.++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997643 34888999999999999999999999 999999999999998887 999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHH
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 732 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~ 732 (843)
+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.............
T Consensus 163 ~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp CCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 99999875431 123458899999999987 778999999999999999999666555443332222211
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.. ....+...+.++.+++..||+.+|.+||++.++++.|+++..
T Consensus 232 ~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 ED-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HT-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hc-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 10 112233335678899999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.31 Aligned_cols=201 Identities=24% Similarity=0.306 Sum_probs=173.4
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CC-----cccceeeeeecCCc
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HR-----NLVSLVGYCDEEGE 581 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~ 581 (843)
..++|++.+.||+|+||+||+|... +++.||||++... .....++..|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999965 6889999999753 333567788999988885 55 49999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc--CCCCCEEeccCCCCcEEEc--CCCcEEEeecc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT--EADPPVFHRDIKASNILLD--HKFTAKVADFG 657 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~--~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfG 657 (843)
.++||||++ |+|.+++.......+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+|||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999995 699999987765678999999999999999999995 45 99999999999994 57889999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~ 724 (843)
+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 207 ~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 207 SSCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TCEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99875421 2335689999999999999999999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.32 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=198.8
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec----CCcEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQML 584 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 584 (843)
.|.+.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+++++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677788999999999999964 68899999987532 3345678999999999999999999998864 356899
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-CCCcEEEeeccccccCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAP 663 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~ 663 (843)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||||+||+++ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999764 34888999999999999999999875 4599999999999998 78999999999997543
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. ......||+.|+|||++. ..++.++|||||||++|||++|+.||...............
T Consensus 184 ~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (290)
T 1t4h_A 184 AS---------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--------- 244 (290)
T ss_dssp TT---------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------
T ss_pred cc---------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc---------
Confidence 21 223456899999999886 45899999999999999999999999765443322211100
Q ss_pred CCCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 744 GNMG-SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 744 ~~~~-~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
+... ..+. ...+.+.+++.+||..||++|||++|+|+|||
T Consensus 245 ~~~~~~~~~---------------------------------------~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 245 GVKPASFDK---------------------------------------VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp TCCCGGGGG---------------------------------------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cCCccccCC---------------------------------------CCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 0000 0000 01112336777788899999999999999999
Q ss_pred ccCC
Q 003158 823 VSSD 826 (843)
Q Consensus 823 f~~~ 826 (843)
|+++
T Consensus 286 f~~~ 289 (290)
T 1t4h_A 286 FQEE 289 (290)
T ss_dssp GC--
T ss_pred cccC
Confidence 9875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.49 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=169.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCC-------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------- 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------- 580 (843)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999976 799999999975433 34578999999999999999999999985543
Q ss_pred --------------------------------------------------cEEEEEecCCCCCHHHHHhhcCC-CCcchh
Q 003158 581 --------------------------------------------------EQMLVYEFMSNGTLRDQLSAKSK-EPLGFA 609 (843)
Q Consensus 581 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~ 609 (843)
..++||||+++|+|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999976543 234555
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc-----cceeeeeecccCC
Q 003158 610 MRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV-----PAHVSTVVKGTPG 684 (843)
Q Consensus 610 ~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~-----~~~~~~~~~gt~~ 684 (843)
.++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++........... .........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 68899999999999999999 999999999999999999999999999876543211000 0112234569999
Q ss_pred ccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCC
Q 003158 685 YLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719 (843)
Q Consensus 685 y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf 719 (843)
|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999986654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=375.68 Aligned_cols=197 Identities=17% Similarity=0.192 Sum_probs=163.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHH---HHHHhccCCccccee-------ee
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEI---QFLSRLHHRNLVSLV-------GY 575 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~ 575 (843)
.++|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+ ++++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 56999999998743 333457889999 455566899999998 55
Q ss_pred eecCC-----------------cEEEEEecCCCCCHHHHHhhcC-----CCCcchhHHHHHHHHHHHHHHHHhcCCCCCE
Q 003158 576 CDEEG-----------------EQMLVYEFMSNGTLRDQLSAKS-----KEPLGFAMRLSIALGSSRGILYLHTEADPPV 633 (843)
Q Consensus 576 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 633 (843)
+.+.+ ..++||||+ +|+|.+++.... ...+++..++.|+.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 54443 379999999 689999997632 123556888899999999999999999 9
Q ss_pred EeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC-----------CCCchhhh
Q 003158 634 FHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-----------KLTDKSDV 702 (843)
Q Consensus 634 iH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv 702 (843)
+||||||+|||++.++.+||+|||+|+... .......| +.|+|||++.+. .++.++||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999998532 12344567 999999999987 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCC
Q 003158 703 YSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 703 wS~G~~l~elltg~~pf~~ 721 (843)
|||||++|||++|+.||..
T Consensus 297 wSlG~il~elltg~~Pf~~ 315 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITK 315 (377)
T ss_dssp HHHHHHHHHHHHSSCCC--
T ss_pred HHHHHHHHHHHHCCCCCcc
Confidence 9999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=348.00 Aligned_cols=257 Identities=22% Similarity=0.355 Sum_probs=205.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|++.+.||+|+||+||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467899999999999999999976 6899999998754321 357899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC----cEEEeeccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 658 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGl 658 (843)
++||||+++++|.+++.... .+++..++.++.|+++||.|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999997643 5889999999999999999999999 99999999999998877 899999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ...
T Consensus 159 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~------- 222 (283)
T 3bhy_A 159 AHKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTN------- 222 (283)
T ss_dssp CEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH-------
T ss_pred ceeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHH-------
Confidence 98654221 12344689999999999999999999999999999999999999975432111 100
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
+.. .....+... .+.......+++.+||..||++|||++|++
T Consensus 223 --~~~-~~~~~~~~~-----------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 264 (283)
T 3bhy_A 223 --ISA-VNYDFDEEY-----------------------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264 (283)
T ss_dssp --HHT-TCCCCCHHH-----------------------------------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred --hHh-cccCCcchh-----------------------------------cccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 000 000011100 011122334788899999999999999999
Q ss_pred CCCcccC
Q 003158 819 KHPYVSS 825 (843)
Q Consensus 819 ~Hp~f~~ 825 (843)
+||||+.
T Consensus 265 ~h~~~~~ 271 (283)
T 3bhy_A 265 EHSWIKA 271 (283)
T ss_dssp HCHHHHH
T ss_pred hCHHHHH
Confidence 9999965
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.84 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=212.3
Q ss_pred CCCCCCcccccCCeeEEEEEeC-C---CcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcE-EEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-D---GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ-MLV 585 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lV 585 (843)
.|...+.||+|+||+||+|.+. + +..||+|++..... ...+.+.+|+++++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999853 2 33799999875433 3457889999999999999999999999766655 999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+.+|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999663 346889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
... .........+++.|+|||.+.+..++.++|||||||++|||++|..|+....+...... .+....
T Consensus 178 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~---------~~~~~~ 245 (298)
T 3pls_A 178 EYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH---------FLAQGR 245 (298)
T ss_dssp GGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH---------HHHTTC
T ss_pred ccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH---------HhhcCC
Confidence 110 11222345678899999999999999999999999999999996666654433222111 112222
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
....+..+++.+.+++..||+.+|.+||++.++++.|+.+.+.+..
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 3344556678899999999999999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.76 Aligned_cols=262 Identities=22% Similarity=0.324 Sum_probs=206.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999975 68999999987433 2345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998543 45889999999999999999999999 99999999999999999999999999976532210
Q ss_pred CCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
........|++.|+|||.+.+..+ +.++|||||||++|||++|+.||.............
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------- 221 (276)
T 2yex_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-------------- 221 (276)
T ss_dssp -----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH--------------
T ss_pred -----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh--------------
Confidence 111234568999999999988765 778999999999999999999997543211111100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
.. .....+.. +..+....+++.+||..||++|||++|+++||||+..
T Consensus 222 --------------~~-----~~~~~~~~--------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 222 --------------KE-----KKTYLNPW--------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp --------------HT-----TCTTSTTG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------------hh-----cccccCch--------------hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 00 00000000 0111223367888889999999999999999999875
Q ss_pred CC
Q 003158 827 VS 828 (843)
Q Consensus 827 ~~ 828 (843)
..
T Consensus 269 ~~ 270 (276)
T 2yex_A 269 LK 270 (276)
T ss_dssp CC
T ss_pred hh
Confidence 44
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=364.92 Aligned_cols=282 Identities=22% Similarity=0.319 Sum_probs=203.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCC------cEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------EQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 583 (843)
..+|++.+.||+|+||+||+|+..++..||+|++..... ...+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 347889999999999999999987777799998764322 2236999999999999999999985443 378
Q ss_pred EEEecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-CCCcEEEeeccccc
Q 003158 584 LVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSR 660 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~ 660 (843)
+||||++++ +.+.+.. .....+++..++.++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999764 4443332 23456889999999999999999999999 99999999999999 79999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ......
T Consensus 191 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~----- 256 (394)
T 4e7w_A 191 ILIAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIK----- 256 (394)
T ss_dssp ECCTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-----
T ss_pred cccCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-----
Confidence 764321 12345689999999999765 589999999999999999999999976553222 111110
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-HHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSM-SEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~-~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
. .+..+.+....... ...-..-|..++.. ..+ ..+...+.+.+|+.+||++||++|+|++|+|
T Consensus 257 -~----~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 257 -V----LGTPSREQIKTMNP--NYMEHKFPQIRPHPFSKV---------FRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp -H----HCCCCHHHHHHHCG--GGSSSCCCCCCCCCHHHH---------SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred -H----hCCCCHHHHHhhCh--hhhhhccccccCCcHHHh---------ccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 0 01111111111000 00001112222211 110 1122345567899999999999999999999
Q ss_pred CCCcccCCCCC
Q 003158 819 KHPYVSSDVSG 829 (843)
Q Consensus 819 ~Hp~f~~~~~~ 829 (843)
+||||++-...
T Consensus 321 ~hp~f~~~~~~ 331 (394)
T 4e7w_A 321 CHPFFDELRTG 331 (394)
T ss_dssp TSGGGSTTTSS
T ss_pred cChhhhhhccc
Confidence 99999875443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=354.28 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=199.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccC--CcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|+++++.++| +||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45788999999999999999998889999999987543 3334678999999999976 9999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||+ .+|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 588999999764 35888999999999999999999999 99999999999997 678999999999876432
Q ss_pred CCCCcccceeeeeecccCCccCchhccc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhh
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~ 734 (843)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+.......
T Consensus 161 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--- 232 (343)
T 3dbq_A 161 TT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA--- 232 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH---
T ss_pred cc-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH---
Confidence 21 112234579999999999975 67889999999999999999999999765443332222
Q ss_pred cccchhhccC-CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 735 SSMMFSVIDG-NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 735 ~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
.++. ....++...+..+.+++..||+.+|.+||++.++++.
T Consensus 233 ------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 1223344455678888899999999999999888764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=369.75 Aligned_cols=278 Identities=21% Similarity=0.289 Sum_probs=199.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecC------CcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE------GEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 583 (843)
.+|++.+.||+|+||+||+|++. +|+.||||++..... ...+|+++++.++||||++++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999975 699999999875322 234699999999999999999998432 2367
Q ss_pred EEEecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC-CcEEEeeccccc
Q 003158 584 LVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSR 660 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~ 660 (843)
+||||+++ ++.+.+.. .....+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999974 77776653 33456899999999999999999999999 9999999999999965 678999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ++.....
T Consensus 206 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~----- 271 (420)
T 1j1b_A 206 QLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIK----- 271 (420)
T ss_dssp ECCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-----
T ss_pred hcccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-----
Confidence 654321 12345689999999999765 78999999999999999999999997654322 2211110
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC-CCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM-PESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~-~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
. .+....+....+ .-......-|.... ..+...+ +...+.+.+||.+||++||++|+|++|+|
T Consensus 272 -~----lg~p~~~~~~~~------~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 272 -V----LGTPTREQIREM------NPNYTEFKFPQIKA-----HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp -H----HCSCCHHHHHHH------CSCCCCCCCCCCCC-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -H----hCCCCHHHHHhh------ChhhhhhccCccCC-----CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 0 011111111110 00000000010000 0000011 22334566899999999999999999999
Q ss_pred CCCcccCC
Q 003158 819 KHPYVSSD 826 (843)
Q Consensus 819 ~Hp~f~~~ 826 (843)
+||||..-
T Consensus 336 ~hp~f~~~ 343 (420)
T 1j1b_A 336 AHSFFDEL 343 (420)
T ss_dssp TSGGGGGG
T ss_pred CCHhhccc
Confidence 99999653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.87 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=205.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+... .....+++.+|+++++.++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 467899999999999999999964 444 3577777543 233467899999999999999999999999865 488
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+|+||+++|+|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997643 45889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......- ...+.
T Consensus 169 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------~~~~~ 233 (327)
T 3lzb_A 169 AEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------SSILE 233 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------HHHHH
T ss_pred Cccc-----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----------HHHHH
Confidence 3221 112233456788999999999999999999999999999999 9999976543111 01112
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+.....+..++..+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222334566677889999999999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=375.96 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=199.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999975 68999999987543 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC---CcEEEeeccccccCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLAP 663 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~ 663 (843)
||+++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.. +.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999887653 4889999999999999999999999 9999999999999764 459999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.. .......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....
T Consensus 191 ~~--------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~------------ 248 (494)
T 3lij_A 191 NQ--------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRK------------ 248 (494)
T ss_dssp TT--------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH------------
T ss_pred CC--------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH------------
Confidence 32 1223456999999999986 56899999999999999999999999754321 11110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
+........ .|. ++..++.+.+|+++||+.||++|||++|+|+||||
T Consensus 249 ----------------i~~~~~~~~---~~~--------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 249 ----------------VEKGKYTFD---SPE--------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp ----------------HHHTCCCCC---SGG--------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ----------------HHhCCCCCC---chh--------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 000000000 000 01112233478888999999999999999999999
Q ss_pred cC
Q 003158 824 SS 825 (843)
Q Consensus 824 ~~ 825 (843)
+.
T Consensus 296 ~~ 297 (494)
T 3lij_A 296 KE 297 (494)
T ss_dssp HH
T ss_pred cc
Confidence 65
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.41 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=208.7
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec---------
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--------- 578 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------- 578 (843)
..++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999975 79999999997543 356789999999999999999998854
Q ss_pred -------CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcE
Q 003158 579 -------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 651 (843)
Q Consensus 579 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 651 (843)
....++||||+++|+|.+++.......+++..++.++.|+++||.|||+++ |+||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 445899999999999999998765567899999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHH
Q 003158 652 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 731 (843)
Q Consensus 652 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~ 731 (843)
||+|||++....... ......|++.|+|||.+.+..++.++|||||||++|||++|..|+........
T Consensus 162 kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT---- 229 (284)
T ss_dssp EECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH----
T ss_pred EECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH----
Confidence 999999998764321 12334689999999999999999999999999999999999988743211111
Q ss_pred HhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
.+..+ ..+..++..+.+++.+||+.+|.+||++.++++.++.+.+..
T Consensus 230 --------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 --------DLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp --------HHHTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred --------Hhhcc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 01111 123344567889999999999999999999999999886543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=356.15 Aligned_cols=287 Identities=22% Similarity=0.359 Sum_probs=206.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeee-----------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----------- 577 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----------- 577 (843)
.++|++.+.||+|+||.||+|... +++.||+|++........+++.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367899999999999999999976 58999999998766666778999999999999999999999873
Q ss_pred ---cCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-CCCcEEE
Q 003158 578 ---EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKV 653 (843)
Q Consensus 578 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl 653 (843)
+....++||||++ |+|.+++.. .++++..++.++.|+++||+|||+++ |+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 699999954 35889999999999999999999999 99999999999997 5679999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHH
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 732 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~ 732 (843)
+|||+++....... .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 163 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~ 237 (320)
T 2i6l_A 163 GDFGLARIMDPHYS----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLI 237 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH
T ss_pred ccCccccccCCCcc----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 99999987542211 0112234457899999999876 6789999999999999999999999986553221 1111
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccC-CCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCC
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDE-TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETP 811 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~-p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R 811 (843)
.. ..+....+...++...+...+..+ ...+.... ...+.....+.+|+.+||+.||++|
T Consensus 238 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 238 LE----------SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT----------QLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HH----------HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHH----------HHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HH----------hcCCCchhhhhhhhhcCcccccccccCCCCChh----------HhcchhhHHHHHHHHHHcCCCcccc
Confidence 10 011122222222211100000000 00111111 1123334456689999999999999
Q ss_pred CCCccCCCCCcccCCCC
Q 003158 812 PSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 812 ~sa~e~L~Hp~f~~~~~ 828 (843)
||++|+|+||||+....
T Consensus 298 pt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 298 LTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CCHHHHHTSHHHHTTCC
T ss_pred CCHHHHhCCcccccccC
Confidence 99999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=363.69 Aligned_cols=275 Identities=22% Similarity=0.358 Sum_probs=206.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcE----
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ---- 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~---- 582 (843)
.++|.+.+.||+|+||+||+|... +|+.||||++.... ....+++.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888999999999999999964 68999999997542 23357789999999999999999999999876654
Q ss_pred --EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 583 --MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 583 --~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
++||||+. ++|.+++.. .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 689888732 3889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus 193 ~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~---- 257 (371)
T 4exu_A 193 HADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV---- 257 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH----
T ss_pred cccc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH----
Confidence 6432 1234568999999999987 788999999999999999999999997654322 22111100
Q ss_pred hhccCCCCCCCHHHHHH-----HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCC
Q 003158 740 SVIDGNMGSYPSECVEK-----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSS 814 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~-----l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa 814 (843)
. +..+.+.... ....... .....+....+ ..+..++.+.+|+.+||+.||++|||+
T Consensus 258 --~----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~ 318 (371)
T 4exu_A 258 --T----GVPGTEFVQKLNDKAAKSYIQS---LPQTPRKDFTQ----------LFPRASPQAADLLEKMLELDVDKRLTA 318 (371)
T ss_dssp --H----CCCCHHHHTTCSCHHHHHHHHH---SCCCCCCCHHH----------HSTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred --h----CCCcHHHHHHhhhhhhhhhhhc---cCCCcchhHHH----------hccccChHHHHHHHHHCCCChhhcCCH
Confidence 0 0111111111 0011111 11111222221 223445566789999999999999999
Q ss_pred ccCCCCCcccCC
Q 003158 815 SSMLKHPYVSSD 826 (843)
Q Consensus 815 ~e~L~Hp~f~~~ 826 (843)
+|+|+||||+.-
T Consensus 319 ~ell~hp~f~~~ 330 (371)
T 4exu_A 319 AQALTHPFFEPF 330 (371)
T ss_dssp HHHHTSGGGTTT
T ss_pred HHHhcCcccccC
Confidence 999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=376.69 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=204.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-------------hhHHHHHHHHHHHHhccCCcccceeee
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------------QGEKEFLTEIQFLSRLHHRNLVSLVGY 575 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 575 (843)
.++|.+.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 568999999999999999999965 689999999875332 224678999999999999999999999
Q ss_pred eecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC---cEE
Q 003158 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF---TAK 652 (843)
Q Consensus 576 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~k 652 (843)
+.+.+..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999987653 4889999999999999999999999 99999999999999776 699
Q ss_pred EeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHH
Q 003158 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 732 (843)
Q Consensus 653 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~ 732 (843)
|+|||+++..... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....
T Consensus 190 l~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~- 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKK- 258 (504)
T ss_dssp ECCCTTCEECCTT--------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-
T ss_pred EEECCCCEEcCCC--------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-
Confidence 9999999876432 1223456999999999987 46899999999999999999999999754321 11110
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~ 812 (843)
+..+. ..++. . .++..++.+.+|+++||+.||++||
T Consensus 259 --------i~~~~-~~~~~------------------------~-----------~~~~~s~~~~~li~~~L~~dp~~R~ 294 (504)
T 3q5i_A 259 --------VEKGK-YYFDF------------------------N-----------DWKNISDEAKELIKLMLTYDYNKRC 294 (504)
T ss_dssp --------HHHCC-CCCCH------------------------H-----------HHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred --------HHcCC-CCCCc------------------------c-----------ccCCCCHHHHHHHHHHcCCChhHCC
Confidence 00000 00110 0 0012233345788999999999999
Q ss_pred CCccCCCCCcccCCC
Q 003158 813 SSSSMLKHPYVSSDV 827 (843)
Q Consensus 813 sa~e~L~Hp~f~~~~ 827 (843)
|++|+|+||||+...
T Consensus 295 t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 295 TAEEALNSRWIKKYA 309 (504)
T ss_dssp CHHHHHTSHHHHHTC
T ss_pred CHHHHhcCHhhhhch
Confidence 999999999997644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=358.42 Aligned_cols=295 Identities=24% Similarity=0.352 Sum_probs=210.9
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe--CCCcEEEEEEeccCChh--hHHHHHHHHHHHHhc---cCCcccceeeeee----
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL--PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRL---HHRNLVSLVGYCD---- 577 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~---- 577 (843)
..++|++.+.||+|+||+||+|.. .+++.||+|++...... ....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 357899999999999999999997 46889999998643221 123566788777766 8999999999986
Q ss_pred -cCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeec
Q 003158 578 -EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 656 (843)
Q Consensus 578 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 656 (843)
.....++||||++ |+|.+++.......+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999997 69999998766667899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcc
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~ 736 (843)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 165 g~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~ 235 (326)
T 1blx_A 165 GLARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVI 235 (326)
T ss_dssp CSCCCCCGG--------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred cccccccCC--------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHc
Confidence 999765321 122345689999999999999999999999999999999999999976543221 11111000
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
. .+.....+... ......+.. ...+. +....+..+....+|+.+||..||++|||++|
T Consensus 236 ~-----~~~~~~~~~~~-----~~~~~~~~~--~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 293 (326)
T 1blx_A 236 G-----LPGEEDWPRDV-----ALPRQAFHS--KSAQP----------IEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293 (326)
T ss_dssp C-----CCCGGGSCTTC-----SSCGGGSCC--CCCCC----------GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred C-----CCCcccCcccc-----ccchhhhcc--cCcch----------hhhccccCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 0 00000000000 000000000 00000 01112223334457999999999999999999
Q ss_pred CCCCCcccCCCCCCccccccCC
Q 003158 817 MLKHPYVSSDVSGSNLVSGVIP 838 (843)
Q Consensus 817 ~L~Hp~f~~~~~~~~~~~~~~~ 838 (843)
+|+||||+........+....|
T Consensus 294 ~l~hp~~~~~~~~~~~~~~~~~ 315 (326)
T 1blx_A 294 ALSHPYFQDLERCKENLDSHLP 315 (326)
T ss_dssp HHTSGGGTTCCCCCCC------
T ss_pred HhcCccccccchhhhhhccCCC
Confidence 9999999876654444443333
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.74 Aligned_cols=259 Identities=20% Similarity=0.317 Sum_probs=189.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh-hH-HHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ-GE-KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++.+.||+|+||+||+|.. .+++.||+|++...... .. +.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999996 47999999999754322 22 33445555688889999999999999999999999
Q ss_pred ecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 587 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 587 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
||++ |+|.+++.. .....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 599888764 2345689999999999999999999998 8 9999999999999999999999999998654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhc----ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
.. .......||+.|+|||++ .+..++.++|||||||++|||++|+.||...............
T Consensus 162 ~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----- 228 (290)
T 3fme_A 162 DD--------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE----- 228 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH-----
T ss_pred cc--------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc-----
Confidence 32 112334689999999996 4567899999999999999999999999754332222211110
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
...... +.. ..+..+.+++.+||+.||++|||++|+++
T Consensus 229 ----~~~~~~-------------------~~~-------------------~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 229 ----EPSPQL-------------------PAD-------------------KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----SCCCCC-------------------CTT-------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----cCCCCc-------------------ccc-------------------cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000000 000 01112335777788888999999999999
Q ss_pred CCcccCCC
Q 003158 820 HPYVSSDV 827 (843)
Q Consensus 820 Hp~f~~~~ 827 (843)
||||+...
T Consensus 267 hp~f~~~~ 274 (290)
T 3fme_A 267 HPFFTLHE 274 (290)
T ss_dssp SHHHHHHH
T ss_pred CcccccCc
Confidence 99997543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=346.07 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=204.1
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEG---SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5788999999999999999996 47999999998753 2334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 587 EFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 587 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
||+++|+|.+++.. .....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999865 23456889999999999999999999999 99999999999999999999999999976542
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.............. ...
T Consensus 189 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~ 253 (310)
T 2wqm_A 189 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--------EQC 253 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH--------HTT
T ss_pred CC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh--------hcc
Confidence 21 112345689999999999999999999999999999999999999975432222111111 111
Q ss_pred CCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 745 NMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 745 ~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
.... .+..+++++.+++..||+.+|.+||++.++++.|+++....+
T Consensus 254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1121 224566789999999999999999999999999999876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=359.58 Aligned_cols=268 Identities=18% Similarity=0.168 Sum_probs=201.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCChhh-----------HHHHHHHHHHHHhccCCcccceee
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGSLQG-----------EKEFLTEIQFLSRLHHRNLVSLVG 574 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~l~~ 574 (843)
.++|.+.+.||+|+||+||+|... ++..||||+........ ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999999999999975 57889999987543211 134667888999999999999999
Q ss_pred eeec----CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-
Q 003158 575 YCDE----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF- 649 (843)
Q Consensus 575 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~- 649 (843)
++.. ....++||||+ +++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9977 67899999999 999999997654 6899999999999999999999999 99999999999999887
Q ss_pred -cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHH-
Q 003158 650 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR- 727 (843)
Q Consensus 650 -~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~- 727 (843)
.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643211111111122445799999999999999999999999999999999999999954221111
Q ss_pred --HHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 728 --EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 728 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
.......... ...+.... .+..+++++.+++..||+.+|.+||++.++++.|+...
T Consensus 270 ~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDEL-PQSVLKWA--PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHTT-THHHHHHS--CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhcccc-cHHHHhhc--cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111000 00000000 01135568999999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.74 Aligned_cols=271 Identities=25% Similarity=0.415 Sum_probs=215.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCC--cE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-----PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~ 582 (843)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|+++++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 368999999998766666778999999999999999999999986544 78
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997643 45889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHH------hhcc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA------YQSS 736 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~------~~~~ 736 (843)
...... ........++..|+|||.+.+..++.++|||||||++|||++|..|+............. ....
T Consensus 196 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 196 PQDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CSSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 532210 111223456778999999999889999999999999999999999886432111000000 0000
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
....+..+.....+..++.++.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0011122223345667788999999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=351.25 Aligned_cols=257 Identities=29% Similarity=0.483 Sum_probs=210.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcE--EEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTV--VAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 585 (843)
++|++.+.||+|+||.||+|... ++.. ||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999964 5664 4999887532 23346789999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcE
Q 003158 586 YEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 651 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 651 (843)
|||+++|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 246899999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHH
Q 003158 652 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVN 730 (843)
Q Consensus 652 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~ 730 (843)
||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 182 kL~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYE 252 (327)
T ss_dssp EECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH
T ss_pred EEcccCcCccccc--------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-HHHH
Confidence 9999999974321 111233457889999999999889999999999999999998 99999765421 1111
Q ss_pred HHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 731 IAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.+..+.....+..+++.+.+++.+||..+|.+||++.++++.|+.+...
T Consensus 253 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 ---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1222223344556778899999999999999999999999999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=356.50 Aligned_cols=294 Identities=21% Similarity=0.299 Sum_probs=209.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecC-----CcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE-----GEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 582 (843)
.++|++.+.||+|+||+||+|... +|+.||||++.... .....++.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468899999999999999999975 68999999997533 33356788999999999999999999988654 678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6999998753 5889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcc---cceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 663 PVPDIEGIV---PAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 663 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
......... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCC
Confidence 532211100 0011233568999999998865 7789999999999999999999999976543221 1111100000
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
. ..+......... ...+.+.. +...+ +.... ...+...+.+.+++.+||..||++|||++|+|
T Consensus 242 ~-~~~~~~~~~~~~---~~~~~~~~-~~~~~--~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 242 P-HSDNDLRCIESP---RAREYIKS-LPMYP--AAPLE----------KMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp C-CSTTTTTTCCCH---HHHHHHHT-SCCCC--CCCHH----------HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred C-chhccccccccc---hhhHHhhc-ccCCC--Ccchh----------hhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0 000000000000 01111110 00000 11111 12233445556899999999999999999999
Q ss_pred CCCcccCCCC
Q 003158 819 KHPYVSSDVS 828 (843)
Q Consensus 819 ~Hp~f~~~~~ 828 (843)
+||||+....
T Consensus 305 ~hp~~~~~~~ 314 (353)
T 2b9h_A 305 EHPYLQTYHD 314 (353)
T ss_dssp TSGGGTTTCC
T ss_pred cCccccccCC
Confidence 9999987544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.65 Aligned_cols=200 Identities=30% Similarity=0.461 Sum_probs=173.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999965 578999999864322 2246788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999997653 4889999999999999999999998 999999999999999999999999998654321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 163 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 2234568999999999999999999999999999999999999997543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.30 Aligned_cols=261 Identities=27% Similarity=0.447 Sum_probs=210.9
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
..++|++.+.||+|+||.||+|.+ .+++.||||++... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356899999999999999999984 24779999999754 33445688999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCC-----CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEE
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSK-----EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKV 653 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl 653 (843)
.++||||+++|+|.+++..... ..+++..++.++.|+++||.|||+++ |+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986532 35889999999999999999999999 999999999999994 446999
Q ss_pred eeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHH
Q 003158 654 ADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIA 732 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~ 732 (843)
+|||+++....... ........|++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 185 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~-- 256 (327)
T 2yfx_A 185 GDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLE-- 256 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH--
T ss_pred Cccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HHHH--
Confidence 99999975432211 111234457889999999999999999999999999999998 99999765421 1111
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+..+.....+..++..+.+++..||+.+|.+||++.++++.++.+..
T Consensus 257 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 -------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 122222334456677889999999999999999999999999998755
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=345.76 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=204.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---------hhhHHHHHHHHHHHHhcc-CCcccceeeeeec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---------LQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE 578 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 578 (843)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999975 68999999987542 112356789999999996 9999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999764 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcc------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHH
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIA 732 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~ 732 (843)
+....... ......|++.|+|||++. ...++.++|||||||++|||++|+.||........ ..
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~-- 239 (298)
T 1phk_A 171 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LR-- 239 (298)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH--
T ss_pred hhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-HH--
Confidence 98654321 123456899999999985 45688899999999999999999999975432111 00
Q ss_pred hhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC
Q 003158 733 YQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP 812 (843)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~ 812 (843)
.+........ .|.. +.......+++.+||..||++||
T Consensus 240 --------------------------~~~~~~~~~~---~~~~--------------~~~~~~l~~li~~~l~~dp~~Rp 276 (298)
T 1phk_A 240 --------------------------MIMSGNYQFG---SPEW--------------DDYSDTVKDLVSRFLVVQPQKRY 276 (298)
T ss_dssp --------------------------HHHHTCCCCC---TTTG--------------GGSCHHHHHHHHHHCCSSGGGSC
T ss_pred --------------------------HHhcCCcccC---cccc--------------cccCHHHHHHHHHHccCCcccCC
Confidence 0000000000 0000 00111233677888999999999
Q ss_pred CCccCCCCCcccCCC
Q 003158 813 SSSSMLKHPYVSSDV 827 (843)
Q Consensus 813 sa~e~L~Hp~f~~~~ 827 (843)
|++|+|+||||....
T Consensus 277 s~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 277 TAEEALAHPFFQQYV 291 (298)
T ss_dssp CHHHHTTSGGGCTTC
T ss_pred CHHHHHhChHhhhcc
Confidence 999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=360.04 Aligned_cols=275 Identities=21% Similarity=0.303 Sum_probs=210.9
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhh-----------------HHHHHHHHHHHHhccCCcccce
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQG-----------------EKEFLTEIQFLSRLHHRNLVSL 572 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~l 572 (843)
.++|++.+.||+|+||.||+|.. +++.||||++....... .+.+.+|+++++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 89999999987432211 1789999999999999999999
Q ss_pred eeeeecCCcEEEEEecCCCCCHHHH------HhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEE
Q 003158 573 VGYCDEEGEQMLVYEFMSNGTLRDQ------LSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILL 645 (843)
Q Consensus 573 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl 645 (843)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|+++||.|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 655445679999999999999999999999 88 9999999999999
Q ss_pred cCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCc-hhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 646 DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTD-KSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 646 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
+.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999865321 23445689999999999887 6666 9999999999999999999998655
Q ss_pred chHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCC
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSE 803 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~ 803 (843)
........... +. ...+..... .. .+...... ....+..+....+++.+|
T Consensus 257 ~~~~~~~~i~~---------~~-~~~~~~~~~--------~~--~~~~~~~~----------~~~~~~~~~~l~~li~~~ 306 (348)
T 2pml_X 257 SLVELFNNIRT---------KN-IEYPLDRNH--------FL--YPLTNKKS----------TCSNNFLSNEDIDFLKLF 306 (348)
T ss_dssp CSHHHHHHHTS---------CC-CCCCCSSSS--------ST--TTTCC------------------CCCHHHHHHHHHH
T ss_pred cHHHHHHHHhc---------cC-cCCccchhh--------hh--cccccccc----------ccchhhcCHHHHHHHHHH
Confidence 42222221111 00 001100000 00 00000000 000112233345789999
Q ss_pred CCCCCCCCCCCccCCCCCcccCCC
Q 003158 804 HTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 804 L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
|..||++|||++|+++||||.+..
T Consensus 307 L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 307 LRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccCChhhCCCHHHHhcCccccCCC
Confidence 999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.62 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=200.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||.||+|... +++.||+|++........+++.+|+++++.++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999975 5899999999876656677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++++|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--- 170 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999986533 35889999999999999999999999 999999999999999999999999987532110
Q ss_pred CcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
........||+.|+|||++. +..++.++|||||||++|||++|+.||........ ... ...
T Consensus 171 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~---------~~~ 236 (302)
T 2j7t_A 171 ----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLK---------IAK 236 (302)
T ss_dssp ----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH---------HHH
T ss_pred ----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHH---------Hhc
Confidence 11123346899999999984 56789999999999999999999999975432111 100 000
Q ss_pred CCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 744 GNMG--SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 744 ~~~~--~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
.... ..+..++ ....+++.+||..||++|||++|+++||
T Consensus 237 ~~~~~~~~~~~~~---------------------------------------~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 237 SDPPTLLTPSKWS---------------------------------------VEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp SCCCCCSSGGGSC---------------------------------------HHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred cCCcccCCccccC---------------------------------------HHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0000 0011111 1223567778888889999999999999
Q ss_pred cccCCCC
Q 003158 822 YVSSDVS 828 (843)
Q Consensus 822 ~f~~~~~ 828 (843)
||++...
T Consensus 278 ~~~~~~~ 284 (302)
T 2j7t_A 278 FVSSITS 284 (302)
T ss_dssp TTTTCCC
T ss_pred HHhhhcc
Confidence 9987554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.42 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=205.9
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc--cCCcccceeeeeecC--
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL--HHRNLVSLVGYCDEE-- 579 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~-- 579 (843)
.......++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334445679999999999999999999975 899999998642 233455566666554 899999999999776
Q ss_pred --CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC--------CCCCEEeccCCCCcEEEcCCC
Q 003158 580 --GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------ADPPVFHRDIKASNILLDHKF 649 (843)
Q Consensus 580 --~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------~~~~iiH~Dlkp~NILl~~~~ 649 (843)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||++ + |+||||||+|||++.++
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 6889999999999999999654 488999999999999999999998 6 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCch------hhhHHHHHHHHHHHhC--------
Q 003158 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDK------SDVYSLGVVFLELLTG-------- 715 (843)
Q Consensus 650 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwS~G~~l~elltg-------- 715 (843)
.+||+|||+++......... ........||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEV---DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp CEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CEEEEeCCCceeeccccccc---cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999997654322110 111124469999999999988766654 9999999999999999
Q ss_pred --CCCCCCCc---chHHHHHHHhhcccchhhccCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 716 --MQPISHGK---NIVREVNIAYQSSMMFSVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 716 --~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
..||.... ........... ........+ .++++++.+++.+||+.+|.+||++.++++.|+.+
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVC-------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHT-------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHHh-------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 66665321 11121211111 111122222 47889999999999999999999999999999998
Q ss_pred hhh
Q 003158 786 WNM 788 (843)
Q Consensus 786 ~~~ 788 (843)
.+.
T Consensus 330 ~~~ 332 (337)
T 3mdy_A 330 SES 332 (337)
T ss_dssp HHT
T ss_pred Hhh
Confidence 764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=376.63 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=207.1
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
..++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3568999999999999999999975 79999999986532 2346789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE---cCCCcEEEeecccccc
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRL 661 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~ 661 (843)
||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999998654 35899999999999999999999999 9999999999999 5678999999999986
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
..... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... +.... +
T Consensus 179 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~---------i 239 (484)
T 3nyv_A 179 FEASK--------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKK---------V 239 (484)
T ss_dssp BCCCC--------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH---------H
T ss_pred ccccc--------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHH---------H
Confidence 54321 2234569999999999876 6899999999999999999999999754421 11110 0
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
..+... + ..|. +...++.+.+|+.+||+.||++|||++|+|+||
T Consensus 240 ~~~~~~-~---------------------~~~~--------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 240 EKGKYT-F---------------------ELPQ--------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHCCCC-C---------------------CSGG--------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HcCCCC-C---------------------CCcc--------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 000000 0 0000 011122334788889999999999999999999
Q ss_pred cccCCC
Q 003158 822 YVSSDV 827 (843)
Q Consensus 822 ~f~~~~ 827 (843)
||+...
T Consensus 284 ~~~~~~ 289 (484)
T 3nyv_A 284 WIQTYT 289 (484)
T ss_dssp HHHHHT
T ss_pred hhcccc
Confidence 997643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=374.37 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=205.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
..++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3568999999999999999999975 78999999986422 22356789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc---CCCcEEEeeccccccC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLA 662 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~ 662 (843)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999987653 4889999999999999999999999 99999999999995 4567999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... +.... +.
T Consensus 175 ~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~---------i~ 235 (486)
T 3mwu_A 175 QQN--------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKR---------VE 235 (486)
T ss_dssp CCC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH---------HH
T ss_pred CCC--------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH---------HH
Confidence 432 12234569999999999876 5899999999999999999999999754321 11110 00
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
.+.. +...|.. ...++.+.+|+.+||+.||++|||++|+|+|||
T Consensus 236 ~~~~----------------------~~~~~~~--------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 236 TGKY----------------------AFDLPQW--------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HTCC----------------------CSCSGGG--------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred hCCC----------------------CCCCccc--------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 0000 0000100 111223347888899999999999999999999
Q ss_pred ccCCCC
Q 003158 823 VSSDVS 828 (843)
Q Consensus 823 f~~~~~ 828 (843)
|+....
T Consensus 280 ~~~~~~ 285 (486)
T 3mwu_A 280 IQKYSS 285 (486)
T ss_dssp HHHTCC
T ss_pred hccCcc
Confidence 976544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=344.86 Aligned_cols=270 Identities=19% Similarity=0.284 Sum_probs=207.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeee-ecCCcEEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVY 586 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV~ 586 (843)
..++|++.+.||+|+||+||+|.. .+++.||||++..... .+++.+|+++++.++|++++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 5789999998764322 23578899999999988877777766 5667889999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE---cCCCcEEEeeccccccCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~ 663 (843)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||++ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999997533 35899999999999999999999999 9999999999999 789999999999998765
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch--HHHHHHHhhcccchhh
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQSSMMFSV 741 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~ 741 (843)
........+........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~ 234 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-----K 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-----H
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc-----c
Confidence 44322211122334567999999999999999999999999999999999999999753221 0001000000 0
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
...........+++.+.+++..||+.+|.+||++.++++.|+++.....
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0000000112335789999999999999999999999999999877544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=353.78 Aligned_cols=272 Identities=23% Similarity=0.314 Sum_probs=204.8
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhccCCcccceeeeeec
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-----LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE 578 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 578 (843)
++....++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45567889999999999999999999964 68999999986432 2335688999999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhc--------------------------------------CCCCcchhHHHHHHHHHHH
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAK--------------------------------------SKEPLGFAMRLSIALGSSR 620 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 620 (843)
.+..++||||+++|+|.+++... ....+++..++.++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 0123467788899999999
Q ss_pred HHHHHhcCCCCCEEeccCCCCcEEEcCCC--cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc--CCC
Q 003158 621 GILYLHTEADPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKL 696 (843)
Q Consensus 621 aL~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 696 (843)
||+|||+++ |+||||||+||+++.++ .+||+|||+++........ .........||+.|+|||++.+ ..+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchhhccCCCCC
Confidence 999999999 99999999999998776 8999999999865322111 0112345569999999999975 678
Q ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 003158 697 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMS 776 (843)
Q Consensus 697 ~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~ 776 (843)
+.++|||||||++|||++|+.||........ .... ...... ...|..
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~---------~~~~~~----------------------~~~~~~- 300 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQV---------LNKKLC----------------------FENPNY- 300 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------HHCCCC----------------------TTSGGG-
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHH---------Hhcccc----------------------cCCccc-
Confidence 9999999999999999999999976543211 1110 000000 000100
Q ss_pred HHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 777 EVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 777 ~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
....+.+.+++.+||..||++|||++|+|+||||++-..
T Consensus 301 -------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 301 -------------NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp -------------GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred -------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 001122335777788888888888889999999977543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=379.75 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=205.1
Q ss_pred CcccccCCeeEEEEEeC---CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILP---DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
+.||+|+||+||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 468899999975432 335789999999999999999999999964 568999999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+........
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---
Confidence 9999999754 35889999999999999999999999 999999999999999999999999999876432211
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. ..+..+.....|
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~--------~~i~~~~~~~~p 594 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT--------AMLEKGERMGCP 594 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH--------HHHHTTCCCCCC
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH--------HHHHcCCCCCCC
Confidence 112233456789999999999999999999999999999998 999997654321 11 122223344556
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
..+++++.+++..||+.+|++||++.++++.|+++..
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 7788999999999999999999999999999998765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=350.96 Aligned_cols=269 Identities=24% Similarity=0.392 Sum_probs=201.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHH--HHhccCCcccceeeeee-----cCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQF--LSRLHHRNLVSLVGYCD-----EEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~-----~~~~~ 582 (843)
.++|++.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46889999999999999999987 68999999997432 2334444444 55589999999998553 23367
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC---------CCCCEEeccCCCCcEEEcCCCcEEE
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE---------ADPPVFHRDIKASNILLDHKFTAKV 653 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------~~~~iiH~Dlkp~NILl~~~~~~kl 653 (843)
++||||+++|+|.+++.... .++..++.++.||++||+|||+. + |+||||||+|||++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 89999999999999996643 47888999999999999999998 7 999999999999999999999
Q ss_pred eeccccccCCCCCCCCc-ccceeeeeecccCCccCchhccc-------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcch
Q 003158 654 ADFGLSRLAPVPDIEGI-VPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 725 (843)
Q Consensus 654 ~DfGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~ 725 (843)
+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653221110 01122234569999999999987 35667899999999999999998887643321
Q ss_pred H----------------HHHHHHhhcccchhhccCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 726 V----------------REVNIAYQSSMMFSVIDGNMG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 726 ~----------------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
. ........... ..+..+ .....+++.+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 0 00100000000 001111 113357788999999999999999999999999999998
Q ss_pred hhCCCC
Q 003158 787 NMMPES 792 (843)
Q Consensus 787 ~~~~~~ 792 (843)
..+...
T Consensus 318 ~~~~~~ 323 (336)
T 3g2f_A 318 MIWERN 323 (336)
T ss_dssp HCCCC-
T ss_pred HHHHhc
Confidence 776544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.20 Aligned_cols=297 Identities=22% Similarity=0.272 Sum_probs=200.0
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCc-
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE- 581 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~- 581 (843)
.......++|++.+.||+|+||+||+|... +++.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999974 68999999986532 223456778888999999999999999865433
Q ss_pred ------EEEEEecCCCCCHHHHHhh--cCCCCcchhHHHHHHHHHHHHHHHHh--cCCCCCEEeccCCCCcEEEcC-CCc
Q 003158 582 ------QMLVYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILYLH--TEADPPVFHRDIKASNILLDH-KFT 650 (843)
Q Consensus 582 ------~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~iiH~Dlkp~NILl~~-~~~ 650 (843)
.++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999975 66555443 23456888999999999999999999 888 999999999999997 899
Q ss_pred EEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHH
Q 003158 651 AKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 729 (843)
Q Consensus 651 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~ 729 (843)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ .
T Consensus 171 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~ 241 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-L 241 (360)
T ss_dssp EEECCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H
T ss_pred EEEeeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-H
Confidence 9999999998764322 123456899999999997654 89999999999999999999999976543221 1
Q ss_pred HHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCC
Q 003158 730 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEE 809 (843)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~ 809 (843)
..... . .+..+.+....+..-. .........+.....+. ..........+.+|+.+||+.||+
T Consensus 242 ~~~~~------~----~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~ 304 (360)
T 3e3p_A 242 HEIVR------V----LGCPSREVLRKLNPSH-TDVDLYNSKGIPWSNVF------SDHSLKDAKEAYDLLSALLQYLPE 304 (360)
T ss_dssp HHHHH------H----HCCCCHHHHHHHCTTC-CCGGGGCCCCCCHHHHT------TTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred HHHHH------H----cCCCCHHHHHhcccch-hhccccccccCCccccc------chhhccccHHHHHHHHHHhccCcc
Confidence 11100 0 0111121111110000 00000000111111110 001111223456899999999999
Q ss_pred CCCCCccCCCCCcccCCCCCCc
Q 003158 810 TPPSSSSMLKHPYVSSDVSGSN 831 (843)
Q Consensus 810 ~R~sa~e~L~Hp~f~~~~~~~~ 831 (843)
+|||++|+|+||||++......
T Consensus 305 ~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 305 ERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp GSCCHHHHTTSGGGGGGGCTTC
T ss_pred ccCCHHHHhcCccccccCCccc
Confidence 9999999999999987655433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.61 Aligned_cols=270 Identities=19% Similarity=0.279 Sum_probs=211.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeee-ecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|.. .+++.||||++..... .+++.+|+++++.++|++++..+.++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999996 5799999999875432 24688999999999998877776666 55677899999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE---cCCCcEEEeeccccccCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~ 664 (843)
|+ +++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||++ ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999997433 46899999999999999999999999 9999999999999 5889999999999987654
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch--HHHHHHHhhcccchhhc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQSSMMFSVI 742 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 742 (843)
.......+........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... . ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~----~~ 235 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-K----KM 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH-H----HH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc-c----cc
Confidence 3322111112234567999999999999999999999999999999999999999753211 000000000 0 00
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
.......+..+++++.+++..||+.+|.+||++.++++.|+.+......
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0000001133457899999999999999999999999999998776543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=356.18 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=199.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcc--CCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.+|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|+++++.++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4689999999999999999998889999999987543 334578899999999996 599999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
| +.+++|.+++.... .+++..++.++.||++||.|||+++ |+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 55889999997654 5788889999999999999999999 99999999999996 5899999999998764321
Q ss_pred CCCcccceeeeeecccCCccCchhccc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~ 735 (843)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+.......
T Consensus 209 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~---- 279 (390)
T 2zmd_A 209 T-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---- 279 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH----
T ss_pred c-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH----
Confidence 1 112234569999999999975 36889999999999999999999999765443322222
Q ss_pred ccchhhccCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 736 SMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 736 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
++++.. ..++...+..+.+++..||+.+|.+||++.++++.
T Consensus 280 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 -----IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 222211 22344445678889999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=351.93 Aligned_cols=198 Identities=30% Similarity=0.504 Sum_probs=172.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.+.|+..+.||+|+||+||+|.. .+++.||||++..... ...+++.+|+++++.++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588899999999999999996 5799999999875432 2246789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+. |+|.+++.... .++++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99996 68888886533 46899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 207 ----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 207 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp ----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12346899999999985 5678999999999999999999999997654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=359.85 Aligned_cols=268 Identities=22% Similarity=0.268 Sum_probs=213.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCC--cEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG--EQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV 585 (843)
.++|.+.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357889999999999999999975 589999999975432 33567889999999999999999999997654 78999
Q ss_pred EecCCCCCHHHHHhhcC-CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE----cCCCcEEEeeccccc
Q 003158 586 YEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL----DHKFTAKVADFGLSR 660 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla~ 660 (843)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997643 234899999999999999999999999 9999999999999 788889999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcc---hHHHH
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN---IVREV 729 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~---~~~~~ 729 (843)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 165 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 165 ELEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCCG--------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EccCC--------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 65432 11234569999999999875 5677899999999999999999999964322 12222
Q ss_pred HHHhhccc---ch---hh---------ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 730 NIAYQSSM---MF---SV---------IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 730 ~~~~~~~~---~~---~~---------~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
........ +. .. ..+.....+......+.+++..||+.||++||++.++++.++++.+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 21111100 00 00 00111234578889999999999999999999999999999987653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.55 Aligned_cols=291 Identities=19% Similarity=0.281 Sum_probs=209.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CC-cEEEEEEeccCChhhHHHHHHHHHHHHhccCCc------ccceeeeeecCCc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DG-TVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN------LVSLVGYCDEEGE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 581 (843)
.++|++.+.||+|+||+||+|... ++ +.||+|++... ....+.+.+|+++++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999964 34 78999999753 344567889999999998766 8999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE----------------
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---------------- 645 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl---------------- 645 (843)
.++||||+ ++++.+++......++++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 678888887766567999999999999999999999998 9999999999999
Q ss_pred ---cCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 646 ---DHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 646 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999864321 23346899999999999999999999999999999999999999865
Q ss_pred cchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh----hhhCCC---CCCC
Q 003158 723 KNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI----WNMMPE---SDTK 795 (843)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~----~~~~~~---~~~~ 795 (843)
.......... .. .+..|.........- ..... ....-+........+... ...... ....
T Consensus 243 ~~~~~~~~~~-------~~----~~~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 243 ENREHLVMME-------KI----LGPIPSHMIHRTRKQ-KYFYK-GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp SHHHHHHHHH-------HH----HCCCCHHHHHHCSCG-GGEET-TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred CHHHHHHHHH-------HH----cCCCcHHHhhhccch-hhhcc-cccccccccchhccccccCCcccccccccchhHHH
Confidence 4322111100 00 112222221110000 00000 000000000000000000 000000 0113
Q ss_pred CCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 796 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 796 ~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+.+|+.+||..||++|||++|+|+||||.+...
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 447999999999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.46 Aligned_cols=200 Identities=28% Similarity=0.446 Sum_probs=168.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHhccCCcccceeeeeecC
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 579 (843)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999965 689999999875321 1124578999999999999999999998765
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc---EEEeec
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADF 656 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~Df 656 (843)
+ .++||||+++++|.+++... ..+++..++.++.||++||.|||+++ |+||||||+||+++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 89999999999999998653 45889999999999999999999999 999999999999987664 999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
|+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 162 g~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 162 GHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp TTCEECCCC--------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred ccceecccc--------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999865421 1123456899999999974 467889999999999999999999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.21 Aligned_cols=254 Identities=17% Similarity=0.211 Sum_probs=207.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEE------eCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc---CCcccceeeeeecC
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEE 579 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~ 579 (843)
..++|.+.+.||+|+||+||+|. ..+++.||||++.... ..++.+|+++++.++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678899999999999999994 3468999999997543 446777888888876 99999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhc---CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---------
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAK---SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--------- 647 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--------- 647 (843)
+..++||||+++|+|.+++... ....+++..++.++.||++||+|||+++ ||||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999752 3456999999999999999999999999 999999999999998
Q ss_pred --CCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch
Q 003158 648 --KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI 725 (843)
Q Consensus 648 --~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~ 725 (843)
++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFP-----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSC-----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred cccCCEEEeeCchhhhhhccC-----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997543211 123345567999999999999999999999999999999999999999643220
Q ss_pred HHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhh
Q 003158 726 VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDAR-PSMSEVMRELESIWNM 788 (843)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~R-Ps~~~vl~~L~~~~~~ 788 (843)
. ..+.......+ ..+.+.+++..|++.+|.+| |++.++.+.++++...
T Consensus 292 ---------~----~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 292 ---------E----CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ---------E----EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------c----eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 01111122222 24567788999999999988 6888888888888765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=345.74 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=203.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
-++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999965 6899999998754322 246789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.... ++++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997653 5889999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .......... ..
T Consensus 188 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~------~~ 253 (309)
T 2h34_A 188 K------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI------PR 253 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC------CC
T ss_pred c------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC------CC
Confidence 1 11223456899999999999999999999999999999999999999765432 1111111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhh
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 787 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~vl~~L~~~~~ 787 (843)
....+..++..+.+++.+||+.+|++|| ++.++++.|+....
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 1122445567889999999999999999 99999999988654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.94 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=209.2
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeee----cCCcEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD----EEGEQM 583 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~ 583 (843)
..++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 356899999999999999999996 579999999987666666778999999999999999999999986 345789
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 584 LVYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
+||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999763 3456899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCc--ccceeeeeecccCCccCchhcccCC---CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcc
Q 003158 662 APVPDIEGI--VPAHVSTVVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSS 736 (843)
Q Consensus 662 ~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~ 736 (843)
......... ..........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-----
Confidence 431100000 0000012345799999999997654 688999999999999999999998531100000000
Q ss_pred cchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 737 MMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
........+.+..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 259 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 ---AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp ---HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ---HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0111111222345667899999999999999999999999999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.68 Aligned_cols=201 Identities=26% Similarity=0.386 Sum_probs=171.1
Q ss_pred CCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 512 NFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
+|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355566899999999999996 4689999999987655556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcC-CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeeccccccCCCCCCC
Q 003158 591 NGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 591 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999997653 345678889999999999999999999 999999999999987 8999999999998654221
Q ss_pred CcccceeeeeecccCCccCchhcccCC--CCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
.......|++.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 178 -----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred -----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 1123456899999999997643 889999999999999999999999643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.98 Aligned_cols=290 Identities=17% Similarity=0.270 Sum_probs=207.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-----------CCcccceeeeee
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCD 577 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~ 577 (843)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999996 47899999999753 334567889999999886 899999999997
Q ss_pred cCC----cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEc------
Q 003158 578 EEG----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLD------ 646 (843)
Q Consensus 578 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~------ 646 (843)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 654 789999999 89999999876666789999999999999999999998 8 99999999999994
Q ss_pred CCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcch-
Q 003158 647 HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNI- 725 (843)
Q Consensus 647 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~- 725 (843)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4448999999999865421 23346899999999999999999999999999999999999999754321
Q ss_pred ----HHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCC-------CCCCCHHHHHHHHHHhhhhCCCCCC
Q 003158 726 ----VREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDET-------DARPSMSEVMRELESIWNMMPESDT 794 (843)
Q Consensus 726 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p-------~~RPs~~~vl~~L~~~~~~~~~~~~ 794 (843)
....... ... .+..|......-. ....++.... .......+++. ......+....
T Consensus 243 ~~~~~~~~~~~------~~~----~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 308 (373)
T 1q8y_A 243 YTKDDDHIAQI------IEL----LGELPSYLLRNGK-YTRTFFNSRGLLRNISKLKFWPLEDVLT---EKYKFSKDEAK 308 (373)
T ss_dssp --CHHHHHHHH------HHH----HCSCCHHHHHHCT-THHHHBCC--CBSSCCCCCBCCHHHHHH---HTTCCCHHHHH
T ss_pred cCChHHHHHHH------HHh----cCCCCHHHHhccc-hhhhhcCCcchhcccccccccchhhhhh---hcccCCcchHH
Confidence 1111100 000 1122222211100 0000111000 00111222211 11100011122
Q ss_pred CCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 795 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 795 ~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
.+.+||.+||+.||++|||++|+|+||||.+...
T Consensus 309 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred HHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 3457999999999999999999999999987543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=351.02 Aligned_cols=200 Identities=24% Similarity=0.374 Sum_probs=175.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhccCCcccceeeeeecC
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 579 (843)
..++|++.+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 357899999999999999999995 47899999998764321 223577899999999999999999999999
Q ss_pred CcEEEEEecCCCC-CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 580 GEQMLVYEFMSNG-TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 580 ~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9999996543 5889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 177 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 177 AAYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CEECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ceECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 98764322 2234569999999999998876 7899999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.75 Aligned_cols=207 Identities=27% Similarity=0.431 Sum_probs=173.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeee--cCCcEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD--EEGEQML 584 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~l 584 (843)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367889999999999999999975 68999999997543 334567899999999999999999999874 4678999
Q ss_pred EEecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCC--CCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 585 VYEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
||||+++++|.+++... ....+++..++.++.|+++||+|||+.+ ..+|+||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 3345899999999999999999999876 2349999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDT-------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---C-------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 654221 11223468999999999999999999999999999999999999997654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=359.18 Aligned_cols=259 Identities=10% Similarity=-0.010 Sum_probs=182.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc--cCCccccee-------eeee
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRL--HHRNLVSLV-------GYCD 577 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~~ 577 (843)
.+|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999965 789999999987543 2345677886555555 699988755 4443
Q ss_pred cC-----------------CcEEEEEecCCCCCHHHHHhhcCCCCcchhHH------HHHHHHHHHHHHHHhcCCCCCEE
Q 003158 578 EE-----------------GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMR------LSIALGSSRGILYLHTEADPPVF 634 (843)
Q Consensus 578 ~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~ii 634 (843)
.. ...++||||++ |+|.+++..... .+.+..+ ..++.||++||+|||+++ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 22 23799999998 899999976422 2455555 778899999999999999 99
Q ss_pred eccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHH
Q 003158 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLEL 712 (843)
Q Consensus 635 H~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~el 712 (843)
||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 999999999999999999999999986531 1224557799999999987 7799999999999999999
Q ss_pred HhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCC
Q 003158 713 LTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 792 (843)
Q Consensus 713 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~ 792 (843)
++|+.||........ ........... ...++.+. ..+..
T Consensus 287 ltg~~Pf~~~~~~~~--------~~~~~~~~~~~----------------------~~~~~~~~-----------~~~~~ 325 (371)
T 3q60_A 287 WCLFLPFGLVTPGIK--------GSWKRPSLRVP----------------------GTDSLAFG-----------SCTPL 325 (371)
T ss_dssp HHSSCSTTBCCTTCT--------TCCCBCCTTSC----------------------CCCSCCCT-----------TSSCC
T ss_pred HhCCCCCCCcCcccc--------cchhhhhhhhc----------------------cccccchh-----------hccCC
Confidence 999999975432100 00000000000 00000000 00111
Q ss_pred CCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 793 DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 793 ~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
++.+.+|+.+||..||++|||++|+|+||||+.
T Consensus 326 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 326 PDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 223346788888999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.60 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=204.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357889999999999999999975 688999999864321 2246789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++.... .+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999997653 4889999999999999999999999 999999999999999999999999998754321
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ... +...
T Consensus 168 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---------~~~~- 227 (284)
T 2vgo_A 168 ---------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRR---------IVNV- 227 (284)
T ss_dssp ---------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH---------HHTT-
T ss_pred ---------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHH---------Hhcc-
Confidence 12335689999999999999999999999999999999999999975442111 110 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
...++... +....+++.+||..||++|||++|+++||||+.
T Consensus 228 ~~~~~~~~---------------------------------------~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 228 DLKFPPFL---------------------------------------SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp CCCCCTTS---------------------------------------CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCCCcC---------------------------------------CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 00111111 112235777788888888889999999999976
Q ss_pred CC
Q 003158 826 DV 827 (843)
Q Consensus 826 ~~ 827 (843)
..
T Consensus 269 ~~ 270 (284)
T 2vgo_A 269 NS 270 (284)
T ss_dssp HC
T ss_pred hc
Confidence 43
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.54 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=177.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999964 68999999997543 3345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++.. .++++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999954 35889999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 11234568999999999999999999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=338.79 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=199.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC----hhhHHHHHHHHHHHHhccCCcccceeeee--ecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS----LQGEKEFLTEIQFLSRLHHRNLVSLVGYC--DEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~ 582 (843)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68999999987532 23356789999999999999999999998 445688
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||++++ |.+++.......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999765 888887766667999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .......
T Consensus 160 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~i-------- 225 (305)
T 2wtk_C 160 HPFAA-----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-YKLFENI-------- 225 (305)
T ss_dssp CTTCS-----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHH--------
T ss_pred Ccccc-----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHHH--------
Confidence 43221 12233456899999999998654 37799999999999999999999976442 1111111
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
. ......+..+++.+.+++.+||+.+|.+||++.++++.
T Consensus 226 -~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 -G-KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -H-HCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -h-cCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 11122344556677778888888888888888777753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=354.19 Aligned_cols=275 Identities=23% Similarity=0.375 Sum_probs=203.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCc------
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE------ 581 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 581 (843)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+++.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999964 69999999997532 2335678999999999999999999999977654
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||++ ++|.+++.. .+++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999996 688887732 4889999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +........
T Consensus 176 ~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~----- 239 (353)
T 3coi_A 176 ADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKV----- 239 (353)
T ss_dssp ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHH-----
T ss_pred CCC----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-----
Confidence 432 1234568999999999987 67899999999999999999999999765432 222111100
Q ss_pred hccCCCCCCCHHHHHHH----HHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 741 VIDGNMGSYPSECVEKF----IKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l----~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
.+..+.+....+ .......+...+ |+.+. ...+...+.+.+|+.+||..||++|||++|
T Consensus 240 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 302 (353)
T 3coi_A 240 -----TGVPGTEFVQKLNDKAAKSYIQSLPQTP--RKDFT----------QLFPRASPQAADLLEKMLELDVDKRLTAAQ 302 (353)
T ss_dssp -----HCBCCHHHHTTCSCHHHHHHHHTSCBCS--SCCTT----------TTCTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred -----hCCCCHHHHHHHhhHHHHHHHHhCcCCC--CccHH----------HhcCCcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 001111111100 000001111111 11111 112233444568999999999999999999
Q ss_pred CCCCCcccCC
Q 003158 817 MLKHPYVSSD 826 (843)
Q Consensus 817 ~L~Hp~f~~~ 826 (843)
+|+||||...
T Consensus 303 ~l~hp~f~~~ 312 (353)
T 3coi_A 303 ALTHPFFEPF 312 (353)
T ss_dssp HHTSGGGTTT
T ss_pred HhcCcchhhc
Confidence 9999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.98 Aligned_cols=200 Identities=28% Similarity=0.414 Sum_probs=168.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367889999999999999999975 799999999875322 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997653 4889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 165 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 165 E--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1234468999999999988765 68999999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.79 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=212.0
Q ss_pred cHHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHh--ccCCcccceeeeeecC
Q 003158 502 TYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSR--LHHRNLVSLVGYCDEE 579 (843)
Q Consensus 502 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~ 579 (843)
+........++|.+.+.||+|+||+||+|.. +++.||||++... ..+.+.+|++++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3334455678999999999999999999998 5899999998642 34577889998887 7899999999999876
Q ss_pred C----cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHh--------cCCCCCEEeccCCCCcEEEcC
Q 003158 580 G----EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH--------TEADPPVFHRDIKASNILLDH 647 (843)
Q Consensus 580 ~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiH~Dlkp~NILl~~ 647 (843)
. ..++||||+++|+|.+++... .+++..++.++.|+++||+||| +.+ |+||||||+||+++.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 5 789999999999999999653 4889999999999999999999 777 999999999999999
Q ss_pred CCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCC------CCchhhhHHHHHHHHHHHhC------
Q 003158 648 KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTG------ 715 (843)
Q Consensus 648 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwS~G~~l~elltg------ 715 (843)
++.+||+|||++......... .........||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCCEEEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999765432210 011223456999999999998753 33689999999999999999
Q ss_pred ----CCCCCCCcc---hHHHHHHHhhcccchhhccCCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 716 ----MQPISHGKN---IVREVNIAYQSSMMFSVIDGNMGSY-----PSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 716 ----~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
..||..... ............ ...+.. ..++++.+.+++.+||+.+|.+||++.++++.|+
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQ-------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTS-------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccccCccccCcCcccHHHHHHHHHHH-------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 778865321 112121111110 111222 3477889999999999999999999999999999
Q ss_pred Hhhhh
Q 003158 784 SIWNM 788 (843)
Q Consensus 784 ~~~~~ 788 (843)
.+.+.
T Consensus 333 ~i~~~ 337 (342)
T 1b6c_B 333 QLSQQ 337 (342)
T ss_dssp HHHHT
T ss_pred HHHHH
Confidence 98764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=359.20 Aligned_cols=269 Identities=20% Similarity=0.289 Sum_probs=210.5
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccC-CcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+++.+|+++++.++| ++|..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36899999999999999999996 5799999998875432 2357889999999987 555566666677788899999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEE---cCCCcEEEeeccccccCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILL---DHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~ 664 (843)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 99999999753 345899999999999999999999999 9999999999999 6889999999999987654
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc--hHHHHHHHhhcccchhhc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 742 (843)
.......+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+....... ......+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~-~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-KKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH-HHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh-ccccccH
Confidence 332211112223356799999999999999999999999999999999999999976432 1111111111 0000000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
...+..++.++.+++..||+.+|++||++.++++.|+.+.....
T Consensus 238 ----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 238 ----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp ----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 00112345788999999999999999999999999999876543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=352.49 Aligned_cols=261 Identities=19% Similarity=0.291 Sum_probs=176.6
Q ss_pred HHcCCCCCC-cccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec----CCcE
Q 003158 509 ATNNFNSST-QIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQ 582 (843)
Q Consensus 509 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 582 (843)
..++|.+.+ .||+|+||+||+|... +++.||||++.... . ...+....++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356788855 6999999999999975 69999999987531 1 12222334566799999999999865 4458
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEEeecccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLS 659 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla 659 (843)
++||||+++|+|.+++.......+++..++.++.|+++||.|||+++ |+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999998776667999999999999999999999999 999999999999986 455999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 179 ~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------ 237 (336)
T 3fhr_A 179 KETTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI------------ 237 (336)
T ss_dssp EEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred eecccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh------------
Confidence 765321 12345689999999999888899999999999999999999999964332100
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
.......+.......|. | .+......+.+|+.+||..||++|||++|+|+
T Consensus 238 --------------~~~~~~~~~~~~~~~~~--~--------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 238 --------------SPGMKRRIRLGQYGFPN--P--------------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------------------------CCCT--T--------------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------------hhhHHHhhhccccccCc--h--------------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000000000000 0 00111223346788889999999999999999
Q ss_pred CCcccCCC
Q 003158 820 HPYVSSDV 827 (843)
Q Consensus 820 Hp~f~~~~ 827 (843)
||||+...
T Consensus 288 hp~~~~~~ 295 (336)
T 3fhr_A 288 HPWINQSM 295 (336)
T ss_dssp SHHHHTGG
T ss_pred Cccccccc
Confidence 99997644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=344.77 Aligned_cols=266 Identities=24% Similarity=0.377 Sum_probs=195.1
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeee--------c
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCD--------E 578 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~--------~ 578 (843)
...+|++.+.||+|+||.||+|... +++.||||++........+.+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3468899999999999999999964 78999999987766666778999999999996 999999999983 3
Q ss_pred CCcEEEEEecCCCCCHHHHHhh-cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
....++||||+. |+|.+++.. ....++++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345899999995 799998865 23456999999999999999999999875 459999999999999999999999999
Q ss_pred ccccCCCCCCCCccc-----ceeeeeecccCCccCchhc---ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHH
Q 003158 658 LSRLAPVPDIEGIVP-----AHVSTVVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 729 (843)
Q Consensus 658 la~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~ 729 (843)
+++............ ........||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 998765322110000 0111244589999999998 56678899999999999999999999996543211
Q ss_pred HHHhhcccchhhccCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 730 NIAYQSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 730 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
...... ...+...+..+.+++..||+.+|.+||++.++++.|+.+.....
T Consensus 261 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 -----------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -----------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 111111 11223344568899999999999999999999999999876543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.88 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=201.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC--CCc--EEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP--DGT--VVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|++.+.||+|+||+||+|.+. +++ .||||++.... ....+++.+|+++++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457889999999999999999853 333 68999987542 234568899999999999999999999998754 8
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
++||||+++++|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999997642 35889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
...... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +.......
T Consensus 172 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~------- 239 (291)
T 1u46_A 172 PQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------- 239 (291)
T ss_dssp CC-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT-------
T ss_pred cccccc----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHHHHHc-------
Confidence 432210 111233457788999999999889999999999999999999 99999765432 11111110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.......+..++..+.+++..||..+|.+||++.++++.|+++..
T Consensus 240 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 -EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111223455677889999999999999999999999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.15 Aligned_cols=209 Identities=30% Similarity=0.454 Sum_probs=172.7
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeec---
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE--- 578 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~--- 578 (843)
.++....++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33444578899999999999999999996 478999999987543 3346789999999999 79999999999976
Q ss_pred ---CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 579 ---EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 579 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
.+..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 467899999999999999998765556889999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCCCcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 656 fGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
||++....... .......|++.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 173 fg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 173 FGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99997654211 1123446899999999997 5678899999999999999999999997544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=372.14 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=213.2
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecC
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP----DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEE 579 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 579 (843)
+.....++|++.+.||+|+||+||+|.+. .+..||||++.... ....+.+.+|+.+++.++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34445678889999999999999999864 25689999987543 333568999999999999999999999985 4
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 6789999999999999999754 345889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccc
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
+...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... +...
T Consensus 539 ~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~~~~-------- 603 (656)
T 2j0j_A 539 RYMEDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG-------- 603 (656)
T ss_dssp CSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH--------
T ss_pred eecCCCc------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-HHHH--------
Confidence 8764322 112233456789999999999999999999999999999997 99999765432 1111
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+..+.....+..+++.+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 604 -~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 604 -RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 122233344566778899999999999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.41 Aligned_cols=202 Identities=29% Similarity=0.454 Sum_probs=172.4
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ..+++.+|+++++.++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999975 58999999997533 34578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999643 345889999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 180 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 180 ------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp ------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 11234468999999999999999999999999999999999999997544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.80 Aligned_cols=276 Identities=24% Similarity=0.352 Sum_probs=188.1
Q ss_pred HHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 507 ALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 507 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|+++++.++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999954 78999999987543 2335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhh------cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 585 VYEFMSNGTLRDQLSA------KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
||||+++++|.+++.. .....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999864 12346899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
+......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 168 ~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------- 238 (303)
T 2vwi_A 168 SAFLATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML------- 238 (303)
T ss_dssp HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-------
T ss_pred hheeccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-------
Confidence 9765432110 01112234568999999999976 5689999999999999999999999976543211111
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
.............. ++ ...........+++.+||..||++|||++|+
T Consensus 239 ---~~~~~~~~~~~~~~-------------~~-----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 285 (303)
T 2vwi_A 239 ---TLQNDPPSLETGVQ-------------DK-----------------EMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285 (303)
T ss_dssp ---HHTSSCCCTTC-----------------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ---HhccCCCccccccc-------------cc-----------------hhhhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence 00010000000000 00 0111112223467778888999999999999
Q ss_pred CCCCcccCCC
Q 003158 818 LKHPYVSSDV 827 (843)
Q Consensus 818 L~Hp~f~~~~ 827 (843)
++||||....
T Consensus 286 l~h~~~~~~~ 295 (303)
T 2vwi_A 286 LRHKFFQKAK 295 (303)
T ss_dssp HTSTTC----
T ss_pred hhChhhhcCC
Confidence 9999997643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=354.01 Aligned_cols=201 Identities=25% Similarity=0.318 Sum_probs=157.9
Q ss_pred CCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEecCC
Q 003158 512 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556789999999998777678999999998643 234678899999886 89999999999999999999999995
Q ss_pred CCCHHHHHhhcCCCC-----cchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC-------------CcEE
Q 003158 591 NGTLRDQLSAKSKEP-----LGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK-------------FTAK 652 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~k 652 (843)
|+|.+++....... ..+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999997643221 134456789999999999999999 9999999999999754 4899
Q ss_pred EeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 003158 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVFLELLT-GMQPISHG 722 (843)
Q Consensus 653 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwS~G~~l~ellt-g~~pf~~~ 722 (843)
|+|||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 169 L~DFG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSS---FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp ECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EcccccceecCCCCcc---ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 9999999876532210 0111234579999999999976 678999999999999999999 99999654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=338.41 Aligned_cols=212 Identities=25% Similarity=0.344 Sum_probs=172.3
Q ss_pred ccHHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcc--CCcccceeeee
Q 003158 501 FTYGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLH--HRNLVSLVGYC 576 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~ 576 (843)
+.++.+....++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 33444445567899999999999999999998889999999987532 334577899999999997 59999999999
Q ss_pred ecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeec
Q 003158 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADF 656 (843)
Q Consensus 577 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 656 (843)
.+.+..++||| +.+++|.+++.... .+++..++.++.|+++||.|||+++ |+||||||+||++++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 55889999997643 5888999999999999999999999 999999999999965 89999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhccc-----------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcc
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~ 724 (843)
|+++....... ........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 171 g~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 171 GIANQMQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp SSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccccCccc-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 99986543211 111234568999999999976 4688899999999999999999999976543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=350.10 Aligned_cols=251 Identities=23% Similarity=0.395 Sum_probs=199.8
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh------hHHHHHHHHHHHHhcc--CCcccceeeeeec
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYCDE 578 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~ 578 (843)
...++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999995 47899999998753221 2245678999999996 5999999999999
Q ss_pred CCcEEEEEecCCC-CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-CCCcEEEeec
Q 003158 579 EGEQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADF 656 (843)
Q Consensus 579 ~~~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~Df 656 (843)
.+..++|||++.+ ++|.+++.... .+++..++.++.||++||+|||+.+ |+||||||+||+++ +++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 9999999999976 89999997643 5889999999999999999999999 99999999999999 7899999999
Q ss_pred cccccCCCCCCCCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhc
Q 003158 657 GLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735 (843)
Q Consensus 657 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~ 735 (843)
|+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 195 g~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------- 255 (320)
T 3a99_A 195 GSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------- 255 (320)
T ss_dssp TTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------
T ss_pred cccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh----------
Confidence 9998764221 233468999999999987765 67899999999999999999999642210
Q ss_pred ccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCc
Q 003158 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS 815 (843)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~ 815 (843)
.... ...+..++++ ..+++.+||..||++|||++
T Consensus 256 ------~~~~-~~~~~~~~~~---------------------------------------~~~li~~~l~~dp~~Rps~~ 289 (320)
T 3a99_A 256 ------IRGQ-VFFRQRVSSE---------------------------------------CQHLIRWCLALRPSDRPTFE 289 (320)
T ss_dssp ------HHCC-CCCSSCCCHH---------------------------------------HHHHHHHHTCSSGGGSCCHH
T ss_pred ------hccc-ccccccCCHH---------------------------------------HHHHHHHHccCChhhCcCHH
Confidence 0000 0011111111 22566677888888888899
Q ss_pred cCCCCCcccCCCC
Q 003158 816 SMLKHPYVSSDVS 828 (843)
Q Consensus 816 e~L~Hp~f~~~~~ 828 (843)
|+++||||.....
T Consensus 290 ~ll~hp~~~~~~~ 302 (320)
T 3a99_A 290 EIQNHPWMQDVLL 302 (320)
T ss_dssp HHHTSGGGSSCCC
T ss_pred HHhcCHhhcCccC
Confidence 9999999987554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=362.48 Aligned_cols=204 Identities=28% Similarity=0.421 Sum_probs=174.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeec------CCc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 581 (843)
.++|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999964 6899999998754 33345678999999999999999999999765 677
Q ss_pred EEEEEecCCCCCHHHHHhhcC-CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCc---EEEeecc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKS-KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFT---AKVADFG 657 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfG 657 (843)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997643 236889999999999999999999999 999999999999997664 9999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~ 724 (843)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 170 ~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 170 YAKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp CCCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred ccccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 998764322 12345789999999999999999999999999999999999999976543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.35 Aligned_cols=267 Identities=22% Similarity=0.320 Sum_probs=205.6
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG 580 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 580 (843)
..++....++|++.+.||+|+||.||+|...+ .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445556789999999999999999999754 499999875322 22356788999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..++||||+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++ ++.+||+|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999999654 346889999999999999999999999 99999999999998 6799999999987
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhccc---------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHH
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT---------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 731 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~ 731 (843)
......... .........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 178 ~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~ 254 (319)
T 2y4i_B 178 ISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQ 254 (319)
T ss_dssp ------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHH
T ss_pred ccccccccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 653221110 1122234458999999999975 4578899999999999999999999976543211 111
Q ss_pred HhhcccchhhccCCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 732 AYQSSMMFSVIDGNMGS-YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 732 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
+..+.... .+..++..+.+++..||..+|.+||++.++++.|+.+.+.
T Consensus 255 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 255 ---------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---------HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---------hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 1223556788999999999999999999999999987654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.55 Aligned_cols=201 Identities=25% Similarity=0.363 Sum_probs=160.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
..+|...+.||+|+||+||.....+++.||||++...... .+.+|+++++.+ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4568888999999999976655668999999998754332 356799999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-----CCcEEEeeccccccCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLAP 663 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~~~ 663 (843)
+. |+|.+++.... ....+..++.++.||++||+|||+++ |+||||||+|||++. ...+||+|||+|+...
T Consensus 100 ~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 95 69999997653 23555667889999999999999999 999999999999953 3368899999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcc---cCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVFLELLT-GMQPISHG 722 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~ 722 (843)
.... .........||+.|+|||++. ...++.++|||||||++|||++ |..||...
T Consensus 175 ~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 175 VGRH----SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCCc----ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 3211 011234467999999999998 4667889999999999999999 88898543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=329.24 Aligned_cols=200 Identities=25% Similarity=0.389 Sum_probs=162.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec----------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE---------- 578 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------- 578 (843)
.++|++.+.||+|+||.||+|... +++.||||++.. .....+.+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 567999999999999999999964 799999999864 33445678999999999999999999998754
Q ss_pred ---CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 579 ---EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 579 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
.+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 45679999999999999999764 345778899999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCCC-------cccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHh
Q 003158 656 FGLSRLAPVPDIEG-------IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLT 714 (843)
Q Consensus 656 fGla~~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~ellt 714 (843)
||++.......... ...........|++.|+|||++.+. .++.++|||||||++|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99998654221000 0001222445689999999999864 78999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=334.74 Aligned_cols=202 Identities=28% Similarity=0.403 Sum_probs=153.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHH-HHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQ-FLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 468889999999999999999975 789999999976432 33455666666 777889999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---cCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccccC
Q 003158 587 EFMSNGTLRDQLSA---KSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 587 e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
||++ |+|.+++.. .....+++..+..++.|+++||.|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 588887753 2345689999999999999999999998 8 999999999999999999999999999765
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhc----ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 177 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 177 VDS--------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccc--------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 422 112334689999999999 45678999999999999999999999997543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.42 Aligned_cols=202 Identities=27% Similarity=0.412 Sum_probs=164.8
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh------hHHHHHHHHHHHHhc----cCCcccceee
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRL----HHRNLVSLVG 574 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv~l~~ 574 (843)
.....++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++++++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999986 47899999999754332 223456799999998 8999999999
Q ss_pred eeecCCcEEEEEec-CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-CCCcEE
Q 003158 575 YCDEEGEQMLVYEF-MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAK 652 (843)
Q Consensus 575 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~k 652 (843)
++.+.+..++|||| +.+++|.+++.... .+++..++.++.||++||+|||+.+ |+||||||+||+++ +++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 78999999997643 5889999999999999999999999 99999999999999 889999
Q ss_pred EeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCC-chhhhHHHHHHHHHHHhCCCCCCC
Q 003158 653 VADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 653 l~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
|+|||+++...... .....|+..|+|||++.+..+. .++|||||||++|||++|+.||..
T Consensus 181 l~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp ECCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999998764321 2344689999999999877664 489999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.84 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=174.0
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
..++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3568999999999999999999975 78999999986532 23457889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC---CcEEEeeccccccC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK---FTAKVADFGLSRLA 662 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~ 662 (843)
|||+++++|.+++.... .+++..++.++.|+++||.|||+++ |+||||||+||+++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999986643 4889999999999999999999999 9999999999999754 47999999999865
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 175 QQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp CCCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 4321 1123458899999999876 48999999999999999999999997643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=333.56 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=153.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh-hH-HHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GE-KEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
.++|++.+.||+|+||.||+|... +|+.||||++...... .. +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 7899999999764332 22 33444555788889999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||+ ++.+..+.... ...+++..++.++.|+++||.|||++ + |+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 55666555432 34688999999999999999999995 8 999999999999999999999999999765422
Q ss_pred CCCCcccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKN 724 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~ 724 (843)
. ......|++.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 179 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (318)
T 2dyl_A 179 K--------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred c--------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Confidence 1 123446899999999995 45688999999999999999999999976443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=336.73 Aligned_cols=191 Identities=24% Similarity=0.267 Sum_probs=159.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh--------hhHHHHHHHHHHHHhcc----------------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------QGEKEFLTEIQFLSRLH---------------- 565 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------------- 565 (843)
.++|++.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+++++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 789999999975422 22367889999999886
Q ss_pred ----------CCcccceeeeeec-------------CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHH
Q 003158 566 ----------HRNLVSLVGYCDE-------------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622 (843)
Q Consensus 566 ----------h~nIv~l~~~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL 622 (843)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 5555555555544 6889999999999977666633 3578999999999999999
Q ss_pred HHHh-cCCCCCEEeccCCCCcEEEcCCC--------------------cEEEeeccccccCCCCCCCCcccceeeeeecc
Q 003158 623 LYLH-TEADPPVFHRDIKASNILLDHKF--------------------TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681 (843)
Q Consensus 623 ~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~g 681 (843)
+||| +++ |+||||||+|||++.++ .+||+|||+|+.... ....|
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~~g 239 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIVVF 239 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEEEC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcEEE
Confidence 9999 899 99999999999999887 999999999986532 13469
Q ss_pred cCCccCchhcccCCCCchhhhHHHHHH-HHHHHhCCCCCC
Q 003158 682 TPGYLDPEYFLTHKLTDKSDVYSLGVV-FLELLTGMQPIS 720 (843)
Q Consensus 682 t~~y~aPE~~~~~~~~~~sDvwS~G~~-l~elltg~~pf~ 720 (843)
|+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999999998766 889999998777 778888988883
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=344.28 Aligned_cols=198 Identities=17% Similarity=0.149 Sum_probs=156.2
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh---hHHHHHHHHHHHHhccC-Ccccceeee----------
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHH-RNLVSLVGY---------- 575 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~nIv~l~~~---------- 575 (843)
.+|...+.||+|+||+||+|.+ .+|+.||||++...... ..+.+.+|+.+++.++| +|......+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466778999999999999995 47999999998843322 24678999999999977 332221111
Q ss_pred -----------eec-----CCcEEEEEecCCCCCHHHHHh-----hcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEE
Q 003158 576 -----------CDE-----EGEQMLVYEFMSNGTLRDQLS-----AKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634 (843)
Q Consensus 576 -----------~~~-----~~~~~lV~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 634 (843)
+.. ....+++|+++ +++|.++++ ......+++..++.++.||++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 22467888876 689999985 233456889999999999999999999999 99
Q ss_pred eccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhc----------ccCCCCchhhhHH
Q 003158 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYF----------LTHKLTDKSDVYS 704 (843)
Q Consensus 635 H~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwS 704 (843)
||||||+|||++.++.+||+|||+++... .......| +.|+|||++ .+..++.++||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT----------EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecC----------CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999999999999987643 12344567 999999999 5556888999999
Q ss_pred HHHHHHHHHhCCCCCCCCc
Q 003158 705 LGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 705 ~G~~l~elltg~~pf~~~~ 723 (843)
|||++|||++|+.||....
T Consensus 303 lGvil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTG
T ss_pred HHHHHHHHHHCCCCCCCcc
Confidence 9999999999999997543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=311.43 Aligned_cols=229 Identities=12% Similarity=0.073 Sum_probs=185.7
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999975 589999999986433 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.++++.. ....++..++.|+++||+|||+++ |+||||||+|||+++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999542 234467889999999999999999 9999999999999999999998544
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
|++ .++.++|||||||++|||+||+.||........ .......+.+.
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~~~ 221 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------LAPAERDTAGQ 221 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-------SEECCBCTTSC
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-------hHHHHHHhccC
Confidence 233 268899999999999999999999976542100 00000111111
Q ss_pred CC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 746 MG---SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 746 ~~---~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.. ..+..+++.+.+++.+||+.+|.+| ++.++++.|+.+..
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 11 1123456789999999999999999 99999999998764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.21 Aligned_cols=239 Identities=20% Similarity=0.320 Sum_probs=181.7
Q ss_pred cCCCCC-CcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHH-HhccCCcccceeeeeec----CCcEE
Q 003158 511 NNFNSS-TQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFL-SRLHHRNLVSLVGYCDE----EGEQM 583 (843)
Q Consensus 511 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~~ 583 (843)
++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 7799999999999996 47899999998642 3567888887 55689999999999876 67889
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEEeeccccc
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSR 660 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~ 660 (843)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999998876667999999999999999999999999 999999999999998 7899999999986
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
... +..++.++|||||||++|||++|+.||........ . .....
T Consensus 169 ~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~-~~~~~ 212 (299)
T 3m2w_A 169 ETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------S-PGMKT 212 (299)
T ss_dssp ECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCC
T ss_pred ccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------h-HHHHH
Confidence 432 13467799999999999999999999975432110 0 00001
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
.+.......+.... ...+..+.+++.+||..||++|||++|+|+|
T Consensus 213 ~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQYEFPNPEW-----------------------------------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCCSSCHHHH-----------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccCCchhc-----------------------------------ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111111121100 1112233467777888888888888888999
Q ss_pred CcccCCCC
Q 003158 821 PYVSSDVS 828 (843)
Q Consensus 821 p~f~~~~~ 828 (843)
|||.....
T Consensus 258 p~~~~~~~ 265 (299)
T 3m2w_A 258 PWIMQSTK 265 (299)
T ss_dssp HHHHTGGG
T ss_pred hhhccccc
Confidence 99876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=348.93 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=194.4
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC--CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCc-----
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP--DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE----- 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 581 (843)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 68999999986533 3445678999999999999999999999987665
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+++++|.+++.. .+++..++.++.||++||.|||+++ ||||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988743 5899999999999999999999999 9999999999999986 899999999986
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
.... ....||+.|+|||++.+.. +.++|||||||++|||++|..||.....
T Consensus 231 ~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------- 281 (681)
T 2pzi_A 231 INSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----------------- 281 (681)
T ss_dssp TTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----------------
T ss_pred cccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----------------
Confidence 5321 3356999999999997764 8899999999999999999888753210
Q ss_pred ccCCCC-CCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhh
Q 003158 742 IDGNMG-SYPSECVEKFIKLALKCCQDETDARPS-MSEVMRELESIW 786 (843)
Q Consensus 742 ~~~~~~-~~~~~~~~~l~~l~~~c~~~~p~~RPs-~~~vl~~L~~~~ 786 (843)
+.... ......++.+.+++.+||+.+|.+||+ ++++.+.+..+.
T Consensus 282 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 282 -DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -SSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -ccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00001 111234577899999999999999995 566666666553
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=319.52 Aligned_cols=280 Identities=16% Similarity=0.206 Sum_probs=228.7
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCcc-CccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGS-LPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 80 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 80 (843)
+|+|++..|..|.++++|++|+|++|.+.+. .+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++.
T Consensus 39 ~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 118 (455)
T 3v47_A 39 LNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118 (455)
T ss_dssp SSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTH
T ss_pred CCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCcc
Confidence 6888888899999999999999999988744 467789999999999999999988888899999999999999999865
Q ss_pred CCcc--cCCCCCCceeeccCCCCCCCCCcc-cCCCCCCcEEEcCCCCCCCCCCCccccCC--------------------
Q 003158 81 IPPE--LSRLPSLVHMLLDNNNLTGYLPPE-LSELPKLLILQLDNNNFEGTTIPASYSNM-------------------- 137 (843)
Q Consensus 81 ~~~~--l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l-------------------- 137 (843)
.+.. |..+++|++|+|++|++++..|.. +.++++|++|+|++|++.+ ..+..+..+
T Consensus 119 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~~~L~~L~l~~n~l~~~~~ 197 (455)
T 3v47_A 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNE 197 (455)
T ss_dssp HHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC-CCTTTSGGGTTCEEEEEECTTCBCTTCST
T ss_pred ccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc-cChhhhhccccccccccccccCcccccch
Confidence 5444 888999999999999998777765 7888999999999998875 334433222
Q ss_pred --------------C---------------------------------------------------------------CC
Q 003158 138 --------------S---------------------------------------------------------------KL 140 (843)
Q Consensus 138 --------------~---------------------------------------------------------------~L 140 (843)
+ +|
T Consensus 198 ~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 277 (455)
T 3v47_A 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV 277 (455)
T ss_dssp TCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCC
T ss_pred hhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCc
Confidence 3 44
Q ss_pred cEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCc
Q 003158 141 LKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218 (843)
Q Consensus 141 ~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 218 (843)
+.|+|++|.+++.++ .+..+++|+.|+|++|++++..|..+.. .+|+.|+|++|.+++..|..|.++++|++|+|++|
T Consensus 278 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 357 (455)
T 3v47_A 278 KTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYN 357 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSS
T ss_pred eEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCC
Confidence 455555555555445 4788899999999999999666655443 48999999999999888999999999999999999
Q ss_pred cCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccCC-cccccCCCCCC
Q 003158 219 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDD 287 (843)
Q Consensus 219 ~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~~-~~~~~~~~~~~ 287 (843)
++++..|..+..+. +|+.|+|++|+|++++... .++.++.|++++|||.|+|. ..++..|+...
T Consensus 358 ~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~ 424 (455)
T 3v47_A 358 HIRALGDQSFLGLP-----NLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 424 (455)
T ss_dssp CCCEECTTTTTTCT-----TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHT
T ss_pred cccccChhhccccc-----cccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcchHHHHHHHhC
Confidence 99988888887654 5569999999999998754 78999999999999999998 56677777543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=319.16 Aligned_cols=278 Identities=21% Similarity=0.220 Sum_probs=221.8
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++...+..|.++++|++|+|++|.+++..
T Consensus 41 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~ 120 (477)
T 2id5_A 41 KNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILL 120 (477)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEEC
T ss_pred CCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCC
Confidence 68888888888999999999999999999888889999999999999999998666677888999999999999998888
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRI 160 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l 160 (843)
+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++++ ..+..|.++++|+.|+|++|.++++++ .+..+
T Consensus 121 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l 199 (477)
T 2id5_A 121 DYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199 (477)
T ss_dssp TTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS-CCHHHHTTCTTCCEEEEESCCCCEECTTCSCSC
T ss_pred hhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc-cChhHhcccCCCcEEeCCCCcCcEeChhhcccC
Confidence 8888889999999999999988888888889999999999998875 334567888888888888888887766 47777
Q ss_pred CCCCEEEcccCcCCCCCCCCCC-------------------------CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeC
Q 003158 161 PNLGYLDLSSNQLNGSIPPGRL-------------------------SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI 215 (843)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p~~~~-------------------------~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 215 (843)
++|+.|++++|.+.+.++...+ ..+|+.|+|++|.+++..+..|.++++|+.|+|
T Consensus 200 ~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 279 (477)
T 2id5_A 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL 279 (477)
T ss_dssp TTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEEC
T ss_pred cccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEEC
Confidence 7666666666554444433221 125667777777776666666777777777777
Q ss_pred cCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccCCcccccCCCC
Q 003158 216 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHS 285 (843)
Q Consensus 216 ~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~~ 285 (843)
++|++++..|..|..+ ++|+.|+|++|+|+.++... .++.++.|++++|||.|+|.+.|+..|..
T Consensus 280 ~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~ 346 (477)
T 2id5_A 280 VGGQLAVVEPYAFRGL-----NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRW 346 (477)
T ss_dssp CSSCCSEECTTTBTTC-----TTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTT
T ss_pred CCCccceECHHHhcCc-----ccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhh
Confidence 7777776666666554 45669999999999998764 68999999999999999999998877653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=335.25 Aligned_cols=267 Identities=32% Similarity=0.516 Sum_probs=233.3
Q ss_pred CccccccCCccccC--CCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCcccc
Q 003158 2 WNKISGSIPKEIGN--IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 79 (843)
Q Consensus 2 ~N~i~~~~p~~i~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 79 (843)
+|+++|.+|..+.. +++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..|.++++|+.|+|++|.+++
T Consensus 377 ~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 456 (768)
T 3rgz_A 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456 (768)
T ss_dssp SSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred CCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccC
Confidence 68888888888877 7889999999999998999999999999999999999998999999999999999999999998
Q ss_pred CCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCC
Q 003158 80 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLS 158 (843)
Q Consensus 80 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~ 158 (843)
.+|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|++++ .+|..++++++|+.|+|++|++++..| .+.
T Consensus 457 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 535 (768)
T 3rgz_A 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG-EIPKWIGRLENLAILKLSNNSFSGNIPAELG 535 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS-CCCGGGGGCTTCCEEECCSSCCEEECCGGGG
T ss_pred cCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCC-cCChHHhcCCCCCEEECCCCcccCcCCHHHc
Confidence 899999999999999999999998899999999999999999999986 678899999999999999999987665 588
Q ss_pred CCCCCCEEEcccCcCCCCCCCCCCC-------------------------------------------------------
Q 003158 159 RIPNLGYLDLSSNQLNGSIPPGRLS------------------------------------------------------- 183 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~l~~~~p~~~~~------------------------------------------------------- 183 (843)
.+++|+.|+|++|+++|.+|...+.
T Consensus 536 ~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 615 (768)
T 3rgz_A 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615 (768)
T ss_dssp GCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCT
T ss_pred CCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccccccc
Confidence 8999999999999998877754221
Q ss_pred ----------------cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCC
Q 003158 184 ----------------LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 247 (843)
Q Consensus 184 ----------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N 247 (843)
.+|+.|||++|+++|.+|..|+++++|+.|+|++|+|+|.+|..+..+.+| +.|||++|
T Consensus 616 ~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L-----~~LdLs~N 690 (768)
T 3rgz_A 616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL-----NILDLSSN 690 (768)
T ss_dssp TSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC-----CEEECCSS
T ss_pred ccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCC-----CEEECCCC
Confidence 258889999999999999999999999999999999999999998877655 48999999
Q ss_pred CCCCC-CCCC-cCCCCcEEEeccCccccc
Q 003158 248 NLTNI-SGSF-NIPPNVTVRLRGNPFCLN 274 (843)
Q Consensus 248 ~l~~~-~~~~-~~~~l~~l~l~~Np~~c~ 274 (843)
+|++. |..+ .++.++.|++++|++...
T Consensus 691 ~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ 719 (768)
T 3rgz_A 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGP 719 (768)
T ss_dssp CCEECCCGGGGGCCCCSEEECCSSEEEEE
T ss_pred cccCcCChHHhCCCCCCEEECcCCccccc
Confidence 99954 4444 788999999999988643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=329.79 Aligned_cols=266 Identities=30% Similarity=0.487 Sum_probs=161.3
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|++++.+|..|.++++|++|+|++|++++.+|..|+++++|++|+|++|.+++.+|..+..+++|++|+|++|++++.+
T Consensus 403 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 482 (768)
T 3rgz_A 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482 (768)
T ss_dssp SSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred CCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcC
Confidence 45666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC------
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP------ 155 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------ 155 (843)
|..+.++++|++|+|++|++++.+|.++..+++|++|+|++|++++ .+|..+.++++|+.|+|++|.+++..|
T Consensus 483 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~ 561 (768)
T 3rgz_A 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG-NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE-ECCGGGGGCTTCCEEECCSSEEESBCCGGGGTT
T ss_pred CHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccC-cCCHHHcCCCCCCEEECCCCccCCcCChHHhcc
Confidence 6666666666666666666666666666666666666666666654 456666666666666666666553222
Q ss_pred -----------------------------------------------------------------CCCCCCCCCEEEccc
Q 003158 156 -----------------------------------------------------------------DLSRIPNLGYLDLSS 170 (843)
Q Consensus 156 -----------------------------------------------------------------~~~~l~~L~~L~Ls~ 170 (843)
.+..+++|+.|||++
T Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~ 641 (768)
T 3rgz_A 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641 (768)
T ss_dssp TTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCS
T ss_pred cchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcC
Confidence 122345566666666
Q ss_pred CcCCCCCCCCCCCc-CcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCC
Q 003158 171 NQLNGSIPPGRLSL-NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNL 249 (843)
Q Consensus 171 N~l~~~~p~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l 249 (843)
|+++|.+|..+... +|+.|+|++|.++|.+|..|+++++|+.|||++|+++|.+|..+..+..| +.|||++|+|
T Consensus 642 N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L-----~~L~ls~N~l 716 (768)
T 3rgz_A 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML-----TEIDLSNNNL 716 (768)
T ss_dssp SCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCC-----SEEECCSSEE
T ss_pred CcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCC-----CEEECcCCcc
Confidence 66666666554432 56666666666666666666666666666666666666666666554433 3566666666
Q ss_pred CCCCCCC-cCCCCcEEEeccCcccc
Q 003158 250 TNISGSF-NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 250 ~~~~~~~-~~~~l~~l~l~~Np~~c 273 (843)
++..+.. .+..+....+.|||.-|
T Consensus 717 ~g~iP~~~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 717 SGPIPEMGQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp EEECCSSSSGGGSCGGGGCSCTEEE
T ss_pred cccCCCchhhccCCHHHhcCCchhc
Confidence 5433322 33333344455666544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-31 Score=300.01 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=230.6
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.+.+.++.++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|.|+.+.+..|.++++|++|+|
T Consensus 43 ~~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TTSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 35678999999999 7777665 78999999999999888899999999999999999999888889999999999999
Q ss_pred cCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCC-CCCCCCCC-CCCCCCCCCEEEcccCcCC
Q 003158 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN-CSLQGPMP-DLSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~-~~~~l~~L~~L~Ls~N~l~ 174 (843)
++|+|+...+..|..+++|++|+|++|++.. ..+..|.++++|+.|+|++ |.+..+++ .|..+++|+.|+|++|+++
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccc-cCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 9999997777789999999999999999975 3456889999999999999 55666666 4899999999999999998
Q ss_pred CCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCC
Q 003158 175 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254 (843)
Q Consensus 175 ~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~ 254 (843)
.+|......+|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..+..|..+. +|+.|+|++|+|+.++.
T Consensus 199 -~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~ 272 (440)
T 3zyj_A 199 -EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ-----SLVEINLAHNNLTLLPH 272 (440)
T ss_dssp -SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT-----TCCEEECTTSCCCCCCT
T ss_pred -cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCC-----CCCEEECCCCCCCccCh
Confidence 777655556999999999999999999999999999999999999988888877654 45689999999999987
Q ss_pred CC--cCCCCcEEEeccCcccccCCcccccCCCCC
Q 003158 255 SF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 286 (843)
Q Consensus 255 ~~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~ 286 (843)
.. .++.++.|+|++|||.|||.+.|+..|+..
T Consensus 273 ~~~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~~~ 306 (440)
T 3zyj_A 273 DLFTPLHHLERIHLHHNPWNCNCDILWLSWWIKD 306 (440)
T ss_dssp TTTSSCTTCCEEECCSSCEECSSTTHHHHHHHHT
T ss_pred hHhccccCCCEEEcCCCCccCCCCchHHHHHHHh
Confidence 65 789999999999999999999999888764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=301.54 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=231.0
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
+...++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|.|+++.+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4678999999999 6776655 789999999999998889999999999999999999998888999999999999999
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCC-CCCCCCCCC-CCCCCCCCEEEcccCcCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN-CSLQGPMPD-LSRIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~ 175 (843)
+|+|+...+..|..+++|++|+|++|++.. ..+..|.++++|+.|+|++ |.++.+++. |..+++|+.|+|++|+++
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~- 209 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK- 209 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcce-eCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-
Confidence 999998777889999999999999999975 3456899999999999999 566766664 899999999999999999
Q ss_pred CCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCC
Q 003158 176 SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 255 (843)
Q Consensus 176 ~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~ 255 (843)
.+|......+|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..|..|..+. +|+.|+|++|+|++++..
T Consensus 210 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~ 284 (452)
T 3zyi_A 210 DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA-----SLVELNLAHNNLSSLPHD 284 (452)
T ss_dssp SCCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCT-----TCCEEECCSSCCSCCCTT
T ss_pred ccccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCC-----CCCEEECCCCcCCccChH
Confidence 567655556999999999999999999999999999999999999988888887654 456999999999999876
Q ss_pred C--cCCCCcEEEeccCcccccCCcccccCCCCC
Q 003158 256 F--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 286 (843)
Q Consensus 256 ~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~ 286 (843)
. .+++++.|+|++|||.|+|.+.|+..|+..
T Consensus 285 ~~~~l~~L~~L~L~~Np~~CdC~~~~l~~~l~~ 317 (452)
T 3zyi_A 285 LFTPLRYLVELHLHHNPWNCDCDILWLAWWLRE 317 (452)
T ss_dssp SSTTCTTCCEEECCSSCEECSTTTHHHHHHHHH
T ss_pred HhccccCCCEEEccCCCcCCCCCchHHHHHHHH
Confidence 5 689999999999999999999999888753
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=296.08 Aligned_cols=252 Identities=28% Similarity=0.423 Sum_probs=220.6
Q ss_pred CCCCEEEccCCcCCc--cCccccCCCCCCcEEEccc-CcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCce
Q 003158 17 KSLELLLLNGNELTG--SLPEELGYLPKLDRIQIDQ-NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 93 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 93 (843)
.+++.|+|++|++++ .+|..|+++++|++|+|++ |.+.+.+|..|.++++|++|+|++|.+++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999998 8999999999999999995 9999899999999999999999999999899999999999999
Q ss_pred eeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCC-CCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccC
Q 003158 94 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMS-KLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSN 171 (843)
Q Consensus 94 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N 171 (843)
|+|++|++++.+|..+..+++|++|+|++|++++ .+|..+..++ +|+.|+|++|++++..+ .+..+. |+.|+|++|
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISG-AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEE-ECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccC-cCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 9999999998899999999999999999999976 6788999988 99999999999986555 577776 999999999
Q ss_pred cCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCC
Q 003158 172 QLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 250 (843)
Q Consensus 172 ~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~ 250 (843)
.+++.+|..+.. .+|+.|+|++|.+++.+|. +..+++|++|+|++|+|++.+|..+..+.+ |+.|+|++|+|+
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-----L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKF-----LHSLNVSFNNLC 281 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTT-----CCEEECCSSEEE
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcC-----CCEEECcCCccc
Confidence 998777665444 4899999999999977665 888999999999999999999998877654 558999999998
Q ss_pred C-CCCCCcCCCCcEEEeccCcccccCC
Q 003158 251 N-ISGSFNIPPNVTVRLRGNPFCLNTN 276 (843)
Q Consensus 251 ~-~~~~~~~~~l~~l~l~~Np~~c~~~ 276 (843)
+ +|....++.+..+++.+||+.|+..
T Consensus 282 ~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 282 GEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp EECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccCCCCccccccChHHhcCCCCccCCC
Confidence 4 4544578899999999999887643
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=318.93 Aligned_cols=280 Identities=19% Similarity=0.237 Sum_probs=194.9
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccc---------------------
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS--------------------- 60 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~--------------------- 60 (843)
+|++++..+..|.++++|++|+|++|+++ .+|..+.++++|++|+|++|.+++..|..
T Consensus 263 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 341 (606)
T 3t6q_A 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341 (606)
T ss_dssp TCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBC
T ss_pred cCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccccc
Confidence 34555555555555555555555555555 45555555555555555555555444444
Q ss_pred ----cccCCCCCEEEccCCccccCC--CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccc
Q 003158 61 ----FANLNKTRHFHMNNNSISGQI--PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 134 (843)
Q Consensus 61 ----~~~l~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 134 (843)
+..+++|++|++++|.+++.. +..+..+++|++|+|++|++++..+..|..+++|++|+|++|++.+...+..+
T Consensus 342 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 421 (606)
T 3t6q_A 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421 (606)
T ss_dssp CSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTT
T ss_pred chhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhh
Confidence 445555555555555555433 44556666666666666666666666677777777777777777653333447
Q ss_pred cCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCC-CCC--CCC-CcCcCEEEccCCcCCCCCCcccCCCCC
Q 003158 135 SNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS-IPP--GRL-SLNITTIKLSNNKLTGTIPSNFSGLPR 209 (843)
Q Consensus 135 ~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~-~p~--~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 209 (843)
.++++|+.|+|++|.+++.++. +..+++|+.|+|++|.+++. ++. ... ..+|+.|+|++|.+++..|..|.++++
T Consensus 422 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 501 (606)
T 3t6q_A 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM 501 (606)
T ss_dssp TTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccC
Confidence 7777778888888777776663 77788888888888887652 221 122 237899999999999888889999999
Q ss_pred CcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccCCcccccCCCCCC
Q 003158 210 LQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDD 287 (843)
Q Consensus 210 L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~ 287 (843)
|++|+|++|++++..|..+..+. .| .|+|++|+++++++.. .++.++.|++++|||.|+|...+|..|+...
T Consensus 502 L~~L~Ls~N~l~~~~~~~l~~l~-----~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w~~~~ 575 (606)
T 3t6q_A 502 MNHVDLSHNRLTSSSIEALSHLK-----GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKEN 575 (606)
T ss_dssp CCEEECCSSCCCGGGGGGGTTCC-----SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHHHHHC
T ss_pred CCEEECCCCccCcCChhHhCccc-----cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHHHHHHHhC
Confidence 99999999999988888876554 45 7999999999988764 6899999999999999999999999998754
Q ss_pred C
Q 003158 288 D 288 (843)
Q Consensus 288 ~ 288 (843)
.
T Consensus 576 ~ 576 (606)
T 3t6q_A 576 M 576 (606)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=314.64 Aligned_cols=295 Identities=17% Similarity=0.206 Sum_probs=229.2
Q ss_pred CCccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccC
Q 003158 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 80 (843)
Q Consensus 1 ~~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 80 (843)
.+|+|++..|.+|.++++|++|+|++|+|+++.+.+|++|++|++|+|++|+|++..+..|.++++|++|+|++|+|+++
T Consensus 60 s~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l 139 (635)
T 4g8a_A 60 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 139 (635)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCS
T ss_pred eCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCC
Confidence 37999988888999999999999999999988888999999999999999999987778899999999999999999987
Q ss_pred CCcccCCCCCCceeeccCCCCCCC-CCcccCCCCCCcEEEcCCCCCCCCCCCcc--------------------------
Q 003158 81 IPPELSRLPSLVHMLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIPAS-------------------------- 133 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------------------------- 133 (843)
.+..|+++++|++|+|++|+++.. .|..+..+++|++|+|++|++++. .+..
T Consensus 140 ~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~ 218 (635)
T 4g8a_A 140 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI-YCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 218 (635)
T ss_dssp TTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE-CGGGGHHHHTCTTCCCEEECTTCCCCEECT
T ss_pred ChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccc-ccccccchhhhhhhhhhhhcccCcccccCc
Confidence 777899999999999999999854 577888899999999998877531 0000
Q ss_pred --------------------------------------------------------------------------------
Q 003158 134 -------------------------------------------------------------------------------- 133 (843)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (843)
T Consensus 219 ~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 298 (635)
T 4g8a_A 219 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGI 298 (635)
T ss_dssp TTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEEC
T ss_pred ccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccch
Confidence
Q ss_pred --------------------------------------------------------------------ccCCCCCcEEEc
Q 003158 134 --------------------------------------------------------------------YSNMSKLLKLSL 145 (843)
Q Consensus 134 --------------------------------------------------------------------~~~l~~L~~L~L 145 (843)
...+++|+.|++
T Consensus 299 ~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~l 378 (635)
T 4g8a_A 299 IDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDL 378 (635)
T ss_dssp TTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEEC
T ss_pred hhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchh
Confidence 001344555555
Q ss_pred CCCCCCC-------------------------------------------------------------------------
Q 003158 146 RNCSLQG------------------------------------------------------------------------- 152 (843)
Q Consensus 146 ~~N~l~~------------------------------------------------------------------------- 152 (843)
++|.+..
T Consensus 379 s~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~ 458 (635)
T 4g8a_A 379 SRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 458 (635)
T ss_dssp CSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCE
T ss_pred hccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccc
Confidence 5554421
Q ss_pred -CCC-CCCCCCCCCEEEcccCcCCCC-CCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchh
Q 003158 153 -PMP-DLSRIPNLGYLDLSSNQLNGS-IPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 228 (843)
Q Consensus 153 -~~~-~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 228 (843)
..+ .+..+++|+.|+|++|++.+. +|..+.. .+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|
T Consensus 459 ~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~ 538 (635)
T 4g8a_A 459 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 538 (635)
T ss_dssp ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGG
T ss_pred cccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHH
Confidence 111 122334455555555543322 3333222 389999999999999999999999999999999999998888888
Q ss_pred hccccCCCCcceeEEcCCCCCCCCCCCC--cC-CCCcEEEeccCcccccCCcccccCCCCCCCcccccCCCCCCCcCC
Q 003158 229 WQSRTLNATETFILDFQNNNLTNISGSF--NI-PPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRA 303 (843)
Q Consensus 229 ~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~-~~l~~l~l~~Np~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 303 (843)
..+. +|++|||++|+|+++++.. .+ +.++.|++++|||.|||.+.||..|+......+. ....+.|..
T Consensus 539 ~~l~-----~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~~~~--~~~~~~C~~ 609 (635)
T 4g8a_A 539 KCLN-----SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV--EVERMECAT 609 (635)
T ss_dssp TTCT-----TCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTTTBS--CGGGCBBCS
T ss_pred hCCC-----CCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCCccC--CCCCceeCC
Confidence 7655 4569999999999998764 55 5799999999999999999999999875543332 233466765
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=311.10 Aligned_cols=161 Identities=19% Similarity=0.195 Sum_probs=105.9
Q ss_pred CCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCCC-CCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcE
Q 003158 136 NMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGS-IPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQR 212 (843)
Q Consensus 136 ~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 212 (843)
++++|+.|++++|.+++..+ .+..+++|+.|++++|.+++. +|..+.. .+|+.|+|++|.+++..|..|.++++|++
T Consensus 422 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 501 (606)
T 3vq2_A 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501 (606)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCE
Confidence 33334444444444433333 244445555555555555432 3333222 36777777777777777777777888888
Q ss_pred EeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC-cCC-CCcEEEeccCcccccCCcccccCCCCCCCcc
Q 003158 213 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIP-PNVTVRLRGNPFCLNTNAEQFCGSHSDDDNE 290 (843)
Q Consensus 213 L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-~~~-~l~~l~l~~Np~~c~~~~~~~~~~~~~~~~~ 290 (843)
|+|++|++++..|..+..+. +|+.|+|++|+|+.+|..+ .++ .++.|++.+|||.|+|.+.++..|+......
T Consensus 502 L~Ls~N~l~~~~~~~~~~l~-----~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l~~~~~~ 576 (606)
T 3vq2_A 502 LNMSHNNLLFLDSSHYNQLY-----SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQF 576 (606)
T ss_dssp EECCSSCCSCEEGGGTTTCT-----TCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTTTTSSSS
T ss_pred EECCCCcCCCcCHHHccCCC-----cCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHHHcCccc
Confidence 88888888777777776544 5669999999999998876 676 5999999999999999999999999764332
Q ss_pred cccCCCCCCCcCC
Q 003158 291 IDRSTNSTLDCRA 303 (843)
Q Consensus 291 ~~~~~~~~~~c~~ 303 (843)
+. ....+.|..
T Consensus 577 ~~--~~~~~~C~~ 587 (606)
T 3vq2_A 577 LV--NVEQMTCAT 587 (606)
T ss_dssp BS--SGGGCCCC-
T ss_pred cc--CCccceeCC
Confidence 22 233455543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=302.34 Aligned_cols=273 Identities=20% Similarity=0.268 Sum_probs=173.7
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccC-
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ- 80 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~- 80 (843)
+|+|++..|.+|.++++|++|+|++|+|++..|+.|+++++|++|+|++|+|+ .+|.. .+++|++|+|++|++++.
T Consensus 61 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~ 137 (562)
T 3a79_B 61 QNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLP 137 (562)
T ss_dssp SSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCC
T ss_pred CCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccC
Confidence 57777777777788888888888888888777777777777777777777777 44443 666777777777776642
Q ss_pred CCcccCCCCCCceeeccCCCCCC---------------------------------------------------------
Q 003158 81 IPPELSRLPSLVHMLLDNNNLTG--------------------------------------------------------- 103 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~N~l~~--------------------------------------------------------- 103 (843)
+|..|+++++|++|+|++|++++
T Consensus 138 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~ 217 (562)
T 3a79_B 138 VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217 (562)
T ss_dssp CCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEE
T ss_pred chHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcc
Confidence 34566666666666666665532
Q ss_pred -------------------------------------------------------------------------CCCccc-
Q 003158 104 -------------------------------------------------------------------------YLPPEL- 109 (843)
Q Consensus 104 -------------------------------------------------------------------------~~~~~~- 109 (843)
.+|..+
T Consensus 218 ~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~ 297 (562)
T 3a79_B 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297 (562)
T ss_dssp SSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCC
T ss_pred cccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhh
Confidence 222221
Q ss_pred ----------------------------------------------------CCCCCCcEEEcCCCCCCCCCCCccccCC
Q 003158 110 ----------------------------------------------------SELPKLLILQLDNNNFEGTTIPASYSNM 137 (843)
Q Consensus 110 ----------------------------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 137 (843)
..+++|++|+|++|++++ ..|..+.++
T Consensus 298 ~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l 376 (562)
T 3a79_B 298 TYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD-SVFQGCSTL 376 (562)
T ss_dssp CCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCT-TTTTTCCSC
T ss_pred hcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCcccc-chhhhhccc
Confidence 333445555555555543 344455555
Q ss_pred CCCcEEEcCCCCCCCCCC---CCCCCCCCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcE
Q 003158 138 SKLLKLSLRNCSLQGPMP---DLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQR 212 (843)
Q Consensus 138 ~~L~~L~L~~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 212 (843)
++|+.|+|++|++++++. .+..+++|+.|+|++|++++.+|...+. .+|+.|+|++|.+++..|..+. ++|+.
T Consensus 377 ~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~ 454 (562)
T 3a79_B 377 KRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKV 454 (562)
T ss_dssp SSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSE
T ss_pred CCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCE
Confidence 555555555555554332 2455555555555555555434443221 2555555555555544443332 46666
Q ss_pred EeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCC-C-cCCCCcEEEeccCcccccCCcccccC-CCCC
Q 003158 213 LFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTNAEQFCG-SHSD 286 (843)
Q Consensus 213 L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~-~-~~~~l~~l~l~~Np~~c~~~~~~~~~-~~~~ 286 (843)
|+|++|+|+ .+|..+.. .++|+.|+|++|+|++++.. + .++.++.|++++|||.|+|.+.++.. |...
T Consensus 455 L~L~~N~l~-~ip~~~~~-----l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~~~~~~ 525 (562)
T 3a79_B 455 LDLHNNRIM-SIPKDVTH-----LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINK 525 (562)
T ss_dssp EECCSSCCC-CCCTTTTS-----SCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHHHHHHHHH
T ss_pred EECCCCcCc-ccChhhcC-----CCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHHHHHHHHh
Confidence 666666666 55555543 35677999999999999987 4 78999999999999999999998855 6543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=318.79 Aligned_cols=272 Identities=20% Similarity=0.173 Sum_probs=169.4
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
|++++..|..|.++++|+.|+|++|++++..|..|.++++|++|+|++|.+++..+..|.++++|+.|+|++|.|+...+
T Consensus 276 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 355 (844)
T 3j0a_A 276 GFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355 (844)
T ss_dssp CCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCS
T ss_pred CcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccCh
Confidence 44444444444555555555555555554444445555555555555555544444445555555555555555544444
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCC--------------------CCCCCccccCCCCCcE
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE--------------------GTTIPASYSNMSKLLK 142 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--------------------~~~~~~~~~~l~~L~~ 142 (843)
..|.++++|+.|+|++|.+++. + .+++|+.|++++|++. +...+..+.++++|+.
T Consensus 356 ~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~ 430 (844)
T 3j0a_A 356 QTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQI 430 (844)
T ss_dssp SCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCE
T ss_pred hhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccce
Confidence 4444455555555555544421 1 1222333333332222 1111112346777788
Q ss_pred EEcCCCCCCCCCCC--CCCCCCCCEEEcccCcCCCCCC-----CCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEe
Q 003158 143 LSLRNCSLQGPMPD--LSRIPNLGYLDLSSNQLNGSIP-----PGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLF 214 (843)
Q Consensus 143 L~L~~N~l~~~~~~--~~~l~~L~~L~Ls~N~l~~~~p-----~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 214 (843)
|+|++|++++.++. +..+++|+.|+|++|.+++..+ ..+.. .+|+.|+|++|.|++..|..|.++++|+.|+
T Consensus 431 L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 510 (844)
T 3j0a_A 431 LILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510 (844)
T ss_dssp EEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEE
T ss_pred eeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeE
Confidence 88888877766553 5667788888888888763222 22222 3788999999999988888899999999999
Q ss_pred CcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccccCCcccccCCCCCC
Q 003158 215 IANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSDD 287 (843)
Q Consensus 215 L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~ 287 (843)
|++|+|++..|..+. ++|+.|+|++|+|+++++.. +..+..|++++|||.|+|.+.+|..|+...
T Consensus 511 Ls~N~l~~l~~~~~~-------~~L~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~c~~~~f~~~~~~~ 575 (844)
T 3j0a_A 511 LNSNRLTVLSHNDLP-------ANLEILDISRNQLLAPNPDV-FVSLSVLDITHNKFICECELSTFINWLNHT 575 (844)
T ss_dssp EESCCCSSCCCCCCC-------SCCCEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCCSSSCCSHHHHHHHT
T ss_pred CCCCCCCccChhhhh-------ccccEEECCCCcCCCCChhH-hCCcCEEEecCCCcccccccHHHHHHHHhc
Confidence 999999876665543 56779999999999987654 668999999999999999999999887543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=302.40 Aligned_cols=168 Identities=21% Similarity=0.308 Sum_probs=106.2
Q ss_pred CCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCC---CCCCCCCCCCEEEcccCcCCCCCCCCCC--CcC
Q 003158 111 ELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPM---PDLSRIPNLGYLDLSSNQLNGSIPPGRL--SLN 185 (843)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~ 185 (843)
.+++|++|+|++|++++ .+|..+.++++|+.|+|++|++++++ ..+..+++|+.|+|++|.+++.+|...+ ..+
T Consensus 322 ~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTD-TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SCCCCCEEECCSSCCCT-TTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hCCcccEEEeECCccCh-hhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 34445555555555543 34445555555555555555555422 1245555555555555555543443321 125
Q ss_pred cCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCC-C-cCCCCcE
Q 003158 186 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS-F-NIPPNVT 263 (843)
Q Consensus 186 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~-~-~~~~l~~ 263 (843)
|+.|+|++|.+++..|..+. ++|+.|+|++|+|+ .+|..+..+ ++|+.|+|++|+|+.++.. + .++.++.
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l-----~~L~~L~L~~N~l~~l~~~~~~~l~~L~~ 472 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKL-----EALQELNVASNQLKSVPDGIFDRLTSLQK 472 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGC-----TTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcC-----CCCCEEECCCCcCCccCHHHhccCCcccE
Confidence 66666666666555554443 56677777777766 566655543 4567999999999999986 4 7899999
Q ss_pred EEeccCcccccCCcccc-cCCCCCC
Q 003158 264 VRLRGNPFCLNTNAEQF-CGSHSDD 287 (843)
Q Consensus 264 l~l~~Np~~c~~~~~~~-~~~~~~~ 287 (843)
|++++|||.|+|.+.++ ..|+...
T Consensus 473 L~l~~N~~~c~c~~~~~~~~~~~~~ 497 (520)
T 2z7x_B 473 IWLHTNPWDCSCPRIDYLSRWLNKN 497 (520)
T ss_dssp EECCSSCBCCCHHHHHHHHHHHHHT
T ss_pred EECcCCCCcccCCchHHHHHHHHhc
Confidence 99999999999999998 7787544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-30 Score=305.42 Aligned_cols=273 Identities=20% Similarity=0.242 Sum_probs=214.2
Q ss_pred cccCCCCCCEEEccCCcCCccCccccCCCCCCcE----------------------------EEcccCcCCccCcccccc
Q 003158 12 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDR----------------------------IQIDQNYISGSLPKSFAN 63 (843)
Q Consensus 12 ~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~----------------------------L~L~~N~l~~~~~~~~~~ 63 (843)
.|..+++|++|+|++|++++..+..|.++++|++ |+|++|++++..|..|..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 4555556666666666665555555555555554 555556666666777888
Q ss_pred CCCCCEEEccCCccccCCC-cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCC-CCCccccCCCCCc
Q 003158 64 LNKTRHFHMNNNSISGQIP-PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLL 141 (843)
Q Consensus 64 l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~l~~L~ 141 (843)
+++|+.|+|++|.+++.++ ..|.++++|++|+|++|++.+..+..|..+++|+.|++++|.+.+. .+|..|.++++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 8888888888888876555 6788888888888888888877788888888888898888887631 4688899999999
Q ss_pred EEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCC----CC-----CCCCcCcCEEEccCCcCCCCCCcccCCCCCCc
Q 003158 142 KLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSI----PP-----GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 211 (843)
Q Consensus 142 ~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~----p~-----~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 211 (843)
.|+|++|+++++++. +..+++|+.|+|++|++++.. |. .....+|+.|+|++|+++...+..|.++++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 999999999998885 899999999999999998431 11 11224899999999999966667899999999
Q ss_pred EEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC---cCCCCcEEEeccCcccccCCc-ccccCCCCCC
Q 003158 212 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCLNTNA-EQFCGSHSDD 287 (843)
Q Consensus 212 ~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~---~~~~l~~l~l~~Np~~c~~~~-~~~~~~~~~~ 287 (843)
.|+|++|+|++..+..|..+. +|+.|+|++|+|++++... .++.+..|++++|||.|+|.. .||..|+...
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~-----~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~~~~ 638 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQV-----SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCT-----TCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCSSCC
T ss_pred eeECCCCCCCcCCHhHhCCCC-----CCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHHHHhc
Confidence 999999999966665565544 5669999999999998764 579999999999999999996 9999998765
Q ss_pred Cc
Q 003158 288 DN 289 (843)
Q Consensus 288 ~~ 289 (843)
..
T Consensus 639 ~~ 640 (680)
T 1ziw_A 639 HT 640 (680)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-30 Score=285.20 Aligned_cols=273 Identities=19% Similarity=0.186 Sum_probs=193.9
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
|.++...+..|.++++|++|+|++|.+++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.++...+
T Consensus 55 ~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~ 134 (390)
T 3o6n_A 55 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 134 (390)
T ss_dssp CEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCH
Confidence 45553333346777888888888888887777778888888888888888887777777888888888888888875544
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccC--------------------------
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSN-------------------------- 136 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-------------------------- 136 (843)
..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++.. ...+.+
T Consensus 135 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~ 213 (390)
T 3o6n_A 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-LSLIPSLFHANVSYNLLSTLAIPIAVEELDAS 213 (390)
T ss_dssp TTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC-GGGCTTCSEEECCSSCCSEEECCSSCSEEECC
T ss_pred HHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc-cccccccceeecccccccccCCCCcceEEECC
Confidence 55677888888888888887776777778888888888888776421 111111
Q ss_pred -----------CCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCccc
Q 003158 137 -----------MSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNF 204 (843)
Q Consensus 137 -----------l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~ 204 (843)
.++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++..|..+.. .+|+.|+|++|.+++ +|..+
T Consensus 214 ~n~l~~~~~~~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~ 291 (390)
T 3o6n_A 214 HNSINVVRGPVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYG 291 (390)
T ss_dssp SSCCCEEECCCCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSS
T ss_pred CCeeeeccccccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCccc
Confidence 12455555555555543 34666777888888888887555544333 378888888888874 45566
Q ss_pred CCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccccCCcccccCCC
Q 003158 205 SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 284 (843)
Q Consensus 205 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~ 284 (843)
..+++|++|+|++|+++ .+|..+..+. +|+.|+|++|+|+.++ ...++.++.|++++|||.|+|...++..+.
T Consensus 292 ~~l~~L~~L~L~~n~l~-~~~~~~~~l~-----~L~~L~L~~N~i~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~ 364 (390)
T 3o6n_A 292 QPIPTLKVLDLSHNHLL-HVERNQPQFD-----RLENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNVA 364 (390)
T ss_dssp SCCTTCCEEECCSSCCC-CCGGGHHHHT-----TCSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTTTCC
T ss_pred CCCCCCCEEECCCCcce-ecCccccccC-----cCCEEECCCCccceeC-chhhccCCEEEcCCCCccchhHHHHHHHHH
Confidence 77888888888888887 5566665544 4568999999999886 336899999999999999999766655544
Q ss_pred C
Q 003158 285 S 285 (843)
Q Consensus 285 ~ 285 (843)
.
T Consensus 365 ~ 365 (390)
T 3o6n_A 365 R 365 (390)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=298.19 Aligned_cols=273 Identities=19% Similarity=0.188 Sum_probs=201.3
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|.+++..+..|.++++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|+++++|+.|+|++|.|++..
T Consensus 60 ~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~ 139 (597)
T 3oja_B 60 NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 139 (597)
T ss_dssp SCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCC
Confidence 34555444455677888888888888888777778888888888888888888777777888888888888888888665
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCC------------------------
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNM------------------------ 137 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l------------------------ 137 (843)
+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|.+++.. ...+.++
T Consensus 140 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~l 218 (597)
T 3oja_B 140 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-LSLIPSLFHANVSYNLLSTLAIPIAVEELDA 218 (597)
T ss_dssp TTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC-GGGCTTCSEEECCSSCCSEEECCTTCSEEEC
T ss_pred HHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC-hhhhhhhhhhhcccCccccccCCchhheeec
Confidence 566788888888888888888777777888888888888888876421 1111111
Q ss_pred -------------CCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcc
Q 003158 138 -------------SKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSN 203 (843)
Q Consensus 138 -------------~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~ 203 (843)
++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++.+|..+.. .+|+.|+|++|.+++ +|..
T Consensus 219 s~n~l~~~~~~~~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~ 296 (597)
T 3oja_B 219 SHNSINVVRGPVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLY 296 (597)
T ss_dssp CSSCCCEEECSCCSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECS
T ss_pred cCCcccccccccCCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcc
Confidence 2355555555555542 34667788888888888888666655443 478888888888885 4666
Q ss_pred cCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccccCCcccccCC
Q 003158 204 FSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGS 283 (843)
Q Consensus 204 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~ 283 (843)
+..+++|+.|+|++|.|+ .+|..+..+. +|+.|+|++|+|+.++ ...++.+..|++++|||.|+|...++..+
T Consensus 297 ~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~-----~L~~L~L~~N~l~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~~ 369 (597)
T 3oja_B 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFD-----RLENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNV 369 (597)
T ss_dssp SSCCTTCCEEECCSSCCC-CCGGGHHHHT-----TCSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTTTC
T ss_pred cccCCCCcEEECCCCCCC-ccCcccccCC-----CCCEEECCCCCCCCcC-hhhcCCCCEEEeeCCCCCChhHHHHHHHH
Confidence 777888888888888888 5777666554 4558999999998885 33688999999999999999966655544
Q ss_pred C
Q 003158 284 H 284 (843)
Q Consensus 284 ~ 284 (843)
.
T Consensus 370 ~ 370 (597)
T 3oja_B 370 A 370 (597)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=304.97 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=226.4
Q ss_pred CCccccccCCccccCCCCCCEEEccCCcCCcc-----------------CccccC--CCCCCcEEEcccCcCCccCcccc
Q 003158 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGS-----------------LPEELG--YLPKLDRIQIDQNYISGSLPKSF 61 (843)
Q Consensus 1 ~~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~ 61 (843)
|+|+++| +|..|+++++|++|+|++|++++. +|+.++ ++++|++|+|++|.+.+.+|..|
T Consensus 191 ~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l 269 (636)
T 4eco_A 191 LSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269 (636)
T ss_dssp CSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTT
T ss_pred ccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHH
Confidence 4789998 999999999999999999999986 999999 99999999999999999999999
Q ss_pred ccCCCCCEEEccCCc-ccc-CCCcccCCC------CCCceeeccCCCCCCCCCc--ccCCCCCCcEEEcCCCCCCCCCCC
Q 003158 62 ANLNKTRHFHMNNNS-ISG-QIPPELSRL------PSLVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNNFEGTTIP 131 (843)
Q Consensus 62 ~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~ 131 (843)
.++++|++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .+.++++|++|+|++|++.| .+|
T Consensus 270 ~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g-~ip 347 (636)
T 4eco_A 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEG-KLP 347 (636)
T ss_dssp TTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEE-ECC
T ss_pred hcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCcc-chh
Confidence 999999999999998 988 788888776 99999999999999 7888 89999999999999999986 678
Q ss_pred ccccCCCCCcEEEcCCCCCCCCCCCCCCCCC-CCEEEcccCcCCCCCCCCCCCc---CcCEEEccCCcCCCCCCcccC--
Q 003158 132 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN-LGYLDLSSNQLNGSIPPGRLSL---NITTIKLSNNKLTGTIPSNFS-- 205 (843)
Q Consensus 132 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~~---~L~~L~Ls~N~l~~~~p~~~~-- 205 (843)
.+.++++|+.|+|++|+++.++..+..+++ |+.|+|++|.++ .+|...... +|+.|+|++|.+++.+|..|.
T Consensus 348 -~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~ 425 (636)
T 4eco_A 348 -AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425 (636)
T ss_dssp -CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTT
T ss_pred -hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccc
Confidence 889999999999999999988778899998 999999999998 788765443 699999999999999998888
Q ss_pred -----CCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC-c-CC-------CCcEEEeccCcc
Q 003158 206 -----GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-N-IP-------PNVTVRLRGNPF 271 (843)
Q Consensus 206 -----~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-~-~~-------~l~~l~l~~Np~ 271 (843)
.+++|++|+|++|+|+ .+|..+.. ..++|+.|+|++|+|+.++... . .. .++.|++++|.+
T Consensus 426 ~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~----~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 500 (636)
T 4eco_A 426 DPTPFKGINVSSINLSNNQIS-KFPKELFS----TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500 (636)
T ss_dssp CSSCCCCCCEEEEECCSSCCC-SCCTHHHH----TTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCC
T ss_pred ccccccCCCCCEEECcCCccC-cCCHHHHc----cCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcC
Confidence 8889999999999998 56655433 1234557888888888777654 2 22 788888888876
Q ss_pred c
Q 003158 272 C 272 (843)
Q Consensus 272 ~ 272 (843)
.
T Consensus 501 ~ 501 (636)
T 4eco_A 501 T 501 (636)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=284.56 Aligned_cols=279 Identities=19% Similarity=0.236 Sum_probs=229.3
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
.|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.|++..
T Consensus 40 ~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 116 (353)
T 2z80_A 40 SGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLS 116 (353)
T ss_dssp STTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCC
T ss_pred CCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCC
Confidence 45666 6777665 58999999999999877778999999999999999999888888999999999999999999665
Q ss_pred CcccCCCCCCceeeccCCCCCCCCC-cccCCCCCCcEEEcCCCC-CCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNN-FEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLS 158 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~ 158 (843)
+..|.++++|++|+|++|+++...+ ..+..+++|++|++++|. +.. ..+..|.++++|+.|++++|++++..+ .+.
T Consensus 117 ~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~ 195 (353)
T 2z80_A 117 SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK-IQRKDFAGLTFLEELEIDASDLQSYEPKSLK 195 (353)
T ss_dssp HHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCE-ECTTTTTTCCEEEEEEEEETTCCEECTTTTT
T ss_pred HhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccc-cCHHHccCCCCCCEEECCCCCcCccCHHHHh
Confidence 5668999999999999999995544 478999999999999995 543 446789999999999999999998766 589
Q ss_pred CCCCCCEEEcccCcCCCCCCCCCC--CcCcCEEEccCCcCCCCCCcccC---CCCCCcEEeCcCccCCCC----CCchhh
Q 003158 159 RIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNNKLTGTIPSNFS---GLPRLQRLFIANNSLSGS----IPSSIW 229 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~----~p~~~~ 229 (843)
.+++|+.|++++|.++ .+|.... ..+|+.|+|++|.+++..+..+. ....++.++|++|.+++. +|..+.
T Consensus 196 ~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~ 274 (353)
T 2z80_A 196 SIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274 (353)
T ss_dssp TCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHH
T ss_pred ccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHh
Confidence 9999999999999987 5554332 34899999999999987665544 467788999999988863 555555
Q ss_pred ccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccCC-cccccCCCCCCCcc
Q 003158 230 QSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDDDNE 290 (843)
Q Consensus 230 ~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~~-~~~~~~~~~~~~~~ 290 (843)
.+ ++|+.|+|++|+|+.++... .+++++.|++++|||.|+|. +.++..|.......
T Consensus 275 ~l-----~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~l~~l~~~~~~~~~~ 333 (353)
T 2z80_A 275 QI-----SGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK 333 (353)
T ss_dssp TC-----TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHHHHHHHHHTTTT
T ss_pred cc-----cCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCCcHHHHHHHHhcccc
Confidence 44 45669999999999999874 78999999999999999996 77777777654433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=307.28 Aligned_cols=235 Identities=21% Similarity=0.271 Sum_probs=191.0
Q ss_pred CccccCCCCCCcEEEcccCcCCc-----------------cCccccc--cCCCCCEEEccCCccccCCCcccCCCCCCce
Q 003158 33 LPEELGYLPKLDRIQIDQNYISG-----------------SLPKSFA--NLNKTRHFHMNNNSISGQIPPELSRLPSLVH 93 (843)
Q Consensus 33 ~p~~~~~l~~L~~L~L~~N~l~~-----------------~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 93 (843)
+|..|++|++|++|+|++|+|++ .+|..++ ++++|+.|+|++|.+.+.+|..|.++++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 77888888899999999999887 3788877 8889999999998888888888888899999
Q ss_pred eeccCCC-CCC-CCCcccCCC-------CCCcEEEcCCCCCCCCCCCc--cccCCCCCcEEEcCCCCCCCCCCCCCCCCC
Q 003158 94 MLLDNNN-LTG-YLPPELSEL-------PKLLILQLDNNNFEGTTIPA--SYSNMSKLLKLSLRNCSLQGPMPDLSRIPN 162 (843)
Q Consensus 94 L~L~~N~-l~~-~~~~~~~~l-------~~L~~L~Ls~N~l~~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 162 (843)
|+|++|+ +++ .+|..+..+ ++|+.|+|++|+++ .+|. .+.++++|+.|+|++|+++.++ .+..+++
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~--~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-~~~~L~~ 596 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE--EFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVK 596 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC--BCCCHHHHTTCTTCCEEECTTSCCCBCC-CCCTTSE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC--ccCChhhhhcCCCCCEEECCCCCcccch-hhcCCCc
Confidence 9999988 876 677655544 48899999999886 5777 8888889999999999888655 7888888
Q ss_pred CCEEEcccCcCCCCCCCCCCCc-C-cCEEEccCCcCCCCCCcccCCCCC--CcEEeCcCccCCCCCCchhhccccCCCCc
Q 003158 163 LGYLDLSSNQLNGSIPPGRLSL-N-ITTIKLSNNKLTGTIPSNFSGLPR--LQRLFIANNSLSGSIPSSIWQSRTLNATE 238 (843)
Q Consensus 163 L~~L~Ls~N~l~~~~p~~~~~~-~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~l~~~~ 238 (843)
|+.|+|++|+++ .+|..+... + |+.|+|++|.|+ .+|..+..++. |+.|+|++|+|++.+|.....+..+..++
T Consensus 597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~ 674 (876)
T 4ecn_A 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674 (876)
T ss_dssp ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCC
Confidence 999999999888 777665543 5 889999999888 77877777654 88899999988887776555555566678
Q ss_pred ceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCccc
Q 003158 239 TFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 239 L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~ 272 (843)
|+.|+|++|+|+.++... .++.|+.|+|++|.+.
T Consensus 675 L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~ 710 (876)
T 4ecn_A 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710 (876)
T ss_dssp EEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS
T ss_pred cCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC
Confidence 888888888888887654 5788888888888765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=291.97 Aligned_cols=128 Identities=16% Similarity=0.246 Sum_probs=89.6
Q ss_pred CCCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCC-CCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccC
Q 003158 157 LSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLT-GTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234 (843)
Q Consensus 157 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l 234 (843)
+..+++|+.|++++|.+++.+|..+.. .+|+.|+|++|.++ +.+|..|..+++|++|+|++|++++..|..+..+
T Consensus 417 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--- 493 (570)
T 2z63_A 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL--- 493 (570)
T ss_dssp TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC---
T ss_pred hhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcc---
Confidence 444555555555555555444433222 36666666666665 4566667777777777777777776666666554
Q ss_pred CCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccCCccccc-CCCCCCCc
Q 003158 235 NATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFC-GSHSDDDN 289 (843)
Q Consensus 235 ~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~~~~~~~-~~~~~~~~ 289 (843)
++|+.|++++|+|++++... .++.++.|++++|||.|+|...++. .|+.....
T Consensus 494 --~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~ 549 (570)
T 2z63_A 494 --SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQ 549 (570)
T ss_dssp --TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGG
T ss_pred --cCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccc
Confidence 45669999999999998754 7899999999999999999988876 88765443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=267.61 Aligned_cols=258 Identities=17% Similarity=0.223 Sum_probs=153.2
Q ss_pred CEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccC--CCcccCCCCCCceeecc
Q 003158 20 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ--IPPELSRLPSLVHMLLD 97 (843)
Q Consensus 20 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~L~ 97 (843)
+.++.+++.++ .+|..+. ++|++|+|++|+++...+..|.++++|+.|+|++|.++.. .+..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 35555555555 4444332 4566666666666533333455666666666666665522 13444455666666666
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCC-
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG- 175 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~- 175 (843)
+|.++ .+|..+..+++|++|+|++|++.+......+..+++|+.|+|++|.+++..+. +..+++|+.|+|++|.+++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 66655 34445555666666666666665321113555666666666666666555443 5556666666666666654
Q ss_pred CCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCC
Q 003158 176 SIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254 (843)
Q Consensus 176 ~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~ 254 (843)
.+|..+.. .+|+.|+|++|.+++..|..|..+++|++|+|++|++++..+..+..+ ++|+.|+|++|++++...
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL-----NSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC-----TTCCEEECTTSCCCBCSS
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc-----ccCCEeECCCCCCcccCH
Confidence 23333322 256666666666666666666666677777777777665555444433 344467777777766554
Q ss_pred CC--cC-CCCcEEEeccCcccccCCcccccCCCCC
Q 003158 255 SF--NI-PPNVTVRLRGNPFCLNTNAEQFCGSHSD 286 (843)
Q Consensus 255 ~~--~~-~~l~~l~l~~Np~~c~~~~~~~~~~~~~ 286 (843)
.. .+ +.+..|++++|+|.|+|...++..|+..
T Consensus 241 ~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~ 275 (306)
T 2z66_A 241 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 275 (306)
T ss_dssp SSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHH
T ss_pred HHHHhhhccCCEEEccCCCeecccChHHHHHHHHh
Confidence 32 45 3789999999999999999999888764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=292.86 Aligned_cols=258 Identities=20% Similarity=0.276 Sum_probs=150.2
Q ss_pred CccccccCCc--cccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCC-CCEEEccCCccc
Q 003158 2 WNKISGSIPK--EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNK-TRHFHMNNNSIS 78 (843)
Q Consensus 2 ~N~i~~~~p~--~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~ 78 (843)
+|+++ .+|. .|+++++|++|+|++|+++|.+| .|+.+++|++|+|++|+++ .+|..+..+++ |+.|+|++|.++
T Consensus 314 ~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~ 390 (636)
T 4eco_A 314 YNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK 390 (636)
T ss_dssp SSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS
T ss_pred CCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc
Confidence 34455 4555 55555555555555555555555 5555555555555555555 45555555555 666666666555
Q ss_pred cCCCcccCCCC--CCceeeccCCCCCCCCCcccC-------CCCCCcEEEcCCCCCCCCCCCc-cccCCCCCcEEEcCCC
Q 003158 79 GQIPPELSRLP--SLVHMLLDNNNLTGYLPPELS-------ELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNC 148 (843)
Q Consensus 79 ~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~-~~~~l~~L~~L~L~~N 148 (843)
.+|..+..++ +|+.|+|++|++++..|..|. .+++|++|+|++|+++ .+|. .+..+++|+.|+|++|
T Consensus 391 -~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~--~lp~~~~~~l~~L~~L~Ls~N 467 (636)
T 4eco_A 391 -YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS--KFPKELFSTGSPLSSINLMGN 467 (636)
T ss_dssp -SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC--SCCTHHHHTTCCCSEEECCSS
T ss_pred -ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC--cCCHHHHccCCCCCEEECCCC
Confidence 4455544433 566666666666655555555 5556666666666665 2333 2344666666666666
Q ss_pred CCCCCCCC-CCCC-------CCCCEEEcccCcCCCCCCCCCC---CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeC--
Q 003158 149 SLQGPMPD-LSRI-------PNLGYLDLSSNQLNGSIPPGRL---SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFI-- 215 (843)
Q Consensus 149 ~l~~~~~~-~~~l-------~~L~~L~Ls~N~l~~~~p~~~~---~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L-- 215 (843)
+++.++.. +... ++|+.|+|++|+++ .+|.... ..+|+.|+|++|+|++ +|..+..+++|+.|+|
T Consensus 468 ~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~ 545 (636)
T 4eco_A 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545 (636)
T ss_dssp CCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCS
T ss_pred CCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCC
Confidence 66655543 2222 26666666666666 5555443 2366666666666665 5666666666666666
Q ss_pred ----cCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccc
Q 003158 216 ----ANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 216 ----~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c 273 (843)
++|++.+.+|..+..+. +|+.|+|++|+|+.+|.... +.++.|++++||+.|
T Consensus 546 N~~ls~N~l~~~~p~~l~~l~-----~L~~L~Ls~N~l~~ip~~~~-~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 546 QRDAQGNRTLREWPEGITLCP-----SLTQLQIGSNDIRKVNEKIT-PNISVLDIKDNPNIS 601 (636)
T ss_dssp CBCTTCCBCCCCCCTTGGGCS-----SCCEEECCSSCCCBCCSCCC-TTCCEEECCSCTTCE
T ss_pred CcccccCcccccChHHHhcCC-----CCCEEECCCCcCCccCHhHh-CcCCEEECcCCCCcc
Confidence 44556666666665543 34467777777777765543 677777777777765
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-28 Score=262.53 Aligned_cols=256 Identities=24% Similarity=0.337 Sum_probs=157.2
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
|+++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.++ .+|
T Consensus 43 ~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~ 118 (332)
T 2ft3_A 43 LGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIP 118 (332)
T ss_dssp SCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCC
T ss_pred CCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccC
Confidence 3444 4555443 46666666666666655666666666666666666666666666666666666666666666 344
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCC-CCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG-TTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
..+. ++|++|++++|+++...+..|.++++|++|+|++|.++. ...+..+..+ +|+.|++++|++++++..+. +
T Consensus 119 ~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~--~ 193 (332)
T 2ft3_A 119 PNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP--E 193 (332)
T ss_dssp SSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC--S
T ss_pred cccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcccc--C
Confidence 4333 566666666666665555556666666777776666642 1234555555 66666666666666555433 5
Q ss_pred CCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcce
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~ 240 (843)
+|+.|+|++|.+++..+..+.. .+|+.|+|++|.+++..+..|..+++|++|+|++|+|+ .+|..+..+. +|+
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~-----~L~ 267 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK-----LLQ 267 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCT-----TCC
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCc-----cCC
Confidence 6666777777766444333332 36677777777776666666666777777777777766 5666554433 344
Q ss_pred eEEcCCCCCCCCCCCC--------cCCCCcEEEeccCcccc
Q 003158 241 ILDFQNNNLTNISGSF--------NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 241 ~L~l~~N~l~~~~~~~--------~~~~l~~l~l~~Np~~c 273 (843)
.|++++|+|+.++... ..+.+..|++.+||+.+
T Consensus 268 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 268 VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp EEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred EEECCCCCCCccChhHccccccccccccccceEeecCcccc
Confidence 6777777777665432 13456667777776653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-28 Score=261.47 Aligned_cols=257 Identities=21% Similarity=0.335 Sum_probs=182.7
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
+.++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.++ .+|
T Consensus 41 ~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~ 116 (330)
T 1xku_A 41 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELP 116 (330)
T ss_dssp SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCC
T ss_pred CCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccC
Confidence 3444 4555443 57778888888888766667788888888888888887776777888888888888888877 445
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCC-CCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
..+. ++|++|++++|++++..+..|.++++|++|+|++|.+... ..+..+.++++|+.|++++|.++.++..+. +
T Consensus 117 ~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~ 192 (330)
T 1xku_A 117 EKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP--P 192 (330)
T ss_dssp SSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--T
T ss_pred hhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc--c
Confidence 4443 6788888888888766666777788888888888877421 345667777888888888888777666543 6
Q ss_pred CCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcce
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~ 240 (843)
+|+.|++++|.+++..+..+.. .+|+.|+|++|.+++..+..|..+++|++|+|++|+|+ .+|..+..+. +|+
T Consensus 193 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~-----~L~ 266 (330)
T 1xku_A 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK-----YIQ 266 (330)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS-----SCC
T ss_pred cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCC-----CcC
Confidence 7888888888877554444333 37888888888887777777777888888888888877 6676665443 455
Q ss_pred eEEcCCCCCCCCCCCC--------cCCCCcEEEeccCcccc
Q 003158 241 ILDFQNNNLTNISGSF--------NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 241 ~L~l~~N~l~~~~~~~--------~~~~l~~l~l~~Np~~c 273 (843)
.|++++|+|++++... ..+.+..|++.+||+.+
T Consensus 267 ~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 267 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp EEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred EEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 7888888888776533 13566777888888754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-28 Score=276.51 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=196.7
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccC-ccccccCCCCCEEEccCCccccC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNNNSISGQ 80 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~ 80 (843)
+++++ .+|. +. ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|.+++.
T Consensus 19 ~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~ 94 (455)
T 3v47_A 19 NRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQL 94 (455)
T ss_dssp SSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEE
T ss_pred CCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCcc
Confidence 34555 5665 33 78999999999999988999999999999999999997544 67899999999999999999988
Q ss_pred CCcccCCCCCCceeeccCCCCCCCCCcc--cCCCCCCcEEEcCCCCCCCCCCCcc-ccCCCCCcEEEcCCCCCCCCCCC-
Q 003158 81 IPPELSRLPSLVHMLLDNNNLTGYLPPE--LSELPKLLILQLDNNNFEGTTIPAS-YSNMSKLLKLSLRNCSLQGPMPD- 156 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~- 156 (843)
.|..|.++++|++|+|++|++++..+.. |..+++|++|+|++|++.+ ..|.. +.++++|+.|+|++|++++..+.
T Consensus 95 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 173 (455)
T 3v47_A 95 ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-IQPASFFLNMRRFHVLDLTFNKVKSICEED 173 (455)
T ss_dssp CTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCS-CCCCGGGGGCTTCCEEECTTCCBSCCCTTT
T ss_pred ChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCc-cCcccccCCCCcccEEeCCCCcccccChhh
Confidence 8999999999999999999999755544 9999999999999999986 44655 89999999999999999987663
Q ss_pred CCC----------------------------------CCCCCEEEcccCcCCCCCCCCC---------------------
Q 003158 157 LSR----------------------------------IPNLGYLDLSSNQLNGSIPPGR--------------------- 181 (843)
Q Consensus 157 ~~~----------------------------------l~~L~~L~Ls~N~l~~~~p~~~--------------------- 181 (843)
+.. +++|+.|++++|++++.+|..+
T Consensus 174 l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~ 253 (455)
T 3v47_A 174 LLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253 (455)
T ss_dssp SGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTS
T ss_pred hhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccc
Confidence 332 3567777777776653221100
Q ss_pred -------------------CCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeE
Q 003158 182 -------------------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242 (843)
Q Consensus 182 -------------------~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L 242 (843)
...+|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..+..+. +|+.|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-----~L~~L 328 (455)
T 3v47_A 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT-----HLLKL 328 (455)
T ss_dssp CCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT-----TCCEE
T ss_pred cccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcc-----cCCEE
Confidence 012566667777777666666677777777777777777666666665443 33466
Q ss_pred EcCCCCCCCCCCCC--cCCCCcEEEeccCcc
Q 003158 243 DFQNNNLTNISGSF--NIPPNVTVRLRGNPF 271 (843)
Q Consensus 243 ~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~ 271 (843)
+|++|+|++++... .++.++.|++++|.+
T Consensus 329 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 359 (455)
T 3v47_A 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359 (455)
T ss_dssp ECCSSCCCEECGGGGTTCTTCCEEECCSSCC
T ss_pred ECCCCccCCcChhHhcCcccCCEEECCCCcc
Confidence 66666666654432 466666666666655
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=294.92 Aligned_cols=260 Identities=24% Similarity=0.307 Sum_probs=225.1
Q ss_pred cCCcccc--CCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCc-CCc-cCccccccCC-------CCCEEEccCCc
Q 003158 8 SIPKEIG--NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY-ISG-SLPKSFANLN-------KTRHFHMNNNS 76 (843)
Q Consensus 8 ~~p~~i~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~Ls~N~ 76 (843)
.+|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+.+++ +|+.|+|++|.
T Consensus 480 ~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~ 559 (876)
T 4ecn_A 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559 (876)
T ss_dssp HTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSC
T ss_pred cCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCc
Confidence 4999988 99999999999999999999999999999999999998 998 7888777766 99999999999
Q ss_pred cccCCCc--ccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCC-CcEEEcCCCCCCCC
Q 003158 77 ISGQIPP--ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK-LLKLSLRNCSLQGP 153 (843)
Q Consensus 77 l~~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~-L~~L~L~~N~l~~~ 153 (843)
|+ .+|. .|.++++|+.|+|++|+++ .+| .|..+++|+.|+|++|++. .+|..+.++++ |+.|+|++|+++.+
T Consensus 560 L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~--~lp~~l~~l~~~L~~L~Ls~N~L~~l 634 (876)
T 4ecn_A 560 LE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE--EIPEDFCAFTDQVEGLGFSHNKLKYI 634 (876)
T ss_dssp CC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS--CCCTTSCEECTTCCEEECCSSCCCSC
T ss_pred CC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc--cchHHHhhccccCCEEECcCCCCCcC
Confidence 99 8888 8999999999999999999 778 9999999999999999997 68989999999 99999999999987
Q ss_pred CCCCCCCC--CCCEEEcccCcCCCCCCCCC------CCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCC
Q 003158 154 MPDLSRIP--NLGYLDLSSNQLNGSIPPGR------LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 225 (843)
Q Consensus 154 ~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~------~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 225 (843)
+..+..+. +|+.|+|++|++++.+|... ...+|+.|+|++|.|+...+..+..+++|+.|+|++|+|+ .+|
T Consensus 635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip 713 (876)
T 4ecn_A 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIP 713 (876)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCC
T ss_pred chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccC
Confidence 76666665 49999999999998776533 1237999999999999544444568999999999999999 777
Q ss_pred chhhcccc--C-CCCcceeEEcCCCCCCCCCCCC---cCCCCcEEEeccCcccc
Q 003158 226 SSIWQSRT--L-NATETFILDFQNNNLTNISGSF---NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 226 ~~~~~l~~--l-~~~~L~~L~l~~N~l~~~~~~~---~~~~l~~l~l~~Np~~c 273 (843)
..+..... + ++++|+.|+|++|+|+.++... .++.|+.|+|++|.+..
T Consensus 714 ~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~ 767 (876)
T 4ecn_A 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS 767 (876)
T ss_dssp TTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred hHHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCc
Confidence 76654321 0 2337889999999999998765 68999999999998763
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=269.64 Aligned_cols=242 Identities=26% Similarity=0.479 Sum_probs=215.3
Q ss_pred Cccccc--cCCccccCCCCCCEEEccC-CcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccc
Q 003158 2 WNKISG--SIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 78 (843)
Q Consensus 2 ~N~i~~--~~p~~i~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 78 (843)
+|+++| .+|..|.++++|++|+|++ |++.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|.++
T Consensus 59 ~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 138 (313)
T 1ogq_A 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138 (313)
T ss_dssp CCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred CCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccC
Confidence 578888 8999999999999999995 9999899999999999999999999999899999999999999999999999
Q ss_pred cCCCcccCCCCCCceeeccCCCCCCCCCcccCCCC-CCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-C
Q 003158 79 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELP-KLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-D 156 (843)
Q Consensus 79 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~ 156 (843)
+.+|..+..+++|++|+|++|++++.+|..+..++ +|++|+|++|++++ .+|..+..++ |+.|+|++|.+++.++ .
T Consensus 139 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~-~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~ 216 (313)
T 1ogq_A 139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-KIPPTFANLN-LAFVDLSRNMLEGDASVL 216 (313)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE-ECCGGGGGCC-CSEEECCSSEEEECCGGG
T ss_pred CcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeec-cCChHHhCCc-ccEEECcCCcccCcCCHH
Confidence 88999999999999999999999988999999998 99999999999986 6788888887 9999999999998777 4
Q ss_pred CCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCC
Q 003158 157 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236 (843)
Q Consensus 157 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~ 236 (843)
+..+++|+.|+|++|.+++.+|......+|+.|+|++|.|++.+|..|..+++|+.|+|++|+|+|.+|.. ..+
T Consensus 217 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l----- 290 (313)
T 1ogq_A 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNL----- 290 (313)
T ss_dssp CCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTG-----
T ss_pred HhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccc-----
Confidence 88999999999999999877777555568999999999999999999999999999999999999988876 444
Q ss_pred CcceeEEcCCCC-CCC
Q 003158 237 TETFILDFQNNN-LTN 251 (843)
Q Consensus 237 ~~L~~L~l~~N~-l~~ 251 (843)
++|+.|++++|. +.+
T Consensus 291 ~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 291 QRFDVSAYANNKCLCG 306 (313)
T ss_dssp GGSCGGGTCSSSEEES
T ss_pred cccChHHhcCCCCccC
Confidence 455589999997 544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=284.16 Aligned_cols=122 Identities=20% Similarity=0.301 Sum_probs=85.8
Q ss_pred CCCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCc-----------------ccCCCCCCcEEeCcCc
Q 003158 157 LSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPS-----------------NFSGLPRLQRLFIANN 218 (843)
Q Consensus 157 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~-----------------~~~~l~~L~~L~L~~N 218 (843)
+..+++|+.|+|++|+++ .+|..... .+|+.|+|++|.|+..... .+..+++|++|+|++|
T Consensus 383 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N 461 (549)
T 2z81_A 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRN 461 (549)
T ss_dssp GGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSS
T ss_pred hhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCC
Confidence 455667777777777776 45544332 2555555555555421111 1247889999999999
Q ss_pred cCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccCC-cccccCCCCC
Q 003158 219 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSD 286 (843)
Q Consensus 219 ~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~~-~~~~~~~~~~ 286 (843)
+|+ .+|.. .. .++|+.|+|++|+|+++++.. .++.++.|++++|||.|+|. ..++..|+..
T Consensus 462 ~l~-~ip~~-~~-----l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l~~~l~~ 525 (549)
T 2z81_A 462 KLK-TLPDA-SL-----FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNK 525 (549)
T ss_dssp CCS-SCCCG-GG-----CTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHHHHHHHH
T ss_pred ccC-cCCCc-cc-----CccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHHHHHHHh
Confidence 998 67763 22 457789999999999998763 79999999999999999998 4556567644
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=258.24 Aligned_cols=261 Identities=20% Similarity=0.291 Sum_probs=221.5
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|..+. ++|++|++++|.+++..
T Consensus 61 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~ 137 (330)
T 1xku_A 61 NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVR 137 (330)
T ss_dssp SSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBC
T ss_pred CCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccC
Confidence 68999888889999999999999999999888999999999999999999999 5665554 79999999999999888
Q ss_pred CcccCCCCCCceeeccCCCCCC--CCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTG--YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLS 158 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~ 158 (843)
+..|.++++|+.|+|++|+++. ..+..+.++++|++|++++|.+. .+|..+. ++|+.|+|++|++++.++ .+.
T Consensus 138 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~--~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~ 213 (330)
T 1xku_A 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT--TIPQGLP--PSLTELHLDGNKITKVDAASLK 213 (330)
T ss_dssp HHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC--SCCSSCC--TTCSEEECTTSCCCEECTGGGT
T ss_pred HhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc--cCCcccc--ccCCEEECCCCcCCccCHHHhc
Confidence 8889999999999999999973 67888999999999999999997 4666554 899999999999999876 599
Q ss_pred CCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhcccc-CCC
Q 003158 159 RIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT-LNA 236 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-l~~ 236 (843)
.+++|+.|+|++|.+++..+..+.. .+|+.|+|++|.++ .+|..+..+++|++|+|++|+|++..+..|..... ...
T Consensus 214 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~ 292 (330)
T 1xku_A 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292 (330)
T ss_dssp TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTS
T ss_pred CCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccccccc
Confidence 9999999999999999655544433 48999999999999 78889999999999999999999777776654422 234
Q ss_pred CcceeEEcCCCCCCCCC--C-CC-cCCCCcEEEeccCc
Q 003158 237 TETFILDFQNNNLTNIS--G-SF-NIPPNVTVRLRGNP 270 (843)
Q Consensus 237 ~~L~~L~l~~N~l~~~~--~-~~-~~~~l~~l~l~~Np 270 (843)
+.|+.|++++|.+.... + .+ .+..++.+++++|.
T Consensus 293 ~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 67889999999998643 2 22 57778888888873
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=261.95 Aligned_cols=228 Identities=21% Similarity=0.287 Sum_probs=208.5
Q ss_pred CCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceee
Q 003158 16 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 95 (843)
Q Consensus 16 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 95 (843)
..+++.|+|++|+++ .+|..++++++|++|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..+.++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 478999999999999 88888999999999999999999 88999999999999999999999 7899999999999999
Q ss_pred ccCCCCCCCCCcccCC---------CCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEE
Q 003158 96 LDNNNLTGYLPPELSE---------LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYL 166 (843)
Q Consensus 96 L~~N~l~~~~~~~~~~---------l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L 166 (843)
|++|++.+.+|..+.. +++|++|+|++|+++ .+|..+.++++|+.|+|++|+++++++.+..+++|+.|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~--~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR--SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC--CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC--cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEE
Confidence 9999999899987765 999999999999997 67899999999999999999999988889999999999
Q ss_pred EcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcC
Q 003158 167 DLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 245 (843)
Q Consensus 167 ~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~ 245 (843)
+|++|.+.+.+|..+.. .+|+.|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|..+..+.++ +.+++.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L-----~~l~l~ 309 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN-----CIILVP 309 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTT-----CEEECC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCc-----eEEeCC
Confidence 99999999999886654 489999999999999999999999999999999999999999999877654 478888
Q ss_pred CCCCCCCC
Q 003158 246 NNNLTNIS 253 (843)
Q Consensus 246 ~N~l~~~~ 253 (843)
.|.+..++
T Consensus 310 ~~~~~~l~ 317 (328)
T 4fcg_A 310 PHLQAQLD 317 (328)
T ss_dssp GGGSCC--
T ss_pred HHHHHHHh
Confidence 87776654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=259.36 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=221.7
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|..+. ++|++|++++|.++...
T Consensus 63 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~ 139 (332)
T 2ft3_A 63 NNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVP 139 (332)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCC
T ss_pred CCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccC
Confidence 68899888889999999999999999999988999999999999999999999 5665554 89999999999999777
Q ss_pred CcccCCCCCCceeeccCCCCC--CCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLT--GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLS 158 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~ 158 (843)
+..|.++++|+.|++++|.++ +..+..+..+ +|++|++++|++++ +|..+. ++|+.|+|++|.+++.++ .+.
T Consensus 140 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~--l~~~~~--~~L~~L~l~~n~i~~~~~~~l~ 214 (332)
T 2ft3_A 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG--IPKDLP--ETLNELHLDHNKIQAIELEDLL 214 (332)
T ss_dssp SGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS--CCSSSC--SSCSCCBCCSSCCCCCCTTSST
T ss_pred HhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc--cCcccc--CCCCEEECCCCcCCccCHHHhc
Confidence 778999999999999999996 4778888888 99999999999974 666554 799999999999999886 599
Q ss_pred CCCCCCEEEcccCcCCCCCCCCCC-CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccc-cCCC
Q 003158 159 RIPNLGYLDLSSNQLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSR-TLNA 236 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~l~~ 236 (843)
.+++|+.|+|++|++++..+..+. ..+|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++..+..+.... ....
T Consensus 215 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 293 (332)
T 2ft3_A 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKR 293 (332)
T ss_dssp TCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSS
T ss_pred CCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccccccc
Confidence 999999999999999965554443 348999999999999 7888899999999999999999977777776542 1225
Q ss_pred CcceeEEcCCCCCC--CCCCC-C-cCCCCcEEEeccCc
Q 003158 237 TETFILDFQNNNLT--NISGS-F-NIPPNVTVRLRGNP 270 (843)
Q Consensus 237 ~~L~~L~l~~N~l~--~~~~~-~-~~~~l~~l~l~~Np 270 (843)
+.|+.|++++|.+. .+++. + .++.++.+++.+|.
T Consensus 294 ~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 67889999999998 44443 2 68889999998874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=273.68 Aligned_cols=260 Identities=20% Similarity=0.271 Sum_probs=201.9
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
++++ .+|..+. .+|+.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|+|+...+
T Consensus 21 ~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 97 (477)
T 2id5_A 21 KRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPL 97 (477)
T ss_dssp CCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCT
T ss_pred CCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCc
Confidence 4566 6777664 689999999999999889999999999999999999998889999999999999999999997777
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIP 161 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~ 161 (843)
..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+.+ ..+..|.++++|+.|+|++|+++++++. +..++
T Consensus 98 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 176 (477)
T 2id5_A 98 GVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH 176 (477)
T ss_dssp TSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE-ECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCT
T ss_pred ccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccce-eChhhccCCCCCCEEECCCCcCcccChhHhcccC
Confidence 789999999999999999998889999999999999999999986 4577899999999999999999998874 89999
Q ss_pred CCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcce
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~ 240 (843)
+|+.|+|++|.+++..+..+.. .+|+.|+|++|.+.+.+|..+....+|++|+|++|+|++..+..+..+ ++|+
T Consensus 177 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~ 251 (477)
T 2id5_A 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL-----VYLR 251 (477)
T ss_dssp TCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTC-----TTCC
T ss_pred CCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCc-----cccC
Confidence 9999999999999654444333 378888877766555555444444455555555555553222233322 2333
Q ss_pred eEEcCCCCCCCCCCCC--cCCCCcEEEeccCcc
Q 003158 241 ILDFQNNNLTNISGSF--NIPPNVTVRLRGNPF 271 (843)
Q Consensus 241 ~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~ 271 (843)
.|+|++|+|+.++... .++.|+.|++++|.+
T Consensus 252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 284 (477)
T 2id5_A 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL 284 (477)
T ss_dssp EEECCSSCCCEECTTSCTTCTTCCEEECCSSCC
T ss_pred eeECCCCcCCccChhhccccccCCEEECCCCcc
Confidence 4555555555544432 444555555555443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=294.71 Aligned_cols=185 Identities=18% Similarity=0.109 Sum_probs=129.8
Q ss_pred cccccCCeeEEEEE-eCCCcEEEEEEeccCC----------hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEE
Q 003158 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGS----------LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 518 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 585 (843)
..+.|++|.+..++ .--|+.||+|++.... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666655 2358899999987532 12235799999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||++|++|.++|.+.+ +++.. +|+.||+.||+|+|++| ||||||||+|||++++|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997654 35443 58899999999999999 999999999999999999999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP 718 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~p 718 (843)
. .......||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus 393 ~-------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 C-------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C-------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 1 223456799999999999764 56789999999999887765433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=253.54 Aligned_cols=237 Identities=21% Similarity=0.248 Sum_probs=173.7
Q ss_pred CCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccC
Q 003158 19 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 98 (843)
Q Consensus 19 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 98 (843)
-+.++.+++.++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 367888888888 556543 46888888888888877777788888888888888888877777888888888888888
Q ss_pred CC-CCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCC
Q 003158 99 NN-LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGS 176 (843)
Q Consensus 99 N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~ 176 (843)
|+ ++...+..|..+++|++|+|++|++.+ ..+..+.++++|++|+|++|+++++++. +..+++|+.|+|++|++++.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCE-ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence 86 776667778888888888888888875 4466778888888888888888877764 77778888888888877732
Q ss_pred CCCCCC-CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCC
Q 003158 177 IPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 255 (843)
Q Consensus 177 ~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~ 255 (843)
.+..+. ..+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..+.
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-------------------------- 222 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA-------------------------- 222 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHT--------------------------
T ss_pred CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcc--------------------------
Confidence 222222 23566666666666666666666666666666666666643333332
Q ss_pred CcCCCCcEEEeccCcccccCCcccccCCCCC
Q 003158 256 FNIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 286 (843)
Q Consensus 256 ~~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~ 286 (843)
.++.++.|++++|||.|+|...++..|+..
T Consensus 223 -~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~ 252 (285)
T 1ozn_A 223 -PLRALQYLRLNDNPWVCDCRARPLWAWLQK 252 (285)
T ss_dssp -TCTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred -cCcccCEEeccCCCccCCCCcHHHHHHHHh
Confidence 356778899999999999999888888753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=279.32 Aligned_cols=249 Identities=21% Similarity=0.241 Sum_probs=220.5
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
+|+.|++++|.+++..+..|+++++|++|+|++|+++ .+|..+.++++|++|++++|.+++..|..+..+++|++|+++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 7999999999999888889999999999999999999 788899999999999999999998888899999999999999
Q ss_pred CCCCCCCCCc-ccCCCCCCcEEEcCCCCCCCCCC--CccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcC
Q 003158 98 NNNLTGYLPP-ELSELPKLLILQLDNNNFEGTTI--PASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQL 173 (843)
Q Consensus 98 ~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l 173 (843)
+|.+.+.++. .+..+++|++|+|++|.+.+ .. +..+.++++|+.|+|++|++++.++ .+..+++|+.|++++|++
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 412 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCE-EEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCcccc-ccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcC
Confidence 9999866654 59999999999999999975 33 6789999999999999999998877 589999999999999999
Q ss_pred CCCCCCCCC--CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCC---CCchhhccccCCCCcceeEEcCCCC
Q 003158 174 NGSIPPGRL--SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS---IPSSIWQSRTLNATETFILDFQNNN 248 (843)
Q Consensus 174 ~~~~p~~~~--~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~l~~~~L~~L~l~~N~ 248 (843)
++..+...+ ..+|+.|+|++|.+++..|..|.++++|++|+|++|++++. .+..+..+ ++|+.|++++|+
T Consensus 413 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l-----~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL-----GRLEILVLSFCD 487 (606)
T ss_dssp ECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGC-----TTCCEEECTTSC
T ss_pred CCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccC-----CCccEEECCCCc
Confidence 977665433 34899999999999999999999999999999999999873 23445544 456699999999
Q ss_pred CCCCCCCC--cCCCCcEEEeccCcccc
Q 003158 249 LTNISGSF--NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 249 l~~~~~~~--~~~~l~~l~l~~Np~~c 273 (843)
++++++.. .++.++.|++++|.+..
T Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 514 (606)
T 3t6q_A 488 LSSIDQHAFTSLKMMNHVDLSHNRLTS 514 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCG
T ss_pred cCccChhhhccccCCCEEECCCCccCc
Confidence 99986543 78999999999998764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=277.83 Aligned_cols=115 Identities=22% Similarity=0.245 Sum_probs=68.0
Q ss_pred CCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCC--CCCcccCCCCCCcEEeCcCccCCCCCCch-hhcccc
Q 003158 158 SRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTG--TIPSNFSGLPRLQRLFIANNSLSGSIPSS-IWQSRT 233 (843)
Q Consensus 158 ~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~ 233 (843)
..+++|+.|++++|++++.+|..+.. .+|+.|+|++|++++ .+|..+..+++|++|+|++|.+++.+|.. +..+.+
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 45666777777777776655554433 367777777777765 34456666777777777777766545543 222211
Q ss_pred CC-----------------CCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCccc
Q 003158 234 LN-----------------ATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 234 l~-----------------~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~ 272 (843)
|+ .++|+.|+|++|+|+.+|... .++.++.|++++|.+.
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCEEECcCCCCCcchhhhhcccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCC
Confidence 11 035566666666666666544 5666666666666654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=278.99 Aligned_cols=125 Identities=19% Similarity=0.227 Sum_probs=88.0
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|++..+.+|.++++|++|+|++|+++++.|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..
T Consensus 41 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 120 (606)
T 3vq2_A 41 FNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSS
T ss_pred CCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccccc
Confidence 56677666667777777777777777777666777777777777777777777666777777777777777777776555
Q ss_pred CcccCCCCCCceeeccCCCCCC-CCCcccCCCCCCcEEEcCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTG-YLPPELSELPKLLILQLDNNNFE 126 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~ 126 (843)
+..++++++|++|+|++|++++ .+|..|.++++|++|+|++|+++
T Consensus 121 ~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~ 166 (606)
T 3vq2_A 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166 (606)
T ss_dssp SSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCC
T ss_pred ccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcce
Confidence 5667777777777777777764 34666777777777766666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-27 Score=264.82 Aligned_cols=241 Identities=19% Similarity=0.232 Sum_probs=212.0
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
++++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+|+...+
T Consensus 53 ~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 129 (440)
T 3zyj_A 53 KNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPN 129 (440)
T ss_dssp CCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCT
T ss_pred CCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCH
Confidence 4455 6777665 689999999999999999999999999999999999998888999999999999999999997777
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN 162 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 162 (843)
..|..+++|++|+|++|+|+...+..|..+++|++|+|++|+..+...+..|.++++|+.|+|++|+++.++ .+..+++
T Consensus 130 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~l~~ 208 (440)
T 3zyj_A 130 GAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-NLTPLIK 208 (440)
T ss_dssp TTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC-CCTTCSS
T ss_pred hHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc-ccCCCcc
Confidence 789999999999999999998888899999999999999955443234457999999999999999999765 5889999
Q ss_pred CCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCccee
Q 003158 163 LGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241 (843)
Q Consensus 163 L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~ 241 (843)
|+.|+|++|++++..|..+.. .+|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+..+. +|+.
T Consensus 209 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-----~L~~ 283 (440)
T 3zyj_A 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH-----HLER 283 (440)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT-----TCCE
T ss_pred cCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc-----CCCE
Confidence 999999999999665655544 4899999999999999999999999999999999999977776666554 5669
Q ss_pred EEcCCCCCCCC
Q 003158 242 LDFQNNNLTNI 252 (843)
Q Consensus 242 L~l~~N~l~~~ 252 (843)
|+|++|.+..-
T Consensus 284 L~L~~Np~~Cd 294 (440)
T 3zyj_A 284 IHLHHNPWNCN 294 (440)
T ss_dssp EECCSSCEECS
T ss_pred EEcCCCCccCC
Confidence 99999998753
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=267.08 Aligned_cols=242 Identities=19% Similarity=0.240 Sum_probs=211.9
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+
T Consensus 64 ~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 140 (452)
T 3zyi_A 64 RGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPS 140 (452)
T ss_dssp SCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCT
T ss_pred CCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccCh
Confidence 3455 6776665 689999999999999999999999999999999999998888999999999999999999998777
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN 162 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 162 (843)
..|.++++|++|+|++|+|+...+..|.++++|++|+|++|...+...+..|.++++|+.|+|++|+++++ +.+..+++
T Consensus 141 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~ 219 (452)
T 3zyi_A 141 GAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVG 219 (452)
T ss_dssp TTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTT
T ss_pred hhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-cccccccc
Confidence 88999999999999999999877789999999999999995443323345799999999999999999987 46889999
Q ss_pred CCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCccee
Q 003158 163 LGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241 (843)
Q Consensus 163 L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~ 241 (843)
|+.|+|++|.+++..|..+.. .+|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..+..+. +|+.
T Consensus 220 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-----~L~~ 294 (452)
T 3zyi_A 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR-----YLVE 294 (452)
T ss_dssp CCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT-----TCCE
T ss_pred ccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc-----CCCE
Confidence 999999999999666655443 4899999999999999999999999999999999999976666665544 5669
Q ss_pred EEcCCCCCCCCC
Q 003158 242 LDFQNNNLTNIS 253 (843)
Q Consensus 242 L~l~~N~l~~~~ 253 (843)
|+|++|.+..-.
T Consensus 295 L~L~~Np~~CdC 306 (452)
T 3zyi_A 295 LHLHHNPWNCDC 306 (452)
T ss_dssp EECCSSCEECST
T ss_pred EEccCCCcCCCC
Confidence 999999987643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=281.38 Aligned_cols=268 Identities=22% Similarity=0.240 Sum_probs=165.5
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|.++++|++|+|++|.+++..
T Consensus 34 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 113 (680)
T 1ziw_A 34 HNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113 (680)
T ss_dssp SSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccC
Confidence 45566555555666666666666666666666666666666666666666666444445666666666666666666555
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccc--cCCCCCcEEEcCCCCCCCCCCC-CC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY--SNMSKLLKLSLRNCSLQGPMPD-LS 158 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~-~~ 158 (843)
+..|.++++|++|+|++|++++..+..+.++++|++|+|++|.+++ ..+..+ ..+++|+.|++++|.+++.++. +.
T Consensus 114 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~ 192 (680)
T 1ziw_A 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192 (680)
T ss_dssp SCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCC-BCHHHHGGGTTCEESEEECTTCCCCCBCTTGGG
T ss_pred hhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccc-cCHHHhhccccccccEEECCCCcccccChhhhh
Confidence 5566666666666666666666556666666666666666666654 223332 2345666666666666655442 22
Q ss_pred CC---------------------------CCCCEEEcccCcCCCCCCCCCCC---cCcCEEEccCCcCCCCCCcccCCCC
Q 003158 159 RI---------------------------PNLGYLDLSSNQLNGSIPPGRLS---LNITTIKLSNNKLTGTIPSNFSGLP 208 (843)
Q Consensus 159 ~l---------------------------~~L~~L~Ls~N~l~~~~p~~~~~---~~L~~L~Ls~N~l~~~~p~~~~~l~ 208 (843)
.+ ++|+.|++++|.+++..|..+.. .+|+.|+|++|.+++..|..|..++
T Consensus 193 ~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 272 (680)
T 1ziw_A 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLP 272 (680)
T ss_dssp GSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcc
Confidence 21 45566666666666544444332 2488888888888888888888888
Q ss_pred CCcEEeCcCccCCCCCCchhhccccCC----------------------------CCcceeEEcCCCCCCCCCCCC--cC
Q 003158 209 RLQRLFIANNSLSGSIPSSIWQSRTLN----------------------------ATETFILDFQNNNLTNISGSF--NI 258 (843)
Q Consensus 209 ~L~~L~L~~N~l~~~~p~~~~~l~~l~----------------------------~~~L~~L~l~~N~l~~~~~~~--~~ 258 (843)
+|++|+|++|++++..|..+..+.+|+ .++|+.|++++|++++++... .+
T Consensus 273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 352 (680)
T 1ziw_A 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352 (680)
T ss_dssp TCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTC
T ss_pred cccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccc
Confidence 888888888888877777665544332 234555666666666554432 45
Q ss_pred CCCcEEEeccCc
Q 003158 259 PPNVTVRLRGNP 270 (843)
Q Consensus 259 ~~l~~l~l~~Np 270 (843)
+.++.|++++|.
T Consensus 353 ~~L~~L~Ls~n~ 364 (680)
T 1ziw_A 353 INLKYLSLSNSF 364 (680)
T ss_dssp TTCCEEECTTCB
T ss_pred cCCcEEECCCCc
Confidence 566666666554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-27 Score=287.64 Aligned_cols=266 Identities=20% Similarity=0.237 Sum_probs=188.6
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccC-ccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSL-PEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ 80 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 80 (843)
+|+|++..|.+|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++.
T Consensus 33 ~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 112 (844)
T 3j0a_A 33 FNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112 (844)
T ss_dssp SCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSC
T ss_pred CCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcc
Confidence 68888888888888888888888888555444 77888888888888888888877788888888888888888888875
Q ss_pred CCcc--cCCCCCCceeeccCCCCCCCCC-cccCCCCCCcEEEcCCCCCCCCCCCccccCC--CCCcEEEcCCCCCCCCCC
Q 003158 81 IPPE--LSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPASYSNM--SKLLKLSLRNCSLQGPMP 155 (843)
Q Consensus 81 ~~~~--l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~ 155 (843)
++.. |.++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++ ..+..+..+ ++|+.|+|++|.+.+..+
T Consensus 113 ~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~-~~~~~l~~l~~~~L~~L~L~~n~l~~~~~ 191 (844)
T 3j0a_A 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL-VCEHELEPLQGKTLSFFSLAANSLYSRVS 191 (844)
T ss_dssp CSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC-CCSGGGHHHHHCSSCCCEECCSBSCCCCC
T ss_pred cccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe-eCHHHcccccCCccceEECCCCccccccc
Confidence 5554 7888888888888888886654 568888888888888888865 345554443 344444444444433222
Q ss_pred -CCCCC--------------------------------------------------------------------CCCCEE
Q 003158 156 -DLSRI--------------------------------------------------------------------PNLGYL 166 (843)
Q Consensus 156 -~~~~l--------------------------------------------------------------------~~L~~L 166 (843)
.+..+ ++|+.|
T Consensus 192 ~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L 271 (844)
T 3j0a_A 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271 (844)
T ss_dssp CCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEE
T ss_pred cchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEE
Confidence 12211 456666
Q ss_pred EcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcC
Q 003158 167 DLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 245 (843)
Q Consensus 167 ~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~ 245 (843)
+|++|.+.+..+..+.. .+|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..+..+. +|+.|+|+
T Consensus 272 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-----~L~~L~L~ 346 (844)
T 3j0a_A 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP-----KVAYIDLQ 346 (844)
T ss_dssp ECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCT-----TCCEEECC
T ss_pred ECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCC-----CCCEEECC
Confidence 66666665443333322 3677777777777777777777777777777777777766666665543 45588888
Q ss_pred CCCCCCCCCCC--cCCCCcEEEeccCcccc
Q 003158 246 NNNLTNISGSF--NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 246 ~N~l~~~~~~~--~~~~l~~l~l~~Np~~c 273 (843)
+|+|+.++... .+++|+.|++++|.+..
T Consensus 347 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp SCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred CCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 88888887653 68889999999988753
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-27 Score=261.14 Aligned_cols=246 Identities=21% Similarity=0.259 Sum_probs=196.1
Q ss_pred CCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCcee
Q 003158 15 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 94 (843)
Q Consensus 15 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 94 (843)
.+.+|+.|++++|.++...+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46899999999999997666678999999999999999998888899999999999999999998888889999999999
Q ss_pred eccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCC------------
Q 003158 95 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN------------ 162 (843)
Q Consensus 95 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~------------ 162 (843)
+|++|+++...+..|.++++|++|+|++|++.+ ..+..+.++++|+.|+|++|++++.+. ..+++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTSSCTTCCEEECCSSCCSBCCG--GGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCc-cChhhccCCCCCCEEECCCCcCCcccc--ccccccceeeccccccc
Confidence 999999996666668999999999999999985 457789999999999999999987643 23333
Q ss_pred -------CCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCC
Q 003158 163 -------LGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235 (843)
Q Consensus 163 -------L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~ 235 (843)
|+.|++++|.++ .+|... ..+|+.|+|++|.+++. ..+..+++|++|+|++|.+++..|..+..+.
T Consensus 200 ~~~~~~~L~~L~l~~n~l~-~~~~~~-~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~--- 272 (390)
T 3o6n_A 200 TLAIPIAVEELDASHNSIN-VVRGPV-NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ--- 272 (390)
T ss_dssp EEECCSSCSEEECCSSCCC-EEECCC-CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCS---
T ss_pred ccCCCCcceEEECCCCeee-eccccc-cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccc---
Confidence 455555555554 223222 23677888888887753 5677788888888888888777777766544
Q ss_pred CCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCccc
Q 003158 236 ATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 236 ~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~ 272 (843)
+|+.|+|++|+|++++... .++.++.|++++|++.
T Consensus 273 --~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~ 308 (390)
T 3o6n_A 273 --RLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL 308 (390)
T ss_dssp --SCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC
T ss_pred --cCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce
Confidence 3447777777777776655 5677777777777764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=244.61 Aligned_cols=217 Identities=25% Similarity=0.340 Sum_probs=153.3
Q ss_pred ccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCC
Q 003158 36 ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 115 (843)
Q Consensus 36 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 115 (843)
.++++++|+++++++|+++ .+|..+. ++|+.|+|++|.|++..+..|.++++|+.|+|++|+|++..+ ...+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcC
Confidence 3567788888888888888 5555443 678888888888887777778888888888888888875433 2677888
Q ss_pred cEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCCCCCCC--CcCcCEEEcc
Q 003158 116 LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLS 192 (843)
Q Consensus 116 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~Ls 192 (843)
++|+|++|++. .+|..+..+++|+.|+|++|+++++++. |..+++|+.|+|++|+|+ .+|...+ ..+|+.|+|+
T Consensus 80 ~~L~Ls~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~ 156 (290)
T 1p9a_G 80 GTLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLA 156 (290)
T ss_dssp CEEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECT
T ss_pred CEEECCCCcCC--cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC-ccChhhcccccCCCEEECC
Confidence 88888888886 4677777788888888888888877763 777777777777777777 3333322 1256666666
Q ss_pred CCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCccc
Q 003158 193 NNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 272 (843)
Q Consensus 193 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~ 272 (843)
+|+|+...+..|..+++|+.|+|++|+|+ .+|..+. ..+.+..+++.+|||.
T Consensus 157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~---------------------------~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF---------------------------GSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT---------------------------TTCCCSEEECCSCCBC
T ss_pred CCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhc---------------------------ccccCCeEEeCCCCcc
Confidence 66666544445555555555555555555 3343332 4556788999999999
Q ss_pred ccCCcccccCCCCCCC
Q 003158 273 LNTNAEQFCGSHSDDD 288 (843)
Q Consensus 273 c~~~~~~~~~~~~~~~ 288 (843)
|+|.+.++..|+....
T Consensus 209 C~c~~~~l~~wl~~~~ 224 (290)
T 1p9a_G 209 CNCEILYFRRWLQDNA 224 (290)
T ss_dssp CSGGGHHHHHHHHHTG
T ss_pred CcCccHHHHHHHHhCc
Confidence 9999999988876543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=277.07 Aligned_cols=173 Identities=15% Similarity=0.210 Sum_probs=92.2
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccC-
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ- 80 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~- 80 (843)
+|+|++..|.+|.++++|++|+|++|++++..|+.|+++++|++|+|++|++++..+..|+++++|++|+|++|.+++.
T Consensus 35 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 114 (549)
T 2z81_A 35 FNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG 114 (549)
T ss_dssp SSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSC
T ss_pred CCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccc
Confidence 4556655566666666666666666666655556666666666666666666655555566666666666666666542
Q ss_pred CCcccCCCCCCceeeccCCCCCCCC-CcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CC
Q 003158 81 IPPELSRLPSLVHMLLDNNNLTGYL-PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LS 158 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~ 158 (843)
.|..+.++++|++|+|++|++.+.+ +..|.++++|++|+|++|++++ ..|..+..+++|+.|++++|.+..++.. +.
T Consensus 115 ~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~ 193 (549)
T 2z81_A 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193 (549)
T ss_dssp SSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE-ECTTTTTTCSEEEEEEEECSBSTTHHHHHHH
T ss_pred hhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc-cChhhhhccccCceEecccCcccccchhhHh
Confidence 3445566666666666666532222 3456666666666666666654 3444444433333333333322211111 12
Q ss_pred CCCCCCEEEcccCcCCC
Q 003158 159 RIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~l~~ 175 (843)
.+++|+.|++++|++++
T Consensus 194 ~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 194 ILSSVRYLELRDTNLAR 210 (549)
T ss_dssp STTTBSEEEEESCBCTT
T ss_pred hcccccEEEccCCcccc
Confidence 24455555555555543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=272.99 Aligned_cols=246 Identities=21% Similarity=0.259 Sum_probs=200.4
Q ss_pred CCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCcee
Q 003158 15 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 94 (843)
Q Consensus 15 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 94 (843)
.+.+++.|++++|.++...+..|.++++|++|+|++|.|++..+..|..+++|+.|+|++|.|++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 45889999999999997777788999999999999999998888899999999999999999998888889999999999
Q ss_pred eccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCC-----------
Q 003158 95 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL----------- 163 (843)
Q Consensus 95 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L----------- 163 (843)
+|++|+|++..+..|.++++|++|+|++|.+.+ ..|..|.++++|+.|+|++|.+++++. ..+++|
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTCTTCCEEECTTSCCSBCCG--GGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC-CChhhhhcCCcCcEEECcCCCCCCcCh--hhhhhhhhhhcccCccc
Confidence 999999997777778999999999999999986 567789999999999999999998653 333444
Q ss_pred --------CEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCC
Q 003158 164 --------GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235 (843)
Q Consensus 164 --------~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~ 235 (843)
+.|++++|.++ .++... ..+|+.|+|++|.+++ +..+..+++|+.|+|++|.|++..|..+..+.
T Consensus 206 ~l~~~~~L~~L~ls~n~l~-~~~~~~-~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--- 278 (597)
T 3oja_B 206 TLAIPIAVEELDASHNSIN-VVRGPV-NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ--- 278 (597)
T ss_dssp EEECCTTCSEEECCSSCCC-EEECSC-CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCS---
T ss_pred cccCCchhheeeccCCccc-cccccc-CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCcc---
Confidence 44444444444 222221 2368888888888875 36778888888888888888877777776554
Q ss_pred CCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCccc
Q 003158 236 ATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 236 ~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~ 272 (843)
+|+.|+|++|+|++++... .++.|..|+|++|++.
T Consensus 279 --~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~ 314 (597)
T 3oja_B 279 --RLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL 314 (597)
T ss_dssp --SCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC
T ss_pred --CCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC
Confidence 4457888888888877655 5778888888888765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-28 Score=261.42 Aligned_cols=246 Identities=20% Similarity=0.290 Sum_probs=208.1
Q ss_pred ccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCC-ccCccccc-------cCCCCCEEEccCCccccCCCcc
Q 003158 13 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYIS-GSLPKSFA-------NLNKTRHFHMNNNSISGQIPPE 84 (843)
Q Consensus 13 i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~ 84 (843)
+...++|+.|++++|.+ .+|..+... |+.|+|++|.++ ..++..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45667899999999999 677776654 999999999995 45666665 7999999999999999888887
Q ss_pred c--CCCCCCceeeccCCCCCCCCCcccCCC-----CCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCC---C
Q 003158 85 L--SRLPSLVHMLLDNNNLTGYLPPELSEL-----PKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP---M 154 (843)
Q Consensus 85 l--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~---~ 154 (843)
+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++.+ ..+..|.++++|+.|+|++|++.+. +
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLN-FSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCC-CCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCcc-chHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 6 8999999999999999977 8878777 999999999999986 4568999999999999999998763 3
Q ss_pred CC--CCCCCCCCEEEcccCcCCCC--CCCCC--CCcCcCEEEccCCcCCCCCC-cccCCCCCCcEEeCcCccCCCCCCch
Q 003158 155 PD--LSRIPNLGYLDLSSNQLNGS--IPPGR--LSLNITTIKLSNNKLTGTIP-SNFSGLPRLQRLFIANNSLSGSIPSS 227 (843)
Q Consensus 155 ~~--~~~l~~L~~L~Ls~N~l~~~--~p~~~--~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~ 227 (843)
+. +..+++|+.|+|++|++++. ++... ...+|+.|+|++|.+++..| ..+..+++|++|+|++|+|+ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 33 48899999999999999831 12121 22489999999999998875 56778999999999999999 78876
Q ss_pred hhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCccc
Q 003158 228 IWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 272 (843)
Q Consensus 228 ~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~ 272 (843)
+. ++|+.|+|++|+|+++|....++.++.|++++|++.
T Consensus 272 ~~-------~~L~~L~Ls~N~l~~~p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 272 LP-------AKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CC-------SEEEEEECCSSCCCSCCCTTTSCEEEEEECTTCTTT
T ss_pred cc-------CCceEEECCCCCCCCChhHhhCCCCCEEeccCCCCC
Confidence 63 578899999999999977448999999999999986
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-26 Score=248.21 Aligned_cols=214 Identities=19% Similarity=0.313 Sum_probs=199.0
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|+ .+|..+.++++|++|+|++|.++ .+|..|+++++|++|+|++|.++ .+|..+.++++|+.|+|++|++.+.+
T Consensus 90 ~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~ 166 (328)
T 4fcg_A 90 SVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL 166 (328)
T ss_dssp SSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCC
T ss_pred CCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCcccc
Confidence 57788 88999999999999999999999 89999999999999999999999 88999999999999999999988899
Q ss_pred CcccCC---------CCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCC
Q 003158 82 PPELSR---------LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 152 (843)
Q Consensus 82 ~~~l~~---------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 152 (843)
|..+.. +++|++|+|++|+++ .+|..+..+++|++|+|++|++++ +|..+..+++|+.|+|++|.+.+
T Consensus 167 p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~--l~~~l~~l~~L~~L~Ls~n~~~~ 243 (328)
T 4fcg_A 167 PEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA--LGPAIHHLPKLEELDLRGCTALR 243 (328)
T ss_dssp CSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC--CCGGGGGCTTCCEEECTTCTTCC
T ss_pred ChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc--CchhhccCCCCCEEECcCCcchh
Confidence 887764 999999999999999 788999999999999999999984 67889999999999999999887
Q ss_pred CCC-CCCCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCC
Q 003158 153 PMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 153 ~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 221 (843)
..+ .+..+++|+.|+|++|++.+.+|..+.. .+|+.|+|++|.+.+.+|..+..+++|+.+++..|.+.
T Consensus 244 ~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp BCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 666 5999999999999999999999987554 48999999999999999999999999999999998887
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.7e-26 Score=247.20 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=183.4
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|++ ++. +.++++|++|+|++|.++. + +.|.++++|++|+|++|.+++. +. +..+++|+.|++++|.....+
T Consensus 75 ~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~ 148 (347)
T 4fmz_A 75 GNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDL 148 (347)
T ss_dssp SSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCC
T ss_pred CCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCEEECcCCcccCc-hh-hccCCceeEEECCCCCCcccc
Confidence 577774 444 8899999999999999985 3 4699999999999999999854 33 888999999999999665343
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
..+..+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+ ++. +..+++|+.|++++|.+++..+ +..++
T Consensus 149 -~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~--~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~ 221 (347)
T 4fmz_A 149 -SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED--ISP-LASLTSLHYFTAYVNQITDITP-VANMT 221 (347)
T ss_dssp -GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC--CGG-GGGCTTCCEEECCSSCCCCCGG-GGGCT
T ss_pred -cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc--ccc-ccCCCccceeecccCCCCCCch-hhcCC
Confidence 348888889999999888885433 7788888888888888864 333 7777788888888887776655 66777
Q ss_pred CCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCccee
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~ 241 (843)
+|+.|++++|.+++ ++......+|+.|++++|.+++. ..+..+++|++|++++|++++. ..+.. .++|+.
T Consensus 222 ~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~-----l~~L~~ 291 (347)
T 4fmz_A 222 RLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNN-----LSQLNS 291 (347)
T ss_dssp TCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGG-----CTTCSE
T ss_pred cCCEEEccCCccCC-CcchhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcC-----CCCCCE
Confidence 77888888887773 33333334777777777777753 4577777777777777777743 22333 234557
Q ss_pred EEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccC
Q 003158 242 LDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNT 275 (843)
Q Consensus 242 L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~ 275 (843)
|++++|++++.+... .++.++.|++++|++....
T Consensus 292 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 327 (347)
T 4fmz_A 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327 (347)
T ss_dssp EECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCG
T ss_pred EECcCCcCCCcChhHhhccccCCEEEccCCcccccc
Confidence 777777777665443 5777777777777766543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-26 Score=266.73 Aligned_cols=256 Identities=19% Similarity=0.232 Sum_probs=193.8
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+
T Consensus 40 ~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~l 115 (562)
T 3a79_B 40 NRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NI 115 (562)
T ss_dssp TSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EE
T ss_pred CCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-cc
Confidence 57888 4887665 89999999999999888899999999999999999999888999999999999999999999 55
Q ss_pred CcccCCCCCCceeeccCCCCCCC-CCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCC--cEEEcCCCCC--CCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL--LKLSLRNCSL--QGPMPD 156 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~ 156 (843)
|.. .+++|++|+|++|++++. .|..|.++++|++|+|++|++.+ ..+..+++| +.|+|++|.+ ++..+.
T Consensus 116 p~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~L~~n~l~~~~~~~~ 189 (562)
T 3a79_B 116 SCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ----LDLLPVAHLHLSCILLDLVSYHIKGGETE 189 (562)
T ss_dssp CSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT----TTTGGGTTSCEEEEEEEESSCCCCSSSCC
T ss_pred Ccc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc----CchhhhhhceeeEEEeecccccccccCcc
Confidence 655 899999999999999964 46899999999999999999974 235555555 8888888888 544332
Q ss_pred -CCCCC--------------------------------------------------------------------------
Q 003158 157 -LSRIP-------------------------------------------------------------------------- 161 (843)
Q Consensus 157 -~~~l~-------------------------------------------------------------------------- 161 (843)
+..+.
T Consensus 190 ~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~ 269 (562)
T 3a79_B 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269 (562)
T ss_dssp EEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHH
T ss_pred cccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHH
Confidence 32221
Q ss_pred -------CCCEEEcccCcCCCCCCCCC-----------------------------------------------------
Q 003158 162 -------NLGYLDLSSNQLNGSIPPGR----------------------------------------------------- 181 (843)
Q Consensus 162 -------~L~~L~Ls~N~l~~~~p~~~----------------------------------------------------- 181 (843)
+|++|++++|.++|.+|...
T Consensus 270 ~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~ 349 (562)
T 3a79_B 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349 (562)
T ss_dssp HHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCC
T ss_pred HHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCc
Confidence 67777777777777776644
Q ss_pred -CCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCC--CCchhhccccCCCCcceeEEcCCCCCCC-CCCCC-
Q 003158 182 -LSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS--IPSSIWQSRTLNATETFILDFQNNNLTN-ISGSF- 256 (843)
Q Consensus 182 -~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~l~~~~L~~L~l~~N~l~~-~~~~~- 256 (843)
...+|+.|+|++|.+++.+|..+.++++|++|+|++|++++. +|..+..+ ++|+.|++++|++++ ++...
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~ 424 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM-----SSLETLDVSLNSLNSHAYDRTC 424 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTC-----TTCCEEECTTSCCBSCCSSCCC
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCC-----CCCCEEECCCCcCCCccChhhh
Confidence 112677777777777776777777777777777777777642 22334333 345577777777776 55542
Q ss_pred -cCCCCcEEEeccCccc
Q 003158 257 -NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 257 -~~~~l~~l~l~~Np~~ 272 (843)
.++.++.|++++|.+.
T Consensus 425 ~~l~~L~~L~l~~n~l~ 441 (562)
T 3a79_B 425 AWAESILVLNLSSNMLT 441 (562)
T ss_dssp CCCTTCCEEECCSSCCC
T ss_pred cCcccCCEEECCCCCCC
Confidence 5677777777777653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-25 Score=239.66 Aligned_cols=220 Identities=18% Similarity=0.229 Sum_probs=197.5
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCc-cccC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-ISGQ 80 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~ 80 (843)
+++++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|. ++..
T Consensus 20 ~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~ 96 (285)
T 1ozn_A 20 QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96 (285)
T ss_dssp SSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCC
T ss_pred cCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCcccc
Confidence 34555 566554 4799999999999998888899999999999999999998889999999999999999997 8877
Q ss_pred CCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCC
Q 003158 81 IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSR 159 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~ 159 (843)
.+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++.+ ..+..|..+++|+.|+|++|+++++++. +..
T Consensus 97 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 175 (285)
T 1ozn_A 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175 (285)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred CHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc-cCHhHhccCCCccEEECCCCcccccCHHHhcC
Confidence 78899999999999999999998889999999999999999999985 4456689999999999999999998885 999
Q ss_pred CCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCC
Q 003158 160 IPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 225 (843)
Q Consensus 160 l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 225 (843)
+++|+.|+|++|.+++..|..+.. .+|+.|+|++|.+++..+..|..+++|+.|+|++|++.+..+
T Consensus 176 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 999999999999999776766554 489999999999998888889999999999999999986543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-26 Score=241.36 Aligned_cols=234 Identities=16% Similarity=0.174 Sum_probs=124.7
Q ss_pred EEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCC
Q 003158 22 LLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNL 101 (843)
Q Consensus 22 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l 101 (843)
++..+.++. .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 444444444 3443332 3455555555555544444555555555555555555544444455555555555555555
Q ss_pred CCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCC--CCCCCCCCCCCEEEcccCcCCCCCCC
Q 003158 102 TGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGP--MPDLSRIPNLGYLDLSSNQLNGSIPP 179 (843)
Q Consensus 102 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~ 179 (843)
++..+..|.++++|++|++++|++.+ ..+..+..+++|+.|+|++|.+++. +..+..+++|+.|+|++|+++
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~----- 162 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ----- 162 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC-----
T ss_pred CccChhhhcCCccccEEECCCCCccc-cCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC-----
Confidence 54444455555555555555555543 2222344555555555555555442 223444444444444444444
Q ss_pred CCCCcCcCEEEccCCcCCCCCCcccCCCCCCc----EEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCC
Q 003158 180 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ----RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGS 255 (843)
Q Consensus 180 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~ 255 (843)
+..+..|..+++|+ .|++++|.+++..+..+. ..+|+.|+|++|+|++++..
T Consensus 163 ------------------~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~------~~~L~~L~L~~n~l~~~~~~ 218 (276)
T 2z62_A 163 ------------------SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK------EIRLKELALDTNQLKSVPDG 218 (276)
T ss_dssp ------------------EECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC------SCCEEEEECCSSCCSCCCTT
T ss_pred ------------------cCCHHHhhhhhhccccceeeecCCCcccccCccccC------CCcccEEECCCCceeecCHh
Confidence 23333333333333 555666665543333221 12456677777777766654
Q ss_pred C--cCCCCcEEEeccCcccccCC-cccccCCCCCCC
Q 003158 256 F--NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDDD 288 (843)
Q Consensus 256 ~--~~~~l~~l~l~~Np~~c~~~-~~~~~~~~~~~~ 288 (843)
. .++.++.|++++|||.|+|. +.+++.|.....
T Consensus 219 ~~~~l~~L~~L~l~~N~~~c~c~~l~~l~~~~~~~~ 254 (276)
T 2z62_A 219 IFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNS 254 (276)
T ss_dssp TTTTCCSCCEEECCSSCBCCCTTTTHHHHHHHHHTG
T ss_pred HhcccccccEEEccCCcccccCCchHHHHHHHHhcc
Confidence 3 57888999999999999996 677888876543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-26 Score=239.30 Aligned_cols=216 Identities=23% Similarity=0.277 Sum_probs=192.5
Q ss_pred cCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCC
Q 003158 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 87 (843)
Q Consensus 8 ~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 87 (843)
.+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.+
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 5777664 58999999999999888889999999999999999999888889999999999999999999888889999
Q ss_pred CCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCC--
Q 003158 88 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLG-- 164 (843)
Q Consensus 88 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~-- 164 (843)
+++|++|++++|++++..+..+..+++|++|+|++|++.+..+|..+.++++|+.|+|++|+++++++ .+..+.+|+
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence 99999999999999988777899999999999999999865578999999999999999999999876 466666665
Q ss_pred --EEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCC
Q 003158 165 --YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 225 (843)
Q Consensus 165 --~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 225 (843)
.|++++|.+++..+......+|+.|+|++|.|++..+..|..+++|+.|+|++|++.+.-|
T Consensus 179 ~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 8999999999554444444589999999999998888888999999999999999997554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=264.16 Aligned_cols=146 Identities=21% Similarity=0.238 Sum_probs=133.9
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCc
Q 003158 4 KISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 83 (843)
Q Consensus 4 ~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 83 (843)
+++ .+|..+. .++++|||++|+|+++.+..|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|+|++..+.
T Consensus 42 ~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~ 118 (635)
T 4g8a_A 42 NFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 118 (635)
T ss_dssp CCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGG
T ss_pred CcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHH
Confidence 455 6777664 4899999999999988889999999999999999999988888999999999999999999988788
Q ss_pred ccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCC
Q 003158 84 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG 152 (843)
Q Consensus 84 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 152 (843)
.|.++++|++|+|++|+|++..+..|+++++|++|+|++|.+++...|..+..+++|++|+|++|++++
T Consensus 119 ~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 119 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp GGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred HhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccc
Confidence 899999999999999999988888899999999999999999876778999999999999999998754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-27 Score=270.40 Aligned_cols=197 Identities=22% Similarity=0.233 Sum_probs=131.2
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
+|+.|+|++|.+++..|..|+.+++|++|+|++|.+++..| |..+++|+.|+|++|.|++.. ..++|+.|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence 67778888777777777777777777777777777775554 777777777777777777432 22677777777
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCC-CCCCCCEEEcccCcCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLS-RIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~-~l~~L~~L~Ls~N~l~~ 175 (843)
+|+|++..+. .+++|+.|+|++|.+++ ..|..+.++++|+.|+|++|.+++.++ .+. .+++|+.|+|++|.|++
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCS-GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCC-CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 7777755443 34677777777777765 446667777777777777777777555 343 56777777777777763
Q ss_pred CCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchh
Q 003158 176 SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 228 (843)
Q Consensus 176 ~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 228 (843)
. +......+|+.|+|++|.|++..| .|..+++|+.|+|++|.|++ +|..+
T Consensus 184 ~-~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 184 V-KGQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp E-ECCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred c-cccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhh
Confidence 3 333334466666666666664333 35666666666666666653 44443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=252.97 Aligned_cols=245 Identities=18% Similarity=0.183 Sum_probs=210.9
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|.++++|++|+|++|+++...
T Consensus 61 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~ 140 (353)
T 2z80_A 61 NNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLG 140 (353)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSC
T ss_pred CCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccC
Confidence 68899877779999999999999999999888999999999999999999999766666999999999999999999554
Q ss_pred C-cccCCCCCCceeeccCC-CCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CC
Q 003158 82 P-PELSRLPSLVHMLLDNN-NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LS 158 (843)
Q Consensus 82 ~-~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~ 158 (843)
+ ..+.++++|++|++++| .++...+..|.++++|++|+|++|++.+ ..|..+.++++|++|++++|+++.++.. +.
T Consensus 141 ~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 219 (353)
T 2z80_A 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219 (353)
T ss_dssp SSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE-ECTTTTTTCSEEEEEEEECSCSTTHHHHHHH
T ss_pred chhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCc-cCHHHHhccccCCeecCCCCccccchhhhhh
Confidence 4 47999999999999999 5777777899999999999999999986 5688999999999999999999876664 55
Q ss_pred CCCCCCEEEcccCcCCCCCCCCCC----CcCcCEEEccCCcCCC----CCCcccCCCCCCcEEeCcCccCCCCCCchh-h
Q 003158 159 RIPNLGYLDLSSNQLNGSIPPGRL----SLNITTIKLSNNKLTG----TIPSNFSGLPRLQRLFIANNSLSGSIPSSI-W 229 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~l~~~~p~~~~----~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~ 229 (843)
.+++|+.|++++|.+++..+.... ...++.++|++|.+++ .+|..+..+++|++|+|++|+|+ .+|..+ .
T Consensus 220 ~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~ 298 (353)
T 2z80_A 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298 (353)
T ss_dssp HTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTT
T ss_pred hcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHh
Confidence 689999999999999965443322 2368899999999886 46778999999999999999999 666654 4
Q ss_pred ccccCCCCcceeEEcCCCCCCCCC
Q 003158 230 QSRTLNATETFILDFQNNNLTNIS 253 (843)
Q Consensus 230 ~l~~l~~~~L~~L~l~~N~l~~~~ 253 (843)
.+ ++|+.|+|++|.++.-.
T Consensus 299 ~l-----~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 299 RL-----TSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp TC-----TTCCEEECCSSCBCCCH
T ss_pred cC-----CCCCEEEeeCCCccCcC
Confidence 44 45669999999998754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=246.18 Aligned_cols=236 Identities=19% Similarity=0.258 Sum_probs=190.1
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCC-ccCccccC-------CCCCCcEEEcccCcCCccCcccc--ccCCCCCEEE
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELT-GSLPEELG-------YLPKLDRIQIDQNYISGSLPKSF--ANLNKTRHFH 71 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~ 71 (843)
+|++ .+|..+... |+.|+|++|+++ ..+|..+. ++++|++|+|++|++++.+|..+ ..+++|++|+
T Consensus 52 ~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~ 127 (312)
T 1wwl_A 52 VDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127 (312)
T ss_dssp CCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEE
T ss_pred cccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEE
Confidence 4666 678777654 899999999994 56777666 78999999999999998888876 8899999999
Q ss_pred ccCCccccCCCcccCCC-----CCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCC-CCCccc--cCCCCCcEE
Q 003158 72 MNNNSISGQIPPELSRL-----PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASY--SNMSKLLKL 143 (843)
Q Consensus 72 Ls~N~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~--~~l~~L~~L 143 (843)
|++|++++. |..+..+ ++|++|+|++|++++..+..|..+++|++|+|++|++.+. ..+..+ ..+++|+.|
T Consensus 128 Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L 206 (312)
T 1wwl_A 128 LRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206 (312)
T ss_dssp EESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEE
T ss_pred ccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEE
Confidence 999999976 7777766 8999999999999988888999999999999999997641 123334 888999999
Q ss_pred EcCCCCCCCCCC---C-CCCCCCCCEEEcccCcCCCCCCCCCC--CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcC
Q 003158 144 SLRNCSLQGPMP---D-LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 217 (843)
Q Consensus 144 ~L~~N~l~~~~~---~-~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 217 (843)
+|++|++++++. . +..+++|+.|+|++|++++.+|...+ ..+|+.|+|++|.|+ .+|..+. ++|++|+|++
T Consensus 207 ~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~ 283 (312)
T 1wwl_A 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSY 283 (312)
T ss_dssp ECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCS
T ss_pred ECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCC
Confidence 999999985432 2 45778999999999999976653322 358999999999998 6777766 8899999999
Q ss_pred ccCCCCCCchhhccccCCCCcceeEEcCCCCCCCC
Q 003158 218 NSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 252 (843)
Q Consensus 218 N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~ 252 (843)
|+|++. |. +.. .++|+.|+|++|+|++.
T Consensus 284 N~l~~~-p~-~~~-----l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 284 NRLDRN-PS-PDE-----LPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp SCCCSC-CC-TTT-----SCEEEEEECTTCTTTCC
T ss_pred CCCCCC-hh-Hhh-----CCCCCEEeccCCCCCCC
Confidence 999865 65 543 45677999999998864
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=241.13 Aligned_cols=242 Identities=19% Similarity=0.229 Sum_probs=210.5
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCcc--CccccccCCCCCEEEccCCccccC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS--LPKSFANLNKTRHFHMNNNSISGQ 80 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~ 80 (843)
++++ .+|..+. ++|++|+|++|+++...+..|+++++|++|+|++|.++.. .+..+..+++|++|+|++|.++ .
T Consensus 17 ~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~ 92 (306)
T 2z66_A 17 KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-T 92 (306)
T ss_dssp SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-E
T ss_pred CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-c
Confidence 4555 6776554 6899999999999966666789999999999999999833 3677888999999999999998 5
Q ss_pred CCcccCCCCCCceeeccCCCCCCCCC-cccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCC--CCCCC
Q 003158 81 IPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG--PMPDL 157 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~ 157 (843)
++..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|.+.+ ..+..+.++++|+.|+|++|.+++ .+..+
T Consensus 93 l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 171 (306)
T 2z66_A 93 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 171 (306)
T ss_dssp EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEE-CSTTTTTTCTTCCEEECTTCEEGGGEECSCC
T ss_pred ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCc-cchhhcccCcCCCEEECCCCccccccchhHH
Confidence 67779999999999999999997655 689999999999999999986 567889999999999999999987 45569
Q ss_pred CCCCCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCC
Q 003158 158 SRIPNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236 (843)
Q Consensus 158 ~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~ 236 (843)
..+++|+.|+|++|.+++..|..+.. .+|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..+..+.
T Consensus 172 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~---- 247 (306)
T 2z66_A 172 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP---- 247 (306)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCC----
T ss_pred hhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhh----
Confidence 99999999999999999666665543 4899999999999998888999999999999999999999998876653
Q ss_pred CcceeEEcCCCCCCCCC
Q 003158 237 TETFILDFQNNNLTNIS 253 (843)
Q Consensus 237 ~~L~~L~l~~N~l~~~~ 253 (843)
++|+.|+|++|.++.-.
T Consensus 248 ~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 248 SSLAFLNLTQNDFACTC 264 (306)
T ss_dssp TTCCEEECTTCCEECSG
T ss_pred ccCCEEEccCCCeeccc
Confidence 25779999999998754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-24 Score=238.20 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=208.9
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+++ .+| .+..+++|++|+|++|+++.. +. +.++++|++|+|++|.++. ++ .+.++++|++|++++|.+++.
T Consensus 53 ~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~~- 125 (347)
T 4fmz_A 53 GEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISDI- 125 (347)
T ss_dssp SSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCCC-
T ss_pred CCccc-cch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccCc-
Confidence 45666 454 488999999999999999954 44 9999999999999999995 33 699999999999999999954
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
+. +..+++|+.|++++|..... +..+..+++|++|++++|.+.+ ++. +..+++|+.|++++|.++++++ +..++
T Consensus 126 ~~-~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~--~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~ 199 (347)
T 4fmz_A 126 SP-LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKD--VTP-IANLTDLYSLSLNYNQIEDISP-LASLT 199 (347)
T ss_dssp GG-GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCC--CGG-GGGCTTCSEEECTTSCCCCCGG-GGGCT
T ss_pred hh-hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCC--chh-hccCCCCCEEEccCCccccccc-ccCCC
Confidence 33 89999999999999976644 4459999999999999999975 333 8899999999999999998766 88899
Q ss_pred CCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCccee
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~ 241 (843)
+|+.|++++|.+++..+ .....+|+.|+|++|.+++..+ +..+++|++|++++|.+++. ..+.. .++|+.
T Consensus 200 ~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~-----l~~L~~ 269 (347)
T 4fmz_A 200 SLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKD-----LTKLKM 269 (347)
T ss_dssp TCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTT-----CTTCCE
T ss_pred ccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhc-----CCCcCE
Confidence 99999999999985443 3334589999999999996544 99999999999999999853 33433 346779
Q ss_pred EEcCCCCCCCCCCCCcCCCCcEEEeccCccc
Q 003158 242 LDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 272 (843)
Q Consensus 242 L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~ 272 (843)
|++++|++++++....++.++.|++++|++.
T Consensus 270 L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 270 LNVGSNQISDISVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp EECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred EEccCCccCCChhhcCCCCCCEEECcCCcCC
Confidence 9999999999966558999999999999975
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-24 Score=243.74 Aligned_cols=203 Identities=20% Similarity=0.196 Sum_probs=141.3
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|++. | .|..+++|++|+|++|++++. | ++.+++|++|+|++|++++. + ++++++|++|+|++|++++.
T Consensus 51 ~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l- 121 (457)
T 3bz5_A 51 NSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL- 121 (457)
T ss_dssp SSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-
T ss_pred CCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-
Confidence 5778864 5 688899999999999999864 4 88889999999999998864 3 88888999999999988853
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
+ ++.+++|++|++++|++++. .+..+++|++|++++|+..+ .+ .+..+++|+.|++++|++++++ +..++
T Consensus 122 ~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~-~~--~~~~l~~L~~L~ls~n~l~~l~--l~~l~ 191 (457)
T 3bz5_A 122 D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKIT-KL--DVTPQTQLTTLDCSFNKITELD--VSQNK 191 (457)
T ss_dssp C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCC-CC--CCTTCTTCCEEECCSSCCCCCC--CTTCT
T ss_pred c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccc-cc--ccccCCcCCEEECCCCccceec--cccCC
Confidence 4 78888888888888888864 26677777777777775433 22 3566667777777777766653 55666
Q ss_pred CCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchh
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSI 228 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 228 (843)
+|+.|++++|++++. + .....+|+.|+|++|++++ +| +..+++|+.|++++|+|++..+..+
T Consensus 192 ~L~~L~l~~N~l~~~-~-l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l 253 (457)
T 3bz5_A 192 LLNRLNCDTNNITKL-D-LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTL 253 (457)
T ss_dssp TCCEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTC
T ss_pred CCCEEECcCCcCCee-c-cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHC
Confidence 666666666666632 2 1222356666666666665 33 5566666666666666665444333
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-25 Score=259.48 Aligned_cols=258 Identities=19% Similarity=0.202 Sum_probs=213.3
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCc
Q 003158 4 KISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 83 (843)
Q Consensus 4 ~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 83 (843)
+++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+.
T Consensus 18 ~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 94 (570)
T 2z63_A 18 NFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94 (570)
T ss_dssp CCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred Ccc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHh
Confidence 444 6776554 5799999999999988888999999999999999999988888899999999999999999988888
Q ss_pred ccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCC
Q 003158 84 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPN 162 (843)
Q Consensus 84 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~ 162 (843)
.|.++++|++|+|++|++++..+..++++++|++|+|++|.+.+..+|..|.++++|++|++++|++++.++ .+..+++
T Consensus 95 ~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 174 (570)
T 2z63_A 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174 (570)
T ss_dssp TTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHT
T ss_pred hhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhc
Confidence 999999999999999999977666799999999999999999865678999999999999999999998776 4777777
Q ss_pred C----CEEEcccCcCCCCCCCCCCCcCcCEEEccCC--------------------------------------------
Q 003158 163 L----GYLDLSSNQLNGSIPPGRLSLNITTIKLSNN-------------------------------------------- 194 (843)
Q Consensus 163 L----~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N-------------------------------------------- 194 (843)
| +.|++++|.+++..+..+...+|+.|+|++|
T Consensus 175 L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l 254 (570)
T 2z63_A 175 MPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254 (570)
T ss_dssp CTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGG
T ss_pred cchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccc
Confidence 7 8999999999866555554457888888877
Q ss_pred --------------cCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCC
Q 003158 195 --------------KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPP 260 (843)
Q Consensus 195 --------------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~ 260 (843)
.+.+..|..|..+++|+.|++++|.++ .+|..+..+ +|+.|++++|+++.++. ..++.
T Consensus 255 ~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~------~L~~L~l~~n~~~~l~~-~~l~~ 326 (570)
T 2z63_A 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF------GWQHLELVNCKFGQFPT-LKLKS 326 (570)
T ss_dssp GGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC------CCSEEEEESCBCSSCCB-CBCSS
T ss_pred cccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC------CccEEeeccCcccccCc-ccccc
Confidence 344556677778888888999888887 577766543 45688888888887765 46788
Q ss_pred CcEEEeccCccc
Q 003158 261 NVTVRLRGNPFC 272 (843)
Q Consensus 261 l~~l~l~~Np~~ 272 (843)
++.|++.+|...
T Consensus 327 L~~L~l~~n~~~ 338 (570)
T 2z63_A 327 LKRLTFTSNKGG 338 (570)
T ss_dssp CCEEEEESCBSC
T ss_pred cCEEeCcCCccc
Confidence 888888887753
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=248.42 Aligned_cols=244 Identities=18% Similarity=0.177 Sum_probs=168.5
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.+++.++++.+.+.......+..+++|++|+|++|++++..|..|.++++|+.|+|++|.+++..+ +..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 346666777777765566666667777777777777776666777777777777777777775443 777777777777
Q ss_pred cCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCC
Q 003158 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~ 175 (843)
++|++++. ...++|++|++++|++++ ++ ...+++|+.|+|++|+++++++ .+..+++|+.|+|++|.+++
T Consensus 88 s~n~l~~l-----~~~~~L~~L~l~~n~l~~--~~--~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 158 (317)
T 3o53_A 88 NNNYVQEL-----LVGPSIETLHAANNNISR--VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158 (317)
T ss_dssp CSSEEEEE-----EECTTCCEEECCSSCCSE--EE--ECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE
T ss_pred cCCccccc-----cCCCCcCEEECCCCccCC--cC--ccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc
Confidence 77777632 233677777777777764 22 1235677777777777777666 46777777777777777775
Q ss_pred CCCCCCC--CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCC
Q 003158 176 SIPPGRL--SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253 (843)
Q Consensus 176 ~~p~~~~--~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~ 253 (843)
..+.... ..+|+.|+|++|.|++. + ....+++|++|+|++|+|++ +|..+..+. +|+.|+|++|+|+.++
T Consensus 159 ~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~-----~L~~L~L~~N~l~~l~ 230 (317)
T 3o53_A 159 VNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAA-----GVTWISLRNNKLVLIE 230 (317)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGT-----TCSEEECTTSCCCEEC
T ss_pred ccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccC-----cccEEECcCCcccchh
Confidence 4444332 24777788888877754 2 33357788888888888874 444455443 4557888888888877
Q ss_pred CCC-cCCCCcEEEeccCcccccCCccc
Q 003158 254 GSF-NIPPNVTVRLRGNPFCLNTNAEQ 279 (843)
Q Consensus 254 ~~~-~~~~l~~l~l~~Np~~c~~~~~~ 279 (843)
..+ .++.++.|++++|+|.|+|...+
T Consensus 231 ~~~~~l~~L~~L~l~~N~~~~~~~~~~ 257 (317)
T 3o53_A 231 KALRFSQNLEHFDLRGNGFHCGTLRDF 257 (317)
T ss_dssp TTCCCCTTCCEEECTTCCCBHHHHHHH
T ss_pred hHhhcCCCCCEEEccCCCccCcCHHHH
Confidence 665 67888889999999988764433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-24 Score=228.55 Aligned_cols=191 Identities=23% Similarity=0.322 Sum_probs=100.6
Q ss_pred CCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEc
Q 003158 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 145 (843)
Q Consensus 66 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 145 (843)
+|+.|+|++|+|+...+..|.++++|++|+|++|+++...+..|.++++|++|+|++|++.+ ..+..|.++++|+.|+|
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCC-CCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCc-CCHhHcccccCCCEEEC
Confidence 34444444444443333344444444444444444443333344444555555555555443 22234445555555555
Q ss_pred CCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCCCCCC-C-CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCC
Q 003158 146 RNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGR-L-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 222 (843)
Q Consensus 146 ~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~-~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 222 (843)
++|+++++++. |..+++|+.|+|++|.++ .+|... . ..+|+.|+|++|.+++..+..|.++++|++|+|++|+|++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR 195 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc
Confidence 55555554443 455555555555555555 222211 1 1244444444444444444556666777777777766664
Q ss_pred CCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccccCC-cccccCCCC
Q 003158 223 SIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN-AEQFCGSHS 285 (843)
Q Consensus 223 ~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c~~~-~~~~~~~~~ 285 (843)
..+..+. .++.+..|++++|||.|+|. +.++..|+.
T Consensus 196 ~~~~~~~---------------------------~l~~L~~L~l~~N~~~c~c~~~~~~~~~l~ 232 (270)
T 2o6q_A 196 VPEGAFD---------------------------SLEKLKMLQLQENPWDCTCNGIIYMAKWLK 232 (270)
T ss_dssp CCTTTTT---------------------------TCTTCCEEECCSSCBCCSSSSSHHHHHHHH
T ss_pred CCHHHhc---------------------------cccCCCEEEecCCCeeCCCccHHHHHHHHH
Confidence 3333222 35667788999999999997 666666764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=247.40 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=191.7
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|++++..| +.++++|++|+|++|++++..+ ++++++|++|+|++|.+++..+ +.++++|++|++++|.+++..
T Consensus 77 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~ 150 (466)
T 1o6v_A 77 NNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS 150 (466)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG
T ss_pred CCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh
Confidence 577775443 8888999999999999885554 8888999999999998885433 888888888888888877431
Q ss_pred C-------------------cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcE
Q 003158 82 P-------------------PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 142 (843)
Q Consensus 82 ~-------------------~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 142 (843)
. ..+.++++|+.|++++|++++. ..+..+++|++|++++|.+.+ ..+ +..+++|+.
T Consensus 151 ~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~ 225 (466)
T 1o6v_A 151 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD-ITP--LGILTNLDE 225 (466)
T ss_dssp GGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG--GGGCTTCCE
T ss_pred hhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccc-ccc--ccccCCCCE
Confidence 1 1266778899999999998854 458888999999999999875 222 777888999
Q ss_pred EEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCC
Q 003158 143 LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 222 (843)
Q Consensus 143 L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 222 (843)
|++++|+++++ +.+..+++|+.|++++|.+++..+ .....+|+.|+|++|.+++..+ +..+++|+.|+|++|++++
T Consensus 226 L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~ 301 (466)
T 1o6v_A 226 LSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301 (466)
T ss_dssp EECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC
T ss_pred EECCCCCcccc-hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccC
Confidence 99999888875 457788888888888888885444 3334478888888888886544 7888888888888888886
Q ss_pred CCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCccccc
Q 003158 223 SIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLN 274 (843)
Q Consensus 223 ~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c~ 274 (843)
..+ +.. .++|+.|+|++|+++++++...++.++.|++++|++...
T Consensus 302 ~~~--~~~-----l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 302 ISP--ISN-----LKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CGG--GGG-----CTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred chh--hcC-----CCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 443 333 345668888888888877655788888888888877543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-24 Score=246.59 Aligned_cols=250 Identities=28% Similarity=0.358 Sum_probs=210.5
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
.|+++ .+| .+..+++|++|+|++|.+++..+ +.++++|++|++++|.+++..+ +.++++|++|+|++|.+++..
T Consensus 55 ~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~ 128 (466)
T 1o6v_A 55 RLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID 128 (466)
T ss_dssp SSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCCh
Confidence 35566 455 48899999999999999996544 9999999999999999996555 999999999999999999653
Q ss_pred CcccCCCCCCceeeccCCCCCCCCC-------------------cccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcE
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLP-------------------PELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 142 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~-------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 142 (843)
+ +.++++|++|+|++|++++... ..+.++++|++|+|++|.+.+ + ..+..+++|+.
T Consensus 129 ~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~--~-~~l~~l~~L~~ 203 (466)
T 1o6v_A 129 P--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--I-SVLAKLTNLES 203 (466)
T ss_dssp G--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCC--C-GGGGGCTTCSE
T ss_pred H--HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCC--C-hhhccCCCCCE
Confidence 3 8999999999999999885311 236678899999999999975 2 45889999999
Q ss_pred EEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCC
Q 003158 143 LSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 222 (843)
Q Consensus 143 L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 222 (843)
|++++|.+++.++ +..+++|+.|++++|.++ .++......+|+.|++++|.+++..+ +..+++|++|++++|.+++
T Consensus 204 L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~-~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 279 (466)
T 1o6v_A 204 LIATNNQISDITP-LGILTNLDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279 (466)
T ss_dssp EECCSSCCCCCGG-GGGCTTCCEEECCSSCCC-CCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC
T ss_pred EEecCCccccccc-ccccCCCCEEECCCCCcc-cchhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc
Confidence 9999999998776 778999999999999998 45544444589999999999997655 8999999999999999996
Q ss_pred CCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccc
Q 003158 223 SIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 223 ~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c 273 (843)
..+ +.. .++|+.|++++|++++++....++.++.|++++|.+..
T Consensus 280 ~~~--~~~-----l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 280 ISP--LAG-----LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp CGG--GTT-----CTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSC
T ss_pred ccc--ccC-----CCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCC
Confidence 544 433 45677999999999999875689999999999998753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-24 Score=243.07 Aligned_cols=238 Identities=18% Similarity=0.183 Sum_probs=200.6
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCc
Q 003158 4 KISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 83 (843)
Q Consensus 4 ~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 83 (843)
.+.+..+..++++++|++|+|++|.+++. | .++.+++|++|+|++|++++. + +..+++|++|+|++|.|++. +
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C-
T ss_pred CcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e-
Confidence 34556677889999999999999999964 5 799999999999999999964 4 89999999999999999965 3
Q ss_pred ccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCC
Q 003158 84 ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNL 163 (843)
Q Consensus 84 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L 163 (843)
++++++|++|+|++|++++. + +..+++|++|+|++|++++ + .++++++|+.|++++|+..+.. .+..+++|
T Consensus 102 -~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~--l--~l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L 172 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE--I--DVSHNTQLTELDCHLNKKITKL-DVTPQTQL 172 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC--C--CCTTCTTCCEEECTTCSCCCCC-CCTTCTTC
T ss_pred -cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce--e--ccccCCcCCEEECCCCCccccc-ccccCCcC
Confidence 89999999999999999974 4 8999999999999999986 3 3889999999999999654433 58889999
Q ss_pred CEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEE
Q 003158 164 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243 (843)
Q Consensus 164 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~ 243 (843)
+.|++++|++++ +| .....+|+.|++++|.+++. .+..+++|+.|+|++|+|++ +| +.. .++|+.|+
T Consensus 173 ~~L~ls~n~l~~-l~-l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~-----l~~L~~L~ 239 (457)
T 3bz5_A 173 TTLDCSFNKITE-LD-VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTP-----LTQLTYFD 239 (457)
T ss_dssp CEEECCSSCCCC-CC-CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTT-----CTTCSEEE
T ss_pred CEEECCCCccce-ec-cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccc-----cCCCCEEE
Confidence 999999999995 66 33345899999999999976 48999999999999999997 56 443 35677999
Q ss_pred cCCCCCCCCCCCCcCCCCcEEEeccCcc
Q 003158 244 FQNNNLTNISGSFNIPPNVTVRLRGNPF 271 (843)
Q Consensus 244 l~~N~l~~~~~~~~~~~l~~l~l~~Np~ 271 (843)
+++|+|++++. ..++.+..|++.+|.+
T Consensus 240 l~~N~l~~~~~-~~l~~L~~L~l~~n~L 266 (457)
T 3bz5_A 240 CSVNPLTELDV-STLSKLTTLHCIQTDL 266 (457)
T ss_dssp CCSSCCSCCCC-TTCTTCCEEECTTCCC
T ss_pred eeCCcCCCcCH-HHCCCCCEEeccCCCC
Confidence 99999999873 2466666665555544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=264.53 Aligned_cols=190 Identities=14% Similarity=0.187 Sum_probs=145.7
Q ss_pred CCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 514 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--------GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 514 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
...+.||+|+||+||+|.. .++.+|+|+....... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 5788899886542211 134589999999999999999777777777788999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+|+.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999864 4579999999999999999 999999999999999 9999999999876432
Q ss_pred CCCCcccceeeeeecccCCccCchhccc--CCCCchhhhHHHHHHHHHHHhCCCCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVFLELLTGMQPI 719 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~G~~l~elltg~~pf 719 (843)
...............||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1000000001235679999999999987 66788899999999988888877766
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=242.54 Aligned_cols=243 Identities=20% Similarity=0.192 Sum_probs=202.0
Q ss_pred CCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCC
Q 003158 9 IPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRL 88 (843)
Q Consensus 9 ~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 88 (843)
+...+..+++|++|+|++|++++..|..|+++++|++|+|++|.+++..+ +..+++|++|+|++|.|++.. ..
T Consensus 26 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~ 98 (317)
T 3o53_A 26 LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VG 98 (317)
T ss_dssp HHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----EC
T ss_pred HHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CC
Confidence 33445567799999999999998888999999999999999999996655 999999999999999998443 34
Q ss_pred CCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-C-CCCCCCCEE
Q 003158 89 PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-L-SRIPNLGYL 166 (843)
Q Consensus 89 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L 166 (843)
++|++|++++|++++..+.. +++|++|+|++|++++ ..+..+..+++|+.|+|++|.+++.++. + ..+++|+.|
T Consensus 99 ~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 174 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (317)
T ss_dssp TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCS-GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCC-ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence 89999999999999665443 6789999999999986 4567889999999999999999987664 4 478999999
Q ss_pred EcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCC
Q 003158 167 DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQN 246 (843)
Q Consensus 167 ~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~ 246 (843)
+|++|.++ .++......+|+.|+|++|.|++. |..+..+++|+.|+|++|+|+ .+|..+..+ ++|+.|++++
T Consensus 175 ~L~~N~l~-~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l-----~~L~~L~l~~ 246 (317)
T 3o53_A 175 NLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFS-----QNLEHFDLRG 246 (317)
T ss_dssp ECTTSCCC-EEECCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCC-----TTCCEEECTT
T ss_pred ECCCCcCc-ccccccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcC-----CCCCEEEccC
Confidence 99999999 456555567999999999999965 445999999999999999999 577776544 4566999999
Q ss_pred CCCC-C-CCCCC-cCCCCcEEEeccCc
Q 003158 247 NNLT-N-ISGSF-NIPPNVTVRLRGNP 270 (843)
Q Consensus 247 N~l~-~-~~~~~-~~~~l~~l~l~~Np 270 (843)
|.++ . ++... .++.+..+++.+|+
T Consensus 247 N~~~~~~~~~~~~~~~~L~~l~l~~~~ 273 (317)
T 3o53_A 247 NGFHCGTLRDFFSKNQRVQTVAKQTVK 273 (317)
T ss_dssp CCCBHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred CCccCcCHHHHHhccccceEEECCCch
Confidence 9998 2 22222 56777777777443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=242.90 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=146.8
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCC-------------cEEEcccCcCCccCccccccCCCCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL-------------DRIQIDQNYISGSLPKSFANLNKTR 68 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~L~~N~l~~~~~~~~~~l~~L~ 68 (843)
.|++ |.+|.+|+++++|++|++++|++.+.+|..++++++| ++|++++|++++ +|.. .++|+
T Consensus 20 ~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~ 94 (454)
T 1jl5_A 20 SSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLE 94 (454)
T ss_dssp ---------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCS
T ss_pred cCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCC
Confidence 4566 5777777777777777777777777777776666543 556666665553 2221 23444
Q ss_pred EEEccCCccccCCCccc----------------CCC-CCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCC
Q 003158 69 HFHMNNNSISGQIPPEL----------------SRL-PSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 131 (843)
Q Consensus 69 ~L~Ls~N~l~~~~~~~l----------------~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 131 (843)
.|++++|.+++ +|..+ ..+ ++|++|+|++|++++ +| .|.++++|++|++++|++++ +|
T Consensus 95 ~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~--lp 169 (454)
T 1jl5_A 95 SLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK--LP 169 (454)
T ss_dssp EEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC--CC
T ss_pred EEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc--cC
Confidence 44444444443 22211 011 467777777777775 45 47777777777777777763 44
Q ss_pred ccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCc
Q 003158 132 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQ 211 (843)
Q Consensus 132 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 211 (843)
..+ .+|+.|++++|++++++ .+..+++|+.|++++|++++ +|... .+|+.|++++|.++ .+| .+..+++|+
T Consensus 170 ~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~-~lp-~~~~l~~L~ 240 (454)
T 1jl5_A 170 DLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILE-ELP-ELQNLPFLT 240 (454)
T ss_dssp CCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCS-SCC-CCTTCTTCC
T ss_pred CCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCC-ccc-ccCCCCCCC
Confidence 433 47777777777777754 57777888888888888773 44432 37888888888887 556 477888888
Q ss_pred EEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccc
Q 003158 212 RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 212 ~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c 273 (843)
+|++++|++++ +|..+ ++|+.|++++|++++++.. .+.++.|++++|.+..
T Consensus 241 ~L~l~~N~l~~-l~~~~--------~~L~~L~l~~N~l~~l~~~--~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 241 TIYADNNLLKT-LPDLP--------PSLEALNVRDNYLTDLPEL--PQSLTFLDVSENIFSG 291 (454)
T ss_dssp EEECCSSCCSS-CCSCC--------TTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSE
T ss_pred EEECCCCcCCc-ccccc--------cccCEEECCCCcccccCcc--cCcCCEEECcCCccCc
Confidence 88888888874 44321 3566777777777776543 3667777777776643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-25 Score=253.88 Aligned_cols=220 Identities=20% Similarity=0.181 Sum_probs=188.9
Q ss_pred CCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcE
Q 003158 38 GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 117 (843)
Q Consensus 38 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 117 (843)
..+++|++|+|++|.+++..|..|..+++|+.|+|++|.|++..+ |..+++|++|+|++|.|++.. ..++|++
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCE
Confidence 344589999999999998888999999999999999999997665 999999999999999998543 3389999
Q ss_pred EEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCCCCCCCCC--CcCcCEEEccCC
Q 003158 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLSNN 194 (843)
Q Consensus 118 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~Ls~N 194 (843)
|+|++|.+++ ..+ ..+++|+.|+|++|.+++.++ .+..+++|+.|+|++|.+++.+|..+. ..+|+.|+|++|
T Consensus 104 L~L~~N~l~~-~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N 179 (487)
T 3oja_A 104 LHAANNNISR-VSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179 (487)
T ss_dssp EECCSSCCCC-EEE---CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred EECcCCcCCC-CCc---cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCC
Confidence 9999999986 223 346899999999999999877 589999999999999999977776654 358999999999
Q ss_pred cCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCcccc
Q 003158 195 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 195 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~c 273 (843)
.|++.. .+..+++|+.|+|++|.|++ +|..+..+. +|+.|+|++|+|+++|..+ .++.+..|++++|++.|
T Consensus 180 ~l~~~~--~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~-----~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 180 FIYDVK--GQVVFAKLKTLDLSSNKLAF-MGPEFQSAA-----GVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CCCEEE--CCCCCTTCCEEECCSSCCCE-ECGGGGGGT-----TCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCH
T ss_pred cccccc--ccccCCCCCEEECCCCCCCC-CCHhHcCCC-----CccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcC
Confidence 999763 35569999999999999996 444566554 5669999999999998876 68999999999999998
Q ss_pred cCC
Q 003158 274 NTN 276 (843)
Q Consensus 274 ~~~ 276 (843)
+|.
T Consensus 252 ~~~ 254 (487)
T 3oja_A 252 GTL 254 (487)
T ss_dssp HHH
T ss_pred cch
Confidence 764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.5e-23 Score=231.13 Aligned_cols=240 Identities=26% Similarity=0.378 Sum_probs=136.3
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|++++ +|.. +++|++|++++|++++ ++.. .++|++|++++|++++ +| .|.++++|++|++++|++++ +
T Consensus 100 ~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-l 168 (454)
T 1jl5_A 100 CNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-L 168 (454)
T ss_dssp SSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-C
T ss_pred CCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-c
Confidence 455554 4432 2455666666665553 2211 1567777777777774 55 47777777777777777764 4
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
|..+ ++|++|++++|++++ +| .+.++++|++|++++|++++ +|... ++|+.|++++|.++.++ .+..++
T Consensus 169 p~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~--l~~~~---~~L~~L~l~~n~l~~lp-~~~~l~ 237 (454)
T 1jl5_A 169 PDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK--LPDLP---LSLESIVAGNNILEELP-ELQNLP 237 (454)
T ss_dssp CCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS--CCCCC---TTCCEEECCSSCCSSCC-CCTTCT
T ss_pred CCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc--CCCCc---CcccEEECcCCcCCccc-ccCCCC
Confidence 4332 467777777777764 34 46667777777777777653 33322 36666666666666444 466666
Q ss_pred CCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCC--CCCchhhccc----c--
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG--SIPSSIWQSR----T-- 233 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~----~-- 233 (843)
+|+.|++++|+++ .+|.. ..+|+.|++++|.+++ +|.. +++|++|++++|++++ .+|..+..+. .
T Consensus 238 ~L~~L~l~~N~l~-~l~~~--~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~ 310 (454)
T 1jl5_A 238 FLTTIYADNNLLK-TLPDL--PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 310 (454)
T ss_dssp TCCEEECCSSCCS-SCCSC--CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCS
T ss_pred CCCEEECCCCcCC-ccccc--ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCC
Confidence 6666666666666 34432 1356666666666654 3322 2455555555555554 2332221110 0
Q ss_pred -C-CC-CcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCccc
Q 003158 234 -L-NA-TETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFC 272 (843)
Q Consensus 234 -l-~~-~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~ 272 (843)
+ .. ++|+.|++++|++++++.. ++.++.|++++|.+.
T Consensus 311 ~i~~~~~~L~~L~Ls~N~l~~lp~~--~~~L~~L~L~~N~l~ 350 (454)
T 1jl5_A 311 SLCDLPPSLEELNVSNNKLIELPAL--PPRLERLIASFNHLA 350 (454)
T ss_dssp EECCCCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCS
T ss_pred cccCCcCcCCEEECCCCcccccccc--CCcCCEEECCCCccc
Confidence 0 11 3566777777777766543 466777777777654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.6e-23 Score=238.69 Aligned_cols=232 Identities=27% Similarity=0.382 Sum_probs=153.7
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|+ .+|..+. ++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|+|++|.|++ +
T Consensus 49 ~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l 116 (622)
T 3g06_A 49 ESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-L 116 (622)
T ss_dssp SSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-C
T ss_pred CCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-C
Confidence 56777 7777775 78999999999888 4555 5788899999999888 4554 67888888888888884 3
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCcccc-----------------CCCCCcEEE
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS-----------------NMSKLLKLS 144 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----------------~l~~L~~L~ 144 (843)
|. .+++|+.|+|++|+|+. +|.. +++|++|+|++|++++ +|..+. .+++|+.|+
T Consensus 117 ~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~--l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~ 187 (622)
T 3g06_A 117 PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS--LPALPSELCKLWAYNNQLTSLPMLPSGLQELS 187 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC--CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEE
T ss_pred CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC--cCCccCCCCEEECCCCCCCCCcccCCCCcEEE
Confidence 43 55778888888888774 4433 3677777887777764 333221 124455555
Q ss_pred cCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCC
Q 003158 145 LRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224 (843)
Q Consensus 145 L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 224 (843)
|++|++++++.. +++|+.|++++|.++ .+|.. ..+|+.|+|++|.|++ +| ..+++|+.|+|++|+|+ .+
T Consensus 188 Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~~~--~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~l 256 (622)
T 3g06_A 188 VSDNQLASLPTL---PSELYKLWAYNNRLT-SLPAL--PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SL 256 (622)
T ss_dssp CCSSCCSCCCCC---CTTCCEEECCSSCCS-SCCCC--CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CC
T ss_pred CCCCCCCCCCCc---cchhhEEECcCCccc-ccCCC--CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cC
Confidence 555555544332 245555555555555 34432 2367777777777764 33 44566777777777776 34
Q ss_pred CchhhccccCCCCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCcccc
Q 003158 225 PSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 225 p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~c 273 (843)
|. ..++|+.|+|++|+|+.+|..+ .++++..|+|++|++..
T Consensus 257 p~--------~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 257 PM--------LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 298 (622)
T ss_dssp CC--------CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCH
T ss_pred Cc--------ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCC
Confidence 44 1245667888888888777655 67778888888887753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-23 Score=218.04 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=180.5
Q ss_pred cccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCC
Q 003158 12 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 91 (843)
Q Consensus 12 ~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 91 (843)
.+.++++|+.|++++|+++ .+|..+. ++|++|+|++|.|++..+..|.++++|+.|+|++|.|++..+ ...+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcC
Confidence 3678999999999999999 6666654 789999999999998888999999999999999999996533 3789999
Q ss_pred ceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEccc
Q 003158 92 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSS 170 (843)
Q Consensus 92 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~ 170 (843)
++|+|++|+|+ .+|..+..+++|++|+|++|++++ ..+..|.++++|+.|+|++|+++++++. |..+++|+.|+|++
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCC-CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcc-cCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence 99999999999 678889999999999999999985 4457899999999999999999998885 78999999999999
Q ss_pred CcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCC
Q 003158 171 NQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 222 (843)
Q Consensus 171 N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 222 (843)
|+|+ .+|...+. .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 158 N~l~-~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 158 NNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp SCCS-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CcCC-ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 9999 66665433 48999999999999 778888889999999999999974
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=219.20 Aligned_cols=205 Identities=19% Similarity=0.266 Sum_probs=116.1
Q ss_pred cCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCce
Q 003158 14 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 93 (843)
Q Consensus 14 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 93 (843)
..+++|+.|++++|.++. + +.++.+++|++|+|++|.+++. ..+..+++|++|+|++|.+++..+..|.++++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp HHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 345566666666666552 2 2355566666666666666532 24556666666666666666555555566666666
Q ss_pred eeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCc
Q 003158 94 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQ 172 (843)
Q Consensus 94 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~ 172 (843)
|+|++|++++..+..|..+++|++|+|++|++++ ..+..+..+++|+.|+|++|+++++++. +..+++|+.|+|++|+
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCc-cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 6666666665555555666666666666666653 2334455666666666666666655553 4556666666666666
Q ss_pred CCCCCCCCCC-CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhc
Q 003158 173 LNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQ 230 (843)
Q Consensus 173 l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 230 (843)
+++..+..+. ..+|+.|+|++|.+.+. +++|+.|+++.|.++|.+|..++.
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~ 244 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGS 244 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccc
Confidence 6643333222 23566666666655432 334555566666666666555543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-22 Score=211.40 Aligned_cols=204 Identities=23% Similarity=0.311 Sum_probs=180.7
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.+++.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.|+...+..|.++++|++|+|
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 46889999999999 5776665 68999999999999877788999999999999999999777777899999999999
Q ss_pred cCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCC
Q 003158 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~ 175 (843)
++|++++..+..|..+++|++|+|++|++++ ..+..|..+++|+.|+|++|.++++++. +..+++|+.|+|++|.+++
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 171 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR 171 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCe-eCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence 9999998878889999999999999999986 4567789999999999999999998885 8999999999999999995
Q ss_pred CCCCCCC-CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCC
Q 003158 176 SIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224 (843)
Q Consensus 176 ~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 224 (843)
..+..+. ..+|+.|+|++|.|++..+..|..+++|+.|+|++|.+...-
T Consensus 172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 4443333 358999999999999888888999999999999999997543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=222.82 Aligned_cols=225 Identities=18% Similarity=0.223 Sum_probs=171.0
Q ss_pred CCCCEEEccCCcCCccCcc---ccCCCCCCcEEEcccCcCCccCcccc--ccCCCCCEEEccCCccccCCC----cccCC
Q 003158 17 KSLELLLLNGNELTGSLPE---ELGYLPKLDRIQIDQNYISGSLPKSF--ANLNKTRHFHMNNNSISGQIP----PELSR 87 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~----~~l~~ 87 (843)
..++.|.+.++.++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3478888888877622111 12235679999999999988888887 888999999999999886554 34567
Q ss_pred CCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCC---CCCCccccCCCCCcEEEcCCCCCCCCCCC----CCCC
Q 003158 88 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG---TTIPASYSNMSKLLKLSLRNCSLQGPMPD----LSRI 160 (843)
Q Consensus 88 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~l 160 (843)
+++|++|+|++|++++..+..|..+++|++|+|++|++.+ ...+..+..+++|++|+|++|+++.++.. +..+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 8899999999999988888888899999999999998753 11133457888999999999998765442 4677
Q ss_pred CCCCEEEcccCcCCCCCCCCCCC----cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCC
Q 003158 161 PNLGYLDLSSNQLNGSIPPGRLS----LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236 (843)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p~~~~~----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~ 236 (843)
++|+.|+|++|++++.+|..... .+|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +.. .
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~-----l 293 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDE-----L 293 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTS-----C
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhh-----C
Confidence 89999999999998776654433 38999999999998 5676664 7899999999999853 33 222 3
Q ss_pred CcceeEEcCCCCCCC
Q 003158 237 TETFILDFQNNNLTN 251 (843)
Q Consensus 237 ~~L~~L~l~~N~l~~ 251 (843)
++|+.|+|++|+|+.
T Consensus 294 ~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 294 PEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCSCEECSSTTTSC
T ss_pred CCccEEECcCCCCCC
Confidence 566789999998875
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=218.69 Aligned_cols=195 Identities=22% Similarity=0.369 Sum_probs=161.2
Q ss_pred ccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCc
Q 003158 13 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 92 (843)
Q Consensus 13 i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 92 (843)
+.++++|+.|++++|+++. ++ .+..+++|++|+|++|.+++..+ +..+++|+.|+|++|.+++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 4567889999999999984 44 68889999999999999985544 88999999999999999854 3688899999
Q ss_pred eeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCc
Q 003158 93 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 172 (843)
Q Consensus 93 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~ 172 (843)
+|+|++|++++. + .+..+++|++|+|++|++++ ++. +..+++|+.|+|++|+++++++ +..+++|+.|+|++|.
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITN--ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCC--CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCc--Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCc
Confidence 999999999864 3 48889999999999999975 333 8889999999999999988766 8889999999999999
Q ss_pred CCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCC
Q 003158 173 LNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 222 (843)
Q Consensus 173 l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 222 (843)
+++ ++......+|+.|+|++|.+++.. .+..+++|+.|+|++|++++
T Consensus 185 l~~-~~~l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 185 ISD-ISPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCC-CGGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred cCc-ChhhcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 984 444333458999999999998655 38889999999999999874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=213.98 Aligned_cols=197 Identities=20% Similarity=0.285 Sum_probs=176.4
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+++ .+ ..+..+++|++|+|++|.+++. +.++.+++|++|+|++|.+++..+..|.++++|++|+|++|++++..
T Consensus 50 ~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 125 (272)
T 3rfs_A 50 NSDIK-SV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLP 125 (272)
T ss_dssp TSCCC-CC-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred CCCcc-cc-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccC
Confidence 35555 33 3688999999999999999963 58999999999999999999888888999999999999999999888
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRI 160 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l 160 (843)
+..|..+++|++|+|++|++++..+..+..+++|++|+|++|++++ ..+..+..+++|+.|+|++|+++++++. +..+
T Consensus 126 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 204 (272)
T 3rfs_A 126 DGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 204 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred HHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc-cCHHHhcCCccCCEEECCCCcCCccCHHHHhCC
Confidence 8889999999999999999998888889999999999999999986 4566789999999999999999998886 8999
Q ss_pred CCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCC
Q 003158 161 PNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPR 209 (843)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 209 (843)
++|+.|+|++|.+.+..| +|+.|+++.|.++|.+|..++.++.
T Consensus 205 ~~L~~L~l~~N~~~~~~~------~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 205 TSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp TTCCEEECCSSCBCCCTT------TTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred cCCCEEEccCCCccccCc------HHHHHHHHHHhCCCcccCcccccCC
Confidence 999999999999986655 6888999999999999998887544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.3e-22 Score=205.41 Aligned_cols=129 Identities=21% Similarity=0.306 Sum_probs=72.3
Q ss_pred CCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcC
Q 003158 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 121 (843)
..++++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556666666666 4444333 456666666666665555556666666666666666665555555566666666666
Q ss_pred CCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCC
Q 003158 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 122 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 174 (843)
+|++++ ..+..|..+++|+.|+|++|+++++++. +..+++|+.|+|++|+|+
T Consensus 92 ~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 144 (251)
T 3m19_A 92 NNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144 (251)
T ss_dssp TSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCcccc-cChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC
Confidence 666553 2334455555555555555555555543 445555555555555554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.3e-23 Score=217.82 Aligned_cols=154 Identities=12% Similarity=0.055 Sum_probs=123.9
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHHhc
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRL 564 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 564 (843)
...+......|.+.+.||+|+||.||+|...+|+.||+|++..... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344444566777799999999999999997799999999864321 1345689999999999
Q ss_pred cCCcccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEE
Q 003158 565 HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 644 (843)
Q Consensus 565 ~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NIL 644 (843)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|+++||.|||+.+ |+||||||+|||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 9 5 677776544 56699999999999988 421 234569999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhccc
Q 003158 645 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT 693 (843)
Q Consensus 645 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 693 (843)
++ ++.+||+|||+|+. +..|+|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~--------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------------CCCCCHHHHHHH
Confidence 99 99999999999863 345789998753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.8e-23 Score=221.36 Aligned_cols=222 Identities=18% Similarity=0.242 Sum_probs=184.9
Q ss_pred CCCcEEEcccCcCCccCcc---ccccCCCCCEEEccCCccccCCCccc--CCCCCCceeeccCCCCCCCCC----cccCC
Q 003158 41 PKLDRIQIDQNYISGSLPK---SFANLNKTRHFHMNNNSISGQIPPEL--SRLPSLVHMLLDNNNLTGYLP----PELSE 111 (843)
Q Consensus 41 ~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~~----~~~~~ 111 (843)
..++.|.+.++.++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4578899998887632111 12345779999999999999999888 899999999999999997655 34567
Q ss_pred CCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCC---CCC--CCCCCCCCCEEEcccCcCCCCCCCC---C--
Q 003158 112 LPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQG---PMP--DLSRIPNLGYLDLSSNQLNGSIPPG---R-- 181 (843)
Q Consensus 112 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~---~-- 181 (843)
+++|++|+|++|++.+ ..+..|..+++|++|+|++|++.+ ++. .+..+++|++|+|++|+++ .++.. .
T Consensus 144 ~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~ 221 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPA-FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAA 221 (310)
T ss_dssp CSCCCEEEEECCSSCC-CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcch-hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHh
Confidence 8999999999999986 567889999999999999999875 333 2578999999999999997 44432 1
Q ss_pred CCcCcCEEEccCCcCCCCCCcccCCC---CCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcC
Q 003158 182 LSLNITTIKLSNNKLTGTIPSNFSGL---PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 258 (843)
Q Consensus 182 ~~~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~ 258 (843)
...+|++|+|++|.|++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++++....+
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-------~~L~~L~Ls~N~l~~~~~~~~l 293 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-------AKLRVLDLSSNRLNRAPQPDEL 293 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-------SCCSCEECCSCCCCSCCCTTSC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-------CCCCEEECCCCcCCCCchhhhC
Confidence 22489999999999999888888877 69999999999999 7787662 4788999999999999776689
Q ss_pred CCCcEEEeccCccc
Q 003158 259 PPNVTVRLRGNPFC 272 (843)
Q Consensus 259 ~~l~~l~l~~Np~~ 272 (843)
+.++.|++++|++.
T Consensus 294 ~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 294 PEVDNLTLDGNPFL 307 (310)
T ss_dssp CCCSCEECSSTTTS
T ss_pred CCccEEECcCCCCC
Confidence 99999999999985
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-22 Score=230.48 Aligned_cols=224 Identities=28% Similarity=0.351 Sum_probs=174.3
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|.|++ +|. +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 89999999999996 776653 88999999999999 667 457999999999999996 666 665 99999999
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 177 (843)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++++. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM--LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc--CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-ch
Confidence 999997 555 67999999999999975 565 67899999999999999777 65 89999999999999 77
Q ss_pred CCCCCCcCc-------CEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCC--CcceeEEcCCCC
Q 003158 178 PPGRLSLNI-------TTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA--TETFILDFQNNN 248 (843)
Q Consensus 178 p~~~~~~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~--~~L~~L~l~~N~ 248 (843)
|. +.. +| +.|+|++|.|+ .+|..+..+++|+.|+|++|+|++.+|..+..+..... .....+++++|+
T Consensus 196 p~-~~~-~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~~~~~~~~~~~~l~~~~ 272 (571)
T 3cvr_A 196 PA-VPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272 (571)
T ss_dssp CC-CC---------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHHSCC---CEEECCC----
T ss_pred hh-HHH-hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhcCccccCCeeEEeecccc
Confidence 77 333 77 99999999999 57888888999999999999999999999888765321 011123444444
Q ss_pred CCCCCCCCcCCCCcEEEeccCcccccCCcccccCCC
Q 003158 249 LTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSH 284 (843)
Q Consensus 249 l~~~~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~ 284 (843)
+.. ..|| .|+|...|+-.+.
T Consensus 273 ~~~---------------~~~p-~~~~~~~Wl~~~~ 292 (571)
T 3cvr_A 273 QNT---------------LHRP-LADAVTAWFPENK 292 (571)
T ss_dssp ---------------------C-CSHHHHTTCC---
T ss_pred ccc---------------cccc-chhhHHHHhhhhc
Confidence 332 2456 7899888774433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-22 Score=206.42 Aligned_cols=194 Identities=19% Similarity=0.232 Sum_probs=131.7
Q ss_pred CCcEEEcccCcCCccCccccccCCCCCEEEccCCc-cccCCCcccCCCCCCceeeccC-CCCCCCCCcccCCCCCCcEEE
Q 003158 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-ISGQIPPELSRLPSLVHMLLDN-NNLTGYLPPELSELPKLLILQ 119 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 119 (843)
+|++|+|++|++++..+..|.++++|+.|+|++|+ ++.+.+..|.++++|++|+|++ |+++...+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 66677777777765555566667777777777775 6655555666677777777776 677655556666777777777
Q ss_pred cCCCCCCCCCCCccccCCCCCc---EEEcCCC-CCCCCCCC-CCCCCCCC-EEEcccCcCCCCCCCCCCC-cCcCEEEcc
Q 003158 120 LDNNNFEGTTIPASYSNMSKLL---KLSLRNC-SLQGPMPD-LSRIPNLG-YLDLSSNQLNGSIPPGRLS-LNITTIKLS 192 (843)
Q Consensus 120 Ls~N~l~~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~-~~~l~~L~-~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls 192 (843)
|++|++++ +|. |..+++|+ .|++++| .++++++. |..+++|+ .|++++|+++ .+|...+. .+|+.|+|+
T Consensus 112 l~~n~l~~--lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 112 IFNTGLKM--FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEECCCS--CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred CCCCCCcc--ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence 77777753 454 66666666 7777777 77776664 77777777 7777777777 55554333 367788888
Q ss_pred CCc-CCCCCCcccCCC-CCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCC
Q 003158 193 NNK-LTGTIPSNFSGL-PRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNN 247 (843)
Q Consensus 193 ~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N 247 (843)
+|. ++...+..|.++ ++|+.|+|++|+|++ +|.. ..++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~-------~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK-------GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT-------TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh-------HhccCceeeccCc
Confidence 884 776667778888 888888888888874 4433 1234556777765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-21 Score=203.41 Aligned_cols=182 Identities=21% Similarity=0.287 Sum_probs=157.1
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.+.+.++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 46789999999999 6776665 68999999999999888889999999999999999999888888999999999999
Q ss_pred cCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCC
Q 003158 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~ 175 (843)
++|+|++..+..|..+++|++|+|++|++++ ..+..|..+++|+.|+|++|+|+++++ .+..+++|+.|+|++|++++
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 169 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS 169 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCC-cChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence 9999998888889999999999999999985 345568899999999999999999888 48888888888888888772
Q ss_pred CCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCC
Q 003158 176 SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 225 (843)
Q Consensus 176 ~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 225 (843)
..+..|..+++|+.|+|++|++.+..+
T Consensus 170 -----------------------~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 170 -----------------------VPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp -----------------------CCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred -----------------------cCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 333456777888888888888876533
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-24 Score=235.44 Aligned_cols=251 Identities=16% Similarity=0.162 Sum_probs=188.5
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCc----cccCCCC-CCcEEEcccCcCCccCccccccC-----CCCCEEE
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLP----EELGYLP-KLDRIQIDQNYISGSLPKSFANL-----NKTRHFH 71 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~ 71 (843)
+|+++|.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|.+++..+..+..+ ++|++|+
T Consensus 7 ~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~ 86 (362)
T 3goz_A 7 LHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLN 86 (362)
T ss_dssp CCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEE
T ss_pred cccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEE
Confidence 688999998888777889999999999997777 7888888 89999999999998878777775 8999999
Q ss_pred ccCCccccCCCccc----CCC-CCCceeeccCCCCCCCCCccc----CC-CCCCcEEEcCCCCCCCC---CCCccccCCC
Q 003158 72 MNNNSISGQIPPEL----SRL-PSLVHMLLDNNNLTGYLPPEL----SE-LPKLLILQLDNNNFEGT---TIPASYSNMS 138 (843)
Q Consensus 72 Ls~N~l~~~~~~~l----~~l-~~L~~L~L~~N~l~~~~~~~~----~~-l~~L~~L~Ls~N~l~~~---~~~~~~~~l~ 138 (843)
|++|.+++..+..+ ..+ ++|++|+|++|+|++..+..+ .. .++|++|+|++|++.+. .++..+..++
T Consensus 87 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~ 166 (362)
T 3goz_A 87 LSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166 (362)
T ss_dssp CCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSC
T ss_pred CcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCC
Confidence 99999987766644 344 899999999999987665544 33 36999999999999741 1233445555
Q ss_pred -CCcEEEcCCCCCCCCCCC-----CCCC-CCCCEEEcccCcCCCC----CCCCCCC--cCcCEEEccCCcCCCCCC----
Q 003158 139 -KLLKLSLRNCSLQGPMPD-----LSRI-PNLGYLDLSSNQLNGS----IPPGRLS--LNITTIKLSNNKLTGTIP---- 201 (843)
Q Consensus 139 -~L~~L~L~~N~l~~~~~~-----~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~--~~L~~L~Ls~N~l~~~~p---- 201 (843)
+|+.|+|++|++++..+. +..+ ++|+.|+|++|.|++. ++..... .+|+.|+|++|.|+...+
T Consensus 167 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 246 (362)
T 3goz_A 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLK 246 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHH
T ss_pred ccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHH
Confidence 899999999999876652 4455 5899999999998842 2222222 379999999999987655
Q ss_pred cccCCCCCCcEEeCcCccCCCCCCchhhcccc--CCCCcceeEEcCCCCCCCC
Q 003158 202 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRT--LNATETFILDFQNNNLTNI 252 (843)
Q Consensus 202 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--l~~~~L~~L~l~~N~l~~~ 252 (843)
..+..+++|+.|+|++|.+.+..+..+..+.. -..++|+.||+++|+|...
T Consensus 247 ~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 247 LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 34567888999999999877555544433221 1344577777777776653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-22 Score=206.04 Aligned_cols=201 Identities=22% Similarity=0.266 Sum_probs=143.6
Q ss_pred cCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCc-CCccCccccccCCCCCEEEccC-CccccCCCccc
Q 003158 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY-ISGSLPKSFANLNKTRHFHMNN-NSISGQIPPEL 85 (843)
Q Consensus 8 ~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~l 85 (843)
.+|. +. .+|++|+|++|+++++.+..|+++++|++|+|++|+ ++...+..|.++++|++|+|++ |.|+...+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4555 43 378888888888887666678888888888888886 7766666778888888888887 78876666777
Q ss_pred CCCCCCceeeccCCCCCCCCCcccCCCCCCc---EEEcCCC-CCCCCCCCccccCCCCCc-EEEcCCCCCCCCCCCCCCC
Q 003158 86 SRLPSLVHMLLDNNNLTGYLPPELSELPKLL---ILQLDNN-NFEGTTIPASYSNMSKLL-KLSLRNCSLQGPMPDLSRI 160 (843)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~l 160 (843)
.++++|++|+|++|++++ +|. |..+++|+ +|+|++| ++++ ..+..|.++++|+ .|+|++|+++.+++.....
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~-i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~ 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTS-IPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCE-ECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhh-cCcccccchhcceeEEEcCCCCCcccCHhhcCC
Confidence 788888888888888875 454 77777777 8888888 7764 2344577788888 8888888887766653333
Q ss_pred CCCCEEEcccCc-CCCCCCCC-CC-C-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCc
Q 003158 161 PNLGYLDLSSNQ-LNGSIPPG-RL-S-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218 (843)
Q Consensus 161 ~~L~~L~Ls~N~-l~~~~p~~-~~-~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 218 (843)
++|+.|+|++|+ ++ .++.. +. . .+|+.|+|++|.|++..+. .+++|+.|+++++
T Consensus 179 ~~L~~L~L~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CEEEEEECTTCTTCC-EECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCEEEcCCCCCcc-cCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 778888888884 77 44433 22 2 4788888888888744333 5667777777765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.1e-22 Score=216.13 Aligned_cols=243 Identities=16% Similarity=0.175 Sum_probs=185.9
Q ss_pred CEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC-cccCCCCCCce-eecc
Q 003158 20 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP-PELSRLPSLVH-MLLD 97 (843)
Q Consensus 20 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~-L~L~ 97 (843)
++++.++++|+ .+|..+ .++|++|+|++|+|+.+.+..|.++++|++|+|++|++.+.++ .+|.++++|.+ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 67888888888 677665 3678999999999986666778999999999999998865554 56788888765 6677
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCC-CCCCCCCCC-CCCCC-CCCEEEcccCcCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN-CSLQGPMPD-LSRIP-NLGYLDLSSNQLN 174 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~-~~~l~-~L~~L~Ls~N~l~ 174 (843)
+|+|+.+.|..|..+++|++|++++|++.. ..+..+....++..|++.+ |++..+++. |..+. .|+.|+|++|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSS-CCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCcccccCchhhhhcccccccccccccccc-CCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 788988778889999999999999999875 3344566667788888865 678777764 66664 6889999999998
Q ss_pred CCCCCCCCC-cCcCEEEccC-CcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEc-CCCCCCC
Q 003158 175 GSIPPGRLS-LNITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF-QNNNLTN 251 (843)
Q Consensus 175 ~~~p~~~~~-~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l-~~N~l~~ 251 (843)
.++...+. .+|+.|++++ |.++.+.+..|.++++|+.|+|++|+|+..-+..+..+ +.|.+ ..++++.
T Consensus 168 -~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L--------~~L~~l~~~~l~~ 238 (350)
T 4ay9_X 168 -EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL--------KKLRARSTYNLKK 238 (350)
T ss_dssp -EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTC--------CEEECTTCTTCCC
T ss_pred -CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccc--------hHhhhccCCCcCc
Confidence 66665444 4899999975 67776666789999999999999999994333334333 34443 3467888
Q ss_pred CCCCCcCCCCcEEEeccCcccccCC
Q 003158 252 ISGSFNIPPNVTVRLRGNPFCLNTN 276 (843)
Q Consensus 252 ~~~~~~~~~l~~l~l~~Np~~c~~~ 276 (843)
+|....+++|..+++. ||+.|.|-
T Consensus 239 lP~l~~l~~L~~l~l~-~~~~c~~~ 262 (350)
T 4ay9_X 239 LPTLEKLVALMEASLT-YPSHCCAF 262 (350)
T ss_dssp CCCTTTCCSCCEEECS-CHHHHHHH
T ss_pred CCCchhCcChhhCcCC-CCccccch
Confidence 9876689999999985 78888663
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-20 Score=219.84 Aligned_cols=215 Identities=25% Similarity=0.321 Sum_probs=155.1
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.+++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 36999999999999 7787776 89999999999999 5665 6799999999999999 4554 7799999999
Q ss_pred cCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCC
Q 003158 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 176 (843)
++|+|++. |. .+++|+.|+|++|+++. +|.. +++|++|+|++|++++++.. +.+|+.|++++|.|+ .
T Consensus 109 s~N~l~~l-~~---~l~~L~~L~L~~N~l~~--lp~~---l~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~ 175 (622)
T 3g06_A 109 FSNPLTHL-PA---LPSGLCKLWIFGNQLTS--LPVL---PPGLQELSVSDNQLASLPAL---PSELCKLWAYNNQLT-S 175 (622)
T ss_dssp CSCCCCCC-CC---CCTTCCEEECCSSCCSC--CCCC---CTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-C
T ss_pred cCCcCCCC-CC---CCCCcCEEECCCCCCCc--CCCC---CCCCCEEECcCCcCCCcCCc---cCCCCEEECCCCCCC-C
Confidence 99999954 44 56899999999999974 5654 48999999999999987653 356777777777776 4
Q ss_pred CCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC
Q 003158 177 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 256 (843)
Q Consensus 177 ~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~ 256 (843)
+| ....+|+.|+|++|.|++ +|.. +++|+.|++++|.|+ .+|..+ ++|+.|+|++|+|++++ .
T Consensus 176 l~--~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~~--------~~L~~L~Ls~N~L~~lp--~ 238 (622)
T 3g06_A 176 LP--MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP--------SGLKELIVSGNRLTSLP--V 238 (622)
T ss_dssp CC--CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCCC--------TTCCEEECCSSCCSCCC--C
T ss_pred Cc--ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCCC--------CCCCEEEccCCccCcCC--C
Confidence 55 223467777777777764 3322 355666666666665 333211 34445555555555554 2
Q ss_pred cCCCCcEEEeccCccc
Q 003158 257 NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 257 ~~~~l~~l~l~~Np~~ 272 (843)
.+++++.|++++|.+.
T Consensus 239 ~l~~L~~L~Ls~N~L~ 254 (622)
T 3g06_A 239 LPSELKELMVSGNRLT 254 (622)
T ss_dssp CCTTCCEEECCSSCCS
T ss_pred CCCcCcEEECCCCCCC
Confidence 3455555555555543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.1e-24 Score=237.09 Aligned_cols=242 Identities=18% Similarity=0.287 Sum_probs=151.5
Q ss_pred cCCccccCCCCCCEEEccCCcCCccCc----cccCCCCCCcEEEcccCc---CCccCcccc-------ccCCCCCEEEcc
Q 003158 8 SIPKEIGNIKSLELLLLNGNELTGSLP----EELGYLPKLDRIQIDQNY---ISGSLPKSF-------ANLNKTRHFHMN 73 (843)
Q Consensus 8 ~~p~~i~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~L~~N~---l~~~~~~~~-------~~l~~L~~L~Ls 73 (843)
.++..+..+++|++|+|++|+++...+ ..+..+++|++|+|++|. +++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 456667777788888888888775533 446677888888887753 334445444 567788888888
Q ss_pred CCcccc----CCCcccCCCCCCceeeccCCCCCCCCCcccC----CC---------CCCcEEEcCCCCCCCCCCC---cc
Q 003158 74 NNSISG----QIPPELSRLPSLVHMLLDNNNLTGYLPPELS----EL---------PKLLILQLDNNNFEGTTIP---AS 133 (843)
Q Consensus 74 ~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~----~l---------~~L~~L~Ls~N~l~~~~~~---~~ 133 (843)
+|.|+. .++..+..+++|+.|+|++|.++...+..+. .+ ++|++|+|++|++....++ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 888775 3555667777888888888877643333333 23 7777888887777532334 35
Q ss_pred ccCCCCCcEEEcCCCCCC--C---CCC-CCCCCCCCCEEEcccCcCC----CCCCCCCCC-cCcCEEEccCCcCCCC---
Q 003158 134 YSNMSKLLKLSLRNCSLQ--G---PMP-DLSRIPNLGYLDLSSNQLN----GSIPPGRLS-LNITTIKLSNNKLTGT--- 199 (843)
Q Consensus 134 ~~~l~~L~~L~L~~N~l~--~---~~~-~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~-~~L~~L~Ls~N~l~~~--- 199 (843)
+..+++|+.|+|++|+++ + +.+ .+..+++|+.|+|++|.++ +.+|..+.. .+|+.|+|++|.|++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 566777777777777776 2 233 5667777777777777774 234432222 3677777777776654
Q ss_pred -CCccc--CCCCCCcEEeCcCccCCC----CCCchhhccccCCCCcceeEEcCCCCCCCCC
Q 003158 200 -IPSNF--SGLPRLQRLFIANNSLSG----SIPSSIWQSRTLNATETFILDFQNNNLTNIS 253 (843)
Q Consensus 200 -~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~ 253 (843)
++..+ ..+++|+.|+|++|.|++ .+|..+.. +.++|+.|+|++|+++...
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~----~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE----KMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHH----HCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHh----cCCCceEEEccCCcCCcch
Confidence 34444 236667777777777665 24444421 1233446666666666543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-24 Score=246.95 Aligned_cols=255 Identities=18% Similarity=0.189 Sum_probs=130.1
Q ss_pred CCCEEEccCCcCCc----cCccccCCCCCCcEEEcccCcCCccC---------------------------------ccc
Q 003158 18 SLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYISGSL---------------------------------PKS 60 (843)
Q Consensus 18 ~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~---------------------------------~~~ 60 (843)
+|++|+|++|+++. .++..+..+++|++|+|++|.+++.. +..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 45555555555552 33555555555555555555554322 223
Q ss_pred cccCCCCCEEEccCCccccCCCcccC-----CCCCCceeeccCCCCCCC----CCcccCCCCCCcEEEcCCCCCCCCCC-
Q 003158 61 FANLNKTRHFHMNNNSISGQIPPELS-----RLPSLVHMLLDNNNLTGY----LPPELSELPKLLILQLDNNNFEGTTI- 130 (843)
Q Consensus 61 ~~~l~~L~~L~Ls~N~l~~~~~~~l~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~- 130 (843)
+..+++|++|+|++|.++...+..+. .+++|++|+|++|++++. ++..+..+++|++|+|++|.+.+...
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 33344444444444444422222221 133555555555555432 23344445555555555555532100
Q ss_pred ---CccccCCCCCcEEEcCCCCCCC-----CCCCCCCCCCCCEEEcccCcCCCCCCCCCC------CcCcCEEEccCCcC
Q 003158 131 ---PASYSNMSKLLKLSLRNCSLQG-----PMPDLSRIPNLGYLDLSSNQLNGSIPPGRL------SLNITTIKLSNNKL 196 (843)
Q Consensus 131 ---~~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------~~~L~~L~Ls~N~l 196 (843)
+..+..+++|++|+|++|.++. ++..+..+++|+.|+|++|.+++..+.... ..+|+.|+|++|.+
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l 325 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCC
Confidence 1122245556666666665554 222344456666666666665422111100 12666777777766
Q ss_pred CCC----CCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCC-----CCCCC-cCCCCcEEEe
Q 003158 197 TGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTN-----ISGSF-NIPPNVTVRL 266 (843)
Q Consensus 197 ~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~-----~~~~~-~~~~l~~l~l 266 (843)
++. ++..+..+++|++|+|++|.+++..+..+...-.-..++|+.|+|++|+++. ++... .++.++.|++
T Consensus 326 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l 405 (461)
T 1z7x_W 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 405 (461)
T ss_dssp BGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEEC
T ss_pred chHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEEC
Confidence 654 3455556677777777777776554444433211123466677777777773 33333 5677777777
Q ss_pred ccCccc
Q 003158 267 RGNPFC 272 (843)
Q Consensus 267 ~~Np~~ 272 (843)
++|++.
T Consensus 406 ~~N~i~ 411 (461)
T 1z7x_W 406 SNNCLG 411 (461)
T ss_dssp CSSSCC
T ss_pred CCCCCC
Confidence 777764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=6.6e-21 Score=204.85 Aligned_cols=214 Identities=21% Similarity=0.354 Sum_probs=140.8
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
++..+.+..+.++.... +..+++|++|++++|.++. ++ .+..+++|+.|+|++|.+++..+ +..+++|++|+|+
T Consensus 20 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~ 93 (308)
T 1h6u_A 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS 93 (308)
T ss_dssp HHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred HHHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEcc
Confidence 34445566666664333 4467888888888888874 44 57788888888888888874433 7888888888888
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 177 (843)
+|++++. ..+..+++|++|+|++|++++ ++. +..+++|+.|+|++|+++++++ +..+++|+.|+|++|.+++ +
T Consensus 94 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~ 166 (308)
T 1h6u_A 94 GNPLKNV--SAIAGLQSIKTLDLTSTQITD--VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-L 166 (308)
T ss_dssp SCCCSCC--GGGTTCTTCCEEECTTSCCCC--CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-C
T ss_pred CCcCCCc--hhhcCCCCCCEEECCCCCCCC--chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-C
Confidence 8888753 367778888888888888864 333 7778888888888888877655 6677777777777777773 3
Q ss_pred CCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCC
Q 003158 178 PPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253 (843)
Q Consensus 178 p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~ 253 (843)
+......+|+.|+|++|.+++..+ +..+++|++|+|++|++++..+ +.. .++|+.|+|++|.++..+
T Consensus 167 ~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~-----l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN-----TSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTT-----CTTCCEEEEEEEEEECCC
T ss_pred hhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccC-----CCCCCEEEccCCeeecCC
Confidence 332223366666666666664332 5666666666666666664332 222 223445555555555443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-23 Score=229.71 Aligned_cols=252 Identities=20% Similarity=0.225 Sum_probs=198.9
Q ss_pred EEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCc----cccccCC-CCCEEEccCCccccCCCcccCCC-----CC
Q 003158 21 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP----KSFANLN-KTRHFHMNNNSISGQIPPELSRL-----PS 90 (843)
Q Consensus 21 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l-----~~ 90 (843)
.++|+.|++++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999999988888889999999999997776 7788898 99999999999998877777664 99
Q ss_pred CceeeccCCCCCCCCCccc----CCC-CCCcEEEcCCCCCCCCCCCcc----ccC-CCCCcEEEcCCCCCCCCCC-----
Q 003158 91 LVHMLLDNNNLTGYLPPEL----SEL-PKLLILQLDNNNFEGTTIPAS----YSN-MSKLLKLSLRNCSLQGPMP----- 155 (843)
Q Consensus 91 L~~L~L~~N~l~~~~~~~~----~~l-~~L~~L~Ls~N~l~~~~~~~~----~~~-l~~L~~L~L~~N~l~~~~~----- 155 (843)
|++|+|++|++++..+..+ ..+ ++|++|+|++|++++ ..+.. +.. .++|++|+|++|.++....
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS-KSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG-SCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc-HHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 9999999999997766644 444 899999999999975 33333 344 3699999999999986443
Q ss_pred CCCCCC-CCCEEEcccCcCCCCCCCCCC-----C-cCcCEEEccCCcCCCC----CCcccCC-CCCCcEEeCcCccCCCC
Q 003158 156 DLSRIP-NLGYLDLSSNQLNGSIPPGRL-----S-LNITTIKLSNNKLTGT----IPSNFSG-LPRLQRLFIANNSLSGS 223 (843)
Q Consensus 156 ~~~~l~-~L~~L~Ls~N~l~~~~p~~~~-----~-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~ 223 (843)
.+..++ +|+.|+|++|++++..+.... . .+|+.|+|++|.|+.. ++..+.. .++|++|+|++|.|++.
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 240 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence 234555 999999999999865543211 1 4899999999999974 4445555 45999999999999977
Q ss_pred CCchhhccccCCCCcceeEEcCCCCCCCCCCC--------C-cCCCCcEEEeccCccccc
Q 003158 224 IPSSIWQSRTLNATETFILDFQNNNLTNISGS--------F-NIPPNVTVRLRGNPFCLN 274 (843)
Q Consensus 224 ~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~--------~-~~~~l~~l~l~~Np~~c~ 274 (843)
.+..+..+.. ..++|+.|+|++|.+..+... . .++.+..|++++|++...
T Consensus 241 ~~~~l~~~~~-~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 241 SLENLKLLKD-SLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp CHHHHHHTTT-TTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHHh-cCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 6655554321 345688999999997766532 2 567788899999997644
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=189.87 Aligned_cols=179 Identities=18% Similarity=0.261 Sum_probs=119.2
Q ss_pred CEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCC
Q 003158 20 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 99 (843)
Q Consensus 20 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 99 (843)
+.++.+++.++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 56777777777 445433 357777777777777666666777777777777777777555556677777777777777
Q ss_pred CCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCCC
Q 003158 100 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIP 178 (843)
Q Consensus 100 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p 178 (843)
++++..+..|..+++|++|+|++|++++ ..+..|.++++|+.|+|++|+++++++. +..+++|+.|+|++|.+.+..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcc-cCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 7776655666777777777777777764 3344567777777777777777766664 6667777777777776654332
Q ss_pred CCCCCcCcCEEEccCCcCCCCCCcccCCCC
Q 003158 179 PGRLSLNITTIKLSNNKLTGTIPSNFSGLP 208 (843)
Q Consensus 179 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 208 (843)
+|+.|+++.|.++|.+|..++.++
T Consensus 166 ------~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 166 ------GIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp ------TTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ------CHHHHHHHHHhCCceeeccCcccc
Confidence 455555555555555555555443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=206.42 Aligned_cols=233 Identities=17% Similarity=0.200 Sum_probs=183.2
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCc-cccccCCCCCE-EEccCCcccc
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRH-FHMNNNSISG 79 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~Ls~N~l~~ 79 (843)
.|+++ .+|..|. ++|++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.++ ..|.++++|++ +.++.|+|+.
T Consensus 18 ~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~ 94 (350)
T 4ay9_X 18 ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 94 (350)
T ss_dssp STTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCE
T ss_pred CCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccc
Confidence 46778 7888773 689999999999997777789999999999999999876554 57899998876 5677899998
Q ss_pred CCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCC-CCCCCCCCCccccCCC-CCcEEEcCCCCCCCCCCCC
Q 003158 80 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN-NNFEGTTIPASYSNMS-KLLKLSLRNCSLQGPMPDL 157 (843)
Q Consensus 80 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~ 157 (843)
+.|..|.++++|+.|++++|+|+...+..+....++..|++.+ |++.. ..+..|..+. .|+.|+|++|+|+.+++..
T Consensus 95 l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~-l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~ 173 (350)
T 4ay9_X 95 INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT-IERNSFVGLSFESVILWLNKNGIQEIHNSA 173 (350)
T ss_dssp ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCE-ECTTSSTTSBSSCEEEECCSSCCCEECTTS
T ss_pred cCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccc-ccccchhhcchhhhhhccccccccCCChhh
Confidence 8899999999999999999999987777788888899999966 56653 2345666664 6899999999999998876
Q ss_pred CCCCCCCEEEccc-CcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccC
Q 003158 158 SRIPNLGYLDLSS-NQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234 (843)
Q Consensus 158 ~~l~~L~~L~Ls~-N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l 234 (843)
....+|+.|++++ |.++ .+|...+. .+|+.|||++|+|+...+..|.+ |+.|.+.++.--..+|. +..
T Consensus 174 f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~~lP~-l~~---- 244 (350)
T 4ay9_X 174 FNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLKKLPT-LEK---- 244 (350)
T ss_dssp STTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCCCCCC-TTT----
T ss_pred ccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcCcCCC-chh----
Confidence 6778999999986 5565 88876544 48999999999999665555554 55555544433335663 333
Q ss_pred CCCcceeEEcCCCC
Q 003158 235 NATETFILDFQNNN 248 (843)
Q Consensus 235 ~~~~L~~L~l~~N~ 248 (843)
+++|+.+++.++.
T Consensus 245 -l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 245 -LVALMEASLTYPS 257 (350)
T ss_dssp -CCSCCEEECSCHH
T ss_pred -CcChhhCcCCCCc
Confidence 3466788887653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.1e-23 Score=229.76 Aligned_cols=256 Identities=18% Similarity=0.191 Sum_probs=195.8
Q ss_pred CCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCc----cccccCCCCCEEEccCCc---cccCCCccc------
Q 003158 19 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP----KSFANLNKTRHFHMNNNS---ISGQIPPEL------ 85 (843)
Q Consensus 19 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~---l~~~~~~~l------ 85 (843)
|+...++...+. .++..+..+++|++|+|++|.++...+ ..+..+++|+.|+|++|. +++.+|..+
T Consensus 11 L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~ 89 (386)
T 2ca6_A 11 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89 (386)
T ss_dssp CEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHH
T ss_pred cccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHH
Confidence 344444444444 577888899999999999999996644 447789999999999964 444555554
Q ss_pred -CCCCCCceeeccCCCCCC----CCCcccCCCCCCcEEEcCCCCCCCC---CCCccccCC---------CCCcEEEcCCC
Q 003158 86 -SRLPSLVHMLLDNNNLTG----YLPPELSELPKLLILQLDNNNFEGT---TIPASYSNM---------SKLLKLSLRNC 148 (843)
Q Consensus 86 -~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~~l---------~~L~~L~L~~N 148 (843)
..+++|++|+|++|++++ .++..+..+++|++|+|++|.+.+. .++..+..+ ++|++|+|++|
T Consensus 90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n 169 (386)
T 2ca6_A 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169 (386)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCC
Confidence 789999999999999997 4677889999999999999999631 122334444 89999999999
Q ss_pred CCCC--CC---CCCCCCCCCCEEEcccCcCCC-----CCC-CCCCCcCcCEEEccCCcCC----CCCCcccCCCCCCcEE
Q 003158 149 SLQG--PM---PDLSRIPNLGYLDLSSNQLNG-----SIP-PGRLSLNITTIKLSNNKLT----GTIPSNFSGLPRLQRL 213 (843)
Q Consensus 149 ~l~~--~~---~~~~~l~~L~~L~Ls~N~l~~-----~~p-~~~~~~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L 213 (843)
+++. ++ ..+..+++|+.|+|++|.++. .++ ......+|+.|+|++|.|+ ..+|..+..+++|++|
T Consensus 170 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L 249 (386)
T 2ca6_A 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249 (386)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred CCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence 9972 22 236678999999999999972 233 2223348999999999996 6788899999999999
Q ss_pred eCcCccCCCCCCchhhc-cccCCCCcceeEEcCCCCCCC-----CCCCC--cCCCCcEEEeccCcccccC
Q 003158 214 FIANNSLSGSIPSSIWQ-SRTLNATETFILDFQNNNLTN-----ISGSF--NIPPNVTVRLRGNPFCLNT 275 (843)
Q Consensus 214 ~L~~N~l~~~~p~~~~~-l~~l~~~~L~~L~l~~N~l~~-----~~~~~--~~~~l~~l~l~~Np~~c~~ 275 (843)
+|++|.|++.....+.. +..-..++|+.|+|++|+|+. ++... .++.+..|++++|++....
T Consensus 250 ~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 99999998663222221 111124577899999999998 66554 4799999999999987554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-23 Score=236.80 Aligned_cols=267 Identities=17% Similarity=0.202 Sum_probs=149.0
Q ss_pred CccccccCCcc-ccCCCCCCEEEccCCcCCc----cCccccCCCCCCcEEEcccCcCCccCcccc-ccCC----CCCEEE
Q 003158 2 WNKISGSIPKE-IGNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYISGSLPKSF-ANLN----KTRHFH 71 (843)
Q Consensus 2 ~N~i~~~~p~~-i~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~----~L~~L~ 71 (843)
+|+++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|.++...+..+ ..++ +|++|+
T Consensus 12 ~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~ 91 (461)
T 1z7x_W 12 CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 91 (461)
T ss_dssp SCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEE
T ss_pred hcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEE
Confidence 34555433333 5567777777777777773 345666777777777777777765433333 2344 577777
Q ss_pred ccCCcccc----CCCcccCCCCCCceeeccCCCCCCCCCccc-----CCCCCCcEEEcCCCCCCCCC---CCccccCCCC
Q 003158 72 MNNNSISG----QIPPELSRLPSLVHMLLDNNNLTGYLPPEL-----SELPKLLILQLDNNNFEGTT---IPASYSNMSK 139 (843)
Q Consensus 72 Ls~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~---~~~~~~~l~~ 139 (843)
|++|.|+. .++..+..+++|++|+|++|.+++..+..+ ...++|++|+|++|++++.. ++..+..+++
T Consensus 92 L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~ 171 (461)
T 1z7x_W 92 LQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171 (461)
T ss_dssp CTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTT
T ss_pred ccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCC
Confidence 77777773 346667777777777777777764333222 22456777777777765311 2344555677
Q ss_pred CcEEEcCCCCCCCCCCC-CC-----CCCCCCEEEcccCcCCCC----CCCCCC-CcCcCEEEccCCcCCCCC-----Ccc
Q 003158 140 LLKLSLRNCSLQGPMPD-LS-----RIPNLGYLDLSSNQLNGS----IPPGRL-SLNITTIKLSNNKLTGTI-----PSN 203 (843)
Q Consensus 140 L~~L~L~~N~l~~~~~~-~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~-~~~L~~L~Ls~N~l~~~~-----p~~ 203 (843)
|++|+|++|.++..... +. ..++|+.|+|++|.+++. ++.... ..+|+.|+|++|.++... +..
T Consensus 172 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~ 251 (461)
T 1z7x_W 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGL 251 (461)
T ss_dssp CCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHH
T ss_pred CCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHH
Confidence 77777777776543221 11 244666666666666532 122111 125666666666665422 222
Q ss_pred cCCCCCCcEEeCcCccCCCC----CCchhhccccCCCCcceeEEcCCCCCCCCCCCC-------cCCCCcEEEeccCccc
Q 003158 204 FSGLPRLQRLFIANNSLSGS----IPSSIWQSRTLNATETFILDFQNNNLTNISGSF-------NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 204 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-------~~~~l~~l~l~~Np~~ 272 (843)
+..+++|++|+|++|.+++. ++..+..+ ++|+.|+|++|+++...... ..+.++.|++++|.+.
T Consensus 252 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~-----~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~ 326 (461)
T 1z7x_W 252 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAK-----ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326 (461)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC-----TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCB
T ss_pred hcCCCCceEEECcCCCCCHHHHHHHHHHHhhC-----CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCc
Confidence 33456666666666666543 23333322 23445666666654332111 1245666666666554
Q ss_pred c
Q 003158 273 L 273 (843)
Q Consensus 273 c 273 (843)
.
T Consensus 327 ~ 327 (461)
T 1z7x_W 327 A 327 (461)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.3e-20 Score=188.15 Aligned_cols=146 Identities=18% Similarity=0.250 Sum_probs=80.6
Q ss_pred CCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEc
Q 003158 90 SLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDL 168 (843)
Q Consensus 90 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L 168 (843)
+|+.|+|++|+|+++.+..|..+++|++|+|++|++++ ..|..|.++++|+.|+|++|+|+.+++. |..+++
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~------ 105 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFS------ 105 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCE-ECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTT------
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCC-cCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCC------
Confidence 44444444444444333344444444444444444432 2234444444444444444444444332 333344
Q ss_pred ccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCC
Q 003158 169 SSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 248 (843)
Q Consensus 169 s~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~ 248 (843)
|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..+..+.
T Consensus 106 -----------------L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------- 149 (220)
T 2v9t_B 106 -----------------LQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS------------------- 149 (220)
T ss_dssp -----------------CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT-------------------
T ss_pred -----------------CCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHh-------------------
Confidence 44444444444445555666777777777777777654444332
Q ss_pred CCCCCCCCcCCCCcEEEeccCcccccCCcccccCCCCC
Q 003158 249 LTNISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 286 (843)
Q Consensus 249 l~~~~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~ 286 (843)
.++.+..|++++|||.|+|.+.|+..|+..
T Consensus 150 --------~l~~L~~L~L~~N~~~c~c~l~~l~~~l~~ 179 (220)
T 2v9t_B 150 --------PLRAIQTMHLAQNPFICDCHLKWLADYLHT 179 (220)
T ss_dssp --------TCTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred --------CCCCCCEEEeCCCCcCCCCccHHHHHHHHh
Confidence 245567888999999999999999888653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.8e-22 Score=216.68 Aligned_cols=222 Identities=19% Similarity=0.259 Sum_probs=138.2
Q ss_pred CCCEEEccCCcCCccCccccCCC--CCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccC-CCcccCCCCCCcee
Q 003158 18 SLELLLLNGNELTGSLPEELGYL--PKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ-IPPELSRLPSLVHM 94 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L 94 (843)
.++.|++++|.+. +..+..+ ++|+.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3667777777666 4555555 6777777777777755444 44667777777777776644 55666677777777
Q ss_pred eccCCCCCCCCCcccCCCCCCcEEEcCCC-CCCCCCCCccccCCCCCcEEEcCCC-CCCCC--CCCCCCCC-CCCEEEcc
Q 003158 95 LLDNNNLTGYLPPELSELPKLLILQLDNN-NFEGTTIPASYSNMSKLLKLSLRNC-SLQGP--MPDLSRIP-NLGYLDLS 169 (843)
Q Consensus 95 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~--~~~~~~l~-~L~~L~Ls 169 (843)
+|++|++++..+..+..+++|++|+|++| .+++..++..+.++++|++|+|++| .+++. +..+..++ +|+.|+|+
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 77777776666666677777777777777 5543224555666777777777777 66642 22355666 77777777
Q ss_pred cC--cCC-CCCCCCC-CCcCcCEEEccCCc-CCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEc
Q 003158 170 SN--QLN-GSIPPGR-LSLNITTIKLSNNK-LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDF 244 (843)
Q Consensus 170 ~N--~l~-~~~p~~~-~~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l 244 (843)
+| .++ +.++... ...+|+.|+|++|. +++..+..+..+++|++|+|++|. +..+..+..+.+ .++|+.|++
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~--~~~L~~L~l 279 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGE--IPTLKTLQV 279 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGG--CTTCCEEEC
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhc--CCCCCEEec
Confidence 77 333 1222221 12367777777776 665666667777777777777775 233333322322 345667777
Q ss_pred CCC
Q 003158 245 QNN 247 (843)
Q Consensus 245 ~~N 247 (843)
++|
T Consensus 280 ~~~ 282 (336)
T 2ast_B 280 FGI 282 (336)
T ss_dssp TTS
T ss_pred cCc
Confidence 777
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=204.40 Aligned_cols=188 Identities=21% Similarity=0.247 Sum_probs=94.0
Q ss_pred cEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccC-CCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCC
Q 003158 44 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS-RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122 (843)
Q Consensus 44 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 122 (843)
+.+++++|+++ .+|..+. ..++.|+|++|+|++..+..|. ++++|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 34555555555 3343322 2345555555555544444444 555555555555555544444455555555555555
Q ss_pred CCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCC
Q 003158 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIP 201 (843)
Q Consensus 123 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p 201 (843)
|+|+. ..+..|.++++|+.|+|++|+|+++.+ .|..+++|+.|+|++|+|+ +..+
T Consensus 98 N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-----------------------~l~~ 153 (361)
T 2xot_A 98 NHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-----------------------RFPV 153 (361)
T ss_dssp SCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-----------------------SCCG
T ss_pred CcCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-----------------------eeCH
Confidence 55542 223344444555555555554444433 2444444444444444444 2222
Q ss_pred ccc---CCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCC--CcEEEeccCcccccCC
Q 003158 202 SNF---SGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPP--NVTVRLRGNPFCLNTN 276 (843)
Q Consensus 202 ~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~--l~~l~l~~Np~~c~~~ 276 (843)
..| ..+++|+.|+|++|+|++..+..+.. ++. +..|+|.+|||.|+|.
T Consensus 154 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~---------------------------l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK---------------------------LPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp GGTC----CTTCCEEECCSSCCCCCCHHHHHH---------------------------SCHHHHTTEECCSSCEECCHH
T ss_pred HHhcCcccCCcCCEEECCCCCCCccCHHHhhh---------------------------ccHhhcceEEecCCCccCCcC
Confidence 222 34555666666666655333233332 222 3568899999999999
Q ss_pred cccc-cCCCC
Q 003158 277 AEQF-CGSHS 285 (843)
Q Consensus 277 ~~~~-~~~~~ 285 (843)
+.++ ..|..
T Consensus 207 l~~~~~~~~~ 216 (361)
T 2xot_A 207 LYQLFSHWQY 216 (361)
T ss_dssp HHHHHHHHHH
T ss_pred cHHHHHHHHH
Confidence 8774 45553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=182.53 Aligned_cols=170 Identities=18% Similarity=0.226 Sum_probs=150.1
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
|.++ .+|..+ .++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+
T Consensus 17 ~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 93 (208)
T 2o6s_A 17 QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPN 93 (208)
T ss_dssp SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCH
Confidence 4455 566555 4689999999999998888889999999999999999997777778999999999999999997777
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN 162 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 162 (843)
..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++ ..+..+..+++|+.|+|++|.+.+ .+++
T Consensus 94 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~------~~~~ 166 (208)
T 2o6s_A 94 GVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDC------TCPG 166 (208)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSCCBCC------CTTT
T ss_pred hHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccce-eCHHHhccCCCccEEEecCCCeec------CCCC
Confidence 778999999999999999998877789999999999999999985 445568999999999999998764 4568
Q ss_pred CCEEEcccCcCCCCCCCCCC
Q 003158 163 LGYLDLSSNQLNGSIPPGRL 182 (843)
Q Consensus 163 L~~L~Ls~N~l~~~~p~~~~ 182 (843)
|+.|+++.|+++|.+|....
T Consensus 167 l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 167 IRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp THHHHHHHHHCTTTBBCTTS
T ss_pred HHHHHHHHHhCCceeeccCc
Confidence 99999999999999998654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.1e-20 Score=212.62 Aligned_cols=182 Identities=23% Similarity=0.344 Sum_probs=82.7
Q ss_pred CCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcC
Q 003158 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 121 (843)
+|+.|+|++|+|++ +|..+ +++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 45555555555553 33333 244555555555554 333 234455555555555553 333 332 45555555
Q ss_pred CCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCC
Q 003158 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIP 201 (843)
Q Consensus 122 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p 201 (843)
+|+|++ +|. .+++|+.|+|++|+|++++. .+++|+.|+|++|+|++ +|.
T Consensus 129 ~N~l~~--lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~---------------------- 177 (571)
T 3cvr_A 129 NNQLTM--LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE---------------------- 177 (571)
T ss_dssp SSCCSC--CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC----------------------
T ss_pred CCcCCC--CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-cch----------------------
Confidence 555543 333 34445555555555544333 33444555555554442 333
Q ss_pred cccCCCCCCcEEeCcCccCCCCCCchhhccccC--CCCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCcccc
Q 003158 202 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL--NATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 202 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l--~~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~c 273 (843)
|. ++|+.|+|++|+|+ .+|. +.. +| ..+.|+.|+|++|+|+.+|... .++++..|+|++|++.+
T Consensus 178 --l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 178 --LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp --CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCCH
T ss_pred --hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCCC
Confidence 33 44555555555554 3333 221 11 1111245555555555555433 45555555555555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.5e-22 Score=215.13 Aligned_cols=236 Identities=18% Similarity=0.221 Sum_probs=180.3
Q ss_pred CccccCC--CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCcc-CccccccCCCCCEEEccCCccccCCCcccC
Q 003158 10 PKEIGNI--KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQIPPELS 86 (843)
Q Consensus 10 p~~i~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 86 (843)
|..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+.
T Consensus 61 ~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~ 139 (336)
T 2ast_B 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 139 (336)
T ss_dssp HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHT
T ss_pred HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHh
Confidence 3445555 8899999999999976665 56799999999999998865 778889999999999999999877888888
Q ss_pred CCCCCceeeccCC-CCCCC-CCcccCCCCCCcEEEcCCC-CCCCCCCCccccCCC-CCcEEEcCCCC--CC--CCCCCCC
Q 003158 87 RLPSLVHMLLDNN-NLTGY-LPPELSELPKLLILQLDNN-NFEGTTIPASYSNMS-KLLKLSLRNCS--LQ--GPMPDLS 158 (843)
Q Consensus 87 ~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~-~L~~L~L~~N~--l~--~~~~~~~ 158 (843)
.+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++..++..+..++ +|++|+|++|. ++ +++..+.
T Consensus 140 ~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~ 219 (336)
T 2ast_B 140 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 219 (336)
T ss_dssp TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHH
T ss_pred cCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHh
Confidence 9999999999999 67742 5666888999999999999 886533577788899 99999999994 43 2333467
Q ss_pred CCCCCCEEEcccCc-CCCCCCCCCC-CcCcCEEEccCCc-CCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCC
Q 003158 159 RIPNLGYLDLSSNQ-LNGSIPPGRL-SLNITTIKLSNNK-LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235 (843)
Q Consensus 159 ~l~~L~~L~Ls~N~-l~~~~p~~~~-~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~ 235 (843)
.+++|+.|+|++|. +++..+.... ..+|+.|+|++|. ++......+..+++|+.|+|++| ++.. .+..+..
T Consensus 220 ~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~-- 293 (336)
T 2ast_B 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKE-- 293 (336)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHH--
T ss_pred hCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHh--
Confidence 78999999999999 6654444333 2489999999995 33222236888999999999998 4422 2333321
Q ss_pred CCcceeEEcCCCCCCCCCC
Q 003158 236 ATETFILDFQNNNLTNISG 254 (843)
Q Consensus 236 ~~~L~~L~l~~N~l~~~~~ 254 (843)
.+..|++++|++++..+
T Consensus 294 --~l~~L~l~~n~l~~~~~ 310 (336)
T 2ast_B 294 --ALPHLQINCSHFTTIAR 310 (336)
T ss_dssp --HSTTSEESCCCSCCTTC
T ss_pred --hCcceEEecccCccccC
Confidence 23357788888887654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=183.86 Aligned_cols=163 Identities=19% Similarity=0.232 Sum_probs=94.1
Q ss_pred eeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccC
Q 003158 93 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSN 171 (843)
Q Consensus 93 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N 171 (843)
.+++++|.++ .+|..+. ..+++|+|++|++++...+..|..+++|+.|+|++|+|+++++ .|..+++|+.|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4555555555 2343332 2345555555555432112335555566666666666555555 3555555655555555
Q ss_pred cCCCCCCCCCC-CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCC
Q 003158 172 QLNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 250 (843)
Q Consensus 172 ~l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~ 250 (843)
.|++..+..+. ..+|++|+|++|.|++..|..|.++++|+.|+|++|+|++..|..|.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--------------------- 150 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD--------------------- 150 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTT---------------------
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhc---------------------
Confidence 55532222111 12455555555555555556666666666666666666655555543
Q ss_pred CCCCCCcCCCCcEEEeccCcccccCCcccccCCCC
Q 003158 251 NISGSFNIPPNVTVRLRGNPFCLNTNAEQFCGSHS 285 (843)
Q Consensus 251 ~~~~~~~~~~l~~l~l~~Np~~c~~~~~~~~~~~~ 285 (843)
.++++..|++++|||.|+|.+.++..|+.
T Consensus 151 ------~l~~L~~L~L~~N~l~c~c~l~~l~~~~~ 179 (220)
T 2v70_A 151 ------TLHSLSTLNLLANPFNCNCYLAWLGEWLR 179 (220)
T ss_dssp ------TCTTCCEEECCSCCEECSGGGHHHHHHHH
T ss_pred ------CCCCCCEEEecCcCCcCCCchHHHHHHHH
Confidence 35567788999999999999999988875
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=191.80 Aligned_cols=191 Identities=23% Similarity=0.317 Sum_probs=139.3
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.++..+.+..+.++...+ +..+++|++|++++|.++.. + .+..+++|+.|+|++|++++..+ +..+++|+.|+|
T Consensus 24 ~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l 97 (291)
T 1h6t_A 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97 (291)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence 334455666666664333 34677788888888887743 3 37777888888888888875433 777888888888
Q ss_pred cCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCC
Q 003158 97 DNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176 (843)
Q Consensus 97 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 176 (843)
++|++++. ..+..+++|++|+|++|++++ + ..+..+++|+.|+|++|+++++ +.+..+++|+.|+|++|++++.
T Consensus 98 ~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~--~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~ 171 (291)
T 1h6t_A 98 DENKVKDL--SSLKDLKKLKSLSLEHNGISD--I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDI 171 (291)
T ss_dssp CSSCCCCG--GGGTTCTTCCEEECTTSCCCC--C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCC
T ss_pred CCCcCCCC--hhhccCCCCCEEECCCCcCCC--C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccc
Confidence 88888752 347778888888888888864 2 4577788888888888888776 5577788888888888888754
Q ss_pred CCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCC
Q 003158 177 IPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 222 (843)
Q Consensus 177 ~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 222 (843)
.+ .....+|+.|+|++|.|++. + .+..+++|+.|++++|+++.
T Consensus 172 ~~-l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 172 VP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred hh-hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 43 33334788888888888854 3 48899999999999999985
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.6e-19 Score=206.90 Aligned_cols=194 Identities=23% Similarity=0.318 Sum_probs=147.9
Q ss_pred CCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceee
Q 003158 16 IKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 95 (843)
Q Consensus 16 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 95 (843)
+..+..+.|..+.+....+ +..|++|+.|+|++|.|.. ++ .+..+++|+.|+|++|.|++..+ +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3456666777777775444 4677888888888888874 33 47888888888888888885544 77888888888
Q ss_pred ccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCC
Q 003158 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 96 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 175 (843)
|++|+|++. ..+..+++|+.|+|++|++.+ + ..+..+++|+.|+|++|.|+++ +.+..+++|+.|+|++|.|++
T Consensus 94 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~--l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKDL--SSLKDLKKLKSLSLEHNGISD--I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCCC--TTSTTCTTCCEEECTTSCCCC--C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCCC--hhhccCCCCCEEEecCCCCCC--C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCC
Confidence 888888753 368888888888888888864 2 4577888888888888888876 567788888888888888886
Q ss_pred CCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCC
Q 003158 176 SIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224 (843)
Q Consensus 176 ~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 224 (843)
..| .....+|+.|+|++|.|++. ..|..+++|+.|+|++|++.+..
T Consensus 168 ~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 168 IVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp CGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred chh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 555 33345888888888888864 46888999999999999988543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-19 Score=188.97 Aligned_cols=192 Identities=23% Similarity=0.397 Sum_probs=112.7
Q ss_pred CCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcC
Q 003158 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 121 (843)
++..+.+..+.+++..+ +..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 25 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence 34444555555553322 45566666666666666633 2 35666666666676666664433 6666666677776
Q ss_pred CCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCC
Q 003158 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIP 201 (843)
Q Consensus 122 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p 201 (843)
+|++++ + ..+..+++|+.|+|++|+++++ +.+..+++|+.|++++|++++ ++......+|+.|+|++|.+++..+
T Consensus 99 ~n~l~~--~-~~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 99 ENKVKD--L-SSLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SSCCCC--G-GGGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CCcCCC--C-hhhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCc-chhhccCCCCCEEEccCCccccchh
Confidence 666653 2 2366666666677766666654 345666666666776666663 3322223366666676666665443
Q ss_pred cccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCC
Q 003158 202 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253 (843)
Q Consensus 202 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~ 253 (843)
+..+++|+.|+|++|.|++ +| .+.. .++|+.|++++|+++..+
T Consensus 174 --l~~l~~L~~L~L~~N~i~~-l~-~l~~-----l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISD-LR-ALAG-----LKNLDVLELFSQECLNKP 216 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCB-CG-GGTT-----CTTCSEEEEEEEEEECCC
T ss_pred --hcCCCccCEEECCCCcCCC-Ch-hhcc-----CCCCCEEECcCCcccCCc
Confidence 6666666667776666663 22 1322 234556666666666543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=179.14 Aligned_cols=164 Identities=18% Similarity=0.239 Sum_probs=78.5
Q ss_pred CEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCC
Q 003158 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 147 (843)
Q Consensus 68 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~ 147 (843)
+.++++++.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|.. ..+..|.++++|+.|+|++
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC-cChhhcccCCCcCEEECCC
Confidence 34444444444 3333222 444455555555544444444444444444444444432 1123334444444444444
Q ss_pred CCCCCCCCC-CCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCc
Q 003158 148 CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 226 (843)
Q Consensus 148 N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 226 (843)
|+|+++++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~------------------------~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT------------------------ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC------------------------SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc------------------------ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 444444432 344444444444444443 2333444444555555555554432222
Q ss_pred hhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEeccCcccccCC-cccccCCCCC
Q 003158 227 SIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRGNPFCLNTN-AEQFCGSHSD 286 (843)
Q Consensus 227 ~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~Np~~c~~~-~~~~~~~~~~ 286 (843)
.+. .++++..|++.+|||.|+|. +.++..|+..
T Consensus 154 ~~~---------------------------~l~~L~~L~l~~N~~~c~c~~~~~l~~~~~~ 187 (229)
T 3e6j_A 154 AFD---------------------------RLSSLTHAYLFGNPWDCECRDIMYLRNWVAD 187 (229)
T ss_dssp TTT---------------------------TCTTCCEEECTTSCBCTTBGGGHHHHHHHHH
T ss_pred HHh---------------------------CCCCCCEEEeeCCCccCCcchhHHHHHHHHh
Confidence 221 34566677888888888885 6666666543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-18 Score=175.61 Aligned_cols=151 Identities=25% Similarity=0.349 Sum_probs=116.9
Q ss_pred CEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCC
Q 003158 20 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 99 (843)
Q Consensus 20 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 99 (843)
+.+++++++++ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 57888888888 5665554 67888888888888766677888888888888888888777788888888888888888
Q ss_pred CCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCC
Q 003158 100 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 100 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 174 (843)
+|+...+..|.++++|++|+|++|++++ ..+..|.++++|+.|+|++|+|+++++. +..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCE-eCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 8886666667778888888888888875 4466777888888888888888877764 777777777777777765
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.5e-19 Score=207.94 Aligned_cols=175 Identities=23% Similarity=0.390 Sum_probs=115.8
Q ss_pred ccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCc
Q 003158 13 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLV 92 (843)
Q Consensus 13 i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 92 (843)
+..|.+|+.|+|++|.+.. ++ .|+.+++|+.|+|++|.|++..+ +..+++|+.|+|++|.|++. + .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-S-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-T-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-h-hhccCCCCC
Confidence 3456677777777777763 33 46677777777777777775443 67777777777777777642 2 566777777
Q ss_pred eeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCc
Q 003158 93 HMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 172 (843)
Q Consensus 93 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~ 172 (843)
.|+|++|+|++. ..+..+++|+.|+|++|++++ + ..+..+++|+.|+|++|.|+++++ +..+++|+.|+|++|.
T Consensus 113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~--l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCC--C-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred EEEecCCCCCCC--ccccCCCccCEEECCCCccCC--c-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCC
Confidence 777777777643 456677777777777777754 2 456677777777777777776665 6677777777777777
Q ss_pred CCCCCCCCCCCcCcCEEEccCCcCCCCC
Q 003158 173 LNGSIPPGRLSLNITTIKLSNNKLTGTI 200 (843)
Q Consensus 173 l~~~~p~~~~~~~L~~L~Ls~N~l~~~~ 200 (843)
|++ ++......+|+.|+|++|.+++..
T Consensus 187 i~~-l~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 187 ISD-LRALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp CCB-CGGGTTCTTCSEEECCSEEEECCC
T ss_pred CCC-ChHHccCCCCCEEEccCCcCcCCc
Confidence 763 443333346777777777776543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-18 Score=174.57 Aligned_cols=153 Identities=20% Similarity=0.250 Sum_probs=128.4
Q ss_pred CCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCc-cccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 19 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLP-KSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 19 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
-+.|++++|.++ .+|..+. ..+++|+|++|+|++..+ ..|..+++|+.|+|++|+|+++.+..|.++++|++|+|+
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 468999999998 5676554 456899999999997644 458889999999999999998877789999999999999
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNG 175 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~ 175 (843)
+|+|++..+..|.++++|++|+|++|++++ ..|..|.++++|+.|+|++|+++++++ .|..+++|+.|+|++|.+.+
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCC-BCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCe-ECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 999998877888899999999999999986 457888888999999999999988866 48888888888888888874
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.4e-18 Score=173.79 Aligned_cols=152 Identities=18% Similarity=0.214 Sum_probs=117.8
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
+.+.++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|+|+.+.+..|..+++|+.|+|+
T Consensus 20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 3567888888887 5665544 778888888888887777788888888888888888876666667788888888888
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 174 (843)
+|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+++++. +..+++|+.|+|++|.+.
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC--SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc--ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 88888766667778888888888888886 5677778888888888888888877764 777777777777777776
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.5e-19 Score=183.19 Aligned_cols=136 Identities=19% Similarity=0.108 Sum_probs=107.8
Q ss_pred CCCCCcccccCCeeEEEEEe-CCCcE--EEEEEeccCChh------------------------hHHHHHHHHHHHHhcc
Q 003158 513 FNSSTQIGQGGYGKVYKGIL-PDGTV--VAVKRAQEGSLQ------------------------GEKEFLTEIQFLSRLH 565 (843)
Q Consensus 513 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 565 (843)
|++.+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 68988 999987543111 1236789999999999
Q ss_pred CCcc--cceeeeeecCCcEEEEEecCCC-C----CHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHh-cCCCCCEEecc
Q 003158 566 HRNL--VSLVGYCDEEGEQMLVYEFMSN-G----TLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH-TEADPPVFHRD 637 (843)
Q Consensus 566 h~nI--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiH~D 637 (843)
|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8864 333332 367899999942 4 77776532 235567889999999999999 888 99999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccC
Q 003158 638 IKASNILLDHKFTAKVADFGLSRLA 662 (843)
Q Consensus 638 lkp~NILl~~~~~~kl~DfGla~~~ 662 (843)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=190.23 Aligned_cols=152 Identities=22% Similarity=0.284 Sum_probs=134.1
Q ss_pred CCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccc-cCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 19 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA-NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 19 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
-+.+++++++|+ .+|..+. +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|+++.+..|.++++|+.|+|+
T Consensus 20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 478999999999 5776654 4689999999999988888887 99999999999999998888899999999999999
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-C---CCCCCCCEEEcccCcC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-L---SRIPNLGYLDLSSNQL 173 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~---~~l~~L~~L~Ls~N~l 173 (843)
+|+|+...+..|.++++|++|+|++|+|.+ ..+..|.++++|+.|+|++|+|+.++.. + ..+++|+.|+|++|+|
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccE-ECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 999998888889999999999999999985 4578899999999999999999998875 4 4577777777777777
Q ss_pred C
Q 003158 174 N 174 (843)
Q Consensus 174 ~ 174 (843)
+
T Consensus 176 ~ 176 (361)
T 2xot_A 176 K 176 (361)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.2e-18 Score=172.34 Aligned_cols=153 Identities=17% Similarity=0.281 Sum_probs=102.1
Q ss_pred cCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCce
Q 003158 14 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 93 (843)
Q Consensus 14 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 93 (843)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..+..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45667777777777777 444 5677777777777777665 2235667777777777777777656666777777777
Q ss_pred eeccCCCCCCCCCcccCCCCCCcEEEcCCCC-CCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCc
Q 003158 94 MLLDNNNLTGYLPPELSELPKLLILQLDNNN-FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQ 172 (843)
Q Consensus 94 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~ 172 (843)
|+|++|++++..+..+..+++|++|+|++|+ +. .++ .+..+++|+.|+|++|++++++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~--~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT--DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC--CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc--ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcc
Confidence 7777777776566667777777777777776 54 233 5666777777777777776644 56666677777777776
Q ss_pred CC
Q 003158 173 LN 174 (843)
Q Consensus 173 l~ 174 (843)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 64
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=6.5e-21 Score=221.24 Aligned_cols=190 Identities=18% Similarity=0.179 Sum_probs=124.1
Q ss_pred cCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCc-------------CCccCccccccCCCCCEEE-ccCCcccc
Q 003158 14 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY-------------ISGSLPKSFANLNKTRHFH-MNNNSISG 79 (843)
Q Consensus 14 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~ 79 (843)
..+++|+.|+|++|+|+ .+|+.++++++|+.|++++|. +.+..|..+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45667777777777776 667777777777777776554 3445555566666666665 4444332
Q ss_pred CCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCC
Q 003158 80 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR 159 (843)
Q Consensus 80 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 159 (843)
+|..+.+++|.|+...+ ..|+.|+|++|+|++ +|. +.++++|+.|+|++|+|+.+|..+..
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~--lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV--LCH-LEQLLLVTHLDLSHNRLRALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS--CCC-GGGGTTCCEEECCSSCCCCCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC--CcC-ccccccCcEeecCcccccccchhhhc
Confidence 33444455555542211 247777777777764 455 77777777777777777766666777
Q ss_pred CCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCC-CcccCCCCCCcEEeCcCccCCCCCC
Q 003158 160 IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI-PSNFSGLPRLQRLFIANNSLSGSIP 225 (843)
Q Consensus 160 l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p 225 (843)
+++|+.|+|++|+|++ +|......+|+.|+|++|+|++.. |..|.++++|+.|+|++|+|++..|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 7777777777777774 553223346777777777777665 7777778888888888888775544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-18 Score=179.77 Aligned_cols=171 Identities=22% Similarity=0.299 Sum_probs=95.9
Q ss_pred CCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCcee
Q 003158 15 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 94 (843)
Q Consensus 15 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 94 (843)
++.++..+++++|.++... .+..+++|++|++++|+++ .++ .+..+++|+.|+|++|+|++..+ +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 3455666666666666322 4556666666666666666 333 45666666666666666664322 5566666666
Q ss_pred eccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCC
Q 003158 95 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 95 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 174 (843)
+|++|++++. +. +.. ++|++|+|++|++++ + ..+..+++|+.|+|++|++++++ .+..+++|
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~--~-~~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L----------- 152 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRD--T-DSLIHLKNLEILSIRNNKLKSIV-MLGFLSKL----------- 152 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSB--S-GGGTTCTTCCEEECTTSCCCBCG-GGGGCTTC-----------
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCC--C-hhhcCcccccEEECCCCcCCCCh-HHccCCCC-----------
Confidence 6666666532 22 222 555555555555543 1 23555555555555555555442 34444444
Q ss_pred CCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCC
Q 003158 175 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGS 223 (843)
Q Consensus 175 ~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 223 (843)
+.|+|++|.+++. ..+..+++|+.|+|++|++++.
T Consensus 153 ------------~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 153 ------------EVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp ------------CEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ------------CEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 4444444444443 4577778888888888888744
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.9e-18 Score=175.96 Aligned_cols=160 Identities=21% Similarity=0.371 Sum_probs=138.6
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
.|.+++ ++ .+..+++|++|++++|+++ .++ .++.+++|++|+|++|+|++..+ +..+++|+.|+|++|++++.
T Consensus 28 ~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l- 100 (263)
T 1xeu_A 28 KQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL- 100 (263)
T ss_dssp CSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCC-
T ss_pred CCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCc-
Confidence 356664 33 6788999999999999999 455 79999999999999999996554 99999999999999999954
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
+. +.. ++|+.|+|++|+|++. ..+..+++|+.|+|++|++++ ++ .+..+++|+.|+|++|++++. ..+..++
T Consensus 101 ~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~--~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~ 172 (263)
T 1xeu_A 101 NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS--IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLK 172 (263)
T ss_dssp TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB--CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCC
T ss_pred Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC--Ch-HHccCCCCCEEECCCCcCcch-HHhccCC
Confidence 43 333 9999999999999964 469999999999999999975 34 689999999999999999988 6689999
Q ss_pred CCCEEEcccCcCCCC
Q 003158 162 NLGYLDLSSNQLNGS 176 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~ 176 (843)
+|+.|++++|.+++.
T Consensus 173 ~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 173 KVNWIDLTGQKCVNE 187 (263)
T ss_dssp CCCEEEEEEEEEECC
T ss_pred CCCEEeCCCCcccCC
Confidence 999999999999843
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=165.26 Aligned_cols=153 Identities=17% Similarity=0.324 Sum_probs=87.5
Q ss_pred CCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcE
Q 003158 38 GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 117 (843)
Q Consensus 38 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 117 (843)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|+|++|++++..+..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44566666666666666 334 46666666666666665542 235556666666666666666555556666666666
Q ss_pred EEcCCCCCCCCCCCccccCCCCCcEEEcCCCC-CCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcC
Q 003158 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCS-LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKL 196 (843)
Q Consensus 118 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l 196 (843)
|+|++|++++ ..+..+..+++|+.|+|++|. ++.++ .+..+++|+.|++++|.++
T Consensus 117 L~Ls~n~i~~-~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~---------------------- 172 (197)
T 4ezg_A 117 LDISHSAHDD-SILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH---------------------- 172 (197)
T ss_dssp EECCSSBCBG-GGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCC----------------------
T ss_pred EEecCCccCc-HhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCc----------------------
Confidence 6666666653 345555566666666666665 44332 3455555555555555554
Q ss_pred CCCCCcccCCCCCCcEEeCcCccCC
Q 003158 197 TGTIPSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 197 ~~~~p~~~~~l~~L~~L~L~~N~l~ 221 (843)
+. + .+..+++|++|++++|++.
T Consensus 173 -~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 173 -DY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp -CC-T-TGGGCSSCCEEEECBC---
T ss_pred -Ch-H-HhccCCCCCEEEeeCcccC
Confidence 32 2 4666677777777777765
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-18 Score=206.84 Aligned_cols=190 Identities=18% Similarity=0.168 Sum_probs=109.2
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcE-----EEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCC
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDR-----IQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 91 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~-----L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 91 (843)
++++.|+|.+|.+.. .+..+....+|.. ++++.|.+. ..+..|..+++|+.|+|++|.|. .+|..+..+++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 568888998888884 3433333222222 233334444 55777888888888888888888 667667788888
Q ss_pred ceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccC
Q 003158 92 VHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSN 171 (843)
Q Consensus 92 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N 171 (843)
++|+|++|+|+ .+|..|.++++|++|+|++|+|+ .+|..|.++++|+.|+|++|.|+.++..|..+++|+.|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT--SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS--SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC--ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCC
Confidence 88888888888 77888888888888888888886 5688888888888888888888877777888888888888888
Q ss_pred cCCCCCCCCCCCc--CcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCc
Q 003158 172 QLNGSIPPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218 (843)
Q Consensus 172 ~l~~~~p~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 218 (843)
.|++.+|..+... .+..|+|++|.+++.+|.. |+.|+++.|
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 8887666654332 2334677888887777654 344556655
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=9e-20 Score=211.63 Aligned_cols=201 Identities=20% Similarity=0.228 Sum_probs=150.4
Q ss_pred CCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCc-------------cccCCCcccCCCCCCceee-ccCCCCCC
Q 003158 38 GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-------------ISGQIPPELSRLPSLVHML-LDNNNLTG 103 (843)
Q Consensus 38 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-------------l~~~~~~~l~~l~~L~~L~-L~~N~l~~ 103 (843)
..+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+..|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45677777777777776 667777777777777776554 2334444555555555555 4444332
Q ss_pred CCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCC
Q 003158 104 YLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLS 183 (843)
Q Consensus 104 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 183 (843)
.|+.+.+++|.+.. ++. ..|+.|+|++|.|++++. +..+++|+.|+|++|.|+ .+|..+..
T Consensus 424 ----------~L~~l~l~~n~i~~--l~~-----~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLK--MEY-----ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHH--HHH-----TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccc--cCc-----cCceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 34444555555542 221 259999999999999765 999999999999999999 78876554
Q ss_pred -cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCC-CchhhccccCCCCcceeEEcCCCCCCCCCCCC-----
Q 003158 184 -LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI-PSSIWQSRTLNATETFILDFQNNNLTNISGSF----- 256 (843)
Q Consensus 184 -~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~----- 256 (843)
.+|+.|+|++|.|++ +| .|+++++|+.|+|++|+|++.. |..+..+.+ |+.|+|++|+|+++++..
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~-----L~~L~L~~N~l~~~~~~~~~l~~ 557 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR-----LVLLNLQGNSLCQEEGIQERLAE 557 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT-----CCEEECTTSGGGGSSSCTTHHHH
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCC-----CCEEEecCCcCCCCccHHHHHHH
Confidence 489999999999997 66 8999999999999999999887 999887655 558999999999987754
Q ss_pred cCCCCcEEEe
Q 003158 257 NIPPNVTVRL 266 (843)
Q Consensus 257 ~~~~l~~l~l 266 (843)
.+|+|+.|++
T Consensus 558 ~lp~L~~L~l 567 (567)
T 1dce_A 558 MLPSVSSILT 567 (567)
T ss_dssp HCTTCSEEEC
T ss_pred HCcccCccCC
Confidence 3788888754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.7e-18 Score=204.25 Aligned_cols=161 Identities=19% Similarity=0.219 Sum_probs=122.5
Q ss_pred EccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCC
Q 003158 23 LLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLT 102 (843)
Q Consensus 23 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 102 (843)
+++.|.+. ..++.|..+++|+.|+|++|.+. .+|..+.++++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 33444444 56888999999999999999999 77878889999999999999999 88999999999999999999999
Q ss_pred CCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCC-CCCEEEcccCcCCCCCCCC
Q 003158 103 GYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIP-NLGYLDLSSNQLNGSIPPG 180 (843)
Q Consensus 103 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~-~L~~L~Ls~N~l~~~~p~~ 180 (843)
.+|..|.++++|++|+|++|.|+ .+|..|.++++|+.|+|++|.|++.++. +..+. .+..|+|++|.+++.+|.
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~- 359 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT--TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH- 359 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC--CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-
T ss_pred -ccChhhcCCCCCCEEECCCCCCC--ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc-
Confidence 77999999999999999999996 6788999999999999999999987774 33322 223578999999988876
Q ss_pred CCCcCcCEEEccCC
Q 003158 181 RLSLNITTIKLSNN 194 (843)
Q Consensus 181 ~~~~~L~~L~Ls~N 194 (843)
.|..|++++|
T Consensus 360 ----~l~~l~l~~n 369 (727)
T 4b8c_D 360 ----ERRFIEINTD 369 (727)
T ss_dssp ----C---------
T ss_pred ----ccceeEeecc
Confidence 5677888877
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=158.92 Aligned_cols=139 Identities=17% Similarity=0.279 Sum_probs=84.2
Q ss_pred cEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCc
Q 003158 116 LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNK 195 (843)
Q Consensus 116 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~ 195 (843)
+.+++++|.+. .+|..+. ++|+.|+|++|+|+.++..+..+++|+.|+|++|.|+
T Consensus 13 ~~l~~~~~~l~--~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~--------------------- 67 (193)
T 2wfh_A 13 TVVRCSNKGLK--VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS--------------------- 67 (193)
T ss_dssp TEEECTTSCCS--SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCC---------------------
T ss_pred CEEEcCCCCCC--cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCC---------------------
Confidence 45555666554 3444332 3555555555555544444555555555555555554
Q ss_pred CCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccc
Q 003158 196 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 196 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c 273 (843)
+..+..|.++++|++|+|++|+|++..|..|..+. +|+.|+|++|+|+.++... .++++..|++++|||.|
T Consensus 68 --~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~-----~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 68 --TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLK-----SLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp --CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCT-----TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred --EeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCC-----CCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 44445555566666666666666555555554433 3335666666666665542 57788899999999999
Q ss_pred cCCcccccCCCCC
Q 003158 274 NTNAEQFCGSHSD 286 (843)
Q Consensus 274 ~~~~~~~~~~~~~ 286 (843)
+|.+.||..|+..
T Consensus 141 ~c~l~~l~~~~~~ 153 (193)
T 2wfh_A 141 DCNMQWLSDWVKS 153 (193)
T ss_dssp SGGGHHHHHHHHH
T ss_pred CCcCHHHHHHHHh
Confidence 9999999988753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=6.7e-17 Score=160.76 Aligned_cols=127 Identities=17% Similarity=0.312 Sum_probs=57.8
Q ss_pred CEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCcc-ccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccC
Q 003158 20 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPK-SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 98 (843)
Q Consensus 20 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 98 (843)
+.|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45555555554 34443322 455555555555533332 244455555555555555444444444444444444444
Q ss_pred CCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCC
Q 003158 99 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSL 150 (843)
Q Consensus 99 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 150 (843)
|+|++..+..|.++++|++|+|++|++++ ..|..|..+++|+.|+|++|.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l 138 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECTTCCB
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCe-eCHHHhhcCCCCCEEEeCCCCc
Confidence 44444444444444444444444444433 2233333333333333333333
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=154.24 Aligned_cols=136 Identities=21% Similarity=0.313 Sum_probs=86.7
Q ss_pred CCCcEEEcccCcCC-ccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEE
Q 003158 41 PKLDRIQIDQNYIS-GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119 (843)
Q Consensus 41 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 119 (843)
++|++|+|++|.++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 45555566666666666666666644 5566666666666666666655566666666777777
Q ss_pred cCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC----CCCCCCCCCEEEcccCcCCCCCCC
Q 003158 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP----DLSRIPNLGYLDLSSNQLNGSIPP 179 (843)
Q Consensus 120 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~ 179 (843)
|++|++++...+..+..+++|+.|+|++|.+++.++ .+..+++|+.|++++|.+. .+|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 777766542222566667777777777777776665 3666777777777777766 4443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=7.1e-16 Score=153.32 Aligned_cols=131 Identities=23% Similarity=0.368 Sum_probs=117.0
Q ss_pred cEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCc-ccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCC
Q 003158 44 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP-ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122 (843)
Q Consensus 44 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 122 (843)
++|++++|+++ .+|..+.. +|+.|+|++|.|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78999999998 67765543 899999999999977664 489999999999999999999899999999999999999
Q ss_pred CCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCCCCC
Q 003158 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIP 178 (843)
Q Consensus 123 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p 178 (843)
|+|++ ..+..|.++++|+.|+|++|+++++++ .+..+++|+.|+|++|.+++..+
T Consensus 88 N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCc-cCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99986 456779999999999999999999877 59999999999999999986554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=173.53 Aligned_cols=139 Identities=17% Similarity=0.203 Sum_probs=99.6
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh--------------hhHHHH--------HHHHHHHHhccCCc
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL--------------QGEKEF--------LTEIQFLSRLHHRN 568 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~h~n 568 (843)
.-|++.+.||+|+||.||+|...+|+.||||+++.... ...... .+|...|.++.+..
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34888999999999999999998999999998753210 001122 34555555554433
Q ss_pred ccceeeeeecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC
Q 003158 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK 648 (843)
Q Consensus 569 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~ 648 (843)
+....-+. ....+|||||++|++|.++.. ......++.|++.+|.|||+.| ||||||||.|||++++
T Consensus 175 v~vp~p~~--~~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIA--QSRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEE--EETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred CCCCeeee--ccCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence 32111111 123479999999988866532 1234568899999999999999 9999999999999887
Q ss_pred C----------cEEEeeccccccC
Q 003158 649 F----------TAKVADFGLSRLA 662 (843)
Q Consensus 649 ~----------~~kl~DfGla~~~ 662 (843)
+ .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999987654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.8e-16 Score=151.65 Aligned_cols=138 Identities=18% Similarity=0.215 Sum_probs=124.3
Q ss_pred CCCCCCEEEccCCcCC-ccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCce
Q 003158 15 NIKSLELLLLNGNELT-GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 93 (843)
Q Consensus 15 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 93 (843)
..++|+.|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|+.|+|++|.+++.+|..+.++++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3478999999999998 78899999999999999999999966 78999999999999999999878888888999999
Q ss_pred eeccCCCCCCCCC-cccCCCCCCcEEEcCCCCCCCCCCCc----cccCCCCCcEEEcCCCCCCCCCCC
Q 003158 94 MLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPA----SYSNMSKLLKLSLRNCSLQGPMPD 156 (843)
Q Consensus 94 L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~ 156 (843)
|+|++|+|++... ..+..+++|++|+|++|.+++ ++. .+..+++|+.|++++|.+...+.+
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~--~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 165 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN--LNDYRESVFKLLPQLTYLDGYDREDQEAPDS 165 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGT--STTHHHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcc--hHHHHHHHHHhCccCcEecCCCCChhhcccc
Confidence 9999999996532 789999999999999999985 454 789999999999999999887664
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.61 E-value=7.3e-18 Score=198.36 Aligned_cols=82 Identities=11% Similarity=0.076 Sum_probs=46.1
Q ss_pred CCCCCCEEEccCCcCCcc----CccccCCCCCCcEEEcccCcCC----ccCccccccCCCCCEEEccCCccccCCCcccC
Q 003158 15 NIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYIS----GSLPKSFANLNKTRHFHMNNNSISGQIPPELS 86 (843)
Q Consensus 15 ~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 86 (843)
++++|++|+|++|.+++. ++..+..+++|++|+|++|.++ +.++..+.++++|+.|+|++|.+.+ ++..+.
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~ 240 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK 240 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence 556777777777766544 3334445666666666666665 2233344556666666666666553 334444
Q ss_pred CCCCCceeecc
Q 003158 87 RLPSLVHMLLD 97 (843)
Q Consensus 87 ~l~~L~~L~L~ 97 (843)
.+++|+.|+++
T Consensus 241 ~~~~L~~L~l~ 251 (592)
T 3ogk_B 241 AAANLEEFCGG 251 (592)
T ss_dssp HCTTCCEEEEC
T ss_pred hhhHHHhhccc
Confidence 44444444444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=4.3e-15 Score=147.69 Aligned_cols=107 Identities=22% Similarity=0.347 Sum_probs=59.1
Q ss_pred CCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEc
Q 003158 66 KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSL 145 (843)
Q Consensus 66 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 145 (843)
+|+.|+|++|.|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++ ..+..|.++++|+.|+|
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCE-eCHHHhCCCCCCCEEEC
Confidence 4555555555554 344445555555555555555554444555555555555555555543 23445555566666666
Q ss_pred CCCCCCCCCCC-CCCCCCCCEEEcccCcCC
Q 003158 146 RNCSLQGPMPD-LSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 146 ~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 174 (843)
++|+|+.+++. |..+++|+.|+|++|.+.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 66666655553 556666666666666665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.2e-16 Score=148.11 Aligned_cols=127 Identities=19% Similarity=0.259 Sum_probs=65.2
Q ss_pred CCCCEEEccCCcCC-ccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceee
Q 003158 17 KSLELLLLNGNELT-GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 95 (843)
Q Consensus 17 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 95 (843)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|+.|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 45555555566666666666655533 4455555555555555555544444444455555555
Q ss_pred ccCCCCCCC-CCcccCCCCCCcEEEcCCCCCCCCCCC---ccccCCCCCcEEEcC
Q 003158 96 LDNNNLTGY-LPPELSELPKLLILQLDNNNFEGTTIP---ASYSNMSKLLKLSLR 146 (843)
Q Consensus 96 L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~~l~~L~~L~L~ 146 (843)
|++|++++. .+..+..+++|++|+|++|.+++ ..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG-STTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc-hHHHHHHHHHHCCCcccccCC
Confidence 555555532 12444455555555555555542 111 234444455544443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.60 E-value=5e-18 Score=199.73 Aligned_cols=264 Identities=14% Similarity=0.087 Sum_probs=163.1
Q ss_pred Ccccccc----CCccccCCCCCCEEEccCCcCC----ccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEcc
Q 003158 2 WNKISGS----IPKEIGNIKSLELLLLNGNELT----GSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN 73 (843)
Q Consensus 2 ~N~i~~~----~p~~i~~l~~L~~L~L~~n~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 73 (843)
+|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++++|++|+|++|.+.+ ++..+.++++|+.|+++
T Consensus 173 ~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 173 ESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGG 251 (592)
T ss_dssp TCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEEC
T ss_pred cccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccc
Confidence 4556554 3344556788888888888887 3445556677888888888888774 45566666666666665
Q ss_pred CCcc--------------------------ccCCCcccCCCCCCceeeccCCCCCCCCC-cccCCCCCCcEEEcCCCCCC
Q 003158 74 NNSI--------------------------SGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFE 126 (843)
Q Consensus 74 ~N~l--------------------------~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 126 (843)
.+.. ...+|..+..+++|++|+|++|.+++... ..+..+++|++|+|+ |.+.
T Consensus 252 ~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~ 330 (592)
T 3ogk_B 252 SLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIG 330 (592)
T ss_dssp BCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGH
T ss_pred ccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccC
Confidence 3211 12345556678899999999998764332 335778888888888 4444
Q ss_pred CCCCCccccCCCCCcEEEcCC-----------CCCCCCCC-C-CCCCCCCCEEEcccCcCCCCCCCCCC--CcCcCEEEc
Q 003158 127 GTTIPASYSNMSKLLKLSLRN-----------CSLQGPMP-D-LSRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKL 191 (843)
Q Consensus 127 ~~~~~~~~~~l~~L~~L~L~~-----------N~l~~~~~-~-~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~L 191 (843)
+..++..+..+++|++|+|++ |.++.... . ...+++|+.|+++.|.+++..+.... ..+|+.|+|
T Consensus 331 ~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l 410 (592)
T 3ogk_B 331 DRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRL 410 (592)
T ss_dssp HHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEE
T ss_pred HHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEE
Confidence 323444556778888888883 45543211 1 34567888888877777653332221 236778887
Q ss_pred c----CCcCCCC-----CCcccCCCCCCcEEeCcCc--cCCCCCCchhhccccCCCCcceeEEcCCCCCCCCC--CC-Cc
Q 003158 192 S----NNKLTGT-----IPSNFSGLPRLQRLFIANN--SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS--GS-FN 257 (843)
Q Consensus 192 s----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~--~~-~~ 257 (843)
+ .|.+++. ++..+.++++|+.|+|++| .+++..+..+.. ..++|+.|+|++|++++.. .. ..
T Consensus 411 ~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~----~~~~L~~L~L~~n~l~~~~~~~~~~~ 486 (592)
T 3ogk_B 411 VLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQ----YSPNVRWMLLGYVGESDEGLMEFSRG 486 (592)
T ss_dssp EECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHH----SCTTCCEEEECSCCSSHHHHHHHHTC
T ss_pred eecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHH----hCccceEeeccCCCCCHHHHHHHHhc
Confidence 5 6677653 3333556777777777642 355444433332 1245667777777766422 11 14
Q ss_pred CCCCcEEEeccCcc
Q 003158 258 IPPNVTVRLRGNPF 271 (843)
Q Consensus 258 ~~~l~~l~l~~Np~ 271 (843)
+++|+.|++++|++
T Consensus 487 ~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 487 CPNLQKLEMRGCCF 500 (592)
T ss_dssp CTTCCEEEEESCCC
T ss_pred CcccCeeeccCCCC
Confidence 66777777777764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=8.5e-16 Score=145.95 Aligned_cols=130 Identities=20% Similarity=0.300 Sum_probs=117.5
Q ss_pred CCCCCcEEEcccCcCC-ccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcE
Q 003158 39 YLPKLDRIQIDQNYIS-GSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLI 117 (843)
Q Consensus 39 ~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 117 (843)
..++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|+|++|++++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999998 78888999999999999999999966 78999999999999999999878888888999999
Q ss_pred EEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC----CCCCCCCCCEEEccc
Q 003158 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP----DLSRIPNLGYLDLSS 170 (843)
Q Consensus 118 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~Ls~ 170 (843)
|+|++|++++...+..+..+++|+.|++++|.+++.++ .+..+++|+.|++++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999999753334789999999999999999999887 488899999999874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-14 Score=141.51 Aligned_cols=131 Identities=19% Similarity=0.325 Sum_probs=80.3
Q ss_pred cEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCC
Q 003158 44 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 123 (843)
Q Consensus 44 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 123 (843)
+.+++++|+++ .+|..+ .++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45555555555 333222 245666666666666554555566666666666666666555555666666666666666
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCCC
Q 003158 124 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIP 178 (843)
Q Consensus 124 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p 178 (843)
++++ ..+..+..+++|+.|+|++|+++++++. +..+++|+.|+|++|.+.+..|
T Consensus 87 ~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred Cccc-cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6654 2344456667777777777777766664 5667777777777777765433
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.3e-16 Score=168.22 Aligned_cols=239 Identities=18% Similarity=0.201 Sum_probs=132.9
Q ss_pred CCCCCEEEccCCcCCccCccccCC-CCCCcEEEcccCcCC--------------------ccCcccccc--------CCC
Q 003158 16 IKSLELLLLNGNELTGSLPEELGY-LPKLDRIQIDQNYIS--------------------GSLPKSFAN--------LNK 66 (843)
Q Consensus 16 l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~~N~l~--------------------~~~~~~~~~--------l~~ 66 (843)
+.+|+.|.++++ +....-..+.. +++|+.|||++|+|. .+....|.+ +++
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~ 102 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQT 102 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTT
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCC
Confidence 456777777654 22111122223 666777777777776 122344555 666
Q ss_pred CCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCC----CCCCCCccccCCCCCc-
Q 003158 67 TRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF----EGTTIPASYSNMSKLL- 141 (843)
Q Consensus 67 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l----~~~~~~~~~~~l~~L~- 141 (843)
|+.|+|.+ .++.+.+.+|.++++|+.|+|++|.+..+.+.+|.++.++..|.+..+.. .. .....|.++.+|+
T Consensus 103 L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~-i~~~~f~~~~~L~~ 180 (329)
T 3sb4_A 103 LEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNR-WEHFAFIEGEPLET 180 (329)
T ss_dssp CCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTT-TTTSCEEESCCCEE
T ss_pred CcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccc-ccccccccccccce
Confidence 66666666 66655556666666666666666666655556666665555555544211 10 0112233333333
Q ss_pred EEEcCCCCC---------------C-----CCCC-----CC-CCCCCCCEEEcccCcCCCCCCCCCCCc--CcCEEEccC
Q 003158 142 KLSLRNCSL---------------Q-----GPMP-----DL-SRIPNLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSN 193 (843)
Q Consensus 142 ~L~L~~N~l---------------~-----~~~~-----~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~~--~L~~L~Ls~ 193 (843)
.+.+....- . +... .+ ..+++|+.|+|++|+++ .|+...+.. +|+.|+|++
T Consensus 181 ~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 181 TIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCT
T ss_pred eEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCc
Confidence 222211000 0 0000 00 02567777777777777 666654432 677777777
Q ss_pred CcCCCCCCcccCCCCCCc-EEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEE
Q 003158 194 NKLTGTIPSNFSGLPRLQ-RLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVR 265 (843)
Q Consensus 194 N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~ 265 (843)
| ++.+.+.+|.++++|+ .|++.+ .++...+.+|..+. +|+.|++++|+++.++... ++++|+.++
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~-----~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCD-----NLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCT-----TEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCc-----cCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 7 6666677777777777 777777 66645556665543 4457777777777776643 566666654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-14 Score=141.19 Aligned_cols=126 Identities=23% Similarity=0.333 Sum_probs=60.3
Q ss_pred CEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCC
Q 003158 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN 147 (843)
Q Consensus 68 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~ 147 (843)
+.+++++|+++ .+|..+ .++|+.|+|++|++++..+..|..+++|++|+|++|++++ ..+..|.++++|+.|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE-eChhHccCCCccCEEECCC
Confidence 44555555554 223222 1355555555555554444444555555555555555543 2233345555555555555
Q ss_pred CCCCCCCCC-CCCCCCCCEEEcccCcCCCCCCCCC-C-CcCcCEEEccCCcCCC
Q 003158 148 CSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGR-L-SLNITTIKLSNNKLTG 198 (843)
Q Consensus 148 N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~-~-~~~L~~L~Ls~N~l~~ 198 (843)
|+++++++. +..+++|+.|+|++|.++ .+|... . ..+|+.|+|++|.+++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeec
Confidence 555554443 445555555555555555 233222 1 1245555555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.2e-15 Score=161.09 Aligned_cols=216 Identities=13% Similarity=0.147 Sum_probs=164.6
Q ss_pred CCCCCEEEccCCcCC--------------------ccCccccCC--------CCCCcEEEcccCcCCccCccccccCCCC
Q 003158 16 IKSLELLLLNGNELT--------------------GSLPEELGY--------LPKLDRIQIDQNYISGSLPKSFANLNKT 67 (843)
Q Consensus 16 l~~L~~L~L~~n~l~--------------------~~~p~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~~l~~L 67 (843)
+++|+.|||++|++. .+...+|.+ +++|++|+|.+ .++.+....|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 678999999999998 344567778 99999999999 8887888899999999
Q ss_pred CEEEccCCccccCCCcccCCCCCCceeeccCCC----CCCCCCcccCCCCCCc-EEEcCCCCC-----------------
Q 003158 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN----LTGYLPPELSELPKLL-ILQLDNNNF----------------- 125 (843)
Q Consensus 68 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L~-~L~Ls~N~l----------------- 125 (843)
+.|+|++|.+..+.+.+|.++.++..+.+..+. ........|.++..|+ .+.+.....
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 999999999988888999998888888777632 2333444565666666 444432110
Q ss_pred -------CCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCCCCCCCCc--CcC-EEEccCC
Q 003158 126 -------EGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSL--NIT-TIKLSNN 194 (843)
Q Consensus 126 -------~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~--~L~-~L~Ls~N 194 (843)
...........+++|+.|+|++|+++.++.. |.++.+|+.|+|++| ++ .|+...+.. +|+ .|+|.+
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~- 283 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA- 283 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-
Confidence 0000000011378999999999999988884 999999999999998 76 677765543 698 999988
Q ss_pred cCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCC
Q 003158 195 KLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235 (843)
Q Consensus 195 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~ 235 (843)
.++.+.+.+|.++++|+.|++++|.++...+.+|.++.+|+
T Consensus 284 ~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~ 324 (329)
T 3sb4_A 284 SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSK 324 (329)
T ss_dssp TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCC
T ss_pred cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchh
Confidence 77778889999999999999999999877777887766554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-13 Score=152.03 Aligned_cols=250 Identities=11% Similarity=0.122 Sum_probs=188.9
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
|+++.+-..+|.+. +|+.+.|.++ ++.+...+|.+. +|+.+.|.+ .++.+....|.++++|+.++|++|.++.+..
T Consensus 122 ~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~ 197 (401)
T 4fdw_A 122 NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPA 197 (401)
T ss_dssp TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECT
T ss_pred CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEech
Confidence 45565566677774 7999999877 776777888884 799999986 6776777889999999999999999986666
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIP 161 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~ 161 (843)
.+|. +.+|+.+.|.++ ++.+...+|.++++|+.|+|..| +.. .....|.+ .+|+.+.| .|.++.+.. .|..++
T Consensus 198 ~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~-I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~ 271 (401)
T 4fdw_A 198 STFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VST-IGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCP 271 (401)
T ss_dssp TTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCE-ECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCT
T ss_pred hhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccC-cccccccc-CCccEEEe-CCCccEEChhHhhCCC
Confidence 6676 589999999854 77677788999999999999875 432 23456766 78999999 456776766 589999
Q ss_pred CCCEEEcccCcCCC----CCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCC
Q 003158 162 NLGYLDLSSNQLNG----SIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLN 235 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~----~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~ 235 (843)
+|+.+++.+|.+.. .++...+. .+|+.++|. |.++.+...+|.++++|+.|+|.+| ++.....+|..+
T Consensus 272 ~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~---- 345 (401)
T 4fdw_A 272 ELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT---- 345 (401)
T ss_dssp TCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS----
T ss_pred CCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC----
Confidence 99999999887741 25554443 389999998 4577777889999999999999655 664555666554
Q ss_pred CCcceeEEcCCCCCCCCCCCC--cCC-CCcEEEeccCc
Q 003158 236 ATETFILDFQNNNLTNISGSF--NIP-PNVTVRLRGNP 270 (843)
Q Consensus 236 ~~~L~~L~l~~N~l~~~~~~~--~~~-~l~~l~l~~Np 270 (843)
+|+.|++++|.+..++... .++ .+..|++..|.
T Consensus 346 --~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 346 --GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp --CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred --CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 4558999999888887654 453 56677776654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=7.1e-15 Score=143.84 Aligned_cols=132 Identities=16% Similarity=0.203 Sum_probs=74.2
Q ss_pred cCCCCCCcEEEcccCcCCccCccccccCC-CCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCC
Q 003158 37 LGYLPKLDRIQIDQNYISGSLPKSFANLN-KTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL 115 (843)
Q Consensus 37 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 115 (843)
+.++++|++|+|++|+++. ++. +..+. +|+.|+|++|.|++. ..|..+++|++|+|++|+|++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4445555555555555552 232 33332 566666666666543 445566666666666666664433444566666
Q ss_pred cEEEcCCCCCCCCCCCc--cccCCCCCcEEEcCCCCCCCCCCC----CCCCCCCCEEEcccCcCC
Q 003158 116 LILQLDNNNFEGTTIPA--SYSNMSKLLKLSLRNCSLQGPMPD----LSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 116 ~~L~Ls~N~l~~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~----~~~l~~L~~L~Ls~N~l~ 174 (843)
++|+|++|++. .+|. .+..+++|+.|+|++|.++..+.. +..+++|+.||++.|.+.
T Consensus 91 ~~L~L~~N~i~--~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV--ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC--CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC--cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 66666666664 2343 556666666666666666655543 556666666666666553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=2e-14 Score=139.67 Aligned_cols=122 Identities=23% Similarity=0.260 Sum_probs=87.0
Q ss_pred CCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeE
Q 003158 163 LGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFIL 242 (843)
Q Consensus 163 L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L 242 (843)
.+.|++++|.++ .+|.... .+|+.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+. +|+.|
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~-~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~-----~L~~L 83 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP-TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLT-----QLTQL 83 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT-----TCCEE
T ss_pred CCEEEeCCCCcC-ccCccCC-CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCC-----CCCEE
Confidence 455666666665 4554432 4677777777777777777777788888888888888765555554443 44578
Q ss_pred EcCCCCCCCCCCC-C-cCCCCcEEEeccCcccccCC-cccccCCCCCCCccc
Q 003158 243 DFQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDDDNEI 291 (843)
Q Consensus 243 ~l~~N~l~~~~~~-~-~~~~l~~l~l~~Np~~c~~~-~~~~~~~~~~~~~~~ 291 (843)
+|++|+|++++.. + .+++|+.|+|++|||.|+|. +.++..|+......+
T Consensus 84 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l~~l~~~l~~~~~~~ 135 (170)
T 3g39_A 84 SLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDILYLSRWISQHPGLV 135 (170)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGGHHHHHHHHHCGGGE
T ss_pred ECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhHHHHHHHHHhCccee
Confidence 8888888887765 3 68889999999999999995 888888876655443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=9.2e-15 Score=143.04 Aligned_cols=135 Identities=23% Similarity=0.255 Sum_probs=116.8
Q ss_pred ccccCCCCCCEEEccCCcCCccCccccCCCC-CCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCC
Q 003158 11 KEIGNIKSLELLLLNGNELTGSLPEELGYLP-KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLP 89 (843)
Q Consensus 11 ~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 89 (843)
..+.++.+|+.|+|++|+++. ++. +..+. +|++|+|++|.|++. ..|..+++|+.|+|++|.|++..+..|..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 356788999999999999994 555 55554 999999999999965 6799999999999999999976556668999
Q ss_pred CCceeeccCCCCCCCCCc--ccCCCCCCcEEEcCCCCCCCCCCCcc----ccCCCCCcEEEcCCCCCCC
Q 003158 90 SLVHMLLDNNNLTGYLPP--ELSELPKLLILQLDNNNFEGTTIPAS----YSNMSKLLKLSLRNCSLQG 152 (843)
Q Consensus 90 ~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~~l~~L~~L~L~~N~l~~ 152 (843)
+|+.|+|++|+|+ .+|. .+..+++|+.|+|++|.+. .+|.. +..+++|+.|++++|.+..
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~--~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT--NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG--GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC--CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999999999997 4555 7899999999999999997 45664 8999999999999998764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.49 E-value=3.7e-13 Score=149.29 Aligned_cols=233 Identities=10% Similarity=0.158 Sum_probs=188.0
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
++++.+-..+|.+ .+|+.+.|.+ .++.+...+|.++++|+.++|++|+++.+....|. ..+|+.+.|.++ ++.+..
T Consensus 144 ~~i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~ 219 (401)
T 4fdw_A 144 EGLKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGS 219 (401)
T ss_dssp TTCCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECT
T ss_pred CCccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehh
Confidence 4567667778877 4799999996 78878889999999999999999999966666666 689999999855 777888
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCC-----CCCC-C
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQ-----GPMP-D 156 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~-~ 156 (843)
.+|.++++|+.++|.+| ++.+...+|.+ .+|+.+.|. |.+.. .....|.+|++|+.+++.+|.+. .+.. .
T Consensus 220 ~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~-I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~a 295 (401)
T 4fdw_A 220 QAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN-IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYC 295 (401)
T ss_dssp TTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE-ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTT
T ss_pred hHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE-EChhHhhCCCCCCEEEeCCccccCCcccEECHHH
Confidence 89999999999999975 66567778888 899999995 45542 34678999999999999998876 3444 4
Q ss_pred CCCCCCCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccC
Q 003158 157 LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTL 234 (843)
Q Consensus 157 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l 234 (843)
|.+|++|+.++|. |.++ .++...+. .+|+.|+|.+| ++.+...+|.++ +|+.|++++|.+....+..|..+..
T Consensus 296 F~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~- 370 (401)
T 4fdw_A 296 LEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPD- 370 (401)
T ss_dssp TTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCT-
T ss_pred hhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCC-
Confidence 9999999999999 5577 77776554 48999999665 777888999999 9999999999988666666655432
Q ss_pred CCCcceeEEcCCCCCCC
Q 003158 235 NATETFILDFQNNNLTN 251 (843)
Q Consensus 235 ~~~~L~~L~l~~N~l~~ 251 (843)
.+..|.+-.|.+..
T Consensus 371 ---~l~~l~vp~~~~~~ 384 (401)
T 4fdw_A 371 ---DITVIRVPAESVEK 384 (401)
T ss_dssp ---TCCEEEECGGGHHH
T ss_pred ---CccEEEeCHHHHHH
Confidence 45567777666543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.48 E-value=9.4e-16 Score=180.36 Aligned_cols=86 Identities=14% Similarity=0.106 Sum_probs=43.4
Q ss_pred CCCCCCEEEccCCcCCccCccccC-CCCCCcEEEcccC-cCCcc-CccccccCCCCCEEEccCCccccCCCccc----CC
Q 003158 15 NIKSLELLLLNGNELTGSLPEELG-YLPKLDRIQIDQN-YISGS-LPKSFANLNKTRHFHMNNNSISGQIPPEL----SR 87 (843)
Q Consensus 15 ~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l----~~ 87 (843)
.+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 445666666666665554444443 4556666666655 33321 22333355566666666655543332222 23
Q ss_pred CCCCceeeccCCC
Q 003158 88 LPSLVHMLLDNNN 100 (843)
Q Consensus 88 l~~L~~L~L~~N~ 100 (843)
+++|+.|+|++|.
T Consensus 183 ~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 183 YTSLVSLNISCLA 195 (594)
T ss_dssp CCCCCEEECTTCC
T ss_pred CCcCcEEEecccC
Confidence 4455555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.7e-14 Score=136.47 Aligned_cols=119 Identities=23% Similarity=0.314 Sum_probs=86.2
Q ss_pred CEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEE
Q 003158 164 GYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILD 243 (843)
Q Consensus 164 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~ 243 (843)
+.+++++|.++ .+|.... .+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+. +|+.|+
T Consensus 15 ~~l~~~~n~l~-~iP~~~~-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~-----~L~~L~ 87 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP-TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLT-----QLTQLD 87 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-----TCCEEE
T ss_pred cEEEeCCCCCC-ccCCCcC-CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcc-----hhhEEE
Confidence 55666666665 5555433 4677777777777777777788888888888888888765444444443 455788
Q ss_pred cCCCCCCCCCCC-C-cCCCCcEEEeccCcccccCC-cccccCCCCCCCc
Q 003158 244 FQNNNLTNISGS-F-NIPPNVTVRLRGNPFCLNTN-AEQFCGSHSDDDN 289 (843)
Q Consensus 244 l~~N~l~~~~~~-~-~~~~l~~l~l~~Np~~c~~~-~~~~~~~~~~~~~ 289 (843)
|++|+|+.++.. + .++++..|+|++|||.|+|. +.++..|+.....
T Consensus 88 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~~~l~~~~~~~~~ 136 (174)
T 2r9u_A 88 LNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYLRNWVADHTS 136 (174)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGGHHHHHHHHHCGG
T ss_pred CCCCccceeCHHHhccccCCCEEEeCCCCcccccccHHHHHHHHHhccc
Confidence 888888888775 3 68899999999999999996 7777777755443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=9.9e-17 Score=160.40 Aligned_cols=155 Identities=22% Similarity=0.304 Sum_probs=121.0
Q ss_pred ccCCCCCCEEEccCCcCCccCcc------ccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccC
Q 003158 13 IGNIKSLELLLLNGNELTGSLPE------ELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELS 86 (843)
Q Consensus 13 i~~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 86 (843)
+.....++.++++.+.+.+..|. .|+.+++|++|+|++|.+++ +| .+..+++|+.|+|++|.|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44556778888888888877776 88889999999999999885 56 7888899999999999988 6677777
Q ss_pred CCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC----------
Q 003158 87 RLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD---------- 156 (843)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---------- 156 (843)
.+++|+.|+|++|++++ +| .+..+++|++|+|++|++++......+..+++|+.|++++|.+.+.++.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 77889999999998885 34 6778888999999998886421113678888888888888888766443
Q ss_pred -CCCCCCCCEEEcccCcCC
Q 003158 157 -LSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 157 -~~~l~~L~~L~Ls~N~l~ 174 (843)
+..+++|+.|| +|.++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 66778888876 55554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.46 E-value=9.3e-16 Score=180.38 Aligned_cols=179 Identities=17% Similarity=0.127 Sum_probs=92.3
Q ss_pred CCCCCceeeccCCCCCCCC-CcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCC---------CCCCCCCC-
Q 003158 87 RLPSLVHMLLDNNNLTGYL-PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRN---------CSLQGPMP- 155 (843)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~---------N~l~~~~~- 155 (843)
.+++|+.|+|++|.+++.. ...+..+++|++|+|++| +.+..++.....+++|+.|+|.+ |.++....
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 4688999999999876432 223567888888888887 43212233334577788887733 33332111
Q ss_pred CC-CCCCCCCEEEcccCcCCCCCCCCCC--CcCcCEEEcc--C----CcCCCCC-----CcccCCCCCCcEEeCcCccCC
Q 003158 156 DL-SRIPNLGYLDLSSNQLNGSIPPGRL--SLNITTIKLS--N----NKLTGTI-----PSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 156 ~~-~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~L~~L~Ls--~----N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~ 221 (843)
.+ ..+++|+.|+++.|.+++....... ..+|+.|+|+ + |.++... +..+..+++|+.|+|++ .++
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 11 2356666666666666532222111 2356666666 3 4444211 11144455666666654 444
Q ss_pred CCCCchhhccccCCCCcceeEEcCCCCCCCCCCC---CcCCCCcEEEeccCcc
Q 003158 222 GSIPSSIWQSRTLNATETFILDFQNNNLTNISGS---FNIPPNVTVRLRGNPF 271 (843)
Q Consensus 222 ~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~---~~~~~l~~l~l~~Np~ 271 (843)
+..+..+.. ..++|+.|+|++|.+++.... ..+++|+.|++++|++
T Consensus 445 ~~~~~~l~~----~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 445 DKVFEYIGT----YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHHHH----HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHHHHHH----hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 333333322 122344566666555432211 1345555666665554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=5.1e-13 Score=129.69 Aligned_cols=105 Identities=20% Similarity=0.291 Sum_probs=52.2
Q ss_pred CCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccC
Q 003158 19 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN 98 (843)
Q Consensus 19 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 98 (843)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 345555555555 3443332 4555555555555544444555555555555555555544444444555555555555
Q ss_pred CCCCCCCCcccCCCCCCcEEEcCCCCCC
Q 003158 99 NNLTGYLPPELSELPKLLILQLDNNNFE 126 (843)
Q Consensus 99 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 126 (843)
|+|++..+..|..+++|++|+|++|.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 5555443444444445555555544443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=9.9e-13 Score=128.13 Aligned_cols=103 Identities=21% Similarity=0.319 Sum_probs=48.5
Q ss_pred CEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCC
Q 003158 20 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 99 (843)
Q Consensus 20 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 99 (843)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555554 3444332 44555555555555444444445555555555555554333333444444444444444
Q ss_pred CCCCCCCcccCCCCCCcEEEcCCCCC
Q 003158 100 NLTGYLPPELSELPKLLILQLDNNNF 125 (843)
Q Consensus 100 ~l~~~~~~~~~~l~~L~~L~Ls~N~l 125 (843)
+|++..+..|..+++|++|+|++|.+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~ 117 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPW 117 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCB
T ss_pred ccceeCHHHhccccCCCEEEeCCCCc
Confidence 44433333344444444444444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.7e-15 Score=151.46 Aligned_cols=143 Identities=20% Similarity=0.301 Sum_probs=123.1
Q ss_pred CccccccCCc------cccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCC
Q 003158 2 WNKISGSIPK------EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNN 75 (843)
Q Consensus 2 ~N~i~~~~p~------~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 75 (843)
.|+++|.+|. .|..+++|++|+|++|++++ +| .+..+++|++|+|++|.++ .+|..+..+++|+.|+|++|
T Consensus 27 ~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N 103 (198)
T 1ds9_A 27 KVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN 103 (198)
T ss_dssp EEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEE
T ss_pred eeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCC
Confidence 4677888777 89999999999999999996 66 8999999999999999999 67888888899999999999
Q ss_pred ccccCCCcccCCCCCCceeeccCCCCCCCCC-cccCCCCCCcEEEcCCCCCCCCCCCc----------cccCCCCCcEEE
Q 003158 76 SISGQIPPELSRLPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPA----------SYSNMSKLLKLS 144 (843)
Q Consensus 76 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----------~~~~l~~L~~L~ 144 (843)
+|++ +| .+..+++|+.|+|++|++++..+ ..+..+++|++|+|++|.+.+ ..|. .+..+++|+.|+
T Consensus 104 ~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~~~~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 104 QIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN-DYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH-HHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred cCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc-ccccccchHHHHHHHHHhCCCcEEEC
Confidence 9996 44 68899999999999999995433 478999999999999999975 3333 378899999987
Q ss_pred cCCCCCCC
Q 003158 145 LRNCSLQG 152 (843)
Q Consensus 145 L~~N~l~~ 152 (843)
+|.++.
T Consensus 181 --~~~i~~ 186 (198)
T 1ds9_A 181 --GMPVDV 186 (198)
T ss_dssp --CGGGTT
T ss_pred --CcccCH
Confidence 666654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-12 Score=141.25 Aligned_cols=112 Identities=20% Similarity=0.231 Sum_probs=74.8
Q ss_pred CcCEEEccC-CcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC-cCCCCc
Q 003158 185 NITTIKLSN-NKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNV 262 (843)
Q Consensus 185 ~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-~~~~l~ 262 (843)
+|+.|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|..+.+ |+.|+|++|+|+.++... ....|.
T Consensus 32 ~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-----L~~L~l~~N~l~~~~~~~~~~~~L~ 106 (347)
T 2ifg_A 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR-----LSRLNLSFNALESLSWKTVQGLSLQ 106 (347)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSC-----CCEEECCSSCCSCCCSTTTCSCCCC
T ss_pred CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcC-----CCEEeCCCCccceeCHHHcccCCce
Confidence 455555553 5555555566777777777777777777666666655443 446777777777776544 333389
Q ss_pred EEEeccCcccccCCcccccCCCCCCCcccccCCCCCCCcCCC
Q 003158 263 TVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNSTLDCRAQ 304 (843)
Q Consensus 263 ~l~l~~Np~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~ 304 (843)
.|+|.+|+|.|+|.+.+|..|.......+ ....+.|.++
T Consensus 107 ~l~l~~N~~~c~c~l~~~~~~~~~~~~~l---~~~~~~C~~~ 145 (347)
T 2ifg_A 107 ELVLSGNPLHCSCALRWLQRWEEEGLGGV---PEQKLQCHGQ 145 (347)
T ss_dssp EEECCSSCCCCCGGGHHHHHHHHTTCSSC---GGGCCCCSSS
T ss_pred EEEeeCCCccCCCccHHHHHHHHhCcccc---cccCCCCCCC
Confidence 99999999999999999998876543322 2345667653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-11 Score=128.49 Aligned_cols=144 Identities=14% Similarity=0.088 Sum_probs=113.5
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEe
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e 587 (843)
....|.....++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 4457887888888999999999854 6889999987532222346888999999985 6778899999988889999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE--------------------------------------- 628 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------- 628 (843)
|++|.+|.+.+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999987641 1223446888999999999981
Q ss_pred -----------------CCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 629 -----------------ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 629 -----------------~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
..+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11349999999999999876667799999775
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=8.9e-12 Score=135.89 Aligned_cols=105 Identities=19% Similarity=0.184 Sum_probs=84.2
Q ss_pred CEEEccCC-cCCccCccccCCCCCCcEEEccc-CcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 20 ELLLLNGN-ELTGSLPEELGYLPKLDRIQIDQ-NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 20 ~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
..++++++ +|+ .+|. +..+++|++|+|++ |.|++..+..|.++++|+.|+|++|+|+++.|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35688887 788 5677 88888888888886 88887777888888888888888888888888888888888888888
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEG 127 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 127 (843)
+|+|++..+..|..++ |+.|+|.+|.+..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 8888866666666655 8888888888864
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=4.1e-14 Score=155.41 Aligned_cols=142 Identities=16% Similarity=0.097 Sum_probs=69.2
Q ss_pred CCCceeeccCCCCCCCCCccc-CCCCCCcEEEcCCCCCCCCCCCccc-----cCCCCCcEEEcCCCCCCCCC-----CCC
Q 003158 89 PSLVHMLLDNNNLTGYLPPEL-SELPKLLILQLDNNNFEGTTIPASY-----SNMSKLLKLSLRNCSLQGPM-----PDL 157 (843)
Q Consensus 89 ~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~-----~~~ 157 (843)
++|++|+|++|.|+......+ ..+++|+.|+|++|.++. .....+ ...++|+.|+|++|.|+... ..+
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~-~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L 179 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGP-EACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCH-HHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCH-HHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence 455555555555542211111 123455555555555532 111111 23455666666666554311 113
Q ss_pred CCCCCCCEEEcccCcCCCCC----CCCCC-CcCcCEEEccCCcCCCC----CCcccCCCCCCcEEeCcCccCCCCCCchh
Q 003158 158 SRIPNLGYLDLSSNQLNGSI----PPGRL-SLNITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSI 228 (843)
Q Consensus 158 ~~l~~L~~L~Ls~N~l~~~~----p~~~~-~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 228 (843)
..+++|++|+|++|.|++.. +.... ..+|+.|+|++|.|+.. +...+...++|++|+|++|.|++.....+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 44556666666666654211 11111 12566666666666532 23344456778888888888775555555
Q ss_pred hcc
Q 003158 229 WQS 231 (843)
Q Consensus 229 ~~l 231 (843)
..+
T Consensus 260 ~~~ 262 (372)
T 3un9_A 260 RDL 262 (372)
T ss_dssp HHC
T ss_pred HHH
Confidence 443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-13 Score=148.86 Aligned_cols=141 Identities=15% Similarity=0.122 Sum_probs=64.1
Q ss_pred CCCCEEEccCCccccCCCccc-CCCCCCceeeccCCCCCCCCCccc-----CCCCCCcEEEcCCCCCCCC---CCCcccc
Q 003158 65 NKTRHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTGYLPPEL-----SELPKLLILQLDNNNFEGT---TIPASYS 135 (843)
Q Consensus 65 ~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~---~~~~~~~ 135 (843)
++|+.|+|++|.|+......+ ..+++|+.|+|++|+|+......+ ...++|++|+|++|.|+.. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 345555555555442211111 123345555555555543222222 2234555555555555320 1222334
Q ss_pred CCCCCcEEEcCCCCCCCCC-----CCCCCCCCCCEEEcccCcCCCCCCCCC-----CCcCcCEEEccCCcCCCCCCcccC
Q 003158 136 NMSKLLKLSLRNCSLQGPM-----PDLSRIPNLGYLDLSSNQLNGSIPPGR-----LSLNITTIKLSNNKLTGTIPSNFS 205 (843)
Q Consensus 136 ~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~~~L~~L~Ls~N~l~~~~p~~~~ 205 (843)
.+++|++|+|++|.|+... ..+..+++|+.|+|++|.|++...... ...+|+.|+|++|.|+......+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 4555666666666554321 124445566666666666652111110 112567777777766654333333
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.5e-10 Score=120.45 Aligned_cols=129 Identities=21% Similarity=0.149 Sum_probs=98.1
Q ss_pred cccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCc--ccceeeeeecCCcEEEEEecCCCCCHHHH
Q 003158 520 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLVGYCDEEGEQMLVYEFMSNGTLRDQ 597 (843)
Q Consensus 520 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 597 (843)
+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998777888999997653 2245778999999986544 456888888888899999999998884
Q ss_pred HhhcCCCCcchhHHHHHHHHHHHHHHHHhcCC------------------------------------------------
Q 003158 598 LSAKSKEPLGFAMRLSIALGSSRGILYLHTEA------------------------------------------------ 629 (843)
Q Consensus 598 l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------------------ 629 (843)
... . ....++.++++.|..||+..
T Consensus 104 ~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 1 12356777888888888643
Q ss_pred -------CCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 630 -------DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 630 -------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.+.++|+|++|.||++++++.+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.2e-09 Score=119.08 Aligned_cols=253 Identities=12% Similarity=0.050 Sum_probs=145.8
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCc-------
Q 003158 4 KISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS------- 76 (843)
Q Consensus 4 ~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~------- 76 (843)
+++.+-..+|.++.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++.+....|.++.+|+.+.+..+-
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~a 135 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEA 135 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeeccee
Confidence 45666677888889999999975 477677888999999999998755 554555666666666665554321
Q ss_pred --------------cccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcE
Q 003158 77 --------------ISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 142 (843)
Q Consensus 77 --------------l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 142 (843)
+..+...+|.++.+|+.+.+.++..+ +....|.++.+|+.+.+..| +.. .....|.++..|+.
T Consensus 136 F~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~-I~~~~F~~~~~L~~ 212 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKI-IRDYCFAECILLEN 212 (394)
T ss_dssp TTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCE-ECTTTTTTCTTCCB
T ss_pred eecccccccccCccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceE-eCchhhccccccce
Confidence 11122345666677777777654332 44556666667776666554 211 11233444444443
Q ss_pred EEcCCCC---------------------CCCCCC-CCCCCCCCCEEEcccCcCC-------------------CCCCCCC
Q 003158 143 LSLRNCS---------------------LQGPMP-DLSRIPNLGYLDLSSNQLN-------------------GSIPPGR 181 (843)
Q Consensus 143 L~L~~N~---------------------l~~~~~-~~~~l~~L~~L~Ls~N~l~-------------------~~~p~~~ 181 (843)
+.+..+. ++.+.. .+..+.+|+.+.+..+..+ ..++...
T Consensus 213 i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~ 292 (394)
T 4fs7_A 213 MEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKT 292 (394)
T ss_dssp CCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTT
T ss_pred eecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeecccc
Confidence 3333221 111112 2445555555555544321 0122222
Q ss_pred CC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--c
Q 003158 182 LS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--N 257 (843)
Q Consensus 182 ~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~ 257 (843)
+. .+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++.....+|.++.+ |+.+++..| ++.+.... +
T Consensus 293 F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~-----L~~i~lp~~-l~~I~~~aF~~ 364 (394)
T 4fs7_A 293 FYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTS-----LSNINFPLS-LRKIGANAFQG 364 (394)
T ss_dssp TTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTT-----CCEECCCTT-CCEECTTTBTT
T ss_pred ccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCC-----CCEEEECcc-ccEehHHHhhC
Confidence 21 26777777654 55566677888888888888644 55444556655444 446777665 77776543 5
Q ss_pred CCCCcEEEeccC
Q 003158 258 IPPNVTVRLRGN 269 (843)
Q Consensus 258 ~~~l~~l~l~~N 269 (843)
..+|+.+++..|
T Consensus 365 C~~L~~i~lp~~ 376 (394)
T 4fs7_A 365 CINLKKVELPKR 376 (394)
T ss_dssp CTTCCEEEEEGG
T ss_pred CCCCCEEEECCC
Confidence 677777777543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.6e-09 Score=118.46 Aligned_cols=141 Identities=22% Similarity=0.316 Sum_probs=105.5
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEec--cCC-hhhHHHHHHHHHHHHhcc--CCcccceeeeeecC---CcEEEEEe
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQ--EGS-LQGEKEFLTEIQFLSRLH--HRNLVSLVGYCDEE---GEQMLVYE 587 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lV~e 587 (843)
.+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998754 578888775 322 123457888999999997 45678889888766 45899999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-------------------------------------- 629 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------------------------------------- 629 (843)
|++|..+.+.. ...++...+..++.+++++|..||+..
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99987775421 123567778889999999999999731
Q ss_pred -----------------CCCEEeccCCCCcEEEcCCCc--EEEeecccccc
Q 003158 630 -----------------DPPVFHRDIKASNILLDHKFT--AKVADFGLSRL 661 (843)
Q Consensus 630 -----------------~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~ 661 (843)
.+.++|+|+++.||+++.++. +.|.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998864
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.88 E-value=5.9e-08 Score=107.47 Aligned_cols=254 Identities=14% Similarity=0.128 Sum_probs=150.5
Q ss_pred ccccCCccccCCC-CCCEEEccCCcCCccCccccCCCCCCcEEEcccCc---CCccCccccccCCCCCEEEccCCccccC
Q 003158 5 ISGSIPKEIGNIK-SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY---ISGSLPKSFANLNKTRHFHMNNNSISGQ 80 (843)
Q Consensus 5 i~~~~p~~i~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 80 (843)
++.+-..+|.+.. .|+.+.|.++ ++.+...+|.++++|+.+.+..|. ++.+....|.++.+|+.+.+.++ ++.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 4445556676663 5777777654 665677777788888888777654 55445566777777777666544 4435
Q ss_pred CCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCC------------CC--------CCCccccCCCCC
Q 003158 81 IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFE------------GT--------TIPASYSNMSKL 140 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~------------~~--------~~~~~~~~l~~L 140 (843)
...+|..+.+|+.+.+..+ +..+....|..+..|+.+.+.++--. .. .....|.++.+|
T Consensus 129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l 207 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFAL 207 (394)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTC
T ss_pred hhhhhhhhcccccccccce-eeeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhcccc
Confidence 5556666667777666543 23244455555666666655433110 00 112234444444
Q ss_pred cEEEcCCCCC------------------------------------CCCCC-CCCCCCCCCEEEcccCcCCCCCCCCCCC
Q 003158 141 LKLSLRNCSL------------------------------------QGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS 183 (843)
Q Consensus 141 ~~L~L~~N~l------------------------------------~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 183 (843)
+......+.. +.+.. .|..+.+|+.+.+..+.. .+....+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~--~I~~~aF~ 285 (394)
T 4gt6_A 208 STITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVV--SIGTGAFM 285 (394)
T ss_dssp CEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCC--EECTTTTT
T ss_pred ceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccc--eecCcccc
Confidence 4443322211 11112 366677777777765544 34444333
Q ss_pred --cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCC
Q 003158 184 --LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIP 259 (843)
Q Consensus 184 --~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~ 259 (843)
.+|+.+.+. +.++.+...+|.++.+|+.++|.++ ++.....+|.++.+| +.+.+..+ ++.+.... +..
T Consensus 286 ~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L-----~~i~ip~s-v~~I~~~aF~~C~ 357 (394)
T 4gt6_A 286 NCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL-----ERIAIPSS-VTKIPESAFSNCT 357 (394)
T ss_dssp TCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC-----CEEEECTT-CCBCCGGGGTTCT
T ss_pred cccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC-----CEEEECcc-cCEEhHhHhhCCC
Confidence 368888885 4566566778888888888888764 554445566655444 47777544 77776543 678
Q ss_pred CCcEEEeccCcc
Q 003158 260 PNVTVRLRGNPF 271 (843)
Q Consensus 260 ~l~~l~l~~Np~ 271 (843)
+|+.+++.+|..
T Consensus 358 ~L~~i~~~~~~~ 369 (394)
T 4gt6_A 358 ALNNIEYSGSRS 369 (394)
T ss_dssp TCCEEEESSCHH
T ss_pred CCCEEEECCcee
Confidence 888888887754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=2.9e-09 Score=113.56 Aligned_cols=192 Identities=16% Similarity=0.152 Sum_probs=120.9
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCc--ccceeeeeecCC---cEEEEEecC
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRN--LVSLVGYCDEEG---EQMLVYEFM 589 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~lV~e~~ 589 (843)
.+.++.|....||+.. ..+++|+... ......+.+|+++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 4588898653 234567899999998884 333 344555443333 348999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE----------------------------------------- 628 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------- 628 (843)
+|.++.+.... .++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888653321 245666677788888888888851
Q ss_pred --------------CCCCEEeccCCCCcEEEcC--CCcEEEeeccccccCCCCC-CCCcc------cceeeeeecccCCc
Q 003158 629 --------------ADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD-IEGIV------PAHVSTVVKGTPGY 685 (843)
Q Consensus 629 --------------~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~-~~~~~------~~~~~~~~~gt~~y 685 (843)
..+.++|+|++|.||++++ ...+.|+||+.+...+... ..... ............++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1245899999999999998 5568899999986532110 00000 00000000001111
Q ss_pred cC-chhcccCCCCchhhhHHHHHHHHHHHhCCCCC
Q 003158 686 LD-PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPI 719 (843)
Q Consensus 686 ~a-PE~~~~~~~~~~sDvwS~G~~l~elltg~~pf 719 (843)
.. |+..... ....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 12368999999999999998776
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.4e-08 Score=110.69 Aligned_cols=185 Identities=16% Similarity=0.082 Sum_probs=120.5
Q ss_pred cCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCC---
Q 003158 28 ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGY--- 104 (843)
Q Consensus 28 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--- 104 (843)
.++.+...+|.++.+|+.+.|.. .++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..+ +..+
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 46667788999999999999975 477677888999999999999865 66566778999999988877654 2212
Q ss_pred -------------------CCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCC
Q 003158 105 -------------------LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLG 164 (843)
Q Consensus 105 -------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~ 164 (843)
...+|.++.+|+.+.+.++... .....|.++.+|+.+.+..| ++.+.. .|..+..|+
T Consensus 135 aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~--I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~ 211 (394)
T 4fs7_A 135 AFKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSMET--LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLE 211 (394)
T ss_dssp TTTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCCE--ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCC
T ss_pred eeecccccccccCccccccchhhhcccCCCcEEecCCccce--eccccccCCCCceEEEcCCC-ceEeCchhhccccccc
Confidence 2335666677777777655431 23445667777777777655 444444 366666666
Q ss_pred EEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccC
Q 003158 165 YLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSL 220 (843)
Q Consensus 165 ~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 220 (843)
.+.+..+... .........+|+.+.+..+ ++......|.++..|+.+.+..+..
T Consensus 212 ~i~~~~~~~~-i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~ 265 (394)
T 4fs7_A 212 NMEFPNSLYY-LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL 265 (394)
T ss_dssp BCCCCTTCCE-ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC
T ss_pred eeecCCCceE-eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc
Confidence 6666555432 1111222235666666543 3334455666777777777766543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.78 E-value=5e-10 Score=121.84 Aligned_cols=134 Identities=19% Similarity=0.266 Sum_probs=67.8
Q ss_pred cCCCCCCceeeccCCC-CCCCCCcccCCCCCCcEEEcCCCCCCCCCCCcccc--CCCCCcEEEcCC--CCCC------CC
Q 003158 85 LSRLPSLVHMLLDNNN-LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS--NMSKLLKLSLRN--CSLQ------GP 153 (843)
Q Consensus 85 l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--~l~~L~~L~L~~--N~l~------~~ 153 (843)
+..+|+|+.|+|++|. +. ++. +. +++|+.|+|..|.+.. .....+. .+++|+.|+|+. |... .+
T Consensus 168 l~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~-~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPD-SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCH-HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCCh-HHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 3455566666665552 21 122 22 5666666666665532 1112222 456666666642 1111 11
Q ss_pred CCCC--CCCCCCCEEEcccCcCCCCCCC----CCCCcCcCEEEccCCcCCCCC----CcccCCCCCCcEEeCcCccCCCC
Q 003158 154 MPDL--SRIPNLGYLDLSSNQLNGSIPP----GRLSLNITTIKLSNNKLTGTI----PSNFSGLPRLQRLFIANNSLSGS 223 (843)
Q Consensus 154 ~~~~--~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~ 223 (843)
.+.+ ..+++|+.|+|++|.+.+..+. ....++|++|+|+.|.|+... +..+..+++|+.|+|++|.|+..
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 1111 2467777777777776532211 112336777777777766532 22233457777777777776643
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.7e-09 Score=115.97 Aligned_cols=179 Identities=13% Similarity=0.193 Sum_probs=96.3
Q ss_pred cccCCCCCCcEEEcccCcCC---------ccCccccccCCCCCEEEccCCc-cccCCCcccCCCCCCceeeccCCCCCCC
Q 003158 35 EELGYLPKLDRIQIDQNYIS---------GSLPKSFANLNKTRHFHMNNNS-ISGQIPPELSRLPSLVHMLLDNNNLTGY 104 (843)
Q Consensus 35 ~~~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 104 (843)
.+...+++|+.|.+..+... +.+...+..+++|+.|+|++|. +. ++. +. +++|+.|+|..|.+...
T Consensus 133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~ 208 (362)
T 2ra8_A 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDS 208 (362)
T ss_dssp TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHH
T ss_pred HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChH
Confidence 33445566666666544321 1233445566777777777663 22 222 32 66777777777776533
Q ss_pred CCcccC--CCCCCcEEEcCC--CCCCCC----CCCccc--cCCCCCcEEEcCCCCCCCCCC-C---CCCCCCCCEEEccc
Q 003158 105 LPPELS--ELPKLLILQLDN--NNFEGT----TIPASY--SNMSKLLKLSLRNCSLQGPMP-D---LSRIPNLGYLDLSS 170 (843)
Q Consensus 105 ~~~~~~--~l~~L~~L~Ls~--N~l~~~----~~~~~~--~~l~~L~~L~L~~N~l~~~~~-~---~~~l~~L~~L~Ls~ 170 (843)
....+. .+|+|+.|+|+. |...+. .+...+ ..+++|+.|+|.+|.+..... . ...+++|+.|+|+.
T Consensus 209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~ 288 (362)
T 2ra8_A 209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288 (362)
T ss_dssp HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCS
T ss_pred HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCC
Confidence 222332 567777777743 221110 011122 246788888888877764211 1 23467888888888
Q ss_pred CcCCCC----CCCC-CCCcCcCEEEccCCcCCCCCCcccCC-CCCCcEEeCcCcc
Q 003158 171 NQLNGS----IPPG-RLSLNITTIKLSNNKLTGTIPSNFSG-LPRLQRLFIANNS 219 (843)
Q Consensus 171 N~l~~~----~p~~-~~~~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~ 219 (843)
|.|.+. ++.. ....+|+.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 289 n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp SCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 887642 2222 11237888888888877543333332 2 3445666655
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.64 E-value=8.6e-07 Score=98.03 Aligned_cols=136 Identities=10% Similarity=0.094 Sum_probs=101.8
Q ss_pred CCccCccccCCCC-CCcEEEcccCcCCccCccccccCCCCCEEEccCCc---cccCCCcccCCCCCCceeeccCCCCCCC
Q 003158 29 LTGSLPEELGYLP-KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS---ISGQIPPELSRLPSLVHMLLDNNNLTGY 104 (843)
Q Consensus 29 l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 104 (843)
++.+...+|.++. .|+.+.|..+ ++.+...+|.++.+|+.+.+++|. ++.+...+|.++.+|+.+.+.++ ++.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 5556677888885 5999999765 776788899999999999999875 66666788999999999988765 5556
Q ss_pred CCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEccc
Q 003158 105 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSS 170 (843)
Q Consensus 105 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~ 170 (843)
...+|..+.+|+.+.+..+-.. .....|.++.+|+.+.+..+ ++.+... |. ..+|+.+.+..
T Consensus 129 ~~~aF~~c~~L~~i~lp~~~~~--I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~ 191 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEGVTS--VADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPA 191 (394)
T ss_dssp CTTTTTTCTTCCEEECCTTCCE--ECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECT
T ss_pred hhhhhhhhcccccccccceeee--ecccceecccccccccccce-eeEecccccc-ccceeEEEECC
Confidence 6788999999999999865432 33557888888998888765 4433332 32 34555555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=5.8e-08 Score=88.92 Aligned_cols=70 Identities=20% Similarity=0.248 Sum_probs=51.7
Q ss_pred EEeCcCccCC-CCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC--cCCCCcEEEeccCcccccCCcccccCCCCCCC
Q 003158 212 RLFIANNSLS-GSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF--NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDD 288 (843)
Q Consensus 212 ~L~L~~N~l~-~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~--~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~~ 288 (843)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+.++... .++.+..|+|.+|||.|||.+.+|..|+....
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp-------~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~~ 84 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP-------VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRP 84 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC-------TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTSS
T ss_pred EEEeCCCCCccccCCCCCC-------cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhCc
Confidence 4555666654 34554331 24567888888888887654 68889999999999999999999999987554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.51 E-value=3.8e-06 Score=92.27 Aligned_cols=230 Identities=12% Similarity=0.074 Sum_probs=106.1
Q ss_pred cCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCC
Q 003158 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 87 (843)
Q Consensus 8 ~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 87 (843)
+-..+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++.+....|.+. +|+.+.+.++- +.+...+|.+
T Consensus 60 Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~i~lp~~~-~~i~~~~F~~ 134 (379)
T 4h09_A 60 IGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDDFEFPGAT-TEIGNYIFYN 134 (379)
T ss_dssp ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSEEECCTTC-CEECTTTTTT
T ss_pred hHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-CcccccCCCcc-cccccccccc
Confidence 33444555555555555433 443444555544 3444444332 332333333332 45555554432 2122233333
Q ss_pred CCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCC----------------------------------CCCcc
Q 003158 88 LPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT----------------------------------TIPAS 133 (843)
Q Consensus 88 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----------------------------------~~~~~ 133 (843)
+ +|+.+.+..+ ++.+....|..+..|+.+.+..+..... .....
T Consensus 135 ~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 212 (379)
T 4h09_A 135 S-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYG 212 (379)
T ss_dssp C-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTT
T ss_pred c-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecc
Confidence 2 3333333322 2323344556666666666554332100 01122
Q ss_pred ccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCC
Q 003158 134 YSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRL 210 (843)
Q Consensus 134 ~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L 210 (843)
+..+.+|+.+.+..+ ++.+.. .+..+.+|+.+.+..+ ++ .+....+. .+|+.+.+..+ ++......|.++.+|
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceecccccccccccc
Confidence 334445555555433 222222 3556666666666554 33 34433332 25666666443 443445566666666
Q ss_pred cEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCC
Q 003158 211 QRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254 (843)
Q Consensus 211 ~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~ 254 (843)
+.+.+.++.++.....+|..+.+| +.++|.++ ++.+..
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L-----~~i~lp~~-l~~I~~ 326 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKL-----SSVTLPTA-LKTIQV 326 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTC-----CEEECCTT-CCEECT
T ss_pred ccccccccccceehhhhhcCCCCC-----CEEEcCcc-ccEEHH
Confidence 666666666654444455444333 35555433 555443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.46 E-value=2.1e-08 Score=98.30 Aligned_cols=117 Identities=14% Similarity=0.200 Sum_probs=56.5
Q ss_pred cccCCCCCCcEEEcccC-cCCcc----CccccccCCCCCEEEccCCccccC----CCcccCCCCCCceeeccCCCCCCC-
Q 003158 35 EELGYLPKLDRIQIDQN-YISGS----LPKSFANLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLTGY- 104 (843)
Q Consensus 35 ~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~- 104 (843)
..+...+.|++|+|++| .|... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|+..
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 33444555555555555 54421 223334445555555555555421 122233345555555555555522
Q ss_pred ---CCcccCCCCCCcEEEc--CCCCCCCCC---CCccccCCCCCcEEEcCCCCCC
Q 003158 105 ---LPPELSELPKLLILQL--DNNNFEGTT---IPASYSNMSKLLKLSLRNCSLQ 151 (843)
Q Consensus 105 ---~~~~~~~l~~L~~L~L--s~N~l~~~~---~~~~~~~l~~L~~L~L~~N~l~ 151 (843)
+...+...++|++|+| ++|.|.... +...+...++|+.|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2334445556666666 556654210 2233444566666666666653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.35 E-value=2.8e-08 Score=102.46 Aligned_cols=105 Identities=28% Similarity=0.309 Sum_probs=65.0
Q ss_pred cCCCCCCcE--EEcccCcCC---ccCccccccCCCCCEEEccCCccccC--CCcccCCCCCCceeeccCCCCCCCCCccc
Q 003158 37 LGYLPKLDR--IQIDQNYIS---GSLPKSFANLNKTRHFHMNNNSISGQ--IPPELSRLPSLVHMLLDNNNLTGYLPPEL 109 (843)
Q Consensus 37 ~~~l~~L~~--L~L~~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 109 (843)
|...+.|.. ++++.|... ..+.....++++|+.|+|++|+|+++ ++..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444445554 566666433 22222225567788888888887753 345556777888888888888754 333
Q ss_pred CCCC--CCcEEEcCCCCCCCCCCC-------ccccCCCCCcEEE
Q 003158 110 SELP--KLLILQLDNNNFEGTTIP-------ASYSNMSKLLKLS 144 (843)
Q Consensus 110 ~~l~--~L~~L~Ls~N~l~~~~~~-------~~~~~l~~L~~L~ 144 (843)
..+. +|++|+|++|.+.+ .+| ..+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~-~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCD-TFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGG-GCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCcc-ccCcchhHHHHHHHHCcccCeEC
Confidence 3333 78888888888764 333 2356778888775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=3.8e-08 Score=96.49 Aligned_cols=113 Identities=19% Similarity=0.183 Sum_probs=54.0
Q ss_pred ccCCCCCCEEEccCC-cCCcc----CccccCCCCCCcEEEcccCcCCcc----CccccccCCCCCEEEccCCccccC---
Q 003158 13 IGNIKSLELLLLNGN-ELTGS----LPEELGYLPKLDRIQIDQNYISGS----LPKSFANLNKTRHFHMNNNSISGQ--- 80 (843)
Q Consensus 13 i~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~--- 80 (843)
+.+.++|++|+|++| .|+.. +...+...+.|++|+|++|.|+.. +...+...++|++|+|++|.|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 334455555555555 55421 333444455555555555555421 222333445555555555555522
Q ss_pred -CCcccCCCCCCceeec--cCCCCCCC----CCcccCCCCCCcEEEcCCCCC
Q 003158 81 -IPPELSRLPSLVHMLL--DNNNLTGY----LPPELSELPKLLILQLDNNNF 125 (843)
Q Consensus 81 -~~~~l~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l 125 (843)
+...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 2333444455555555 55555522 122333345555555555554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.6e-06 Score=89.46 Aligned_cols=136 Identities=21% Similarity=0.204 Sum_probs=92.1
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCC---cccceeeeee-cCCcEEEEEecCCC
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR---NLVSLVGYCD-EEGEQMLVYEFMSN 591 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lV~e~~~~ 591 (843)
.+.++.|....||+. ++.+++|+.. .......+.+|+++|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 5678888853 233456789999999999753 3556666663 45678899999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE------------------------------------------- 628 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------------- 628 (843)
.++.+..-. .++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888663211 122333334444444444444432
Q ss_pred --------------CCCCEEeccCCCCcEEEcC---CCc-EEEeecccccc
Q 003158 629 --------------ADPPVFHRDIKASNILLDH---KFT-AKVADFGLSRL 661 (843)
Q Consensus 629 --------------~~~~iiH~Dlkp~NILl~~---~~~-~kl~DfGla~~ 661 (843)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335899999999999997 455 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.4e-06 Score=87.87 Aligned_cols=135 Identities=16% Similarity=0.147 Sum_probs=98.6
Q ss_pred cccccCCe-eEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 518 QIGQGGYG-KVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 518 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
.+..|..| .||+.... ++..+++|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556666 68988754 5678899986532 3456788999998884 33467788999888999999999999888
Q ss_pred HHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 003158 595 RDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA--------------------------------------------- 629 (843)
Q Consensus 595 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------------- 629 (843)
.+..... ......++.++++.|.-||+..
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7765321 1233456666777777777421
Q ss_pred ----------CCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 630 ----------DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 630 ----------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887778999998753
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.23 E-value=9.8e-08 Score=98.44 Aligned_cols=106 Identities=25% Similarity=0.270 Sum_probs=75.3
Q ss_pred cccCCCCCE--EEccCCccc---cCCCcccCCCCCCceeeccCCCCCC--CCCcccCCCCCCcEEEcCCCCCCCCCCCcc
Q 003158 61 FANLNKTRH--FHMNNNSIS---GQIPPELSRLPSLVHMLLDNNNLTG--YLPPELSELPKLLILQLDNNNFEGTTIPAS 133 (843)
Q Consensus 61 ~~~l~~L~~--L~Ls~N~l~---~~~~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 133 (843)
|...+.|.. ++++.|... ..++....++++|+.|+|++|+|++ .++..+..+++|+.|+|++|+|++......
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~ 216 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 216 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhh
Confidence 444455555 677888543 2222223568899999999999997 345667789999999999999986322233
Q ss_pred ccCCCCCcEEEcCCCCCCCCCCC--------CCCCCCCCEEE
Q 003158 134 YSNMSKLLKLSLRNCSLQGPMPD--------LSRIPNLGYLD 167 (843)
Q Consensus 134 ~~~l~~L~~L~L~~N~l~~~~~~--------~~~l~~L~~L~ 167 (843)
+..+ +|+.|+|++|.+.+..+. +..+++|+.||
T Consensus 217 l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 217 IKGL-KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GTTS-CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred cccC-CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3444 999999999999864331 56789999887
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.16 E-value=4.7e-05 Score=83.41 Aligned_cols=232 Identities=12% Similarity=0.084 Sum_probs=130.3
Q ss_pred cccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCc
Q 003158 4 KISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPP 83 (843)
Q Consensus 4 ~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 83 (843)
+++.+-..+|.+. +|+.+.+..+ ++.+...+|.+ .+|+.+.+.++-.. .....|.+. +|+.+.+..+ ++.+...
T Consensus 79 ~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~ 152 (379)
T 4h09_A 79 TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDG 152 (379)
T ss_dssp TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSC
T ss_pred cceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcccc-ccccccccc-eeeeeeccce-eeccccc
Confidence 3444445566655 5677766543 44345555554 36777777654322 333334333 4444444332 2223334
Q ss_pred ccCCCCCCceeeccCCC-----------------------------------CCCCCCcccCCCCCCcEEEcCCCCCCCC
Q 003158 84 ELSRLPSLVHMLLDNNN-----------------------------------LTGYLPPELSELPKLLILQLDNNNFEGT 128 (843)
Q Consensus 84 ~l~~l~~L~~L~L~~N~-----------------------------------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 128 (843)
.|..+.+++.+.+..+. ........+..+..|+.+.+..+--.
T Consensus 153 ~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~~~~-- 230 (379)
T 4h09_A 153 IGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSGVTT-- 230 (379)
T ss_dssp TTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTTCCE--
T ss_pred hhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccccccccceeeeccceeE--
Confidence 44444444444333221 11122344556677787777655321
Q ss_pred CCCccccCCCCCcEEEcCCCCCCCCCC-CCCCCCCCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccC
Q 003158 129 TIPASYSNMSKLLKLSLRNCSLQGPMP-DLSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFS 205 (843)
Q Consensus 129 ~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~ 205 (843)
.....|.++.+|+.+.+..+ ++.+.. .|..+.+|+.+.+..+ ++ .++...+. .+|+.+.+.++.++.+...+|.
T Consensus 231 i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~ 307 (379)
T 4h09_A 231 LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFM 307 (379)
T ss_dssp ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTT
T ss_pred EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhc
Confidence 23456777788888888765 555555 4777788888887654 44 45554443 3788888887777766777888
Q ss_pred CCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCC
Q 003158 206 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNIS 253 (843)
Q Consensus 206 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~ 253 (843)
++.+|+.+.|.++ ++.....+|.++.+|+ .+.+..+ ++.+.
T Consensus 308 ~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~-----~i~ip~~-v~~I~ 348 (379)
T 4h09_A 308 DCVKLSSVTLPTA-LKTIQVYAFKNCKALS-----TISYPKS-ITLIE 348 (379)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCC-----CCCCCTT-CCEEC
T ss_pred CCCCCCEEEcCcc-ccEEHHHHhhCCCCCC-----EEEECCc-cCEEc
Confidence 8888888888654 5544445665554443 4555433 55554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=2.7e-06 Score=92.58 Aligned_cols=79 Identities=4% Similarity=-0.014 Sum_probs=55.5
Q ss_pred Ccc-cccCCeeEEEEEeC-------CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcc-C--CcccceeeeeecC---
Q 003158 517 TQI-GQGGYGKVYKGILP-------DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEE--- 579 (843)
Q Consensus 517 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~--- 579 (843)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999988754 26788899865422 111245778999888885 3 3567788887655
Q ss_pred CcEEEEEecCCCCCHH
Q 003158 580 GEQMLVYEFMSNGTLR 595 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~ 595 (843)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4578999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=5.4e-05 Score=83.55 Aligned_cols=75 Identities=16% Similarity=0.080 Sum_probs=49.4
Q ss_pred CCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-------hhHHHHHHHHHHHHhccC--Cc-ccceeeeeecCCcEEE
Q 003158 516 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-------QGEKEFLTEIQFLSRLHH--RN-LVSLVGYCDEEGEQML 584 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-Iv~l~~~~~~~~~~~l 584 (843)
.+.||.|.++.||++... +++.|+||....... ....++..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999854 468899998653221 122456779998888742 33 3455544 3445689
Q ss_pred EEecCCCC
Q 003158 585 VYEFMSNG 592 (843)
Q Consensus 585 V~e~~~~g 592 (843)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00013 Score=78.57 Aligned_cols=140 Identities=19% Similarity=0.200 Sum_probs=80.2
Q ss_pred CcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccC--Ccccceee------eeecCCcEEEEEec
Q 003158 517 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVG------YCDEEGEQMLVYEF 588 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~------~~~~~~~~~lV~e~ 588 (843)
+.|+.|..+.||+....+| .+++|+.... ..++..|+++++.+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999987655 4889988752 2334456666665531 12334443 12345678999999
Q ss_pred CCCCCHH-----------H---HHhhc-CCC--C---------cchhH-------------------------------H
Q 003158 589 MSNGTLR-----------D---QLSAK-SKE--P---------LGFAM-------------------------------R 611 (843)
Q Consensus 589 ~~~gsL~-----------~---~l~~~-~~~--~---------l~~~~-------------------------------~ 611 (843)
++|.++. + .+|.. ... + ..|.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1 11211 000 0 11111 0
Q ss_pred HHHHHHHHHHHHHHhc----------CCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 612 LSIALGSSRGILYLHT----------EADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 612 ~~i~~~ia~aL~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
..+...+.+++++|+. ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223446667763 1234599999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=5.8e-05 Score=79.26 Aligned_cols=79 Identities=19% Similarity=0.235 Sum_probs=57.8
Q ss_pred CCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCC---cccceeeeeecCCcEEEEEec
Q 003158 512 NFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR---NLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.....+.+|.|..+.||+....||+.|++|+...........|..|++.|+.+.-. -+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 34446778999999999999999999999987654444445678899999888422 344455442 34789999
Q ss_pred CCCCCH
Q 003158 589 MSNGTL 594 (843)
Q Consensus 589 ~~~gsL 594 (843)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.77 E-value=7.1e-06 Score=78.42 Aligned_cols=83 Identities=18% Similarity=0.140 Sum_probs=44.4
Q ss_pred CCcEEEcccCcCCccCccccccCCCCCEEEccCCc-cccCCCcccCCC----CCCceeeccCCC-CCCCCCcccCCCCCC
Q 003158 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNS-ISGQIPPELSRL----PSLVHMLLDNNN-LTGYLPPELSELPKL 115 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~L 115 (843)
+|+.|||+++.|+...-..+..+++|+.|+|++|. |+...-..+..+ ++|++|+|++|. |++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45666666665554444445556666666666653 442222223332 356666666653 554333445566666
Q ss_pred cEEEcCCCC
Q 003158 116 LILQLDNNN 124 (843)
Q Consensus 116 ~~L~Ls~N~ 124 (843)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00015 Score=76.65 Aligned_cols=137 Identities=16% Similarity=0.141 Sum_probs=91.4
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc---CCcccceeeeeecCCcEEEEEecCCCC
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGYCDEEGEQMLVYEFMSNG 592 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~e~~~~g 592 (843)
.+.|+.|....+|+... +++.+++|+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45789999999999886 4677888987642 3557888999998884 356888888888788899999999987
Q ss_pred CHH--------H---HHhhcCC-CC-------------------cchhHHH---HHH----------------HHHH-HH
Q 003158 593 TLR--------D---QLSAKSK-EP-------------------LGFAMRL---SIA----------------LGSS-RG 621 (843)
Q Consensus 593 sL~--------~---~l~~~~~-~~-------------------l~~~~~~---~i~----------------~~ia-~a 621 (843)
.+. + .|+.... .. -+|.... ++. ..+. ..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 652 1 1232211 10 1232211 011 0111 11
Q ss_pred HHHHhc-CCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 622 ILYLHT-EADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 622 L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 233432 2356799999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.63 E-value=9e-06 Score=77.72 Aligned_cols=82 Identities=9% Similarity=0.106 Sum_probs=35.2
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCc-CCccCccccccC----CCCCEEEccCCc-cccCCCcccCCCCCC
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNY-ISGSLPKSFANL----NKTRHFHMNNNS-ISGQIPPELSRLPSL 91 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~l~~l~~L 91 (843)
+|+.|||++|.|+...-..+.++++|++|+|++|. |++..-..++.+ ++|+.|+|++|. |+...-..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34455555544444434444444555555555442 443222233332 234455554442 442222233444445
Q ss_pred ceeeccCC
Q 003158 92 VHMLLDNN 99 (843)
Q Consensus 92 ~~L~L~~N 99 (843)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55554444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0004 Score=77.10 Aligned_cols=73 Identities=11% Similarity=0.132 Sum_probs=45.2
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccC------C-h--hhHHHHHHHHHHHH-hccCCcccceeeeeecCCcEEEE
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEG------S-L--QGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
.+.+|.|..+.||++.. +++.++||..... . . .....+..|+..+. ......+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45689999999999965 5678999943211 1 0 12233444443332 22234566676665 4677999
Q ss_pred EecC-CC
Q 003158 586 YEFM-SN 591 (843)
Q Consensus 586 ~e~~-~~ 591 (843)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.40 E-value=3.9e-05 Score=74.69 Aligned_cols=88 Identities=19% Similarity=0.223 Sum_probs=36.7
Q ss_pred ccCCCCCEEEccCCccccCC----CcccCCCCCCceeeccCCCCCCC----CCcccCCCCCCcEEEcCCCC---CCC---
Q 003158 62 ANLNKTRHFHMNNNSISGQI----PPELSRLPSLVHMLLDNNNLTGY----LPPELSELPKLLILQLDNNN---FEG--- 127 (843)
Q Consensus 62 ~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~---l~~--- 127 (843)
..-+.|+.|+|++|.|+... ...+..-+.|++|+|++|+|... +.+.+..-+.|+.|+|++|. +..
T Consensus 67 ~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~ 146 (197)
T 1pgv_A 67 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE 146 (197)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred hhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHH
Confidence 33344455555555444211 12222334455555555555421 11233334445555555432 110
Q ss_pred CCCCccccCCCCCcEEEcCCCC
Q 003158 128 TTIPASYSNMSKLLKLSLRNCS 149 (843)
Q Consensus 128 ~~~~~~~~~l~~L~~L~L~~N~ 149 (843)
..+...+..-+.|+.|+++.|.
T Consensus 147 ~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 147 MDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHhCCCcCeEeccCCC
Confidence 0112234444556666665554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00099 Score=71.34 Aligned_cols=140 Identities=15% Similarity=0.132 Sum_probs=73.5
Q ss_pred CcccccCCee-EEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCC--cccceeeeeecCCcEEEEEecCCCCC
Q 003158 517 TQIGQGGYGK-VYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHR--NLVSLVGYCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 517 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~lV~e~~~~gs 593 (843)
+.|+.|+... +|+....+++.+++|....... .++..|+.+++.+... .+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3455555444 6677654467777886543221 2345577777766422 3456666644333 78999997766
Q ss_pred HHHHHhhc---------------------CC---CCcchhHHH-------H-H------------HHHHHHHHHHHh---
Q 003158 594 LRDQLSAK---------------------SK---EPLGFAMRL-------S-I------------ALGSSRGILYLH--- 626 (843)
Q Consensus 594 L~~~l~~~---------------------~~---~~l~~~~~~-------~-i------------~~~ia~aL~yLH--- 626 (843)
+.+++... .. ..++..... . + ...+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443211 00 011111000 0 0 001111222221
Q ss_pred cCCCCCEEeccCCCCcEEEcCC----CcEEEeecccccc
Q 003158 627 TEADPPVFHRDIKASNILLDHK----FTAKVADFGLSRL 661 (843)
Q Consensus 627 ~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~ 661 (843)
....+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0022 Score=68.15 Aligned_cols=157 Identities=13% Similarity=0.119 Sum_probs=87.5
Q ss_pred ccHHHHHHHHcCCCC-----CCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCc--cccee
Q 003158 501 FTYGEMALATNNFNS-----STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLV 573 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~ 573 (843)
++.+++.....+|.. .+.|+.|....+|+....+| .+++|+.... ....++..|+.+++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555556654 23466788889999987666 5778988652 12234566888877774222 23333
Q ss_pred ee------eecCCcEEEEEecCCCCCHHH--------------HHhhcC---CCC-------cchhHHHH----------
Q 003158 574 GY------CDEEGEQMLVYEFMSNGTLRD--------------QLSAKS---KEP-------LGFAMRLS---------- 613 (843)
Q Consensus 574 ~~------~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~---~~~-------l~~~~~~~---------- 613 (843)
.. ....+..++||+|++|..+.. .++... ..+ ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122356789999998865311 112110 000 11211100
Q ss_pred --HHHHHHHHHHHHhcC----CCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 614 --IALGSSRGILYLHTE----ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 614 --i~~~ia~aL~yLH~~----~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
+...+.+.++++++. ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011134455555532 12359999999999999987666899999775
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00011 Score=71.60 Aligned_cols=42 Identities=17% Similarity=0.253 Sum_probs=18.7
Q ss_pred cCCCCCCceeeccCCCCCCC----CCcccCCCCCCcEEEcCCCCCC
Q 003158 85 LSRLPSLVHMLLDNNNLTGY----LPPELSELPKLLILQLDNNNFE 126 (843)
Q Consensus 85 l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 126 (843)
+..-+.|+.|+|++|+|... +.+.+..-+.|++|+|+.|.|.
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 33444555555555555421 1222223344555555555553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0085 Score=63.72 Aligned_cols=141 Identities=17% Similarity=0.183 Sum_probs=81.3
Q ss_pred CcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCc--ccceeee-----eecCCcEEEEEecC
Q 003158 517 TQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN--LVSLVGY-----CDEEGEQMLVYEFM 589 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~-----~~~~~~~~lV~e~~ 589 (843)
..++ |....||+....+|+.+++|+..... .....+..|..+++.+.... +.+++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 78889999887778789999986432 23456777888888774222 3444443 12245668899999
Q ss_pred CCCCHH-----H------H---Hhhc----C---CCCcchhHH----HHH---------------HHHHHHHHHHHhc--
Q 003158 590 SNGTLR-----D------Q---LSAK----S---KEPLGFAMR----LSI---------------ALGSSRGILYLHT-- 627 (843)
Q Consensus 590 ~~gsL~-----~------~---l~~~----~---~~~l~~~~~----~~i---------------~~~ia~aL~yLH~-- 627 (843)
+|..+. . . ++.. . ....++... ..+ ...+.+.++.+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 1 1 1110 0 011111110 000 1111122223221
Q ss_pred --CCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 628 --EADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 628 --~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234489999999999999 4 899999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0015 Score=68.84 Aligned_cols=71 Identities=8% Similarity=0.067 Sum_probs=45.0
Q ss_pred CCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcc-cceeeeeecCCcEEEEEecC-CCCC
Q 003158 516 STQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFM-SNGT 593 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~~-~~gs 593 (843)
.+.|+.|....+|+. +.+++|+........ .+..+|+.+++.+....+ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567889999999998 568888876432111 123468887777753333 4555544 33457899999 6654
Q ss_pred H
Q 003158 594 L 594 (843)
Q Consensus 594 L 594 (843)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0021 Score=71.32 Aligned_cols=73 Identities=18% Similarity=0.214 Sum_probs=50.4
Q ss_pred CCcccccCCeeEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcc-cceeeeeecCCcEEEEE
Q 003158 516 STQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~ 586 (843)
.+.|+.|....||+....+ ++.+++|+..... ....+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567888889999998753 5789999885321 12355679999888853334 567776643 3899
Q ss_pred ecCCCCCH
Q 003158 587 EFMSNGTL 594 (843)
Q Consensus 587 e~~~~gsL 594 (843)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0016 Score=70.85 Aligned_cols=140 Identities=20% Similarity=0.214 Sum_probs=82.3
Q ss_pred CcccccCCeeEEEEEeC--------CCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEe
Q 003158 517 TQIGQGGYGKVYKGILP--------DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+.+..|-...+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888889998864 3578999986432 223455678999998885 3333566776654 29999
Q ss_pred cCCCCCHHH--------------HH---hhc----CCCCc-chhHHHHHHHHHHH-------------------HHHH--
Q 003158 588 FMSNGTLRD--------------QL---SAK----SKEPL-GFAMRLSIALGSSR-------------------GILY-- 624 (843)
Q Consensus 588 ~~~~gsL~~--------------~l---~~~----~~~~l-~~~~~~~i~~~ia~-------------------aL~y-- 624 (843)
|++|.+|.. .| +.. ...+. -+.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998765421 11 111 11111 23344444433321 1222
Q ss_pred --HhcC-CCCCEEeccCCCCcEEEcCC----CcEEEeecccccc
Q 003158 625 --LHTE-ADPPVFHRDIKASNILLDHK----FTAKVADFGLSRL 661 (843)
Q Consensus 625 --LH~~-~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~ 661 (843)
|... ....++|+|+.+.||+++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 23459999999999999876 7899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0075 Score=67.24 Aligned_cols=74 Identities=14% Similarity=-0.003 Sum_probs=48.1
Q ss_pred CCcccccCCeeEEEEEeCC-CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcc-cceeeeeecCCcEEEEEecCCCCC
Q 003158 516 STQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL-VSLVGYCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~~~~gs 593 (843)
.+.|+.|-...+|+....+ +..+++|+....... .-+-.+|..+++.+...++ .++++++.. .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3568888889999998765 578889987542211 1112578888988865444 567777632 35999998754
Q ss_pred H
Q 003158 594 L 594 (843)
Q Consensus 594 L 594 (843)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0037 Score=56.65 Aligned_cols=56 Identities=25% Similarity=0.447 Sum_probs=42.0
Q ss_pred EEEcccCcCC-CCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCC
Q 003158 165 YLDLSSNQLN-GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 165 ~L~Ls~N~l~-~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 221 (843)
.++.+++.|+ ..+|.. ...+|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-FPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-CCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-CCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666777665 244433 2336888888888888777788899999999999999886
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0029 Score=68.81 Aligned_cols=73 Identities=14% Similarity=0.105 Sum_probs=44.3
Q ss_pred CcccccCCeeEEEEEeCC---------CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCc-ccceeeeeecCCcEEEEE
Q 003158 517 TQIGQGGYGKVYKGILPD---------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lV~ 586 (843)
..++.|....+|+....+ ++.+++|+....... ..+...|.++++.+.... ..++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 457788888999988654 268889987643211 112357888888875333 346665542 37899
Q ss_pred ecCCCCCH
Q 003158 587 EFMSNGTL 594 (843)
Q Consensus 587 e~~~~gsL 594 (843)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.028 Score=60.10 Aligned_cols=68 Identities=10% Similarity=0.080 Sum_probs=44.0
Q ss_pred cccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc---CCcccceeee------eecCCcEEEEEecCC
Q 003158 520 GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH---HRNLVSLVGY------CDEEGEQMLVYEFMS 590 (843)
Q Consensus 520 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~------~~~~~~~~lV~e~~~ 590 (843)
|.|....||+....+| .+++|+...... ..|+.+++.+. -+.+.+.+.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444678999987777 899998775432 34556665553 1224444432 233567899999999
Q ss_pred CCCH
Q 003158 591 NGTL 594 (843)
Q Consensus 591 ~gsL 594 (843)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.0015 Score=70.09 Aligned_cols=59 Identities=14% Similarity=0.200 Sum_probs=40.4
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhhCC----CCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 766 QDETDARPSMSEVMRELESIWNMMP----ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 766 ~~~p~~RPs~~~vl~~L~~~~~~~~----~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
-..|-...+..+++..+..- .++ ..++.+.+||.+||+.||++|+|++|+|+||||+..
T Consensus 221 G~~PF~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 221 LKHAFEAGSMKNLVLKIISG--SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SSCSCCCSSHHHHHHHHHHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCCCCCCcCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 34455555565555443321 122 223445689999999999999999999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=95.56 E-value=0.002 Score=66.73 Aligned_cols=63 Identities=13% Similarity=0.268 Sum_probs=43.9
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhhCCC-CCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 766 QDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 766 ~~~p~~RPs~~~vl~~L~~~~~~~~~-~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
...|-...+..+..+.+......++. ......+++.+||..||++|||++|+++||||++...
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 203 GKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp SSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred CCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 34455555666666655554333332 2333568999999999999999999999999976544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.48 E-value=0.085 Score=51.54 Aligned_cols=100 Identities=15% Similarity=0.158 Sum_probs=65.6
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
-+|.+.|+.. ..++++.++|.++.|.+.+|.-+-.+..+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3799999765 45899999999999999988776221111 1223446899999999998874 2111
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 715 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg 715 (843)
.....+.|||... ...+.+.=|||+|+++|.-+--
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0122466888763 3456788999999999998863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=94.82 E-value=0.0026 Score=65.69 Aligned_cols=63 Identities=6% Similarity=0.106 Sum_probs=42.3
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhhCCC-CCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 766 QDETDARPSMSEVMRELESIWNMMPE-SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 766 ~~~p~~RPs~~~vl~~L~~~~~~~~~-~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
...|-......++.+.+..-....+. .+....+++.+||..||++|||++|+++||||+.+..
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 207 GTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred CCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 34454445555555544432222222 2334567999999999999999999999999987643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.56 E-value=0.1 Score=57.29 Aligned_cols=73 Identities=12% Similarity=0.089 Sum_probs=47.5
Q ss_pred CcccccCCeeEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHHhccCCc-ccceeeeeecCCcEEEEEe
Q 003158 517 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRN-LVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lV~e 587 (843)
+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+.-.. ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456778888999998753 5789999875432 11112356888888875322 345565442 278999
Q ss_pred cCCCCCH
Q 003158 588 FMSNGTL 594 (843)
Q Consensus 588 ~~~~gsL 594 (843)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.43 E-value=0.021 Score=38.81 Aligned_cols=27 Identities=22% Similarity=0.560 Sum_probs=19.8
Q ss_pred CCCCCccceeehhHHHHHHHHHHHHHH
Q 003158 441 NSGISKAALAGIILGAIAGAVTISAIV 467 (843)
Q Consensus 441 ~~~~~~~~~~~ii~g~~~~~~~~~~~~ 467 (843)
+++.+..+++||++|++++++++.+++
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~ 31 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGIL 31 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHH
Confidence 345677889999999888777665544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=94.27 E-value=0.0084 Score=62.16 Aligned_cols=13 Identities=23% Similarity=0.102 Sum_probs=5.6
Q ss_pred cCCCCCCCHHHHH
Q 003158 767 DETDARPSMSEVM 779 (843)
Q Consensus 767 ~~p~~RPs~~~vl 779 (843)
..|-..++..+..
T Consensus 209 ~~pf~~~~~~~~~ 221 (284)
T 2vgo_A 209 MPPFDSPSHTETH 221 (284)
T ss_dssp SCTTCCSSHHHHH
T ss_pred CCCCCCCCHhHHH
Confidence 3444444444443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.07 E-value=0.0084 Score=62.83 Aligned_cols=63 Identities=5% Similarity=0.044 Sum_probs=41.9
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhhCC-CCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 766 QDETDARPSMSEVMRELESIWNMMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 766 ~~~p~~RPs~~~vl~~L~~~~~~~~-~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
...|....+..++.+.+..-....+ ...+...+++.+||..||++|||++|+++||||.....
T Consensus 209 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 209 GLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 3345444455555554443221122 22334568999999999999999999999999977554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=93.76 E-value=0.0076 Score=64.47 Aligned_cols=12 Identities=0% Similarity=-0.125 Sum_probs=4.6
Q ss_pred CCCCCCCHHHHH
Q 003158 768 ETDARPSMSEVM 779 (843)
Q Consensus 768 ~p~~RPs~~~vl 779 (843)
.|-...+..+..
T Consensus 274 ~pf~~~~~~~~~ 285 (345)
T 3hko_A 274 VPFPGVNDADTI 285 (345)
T ss_dssp CSSCCSSHHHHH
T ss_pred CCCCCCChHHHH
Confidence 343333444333
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=93.31 E-value=0.01 Score=61.87 Aligned_cols=31 Identities=10% Similarity=0.223 Sum_probs=28.1
Q ss_pred CCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 796 TPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 796 ~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
..+++.+||..||++|||++|+++||||...
T Consensus 260 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 3578999999999999999999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=93.31 E-value=0.0044 Score=65.00 Aligned_cols=32 Identities=25% Similarity=0.226 Sum_probs=29.4
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
...+++++.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 48899999999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=92.97 E-value=0.0074 Score=64.00 Aligned_cols=28 Identities=4% Similarity=0.238 Sum_probs=22.9
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+++.+||..||++|||++|+|+||||++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 4666677788888889999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=92.61 E-value=0.0076 Score=63.01 Aligned_cols=34 Identities=24% Similarity=0.471 Sum_probs=30.1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~ 781 (843)
.....++..+.+++.+||+.+|.+||++.++++.
T Consensus 255 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 3467788999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.50 E-value=0.04 Score=57.80 Aligned_cols=34 Identities=21% Similarity=0.446 Sum_probs=30.3
Q ss_pred CCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 795 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 795 ~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
.+.+++.+||..||++|||++|+++||||.+...
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 3457999999999999999999999999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=92.37 E-value=0.017 Score=59.97 Aligned_cols=33 Identities=15% Similarity=0.282 Sum_probs=29.2
Q ss_pred CCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 794 TKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 794 ~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
....+++.+||..||++|||++|+|+||||...
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 345679999999999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.98 E-value=0.022 Score=59.18 Aligned_cols=30 Identities=10% Similarity=0.231 Sum_probs=21.5
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
+++.+||..||++|||++|+|+||||....
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 455666777777888888888899987644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.90 E-value=0.015 Score=62.18 Aligned_cols=33 Identities=18% Similarity=0.302 Sum_probs=29.2
Q ss_pred CCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 795 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 795 ~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
.+.+++.+||..||++|||++|+|+||||+...
T Consensus 249 ~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 249 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 356799999999999999999999999997543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.81 E-value=0.017 Score=61.68 Aligned_cols=30 Identities=13% Similarity=0.302 Sum_probs=21.0
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
+++.+||..||++|||++|+++||||+...
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 455566667777777777788888886643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.51 E-value=0.012 Score=62.00 Aligned_cols=36 Identities=17% Similarity=0.286 Sum_probs=29.5
Q ss_pred CCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 793 DTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 793 ~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
.....+++.+||..||++|||++|+++||||.....
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 344567999999999999999999999999987543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.32 E-value=0.26 Score=34.51 Aligned_cols=18 Identities=17% Similarity=0.303 Sum_probs=8.1
Q ss_pred cceeehhHHHHHHHHHHH
Q 003158 447 AALAGIILGAIAGAVTIS 464 (843)
Q Consensus 447 ~~~~~ii~g~~~~~~~~~ 464 (843)
.++++.++|.++++++++
T Consensus 11 ~~IA~gVVgGv~~~~ii~ 28 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVA 28 (44)
T ss_dssp SSSTHHHHHHHHHHHHHH
T ss_pred ceEEeehhHHHHHHHHHH
Confidence 345555554444444333
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=91.26 E-value=0.019 Score=60.48 Aligned_cols=31 Identities=19% Similarity=0.329 Sum_probs=21.8
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+++.+||..||++|||++|+|+||||+....
T Consensus 271 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 271 DVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred HHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 4555667777777888888888999876543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.95 E-value=0.19 Score=35.05 Aligned_cols=17 Identities=18% Similarity=0.278 Sum_probs=6.9
Q ss_pred ceeehhHHHHHHHHHHH
Q 003158 448 ALAGIILGAIAGAVTIS 464 (843)
Q Consensus 448 ~~~~ii~g~~~~~~~~~ 464 (843)
++++.++|.++++++++
T Consensus 11 aIA~gVVgGv~~v~ii~ 27 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVG 27 (44)
T ss_dssp HHHHHHHHHHHHHHHHH
T ss_pred eEEEeehHHHHHHHHHH
Confidence 34444444433333333
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=90.69 E-value=0.024 Score=61.90 Aligned_cols=33 Identities=18% Similarity=0.302 Sum_probs=29.2
Q ss_pred CCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 795 KTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 795 ~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
.+.+++.+||..||++|||++|+|+||||....
T Consensus 296 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 296 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 356799999999999999999999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.68 E-value=0.019 Score=60.67 Aligned_cols=31 Identities=23% Similarity=0.554 Sum_probs=23.7
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+++.+||..||++|||++|+++||||+....
T Consensus 265 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred HHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 4566677777888888888999999976543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=90.53 E-value=0.055 Score=55.63 Aligned_cols=62 Identities=16% Similarity=0.130 Sum_probs=41.3
Q ss_pred cCCCCCCCHHHHHHHHHHhhh-hCC-CCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 767 DETDARPSMSEVMRELESIWN-MMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 767 ~~p~~RPs~~~vl~~L~~~~~-~~~-~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
..|..-.+..++...+..-.. ..+ .......+++.+||..||++|||++|+++|+|+.+...
T Consensus 213 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 213 MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred CCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 344444455555554443211 111 12334567999999999999999999999999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.15 E-value=0.029 Score=59.01 Aligned_cols=28 Identities=18% Similarity=0.466 Sum_probs=21.5
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+++.+||..||++|||++|+++||||..
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 4556667777888888888899999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=89.45 E-value=0.072 Score=55.54 Aligned_cols=33 Identities=18% Similarity=0.420 Sum_probs=29.4
Q ss_pred CCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 796 TPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 796 ~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
..+++.+||..||++|||++|+++||||.....
T Consensus 247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 467999999999999999999999999976544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.34 E-value=1.8 Score=47.11 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=24.9
Q ss_pred EEeccCCCCcEEE------cCCCcEEEeecccccc
Q 003158 633 VFHRDIKASNILL------DHKFTAKVADFGLSRL 661 (843)
Q Consensus 633 iiH~Dlkp~NILl------~~~~~~kl~DfGla~~ 661 (843)
++|+|+.+.||++ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=89.18 E-value=0.021 Score=60.55 Aligned_cols=28 Identities=32% Similarity=0.576 Sum_probs=23.0
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
+++.+||..||++|||++|+++||||..
T Consensus 264 ~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 264 NFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 5666778888888889999999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=88.43 E-value=0.043 Score=58.85 Aligned_cols=31 Identities=26% Similarity=0.449 Sum_probs=22.9
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 798 EFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 798 dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+|+.+||..||++|||++|+++||||.....
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 4555666777788888888899999876543
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.24 E-value=0.57 Score=32.66 Aligned_cols=8 Identities=13% Similarity=0.592 Sum_probs=5.2
Q ss_pred ceeehhHH
Q 003158 448 ALAGIILG 455 (843)
Q Consensus 448 ~~~~ii~g 455 (843)
.++++++|
T Consensus 13 ~Ia~~vVG 20 (44)
T 2jwa_A 13 SIISAVVG 20 (44)
T ss_dssp HHHHHHHH
T ss_pred chHHHHHH
Confidence 46666666
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 843 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-68 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 1e-73
Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 18/277 (6%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
+IG G +G VYKG V + + Q + F E+ L + H N++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 578 EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRD 637
+ +V ++ +L L + + IA +++G+ YLH + HRD
Sbjct: 75 -APQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 638 IKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK-- 695
+K++NI L T K+ DFGL+ + +H + G+ ++ PE
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWS-----GSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 696 -LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
+ +SDVY+ G+V EL+TG P S+ N + + + + + ++ S C
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-----GYLSPDLSKVRSNCP 239
Query: 755 EKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791
+ +L +C + + D RP +++ +E + +P+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-68
Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 20/275 (7%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
++G G +G+V+ G T VAVK ++GS FL E + +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
L + ++ E+M NG+L D L S L L +A + G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
HRD++A+NIL+ + K+ADFGL+RL + K + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------YTAREGAKFPIKWTAPEA 181
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
T KSDV+S G++ E++T + G ++ ++ G P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQNLERGYRMVRP 232
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
C E+ +L C ++ + RP+ + LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 8e-68
Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 20/275 (7%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
+ +IG G +G V+ G + VA+K +EG+ E++F+ E + + +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
L G C E+ LV+EFM +G L D + L + L G + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
V HRD+ A N L+ KV+DFG++R ST K + PE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEV 173
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
F + + KSDV+S GV+ E+ + + ++ S ++ + G P
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEVVEDISTGFRLYKP 224
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
++ C ++ + RP+ S ++R+L I
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-65
Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 23/293 (7%)
Query: 505 EMALATNNFN-SSTQIGQGGYGKVYKGIL---PDGTVVAVKRAQEGSLQGE-KEFLTEIQ 559
++ L +N + ++G G +G V +G+ VA+K ++G+ + + +E + E Q
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 560 FLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 619
+ +L + +V L+G C + MLV E G L L K +E + + + S
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVS 119
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
G+ YL + HRD+ A N+LL ++ AK++DFGLS+ D +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAG 172
Query: 680 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739
K + PE K + +SDV+S GV E L+ Q +M
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------GPEVMA 223
Query: 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 792
+ G P EC + L C + + RP V + + + + +
Sbjct: 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (556), Expect = 2e-65
Identities = 82/296 (27%), Positives = 128/296 (43%), Gaps = 20/296 (6%)
Query: 499 RSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTE 557
S Y + + + ++G G YG+VY+G+ VAVK +E +++ E EFL E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 558 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALG 617
+ + H NLV L+G C E ++ EFM+ G L D L +++ + + L +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 618 SSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVST 677
S + YL HRD+ A N L+ KVADFGLSRL
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHA 174
Query: 678 VVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737
K + PE +K + KSDV++ GV+ E+ T G ++ + +
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------ 228
Query: 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESD 793
+ P C EK +L C Q RPS +E+ + E+++ SD
Sbjct: 229 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (555), Expect = 3e-65
Identities = 76/310 (24%), Positives = 123/310 (39%), Gaps = 46/310 (14%)
Query: 505 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKR-AQEGSLQGEKEFLTE 557
+ NN IG+G +G+V++ P T+VAVK +E S + +F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 558 IQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL------------------- 598
++ + N+V L+G C L++E+M+ G L + L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 599 ---SAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655
S+ PL A +L IA + G+ YL + HRD+ N L+ K+AD
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 656 FGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 715
FGLSR D ++ PE ++ T +SDV++ GVV E+ +
Sbjct: 184 FGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 716 MQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSM 775
+G +++ V DGN+ + P C + L C RPS
Sbjct: 239 GLQPYYGMA---------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 289
Query: 776 SEVMRELESI 785
+ R L+ +
Sbjct: 290 CSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 3e-65
Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 20/282 (7%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
+ ++GQG +G+V+ G T VA+K + G+ + FL E Q + +L H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
L E +V E+MS G+L D L ++ + L + +A + G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
HRD++A+NIL+ KVADFGL+RL + K + PE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEA 185
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
L + T KSDV+S G++ EL T + G ++ V G P
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCP 236
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES 792
EC E L +C + E + RP+ + LE +
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (555), Expect = 4e-65
Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 29/302 (9%)
Query: 498 VRSFTYGEMALATNNFNSSTQ---------IGQGGYGKVYKGILP----DGTVVAVKRAQ 544
+ FT+ + A F IG G +G+V G L VA+K +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 545 EG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK 603
G + + ++FL+E + + H N++ L G + M++ EFM NG+L D ++
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQND 122
Query: 604 EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663
+ + G + G+ YL D HRD+ A NIL++ KV+DFGLSR
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-- 177
Query: 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723
+ D + K + PE K T SDV+S G+V E+++ +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
++ ++ P +C +L L C Q + + RP +++ L+
Sbjct: 238 T---------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 784 SI 785
+
Sbjct: 289 KM 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-65
Identities = 72/276 (26%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
IG+G +G V G G VAVK + + + FL E +++L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 571 SLVGYC-DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
L+G +E+G +V E+M+ G+L D L ++ + LG L +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
HRD+ A N+L+ AKV+DFGL++ A K + PE
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVKWTAPE 170
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749
K + KSDV+S G++ E+ + + + ++ V G
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPRVEKGYKMDA 221
Query: 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P C ++ C + RPS ++ +LE I
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-65
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 20/275 (7%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
+ ++G G +G V G VA+K +EGS E EF+ E + + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
L G C ++ ++ E+M+NG L + L + L + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
HRD+ A N L++ + KV+DFGLSR + S K + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEV 172
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
+ K + KSD+++ GV+ E+ + + S + G P
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---------NSETAEHIAQGLRLYRP 223
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
EK + C ++ D RP+ ++ + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 6e-65
Identities = 85/313 (27%), Positives = 139/313 (44%), Gaps = 22/313 (7%)
Query: 487 HSSKTSIKIDGVRSFTYGEMALATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKR 542
H +++ + V++ + + ++ + + IG+G +G VY G L D AVK
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 543 AQEGSLQGE-KEFLTEIQFLSRLHHRNLVSLVGYC-DEEGEQMLVYEFMSNGTLRDQLSA 600
+ GE +FLTE + H N++SL+G C EG ++V +M +G LR+
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIR 121
Query: 601 KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660
+ L ++G + A HRD+ A N +LD KFT KVADFGL+R
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPIS 720
+ + + H T K ++ E T K T KSDV+S GV+ EL+T P
Sbjct: 179 DMYDKEFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 721 HGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
N + ++ G P C + ++ LKC + + RPS SE++
Sbjct: 236 PDVNTF---------DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 781 ELESIWNMMPESD 793
+ +I++
Sbjct: 287 RISAIFSTFIGEH 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-63
Identities = 73/298 (24%), Positives = 130/298 (43%), Gaps = 24/298 (8%)
Query: 508 LATNNFNSSTQIGQGGYGKVYKGILPDGT-----VVAVKRAQEGSLQGEK-EFLTEIQFL 561
+ + IG G +G+VYKG+L + VA+K + G + ++ +FL E +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 562 SRLHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 621
+ H N++ L G + M++ E+M NG L + + + G + G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAG 122
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+ YL + HRD+ A NIL++ KV+DFGLSR+ + + ++ K
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEATYTTSGGKI 175
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741
+ PE K T SDV+S G+V E++T + + +M ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMKAI 226
Query: 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEF 799
DG P +C +L ++C Q E RP ++++ L+ + P+S +F
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR-APDSLKTLADF 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-62
Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 25/280 (8%)
Query: 518 QIGQGGYGKVYKGILPD---GTVVAVKRAQEGSLQGE--KEFLTEIQFLSRLHHRNLVSL 572
++G G +G V KG VAVK + + E L E + +L + +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G C+ E MLV E G L L + + + + S G+ YL +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
HRD+ A N+LL + AK++DFGLS+ T K + PE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYAPECIN 183
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752
+K + KSDV+S GV+ E + Q G S + + G P+
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------GSEVTAMLEKGERMGCPAG 234
Query: 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESIW-NMMPE 791
C + L C + + RP + V L + + +++ E
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-60
Identities = 71/326 (21%), Positives = 127/326 (38%), Gaps = 33/326 (10%)
Query: 506 MALATNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSR 563
M L ++F +++G G G V+K P G V+A K + + E+Q L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 623
+ +V G +GE + E M G+L L K + + +++ +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 118
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
YL + + HRD+K SNIL++ + K+ DFG+S + ++ GT
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG---------QLIDSMANSFVGTR 167
Query: 684 GYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743
Y+ PE + +SD++S+G+ +E+ G PI + M ++
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-------DAKELELMFGCQVE 220
Query: 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP---ESDTKTPE-- 798
G+ P D+RP M+ + L+ I N P S + E
Sbjct: 221 GDAAETPPRP----RTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 799 -FINSEHTSKEETPPSSSSMLKHPYV 823
F+N ++ H ++
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-60
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 34/294 (11%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577
IG+G +G+V++G G VAVK + EI L H N++ + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 578 EEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---- 629
++ LV ++ +G+L D L+ + + + +AL ++ G+ +LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 630 -DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
P + HRD+K+ NIL+ T +AD GL+ D GT Y+ P
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH---DSATDTIDIAPNHRVGTKRYMAP 181
Query: 689 EYFLTH------KLTDKSDVYSLGVVFLELLTGMQPISHGKN-----IVREVNIAYQSSM 737
E + ++D+Y++G+VF E+ ++ + M
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 738 MFSVIDGNM------GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
V + + E + K+ +C AR + + + L +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 26/278 (9%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRN 568
++ IG G YG+ K DG ++ K GS+ ++ ++E+ L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 569 LVSLVGYCDEEGEQML--VYEFMSNGTLRDQLSA--KSKEPLGFAMRLSIALGSSRGILY 624
+V + L V E+ G L ++ K ++ L L + + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 625 LH--TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
H ++ V HRD+K +N+ LD K K+ DFGL+R+ + GT
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------SFAKAFVGT 177
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
P Y+ PE +KSD++SLG + EL M P + Q + +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----------QKELAGKIR 227
Query: 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+G P ++ ++ + + RPS+ E++
Sbjct: 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-59
Identities = 76/338 (22%), Positives = 130/338 (38%), Gaps = 58/338 (17%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPDG---TVVAVKR-AQEGSLQGEKEFLTEIQFLSRL-H 565
N+ IG+G +G+V K + A+KR + S ++F E++ L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPLGFAMR 611
H N+++L+G C+ G L E+ +G L D L + + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 612 LSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671
L A +RG+ YL HRD+ A NIL+ + AK+ADFGLSR
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 178
Query: 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 731
T+ + ++ E T SDV+S GV+ E+++ G
Sbjct: 179 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---- 234
Query: 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791
+ + G P C ++ L +C +++ RPS ++++ L +
Sbjct: 235 -----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM------ 283
Query: 792 SDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVSG 829
+ +T +++ K Y D S
Sbjct: 284 -------------LEERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-58
Identities = 67/273 (24%), Positives = 106/273 (38%), Gaps = 25/273 (9%)
Query: 518 QIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQGEKE-FLTEIQFLSRLHHRNLVSL 572
IG+G +G V++GI VA+K + + +E FL E + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+G E ++ E + G LR K L A + A S + YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
HRDI A N+L+ K+ DFGLSR + ++ K ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN 182
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752
+ T SDV+ GV E+L G + ++ + +G P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------NNDVIGRIENGERLPMPPN 233
Query: 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
C L KC + RP +E+ +L +I
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 4e-58
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 31/272 (11%)
Query: 518 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVG 574
+IG+G + VYKG+ + VA Q+ L + F E + L L H N+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 575 YCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
+ + +LV E M++GTL+ L K + + + S +G+ +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH-TRT 132
Query: 631 PPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
PP+ HRD+K NI + + K+ D GL+ L A + V GTP ++ PE
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIGTPEFMAPE 183
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN-MGS 748
K + DVY+ G+ LE+ T P S +N + + V G S
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVTSGVKPAS 233
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + + ++ C + D R S+ +++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 8e-58
Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 45/303 (14%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD------GTVVAVKRAQEGSLQGEKE-FLTEIQFLSR 563
N +G G +GKV VAVK +E + E+E ++E++ +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 564 L-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSK------------------- 603
L H N+V+L+G C G L++E+ G L + L +K +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 604 --EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661
L F L A ++G+ +L HRD+ A N+L+ H K+ DFGL+R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR- 212
Query: 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 721
DI V + ++ PE T KSDV+S G++ E+ +
Sbjct: 213 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 722 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781
G + + +G P E+ + C ++ RPS +
Sbjct: 269 GIPVDAN--------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 782 LES 784
L
Sbjct: 321 LGC 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 2e-57
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 32/275 (11%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHRN 568
F+ +IG G +G VY + + VVA+K+ Q ++ + E++FL +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+ G E LV E+ K+PL ++ G+ +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH-- 132
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRD+KA NILL K+ DFG + + + GTP ++ P
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----------MAPANSFVGTPYWMAP 180
Query: 689 EYFLTH---KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
E L + K DV+SLG+ +EL P+ + + +IA S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----- 235
Query: 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
E F C Q RP+ +++
Sbjct: 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-57
Identities = 74/328 (22%), Positives = 132/328 (40%), Gaps = 33/328 (10%)
Query: 513 FNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRA-----QEGSLQGEKEFLTEIQFLSRLHH 566
F +G G +G VYKG+ +P+G V + A + S + KE L E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
++ L+G C L+ + M G L D + K+ +G L+ + ++G+ YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
D + HRD+ A N+L+ K+ DFGL++L + E + + K ++
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----YHAEGGKVPIKWM 180
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
E L T +SDV+S GV EL+T G S + + G
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------ASEISSILEKGER 231
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTS 806
P C + +KC + D+RP E++ E + + P+
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM--------ARDPQRYLVIQGD 283
Query: 807 KEETPPSSSSMLKHPYVSSDVSGSNLVS 834
+ PS + + + + ++V
Sbjct: 284 ERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 6e-57
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 42/293 (14%)
Query: 518 QIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSLQGEKE-FLTEIQFLSRL-HHRNL 569
+G G +GKV + VAVK + + E+E ++E++ LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAK----------------SKEPLGFAMRLS 613
V+L+G C G +++ E+ G L + L K + L LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 614 IALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPA 673
+ ++G+ +L HRD+ A NILL H K+ DFGL+R
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 201
Query: 674 HVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733
V + ++ PE T +SDV+S G+ EL + G
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--------- 252
Query: 734 QSSMMFSVIDGNM-GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
S + +I P + + C + RP+ ++++ +E
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-56
Identities = 67/274 (24%), Positives = 104/274 (37%), Gaps = 29/274 (10%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 566
+F +G+G +G VY ++A+K +AQ E + E++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
N++ L GY + L+ E+ GT+ +L + + + + Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
V HRDIK N+LL K+ADFG S P+ T + GT YL
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH---------APSSRRTTLCGTLDYL 171
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE +K D++SLGV+ E L G P + I
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----------ETYKRISRVE 220
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
++P E L + + RP + EV+
Sbjct: 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-56
Identities = 62/276 (22%), Positives = 102/276 (36%), Gaps = 26/276 (9%)
Query: 518 QIGQGGYGKVYKGILP----DGTVVAVKR---AQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
++G G +G V +G VAVK + +F+ E+ + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
L G +V E G+L D K + A+ + G+ YL
Sbjct: 75 RLYGVV-LTPPMKMVTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 631 PPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
HRD+ A N+LL + K+ DFGL R P + + K + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYVMQEHRKVPFAWCAPES 185
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI-DGNMGSY 749
T + SD + GV E+ T Q G N + ++ + +G
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEGERLPR 236
Query: 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
P +C + + ++C + + RP+ + L
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 4e-56
Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 25/269 (9%)
Query: 518 QIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
++G G +GKVYK + + A K S + ++++ EI L+ H N+V L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E ++ EF + G + + + + PL + + + + YLH D + HR
Sbjct: 79 YYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
D+KA NIL K+ADFG+S GTP ++ PE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTI-------QRRDSFIGTPYWMAPEVVMCETS 187
Query: 697 TD-----KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPS 751
D K+DV+SLG+ +E+ P + + IA + PS
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--------AQPS 239
Query: 752 ECVEKFIKLALKCCQDETDARPSMSEVMR 780
F KC + DAR + S++++
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-55
Identities = 71/308 (23%), Positives = 122/308 (39%), Gaps = 36/308 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSR 563
S ++GQG +G VY+G+ T VA+K + S++ EFL E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------SAKSKEPLGFAMRLSIA 615
+ ++V L+G + +++ E M+ G L+ L + P + + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 616 LGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHV 675
+ G+ YL+ HRD+ A N ++ FT K+ DFG++R D
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RK 191
Query: 676 STVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQS 735
++ PE T SDV+S GVV E+ T + G +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------NE 242
Query: 736 SMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTK 795
++ V++G + P C + +L C Q RPS E++ ++ E +
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM----EPGFR 298
Query: 796 TPEFINSE 803
F SE
Sbjct: 299 EVSFYYSE 306
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 6e-55
Identities = 62/294 (21%), Positives = 119/294 (40%), Gaps = 28/294 (9%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IGQG G VY + + G VA+++ ++ + EI + + N+V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
E +V E+++ G+L D ++ + ++ + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 637 DIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL 696
DIK+ NILL + K+ DFG + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 697 TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEK 756
K D++SLG++ +E++ G P + + IA + P +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------QNPEKLSAI 245
Query: 757 FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEET 810
F +C + + R S E+ L+ + + + + I + +KE T
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKEL---LQHQFLKIAKPLSSLTPLIAA---AKEAT 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-54
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 21/273 (7%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR-AQEGSLQGEKEFLTEIQFLSRLHHRN 568
+++ +G+G YG+V + VAVK + ++ + EI L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+V G+ E Q L E+ S G L D++ + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRDIK N+LLD + K++DFGL+ + + E + + GT Y+ P
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAP 174
Query: 689 EYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
E + + DV+S G+V +L G P + +E +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--------KEKKTYL 226
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + + L K + AR ++ ++ +
Sbjct: 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-54
Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 39/291 (13%)
Query: 518 QIGQGGYGKVYKGI------LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSR-LHHRNL 569
+G+G +G+V + VAVK +EG+ E + ++E++ L HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 570 VSLVGYCDEEGEQ-MLVYEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSI 614
V+L+G C + G M++ EF G L L +K K+ L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 615 ALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAH 674
+ ++G+ +L + HRD+ A NILL K K+ DFGL+R
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYV 191
Query: 675 VSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734
+ ++ PE T +SDV+S GV+ E+ + G I E
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----- 246
Query: 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ +G P + + L C E RP+ SE++ L ++
Sbjct: 247 ---CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-53
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILP--------DGTVVAVKR-AQEGSLQGEKEFLTEIQFL 561
+ +G+G +G+V T VAVK + + + + ++E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 562 SRL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQL--------------SAKSKEPL 606
+ H+N+++L+G C ++G ++ E+ S G LR+ L S +E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 607 GFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666
+S A +RG+ YL HRD+ A N+L+ K+ADFGL+R D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----D 184
Query: 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV 726
I I +T + ++ PE T +SDV+S GV+ E+ T G +
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243
Query: 727 REVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786
+ + +G+ PS C + + C RP+ +++ +L+ I
Sbjct: 244 --------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 787 NM 788
+
Sbjct: 296 AL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 5e-50
Identities = 65/318 (20%), Positives = 125/318 (39%), Gaps = 30/318 (9%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL 569
++++ ++G G +G V++ G A K ++ EIQ +S L H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 570 VSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
V+L +++ E +++YEFMS G L ++++ + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGLCHMH--- 141
Query: 630 DPPVFHRDIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ H D+K NI+ K K+ DFGL+ + P V GT +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------LDPKQSVKVTTGTAEFAA 193
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
PE + +D++S+GV+ LL+G+ P G+N +
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMD------D 246
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR-------ELESIWNMMPESD-TKTPEF 799
S S E K + + R ++ + + + +P S TK +
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
Query: 800 INSEHTSKEETPPSSSSM 817
I +++ + E P +
Sbjct: 307 IKTKYDAWPEPLPPLGRI 324
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 6e-50
Identities = 50/276 (18%), Positives = 91/276 (32%), Gaps = 25/276 (9%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLHHR 567
+F +G+G + V L A+K ++ + E E +SRL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
V L ++ + + NG L + + + + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI-----VSALEY 123
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ HRD+K NILL+ ++ DFG +++ + GT Y+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-----KQARANSFVGTAQYVS 178
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
PE SD+++LG + +L+ G+ P G + + +I
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------IFQKIIKLEY- 227
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783
+P + K L K + R E+
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (446), Expect = 2e-49
Identities = 59/313 (18%), Positives = 125/313 (39%), Gaps = 28/313 (8%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
++G G +G V++ + G V K + EI +++LHH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
+++ E +L+ EF+S G L D+++A+ + A ++ + G+ ++H + + H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 637 DIKASNILLDHKF--TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
DIK NI+ + K + K+ DFGL+ + P + V T + PE
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATK--------LNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
+ +D++++GV+ LL+G+ P + ++ N+ S
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-------DAFSSVS 256
Query: 755 EKFIKLALKCCQDETDARPSMSEVMR------ELESIWNMMPESDTKTPEFINSEHTSKE 808
+ Q E R ++ + + + ++ + +P S E +
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316
Query: 809 ETPPSSSSMLKHP 821
P + + +
Sbjct: 317 PAPQPAIGRIANF 329
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (417), Expect = 2e-46
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 25/287 (8%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE---KEFLTEIQFLSRLH 565
++ + +G GG +V+ L VAVK + + F E Q + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 566 HRNLVSLVGYCDEEGEQ----MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 621
H +V++ + E +V E++ TLRD + ++ P+ + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQA 123
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+ + H + HRD+K +NI++ KV DFG++R + + V G
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA----DSGNSVTQTAAVIG 176
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741
T YL PE + +SDVYSLG V E+LTG P + + + + S
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 235
Query: 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIWN 787
+ + LK + R + +E+ +L + N
Sbjct: 236 ------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 4e-46
Identities = 54/273 (19%), Positives = 102/273 (37%), Gaps = 19/273 (6%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG-EKEFLTEIQFLSRLHHR 567
+ ++ +G G + +V +VA+K + +L+G E EI L ++ H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
N+V+L + G L+ + +S G L D++ K + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ LD ++DFGLS++ P V + GTPGY+
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------EDPGSVLSTACGTPGYVA 177
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747
PE + D +S+GV+ LL G P + +N + ++ F
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDS------ 230
Query: 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
Y + + + + + R + + ++
Sbjct: 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 52/266 (19%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+G+G +G V++ + K + + EI L+ HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 577 DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHR 636
+ E ++++EF+S + ++++ S L +S + +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 637 DIKASNILLDHK--FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
DI+ NI+ + T K+ +FG +R D ++ P Y PE
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHD 178
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECV 754
++ +D++SLG + LL+G+ P N NI E
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------EAFKEIS 231
Query: 755 EKFIKLALKCCQDETDARPSMSEVMR 780
+ + + E +R + SE ++
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (412), Expect = 1e-45
Identities = 67/286 (23%), Positives = 99/286 (34%), Gaps = 37/286 (12%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKR---------AQEGSLQGEKEFLTEIQFL 561
N+ +G+G V + I P AVK + E + + L E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 562 SRLH-HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSR 620
++ H N++ L + LV++ M G L D L K L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 621 GILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVK 680
I LH + HRD+K NILLD K+ DFG S + P V
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------LDPGEKLREVC 170
Query: 681 GTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQ 734
GTP YL PE + D++S GV+ LL G P H K ++ I
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 735 SSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ S + + L + + R + E +
Sbjct: 231 NYQFGS-------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 1e-45
Identities = 51/274 (18%), Positives = 90/274 (32%), Gaps = 15/274 (5%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IG G +G +Y G + G VA+K + + E + + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 577 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
EG+ ++V E + L +A I Y+H H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 636 RDIKASNIL---LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
RD+K N L + DFGL++ +P + + GT Y L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 693 THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSE 752
+ + + D+ SLG V + G P K + S S +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL---CKG 243
Query: 753 CVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786
+F C D +P S + + +++
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 3e-44
Identities = 60/332 (18%), Positives = 116/332 (34%), Gaps = 46/332 (13%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK---RAQEGSLQGEKEFLTEIQFLSRLHH 566
+F +G G +G+V+ +G A+K + L+ + E LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
++ + G + + ++ +++ G L L + P A + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ +RD+K NILLD K+ DFG ++ P V+ + GTP Y+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----------DVTYTLCGTPDYI 168
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE T D +S G++ E+L G P +++ +
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----------TMKTYEKILNAEL 218
Query: 747 GSYPSECVEKFIKLALKCCQDE-----TDARPSMSEVMRE--LESI-WNMMPESDTKTP- 797
+P E L + + + + +V + + W + + +TP
Sbjct: 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPY 277
Query: 798 -------EFINSEHTSKEETPPSSSSMLKHPY 822
+ S+ E + + PY
Sbjct: 278 EPPIQQGQGDTSQFDKYPEEDINYGVQGEDPY 309
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (398), Expect = 1e-43
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 17/275 (6%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYC 576
+IG+G +G +++G L + VA+K E + E + L + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 577 DEEGEQ-MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
+EG +LV + + G + L A + +H + + +
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 636 RDIKASNILLD-----HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEY 690
RDIK N L+ + V DFG+ + P + +P + GT Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 691 FLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750
L + + + D+ +LG VF+ L G P K + S +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---PLRELC 241
Query: 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785
+ E+F K DA P + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (400), Expect = 4e-43
Identities = 60/275 (21%), Positives = 100/275 (36%), Gaps = 30/275 (10%)
Query: 511 NNFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSL---QGEKEFLTE---IQFLSR 563
N+F+ IG+GG+G+VY D G + A+K + + QGE L E + +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 564 LHHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGIL 623
+V + + + + M+ G L LS + + G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLE 121
Query: 624 YLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTP 683
++H + V +RD+K +NILLD +++D GL+ GT
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD---------FSKKKPHASVGTH 169
Query: 684 GYLDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742
GY+ PE D +D +SLG + +LL G P K + +M
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226
Query: 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSE 777
P + L Q + + R
Sbjct: 227 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 70/338 (20%), Positives = 127/338 (37%), Gaps = 48/338 (14%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSR-LH 565
+F +G+G +GKV+ A+K ++ + + + + E + LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 566 HRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYL 625
H L + + V E+++ G L + + K L A + + IL L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI-----ILGL 116
Query: 626 HTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
+ +RD+K NILLD K+ADFG+ + E ++ + GTP Y
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDY 169
Query: 686 LDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745
+ PE L K D +S GV+ E+L G P HG++ +F I +
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEE----------LFHSIRMD 218
Query: 746 MGSYPSECVEKFIKLALKCCQDETDARPSM-SEVM---------------RELESIWNMM 789
YP ++ L +K E + R + ++ +E++ +
Sbjct: 219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPK 278
Query: 790 PESDTKT----PEFINSEHTSKEETPPSSSSMLKHPYV 823
+S EF+N + +SM ++ +
Sbjct: 279 VKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFR 316
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 60/274 (21%), Positives = 100/274 (36%), Gaps = 41/274 (14%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKR------AQEGSLQGEKEFLTEIQFLSRLH--HRN 568
+G GG+G VY GI + D VA+K + G L E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
++ L+ + + +L+ E + L + S + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 629 ADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ V HRDIK NIL+D ++ K+ DFG L + V T GT Y
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---------LKDTVYTDFDGTRVYSP 177
Query: 688 PEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE+ H+ +S V+SLG++ +++ G P H + I+R
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--------------- 222
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
+ + L C RP+ E+
Sbjct: 223 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-42
Identities = 71/300 (23%), Positives = 109/300 (36%), Gaps = 40/300 (13%)
Query: 509 ATNNFNSSTQIGQGGYGKVYKG--ILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRL 564
A + +IG+G YGKV+K + G VA+K R Q G + E+ L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 565 ---HHRNLVSLVGYC-----DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIAL 616
H N+V L C D E + LV+E + L + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123
Query: 617 GSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVS 676
RG+ +LH+ V HRD+K NIL+ K+ADFGL+R+
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------FQMAL 172
Query: 677 TVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP------ISHGKNIVREV- 729
T V T Y PE L D++S+G +F E+ + I+ +
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 730 ---------NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
++A S + + ++ E L LKC R S +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 54/296 (18%), Positives = 108/296 (36%), Gaps = 34/296 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE------KEFLTEIQFLSRLHHRNLV 570
++G G + V K G A K ++ + ++ E+ L + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 571 SLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEAD 630
+L + + + +L+ E ++ G L D L+ K A + + ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHS 131
Query: 631 PPVFHRDIKASNILLDH----KFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ H D+K NI+L K K+ DFGL+ I + + GTP ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--------IDFGNEFKNIFGTPEFV 183
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE L ++D++S+GV+ LL+G P N++ +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------ 237
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESI-WNMMPESDTKTPEF 799
Y S + + R ++ + ++ ++ S P+F
Sbjct: 238 -EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 67/290 (23%), Positives = 107/290 (36%), Gaps = 31/290 (10%)
Query: 512 NFNSSTQIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRN 568
NF +IG+G YG VYK G VVA+K R + + EI L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 569 LVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+V L+ E + LV+EF+ L+ + A + + + S +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
V HRD+K N+L++ + K+ADFGL+R VP + V
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPE 172
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748
+ D++SLG +F E++T I + I V+ + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 749 YP------------------SECVEKFIKLALKCCQDETDARPSMSEVMR 780
P E L + + + R S +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 56/286 (19%), Positives = 97/286 (33%), Gaps = 36/286 (12%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKR-----AQEGSLQGEKEFLTEIQFLSRLHHRNLVSL 572
+G+G + VYK +VA+K+ E + L EI+ L L H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 573 VGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+ + LV++FM + + L
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-----LQGLEYLHQHW 120
Query: 633 VFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFL 692
+ HRD+K +N+LLD K+ADFGL++ P+ T T Y PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-------RAYTHQVVTRWYRAPELLF 173
Query: 693 THKLTD-KSDVYSLGVVFLELLTGMQP------------ISHGKNIVREVNIAYQSSMMF 739
++ D++++G + ELL + I E S+
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 740 SVIDGNMGSYP-----SECVEKFIKLALKCCQDETDARPSMSEVMR 780
V + P S + + L AR + ++ ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 64/315 (20%), Positives = 109/315 (34%), Gaps = 35/315 (11%)
Query: 519 IGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYC 576
+G G GKV + A+K LQ + E++ R ++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 577 D----EEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPP 632
+ ++V E + G L ++ + + I I YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 633 VFHRDIKASNILLDHKF---TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRD+K N+L K K+ DFG ++ + T TP Y+ PE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--------TTSHNSLTTPCYTPYYVAPE 183
Query: 690 YFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749
K D++SLGV+ LL G P + + + M S
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW----NMMPESDTKTPEFINSEHT 805
SE V+ I+ + E R +++E + W +P++ T + +
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 806 SKEETPPSSSSMLKH 820
E+ +S L
Sbjct: 298 RWEDVKEEMTSALAT 312
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (366), Expect = 2e-39
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 31/283 (10%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGY 575
+IG+G YG VYK G A+K R ++ + EI L L H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635
+ +LV+E + + + L S L GI Y H D V H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK 695
RD+K N+L++ + K+ADFGL+R +P + + + K
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPV------RKYTHEIVTLWYRAPDVLMGSKK 177
Query: 696 LTDKSDVYSLGVVFLELLTGMQPIS------------------HGKNIVREVNIAYQSSM 737
+ D++S+G +F E++ G + KN +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
S+ E I L K + + + R + + +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-39
Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 27/269 (10%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 566
N+F+ +G+G +GKV G A+K ++ + + E +TE + L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
L +L V E+ + G L LS + A + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI-----VSALE 119
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
V +RDIK N++LD K+ DFGL + GTP YL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-------ATMKTFCGTPEYL 172
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE + D + LGVV E++ G P + ++ R +F +I
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHER----------LFELILMEE 221
Query: 747 GSYPSECVEKFIKLALKCCQDETDARPSM 775
+P + L + + R
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 59/295 (20%), Positives = 103/295 (34%), Gaps = 31/295 (10%)
Query: 510 TNNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGE-KEFLTEIQFLSRLHHR 567
+ + + IG+G YG V + VA+K+ Q + L EI+ L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTL-RDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
N++ + + + ++ + D + L RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
V HRD+K SN+LL+ K+ DFGL+R+A T T Y
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD----PDHDHTGFLTEYVATRWYR 179
Query: 687 DPEYFLTHKLTDKS-DVYSLGVVFLELLTGMQPISHGKNI-----VREVNIAYQSSMMFS 740
PE L K KS D++S+G + E+L+ + + + + +
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 741 VIDGNMGSYPSECVEK---------------FIKLALKCCQDETDARPSMSEVMR 780
+I+ +Y K + L K R + + +
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-38
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 33/285 (11%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+IG+G YG V+K +VA+K R + L EI L L H+N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 575 YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVF 634
+ + LV+EF + S L + L V
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL-----LKGLGFCHSRNVL 123
Query: 635 HRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH 694
HRD+K N+L++ K+A+FGL+R +P S V F
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV------RCYSAEVVTLWYRPPDVLFGAK 177
Query: 695 KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID----------- 743
+ D++S G +F EL +P+ G ++ ++ ++ +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 744 --------GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780
++ + + L + R S E ++
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-38
Identities = 66/328 (20%), Positives = 119/328 (36%), Gaps = 38/328 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQG--EKEFLTEIQFLSRLHHR 567
+ + +IGQG +G+V+K G VA+K+ + + L EI+ L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 568 NLVSLVGYCDE--------EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSS 619
N+V+L+ C +G LV++F + + K L R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 620 RGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVV 679
+ L+ + HRD+KA+N+L+ K+ADFGL+R + + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS---QPNRYTNR 181
Query: 680 KGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738
T Y PE L + D++ G + E+ T + + I+ +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE 798
+ N+ +Y + +K + +D A + ++ + + P
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR----- 296
Query: 799 FINSEHTSKEETPPSSSSMLKHPYVSSD 826
S L H + SD
Sbjct: 297 -------------IDSDDALNHDFFWSD 311
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 70/339 (20%), Positives = 122/339 (35%), Gaps = 47/339 (13%)
Query: 512 NFNSSTQIGQGGYGKVYKGILPD-GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV 570
++ + IG G +G VY+ L D G +VA+K+ LQ ++ E+Q + +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 571 SLVGYCDEEGEQM------LVYEFMSNGTLRDQLS-AKSKEPLGFAMRLSIALGSSRGIL 623
L + GE+ LV +++ R +++K+ L R +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 624 YLHTEADPPVFHRDIKASNILLDHK-FTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGT 682
Y+H + HRDIK N+LLD K+ DFG ++ + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-------PNVSYICSR 186
Query: 683 PGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQP------ISHGKNIVREVNIAYQSS 736
F T DV+S G V ELL G + I++ + +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 737 MMFSVIDGNMGSYPS------------ECVEKFIKLALKCCQDETDARPSMSEVM----- 779
+ + +P + I L + + AR + E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 780 RELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818
EL +P + TP N PP ++ ++
Sbjct: 307 DELRDPNVKLP-NGRDTPALFNFTTQELSSNPPLATILI 344
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-36
Identities = 52/279 (18%), Positives = 99/279 (35%), Gaps = 35/279 (12%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKE---FLTEIQFLSRLHH 566
+ F+ +G G +G+V G A+K + + K+ L E + L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 567 RNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
LV L + +V E+++ G + L + A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 627 TEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYL 686
+ +RD+K N+L+D + +V DFG ++ + + GTP L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTWTLCGTPEAL 205
Query: 687 DPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746
PE L+ D ++LGV+ E+ G P ++ ++ I
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQ----------IYEKIVSGK 254
Query: 747 GSYPSECVEKFIKLALKCCQDE-----TDARPSMSEVMR 780
+PS L Q + + + ++++
Sbjct: 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 63/324 (19%), Positives = 113/324 (34%), Gaps = 49/324 (15%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G G YG V + G VA+K S K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 575 YCDEEG------EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+ + LV FM GT +L E LG + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKL--MKHEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRD+K N+ ++ K+ DFGL+R + ++ V
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------QADSEMTGYVVTRWYRAPE 188
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI-------------AYQS 735
+ T D++S+G + E++TG ++ + I QS
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 736 SMMFSVIDG-------NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE--LESIW 786
+ + G + S + + L K + + R + E + ES+
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 787 NMMPESDTKT--PEFINSEHTSKE 808
+ E + F + + T E
Sbjct: 309 DTEDEPQVQKYDDSFDDVDRTLDE 332
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 1e-31
Identities = 54/318 (16%), Positives = 119/318 (37%), Gaps = 37/318 (11%)
Query: 511 NNFNSSTQIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRN 568
+++ ++G+G Y +V++ I + + V VK + +K+ EI+ L L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 569 LVSLVGYCDEEGEQM--LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLH 626
+++L + + LV+E ++N + + L + + Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146
Query: 627 TEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGY 685
+ HRD+K N+++DH+ ++ D+GL+ P V + +
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--------YHPGQEYNVRVASRYF 195
Query: 686 LDPEYFLTHKLTD-KSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744
PE + +++ D D++SLG + ++ +P HG + Q + V+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD------QLVRIAKVLGT 249
Query: 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEH 804
+ K ++ D S E + +F++
Sbjct: 250 ED------LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 805 TSKEETPPSSSSMLKHPY 822
++ ++ ++HPY
Sbjct: 304 RYDHQSRLTAREAMEHPY 321
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 62/282 (21%), Positives = 100/282 (35%), Gaps = 29/282 (10%)
Query: 511 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLS 562
NF +G G YGKV+ G + A+K ++ ++ + + TE Q L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 563 RL-HHRNLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRG 621
+ LV+L E + L+ ++++ G L LS + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 622 ILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
+L L + +RDIK NILLD + DFGLS+ + E G
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------G 192
Query: 682 TPGYLDPEYFLTHK--LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739
T Y+ P+ D +SLGV+ ELLTG P + + +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-------GEKNSQAEIS 245
Query: 740 SVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRE 781
I + YP E L + + R +
Sbjct: 246 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 6e-30
Identities = 59/319 (18%), Positives = 111/319 (34%), Gaps = 39/319 (12%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
IG G G V VA+K + K E+ + ++H+N++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 575 YC------DEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE 628
+E + LV E M + E + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLH-- 136
Query: 629 ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDP 688
+ HRD+K SNI++ T K+ DFGL+R A + + T T Y P
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------TSFMMTPYVVTRYYRAP 187
Query: 689 EYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748
E L + D++S+G + E++ + + G++ + ++ + +G+
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYID----------QWNKVIEQLGT 236
Query: 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPE---FINSEHT 805
E ++K ++ + + K + ++
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 806 SKEETPPSSSSMLKHPYVS 824
S L+HPY++
Sbjct: 297 IDPAKRISVDDALQHPYIN 315
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 9e-28
Identities = 58/292 (19%), Positives = 96/292 (32%), Gaps = 45/292 (15%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVK--RAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG 574
+G G YG V G VAVK S+ K E++ L + H N++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 575 YCDE-----EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA 629
E + + + D + + L + RG+ Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 630 DPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPE 689
+ HRD+K SN+ ++ K+ DFGL+R T T Y PE
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTDDEMTGYVATRWYRAPE 188
Query: 690 YFLTHKLTD-KSDVYSLGVVFLELLTGMQP------------ISHGKNIVREVNIAYQSS 736
L + D++S+G + ELLTG I + SS
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 737 MMFSVIDGNMGSYPSECVEK--------FIKLALKCCQDETDARPSMSEVMR 780
++ P + L K ++D R + ++ +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 6e-24
Identities = 44/331 (13%), Positives = 101/331 (30%), Gaps = 26/331 (7%)
Query: 518 QIGQGGYGKVYKGI-LPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVG-- 574
++G G + V+ + + T VA+K G + EI+ L R++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 575 ------------YCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGI 622
+ G +++ + L + + I+ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 623 LYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKG 681
Y+H + H DIK N+L++ + ++ L T
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHYTNSIQ 191
Query: 682 TPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741
T Y PE L +D++S + EL+TG + + + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFIN 801
+ G + SY + ++ + L + + + +F++
Sbjct: 251 L-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 802 SEHTSKEETPPSSSSMLKHPYVSSDVSGSNL 832
+ ++ HP++ + +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 340
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 2e-20
Identities = 31/204 (15%), Positives = 59/204 (28%), Gaps = 29/204 (14%)
Query: 518 QIGQGGYGKVYKGILPDGTVVAVKRAQEGSL----------QGEKEFLTEIQFLSRLHHR 567
+G+G V+ VK + G G+ F +R R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 568 NLVSLVGYCDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT 627
L L G + VY + N L + + AK + + + +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 628 EADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLD 687
+ H D+ N+L+ + + DF S I+ V ++
Sbjct: 121 --HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT------- 170
Query: 688 PEYFLTHKLTDKSDVYSLGVVFLE 711
+ + + D+ S L+
Sbjct: 171 ---YFSRTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.7 bits (216), Expect = 5e-19
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 15/194 (7%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
N+IS P I + +L+ L LNGN+L L L L + + N IS P
Sbjct: 205 TNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-- 258
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
+ L K + N IS P L+ L +L ++ L+ N L P L L L L
Sbjct: 259 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTL 314
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
NN + S+++KL +L N + L+ + N+ +L NQ++ P
Sbjct: 315 YFNNISD---ISPVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQISDLTPLA 370
Query: 181 RLSLNITTIKLSNN 194
L+ IT + L++
Sbjct: 371 NLT-RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.4 bits (210), Expect = 3e-18
Identities = 42/186 (22%), Positives = 65/186 (34%), Gaps = 31/186 (16%)
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
A L NN IS P + +L + L+ N L L+ L L L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLS---------------------R 159
NN A S ++KL +L L + P
Sbjct: 249 ANNQISN---LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 160 IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNS 219
+ NL YL L N ++ P L+ + + +NNK++ S+ + L + L +N
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLT-KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 220 LSGSIP 225
+S P
Sbjct: 363 ISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 7e-09
Identities = 54/286 (18%), Positives = 100/286 (34%), Gaps = 33/286 (11%)
Query: 13 IGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHM 72
+ + +L + + N+LT P L L KL I ++ N I+ P +
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 73 NNNSISGQIPP------------ELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQL 120
N + + +S + +L + G +L L L L+
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 121 DNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180
+ + + + + ++ L L N + P + NL L L+ NQL
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPL-GILTNLDELSLNGNQLKDIGTLA 238
Query: 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
L+ N+T + L+NN+++ P SGL +L L + N +S P + + T
Sbjct: 239 SLT-NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295
Query: 241 ---------------ILDFQNNNLTNISGSFNIPPNVTVRLRGNPF 271
L NN+++IS ++ + N
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKV 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 1e-04
Identities = 14/74 (18%), Positives = 31/74 (41%), Gaps = 4/74 (5%)
Query: 110 SELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLS 169
+ L + + L N T S +++ ++ L ++ + + + NL ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFS 74
Query: 170 SNQLNGSIPPGRLS 183
+NQL P L+
Sbjct: 75 NNQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 3e-04
Identities = 38/246 (15%), Positives = 80/246 (32%), Gaps = 27/246 (10%)
Query: 40 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 99
L + + + + ++ ++ ++ +L++ + I + L +L + NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 100 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSR 159
LT L L KL+ + ++NN T A+ +N++ L + + + +
Sbjct: 77 QLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 160 IPNLGYL--------------DLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFS 205
+ N L+ T +L + + S +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 206 GLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVR 265
L L+ L NN +S P I + L N L +I ++ +
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLD-------ELSLNGNQLKDIGTLASLTNLTDLD 247
Query: 266 LRGNPF 271
L N
Sbjct: 248 LANNQI 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 6e-19
Identities = 55/273 (20%), Positives = 111/273 (40%), Gaps = 23/273 (8%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
+PK++ LL L N++T + L L + + N IS P +FA L K
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEG 127
+++ N + +P ++ + + + N +T + L ++++++L N +
Sbjct: 82 ERLYLSKNQLKE-LPEKMPKTLQELRVH--ENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 128 TT-IPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-N 185
+ ++ M KL + + + ++ L P+L L L N++ L N
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNN 196
Query: 186 ITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 245
+ + LS N ++ + + P L+ L + NN L +P + + + ++
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ-----VVYLH 250
Query: 246 NNNLTNISGSFNIPPNV--------TVRLRGNP 270
NNN++ I + PP V L NP
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.3 bits (207), Expect = 3e-18
Identities = 54/267 (20%), Positives = 95/267 (35%), Gaps = 37/267 (13%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
NKI+ + N+K+L L+L N+++ P L KL+R+ + +N + LP+
Sbjct: 41 NKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP 99
Query: 63 NLNKTRHFHMN------------------------NNSISGQIPPELSRLPSLVHMLLDN 98
+ H N SG + L ++ + +
Sbjct: 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159
Query: 99 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLS 158
N+T +P L P L L LD N AS ++ L KL L S+
Sbjct: 160 TNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSL 215
Query: 159 R-IPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG------LPRLQ 211
P+L L L++N+L I + L NN ++ ++F
Sbjct: 216 ANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 275
Query: 212 RLFIANNSLS-GSIPSSIWQSRTLNAT 237
+ + +N + I S ++ + A
Sbjct: 276 GVSLFSNPVQYWEIQPSTFRCVYVRAA 302
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 85.6 bits (210), Expect = 1e-18
Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 9/250 (3%)
Query: 3 NKISG--SIPKEIGNIKSLELLLLNGNE-LTGSLPEELGYLPKLDRIQIDQNYISGSLPK 59
+ IP + N+ L L + G L G +P + L +L + I +SG++P
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 60 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
+ + + N++SG +PP +S LP+LV + D N ++G +P KL
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 179
+ N IP +++N++ RN N + L+ N L +
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 180 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239
LS N+ + L NN++ GT+P + L L L ++ N+L G IP + +
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFD---- 294
Query: 240 FILDFQNNNL 249
+ + NN
Sbjct: 295 -VSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 5e-10
Identities = 32/180 (17%), Positives = 65/180 (36%), Gaps = 6/180 (3%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
+N +SG++P I ++ +L + +GN ++G++P+ G KL L
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN---RLTGK 189
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDN--NNLTGYLPPELSELPKLLIL 118
+ + S + S + + N + ++ L L
Sbjct: 190 IPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL 249
Query: 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 178
L NN GT +P + + L L++ +L G +P + ++N+ P
Sbjct: 250 DLRNNRIYGT-LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.6 bits (88), Expect = 0.002
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 5/150 (3%)
Query: 86 SRLPSLVHMLLDNNNLTGY--LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKL 143
++ + ++ L NL +P L+ LP L L + N IP + + +++L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 144 SL-RNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIKLSNNKLTGTIP 201
+ LS+I L LD S N L+G++PP SL N+ I N+++G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 202 SNFSGLPRLQR-LFIANNSLSGSIPSSIWQ 230
++ +L + I+ N L+G IP +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (183), Expect = 2e-15
Identities = 43/245 (17%), Positives = 79/245 (32%), Gaps = 28/245 (11%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNE-------------------------LTGSLPEEL 37
N+IS ++L +L L+ N L P
Sbjct: 42 NRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATF 101
Query: 38 GYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97
L +L + +D+ + P F L ++ ++ +N++ L +L H+ L
Sbjct: 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161
Query: 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDL 157
N ++ L L L L N A + N P L
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 158 SRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 217
+ + L YL L+ N L + + S++++ ++P +G + +A
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAA 278
Query: 218 NSLSG 222
N L G
Sbjct: 279 NDLQG 283
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 5e-09
Identities = 23/107 (21%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGS 176
+L L + + T+ + + L L + L+ P L+ + L L S N +
Sbjct: 2 VLHLAHKDL---TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA-LEN 57
Query: 177 IPPGRLSLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSG 222
+ + + L NN+L + PRL L + NSL
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 1e-06
Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 5/110 (4%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
++ + + + L L+ N L P L L L+ + + + ANL +
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVL--QASDNALENVDGVANLPRL 67
Query: 68 RHFHMNNNSI-SGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 116
+ + NN + L P LV + L N+L L ++L
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 5e-05
Identities = 24/125 (19%), Positives = 46/125 (36%), Gaps = 29/125 (23%)
Query: 68 RHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL------------ 115
R H+ + ++ + L +L + H+ L +N L PP L+ L L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 116 ----------LILQLDNNNFEGTTIPASYSNMSKLLKLSLRN---CSLQGPMPDL-SRIP 161
L L NN + + + +L+ L+L+ C +G L +P
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 162 NLGYL 166
++ +
Sbjct: 118 SVSSI 122
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (123), Expect = 8e-08
Identities = 32/187 (17%), Positives = 52/187 (27%), Gaps = 22/187 (11%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKL-----DRIQIDQNYISGSLPK--- 59
++P ++ K +L L+ N L L +L DR ++ + + G+LP
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 60 ------------SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPP 107
+ + +P R + L N LPP
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141
Query: 108 ELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 167
L L NN + + L L L+ SL L +
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAF 201
Query: 168 LSSNQLN 174
L N
Sbjct: 202 LHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 39/210 (18%), Positives = 69/210 (32%), Gaps = 8/210 (3%)
Query: 12 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFH 71
E+ + S + + LT +LP +L + + +N + + + +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 72 MNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP 131
++ ++ LP L + L +N L + ++ + N +
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 132 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-NITTIK 190
A N P L+ P L L L++N L L N+ T+
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 191 LSNNKLTGTIPSNFSGLPRLQRLFIANNSL 220
L N L TIP F G L F+ N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 8e-07
Identities = 51/265 (19%), Positives = 88/265 (33%), Gaps = 22/265 (8%)
Query: 60 SFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119
+ + + + +++ +PP+L + L N L + L +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 179
LD + + + L + SL L + L L +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP--LGA 119
Query: 180 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATET 239
R + + L N+L P + P+L++L +ANN+L+ + L+
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD---- 175
Query: 240 FILDFQNNNLTNI-SGSFNIPPNVTVRLRGNPF-C----------LNTNAEQFCGSHSDD 287
L Q N+L I G F L GNP+ C L NAE
Sbjct: 176 -TLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGV 234
Query: 288 DNEIDRSTNSTLDCRAQSCPTDYEY 312
D + S +++ C Y+Y
Sbjct: 235 DVKAMTSNVASVQCDNSDKFPVYKY 259
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 8e-07
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 2/67 (2%)
Query: 153 PMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQR 212
P+ ++S++ + ++ L ++PP L + T + LS N L + RL +
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPD-LPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 213 LFIANNS 219
L +
Sbjct: 60 LNLDRAE 66
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 32/215 (14%), Positives = 66/215 (30%), Gaps = 17/215 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
+ ++ ++ + ++ + L G +T E + YL L +++ N I+ P
Sbjct: 29 SNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPLKNL 84
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
N I S + + L L L +
Sbjct: 85 TKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNI 144
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
+ G T S + + L+ + L L N+++ P L
Sbjct: 145 SPLAGLTNLQYLSIG----------NAQVSDLTPLANLSKLTTLKADDNKISDISPLASL 194
Query: 183 SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 217
N+ + L NN+++ P + L + + N
Sbjct: 195 P-NLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 32/201 (15%), Positives = 66/201 (32%), Gaps = 21/201 (10%)
Query: 40 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 99
L +I ++ ++ ++ + A+L+ ++ + L +L+ + L +N
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 100 NLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYS----------NMSKLLKLSLRNCS 149
+T P + L L + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 150 LQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL-----NITTIKLSNNKLTGTIPSNF 204
L + ++ I L L G+ L+ +TT+K +NK++ P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 205 SGLPRLQRLFIANNSLSGSIP 225
+ LP L + + NN +S P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 4/98 (4%)
Query: 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177
L L N S ++ + P+ + + ++DLS++ + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 178 PPGRLSL--NITTIKLSNNKLTGTIPSNFSGLPRLQRL 213
G LS + + L +L+ I + + L RL
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 20/95 (21%), Positives = 38/95 (40%), Gaps = 3/95 (3%)
Query: 74 NNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPAS 133
++ + L ++ + + L S ++ + L N+ E +T+
Sbjct: 9 GKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGI 66
Query: 134 YSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLD 167
S SKL LSL L P+ + L++ NL L+
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 6/93 (6%)
Query: 162 NLGYLDLSSNQLNGSIPPGRLSL--NITTIKLSNNKLTG----TIPSNFSGLPRLQRLFI 215
++ LD+ +L+ + L L ++L + LT I S P L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 216 ANNSLSGSIPSSIWQSRTLNATETFILDFQNNN 248
+N L + Q + + L QN
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 12/72 (16%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 183 SLNITTIKLSNNKLTGT-IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFI 241
SL+I ++ + +L+ L + Q + + + L+ + I + +N
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE- 59
Query: 242 LDFQNNNLTNIS 253
L+ ++N L ++
Sbjct: 60 LNLRSNELGDVG 71
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 7e-05
Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 68 RHFHMNNNSISGQIPPEL-SRLPSLVHMLLDNNNLTG----YLPPELSELPKLLILQLDN 122
+ + +S EL L + LD+ LT + L P L L L +
Sbjct: 5 QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64
Query: 123 NNFEGTTIP----ASYSNMSKLLKLSLRNC 148
N + + K+ KLSL+NC
Sbjct: 65 NELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 16/91 (17%), Positives = 25/91 (27%), Gaps = 11/91 (12%)
Query: 115 LLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLDLS 169
+ L + + + + L +C L L P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 170 SNQLNGSIPPG------RLSLNITTIKLSNN 194
SN+L S I + L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 8/73 (10%), Positives = 25/73 (34%), Gaps = 4/73 (5%)
Query: 185 NITTIKLSNNKLTGT----IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240
+ + L++ ++ + + + L+ L ++NN L + + +S
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 241 ILDFQNNNLTNIS 253
L + +
Sbjct: 430 QLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 20/102 (19%), Positives = 31/102 (30%), Gaps = 17/102 (16%)
Query: 131 PASYSNMSKLLKLSLRNCSLQGPMPD-----LSRIPNLGYLDLSSNQLNGSIPPG----- 180
S L L L +C + L +L LDLS+N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 181 -RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
+ + + L + + + RLQ L SL
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 9e-04
Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 10/93 (10%)
Query: 43 LDRIQIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLD 97
+ + I +S + + L + + +++ ++ I L P+L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 98 NNNLTGYLPPELSEL-----PKLLILQLDNNNF 125
+N L + + K+ L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 11/84 (13%), Positives = 28/84 (33%), Gaps = 5/84 (5%)
Query: 2 WNKISGSIPKEI-GNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYISGS 56
++S + E+ ++ +++ L+ LT + L P L + + N +
Sbjct: 11 CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV 70
Query: 57 LPKSFANLNKTRHFHMNNNSISGQ 80
+T + S+
Sbjct: 71 GVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 8e-07
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 12/102 (11%)
Query: 69 HFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT 128
N+ S +I PSL + + NN L LP + P+L L N+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL--A 317
Query: 129 TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSS 170
+P L +L + L+ PD+ ++ L ++S
Sbjct: 318 EVPEL---PQNLKQLHVEYNPLRE-FPDI--PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 9/84 (10%)
Query: 147 NCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSG 206
N S P+L L++S+N+L +P L + S N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL--ERLIASFNHLA-EVPEL--- 322
Query: 207 LPRLQRLFIANNSLSG--SIPSSI 228
L++L + N L IP S+
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 21/91 (23%), Positives = 35/91 (38%), Gaps = 9/91 (9%)
Query: 1 MWNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKS 60
N S I SLE L ++ N+L LP L +L N+++ +P+
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPEL 322
Query: 61 FANLNKTRHFHMNNNSISGQIPPELSRLPSL 91
NL + H+ N + + P + L
Sbjct: 323 PQNL---KQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 42/207 (20%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 26 GNELTGSLPEELGY------LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISG 79
G+E ++P + + + + + ++ ++ ++ LN NN+ I
Sbjct: 4 GSETI-TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60
Query: 80 QIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSK 139
+ LP++ + L+ N LT L+ L L L LD N + + +
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116
Query: 140 LLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 199
L + G L +P L L L +N++ RL+ + T+ L +N+++
Sbjct: 117 LSLEHNGISDING----LVHLPQLESLYLGNNKITDITVLSRLT-KLDTLSLEDNQISDI 171
Query: 200 IPSNFSGLPRLQRLFIANNSLSGSIPS 226
+P +GL +LQ L+++ N +S + +
Sbjct: 172 VP--LAGLTKLQNLYLSKNHIS-DLRA 195
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 32/191 (16%), Positives = 76/191 (39%), Gaps = 15/191 (7%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
++ ++ + + S++ ++ N +++ + YLP + ++ ++ N ++ K A
Sbjct: 34 KSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD--IKPLA 87
Query: 63 NLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDN 122
NL ++ N + + L + +L +++ L L L+
Sbjct: 88 NLKNLGWLFLDENKVKDLSSLK-------DLKKLKSLSLEHNGISDINGLVHLPQLESLY 140
Query: 123 NNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRL 182
T S ++KL LSL + + + L+ + L L LS N ++ L
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHISDLRALAGL 199
Query: 183 SLNITTIKLSN 193
N+ ++L +
Sbjct: 200 K-NLDVLELFS 209
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 6/125 (4%)
Query: 105 LPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLG 164
L +S+ LD + + L+ R+ IP L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL---RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 165 YLDLSSNQLNGSIPPGRLS---LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
L+LS+N+L + N+ + LS N+L + +L+ L++ NSLS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 222 GSIPS 226
+
Sbjct: 129 DTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 3e-04
Identities = 25/162 (15%), Positives = 51/162 (31%), Gaps = 22/162 (13%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKT 67
+ + L+ L +L + + + +L N+ +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 68 RHFHMNNNSISGQ--IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNF 125
+++NN + + + + P+L + L N L + + KL L LD N+
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 126 EGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLD 167
T + +S + + R P L LD
Sbjct: 128 S-DTFRDQSTYISAIRE----------------RFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 11/109 (10%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTG--SLPEELGYLPKLDRIQIDQNYISGSLPKS 60
+ ++ ++ NI L L L+ N L + + P L + + N +
Sbjct: 51 SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELD 110
Query: 61 FANLNKTRHFHMNNNSISGQIPPE-------LSRLPSLVHMLLDNNNLT 102
K ++ NS+S + R P L+ LD + L
Sbjct: 111 KIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR--LDGHELP 157
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 30/224 (13%), Positives = 62/224 (27%), Gaps = 10/224 (4%)
Query: 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLP---KLDRIQIDQNYISGSLPKSFANL 64
IP ++ ++ L +L K++ Q D + + S
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 65 NKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNN 124
NN + + ++ + ++ L K+L+ DN N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 125 FEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSL 184
+ + + L L +Q L L+LS N +P
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 185 --NITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPS 226
+ +S ++ L +L+ N +P+
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 166 LDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIP 225
+++ IP L N ++ KL FSG L+++ I+ N + I
Sbjct: 13 FLCQESKVT-EIPSD-LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70
Query: 226 SSIWQ 230
+ ++
Sbjct: 71 ADVFS 75
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 21/147 (14%), Positives = 37/147 (25%), Gaps = 3/147 (2%)
Query: 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLK 142
P+ + + L L L ++N + +L
Sbjct: 2 PDACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 143 LSLRNCSLQGP-MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTI- 200
L++ L+ P L L+LS N L L++ + LS N L +
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 201 PSNFSGLPRLQRLFIANNSLSGSIPSS 227
+ L
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGP 147
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 14/90 (15%), Positives = 27/90 (30%), Gaps = 13/90 (14%)
Query: 69 HFHMNNNSISGQIPPELSR------LPSLVHMLLDNNNLTGYLPPELSE-----LPKLLI 117
+N+ +S + + L + L N + L +P LL
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 118 LQLDNNNFEGTTIPASYSNMSKLLKLSLRN 147
L+L+ N F + ++ R
Sbjct: 307 LELNGNRFSE--EDDVVDEIREVFSTRGRG 334
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 21/120 (17%), Positives = 43/120 (35%), Gaps = 7/120 (5%)
Query: 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFA 62
KI I + + + + NE+ + L +L + ++ N I
Sbjct: 28 YKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNNRICRIGEGLDQ 84
Query: 63 NLNKTRHFHMNNNSISG-QIPPELSRLPSLVHMLLDNNN---LTGYLPPELSELPKLLIL 118
L + NNS+ L+ L SL ++ + N Y + ++P++ +L
Sbjct: 85 ALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 132 ASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKL 191
A Y+N + +L LR + + + +D S N++ L + T+ +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLR-RLKTLLV 70
Query: 192 SNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221
+NN++ LP L L + NNSL
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 34/199 (17%), Positives = 68/199 (34%), Gaps = 15/199 (7%)
Query: 15 NIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNN 74
+ +L +T ++ + L ++ +Q D+ I S+ LN + +N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 75 NSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASY 134
N ++ P L ++ + L L F
Sbjct: 72 NQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 135 SNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNN 194
L + + + LS + +L L+ SSNQ+ P L+ + + +S+N
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLT-TLERLDISSN 182
Query: 195 KLTGTIPSNFSGLPRLQRL 213
K++ S + L L+ L
Sbjct: 183 KVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 24/182 (13%), Positives = 57/182 (31%), Gaps = 16/182 (8%)
Query: 3 NKISGSIP-KEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSF 61
++ ++ ++ + +L+ L + G + YL L +I N ++ P
Sbjct: 28 TNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITPLKN 82
Query: 62 ANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121
+ N + + + + + L+ L D
Sbjct: 83 LTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD 142
Query: 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGR 181
+ G T + + + P L+ + L LD+SSN+++ +
Sbjct: 143 ISALSGLTSLQQLNFS---------SNQVTDLKP-LANLTTLERLDISSNKVSDISVLAK 192
Query: 182 LS 183
L+
Sbjct: 193 LT 194
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 843 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.65 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.34 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.33 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.8 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.38 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.25 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.84 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.22 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.02 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 95.46 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 92.17 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 84.5 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 80.65 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=430.18 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=208.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999975 68999999987432 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|||++|+|.+++.... .+++..++.++.||++||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997654 4889999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
......||+.|||||++.+..++.++|||||||++|||++|+.||..... .+..... .. ..
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i---------~~-~~ 220 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYKRI---------SR-VE 220 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHH---------HT-TC
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-HHHHHHH---------Hc-CC
Confidence 22445799999999999999999999999999999999999999965432 1111110 00 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
..+|+. .++.+.+|+.+||..||++|||++|+|+||||+++
T Consensus 221 ~~~p~~---------------------------------------~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 221 FTFPDF---------------------------------------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CCCCTT---------------------------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCCCcc---------------------------------------CCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 111111 12223467888899999999999999999999875
Q ss_pred C
Q 003158 827 V 827 (843)
Q Consensus 827 ~ 827 (843)
.
T Consensus 262 s 262 (263)
T d2j4za1 262 S 262 (263)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=450.76 Aligned_cols=292 Identities=22% Similarity=0.366 Sum_probs=214.6
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++.... ...+++.+|+++|+.++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999964 789999999975433 33568899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||++|+|.+++.+.. .+++..++.++.|+++||.|||++ + |+||||||+|||+++++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999997654 488999999999999999999974 7 99999999999999999999999999986531
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|||||++.+..|+.++||||+||++|||++|+.||........+.... ....+.
T Consensus 158 --------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~-------~~~~~~ 222 (322)
T d1s9ja_ 158 --------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG-------CQVEGD 222 (322)
T ss_dssp --------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred --------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------HHhcCC
Confidence 12244679999999999999999999999999999999999999998655432221110 000000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCC------CCCCCccccCCCCCCCCCCCCCccCCC
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPES------DTKTPEFINSEHTSKEETPPSSSSMLK 819 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~------~~~~~dll~~~L~~dp~~R~sa~e~L~ 819 (843)
. ...+.................+|... ..+.+..+....+.. +.++.||+.+||++||++||||+|+|+
T Consensus 223 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 223 A----AETPPRPRTPGRPLSSYGMDSRPPMA-IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------------------CCCC-HHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c----ccCCcccccccccccccccccccchh-HHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 01111111111222222333343322 112222222222211 234568999999999999999999999
Q ss_pred CCcccCC
Q 003158 820 HPYVSSD 826 (843)
Q Consensus 820 Hp~f~~~ 826 (843)
||||+..
T Consensus 298 Hpf~~~~ 304 (322)
T d1s9ja_ 298 HAFIKRS 304 (322)
T ss_dssp SHHHHHH
T ss_pred CHhhCcC
Confidence 9999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=428.84 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=210.9
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++++.++||||+++++++.+++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999996 479999999998655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+++.+. .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc---
Confidence 999999988653 4889999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....
T Consensus 171 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~------------------ 227 (293)
T d1yhwa1 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYL------------------ 227 (293)
T ss_dssp ----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH------------------
T ss_pred ----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHH------------------
Confidence 22344579999999999999999999999999999999999999997544211 1111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCCC
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDVS 828 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~~ 828 (843)
+... ..|.- +.. +..++.+.+||.+||..||++|+||+|+|+||||+....
T Consensus 228 ----------~~~~---~~~~~-~~~--------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~ 278 (293)
T d1yhwa1 228 ----------IATN---GTPEL-QNP--------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (293)
T ss_dssp ----------HHHH---CSCCC-SSG--------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ----------HHhC---CCCCC-CCc--------------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence 0000 00000 000 001222346788889999999999999999999976443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=430.53 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=221.2
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+++..++|++.+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 334456888999999999999999999888999999997543 345689999999999999999999998865 567999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
|||+++|+|.+++......++++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 99999999999887655556899999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
. ........||+.|+|||++.+..++.++|||||||++|||+||..|+.......+... .+..+.
T Consensus 163 ~------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---------~i~~~~ 227 (272)
T d1qpca_ 163 E------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---------NLERGY 227 (272)
T ss_dssp C------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---------HHHTTC
T ss_pred c------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH---------HHHhcC
Confidence 2 1223345689999999999999999999999999999999997666655444332222 223334
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
....|..+++++.+++.+||+.+|++|||+.++++.|+++...
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 4455677888999999999999999999999999999988653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-51 Score=432.15 Aligned_cols=266 Identities=29% Similarity=0.461 Sum_probs=226.6
Q ss_pred HHHHHHHHcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 003158 503 YGEMALATNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGE 581 (843)
Q Consensus 503 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 581 (843)
+++|++..++|++.+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3455566778999999999999999999975 58999999987543 345689999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++|||||++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999998877778999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
..... ........|++.|+|||++.+..++.++|||||||++|||++|..||....+....... +
T Consensus 165 ~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~---------i 229 (287)
T d1opja_ 165 MTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---------L 229 (287)
T ss_dssp CCSSS------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---------H
T ss_pred cCCCC------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH---------H
Confidence 64322 22334456899999999999999999999999999999999988887665543332221 1
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
..+.....|..+++++.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1223345667788899999999999999999999999999987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=428.67 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=206.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999974 699999999875433 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|+|.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 9999999999643 46899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.........||+.|||||++.+..+ +.++||||+||++|||+||+.||....+..........
T Consensus 158 ---~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~------------- 221 (271)
T d1nvra_ 158 ---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------- 221 (271)
T ss_dssp ---EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-------------
T ss_pred ---ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Confidence 1122345679999999999998876 57899999999999999999999754432111111000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
.+...+.. +..++.+.+|+.+||..||++|||++|+|+||||+...
T Consensus 222 --------------------~~~~~~~~--------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 222 --------------------KKTYLNPW--------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp --------------------TCTTSTTG--------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --------------------CCCCCCcc--------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 00000000 01122334788889999999999999999999998654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=427.09 Aligned_cols=266 Identities=26% Similarity=0.462 Sum_probs=212.6
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEG--SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
+..++|++.+.||+|+||+||+|+++ ..||||+++.. .....++|.+|++++++++||||+++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34578999999999999999999864 35999998743 23445789999999999999999999998864 568999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||||++|+|.+++.... ..+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999997543 45899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.. ........||+.|||||++.+ ..++.++|||||||++|||+||+.||............. .. ...
T Consensus 158 ~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~-~~----~~~ 227 (276)
T d1uwha_ 158 SG-----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-GR----GYL 227 (276)
T ss_dssp -------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-HH----TSC
T ss_pred CC-----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH-hc----CCC
Confidence 21 222345679999999999975 358899999999999999999999998655433222111 11 111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCC
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMP 790 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~ 790 (843)
.+.....+.++++++.+++.+||+.+|.+|||+.++++.|+.+.+.+|
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 112223456677889999999999999999999999999999887665
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=422.40 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=208.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
++|+..+.||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468888999999999999999988999999999763 3345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~---- 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 155 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC----
Confidence 99999998654 345889999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
........||+.|+|||++.+..++.++|||||||++|||+|+..|+.......+... .+..+.....|
T Consensus 156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~---------~i~~~~~~~~p 224 (263)
T d1sm2a_ 156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---------DISTGFRLYKP 224 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH---------HHHHTCCCCCC
T ss_pred --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH---------HHHhcCCCCCc
Confidence 1222345689999999999999999999999999999999996555544443333222 12223334456
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
..+++++.+++.+||+.+|++||+++++++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 6778899999999999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=426.96 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=208.4
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+.|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++||||+++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999964 68999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+++.+.. .++++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 9999999986543 45899999999999999999999999 999999999999999999999999999754311
Q ss_pred cccceeeeeecccCCccCchhcc-----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
........||+.|+|||++. +..++.++|||||||++|||+||+.||........ . ..+...
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~---------~~i~~~ 230 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-L---------LKIAKS 230 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H---------HHHHHS
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-H---------HHHHcC
Confidence 11223467999999999984 45688999999999999999999999975432111 0 011111
Q ss_pred CCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCc
Q 003158 745 NMG--SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPY 822 (843)
Q Consensus 745 ~~~--~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~ 822 (843)
..+ ..+.. .++.+.+||.+||+.||++|||++|+|+|||
T Consensus 231 ~~~~~~~~~~---------------------------------------~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 231 EPPTLAQPSR---------------------------------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp CCCCCSSGGG---------------------------------------SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred CCCCCCcccc---------------------------------------CCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000 00111 1223346788888999999999999999999
Q ss_pred ccCCC
Q 003158 823 VSSDV 827 (843)
Q Consensus 823 f~~~~ 827 (843)
|+.+.
T Consensus 272 ~~~~~ 276 (288)
T d2jfla1 272 VTVDS 276 (288)
T ss_dssp GCCCC
T ss_pred cCCCC
Confidence 98653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-50 Score=430.64 Aligned_cols=272 Identities=21% Similarity=0.353 Sum_probs=221.0
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4689999999999999999996 469999999987432 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|||+||+|..++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999987654 4678888899999999999999999 999999999999999999999999999876421
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.....||+.|||||++.+..++.++||||+||++|||++|+.||..... .+.... +..+ .
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~---------i~~~-~ 217 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEK---------ILNA-E 217 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHH---------HHHC-C
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-HHHHHH---------HHcC-C
Confidence 2346799999999999999999999999999999999999999976542 221111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
..+|...++++.+++.+|+..+|.+|+ +..|+|++|+|+||||++.
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~----------------------------------~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRL----------------------------------GNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCT----------------------------------TSSTTTTHHHHTSGGGSSC
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhcc----------------------------------ccchhhHHHHHcCcccccC
Confidence 233445566777788888888888876 2357899999999999887
Q ss_pred CCCCccccccCCCCCC
Q 003158 827 VSGSNLVSGVIPTITP 842 (843)
Q Consensus 827 ~~~~~~~~~~~~~~~~ 842 (843)
.+.........|++.|
T Consensus 264 ~~~~l~~~~~~~p~~p 279 (316)
T d1fota_ 264 VWEKLLSRNIETPYEP 279 (316)
T ss_dssp CHHHHHTTCSCCSCCC
T ss_pred CHHHHHhCCCCcCCCC
Confidence 6543333444444443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=425.40 Aligned_cols=259 Identities=19% Similarity=0.312 Sum_probs=207.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999964 799999999874322 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987654 5889999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +... .
T Consensus 163 ~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~---------i~~~-~ 226 (288)
T d1uu3a_ 163 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQK---------IIKL-E 226 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH---------HHTT-C
T ss_pred c-----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-HHHHHH---------HHcC-C
Confidence 1 1223445799999999999999999999999999999999999999975432 111110 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC------CCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM------LKH 820 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~------L~H 820 (843)
..+|.. .++.+.|||++||+.||++|+|++|+ ++|
T Consensus 227 ~~~p~~---------------------------------------~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~H 267 (288)
T d1uu3a_ 227 YDFPEK---------------------------------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267 (288)
T ss_dssp CCCCTT---------------------------------------CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred CCCCcc---------------------------------------CCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcC
Confidence 111111 12223468888888888888888885 779
Q ss_pred CcccCCCCC
Q 003158 821 PYVSSDVSG 829 (843)
Q Consensus 821 p~f~~~~~~ 829 (843)
|||++-.+.
T Consensus 268 pff~~i~w~ 276 (288)
T d1uu3a_ 268 PFFESVTWE 276 (288)
T ss_dssp GGGTTCCCT
T ss_pred CccCCCCHH
Confidence 999887654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=423.40 Aligned_cols=261 Identities=27% Similarity=0.451 Sum_probs=204.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DG---TVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
++|++.+.||+|+||+||+|.++ ++ ..||||.+.... ....++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34556689999999999999974 23 368999987543 33457899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||||++|+|.+++... ...+++.++..++.||++||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999988654 345899999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
.... .........||+.|||||.+.+..++.++|||||||++|||+| |+.||...... +.. ..+..+
T Consensus 182 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~---------~~i~~~ 249 (299)
T d1jpaa_ 182 TSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVI---------NAIEQD 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHH---------HHHHTT
T ss_pred CCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-HHH---------HHHHcC
Confidence 2110 0112233458899999999999999999999999999999998 89999765431 111 122233
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
...+.|.++++.+.+++.+||+.+|.+||++.++++.|+++.+
T Consensus 250 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 4445677788899999999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=412.25 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=217.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMS 590 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 590 (843)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57899999999999999999998899999999986443 45689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCc
Q 003158 591 NGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGI 670 (843)
Q Consensus 591 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 670 (843)
+|+|.+++.... ..+++..+++++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+......
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~---- 154 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---- 154 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS----
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC----
Confidence 999999976543 35788999999999999999999999 9999999999999999999999999998765332
Q ss_pred ccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 671 VPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 671 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... + +. ..+..+.....
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~-~~--------~~i~~~~~~~~ 222 (258)
T d1k2pa_ 155 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-E-TA--------EHIAQGLRLYR 222 (258)
T ss_dssp --CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-H-HH--------HHHHTTCCCCC
T ss_pred --ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-H-HH--------HHHHhCCCCCC
Confidence 112234568999999999999999999999999999999998 89999765432 1 11 12333444556
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELES 784 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~ 784 (843)
|..+++++.+++.+||+.+|++||+++++++.|.+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 77788899999999999999999999999998865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=431.89 Aligned_cols=201 Identities=26% Similarity=0.346 Sum_probs=179.4
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999996 479999999997532 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|||++|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++++|.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999997754 4788899999999999999999999 9999999999999999999999999998654321
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
.......||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 160 -------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 160 -------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp -------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 22345679999999999999999999999999999999999999997654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=432.44 Aligned_cols=272 Identities=20% Similarity=0.280 Sum_probs=218.0
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999964 799999999864321 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999997654 4889999999999999999999999 999999999999999999999999999876421
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... ....... .. ..
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i---------~~-~~ 254 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKI---------VS-GK 254 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH---------HH-CC
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-HHHHHHH---------hc-CC
Confidence 2345799999999999999999999999999999999999999975432 2221111 11 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
..+|..+++++.+++.+|+..||.+|+ +..|+|++|+++||||++.
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~----------------------------------~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRF----------------------------------GNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCT----------------------------------TSSTTTTHHHHTSGGGTTC
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhcc----------------------------------ccccccHHHHHcCccccCC
Confidence 223444556666677777777776664 2336799999999999886
Q ss_pred CCCCccccccCCCCCC
Q 003158 827 VSGSNLVSGVIPTITP 842 (843)
Q Consensus 827 ~~~~~~~~~~~~~~~~ 842 (843)
.+.........|++.|
T Consensus 301 ~~~~~~~~~~~~p~~p 316 (350)
T d1rdqe_ 301 DWIAIYQRKVEAPFIP 316 (350)
T ss_dssp CHHHHHTTCSCCSCCC
T ss_pred CHHHHHhcCCCcCccC
Confidence 6543333333344443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-50 Score=426.12 Aligned_cols=260 Identities=23% Similarity=0.393 Sum_probs=194.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
.+.|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|+.++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999965 6899999999764433 34578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc---CCCcEEEeeccccccCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD---HKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~~~ 664 (843)
||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999654 45899999999999999999999999 99999999999995 578999999999986542
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. .......||+.|||||++.+..++.++||||+||++|||++|+.||....... .... +...
T Consensus 163 ~--------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~---------i~~~ 224 (307)
T d1a06a_ 163 G--------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQ---------ILKA 224 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH---------HHTT
T ss_pred C--------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHH---------Hhcc
Confidence 2 22344579999999999999999999999999999999999999997543211 1110 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
... . ..| ..+..++.+.+|+.+||..||++|||++|+|+||||+
T Consensus 225 ~~~-------------------~---~~~--------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 225 EYE-------------------F---DSP--------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp CCC-------------------C---CTT--------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred CCC-------------------C---CCc--------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 000 0 000 0011122344788889999999999999999999998
Q ss_pred CCCC
Q 003158 825 SDVS 828 (843)
Q Consensus 825 ~~~~ 828 (843)
++..
T Consensus 269 ~~~~ 272 (307)
T d1a06a_ 269 GDTA 272 (307)
T ss_dssp SSCC
T ss_pred CCCc
Confidence 7554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=418.29 Aligned_cols=260 Identities=30% Similarity=0.446 Sum_probs=215.3
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+..++|++.+.||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 345689999999999999999999988889999999754 3345789999999999999999999999854 56899999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+++|+|.+++.......+++..++.++.||++||+|||+++ |+||||||+|||+++++++||+|||+|+......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence 999999999997765567999999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
........||+.|+|||++.+..++.++|||||||++|||++|..|+.......+.... +..+...
T Consensus 168 -----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---------i~~~~~~ 233 (285)
T d1fmka3 168 -----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------VERGYRM 233 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCC
T ss_pred -----ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---------HHhcCCC
Confidence 12234456899999999999999999999999999999999987777665544333322 2223334
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+.+..+++++.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 5667788899999999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.8e-49 Score=428.47 Aligned_cols=259 Identities=21% Similarity=0.384 Sum_probs=213.1
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++||||+++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999996 479999999998766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc--CCCcEEEeeccccccCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD--HKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~~~~~ 667 (843)
++|+|.+++... ..++++..++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999999987543 346999999999999999999999999 99999999999998 6789999999999876532
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ....
T Consensus 183 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~----------------- 238 (352)
T d1koba_ 183 ------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQ----------------- 238 (352)
T ss_dssp ------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH-----------------
T ss_pred ------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHH-----------------
Confidence 2345567999999999999999999999999999999999999999754421 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
-+..+--.-|.. ..+..++.+.+||.+||+.||++|+|++|+|+||||+++.
T Consensus 239 ------------~i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 239 ------------NVKRCDWEFDED----------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp ------------HHHHCCCCCCSS----------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ------------HHHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 011110000100 0111233345789999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=415.84 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=214.8
Q ss_pred cCCCCCC-cccccCCeeEEEEEeC---CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSST-QIGQGGYGKVYKGILP---DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
++|.+.+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999864 35689999997643 3345789999999999999999999999865 568999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||||++|+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999998553 346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
+.. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.. ..+..+
T Consensus 163 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~---------~~i~~~ 228 (285)
T d1u59a_ 163 DSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVM---------AFIEQG 228 (285)
T ss_dssp SCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHH---------HHHHTT
T ss_pred ccc----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHH---------HHHHcC
Confidence 211 112234568899999999999999999999999999999998 89999765432 111 123344
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.....|+.+++++.+++..||+.+|++||++.++++.|+....
T Consensus 229 ~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4556677888999999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=414.41 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=197.2
Q ss_pred CCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec----CCcEEEEE
Q 003158 514 NSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE----EGEQMLVY 586 (843)
Q Consensus 514 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~ 586 (843)
+..++||+|+||+||+|... +++.||+|++.... ....+.+.+|+++|++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44567999999999999965 68899999987532 3335678999999999999999999999854 34679999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEc-CCCcEEEeeccccccCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLD-HKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~ 665 (843)
||+++|+|.+++.+.. .+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 9999999999997653 5889999999999999999999875 5599999999999997 578999999999986432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
.......||+.|||||++.+ +++.++|||||||++|||++|+.||....+........ ..+.
T Consensus 168 --------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i---------~~~~ 229 (270)
T d1t4ha_ 168 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------TSGV 229 (270)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---------TTTC
T ss_pred --------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH---------HcCC
Confidence 12345679999999999865 69999999999999999999999997554332211110 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCccc
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVS 824 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~ 824 (843)
. + +.. .....+++.+++.+||..||++|||++|+|+||||+
T Consensus 230 ~---~----------------------~~~-------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 230 K---P----------------------ASF-------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp C---C----------------------GGG-------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred C---C----------------------ccc-------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0 0 000 001122234678888889999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=416.07 Aligned_cols=206 Identities=27% Similarity=0.445 Sum_probs=166.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeec--CCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE--EGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV 585 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999964 799999999876432 234678999999999999999999999864 4568999
Q ss_pred EecCCCCCHHHHHhhc--CCCCcchhHHHHHHHHHHHHHHHHhcCC--CCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 586 YEFMSNGTLRDQLSAK--SKEPLGFAMRLSIALGSSRGILYLHTEA--DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
||||++|+|.+++.+. ....+++..++.++.||+.||+|||+++ ..+||||||||+|||+++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998652 3456999999999999999999999865 23599999999999999999999999999987
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCc
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGK 723 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~ 723 (843)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 164 ~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 164 LNHDT-------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp C------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCC-------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 64321 22345679999999999999999999999999999999999999997543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-49 Score=429.32 Aligned_cols=260 Identities=22% Similarity=0.360 Sum_probs=211.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999964 7999999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC--CCcEEEeeccccccCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH--KFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~ 666 (843)
|++|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.....
T Consensus 105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999999999653 345999999999999999999999999 999999999999964 678999999999876432
Q ss_pred CCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|||||++.+..++.++||||+||++|||++|+.||..... .+....
T Consensus 180 -------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~--------------- 236 (350)
T d1koaa2 180 -------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRN--------------- 236 (350)
T ss_dssp -------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH---------------
T ss_pred -------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHH---------------
Confidence 223456799999999999999999999999999999999999999975432 111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
+..+-..-+.. ..+..++.+.+||.+||..||++|||++|+|+||||+..
T Consensus 237 --------------i~~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 237 --------------VKSCDWNMDDS----------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp --------------HHHTCCCSCCG----------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred --------------HHhCCCCCCcc----------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11110000000 001112233468888889999999999999999999764
Q ss_pred C
Q 003158 827 V 827 (843)
Q Consensus 827 ~ 827 (843)
.
T Consensus 287 ~ 287 (350)
T d1koaa2 287 N 287 (350)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=412.55 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=210.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCC-----cEEEEEEeccCCh-hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDG-----TVVAVKRAQEGSL-QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
+.|+..+.||+|+||+||+|.+++. ..||||++..... ...++|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997532 4799999975433 335679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|||||.+|++.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999988654 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
... .........||+.|||||++.+..++.++|||||||++|||++|..|+.......+... .+.++
T Consensus 163 ~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---------~i~~~ 229 (283)
T d1mqba_ 163 DPE----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---------AINDG 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---------HHHTT
T ss_pred CCc----cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH---------HHhcc
Confidence 221 11223345689999999999999999999999999999999997777665544332222 23334
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 745 NMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
...+.|.+++.++.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 4556677788999999999999999999999999999998765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=411.37 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=206.1
Q ss_pred CcccccCCeeEEEEEeCC---CcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecCCC
Q 003158 517 TQIGQGGYGKVYKGILPD---GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFMSN 591 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 591 (843)
++||+|+||+||+|.+++ ++.||||+++.... ...++|.+|+++|++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 56899999975332 235689999999999999999999999965 567899999999
Q ss_pred CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcc
Q 003158 592 GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIV 671 (843)
Q Consensus 592 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 671 (843)
|+|.++++.. .++++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~---- 162 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---- 162 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS----
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc----
Confidence 9999999764 35899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCCCCC
Q 003158 672 PAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSYP 750 (843)
Q Consensus 672 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (843)
.........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... + +. ..+..+...+.|
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~-~~--------~~i~~~~~~~~p 232 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E-VT--------AMLEKGERMGCP 232 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-H-HH--------HHHHTTCCCCCC
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-H-HH--------HHHHcCCCCCCC
Confidence 1122334568999999999999999999999999999999998 89999765421 1 11 122234455667
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 751 SECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 751 ~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
..+++++.+++.+||+.+|++||+++++++.|+.++.
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 7888999999999999999999999999999988653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=416.78 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=209.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh------hhHHHHHHHHHHHHhccCCcccceeeeeecCCcE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL------QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQ 582 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 582 (843)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++||||+++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999997 4799999999874322 2357899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC----cEEEeeccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF----TAKVADFGL 658 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGl 658 (843)
++|||||++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997654 5899999999999999999999999 99999999999998776 599999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMM 738 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 738 (843)
|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....
T Consensus 164 a~~~~~~--------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~------- 227 (293)
T d1jksa_ 164 AHKIDFG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLAN------- 227 (293)
T ss_dssp CEECTTS--------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-------
T ss_pred hhhcCCC--------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHHH-------
Confidence 9876432 2233456899999999999999999999999999999999999999754321 11110
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCC
Q 003158 739 FSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSML 818 (843)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L 818 (843)
+... ...++... .+..++.+.+||++||..||++|||++|+|
T Consensus 228 --i~~~-~~~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 228 --VSAV-NYEFEDEY-----------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp --HHTT-CCCCCHHH-----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred --HHhc-CCCCCchh-----------------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0000 00111100 012233345789999999999999999999
Q ss_pred CCCcccCCCC
Q 003158 819 KHPYVSSDVS 828 (843)
Q Consensus 819 ~Hp~f~~~~~ 828 (843)
+||||+....
T Consensus 270 ~hp~~~~~~~ 279 (293)
T d1jksa_ 270 QHPWIKPKDT 279 (293)
T ss_dssp HSTTTCC---
T ss_pred cCcccCCCCh
Confidence 9999986544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=417.38 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=202.3
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh---hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 586 (843)
+.|+..+.||+|+||+||+|+. .+|+.||||++...... ..+++.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4689999999999999999996 47899999998754332 3467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPD 666 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 666 (843)
|||++|+|..++..+ .++++..++.++.||++||.|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999998776543 45899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCcccceeeeeecccCCccCchhccc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 667 IEGIVPAHVSTVVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... .... +..
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~---------i~~ 228 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYH---------IAQ 228 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH---------HHH
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHH---------HHh
Confidence 123469999999999964 458999999999999999999999997543211 1111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
... |...+ ...++.+.+|+.+||..||++||||+|+|+||||
T Consensus 229 ~~~----------------------~~~~~----------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 229 NES----------------------PALQS----------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp SCC----------------------CCCSC----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CCC----------------------CCCCC----------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 111 11000 0011223367777888888888899999999999
Q ss_pred cCCC
Q 003158 824 SSDV 827 (843)
Q Consensus 824 ~~~~ 827 (843)
....
T Consensus 271 ~~~~ 274 (309)
T d1u5ra_ 271 LRER 274 (309)
T ss_dssp HSCC
T ss_pred cCCC
Confidence 7644
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-48 Score=423.69 Aligned_cols=270 Identities=22% Similarity=0.315 Sum_probs=206.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHH---HHHHHHhccCCcccceeeeeecCCcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSL---QGEKEFLT---EIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+ |+++++.++||||+++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999965 699999999864322 12233444 466777788999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+|||||++|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997654 4788999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchH-HHHHHHhhcccchhh
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIV-REVNIAYQSSMMFSV 741 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~ 741 (843)
.. ......||+.|+|||++.. ..++.++|||||||++|||+||+.||....... .... ..
T Consensus 159 ~~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---------~~ 220 (364)
T d1omwa3 159 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------RM 220 (364)
T ss_dssp SS---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---------HH
T ss_pred CC---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------Hh
Confidence 32 1234569999999999975 568999999999999999999999997543210 0000 00
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC-----Ccc
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS-----SSS 816 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s-----a~e 816 (843)
........|..+++++ .+||.+||..||++|+| |+|
T Consensus 221 ~~~~~~~~~~~~s~~~---------------------------------------~~li~~~L~~dP~~R~t~~~~~a~e 261 (364)
T d1omwa3 221 TLTMAVELPDSFSPEL---------------------------------------RSLLEGLLQRDVNRRLGCLGRGAQE 261 (364)
T ss_dssp SSSCCCCCCSSSCHHH---------------------------------------HHHHHHHTCSSTTTSTTTSSSTHHH
T ss_pred cccCCCCCCCCCCHHH---------------------------------------HHHHHHHcccCHHHhCCCcccCHHH
Confidence 1111111222222333 35566666666666666 799
Q ss_pred CCCCCcccCCCCCCccccccCCCCCC
Q 003158 817 MLKHPYVSSDVSGSNLVSGVIPTITP 842 (843)
Q Consensus 817 ~L~Hp~f~~~~~~~~~~~~~~~~~~~ 842 (843)
+++||||++..+.......+.|++.|
T Consensus 262 il~Hp~f~~i~~~~~~~~~~~~p~~p 287 (364)
T d1omwa3 262 VKESPFFRSLDWQMVFLQKYPPPLIP 287 (364)
T ss_dssp HHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHcCccccCCCHHHHhcCCCCcCcCC
Confidence 99999998876654444444455443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=416.08 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=211.6
Q ss_pred HHHcCCCCCCcccccCCeeEEEEEeCC-C-----cEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 003158 508 LATNNFNSSTQIGQGGYGKVYKGILPD-G-----TVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEE 579 (843)
Q Consensus 508 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 579 (843)
+..++|++.+.||+|+||+||+|++.. + ..||||.+..... .....+.+|+.+++++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 344688899999999999999999642 2 3699999865432 3346789999999998 899999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCC---------------------CCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccC
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSK---------------------EPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDI 638 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dl 638 (843)
+..++|||||++|+|.++++.+.. ..+++..++.++.||++||+|||+++ ||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999976432 35889999999999999999999998 999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCC
Q 003158 639 KASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQ 717 (843)
Q Consensus 639 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~ 717 (843)
||+|||++.++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||+| |+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred chhccccccCCeEEEeeccccccccCCCc-----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 99999999999999999999986543221 122334568999999999999999999999999999999998 899
Q ss_pred CCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003158 718 PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELE 783 (843)
Q Consensus 718 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~ 783 (843)
||........ .... +..+...+.|..+++++.+++.+||+.+|++|||++++++.|.
T Consensus 266 Pf~~~~~~~~-~~~~--------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDAN-FYKL--------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SSTTCCCSHH-HHHH--------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHH-HHHH--------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9976443221 1111 1122234566778889999999999999999999999999885
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=416.30 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=205.5
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHH-hccCCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS---LQGEKEFLTEIQFLS-RLHHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lV 585 (843)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999965 69999999997432 122345677777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCC
Q 003158 586 YEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 665 (843)
||||++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997654 4788899999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+...
T Consensus 157 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~--------------- 213 (320)
T d1xjda_ 157 D-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFH--------------- 213 (320)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH---------------
T ss_pred c-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-HHHHH---------------
Confidence 1 223445799999999999999999999999999999999999999975432 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCc-cCCCCCccc
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSS-SMLKHPYVS 824 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~-e~L~Hp~f~ 824 (843)
-+..+ .|. -| +..++.+.+|+++||+.||++|+|++ |+++||||+
T Consensus 214 --------------~i~~~---~~~-~p----------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 214 --------------SIRMD---NPF-YP----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp --------------HHHHC---CCC-CC----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred --------------HHHcC---CCC-CC----------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 01110 110 01 01123344788888999999999995 899999998
Q ss_pred CCCC
Q 003158 825 SDVS 828 (843)
Q Consensus 825 ~~~~ 828 (843)
+-.+
T Consensus 260 ~~~~ 263 (320)
T d1xjda_ 260 EINW 263 (320)
T ss_dssp TCCH
T ss_pred cCCH
Confidence 7443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-48 Score=411.18 Aligned_cols=264 Identities=28% Similarity=0.457 Sum_probs=218.8
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCD 577 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 577 (843)
+++...++|++.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44455678999999999999999999863 3578999999764433 3578999999999999999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC----------------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEe
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKS----------------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFH 635 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 635 (843)
+.+..++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999996432 234788999999999999999999999 999
Q ss_pred ccCCCCcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhC
Q 003158 636 RDIKASNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTG 715 (843)
Q Consensus 636 ~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg 715 (843)
|||||+|||++.++.+||+|||+|+...... .....+...|++.|+|||.+.+..++.++|||||||++|||++|
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCc-----cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 9999999999999999999999997654221 12223456688999999999999999999999999999999998
Q ss_pred CC-CCCCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 003158 716 MQ-PISHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIW 786 (843)
Q Consensus 716 ~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~ 786 (843)
.. ||.... ..+.. ..+.++.....|..+++++.+++.+||+.+|++||+|.+|++.|+++.
T Consensus 239 ~~~p~~~~~-~~e~~---------~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 239 GLQPYYGMA-HEEVI---------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCCTTTTSC-HHHHH---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCCC-HHHHH---------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 65 565433 22222 233444455567778889999999999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=402.04 Aligned_cols=252 Identities=29% Similarity=0.463 Sum_probs=207.0
Q ss_pred HcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec-CCcEEEEEec
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEF 588 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e~ 588 (843)
.++|+..+.||+|+||.||+|++ .|+.||||+++... ..+++.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35678889999999999999998 47889999997543 34679999999999999999999999854 4678999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+++|+|.+++..+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999999997765556899999999999999999999998 999999999999999999999999999865321
Q ss_pred CcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||..... .+ ....+..+..+
T Consensus 157 -------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~~---------~~~~i~~~~~~ 219 (262)
T d1byga_ 157 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD---------VVPRVEKGYKM 219 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GG---------HHHHHTTTCCC
T ss_pred -------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-HH---------HHHHHHcCCCC
Confidence 233457899999999999999999999999999999999 6777654332 11 11223334556
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+.|..+++++.+++.+||+.+|.+||++.+++++|+.+..
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 6777788899999999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=415.07 Aligned_cols=278 Identities=22% Similarity=0.332 Sum_probs=202.9
Q ss_pred CCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhh-----HHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 516 STQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQG-----EKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
+++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999964 69999999987543222 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
.++++..+... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--- 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--- 154 (299)
T ss_dssp SEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---
T ss_pred cchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc---
Confidence 88777766533 345889999999999999999999999 9999999999999999999999999998654322
Q ss_pred cccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGS 748 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (843)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||....+. +......... ..+....
T Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~-----~~~~~~~ 224 (299)
T d1ua2a_ 155 ----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETL-----GTPTEEQ 224 (299)
T ss_dssp ----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-----CCCCTTT
T ss_pred ----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhc-----CCCChhh
Confidence 122345689999999998754 5799999999999999999999998755432 2222111100 0000000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCCC
Q 003158 749 YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSDV 827 (843)
Q Consensus 749 ~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~~ 827 (843)
.+... ... ....-...|... .....+..++.+.||+++||+.||++|+||+|+|+||||++..
T Consensus 225 ~~~~~-----~~~---~~~~~~~~~~~~--------~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 225 WPDMC-----SLP---DYVTFKSFPGIP--------LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp SSSTT-----SST---TCCCCCCCCCCC--------HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccchh-----ccc---hhhhhccCCCCC--------hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 00000 000 000000111100 0112234455667899999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=404.26 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=205.9
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCC----CcEEEEEEeccCChh-hHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPD----GTVVAVKRAQEGSLQ-GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
..++|++.+.||+|+||+||+|++.. +..||||.++..... ..+.+.+|++++++++||||++++|++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35689999999999999999998642 457999998754333 3567999999999999999999999996 46789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|+|.+++... ..++++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+...
T Consensus 84 iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999987654 346899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
... ........||+.|+|||++.+..++.++|||||||++|||+| |..||....... ....+.
T Consensus 160 ~~~------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----------~~~~i~ 223 (273)
T d1mp8a_ 160 DST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------VIGRIE 223 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------HHHHHH
T ss_pred CCc------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----------HHHHHH
Confidence 322 222344568999999999999999999999999999999998 888887654311 112233
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
.+...+.|..+++++.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 444456677888999999999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-47 Score=399.67 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=205.4
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh---------hHHHHHHHHHHHHhcc-CCcccceeeeeecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ---------GEKEFLTEIQFLSRLH-HRNLVSLVGYCDEE 579 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 579 (843)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999996 47999999998753211 1246889999999997 99999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccc
Q 003158 580 GEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLS 659 (843)
Q Consensus 580 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 659 (843)
+..|+|||||++|+|.++++.+. ++++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997654 5899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhccc------CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHh
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAY 733 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~ 733 (843)
+..... .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....
T Consensus 158 ~~~~~~--------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~-- 226 (277)
T d1phka_ 158 CQLDPG--------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRM-- 226 (277)
T ss_dssp EECCTT--------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH--
T ss_pred eEccCC--------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHH--
Confidence 876432 12244579999999999964 346889999999999999999999997654211 1111
Q ss_pred hcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCC
Q 003158 734 QSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPS 813 (843)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~s 813 (843)
+...-.+. | .|. .+..++++.+|+.+||+.||++|+|
T Consensus 227 --------------------------i~~~~~~~-~--~~~--------------~~~~s~~~~~li~~~L~~~p~~R~s 263 (277)
T d1phka_ 227 --------------------------IMSGNYQF-G--SPE--------------WDDYSDTVKDLVSRFLVVQPQKRYT 263 (277)
T ss_dssp --------------------------HHHTCCCC-C--TTT--------------GGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred --------------------------HHhCCCCC-C--Ccc--------------cccCCHHHHHHHHHHccCChhHCcC
Confidence 11000000 0 000 0111233446888889999999999
Q ss_pred CccCCCCCcccC
Q 003158 814 SSSMLKHPYVSS 825 (843)
Q Consensus 814 a~e~L~Hp~f~~ 825 (843)
++|+|+||||+.
T Consensus 264 ~~eil~h~~~~~ 275 (277)
T d1phka_ 264 AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHTTSGGGCT
T ss_pred HHHHHcCHHHHH
Confidence 999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=410.50 Aligned_cols=283 Identities=26% Similarity=0.378 Sum_probs=210.2
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+++.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999996 57999999999754322 24678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
|+. |++.+++.......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 996 56666665555667999999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCcccceeeeeecccCCccCchhcccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||...... +......... ..+
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~-----~~~-- 222 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTL-----GTP-- 222 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH-----CCC--
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhc-----CCC--
Confidence 2233457999999999987765 578999999999999999999999765432 2222111100 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccC-CCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 747 GSYPSECVEKFIKLALKCCQDE-TDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~-p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
++.......... ...... ...+.... ...+..+..+.||+++||+.||++|+||+|+|+||||++
T Consensus 223 ---~~~~~~~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 223 ---DEVVWPGVTSMP-DYKPSFPKWARQDFS----------KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp ---CTTTSTTGGGST-TCCTTSCCCCCCCHH----------HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ---chhhcccccccc-ccccccccccccchh----------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 000000000000 000000 01111111 122344455678999999999999999999999999976
Q ss_pred C
Q 003158 826 D 826 (843)
Q Consensus 826 ~ 826 (843)
-
T Consensus 289 ~ 289 (298)
T d1gz8a_ 289 V 289 (298)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=409.54 Aligned_cols=257 Identities=19% Similarity=0.354 Sum_probs=206.8
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEecC
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEFM 589 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 589 (843)
++|++.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++|+.++||||+++++++.+++..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 67999999999999999999965 68999999998644 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCC--CcEEEeeccccccCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHK--FTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~~~~~ 667 (843)
+||+|.+++.... .++++.+++.++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 9999999996543 35899999999999999999999999 9999999999999854 48999999999875432
Q ss_pred CCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......||+.|+|||...+..++.++||||+||++|||++|+.||...... +.... +.... .
T Consensus 158 ------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~---------i~~~~-~ 220 (321)
T d1tkia_ 158 ------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIEN---------IMNAE-Y 220 (321)
T ss_dssp ------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH---------HHHTC-C
T ss_pred ------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHH---------HHhCC-C
Confidence 2334567899999999999999999999999999999999999999764421 11110 10000 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
.++... ++..++.+.+|+++||+.||++|+|++|+|+||||+..
T Consensus 221 ~~~~~~-----------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 221 TFDEEA-----------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCHHH-----------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCChhh-----------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 111110 01122334578888888888888888888888888654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-47 Score=405.97 Aligned_cols=282 Identities=22% Similarity=0.297 Sum_probs=207.7
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChh--hHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQ--GEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 588 (843)
++|++.++||+|+||+||+|+.++|+.||||+++..... ..+++.+|+.+|++++||||+++++++.+++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999989999999999764332 247899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIE 668 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 668 (843)
+.++.+..+... ...+++..++.++.||++||+|||+++ ||||||||+|||++.++.+|++|||.|.....+.
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 987766666543 346999999999999999999999999 9999999999999999999999999998754322
Q ss_pred CcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCC
Q 003158 669 GIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMG 747 (843)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (843)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||..... .+........ .......
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~-----~~~~~~~ 223 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRI-----LGTPNSK 223 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHH-----HCCCCTT
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHh-----hCCCChh
Confidence 223344689999999999764 568999999999999999999999976543 2222211100 0000000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
.. .................+.. .....+..++.+.||+++||+.||++|+||+|+|+||||+.
T Consensus 224 ~~-----~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 224 NW-----PNVTELPKYDPNFTVYEPLP----------WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TS-----TTGGGSTTCCTTCCCCCCCC----------GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hc-----cchhhhhhcccccccccCcc----------hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 00 00000000000000000000 01122333445568999999999999999999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=402.98 Aligned_cols=267 Identities=25% Similarity=0.412 Sum_probs=207.3
Q ss_pred HHHHHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeee
Q 003158 504 GEMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGY 575 (843)
Q Consensus 504 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 575 (843)
.+|++..++|++.+.||+|+||+||+|.+. +++.||||+++.... ...+.+.+|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344455678999999999999999999853 346899999975433 3356788888888777 68999999999
Q ss_pred eecC-CcEEEEEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCC
Q 003158 576 CDEE-GEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKA 640 (843)
Q Consensus 576 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp 640 (843)
+.+. ...++|||||++|+|.++++... ...+++..++.++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8654 56899999999999999997532 235889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCC-CCC
Q 003158 641 SNILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGM-QPI 719 (843)
Q Consensus 641 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~-~pf 719 (843)
+|||+++++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+||. .||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceeECCCCcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 999999999999999999986543321 11223457999999999999999999999999999999999975 566
Q ss_pred CCCcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 720 SHGKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
........ ... .+..+.....|+.+++++.+++.+||+.+|++||++.+++++|+++.+
T Consensus 238 ~~~~~~~~-~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 238 PGVKIDEE-FCR--------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TTCCCSHH-HHH--------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHH-HHH--------HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 54433222 111 122233445667778899999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=403.27 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=208.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGT----VVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQML 584 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 584 (843)
++|++.+.||+|+||+||+|.+. +|+ .||+|+++.. .....++|.+|++++++++|||||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46899999999999999999964 444 6899988653 33446789999999999999999999999976 46788
Q ss_pred EEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCC
Q 003158 585 VYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPV 664 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 664 (843)
|+||+.+|+|.+++... ...+++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999988764 446899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhcc
Q 003158 665 PDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVID 743 (843)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 743 (843)
... ........||+.|+|||++.+..++.++|||||||++|||+| |..||...... + + ...+..
T Consensus 164 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~-~--------~~~i~~ 228 (317)
T d1xkka_ 164 EEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-I--------SSILEK 228 (317)
T ss_dssp TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-G-H--------HHHHHH
T ss_pred ccc-----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-H-H--------HHHHHc
Confidence 321 122334568999999999999999999999999999999999 78888654321 1 1 112223
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 744 GNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 744 ~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
+...+.|..+++++.+++.+||+.+|.+||++.++++.++.+..
T Consensus 229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 34455677788899999999999999999999999999887653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=397.70 Aligned_cols=260 Identities=31% Similarity=0.497 Sum_probs=213.1
Q ss_pred CCcccccCCeeEEEEEeCC----CcEEEEEEeccC-ChhhHHHHHHHHHHHHhccCCcccceeeeeec-CCcEEEEEecC
Q 003158 516 STQIGQGGYGKVYKGILPD----GTVVAVKRAQEG-SLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-EGEQMLVYEFM 589 (843)
Q Consensus 516 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e~~ 589 (843)
.++||+|+||+||+|.+.+ ...||||+++.. .....++|.+|+++|++++||||++++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999999743 236899999753 44445789999999999999999999999865 56889999999
Q ss_pred CCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCCCC
Q 003158 590 SNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDIEG 669 (843)
Q Consensus 590 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 669 (843)
++|+|.+++... ....++..++.++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999998654 345778889999999999999999999 9999999999999999999999999998765432211
Q ss_pred cccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCCCCC
Q 003158 670 IVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNMGSY 749 (843)
Q Consensus 670 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (843)
........||+.|+|||.+.+..++.++|||||||++|||+||..||....+..+. ...+..+.....
T Consensus 188 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~---------~~~i~~g~~~~~ 255 (311)
T d1r0pa_ 188 ---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---------TVYLLQGRRLLQ 255 (311)
T ss_dssp ---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C---------HHHHHTTCCCCC
T ss_pred ---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH---------HHHHHcCCCCCC
Confidence 12223456899999999999999999999999999999999988888754432221 223344445556
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCC
Q 003158 750 PSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPE 791 (843)
Q Consensus 750 ~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~ 791 (843)
|..+++++.+++.+||+.+|++||++.||++.|+++.+.+..
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 777888999999999999999999999999999999876443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=409.66 Aligned_cols=197 Identities=24% Similarity=0.365 Sum_probs=171.4
Q ss_pred HcCCCCCC-cccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-cCCcccceeeeeec----CCcE
Q 003158 510 TNNFNSST-QIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE----EGEQ 582 (843)
Q Consensus 510 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~ 582 (843)
.++|.+.. .||+|+||+||+|+. .+++.||||+++.. +.+.+|++++.++ +||||++++++|.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788775 599999999999996 57999999998642 4577899987655 89999999999865 4678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEEeecccc
Q 003158 583 MLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLS 659 (843)
Q Consensus 583 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla 659 (843)
|+|||||+||+|.+++..++...+++..++.++.||+.||+|||+++ |+||||||+|||+++ .+.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999998766678999999999999999999999999 999999999999985 567999999999
Q ss_pred ccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 003158 660 RLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHG 722 (843)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~ 722 (843)
+...... ......||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 162 KETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp EECCCCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eeccCCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 8764322 224457999999999999999999999999999999999999999654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=398.63 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=211.9
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCc--EEEEEEeccCC-hhhHHHHHHHHHHHHhc-cCCcccceeeeeecCCcEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGT--VVAVKRAQEGS-LQGEKEFLTEIQFLSRL-HHRNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 585 (843)
++|++.+.||+|+||+||+|+++ +|. .||||++.... ....+++.+|+++|+++ +||||++++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999975 444 57888876433 33456799999999998 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhc--------------CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcE
Q 003158 586 YEFMSNGTLRDQLSAK--------------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTA 651 (843)
Q Consensus 586 ~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 651 (843)
|||+++|+|.++++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 2356899999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHH
Q 003158 652 KVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNI 731 (843)
Q Consensus 652 kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~ 731 (843)
||+|||+|+..... .......||..|+|||.+.+..++.++|||||||++|||++|..|+....+..+...
T Consensus 167 kl~DfG~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE- 237 (309)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-
T ss_pred EEcccccccccccc--------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH-
Confidence 99999999764321 112344689999999999999999999999999999999997665444433322221
Q ss_pred HhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 732 AYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
.+..+.....|..+++++.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 238 --------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 --------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp --------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2334445566777889999999999999999999999999999998753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=397.18 Aligned_cols=266 Identities=24% Similarity=0.380 Sum_probs=218.2
Q ss_pred HHHHHcCCCCCCcccccCCeeEEEEEe------CCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeee
Q 003158 506 MALATNNFNSSTQIGQGGYGKVYKGIL------PDGTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCD 577 (843)
Q Consensus 506 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 577 (843)
|+...++|++.+.||+|+||.||+|++ .+++.||||+++.... ....++.+|+.+++++ +|||||+++|+|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 444567899999999999999999985 2467899999986443 3456789999999999 6999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhcC----------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCC
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAKS----------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKAS 641 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~ 641 (843)
+.+..++|||||++|+|.++++... ...+++..+..++.||++||+|||+++ ||||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999997643 235889999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 003158 642 NILLDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISH 721 (843)
Q Consensus 642 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~ 721 (843)
||+++.++.+|++|||.++....... ........||+.|+|||++.+..++.++|||||||++|||+|+..|+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999987653321 2233456789999999999999999999999999999999995555544
Q ss_pred CcchHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 722 GKNIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
..+....+.... ..+.....+..+++.+.+++..||+.+|.+||++.+++++|+++..
T Consensus 250 ~~~~~~~~~~~i--------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 250 GMPVDSKFYKMI--------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp TCCSSHHHHHHH--------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHH--------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 333222222111 1222334566677889999999999999999999999999998654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=391.19 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=201.1
Q ss_pred cCCCCCCcccccCCeeEEEEEeC--CC--cEEEEEEeccCC---hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP--DG--TVVAVKRAQEGS---LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 583 (843)
++|++.+.||+|+||+||+|++. ++ ..||||+++... ....++|.+|++++++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999853 23 478999987532 2335689999999999999999999999975 4678
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
+||||+++|++.+++..+. .++++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999887643 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
.... .........|+..|+|||++.+..++.++|||||||++|||+| |+.||..... .+...... .
T Consensus 163 ~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-~~~~~~i~--------~ 229 (273)
T d1u46a_ 163 QNDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKID--------K 229 (273)
T ss_dssp C-CC----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHH--------T
T ss_pred cCCC----cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-HHHHHHHH--------h
Confidence 3321 1122334567889999999999999999999999999999998 8999975443 22222111 1
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 743 DGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 743 ~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
.+...+.+..++..+.+++..||+.+|++||++.++.+.|++.
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1223345667778899999999999999999999999888763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=394.56 Aligned_cols=261 Identities=26% Similarity=0.459 Sum_probs=212.8
Q ss_pred HHcCCCCCCcccccCCeeEEEEEeCC--------CcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 003158 509 ATNNFNSSTQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSL-QGEKEFLTEIQFLSRL-HHRNLVSLVGYCDE 578 (843)
Q Consensus 509 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 578 (843)
..++|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +||||++++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 35688889999999999999998532 35799999976543 3357889999999888 89999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcC--------------CCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEE
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKS--------------KEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNIL 644 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NIL 644 (843)
++..++||||+++|+|.+++..+. ...+++.+++.++.||++||+|||+.+ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999997643 235899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCc
Q 003158 645 LDHKFTAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLT-GMQPISHGK 723 (843)
Q Consensus 645 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~ellt-g~~pf~~~~ 723 (843)
++.++.+||+|||+++....... ........|++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCT-----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCCCCeEeccchhhcccccccc-----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999987653321 122344568999999999999999999999999999999998 677776443
Q ss_pred chHHHHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 724 NIVREVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
. .+ +.. .+..+.....|..+++++.+++.+||+.+|.+|||+.++++.|+++..
T Consensus 243 ~-~~-~~~--------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 V-EE-LFK--------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H-HH-HHH--------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HH-HHH--------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2 21 111 223344455667778899999999999999999999999999998864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=398.12 Aligned_cols=264 Identities=26% Similarity=0.442 Sum_probs=218.2
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeee
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILP------DGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCD 577 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 577 (843)
+|++..++|++.+.||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++||||++++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34455678999999999999999999863 35789999997543 334467899999999999999999999999
Q ss_pred cCCcEEEEEecCCCCCHHHHHhhc--------CCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC
Q 003158 578 EEGEQMLVYEFMSNGTLRDQLSAK--------SKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF 649 (843)
Q Consensus 578 ~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 649 (843)
.++..++|||||++|+|.+++... ....+++..+..++.|+|+||.|||+++ |+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 999999999999999999998642 2234688899999999999999999998 99999999999999999
Q ss_pred cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHH
Q 003158 650 TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREV 729 (843)
Q Consensus 650 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~ 729 (843)
++||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++|||+||..|+....+..+..
T Consensus 171 ~~Kl~DFGla~~~~~~~-----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGG-----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred eEEEeecccceeccCCc-----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999998654321 1122234468999999999999999999999999999999999864443333333322
Q ss_pred HHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 003158 730 NIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESI 785 (843)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~ 785 (843)
. .+.++.....|..+++.+.+++.+||+.+|++||++.++++.|++.
T Consensus 246 ~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 246 R---------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp H---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H---------HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2 2334555566777888999999999999999999999999998875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=400.35 Aligned_cols=247 Identities=24% Similarity=0.413 Sum_probs=199.2
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChh------hHHHHHHHHHHHHhcc--CCcccceeeeeecCC
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQ------GEKEFLTEIQFLSRLH--HRNLVSLVGYCDEEG 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~ 580 (843)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999996 47999999998743211 1234678999999996 899999999999999
Q ss_pred cEEEEEecCCC-CCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-CCcEEEeeccc
Q 003158 581 EQMLVYEFMSN-GTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-KFTAKVADFGL 658 (843)
Q Consensus 581 ~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGl 658 (843)
..++||||+.+ +++.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 68888886643 5889999999999999999999999 999999999999985 47999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||......
T Consensus 158 a~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------ 216 (273)
T d1xwsa_ 158 GALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------ 216 (273)
T ss_dssp CEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------
T ss_pred ceecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------------
Confidence 9865422 2234579999999999988765 56789999999999999999999642210
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
..+. ..++ + ..++.+.+|+++||+.||++|||++|+
T Consensus 217 ----~~~~-~~~~----------------------~-----------------~~s~~~~~li~~~L~~dp~~R~s~~ei 252 (273)
T d1xwsa_ 217 ----IRGQ-VFFR----------------------Q-----------------RVSSECQHLIRWCLALRPSDRPTFEEI 252 (273)
T ss_dssp ----HHCC-CCCS----------------------S-----------------CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----hhcc-cCCC----------------------C-----------------CCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 0000 0000 0 012223468888999999999999999
Q ss_pred CCCCcccCC
Q 003158 818 LKHPYVSSD 826 (843)
Q Consensus 818 L~Hp~f~~~ 826 (843)
|+||||++.
T Consensus 253 l~hp~~~~~ 261 (273)
T d1xwsa_ 253 QNHPWMQDV 261 (273)
T ss_dssp HTSGGGSSC
T ss_pred hcCHhhCCC
Confidence 999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=402.76 Aligned_cols=282 Identities=24% Similarity=0.353 Sum_probs=203.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CC-CcEEEEEEeccCCh--hhHHHHHHHHHHHHhc---cCCcccceeeeeec----
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PD-GTVVAVKRAQEGSL--QGEKEFLTEIQFLSRL---HHRNLVSLVGYCDE---- 578 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~---- 578 (843)
.++|++.+.||+|+||+||+|+. .+ ++.||||++..... .....+.+|+++++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 67899999864322 1223566788777666 79999999999843
Q ss_pred -CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecc
Q 003158 579 -EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFG 657 (843)
Q Consensus 579 -~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 657 (843)
....+++|||++++++.... ......+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 35789999999876665444 344556889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 658 LSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 658 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... +..........
T Consensus 162 ~~~~~~~--------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~ 232 (305)
T d1blxa_ 162 LARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIG 232 (305)
T ss_dssp SCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHC
T ss_pred hhhhhcc--------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhC
Confidence 9876432 22234567999999999999999999999999999999999999999765432 22211110000
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
.+.....+... ....... ......| .....+..++.+.|||.+||++||++||||+|+
T Consensus 233 -----~~~~~~~~~~~-----~~~~~~~-~~~~~~~-----------~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 233 -----LPGEEDWPRDV-----ALPRQAF-HSKSAQP-----------IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp -----CCCGGGSCTTC-----SSCGGGS-CCCCCCC-----------GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred -----CCchhcccccc-----cchhhhh-ccccccc-----------hhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 00000000000 0000000 0000000 111223334455689999999999999999999
Q ss_pred CCCCcccCC
Q 003158 818 LKHPYVSSD 826 (843)
Q Consensus 818 L~Hp~f~~~ 826 (843)
|+||||+.-
T Consensus 291 L~Hpff~~i 299 (305)
T d1blxa_ 291 LSHPYFQDL 299 (305)
T ss_dssp HTSGGGTTC
T ss_pred hcChhhcCc
Confidence 999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.3e-45 Score=383.88 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=205.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhccCCcccceeeeeecCC----c
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL---QGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----E 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~ 581 (843)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 4799999999975433 23467899999999999999999999987654 3
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.|+||||+++|+|.+++...+ ++++.+++.++.||++||+|||+++ |+||||||+|||++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999987654 5889999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
...... .........||+.|+|||++.+..++.++||||+||++|||+||+.||...... +............
T Consensus 161 ~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~~~~~~~~~-- 233 (277)
T d1o6ya_ 161 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIP-- 233 (277)
T ss_dssp CC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCCCCC--
T ss_pred hccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-HHHHHHHhcCCCC--
Confidence 543221 112334567999999999999999999999999999999999999999765432 2222211111100
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhh
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARP-SMSEVMRELESIW 786 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RP-s~~~vl~~L~~~~ 786 (843)
.......+++++.+++.+|++.+|.+|| +++++.+.|.++.
T Consensus 234 ----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0012334567889999999999999999 8999999888764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=395.77 Aligned_cols=292 Identities=21% Similarity=0.282 Sum_probs=207.6
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhccCCcccceeeeeec--------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSL--QGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-------- 578 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 578 (843)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 4799999999864322 234678999999999999999999998854
Q ss_pred CCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccc
Q 003158 579 EGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGL 658 (843)
Q Consensus 579 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 658 (843)
.+..++||||++++.+..+.. ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 346899999998776665443 3345888889999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhccc
Q 003158 659 SRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSM 737 (843)
Q Consensus 659 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~ 737 (843)
++......... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....+... .......
T Consensus 164 ~~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~-- 237 (318)
T d3blha1 164 ARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQL-- 237 (318)
T ss_dssp CEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH--
T ss_pred eeecccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHHh--
Confidence 98665332111 1122335699999999999865 689999999999999999999999976543221 1111000
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
.............. ... ..........++...+.+.... .++.+.|||.+||++||++|+||+|+
T Consensus 238 ~~~~~~~~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 238 CGSITPEVWPNVDN---YEL----YEKLELVKGQKRKVKDRLKAYV--------RDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp HCCCCTTTSTTCCC---C-----------CCSSCCBCHHHHHHHHH--------CCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cCCCChhhccccch---hhh----hhhhcccccccccchhhhcccc--------CCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 00000000000000 000 0111223333444444433211 13445689999999999999999999
Q ss_pred CCCCcccCCC
Q 003158 818 LKHPYVSSDV 827 (843)
Q Consensus 818 L~Hp~f~~~~ 827 (843)
|+||||+.+.
T Consensus 303 L~Hpff~~~p 312 (318)
T d3blha1 303 LNHDFFWSDP 312 (318)
T ss_dssp HHSGGGSSSS
T ss_pred HcChhhccCC
Confidence 9999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=391.27 Aligned_cols=283 Identities=24% Similarity=0.367 Sum_probs=213.3
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCCcEEEEEe
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 587 (843)
++|++.+.||+|+||+||+|+. .+++.||||+++... ....+++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 478999999986533 2335788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAPVPDI 667 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 667 (843)
++.++++..++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999998887654 45788899999999999999999999 9999999999999999999999999998765332
Q ss_pred CCcccceeeeeecccCCccCchhcccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCCC
Q 003158 668 EGIVPAHVSTVVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGNM 746 (843)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (843)
.......+++.|+|||.+.... ++.++||||+||++|||++|+.||....+..+......... ....
T Consensus 156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------~~~~ 223 (292)
T d1unla_ 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL------GTPT 223 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH------CCCC
T ss_pred ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc------CCCC
Confidence 1223345778999999998765 68999999999999999999999887766555443321110 0000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCCcccC
Q 003158 747 GSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHPYVSS 825 (843)
Q Consensus 747 ~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f~~ 825 (843)
........+... .. .-..++.. .......+..++.+.||+++||++||++|+||+|+|+||||+.
T Consensus 224 ----~~~~~~~~~~~~--~~-~~~~~~~~-------~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 224 ----EEQWPSMTKLPD--YK-PYPMYPAT-------TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp ----TTTCTTGGGSTT--CC-CCCCCCTT-------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ----hhhhhhhhhccc--cc-cccccccc-------chhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 000000000000 00 00000000 0011122233344568999999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=398.17 Aligned_cols=274 Identities=23% Similarity=0.290 Sum_probs=210.9
Q ss_pred cCCCCCCcccccCCeeEEEEEe----CCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhccC-CcccceeeeeecCCc
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL----PDGTVVAVKRAQEGSL----QGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGE 581 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~ 581 (843)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999985 2488999999864321 224568899999999976 899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++||||+.+|+|.+++..... +.+..++.++.||+.||+|+|+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999977654 567888899999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCcch--HHHHHHHhhccc
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVFLELLTGMQPISHGKNI--VREVNIAYQSSM 737 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwS~G~~l~elltg~~pf~~~~~~--~~~~~~~~~~~~ 737 (843)
..... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... .......
T Consensus 179 ~~~~~------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~----- 247 (322)
T d1vzoa_ 179 FVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR----- 247 (322)
T ss_dssp CCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-----
T ss_pred hcccc------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-----
Confidence 54322 2223446799999999999764 4678999999999999999999999754321 1100000
Q ss_pred chhhccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCC-----
Q 003158 738 MFSVIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPP----- 812 (843)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~----- 812 (843)
.......+|..+++ .+.+|+++||.+||++|+
T Consensus 248 ----~~~~~~~~~~~~s~---------------------------------------~~~~li~~~l~~dP~~R~s~~~~ 284 (322)
T d1vzoa_ 248 ----ILKSEPPYPQEMSA---------------------------------------LAKDLIQRLLMKDPKKRLGCGPR 284 (322)
T ss_dssp ----HHHCCCCCCTTSCH---------------------------------------HHHHHHHHHTCSSGGGSTTSSTT
T ss_pred ----cccCCCCCcccCCH---------------------------------------HHHHHHHHHcccCHHHcCCCCcc
Confidence 00001111222222 233566666777777776
Q ss_pred CCccCCCCCcccCCCCCCccccccCCCCCCC
Q 003158 813 SSSSMLKHPYVSSDVSGSNLVSGVIPTITPR 843 (843)
Q Consensus 813 sa~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~ 843 (843)
||+|+|+||||+...+.......+-||+.||
T Consensus 285 t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~ 315 (322)
T d1vzoa_ 285 DADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315 (322)
T ss_dssp THHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cHHHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence 5899999999998766655666666788875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=397.75 Aligned_cols=279 Identities=22% Similarity=0.361 Sum_probs=204.3
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG------ 580 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 580 (843)
.++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 69999999997532 233567899999999999999999999997654
Q ss_pred cEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 581 EQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 581 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
+.++||||+ +.+|..+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 579999999 67888877543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccch
Q 003158 661 LAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMF 739 (843)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 739 (843)
..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ......
T Consensus 170 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~----- 233 (346)
T d1cm8a_ 170 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMK----- 233 (346)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-----
T ss_pred ccCCc----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHh-----
Confidence 65421 2445799999999999874 568999999999999999999999976654222 111110
Q ss_pred hhccCCCCCCCHHHHHHHHHH-HHHhcccCCC-CCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccC
Q 003158 740 SVIDGNMGSYPSECVEKFIKL-ALKCCQDETD-ARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSM 817 (843)
Q Consensus 740 ~~~~~~~~~~~~~~~~~l~~l-~~~c~~~~p~-~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~ 817 (843)
..+..+.+........ ........+. .+... ....+..++.+.|||++||++||++||||+|+
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei 298 (346)
T d1cm8a_ 234 -----VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF----------ASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298 (346)
T ss_dssp -----HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG----------GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred -----ccCCCcHHHHhhhcchhhhhhhccCCcccccch----------HHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 0111222222111000 0000000111 11111 11223344556689999999999999999999
Q ss_pred CCCCcccCC
Q 003158 818 LKHPYVSSD 826 (843)
Q Consensus 818 L~Hp~f~~~ 826 (843)
|+||||++.
T Consensus 299 L~Hp~f~~~ 307 (346)
T d1cm8a_ 299 LAHPYFESL 307 (346)
T ss_dssp HHSGGGTTT
T ss_pred hcChhhCcC
Confidence 999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=397.35 Aligned_cols=288 Identities=22% Similarity=0.319 Sum_probs=209.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhccCCcccceeeeeecCC----cEE
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS-LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQM 583 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~ 583 (843)
+++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+++.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999996 579999999997543 333568899999999999999999999986543 234
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeeccccccCC
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRLAP 663 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 663 (843)
++++|+.+|+|.+++..+ .+++..++.++.||++||+|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 455566699999999654 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhc
Q 003158 664 VPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVI 742 (843)
Q Consensus 664 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 742 (843)
..... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||........ ...... ..
T Consensus 161 ~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~------~~ 229 (345)
T d1pmea_ 161 PDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILG------IL 229 (345)
T ss_dssp GGGCB----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH------HH
T ss_pred CCCcc----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhh------hc
Confidence 32111 112244569999999999854 5678899999999999999999999976543222 111100 00
Q ss_pred cCCCCCCCHHHHHH-HHHHHHHhcccCCCCC-CCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 743 DGNMGSYPSECVEK-FIKLALKCCQDETDAR-PSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 743 ~~~~~~~~~~~~~~-l~~l~~~c~~~~p~~R-Ps~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
.....+.... ...-...+....|... +.... .++..++.+.+|+.+||+.||++|+||+|+|+|
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 ----GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR----------LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp ----CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH----------HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cCCChhhhhhhhhhhhhcccccCCccCCCCHHH----------hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011111100 0001112222233322 23332 233445566789999999999999999999999
Q ss_pred CcccCCCC
Q 003158 821 PYVSSDVS 828 (843)
Q Consensus 821 p~f~~~~~ 828 (843)
|||+....
T Consensus 296 pf~~~~~~ 303 (345)
T d1pmea_ 296 PYLEQYYD 303 (345)
T ss_dssp GGGTTTCC
T ss_pred HhhccCCC
Confidence 99986544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=393.63 Aligned_cols=281 Identities=21% Similarity=0.273 Sum_probs=202.4
Q ss_pred CCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeec------CCcEEE
Q 003158 512 NFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGEQML 584 (843)
Q Consensus 512 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~l 584 (843)
+|+..++||+|+||+||+|+.. +|+.||||++..... ...+|+++|++++||||++++++|.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999975 699999999975432 23469999999999999999999843 235789
Q ss_pred EEecCCCCCHHHHHhh-cCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccC
Q 003158 585 VYEFMSNGTLRDQLSA-KSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLA 662 (843)
Q Consensus 585 V~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 662 (843)
|||||+++.+..+.+. .....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976544443322 34557999999999999999999999999 99999999999999775 8999999999876
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhccc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .......
T Consensus 174 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~------- 237 (350)
T d1q5ka_ 174 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIK------- 237 (350)
T ss_dssp CTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHH-------
T ss_pred cCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHH-------
Confidence 4322 2234569999999999875 578999999999999999999999997654322 1111110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCccCCCCC
Q 003158 742 IDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSSMLKHP 821 (843)
Q Consensus 742 ~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp 821 (843)
..+..+.+.......-............|.. ....+..++.+.|||.+||++||++|+||+|+|+||
T Consensus 238 ---~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 238 ---VLGTPTREQIREMNPNYTEFKFPQIKAHPWT----------KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp ---HHCCCCHHHHHHHCC---CCCCCCCCCCCGG----------GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ---HhCCChHHhhhhhccchhhccccccccCchh----------hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0111222222211110000000000000000 001123344566899999999999999999999999
Q ss_pred cccCCCC
Q 003158 822 YVSSDVS 828 (843)
Q Consensus 822 ~f~~~~~ 828 (843)
||+....
T Consensus 305 ~f~~~~~ 311 (350)
T d1q5ka_ 305 FFDELRD 311 (350)
T ss_dssp GGGGGGC
T ss_pred hhccccC
Confidence 9976543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=381.24 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=199.2
Q ss_pred cCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccceeeeeecCC----cEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSLVGYCDEEG----EQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~ 586 (843)
.+|...+.||+|+||+||+|++ +|+.||||++..... .....+.|+..+..++||||++++++|.+++ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3566778999999999999997 688999999964322 1222334555666789999999999997654 579999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCC-----CCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA-----DPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
|||++|+|.+++++. ++++..++.++.|+|.||+|+|+.. +++||||||||+|||+++++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999764 4889999999999999999999741 23499999999999999999999999999987
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCC------CCchhhhHHHHHHHHHHHhCCCCCCCCcc-----------
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVFLELLTGMQPISHGKN----------- 724 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwS~G~~l~elltg~~pf~~~~~----------- 724 (843)
....... .........||+.|+|||++.+.. ++.++|||||||++|||+||..||.....
T Consensus 158 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 158 HDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EETTTTE---ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccCCCcc---eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 6432210 111234567999999999987643 56789999999999999999887743211
Q ss_pred --hHHHHHHHhhcccchhhccCCCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhh
Q 003158 725 --IVREVNIAYQSSMMFSVIDGNMGS--YPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNM 788 (843)
Q Consensus 725 --~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~ 788 (843)
........... ....+..+. .+.+....+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 235 ~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 01111111100 011111111 1335667899999999999999999999999999988653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.3e-45 Score=393.96 Aligned_cols=278 Identities=18% Similarity=0.318 Sum_probs=206.1
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeec--CCcEEEEE
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDE--EGEQMLVY 586 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lV~ 586 (843)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5899999999999999999996 47999999999753 3457889999999995 9999999999864 45789999
Q ss_pred ecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCC-cEEEeeccccccCCCC
Q 003158 587 EFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKF-TAKVADFGLSRLAPVP 665 (843)
Q Consensus 587 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~ 665 (843)
||+.+++|.++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997764 34889999999999999999999999 99999999999998655 6999999999876432
Q ss_pred CCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDG 744 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (843)
. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....+.......... ...
T Consensus 184 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~------~~g- 248 (328)
T d3bqca1 184 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK------VLG- 248 (328)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH------HHC-
T ss_pred C--------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH------HHC-
Confidence 1 23445689999999998875 4799999999999999999999999876654433222110 000
Q ss_pred CCCCCCHHHHHHHHHHH--------HHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 745 NMGSYPSECVEKFIKLA--------LKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 745 ~~~~~~~~~~~~l~~l~--------~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
........... ...... ..+........ .......++++.|||++||++||++|+||+|
T Consensus 249 ------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 249 ------TEDLYDYIDKYNIELDPRFNDILGR--HSRKRWERFVH-----SENQHLVSPEALDFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp ------HHHHHHHHHHTTCCCCGGGGGTCCC--CCCCCGGGGCC-----TTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ------CchhhhhhhhcccccCcccchhccc--ccccchhhccc-----ccccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 00000000000 000000 01111100000 0000112334568999999999999999999
Q ss_pred CCCCCcccCCC
Q 003158 817 MLKHPYVSSDV 827 (843)
Q Consensus 817 ~L~Hp~f~~~~ 827 (843)
+|+||||++..
T Consensus 316 ~L~Hp~F~~v~ 326 (328)
T d3bqca1 316 AMEHPYFYTVV 326 (328)
T ss_dssp HHTSGGGTTSC
T ss_pred HhcCcccCCCC
Confidence 99999998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=389.77 Aligned_cols=277 Identities=20% Similarity=0.346 Sum_probs=204.8
Q ss_pred HcCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec-----CCc
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE-----EGE 581 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 581 (843)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|+.++||||+++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999996 579999999997543 3345678999999999999999999999853 334
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.++|++|+.+|+|.+++..+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||.|..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 56677788899999999543 5899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFS 740 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 740 (843)
... ......|++.|+|||...+. .++.++||||+||++|||++|+.||........ .......
T Consensus 171 ~~~----------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~----- 234 (348)
T d2gfsa1 171 TDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRL----- 234 (348)
T ss_dssp CTG----------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH-----
T ss_pred cCc----------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-----
Confidence 432 22345689999999998775 468899999999999999999999976543222 1111100
Q ss_pred hccCCCCCCCHHHHHH----HHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCccccCCCCCCCCCCCCCcc
Q 003158 741 VIDGNMGSYPSECVEK----FIKLALKCCQDETDARPSMSEVMRELESIWNMMPESDTKTPEFINSEHTSKEETPPSSSS 816 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~----l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dll~~~L~~dp~~R~sa~e 816 (843)
.+..+.+.... ...-........ .+..... .....++.+.|||++||+.||++|+||+|
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 235 -----VGTPGAELLKKISSESARNYIQSLTQM--PKMNFAN----------VFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp -----HCCCCHHHHTTCCCHHHHHHHTTSCCC--CCCCHHH----------HSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred -----cCCCChHHhhhccchhhhhhhhhcccC--CCcchhh----------hcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 00111111110 000001111111 1122221 22344556678999999999999999999
Q ss_pred CCCCCcccC
Q 003158 817 MLKHPYVSS 825 (843)
Q Consensus 817 ~L~Hp~f~~ 825 (843)
+|+||||+.
T Consensus 298 lL~Hp~f~~ 306 (348)
T d2gfsa1 298 ALAHAYFAQ 306 (348)
T ss_dssp HHTSGGGTT
T ss_pred HhcCHhhCC
Confidence 999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=393.61 Aligned_cols=284 Identities=21% Similarity=0.280 Sum_probs=197.3
Q ss_pred cCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhccCCcccceeeeeec------CCc
Q 003158 511 NNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGS--LQGEKEFLTEIQFLSRLHHRNLVSLVGYCDE------EGE 581 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 581 (843)
++|++.++||+|+||+||+|.+. +|+.||||++.... ....+++.+|+.++++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999965 69999999997543 3334678999999999999999999999853 367
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEeecccccc
Q 003158 582 QMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVADFGLSRL 661 (843)
Q Consensus 582 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 661 (843)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 89999999654 545443 24789999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhh
Q 003158 662 APVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSV 741 (843)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 741 (843)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......
T Consensus 169 ~~~~--------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~------ 233 (355)
T d2b1pa1 169 AGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQ------ 233 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH------
T ss_pred cccc--------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHh------
Confidence 5432 233455789999999999999999999999999999999999999976543222 1111100
Q ss_pred ccCCCCCCCHHHHH----HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC----CCCCCCCCccccCCCCCCCCCCCC
Q 003158 742 IDGNMGSYPSECVE----KFIKLALKCCQDETDARPSMSEVMRELESIWNMM----PESDTKTPEFINSEHTSKEETPPS 813 (843)
Q Consensus 742 ~~~~~~~~~~~~~~----~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~----~~~~~~~~dll~~~L~~dp~~R~s 813 (843)
. ...+.+... ...+..... .+....+...+.. +...... ...++.+.|||++||.+||++|||
T Consensus 234 ~----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 304 (355)
T d2b1pa1 234 L----GTPCPEFMKKLQPTVRNYVENR---PKYAGLTFPKLFP--DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_dssp H----CCCCHHHHTTSCHHHHHHHHTS---CCCCCCCHHHHSC--GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred c----cCCCHHHHHHhhhhHHHHhhcC---ccccccccccccc--cccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 0 011111111 111111111 1111111111100 0000000 000123457999999999999999
Q ss_pred CccCCCCCcccCC
Q 003158 814 SSSMLKHPYVSSD 826 (843)
Q Consensus 814 a~e~L~Hp~f~~~ 826 (843)
|+|+|+||||+..
T Consensus 305 a~elL~Hpw~~~~ 317 (355)
T d2b1pa1 305 VDDALQHPYINVW 317 (355)
T ss_dssp HHHHHTSTTTGGG
T ss_pred HHHHhcCcccCCC
Confidence 9999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-42 Score=366.67 Aligned_cols=268 Identities=19% Similarity=0.255 Sum_probs=212.1
Q ss_pred HcCCCCCCcccccCCeeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHHhccC-CcccceeeeeecCCcEEEEEe
Q 003158 510 TNNFNSSTQIGQGGYGKVYKGILP-DGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH-RNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 510 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~e 587 (843)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999964 68999999986533 22357789999999965 899999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC-----CCcEEEeeccccccC
Q 003158 588 FMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH-----KFTAKVADFGLSRLA 662 (843)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~~ 662 (843)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 789999986543 46889999999999999999999999 999999999999974 578999999999887
Q ss_pred CCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcc--hHHHHHHHhhcccchh
Q 003158 663 PVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKN--IVREVNIAYQSSMMFS 740 (843)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~ 740 (843)
.........+........||+.|||||.+.+..++.++|||||||++|||+||+.||..... ........... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-~~-- 233 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQ-- 233 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HH--
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-cC--
Confidence 54433222223334556799999999999999999999999999999999999999975432 11111111000 00
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhhhC
Q 003158 741 VIDGNMGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWNMM 789 (843)
Q Consensus 741 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~~~ 789 (843)
.......+..+++++.+++..|+..+|++||+++.+.+.++++.+..
T Consensus 234 --~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 --STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp --HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00000112234567889999999999999999999999888877654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-42 Score=370.37 Aligned_cols=267 Identities=19% Similarity=0.259 Sum_probs=203.7
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcccce-eeeeecCCcEEEEEec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLVSL-VGYCDEEGEQMLVYEF 588 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l-~~~~~~~~~~~lV~e~ 588 (843)
++|++.+.||+|+||+||+|++ .+|+.||||++..... .+++..|+++++.++|+|++.. .+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999996 4689999999875432 2457889999999987765555 5555777888999999
Q ss_pred CCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcC---CCcEEEeeccccccCCCC
Q 003158 589 MSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDH---KFTAKVADFGLSRLAPVP 665 (843)
Q Consensus 589 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~ 665 (843)
+ ++++.+.+... ...+++..+..++.|+++||+|||+++ ||||||||+|||++. +..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 66777776543 346899999999999999999999999 999999999999863 557999999999987654
Q ss_pred CCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHHHHHHHhhcccchhhccCC
Q 003158 666 DIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVREVNIAYQSSMMFSVIDGN 745 (843)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (843)
...............||+.|||||.+.+..++.++|||||||++|||+||+.||................. ......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---~~~~~~ 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---KKMSTP 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---HHHHSC
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---ccCCCC
Confidence 33222223334556799999999999999999999999999999999999999976433211110000000 000000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhh
Q 003158 746 MGSYPSECVEKFIKLALKCCQDETDARPSMSEVMRELESIWN 787 (843)
Q Consensus 746 ~~~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~~L~~~~~ 787 (843)
....+..+++++.+++..||+.+|++||++.++.+.|+.+..
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 001123456788999999999999999999999998888754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-39 Score=356.48 Aligned_cols=291 Identities=18% Similarity=0.234 Sum_probs=199.7
Q ss_pred cCCCCCCcccccCCeeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-----------CCcccceeeeeec
Q 003158 511 NNFNSSTQIGQGGYGKVYKGIL-PDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-----------HRNLVSLVGYCDE 578 (843)
Q Consensus 511 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~ 578 (843)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999996 579999999998643 23457788999888875 5789999998854
Q ss_pred --CCcEEEEEecCCCCC-HHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhc-CCCCCEEeccCCCCcEEEcCCC-----
Q 003158 579 --EGEQMLVYEFMSNGT-LRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHT-EADPPVFHRDIKASNILLDHKF----- 649 (843)
Q Consensus 579 --~~~~~lV~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~----- 649 (843)
....++||+++..+. ............+++..++.++.||++||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 345666666655443 3344444555678889999999999999999998 77 99999999999998665
Q ss_pred -cEEEeeccccccCCCCCCCCcccceeeeeecccCCccCchhcccCCCCchhhhHHHHHHHHHHHhCCCCCCCCcchHH-
Q 003158 650 -TAKVADFGLSRLAPVPDIEGIVPAHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVFLELLTGMQPISHGKNIVR- 727 (843)
Q Consensus 650 -~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~G~~l~elltg~~pf~~~~~~~~- 727 (843)
.++++|||.|...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||........
T Consensus 169 ~~~kl~dfg~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp EEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceeeEeecccccccccc----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 4999999999764321 2345699999999999999999999999999999999999999975332100
Q ss_pred -HHHHHhhcccchhhccCCCCCCCHHHHHHHHHHHHHhc-------ccCCCCCCCHHHHHHHHHHhhhhCCCCCCCCCcc
Q 003158 728 -EVNIAYQSSMMFSVIDGNMGSYPSECVEKFIKLALKCC-------QDETDARPSMSEVMRELESIWNMMPESDTKTPEF 799 (843)
Q Consensus 728 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~-------~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~dl 799 (843)
....... .... ++..+.+....-.. ....+ ......+....+.... .....+..++.+.||
T Consensus 239 ~~~~~~~~---~~~~----lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 239 KDDDHIAQ---IIEL----LGELPSYLLRNGKY-TRTFFNSRGLLRNISKLKFWPLEDVLTE---KYKFSKDEAKEISDF 307 (362)
T ss_dssp CHHHHHHH---HHHH----HCSCCHHHHHHCTT-HHHHBCC--CBSSCCCCCBCCHHHHHHH---TTCCCHHHHHHHHHH
T ss_pred chhHHHHH---HHHH----hCCCCHHHhhcccc-cccccccchhhhccccccCCchhhhccc---ccccCcccCHHHHHH
Confidence 0000000 0001 11222222211100 01111 1111222333333321 111111223446689
Q ss_pred ccCCCCCCCCCCCCCccCCCCCcccCC
Q 003158 800 INSEHTSKEETPPSSSSMLKHPYVSSD 826 (843)
Q Consensus 800 l~~~L~~dp~~R~sa~e~L~Hp~f~~~ 826 (843)
|.+||++||++||||+|+|+||||+.-
T Consensus 308 l~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999844
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=8.2e-29 Score=265.06 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=210.1
Q ss_pred CCCCEEEccCCcCCc--cCccccCCCCCCcEEEccc-CcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCce
Q 003158 17 KSLELLLLNGNELTG--SLPEELGYLPKLDRIQIDQ-NYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 93 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 93 (843)
.+++.|+|++|++.+ .+|+.+++|++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468889999999887 4788999999999999987 7888889999999999999999999999888888888999999
Q ss_pred eeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCC-cEEEcCCCCCCCCCCC-CCCCCCCCEEEcccC
Q 003158 94 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKL-LKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSN 171 (843)
Q Consensus 94 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N 171 (843)
+++++|++.+.+|..+.+++.|+.+++++|.+.+ .+|..+..+.++ +.+++++|++++..+. +..+ .+..++++.|
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~-~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l-~~~~l~l~~~ 207 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISG-AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEE-ECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC-CCSEEECCSS
T ss_pred cccccccccccCchhhccCcccceeecccccccc-cccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 9999999988889999999999999999999886 678888888776 8899999999887764 5554 4457999999
Q ss_pred cCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCC
Q 003158 172 QLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLT 250 (843)
Q Consensus 172 ~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~ 250 (843)
.+.+.+|..... .+|+.|++++|.+++.++ .+..+++|+.|+|++|+|+|.+|..+.++++ |+.|+|++|+|+
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~-----L~~L~Ls~N~l~ 281 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF-----LHSLNVSFNNLC 281 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTT-----CCEEECCSSEEE
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCC-----CCEEECcCCccc
Confidence 988887776544 379999999999987654 6888899999999999999999998877654 558999999998
Q ss_pred -CCCCCCcCCCCcEEEeccCcccccCC
Q 003158 251 -NISGSFNIPPNVTVRLRGNPFCLNTN 276 (843)
Q Consensus 251 -~~~~~~~~~~l~~l~l~~Np~~c~~~ 276 (843)
.+|....+..+..+++.+|++.|..+
T Consensus 282 g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 282 GEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp EECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccCCCcccCCCCCHHHhCCCccccCCC
Confidence 46654467888888999998766543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=1.4e-28 Score=263.26 Aligned_cols=243 Identities=26% Similarity=0.471 Sum_probs=218.1
Q ss_pred Cccccc--cCCccccCCCCCCEEEccC-CcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccc
Q 003158 2 WNKISG--SIPKEIGNIKSLELLLLNG-NELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSIS 78 (843)
Q Consensus 2 ~N~i~~--~~p~~i~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 78 (843)
.|+++| .+|.+|++|++|++|+|++ |+++|.+|..|++|++|++|+|++|++.+..+..+..+.+|+.+++++|.+.
T Consensus 59 ~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~ 138 (313)
T d1ogqa_ 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138 (313)
T ss_dssp CCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred CCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccccc
Confidence 467777 5899999999999999997 8999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCC-cEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-
Q 003158 79 GQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKL-LILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD- 156 (843)
Q Consensus 79 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~- 156 (843)
+.+|..+.++++|+.+++++|.+++.+|..+..+..+ +.+++++|++++ ..|..+.++..+ .+++++|.+.+.++.
T Consensus 139 ~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~-~~~~~~~~l~~~-~l~l~~~~~~~~~~~~ 216 (313)
T d1ogqa_ 139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-KIPPTFANLNLA-FVDLSRNMLEGDASVL 216 (313)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE-ECCGGGGGCCCS-EEECCSSEEEECCGGG
T ss_pred ccCchhhccCcccceeeccccccccccccccccccccccccccccccccc-cccccccccccc-cccccccccccccccc
Confidence 9999999999999999999999999999999988886 899999999987 567888877554 799999999888774
Q ss_pred CCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCC
Q 003158 157 LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNA 236 (843)
Q Consensus 157 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~ 236 (843)
+..+++|+.|++++|.+.+.++......+|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|. +..+
T Consensus 217 ~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L----- 290 (313)
T d1ogqa_ 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNL----- 290 (313)
T ss_dssp CCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTG-----
T ss_pred ccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccC-----
Confidence 8889999999999999998877665566999999999999999999999999999999999999999995 3444
Q ss_pred CcceeEEcCCCC-CCCC
Q 003158 237 TETFILDFQNNN-LTNI 252 (843)
Q Consensus 237 ~~L~~L~l~~N~-l~~~ 252 (843)
.+|+.+++++|+ +.+.
T Consensus 291 ~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 291 QRFDVSAYANNKCLCGS 307 (313)
T ss_dssp GGSCGGGTCSSSEEEST
T ss_pred CCCCHHHhCCCccccCC
Confidence 355689999997 4443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.2e-26 Score=235.84 Aligned_cols=212 Identities=25% Similarity=0.329 Sum_probs=128.9
Q ss_pred CCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEE
Q 003158 39 YLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLIL 118 (843)
Q Consensus 39 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 118 (843)
+...+.+++.++++|+ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.. + .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccc
Confidence 4455566677777776 4554442 4566677777776655555666666677777766666632 2 34556666666
Q ss_pred EcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCCCCCCCC--cCcCEEEccCCc
Q 003158 119 QLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLS--LNITTIKLSNNK 195 (843)
Q Consensus 119 ~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~ 195 (843)
+|++|+++. .+..+.++++|+.|++++|.+..+.+. +..+.+|+.|++++|.++ .++...+. .+|+.|++++|+
T Consensus 83 ~Ls~N~l~~--~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 83 DLSHNQLQS--LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp ECCSSCCSS--CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSC
T ss_pred ccccccccc--cccccccccccccccccccccceeeccccccccccccccccccccc-eeccccccccccchhccccccc
Confidence 666666652 455566666666666666666655553 555566666666666665 33322221 245555555555
Q ss_pred CCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCccccc
Q 003158 196 LTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLN 274 (843)
Q Consensus 196 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~c~ 274 (843)
|++..+..|..+++|++|+|++|+| +.+|..+ .++.++.|+|+||||.|+
T Consensus 160 l~~~~~~~~~~l~~L~~L~Ls~N~L-----------------------------~~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 160 LTELPAGLLNGLENLDTLLLQENSL-----------------------------YTIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCC-----------------------------CCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ccccCccccccccccceeecccCCC-----------------------------cccChhHCCCCCCCEEEecCCCCCCC
Confidence 5544444455555555555555554 4444433 466778899999999999
Q ss_pred CCcccccCCCCCC
Q 003158 275 TNAEQFCGSHSDD 287 (843)
Q Consensus 275 ~~~~~~~~~~~~~ 287 (843)
|.+.+|..|+...
T Consensus 211 C~~~~l~~wl~~~ 223 (266)
T d1p9ag_ 211 CEILYFRRWLQDN 223 (266)
T ss_dssp GGGHHHHHHHHHT
T ss_pred cchHHHHHHHHhc
Confidence 9999999887543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4e-25 Score=232.54 Aligned_cols=236 Identities=21% Similarity=0.261 Sum_probs=157.1
Q ss_pred CEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec-cC
Q 003158 20 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL-DN 98 (843)
Q Consensus 20 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L-~~ 98 (843)
..++.++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|+.|++++|+|..+.+..+.+++.+..+.. ..
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 34566777777 5565443 45677777777777555566777777777777777777666666777777777654 35
Q ss_pred CCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCC
Q 003158 99 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSI 177 (843)
Q Consensus 99 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~ 177 (843)
|.++...+..|.++++|++|+|++|.+.. ..+..+..+.+|+.+++++|+|+++++. |..+++|+.|++++|++++..
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cccccccchhhcccccCCEEecCCccccc-ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 55665556677777777777777777654 3345566667777777777777766653 666666777777777766322
Q ss_pred CCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC
Q 003158 178 PPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF 256 (843)
Q Consensus 178 p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~ 256 (843)
+..+.. .+|+.|++++|++++..|..|.++++|++|++++|++.+..+..|.
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~--------------------------- 222 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA--------------------------- 222 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHT---------------------------
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccc---------------------------
Confidence 222221 2566666666666666666666666666666666666654444443
Q ss_pred cCCCCcEEEeccCcccccCCcccccCCCCC
Q 003158 257 NIPPNVTVRLRGNPFCLNTNAEQFCGSHSD 286 (843)
Q Consensus 257 ~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~ 286 (843)
.++.+..|++++|||.|+|++.++..|+..
T Consensus 223 ~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~ 252 (284)
T d1ozna_ 223 PLRALQYLRLNDNPWVCDCRARPLWAWLQK 252 (284)
T ss_dssp TCTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred cccccCEEEecCCCCCCCccchHHHHHHHh
Confidence 355677899999999999999988888764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=2.6e-24 Score=228.75 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=217.9
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
++++ .+|..|. ++|++|+|++|+|+.+.+..|.++++|++|++++|.+....|..|.++++|+.|++++|+|+ .+|
T Consensus 20 ~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~ 95 (305)
T d1xkua_ 20 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELP 95 (305)
T ss_dssp SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCC
T ss_pred CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCc
Confidence 3567 7788774 68999999999999666678999999999999999999888899999999999999999999 455
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCC-CCCccccCCCCCcEEEcCCCCCCCCCCCCCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGT-TIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIP 161 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 161 (843)
..+ ...+..|++.+|.+....+..+.....+..++...|..... ..+..+..+++|+.+++++|.+..++..+ ++
T Consensus 96 ~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~ 171 (305)
T d1xkua_ 96 EKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PP 171 (305)
T ss_dssp SSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSC--CT
T ss_pred cch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCccc--CC
Confidence 433 36899999999999987777788889999999999876421 23557889999999999999998876543 68
Q ss_pred CCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcce
Q 003158 162 NLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETF 240 (843)
Q Consensus 162 ~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~ 240 (843)
+|+.|++++|.+++..+..+.. ..++.|++++|.+++..+..|.++++|++|+|++|+|+ .+|..+..++ +|+
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~-----~L~ 245 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK-----YIQ 245 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS-----SCC
T ss_pred ccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccccc-----CCC
Confidence 9999999999999766655443 38999999999999999999999999999999999998 6788876654 556
Q ss_pred eEEcCCCCCCCCCCCC--------cCCCCcEEEeccCcccc
Q 003158 241 ILDFQNNNLTNISGSF--------NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 241 ~L~l~~N~l~~~~~~~--------~~~~l~~l~l~~Np~~c 273 (843)
.|+|++|+|+.++... ..+.+..|+|.+|||.+
T Consensus 246 ~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp EEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred EEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 9999999999996532 46789999999999975
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=7.4e-23 Score=215.05 Aligned_cols=218 Identities=18% Similarity=0.233 Sum_probs=194.2
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEcc-CCccccCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMN-NNSISGQI 81 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~ 81 (843)
++++ ++|..|. +++++|+|++|+|+.+.+..|.++++|++|++++|++....+..+.++..++.+... .|.++...
T Consensus 21 ~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~ 97 (284)
T d1ozna_ 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97 (284)
T ss_dssp SCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCC
T ss_pred CCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccccccc
Confidence 4456 7777664 578999999999997777889999999999999999998888899999999998764 66788777
Q ss_pred CcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRI 160 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l 160 (843)
+..|.++++|++|++++|.+....+..+..+++|+.+++++|++++ ..+..|..+++|+.|+|++|+++.+++. |..+
T Consensus 98 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~-i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l 176 (284)
T d1ozna_ 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176 (284)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred chhhcccccCCEEecCCcccccccccccchhcccchhhhccccccc-cChhHhccccchhhcccccCcccccchhhhccc
Confidence 8889999999999999999998778889999999999999999985 4467899999999999999999998874 8999
Q ss_pred CCCCEEEcccCcCCCCCCCCCCC-cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCC
Q 003158 161 PNLGYLDLSSNQLNGSIPPGRLS-LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSI 224 (843)
Q Consensus 161 ~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 224 (843)
++|+.|++++|++++..|..+.. .+|+.|++++|.+++..+..|..+++|++|+|++|.+.+.-
T Consensus 177 ~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred cccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 99999999999999766766554 38999999999999999999999999999999999998643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=8.6e-22 Score=204.61 Aligned_cols=201 Identities=22% Similarity=0.272 Sum_probs=173.5
Q ss_pred cCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCce
Q 003158 14 GNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVH 93 (843)
Q Consensus 14 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 93 (843)
.+...+.+++.++++|+ .+|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.. + .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 45667788899999999 5787664 6799999999999977778899999999999999999844 3 4678999999
Q ss_pred eeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCc
Q 003158 94 MLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQ 172 (843)
Q Consensus 94 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~ 172 (843)
|+|++|+++ ..+..+..+++|++|++++|.+.. ..+..+..+.+|+.|++++|.++.+++. +..+++|+.|++++|+
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~-~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCC-CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred ccccccccc-ccccccccccccccccccccccce-eeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 999999999 457789999999999999999975 4567788999999999999999998885 7889999999999999
Q ss_pred CCCCCCCCCC-CcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCC
Q 003158 173 LNGSIPPGRL-SLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSG 222 (843)
Q Consensus 173 l~~~~p~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 222 (843)
|++..+..+. ..+|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 9955444443 348999999999999 788888899999999999999874
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1.2e-21 Score=214.74 Aligned_cols=248 Identities=27% Similarity=0.338 Sum_probs=164.5
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+|+. + +.|..+++|++|+|++|+|++. + .|+++++|++|++++|++.+..+ +.++++|+.|++++|.+++..
T Consensus 53 ~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~~~ 126 (384)
T d2omza2 53 RLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID 126 (384)
T ss_dssp SSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccccc--ccccccccccccccccccccc
Confidence 456663 3 4688899999999999999954 3 39999999999999999985433 889999999999988776321
Q ss_pred ---------------------------------------------------------------CcccCCCCCCceeeccC
Q 003158 82 ---------------------------------------------------------------PPELSRLPSLVHMLLDN 98 (843)
Q Consensus 82 ---------------------------------------------------------------~~~l~~l~~L~~L~L~~ 98 (843)
...+..+++++.+++++
T Consensus 127 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~ 206 (384)
T d2omza2 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATN 206 (384)
T ss_dssp GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccC
Confidence 12344567788889999
Q ss_pred CCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCC
Q 003158 99 NNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIP 178 (843)
Q Consensus 99 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 178 (843)
|.+++..+ +..+++|++|++++|+++. ...+..+++|+.|++++|.++++++ +..+++|+.|++++|.+++ ++
T Consensus 207 n~i~~~~~--~~~~~~L~~L~l~~n~l~~---~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~-~~ 279 (384)
T d2omza2 207 NQISDITP--LGILTNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISN-IS 279 (384)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCC---CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCC-CG
T ss_pred CccCCCCc--ccccCCCCEEECCCCCCCC---cchhhcccccchhccccCccCCCCc-ccccccCCEeeccCcccCC-CC
Confidence 99886544 4556788999999998864 3467788889999999988887654 7778888888888888874 33
Q ss_pred CCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcC
Q 003158 179 PGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNI 258 (843)
Q Consensus 179 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~ 258 (843)
.......++.+++++|.+++. ..+..+++++.|++++|++++..+ +.. .++|+.|++++|+|+.++....+
T Consensus 280 ~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~-----l~~L~~L~L~~n~l~~l~~l~~l 350 (384)
T d2omza2 280 PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSS-----LTKLQRLFFANNKVSDVSSLANL 350 (384)
T ss_dssp GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGG-----CTTCCEEECCSSCCCCCGGGGGC
T ss_pred ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--ccc-----CCCCCEEECCCCCCCCChhHcCC
Confidence 322223455555555555431 234445555555555555543221 222 12334555555555554432245
Q ss_pred CCCcEEEeccCcc
Q 003158 259 PPNVTVRLRGNPF 271 (843)
Q Consensus 259 ~~l~~l~l~~Np~ 271 (843)
++|+.|++++|.+
T Consensus 351 ~~L~~L~l~~N~l 363 (384)
T d2omza2 351 TNINWLSAGHNQI 363 (384)
T ss_dssp TTCCEEECCSSCC
T ss_pred CCCCEEECCCCcC
Confidence 5555555555544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.87 E-value=2.6e-21 Score=205.30 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=207.6
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
.++.++=++++++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 5788999999999 6777664 689999999999996666789999999999999999998888999999999999999
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC---CCCCCCCCCEEEcccCcCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP---DLSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~ 174 (843)
+|+|+ .+|..+. ..|..|++++|.+.+ ..+..+.....+..+++..|....... .+..+++|+.+++++|.++
T Consensus 88 ~n~l~-~l~~~~~--~~l~~L~~~~n~l~~-l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 88 KNQLK-ELPEKMP--KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCccC-cCccchh--hhhhhhhccccchhh-hhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 99999 4554443 689999999999975 334567788899999999987654322 3788999999999999998
Q ss_pred CCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCC
Q 003158 175 GSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG 254 (843)
Q Consensus 175 ~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~ 254 (843)
.+|... ..+|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+..+. +|+.|+|++|+|+++|.
T Consensus 164 -~l~~~~-~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~-----~L~~L~L~~N~L~~lp~ 236 (305)
T d1xkua_ 164 -TIPQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP-----HLRELHLNNNKLVKVPG 236 (305)
T ss_dssp -SCCSSC-CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST-----TCCEEECCSSCCSSCCT
T ss_pred -ccCccc-CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc-----cceeeeccccccccccc
Confidence 676654 45899999999999999999999999999999999999988888777654 56699999999999987
Q ss_pred CC-cCCCCcEEEeccCccc
Q 003158 255 SF-NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 255 ~~-~~~~l~~l~l~~Np~~ 272 (843)
.+ .++.|+.|++++|.+.
T Consensus 237 ~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 237 GLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TTTTCSSCCEEECCSSCCC
T ss_pred ccccccCCCEEECCCCccC
Confidence 66 7999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.1e-22 Score=200.10 Aligned_cols=133 Identities=14% Similarity=0.128 Sum_probs=106.4
Q ss_pred CCCCcccccCCeeEEEEEeCCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHHhccCCcccceeee
Q 003158 514 NSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSL------------------QGEKEFLTEIQFLSRLHHRNLVSLVGY 575 (843)
Q Consensus 514 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 575 (843)
.+.++||+|+||+||+|...+|+.||||+++.... ........|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35678999999999999988999999998753211 012345678899999999999988766
Q ss_pred eecCCcEEEEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCCCCCEEeccCCCCcEEEcCCCcEEEee
Q 003158 576 CDEEGEQMLVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEADPPVFHRDIKASNILLDHKFTAKVAD 655 (843)
Q Consensus 576 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 655 (843)
.. .++||||++++.+.+ ++......++.|+++|++|||+++ |+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 42 379999998755433 344556789999999999999999 9999999999999965 589999
Q ss_pred ccccccCC
Q 003158 656 FGLSRLAP 663 (843)
Q Consensus 656 fGla~~~~ 663 (843)
||.|....
T Consensus 146 FG~a~~~~ 153 (191)
T d1zara2 146 FPQSVEVG 153 (191)
T ss_dssp CTTCEETT
T ss_pred CCCcccCC
Confidence 99997654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=7.2e-21 Score=208.44 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=201.6
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
+++++.+. ...+.+|++|++++|+|+. + +.+..|++|++|+|++|+|++.. .+.++++|++|++++|.|++..
T Consensus 32 ~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~- 104 (384)
T d2omza2 32 TNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT- 104 (384)
T ss_dssp SSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG-
T ss_pred CCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc-
Confidence 44555543 3567899999999999994 3 56889999999999999999654 3999999999999999998553
Q ss_pred cccCCCCCCceeeccCCCCCCCC---------------------------------------------------------
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYL--------------------------------------------------------- 105 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~--------------------------------------------------------- 105 (843)
.++.+++|+.|++++|.+++..
T Consensus 105 -~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (384)
T d2omza2 105 -PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183 (384)
T ss_dssp -GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECC
T ss_pred -cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccc
Confidence 3899999999999998876321
Q ss_pred ------CcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCC
Q 003158 106 ------PPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPP 179 (843)
Q Consensus 106 ------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 179 (843)
...+..+++++.|++++|.+++. + .+..+++|+.|++++|.++.+ +.+..+++|+.|++++|.+++ ++.
T Consensus 184 ~~~~~~~~~~~~l~~~~~l~l~~n~i~~~--~-~~~~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~-~~~ 258 (384)
T d2omza2 184 SNKVSDISVLAKLTNLESLIATNNQISDI--T-PLGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISN-LAP 258 (384)
T ss_dssp SSCCCCCGGGGGCTTCSEEECCSSCCCCC--G-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC-CGG
T ss_pred ccccccccccccccccceeeccCCccCCC--C-cccccCCCCEEECCCCCCCCc-chhhcccccchhccccCccCC-CCc
Confidence 12344568899999999999752 2 356778999999999999975 357889999999999999995 444
Q ss_pred CCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCC
Q 003158 180 GRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIP 259 (843)
Q Consensus 180 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~ 259 (843)
.....+|+.|++++|.+++.. .+..++.++.+++++|.+++. ..+..+ ++++.|++++|+|+++++...++
T Consensus 259 ~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~-----~~l~~L~ls~n~l~~l~~l~~l~ 329 (384)
T d2omza2 259 LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNL-----KNLTYLTLYFNNISDISPVSSLT 329 (384)
T ss_dssp GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGC-----TTCSEEECCSSCCSCCGGGGGCT
T ss_pred ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchh-----cccCeEECCCCCCCCCcccccCC
Confidence 444568999999999998653 488999999999999999852 233333 45669999999999997655899
Q ss_pred CCcEEEeccCccc
Q 003158 260 PNVTVRLRGNPFC 272 (843)
Q Consensus 260 ~l~~l~l~~Np~~ 272 (843)
+++.|++++|.+.
T Consensus 330 ~L~~L~L~~n~l~ 342 (384)
T d2omza2 330 KLQRLFFANNKVS 342 (384)
T ss_dssp TCCEEECCSSCCC
T ss_pred CCCEEECCCCCCC
Confidence 9999999999875
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=1.3e-18 Score=175.80 Aligned_cols=186 Identities=20% Similarity=0.318 Sum_probs=88.5
Q ss_pred EEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCC
Q 003158 21 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNN 100 (843)
Q Consensus 21 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 100 (843)
.++++.+++++.. .+..+.+|++|++.+|+|+. ++ .+..+++|++|++++|.+++..+ +..+++|+.+++++|.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 3444444444322 23344555555555555552 22 34555555555555555543322 4555555555555555
Q ss_pred CCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCC
Q 003158 101 LTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPG 180 (843)
Q Consensus 101 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 180 (843)
++.. ..+.++++|+.+++++|...+ ...+...+.+..+.++.+.+.... .+..+++|+.|++++|.+++ .+..
T Consensus 97 ~~~i--~~l~~l~~L~~l~l~~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~~-~~~l 169 (227)
T d1h6ua2 97 LKNV--SAIAGLQSIKTLDLTSTQITD---VTPLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSD-LTPL 169 (227)
T ss_dssp CSCC--GGGTTCTTCCEEECTTSCCCC---CGGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCC-CGGG
T ss_pred cccc--ccccccccccccccccccccc---cchhccccchhhhhchhhhhchhh-hhcccccccccccccccccc-chhh
Confidence 5421 234455555555555555432 222444455555555555544322 23444555555555555542 2222
Q ss_pred CCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCC
Q 003158 181 RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 181 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 221 (843)
....+|+.|+|++|++++. + .|+++++|++|+|++|+|+
T Consensus 170 ~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp TTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCC
T ss_pred cccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCC
Confidence 2223555555555555532 2 2555566666666666655
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=7.6e-18 Score=171.78 Aligned_cols=209 Identities=16% Similarity=0.191 Sum_probs=152.8
Q ss_pred CCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC-CcccCCCCCCceeecc
Q 003158 19 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI-PPELSRLPSLVHMLLD 97 (843)
Q Consensus 19 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~ 97 (843)
.+.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.++++++++.+.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 367888888888 6665543 57888899988888666667888888999999888876543 4567888888888765
Q ss_pred -CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCC-CCCEEEcccCcCC
Q 003158 98 -NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIP-NLGYLDLSSNQLN 174 (843)
Q Consensus 98 -~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~-~L~~L~Ls~N~l~ 174 (843)
.|++....+..|.++++|+.|++++|.+........+..+..+..+...++.+..+... +..++ .++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 46777777778888889999999988886432233455566677777788888877663 66554 7888999999998
Q ss_pred CCCCCCCC-CcCcCEE-EccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhcc
Q 003158 175 GSIPPGRL-SLNITTI-KLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQS 231 (843)
Q Consensus 175 ~~~p~~~~-~~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 231 (843)
.++...+ ..+++.+ ++++|+|+...+..|.++++|++|+|++|+|+...+..|..+
T Consensus 167 -~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 167 -EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp -EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred -ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 4554433 3455544 578888886666778999999999999999984434344443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=7.5e-18 Score=170.05 Aligned_cols=209 Identities=20% Similarity=0.318 Sum_probs=171.7
Q ss_pred CCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEE
Q 003158 40 LPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQ 119 (843)
Q Consensus 40 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 119 (843)
|.++..++++.+++++.. .++.+.+|+.|++.+|.|+.. ..+.++++|++|+|++|++++.. .+..+++|++|+
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--cccccccccccc
Confidence 455566788888888654 478899999999999999954 45899999999999999999653 489999999999
Q ss_pred cCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCC
Q 003158 120 LDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGT 199 (843)
Q Consensus 120 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~ 199 (843)
+++|.++. + ..+..+++|+.|++++|...+..+ +...+.+..+.++.+.+.. ........+|+.|++++|.++..
T Consensus 92 ~~~n~~~~--i-~~l~~l~~L~~l~l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~-~~~~~~~~~L~~L~l~~n~~~~~ 166 (227)
T d1h6ua2 92 LSGNPLKN--V-SAIAGLQSIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQVSDL 166 (227)
T ss_dssp CCSCCCSC--C-GGGTTCTTCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCCC
T ss_pred cccccccc--c-ccccccccccccccccccccccch-hccccchhhhhchhhhhch-hhhhccccccccccccccccccc
Confidence 99999864 3 458899999999999998876533 6778899999999999974 33334445899999999999854
Q ss_pred CCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEecc
Q 003158 200 IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLRG 268 (843)
Q Consensus 200 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~ 268 (843)
..+.++++|++|+|++|++++ ++. +..+ ++|+.|+|++|+|+++++...++.|+.|++++
T Consensus 167 --~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l-----~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 --TPLANLSKLTTLKADDNKISD-ISP-LASL-----PNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226 (227)
T ss_dssp --GGGTTCTTCCEEECCSSCCCC-CGG-GGGC-----TTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred --hhhcccccceecccCCCccCC-Chh-hcCC-----CCCCEEECcCCcCCCCcccccCCCCCEEEeeC
Confidence 348999999999999999985 332 4443 46779999999999998766899999999863
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.2e-17 Score=166.32 Aligned_cols=185 Identities=23% Similarity=0.317 Sum_probs=140.4
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
++...++..+.+++.++. ..+.+|++|++++|.++... .+..+++|++|+|++|+|++.. .++.+++|+.|+++
T Consensus 25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred HHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccc
Confidence 344456777777755553 35678888888888888433 3788888889999888888543 36788888999998
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 177 (843)
+|+|++. + .+.++++|+.|++++|.+.. ...+..+++|+.+++++|.++... .+..+++|+.+++++|++++ +
T Consensus 99 ~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~---~~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~-i 171 (210)
T d1h6ta2 99 ENKVKDL-S-SLKDLKKLKSLSLEHNGISD---INGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISD-I 171 (210)
T ss_dssp SSCCCCG-G-GGTTCTTCCEEECTTSCCCC---CGGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCC-C
T ss_pred ccccccc-c-cccccccccccccccccccc---cccccccccccccccccccccccc-cccccccccccccccccccc-c
Confidence 8888853 3 58888889999998888753 345778888899999888887543 46678889999999998884 4
Q ss_pred CCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcC
Q 003158 178 PPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 217 (843)
Q Consensus 178 p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 217 (843)
+......+|+.|+|++|+|+. ++ .|.++++|++|+|++
T Consensus 172 ~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 443344589999999999884 44 699999999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=7.2e-18 Score=166.41 Aligned_cols=145 Identities=26% Similarity=0.371 Sum_probs=81.6
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
++..+.++.+.+++.+. ...+.+|++|++++|.++. + +.+..+++|++|+|++|+|++..+ +.++++|++|+++
T Consensus 19 ~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~ 92 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 92 (199)
T ss_dssp HHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccc
Confidence 33344555666554333 2345666666666666663 2 235666666666666666664322 6666666666666
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLN 174 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 174 (843)
+|.+... + .+.+++.|+.|++++|.+.. ...+..+++|+.|++++|++..+ +.+..+++|+.|++++|+++
T Consensus 93 ~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~---~~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 93 NNQIADI-T-PLANLTNLTGLTLFNNQITD---IDPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp SSCCCCC-G-GGTTCTTCSEEECCSSCCCC---CGGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCC
T ss_pred ccccccc-c-cccccccccccccccccccc---ccccchhhhhHHhhhhhhhhccc-cccccccccccccccccccc
Confidence 6666532 2 35666666666666666542 22355566666666666665543 23555556666666666555
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=4.9e-18 Score=166.57 Aligned_cols=170 Identities=20% Similarity=0.293 Sum_probs=85.7
Q ss_pred EEEcccCcCCccCccccccCCCCCEEEccCCccccC-CCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCC
Q 003158 45 RIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ-IPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 123 (843)
Q Consensus 45 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 123 (843)
.++.++|+++ .+|..+. +++++|+|++|+|+.. .+..|.++++|+.|+|++|++....+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4444444444 3333321 3455555555555432 2334455555555555555555555555555555555555555
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-CCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCc
Q 003158 124 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-LSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPS 202 (843)
Q Consensus 124 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~ 202 (843)
+|.. ..+..|.++++|++|+|++|+|+++++. |..+++|++|+|++|.+........+...++.+.+..|.++...|.
T Consensus 89 ~l~~-l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred cccc-cCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence 5553 2344555666666666666666665553 5666666666666666653222111111344444455555544443
Q ss_pred ccCCCCCCcEEeCcCccCC
Q 003158 203 NFSGLPRLQRLFIANNSLS 221 (843)
Q Consensus 203 ~~~~l~~L~~L~L~~N~l~ 221 (843)
.+. .++.++|+.|.+.
T Consensus 168 ~l~---~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 168 KVR---DVQIKDLPHSEFK 183 (192)
T ss_dssp TTT---TSBGGGSCTTTCC
T ss_pred hhc---CCEeeecCHhhCc
Confidence 332 2344455555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=3e-17 Score=167.31 Aligned_cols=210 Identities=20% Similarity=0.240 Sum_probs=166.4
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccC-ccccccCCCCCEEEccC-CccccC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSL-PKSFANLNKTRHFHMNN-NSISGQ 80 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~-N~l~~~ 80 (843)
++++ .+|+.+. +++++|+|++|+|+.+.+..|.++++|++|+|++|.+...+ +..|.+++++++|.+.. |.+...
T Consensus 18 ~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~ 94 (242)
T d1xwdc1 18 SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI 94 (242)
T ss_dssp CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEE
T ss_pred CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccc
Confidence 4566 7887664 58999999999999777778999999999999999987544 56789999999998764 688878
Q ss_pred CCcccCCCCCCceeeccCCCCCCCCCc-ccCCCCCCcEEEcCCCCCCCCCCCccccCCC-CCcEEEcCCCCCCCCCCCCC
Q 003158 81 IPPELSRLPSLVHMLLDNNNLTGYLPP-ELSELPKLLILQLDNNNFEGTTIPASYSNMS-KLLKLSLRNCSLQGPMPDLS 158 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~ 158 (843)
.+..|.++++|+.|++++|++....+. .+..+..+..+..+++.+.. ..+..|.+++ .++.|++++|+++.+.....
T Consensus 95 ~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~-i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~ 173 (242)
T d1xwdc1 95 NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT-IERNSFVGLSFESVILWLNKNGIQEIHNCAF 173 (242)
T ss_dssp CTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE-ECTTSSTTSBSSCEEEECCSSCCCEECTTTT
T ss_pred ccccccccccccccccchhhhccccccccccccccccccccccccccc-ccccccccccccceeeecccccccccccccc
Confidence 888899999999999999999854332 34456677777778888864 2345666654 79999999999999888766
Q ss_pred CCCCCCEE-EcccCcCCCCCCCCCCC--cCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcC
Q 003158 159 RIPNLGYL-DLSSNQLNGSIPPGRLS--LNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIAN 217 (843)
Q Consensus 159 ~l~~L~~L-~Ls~N~l~~~~p~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 217 (843)
...++..+ ++++|+++ .+|...+. .+|+.|+|++|.|+...+..|.++++|+.|++.+
T Consensus 174 ~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 174 NGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp TTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 66666555 57888898 67765443 5999999999999977677788888888776643
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=4.7e-17 Score=160.45 Aligned_cols=158 Identities=25% Similarity=0.421 Sum_probs=133.6
Q ss_pred ccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCC
Q 003158 3 NKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIP 82 (843)
Q Consensus 3 N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 82 (843)
+++++.++ ...+.+|+.|++++|+++. + +.++.+++|++|+|++|++++..+ +.++++|+.|++++|.+... +
T Consensus 28 ~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~ 100 (199)
T d2omxa2 28 TNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T 100 (199)
T ss_dssp SSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G
T ss_pred CCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c
Confidence 45555443 3467899999999999994 3 458899999999999999996543 99999999999999999843 3
Q ss_pred cccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCC
Q 003158 83 PELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPN 162 (843)
Q Consensus 83 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 162 (843)
.+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++.+|+++++++ +.++++
T Consensus 101 -~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~--~-~~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~ 173 (199)
T d2omxa2 101 -PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--I-SALSGLTSLQQLNFSSNQVTDLKP-LANLTT 173 (199)
T ss_dssp -GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC--C-GGGTTCTTCSEEECCSSCCCCCGG-GTTCTT
T ss_pred -ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc--c-ccccccccccccccccccccCCcc-ccCCCC
Confidence 489999999999999999853 458899999999999999963 3 468899999999999999998654 788899
Q ss_pred CCEEEcccCcCC
Q 003158 163 LGYLDLSSNQLN 174 (843)
Q Consensus 163 L~~L~Ls~N~l~ 174 (843)
|+.|++++|+++
T Consensus 174 L~~L~ls~N~i~ 185 (199)
T d2omxa2 174 LERLDISSNKVS 185 (199)
T ss_dssp CCEEECCSSCCC
T ss_pred CCEEECCCCCCC
Confidence 999999988887
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.6e-17 Score=162.76 Aligned_cols=184 Identities=23% Similarity=0.367 Sum_probs=127.4
Q ss_pred CCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcC
Q 003158 42 KLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLD 121 (843)
Q Consensus 42 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 121 (843)
++....+..+.+++.++ ...+.+|+.|++++|.++... .+..+++|++|+|++|+|++.. .++.+++|++|+++
T Consensus 25 ~~i~~~l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred HHHHHHhCcCccCCccC--HHHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccc
Confidence 34445666677765544 245677888888888887442 3677888888888888887542 46778888888888
Q ss_pred CCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCC
Q 003158 122 NNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIP 201 (843)
Q Consensus 122 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p 201 (843)
+|++++ ++ .+.++++|+.|++++|.+..+ +.+..+++|+.++++.|.++ ..+......+|+.+++++|++++. +
T Consensus 99 ~n~i~~--l~-~l~~l~~L~~L~l~~~~~~~~-~~l~~l~~l~~l~~~~n~l~-~~~~~~~l~~L~~l~l~~n~l~~i-~ 172 (210)
T d1h6ta2 99 ENKVKD--LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDI-V 172 (210)
T ss_dssp SSCCCC--GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCC-CCGGGGGCTTCSEEECCSSCCCCC-G
T ss_pred cccccc--cc-ccccccccccccccccccccc-cccccccccccccccccccc-cccccccccccccccccccccccc-c
Confidence 888863 34 477788888888888887653 34677788888888888887 333333334788888888888753 2
Q ss_pred cccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcC
Q 003158 202 SNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQ 245 (843)
Q Consensus 202 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~ 245 (843)
.+.++++|++|+|++|+|+. +| .+..+ ++|++|+|+
T Consensus 173 -~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l-----~~L~~L~Ls 208 (210)
T d1h6ta2 173 -PLAGLTKLQNLYLSKNHISD-LR-ALAGL-----KNLDVLELF 208 (210)
T ss_dssp -GGTTCTTCCEEECCSSCCCB-CG-GGTTC-----TTCSEEEEE
T ss_pred -cccCCCCCCEEECCCCCCCC-Ch-hhcCC-----CCCCEEEcc
Confidence 37788888888888888873 33 34433 345577775
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.70 E-value=1.3e-15 Score=163.56 Aligned_cols=229 Identities=26% Similarity=0.327 Sum_probs=137.9
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
+|++|||++|+|+ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++. + .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--cccccccccc
Confidence 5677777777776 45543 356677777777777 45543 346667777777766 2222 1 1356777777
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCC-----------------CCCccccCCCCCcEEEcCCCCCCCCC------
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGT-----------------TIPASYSNMSKLLKLSLRNCSLQGPM------ 154 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------~~~~~~~~l~~L~~L~L~~N~l~~~~------ 154 (843)
+|.++. +| .++.+++|+.|++++|.+... .....+..++.++.|++.+|.+...+
T Consensus 107 ~n~l~~-lp-~~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 107 NNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp SSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred cccccc-cc-chhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 777763 34 245667777777766665421 11223455667777777777654421
Q ss_pred -------------CCCCCCCCCCEEEcccCcCCCCCCCCCC------------------CcCcCEEEccCCcCCCC----
Q 003158 155 -------------PDLSRIPNLGYLDLSSNQLNGSIPPGRL------------------SLNITTIKLSNNKLTGT---- 199 (843)
Q Consensus 155 -------------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------------------~~~L~~L~Ls~N~l~~~---- 199 (843)
+.+..++.|+.+++++|... .++.... ..++..+++..|.+.+.
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~ 263 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCC
T ss_pred ccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22455677788888877765 3332111 01233344443333211
Q ss_pred ------------CCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCCcCCCCcEEEec
Q 003158 200 ------------IPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSFNIPPNVTVRLR 267 (843)
Q Consensus 200 ------------~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~ 267 (843)
+......+++|++|+|++|+|+ .+|.. .++|+.|+|++|+|++++.. +++++.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~--------~~~L~~L~L~~N~L~~l~~~--~~~L~~L~L~ 332 (353)
T d1jl5a_ 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--------PPRLERLIASFNHLAEVPEL--PQNLKQLHVE 332 (353)
T ss_dssp TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC--------CTTCCEEECCSSCCSCCCCC--CTTCCEEECC
T ss_pred chhcccccccCccccccccCCCCCEEECCCCccC-ccccc--------cCCCCEEECCCCcCCccccc--cCCCCEEECc
Confidence 1111233578999999999998 56653 24677899999999988753 4578899999
Q ss_pred cCccc
Q 003158 268 GNPFC 272 (843)
Q Consensus 268 ~Np~~ 272 (843)
+|++.
T Consensus 333 ~N~L~ 337 (353)
T d1jl5a_ 333 YNPLR 337 (353)
T ss_dssp SSCCS
T ss_pred CCcCC
Confidence 99875
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=6.2e-18 Score=165.86 Aligned_cols=174 Identities=15% Similarity=0.207 Sum_probs=124.9
Q ss_pred CCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCc-cCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeecc
Q 003158 19 LELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISG-SLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLD 97 (843)
Q Consensus 19 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 97 (843)
.++++.++++|+ .+|..+. +++++|+|++|+|+. ..+..|.++++|+.|+|++|.+....+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 457888888888 5666553 678888888888875 345667888888888888888887778888888888888888
Q ss_pred CCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCC
Q 003158 98 NNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSI 177 (843)
Q Consensus 98 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 177 (843)
+|+|+.+.+.+|.++++|++|+|++|+|+. ..+..|..+++|++|+|++|.+........-...|+.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~-i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccc-cCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCC
Confidence 888887777788888888888888888875 3466788888888888888887754432111123455566667766555
Q ss_pred CCCCCCcCcCEEEccCCcCCC
Q 003158 178 PPGRLSLNITTIKLSNNKLTG 198 (843)
Q Consensus 178 p~~~~~~~L~~L~Ls~N~l~~ 198 (843)
|.... +++.++|+.|.++-
T Consensus 166 p~~l~--~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 166 PSKVR--DVQIKDLPHSEFKC 184 (192)
T ss_dssp STTTT--TSBGGGSCTTTCCC
T ss_pred Chhhc--CCEeeecCHhhCcC
Confidence 54332 45556777777763
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.65 E-value=1.6e-14 Score=154.90 Aligned_cols=236 Identities=28% Similarity=0.360 Sum_probs=163.5
Q ss_pred CccccccCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC
Q 003158 2 WNKISGSIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI 81 (843)
Q Consensus 2 ~N~i~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 81 (843)
+|+++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++. + .+.|++|++++|.+. .+
T Consensus 47 ~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~l 113 (353)
T d1jl5a_ 47 NLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KL 113 (353)
T ss_dssp TSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SC
T ss_pred CCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cc
Confidence 46777 67753 468999999999999 678654 57899999999988 3432 1 246999999999998 45
Q ss_pred CcccCCCCCCceeeccCCCCCCCC------------------CcccCCCCCCcEEEcCCCCCCCCC--------------
Q 003158 82 PPELSRLPSLVHMLLDNNNLTGYL------------------PPELSELPKLLILQLDNNNFEGTT-------------- 129 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~~~~------------------~~~~~~l~~L~~L~Ls~N~l~~~~-------------- 129 (843)
|. ++.+++|+.|++++|.+.... ...+..++.++.|++++|.+....
T Consensus 114 p~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~ 192 (353)
T d1jl5a_ 114 PE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNN 192 (353)
T ss_dssp CC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSS
T ss_pred cc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccc
Confidence 53 678999999999999876332 123455678888888888765310
Q ss_pred ---CCccccCCCCCcEEEcCCCCCCCCCCCCC-----------------CCCCCCEEEcccCcCCCC--CCCC-------
Q 003158 130 ---IPASYSNMSKLLKLSLRNCSLQGPMPDLS-----------------RIPNLGYLDLSSNQLNGS--IPPG------- 180 (843)
Q Consensus 130 ---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----------------~l~~L~~L~Ls~N~l~~~--~p~~------- 180 (843)
....+..++.|+.+++++|.....+.... ...++..+++..|.+.+. .+..
T Consensus 193 ~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~ 272 (353)
T d1jl5a_ 193 ILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272 (353)
T ss_dssp CCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhcccccc
Confidence 11234567889999999988776443211 123344455444443321 1110
Q ss_pred --------CCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCC
Q 003158 181 --------RLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNI 252 (843)
Q Consensus 181 --------~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~ 252 (843)
....+|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ..+|+.|+|++|+|+.+
T Consensus 273 ~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~--------~~~L~~L~L~~N~L~~l 339 (353)
T d1jl5a_ 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL--------PQNLKQLHVEYNPLREF 339 (353)
T ss_dssp SSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC--------CTTCCEEECCSSCCSSC
T ss_pred cCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc--------cCCCCEEECcCCcCCCC
Confidence 01137999999999999 5564 4688999999999998 56653 23677999999999999
Q ss_pred CCCCcCCCCcEEEe
Q 003158 253 SGSFNIPPNVTVRL 266 (843)
Q Consensus 253 ~~~~~~~~l~~l~l 266 (843)
|.. ...+..|++
T Consensus 340 p~~--~~~L~~L~~ 351 (353)
T d1jl5a_ 340 PDI--PESVEDLRM 351 (353)
T ss_dssp CCC--CTTCCEEEC
T ss_pred Ccc--ccccCeeEC
Confidence 753 235666655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=3.9e-15 Score=140.79 Aligned_cols=128 Identities=17% Similarity=0.181 Sum_probs=72.1
Q ss_pred cCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCc
Q 003158 37 LGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLL 116 (843)
Q Consensus 37 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 116 (843)
|.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+.. +.|..+++|++|+|++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 445555556666666655 3344445556666666666666533 2355666666666666666644444445566666
Q ss_pred EEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCC----CCCCCCCCCEEE
Q 003158 117 ILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMP----DLSRIPNLGYLD 167 (843)
Q Consensus 117 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~ 167 (843)
.|+|++|++.....-..+..+++|++|++++|.++..+. .+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 666666666532111345666666666666666655543 145566666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=2.9e-14 Score=128.10 Aligned_cols=101 Identities=27% Similarity=0.420 Sum_probs=52.3
Q ss_pred CEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCC
Q 003158 20 ELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNN 99 (843)
Q Consensus 20 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 99 (843)
|+|+|++|+|+ .++ .++++++|++|++++|.|+ .+|..|..+++|+.|++++|.|+.. + .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 35566666665 333 2555555555555555555 3444555555555555555555532 2 3555555555555555
Q ss_pred CCCCCC-CcccCCCCCCcEEEcCCCCC
Q 003158 100 NLTGYL-PPELSELPKLLILQLDNNNF 125 (843)
Q Consensus 100 ~l~~~~-~~~~~~l~~L~~L~Ls~N~l 125 (843)
+|+... ...+..+++|+.|++++|.+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence 555322 13344455555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=3e-14 Score=133.71 Aligned_cols=136 Identities=18% Similarity=0.167 Sum_probs=88.2
Q ss_pred CCcEEEcCCCCCCCCCCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCCCCcEEeCcCc
Q 003158 139 KLLKLSLRNCSLQGPMPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLPRLQRLFIANN 218 (843)
Q Consensus 139 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 218 (843)
..+.++++++.+...+..+..+++|+.|++++|+ .|+.+.+..|.++++|+.|+|++|
T Consensus 9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~----------------------~l~~i~~~~f~~l~~L~~L~Ls~N 66 (156)
T d2ifga3 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQ----------------------HLQHLELRDLRGLGELRNLTIVKS 66 (156)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCS----------------------SCCEECGGGSCSCCCCSEEECCSS
T ss_pred CCCeEEecCCCCccCcccccCccccCeeecCCCc----------------------cccccCchhhccccccCcceeecc
Confidence 3444555555555554444444455555444332 355455566777777777777777
Q ss_pred cCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCCCC-cCCCCcEEEeccCcccccCCcccccCCCCCCCcccccCCCC
Q 003158 219 SLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISGSF-NIPPNVTVRLRGNPFCLNTNAEQFCGSHSDDDNEIDRSTNS 297 (843)
Q Consensus 219 ~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~~~-~~~~l~~l~l~~Np~~c~~~~~~~~~~~~~~~~~~~~~~~~ 297 (843)
+|+...|.+|..+. +|+.|+|++|+|+.++... ....+..|+|++|||.|+|.+.|+..|.......+. ..
T Consensus 67 ~l~~i~~~~f~~l~-----~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~---~~ 138 (156)
T d2ifga3 67 GLRFVAPDAFHFTP-----RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVP---EQ 138 (156)
T ss_dssp CCCEECTTGGGSCS-----CCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCG---GG
T ss_pred ccCCcccccccccc-----cccceeccCCCCcccChhhhccccccccccCCCcccCCchHHHHHHHHHhccCccC---cC
Confidence 77765566665543 3447777777777777654 455788999999999999999999999865544332 24
Q ss_pred CCCcCCC
Q 003158 298 TLDCRAQ 304 (843)
Q Consensus 298 ~~~c~~~ 304 (843)
.+.|.++
T Consensus 139 ~~~C~~p 145 (156)
T d2ifga3 139 KLQCHGQ 145 (156)
T ss_dssp CCCCSSS
T ss_pred CcEECcC
Confidence 5666653
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=8.6e-15 Score=138.40 Aligned_cols=129 Identities=22% Similarity=0.229 Sum_probs=110.7
Q ss_pred cccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCC
Q 003158 12 EIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSL 91 (843)
Q Consensus 12 ~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 91 (843)
.+.+..+|+.|+|++|+|+ .++..+..+++|+.|+|++|+|+. ++ .|..+++|++|++++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4668889999999999999 557778889999999999999994 43 58999999999999999997666667889999
Q ss_pred ceeeccCCCCCCCCC-cccCCCCCCcEEEcCCCCCCCCCCCc----cccCCCCCcEEEc
Q 003158 92 VHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPA----SYSNMSKLLKLSL 145 (843)
Q Consensus 92 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~~l~~L~~L~L 145 (843)
+.|+|++|+|+.... ..+..+++|++|++++|.++. .+. .+..+++|+.||-
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~--~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN--KKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG--STTHHHHHHHHCTTCSEETT
T ss_pred ccceeccccccccccccccccccccchhhcCCCcccc--ccchHHHHHHHCCCcCeeCC
Confidence 999999999985422 468899999999999999963 443 5788999999874
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=3.3e-14 Score=127.76 Aligned_cols=118 Identities=20% Similarity=0.323 Sum_probs=99.5
Q ss_pred cEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceeeccCCCCCCCCCcccCCCCCCcEEEcCCC
Q 003158 44 DRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLLDNNNLTGYLPPELSELPKLLILQLDNN 123 (843)
Q Consensus 44 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 123 (843)
+.|+|++|+|+ .++ .+.++++|++|++++|+|+ .+|..++.+++|+.|++++|+|+.. + .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 57999999999 444 4899999999999999998 6677899999999999999999954 3 5999999999999999
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC----CCCCCCCCEE
Q 003158 124 NFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD----LSRIPNLGYL 166 (843)
Q Consensus 124 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~l~~L~~L 166 (843)
++........+..+++|+.|++++|.++..... ...+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 998543345789999999999999999865432 4456777766
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=7.7e-16 Score=165.46 Aligned_cols=246 Identities=17% Similarity=0.225 Sum_probs=115.6
Q ss_pred CCccccCCCCCCEEEccCCcCCcc----CccccCCCCCCcEEEcccCcCCcc----------CccccccCCCCCEEEccC
Q 003158 9 IPKEIGNIKSLELLLLNGNELTGS----LPEELGYLPKLDRIQIDQNYISGS----------LPKSFANLNKTRHFHMNN 74 (843)
Q Consensus 9 ~p~~i~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----------~~~~~~~l~~L~~L~Ls~ 74 (843)
+..++.+..+|+.|+|++|.++.. +...+..+++|+.|+++++.+... +...+..+++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 344455566677777777766522 334455566677777666554311 112233445666666666
Q ss_pred CccccCC----CcccCCCCCCceeeccCCCCCCCCCcc-------------cCCCCCCcEEEcCCCCCCCCC---CCccc
Q 003158 75 NSISGQI----PPELSRLPSLVHMLLDNNNLTGYLPPE-------------LSELPKLLILQLDNNNFEGTT---IPASY 134 (843)
Q Consensus 75 N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N~l~~~~---~~~~~ 134 (843)
|.++... ...+..+++|+.|++++|.+....... ....+.|+.|++++|++.... +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 6655331 122334556666666666553110000 123345555555555553210 11123
Q ss_pred cCCCCCcEEEcCCCCCCCC------CCCCCCCCCCCEEEcccCcCCCCCCCCCCCcCcCEEEccCCcCCCCCCcccCCCC
Q 003158 135 SNMSKLLKLSLRNCSLQGP------MPDLSRIPNLGYLDLSSNQLNGSIPPGRLSLNITTIKLSNNKLTGTIPSNFSGLP 208 (843)
Q Consensus 135 ~~l~~L~~L~L~~N~l~~~------~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 208 (843)
..++.|+.|+|++|+++.. ...+..+++|+.|+|++|.++.... ..+...+..++
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~-------------------~~L~~~l~~~~ 243 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS-------------------SALAIALKSWP 243 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH-------------------HHHHHHGGGCT
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccc-------------------ccccccccccc
Confidence 3445555555555555421 1123444455555555554431100 01223444555
Q ss_pred CCcEEeCcCccCCCCCCchhhc-cccCCCCcceeEEcCCCCCCCCCC-----CC--cCCCCcEEEeccCcccc
Q 003158 209 RLQRLFIANNSLSGSIPSSIWQ-SRTLNATETFILDFQNNNLTNISG-----SF--NIPPNVTVRLRGNPFCL 273 (843)
Q Consensus 209 ~L~~L~L~~N~l~~~~p~~~~~-l~~l~~~~L~~L~l~~N~l~~~~~-----~~--~~~~l~~l~l~~Np~~c 273 (843)
+|++|+|++|.|++.....+.. +.....+.|+.|++++|+|+.-.. .. ..+.++.|+++||.+..
T Consensus 244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 6666666666655433333322 122233445566666666544211 11 34566666666666653
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=7e-16 Score=171.91 Aligned_cols=271 Identities=17% Similarity=0.175 Sum_probs=154.6
Q ss_pred CccccccC-CccccCCCCCCEEEccCCcCCc----cCccccCCCCCCcEEEcccCcCCccC----ccccc-cCCCCCEEE
Q 003158 2 WNKISGSI-PKEIGNIKSLELLLLNGNELTG----SLPEELGYLPKLDRIQIDQNYISGSL----PKSFA-NLNKTRHFH 71 (843)
Q Consensus 2 ~N~i~~~~-p~~i~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~ 71 (843)
+|+|++.- .+-+..+++|++|+|++|+|+. .+...+..+++|++|||++|+|+... ...+. ...+|++|+
T Consensus 11 ~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~ 90 (460)
T d1z7xw1 11 CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 90 (460)
T ss_dssp SCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEE
T ss_pred CCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEE
Confidence 56666521 2334567899999999999883 34566788999999999999986321 22222 235799999
Q ss_pred ccCCccccC----CCcccCCCCCCceeeccCCCCCCCCCc---------------------------------ccCCCCC
Q 003158 72 MNNNSISGQ----IPPELSRLPSLVHMLLDNNNLTGYLPP---------------------------------ELSELPK 114 (843)
Q Consensus 72 Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~---------------------------------~~~~l~~ 114 (843)
|++|+|+.. ++..+..+++|++|+|++|.++..... .+.....
T Consensus 91 L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (460)
T d1z7xw1 91 LQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 170 (460)
T ss_dssp CTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTT
T ss_pred CCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccc
Confidence 999998744 345678889999999999976421000 0011234
Q ss_pred CcEEEcCCCCCCC-----------------------------CC---CCccccCCCCCcEEEcCCCCC------------
Q 003158 115 LLILQLDNNNFEG-----------------------------TT---IPASYSNMSKLLKLSLRNCSL------------ 150 (843)
Q Consensus 115 L~~L~Ls~N~l~~-----------------------------~~---~~~~~~~l~~L~~L~L~~N~l------------ 150 (843)
++.++++++.+.. .. ....+...+.++.+++.+|.+
T Consensus 171 ~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~ 250 (460)
T d1z7xw1 171 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGL 250 (460)
T ss_dssp CCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhccc
Confidence 4444444333210 00 000112234444555554443
Q ss_pred -----------------CCCCC-----CCCCCCCCCEEEcccCcCCCCCCC------CCCCcCcCEEEccCCcCCCCCCc
Q 003158 151 -----------------QGPMP-----DLSRIPNLGYLDLSSNQLNGSIPP------GRLSLNITTIKLSNNKLTGTIPS 202 (843)
Q Consensus 151 -----------------~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~p~------~~~~~~L~~L~Ls~N~l~~~~p~ 202 (843)
..... .+...+.++.+++++|.+++.... ......|+.+++++|.++.....
T Consensus 251 ~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~ 330 (460)
T d1z7xw1 251 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS 330 (460)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhh
Confidence 22110 022334455555555544311000 01112678888888877754333
Q ss_pred ----ccCCCCCCcEEeCcCccCCCCCCchhhccccCCCCcceeEEcCCCCCCCCCC-----CC-cCCCCcEEEeccCccc
Q 003158 203 ----NFSGLPRLQRLFIANNSLSGSIPSSIWQSRTLNATETFILDFQNNNLTNISG-----SF-NIPPNVTVRLRGNPFC 272 (843)
Q Consensus 203 ----~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~l~~~~L~~L~l~~N~l~~~~~-----~~-~~~~l~~l~l~~Np~~ 272 (843)
.+...++|++|+|++|+|++.....+...-.-..+.|+.|+|++|+|+.... .. ..+.++.|+|++|++.
T Consensus 331 ~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 331 HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred hcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 2344567888888888886433233322111123457788888888876321 11 4678888888888864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=1e-14 Score=156.53 Aligned_cols=111 Identities=15% Similarity=0.096 Sum_probs=68.2
Q ss_pred CCCCCEEEcccCcCCCCCCCCC-----CCcCcCEEEccCCcCCCC-----CCcccCCCCCCcEEeCcCccCCCCCCchhh
Q 003158 160 IPNLGYLDLSSNQLNGSIPPGR-----LSLNITTIKLSNNKLTGT-----IPSNFSGLPRLQRLFIANNSLSGSIPSSIW 229 (843)
Q Consensus 160 l~~L~~L~Ls~N~l~~~~p~~~-----~~~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 229 (843)
.+.|+.|++++|.++...-..+ ...+|+.|+|++|.|+.. +...+..+++|+.|+|++|.++......+.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 3456666666665542110000 012566777777766531 234567789999999999998744333332
Q ss_pred c-cccCCCCcceeEEcCCCCCCCCCCC--------CcCCCCcEEEeccCccc
Q 003158 230 Q-SRTLNATETFILDFQNNNLTNISGS--------FNIPPNVTVRLRGNPFC 272 (843)
Q Consensus 230 ~-l~~l~~~~L~~L~l~~N~l~~~~~~--------~~~~~l~~l~l~~Np~~ 272 (843)
. +.. .++|+.|+|++|.|++.... ...+.++.|++++|.+.
T Consensus 237 ~~l~~--~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 237 IALKS--WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HHGGG--CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred ccccc--cccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 1 122 45788999999999864321 13467999999999863
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.4e-14 Score=150.72 Aligned_cols=220 Identities=19% Similarity=0.210 Sum_probs=112.6
Q ss_pred EEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccC-CCcccCCCCCCceeeccCC
Q 003158 21 LLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQ-IPPELSRLPSLVHMLLDNN 99 (843)
Q Consensus 21 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~N 99 (843)
.|||+++.+.......+.. ..+..+.++.+.+..... ......+|++|+|++|.++.. +...+.++++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5677766664221111111 234455555555442222 223445667777776666532 2334566667777777777
Q ss_pred CCCCCCCcccCCCCCCcEEEcCCC-CCCCCCCCccccCCCCCcEEEcCCC-CCCCC--CCCC-CCCCCCCEEEcccCc--
Q 003158 100 NLTGYLPPELSELPKLLILQLDNN-NFEGTTIPASYSNMSKLLKLSLRNC-SLQGP--MPDL-SRIPNLGYLDLSSNQ-- 172 (843)
Q Consensus 100 ~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~--~~~~-~~l~~L~~L~Ls~N~-- 172 (843)
.+++..+..+..+++|++|+|+++ .+++..+...+.++++|++|+|+++ .++.. ...+ ...++|+.|+++++.
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 161 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence 666555556666667777777663 4432112223345667777777664 33221 1111 123566777766542
Q ss_pred CCCC-CCCC-CCCcCcCEEEccCC-cCCCCCCcccCCCCCCcEEeCcCc-cCCCCCCchhhccccCCCCcceeEEcCCC
Q 003158 173 LNGS-IPPG-RLSLNITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANN-SLSGSIPSSIWQSRTLNATETFILDFQNN 247 (843)
Q Consensus 173 l~~~-~p~~-~~~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~l~~~~L~~L~l~~N 247 (843)
++.. +... ...++|++|+|++| .++......+..+++|++|+|+++ .+++.....+.+ .++|+.|+++++
T Consensus 162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~-----~~~L~~L~l~~~ 235 (284)
T d2astb2 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE-----IPTLKTLQVFGI 235 (284)
T ss_dssp SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG-----CTTCCEEECTTS
T ss_pred cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhc-----CCCCCEEeeeCC
Confidence 2211 0000 01125677777664 456555666667777777777773 455433333332 234556666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=1.1e-13 Score=143.79 Aligned_cols=200 Identities=18% Similarity=0.200 Sum_probs=134.8
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCcc-CccccccCCCCCEEEccCCccccCCCcccCCCCCCceeec
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGS-LPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHMLL 96 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 96 (843)
.+..+.++...+... ........+|++|||++|.++.. +...+..+++|++|+|++|.++......+..+++|+.|+|
T Consensus 24 ~~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 102 (284)
T d2astb2 24 GVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 102 (284)
T ss_dssp TCSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred cceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccc
Confidence 356677776666532 23344556888899988887743 3455778888999999888887666777888888999998
Q ss_pred cCC-CCCCCC-CcccCCCCCCcEEEcCCC-CCCCCCCCcccc-CCCCCcEEEcCCCC--CCCC-CCC-CCCCCCCCEEEc
Q 003158 97 DNN-NLTGYL-PPELSELPKLLILQLDNN-NFEGTTIPASYS-NMSKLLKLSLRNCS--LQGP-MPD-LSRIPNLGYLDL 168 (843)
Q Consensus 97 ~~N-~l~~~~-~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~-~l~~L~~L~L~~N~--l~~~-~~~-~~~l~~L~~L~L 168 (843)
+++ .+++.. ...+.++++|++|+|+++ .+++..+...+. ..++|+.|+++++. ++.. ... ...+++|+.|++
T Consensus 103 s~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L 182 (284)
T d2astb2 103 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182 (284)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred cccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccc
Confidence 884 555221 122346788999999885 343211222233 34688999988753 3321 111 356788999999
Q ss_pred ccCc-CCCCCCCCCC-CcCcCEEEccCC-cCCCCCCcccCCCCCCcEEeCcCc
Q 003158 169 SSNQ-LNGSIPPGRL-SLNITTIKLSNN-KLTGTIPSNFSGLPRLQRLFIANN 218 (843)
Q Consensus 169 s~N~-l~~~~p~~~~-~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N 218 (843)
++|. +++....... ..+|++|+|++| .++......++.+++|+.|+++++
T Consensus 183 ~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 8864 5543333222 247999999984 777777778889999999999987
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=9.2e-15 Score=143.22 Aligned_cols=145 Identities=21% Similarity=0.302 Sum_probs=106.5
Q ss_pred CCCCEEEccCC--cCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCcee
Q 003158 17 KSLELLLLNGN--ELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHM 94 (843)
Q Consensus 17 ~~L~~L~L~~n--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 94 (843)
..++.+++.++ .++ .++..+..|++|++|+|++|+|+. ++ .+..+++|+.|+|++|.|+ .++..+..+++|++|
T Consensus 23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L 98 (198)
T d1m9la_ 23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98 (198)
T ss_dssp TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEE
T ss_pred cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccc
Confidence 34566677655 344 566788888999999999999884 44 4888889999999999888 455555556788899
Q ss_pred eccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCCccccCCCCCcEEEcCCCCCCCCCCC-----------CCCCCCC
Q 003158 95 LLDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIPASYSNMSKLLKLSLRNCSLQGPMPD-----------LSRIPNL 163 (843)
Q Consensus 95 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----------~~~l~~L 163 (843)
++++|+|+.. +.+..+++|++|+|++|+++.......+..+++|+.|+|++|.+....+. +..+++|
T Consensus 99 ~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L 176 (198)
T d1m9la_ 99 WISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176 (198)
T ss_dssp ECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSC
T ss_pred cccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCc
Confidence 9999988853 45777888899999988886421114578888888888888887654432 3456777
Q ss_pred CEEE
Q 003158 164 GYLD 167 (843)
Q Consensus 164 ~~L~ 167 (843)
+.||
T Consensus 177 ~~LD 180 (198)
T d1m9la_ 177 KKLD 180 (198)
T ss_dssp CEES
T ss_pred CEeC
Confidence 7776
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=1.4e-14 Score=161.18 Aligned_cols=270 Identities=19% Similarity=0.150 Sum_probs=169.9
Q ss_pred Cccccc----cCCccccCCCCCCEEEccCCcCCcc----CccccCC-CCCCcEEEcccCcCCcc----CccccccCCCCC
Q 003158 2 WNKISG----SIPKEIGNIKSLELLLLNGNELTGS----LPEELGY-LPKLDRIQIDQNYISGS----LPKSFANLNKTR 68 (843)
Q Consensus 2 ~N~i~~----~~p~~i~~l~~L~~L~L~~n~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~ 68 (843)
+|+|+. .+...+..+++|+.|||++|+|+.. +...+.. ..+|++|+|++|+++.. ++..+..+++|+
T Consensus 36 ~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~ 115 (460)
T d1z7xw1 36 DCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 115 (460)
T ss_dssp SSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCC
T ss_pred CCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhcccccc
Confidence 355553 3455677889999999999999732 2333332 35799999999999854 455678899999
Q ss_pred EEEccCCccccCCC---------------------------------cccCCCCCCceeeccCC----------------
Q 003158 69 HFHMNNNSISGQIP---------------------------------PELSRLPSLVHMLLDNN---------------- 99 (843)
Q Consensus 69 ~L~Ls~N~l~~~~~---------------------------------~~l~~l~~L~~L~L~~N---------------- 99 (843)
+|+|++|.|+.... ..+.....++.++++++
T Consensus 116 ~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~ 195 (460)
T d1z7xw1 116 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKD 195 (460)
T ss_dssp EEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHH
T ss_pred ccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc
Confidence 99999998752100 00001123333333333
Q ss_pred -------------CCCC---------------------------------CCCcccCCCCCCcEEEcCCCCCCCCC---C
Q 003158 100 -------------NLTG---------------------------------YLPPELSELPKLLILQLDNNNFEGTT---I 130 (843)
Q Consensus 100 -------------~l~~---------------------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~---~ 130 (843)
.+.. ...........|+.|++++|.+.... .
T Consensus 196 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~ 275 (460)
T d1z7xw1 196 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 275 (460)
T ss_dssp SCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred ccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccc
Confidence 2110 00111223456777888887775311 1
Q ss_pred CccccCCCCCcEEEcCCCCCCCCCC-----C-CCCCCCCCEEEcccCcCCCCCCCCC-----CCcCcCEEEccCCcCCCC
Q 003158 131 PASYSNMSKLLKLSLRNCSLQGPMP-----D-LSRIPNLGYLDLSSNQLNGSIPPGR-----LSLNITTIKLSNNKLTGT 199 (843)
Q Consensus 131 ~~~~~~l~~L~~L~L~~N~l~~~~~-----~-~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~~~L~~L~Ls~N~l~~~ 199 (843)
...+...+.++.+++++|.++.... . ......|+.+++++|.++....... ...+|+.|+|++|.|+..
T Consensus 276 ~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~ 355 (460)
T d1z7xw1 276 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 355 (460)
T ss_dssp HHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred cccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCc
Confidence 2234567899999999999864211 1 2345689999999999874321111 112799999999999753
Q ss_pred ----CCcccC-CCCCCcEEeCcCccCCCCCCchhhc-cccCCCCcceeEEcCCCCCCCCCC-----CC--cCCCCcEEEe
Q 003158 200 ----IPSNFS-GLPRLQRLFIANNSLSGSIPSSIWQ-SRTLNATETFILDFQNNNLTNISG-----SF--NIPPNVTVRL 266 (843)
Q Consensus 200 ----~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~-l~~l~~~~L~~L~l~~N~l~~~~~-----~~--~~~~l~~l~l 266 (843)
++..+. ..+.|++|+|++|.|+......+.. +.. .++|+.|||++|+|+.-.. .. ....++.|++
T Consensus 356 g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~--~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l 433 (460)
T d1z7xw1 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA--NHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH--CCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred ccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhc--CCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEEC
Confidence 233343 5678999999999998543222221 111 2467799999999975221 11 2346889999
Q ss_pred ccCcccc
Q 003158 267 RGNPFCL 273 (843)
Q Consensus 267 ~~Np~~c 273 (843)
.+|.|..
T Consensus 434 ~~~~~~~ 440 (460)
T d1z7xw1 434 YDIYWSE 440 (460)
T ss_dssp TTCCCCH
T ss_pred CCCCCCH
Confidence 9998863
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=4.7e-12 Score=118.42 Aligned_cols=108 Identities=15% Similarity=0.113 Sum_probs=84.5
Q ss_pred CCCCEEEccCCcCCccCccccCCCCCCcEEEcccC-cCCccCccccccCCCCCEEEccCCccccCCCcccCCCCCCceee
Q 003158 17 KSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQN-YISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSRLPSLVHML 95 (843)
Q Consensus 17 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 95 (843)
...+.++.+++++. ..|..+..+++|++|+|++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 45567888888887 56777888888888888766 48766677788888888888888888877788888888888888
Q ss_pred ccCCCCCCCCCcccCCCCCCcEEEcCCCCCC
Q 003158 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFE 126 (843)
Q Consensus 96 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 126 (843)
|++|+|+...+..|.. ..|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 8888888544445544 46888888888875
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=2.6e-14 Score=139.87 Aligned_cols=131 Identities=20% Similarity=0.286 Sum_probs=108.6
Q ss_pred cCCccccCCCCCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCCCcccCC
Q 003158 8 SIPKEIGNIKSLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQIPPELSR 87 (843)
Q Consensus 8 ~~p~~i~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 87 (843)
.+|.+|..+++|++|+|++|+|+. ++ .+.++++|++|+|++|.|+ .++..+..+++|+.|++++|+|+.. ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 455788899999999999999994 44 5899999999999999998 5666667778999999999999854 45888
Q ss_pred CCCCceeeccCCCCCCCCC-cccCCCCCCcEEEcCCCCCCCCCCCc----------cccCCCCCcEEE
Q 003158 88 LPSLVHMLLDNNNLTGYLP-PELSELPKLLILQLDNNNFEGTTIPA----------SYSNMSKLLKLS 144 (843)
Q Consensus 88 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----------~~~~l~~L~~L~ 144 (843)
+++|+.|+|++|+|+.... ..+..+++|+.|+|++|.+.. ..+. .+..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN-DYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH-HHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCcccc-CcccccchhhHHHHHHHHCCCcCEeC
Confidence 9999999999999985422 468999999999999998853 1121 156789999986
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=7.1e-07 Score=90.08 Aligned_cols=148 Identities=14% Similarity=0.100 Sum_probs=101.0
Q ss_pred HHHHHHcCCCCCCcccccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEE
Q 003158 505 EMALATNNFNSSTQIGQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQM 583 (843)
Q Consensus 505 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 583 (843)
++...-+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445556676655544444568998875 45567788876543333445778888888774 334567788888888999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCcchhHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 003158 584 LVYEFMSNGTLRDQLSAKSKEPLGFAMRLSIALGSSRGILYLHTEA---------------------------------- 629 (843)
Q Consensus 584 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------- 629 (843)
+||++++|.++.+.... ......++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999888665421 1122335555666666666421
Q ss_pred ----------------------CCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 630 ----------------------DPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 630 ----------------------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
.+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1138999999999999987767799999875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=1.5e-08 Score=94.72 Aligned_cols=80 Identities=30% Similarity=0.358 Sum_probs=37.2
Q ss_pred CCCCCCceeeccCCCCCCCC--CcccCCCCCCcEEEcCCCCCCCCCCCc-cccCCCCCcEEEcCCCCCCCCCCC------
Q 003158 86 SRLPSLVHMLLDNNNLTGYL--PPELSELPKLLILQLDNNNFEGTTIPA-SYSNMSKLLKLSLRNCSLQGPMPD------ 156 (843)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~------ 156 (843)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+. ++. .+....+|+.|++++|.+......
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~--l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS--ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC--GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc--chhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 34455555555555554321 1233445555555555555542 121 222233455555555555543221
Q ss_pred --CCCCCCCCEEE
Q 003158 157 --LSRIPNLGYLD 167 (843)
Q Consensus 157 --~~~l~~L~~L~ 167 (843)
+..+|+|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 34556666654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.19 E-value=3.3e-08 Score=92.24 Aligned_cols=121 Identities=21% Similarity=0.159 Sum_probs=86.0
Q ss_pred CCCEEEccCCcCCccCccccCCCCCCcEEEcccCcCCccCccccccCCCCCEEEccCCccccCC--CcccCCCCCCceee
Q 003158 18 SLELLLLNGNELTGSLPEELGYLPKLDRIQIDQNYISGSLPKSFANLNKTRHFHMNNNSISGQI--PPELSRLPSLVHML 95 (843)
Q Consensus 18 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~ 95 (843)
+.+.|+++++... ..+..+..+..|+...|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 5667788766543 22445555666666666554 55566678999999999999998543 34467789999999
Q ss_pred ccCCCCCCCCCcccCCCCCCcEEEcCCCCCCCCCCC-------ccccCCCCCcEEE
Q 003158 96 LDNNNLTGYLPPELSELPKLLILQLDNNNFEGTTIP-------ASYSNMSKLLKLS 144 (843)
Q Consensus 96 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-------~~~~~l~~L~~L~ 144 (843)
|++|+|+...+-.+.....|+.|+|++|.+.. ... ..+..+++|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~-~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSD-TFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS-SSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCc-CcccchhHHHHHHHHCCCCCEEC
Confidence 99999996544344445679999999999975 222 2367789999885
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=1.8e-05 Score=78.85 Aligned_cols=74 Identities=23% Similarity=0.231 Sum_probs=54.0
Q ss_pred cccccCC-eeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccC--CcccceeeeeecCCcEEEEEecCCCCCH
Q 003158 518 QIGQGGY-GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHH--RNLVSLVGYCDEEGEQMLVYEFMSNGTL 594 (843)
Q Consensus 518 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~e~~~~gsL 594 (843)
.+..|.. +.||+...+++..+++|....... ..+..|...++.+.. -.+.+++++..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445554 578999888888899998765432 246678888877743 3356778888888899999999987665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.80 E-value=4.5e-06 Score=77.74 Aligned_cols=88 Identities=16% Similarity=0.182 Sum_probs=49.9
Q ss_pred CCCCCCEEEccCC-cCCcc----CccccCCCCCCcEEEcccCcCCcc----CccccccCCCCCEEEccCCccccC----C
Q 003158 15 NIKSLELLLLNGN-ELTGS----LPEELGYLPKLDRIQIDQNYISGS----LPKSFANLNKTRHFHMNNNSISGQ----I 81 (843)
Q Consensus 15 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~ 81 (843)
+.++|+.|+|+++ .++.. +-..+...+.|++|+|++|.++.. +...+...+.|++|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4467777777764 45522 334555666777777777777622 223344456667777776666532 1
Q ss_pred CcccCCCCCCceeeccCCCCC
Q 003158 82 PPELSRLPSLVHMLLDNNNLT 102 (843)
Q Consensus 82 ~~~l~~l~~L~~L~L~~N~l~ 102 (843)
-.++...++|++|+|++|++.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 223445555666666655544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.66 E-value=6.7e-06 Score=76.52 Aligned_cols=87 Identities=21% Similarity=0.221 Sum_probs=44.8
Q ss_pred CCCCCcEEEcccC-cCCcc----CccccccCCCCCEEEccCCccccC----CCcccCCCCCCceeeccCCCCCCC----C
Q 003158 39 YLPKLDRIQIDQN-YISGS----LPKSFANLNKTRHFHMNNNSISGQ----IPPELSRLPSLVHMLLDNNNLTGY----L 105 (843)
Q Consensus 39 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~ 105 (843)
+.+.|++|+|+++ .++.. +-..+...+.|++|+|++|.++.. +...+...+.|+.|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4566777777653 45421 223344556666666666666522 112233445666666666665521 1
Q ss_pred CcccCCCCCCcEEEcCCCCC
Q 003158 106 PPELSELPKLLILQLDNNNF 125 (843)
Q Consensus 106 ~~~~~~l~~L~~L~Ls~N~l 125 (843)
...+...+.|++|+|++|++
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSS
T ss_pred HHHHHhCCcCCEEECCCCcC
Confidence 22344445555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.38 E-value=0.00044 Score=73.30 Aligned_cols=75 Identities=19% Similarity=0.107 Sum_probs=47.9
Q ss_pred CcccccCCeeEEEEEeCC-CcEEEEEEeccC------C-hhhHHHHHHHHHHHHhcc-C--CcccceeeeeecCCcEEEE
Q 003158 517 TQIGQGGYGKVYKGILPD-GTVVAVKRAQEG------S-LQGEKEFLTEIQFLSRLH-H--RNLVSLVGYCDEEGEQMLV 585 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lV 585 (843)
+.||.|....||+....+ ++.|+||..... . .....+...|.+.|+.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 678999965421 1 112234567888887663 2 345555544 34566899
Q ss_pred EecCCCCC
Q 003158 586 YEFMSNGT 593 (843)
Q Consensus 586 ~e~~~~gs 593 (843)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.25 E-value=1.2e-05 Score=74.67 Aligned_cols=110 Identities=19% Similarity=0.197 Sum_probs=58.3
Q ss_pred cCCCCCCEEEccC-CcCCcc----CccccCCCCCCcEEEcccCcCCcc----CccccccCCCCCEEEccCCccccC----
Q 003158 14 GNIKSLELLLLNG-NELTGS----LPEELGYLPKLDRIQIDQNYISGS----LPKSFANLNKTRHFHMNNNSISGQ---- 80 (843)
Q Consensus 14 ~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~---- 80 (843)
.+.++|++|+|++ +.++.. +-.++...++|++|+|++|.++.. +...+...+.|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4557777777776 446522 334455667777777777777632 223344556677777777666522
Q ss_pred CCcccCCCCCCceeec--cCCCCCC----CCCcccCCCCCCcEEEcCCC
Q 003158 81 IPPELSRLPSLVHMLL--DNNNLTG----YLPPELSELPKLLILQLDNN 123 (843)
Q Consensus 81 ~~~~l~~l~~L~~L~L--~~N~l~~----~~~~~~~~l~~L~~L~Ls~N 123 (843)
+...+...++|+.++| ++|.+.. .+...+...+.|+.|+++.+
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 1233445555655433 3344432 11222334455555555443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.84 E-value=0.0029 Score=64.91 Aligned_cols=68 Identities=19% Similarity=0.183 Sum_probs=46.7
Q ss_pred eeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCcc--cceee-----eeecCCcEEEEEecCCCCC
Q 003158 525 GKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNL--VSLVG-----YCDEEGEQMLVYEFMSNGT 593 (843)
Q Consensus 525 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~-----~~~~~~~~~lV~e~~~~gs 593 (843)
-.||++..++|+.|++|+.... ....+++..|...+..+....+ +..+. .+...+..+.|+++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 4799999999999999998653 3345678889998888753322 11111 2234567789999997643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.81 E-value=5.7e-05 Score=69.84 Aligned_cols=113 Identities=15% Similarity=0.227 Sum_probs=57.3
Q ss_pred ccCCCCCCcEEEccc-CcCCcc----CccccccCCCCCEEEccCCccccCC----CcccCCCCCCceeeccCCCCCCC--
Q 003158 36 ELGYLPKLDRIQIDQ-NYISGS----LPKSFANLNKTRHFHMNNNSISGQI----PPELSRLPSLVHMLLDNNNLTGY-- 104 (843)
Q Consensus 36 ~~~~l~~L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~-- 104 (843)
...+.+.|++|+|++ +.++.. +-..+...++|++|+|++|.++... -..+...++++.+++++|.++..
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~ 91 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 91 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence 344567777777776 445522 2233445667777777777765332 12234456666666666666522
Q ss_pred --CCcccCCCCCCcEEEcC--CCCCCCC---CCCccccCCCCCcEEEcCCC
Q 003158 105 --LPPELSELPKLLILQLD--NNNFEGT---TIPASYSNMSKLLKLSLRNC 148 (843)
Q Consensus 105 --~~~~~~~l~~L~~L~Ls--~N~l~~~---~~~~~~~~l~~L~~L~L~~N 148 (843)
+...+...++|+.++|+ +|.+... .+...+...++|+.|++..+
T Consensus 92 ~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 92 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 12334445556554443 3444210 11223344555555555444
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.22 E-value=0.0081 Score=63.23 Aligned_cols=72 Identities=15% Similarity=0.156 Sum_probs=49.2
Q ss_pred CcccccCCeeEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHHhcc-CCcccceeeeeecCCcEEEEEe
Q 003158 517 TQIGQGGYGKVYKGILPD--------GTVVAVKRAQEGSLQGEKEFLTEIQFLSRLH-HRNLVSLVGYCDEEGEQMLVYE 587 (843)
Q Consensus 517 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e 587 (843)
+.|+.|-.-.+|+....+ .+.|.+++.... ...-...+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467778888999988653 356777776532 22334567999888885 4334577877753 68999
Q ss_pred cCCCCCH
Q 003158 588 FMSNGTL 594 (843)
Q Consensus 588 ~~~~gsL 594 (843)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.02 E-value=0.007 Score=61.47 Aligned_cols=157 Identities=10% Similarity=0.032 Sum_probs=84.6
Q ss_pred ccHHHHHHHHcCCCCCCcc-----cccCCeeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHHhccCCccc--cee
Q 003158 501 FTYGEMALATNNFNSSTQI-----GQGGYGKVYKGILPDGTVVAVKRAQEGSLQGEKEFLTEIQFLSRLHHRNLV--SLV 573 (843)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv--~l~ 573 (843)
.+.++++....+|.+.+.. ..|---+.|+....+|+ +++|+..... ..+++..|++++..+....+. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4556777777888775443 35555788998877665 7899886432 223556677777777533221 111
Q ss_pred e------eeecCCcEEEEEecCCCCCHHH--------------HHhhc---CCC----------------------Ccch
Q 003158 574 G------YCDEEGEQMLVYEFMSNGTLRD--------------QLSAK---SKE----------------------PLGF 608 (843)
Q Consensus 574 ~------~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~---~~~----------------------~l~~ 608 (843)
. +....+....++.++.+..... .++.. ... ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1122445667777776543310 01100 000 0011
Q ss_pred hHHHHHHHHHHHHHHHHhcC-CCCCEEeccCCCCcEEEcCCCcEEEeeccccc
Q 003158 609 AMRLSIALGSSRGILYLHTE-ADPPVFHRDIKASNILLDHKFTAKVADFGLSR 660 (843)
Q Consensus 609 ~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 660 (843)
......+..+...+.-.+.. -..++||+|+.++||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11112222222233333221 12349999999999999998877899999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.46 E-value=0.0011 Score=66.09 Aligned_cols=60 Identities=18% Similarity=0.231 Sum_probs=40.3
Q ss_pred hcccCCCCCCCHHHHHHHHHHhh-hhCC-CCCCCCCccccCCCCCCCCCCCCCccCCCCCcc
Q 003158 764 CCQDETDARPSMSEVMRELESIW-NMMP-ESDTKTPEFINSEHTSKEETPPSSSSMLKHPYV 823 (843)
Q Consensus 764 c~~~~p~~RPs~~~vl~~L~~~~-~~~~-~~~~~~~dll~~~L~~dp~~R~sa~e~L~Hp~f 823 (843)
|.-..|-.-.+..++...+..-. ...+ ..++.+.+|+++||+.||++|||++|+|+|||+
T Consensus 208 ~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 208 CALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 33444555556666655543321 1122 223446789999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.17 E-value=0.022 Score=56.89 Aligned_cols=16 Identities=0% Similarity=-0.228 Sum_probs=7.1
Q ss_pred ccCCCCCCCHHHHHHH
Q 003158 766 QDETDARPSMSEVMRE 781 (843)
Q Consensus 766 ~~~p~~RPs~~~vl~~ 781 (843)
-..|-...+..++.+.
T Consensus 206 g~~Pf~~~~~~~~~~~ 221 (288)
T d1uu3a_ 206 GLPPFRAGNEYLIFQK 221 (288)
T ss_dssp SSCSSCCSSHHHHHHH
T ss_pred CCCCCCCcCHHHHHHH
Confidence 3344444455554443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=84.50 E-value=0.53 Score=47.69 Aligned_cols=33 Identities=6% Similarity=0.125 Sum_probs=29.5
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003158 748 SYPSECVEKFIKLALKCCQDETDARPSMSEVMR 780 (843)
Q Consensus 748 ~~~~~~~~~l~~l~~~c~~~~p~~RPs~~~vl~ 780 (843)
..+...++++.+++.+|+..||.+|||++|+++
T Consensus 295 ~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 295 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp CCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred ccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 356778889999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.65 E-value=0.24 Score=47.96 Aligned_cols=55 Identities=16% Similarity=0.150 Sum_probs=38.9
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhh-CCCC-CCCCCccccCCCCCCCCCCCCCccCCCC
Q 003158 766 QDETDARPSMSEVMRELESIWNM-MPES-DTKTPEFINSEHTSKEETPPSSSSMLKH 820 (843)
Q Consensus 766 ~~~p~~RPs~~~vl~~L~~~~~~-~~~~-~~~~~dll~~~L~~dp~~R~sa~e~L~H 820 (843)
...|-..-+..++.+.+..-... .|.. .+.+.+|+.+|++.||++|||++|+++|
T Consensus 198 g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 198 GKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 45677777888877766653221 1111 2234589999999999999999999886
|